PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bellamy-Mclntyre, AK; Lay, CS; Bar, S; Maerz, AL; Talbo, GH; Drummer, HE; Poumbourios, P				Bellamy-Mclntyre, Anna K.; Lay, Chan-Sien; Baer, Severine; Maerz, Anne L.; Talbo, Gert H.; Drummer, Heidi E.; Poumbourios, Pantelis			Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 ENVELOPE GLYCOPROTEIN; VIRION-ASSOCIATED CHOLESTEROL; HUMAN MONOCLONAL-ANTIBODIES; CELL-CELL FUSION; HIV-1 GP41; INFLUENZA HEMAGGLUTININ; RECEPTOR-BINDING; EXTERNAL REGION; NEUTRALIZING ANTIBODIES; CONFORMATIONAL-CHANGES	The binding of CD4 and chemokine receptors to the gp120 attachment glycoprotein of human immunodeficiency virus triggers refolding of the associated gp41 fusion glycoprotein into a trimer of hairpins with a 6-helix bundle (6HB) core. These events lead to membrane fusion and viral entry. Here, we examined the functions of the fusion peptide-proximal polar segment and membrane-proximal Trp-rich region (MPR), which are exterior to the 6HB. Alanine substitution of Trp(666), Trp(672), Phe(673), and Ile(675) in the MPR reduced entry by up to 120-fold without affecting gp120-gp41 association or cell-cell fusion. The L537A polar segment mutation led to the loss of gp120 from the gp120-gp41 complex, reduced entry by similar to 10-fold, but did not affect cell-cell fusion. Simultaneous Ala substitution of Leu(537) with Trp(666), Trp(672), Phe(673), or Ile(675) abolished entry with 50-80% reductions in cell-cell fusion. gp120-gp41 complexes of fusion-defective double mutants were resistant to soluble CD4-induced shedding of gp120, suggesting that their ability to undergo receptorinduced conformational changes was compromised. Consistent with this idea, a representative mutation, L537A/W666A, led to an similar to 80% reduction in lipophilic fluorescent dye transfer between gp120-gp41-expressing cells and receptor-expressing targets, indicating a block prior to the lipid-mixing phase. The L537A/W666A double mutation increased the chymotrypsin sensitivity of the polar segment in a trimer of hairpins model, comprising the 6HB core, the polar segment, and MPR linked N-terminally to maltose-binding protein. The data indicate that the polar segment and MPR of gp41 act synergistically in forming a fusion-competent gp120-gp41 complex and in stabilizing the membrane-interactive end of the trimer of hairpins.	Macfarlane Burnet Inst Med Res & Publ Hlth, Prahran, Vic 3004, Australia; Monash Univ, Dept Microbiol, Clayton, Vic 3070, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3058, Australia; Inst Cochin, Dept Cell Biol, F-75014 Paris, France; Baker Heart Res Inst, Proteom Ctr, Melbourne, Vic 3004, Australia	Burnet Institute; Monash University; University of Melbourne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Baker Heart and Diabetes Institute	Poumbourios, P (corresponding author), 85 Commercial Rd, Melbourne, Vic 3004, Australia.	apoumbourios@burnet.edu.au	Bar, Severine/D-4060-2017; Bär, Séverine/AAC-4889-2019	Drummer, Heidi/0000-0002-0042-6277; Bar, Severine/0000-0003-2009-6110				ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; Basmaciogullari S, 2002, J VIROL, V76, P10791, DOI 10.1128/JVI.76.21.10791-10800.2002; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bjorndal A, 1997, J VIROL, V71, P7478; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; Borrego-Diaz E, 2003, VIROLOGY, V316, P234, DOI 10.1016/j.virol.2003.07.006; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chang DK, 1999, J BIOL CHEM, V274, P5299, DOI 10.1074/jbc.274.9.5299; Chang DK, 1997, J VIROL, V71, P6593, DOI 10.1128/JVI.71.9.6593-6602.1997; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Egashira M, 2002, BIOCHEMISTRY-US, V41, P4165, DOI 10.1021/bi011885+; Finnegan CM, 2002, J VIROL, V76, P12123, DOI 10.1128/JVI.76.23.12123-12134.2002; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; Gordon LM, 2002, BBA-BIOMEMBRANES, V1559, P96, DOI 10.1016/S0005-2736(01)00443-6; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; HAIGWOOD NL, 1990, AIDS RES HUM RETROV, V6, P855, DOI 10.1089/aid.1990.6.855; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Jaroniec CP, 2005, BIOCHEMISTRY-US, V44, P16167, DOI 10.1021/bi051672a; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lay CS, 2004, FEBS LETT, V567, P183, DOI 10.1016/j.febslet.2004.04.054; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Lorizate M, 2006, BIOCHEMISTRY-US, V45, P14337, DOI 10.1021/bi0612521; Lorizate M, 2006, J MOL BIOL, V360, P45, DOI 10.1016/j.jmb.2006.04.056; Lorizate M, 2006, J BIOL CHEM, V281, P39598, DOI 10.1074/jbc.M605998200; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; MYERS R, 1993, 93 GEN M AM SOC MICR; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Park HE, 2003, NAT STRUCT BIOL, V10, P1048, DOI 10.1038/nsb1012; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Poumbourios P, 1997, J VIROL, V71, P2041, DOI 10.1128/JVI.71.3.2041-2049.1997; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; POUMBOURIOS P, 1995, J VIROL, V69, P1209, DOI 10.1128/JVI.69.2.1209-1218.1995; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Sackett K, 2005, J MOL BIOL, V350, P790, DOI 10.1016/j.jmb.2005.05.030; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Saez-Cirion A, 2002, J BIOL CHEM, V277, P21776, DOI 10.1074/jbc.M202255200; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SATTENTAU QJ, 1995, VIROLOGY, V206, P713, DOI 10.1016/S0042-6822(95)80094-8; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Shnaper S, 2004, J BIOL CHEM, V279, P18526, DOI 10.1074/jbc.M304950200; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Takikawa S, 2000, J VIROL, V74, P5066, DOI 10.1128/JVI.74.11.5066-5074.2000; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; WILLEY RL, 1994, J VIROL, V68, P1029, DOI 10.1128/JVI.68.2.1029-1039.1994; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Yang XZ, 2006, J VIROL, V80, P4388, DOI 10.1128/JVI.80.9.4388-4395.2006; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	96	65	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23104	23116		10.1074/jbc.M703485200	http://dx.doi.org/10.1074/jbc.M703485200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17526486	hybrid			2022-12-27	WOS:000248577500013
J	Tanneberger, K; Kirchberger, J; Bar, J; Schellenberger, W; Rothemund, S; Kamprad, M; Otto, H; Schoneberg, T; Edelmann, A				Tanneberger, Katrin; Kirchberger, Juergen; Bar, Joerg; Schellenberger, Wolfgang; Rothemund, Sven; Kamprad, Manja; Otto, Henning; Schoeneberg, Torsten; Edelmann, Anke			A novel form of 6-phosphofructokinase - Identification and functional relevance of a third type of subunit in pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PHOSPHOFRUCTOKINASE; FRUCTOSE 2,6-BISPHOSPHATE; CARBOHYDRATE-METABOLISM; FLOCCULATION; EVOLUTION; GENE; PURIFICATION; GLYCOLYSIS; PROTEINS	Classically, 6-phosphofructokinases are homo-and heterooligomeric enzymes consisting of alpha subunits and alpha/beta subunits, respectively. Herein, we describe a new form of 6-phosphofructokinase (Pfk) present in several Pichia species, which is composed of three different types of subunit, alpha,beta, and gamma. The sequence of the gamma subunit shows no similarity to classic Pfk subunits or to other known protein sequences. In-depth structural and functional studies revealed that the gamma subunit is a constitutive component of Pfk from Pichia pastoris (PpPfk). Analyses of the purified PpPfk suggest a heterododecameric assembly from the three different subunits. Accordingly, it is the largest and most complex Pfk identified yet. Although, the gamma subunit is not required for enzymatic activity, the gamma subunit-deficient mutant displays a decreased growth on nutrient limitation and reduced cell flocculation when compared with the P. pastoris wild-type strain. Subsequent characterization of purified Pfks from wildtype and gamma subunit-deficient strains revealed that the allosteric regulation of the PpPfk by ATP, fructose 2,6-bisphosphate, and AMP is fine-tuned by the gamma subunit. Therefore, we suggest that the gamma subunit contributes to adaptation of P. pastoris to energy resources.	Univ Leipzig, Fac Med, Inst Biochem, D-04103 Leipzig, Germany; Univ Leipzig, Fac Med, IZKF Core Unit Peptide Technol, D-04103 Leipzig, Germany; Univ Leipzig, Fac Med, Inst Clin Immunol & Transfus Med, D-04103 Leipzig, Germany; Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Leipzig University; Leipzig University; Leipzig University; Free University of Berlin	Edelmann, A (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Kamprad, Manja/B-2222-2008					Alves AMCR, 2001, J BACTERIOL, V183, P7231, DOI 10.1128/JB.183.24.7231-7240.2001; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Bapteste E, 2003, GENE, V318, P185, DOI 10.1016/S0378-1119(03)00797-2; Bar J, 1997, YEAST, V13, P1309, DOI 10.1002/(SICI)1097-0061(199711)13:14<1309::AID-YEA181>3.0.CO;2-#; Bar J, 2000, BIOCHEMISTRY-US, V39, P6960, DOI 10.1021/bi9928142; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; BARTRONS R, 1982, FEBS LETT, V143, P137, DOI 10.1016/0014-5793(82)80290-1; Bony M, 1998, YEAST, V14, P25, DOI 10.1002/(SICI)1097-0061(19980115)14:1<25::AID-YEA197>3.3.CO;2-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLIFTON D, 1978, GENETICS, V88, P1; Dlauchy D, 2003, ANTON LEEUW INT J G, V83, P327, DOI 10.1023/A:1023318829389; Edelmann A, 2005, J CLIN MICROBIOL, V43, P6164, DOI 10.1128/JCM.43.12.6164-6166.2005; Edelmann A, 2002, YEAST, V19, P949, DOI 10.1002/yea.889; EVANS PR, 1979, NATURE, V279, P500, DOI 10.1038/279500a0; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; FERNANDES PA, 1993, YEAST, V9, P859, DOI 10.1002/yea.320090806; Flores CL, 2005, MICROBIOL-SGM, V151, P1465, DOI 10.1099/mic.0.27856-0; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; FOE LG, 1985, J BIOL CHEM, V260, P726; Fraenkel DG, 2003, CURR OPIN MICROBIOL, V6, P198, DOI 10.1016/S1369-5274(03)00023-7; GANCEDO JM, 1973, BIOCHIMIE, V55, P205, DOI 10.1016/S0300-9084(73)80393-1; HEINISCH J, 1989, GENE, V78, P309; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; HERS HG, 1982, BIOCHEM J, V206, P1; HOFMANN E, 1982, METHOD ENZYMOL, V90, P49; HOFMANN E, 1976, REV PHYSIOL BIOCH P, V75, P1, DOI 10.1007/BFb0030484; HOLLAND MJ, 1987, MOL CELL BIOL, V7, P813, DOI 10.1128/MCB.7.2.813; HUSE K, 1988, FEBS LETT, V234, P185, DOI 10.1016/0014-5793(88)81330-9; HUSE K, 1983, FEBS LETT, V155, P50, DOI 10.1016/0014-5793(83)80207-5; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; Kirchberger J, 2002, YEAST, V19, P933, DOI 10.1002/yea.885; KIRSCHENBAUM DM, 1973, ANAL BIOCHEM, V56, P237, DOI 10.1016/0003-2697(73)90186-3; Klinder A, 1998, YEAST, V14, P323, DOI 10.1002/(SICI)1097-0061(19980315)14:4<323::AID-YEA223>3.0.CO;2-W; KOPPERSCHLAGER G, 1995, FEBS LETT, V363, P17, DOI 10.1016/0014-5793(95)00269-F; KOPPERSCHLAGER G, 1992, PROTEIN INTERACTIONS, P345; KOPPERSCHLAGER G, 1977, EUR J BIOCHEM, V81, P317, DOI 10.1111/j.1432-1033.1977.tb11954.x; Kricke J, 1999, INT J BIOL MACROMOL, V24, P27, DOI 10.1016/S0141-8130(98)00063-4; Larsson C, 2000, YEAST, V16, P797, DOI 10.1002/1097-0061(20000630)16:9<797::AID-YEA553>3.3.CO;2-X; MBAWALA A, 1990, J GEN MICROBIOL, V136, P1279, DOI 10.1099/00221287-136-7-1279; MOORE PA, 1991, MOL CELL BIOL, V11, P5330, DOI 10.1128/MCB.11.10.5330; Muller M, 2001, J BACTERIOL, V183, P6714, DOI 10.1128/JB.183.22.6714-6716.2001; Nakagawa T, 2000, APPL ENVIRON MICROB, V66, P4253, DOI 10.1128/AEM.66.10.4253-4257.2000; NISSLER K, 1983, BIOCHEM BIOPH RES CO, V111, P294, DOI 10.1016/S0006-291X(83)80150-8; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Pearce AK, 2001, MICROBIOL-SGM, V147, P391, DOI 10.1099/00221287-147-2-391; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Rais B, 2000, BBA-PROTEIN STRUCT M, V1479, P303, DOI 10.1016/S0167-4838(00)00047-9; Rakus D, 2004, BIOCHEMISTRY-US, V43, P14948, DOI 10.1021/bi048886x; Reuter R, 2000, YEAST, V16, P1273, DOI 10.1002/1097-0061(200010)16:14<1273::AID-YEA621>3.3.CO;2-R; Ruiz T, 2003, J STRUCT BIOL, V143, P124, DOI 10.1016/S1047-8477(03)00140-0; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Sampermans S, 2005, J APPL MICROBIOL, V98, P525, DOI 10.1111/j.1365-2672.2004.02486.x; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Schroter A, 1996, FEMS MICROBIOL LETT, V142, P247; Schwock J, 2004, YEAST, V21, P483, DOI 10.1002/yea.1114; SHEN LC, 1968, BIOCHEMISTRY-US, V7, P4041, DOI 10.1021/bi00851a035; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; SIERKSTRA LN, 1992, J GEN MICROBIOL, V138, P2559, DOI 10.1099/00221287-138-12-2559; Slamovits CH, 2006, EUKARYOT CELL, V5, P148, DOI 10.1128/EC.5.1.148-154.2006; Spivey HO, 1999, METHODS, V19, P306, DOI 10.1006/meth.1999.0858; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yuan WP, 1997, J CELL SCI, V110, P1935	66	11	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23687	23697		10.1074/jbc.M611547200	http://dx.doi.org/10.1074/jbc.M611547200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17522059	hybrid			2022-12-27	WOS:000248577500072
J	Wada, M; DeLong, CJ; Hong, YH; Rieke, CJ; Song, I; Sidhu, RS; Yuan, C; Warnock, M; Schmaier, AH; Yokoyama, C; Smyth, EM; Wilson, SJ; FitzGerald, GA; Garavito, M; Sui, DX; Regan, JW; Smith, WL				Wada, Masayuki; DeLong, Cynthia J.; Hong, Yu H.; Rieke, Caroline J.; Song, Inseok; Sidhu, Ranjinder S.; Yuan, Chong; Warnock, Mark; Schmaier, Alvin H.; Yokoyama, Chieko; Smyth, Emer M.; Wilson, Stephen J.; FitzGerald, Garret A.; Garavito, Michael; Sui, De Xin; Regan, John W.; Smith, William L.			Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYTOSOLIC PHOSPHOLIPASE A(2); POLYUNSATURATED FATTY-ACIDS; ENDOPEROXIDE-H SYNTHASE-1; CORONARY-HEART-DISEASE; PROTEIN-KINASE-C; CYCLOOXYGENASE ACTIVITIES; DOCOSAHEXAENOIC ACID; FISH CONSUMPTION; MICE LACKING; VASCULAR-PERMEABILITY	Dietary fish oil containing omega 3 highly unsaturated fatty acids has cardioprotective and anti-inflammatory effects. Prostaglandins ( PGs) and thromboxanes are produced in vivo both from the omega 6 fatty acid arachidonic acid (AA) and the omega 3 fatty acid eicosapentaenoic acid (EPA). Certain beneficial effects of fish oil may result from altered PG metabolism resulting from increases in the EPA/AA ratios of precursor phospholipids. Here we report in vitro specificities of prostanoid enzymes and receptors toward EPA-derived, 3-series versus AA-derived, 2-series prostanoid substrates and products. The largest difference was seen with PG endoperoxide H synthase ( PGHS)-1. Under optimal conditions purified PGHS-1 oxygenates EPA with only 10% of the efficiency of AA, and EPA significantly inhibits AA oxygenation by PGHS-1. Two- to 3-fold higher activities or potencies with 2-series versus 3-series compounds were observed with PGHS-2, PGD synthases, microsomal PGE synthase-1 and EP1, EP2, EP3, and FP receptors. Our most surprising observation was that AA oxygenation by PGHS-2 is only modestly inhibited by EPA (i.e. PGHS-2 exhibits a marked preference for AA when EPA and AA are tested together). Also unexpectedly, TxA(3) is about equipotent to TxA(2) at the TP alpha receptor. Our biochemical data predict that increasing phospholipidEPA/AA ratios in cells would dampen prostanoid signaling with the largest effects being on PGHS-1 pathways involving PGD, PGE, and PGF. Production of 2-series prostanoids from AA by PGHS-2 would be expected to decrease in proportion to the compensatory decrease in the AA content of phospholipids that would result from increased incorporation of omega 3 fatty acids such as EPA.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, 21st Century Ctr Excellence Program, Tokyo 1138549, Japan; Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48109 USA; Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Case Western Reserve University; Tokyo Medical & Dental University (TMDU); University of Pennsylvania; Pennsylvania Medicine; Michigan State University; University of Arizona	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 Med Sci Res Bldg III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@umich.edu	FitzGerald, Garret A/A-4222-2010; Schmaier, Alvin/AAM-1063-2020	Schmaier, Alvin/0000-0002-3884-6234; DeLong, Cynthia/0000-0002-6823-8619	NHLBI NIH HHS [HL075993, HL56773] Funding Source: Medline; NIGMS NIH HHS [GM68848] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL075993, R01HL056773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTI M, 1992, GASTROENTEROLOGY, V103, P883, DOI 10.1016/0016-5085(92)90021-P; Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bortuzzo C, 1996, BBA-LIPID LIPID MET, V1300, P240, DOI 10.1016/0005-2760(96)00003-3; Boulet L, 2004, J BIOL CHEM, V279, P23229, DOI 10.1074/jbc.M400443200; BRADEN GA, 1990, CIRCULATION, V82, P178, DOI 10.1161/01.CIR.82.1.178; Burr G, 1932, J BIOL CHEM, V97, P1; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; CAPDEVILA JH, 1995, BIOCHEMISTRY-US, V34, P3325, DOI 10.1021/bi00010a023; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; De Caterina R, 2001, LIPIDS, V36, pS69, DOI 10.1007/s11745-001-0685-9; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; FISHER SK, 1989, MOL PHARMACOL, V35, P195; Fujino H, 2000, J BIOL CHEM, V275, P29907, DOI 10.1074/jbc.M003467200; Fujino H, 2006, MOL PHARMACOL, V69, P13, DOI 10.1124/mol.105.017749; Fujino H, 2002, J BIOL CHEM, V277, P48786, DOI 10.1074/jbc.M209393200; FUNK CD, 1993, J BIOL CHEM, V268, P26767; Gao L, 2006, J BIOL CHEM, V281, P14092, DOI 10.1074/jbc.M601035200; Gawrisch K, 2003, LIPIDS, V38, P445, DOI 10.1007/s11745-003-1082-0; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; GLOMSET JA, 2006, SCI STKE, pE6; Goulet JL, 2004, J IMMUNOL, V173, P1321, DOI 10.4049/jimmunol.173.2.1321; HANEL AM, 1993, BIOCHEMISTRY-US, V32, P5949, DOI 10.1021/bi00074a005; HANSEN HS, 1983, LIPIDS, V18, P682, DOI 10.1007/BF02534534; HECKER M, 1989, J BIOL CHEM, V264, P141; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Huang YC, 1996, LIPIDS, V31, pS313, DOI 10.1007/BF02637099; Jho David H, 2004, Integr Cancer Ther, V3, P98, DOI 10.1177/1534735404264736; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kieran NE, 2004, KIDNEY INT, V65, P1145, DOI 10.1111/j.1523-1755.2004.00487.x; Kobzar G, 2001, CELL PHYSIOL BIOCHEM, V11, P279, DOI 10.1159/000047814; Kotani M, 1997, GENOMICS, V40, P425, DOI 10.1006/geno.1996.4585; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, pE20, DOI 10.1161/01.ATV.0000038493.65177.94; KROMHOUT D, 1995, INT J EPIDEMIOL, V24, P340, DOI 10.1093/ije/24.2.340; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Kulmacz RJ, 2005, BIOCHEM BIOPH RES CO, V338, P25, DOI 10.1016/j.bbrc.2005.08.030; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; LANDS WEM, 1992, BIOCHIM BIOPHYS ACTA, V1180, P147, DOI 10.1016/0925-4439(92)90063-S; LANDS WEM, 1973, ADV BIOSCI, V9, P15; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Liu W, 2006, FASEB J, V20, P1097, DOI 10.1096/fj.05-5273com; MAHADEVAPPA VG, 1987, J LIPID RES, V28, P1275; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mitchell DC, 2003, J PEDIATR-US, V143, pS80, DOI 10.1067/S0022-3476(03)00405-0; MOHRHAUER H, 1963, J LIPID RES, V4, P151; Monneret G, 2003, J PHARMACOL EXP THER, V304, P349, DOI 10.1124/jpet.102.042937; MORITA I, 1983, J BIOL CHEM, V258, P197; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2002, PROSTAG OTH LIPID M, V68-9, P383, DOI 10.1016/S0090-6980(02)00043-6; Murakami M, 2006, CURR PHARM DESIGN, V12, P943, DOI 10.2174/138161206776055912; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; NEEDLEMAN P, 1979, P NATL ACAD SCI USA, V76, P944, DOI 10.1073/pnas.76.2.944; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Ouellet M, 2002, PROTEIN EXPRES PURIF, V26, P489, DOI 10.1016/S1046-5928(02)00566-1; Pessach I, 2001, J BIOL CHEM, V276, P33495, DOI 10.1074/jbc.M011417200; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Petrik MBH, 2000, J NUTR, V130, P1153, DOI 10.1093/jn/130.5.1153; Pinzar E, 2000, J BIOL CHEM, V275, P31239, DOI 10.1074/jbc.M000750200; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; Quackenbush FW, 1942, J NUTR, V24, P213, DOI 10.1093/jn/24.3.213; REDDY ST, 1994, J BIOL CHEM, V269, P15473; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Schachter JB, 1996, BBA-GEN SUBJECTS, V1291, P167, DOI 10.1016/0304-4165(96)00063-3; Schneider A, 2004, KIDNEY INT, V65, P1205, DOI 10.1111/j.1523-1755.2004.00493.x; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; SHIKANO M, 1994, BBA-LIPID LIPID MET, V1212, P211, DOI 10.1016/0005-2760(94)90255-0; Smith W.L., 2002, BIOCH LIPIDS LIPOPRO; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; TANAKA Y, 1987, J BIOL CHEM, V262, P1374; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; URADE Y, 1987, J BIOL CHEM, V262, P3820; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1995, J BIOL CHEM, V270, P1422, DOI 10.1074/jbc.270.3.1422; Waclawik A, 2006, ENDOCRINOLOGY, V147, P210, DOI 10.1210/en.2005-0880; Wada M, 2004, J BIOCHEM, V135, P455, DOI 10.1093/jb/mvh059; Wang Y, 2002, J AM CHEM SOC, V124, P7690, DOI 10.1021/ja0200488; Watanabe K, 2002, PROSTAG OTH LIPID M, V68-9, P401, DOI 10.1016/S0090-6980(02)00044-8; WHITAKER MO, 1979, P NATL ACAD SCI USA, V76, P5919, DOI 10.1073/pnas.76.11.5919; Wilson SJ, 2006, J BIOL CHEM, V281, P11780, DOI 10.1074/jbc.M513110200; YOKOYAMA C, 1993, FEBS LETT, V318, P91, DOI 10.1016/0014-5793(93)81335-W; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Zeyda M, 2002, J BIOL CHEM, V277, P28418, DOI 10.1074/jbc.M203343200; Zhang JJ, 1999, PREV MED, V28, P520, DOI 10.1006/pmed.1998.0472; Zhang L, 2006, MOL PHARMACOL, V69, P1433, DOI 10.1124/mol.105.019703	120	308	368	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22254	22266		10.1074/jbc.M703169200	http://dx.doi.org/10.1074/jbc.M703169200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17519235	hybrid			2022-12-27	WOS:000248354200003
J	Abbott, RJM; Spendlove, I; Roversi, P; Fitzgibbon, H; Knott, V; Teriete, P; McDonnell, JM; Handford, PA; Lea, SM				Abbott, Rachel J. M.; Spendlove, Ian; Roversi, Pietro; Fitzgibbon, Hannah; Knott, Vroni; Teriete, Peter; McDonnell, James M.; Handford, Penny A.; Lea, Susan M.			Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECAY-ACCELERATING FACTOR; 7-SPAN TRANSMEMBRANE MOLECULE; ACTIVATION ANTIGEN CD97; EGF-TM7 RECEPTOR; LIGAND CD55; MAXIMUM-LIKELIHOOD; EXPRESSION; DOMAIN; EMR2; REFINEMENT	CD97, the archetypal member of the EGF-TM7 protein family, is constitutively expressed on granulocytes and monocytes and rapidly up-regulated on T and B cells following activation. The key isoform of CD97 expressed on leukocytes binds the complement regulatory protein CD55 (also termed decay-accelerating factor). CD97 has been shown recently to mediate co-stimulation of T cells via CD55. Here, we demonstrate that blocking the interaction between CD55 on monocytes and CD97 on T cells leads to inhibition of proliferation and interferon-gamma secretion. This implies that bidirectional interactions between CD97 and CD55 are involved in T cell regulation. Structural studies presented here reveal the molecular basis for this activity. We have solved the structure of EMR2, a very close homolog of CD97, using x-ray crystallography. NMR-based chemical shift mapping of the EMR2-CD55 interaction has allowed us to generate a model for the CD97-CD55 complex. The structure of the complex reveals that the T cell and complement regulatory activities of CD55 occur on opposite faces of the molecule. This suggests that CD55 might simultaneously regulate both the innate and adaptive immune responses, and we have shown that CD55 can still regulate complement when bound to CD97.	Univ Nottingham, City Hosp, Sch Mol Med Sci, Acad Clin Oncol, Nottingham NG5 1PB, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Oxford; University of Oxford	Lea, SM (corresponding author), Univ Nottingham, City Hosp, Sch Mol Med Sci, Acad Clin Oncol, Hucknall Rd, Nottingham NG5 1PB, England.	susan.lea@path.ox.ac.uk	Roversi, Pietro/F-8925-2011; Teriete, Peter/N-3331-2014; Roversi, Pietro/AAK-4241-2021; Lea, Susan M/B-7678-2009	Roversi, Pietro/0000-0001-9280-9437; Teriete, Peter/0000-0003-3692-9308; Roversi, Pietro/0000-0001-9280-9437; Lea, Susan M/0000-0001-9287-8053; McDonnell, James/0000-0001-9037-2980; Abbott, Rachel/0000-0003-1902-1429; Spendlove, Ian/0000-0002-7480-3768	Medical Research Council [G0400775] Funding Source: Medline; Medical Research Council [G0400503B] Funding Source: researchfish; MRC [G0400775] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbott RJM, 2004, ACTA CRYSTALLOGR D, V60, P936, DOI 10.1107/S0907444904005098; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aust G, 2002, AM J CLIN PATHOL, V118, P699; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Capasso M, 2006, J IMMUNOL, V177, P1070, DOI 10.4049/jimmunol.177.2.1070; Chang GW, 2007, BIOCHEM BIOPH RES CO, V353, P133, DOI 10.1016/j.bbrc.2006.11.148; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eichler W, 1997, TISSUE ANTIGENS, V50, P429, DOI 10.1111/j.1399-0039.1997.tb02897.x; Freedman SJ, 1996, BIOCHEMISTRY-US, V35, P13733, DOI 10.1021/bi9610257; Gray JX, 1996, J IMMUNOL, V157, P5438; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hamann J, 1999, ARTHRITIS RHEUM-US, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hamann J, 1996, GENOMICS, V32, P144, DOI 10.1006/geno.1996.0092; Hubbard S. J., 1993, NACCESS; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Jaspars LH, 2001, TISSUE ANTIGENS, V57, P325, DOI 10.1034/j.1399-0039.2001.057004325.x; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kwakkenbos MJ, 2005, J LEUKOCYTE BIOL, V77, P112, DOI 10.1189/jlb.0704402; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lesk A.M., 2004, INTRO PROTEIN SCI AR, V2; Li L, 2001, BRIT J CANCER, V84, P80, DOI 10.1054/bjoc.2000.1570; Lin HH, 2001, J BIOL CHEM, V276, P24160, DOI 10.1074/jbc.M101770200; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POST TW, 1990, J IMMUNOL, V144, P740; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Stacey M, 2001, J BIOL CHEM, V276, P18863, DOI 10.1074/jbc.M101147200; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Visser L, 2002, J NEUROIMMUNOL, V132, P156, DOI 10.1016/S0165-5728(02)00306-5; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; White J, 2004, PROTEIN SCI, V13, P2406, DOI 10.1110/ps.03455604	42	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22023	22032		10.1074/jbc.M702588200	http://dx.doi.org/10.1074/jbc.M702588200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17449467	hybrid			2022-12-27	WOS:000248196800049
J	Kim, T; Buratowski, S				Kim, TaeSoo; Buratowski, Stephen			Two Saccharomyces cerevisiae JmjC domain proteins demethylate histone H3 Lys(36) in transcribed regions to promote elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DOMAIN; PHD FINGER; METHYLATION; SET2; METHYLTRANSFERASE; PHOSPHORYLATION; KINASE; YEAST; BUR1; TRIMETHYLATION	Histone methylation is a reversible modification regulated by the antagonistic functions of residue-specific histone methyl-transferases and demethylases. Although methylation of histone H3 at lysines 4 and 36 is linked to transcription, the roles of histone demethylases in transcription regulation are not understood. Here we show that overexpression of either Jhd1 or Rph1, two JmjC-domain proteins, bypasses the requirement for the positive elongation factor gene BUR1. Biochemical analysis and chromatin immunoprecipitation experiments indicate that Rph1 functions as a specific demethylase for H3 K36me3 and K36me2, directly regulating Lys(36) methylation in transcribed regions. Both Jhd1 and Rph1 are required for normal levels of RNA polymerase II cross-linking to genes. Taken together, these findings indicate that a general function of histone demethylases for H3 Lys(36) is to promote transcription elongation by antagonizing repressive Lys(36) methylation by Set2.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	SteveB@hms.harvard.edu		Kim, TaeSoo/0000-0002-3902-1058	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, R29GM046498] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Dyson MH, 2001, FRONT BIOSCI, V6, pD853, DOI 10.2741/Dyson; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Howe L, 2002, MOL CELL BIOL, V22, P5047, DOI 10.1128/MCB.22.14.5047-5053.2002; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; HUARTE M, 2007, J BIOL CHEM     0605, DOI DOI 10.1074/JBCM703897200; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kim EM, 2002, NUCLEIC ACIDS RES, V30, P643, DOI 10.1093/nar/30.3.643; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; PRELICH G, 1993, GENETICS, V135, P665; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	56	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20827	20835		10.1074/jbc.M703034200	http://dx.doi.org/10.1074/jbc.M703034200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17525156	hybrid			2022-12-27	WOS:000248047500008
J	Maryon, EB; Molloy, SA; Kaplan, JH				Maryon, Edward B.; Molloy, Shannon A.; Kaplan, Jack H.			O-linked glycosylation at threonine 27 protects the copper transporter hCTR1 from proteolytic cleavage in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; MUCIN TANDEM REPEAT; BIOCHEMICAL-CHARACTERIZATION; CTR1; EXPRESSION; MECHANISM; SITE; LOCALIZATION; GENERATION; INTERACTS	The major human copper uptake protein, hCTR1, has 190 amino acids and a predicted mass of 21 kDa. hCTR1 antibodies recognize multiple bands in SDS-PAGE centered at 35 kDa. Part of this increased mass is due to N-linked glycosylation at Asn-15. We show that in mammalian cells the N15Q mutant protein trafficked to the plasma membrane and mediated copper uptake at 75% of the rate of wild-type hCTR1. We demonstrate that the extracellular amino terminus of hCTR1 also contains O-linked polysaccharides. Glycosidase treatment that removed O-linked sugars reduced the apparent mass of hCTR1 or N15Q mutant protein by 1-2 kDa. Expression of amino-terminal truncations and alanine substitution mutants of hCTR1 in HEK293 and MDCK cells localized the site of O-linked glycosylation to Thr27. Expression of alanine substitutions at Thr-27 resulted in proteolytic cleavage of hCTR1 on the carboxyl side of the T27A mutations. This cleavage produced a 17-kDa polypeptide missing approximately the first 30 amino acids of hCTR1. Expression of wild-type hCTR1 in mutant Chinese hamster ovary cells that were unable to initiate O-glycosylation also resulted in hCTR1 cleavage to produce the 17-kDa polypeptide. The 17-kDa hCTR1 polypeptide was located in the plasma membrane and mediated copper uptake at about 50% that of the rate of wildtype hCTR1. Thus, O-linked glycosylation at Thr-27 is necessary to prevent proteolytic cleavage that removes half of the extracellular amino terminus of hCTR1 and significantly impairs transport activity of the remaining polypeptide.	Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574				Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chesneau V, 2003, J BIOL CHEM, V278, P22331, DOI 10.1074/jbc.M302781200; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Dassler K, 2006, J BIOL CHEM, V281, P3297, DOI 10.1074/jbc.M511341200; Dello Sbarba P, 2002, BIOL CHEM, V383, P69; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Gatto C, 2001, AM J PHYSIOL-CELL PH, V281, pC982, DOI 10.1152/ajpcell.2001.281.3.C982; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 2002, J BIOL CHEM, V277, P7736, DOI 10.1074/jbc.M111690200; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; Hardman B, 2006, PLACENTA, V27, P968, DOI 10.1016/j.placenta.2005.10.011; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Klomp AEM, 2003, BIOCHEM J, V370, P881, DOI 10.1042/BJ20021128; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; KOZARSKY KF, 1988, MOL CELL BIOL, V8, P3357, DOI 10.1128/MCB.8.8.3357; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Leuenberger B, 2003, BIOCHEM J, V369, P659, DOI 10.1042/BJ20021398; Linder MC, 2001, MUTAT RES-FUND MOL M, V475, P141, DOI 10.1016/S0027-5107(01)00076-8; Linder MC, 1996, AM J CLIN NUTR, V63, P797; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; REMALEY AT, 1991, J BIOL CHEM, V266, P24176; RUTLEDGE EA, 1994, BLOOD, V83, P580; RUTLEDGE EA, 1994, J BIOL CHEM, V269, P31864; TAYLOR KE, 2004, INTRO GLYOBIOLOGY, P58; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	44	68	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20376	20387		10.1074/jbc.M701806200	http://dx.doi.org/10.1074/jbc.M701806200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17525160	hybrid			2022-12-27	WOS:000247819300040
J	Zhou, RF; Patel, SV; Snyder, PM				Zhou, Ruifeng; Patel, Saumil V.; Snyder, Peter M.			Nedd4-2 catalyzes ubiquitination and degradation of cell surface ENaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; LIDDLES-SYNDROME; SODIUM-CHANNEL; PROTEIN LIGASE; EXPRESSION; PHOSPHORYLATION; INHIBITION; SERUM; ENDOCYTOSIS; MECHANISM	Epithelial Na+ absorption is regulated by Nedd4-2, an E3 ubiquitin-protein ligase that reduces expression of the epithelial Na+ channel ENaC at the cell surface. Defects in this regulation cause Liddle syndrome, an inherited form of hypertension. Previous work found that Nedd4-2 binds to ENaC via PY motifs located in the C termini of alpha-, beta-, and gamma ENaC. However, little is known about the mechanism by which Nedd4-2 regulates ENaC surface expression. Here we found that Nedd4-2 catalyzes ubiquitination of alpha-, beta-, and gamma ENaC; Nedd4-2 overexpression increased ubiquitination, whereas Nedd4-2 silencing decreased ubiquitination. Although Nedd4-2 increased both mono/oligoubiquitinated and multiubiquitinated forms of ENaC, monoubiquitination was sufficient for Nedd4-2 to reduce ENaC surface expression and reduce ENaC current. Ubiquitination was disrupted by Liddle syndrome-associated mutations in ENaC or mutation of the catalytic HECT domain in Nedd4-2. Several findings suggest that the interaction between Nedd4-2 and ENaC is localized to the cell surface. First, Nedd4-2 bound to a population of ENaC at the cell surface. Second, Nedd4-2 catalyzed ubiquitination of cell surface ENaC. Third, Nedd4-2 selectively reduced ENaC expression at the cell surface but did not alter the quantity of immature ENaC in the biosynthetic pathway. Finally, Nedd4-2 induced degradation of the cell surface pool of ENaC. Together, the data suggest a model in which Nedd4-2 binds to and ubiquitinates ENaC at the cell surface, which targets surface ENaC for degradation, and thus, reduces epithelial Na+ transport.	Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Coll Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu						BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Itani OA, 2005, AM J PHYSIOL-RENAL, V289, pF334, DOI 10.1152/ajprenal.00394.2004; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	27	158	161	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20207	20212		10.1074/jbc.M611329200	http://dx.doi.org/10.1074/jbc.M611329200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502380	hybrid			2022-12-27	WOS:000247819300022
J	Ko, MH; Puglielli, L				Ko, Mi Hee; Puglielli, Luigi			The sterol carrier protein SCP-x/Pro-SCP-2 gene has transcriptional activity and regulates the Alzheimer disease gamma-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PEPTIDE GENERATION; BINDING-SITE; MEMBRANE; DOMAIN; CELLS; IDENTIFICATION; LOCALIZATION; RESOLUTION; PROMOTER; RECEPTOR	The sterol carrier protein SCP-x/pro-SCP-2 gene is a fusion gene having two initiation sites that generate a long (SCP-x; 58.9-kDa) and a short (pro-SCP- 2; 15.4-kDa) product, both containing the common SCP-2 module at the C terminus. Here, we show that SCP-x is processed on the peroxisomal surface to liberate a short C-terminal product of 12.9 kDa. This fragment has DNA binding activity in vivo and in vitro, as assessed by chromatin immunoprecipitation analysis, DNA-protein pull-down, electrophoretic mobility shift assay, and luciferase reporter activity. In addition, it is preferentially found in the nucleus where it regulates the transcription of CD147, the regulatory subunit of the Alzheimer disease gamma-secretase. Overexpression of SCP-x increased, whereas antisense oligonucleotides against scp-x decreased, the generation of the above transcription factor. Both biochemical and genetic approaches indicate that pro-SCP-2 acts as a competitive inhibitor of SCP- x processing, thereby controlling the release of the 12.9-kDa transcriptionally active fragment. The transcription regulatory function of proSCP-2 requires a peroxisomal targeting sequence at the C terminus and a 20-amino acid leading sequence at the N terminus. Finally, pro-SCP- 2 has also cholesterol carrier activity, which is functionally separated from the transcription regulatory one. In conclusion, we have identified two novel functions (transcriptional and transcription regulatory) of the SCP-x/pro-SCP-2 gene that have impact on gamma-secretase activity.	Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, 2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu						Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Baum CL, 1997, J BIOL CHEM, V272, P6490, DOI 10.1074/jbc.272.10.6490; Brissette L, 1996, BIOCHEM J, V318, P841, DOI 10.1042/bj3180841; Costantini C, 2005, BIOCHEM J, V391, P59, DOI 10.1042/BJ20050700; Costantini C, 2006, EMBO J, V25, P1997, DOI 10.1038/sj.emboj.7601062; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; Edqvist J, 2006, J MOL EVOL, V62, P292, DOI 10.1007/s00239-005-0086-3; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guo HM, 1998, GENE, V220, P99, DOI 10.1016/S0378-1119(98)00400-4; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Huang H, 2002, BIOCHEMISTRY-US, V41, P12149, DOI 10.1021/bi0260536; Lan Q, 2004, J LIPID RES, V45, P1468, DOI 10.1194/jlr.M400003-JLR200; Lensink MF, 2002, J MOL BIOL, V323, P99, DOI 10.1016/S0022-2836(02)00939-7; Liang L, 2002, GENE, V282, P75, DOI 10.1016/S0378-1119(01)00847-2; OHBA T, 1995, BIOCHEMISTRY-US, V34, P10660, DOI 10.1021/bi00033a042; OHBA T, 1994, GENOMICS, V24, P370, DOI 10.1006/geno.1994.1630; Puglielli L, 1996, BIOCHEM J, V317, P681, DOI 10.1042/bj3170681; PUGLIELLI L, 1995, J BIOL CHEM, V270, P18723, DOI 10.1074/jbc.270.32.18723; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Schroeder F, 2000, J BIOL CHEM, V275, P25547, DOI 10.1074/jbc.M000431200; Shetty S, 2000, J BIOL CHEM, V275, P13771, DOI 10.1074/jbc.275.18.13771; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Zanlungo S, 2000, GASTROENTEROLOGY, V119, P1708, DOI 10.1053/gast.2000.20198; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	31	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19742	19752		10.1074/jbc.M611426200	http://dx.doi.org/10.1074/jbc.M611426200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17485462	hybrid			2022-12-27	WOS:000247650600049
J	Wang, LF; Harris, TE; Roth, RA; Lawrence, JC				Wang, Lifu; Harris, Thurl E.; Roth, Richard A.; Lawrence, John C., Jr.			PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; RAPAMYCIN MTOR; CELL-GROWTH; PHAS-I; DISTINCT ROLES; PHOSPHORYLATION; RAPTOR; TOR; INSULIN; AKT	Mammalian target of rapamycin ( mTOR) functions in two distinct signaling complexes, mTORC1 and mTORC2. In response to insulin and nutrients, mTORC1, consisting of mTOR, raptor (regulatory-associated protein of mTOR), and mLST8, is activated and phosphorylates eukaryotic initiation factor 4E-binding protein (4EBP) and p70 S6 kinase to promote protein synthesis and cell size. Previously we found that activation of mTOR kinase in response to insulin was associated with increased 4EBP1 binding to raptor. Here we identify prolinerich Akt substrate 40 (PRAS40) as a binding partner for mTORC1. A putative TOR signaling motif, FVMDE, is identified in PRAS40 and shown to be required for interaction with raptor. Insulin stimulation markedly decreases the level of PRAS40 bound by mTORC1. Recombinant PRAS40 inhibits mTORC1 kinase activity in vivo and in vitro, and this inhibition depends on PRAS40 association with raptor. Furthermore, decreasing PRAS40 expression by short hairpin RNA enhances 4E-BP1 binding to raptor, and recombinant PRAS40 competes with 4E-BP1 binding to raptor. We, therefore, propose that PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.	Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	University of Virginia; Stanford University	Wang, LF (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, PO Box 800735,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	lw6j@virginia.edu	wang, lifu/E-1436-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028312, R01DK052753] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52753, DK28312] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; HARRIS TE, 2003, SCI STKE 2003; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; LIN TA, 1995, J BIOL CHEM, V270, P18531, DOI 10.1074/jbc.270.31.18531; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; McMahon LP, 2005, MOL ENDOCRINOL, V19, P175, DOI 10.1210/me.2004-0305; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979	36	349	362	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					20036	20044		10.1074/jbc.M702376200	http://dx.doi.org/10.1074/jbc.M702376200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17510057	hybrid			2022-12-27	WOS:000247650600077
J	Shen, YQ; Khusial, PR; Li, X; Ichikawa, H; Moreno, AP; Goldberg, GS				Shen, Yongquan; Khusial, P. Raaj; Li, Xun; Ichikawa, Hitoshi; Moreno, Alonso P.; Goldberg, Gary S.			Src utilizes Cas to block gap junctional communication mediated by connexin43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRK-ASSOCIATED SUBSTRATE; TYROSINE PHOSPHORYLATION SITES; FOCAL ADHESION KINASE; C6 GLIOMA-CELLS; V-SRC; INTERCELLULAR COMMUNICATION; IN-VIVO; TRANSFORMED-CELLS; TUMOR-CELLS; GROWTH	The Src tyrosine kinase phosphorylates Cas (Crk-associated substrate) to confer anchorage independence and invasive growth potential to transformed cells. Gap junctional communication is often lower between aggressive tumor cells compared with normal or benign precursors. The gap junction protein connexin43 (Cx43) is a tumor suppressor that can inhibit tumor cell growth. Src can phosphorylate Cx43 to block gap junctional communication between transformed cells. However, mechanisms by which this event actually closes intercellular channels have not been clearly defined. Here, we report that Src and Cas associate with each other at intercellular junctions. In addition, Cas is required for Src to reduce dye transfer and electrical coupling between cells expressing Cx43. Thus, Src utilizes Cas to inhibit gap junctional communication mediated by Cx43. This finding introduces a novel role of the Cas focal adhesion linker protein in the gap junction complex. This observation may help explain how gap junctional communication can be suppressed between malignant and metastatic tumor cells.	Univ Med & Dent New Jersey, Ctr Sci, Dept Mol Biol, Stratford, NJ 08084 USA; Natl Canc Ctr, Res Inst, Canc Transcriptome Project, Chuo Ku, Tokyo 1040045, Japan; Univ Utah, Nora Eccles Harrison Cardiovasc Res&Training Inst, Salt Lake City, UT 84112 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; National Cancer Center - Japan; Utah System of Higher Education; University of Utah	Goldberg, GS (corresponding author), Univ Med & Dent New Jersey, Ctr Sci, Dept Mol Biol, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	garygoldberg@comcast.net			NCI NIH HHS [CA88805] Funding Source: Medline; NEI NIH HHS [EY014479] Funding Source: Medline; NHLBI NIH HHS [HL63969] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088805] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R03EY014479] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; AZARNIA R, 1984, J MEMBRANE BIOL, V82, P191, DOI 10.1007/BF01871629; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Burnham MR, 1996, ONCOGENE, V12, P2467; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Goldberg GS, 2000, CANCER RES, V60, P6018; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; GOLDBERG GS, 1993, BIOCHEM J, V295, P735, DOI 10.1042/bj2950735; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Goldberg GS, 2001, METH MOL B, V154, P329; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Huang RP, 1998, CANCER RES, V58, P5089; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Jansen LAM, 1996, CARCINOGENESIS, V17, P1527, DOI 10.1093/carcin/17.7.1527; Kanemitsu MY, 1997, J BIOL CHEM, V272, P22824, DOI 10.1074/jbc.272.36.22824; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 1999, CANCER RES, V59, P4104; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; Lin R, 2006, CELL COMMUN ADHES, V13, P199, DOI 10.1080/15419060600848516; Loo LWM, 1999, MOL CARCINOGEN, V25, P187, DOI 10.1002/(SICI)1098-2744(199907)25:3<187::AID-MC5>3.3.CO;2-F; Naus CC, 2005, GAP JUNCTIONS IN DEVELOPMENT AND DISEASE, P253, DOI 10.1007/3-540-28621-7_12; Naus CCG, 2002, CAN J PHYSIOL PHARM, V80, P136, DOI 10.1139/Y02-009; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Patwardhan P, 2006, J BIOL CHEM, V281, P20689, DOI 10.1074/jbc.M602311200; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Sieg DJ, 1999, J CELL SCI, V112, P2677; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Staley CA, 1997, CELL GROWTH DIFFER, V8, P269; SWENSON KI, 1990, CELL REGUL, V1, P989, DOI 10.1091/mbc.1.13.989; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	54	29	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18914	18921		10.1074/jbc.M608980200	http://dx.doi.org/10.1074/jbc.M608980200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17488714	Green Published, hybrid			2022-12-27	WOS:000247475300032
J	Fujimori, K; Aritake, K; Urade, Y				Fujimori, Ko; Aritake, Kosuke; Urade, Yoshihiro			Novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ADIPOSE-TISSUE; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL ACTIVATION; OBESITY; ACID; ATHEROSCLEROSIS; IDENTIFICATION; ADIPOGENESIS; MECHANISM	Lipocalin-type prostaglandin (PG) D synthase (L-PGDS) is expressed in adipocytes and is proposed to be involved in the regulation of glucose tolerance and atherosclerosis in type 2 diabetes, because L-PGDS gene knock-out mice show abnormalities in these functions. However, the role of L-PGDS and the regulation mechanism governing its gene expression in adipocytes remain unclear. Here, we applied small interference RNA of L-PGDS to mouse 3T3-L1 cells and found that it suppressed differentiation of these cells into adipocytes. Reporter analysis of the mouse L-PGDS promoter demonstrated that a responsive element for liver receptor homolog-1 (LRH-1) at -233 plays a critical role in preadipocytic 3T3-L1 cells. Moreover, we identified two sterol regulatory elements (SREs) at -194 to be cis-elements for activation of L-PGDS gene expression in adipocytic 3T3-L1 cells. L-PGDS mRNA was induced in response to synthetic liver X receptor agonist, T0901317, through activation of the expression of SRE-binding protein-1c (SREBP-1c) in the adipocytic 3T3-L1 cells. The results of electrophoretic mobility shift assay and chromatin immunoprecipitation assay revealed that LRH-1 and SREBP-1c bound to their respective binding elements in the promoter of L-PGDS gene. Small interference RNA-mediated suppression of LRH-1 or SREBP-1c decreased L-PGDS gene expression in preadipocytic or adipocytic 3T3-L1 cells, respectively. These results indicate that L-PGDS gene expression is activated by LRH-1 in preadipocytes and by SREBP-1c in adipocytes. Liver X receptor-mediated up-regulation of L-PGDS through activation of SREBP-1c is a novel pathway to enhance adipocyte differentiation.	Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan		Urade, Y (corresponding author), Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Takatsuki, Osaka 569, Japan.	uradey@obi.or.jp	Fujimori, Ko/AAD-5428-2021	Fujimori, Ko/0000-0002-2506-0769				Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Boizard M, 1998, J BIOL CHEM, V273, P29164, DOI 10.1074/jbc.273.44.29164; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P1259, DOI 10.1161/01.ATV.0000133192.39901.be; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Fujimori K, 2003, J BIOL CHEM, V278, P6018, DOI 10.1074/jbc.M208288200; Fujimori K, 2002, J BIOCHEM, V131, P383, DOI 10.1093/oxfordjournals.jbchem.a003113; Fujimori K, 2000, J BIOL CHEM, V275, P40511, DOI 10.1074/jbc.M007688200; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hummasti S, 2004, J LIPID RES, V45, P616, DOI 10.1194/jlr.M300312-JLR200; Jowsey IR, 2003, PROSTAG OTH LIPID M, V70, P267, DOI 10.1016/S0090-6980(02)00134-X; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Miwa Y, 2004, BIOCHEM BIOPH RES CO, V322, P428, DOI 10.1016/j.bbrc.2004.07.143; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Nadler ST, 2001, J NUTR, V131, P2078, DOI 10.1093/jn/131.8.2078; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Quinkler M, 2006, GENE, V380, P137, DOI 10.1016/j.gene.2006.05.026; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rosen ED, 2000, GENE DEV, V14, P1293; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Urade Y, 2006, LIPOCALINS, P99; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; Xie Y, 2006, DIABETES OBES METAB, V8, P83, DOI 10.1111/j.1463-1326.2005.00472.x; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	42	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18458	18466		10.1074/jbc.M701141200	http://dx.doi.org/10.1074/jbc.M701141200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17439953	hybrid			2022-12-27	WOS:000247302000052
J	Qanungo, S; Starke, DW; Pai, HV; Mieyal, JJ; Nieminen, AL				Qanungo, Suparna; Starke, David W.; Pai, Harish V.; Mieyal, John J.; Nieminen, Anna-Liisa			Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NF kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACETYL-L-CYSTEINE; REDOX SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; PROTEIN-THIOLS; THIOLTRANSFERASE GLUTAREDOXIN; CRYSTAL-STRUCTURE; NITRIC-OXIDE; ACTIVATION; EXPRESSION	In murine embryonic fibroblasts, N-acetyl-L-cysteine (NAC), a GSH generating agent, enhances hypoxic apoptosis by blocking the NF kappa B survival pathway (Qanungo, S., Wang, M., and Nieminen, A. L. (2004) J. Biol. Chem. 279, 50455-50464). Here, we examined sulfhydryl modifications of the p65 subunit of NF kappa B that are responsible for NF kappa B inactivation. In MIA PaCa-2 pancreatic cancer cells, hypoxia increased p65-NF kappa B DNA binding and NF kappa B transactivation by 2.6- and 2.8-fold, respectively. NAC blocked these events without having an effect on p65-NF kappa B protein levels and p65-NF kappa B nuclear translocation during hypoxia. Pharmacological inhibition of the NF kappa B pathway also induced hypoxic apoptosis, indicating that the NF kappa B signaling pathway is a major protective mechanism against hypoxic apoptosis. In cell lysates after hypoxia and treatment with N-ethylmaleimide (thiol alkylating agent), dithiothreitol (disulfide reducing agent) was not able to increase binding of p65-NF kappa B to DNA, suggesting that most sulfhydryls in p65-NF kappa B protein were in reduced and activated forms after hypoxia, thereby being blocked by N-ethylmaleimide. In contrast, with hypoxic cells that were also treated with NAC, dithiothreitol increased p65-NF kappa B DNA binding. Glutaredoxin (GRx), which specifically catalyzes reduction of protein-SSG mixed disulfides, reversed inhibition of p65-NF kappa B DNA binding in extracts from cells treated with hypoxia plus NAC and restored NF kappa B activity. This finding indicated that p65-NF kappa B-SSG was formed in situ under hypoxia plus NAC conditions. In cells, knock-down of endogenous GRx1, which also promotes protein glutathionylation under hypoxic radical generating conditions, prevented NAC-induced NF kappa B inactivation and hypoxic apoptosis. The results indicate that GRx-dependent S-glutathionylation of p65-NF kappa B is most likely responsible for NAC-mediated NF kappa B inactivation and enhanced hypoxic apoptosis.	Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Anat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Nieminen, AL (corresponding author), 3-134 Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	axn25@case.edu			NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885, R01AG024413] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA43703] Funding Source: Medline; NIA NIH HHS [R01 AG024413, P01 AG15885] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berkowitz B, 2002, J BIOL CHEM, V277, P24694, DOI 10.1074/jbc.M200006200; Biaglow JE, 2006, RADIAT RES, V165, P307, DOI 10.1667/RR3505.1; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Brar SS, 2004, MOL CANCER THER, V3, P1049; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Chiueh CC, 1999, ANN NY ACAD SCI, V890, P301, DOI 10.1111/j.1749-6632.1999.tb08007.x; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Cotgreave IA, 2002, METHOD ENZYMOL, V348, P175, DOI 10.1016/S0076-6879(02)48636-3; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; GALLOGLY MM, 2007, IN PRESS CURR OPIN P; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gravina Mieyal S.A, 1995, BIOTHIOLS HLTH DIS, P305; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Guo GW, 2006, ANTIOXID REDOX SIGN, V8, P911, DOI 10.1089/ars.2006.8.911; Huang DB, 2005, J MOL BIOL, V346, P147, DOI 10.1016/j.jmb.2004.11.042; Humphries KM, 2002, J BIOL CHEM, V277, P43505, DOI 10.1074/jbc.M207088200; Huxford T, 1999, COLD SPRING HARB SYM, V64, P533, DOI 10.1101/sqb.1999.64.533; Jiang BB, 2000, HYPERTENSION, V35, P914, DOI 10.1161/01.HYP.35.4.914; JONES DP, 1995, IMMUNOL LETT, V45, P205, DOI 10.1016/0165-2478(95)00004-O; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Li XX, 2002, EXP HEMATOL, V30, P285, DOI 10.1016/S0301-472X(02)00777-4; Li YQ, 2006, ACTA PHARMACOL SIN, V27, P339, DOI 10.1111/j.1745-7254.2006.00264.x; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Nulton-Persson AC, 2003, BIOCHEMISTRY-US, V42, P4235, DOI 10.1021/bi027370f; Qanungo S, 2002, ONCOGENE, V21, P4149, DOI 10.1038/sj.onc.1205508; Qanungo S, 2004, J BIOL CHEM, V279, P50455, DOI 10.1074/jbc.M406749200; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200; Shackelford RE, 2005, ANTIOXID REDOX SIGN, V7, P940, DOI 10.1089/ars.2005.7.940; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; THOMAS JA, 1994, METHOD ENZYMOL, V233, P385; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vaupel P, 2005, TRANSFUS CLIN BIOL, V12, P5, DOI 10.1016/j.tracli.2004.11.005; Wang CY, 1999, MOL CELL BIOL, V19, P5923; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zhu S, 1998, ENVIRON HEALTH PERSP, V106, P1157, DOI 10.2307/3433979	46	132	136	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18427	18436		10.1074/jbc.M610934200	http://dx.doi.org/10.1074/jbc.M610934200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17468103	hybrid			2022-12-27	WOS:000247302000049
J	Tzatsos, A; Tsichlis, PN				Tzatsos, Alexandros; Tsichlis, Philip N.			Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; MOUSE SKELETAL-MUSCLE; MAMMALIAN TARGET; AS160 PHOSPHORYLATION; GLUCOSE-TRANSPORT; CANCER-CELLS; IN-VIVO; LKB1; RAPAMYCIN; PATHWAY	Energy depletion activates AMP-activated protein kinase (AMPK) and inhibits cell growth via TSC2-dependent suppression of mTORC1 signaling. Long term energy depletion also induces apoptosis by mechanisms that are not well understood to date. Here we show that AMPK, activated by energy depletion, inhibited cell survival by binding to and phosphorylating IRS-1 at Ser-794. Phosphorylation of IRS-1 at this site inhibited phosphatidylinositol 3- kinase/Akt signaling, suppressed the mitochondrial membrane potential, and promoted apoptosis. Of the treatments promoting energy depletion, glucose deprivation, hypoxia, and inhibition of ATP synthesis in the mitochondria stimulated phosphorylation of IRS-1 at Ser-794 via an LKB1/AMPK-dependent manner, whereas oxidative stress and 2-deoxyglucose stimulated phosphorylation at this site via a Ca2+/calmodulin-dependent protein kinase kinase beta/AMPK axis. These data define a novel pathway that cooperates with other adaptive mechanisms to formulate the cellular response to energy depletion.	Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Tsichlis, PN (corresponding author), Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, 750 Washington St,5609, Boston, MA 02111 USA.	ptsichlis@tufts-nemc.org			NATIONAL CANCER INSTITUTE [R01CA057436] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA57436] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Heath-Engel HM, 2006, BBA-MOL CELL RES, V1763, P549, DOI 10.1016/j.bbamcr.2006.02.006; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Jimenez AI, 2003, CANCER RES, V63, P1382; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Nakano M, 2006, METABOLISM, V55, P300, DOI 10.1016/j.metabol.2005.09.003; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; Qiao LY, 2002, J BIOL CHEM, V277, P26530, DOI 10.1074/jbc.M201494200; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	47	116	120	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18069	18082		10.1074/jbc.M610101200	http://dx.doi.org/10.1074/jbc.M610101200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17459875	hybrid			2022-12-27	WOS:000247302000013
J	Goemaere, EL; Devert, A; Lloubes, R; Cascales, E				Goemaere, Emilie L.; Devert, Anthony; Lloubes, Roland; Cascales, Eric			Movements of the TolR C-terminal domain depend on TolQR ionizable key residues and regulate activity of the tol complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ENVELOPE INTEGRITY; PROTON MOTIVE FORCE; ESCHERICHIA-COLI; OUTER-MEMBRANE; MUTATIONAL ANALYSIS; POTASSIUM CHANNELS; FLAGELLAR MOTOR; INNER MEMBRANE; PAL PROTEINS; TONB	The TolQRA proteins of Escherichia coli form an inner membrane complex involved in the maintenance of the outer membrane stability and in the late stages of cell division. The TolQR complex uses the proton-motive force to regulate TolA conformation and its interaction with the outer membrane Pal lipoprotein. It has been proposed that an ion channel forms at the TolQR transmembrane helix interface. This complex assembles with a minimal TolQ/TolR ratio of 4:2, therefore involving at least 14 transmembrane helices, which may form the ion pathway. The C-terminal periplasmic domain of TolR protein interacts with TolQ and has been proposed to control the TolQR channel activity. Here, we constructed unique cysteine substitutions in the last 27 residues of TolR. Each of the substitutions results in a functional TolR protein. Disulfide cross-linking demonstrates that the TolQR complex is dynamic, involving conformational modifications of TolR C-terminal domain. We monitored these structural changes by cysteine accessibility experiments and showed that the conformation of this domain is responsive to the proton-motive force and on the presence of critical residues of the ion pathway.	CNRS, Lab Ingn Syst Macromol, Inst Biol Struct & Microbiol, UPR 9027, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cascales, E (corresponding author), CNRS, Lab Ingn Syst Macromol, Inst Biol Struct & Microbiol, UPR 9027, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	cascales@ibsm.cnrs-mrs.fr	CASCALES, ERIC/G-7420-2011	CASCALES, ERIC/0000-0003-0611-9179; LLOUBES, Roland/0000-0002-9520-1053				Abergel C, 2001, ACTA CRYSTALLOGR D, V57, P323, DOI 10.1107/S0907444900020837; Blair DF, 2003, FEBS LETT, V545, P86, DOI 10.1016/S0014-5793(03)00397-1; Braun V, 1996, J BACTERIOL, V178, P2836, DOI 10.1128/jb.178.10.2836-2845.1996; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; DEROUICHE R, 1995, J BIOL CHEM, V270, P11078, DOI 10.1074/jbc.270.19.11078; Garza AG, 1996, J MOL BIOL, V258, P270, DOI 10.1006/jmbi.1996.0249; Garza AG, 1996, J BACTERIOL, V178, P6116, DOI 10.1128/jb.178.21.6116-6122.1996; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 1998, J BACTERIOL, V180, P6433, DOI 10.1128/JB.180.24.6433-6439.1998; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; Hosking ER, 2006, J MOL BIOL, V364, P921, DOI 10.1016/j.jmb.2006.09.035; Journet L, 2001, MOL MICROBIOL, V42, P331, DOI 10.1046/j.1365-2958.2001.02592.x; Journet L, 1999, J BACTERIOL, V181, P4476, DOI 10.1128/JB.181.15.4476-4484.1999; KAMPFENKEL K, 1993, J BACTERIOL, V175, P4485, DOI 10.1128/JB.175.14.4485-4491.1993; KUMPF RA, 1993, SCIENCE, V261, P1708, DOI 10.1126/science.8378771; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; Larsen RA, 2001, J BIOL CHEM, V276, P8111, DOI 10.1074/jbc.M007479200; LAZZARONI JC, 1995, J MOL BIOL, V246, P1, DOI 10.1006/jmbi.1994.0058; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; MULLER MM, 1993, J BACTERIOL, V175, P6059, DOI 10.1128/JB.175.18.6059-6061.1993; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; SUN TP, 1987, J BACTERIOL, V169, P2667, DOI 10.1128/jb.169.6.2667-2674.1987; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; VIANNEY A, 1994, J BACTERIOL, V176, P822, DOI 10.1128/jb.176.3.822-829.1994; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	29	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17749	17757		10.1074/jbc.M701002200	http://dx.doi.org/10.1074/jbc.M701002200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17442676	hybrid, Green Published			2022-12-27	WOS:000247084500048
J	Islinger, M; Luers, GH; Li, KW; Loos, M; Volkl, A				Islinger, Markus; Luers, Georg H.; Li, Ka Wan; Loos, Maarten; Volkl, Alfred			Rat liver peroxisomes after fibrate treatment - A survey using quantitative mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA OXIDASE; ISOLATED SUBCELLULAR MEMBRANES; GLUTATHIONE-S-TRANSFERASE; BETA-OXIDATION; BINDING PROTEIN; GENE-EXPRESSION; MULTIFUNCTIONAL PROTEIN-2; SPECTROPHOTOMETRIC ASSAY; SELECTIVE INDUCTION; PROTEOMIC ANALYSIS	Fibrates are known to induce peroxisome proliferation and the expression of peroxisomal beta-oxidation enzymes. To analyze fibrate-induced changes of complex metabolic networks, we have compared the proteome of rat liver peroxisomes from control and bezafibrate-treated rats. Highly purified peroxisomes were subfractionated, and the proteins of the matrix, peripheral, and integral membrane subfractions thus obtained were analyzed by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry after labeling of tryptic peptides with the iTRAQ reagent. By means of this quantitative technique, we were able to identify 134 individual proteins, covering most of the known peroxisomal proteome. Ten predicted new open reading frames were verified by cDNA cloning, and seven of them could be localized to peroxisomes by immunocytochemistry. Moreover, quantitative mass spectrometry substantiated the induction of most of the known peroxisome proliferator-activated receptor alpha-regulated peroxisomal proteins upon treatment with bezafibrate, documenting the suitability of the iTRAQ procedure in larger scale experiments. However, not all proteins reacted to a similar extent but exerted a fibrate-specific induction scheme showing the variability of peroxisome proliferator-activated receptor alpha-transmitted responses to specific ligands. In view of our data, rat hepatic peroxisomes are apparently not specialized to sequester very long chain fatty acids (C22-C26) but rather metabolize preferentially long chain fatty acids (C16-18).	Heidelberg Univ, Dept Anat & Cell Biol, D-69120 Heidelberg, Germany; Univ Marburg, Dept Anat & Cell Biol, D-35033 Marburg, Germany; Vrije Univ Amsterdam, Res Inst Neurosci, NL-1081 HV Amsterdam, Netherlands	Ruprecht Karls University Heidelberg; Philipps University Marburg; Vrije Universiteit Amsterdam	Islinger, M (corresponding author), Heidelberg Univ, Dept Anat & Cell Biol, Im Neuenheimer Feld 307, D-69120 Heidelberg, Germany.	Markus.Islinger@urz.uni-heidelberg.de	Loos, Maarten/A-2768-2012	Loos, Maarten/0000-0003-1629-2928; li, ka wan/0000-0001-6983-5055				ALEXSON SEH, 1985, J CELL BIOL, V101, P294, DOI 10.1083/jcb.101.1.294; Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780; ANGERMULLER S, 1987, EUR J CELL BIOL, V45, P137; Antonenkov VD, 2006, BIOCHEM J, V394, P475, DOI 10.1042/BJ20051058; Antonenkov VD, 2004, J CELL SCI, V117, P5633, DOI 10.1242/jcs.01485; AOYAMA T, 1994, BIOCHEM BIOPH RES CO, V201, P1541, DOI 10.1006/bbrc.1994.1879; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Baker VA, 2004, ENVIRON HEALTH PERSP, V112, P428, DOI 10.1289/ehp.6677; BEIER K, 1988, EUR J CELL BIOL, V46, P383; BELL DR, 1992, EUR J BIOCHEM, V206, P979, DOI 10.1111/j.1432-1033.1992.tb17009.x; CHEN NH, 1992, BIOCHEM J, V283, P605, DOI 10.1042/bj2830605; Cornwell PD, 2004, MUTAT RES-FUND MOL M, V549, P131, DOI 10.1016/j.mrfmmm.2003.12.019; FAHIMI HD, 1982, ANN NY ACAD SCI, V386, P111, DOI 10.1111/j.1749-6632.1982.tb21410.x; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; FOWLER S, 1976, J CELL BIOL, V71, P535, DOI 10.1083/jcb.71.2.535; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; Goshe MB, 2003, J PROTEOME RES, V2, P153, DOI 10.1021/pr0255607; Helledie T, 2002, J BIOL CHEM, V277, P26821, DOI 10.1074/jbc.M111295200; Hogenboom S, 2003, MOL GENET METAB, V80, P290, DOI 10.1016/S1096-7192(03)00143-4; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; HOVIK R, 1989, BIOCHEM J, V263, P297, DOI 10.1042/bj2630297; HRYB DJ, 1979, BIOCHEM BIOPH RES CO, V87, P1200, DOI 10.1016/S0006-291X(79)80034-0; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Huyghe S, 2006, BBA-MOL CELL BIOL L, V1761, P973, DOI 10.1016/j.bbalip.2006.04.006; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; INESTROSA NC, 1979, LIFE SCI, V25, P1127, DOI 10.1016/0024-3205(79)90134-6; Islinger M, 2006, PROTEOMICS, V6, P804, DOI 10.1002/pmic.200401347; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kovacs WJ, 2001, EUR J BIOCHEM, V268, P4850, DOI 10.1046/j.0014-2956.2001.02409.x; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Latruffe N, 2000, BIOL CELL, V92, P389, DOI 10.1016/S0248-4900(00)01083-2; LAZAROW PB, 1982, FEBS LETT, V150, P307, DOI 10.1016/0014-5793(82)80757-6; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LAZAROW PB, 1977, SCIENCE, V197, P580, DOI 10.1126/science.195342; LEIGHTON F, 1975, J CELL BIOL, V67, P281, DOI 10.1083/jcb.67.2.281; Li HY, 2003, PLANT MOL BIOL, V51, P483, DOI 10.1023/A:1022330304402; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MIYAUCHI K, 1993, CELL STRUCT FUNCT, V18, P427, DOI 10.1247/csf.18.427; MIYAZAWA S, 1981, J BIOCHEM, V90, P511, DOI 10.1093/oxfordjournals.jbchem.a133499; MOODY DE, 1976, J CELL BIOL, V71, P768, DOI 10.1083/jcb.71.3.768; Morel F, 2004, J BIOL CHEM, V279, P16246, DOI 10.1074/jbc.M313357200; Moser HW, 2000, FRONT BIOSCI, V5, pD298, DOI 10.2741/Moser; NEMALI MR, 1988, CANCER RES, V48, P5316; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; PILL J, 1992, ARCH TOXICOL, V66, P327, DOI 10.1007/BF01973627; Raymond Gerald V., 1999, Current Opinion in Pediatrics, V11, P572, DOI 10.1097/00008480-199912000-00017; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reguenga C, 1999, BBA-GENE STRUCT EXPR, V1445, P337, DOI 10.1016/S0167-4781(99)00061-5; REMACLE J, 1976, J CELL BIOL, V71, P551, DOI 10.1083/jcb.71.2.551; Richert L, 2003, TOXICOL APPL PHARM, V191, P130, DOI 10.1016/S0041-008X(03)00231-X; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schirmer EC, 2005, TRENDS BIOCHEM SCI, V30, P551, DOI 10.1016/j.tibs.2005.08.003; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Schrader M, 1998, EUR J CELL BIOL, V75, P87, DOI 10.1016/S0171-9335(98)80051-4; SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; Van Ael E, 2006, BBA-MOL CELL RES, V1763, P1629, DOI 10.1016/j.bbamcr.2006.08.020; VANBROEKHOVEN A, 1981, BIOCHEM BIOPH RES CO, V100, P305, DOI 10.1016/S0006-291X(81)80097-6; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; VOLKL A, 1985, EUR J BIOCHEM, V149, P257, DOI 10.1111/j.1432-1033.1985.tb08920.x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weber G, 2004, ELECTROPHORESIS, V25, P1735, DOI 10.1002/elps.200305834; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Yadetie F, 2003, PHYSIOL GENOMICS, V15, P9, DOI 10.1152/physiolgenomics.00064.2003; Zhang XG, 2006, BIOCHEM BIOPH RES CO, V346, P1307, DOI 10.1016/j.bbrc.2006.06.042	70	79	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23055	23069		10.1074/jbc.M610910200	http://dx.doi.org/10.1074/jbc.M610910200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17522052	Green Published, hybrid			2022-12-27	WOS:000248577500008
J	Richard, MN; Deniset, JF; Kneesh, AL; Blackwood, D; Pierce, GN				Richard, Melanie N.; Deniset, Justin F.; Kneesh, Annette L.; Blackwood, David; Pierce, Grant N.			Mechanical stretching stimulates smooth muscle cell growth, nuclear protein import, and nuclear pore expression through mitogen-activated protein kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPONTANEOUSLY HYPERTENSIVE RATS; BLOOD-VESSELS; COMPLEX; NUCLEOPORINS; STRESS; CYCLE; ATHEROSCLEROSIS; CARDIOMYOCYTES; HYPERTROPHY; ANGIOTENSIN	Although it is known that mechanical stretching of cells can induce significant increases in cell growth and shape, the intracellular signaling pathways that induce this response at the level of the cell nucleus is unknown. The transport of molecules from the cell cytoplasm to the nucleoplasm through the nuclear pore is a key pathway through which gene expression can be controlled in some conditions. It is presently unknown if mechanical stimuli can induce changes in nuclear pore expression and/or function. The purpose of the present investigation was to determine if mechanical stretching of a cell will alter nuclear protein import and the mechanisms that may be responsible. Vascular smooth muscle cells that were mechanically stretched exhibited an increase in proliferating cell nuclear antigen expression, cell number, and cell size within 24-48 h. Cells were microinjected with marker proteins for nuclear import. Nuclear protein import was significantly stimulated in stretched cells when compared with control. This was associated with an increase in the expression of nuclear pore proteins as detected by Western blots. Inhibition of the MAPK pathway blocked the stretch-induced stimulation of both cell proliferation and nuclear protein import. We conclude that nuclear protein import and nuclear pore density can adapt to mechanical stimuli during the process of cell growth through a MAPK-mediated mechanism.	Univ Manitoba, St Boniface Gen Hosp, Fac Med & Pharm,Res Ctr, Dept Physiol,Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Pierce, GN (corresponding author), Univ Manitoba, St Boniface Gen Hosp, Fac Med & Pharm,Res Ctr, Dept Physiol,Inst Cardiovasc Sci, 351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	gpierce@sbrc.ca						ADAM SA, 1991, METHOD CELL BIOL, V35, P469; Allen TD, 2000, J CELL SCI, V113, P1651; Bagley S, 2000, J CELL SCI, V113, P3885; Batetta B, 2002, CELL PROLIFERAT, V35, P143; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Cheng JJ, 1996, HYPERTENSION, V28, P386, DOI 10.1161/01.HYP.28.3.386; Cornelissen J, 2004, ARTERIOSCL THROM VAS, V24, P451, DOI 10.1161/01.ATV.0000116690.17017.8b; Csermely P, 1995, BBA-REV BIOMEMBRANES, V1241, P425, DOI 10.1016/0304-4157(95)00015-1; Czubryt MP, 2000, J CELL BIOL, V148, P7, DOI 10.1083/jcb.148.1.7; DEVLIN AM, 1995, J HYPERTENS, V13, P211; DEVLIN AM, 1995, J HUM HYPERTENS, V9, P497; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Dzau V J, 1993, Curr Opin Nephrol Hypertens, V2, P27, DOI 10.1097/00041552-199301000-00004; Faustino RS, 2007, MOL PHARMACOL, V71, P438, DOI 10.1124/mol.105.021667; Faustino RS, 2006, CAN J PHYSIOL PHARM, V84, P469, DOI 10.1139/Y05-131; Faustino RS, 2002, METHOD ENZYMOL, V352, P123; HOLLANDER W, 1976, AM J CARDIOL, V38, P786, DOI 10.1016/0002-9149(76)90357-X; Hosokawa H, 2002, BIOL PHARM BULL, V25, P1588, DOI 10.1248/bpb.25.1588; Irace C, 2004, STROKE, V35, P464, DOI 10.1161/01.STR.0000111597.34179.47; Iwasaki H, 2000, AM J PHYSIOL-HEART C, V278, pH521, DOI 10.1152/ajpheart.2000.278.2.H521; Jankowski R, 2000, J PHARMACOL TOXICOL, V44, P421, DOI 10.1016/S1056-8719(00)00119-2; Kleinstreuer C, 2001, CRIT REV BIOMED ENG, V29, P1, DOI 10.1615/CritRevBiomedEng.v29.i1.10; LEE RMKW, 1995, CAN J PHYSIOL PHARM, V73, P574, DOI 10.1139/y95-073; Lehoux S, 1998, HYPERTENSION, V32, P338, DOI 10.1161/01.HYP.32.2.338; Lehoux S, 2003, J BIOMECH, V36, P631, DOI 10.1016/S0021-9290(02)00441-4; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; MARKOVICS J, 1974, EXP CELL RES, V85, P443, DOI 10.1016/0014-4827(74)90148-7; MAUL GG, 1977, J CELL BIOL, V74, P492, DOI 10.1083/jcb.74.2.492; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; MAUL GG, 1980, CYTOGENET CELL GENET, V26, P175, DOI 10.1159/000131439; MAUL GG, 1971, J CELL BIOL, V51, P405, DOI 10.1083/jcb.51.2.405; MAUL HM, 1973, J CELL BIOL, V59, P669, DOI 10.1083/jcb.59.3.669; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; OWENS GK, 1985, CIRC RES, V57, P695, DOI 10.1161/01.RES.57.5.695; OWENS GK, 1989, AM J PHYSIOL, V257, pH1755, DOI 10.1152/ajpheart.1989.257.6.H1755; OWENS GK, 1982, CIRC RES, V51, P280, DOI 10.1161/01.RES.51.3.280; OWENS GK, 1988, HYPERTENSION, V11, P198, DOI 10.1161/01.HYP.11.2.198; PAULETTO P, 1994, AM J HYPERTENS, V7, P661, DOI 10.1093/ajh/7.7.661; Perez-Terzic C, 2003, CIRC RES, V92, P444, DOI 10.1161/01.RES.0000059415.25070.54; Perez-Terzic C, 1999, CIRC RES, V84, P1292, DOI 10.1161/01.RES.84.11.1292; Quinn TP, 2002, AM J PHYSIOL-LUNG C, V282, pL897, DOI 10.1152/ajplung.00044.2001; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Shaw Anthony, 2003, Current Vascular Pharmacology, V1, P41, DOI 10.2174/1570161033386745; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Spofford CM, 2001, AM J PHYSIOL-HEART C, V280, pH1354, DOI 10.1152/ajpheart.2001.280.3.H1354; Zeidan A, 2003, ARTERIOSCL THROM VAS, V23, P1528, DOI 10.1161/01.ATV.0000090129.75275.C2; Zettler ME, 2003, AM J PHYSIOL-HEART C, V284, pH644, DOI 10.1152/ajpheart.00494.2001	48	48	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23081	23088		10.1074/jbc.M703602200	http://dx.doi.org/10.1074/jbc.M703602200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17525165	hybrid			2022-12-27	WOS:000248577500010
J	Hunter, WN				Hunter, William N.			The non-mevalonate pathway of isoprenoid precursor biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; METHYLERYTHRITOL PHOSPHATE-PATHWAY; ISOPENTENYL DIPHOSPHATE ISOMERASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; 2C-METHYL-D-ERYTHRITOL-2,4-CYCLODIPHOSPHATE SYNTHASE; 2,4-CYCLODIPHOSPHATE SYNTHASE; CATALYTIC MECHANISM; ACTIVE-SITE; ENZYME	The recently discovered non-mevalonate biosynthetic route to isoprenoid precursors is an essential metabolic pathway in plants, apicomplexan parasites, and many species of bacteria. The pathway relies on eight enzymes exploiting different cofactors and metal ions. Structural and mechanistic data now exist for most components of the pathway though there remain some gaps in our knowledge. The individual enzymes represent new, validated targets for broad spectrum antimicrobial drug and herbicide development. Detailed knowledge of the pathway may also be exploited to genetically modify microorganisms and plants to produce compounds of agricultural and medical interest.	Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland	University of Dundee	Hunter, WN (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	w.n.hunter@dundee.ac.uk	Torero, Rebeca/C-1703-2012; Hunter, William/AAE-3947-2019		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; BORK P, 1993, PROTEIN SCI, V2, P31; Cassera MB, 2004, J BIOL CHEM, V279, P51749, DOI 10.1074/jbc.M408360200; de Ruyck J, 2005, BIOCHEM BIOPH RES CO, V338, P1515, DOI 10.1016/j.bbrc.2005.10.114; Durbecq V, 2001, EMBO J, V20, P1530, DOI 10.1093/emboj/20.7.1530; Eisenreich W, 2001, TRENDS PLANT SCI, V6, P78, DOI 10.1016/S1360-1385(00)01812-4; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Fiedler E, 2002, P NATL ACAD SCI USA, V99, P591, DOI 10.1073/pnas.022510999; Gabrielsen M, 2006, FEBS J, V273, P1065, DOI 10.1111/j.1742-4658.2006.05133.x; Gabrielsen M, 2004, J BIOL CHEM, V279, P52753, DOI 10.1074/jbc.M408895200; Gabrielsen M, 2004, EUR J BIOCHEM, V271, P3028, DOI 10.1111/j.1432-1033.2004.04234.x; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HASAN S, 2006, PLOS COMPUT BIOL, V6, P1; Henriksson LM, 2006, ACTA CRYSTALLOGR D, V62, P807, DOI 10.1107/S0907444906019196; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kellogg BA, 1997, CURR OPIN CHEM BIOL, V1, P570, DOI 10.1016/S1367-5931(97)80054-3; Kemp LE, 2005, ACTA CRYSTALLOGR D, V61, P45, DOI 10.1107/S0907444904025971; Kemp LE, 2003, ACTA CRYSTALLOGR D, V59, P607, DOI 10.1107/S090744490202365X; Kemp LE, 2002, P NATL ACAD SCI USA, V99, P6591, DOI 10.1073/pnas.102679799; Kishida H, 2003, ACTA CRYSTALLOGR D, V59, P23, DOI 10.1107/S0907444902017705; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Lherbet C, 2006, BIOCHEMISTRY-US, V45, P3548, DOI 10.1021/bi0520075; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Mac Sweeney A, 2005, J MOL BIOL, V345, P115, DOI 10.1016/j.jmb.2004.10.030; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Miallau L, 2003, P NATL ACAD SCI USA, V100, P9173, DOI 10.1073/pnas.1533425100; Ni SS, 2004, ACTA CRYSTALLOGR D, V60, P1949, DOI 10.1107/S0907444904021791; Proteau PJ, 2004, BIOORG CHEM, V32, P483, DOI 10.1016/j.bioorg.2004.08.004; Puan KJ, 2005, FEBS LETT, V579, P3802, DOI 10.1016/j.febslet.2005.05.047; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Reuter K, 2002, J BIOL CHEM, V277, P5378, DOI 10.1074/jbc.M109500200; Ricagno S, 2004, BBA-PROTEINS PROTEOM, V1698, P37, DOI 10.1016/j.bbapap.2003.10.006; Richard SB, 2004, BIOCHEMISTRY-US, V43, P12189, DOI 10.1021/bi0487241; Richard SB, 2002, J BIOL CHEM, V277, P8667, DOI 10.1074/jbc.C100739200; Richard SB, 2001, NAT STRUCT BIOL, V8, P641, DOI 10.1038/89691; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rohdich F, 2004, BIOORG CHEM, V32, P292, DOI 10.1016/j.bioorg.2004.05.012; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Rohmer M., 1999, COMPR NAT PROD CHEM, V2, P45, DOI 10.1016/B978-0-08-091283-7.00036-9; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Steinbacher S, 2003, J MOL BIOL, V329, P973, DOI 10.1016/S0022-2836(03)00527-8; Steinbacher S, 2003, J BIOL CHEM, V278, P18401, DOI 10.1074/jbc.M300993200; Steinbacher S, 2002, J MOL BIOL, V316, P79, DOI 10.1006/jmbi.2001.5341; Wada T, 2003, J BIOL CHEM, V278, P30022, DOI 10.1074/jbc.M304339200; Wouters J, 2003, J BIOL CHEM, V278, P11903, DOI 10.1074/jbc.M212823200; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Yajima S, 2004, J AM CHEM SOC, V126, P10824, DOI 10.1021/ja040126m; Yajima S, 2002, J BIOCHEM, V131, P313, DOI 10.1093/oxfordjournals.jbchem.a003105; Zhang C, 2007, J MOL BIOL, V366, P1437, DOI 10.1016/j.jmb.2006.10.092; Zheng W, 2007, J MOL BIOL, V366, P1447, DOI 10.1016/j.jmb.2006.12.055	52	236	253	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21573	21577		10.1074/jbc.R700005200	http://dx.doi.org/10.1074/jbc.R700005200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17442674	hybrid			2022-12-27	WOS:000248196800001
J	Armstrong, VJ; Muzylak, M; Sunters, A; Zaman, G; Saxon, LK; Price, JS; Lanyon, LE				Armstrong, Victoria J.; Muzylak, Mariusz; Sunters, Andrew; Zaman, Gul; Saxon, Leanne K.; Price, Joanna S.; Lanyon, Lance E.			Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MECHANICAL STRAIN; TRANSCRIPTIONAL ACTIVITY; UP-REGULATION; SEX STEROIDS; MINERAL DENSITY; WNT CORECEPTOR; CANCER CELLS; FLUID SHEAR; LRP5 GENE	The Wnt/beta-catenin pathway has been implicated in bone cell response to their mechanical environment. This response is the origin of the mechanism by which bone cells adjust bone architecture to maintain bone strength. Osteoporosis is the most widespread failure of this mechanism. The degree of osteoporotic bone loss in men and women is related to bio-available estrogen. Here we report that in osteoblastic ROS 17/2.8 cells and primary osteoblast cultures, a single short period of dynamic mechanical strain, as well as the glycogen synthase kinase-3 beta (GSK-3 beta) inhibitor LiCl, increased nuclear accumulation of activated beta-catenin and stimulated TCF/LEF reporter activity. This effect was blocked by the estrogen receptor ( ER) modulators ICI 182,780 and tamoxifen and was absent in primary osteoblast cultures from mice lacking ER alpha. Microarray expression data for 25,000 genes from total RNA extracted from tibiae of wild-type mice within 24 h of being loaded in vivo showed differential gene regulation between loaded and contralateral non-loaded bones of 10 genes established to be involved in the Wnt pathway. Only 2 genes were involved in loaded tibiae from mice lacking ER alpha (ER alpha(-/-)). Together these data suggest that Wnt/beta-catenin signaling contributes to bone cell early responses to mechanical strain and that its effectiveness requires ER alpha. Reduced effectiveness of bone cell responses to bone loading, associated with estrogen-related decline in ER alpha, may contribute to the failure to maintain structurally appropriate bone mass in osteoporosis in both men and women.	Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England	University of London; University of London Royal Veterinary College	Lanyon, LE (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Royal Coll St, London NW1 0TU, England.	llanyon@rvc.ac.uk			BBSRC [BB/D524883/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524883/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Ankrom MA, 1998, BIOCHEM J, V333, P787, DOI 10.1042/bj3330787; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Batra GS, 2003, J PATHOL, V200, P65, DOI 10.1002/path.1332; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bettini E, 2002, NEUROSCI LETT, V317, P50, DOI 10.1016/S0304-3940(01)02405-3; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J; CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6; Cheng MZ, 1996, J BONE MINER RES, V11, P502; Damien E, 1998, J BONE MINER RES, V13, P1275, DOI 10.1359/jbmr.1998.13.8.1275; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dupont S, 2000, DEVELOPMENT, V127, P4277; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Horton MA, 2003, BRIT J HAEMATOL, V122, P950, DOI 10.1046/j.1365-2141.2003.04530.x; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; Howe EG, 2000, J CLIN ETHIC, V11, P3; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Hoyland JA, 1999, J PATHOL, V188, P294; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Masiello D, 2004, MOL ENDOCRINOL, V18, P2388, DOI 10.1210/me.2003-0436; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; RAWLINSON SCF, 1991, J BONE MINER RES, V6, P1345; Rawlinson SCF, 2000, BONE, V27, P241, DOI 10.1016/S8756-3282(00)00323-9; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; ROBLING AG, 2006, AM SOC BONE MINERAL; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Saitoh T, 2002, INT J ONCOL, V20, P117; SAWAKAMI K, 2004, AM SOC BONE MINERAL, P1149; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Scholten AN, 2003, J PATHOL, V201, P460, DOI 10.1002/path.1402; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Slemenda CW, 1997, J CLIN INVEST, V100, P1755, DOI 10.1172/JCI119701; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Suuriniemi M, 2004, J BONE MINER RES, V19, P1758, DOI 10.1359/JBMR.040918; Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626; Truica CI, 2000, CANCER RES, V60, P4709; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vietor I, 2005, J BIOL CHEM, V280, P39795, DOI 10.1074/jbc.M509836200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; Zaman G, 2000, BONE, V27, P233, DOI 10.1016/S8756-3282(00)00324-0; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000	83	218	237	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20715	20727		10.1074/jbc.M703224200	http://dx.doi.org/10.1074/jbc.M703224200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17491024	hybrid			2022-12-27	WOS:000247819300074
J	Cho, YW; Hong, T; Hong, S; Guo, H; Yu, H; Kim, D; Guszczynski, T; Dressler, GR; Copeland, TD; Kalkum, M; Ge, K				Cho, Young-Wook; Hong, Teresa; Hong, SunHwa; Guo, Hong; Yu, Hong; Kim, Doyeob; Guszczynski, Tad; Dressler, Gregory R.; Copeland, Terry D.; Kalkum, Markus; Ge, Kai			PTIP associates with MLL3-and MLL4-containing histone H3 lysine 4 methyltransferase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DROSOPHILA-TRITHORAX; ACTIVE CHROMATIN; SET1 COMPLEX; TARGET GENES; METHYLATION; PROTEIN; COACTIVATOR; GROWTH; MLL2	PTIP, a protein with tandem BRCT domains, has been implicated in DNA damage response. However, its normal cellular functions remain unclear. Here we show that while ectopically expressed PTIP is capable of interacting with DNA damage response proteins including 53BP1, endogenous PTIP, and a novel protein PA1 are both components of a Set1-like histone methyltransferase (HMT) complex that also contains ASH2L, RBBP5, WDR5, hDPY-30, NCOA6, SET domain-containing HMTsMLL3 and MLL4, and substoichiometric amount of JmjC domain-containing putative histone demethylase UTX. PTIP complex carries robust HMT activity and specifically methylates lysine 4 (K4) on histone H3. Furthermore, PA1 binds PTIP directly and requires PTIP for interaction with the rest of the complex. Moreover, we show that hDPY-30 binds ASH2L directly. The evolutionarily conserved hDPY-30, ASH2L, RBBP5, and WDR5 likely constitute a subcomplex that is shared by all human Set1-likeHMTcomplexes. In contrast, PTIP, PA1, and UTX specifically associate with the PTIP complex. Thus, in cells without DNA damage agent treatment, the endogenous PTIP associates with a Set1-like HMT complex of unique subunit composition. As histone H3 K4 methylation associates with active genes, our study suggests a potential role of PTIP in the regulation of gene expression.	NIDDK, NIH, Nucl Receptor Biol Sect, Bethesda, MD 20892 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; NCI, Natl Inst Hlth, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); City of Hope; Beckman Research Institute of City of Hope; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ge, K (corresponding author), NIDDK, NIH, Nucl Receptor Biol Sect, Bethesda, MD 20892 USA.	kaig@niddk.nih.gov	Cho, Young-Wook/F-8269-2011; Ge, Kai/H-2810-2019	Ge, Kai/0000-0002-7442-5138; Kalkum, Markus/0000-0002-9506-671X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, Z01DK075003, ZIADK047055, ZIADK075017, Z01DK047055] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK047055-01, Z01 DK075003-04, Z99 DK999999] Funding Source: Medline; NIDDK NIH HHS [ZIADK075003-06, ZIADK075017-01, ZIADK047055-03] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; DOU Y, 2006, NAT STRUCT MOL BIOL, V20, P586; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kalkum M, 2003, P NATL ACAD SCI USA, V100, P2795, DOI 10.1073/pnas.0436605100; Kim D, 2007, J AM SOC NEPHROL, V18, P1458, DOI 10.1681/ASN.2006060625; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Mahajan MA, 2005, ENDOCR REV, V26, P583, DOI 10.1210/er.2004-0012; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Shimizu K, 2001, MOL CELL BIOL, V21, P3901, DOI 10.1128/MCB.21.12.3901-3912.2001; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021	40	404	425	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20395	20406		10.1074/jbc.M701574200	http://dx.doi.org/10.1074/jbc.M701574200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17500065	Green Accepted, hybrid			2022-12-27	WOS:000247819300042
J	Deikus, G; Bechhofer, DH				Deikus, Gintaras; Bechhofer, David H.			Initiation of decay of Bacillus subtilis trp leader RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING ATTENUATION PROTEIN; MESSENGER-RNA; ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; TRANSCRIPTION ATTENUATION; DEGRADATION; STRAIN	Transcription termination in the leader region of the Bacillus subtilis trp operon is regulated by binding of the 11-mer TRAP complex to nascent trp RNA, which results in formation of a terminator structure. Rapid decay of trp leader RNA, which is required to release the TRAP complex and maintain a sufficient supply of free TRAP, is mediated by polynucleotide phosphorylase (PNPase). Using purified B. subtilis PNPase, we showed that, when TRAP was present, PNPase binding to the 3' end of trp leader RNA and PNPase digestion of trp leader RNA from the 3' end were inefficient. These results suggested that initiation of trp leader RNA may begin with an endonuclease cleavage upstream of the transcription terminator structure. Such cleavage was observed in vivo. Mutagenesis of nucleotides at the cleavage site abolished processing and resulted in a 4-fold increase in trp leader RNA half-life. This is the first mapping of a decay-initiating endonuclease cleavage site on a native B. subtilis RNA.	NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University	Bechhofer, DH (corresponding author), NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, 550 1St Ave, New York, NY 10029 USA.	david.bechhofer@mssm.edu			NIGMS NIH HHS [GM 48804] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTA JA, 1994, J BIOL CHEM, V269, P4532; Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; BROSIUS J, 1992, METHOD ENZYMOL, V216, P469; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; Coburn GA, 1998, J MOL BIOL, V279, P1061, DOI 10.1006/jmbi.1998.1842; COHEN SN, 1995, CELL, V80, P829, DOI 10.1016/0092-8674(95)90284-8; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; Deikus G, 2004, P NATL ACAD SCI USA, V101, P2747, DOI 10.1073/pnas.0307343101; DEUTSCHER MP, 1991, P NATL ACAD SCI USA, V88, P3277, DOI 10.1073/pnas.88.8.3277; GOLLNICK P, 1990, P NATL ACAD SCI USA, V87, P8726, DOI 10.1073/pnas.87.22.8726; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hambraeus G, 2003, MOL GENET GENOMICS, V269, P706, DOI 10.1007/s00438-003-0883-6; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Kagedal L., 1998, PROTEIN PURIFICATION, P311; Kossen K, 1999, NUCLEIC ACIDS RES, V27, P3811, DOI 10.1093/nar/27.19.3811; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; LITTAUER UZ, 1980, ENZYMES, P517; Marujo PE, 2003, MOL MICROBIOL, V50, P1283, DOI 10.1046/j.1365-2958.2003.03753.x; Matsunaga J, 1996, MOL MICROBIOL, V22, P977, DOI 10.1046/j.1365-2958.1996.01529.x; Oussenko IA, 2005, J BACTERIOL, V187, P2758, DOI 10.1128/JB.187.8.2758-2767.2005; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Stickney LM, 2005, J BACTERIOL, V187, P7214, DOI 10.1128/JB.187.21.7214-7221.2005; Wang W, 1996, J BACTERIOL, V178, P2375, DOI 10.1128/jb.178.8.2375-2382.1996; Yakhnin AV, 2000, J BIOL CHEM, V275, P4519, DOI 10.1074/jbc.275.6.4519	26	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20238	20244		10.1074/jbc.M702747200	http://dx.doi.org/10.1074/jbc.M702747200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17507374	hybrid			2022-12-27	WOS:000247819300026
J	Figueiredo, RT; Fernandez, PL; Mourao-Sa, DS; Porto, BN; Dutra, FF; Alves, LS; Oliveira, MF; Oliveira, PL; Graca-Souza, AV; Bozza, MT				Figueiredo, Rodrigo T.; Fernandez, Patricia L.; Mourao-Sa, Diego S.; Porto, Barbara N.; Dutra, Fabianno F.; Alves, Leticia S.; Oliveira, Marcus F.; Oliveira, Pedro L.; Graca-Souza, Aurelio V.; Bozza, Marcelo T.			Characterization of heme as activator of toll-like receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; TUMOR-NECROSIS-FACTOR; MURINE MACROPHAGES; DENDRITIC CELLS; ENDOTOXIN CONTAMINATION; CUTTING EDGE; TLR4; MICE; LIPOPOLYSACCHARIDE; IDENTIFICATION	Heme is an ancient and ubiquitous molecule present in organisms of all kingdoms, composed of an atom of iron linked to four ligand groups of porphyrin. A high amount of free heme, a potential amplifier of the inflammatory response, is a characteristic feature of diseases with increased hemolysis or extensive cell damage. Here we demonstrate that heme, but not its analogs/ precursors, induced tumor necrosis factor-alpha (TNF-alpha) secretion by macrophages dependently on MyD88, TLR4, and CD14. The activation of TLR4 by heme is exquisitely strict, requiring its coordinated iron and the vinyl groups of the porphyrin ring. Signaling of heme through TLR4 depended on an interaction distinct from the one established between TLR4 and lipopolysaccharide (LPS) since anti-TLR4/MD2 antibody or a lipid A antagonist inhibited LPS-induced TNF-alpha secretion but not heme activity. Conversely, protoporphyrin IX antagonized heme without affecting LPS-induced activation. Moreover, heme induced TNF-alpha and keratinocyte chemokine but was ineffective to induce interleukin-6, interleukin-12, and interferon-inducible protein-10 secretion or co-stimulatory molecule expression. These findings support the concept that the broad ligand specificity of TLR4 and the different activation profiles might in part reside in its ability to recognize different ligands in different binding sites. Finally, heme induced oxidative burst, neutrophil recruitment, and heme oxygenase-1 expression independently of TLR4. Thus, our results presented here reveal a previous unrecognized role of heme as an extracellular signaling molecule that affects the innate immune response through a receptor-mediated mechanism.	Univ Fed Rio de Janeiro, Inst Microbiol, Dept Immunol, CCS Bloco I, BR-21941 Rio De Janeiro, RJ, Brazil; Inst Adv Sci Invest & High Technol Serv, Panama City 0816, Panama; Univ Fed Rio de Janeiro, Inst Med Biochem, Program Biotechnol & Biol Mol, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol, Dept Immunol, CCS Bloco I, Avenida Carlos Chagas Filho,373 Cidade Univ, BR-21941 Rio De Janeiro, RJ, Brazil.	mbozza@micro.ufrj.br	Ferreira Dutra, Fabianno/AAE-2895-2022; Mourao-Sa, Diego/C-5977-2009; Oliveira, Marcus/G-3158-2011; Dutra, Fabianno F/C-1387-2015; L. Oliveira, Pedro/A-9438-2010; Figueiredo, Rodrigo/F-5176-2016	Ferreira Dutra, Fabianno/0000-0003-3106-7585; Oliveira, Marcus/0000-0002-9890-8425; Dutra, Fabianno F/0000-0003-3106-7585; Bozza, Marcelo/0000-0003-3683-7550; Llanes Fernandez, Patricia/0000-0002-0762-0566; L. Oliveira, Pedro/0000-0003-0307-354X; Mourao, Diego/0000-0001-6618-6969; Figueiredo, Rodrigo/0000-0002-7551-8782				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; ASEA A, 2001, J IMMUNOL, V167, P2887; Balla J, 2000, BLOOD, V95, P3442, DOI 10.1182/blood.V95.11.3442.011k51_3442_3450; Barsness KA, 2004, AM J PHYSIOL-REG I, V287, pR592, DOI 10.1152/ajpregu.00412.2003; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; CHOU AC, 1980, J CLIN INVEST, V66, P856, DOI 10.1172/JCI109925; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; GALBRAITH RA, 1990, J HEPATOL, V10, P305, DOI 10.1016/0168-8278(90)90137-G; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Perera PY, 1997, J IMMUNOL, V158, P4422; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Reed RC, 2003, J BIOL CHEM, V278, P31853, DOI 10.1074/jbc.M305480200; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5	55	389	404	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20221	20229		10.1074/jbc.M610737200	http://dx.doi.org/10.1074/jbc.M610737200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502383	hybrid			2022-12-27	WOS:000247819300024
J	Tembe, V; Henderson, BR				Tembe, Varsha; Henderson, Beric R.			BARD1 translocation to mitochondria correlates with bax oligomerization, loss of mitochondrial membrane potential, and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; RING DOMAIN; TUMOR-SUPPRESSOR; CELL-DEATH; P53-DEPENDENT APOPTOSIS; BRCA1/BARD1 HETERODIMER; NUCLEAR EXPORT; BREAST-CANCER; CYTOCHROME-C; DNA-DAMAGE	The breast cancer regulatory protein-1 (BRCA1)-associated RING domain 1 (BARD1) gene is mutated in a subset of breast/ovarian cancers. BARD1 functions as a heterodimer with BRCA1 in nuclear DNA repair. BARD1 also has a BRCA1-independent apoptotic activity. Here we investigated the link between cytoplasmic localization and apoptotic function of BARD1. We used immunofluorescence microscopy and deconvolution analysis to resolve BARD1 cytoplasmic staining patterns and detected endogenous BARD1 at mitochondria. BARD1 was also detected in mitochondrial cell fractions by immunoblotting. The targeting of BARD1 to mitochondria was modestly stimulated by DNA damage and did not require BRCA1 as indicated by RNA interference and peptide-competition experiments. Transiently expressed yellow fluorescence protein-BARD1 localized to mitochondria, and the targeting sequences were mapped to both the N and C terminus of BARD1. Ectopic yellow fluorescence protein-BARD1 induced apoptosis and loss of mitochondrial membrane potential in MCF-7 breast tumor cells. BARD1 apoptotic function was associated with stimulation of Bax oligomerization at mitochondria. This distinguishes it from BRCA1, which is pro-apoptotic but did not induce Bax oligomerization. The cancer-associated BARD1 splice-variant Delta RIN (lacks the BRCA1 binding domain and ankyrin repeats) was recruited to mitochondria but did not stimulate apoptosis or alter membrane permeability. We propose that BARD1 has two main sites of action in its cellular response to DNA damage, the nucleus, where it promotes cell survival through DNA repair, and the mitochondria, where BARD1 regulates apoptosis.	Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Henderson, BR (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia.	beric_henderson@wmi.usyd.edu.au						Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Au WWY, 2005, J BIOL CHEM, V280, P6993, DOI 10.1074/jbc.M408879200; Ayi TC, 1998, ONCOGENE, V17, P2143, DOI 10.1038/sj.onc.1202123; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Charlot JF, 2004, APOPTOSIS, V9, P333, DOI 10.1023/B:APPT.0000025810.58981.4c; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103; Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Fabbro M, 2004, EXP CELL RES, V298, P661, DOI 10.1016/j.yexcr.2004.05.004; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Gautier F, 2000, CANCER RES, V60, P6895; Ghimenti C, 2002, GENE CHROMOSOME CANC, V33, P235, DOI 10.1002/gcc.1223; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Jefford CE, 2004, ONCOGENE, V23, P3509, DOI 10.1038/sj.onc.1207427; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Karppinen SM, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.020669; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; McCarthy EE, 2003, MOL CELL BIOL, V23, P5056, DOI 10.1128/MCB.23.14.5056-5063.2003; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Rodriguez JA, 2004, ONCOGENE, V23, P1809, DOI 10.1038/sj.onc.1207302; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Schuchner S, 2005, J BIOL CHEM, V280, P8855, DOI 10.1074/jbc.M413741200; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Starita LM, 2005, J BIOL CHEM, V280, P24498, DOI 10.1074/jbc.M414020200; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Tsuzuki M, 2006, CANCER LETT, V233, P108, DOI 10.1016/j.canlet.2005.03.012; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	47	35	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20513	20522		10.1074/jbc.M702627200	http://dx.doi.org/10.1074/jbc.M702627200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17510055	hybrid			2022-12-27	WOS:000247819300054
J	Andrade, J; Karmali, A; Carrondo, MA; Frazao, C				Andrade, Jorge; Karmali, Amin; Carrondo, Maria A.; Frazao, Carlos			Structure of amidase from Pseudomonas aeruginosa showing a trapped acyl transfer reaction intermediate state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; AMINO-ACID AMIDOHYDROLASE; CRYSTAL-STRUCTURE; ALIPHATIC AMIDASE; ACTIVE-SITE; NUCLEOTIDE-SEQUENCE; GENE; RESOLUTION; NITRILASE; STRAIN	Microbial amidases belong to the thiol nitrilases family and have potential biotechnological applications in chemical and pharmaceutical industries as well as in bioremediation. The amidase from Pseudomonas aeruginosa is a 6 x 38-kDa enzyme that catalyzes the hydrolysis of a small range of short aliphatic amides. The hereby reported high resolution crystallographic structure shows that each amidase monomer is formed by a globular four-layer alpha beta beta alpha sandwich domain with an additional 81-residue long C-terminal segment. This wraps arm-in-arm with a homologous C-terminal chain of another monomer, producing a strongly packed dimer. In the crystal, the biological active homo-hexameric amidase is built grouping three such dimers around a crystallographic 3-fold axis. The structure also elucidates the structural basis for the enzyme activity, with the nitrilases catalytic triad at the bottom of a 13-angstrom deep, funnelshaped pocket, accessible from the solvent through a narrow neck with 3-angstrom diameter. An acyl transfer intermediate, resulting from the purification protocol, was found bound to the amidase nucleophilic agent, Cys166. These results suggest that some pocket defining residues should undergo conformational shifts to allow substrates and products to access and leave the catalytic pocket, for turnover to occur.	Univ Nova Lisboa, Inst Technol Quim & Biol, P-2781 Oeiras, Portugal; Inst Super Engn Lisboa, Ctr Invest Engn Quim & Biotechnol, P-1950 Lisbon, Portugal	Universidade Nova de Lisboa; Polytechnic Institute of Lisbon	Frazao, C (corresponding author), Univ Nova Lisboa, Inst Technol Quim & Biol, Avenida da Republ, P-2781 Oeiras, Portugal.	frazao@itqb.unl.pt	Karmali, Amin/GPX-0993-2022; Karmali, Amin/AAI-4633-2020; Karmali, Amin/E-4787-2011; Andrade, Jorge/AAD-6324-2021; Frazao, Carlos/C-1965-2008	Karmali, Amin/0000-0003-0419-401X; Carrondo, Maria Armenia/0000-0002-1261-1162; Frazao, Carlos/0000-0002-7725-1671; Andrade, Jorge/0000-0002-4577-8620				Agarkar VB, 2006, ACTA CRYSTALLOGR F, V62, P1174, DOI 10.1107/S1744309106043855; Andrade J, 2007, ACTA CRYSTALLOGR F, V63, P214, DOI 10.1107/S1744309107005830; BABU GRV, 1995, APPL MICROBIOL BIOT, V43, P739; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BETZ JL, 1972, J GEN MICROBIOL, V73, P161, DOI 10.1099/00221287-73-1-161; BRAMMAR WJ, 1987, FEBS LETT, V215, P291, DOI 10.1016/0014-5793(87)80164-3; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; BROWN JE, 1970, J GEN MICROBIOL, V64, P329, DOI 10.1099/00221287-64-3-329; BROWN JE, 1969, J GEN MICROBIOL, V57, P273, DOI 10.1099/00221287-57-2-273; BROWN PR, 1972, J GEN MICROBIOL, V70, P287, DOI 10.1099/00221287-70-2-287; Caliandro R, 2005, ACTA CRYSTALLOGR D, V61, P556, DOI 10.1107/S090744490500404X; Cawston TE, 1996, PHARMACOL THERAPEUT, V70, P163, DOI 10.1016/0163-7258(96)00015-0; CLARKE PH, 1972, J GEN MICROBIOL, V71, P241, DOI 10.1099/00221287-71-2-241; DeLano W.L, PYMOL MOL GRAPHICS S; DOMINGOS A, 1989, BIOCHIMIE, V71, P1179, DOI 10.1016/0300-9084(89)90021-7; Farnaud S, 1999, BIOCHEM J, V340, P711, DOI 10.1042/0264-6021:3400711; FINDLATE.JD, 1973, FEBS LETT, V35, P109, DOI 10.1016/0014-5793(73)80588-5; Fournand D, 1998, APPL ENVIRON MICROB, V64, P2844; Fournand D, 1998, J MOL CATAL B-ENZYM, V4, P77, DOI 10.1016/S1381-1177(97)00024-6; Fournand D, 1997, ENZYME MICROB TECH, V20, P424, DOI 10.1016/S0141-0229(96)00170-6; GAO WY, 1995, BIOCHEM PHARMACOL, V50, P274, DOI 10.1016/0006-2952(95)00106-A; GREGORIOU M, 1979, EUR J BIOCHEM, V96, P101, DOI 10.1111/j.1432-1033.1979.tb13018.x; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Karmali A, 2001, MOL BIOTECHNOL, V17, P201, DOI 10.1385/MB:17:3:201; Karmali A, 2000, MOL BIOTECHNOL, V16, P5, DOI 10.1385/MB:16:1:05; KELLY M, 1962, J GEN MICROBIOL, V27, P305, DOI 10.1099/00221287-27-2-305; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Kumaran D, 2003, PROTEINS, V52, P283, DOI 10.1002/prot.10417; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; MAESTRACCI M, 1986, AGR BIOL CHEM TOKYO, V50, P2237, DOI 10.1080/00021369.1986.10867736; Martins S, 2005, MOL BIOTECHNOL, V30, P207, DOI 10.1385/MB:30:3:207; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2000, STRUCTURE, V8, P729, DOI 10.1016/S0969-2126(00)00160-X; NAWAZ MS, 1991, CAN J MICROBIOL, V37, P411, DOI 10.1139/m91-067; NAWAZ MS, 1991, APPL BIOCHEM BIOTECH, V28-9, P865, DOI 10.1007/BF02922656; NOVO C, 1995, FEBS LETT, V367, P275, DOI 10.1016/0014-5793(95)00585-W; Novo C, 2002, BIOCHEM J, V365, P731, DOI 10.1042/BJ20011714; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace HC, 2000, CURR BIOL, V10, P907, DOI 10.1016/S0960-9822(00)00621-7; Pace HC, 2001, GENOME BIOL, V2; Pacheco R, 2005, ANAL BIOCHEM, V346, P49, DOI 10.1016/j.ab.2005.07.027; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; PLOEGMAN JH, 1978, J MOL BIOL, V123, P557, DOI 10.1016/0022-2836(78)90207-3; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; STEVENSON DE, 1992, BIOTECHNOL APPL BIOC, V15, P283; STEVENSON DE, 1990, FEBS LETT, V277, P112, DOI 10.1016/0014-5793(90)80821-Y; TATA R, 1994, BBA-PROTEIN STRUCT M, V1205, P139, DOI 10.1016/0167-4838(94)90102-3; Tsafack A, 1996, J LAB CLIN MED, V127, P574, DOI 10.1016/S0022-2143(96)90148-1; Vanjari H, 2003, J PHARMACEUT BIOMED, V33, P783, DOI 10.1016/S0731-7085(03)00282-6; Wang WC, 2001, J MOL BIOL, V306, P251, DOI 10.1006/jmbi.2000.4380; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WOODS MJ, 1979, BIOCHIM BIOPHYS ACTA, V567, P225, DOI 10.1016/0005-2744(79)90189-X; Wu SJ, 1998, DNA CELL BIOL, V17, P915, DOI 10.1089/dna.1998.17.915	67	40	42	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19598	19605		10.1074/jbc.M701039200	http://dx.doi.org/10.1074/jbc.M701039200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17442671	hybrid			2022-12-27	WOS:000247650600034
J	De Nicola, F; Bruno, T; Iezzi, S; Di Padova, M; Floridi, A; Passananti, C; Del Sal, G; Fanciulli, M				De Nicola, Francesca; Bruno, Tiziana; Iezzi, Simona; Di Padova, Monica; Floridi, Aristide; Passananti, Claudio; Del Sal, Giannino; Fanciulli, Maurizio			The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; P53 STABILITY; CELL-GROWTH; PHOSPHORYLATION; INTERACTS; RB; DOMAINS; MDM2; TAU; IDENTIFICATION	We have previously demonstrated that DNA damage leads to stabilization and accumulation of Che-1, an RNA polymerase II-binding protein that plays an important role in transcriptional activation of p53 and in maintenance of the G2/M checkpoint. Here we show that Che-1 is down-regulated during the apoptotic process. We found that the E3 ligase HMD2 physically and functionally interacts with Che-1 and promotes its degradation via the ubiquitin-dependent proteasomal system. Furthermore, we found that in response to apoptotic stimuli Che-1 interacts with the peptidyl-prolyl isomerase Pin1 and that conformational changes generated by Pin1 are required for Che-1/HDM2 interaction. Notably, a Che-1 mutant lacking the capacity to bind Pin1 exhibits an increased half-life and this correlates with a diminished apoptosis in response to genotoxic stress. Our results establish Che-1 as a new Pin1 and HDM2 target and confirm its important role in the cellular response to DNA damage.	Regina Elena Inst Canc Res, Lab B Expt Res Ctr, I-00158 Rome, Italy; Regina Elena Inst Canc Res, Reome Oncogenom Ctr, I-00158 Rome, Italy; Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; CNR, Ist Biol & Patol Mol, I-00137 Rome, Italy; Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, Lab Nazl Consorzio Interuniv Biotechnol, I-34100 Trieste, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of Trieste	Fanciulli, M (corresponding author), Regina Elena Inst Canc Res, Lab B Expt Res Ctr, Via delle Messi Oro 156, I-00158 Rome, Italy.	fanciulli@.ifo.it	Passananti, Claudio/K-9593-2016; De Nicola, Francesca/AAC-6887-2022; Fanciulli, Marco/J-9940-2013; bruno, tiziana/AAC-4913-2022; fanciulli, maurizio/ABH-6745-2020; Iezzi, Simona/AAA-3275-2021	Fanciulli, Marco/0000-0003-2951-0859; bruno, tiziana/0000-0003-0352-4523; Iezzi, Simona/0000-0002-7484-5861; PASSANANTI, CLAUDIO/0000-0002-9288-5736; De Nicola, FRANCESCA/0000-0002-2187-7544; DEL SAL, GIANNINO/0000-0003-2185-6003; DI PADOVA, Monica/0000-0003-3808-7159				Barbato C, 2003, MOL CELL NEUROSCI, V24, P1038, DOI 10.1016/j.mcn.2003.08.002; Bruno T, 2002, CANCER CELL, V2, P387, DOI 10.1016/S1535-6108(02)00182-4; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Di Padova M, 2003, J BIOL CHEM, V278, P36496, DOI 10.1074/jbc.M306694200; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leister P., 2003, SIGNAL TRANSDUCTION, V3, P17, DOI [10.1002/sita.200300020, DOI 10.1002/SITA.200300020]; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; Lindfors K, 2000, BIOCHEM BIOPH RES CO, V276, P660, DOI 10.1006/bbrc.2000.3480; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Monaco L, 2003, GENE, V321, P57, DOI 10.1016/S0378-1119(03)00834-5; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; Page G, 1999, FEBS LETT, V462, P187, DOI 10.1016/S0014-5793(99)01529-X; Pathan N, 2001, NEOPLASIA, V3, P70, DOI 10.1038/sj.neo.7900131; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Thomas T, 2000, DEV BIOL, V227, P324, DOI 10.1006/dbio.2000.9915; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	38	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19685	19691		10.1074/jbc.M610282200	http://dx.doi.org/10.1074/jbc.M610282200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17468107	hybrid			2022-12-27	WOS:000247650600043
J	Grigorian, A; Lee, SU; Tian, WQ; Chen, IJ; Gao, GY; Mendelsohn, R; Dennis, JW; Demetriou, M				Grigorian, Ani; Lee, Sung-Uk; Tian, Wenqiang; Chen, I.-Ju; Gao, Guoyan; Mendelsohn, Richard; Dennis, James W.; Demetriou, Michael			Control of T cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DIABETES-MELLITUS; MULTIPLE-SCLEROSIS; CBL-B; ACETYLGLUCOSAMINYLTRANSFERASE-V; NEGATIVE REGULATION; MOLECULAR MIMICRY; VITAMIN-D; ENCEPHALOMYELITIS; GLYCOSYLATION; GLUCOSAMINE	Autoimmunity is a complex trait disease where the environment influences susceptibility to disease by unclear mechanisms. T cell receptor clustering and signaling at the immune synapse, T cell proliferation, CTLA-4 endocytosis, TH1 differentiation, and autoimmunity are negatively regulated by beta 1,6GlcNAc-branched N-glycans attached to cell surface glycoproteins. beta 1,6GlcNAc-branched N-glycan expression in T cells is dependent on metabolite supply to UDP-GlcNAc biosynthesis ( hexosamine pathway) and in turn to Golgi N-acetylglucosaminyltransferases Mgat1,-2, -4, and -5. In Jurkat T cells, beta 1,6GlcNAc- branching in N-glycans is stimulated by metabolites supplying the hexosamine pathway including glucose, GlcNAc, acetoacetate, glutamine, ammonia, or uridine but not by control metabolites mannosamine, galactose, mannose, succinate, or pyruvate. Hexosamine supplementation in vitro and in vivo also increases beta 1,6GlcNAc- branched N-glycans in naive mouse T cells and suppresses T cell receptor signaling, T cell proliferation, CTLA-4 endocytosis, TH1 differentiation, experimental autoimmune encephalomyelitis, and autoimmune diabetes in non-obese diabetic mice. Our results indicate that metabolite flux through the hexosamine and N-glycan pathways conditionally regulates autoimmunity by modulating multiple T cell functionalities downstream of beta 1,6GlcNAc- branched N-glycans. This suggests metabolic therapy as a potential treatment for autoimmune disease.	Univ Calif Irvine, Dept Neurol & Microbiol & Mol Genet, Irvine, CA 92697 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L5, Canada	University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol & Microbiol & Mol Genet, 250 Sprague Hall, Irvine, CA 92697 USA.	mdemetri@uci.edu	Dennis, James/E-7268-2013	Demetriou, Michael/0000-0002-2224-7798				Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Granovsky M, 2000, NAT MED, V6, P306; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Ma LL, 2002, J BIOL CHEM, V277, P39343, DOI 10.1074/jbc.M204924200; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Nakagawa H, 1996, EUR J BIOCHEM, V237, P76, DOI 10.1111/j.1432-1033.1996.0076n.x; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; SCHAEFER HF, 1989, CHIMIA, V43, P1; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Tao X, 1997, J IMMUNOL, V159, P5956; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; WALL KA, 1988, P NATL ACAD SCI USA, V85, P5644, DOI 10.1073/pnas.85.15.5644; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zella JB, 2003, ARCH BIOCHEM BIOPHYS, V417, P77, DOI 10.1016/S0003-9861(03)00338-2; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202	47	97	107	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					20027	20035		10.1074/jbc.M701890200	http://dx.doi.org/10.1074/jbc.M701890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488719	Green Published, hybrid			2022-12-27	WOS:000247650600076
J	Ito, K; Ikebe, M; Kashiyama, T; Mogami, T; Kon, T; Yamamoto, K				Ito, Kohji; Ikebe, Mitsuo; Kashiyama, Taku; Mogami, Toshifumi; Kon, Takahide; Yamamoto, Keiichi			Kinetic mechanism of the fastest motor protein, Chara myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTOR; DUTY RATIO MOTOR; DICTYOSTELIUM-DISCOIDEUM MYOSIN; LARGE STEP-SIZE; ATPASE ACTIVITY; SMOOTH-MUSCLE; ACTOMYOSIN SUBFRAGMENT-1; NUCLEOTIDE-BINDING; CONFORMATIONAL-CHANGE; MOTILE PROPERTIES	Chara corallina class XI myosin is by far the fastest molecular motor. To investigate the molecular mechanism of this fast movement, we performed a kinetic analysis of a recombinant motor domain of Chara myosin. We estimated the time spent in the strongly bound state with actin by measuring rate constants of ADP dissociation from actin(.)motor domain complex and ATP-induced dissociation of the motor domain from actin. The rate constant of ADP dissociation from acto-motor domain was > 2800 s(-1), and the rate constant of ATP-induced dissociation of the motor domain from actin at physiological ATP concentration was 2200 s(-1). From these data, the time spent in the strongly bound state with actin was estimated to be < 0.82 ms. This value is the shortest among known values for various myosins and yields the duty ratio of < 0.3 with a V-max value of the actin-activated ATPase activity of 390 s(-1). The addition of the long neck domain of myosin Va to the Chara motor domain largely increased the velocity of the motility without increasing the ATP hydrolysis cycle rate, consistent with the swinging lever model. In addition, this study reveals some striking kinetic features of Chara myosin that are suited for the fast movement: a dramatic acceleration of ADP release by actin (1000-fold) and extremely fast ATP binding rate.	Chiba Univ, Dept Biol, Inage Ku, Chiba 263, Japan; Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 153, Japan	Chiba University; University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo	Ito, K (corresponding author), Chiba Univ, Dept Biol, Inage Ku, Chiba 263, Japan.	k-ito@faculty.chiba-u.jp	Ito, Kohji/K-8441-2017; Kon, Takahide/AAG-6975-2021	Ito, Kohji/0000-0001-9573-432X; Kon, Takahide/0000-0002-1231-7609	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048526, R01AR048898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR048526, AR048898] Funding Source: Medline; NIDCD NIH HHS [DC006103] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Awata J, 2003, J MOL BIOL, V326, P659, DOI 10.1016/S0022-2836(02)01469-9; Awata J, 2001, PLANT CELL PHYSIOL, V42, P828, DOI 10.1093/pcp/pce107; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; GORDON DJ, 1976, J BIOL CHEM, V251, P7474; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; HIGASHIFUJIME S, 1995, FEBS LETT, V375, P151, DOI 10.1016/0014-5793(95)01208-V; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2005, J BIOL CHEM, V280, P29381, DOI 10.1074/jbc.M504779200; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; Ito K, 2003, BIOCHEM BIOPH RES CO, V312, P958, DOI 10.1016/j.bbrc.2003.10.202; Ito K, 2003, J BIOL CHEM, V278, P31049, DOI 10.1074/jbc.M304138200; Iwane AH, 2005, J MOL BIOL, V353, P213, DOI 10.1016/j.jmb.2005.08.013; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Jontes JD, 1997, P NATL ACAD SCI USA, V94, P14332, DOI 10.1073/pnas.94.26.14332; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Kambara T, 2006, J BIOL CHEM, V281, P37291, DOI 10.1074/jbc.M603823200; Kashiyama T, 2000, J BIOCHEM-TOKYO, V127, P1065, DOI 10.1093/oxfordjournals.jbchem.a022699; Kimura Y, 2003, J MOL BIOL, V328, P939, DOI 10.1016/S0022-2836(03)00341-3; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Kovacs M, 2002, J BIOL CHEM, V277, P28459, DOI 10.1074/jbc.M202180200; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Kurzawa-Goertz SE, 1998, BIOCHEMISTRY-US, V37, P7517, DOI 10.1021/bi972844+; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Miller BM, 2003, J BIOL CHEM, V278, P50293, DOI 10.1074/jbc.M308318200; Morimatsu M, 2000, BIOCHEM BIOPH RES CO, V270, P147, DOI 10.1006/bbrc.2000.2391; Murphy CT, 1998, BIOCHEMISTRY-US, V37, P6738, DOI 10.1021/bi972903j; Ostap EM, 1996, J CELL BIOL, V132, P1053, DOI 10.1083/jcb.132.6.1053; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2000, J BIOL CHEM, V275, P25418, DOI 10.1074/jbc.M002685200; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Seki M, 2004, J MOL BIOL, V344, P311, DOI 10.1016/j.jmb.2004.09.039; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Silva R, 2003, J MUSCLE RES CELL M, V24, P489, DOI 10.1023/B:JURE.0000009809.69829.74; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; TRYBUS KM, 1982, BIOCHEMISTRY-US, V21, P1284, DOI 10.1021/bi00535a028; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Uyeda TQP, 2002, BIOCHEMISTRY-US, V41, P9525, DOI 10.1021/bi026177i; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WILLIAMS R, 1994, CELL MOTIL CYTOSKEL, V27, P41, DOI 10.1002/cm.970270105; Woodward SKA, 1995, BIOCHEMISTRY-US, V34, P16056, DOI 10.1021/bi00049a020; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; YAMAMOTO K, 1994, P JPN ACAD B-PHYS, V70, P175, DOI 10.2183/pjab.70.175; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200	77	52	52	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19534	19545		10.1074/jbc.M611802200	http://dx.doi.org/10.1074/jbc.M611802200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488711	hybrid			2022-12-27	WOS:000247650600028
J	Papa, S; Monti, SM; Vitale, RM; Bubici, C; Jayawardena, S; Alvarez, K; De Smaele, E; Dathan, N; Pedone, C; Ruvo, M; Franzoso, G				Papa, Salvatore; Monti, Simona M.; Vitale, Rosa Maria; Bubici, Concetta; Jayawardena, Shanthi; Alvarez, Kellean; De Smaele, Enrico; Dathan, Nina; Pedone, Carlo; Ruvo, Menotti; Franzoso, Guido			Insights into the structural basis of the GADD45 beta-mediated inactivation of the JNK kinase, MKK7/JNKK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CRYSTAL-STRUCTURE; CELL-DEATH; ACTIVATION; PROTEIN; GADD45; DIFFERENTIATION; TRANSDUCTION; INHIBITION; HOMOLOGY	NF-kappa B/Rel factors control programmed cell death (PCD), and this control is crucial to oncogenesis, cancer chemoresistance, and antagonism of tumor necrosis factor (TNF) alpha-induced killing. With TNF alpha, NF-kappa B-mediated protection involves suppression of the c-Jun-N-terminal kinase (JNK) cascade, and we have identified Gadd45 beta, a member of the Gadd45 family, as a pivotal effector of this activity of NF-kappa B. Inhibition of TNF alpha-induced JNK signaling by Gadd45 beta depends on direct targeting of the JNK kinase, MKK7/JNKK2. The mechanism by which Gadd45 beta blunts MKK7, however, is unknown. Here we show that Gadd45 beta is a structured protein with a predicted four-stranded beta-sheet core, five alpha-helices, and two acidic loops. Association of Gadd45 beta with MKK7 involves a network of interactions mediated by its putative helices alpha 3 and alpha 4 and loops 1 and 2. Whereas alpha 3 appears to primarily mediate docking to MKK7, loop 1 and alpha 4-loop 2 seemingly afford kinase inactivation by engaging the ATP-binding site and causing conformational changes that impede catalytic function. These data provide a basis for Gadd45 beta-mediated blockade of MKK7, and ultimately, TNF alpha-induced PCD. They also have important implications for treatment of widespread diseases.	Ist Biostrutture & Bioemmagini, Consiglio Nazl Rich, I-80134 Naples, Italy		Ruvo, M (corresponding author), Univ Chicago, Ben May Inst, Ben May Inst Canc Res, Chicago, IL 60637 USA.	menotti.ruvo@unina.it; gfranzos@midway.uchicago.edu	Papa, Salvatore/J-9413-2012; Vitale, Rosa Maria/AAY-1522-2020; Franzoso, Guido/GRR-8628-2022; De Smaele, Enrico/C-1124-2013; Monti, Simona M/J-5214-2012; MONTI, SIMONA MARIA/GQQ-0129-2022	Papa, Salvatore/0000-0002-8369-6538; Vitale, Rosa Maria/0000-0001-9243-1307; De Smaele, Enrico/0000-0003-4524-4423; MONTI, SIMONA MARIA/0000-0001-9647-7089; Franzoso, Guido/0000-0002-0778-988X; Bubici, Concetta/0000-0002-8074-4661	NATIONAL CANCER INSTITUTE [R01CA084040, R01CA098583] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA84040, R01 CA098583] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Claudio E, 2006, CELL DEATH DIFFER, V13, P697, DOI 10.1038/sj.cdd.4401894; D'Ambrosio C, 2003, BIOCHEMISTRY-US, V42, P4430, DOI 10.1021/bi0206715; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Koonin EV, 1997, J MOL MED-JMM, V75, P236; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Liebermann DA, 2002, ONCOGENE, V21, P3391, DOI 10.1038/sj.onc.1205312; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Snyder EL, 2001, CURR OPIN MOL THER, V3, P147; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021	35	51	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19029	19041		10.1074/jbc.M703112200	http://dx.doi.org/10.1074/jbc.M703112200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17485467	hybrid			2022-12-27	WOS:000247475300045
J	Fierro-Fernandez, M; Hernandez, P; Krimer, DB; Schvartzman, JB				Fierro-Fernandez, Marta; Hernandez, Pablo; Krimer, Dora B.; Schvartzman, Jorge B.			Replication fork reversal occurs spontaneously after digestion but is constrained in supercoiled domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA GENES; DNA-REPLICATION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PLASMID REPLICATION; POTENTIAL ORIGINS; EGG EXTRACTS; TERMINATION; REGRESSION; INITIATION	Replication fork reversal was investigated in undigested and linearized replication intermediates of bacterial DNA plasmids containing a stalled fork. Two-dimensional agarose gel electrophoresis, a branch migration and extrusion assay, electron microscopy, and DNA-psoralen cross-linking were used to show that extensive replication fork reversal and extrusion of the nascent-nascent duplex occurs spontaneously after DNA nicking and restriction enzyme digestion but that fork retreat is severely limited in covalently closed supercoiled domains.	CSIC, Ctr Invest Biol, Dept Biol Celular & Desarrollo, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Schvartzman, JB (corresponding author), CSIC, Ctr Invest Biol, Dept Biol Celular & Desarrollo, Ramiro Maeztu 9, E-28040 Madrid, Spain.	schvartzman@cib.csic.es	Schvartzman, Jorge B/J-9171-2014; Krimer, Dora/J-9176-2014	Krimer, Dora/0000-0001-9972-3994; Pablo, Hernandez/0000-0002-8113-1277				ALLERS T, 2006, NUCLEIC ACIDS RES, V28, pE6; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Bastia D., 1996, DNA REPLICATION EUKA, P177; Bates A.D., 2005, DNA TOPOLOGY, P198; Bessler JB, 2004, GENETICS, V168, P1205, DOI 10.1534/genetics.104.028035; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; Duncker BP, 1999, MOL CELL BIOL, V19, P1226; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; Fierro-Fernandez M, 2007, P NATL ACAD SCI USA, V104, P1500, DOI 10.1073/pnas.0609204104; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; HILL TM, 1992, ANNU REV MICROBIOL, V46, P603, DOI 10.1146/annurev.micro.46.1.603; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; LITTLE RD, 1993, MOL CELL BIOL, V13, P6600, DOI 10.1128/MCB.13.10.6600; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; LUCCHINI R, 1995, NATURE, V374, P276, DOI 10.1038/374276a0; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mohanty BK, 2004, J BIOL CHEM, V279, P1932, DOI 10.1074/jbc.M309078200; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Olavarrieta L, 2002, NUCLEIC ACIDS RES, V30, P656, DOI 10.1093/nar/30.3.656; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Pohlhaus JR, 2005, MOL MICROBIOL, V56, P1416, DOI 10.1111/j.1365-2958.2005.04638.x; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Santamaria D, 2000, J MOL BIOL, V300, P75, DOI 10.1006/jmbi.2000.3843; Santamaria D, 2000, NUCLEIC ACIDS RES, V28, P2099, DOI 10.1093/nar/28.10.2099; Schvartzman JB, 2004, EMBO REP, V5, P256, DOI 10.1038/sj.embor.7400101; SCHVARTZMAN JB, 1990, MOL CELL BIOL, V10, P3078, DOI 10.1128/MCB.10.6.3078; SINDEN RR, 1980, CELL, V21, P773, DOI 10.1016/0092-8674(80)90440-7; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SOGO JM, 1989, METHOD ENZYMOL, V170, P142; SOGO JM, 1987, ELECTRON MICROS, P61; VAUGHN JP, 1990, CELL, V61, P1075, DOI 10.1016/0092-8674(90)90071-L; Veaute X, 1997, J BIOL CHEM, V272, P15351, DOI 10.1074/jbc.272.24.15351; Vengrova S, 2004, GENE DEV, V18, P794, DOI 10.1101/gad.289404; Viguera E, 2000, NUCLEIC ACIDS RES, V28, P498, DOI 10.1093/nar/28.2.498; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733	53	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18190	18196		10.1074/jbc.M701559200	http://dx.doi.org/10.1074/jbc.M701559200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17456472	Green Submitted, hybrid			2022-12-27	WOS:000247302000025
J	Chun, YJ; Shimada, T; Sanchez-Ponce, R; Martin, MV; Lei, L; Zhao, B; Kelly, SL; Waterman, MR; Lamb, DC; Guengerich, FP				Chun, Young-Jin; Shimada, Tsutomu; Sanchez-Ponce, Raymundo; Martin, Martha V.; Lei, Li; Zhao, Bin; Kelly, Steven L.; Waterman, Michael R.; Lamb, David C.; Guengerich, F. Peter			Electron transport pathway for a Streptomyces cytochrome P450 - Cytochrome P450 105D5-catalyzed fatty acid hydroxylation in Streptomyces coelicolor A3(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY MASS-SPECTROMETRY; RATE-LIMITING STEPS; METHYLENE HYDROXYLATION; COMPLEMENT CYPOME; TRANSFER PROTEINS; LIVER MICROSOMES; DOUBLE BOND; REDUCTASE; FERREDOXIN; GRISEUS	Streptomyces and other bacterial actinomycete species produce many important natural products, including the majority of known antibiotics, and cytochrome P450 ( P450) enzymes catalyze important biosynthetic steps. Relatively few electron transport pathways to P450s have been characterized in bacteria, particularly streptomycete species. One of the 18 P450s in Streptomyces coelicolor A3( 2), P450 105D5, was found to bind fatty acids tightly and form hydroxylated products when electrons were delivered from heterologous systems. The six ferredoxin ( Fdx) and four flavoprotein Fdx reductase ( FDR) proteins coded by genes in S. coelicolor were expressed in Escherichia coli, purified, and used to characterize the electron transfer pathway. Of the many possibilities, the primary pathway was NADH -> FDR1 -> Fdx4 -> P450 105D5. The genes coding for FDR1, Fdx4, and P450 105D5 are located close together in the S. coelicolor genome. Several fatty acids examined were substrates, including those found in S. coelicolor extracts, and all yielded several products. Mass spectra of the products of lauric acid imply the 8-, 9-, 10-, and 11-hydroxy derivatives. Hydroxylated fatty acids were also detected in vivo in S. coelicolor. Rates of electron transfer between the proteins were measured; all steps were faster than overall hydroxylation and consistent with rates of NADH oxidation. Substrate binding, product release, and oxygen binding were relatively fast in the catalytic cycle; high kinetic deuterium isotope effects for all four lauric acid hydroxylations indicated that the rate of C-H bond breaking is rate-limiting in every case. Thus, an electron transfer pathway to a functional Streptomyces P450 has been established.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; Univ Coll Swansea, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales; Univ Coll Swansea, Sch Med, Swansea SA2 8PP, W Glam, Wales	Vanderbilt University; Vanderbilt University; Chung Ang University; Swansea University; Swansea University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,23rd & Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Shimada, Tsutomu/0000-0003-2552-4348	NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069970] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA090426] Funding Source: Medline; NIEHS NIH HHS [T32 ES07028, P30 ES00267] Funding Source: Medline; NIGMS NIH HHS [R01 GM069970] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; BAUER E, 1995, CHEM RES TOXICOL, V8, P136, DOI 10.1021/tx00043a018; BODDUPALLI SS, 1992, J BIOL CHEM, V267, P10375; BROWN HC, 1967, J AM CHEM SOC, V89, P1522, DOI 10.1021/ja00982a043; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; Capdevila J., 2005, CYTOCHROME P450 STRU, P531; DEMONTELLANO PRO, 1984, J BIOL CHEM, V259, P4136; FOUST GP, 1969, J BIOL CHEM, V244, P964; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2001, PRINCIPLES METHODS T, P1625; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; Johnson Kenneth A., 2003, P1; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; Krauser JA, 2005, J BIOL CHEM, V280, P19496, DOI 10.1074/jbc.M501854200; Lamb DC, 2003, BIOCHEM BIOPH RES CO, V307, P610, DOI 10.1016/S0006-291X(03)01231-2; Lamb DC, 2002, J BIOL CHEM, V277, P24000, DOI 10.1074/jbc.M111109200; LAMBETH JD, 1982, MOL CELL BIOCHEM, V45, P13, DOI 10.1007/BF01283159; Lei L, 2004, P NATL ACAD SCI USA, V101, P494, DOI 10.1073/pnas.2435922100; LU AYH, 1968, J BIOL CHEM, V243, P1331; Matsson O, 1998, ADV PHYS ORG CHEM, V31, P143; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McMurry T. J., 1986, CYTOCHROME P450 STRU, P1; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; NARHI LO, 1982, J BIOL CHEM, V257, P2147; NEBERT DW, 1968, J BIOL CHEM, V243, P6242; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; OKEEFE DP, 1991, BIOCHEMISTRY-US, V30, P447, DOI 10.1021/bi00216a021; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; Palmer CNA, 1999, BIOCHEM SOC T, V27, P374, DOI 10.1042/bst0270374; PALMER G, 1992, J BIOL CHEM, V267, P665; Parajuli N, 2004, ARCH BIOCHEM BIOPHYS, V425, P233, DOI 10.1016/j.abb.2004.03.011; PERKINS EG, 1969, LIPIDS, V4, P619, DOI 10.1007/BF02531051; Prough R A, 1978, Methods Enzymol, V52, P372; Puchkaev AV, 2005, ARCH BIOCHEM BIOPHYS, V434, P169, DOI 10.1016/j.abb.2004.10.022; RAMACHANDRA M, 1991, J BACTERIOL, V173, P7106, DOI 10.1128/jb.173.22.7106-7112.1991; ROOME PW, 1988, ARCH BIOCHEM BIOPHYS, V266, P32, DOI 10.1016/0003-9861(88)90233-0; Sasaki M, 2005, APPL ENVIRON MICROB, V71, P8024, DOI 10.1128/AEM.71.12.8024-8030.2005; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schmid E, 1999, MICROBIOL-SGM, V145, P3331, DOI 10.1099/00221287-145-12-3331; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; Shimada T, 1996, CANCER RES, V56, P2979; Taylor M, 1999, BIOCHEM BIOPH RES CO, V263, P838, DOI 10.1006/bbrc.1999.1427; TROWER MK, 1992, MOL MICROBIOL, V6, P2125, DOI 10.1111/j.1365-2958.1992.tb01386.x; TROWER MK, 1988, BIOCHEM BIOPH RES CO, V157, P1417, DOI 10.1016/S0006-291X(88)81033-7; TROWER MK, 1993, MOL MICROBIOL, V7, P1024, DOI 10.1111/j.1365-2958.1993.tb01194.x; TYSON CA, 1972, J BIOL CHEM, V247, P5777; Ueno M, 2005, J BIOSCI BIOENG, V100, P567, DOI 10.1263/jbb.100.567; WHEELAN P, 1995, J AM SOC MASS SPECTR, V6, P40, DOI 10.1016/1044-0305(94)00090-M; Wood KV, 2001, RAPID COMMUN MASS SP, V15, P873, DOI 10.1002/rcm.285; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; YAMAZAKI H, 1995, BIOCHEMISTRY-US, V34, P8380, DOI 10.1021/bi00026a020; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200	59	70	75	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17486	17500		10.1074/jbc.M700863200	http://dx.doi.org/10.1074/jbc.M700863200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17446171	hybrid			2022-12-27	WOS:000247084500019
J	Li, YF; D'Aurelio, M; Deng, JH; Park, JS; Manfredi, G; Hu, PQ; Lu, JX; Bai, YD				Li, Youfen; D'Aurelio, Marilena; Deng, Jian-Hong; Park, Jeong-Soon; Manfredi, Giovanni; Hu, Peiqing; Lu, Jianxin; Bai, Yidong			An assembled complex IV maintains the stability and activity of complex I in mammalian mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; STOP-CODON MUTATION; RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; NATIVE ELECTROPHORESIS; NADH DEHYDROGENASE; SUBUNIT; CELLS; ASSEMBLY/STABILITY; SUPERCOMPLEXES	In the mammalian mitochondrial electron transfer system, the majority of electrons enter at complex I, go through complexes III and IV, and are finally delivered to oxygen. Previously we generated several mouse cell lines with suppressed expression of the nuclearly encoded subunit 4 of complex IV. This led to a loss of assembly of complex IV and its defective function. Interestingly, we found that the level of assembled complex I and its activity were also significantly reduced, whereas levels and activity of complex III were normal or up-regulated. The structural and functional dependence of complex I on complex IV was verified using a human cell line carrying a nonsense mutation in the mitochondrially encoded complex IV subunit 1 gene. Our work documents that, although there is no direct electron transfer between them, an assembled complex IV helps to maintain complex I in mammalian cells.	Univ Texas, Hlth Sci Ctr, Dept Cell & Struct Biol, San Antonio, TX 78229 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Wenzhou Med Coll, Zhejiang Prov Key Lab Med Genet, Inst Mol & Cellular Med, Wenzhou 325035, Peoples R China	University of Texas System; University of Texas Health San Antonio; Cornell University; Wenzhou Medical University	Bai, YD (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cell & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	baiy@uthscsa.edu	Bai, Yidong/A-4959-2012		Telethon [GFP03008] Funding Source: Medline	Telethon(Fondazione Telethon)		Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; Deng JH, 2006, MOL CELL BIOL, V26, P1077, DOI 10.1128/MCB.26.3.1077-1086.2006; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Lenaz G, 2004, METHOD ENZYMOL, V382, P3; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; LITTLEFIELD JW, 1963, P NATL ACAD SCI USA, V50, P568, DOI 10.1073/pnas.50.3.568; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Schagger H, 1996, Methods Enzymol, V264, P555, DOI 10.1016/S0076-6879(96)64048-8; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; VOGEL RO, 2007, J BIOL CHEM; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wallace D C, 2001, Novartis Found Symp, V235, P247; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200	35	89	91	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17557	17562		10.1074/jbc.M701056200	http://dx.doi.org/10.1074/jbc.M701056200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452320	hybrid			2022-12-27	WOS:000247084500026
J	Mineva, ND; Rothstein, TL; Meyers, JA; Lerner, A; Sonenshein, GE				Mineva, Nora D.; Rothstein, Thomas L.; Meyers, John A.; Lerner, Adam; Sonenshein, Gail E.			CD40 ligand-mediated activation of the de Novo RelB NF-kappa B synthesis pathway in transformed B cells promotes rescue from apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; C-MYC EXPRESSION; PROSTATE-CANCER; CROSS-LINKING; DIFFERENTIAL REGULATION; DENDRITIC CELLS; TRANSGENIC MICE; LYMPHOMA-CELLS; IG-RECEPTOR; IN-VIVO	CD40, a tumor necrosis factor receptor family member, is expressed on B lymphocytes. Interaction between CD40 and its ligand ( CD40L), expressed on activated T lymphocytes, is critical for B cell survival. Here, we demonstrate that CD40 signals B cell survival in part via transcriptional activation of the RelB NF-kappa B subunit. CD40L treatment of chronic lymphocytic leukemia cells induced levels of relB mRNA. Similarly, CD40L-mediated rescue of WEHI 231 B lymphoma cells from apoptosis induced upon B cell receptor ( surface IgM) engagement led to increased relB mRNA levels. Recently, we characterized a new de novo synthesis pathway for the RelB NF-kappa B subunit, induced by the cytomegalovirus IE1 protein, in which binding of p50/p65 NF-kappa B and c-Jun/Fra-2 AP-1 complexes to the relB promoter works in synergy to potently activate transcription ( Wang, X., and Sonenshein, G. E. ( 2005) J. Virol. 79, 95-105). CD40L treatment of WEHI 231 cells caused induction of AP-1 family members Fra-2, c-Jun, JunD, and JunB. Cotransfection of Fra-2 with the Jun AP-1 subunits and p50/c-Rel NF-kappa B led to synergistic activation of the relB promoter. Ectopic expression of relB or RelB knockdown using small interfering RNA demonstrated the important role of this subunit in control of WEHI 231 cell survival and implicated activation of the anti-apoptotic factors Survivin and manganese superoxide dismutase. Thus, CD40 engagement of transformed B cells activates relB gene transcription via a process we have termed the de novo RelB synthesis pathway, which protects these cells from apoptosis.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Sonenshein, GE (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	gsonensh@bu.edu		Meyers, John/0000-0001-9560-5667; Lerner, Adam/0000-0001-9259-7868	NATIONAL CANCER INSTITUTE [R01CA036355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040181] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA36355] Funding Source: Medline; NIAID NIH HHS [R01 AI40181] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal SK, 2003, P NATL ACAD SCI USA, V100, P10770, DOI 10.1073/pnas.1834524100; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Challa A, 2002, BLOOD, V99, P3411, DOI 10.1182/blood.V99.9.3411; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Clark GJ, 1999, IMMUNOLOGY, V98, P189; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Costello RT, 1999, IMMUNOL TODAY, V20, P488, DOI 10.1016/S0167-5699(99)01507-8; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; Foo SY, 1999, TRENDS GENET, V15, P229; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Gilmore TD, 1996, ONCOGENE, V13, P1367; GORDON J, 1995, BLOOD REV, V9, P53, DOI 10.1016/0268-960X(95)90040-3; Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777; Gricks CS, 2004, BLOOD, V104, P4002, DOI 10.1182/blood-2004-02-0494; GRUDA MC, 1994, ONCOGENE, V9, P2537; Israel A, 2006, TRENDS IMMUNOL, V27, P395, DOI 10.1016/j.it.2006.07.003; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jiang HY, 2002, J VIROL, V76, P5737, DOI 10.1128/JVI.76.11.5737-5747.2002; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Kehry MR, 1996, J IMMUNOL, V156, P2345; LA RF, 1994, MOL CELL BIOL, V14, P1039; LEE HY, 1995, J EXP MED, V181, P1169, DOI 10.1084/jem.181.3.1169; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; LIU JL, 1991, J IMMUNOL, V146, P1685; LO D, 1992, AM J PATHOL, V141, P1237; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Neumann M, 1996, J IMMUNOL, V157, P4862; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; Romano MF, 1998, BLOOD, V92, P990; Romieu-Mourez R, 2003, MOL CELL BIOL, V23, P5738, DOI 10.1128/MCB.23.16.5738-5754.2003; ROONEY JW, 1991, EUR J IMMUNOL, V21, P2993, DOI 10.1002/eji.1830211214; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Schauer SL, 1996, J IMMUNOL, V157, P81; Schjerven H, 2004, J IMMUNOL, V173, P1849, DOI 10.4049/jimmunol.173.3.1849; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stoffel A, 2004, P NATL ACAD SCI USA, V101, P9079, DOI 10.1073/pnas.0402415101; Suhasini M, 1999, ONCOGENE, V18, P7360, DOI 10.1038/sj.onc.1203158; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; TOTH CR, 1995, J BIOL CHEM, V270, P7661, DOI 10.1074/jbc.270.13.7661; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang XB, 2005, J VIROL, V79, P95, DOI 10.1128/JVI.79.1.95-105.2005; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Weih F, 1997, J IMMUNOL, V158, P5211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Weylie B, 2006, J VASC RES, V43, P61, DOI 10.1159/000089492; Wu M, 1998, J EXP MED, V187, P1671, DOI 10.1084/jem.187.10.1671; Wu M, 1996, MOL CELL BIOL, V16, P5015; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Yamaguchi K, 1997, J IMMUNOL, V158, P2165; Younes A, 1998, BRIT J HAEMATOL, V100, P135, DOI 10.1046/j.1365-2141.1998.00522.x; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101; Zhu L, 2001, FEBS LETT, V508, P369, DOI 10.1016/S0014-5793(01)03084-8	65	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17475	17485		10.1074/jbc.M607313200	http://dx.doi.org/10.1074/jbc.M607313200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17446175	hybrid			2022-12-27	WOS:000247084500018
J	Lukasiewicz, R; Velazquez-Dones, A; Huynh, N; Hagopian, J; Fu, XD; Adams, J; Ghosh, G				Lukasiewicz, Randall; Velazquez-Dones, Adolfo; Huynh, Nhat; Hagopian, Jonathan; Fu, Xiang-Dong; Adams, Joseph; Ghosh, Gourisankar			Structurally unique yeast and mammalian serine-arginine protein kinases catalyze evolutionarily conserved phosphorylation reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH SPLICING FACTORS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; NUCLEAR IMPORT; SRPK1; CLK/STY; SKY1P; MOTIF; INACTIVATION; METHYLATION	The mammalian serine-arginine (SR) protein, ASF/SF2, contains multiple contiguous RS dipeptides at the C terminus, and similar to 12 of these serines are processively phosphorylated by the SR protein kinase 1 (SRPK1). We have recently shown that a docking motif in ASF/SF2 specifically interacts with a groove in SRPK1, and this interaction is necessary for processive phosphorylation. We previously showed that SRPK1 and its yeast ortholog Sky1p maintain their active conformations using diverse structural strategies. Here we tested if the mechanism of ASF/SF2 phosphorylation by SRPK is evolutionarily conserved. We show that Sky1p forms a stable complex with its heterologous mammalian substrate ASF/SF2 and processively phosphorylates the same sites as SRPK1. We further show that Sky1p utilizes the same docking groove to bind yeast SR-like protein Gbp2p and phosphorylates all three serines present in a contiguous RS dipeptide stretch. However, the mechanism of Gbp2p phosphorylation appears to be non-processive. Thus, there are physical attributes of SR and SR-like substrates that dictate the mechanism of phosphorylation, whereas the ability to processively phosphorylate substrates is inherent to SR protein kinases.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,3103 Nat Sci Bldg, La Jolla, CA 92093 USA.	gghosh@ucsd.edu			NCI NIH HHS [T32 CA009523] Funding Source: Medline; NIGMS NIH HHS [GM08326, GM67969] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 1999, BIOCHEM CELL BIOL, V77, P277, DOI 10.1139/bcb-77-4-277; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; FU XD, 1995, RNA, V1, P663; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Izaurralde E, 2004, NAT STRUCT MOL BIOL, V11, P210, DOI 10.1038/nsmb0304-210; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Lukasiewicz R, 2007, J MOL BIOL, V367, P249, DOI 10.1016/j.jmb.2006.12.031; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; Ngo JCK, 2007, STRUCTURE, V15, P123, DOI 10.1016/j.str.2006.11.011; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Sandri-Goldin RM, 1998, GENE DEV, V12, P868, DOI 10.1101/gad.12.6.868; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Schenk PW, 2001, CANCER RES, V61, P6982; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Velazquez-Dones A, 2005, J BIOL CHEM, V280, P41761, DOI 10.1074/jbc.M504156200; Windgassen M, 2003, EMBO REP, V4, P278, DOI 10.1038/sj.embor.embor763; Yeakley JM, 1999, J CELL BIOL, V145, P447, DOI 10.1083/jcb.145.3.447; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707	28	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23036	23043		10.1074/jbc.M611305200	http://dx.doi.org/10.1074/jbc.M611305200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17517895	hybrid			2022-12-27	WOS:000248577500006
J	Braun, GS; Kretzler, M; Heider, T; Floege, J; Holzman, LB; Kriz, W; Moeller, MJ				Braun, Gerald S.; Kretzler, Matthias; Heider, Torsten; Floege, Juergen; Holzman, Lawrence B.; Kriz, Wilhelm; Moeller, Marcus J.			Differentially spliced isoforms of FAT1 are asymmetrically distributed within migrating cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAFFOLDING PROTEINS; MAMMALIAN-CELLS; ACTIN DYNAMICS; EXPRESSION; GENE; ASSOCIATION; POLARIZATION; STABILITY; MOLECULES; CADHERINS	Cadherin FAT1 is localized along the leading edge of mammalian cells and is necessary for polarization and directed migration. It is essential for maintenance of the complex cytoarchitecture of the glomerular filtration barrier within the kidney. In this study, three novel splice isoforms of FAT1 with important functional differences in comparison with wild-type FAT1, FAT1(WT), were identified. The novel variants contained additional short peptide sequences at a specific site of the cytoplasmic domain (+ 12 or + 32 or + 8 amino acids, the latter resulting in a premature stop codon). FAT1(+ 12) was expressed in all peripheral tissues together with FAT1(WT), whereas FAT1(+ 32) and -( + 8TR) were brain-specific. At the subcellular level, exclusively FAT1(WT) was localized along the cellular leading edge, whereas spliced FAT1 isoforms were confined to intercellular junctions. A shift of FAT1(WT) expression toward a predominance of FAT1(+ 12) was observed in migratory versus quiescent cells. A similar shift was observed in vivo when glomeruli from healthy individuals were compared with those from patients affected by glomerulonephritis. At the molecular level, the differential subcellular localization of FAT1 isoforms was mediated by a novel region harboring a phosphotyrosine-binding-like motif( DN_XYH), which was disrupted by the peptide inserts in the alternative splice variants. Overexpression of FAT1(WT) or specific knockdown of spliced FAT1 isoforms resulted in formation of cellular protrusions or increased wound healing, respectively. In summary, FAT1(WT) is the only FAT1 isoform located along the cellular leading edge. Only FAT1(WT) is up-regulated in migration, induces cellular process formation when overexpressed, and is necessary for efficient wound healing.	Rhein Westfal TH Aachen, Div Nephrol & Immunol, D-52074 Aachen, Germany; Univ Heidelberg, Inst Anat & Cell Biol 1, D-69120 Heidelberg, Germany; Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA	RWTH Aachen University; Ruprecht Karls University Heidelberg; University of Michigan System; University of Michigan	Moeller, MJ (corresponding author), Rhein Westfal TH Aachen, Div Nephrol & Immunol, Pauwelsstr 30, D-52074 Aachen, Germany.	mmoeller@ukaachen.de	Moeller, Marcus J/L-1836-2015	Braun, Gerald/0000-0002-4783-9669; Holzman, Lawrence/0000-0002-8961-234X				Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Blair IP, 2006, MOL PSYCHIATR, V11, P372, DOI 10.1038/sj.mp.4001784; Braun GS, 2002, PFLUG ARCH EUR J PHY, V445, P321, DOI 10.1007/s00424-002-0906-x; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Castillejo-Lopez C, 2004, J BIOL CHEM, V279, P24034, DOI 10.1074/jbc.M313878200; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Inoue T, 2001, KIDNEY INT, V59, P1003, DOI 10.1046/j.1523-1755.2001.00583.x; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Langford KJ, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-3; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; Moeller MJ, 2006, NEPHRON EXP NEPHROL, V103, pE69, DOI 10.1159/000090619; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Schreiner D, 2006, FEBS LETT, V580, P5295, DOI 10.1016/j.febslet.2006.08.079; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Zhang LH, 2001, J BIOL CHEM, V276, P10476, DOI 10.1074/jbc.M008991200	33	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22823	22833		10.1074/jbc.M701758200	http://dx.doi.org/10.1074/jbc.M701758200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17500054	hybrid			2022-12-27	WOS:000248354200060
J	Panne, D; McWhirter, SM; Maniatis, T; Harrison, SC				Panne, Daniel; McWhirter, Sarah M.; Maniatis, Tom; Harrison, Stephen C.			Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; IRF-3 TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; VIRUS-INFECTION; GENE-EXPRESSION; VIRAL-INFECTION; BETA ENHANCER; IKK-EPSILON; IN-VIVO; KAPPA-B	The transcription factor interferon regulatory factor 3 (IRF-3) regulates genes in the innate immune response. IRF-3 is activated through phosphorylation by the kinases IKK is an element of and/or TBK1. Phosphorylation results in IRF-3 dimerization and removal of an autoinhibitory structure to allow interaction with the coactivators CBP/p300. The precise role of the different phosphorylation sites has remained controversial. Using purified proteins we show that TBK1 can directly phosphorylate full-length IRF-3 in vitro. Phosphorylation at residues in site 2 (Ser(396) - Ser(405)) alleviates autoinhibition to allow interaction with CBP ((C) under bar CREB-(b) under bar binding (p) under bar protein) and facilitates phosphorylation at site 1 (Ser(385) or Ser(386)). Phosphorylation at site 1 is, in turn, required for IRF-3 dimerization. The data support a two-step phosphorylation model for IRF-3 activation mediated by TBK1.	Harvard Univ, Sch Med, Howard Huges Med Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol & Cell Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Howard Huges Med Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Panne, Daniel/I-8368-2017	Panne, Daniel/0000-0001-9158-5507				Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; JOHNSON J, 2007, J BIOL CHEM; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	23	118	121	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22816	22822		10.1074/jbc.M703019200	http://dx.doi.org/10.1074/jbc.M703019200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17526488	Green Published, hybrid			2022-12-27	WOS:000248354200059
J	Shu, L; Shayman, JA				Shu, Liming; Shayman, James A.			Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-GAMMA ACTIVITY; PICK TYPE-C; FABRY-DISEASE; CELLS; CHOLESTEROL; MEMBRANE; GLYCOSPHINGOLIPIDS; FIBROBLASTS; METABOLISM; HEPARIN	Cardiovascular complications, including stroke and myocardial infarction, result in premature mortality in patients with Fabry disease, an X-linked deficiency of alpha-galactosidase A (alpha-Gal A). The enzymatic defect results in the deposition of globotriaosylceramide (Gb3) in the vascular endothelium. To better understand the underlying pathogenesis of Fabry disease, the caveolar lipid content of primary cultured mouse aortic endothelial cells isolated from alpha-Gal A null mice was measured. Lipid mass analysis revealed that the excessive Gb3 in cultured alpha-Gal A-deficient mouse aortic endothelial cells accumulated in endothelial plasma membrane caveolar fractions. The levels of glucosylceramide and lactosylceramide increased in parallel with Gb3 levels in an age-dependent manner, whereas globotetraosylceramide (Gb4) levels reached maximal levels by 6 months of age and then rapidly decreased at older ages. The levels of cholesterol enriched in caveolar membranes declined in parallel with the progressive deposition of Gb3. Depleting Gb3 with recombinant human alpha-Gal A protein or D-threo-ethylenedioxyphenyl-P4, an inhibitor of glucosylceramide synthase, restored cholesterol in cultured alpha-Gal A-deficient mouse aortic endothelial cell caveolae. By contrast, recombinant human alpha-Gal A was less effective in normalizing the cholesterol content. These results demonstrate the caveolar accumulation of glycosphingolipids in an in vitro model of a lysosomal storage disease and raise the possibility that dynamic changes in the composition of plasma membrane lipid microdomains may mediate the endothelial dysfunction seen in Fabry disease.	Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48103 USA	University of Michigan System; University of Michigan	Shayman, JA (corresponding author), Univ Michigan, Dept Internal Med, Div Nephrol, Rm 1560 MSRB 2,1150 W Med Ctr Dr, Ann Arbor, MI 48103 USA.	jshayman@umich.edu						AMES GF, 1968, J BACTERIOL, V95, P833, DOI 10.1128/JB.95.3.833-843.1968; Anderson W., 1898, BRIT J DERMATOL, V10, P113, DOI [10.1111/j.1365-2133.1898.tb16317.x, DOI 10.1111/J.1365-2133.1898.TB16317.X]; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; BREMER EG, 1984, J BIOL CHEM, V259, P6818; CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044; CLOWES AW, 1978, J SURG RES, V24, P161, DOI 10.1016/0022-4804(78)90169-5; DAHL NK, 1992, J BIOL CHEM, V267, P4889; Desnick R J, 2001, Adv Nephrol Necker Hosp, V31, P317; DUVE CD, 1975, SCIENCE, V189, P186, DOI 10.1126/science.1138375; Eitzman DT, 2003, J AM SOC NEPHROL, V14, P298, DOI 10.1097/01.ASN.0000043901.45141.D4; Fabry J., 1898, ARCH DERMATOL SYPHIL, V43, P187; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Ikonen Elina, 2005, Sci STKE, V2005, ppe3; Koike T, 1998, BBA-MOL BASIS DIS, V1406, P327, DOI 10.1016/S0925-4439(98)00019-2; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 2002, J LIPID RES, V43, P198; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Shu LM, 2005, J AM SOC NEPHROL, V16, P2636, DOI 10.1681/ASN.2005040383; Shu LM, 2003, J BIOL CHEM, V278, P31419, DOI 10.1074/jbc.M303783200; Shu LM, 2002, J BIOL CHEM, V277, P18447, DOI 10.1074/jbc.M111363200; Shu LM, 2000, ARCH BIOCHEM BIOPHYS, V373, P83, DOI 10.1006/abbi.1999.1553; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	28	37	39	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20960	20967		10.1074/jbc.M702436200	http://dx.doi.org/10.1074/jbc.M702436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535804	hybrid			2022-12-27	WOS:000248047500022
J	Markovic, J; Borras, C; Ortega, A; Sastre, J; Vina, J; Pallardo, FV				Markovic, Jelena; Borras, Consuelo; Ortega, Angel; Sastre, Juan; Vina, Jose; Pallardo, Federico V.			Glutathione is recruited into the nucleus in early phases of cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DAMAGE; RAT HEPATOCYTES; BCL-2; MITOCHONDRIAL; EXPRESSION; DNA; COMPARTMENTATION; FIBROBLASTS; ONCOPROTEIN; THALIDOMIDE	We have studied the possible correlation between nuclear glutathione distribution and the progression of the cell cycle. The former was studied by confocal microscopy using 5-chloromethyl fluorescein diacetate and the latter by flow cytometry and protein expression of Id2 and p107. In proliferating cells, when 41% of them were in the S + G(2)/M phase of the cell cycle GSH was located mainly in the nucleus. When cells reached confluence (G0/G1) GSH was localized in the cytoplasm with a perinuclear distribution. The nucleus/cytoplasm fluorescence ratio for GSH reached a maximal mean value of 4.2 +/- 0.8 at 6 h after cell plating. A ratio higher than 2 was maintained during exponential cell growth. In the G0/G1 phase of the cell cycle, the nucleus/cytoplasm GSH ratio decreased to values close to 1. We report here that cells concentrate GSH in the nucleus in the early phases of cell growth, when most of the cells are in an active division phase, and that GSH redistributes uniformly between the nucleus and the cytoplasm when cells reach confluence.	Univ Valencia, Fac Med, Dept Fis, E-46010 Valencia, Spain; Univ Valencia, Fac Med, Dept Physiol, Valencia 46010, Spain	University of Valencia; University of Valencia	Pallardo, FV (corresponding author), Univ Valencia, Fac Med, Dept Fis, E-46010 Valencia, Spain.	pallardo@uv.es	borras, consuelo/Y-3407-2019; Pallardo, Federico V./T-1156-2017; Ortega, Angel L./A-4113-2014; Vina, Jose/AAB-3069-2021	borras, consuelo/0000-0003-4606-1792; Pallardo, Federico V./0000-0003-3715-1980; Ortega, Angel L./0000-0002-9901-3383; Vina, Jose/0000-0001-9709-0089				ASENSI M, 1994, ANAL BIOCHEM, V217, P323, DOI 10.1006/abio.1994.1126; ATZORI L, 1994, EXP CELL RES, V211, P115, DOI 10.1006/excr.1994.1066; BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412; Bellomo G, 1997, MICROSC RES TECHNIQ, V36, P243, DOI 10.1002/(SICI)1097-0029(19970215)36:4<243::AID-JEMT3>3.0.CO;2-N; BIAGLOW JE, 1983, RADIAT RES, V95, P437, DOI 10.2307/3576092; Borras C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200; BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X; BRIVIBA K, 1993, BIOCHEM J, V294, P631, DOI 10.1042/bj2940631; Chen JQ, 2003, TOXICOL SCI, V75, P271, DOI 10.1093/toxsci/kfg183; Conour JE, 2004, PHYSIOL GENOMICS, V18, P196, DOI 10.1152/physiolgenomics.00058.2004; Ellerby LM, 1996, J NEUROCHEM, V67, P1259; Esteve JM, 1999, FASEB J, V13, P1055, DOI 10.1096/fasebj.13.9.1055; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hansen JM, 2002, J PHARMACOL EXP THER, V300, P768, DOI 10.1124/jpet.300.3.768; HEDLEY DW, 1994, CYTOMETRY, V15, P349, DOI 10.1002/cyto.990150411; Ho Y.F., 1994, TOXICOLOGIST, V14, P178; Hoetelmans RWM, 2003, CELL PROLIFERAT, V36, P35, DOI 10.1046/j.1365-2184.2003.00252.x; Jang JH, 2003, BIOCHEM PHARMACOL, V66, P1371, DOI 10.1016/S0006-2952(03)00487-8; Kim JR, 2004, FEBS LETT, V567, P189, DOI 10.1016/j.febslet.2004.04.055; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; MCBRIDE WG, 1961, LANCET, V2, P1358; Meredith MJ, 1998, BIOCHEM BIOPH RES CO, V248, P458, DOI 10.1006/bbrc.1998.8998; Morales A, 1998, INT J RADIAT ONCOL, V42, P191, DOI 10.1016/S0360-3016(98)00185-0; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rimpler MM, 1999, BIOCHEM J, V340, P291, DOI 10.1042/0264-6021:3400291; Schor NF, 2000, ONCOGENE, V19, P472, DOI 10.1038/sj.onc.1203324; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; Soderdahl T, 2002, FASEB J, V16, P124, DOI 10.1096/fj.02-0259fje; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; THOMAS M, 1995, BRIT J CANCER, V72, P45, DOI 10.1038/bjc.1995.275; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Vahrmeijer AL, 2000, BIOCHEM PHARMACOL, V59, P1557, DOI 10.1016/S0006-2952(00)00286-0; Vina J., 1990, GLUTATHIONE METABOLI; Voehringer DW, 1998, P NATL ACAD SCI USA, V95, P2956, DOI 10.1073/pnas.95.6.2956; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273	37	138	141	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20416	20424		10.1074/jbc.M609582200	http://dx.doi.org/10.1074/jbc.M609582200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17452333	hybrid			2022-12-27	WOS:000247819300044
J	Narayanan, S; Sato, T; Wolfe, MS				Narayanan, Saravanakumar; Sato, Toru; Wolfe, Michael S.			A C-terminal region of signal peptide peptidase defines a functional domain for intramembrane aspartic protease catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE REVEALS; ACTIVE-SITE; TRANSMEMBRANE DOMAIN; PRESENILIN; PROTEOLYSIS; FAMILY; IDENTIFICATION; RECONSTITUTION; ORGANIZATION; NICASTRIN	Intramembrane proteolysis is now firmly established as a prominent biological process, and structure elucidation is emerging as the new frontier in the understanding of these novel membrane-embedded enzymes. Reproducing this unusual hydrolysis within otherwise water-excluding transmembrane regions with purified proteins is a challenging prerequisite for such structural studies. Here we show the bacterial expression, purification, and reconstitution of proteolytically active signal peptide peptidase (SPP), a membrane-embedded enzyme in the presenilin family of aspartyl proteases. This finding formally proves that, unlike presenilin, SPP does not require any additional proteins for proteolysis. Surprisingly, the conserved C-terminal half of SPP is sufficient for proteolytic activity; purification and reconstitution of this engineered fragment of several SPP orthologues revealed that this region defines a functional domain for an intramembrane aspartyl protease. The discovery of minimal requirements for intramembrane proteolysis should facilitate mechanistic and structural analysis and help define general biochemical principles of hydrolysis in a hydrophobic environment.	Brigham & Womens Hosp, Harvard Med Sch, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wolfe, MS (corresponding author), Brigham & Womens Hosp, Harvard Med Sch, Ctr Neurol Dis, 77 Ave Louis Pasteur,HIM 754, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu			NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG017574] Funding Source: NIH RePORTER; NIA NIH HHS [AG 17574, AG 15379] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brunkan AL, 2005, J NEUROCHEM, V94, P1315, DOI 10.1111/j.1471-4159.2005.03278.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2004, BIOORG MED CHEM LETT, V14, P1935, DOI 10.1016/j.bmcl.2004.01.077; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kornilova AY, 2006, BIOCHEMISTRY-US, V45, P7598, DOI 10.1021/bi060107k; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	34	56	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20172	20179		10.1074/jbc.M701536200	http://dx.doi.org/10.1074/jbc.M701536200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517891	hybrid			2022-12-27	WOS:000247819300018
J	Ji, JY; Lee, RT; Vergnes, L; Fong, LG; Stewart, CL; Reue, K; Young, SG; Zhang, QP; Shanahan, CM; Lammerding, J				Ji, Julie Y.; Lee, Richard T.; Vergnes, Laurent; Fong, Loren G.; Stewart, Colin L.; Reue, Karen; Young, Stephen G.; Zhang, Qiuping; Shanahan, Catherine M.; Lammerding, Jan			Cell nuclei spin in the absence of lamin B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; MEMBRANE-PROTEIN; MAMMALIAN-CELLS; GENE-EXPRESSION; INTERPHASE NUCLEI; ENVELOPE PROTEINS; CHROMATIN MOTION; BUILDING-BLOCKS; PORE COMPLEXES; LIVING CELLS	Mutations of the nuclear lamins cause a wide range of human diseases, including Emery-Dreifuss muscular dystrophy and Hutchinson-Gilford progeria syndrome. Defects in A-type lamins reduce nuclear structural integrity and affect transcriptional regulation, but few data exist on the biological role of B-type lamins. To assess the functional importance of lamin B1, we examined nuclear dynamics in fibroblasts from Lmnb1(Delta/Delta) and wild-type littermate embryos by time-lapse videomicroscopy. Here, we report that Lmnb1(Delta/Delta) cells displayed striking nuclear rotation, with similar to 90% of Lmnb1(Delta/Delta) nuclei rotating at least 90 during an 8-h period. The rotation involved the nuclear interior as well as the nuclear envelope. The rotation of nuclei required an intact cytoskeletal network and was eliminated by expressing lamin B1 in cells. Nuclear rotation could also be abolished by expressing larger nesprin isoforms with long spectrin repeats. These findings demonstrate that lamin B1 serves a fundamental role within the nuclear envelope: anchoring the nucleus to the cytoskeleton.	Partners Res Facil, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Div Cardiovasc, Cambridge, MA 02139 USA; NCI, NIH, Frederick, MD 21702 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90073 USA; Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Cardiovasc Med, Cambridge CB2 2QQ, England	Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lammerding, J (corresponding author), Partners Res Facil, 65 Landsdowne St, Cambridge, MA 02139 USA.	jlammerding@rics.bwh.harvard.edu	Lammerding, Jan/A-9498-2016; Zhang, Qiuping/L-3522-2019	Lammerding, Jan/0000-0003-4335-8611; Zhang, Qiuping/0000-0002-4000-3957; Shanahan, Catherine/0000-0002-8352-8171; Lee, Richard/0000-0003-4687-1381; vergnes, laurent/0000-0002-8804-589X; Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [HL073809, HL64858, HL079862, R01 HL082792, HL082792] Funding Source: Medline; NIAMS NIH HHS [AR050200] Funding Source: Medline; NINDS NIH HHS [R01 NS059348] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010377] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073809, R01HL082792, F32HL079862, P01HL064858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; BARD F, 1985, BIOL CELL, V54, P135, DOI 10.1111/j.1768-322X.1985.tb00388.x; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; DEBONI U, 1988, ANTICANCER RES, V8, P885; ENGLANDER LL, 1987, J CELL BIOL, V104, P87, DOI 10.1083/jcb.104.1.87; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fan J, 2004, J CELL SCI, V117, P619, DOI 10.1242/jcs.00892; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Georgatos SD, 2001, EMBO J, V20, P2989, DOI 10.1093/emboj/20.12.2989; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Harborth J, 2001, J CELL SCI, V114, P4557; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; HAY M, 1991, CELL MOTIL CYTOSKEL, V18, P63, DOI 10.1002/cm.970180107; Herbomel P, 1999, CURR BIOL, V9, pR627, DOI 10.1016/S0960-9822(99)80407-2; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Hutchison CJ, 2001, J CELL SCI, V114, P9; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; MAISON C, 1995, EMBO J, V14, P3311, DOI 10.1002/j.1460-2075.1995.tb07338.x; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McGee MD, 2006, MOL BIOL CELL, V17, P1790, DOI 10.1091/mbc.E05-09-0894; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Munter S, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-23; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; POMERAT CM, 1953, EXP CELL RES, V5, P191, DOI 10.1016/0014-4827(53)90104-9; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918; Soderqvist H, 1997, EUR J BIOCHEM, V250, P808, DOI 10.1111/j.1432-1033.1997.00808.x; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Szabo B, 2004, CELL MOTIL CYTOSKEL, V59, P38, DOI 10.1002/cm.20022; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Worman HJ, 2006, TRENDS CELL BIOL, V16, P67, DOI 10.1016/j.tcb.2005.12.006; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485	57	73	74	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					20015	20026		10.1074/jbc.M611094200	http://dx.doi.org/10.1074/jbc.M611094200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488709	hybrid			2022-12-27	WOS:000247650600075
J	Khoo, SK; Loll, B; Chan, WT; Shoeman, RL; Ngoo, L; Yeo, CC; Meinhart, A				Khoo, Seok Kooi; Loll, Bernhard; Chan, Wai Ting; Shoeman, Robert L.; Ngoo, Lena; Yeo, Chew Chieng; Meinhart, Anton			Molecular and structural characterization of the PezAT chromosomal toxin-antitoxin system of the human pathogen Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PLASMID MAINTENANCE; CRYSTAL-STRUCTURE; MESSENGER-RNAS; CELL-DEATH; PSM19035; LOCI; INACTIVATION; MECHANISM	The chromosomal pezT gene of the Gram-positive pathogen Streptococcus pneumoniae encodes a protein that is homologous to the zeta toxin of the Streptococcus pyogenes plasmid pSM19035-encoded epsilon-zeta toxin-antitoxin system. Overexpression of pezT in Escherichia coli led to severe growth inhibition from which the bacteria recovered similar to 3 h after induction of expression. The toxicity of PezT was counteracted by PezA, which is encoded immediately upstream of pezT and shares weak sequence similarities in the C-terminal region with the epsilon antitoxin. The pezAT genes form a bicistronic operon that is co-transcribed from a sigma(70)-like promoter upstream of pezA and is negatively autoregulated with PezA functioning as a transcriptional repressor and PezT as a co-repressor. Both PezA and the non-toxic PezA(2)PezT(2) protein complex bind to a palindrome sequence that overlaps the promoter. This differs from the epsilon-zeta system in which epsilon functions solely as the antitoxin and transcriptional regulation is carried out by another protein designated omega. Results from site-directed mutagenesis experiments demonstrated that the toxicity of PezT is dependent on a highly conserved phosphoryltransferase active site and an ATP/GTP nucleotide binding site. In the PezA(2)PezT(2) complex, PezA neutralizes the toxicity of PezT by blocking the nucleotide binding site through steric hindrance.	Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; Malaysia Univ Sci & Technol, Dept Biotechnol, Petaling Jaya, Malaysia	Max Planck Society	Yeo, CC (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	ccyeo@must.edu.my	Yeo, Chew Chieng/I-7082-2019; Loll, Bernhard/J-4815-2019; Meinhart, Anton/M-9647-2014	Yeo, Chew Chieng/0000-0002-9644-6925; Loll, Bernhard/0000-0001-7928-4488; 				Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Brown JS, 2004, INFECT IMMUN, V72, P1587, DOI 10.1128/IAI.72.3.1587-1593.2004; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; CEGLOWSKI P, 1993, GENE, V136, P1, DOI 10.1016/0378-1119(93)90441-5; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Izard T, 2000, EMBO J, V19, P2690, DOI 10.1093/emboj/19.11.2690; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; McLean BW, 1997, CAN J MICROBIOL, V43, P981, DOI 10.1139/m97-141; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nieto C, 2006, MOL MICROBIOL, V59, P1280, DOI 10.1111/j.1365-2958.2006.05027.x; Nieto C, 2007, J BACTERIOL, V189, P1266, DOI 10.1128/JB.01130-06; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	39	84	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19606	19618		10.1074/jbc.M701703200	http://dx.doi.org/10.1074/jbc.M701703200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488720	Green Published, hybrid			2022-12-27	WOS:000247650600035
J	Cheng, M; Foo, SY; Shi, ML; Tang, RH; Kong, LS; Law, SKA; Tan, SM				Cheng, Ming; Foo, Shen-Yun; Shi, Min-Long; Tang, Ren-Hong; Kong, Le-Sheng; Law, S. K. Alex; Tan, Suet-Mien			Mutation of a conserved asparagine in the I-like domain promotes constitutively active integrins alpha(L)ss(2) and alpha(IIb)ss(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE ADHESION DEFICIENCY; ALPHA(L)BETA(2) HYBRID DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EXTRACELLULAR SEGMENT; MONOCLONAL-ANTIBODY; SURFACE EXPRESSION; BETA-2 INTEGRINS; DISULFIDE BONDS; A-DOMAIN	The leukocyte beta(2) integrins are heterodimeric adhesion receptors required for a functional immune system. Many leukocyte adhesion deficiency-1 (LAD-1) mutations disrupt the expression and function of beta(2) integrins. Herein, we further characterized the LAD-1 mutation N329S in the beta(2) inserted (I)-like domain. This mutation converted alpha(L)beta(2) from a resting into a high affinity conformer because alpha(L)beta(2)N329S transfectants adhered avidly to ligand intercellular adhesion molecule (ICAM)-3 in the absence of additional activating agent. An extended open conformation is adopted by alpha(L)beta(2)N329S because of its reactivity with the beta(2) activation reporter monoclonal antibodies MEM148 and KIM127. A corresponding mutation in beta(3) generated constitutively active alpha(IIb)beta(3) that adhered to fibrinogen. This Asn is conserved in all human beta sub-units, and it resides before the last helix of the I-like domain, which is known to be important in activation signal propagation. By mutagenesis studies and review of existing integrin structures, we conjectured that this conserved Asn may have a primary role in shaping the I- like domain by stabilizing the conformation of the alpha 7 helix and the beta 6-alpha 7 loop in the I-like domain.	Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; Natl Univ Singapore, Computat Res Grp, Res Link 1, Temasek Life Sci Lab, Singapore 117604, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Law, SKA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	alaw@ntu.edu.sg; smtan@ntu.edu.sg	Tan, Suet/A-2224-2011; Kong, Lesheng/O-8933-2015; Law, Alex/A-2212-2011; shi, minlong/G-8734-2013	Kong, Lesheng/0000-0002-9225-3421; Tan, Suet-Mien/0000-0003-2371-8739				ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Artoni A, 2004, P NATL ACAD SCI USA, V101, P13114, DOI 10.1073/pnas.0404201101; Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; HILDRETH JEK, 1985, J IMMUNOL, V134, P3272; Hogg N, 1999, J CLIN INVEST, V103, P97, DOI 10.1172/JCI3312; Hogg N, 2000, MATRIX BIOL, V19, P211, DOI 10.1016/S0945-053X(00)00066-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Mathew EC, 2000, CLIN EXP IMMUNOL, V121, P133, DOI 10.1046/j.1365-2249.2000.01277.x; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; NELSON C, 1992, J BIOL CHEM, V267, P3351; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Shaw JM, 2001, CLIN EXP IMMUNOL, V126, P311, DOI 10.1046/j.1365-2249.2001.01661.x; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2002, P NATL ACAD SCI USA, V99, P16737, DOI 10.1073/pnas.252633099; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; SIMMONS DL, 1993, CELLULAR INTERACTION, P93; Stephens P, 1995, CELL ADHES COMMUN, V3, P375, DOI 10.3109/15419069509081292; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Tang RH, 2005, J BIOL CHEM, V280, P29208, DOI 10.1074/jbc.M503239200; Tng E, 2004, J BIOL CHEM, V279, P54334, DOI 10.1074/jbc.M407818200; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101	48	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18225	18232		10.1074/jbc.M701386200	http://dx.doi.org/10.1074/jbc.M701386200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17468108	hybrid			2022-12-27	WOS:000247302000029
J	Lorin, A; Charloteaux, B; Fridmann-Sirkis, Y; Thomas, A; Shai, Y; Brasseur, R				Lorin, Aurelien; Charloteaux, Benoit; Fridmann-Sirkis, Yael; Thomas, Annick; Shai, Yechiel; Brasseur, Robert			Mode of membrane interaction and fusogenic properties of a de Novo transmembrane model peptide depend on the length of the hydrophobic core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HELICAL PEPTIDES; SOLID-STATE NMR; LIPID-BILAYERS; PHOSPHATIDYLCHOLINE BILAYERS; FLANKING RESIDUES; AMPHIPHILIC PEPTIDES; MOLECULAR-STRUCTURE; ESCHERICHIA-COLI; CHARGED RESIDUES; DOMAIN FORMATION	Model peptides composed of alanine and leucine residues are often used to mimic single helical transmembrane domains. Many studies have been carried out to determine how they interact with membranes. However, few studies have investigated their lipid-destabilizing effect. We designed three peptides designated KALRs containing a hydrophobic stretch of 14, 18, or 22 alanines/leucines surrounded by charged amino acids. Molecular modeling simulations in an implicit membrane model as well as attenuated total reflection-Fourier transform infrared analyses show that KALR is a good model of a transmembrane helix. However, tryptophan fluorescence and attenuated total reflection-Fourier transform infrared spectroscopy indicate that the extent of binding and insertion into lipids increases with the length of the peptide hydrophobic core. Although binding can be directly correlated to peptide hydrophobicity, we show that insertion of peptides into a membrane is determined by the length of the peptide hydrophobic core. Functional studies were performed by measuring the ability of peptides to induce lipid mixing and leakage of liposomes. The data reveal that whereas KALR(14) does not destabilize liposomal membranes, KALR(18) and KALR(22) induce 40 and 50% of lipid-mixing, and 65 and 80% of leakage, respectively. These results indicate that a transmembrane model peptide can induce liposome fusion in vitro if it is long enough. The reasons for the link between length and fusogenicity are discussed in relation to studies of transmembrane domains of viral fusion proteins. We propose that fusogenicity depends not only on peptide insertion but also on the ability of peptides to destabilize the two leaflets of the liposome membrane.	Gembloux Agr Univ, Ctr Biophys Mol Numerique, B-5030 Gembloux, Belgium; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Liege; Weizmann Institute of Science	Brasseur, R (corresponding author), Gembloux Agr Univ, Ctr Biophys Mol Numerique, B-5030 Gembloux, Belgium.	brasseur.r@fsagx.ac.be						Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614; Bechinger B, 2001, BIOPHYS J, V81, P2251, DOI 10.1016/S0006-3495(01)75872-9; Bos ECW, 1995, VIROLOGY, V214, P453, DOI 10.1006/viro.1995.0056; Busquets MA, 2003, CURR DRUG TARGETS, V4, P633, DOI 10.2174/1389450033490795; Bystrom T, 2003, COLLOID SURFACE A, V228, P37, DOI 10.1016/S0927-7757(03)00303-0; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; Castano S, 2005, BBA-BIOMEMBRANES, V1715, P81, DOI 10.1016/j.bbamem.2005.07.008; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Charloteaux B, 2006, J MOL BIOL, V359, P597, DOI 10.1016/j.jmb.2006.04.018; Chung LA, 1996, BIOCHEMISTRY-US, V35, P11343, DOI 10.1021/bi960080c; Creighton T. E, 1992, PROTEINS STRUCTURE M, p[182, 221]; DAVIS JH, 1983, BIOCHEMISTRY-US, V22, P5298, DOI 10.1021/bi00292a008; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; de Planque MRR, 1999, J BIOL CHEM, V274, P20839, DOI 10.1074/jbc.274.30.20839; de Planque MRR, 2002, BIOCHEMISTRY-US, V41, P8396, DOI 10.1021/bi0257686; de Planque MRR, 2001, BIOCHEMISTRY-US, V40, P5000, DOI 10.1021/bi000804r; Deber CM, 2002, CURR TOP MEMBR, V52, P465; Dennison SM, 2002, BIOCHEMISTRY-US, V41, P14925, DOI 10.1021/bi0203233; Ducarme P, 1998, PROTEINS, V30, P357, DOI 10.1002/(SICI)1097-0134(19980301)30:4<357::AID-PROT3>3.0.CO;2-G; Eiler S, 2001, PROTEIN EXPRES PURIF, V22, P165, DOI 10.1006/prep.2001.1409; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Harzer U, 2000, BIOCHEMISTRY-US, V39, P13106, DOI 10.1021/bi000770n; HAUSER HGP, 2005, STRUCTURE BIOL MEMBR; Hofmann MW, 2004, P NATL ACAD SCI USA, V101, P14776, DOI 10.1073/pnas.0405175101; Killian JA, 2006, CURR OPIN STRUC BIOL, V16, P473, DOI 10.1016/j.sbi.2006.06.007; Killian JA, 2003, FEBS LETT, V555, P134, DOI 10.1016/S0014-5793(03)01154-2; Killian JA, 1996, BIOCHEMISTRY-US, V35, P1037, DOI 10.1021/bi9519258; Killian JA, 1998, PURE APPL CHEM, V70, P75; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Langosch D, 2001, J BIOL CHEM, V276, P32016, DOI 10.1074/jbc.M102579200; Langosch D, 2001, J MOL BIOL, V311, P709, DOI 10.1006/jmbi.2001.4889; LEAR JD, 1987, J BIOL CHEM, V262, P6500; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Lewis RNAH, 2002, BIOELECTROCHEMISTRY, V56, P135, DOI 10.1016/S1567-5394(02)00012-9; Lewis RNAH, 2001, BIOCHEMISTRY-US, V40, P12103, DOI 10.1021/bi010555m; Lins L, 2006, BIOPHYS J, V90, P470, DOI 10.1529/biophysj.105.068213; Lins L, 2001, PROTEINS, V44, P435, DOI 10.1002/prot.1109; Liu F, 2004, BIOCHEMISTRY-US, V43, P3679, DOI 10.1021/bi036214l; Liu F, 2002, BIOCHEMISTRY-US, V41, P9197, DOI 10.1021/bi025661i; Liu F, 2001, BIOCHEMISTRY-US, V40, P760, DOI 10.1021/bi001942j; Liu LP, 1996, BIOPOLYMERS, V39, P465, DOI 10.1002/(SICI)1097-0282(199609)39:3<465::AID-BIP17>3.0.CO;2-A; Lorin A, 2006, CHEM PHYS LIPIDS, V141, P185, DOI 10.1016/j.chemphyslip.2006.02.019; Martin I, 2000, BIOSCIENCE REP, V20, P483, DOI 10.1023/A:1010454803579; Milhiet PE, 2001, BIOPHYS J, V81, P547, DOI 10.1016/S0006-3495(01)75721-9; MOLL TS, 1994, BIOCHEMISTRY-US, V33, P15469, DOI 10.1021/bi00255a029; Morein S, 2000, BIOPHYS J, V78, P2475, DOI 10.1016/S0006-3495(00)76792-0; Morein S, 2002, BIOPHYS J, V82, P1405, DOI 10.1016/S0006-3495(02)75495-7; Morein S, 1997, BIOPHYS J, V73, P3078, DOI 10.1016/S0006-3495(97)78335-8; MRSNY RJ, 1986, CHEM PHYS LIPIDS, V39, P185, DOI 10.1016/0009-3084(86)90111-8; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V312, P825, DOI 10.1016/j.bbrc.2003.10.193; NEZIL FA, 1992, BIOPHYS J, V61, P1176, DOI 10.1016/S0006-3495(92)81926-4; OWENS RJ, 1994, J VIROL, V68, P570, DOI 10.1128/JVI.68.1.570-574.1994; Ozdirekcan S, 2005, BIOCHEMISTRY-US, V44, P1004, DOI 10.1021/bi0481242; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Percot A, 1999, BIOPOLYMERS, V50, P647, DOI 10.1002/(SICI)1097-0282(199911)50:6<647::AID-BIP9>3.0.CO;2-T; Pietschmann T, 2000, J VIROL, V74, P4474, DOI 10.1128/JVI.74.10.4474-4482.2000; RAGHEB JA, 1994, J VIROL, V68, P3207, DOI 10.1128/JVI.68.5.3207-3219.1994; RAHMAN M, 1994, J MOL GRAPHICS, V12, P212, DOI 10.1016/0263-7855(94)80090-1; REITHMEIER RAF, 1995, CURR OPIN STRUC BIOL, V5, P491, DOI 10.1016/0959-440X(95)80034-4; Ren JH, 1997, BIOCHEMISTRY-US, V36, P10213, DOI 10.1021/bi9709295; Rinia HA, 2002, BIOCHEMISTRY-US, V41, P2814, DOI 10.1021/bi011796x; RIZZO V, 1987, BIOCHEMISTRY-US, V26, P2751, DOI 10.1021/bi00384a015; Rohl CA, 1999, P NATL ACAD SCI USA, V96, P3682, DOI 10.1073/pnas.96.7.3682; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Salamon Z, 2005, J BIOL CHEM, V280, P11175, DOI 10.1074/jbc.M411197200; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Sharpe S, 2002, BIOPHYS J, V83, P345, DOI 10.1016/S0006-3495(02)75174-6; Siegel DP, 2006, BIOPHYS J, V90, P200, DOI 10.1529/biophysj.105.070466; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sparr E, 2005, J BIOL CHEM, V280, P39324, DOI 10.1074/jbc.M502810200; Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402; Strandberg E, 2002, BIOCHEMISTRY-US, V41, P7190, DOI 10.1021/bi012047i; Tristram-Nagle S, 1998, BIOPHYS J, V75, P917, DOI 10.1016/S0006-3495(98)77580-0; Van Bambeke F, 2000, LIPIDS, V35, P213, DOI 10.1007/BF02664772; van der Wel PCA, 2000, BIOCHEMISTRY-US, V39, P3124, DOI 10.1021/bi9922594; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; Webb RJ, 1998, BIOCHEMISTRY-US, V37, P673, DOI 10.1021/bi972441+; Weiss TM, 2003, BIOPHYS J, V84, P379, DOI 10.1016/S0006-3495(03)74858-9; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; ZHANG YP, 1995, BIOCHEMISTRY-US, V34, P2362, DOI 10.1021/bi00007a032; ZHANG YP, 1995, BIOCHEMISTRY-US, V34, P2348, DOI 10.1021/bi00007a031; ZHANG YP, 1992, BIOCHEMISTRY-US, V31, P11579, DOI 10.1021/bi00161a042; Zhang YP, 2001, BIOCHEMISTRY-US, V40, P474, DOI 10.1021/bi002170u; Zhao JB, 1996, BBA-BIOMEMBRANES, V1283, P37, DOI 10.1016/0005-2736(96)00071-5	87	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18388	18396		10.1074/jbc.M700099200	http://dx.doi.org/10.1074/jbc.M700099200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17459883	hybrid			2022-12-27	WOS:000247302000045
J	Malnasi-Csizmadia, A; Toth, J; Pearson, DS; Hetenyi, C; Nyitray, L; Geeves, MA; Bagshaw, CR; Kovacs, M				Malnasi-Csizmadia, Andras; Toth, Judit; Pearson, David S.; Hetenyi, Csaba; Nyitray, Laszlo; Geeves, Michael A.; Bagshaw, Clive R.; Kovacs, Mihaly			Selective perturbation of the myosin recovery stroke by point mutations at the base of the lever arm affects ATP hydrolysis and phosphate release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; II MOTOR DOMAIN; KINETIC CHARACTERIZATION; TRYPTOPHAN RESIDUE; MOLECULAR MOTOR; DICTYOSTELIUM; MECHANISM; RESOLUTION; TRANSITION; DYNAMICS	After ATP binding the myosin head undergoes a large structural rearrangement called the recovery stroke. This transition brings catalytic residues into place to enable ATP hydrolysis, and at the same time it causes a swing of the myosin lever arm into a primed state, which is a prerequisite for the power stroke. By introducing point mutations into a subdomain interface at the base of the myosin lever arm at positions Lys(84) and Arg(704), we caused modulatory changes in the equilibrium constant of the recovery stroke, which we could accurately resolve using the fluorescence signal of single tryptophan Dictyostelium myosin II constructs. Our results shed light on a novel role of the recovery stroke: fine-tuning of this reversible equilibrium influences the functional properties of myosin through controlling the effective rates of ATP hydrolysis and phosphate release.	Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	Eotvos Lorand University; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Kent	Kovacs, M (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany P Setany 1-C, H-1117 Budapest, Hungary.	kovacsm@elte.hu	Pearson, David S/A-7892-2010; Bagshaw, Clive R./L-5484-2019; Hetenyi, Csaba/G-5249-2010; Kovacs, Mihaly/A-6841-2011; Csizmadia, András Málnási/K-7632-2018; Nyitray, László/AAE-5910-2020; Geeves, Michael/F-7583-2011	Pearson, David S/0000-0002-4088-8097; Bagshaw, Clive R./0000-0002-5396-153X; Hetenyi, Csaba/0000-0002-8013-971X; Csizmadia, András Málnási/0000-0002-2430-8398; Nyitray, László/0000-0003-4717-5994; Geeves, Michael/0000-0002-9364-8898; Kovacs, Mihaly/0000-0002-1200-4741	FOGARTY INTERNATIONAL CENTER [R01TW006230, R01TW007241] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW006230, R01 TW007241-01] Funding Source: Medline; Wellcome Trust [070021, 071525] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ajtai K, 1999, BIOCHEMISTRY-US, V38, P6428, DOI 10.1021/bi990149r; BAGSHAW CR, 1973, BIOCHEM J, V133, P323, DOI 10.1042/bj1330323; Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Kovacs M, 2004, J MUSCLE RES CELL M, V25, P95, DOI 10.1023/B:JURE.0000021352.80800.b8; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2001, J BIOL CHEM, V276, P19483, DOI 10.1074/jbc.M010886200; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; Ostap EM, 1996, J CELL BIOL, V132, P1053, DOI 10.1083/jcb.132.6.1053; Pearson DS, 2002, BIOCHEM J, V366, P643, DOI 10.1042/BJ20020462; Sellers J. R., 1999, MYOSINS; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Urbanke C, 2001, BIOCHEM J, V358, P165, DOI 10.1042/0264-6021:3580165; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Zeng W, 2004, PHILOS T R SOC B, V359, P1843, DOI 10.1098/rstb.2004.1527	22	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17658	17664		10.1074/jbc.M701447200	http://dx.doi.org/10.1074/jbc.M701447200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17449872	hybrid			2022-12-27	WOS:000247084500038
J	Nitsche-Schmitz, DP; Johansson, HM; Sastalla, I; Reissmann, S; Frick, IM; Chhatwal, GS				Nitsche-Schmitz, D. Patric; Johansson, Helena M.; Sastalla, Inka; Reissmann, Silvana; Frick, Inga-Maria; Chhatwal, Gursharan S.			Group G streptococcal IgG binding molecules FOG and protein G have different impacts on opsonization by C1q	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 PARTS; COMPLEMENT; MECHANISM; PYOGENES; IMMUNOLOGY; BACTEREMIA; RECEPTORS; COLLAGEN; TARGETS; REGION	Recent epidemiological data on diseases caused by beta-hemolytic streptococci belonging to Lancefield group C and G ( GCS, GGS) underline that they are an emerging threat to human health. Among various virulence factors expressed by GCS and GGS isolates from human infections, M and M-like proteins are considered important because of their anti-phagocytic activity. In addition, protein G has been implicated in the accumulation of IgG on the bacterial surface through non-immune binding. The function of this interaction, however, is still unknown. Using isogenic mutants lacking protein G or the M-like protein FOG ( group G streptococci), respectively, we could show that FOG contributes substantially to IgG binding. A detailed characterization of the interaction between IgG and FOG revealed its ability to bind the Fc region of human IgG and its binding to the subclasses IgG1, IgG2, and IgG4. FOG was also found to bind IgG of several animal species. Surface plasmon resonance measurements indicate a high affinity to human IgG with a dissociation constant of 2.4 pM. The binding site was localized in a central motif of FOG. It has long been speculated about anti-opsonic functions of streptococcal Fc-binding proteins. The presented data for the first time provide evidence and, furthermore, indicate functional differences between protein G and FOG. By obstructing the interaction between IgG and C1q, protein G prevented recognition by the classical pathway of the complement system. In contrast, IgG that was bound to FOG remained capable of binding C1q, an effect that may have important consequences in the pathogenesis of GGS infections.	Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; Lund Univ, Biomed Ctr, Dept Clin Sci, Sect Clin & Expt Infect Med, S-22184 Lund, Sweden	Helmholtz Association; Helmholtz-Center for Infection Research; Lund University	Nitsche-Schmitz, DP (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.	patric.nitsche@helmholtz-hzi.de		Linge, Helena/0000-0002-8919-0300; Sastalla, Inka/0000-0003-4128-0742				AKERSTROM B, 1986, J BIOL CHEM, V261, P240; Berge A, 1997, J BIOL CHEM, V272, P20774, DOI 10.1074/jbc.272.33.20774; BJORCK L, 1984, J IMMUNOL, V133, P969; BOBAK DA, 1987, J IMMUNOL, V138, P1150; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; CLEARY PP, 1991, INFECT IMMUN, V59, P2305, DOI 10.1128/IAI.59.7.2305-2310.1991; Cohen-Poradosu R, 2004, EMERG INFECT DIS, V10, P1455, DOI 10.3201/eid1008.030840; Dinkla K, 2003, MOL MICROBIOL, V47, P861, DOI 10.1046/j.1365-2958.2003.03352.x; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; FRICK IM, 1992, P NATL ACAD SCI USA, V89, P8532, DOI 10.1073/pnas.89.18.8532; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Johansson HM, 2004, MICROBIOL-SGM, V150, P4211, DOI 10.1099/mic.0.27269-0; JOINER K, 1983, J IMMUNOL, V130, P845; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mathur P, 2004, INDIAN J MED RES, V120, P199; McLaughlin R E, 1995, Methods Mol Biol, V47, P185; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; NOHLGARD C, 1992, ACTA DERM-VENEREOL, V72, P128; PEREZCASAL J, 1995, MOL MICROBIOL, V15, P907, DOI 10.1111/j.1365-2958.1995.tb02360.x; REIS KJ, 1984, J IMMUNOL, V132, P3098; SIMPSON WJ, 1987, MICROB PATHOGENESIS, V3, P339, DOI 10.1016/0882-4010(87)90004-0; STONE GC, 1989, J IMMUNOL, V143, P565; Sylvetsky N, 2002, AM J MED, V112, P622, DOI 10.1016/S0002-9343(02)01117-8; TENNER AJ, 1982, J IMMUNOL, V128, P2547; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144	28	24	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17530	17536		10.1074/jbc.M702612200	http://dx.doi.org/10.1074/jbc.M702612200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17449474	hybrid			2022-12-27	WOS:000247084500023
J	Herrera, K; Cahoon, RE; Kumaran, S; Jez, JM				Herrera, Katherine; Cahoon, Rebecca E.; Kumaran, Sangaralingam; Jez, Joseph M.			Reaction mechanism of glutathione synthetase from Arabidopsis thaliana - Site-directed mutagenesis of active residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI-B; BIOTIN CARBOXYLASE; KINETIC MECHANISM; FLEXIBLE LOOP; LIGASE; ATP; MUTATIONS; DEUTERIUM; PHOSPHATE; BINDING	Glutathione is essential for maintaining the intracellular redox environment and is synthesized from gamma-glutamylcysteine, glycine, and ATP by glutathione synthetase (GS). To examine the reaction mechanism of a eukaryotic GS, 24 Arabidopsis thaliana GS (AtGS) mutants were kinetically characterized. Within the gamma-glutamylcysteine/glutathione-binding site, the S153A and S155A mutants displayed less than 4-fold changes in kinetic parameters with mutations of Glu-220 (E220A/E220Q), Gln-226 (Q226A/Q226N), and Arg-274 (R274A/R274K) at the distal end of the binding site resulting in 24-180-fold increases in the K-m values for gamma-glutamylcysteine. Substitution of multiple residues interacting with ATP (K313M, K367M, and E429A/E429Q) or coordinating magnesium ions to ATP (E148A/E148Q, N150A/N150D, and E371A) yielded inactive protein because of compromised nucleotide binding, as determined by fluorescence titration. Other mutations in the ATP-binding site (E371Q, N376A, and K456M) resulted in greater than 30-fold decreases in affinity for ATP and up to 80-fold reductions in turnover rate. Mutation of Arg-132 and Arg-454, which are positioned at the interface of the two substrate-binding sites, affected the enzymatic activity differently. The R132A mutant was inactive, and the R132K mutant decreased kcat by 200-fold; however, both mutants bound ATP with Kd values similar to wild-type enzyme. Minimal changes in kinetic parameters were observed with the R454K mutant, but the R454A mutant displayed a 160-fold decrease in kcat. In addition, the R132K, R454A, and R454K mutations elevated the Km value for glycine up to 11-fold. Comparison of the pH profiles and the solvent deuterium isotope effects of A. thaliana GS and the Arg-132 and Arg-454 mutants also suggest distinct mechanistic roles for these residues. Based on these results, a catalytic mechanism for the eukaryotic GS is proposed.	Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Jez, JM (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	jjez@danforthcenter.org						Cleland W W, 1979, Methods Enzymol, V63, P103; Dinescu A, 2004, J BIOL CHEM, V279, P22412, DOI 10.1074/jbc.M401334200; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Gali RR, 1997, BIOCHEM J, V321, P207, DOI 10.1042/bj3210207; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gogos A, 2002, STRUCTURE, V10, P1669, DOI 10.1016/S0969-2126(02)00906-1; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; Jez JM, 2004, J BIOL CHEM, V279, P42726, DOI 10.1074/jbc.M407961200; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; KATO H, 1994, BIOCHEMISTRY-US, V33, P4995, DOI 10.1021/bi00183a001; KATSUBE Y, 1993, J MOL BIOL, V229, P1083; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MULLINS LS, 1990, J BIOL CHEM, V265, P8993; NISHIMURA JS, 1964, J BIOL CHEM, V239, P2553; Njalsson R, 2000, BIOCHEM J, V349, P275, DOI 10.1042/0264-6021:3490275; Njalsson R, 2001, BIOCHEM BIOPH RES CO, V289, P80, DOI 10.1006/bbrc.2001.5961; Noctor G, 1998, J EXP BOT, V49, P623, DOI 10.1093/jexbot/49.321.623; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Polekhina G, 1999, EMBO J, V18, P3204, DOI 10.1093/emboj/18.12.3204; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Sloane V, 2001, J BIOL CHEM, V276, P24991, DOI 10.1074/jbc.M101472200; SWAIN CG, 1953, J AM CHEM SOC, V75, P141, DOI 10.1021/ja01097a041; TANAKA T, 1992, BIOCHEMISTRY-US, V31, P2259, DOI 10.1021/bi00123a007; TANAKA T, 1993, BIOCHEMISTRY-US, V32, P12398, DOI 10.1021/bi00097a018; TIPTON PA, 1988, BIOCHEMISTRY-US, V27, P4325, DOI 10.1021/bi00412a020; TIPTON PA, 1988, BIOCHEMISTRY-US, V27, P4317, DOI 10.1021/bi00412a019; YAMAGUCHI H, 1993, J MOL BIOL, V229, P1083, DOI 10.1006/jmbi.1993.1106; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2	30	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					17157	17165		10.1074/jbc.M700804200	http://dx.doi.org/10.1074/jbc.M700804200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17452339	hybrid			2022-12-27	WOS:000246946500049
J	Hou, JH; Shan, QA; Wang, T; Gomes, AS; Yan, QS; Paul, DL; Bleich, M; Goodenough, DA				Hou, Jianghui; Shan, Qixian; Wang, Tong; Gomes, Antonio S.; Yan, QingShang; Paul, David L.; Bleich, Markus; Goodenough, Daniel A.			Transgenic RNAi depletion of claudin-16 and the renal handling of magnesium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; FAMILIAL HYPOMAGNESEMIA; HENLES LOOP; MG2+ TRANSPORT; RABBIT KIDNEY; EXPRESSION; MOUSE; MICE; INTERFERENCE; NEPHRON	Tight junctions play a key role in mediating paracellular ion reabsorption in the kidney. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a human disorder caused by mutations in the tight junction protein claudin-16. However, the molecular mechanisms underlining the renal handling of magnesium and its dysfunction causing FHHNC are unknown. Here we show that claudin-16 plays a key role in maintaining the paracellular cation selectivity of the thick ascending limbs of the nephron. Using RNA interference, we have generated claudin-16-deficient mouse models. Claudin-16 knock-down (KD) mice exhibit chronic renal wasting of magnesium and calcium and develop renal nephrocalcinosis. Our data suggest that claudin-16 forms a non-selective paracellular cation channel, rather than a selective Mg2+ /Ca2+ channel as previously proposed. Our study highlights the pivotal importance of the tight junction in renal control of ion homeostasis and provides answer to the pathogenesis of FHHNC. We anticipate our study to be a starting point for more sophisticated in vivo analysis of tight junction proteins in renal functions. Furthermore, tight junction proteins could be major targets of drug development for electrolyte disorders.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Kiel, Inst Physiol, D-24098 Kiel, Germany; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Kiel; Yale University	Goodenough, DA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_goodenough@hms.harvard.edu	Bleich, Markus/A-2812-2010	Bleich, Markus/0000-0002-1745-2295	NATIONAL EYE INSTITUTE [R01EY014127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018974, R01GM037751, R01GM018974] Funding Source: NIH RePORTER; NEI NIH HHS [EY014127] Funding Source: Medline; NIGMS NIH HHS [GM37751, GM18974] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Bailey MA, 2004, J PHYSIOL-LONDON, V561, P765, DOI 10.1113/jphysiol.2004.074716; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; DISTEFANO A, 1993, RENAL PHYSIOL BIOCH, V16, P157; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; GREGER R, 1981, PFLUG ARCH EUR J PHY, V390, P30, DOI 10.1007/BF00582707; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; GREGER R, 1983, PFLUG ARCH EUR J PHY, V396, P315, DOI 10.1007/BF01063937; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; HALPERIN ML, 1986, AM J NEPHROL, V6, P241, DOI 10.1159/000167170; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HEBERT SC, 1981, AM J PHYSIOL, V241, pF412, DOI 10.1152/ajprenal.1981.241.4.F412; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Kuwertz-Broking E, 2001, CLIN NEPHROL, V56, P155; Liggett SB, 2004, NAT REV GENET, V5, P657, DOI 10.1038/nrg1429; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; MAGALDI AJ, 1989, AM J PHYSIOL, V257, pF738, DOI 10.1152/ajprenal.1989.257.5.F738; MANDON B, 1993, PFLUG ARCH EUR J PHY, V424, P558, DOI 10.1007/BF00374924; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PRAGA M, 1995, KIDNEY INT, V47, P1419, DOI 10.1038/ki.1995.199; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SHAREGHI GR, 1982, J CLIN INVEST, V69, P759, DOI 10.1172/JCI110514; Sheehan D, 1980, THEORY PRACTICE HIST, Vsecond, P226; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Weber S, 2001, J AM SOC NEPHROL, V12, P1872, DOI 10.1681/ASN.V1291872; Xia XG, 2006, PLOS GENET, V2, P73, DOI 10.1371/journal.pgen.0020010; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	44	121	123	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					17114	17122		10.1074/jbc.M700632200	http://dx.doi.org/10.1074/jbc.M700632200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17442678	hybrid			2022-12-27	WOS:000246946500044
J	Li, N; Lorinczi, M; Ireton, K; Elferink, LA				Li, Ning; Lorinczi, Marta; Ireton, Keith; Elferink, Lisa A.			Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GRB2 BINDING-SITE; PLECKSTRIN HOMOLOGY DOMAIN; MET RECEPTOR; C-CBL; EGF RECEPTOR; SOMATIC MUTATIONS; PHOSPHOINOSITIDE 3-KINASE; LISTERIA-MONOCYTOGENES; CELL-TRANSFORMATION	Lysosomal degradation of the receptor-tyrosine kinase cMet requires receptor ubiquitination by the E3 ubiquitin ligase Cbl followed by clathrin-dependent internalization. A role for Cbl as an adaptor for cMet internalization has been previously reported. However, the requirement for Cbl ubiquitin ligase activity in this process and its mode of recruitment to cMet has yet to be determined. Cbl can directly bind cMet at phosphotyrosine 1003 or indirectly via Grb2 to phosphotyrosine 1356 in the multisubstrate binding domain of cMet. The direct binding of Cbl with cMet is critical for receptor degradation and not receptor internalization. Here we show a strict requirement for Grb2 and the ubiquitin ligase activity of Cbl for cMet endocytosis. Receptor internalization was impaired by small interfering RNA depletion of Grb2, overexpression of dominant negative Grb2 mutants, and point mutations in the cMet multisubstrate docking site that inhibits the direct association of Grb2 with cMet. The requirement for Grb2 was specific and did not involve the multiadaptor Gab1. cMet internalization was impaired in cells expressing an ubiquitin ligase-deficient Cbl mutant or conjugation-deficient ubiquitin but was unaffected in cells expressing a Cbl mutant that is unable to bind cMet directly. Expression of a Cbl-Grb2 chimera rescued impaired cMet endocytosis in cells depleted of endogenous Grb2. These results indicate that the ubiquitin ligase activity of Cbl is critical for clathrin-dependent cMet internalization and suggest a role for Grb2 as an intermediary linking Cbl ubiquitin ligase activity to this process.	Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32826 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Central Florida	Elferink, LA (corresponding author), Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	laelferi@utmb.edu			NATIONAL CANCER INSTITUTE [R01CA119075, R21CA112605] Funding Source: NIH RePORTER; NCI NIH HHS [CA-119075, CA-112605] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Bardelli A, 1997, ONCOGENE, V15, P3103, DOI 10.1038/sj.onc.1201561; Basar T, 2005, INFECT IMMUN, V73, P2061, DOI 10.1128/IAI.73.4.2061-2074.2005; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Carter S, 2004, J BIOL CHEM, V279, P52835, DOI 10.1074/jbc.M407769200; CHAN AML, 1988, ONCOGENE, V2, P593; Chan PC, 2003, J BIOL CHEM, V278, P44075, DOI 10.1074/jbc.M305745200; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; Cully M, 2004, P NATL ACAD SCI USA, V101, P15358, DOI 10.1073/pnas.0406613101; de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; DEAN M, 1987, MOL CELL BIOL, V7, P921, DOI 10.1128/MCB.7.2.921; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Fixman ED, 1996, J BIOL CHEM, V271, P13116, DOI 10.1074/jbc.271.22.13116; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Fourier TM, 1996, J BIOL CHEM, V271, P22211, DOI 10.1074/jbc.271.36.22211; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Ieraci A, 2002, P NATL ACAD SCI USA, V99, P15200, DOI 10.1073/pnas.222362099; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Kjelsberg C, 1997, AM J PHYSIOL-RENAL, V272, pF222, DOI 10.1152/ajprenal.1997.272.2.F222; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Li N, 2005, TRAFFIC, V6, P459, DOI 10.1111/j.1600-0854.2005.00290.x; Lock LS, 2003, J BIOL CHEM, V278, P30083, DOI 10.1074/jbc.M302675200; Lock LS, 2000, J BIOL CHEM, V275, P31536, DOI 10.1074/jbc.M003597200; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; Mansell A, 2001, J BIOL CHEM, V276, P43597, DOI 10.1074/jbc.M105202200; Mansell A, 2000, CELL MICROBIOL, V2, P127, DOI 10.1046/j.1462-5822.2000.00038.x; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; MEISNER H, 1995, J BIOL CHEM, V270, P25332, DOI 10.1074/jbc.270.43.25332; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; Okabayashi Y, 1996, J BIOL CHEM, V271, P5265; Olivero M, 1999, INT J CANCER, V82, P640, DOI 10.1002/(SICI)1097-0215(19990827)82:5<640::AID-IJC4>3.0.CO;2-6; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Park WS, 1999, CANCER RES, V59, P307; PELICCI G, 1995, ONCOGENE, V10, P1631; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rodrigues G A, 1993, EXS, V65, P167; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Sachs M, 1996, J CELL BIOL, V133, P1095, DOI 10.1083/jcb.133.5.1095; Sakaguchi K, 2001, BIOCHEM BIOPH RES CO, V282, P1154, DOI 10.1006/bbrc.2001.4680; Saucier C, 2002, ONCOGENE, V21, P1800, DOI 10.1038/sj.onc.1205261; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SORKIN A, 1992, J BIOL CHEM, V267, P8672; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Taher TEI, 2002, J IMMUNOL, V169, P3793, DOI 10.4049/jimmunol.169.7.3793; Tanyi J, 1999, Pathol Oncol Res, V5, P187, DOI 10.1053/paor.1999.0219; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; Yamazaki T, 2002, J CELL SCI, V115, P1791; YOKOTE K, 1994, J BIOL CHEM, V269, P15337; ZHEN Z, 1994, ONCOGENE, V9, P1691	74	33	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16764	16775		10.1074/jbc.M610835200	http://dx.doi.org/10.1074/jbc.M610835200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17449471	Green Published, hybrid			2022-12-27	WOS:000246946500008
J	Sauve, V; Bruno, S; Berks, BC; Hemmings, AM				Sauve, Veronique; Bruno, Stefano; Berks, Ben C.; Hemmings, Andrew M.			The SoxYZ complex carries sulfur cycle intermediates on a peptide swinging arm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM ALLOCHROMATIUM-VINOSUM; PARACOCCUS-PANTOTROPHUS; ESCHERICHIA-COLI; GENE-CLUSTER; OXIDATION; PROTEIN; BIOSYNTHESIS; THIOSULFATE; MECHANISM; ENZYME	The bacterial Sox (sulfur oxidizing) system allows the utilization of inorganic sulfur compounds in energy metabolism. Central to this process is the SoxYZ complex that carries the pathway intermediates on a cysteine residue near the C terminus of SoxY. Crystal structures have been determined for Paracoccus pantotrophus SoxYZ with the carrier cysteine in the underivatized state, conjugated to the polysulfide mimic beta-mercaptoethanol, and as the sulfonate adduct pathway intermediate. The carrier cysteine is located on a peptide swinging arm and is bracketed on either side by diglycine dipeptides acting as molecular universal joints. This structure provides a novel solution to the requirement that the cysteine-bound intermediates be able to access and orient themselves within the active sites of multiple partner enzymes. Adjacent to the swinging arm there is a conserved, deep, apolar pocket into which the beta-mercaptoethanol adduct extends. This pocket would be well suited to a role in protecting labile pathway intermediates from adventitious reactions.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England	University of Oxford; University of East Anglia; University of East Anglia	Berks, BC (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	ben.berks@bioch.ox.ac.uk; a.hemmings@uea.ac.uk	Bruno, Stefano/A-4582-2011; HEMMINGS, ANDREW MICHAEL/E-5517-2011	Bruno, Stefano/0000-0002-7890-2472; HEMMINGS, ANDREW MICHAEL/0000-0003-3053-3134; Berks, Ben/0000-0001-9685-4067				Appia-Ayme C, 2001, J BACTERIOL, V183, P6107, DOI 10.1128/JB.183.20.6107-6118.2001; BAK F, 1987, ARCH MICROBIOL, V147, P184, DOI 10.1007/BF00415282; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; Binkowski TA, 2003, J MOL BIOL, V332, P505, DOI 10.1016/S0022-2836(03)00882-9; Bordo D, 2000, J MOL BIOL, V298, P691, DOI 10.1006/jmbi.2000.3651; Cort JR, 2001, EUR J BIOCHEM, V268, P5842, DOI 10.1046/j.0014-2956.2001.02529.x; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dahl C., 2002, BIOPOLYMERS, P35; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Iciek M, 2001, POL J PHARMACOL, V53, P215; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; LANDAU M, 2003, BIOINFORMATICS, V19, P163; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Lengeler J. W., 1999, BIOL PROKARYOTES; Lin YJ, 2004, BIOCHEMISTRY-US, V43, P1418, DOI 10.1021/bi0356597; Mukhopadhyaya PN, 2000, J BACTERIOL, V182, P4278, DOI 10.1128/JB.182.15.4278-4287.2000; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PIERIK AJ, 1992, EUR J BIOCHEM, V205, P111, DOI 10.1111/j.1432-1033.1992.tb16757.x; Quentmeier A, 2003, BIOCHEM BIOPH RES CO, V312, P1011, DOI 10.1016/j.bbrc.2003.11.021; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Rawlings DE, 2002, ANNU REV MICROBIOL, V56, P65, DOI 10.1146/annurev.micro.56.012302.161052; Rother D, 2001, J BACTERIOL, V183, P4499, DOI 10.1128/JB.183.15.4499-4508.2001; Rudolph MJ, 2003, J BIOL CHEM, V278, P14514, DOI 10.1074/jbc.M300449200; SMITH AJ, 1966, J GEN MICROBIOL, V42, P357, DOI 10.1099/00221287-42-3-357; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Urich T, 2006, SCIENCE, V311, P996, DOI 10.1126/science.1120306; Wodara C, 1997, J BACTERIOL, V179, P5014, DOI 10.1128/jb.179.16.5014-5023.1997; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Yeh AP, 2000, BIOCHEMISTRY-US, V39, P2499, DOI 10.1021/bi992428k	41	67	68	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23194	23204		10.1074/jbc.M701602200	http://dx.doi.org/10.1074/jbc.M701602200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17522046	hybrid			2022-12-27	WOS:000248577500021
J	Sevostyanova, A; Feklistov, A; Barinova, N; Heyduk, E; Bass, I; Klimasauskas, S; Heyduk, T; Kulbachinskiy, A				Sevostyanova, Anastasiya; Feklistov, Andrey; Barinova, Nataliya; Heyduk, Ewa; Bass, Irina; Klimasauskas, Saulius; Heyduk, Tomasz; Kulbachinskiy, Andrey			Specific recognition of the-10 promoter element by the free RNA polymerase sigma subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-SPECIFIC INTERACTION; AROMATIC-AMINO-ACIDS; ESCHERICHIA-COLI; NONTEMPLATE STRAND; TRANSCRIPTION INITIATION; CRYSTAL-STRUCTURE; CROSS-LINKING; ANGSTROM RESOLUTION; CONSERVED REGION-2; STRUCTURAL BASIS	Bacterial RNA polymerase holoenzyme relies on its sigma subunit for promoter recognition and opening. In the holoenzyme, regions 2 and 4 of the sigma subunit are positioned at an optimal distance to allow specific recognition of the -10 and -35 promoter elements, respectively. In free sigma, the promoter binding regions are positioned closer to each other and are masked for interactions with the promoter, with sigma region 1 playing a role in the masking. To analyze the DNA-binding properties of the free sigma, we selected single-stranded DNA aptamers that are specific to primary sigma subunits from several bacterial species, including Escherichia coli and Thermus aquaticus. The aptamers share a consensus motif, TGTAGAAT, that is similar to the extended -10 promoter. We demonstrate that recognition of this motif by sigma region 2 occurs without major structural rearrangements of sigma observed upon the holoenzyme formation and is not inhibited by sigma regions 1 and 4. Thus, the complex process of the -10 element recognition by RNA polymerase holoenzyme can be reduced to a simple system consisting of an isolated sigma subunit and a short aptamer oligonucleotide.	Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Inst Biotechnol, LT-02241 Vilnius, Lithuania	Russian Academy of Sciences; Saint Louis University; Vilnius University	Kulbachinskiy, A (corresponding author), Russian Acad Sci, Inst Mol Genet, 2 Kurchatov Sq, Moscow 123182, Russia.	akulb@img.ras.ru	Kulbachinskiy, Andrey/P-5401-2016; Sevostiyanova, Anastasia/G-4935-2011; Klimasauskas, Saulius/M-3053-2016	Kulbachinskiy, Andrey/0000-0002-2292-6424; Klimasauskas, Saulius/0000-0002-1395-2030	NIGMS NIH HHS [GM50514] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050514, R21GM050514] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Callaci S, 1998, J BIOL CHEM, V273, P32995, DOI 10.1074/jbc.273.49.32995; Callaci S, 1998, BIOCHEMISTRY-US, V37, P3312, DOI 10.1021/bi972041m; Camarero JA, 2002, P NATL ACAD SCI USA, V99, P8536, DOI 10.1073/pnas.132033899; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; Dombroski AJ, 1997, J BIOL CHEM, V272, P3487; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Fedoriw AM, 1998, BIOCHEMISTRY-US, V37, P11971, DOI 10.1021/bi980980o; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gowrishankar J, 2003, J BACTERIOL, V185, P2673, DOI 10.1128/JB.185.8.2673-2679.2003; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Heyduk E, 2002, BIOCHEMISTRY-US, V41, P2876, DOI 10.1021/bi012133i; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; Kulbachinskiy A, 1999, FEBS LETT, V454, P71, DOI 10.1016/S0014-5793(99)00778-4; Kulbachinskiy A, 2004, J BACTERIOL, V186, P7818, DOI 10.1128/JB.186.22.7818-7820.2004; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Mustaev A, 2003, METHOD ENZYMOL, V371, P191; Roberts CW, 1996, CELL, V86, P495; Rudakova EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P640; Sanderson A, 2003, FEBS LETT, V544, P199, DOI 10.1016/S0014-5793(03)00500-3; SAVINKOVA L K, 1988, Molekulyarnaya Biologiya (Moscow), V22, P807; SETHI VS, 1970, FEBS LETT, V8, P236, DOI 10.1016/0014-5793(70)80274-5; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Sorenson MK, 2006, P NATL ACAD SCI USA, V103, P16722, DOI 10.1073/pnas.0606482103; Sorenson MK, 2004, MOL CELL, V14, P127, DOI 10.1016/S1097-2765(04)00150-9; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555	41	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22033	22039		10.1074/jbc.M702495200	http://dx.doi.org/10.1074/jbc.M702495200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17535803	hybrid			2022-12-27	WOS:000248196800050
J	Kao, GD; Jiang, Z; Fernandes, AM; Gupta, AK; Maity, A				Kao, Gary D.; Jiang, Zibin; Fernandes, Anne Marie; Gupta, Anjali K.; Maity, Amit			Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DEPENDENT PROTEIN-KINASE; HUMAN TUMOR-CELLS; HISTONE H2AX; 3-KINASE INHIBITORS; GENOMIC INSTABILITY; IN-VITRO; LY294002; PATHWAY; RAS	Radiation therapy is a mainstay in the treatment of glioblastomas, but these tumors are often associated with radioresistance. Activation of the phosphatidylinositol-3-OH kinase (PI3K)/Akt pathway, which occurs frequently in glioblastomas due to inactivation of the tumor suppressor phosphatase and tensin homologue (PTEN), correlates with radioresistance. To directly test the link between Akt activation and radioresistance, we utilized PTEN-deficient U251 glioblastoma cells engineered to inducibly restore PTEN upon exposure to doxycycline. These cells showed high basal levels of Akt activation (i.e. high levels of phospho-Akt), but induction of PTEN led to substantially decreased phospho-Akt and was associated with radiosensitization. To investigate whether the PTEN-induced radiosensitization was attributable to impaired sensing versus repair of DNA damage, we assessed levels of gamma-H2AX after ionizing radiation in U251 cells induced for PTEN. Initial post-radiation levels of alpha-H2AX foci were not decreased in PTEN-induced cells; however, the resolution of these foci was significantly delayed. In contrast to these results, induction of phosphatase-dead PTEN showed no appreciable effect. Finally, exposure of cells to the PI3K inhibitor LY294002 did not decrease the occurrence of alpha-H2AX foci after irradiation but did markedly delay their resolution. These results together support a direct link between Akt activation, repair of DNA damage, and radioresistance in glioblastoma. Targeting the PI3K/Akt pathway may modulate DNA repair to improve the efficacy of radiation therapy.	Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania	Maity, A (corresponding author), Univ Penn, Sch Med, Dept Radiat Oncol, 195 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	maity@xrt.upenn.edu	Gupta, Anjali/HCH-5986-2022	Maity, Amit/0000-0001-7151-2845	NCI NIH HHS [P01CA075138, P01 CA075138, R01 CA107956, R01 CA093638] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107956, P01CA075138, R01CA093638] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; BENNER SE, 1993, J CELL BIOCHEM, P250; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Choe G, 2003, CANCER RES, V63, P2742; Edwards E, 2002, CANCER RES, V62, P4671; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Forrester HB, 2000, RADIAT RES, V154, P625, DOI 10.1667/0033-7587(2000)154[0625:CVTLAO]2.0.CO;2; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Gottschalk AR, 2005, INT J RADIAT ONCOL, V63, P1221, DOI 10.1016/j.ijrobp.2005.08.014; Grana TM, 2002, CANCER RES, V62, P4142; Gupta AK, 2001, CANCER RES, V61, P4278; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Gupta AK, 2002, CLIN CANCER RES, V8, P885; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Izzard RA, 1999, CANCER RES, V59, P2581; Kim IA, 2005, CANCER RES, V65, P7902, DOI 10.1158/0008-5472.CAN-05-0513; Lee CM, 2006, CLIN CANCER RES, V12, P250, DOI 10.1158/1078-0432.CCR-05-1084; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Nakamura JL, 2005, J NEURO-ONCOL, V71, P215, DOI 10.1007/s11060-004-1718-y; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; POWIS G, 1994, CANCER RES, V54, P2419; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stopper H, 1997, MUTAT RES-DNA REPAIR, V383, P107, DOI 10.1016/S0921-8777(96)00049-3; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; VINDELOV LL, 1990, CYTOMETRY, V11, P753, DOI 10.1002/cyto.990110702; Willers H, 2004, BRIT J CANCER, V90, P1297, DOI 10.1038/sj.bjc.6601729	38	182	193	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21206	21212		10.1074/jbc.M703042200	http://dx.doi.org/10.1074/jbc.M703042200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17513297	hybrid, Green Accepted			2022-12-27	WOS:000248047500047
J	Al-Ayyoubi, M; Schwartz, BS; Gettins, PGW				Al-Ayyoubi, Maher; Schwartz, Bradford S.; Gettins, Peter G. W.			Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE CENTER LOOP; SERPIN-PROTEINASE COMPLEX; ALPHA(1)-PROTEINASE INHIBITOR; TRYPSIN-INHIBITOR; SERINE PROTEASES; CELL-MIGRATION; SITE; MAMMARY; SYSTEM; CANCER	Maspin is a member of the serpin family with a reactive center loop that is incompatible with proteinase inhibition by the serpin conformational change mechanism. Despite this there are reports that maspin might regulate uPA-dependent processes in vivo. Using exogenous and endogenous fluorescence, we demonstrate here that maspin can bind uPA and tPA in both singlechain and double-chain forms, with K-d values between 300 and 600 nM. Binding is at an exosite on maspin close to, but outside of, the reactive center loop and is therefore insensitive to mutation of Arg(340) within the reactive center loop. The binding site on tPA does not involve the proteinase active site, with the result that maspin can bind to S195A tPA that is already complexed to plasminogen activator inhibitor-1. The ability of maspin to bind these proteinases without involvement of the reactive center loop leaves the latter free to engage in additional, as yet unidentified, maspin- protein interactions that may serve to regulate the properties of the exosite- bound proteinase. This may help to reconcile apparently conflicting studies that demonstrate the importance of the reactive center loop in certain maspin functions, despite the inability of maspin to directly inhibit tPA or uPA catalytic activity in in vitro assays through engagement between its reactive center loop and the active site of the proteinase.	Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign	Gettins, PGW (corresponding author), 900 S Ashland,M-C 669, Chicago, IL 60607 USA.	pgettins@uic.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015958] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049234] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR15958] Funding Source: Medline; NHLBI NIH HHS [R37 HL49234] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Biliran H, 2001, CANCER RES, V61, P8676; Chen ZX, 2003, J UROLOGY, V169, P1316, DOI 10.1097/01.ju.0000050648.40164.0d; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Filfil R, 2004, BIOCHEMISTRY-US, V43, P1315, DOI 10.1021/bi030188+; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Ke SH, 1997, J BIOL CHEM, V272, P20456, DOI 10.1074/jbc.272.33.20456; Khalkhali-Ellis Z, 2006, CLIN CANCER RES, V12, P7279, DOI 10.1158/1078-0432.CCR-06-1589; Krueger SR, 1997, J NEUROSCI, V17, P8984; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LAWRENCE DA, 1990, J BIOL CHEM, V265, P20293; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; McGowen R, 2000, CANCER RES, V60, P4771; NASKI MC, 1993, J BIOL CHEM, V268, P12367; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Pasternak A, 2001, PROTEIN SCI, V10, P1331, DOI 10.1110/ps.44101; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6275, DOI 10.1021/bi0100992; ROVELLI G, 1992, BIOCHEMISTRY-US, V31, P3542, DOI 10.1021/bi00128a031; Sager R, 1996, CURR TOP MICROBIOL, V213, P51; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schwartz BS, 1999, J BIOL CHEM, V274, P15278, DOI 10.1074/jbc.274.21.15278; SCOTT RW, 1985, J BIOL CHEM, V260, P7029; Seftor REB, 1998, CANCER RES, V58, P5681; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; SHENG SJ, 1994, J BIOL CHEM, V269, P30988; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; Stratikos E, 1998, J BIOL CHEM, V273, P15582, DOI 10.1074/jbc.273.25.15582; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Tesch LD, 2005, PROTEIN SCI, V14, P533, DOI 10.1110/ps.041104905; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	42	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19502	19509		10.1074/jbc.M702445200	http://dx.doi.org/10.1074/jbc.M702445200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17510061	hybrid			2022-12-27	WOS:000247650600024
J	Guy, JE; Whittle, E; Kumaran, D; Lindqvist, Y; Shanklin, J				Guy, Jodie E.; Whittle, Edward; Kumaran, Desigan; Lindqvist, Ylva; Shanklin, John			The crystal structure of the ivy Delta(4)-16 : 0-ACP desaturase reveals structural details of the oxidized active site and potential determinants of regioselectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER-PROTEIN-DESATURASE; THUNBERGIA-ALATA ENDOSPERM; STEAROYL-ACP DESATURASE; FATTY-ACID DESATURASES; SUBSTRATE-SPECIFICITY; DELTA(9) DESATURASE; DIIRON(III) SITE; OLEIC-ACID; SEED; METHANE	The multifunctional acyl-acyl carrier protein (ACP) desaturase from Hedera helix ( English ivy) catalyzes the Delta(4) desaturation of 16:0-ACP and the Delta(9) desaturation of 18: 0-ACP and further desaturates Delta(9)-16: 1 or Delta(9)-18: 1 to the corresponding Delta(4,9) dienes. The crystal structure of the enzyme has been solved to 1.95 angstrom resolution, and both the iron-iron distance of similar to 3.2 angstrom and the presence of a mu-oxo bridge reveal this to be the only reported structure of a desaturase in the oxidized FeIII-FeIII form. Significant differences are seen between the oxidized active site and the reduced active site of the Ricinus communis ( castor) desaturase; His(227) coordination to Fe2 is lost, and the side chain of Glu(224), which bridges the two iron ions in the reduced structure, does not interact with either iron. Although carboxylate shifts have been observed on oxidation of other diiron proteins, this is the first example of the residue moving beyond the coordination range of both iron ions. Comparison of the ivy and castor structures reveal surface amino acids close to the annulus of the substrate-binding cavity and others lining the lower portion of the cavity that are potential determinants of their distinct substrate specificities. We propose a hypothesis that differences in side chain packing explains the apparent paradox that several residues lining the lower portion of the cavity in the ivy desaturase are bulkier than their equivalents in the castor enzyme despite the necessity for the ivy enzyme to accommodate three more carbons beyond the diiron site.	Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Karolinska Institutet; United States Department of Energy (DOE); Brookhaven National Laboratory	Lindqvist, Y (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	ylva.lindqvist@ki.se; shanklin@bnl.gov	Lindqvist, Ylva/F-9009-2010	Shanklin, John/0000-0002-6774-8043; Guy, Jodie/0000-0003-0331-0699; Lindqvist, Ylva/0000-0003-3162-8661				Ai JY, 1997, J BIOL INORG CHEM, V2, P37, DOI 10.1007/s007750050104; Behrouzian B, 2002, J AM CHEM SOC, V124, P3277, DOI 10.1021/ja012252l; BLOOMFIELD DK, 1960, J BIOL CHEM, V235, P337; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Cahoon EB, 1997, PLANT MOL BIOL, V33, P1105, DOI 10.1023/A:1005821007291; Cahoon EB, 1998, PLANT PHYSIOL, V117, P593, DOI 10.1104/pp.117.2.593; Cahoon EB, 2000, P NATL ACAD SCI USA, V97, P12350, DOI 10.1073/pnas.210276297; Cahoon EB, 1997, P NATL ACAD SCI USA, V94, P4872, DOI 10.1073/pnas.94.10.4872; CAHOON EB, 1992, P NATL ACAD SCI USA, V89, P11184, DOI 10.1073/pnas.89.23.11184; CAHOON EB, 1994, PLANT PHYSIOL, V106, P807, DOI 10.1104/pp.106.2.807; CAHOON EB, 1994, J BIOL CHEM, V269, P27519; Davydov R, 2005, BIOCHEMISTRY-US, V44, P1309, DOI 10.1021/bi048599t; DeLano W.L, PYMOL MOL GRAPHICS S; Dyer DH, 2005, PROTEIN SCI, V14, P1508, DOI 10.1110/ps.041288005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOX BG, 1994, BIOCHEMISTRY-US, V33, P12776, DOI 10.1021/bi00209a008; Guy JE, 2006, P NATL ACAD SCI USA, V103, P17220, DOI 10.1073/pnas.0607165103; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCKEON TA, 1982, J BIOL CHEM, V257, P2141; Moche M, 2003, J BIOL CHEM, V278, P25072, DOI 10.1074/jbc.M301662200; MOCHE M, 2003, THESIS KAROLINSKA I; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reipa V, 2004, CHEM COMMUN, P2406, DOI 10.1039/b409595b; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; SCHROEPF.GJ, 1965, J BIOL CHEM, V240, P54; Schultz DJ, 1996, P NATL ACAD SCI USA, V93, P8771, DOI 10.1073/pnas.93.16.8771; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Shu LJ, 1998, J BIOL INORG CHEM, V3, P392, DOI 10.1007/s007750050249; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; THOMPSON GA, 1991, P NATL ACAD SCI USA, V88, P2578, DOI 10.1073/pnas.88.6.2578; Tremblay AE, 2007, ORG BIOMOL CHEM, V5, P1270, DOI 10.1039/b617942h; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whittington DA, 2001, J AM CHEM SOC, V123, P827, DOI 10.1021/ja003240n; Whittle E, 2005, J BIOL CHEM, V280, P28169, DOI 10.1074/jbc.M504205200; Whittle E, 2001, J BIOL CHEM, V276, P21500, DOI 10.1074/jbc.M102129200	45	43	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19863	19871		10.1074/jbc.M702520200	http://dx.doi.org/10.1074/jbc.M702520200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17463003	hybrid			2022-12-27	WOS:000247650600061
J	Leali, D; Moroni, E; Bussolino, F; Presta, M				Leali, Daria; Moroni, Emanuela; Bussolino, Federico; Presta, Marco			Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-ASPARTIC ACID; CELL-MIGRATION; GROWTH-FACTOR; SMOOTH-MUSCLE; TYROSINE PHOSPHORYLATION; ATHEROSCLEROTIC PLAQUES; MEDIATED ADHESION; FOCAL-ADHESION; RHO-GTPASES; ANGIOGENESIS	The extracellular matrix protein osteopontin (OPN) plays a nonredundant role in atherosclerosis and restenosis. Here we investigated the impact of OPN up-regulation in an in vitro model of re-endothelialization after mechanical injury of the endothelial cell monolayer. Murine aortic endothelial (MAE) cells interact via alpha(v) integrins with the integrin-binding Arg-Gly-Asp OPN sequence and adhere to immobilized OPN. On this basis, MAE cells were stably transfected with a wild-type OPN cDNA (OPN-MAE cells), with an OPN mutant lacking the Arg-Gly-Asp sequence (Delta RGD-OPN-MAE cells), or with vector alone (mock-MAE cells). When compared with mock-MAE and Delta RGD-OPN-MAE cells, OPN-MAE cells showed a reduced sprouting activity in fibrin gel, a reduced motility in a Boyden chamber assay, and a reduced capacity to repair the wounded monolayer. Accordingly, OPN-MAE cells at the edge of the wound were unable to form membrane ruffles, to reorganize their cytoskeleton, and to activate the focal adhesion kinase and the small GTPase Rac1, key regulators of the cell entry into the first phase of the cell migration cycle. Accordingly, wounded OPN-MAE cells failed to activate the intracellular signals RhoA and ERK1/2, involved in the later phases of the cell migration cycle. Also, parental MAE cells showed reduced re-endothelialization after wounding when seeded on immobilized OPN and exhibited increased adhesiveness to OPN-enriched extracellular matrix. In conclusion, OPN up-regulation impairs re-endothelialization by inhibiting the first phase of the cell migration cycle via sigma(v) integrin engagement by the extracellular matrixim-mobilized protein. This may contribute to the adverse effects exerted by OPN in restenosis and atherosclerosis.	Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Unit Gen Pathol, I-25123 Brescia, Italy; Univ Turin, Inst Canc Res & Treatment, Dept Oncol Sci, I-10100 Turin, Italy	University of Brescia; University of Turin	Presta, M (corresponding author), Univ Brescia, Dept Biomed Sci & Biotechnol, Viale Europa 11, I-25123 Brescia, Italy.	presta@med.unibs.it	Bussolino, Federico/AES-3951-2022; Presta, Marco/B-4345-2010; Bussolino, Federico/K-2500-2016	Bussolino, Federico/0000-0002-5348-1341; PRESTA, Marco/0000-0002-4398-8376				Bastaki M, 1997, ARTERIOSCL THROM VAS, V17, P454, DOI 10.1161/01.ATV.17.3.454; Belleri M, 2005, MOL PHARMACOL, V67, P1451, DOI 10.1124/mol.104.009043; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Dell'Era P, 2002, ONCOGENE, V21, P2433, DOI 10.1038/sj.onc.1205301; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FALCONE DJ, 1993, J BIOL CHEM, V268, P11951; FISHMAN JA, 1975, LAB INVEST, V32, P339; Furger Kara A., 2001, Current Molecular Medicine (Hilversum), V1, P621, DOI 10.2174/1566524013363339; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; IKEDA T, 1993, J CLIN INVEST, V92, P2814, DOI 10.1172/JCI116901; Isoda K, 2002, CIRC RES, V91, P77, DOI 10.1161/01.RES.0000025268.10302.0C; Katagiri YU, 1999, CANCER RES, V59, P219; KUIJPERS TW, 1993, J EXP MED, V178, P279, DOI 10.1084/jem.178.1.279; Kumar CC, 2001, CANCER RES, V61, P2232; Leali D, 2003, J IMMUNOL, V171, P1085, DOI 10.4049/jimmunol.171.2.1085; Lee TYJ, 1999, CELL TISSUE RES, V297, P435, DOI 10.1007/s004410051370; Liaw L, 1997, ARTERIOSCL THROM VAS, V17, P188, DOI 10.1161/01.ATV.17.1.188; LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; MONTESANO R, 1985, CELL, V42, P469, DOI 10.1016/0092-8674(85)90104-7; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; OBRIEN ER, 1994, ARTERIOSCLER THROMB, V14, P1648, DOI 10.1161/01.ATV.14.10.1648; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; RUNYAN RB, 1988, J CELL BIOL, V107, P1863, DOI 10.1083/jcb.107.5.1863; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Senger DR, 1996, AM J PATHOL, V149, P293; SINGH K, 1995, J BIOL CHEM, V270, P28471; Tassiopoulos AK, 2000, J BIOMAT SCI-POLYM E, V11, P1275, DOI 10.1163/156856200744200; TOSATTI MP, 1996, CELL GROWTH DIFFER, V7, P147; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; XUAN JW, 1995, J CELL BIOCHEM, V57, P680, DOI 10.1002/jcb.240570413; YOSHIMURA M, 1995, J BIOL CHEM, V270, P2298, DOI 10.1074/jbc.270.5.2298; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	48	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19676	19684		10.1074/jbc.M606938200	http://dx.doi.org/10.1074/jbc.M606938200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17456474	hybrid			2022-12-27	WOS:000247650600042
J	Swartz, JE; Bor, YC; Misawa, Y; Rekosh, D; Hammarskjold, ML				Swartz, Jennifer E.; Bor, Yeou-Cherng; Misawa, Yukiko; Rekosh, David; Hammarskjold, Marie-Louise			The shuttling SR protein 9G8 plays a role in translation of unspliced mRNA containing a constitutive transport element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRON-CONTAINING RNA; VIRUS ENV EXPRESSION; NUCLEAR-PORE COMPLEX; SPLICING FACTORS; MAMMALIAN-CELLS; NUCLEOCYTOPLASMIC EXPORT; TAP; REV; PHOSPHORYLATION; RECOGNITION	The splicing regulatory SR protein, 9G8, has recently been proposed to function in mRNA export in conjunction with the export protein, Tap/NXF1. Tap interacts directly with the Mason-Pfizer monkey virus constitutive transport element (CTE), an element that enables export of unspliced, intron-containing mRNA. Based on our previous finding that Tap can promote polysome association and translation of CTE-RNA, we investigated the effect of 9G8 on cytoplasmic RNA fate. 9G8 was shown to enhance expression of unspliced RNA containing either the Mason-Pfizer monkey virus-CTE or the recently discovered Tap-CTE. 9G8 also enhanced polyribosome association of unspliced RNA containing a CTE. Hyperphosphorylated 9G8 was present in monosomes and small polyribosomes, whereas soluble fractions contained only hypophosphorylated protein. Our results are consistent with a model in which hypophosphorylated SR proteins remain stably associated with messenger ribonucleoprotein ( mRNP) complexes during export and are released during translation initiation concomitant with increased phosphorylation. These results provide further evidence for crucial links between RNA splicing, export and translation.	Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Ctr AIDS & Human Retrovirus Res, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Hammarskjold, ML (corresponding author), Univ Virginia, Dept Microbiol, PO Box 800734, Jordan Hall 7-85, Charlottesville, VA 22908 USA.	mh7g@virginia.edu			NIAID NIH HHS [AI054335, AI34721, AI47008] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034721, R01AI054335, R01AI047008] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Black BE, 1999, MOL CELL BIOL, V19, P8616; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blencowe BJ, 2003, CURR BIOL, V13, pR149, DOI 10.1016/S0960-9822(03)00079-4; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; CALZONE FJ, 1982, NUCLEIC ACIDS RES, V10, P2145, DOI 10.1093/nar/10.6.2145; Cao WH, 1997, RNA, V3, P1456; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; Cowper AE, 2001, J BIOL CHEM, V276, P48908, DOI 10.1074/jbc.M103967200; Coyle JH, 2003, MOL CELL BIOL, V23, P92, DOI 10.1128/MCB.23.1.92-103.2003; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; CULLEN BR, 1992, METHOD ENZYMOL, V216, P362; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; FU XD, 1995, RNA, V1, P663; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; Hammarskjold ML, 1997, SEMIN CELL DEV BIOL, V8, P83, DOI 10.1006/scdb.1996.0127; HAMMARSKJOLD ML, 1994, J VIROL, V68, P951; HAMMARSKJOLD ML, 1989, J VIROL, V63, P1959; Hammarskjold ML, 2001, CURR TOP MICROBIOL, V259, P77; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jin L, 2003, GENE DEV, V17, P3075, DOI 10.1101/gad.1155703; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Levesque L, 2001, J BIOL CHEM, V276, P44953, DOI 10.1074/jbc.M106558200; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Sanford JR, 2004, J CELL SCI, V117, P6261, DOI 10.1242/jcs.01513; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Srinivasakumar N, 1997, J VIROL, V71, P5841, DOI 10.1128/JVI.71.8.5841-5848.1997; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Wiegand HL, 2002, MOL CELL BIOL, V22, P245, DOI 10.1128/MCB.22.1.245-256.2002; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200	75	69	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19844	19853		10.1074/jbc.M701660200	http://dx.doi.org/10.1074/jbc.M701660200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17513303	hybrid			2022-12-27	WOS:000247650600059
J	Yano, N; Suzuki, D; Endoh, M; Zhao, TC; Padbury, JF; Tseng, YT				Yano, Naohiro; Suzuki, Daisuke; Endoh, Masayuki; Zhao, Ting C.; Padbury, James F.; Tseng, Yi-Tang			A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; REQUIRES METALLOPROTEINASE CLEAVAGE; EGF RECEPTOR TRANSACTIVATION; PROTEIN-COUPLED RECEPTORS; SIGNAL-TRANSDUCTION; INHIBITS APOPTOSIS; REGULATED KINASE; TYROSINE KINASE; PROHB-EGF	Chronic activation of the angiotensin II (ANG II) type 1 receptor (AT-1R) is critical in the development of chronic kidney disease. ANG II activates mesangial cells (MCs) and stimulates the synthesis of extracellular matrix components. To determine the molecular mechanisms underlying the induction of MC collagen, a mouse mesangial cell line MES-13 was employed. ANG II treatment induced an increase in collagen synthesis, which was abrogated by co-treatment with losartan (an AT-1R antagonist), wortmannin (a phosphoinositide 3-kinase (PI3K) inhibitor), an Akt inhibitor, and stable transfection of dominant negative-Akt1. ANG II induced a significant increase in PI3K activity, which was abolished by co-treatment with losartan or 2', 5'-dideoxyade-nosine (2', 5'-DOA, an adenylyl cyclase inhibitor) but not by PD123319 (an AT-2R antagonist) or H89 (a protein kinase A (PKA) inhibitor). The Epac (exchange protein directly activated by cAMP)-specific cAMP analog, 8-pHPT-2'-O-MecAMP, significantly increased PI3K activity, whereas a PKA-specific analog, 6-benzoyladenosine-cAMP, showed no effect. The ANG II-induced increase in PI3K activity was also blocked by co-treatment with PP2, an Src inhibitor, or AG1478, an epidermal growth factor receptor (EGFR) antagonist. ANG II induced phosphorylation of Akt and p70S6K and EGFR, which was abrogated by knockdown of c-Src by small interference RNA. Knockdown of Src also effectively abolished ANG II-induced collagen synthesis. Conversely, stable transfection of a constitutively active Src mutant enhanced basal PI3K activity and collagen production, which was abrogated by AG1478 but not by 2', 5'-DOA. Moreover, acute treatment with ANG II significantly increased Src activity, which was abrogated with co-treatment of 2', 5'-DOA. Taken together, these results suggest that ANG II induces collagen synthesis in MCs by activating the ANG II/AT-1R-EGFR-PI3K pathway. This transactivation is dependent on cAMP/Epac but not on PKA. Src kinase plays a pivotal role in this signaling pathway between cAMP and EGFR. This is the first demonstration that an AT1R-PI3K/Akt crosstalk, along with transactivation of EGFR, mediates ANG II-induced collagen synthesis in MCs.	Brown Univ, Women & Infants Hosp, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02905 USA; Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol & Metab, Isehara, Kanagawa 25911, Japan	Brown University; Women & Infants Hospital Rhode Island; Tokai University	Tseng, YT (corresponding author), Women & Infants Hosp Rhode Isl, Dept Pediat, 101 Dudley St,Kilguss 122, Providence, RI 02905 USA.	YTseng@wihri.org			NCRR NIH HHS [P20 RR018728] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andresen BT, 2003, HYPERTENSION, V41, P781, DOI 10.1161/01.HYP.0000049426.61176.DF; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; Bolick DT, 2003, ENDOCRINOLOGY, V144, P5227, DOI 10.1210/en.2003-0739; Brewster UC, 2004, AM J MED, V116, P263, DOI 10.1016/j.amjmed.2003.09.034; Butani L, 2005, PEDIATR NEPHROL, V20, P1651, DOI 10.1007/s00467-005-2031-5; CHAN TO, 1990, MOL CELL BIOL, V10, P3280, DOI 10.1128/MCB.10.6.3280; Che Q, 2002, HYPERTENSION, V40, P700, DOI 10.1161/01.HYP.0000035524.10948.93; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Cullen KA, 2004, AM J PHYSIOL-GASTR L, V287, pG334, DOI 10.1152/ajpgi.00517.2003; Deambrosis I, 2005, INT J IMMUNOPATH PH, V18, P327, DOI 10.1177/039463200501800215; Del Prete D, 2003, KIDNEY INT, V64, P149, DOI 10.1046/j.1523-1755.2003.00065.x; Dremier S, 1997, MOL CELL BIOL, V17, P6717, DOI 10.1128/MCB.17.11.6717; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Eguchi S, 2000, REGUL PEPTIDES, V91, P13, DOI 10.1016/S0167-0115(00)00126-9; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; ERNSBERGE RP, 1992, AM J PHYSIOL, V263, pF411; Everett AD, 2001, AM J PHYSIOL-HEART C, V281, pH161, DOI 10.1152/ajpheart.2001.281.1.H161; Feng LX, 2000, J BIOL CHEM, V275, P25572, DOI 10.1074/jbc.M002218200; Gambaryan S, 2006, AM J PHYSIOL-ENDOC M, V290, pE423, DOI 10.1152/ajpendo.00128.2005; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ghosh PM, 2001, AM J PHYSIOL-RENAL, V280, pF972, DOI 10.1152/ajprenal.2001.280.6.F972; GomezGarre D, 1996, HYPERTENSION, V27, P885, DOI 10.1161/01.HYP.27.4.885; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Haider UGB, 2005, MOL PHARMACOL, V68, P41, DOI 10.1124/mol.104.005421; Hamelink C, 2002, J NEUROSCI, V22, P5310; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hirshman CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1468, DOI 10.1152/ajpcell.2001.281.5.C1468; Hur EM, 2004, J BIOL CHEM, V279, P5852, DOI 10.1074/jbc.M311687200; Iodice C, 2003, KIDNEY INT, V63, P2214, DOI 10.1046/j.1523-1755.2003.00015.x; Ishimatsu S, 2006, PLACENTA, V27, P587, DOI 10.1016/j.placenta.2005.07.001; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krepinsky JC, 2005, J AM SOC NEPHROL, V16, P1661, DOI 10.1681/ASN.2004100897; Krieg T, 2004, J MOL CELL CARDIOL, V36, P435, DOI 10.1016/j.yjmcc.2003.12.013; Lai KN, 2004, KIDNEY INT, V66, P1403, DOI 10.1111/j.1523-1755.2004.00874.x; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; LEE LK, 1995, J CLIN INVEST, V96, P953, DOI 10.1172/JCI118143; Li XF, 2001, P NATL ACAD SCI USA, V98, P14416, DOI 10.1073/pnas.251547198; Nakamura T, 1999, KIDNEY INT, V55, P877, DOI 10.1046/j.1523-1755.1999.055003877.x; Ohashi H, 2004, CIRC RES, V94, P785, DOI 10.1161/01.RES.0000121103.03275.EC; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Saward L, 1997, CIRC RES, V81, P249, DOI 10.1161/01.RES.81.2.249; Shimamura H, 2003, J AM SOC NEPHROL, V14, P1427, DOI 10.1097/01.ASN.0000066140.99610.32; Staples KJ, 2001, J IMMUNOL, V167, P2074, DOI 10.4049/jimmunol.167.4.2074; Stratta P, 2004, NEPHROL DIAL TRANSPL, V19, P587, DOI 10.1093/ndt/gfg604; Takahashi T, 1999, AM J PHYSIOL-HEART C, V276, pH1927, DOI 10.1152/ajpheart.1999.276.6.H1927; Tseng YT, 2005, AM J PHYSIOL-HEART C, V289, pH1834, DOI 10.1152/ajpheart.00435.2005; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; WOLF G, 1992, AM J PATHOL, V140, P95; Yang H, 2001, ENDOCRINOLOGY, V142, P3502, DOI 10.1210/en.142.8.3502; YANO N, 2007, IN PRESS AM J PHYSL	59	43	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18819	18830		10.1074/jbc.M610537200	http://dx.doi.org/10.1074/jbc.M610537200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17493931	hybrid			2022-12-27	WOS:000247475300021
J	Sung, HY; Guan, HT; Czibula, A; King, AR; Eder, K; Heath, E; Suvarna, SK; Dower, SK; Wilson, AG; Francis, SE; Crossman, DC; Kiss-Toth, E				Sung, Hye Youn; Guan, Hongtao; Czibula, Agnes; King, Andrea R.; Eder, Katalin; Heath, Emily; Suvarna, S. Kim; Dower, Steven K.; Wilson, Anthony G.; Francis, Sheila E.; Crossman, David C.; Kiss-Toth, Endre			Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AMERICAN-HEART-ASSOCIATION; TUMOR-NECROSIS-FACTOR; HISTOLOGICAL CLASSIFICATION; ATHEROSCLEROTIC LESIONS; ENDOTHELIAL-CELLS; COMPLEMENTATION ASSAYS; EXPRESSION CLONING; VASCULAR-LESIONS; GENE-EXPRESSION	Migration and proliferation of smooth muscle cells are key to a number of physiological and pathological processes, including wound healing and the narrowing of the vessel wall. Previous work has shown links between inflammatory stimuli and vascular smooth muscle cell proliferation and migration through mitogen-activated protein kinase (MAPK) activation, although the molecular mechanisms of this process are poorly understood. Here we report that tribbles-1, a recently described modulator of MAPK activation, controls vascular smooth muscle cell proliferation and chemotaxis via the Jun kinase pathway. Our findings demonstrate that this regulation takes place via direct interactions between tribbles-1 and MKK4/SEK1, a Jun activator kinase. The activity of this kinase is dependent on tribbles-1 levels, whereas the activation and the expression of MKK4/SEK1 are not. In addition, tribbles-1 expression is elevated in human atherosclerotic arteries when compared with non-atherosclerotic controls, suggesting that this protein may play a role in disease in vivo. In summary, the data presented here suggest an important regulatory role for trb-1 in vascular smooth muscle cell biology.	Univ Sheffield, Cardiovasc Res Unit, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Sect Infect Infkam & Immun, Sheffield S10 2TN, S Yorkshire, England; No Gen Hosp, Dept Histopathol, Sheffield S5 7AU, S Yorkshire, England; Inst Biochem, Biol Res Ctr, H-67601 Szeged, Hungary	University of Sheffield; University of Sheffield; Northern General Hospital; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Kiss-Toth, E (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Cardiovasc Res Unit, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	E.Kiss-Toth@sheffield.ac.uk	Kiss-Toth, Endre/AAC-4252-2020; Eder, Katalin/E-2480-2014; Kiss-Toth, Endre/A-8596-2014	Kiss-Toth, Endre/0000-0003-4406-4017; Eder, Katalin/0000-0002-3739-423X; Kiss-Toth, Endre/0000-0003-4406-4017; Czibula, Agnes/0000-0003-4461-2773; Wilson, Anthony Gerard/0000-0003-4855-3926; dower, steve/0000-0002-4675-4225; Francis, Sheila/0000-0001-6552-0339	British Heart Foundation [PG/02/122/14495, PG/05/100/19606] Funding Source: Medline; Medical Research Council [G0301063] Funding Source: Medline; MRC [G0301063] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bonventre JV, 1998, CURR OPIN NEPHROL HY, V7, P425, DOI 10.1097/00041552-199807000-00013; Che W, 2001, CIRCULATION, V104, P1399, DOI 10.1161/hc3701.095581; Choukroun G, 1998, J CLIN INVEST, V102, P1311, DOI 10.1172/JCI3512; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Force T, 1998, HYPERTENSION, V31, P152, DOI 10.1161/01.HYP.31.1.152; Goldschmidt ME, 2001, CIRC RES, V88, P674, DOI 10.1161/hh0701.089749; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Iynedjian PB, 2005, BIOCHEM J, V386, P113, DOI 10.1042/BJ20041425; Jones PL, 1999, J CELL SCI, V112, P435; Ju HS, 2002, J PHARMACOL EXP THER, V301, P15, DOI 10.1124/jpet.301.1.15; King AR, 2003, LAB INVEST, V83, P1497, DOI 10.1097/01.LAB.0000093096.62765.85; Kiss-Toth E, 2005, BIOCHEM SOC T, V33, P1405, DOI 10.1042/BST0331405; Kiss-Toth E, 2006, CELL SIGNAL, V18, P202, DOI 10.1016/j.cellsig.2005.04.012; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lai KH, 1996, J CLIN INVEST, V98, P1560, DOI 10.1172/JCI118949; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Michnick SW, 2004, DRUG DISCOV TODAY, V9, P262, DOI 10.1016/S1359-6446(03)03022-8; Mii S, 1996, AM J PHYSIOL-HEART C, V270, pH142, DOI 10.1152/ajpheart.1996.270.1.H142; Morton AC, 2005, CARDIOVASC RES, V68, P493, DOI 10.1016/j.cardiores.2005.06.026; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Remy I, 2004, METHODS, V32, P381, DOI 10.1016/j.ymeth.2003.10.011; Remy Ingrid, 2004, Methods Mol Biol, V261, P411; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Saka Y, 2004, DEV BIOL, V273, P210, DOI 10.1016/j.ydbio.2004.05.032; SATO Y, 1990, J CELL BIOL, V111, P757, DOI 10.1083/jcb.111.2.757; Satterthwaite G, 2005, AM HEART J, V150, P488, DOI 10.1016/j.ahj.2004.10.025; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Takeishi Y, 2001, J MOL CELL CARDIOL, V33, P1989, DOI 10.1006/jmcc.2001.1463; Touyz RM, 2000, PHARMACOL REV, V52, P639; WARNER SJC, 1989, J IMMUNOL, V142, P100; Wilkin F, 1997, EUR J BIOCHEM, V248, P660, DOI 10.1111/j.1432-1033.1997.t01-1-00660.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamakawa T, 1999, ENDOCRINOLOGY, V140, P3562, DOI 10.1210/en.140.8.3562; Yang CM, 2001, BRIT J PHARMACOL, V132, P1531, DOI 10.1038/sj.bjp.0703976; YUE TL, 1994, BIOCHEM BIOPH RES CO, V204, P1186, DOI 10.1006/bbrc.1994.2588	47	76	80	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18379	18387		10.1074/jbc.M610792200	http://dx.doi.org/10.1074/jbc.M610792200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452330	Green Accepted, hybrid			2022-12-27	WOS:000247302000044
J	Wahlbom, M; Wang, X; Lindstrom, V; Carlemalm, E; Jaskolski, M; Grubb, A				Wahlbom, Maria; Wang, Xin; Lindstrom, Veronica; Carlemalm, Eric; Jaskolski, Mariusz; Grubb, Anders			Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-LIKE FIBRILS; PRION PROTEIN; CRYSTAL-STRUCTURE; COMMON MECHANISM; AGGREGATION; DISEASE; DIMERIZATION; CONVERSION; IMPLIES; VARIANT	Cystatin C and the prion protein have been shown to form dimers via three-dimensional domain swapping, and this process has also been hypothesized to be involved in amyloidogenesis. Production of oligomers of other amyloidogenic proteins has been reported to precede fibril formation, suggesting oligomers as intermediates in fibrillogenesis. A variant of cystatin C, with a Leu(68)-> Gln substitution, is highly amyloidogenic, and carriers of this mutation suffer from massive cerebral amyloidosis leading to brain hemorrhage and death in early adulthood. This work describes doughnut-shaped oligomers formed by wild type and L68Q cystatin C upon incubation of the monomeric proteins. Purified oligomers of cystatin C are shown to fibrillize faster and at a lower concentration than the monomeric protein, indicating a role of the oligomers as fibril-assembly intermediates. Moreover, the present work demonstrates that three-dimensional domain swapping is involved in the formation of the oligomers, because variants of monomeric cystatin C, stabilized against three-dimensional domain swapping by engineered disulfide bonds, do not produce oligomers upon incubation under non-reducing conditions. Redox experiments using wild type and stabilized cystatin C strongly suggest that the oligomers, and thus probably the fibrils as well, are formed by propagated domain swapping rather than by assembly of domain-swapped cystatin C dimers.	Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden; Lund Univ, Dept Clin Sci, S-22362 Lund, Sweden; Adam Mickiewicz Univ, Ctr Biocrystallog Res, Inst Bioorgan Chem, Fac Chem, PL-60780 Poznan, Poland; Adam Mickiewicz Univ, Ctr Biocrystallog Res, Polish Acad Sci, Dept Crystallog, PL-60780 Poznan, Poland	Lund University; Skane University Hospital; Lund University; Adam Mickiewicz University; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Adam Mickiewicz University; Polish Academy of Sciences	Grubb, A (corresponding author), Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden.	anders.grubb@med.lu.se		Grubb, Anders/0000-0002-0125-3662; Jaskolski, Mariusz/0000-0003-1587-6489				Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buxbaum JN, 2003, TRENDS BIOCHEM SCI, V28, P585, DOI 10.1016/j.tibs.2003.09.009; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Gerhartz B, 1998, BIOCHEMISTRY-US, V37, P17309, DOI 10.1021/bi980873u; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1999, METHOD ENZYMOL, V309, P467; LINDAHL P, 1992, BIOCHEM J, V281, P49, DOI 10.1042/bj2810049; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nelson R., 2006, CURR OPIN STRUC BIOL, V16, P1; Newcomer ME, 2001, NAT STRUCT BIOL, V8, P282, DOI 10.1038/86134; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Ohnishi S, 2004, CELL MOL LIFE SCI, V61, P511, DOI 10.1007/s00018-003-3264-8; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Sabella S, 2004, ELECTROPHORESIS, V25, P3186, DOI 10.1002/elps.200406062; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; SERPELL LC, 1995, J MOL BIOL, V254, P113, DOI 10.1006/jmbi.1995.0604; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x	46	101	103	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18318	18326		10.1074/jbc.M611368200	http://dx.doi.org/10.1074/jbc.M611368200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17470433	hybrid, Green Submitted			2022-12-27	WOS:000247302000038
J	Qiang, Z; Yu, K; Cui, YY; Ying, C; Hartzell, C				Qiang, Zhi; Yu, Kuai; Cui, Yuan Yuan; Ying, Carl; Hartzell, Criss			Activation of bestrophin Cl- channels is regulated by C-terminal domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACULAR DYSTROPHY; MOUSE BESTROPHIN-2; CHLORIDE CHANNELS; FAMILY; GENE; IDENTIFICATION; TRANSDUCTION; PROTEIN; VMD2	Bestrophins ( VMD2, VMD2L1, VMD2L2, and VMD2L3) are a new family of anion channels. The mechanisms of their regulation are not yet well understood. Recently, we found that a domain ( amino acids 356-364) in the C terminus of mouse VMD2L3 ( mBest3) inhibited channel activity when it was expressed in HEK293 cells ( Qu, Z., Cui, Y., and Hartzell, H. C. ( 2006) FEBS Lett. 580, 2141-2214). Here we show that this auto-inhibitory ( AI) domain in mBest3 and human ( h) Best3 is composed of seven critical residues, (356)IPSFLGS(362). Replacement of any residue ( except Pro(357)) in the domain with alanine activated Cl- currents. Substitution of Pro357 with other amino acids, especially phenylalanine, did activate currents. Membrane biotinylation demonstrated that nonfunctional mBest3 protein was trafficked to the plasma membrane, implying that the AI domain inhibited channel gating but not trafficking. mBest3-F359A and hBest3-G361A mutations induced outwardly rectifying currents, suggesting that the AI domain is associated with the channel pore or gating mechanism. Supporting this suggestion, the mBest3 AI domain was demonstrated to be located within a membrane-associated region. When the wild-type mBest3 C terminus ( amino acids 292-669) was expressed in HEK293 cells, the protein was located mainly in the particulate fraction, but it became soluble when a sequence containing the AI domain was deleted ( Delta 353-404). There is an AI domain( (357)QPSFQGS(363)) in mouse VMD2L1( mBest2) as well, but its inhibitory effect is competed by a downstream facilitatory sequence ( amino acids 405-454). These results suggest that an auto-inhibitory mechanism in C termini may be universal among bestrophins investigated in the study.	Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Emory University; Emory University	Qiang, Z (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, 615 Michael St,535 Whitehead Bldg, Atlanta, GA 30322 USA.	zqu@emory.edu			NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER; NEI NIH HHS [EY014852] Funding Source: Medline; NIGMS NIH HHS [GM60448] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Kramer F, 2004, CYTOGENET GENOME RES, V105, P107, DOI 10.1159/000078016; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Qu ZQ, 2007, FEBS LETT, V581, P580, DOI 10.1016/j.febslet.2007.01.012; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2006, FEBS LETT, V580, P2141, DOI 10.1016/j.febslet.2006.03.025; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; SORIA RB, 2006, J BIOL CHEM; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200	17	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17460	17467		10.1074/jbc.M701043200	http://dx.doi.org/10.1074/jbc.M701043200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17442670	hybrid			2022-12-27	WOS:000247084500016
J	Tian, Y; Zhang, Y; Zhong, B; Wang, YY; Diao, FC; Wang, RP; Zhang, M; Chen, DY; Zhai, ZH; Shu, HB				Tian, Yang; Zhang, Yan; Zhong, Bo; Wang, Yan-Yi; Diao, Fei-Ci; Wang, Rui-Peng; Zhang, Min; Chen, Dan-Ying; Zhai, Zhong-He; Shu, Hong-Bing			RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappa B activation by targeting TAB2/3 for degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; INTERACTING PROTEIN; MOLECULAR-CLONING; KINASE; IRAK; FAMILY; TRAF6; IL-1; IDENTIFICATION; BINDING	Inflammation is a homeostatic mechanism that limits the effects of infectious agents. Tumor necrosis factor (TNF) and interleukin (IL)-1 are two cytokines that induce inflammation through activation of the transcription factor NF-kappa B. Various studies have suggested that two homologous and structurally related adapter proteins TAB2 and TAB3 play redundant roles in TNF- and IL-1-mediated NF-kappa B activation pathways. Both TAB2 and TAB3 contain CUE, coiled-coil, and nuclear protein localization 4 zinc finger (NZF) domains. The NZF domains of TAB2/ 3 are critical for TAB2/ 3 to bind to Lys63-linked polyubiquitin chains of other adaptor proteins, such as receptor-interacting protein and TRAF6, which are two signaling proteins essential for TNF- and IL-1-induced NF-kappa B activation, respectively. In a search for proteins containing NZF domains conserved with those of TAB2/ 3, we identified RBCK1, which has been shown to act as an E3 ubiquitin ligase in iron metabolism. Overexpression of RBCK1 negatively regulates TAB2/ 3-mediated and TNF- and IL-1-induced NF-kappa B activation, whereas knockdown of RBCK1 by RNA interference potentiates TNF- and IL-1-induced NF-kappa B activation. RBCK1 physically interacts with TAB2/ 3 and facilitates degradation of TAB2/ 3 through a proteasome-dependent process. Taken together, our findings suggest that RBCK1 is involved in negative regulation of inflammatory signaling triggered by TNF and IL-1 through targeting TAB2/ 3 for degradation.	Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Wuhan University; Peking University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn	Wang, Ruipeng/I-1407-2013	Wang, Ruipeng/0000-0002-1003-1420				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chen DY, 2002, J BIOL CHEM, V277, P15985, DOI 10.1074/jbc.M108675200; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Cong YS, 1997, J BIOL CHEM, V272, P16482, DOI 10.1074/jbc.272.26.16482; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tatematsu K, 2005, J BIOL CHEM, V280, P22937, DOI 10.1074/jbc.M413476200; Tokunaga C, 1998, BIOCHEM BIOPH RES CO, V244, P353, DOI 10.1006/bbrc.1998.8270; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952	38	54	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16776	16782		10.1074/jbc.M701913200	http://dx.doi.org/10.1074/jbc.M701913200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17449468	hybrid			2022-12-27	WOS:000246946500009
J	Zhang, ZQ; Klatt, A; Gilmour, DS; Henderson, AJ				Zhang, Zhiqiang; Klatt, Alicia; Gilmour, David S.; Henderson, Andrew J.			Negative elongation factor NELF represses human immunodeficiency virus transcription by pausing the RNA polymerase II complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERMINAL REPEAT; TEFB-MEDIATED PHOSPHORYLATION; TAT-ACTIVATED TRANSCRIPTION; P-TEFB; POSTINTEGRATION LATENCY; HISTONE ACETYLATION; TYPE-1 PROMOTER; HSP70 PROMOTER; CELL-LINE; IN-VITRO	Human immunodeficiency virus (HIV) transcription requires virally encoded Tat and the P-TEFb protein complex, which together associate with the Tat-activating region, a structured region in the nascent transcript. P-TEFb phosphorylates proteins in the transcription elongation complex, including RNA polymerase II (pol II), to stimulate elongation and to overcome premature termination. However, the status of the elongation complex on the HIV long terminal repeat (LTR) in a repressed state is not known. Chromatin immunoprecipitation demonstrated that NELF, a negative transcription elongation factor, was associated with the LTR. Depleting NELF increased processive HIV transcription and replication. Mapping pol II on the LTR showed that pol II was paused and that NELF depletion released pol II. Decreasing NELF also correlated with displacement of a positioned nucleosome and increased acetylation of histone H4, suggesting coupling of transcription elongation and chromatin remodeling. Previous work has indicated that the Tat-activating region plays a critical role in regulating transcription from the LTR. Our results reveal an earlier stage, mediated by NELF, when repression occurs at the HIV LTR.	Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Grad Program Pathobiol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Henderson, AJ (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Infect Dis,Ctr HIV AIDS Care & Res, EBRC,650 Albany St, Boston, MA 02118 USA.	andrew.henderson@bmc.org	Koukam, Abderrafiaa A/J-2860-2013	Koukam, Abderrafiaa A/0000-0002-7383-5143; Henderson, Andrew/0000-0002-9299-5302	NIAID NIH HHS [AI62467] Funding Source: Medline; NIGMS NIH HHS [GM47477] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI062467, R01AI062467] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Benjamin LR, 1998, NUCLEIC ACIDS RES, V26, P1051, DOI 10.1093/nar/26.4.1051; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; CANNON P, 1994, J VIROL, V68, P1993, DOI 10.1128/JVI.68.3.1993-1997.1994; Cujec TP, 1997, MOL CELL BIOL, V17, P1817, DOI 10.1128/MCB.17.4.1817; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; FEINBERG MB, 1991, P NATL ACAD SCI USA, V88, P4045, DOI 10.1073/pnas.88.9.4045; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1988, J IMMUNOL, V140, P1117; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JEANG KT, 1992, J BIOL CHEM, V267, P17891; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KESSLER M, 1991, P NATL ACAD SCI USA, V88, P10018, DOI 10.1073/pnas.88.22.10018; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Lee ES, 2002, VIROLOGY, V299, P20, DOI 10.1006/viro.2002.1500; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Ping Yueh-Hsin, 2004, Retrovirology, V1, P46, DOI 10.1186/1742-4690-1-46; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Pumfery A, 2003, CURR HIV RES, V1, P343, DOI 10.2174/1570162033485186; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Rao JN, 2006, BIOCHEM J, V400, P449, DOI 10.1042/BJ20060421; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	48	81	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16981	16988		10.1074/jbc.M610688200	http://dx.doi.org/10.1074/jbc.M610688200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17442680	hybrid			2022-12-27	WOS:000246946500031
J	Roujeinikova, A; Hothi, P; Masgrau, L; Sutcliffe, MJ; Scrutton, NS; Leys, D				Roujeinikova, Anna; Hothi, Parvinder; Masgrau, Laura; Sutcliffe, Michael J.; Scrutton, Nigel S.; Leys, David			New insights into the reductive half-reaction mechanism of aromatic amine dehydrogenase revealed by reaction with carbinolamine substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN TRYPTOPHYLQUINONE ENZYME; ALCALIGENES-FAECALIS; MOLECULAR-DYNAMICS	Aromatic amine dehydrogenase uses a tryptophan tryptophylquinone( TTQ) cofactor to oxidatively deaminate primary aromatic amines. In the reductive half-reaction, a proton is transferred from the substrate C1 to beta Asp-128 O-2, in a reaction that proceeds by H-tunneling. Using solution studies, kinetic crystallography, and computational simulation we show that the mechanism of oxidation of aromatic carbinolamines is similar to amine oxidation, but that carbinolamine oxidation occurs at a substantially reduced rate. This has enabled us to determine for the first time the structure of the intermediate prior to the H-transfer/reduction step. The proton-beta Asp-128 O-2 distance is similar to 3.7 angstrom, in contrast to the distance of similar to 2.7 angstrom predicted for the intermediate formed with the corresponding primary amine substrate. This difference of similar to 1.0 angstrom is due to an unexpected conformation of the substrate moiety, which is supported by molecular dynamic simulations and reflected in the similar to 10(7)-fold slower TTQ reduction rate with phenylaminoethanol compared with that with primary amines. A water molecule is observed near TTQ C-6 and is likely derived from the collapse of the preceding carbinolamine TTQ-adduct. We suggest this water molecule is involved in consecutive proton transfers following TTQ reduction, and is ultimately repositioned near the TTQ O-7 concomitant with protein rearrangement. For all carbinolamines tested, highly stable amide-TTQ adducts are formed following proton abstraction and TTQ reduction. Slow hydrolysis of the amide occurs after, rather than prior to, TTQ oxidation and leads ultimately to a carboxylic acid product.	Univ Manchester, Manchester Interdiscilinary Bioctr, Manchester M1 7DN, Lancs, England; Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England; Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M1 7DN, Lancs, England; Inst Pasteur, Unite Bioinformat Struct, F-75724 Paris, France	University of Manchester; University of Manchester; University of Manchester; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Leys, D (corresponding author), 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Masgrau, Laura/ABA-9339-2020; Masgrau, Laura/O-1214-2015	Masgrau, Laura/0000-0003-4495-508X; Masgrau, Laura/0000-0003-4495-508X; Roujeinikova, Anna/0000-0001-8478-4751; Sutcliffe, Mike/0000-0003-0414-1700	BBSRC [BB/D01963X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01963X/1, B19724/2] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ARMSTRONG JM, 1964, BIOCHIM BIOPHYS ACTA, V86, P194; Basran J, 2001, J BIOL CHEM, V276, P6234, DOI 10.1074/jbc.M008141200; Bishop GR, 1998, BIOCHEM J, V330, P1159, DOI 10.1042/bj3301159; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1983, J CHEM PHYS, V79, P6312, DOI 10.1063/1.445724; Chistoserdov AY, 2001, MICROBIOL-SGM, V147, P2195, DOI 10.1099/00221287-147-8-2195; DAVIDSON VL, 1990, METHOD ENZYMOL, V188, P241; DAVIS CD, 1993, CANCER LETT, V73, P95, DOI 10.1016/0304-3835(93)90250-D; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Gao JL, 1998, J PHYS CHEM A, V102, P4714, DOI 10.1021/jp9809890; GOVINDARAJ S, 1994, J BACTERIOL, V176, P2922, DOI 10.1128/JB.176.10.2922-2929.1994; Hothi P, 2005, FEBS J, V272, P5894, DOI 10.1111/j.1742-4658.2005.04990.x; HUSAIN M, 1985, J BIOL CHEM, V260, P4626; HYUN YL, 1995, BIOCHEMISTRY-US, V34, P816, DOI 10.1021/bi00003a015; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; Masgrau L, 2007, J PHYS CHEM B, V111, P3032, DOI 10.1021/jp067898k; MCLEOD RK, 1961, J ORG CHEM, V26, P1094, DOI 10.1021/jo01063a028; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOZAKI M, 1987, METHOD ENZYMOL, V142, P650; Roujeinikova A, 2006, J BIOL CHEM, V281, P40264, DOI 10.1074/jbc.M605559200; Roussel A., 1991, SILICON GRAPHICS GEO, V86; Sukumar N, 2006, BIOCHEMISTRY-US, V45, P13500, DOI 10.1021/bi0612972	24	13	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2007	282	33					23766	23777		10.1074/jbc.M700677200	http://dx.doi.org/10.1074/jbc.M700677200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	199HK	17475620	hybrid			2022-12-27	WOS:000248686600005
J	Nakanishi, M; Ozaki, T; Yamamoto, H; Hanamoto, T; Kikuchi, H; Furuya, K; Asaka, M; Delia, D; Nakagawara, A				Nakanishi, Mitsuru; Ozaki, Toshinori; Yamamoto, Hideki; Hanamoto, Takayuki; Kikuchi, Hironobu; Furuya, Kazushige; Asaka, Masahiro; Delia, Domenico; Nakagawara, Akira			NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BRCT DOMAIN; TRANSCRIPTIONAL ACTIVATION; IONIZING-RADIATION; WILD-TYPE; PHOSPHORYLATION; CHECKPOINT; MDM2; PROTEIN; ATM	NFBD1/MDC1, which belongs to the BRCT superfamily, has an anti-apoptotic activity and contributes to the early cellular responses to DNA damage. Here we found that NFBD1 protects cells from apoptotic cell death by inhibiting phosphorylation of p53 at Ser-15 under steady state as well as early phase of DNA damage, thereby blocking its transcriptional and pro-apoptotic activities. During late phase of DNA damage, a remarkable reduction of NFBD1 was observed in dying but not in surviving A549 cells bearing wild-type p53. Small interference RNA-mediated knockdown of the endogenous NFBD1 resulted in an increase in sensitivity to adriamycin in A549 cells but not in p53-deficient H1299 cells. Immunoprecipitation and luciferase reporter analyses demonstrated that NFBD1 binds to the NH2-terminal region of p53 and strongly inhibits its transcriptional activity. Additionally, BRCT domains, which can interact with p53, reduced the adriamycin-induced phosphorylation levels of p53 at Ser-15 and also suppressed the transcriptional activity of p53. Thus, our present findings strongly suggest that NFBD1 plays an important role in the decision of cell survival and death after DNA damage through the regulation of p53.	Chiba Canc Ctr Res Inst, Div Biochem, Chiba 2608717, Japan; Hokkaido Univ, Sch Med, Dept Gastroenterol, Sapporo, Hokkaido 0608638, Japan; Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy	Chiba Cancer Center; Hokkaido University; Fondazione IRCCS Istituto Nazionale Tumori Milan	Nakagawara, A (corresponding author), Chiba Canc Ctr Res Inst, Div Biochem, Chiba 2608717, Japan.	akiranak@chiba-cc.jp	Asaka, Masahiro/A-5948-2012					Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Bork P, 1996, CURR OPIN STRUC BIOL, V6, P366, DOI 10.1016/S0959-440X(96)80057-1; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chai YL, 1999, ONCOGENE, V18, P263, DOI 10.1038/sj.onc.1202323; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chehab NH, 2000, GENE DEV, V14, P278; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; HIRAO A, 2003, SCIENCE, V287, P37536; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Peng AM, 2005, CANCER RES, V65, P1158, DOI 10.1158/0008-5472.CAN-04-2508; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rodicker F, 2003, CANCER RES, V63, P2737; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; VAN AD, 1996, SCIENCE, V274, P787; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	51	42	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22993	23004		10.1074/jbc.M611412200	http://dx.doi.org/10.1074/jbc.M611412200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17535811	hybrid			2022-12-27	WOS:000248354200076
J	Bergfeld, AK; Claus, H; Vogel, U; Muhlenhoff, M				Bergfeld, Anne K.; Claus, Heike; Vogel, Ulrich; Muehlenhoff, Martina			Biochemical characterization of thepolysialic acid-specific O-acetyltransferase NeuO of Escherichia coli K1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; ACETYL-COENZYME-A; SIALIC-ACID; SERINE ACETYLTRANSFERASE; CAPSULAR POLYSACCHARIDE; CRYSTAL-STRUCTURE; POLYSIALIC ACID; BACTERIAL-MENINGITIS; NEONATAL MENINGITIS; FORM VARIATION	Escherichia coli K1 is a leading pathogen in neonatal sepsis and meningitis. The K1 capsule, composed of alpha 2,8-linked polysialic acid, represents the major virulence factor. In some K1 strains, phase-variable O-acetylation of the capsular polysaccharide is observed, a modification that is catalyzed by the prophage-encoded O-acetyltransferase NeuO. Phase variation is mediated by changes in the number of heptanucleotide repeats within the 5'-coding region of neuO, and full-length translation is restricted to repeat numbers that are a multiple of three. To understand the biochemical basis of K1 capsule O-acetylation, NeuO encoded by alleles containing 0, 12, 24, and 36 repeats was expressed and purified to homogeneity via a C-terminal hexahistidine tag. All NeuO variants assembled into hexamers and were enzymatically active with a high substrate specificity toward polysialic acid with > 14 residues. Remarkably, the catalytic efficiency (k(cat)/K-m(donor)) increased linearly with increasing numbers of repeats, revealing a new mechanism for modulating NeuO activity. Using homology modeling, we predicted a three-dimensional structure primarily composed of a left-handed parallel beta-helix with one protruding loop. Two amino acids critical for catalytic activity were identified and corresponding alanine substitutions, H119A and W143A, resulted in a complete loss of activity without affecting the oligomerization state. Our results indicate that in NeuO typical features of an acetyltransferase of the left- handed beta-helix family are combined with a unique regulatory mechanism based on variable N-terminal protein extensions formed by tandem copies of an RLKTQDS heptad.	Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany; Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany	Hannover Medical School; University of Wurzburg	Muhlenhoff, M (corresponding author), Hannover Med Sch, Dept Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de						ALPERS DH, 1965, J BIOL CHEM, V240, P10; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; Bonacorsi S, 2005, INT J MED MICROBIOL, V295, P373, DOI 10.1016/j.ijmm.2005.07.011; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; Dunn SM, 1996, PROTEIN SCI, V5, P538; Feng L, 2005, J BACTERIOL, V187, P758, DOI 10.1128/JB.187.2.758-764.2005; Fowler MI, 2004, CELL MICROBIOL, V6, P555, DOI 10.1111/j.1462-5822.2004.00382.x; FRASA H, 1993, J CLIN MICROBIOL, V31, P3174, DOI 10.1128/JCM.31.12.3174-3178.1993; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; GAMIAN A, 1992, CARBOHYD RES, V236, P195, DOI 10.1016/0008-6215(92)85016-S; GERARDYSCHAHN R, 1995, MOL MICROBIOL, V16, P441, DOI 10.1111/j.1365-2958.1995.tb02409.x; Harvey D, 1999, SEMIN PERINATOL, V23, P218, DOI 10.1016/S0146-0005(99)80066-4; HIGA HH, 1988, J BIOL CHEM, V263, P8872; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Johnson CM, 2005, ARCH BIOCHEM BIOPHYS, V433, P85, DOI 10.1016/j.abb.2004.08.014; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; Lemercinier X, 1996, CARBOHYD RES, V296, P83, DOI 10.1016/S0008-6215(96)00253-4; LEWENDON A, 1995, J BIOL CHEM, V270, P26326, DOI 10.1074/jbc.270.44.26326; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; LEYING H, 1990, INFECT IMMUN, V58, P222, DOI 10.1128/IAI.58.1.222-227.1990; Lo Leggio L, 2003, BIOCHEMISTRY-US, V42, P5225, DOI 10.1021/bi0271446; MCCRACKEN GH, 1974, LANCET, V2, P246; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Olsen LR, 2001, BIOCHEMISTRY-US, V40, P1913, DOI 10.1021/bi002503n; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; PELKONEN S, 1988, J BACTERIOL, V170, P2646, DOI 10.1128/jb.170.6.2646-2653.1988; PLUSCHKE G, 1983, INFECT IMMUN, V42, P907, DOI 10.1128/IAI.42.3.907-913.1983; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; ROBBINS JB, 1974, NEW ENGL J MED, V290, P1216, DOI 10.1056/NEJM197405302902202; ROHR TE, 1980, J BIOL CHEM, V255, P2332; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; SARFF LD, 1975, LANCET, V1, P1099; SKOZA L, 1976, BIOCHEM J, V159, P457, DOI 10.1042/bj1590457; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; Sugantino M, 2002, BIOCHEMISTRY-US, V41, P2209, DOI 10.1021/bi011991b; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; Wang XG, 2002, STRUCTURE, V10, P581, DOI 10.1016/S0969-2126(02)00741-4; Wyckoff TJO, 1999, J BIOL CHEM, V274, P27047, DOI 10.1074/jbc.274.38.27047; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001	56	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22217	22227		10.1074/jbc.M703044200	http://dx.doi.org/10.1074/jbc.M703044200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17519228	hybrid			2022-12-27	WOS:000248196800067
J	Jerga, A; Lu, YJ; Schujman, GE; de Mendoza, D; Rock, CO				Jerga, Agoston; Lu, Ying-Jie; Schujman, Gustavo E.; de Mendoza, Diego; Rock, Charles O.			Identification of a soluble diacylglycerol kinase required for lipoteichoic acid production in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-DERIVED OLIGOSACCHARIDES; BACTERIAL CELL WALLS; ESCHERICHIA-COLI; DIGLYCERIDE KINASE; STAPHYLOCOCCUS-AUREUS; C55-ISOPRENOID ALCOHOL; STREPTOCOCCUS-MUTANS; BIOSYNTHESIS; GENE; PHOSPHATIDYLGLYCEROL	Diacylglycerol kinases (DagKs) are key enzymes in lipid metabolism that function to reintroduce diacylglycerol formed from the hydrolysis of phospholipids into the biosynthetic pathway. Bacillus subtilis is a prototypical Gram-positive bacterium with a lipoteichoic acid structure containing repeating units of sn-glycerol-1-P groups derived from phosphatidylglycerol head groups. The B. subtilis homolog of the prokaryotic DagK gene family (dgkA; Pfam01219) was not a DagK but rather was an undecaprenol kinase. The three members of the soluble DagK protein family (Pfam00781) in B. subtilis were tested by complementation of an E. coli dgkA mutant, and only the essential yerQ gene possessed DagK activity. This gene was dubbed dgkB, and the soluble protein product was purified, and its DagK activity was verified in vitro. Conditional inactivation of dgkB led to the accumulation of diacylglycerol and the cessation of lipoteichoic acid formation in B. subtilis. This study identifies a soluble protein encoded by the dgkB (yerQ) gene as an essential kinase in the diacylglycerol cycle that drives lipoteichoic acid production.	St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Argentina; Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, RA-2000 Rosario, Argentina	St Jude Children's Research Hospital; National University of Rosario; National University of Rosario	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale, Memphis, TN 38105 USA.	charles.rock@stjude.org			NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NIGMS NIH HHS [GM34496] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amiteye S, 2003, J BACTERIOL, V185, P5306, DOI 10.1128/JB.185.17.5306-5309.2003; Bakali HMA, 2007, J BIOL CHEM, V282, P19644, DOI 10.1074/jbc.M604852200; BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; BISHOP DG, 1967, EUR J BIOCHEM, V2, P448, DOI 10.1111/j.1432-1033.1967.tb00158.x; CABACUNGAN E, 1981, J BACTERIOL, V147, P75, DOI 10.1128/JB.147.1.75-79.1981; CAIN BD, 1993, J BACTERIOL, V175, P3784, DOI 10.1128/JB.175.12.3784-3789.1993; Chen P, 1998, J BACTERIOL, V180, P167, DOI 10.1128/JB.180.1.167-170.1998; EL GM, 2004, J BIOL CHEM, V279, P30106; FIEDLER W, 1985, J BIOL CHEM, V260, P4799; GOLDBERG DE, 1981, P NATL ACAD SCI-BIOL, V78, P5513, DOI 10.1073/pnas.78.9.5513; HIGASHI Y, 1970, J BIOL CHEM, V245, P3683; HIGASHI Y, 1970, J BIOL CHEM, V245, P3697; JACKSON BJ, 1984, J BACTERIOL, V160, P976, DOI 10.1128/JB.160.3.976-981.1984; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KOCH HU, 1984, EUR J BIOCHEM, V138, P357, DOI 10.1111/j.1432-1033.1984.tb07923.x; KOGA Y, 1984, BIOCHIM BIOPHYS ACTA, V793, P86; LACROIX JM, 1991, MOL MICROBIOL, V5, P1745, DOI 10.1111/j.1365-2958.1991.tb01924.x; Lau FW, 1999, BIOCHEMISTRY-US, V38, P5521, DOI 10.1021/bi982763t; Lis M, 2003, FEMS MICROBIOL LETT, V229, P179, DOI 10.1016/S0378-1097(03)00818-8; Lis M, 2003, INFECT IMMUN, V71, P1938, DOI 10.1128/IAI.71.4.1938-1943.2003; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nguyen HD, 2005, PLASMID, V54, P241, DOI 10.1016/j.plasmid.2005.05.001; NOTO T, 1982, J ANTIBIOT, V35, P401, DOI 10.7164/antibiotics.35.401; Owens RM, 2006, MOL MICROBIOL, V60, P1152, DOI 10.1111/j.1365-2958.2006.05174.x; Oxenoid K, 2002, BIOCHEMISTRY-US, V41, P12876, DOI 10.1021/bi020335o; RAETZ CRH, 1978, J BIOL CHEM, V253, P3882; RAETZ CRH, 1979, J BACTERIOL, V137, P860, DOI 10.1128/JB.137.2.860-868.1979; RUMLEY MK, 1992, J BIOL CHEM, V267, P11806; SANDERMA.H, 1971, P NATL ACAD SCI USA, V68, P2441, DOI 10.1073/pnas.68.10.2441; SCHNEIDER EG, 1976, BIOCHIM BIOPHYS ACTA, V441, P201, DOI 10.1016/0005-2760(76)90163-6; SCHNEIDER EG, 1973, J BIOL CHEM, V248, P3739; SCHULMAN H, 1977, J BIOL CHEM, V252, P4250; SMITH RL, 1994, J BACTERIOL, V176, P5459, DOI 10.1128/JB.176.17.5459-5465.1994; TARON DJ, 1983, J BACTERIOL, V154, P1110, DOI 10.1128/JB.154.3.1110-1116.1983; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; WALSH JP, 1986, J BIOL CHEM, V261, P6239; Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141	41	50	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21738	21745		10.1074/jbc.M703536200	http://dx.doi.org/10.1074/jbc.M703536200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17535816	hybrid			2022-12-27	WOS:000248196800021
J	Liu, D; Ding, X; Du, J; Cai, X; Huang, YJ; Ward, T; Shaw, A; Yang, Y; Hu, R; Jin, CJ; Yao, X				Liu, Dan; Ding, Xia; Du, Jian; Cai, Xin; Huang, Yuejia; Ward, Tarsha; Shaw, Andrew; Yang, Yong; Hu, Renming; Jin, Changjiang; Yao, Xuebiao			Human NUF2 interacts with centromere-associated protein E and is essential for a stable spindle microtubule-kinetochore attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-E; MITOTIC CHECKPOINT; NDC80 COMPLEX; BUDDING YEAST; CHROMOSOME CONGRESSION; VERTEBRATE CELLS; HEC1; COMPONENTS; METAPHASE; LOCALIZATION	Chromosome segregation in mitosis is orchestrated by dynamic interaction between spindle microtubules and the kinetochore, a multiprotein complex assembled onto centromeric DNA of the chromosome. Here, we show that Homo sapiens (Hs) NUF2 is required for stable kinetochore localization of centromere-associated protein E (CENP-E) in HeLa cells. HsNUF2 specifies the kinetochore association of CENP-E by interacting with its C-terminal domain. The region of HsNUF2 binding to CENP-E was mapped to its C-terminal domain by glutathione S-transferase pulldown and yeast two-hybrid assays. Suppression of synthesis of HsNUF2 by small interfering RNA abrogated the localization of CENP-E to the kinetochore, demonstrating the requirement of HsNUF2 for CENP-E kinetochore localization. In addition, depletion of HsNUF2 caused aberrant chromosome segregation. These HsNUF2-suppressed cells displayed reduced tension at kinetochores of bi-orientated chromosomes. Double knockdown of CENP-E and HsNUF2 further abolished the tension at the kinetochores. Our results indicate that HsNUF2 and CENP-E are required for organization of stable microtubule-kinetochore attachment that is essential for faithful chromosome segregation in mitosis.	Univ Sci & Technol China, Lab Cellular Dynam, Hefei 230027, Peoples R China; Natl Lab Phys Sci, Hefei 230027, Peoples R China; Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; Morehouse Sch Med, Canc Biol Program, Atlanta, GA 30310 USA; Beijing Univ Chinese Med, Dept Med, Beijing 100029, Peoples R China; Fudan Univ, Dept Endocrinol & Metab, Shanghai 200040, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Morehouse School of Medicine; Beijing University of Chinese Medicine; Fudan University	Jin, CJ (corresponding author), Univ Sci & Technol China, Lab Cellular Dynam, Hefei 230027, Peoples R China.	jincj@ustc.edu.cn	Yang, Yong/U-4781-2019; Yang, Yong/P-8322-2018					Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Fukagawa T, 2004, EXP CELL RES, V296, P21, DOI 10.1016/j.yexcr.2004.03.004; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Lin YT, 2006, ONCOGENE, V25, P6901, DOI 10.1038/sj.onc.1209687; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Mikami Y, 2005, MOL CELL BIOL, V25, P1958, DOI 10.1128/MCB.25.5.1958-1970.2005; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Xue Y, 2006, CHINESE SCI BULL, V51, P1836, DOI 10.1007/s11434-006-2054-8; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x	37	66	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21415	21424		10.1074/jbc.M609026200	http://dx.doi.org/10.1074/jbc.M609026200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535814	hybrid			2022-12-27	WOS:000248047500069
J	Reigstad, CS; Hultgren, SJ; Gordon, JI				Reigstad, Christopher S.; Hultgren, Scott J.; Gordon, Jeffrey I.			Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URINARY-TRACT-INFECTIONS; EPITHELIAL-CELLS; IRON-METABOLISM; EXPRESSION ANALYSIS; MOUSE INTESTINE; MESSENGER-RNA; HEME; K-12; DIFFERENTIATION; GENES	Uropathogenic Escherichia coli (UPEC), the principal cause of urinary tract infection in women, colonizes the gut as well as the genitourinary tract. Studies of mice inoculated with UTI89, a sequenced isolate, have revealed a complex life cycle that includes formation of intracellular bacterial communities (IBCs) in bladder urothelial cells. To understand how UPEC adapts to life in IBCs, we have used GeneChips and/or quantitative reverse transcriptase PCR to study UTI89 recovered from the distal gut of gnotobiotic mice and from IBCs harvested by laser capture microdissection from the bladder urothelium of infected C3H/HeJ female mice. Host responses were characterized in laser capture microdissected urothelial cells that do or do not contain IBCs. The results reveal components of ferric iron acquisition systems in UTI89 that are expressed at significantly higher levels in IBCs compared with the intestine, including the hemin receptor chuA (1,390 +/- 188-fold). Localized urothelial responses to IBCs help oppose bacterial salvage of host cell iron (e.g. up-regulation of Tfrc (transferrin receptor) and Lcn2 (lipocalin 2)), facilitate glucose import (e.g. Hk2 (hexokinase 2)), and maintain epithelial structural integrity (e.g. Ivl (involucrin) and Sbsn (suprabasin)). Delta chuA mutants produce significantly smaller IBCs compared with wild type UTI89. This difference was not observed in strains lacking sitA (ABC-type iron/manganese transporter subunit), iroN (salmochelin receptor), hlyA (alpha-hemolysin), or entF (enterobactin synthetase subunit). Together, these studies indicate that heme- and siderophore-associated iron play key roles in IBC development and provide a series of microbial and host biomarkers for comparing UPEC strains isolated from humans.	Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; Washington Univ, Sch Med, Dept Mol Biol, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci, Campus Box 8510,4444 Forest Pk Blvd, St Louis, MO 63108 USA.	jgordon@wustl.edu			NIAMS NIH HHS [AR049475] Funding Source: Medline; PHS HHS [T32H000045] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BROCK JH, 1991, INFECT IMMUN, V59, P3185, DOI 10.1128/IAI.59.9.3185-3190.1991; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Hickey EK, 1997, INFECT IMMUN, V65, P133, DOI 10.1128/IAI.65.1.133-143.1997; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hooton TM, 2001, INT J ANTIMICROB AG, V17, P259, DOI 10.1016/S0924-8579(00)00350-2; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Janke B, 2001, FEMS MICROBIOL LETT, V199, P61, DOI 10.1111/j.1574-6968.2001.tb10651.x; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; KASTURI L, 1993, EXP CELL RES, V205, P84, DOI 10.1006/excr.1993.1061; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; LEBEK G, 1985, INFECT IMMUN, V50, P682, DOI 10.1128/IAI.50.3.682-686.1985; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nagpal S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh048; Nagy G, 2001, INFECT IMMUN, V69, P1924, DOI 10.1128/IAI.69.3.1924-1928.2001; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Park GT, 2002, J BIOL CHEM, V277, P45195, DOI 10.1074/jbc.M205380200; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Runyen-Janecky LJ, 2003, INFECT IMMUN, V71, P1919, DOI 10.1128/IAI.71.4.1919-1928.2003; Sannes MR, 2004, J INFECT DIS, V190, P2121, DOI 10.1086/425984; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stappenbeck TS, 2002, METHOD ENZYMOL, V356, P167; Straub KL, 2001, FEMS MICROBIOL ECOL, V34, P181, DOI 10.1016/S0168-6496(00)00088-X; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Turner PC, 1998, INFECT IMMUN, V66, P5215, DOI 10.1128/IAI.66.11.5215-5223.1998; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978	56	108	111	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21259	21267		10.1074/jbc.M611502200	http://dx.doi.org/10.1074/jbc.M611502200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17504765	hybrid			2022-12-27	WOS:000248047500054
J	Choi, MM; Kim, EA; Yang, SJ; Choi, SY; Cho, SW; Huh, JW				Choi, Myung-Min; Kim, Eun-A; Yang, Seung-Ju; Choi, Soo Young; Cho, Sung-Woo; Huh, Jae-Wan			Amino acid changes within antenna helix are responsible for different regulatory preferences of human glutamate dehydrogenase isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERINSULINISM/HYPERAMMONEMIA SYNDROME; OLIVOPONTOCEREBELLAR ATROPHY; SPINOCEREBELLAR DEGENERATION; CASSETTE MUTAGENESIS; ESCHERICHIA-COLI; MOLECULAR-BASIS; BINDING DOMAIN; GENE; TISSUE; IDENTIFICATION	Human glutamate dehydrogenase (hGDH) exists in hGDH1 (housekeeping isozyme) and in hGDH2 (nerve-specific isozyme), which differ markedly in their allosteric regulation. Because they differ in only 16 of their 505 amino acids, the regulatory preferences must arise from amino acid residues that are not common between hGDH1 and hGDH2. To our knowledge none of the mutagenesis studies on the hGDH isozymes to date have identified the amino acid residues fully responsible for the different regulatory preferences between hGDH1 and hGDH2. In this study we constructed hGDH1(hGDH2390-448) hGDH1 (amino acid segment 390 448 of hGDH1 replaced by the corresponding hGDH2 segment) and hGDH2(hGDH1390-448) hGDH2 (amino acid segment 390-448 of hGDH2 replaced by the corresponding hGDH1 segment) by swapping the corresponding amino acid segments in hGDH1 and hGDH2. The chimeric enzymes by reciprocal swapping resulted in double mutations in amino acid sequences at 415 and 443 residues that are not common between hGDH1 and hGDH2 and are located in the C-terminal 48-residue "antenna" helix, which is thought to be part of the regulatory domain of mammalian GDHs. Functional analyses revealed that the doubly mutated chimeric enzymes almost completely acquired most of the different regulatory preferences between hGDH1 and hGDH2 for electrophoretic mobility, heat-stability, ADP activation, palmitoyl-CoA inhibition, and L-leucine activation, except for GTP inhibition. Our results indicate that substitutions of the residues in the antenna region may be important evolutionary changes that led to the adaptation of hGDH2 to the unique metabolic needs of the nerve tissue.	Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul 138736, South Korea; Kanyang Univ, Dept Biomed Lab Sci, Taejon 302718, South Korea; Hallym Univ, Dept Biomed Sci, Chunchon 200702, South Korea	University of Ulsan; Hallym University	Cho, SW (corresponding author), 388-1 Poongnap-2dong, Seoul 138736, South Korea.	swcho@amc.seoul.kr; jwhuh72@amc.seoul.kr						ABE T, 1992, INVEST OPHTH VIS SCI, V33, P447; Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Cho SW, 1996, BIOCHEMISTRY-US, V35, P13907, DOI 10.1021/bi9618575; CHO SW, 1995, EUR J BIOCHEM, V233, P340, DOI 10.1111/j.1432-1033.1995.340_1.x; Cho SW, 2001, EUR J BIOCHEM, V268, P3205, DOI 10.1046/j.1432-1327.2001.02209.x; DUVOISIN RC, 1983, NEUROLOGY, V33, P1322; Fang J, 2002, BIOCHEM J, V363, P81, DOI 10.1042/0264-6021:3630081; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HUSSAIN MM, 1989, J BIOL CHEM, V264, P20730; IWATSUJI K, 1989, GERONTOLOGY, V35, P218, DOI 10.1159/000213026; Jang SH, 2003, EXP MOL MED, V35, P249, DOI 10.1038/emm.2003.33; JULLIARD JH, 1979, J BIOL CHEM, V254, P3427; KAJIYAMA K, 1988, J NEUROL NEUROSUR PS, V51, P1078, DOI 10.1136/jnnp.51.8.1078; Kanavouras K, 2007, J NEUROSCI RES, V85, P1101, DOI 10.1002/jnr.21197; Knapp S, 1997, J MOL BIOL, V267, P916, DOI 10.1006/jmbi.1996.0900; KONAGAYA Y, 1986, J NEUROL SCI, V74, P231, DOI 10.1016/0022-510X(86)90108-5; Lee EY, 2001, J BIOL CHEM, V276, P47930, DOI 10.1074/jbc.M108918200; MacMullen C, 2001, J CLIN ENDOCR METAB, V86, P1782, DOI 10.1210/jc.86.4.1782; Mastorodemos V, 2005, J NEUROSCI RES, V79, P65, DOI 10.1002/jnr.20353; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Plaitakis A, 2003, NEUROCHEM INT, V43, P401, DOI 10.1016/S0197-0186(03)00028-7; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; PLAITAKIS A, 1982, SCIENCE, V216, P193, DOI 10.1126/science.6121377; Plaitakis A, 2000, J NEUROL, V247, P25, DOI 10.1007/PL00007757; Shashidharan P, 1997, J NEUROCHEM, V68, P1804; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tanizawa Y, 2002, DIABETES, V51, P712, DOI 10.2337/diabetes.51.3.712; TELLER JK, 1992, EUR J BIOCHEM, V206, P151, DOI 10.1111/j.1432-1033.1992.tb16912.x; Yang SJ, 2004, FEBS LETT, V562, P59, DOI 10.1016/S0014-5793(04)00183-8; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; Zaganas I, 2002, J BIOL CHEM, V277, P46552, DOI 10.1074/jbc.M208596200; Zaganas I, 2002, J BIOL CHEM, V277, P26422, DOI 10.1074/jbc.M200022200	43	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19510	19517		10.1074/jbc.M703018200	http://dx.doi.org/10.1074/jbc.M703018200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17507377	hybrid			2022-12-27	WOS:000247650600025
J	Manavathi, B; Rayala, SK; Kumar, R				Manavathi, Bramanandam; Rayala, Suresh K.; Kumar, Rakesh			Phosphorylation-dependent regulation of stability and transforming potential of ETS transcriptional factor ESE-1 by p21-activated kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; PAK1 PHOSPHORYLATION; EXPRESSION; CANCER; FAMILY; GROWTH; GENE; DIFFERENTIATION; TRANSITION; EPITHELIUM	Differential phosphorylation of transcription factors by signal transduction pathways play an important role in regulation of gene expression and functions. ESE-1 is an epithelium-specific ETS transcription factor that transforms human breast epithelial cells through a serine- and aspartic acid-rich domain (SAR) by an unknown cytoplasmic mechanism. Here we found that a signaling kinase, p21-activated kinase-1 (Pak1), interacts with and phosphorylates ESE-1. Interestingly, Pak1 selectively phosphorylates ESE-1 at Ser207, which is located within the SAR domain. A S207A substitution in ESE-1 reduced its ability to transform breast cancer cells. We also found that ESE-1 is a labile protein and by interacting with F-box-binding protein beta-TrCP, undergoes ubiquitin-dependent proteolysis. Intriguingly, Pak1 phosphorylation inactive mutant ESE1-S207A is more unstable than either wild-type ESE-1 or its Pak1 phosphorylation mimetic mutant, i.e. ESE1-S207E. These findings provide novel insights into the mechanism of transformation potential of ESE-1 and discovered that ESE-1 functions are coordinately regulated by Pak1 phosphorylation and beta-TrCP-dependent ubiquitin-proteasome pathways.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Kumar, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rkumar@mdanderson.org	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Manavathi, Bramanandam/0000-0002-1797-398X; Rayala, Suresh/0000-0003-4394-4450	NCI NIH HHS [CA65746, CA90970] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA065746, R01CA090970, R01CA065746] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brown C, 2004, J BIOL CHEM, V279, P12794, DOI 10.1074/jbc.M308593200; Cabral A, 2003, J BIOL CHEM, V278, P17792, DOI 10.1074/jbc.M300508200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; DITTMER J, 1998, BIOCHIM BIOPHYS ACTA, V1377, P1; Feldman RJ, 2003, ANTICANCER RES, V23, P2125; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Grall FT, 2005, FEBS J, V272, P1676, DOI 10.1111/j.1742-4658.2005.04592.x; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Jobling AI, 2002, INVEST OPHTH VIS SCI, V43, P3530; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kurpios NA, 2003, J MAMMARY GLAND BIOL, V8, P177, DOI 10.1023/A:1025948823955; Kwon JH, 2003, J BIOL CHEM, V278, P875, DOI 10.1074/jbc.M208241200; Li F, 2002, EMBO REP, V3, P767, DOI 10.1093/embo-reports/kvf157; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Manavathi B, 2005, CANCER RES, V65, P5571, DOI 10.1158/0008-5472.CAN-04-4664; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Neve RM, 2002, ONCOGENE, V21, P3934, DOI 10.1038/sj.onc.1205503; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reddy SPM, 2003, J BIOL CHEM, V278, P21378, DOI 10.1074/jbc.M212258200; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Scott GK, 2000, ONCOGENE, V19, P6490, DOI 10.1038/sj.onc.1204041; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Vadlamudi RK, 2005, ONCOGENE, V24, P4591, DOI 10.1038/sj.onc.1208672; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wiese C, 2001, BIOTECHNIQUES, V30, P960, DOI 10.2144/01305bm07; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	43	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19820	19830		10.1074/jbc.M702309200	http://dx.doi.org/10.1074/jbc.M702309200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17491012	hybrid			2022-12-27	WOS:000247650600057
J	Sullivan, M; Morgan, DO				Sullivan, Matt; Morgan, David O.			A novel destruction sequence targets the meiotic regulator Spo13 for anaphase-promoting complex-dependent degradation in anaphase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERIC COHESION; KINASE CDC5; KEN-BOX; SACCHAROMYCES-CEREVISIAE; A-BOX; RECOGNITION; SUBUNIT; SEGREGATION; COMPLEX/CYCLOSOME; RECRUITMENT	The anaphase-promoting complex (APC) or cyclosome is a multisubunit ubiquitin-protein ligase that ubiquitinates and thereby promotes the destruction of the mitotic cyclins and the separase inhibitor, securin. The contributions of the APC to progression through the meiotic program are not clear. To clarify the function of the APC in meiosis, we screened several yeast meiotic proteins as APC substrates in vitro. We found that the meiotic regulator Spo13 is an APC substrate that is degraded during anaphase I. Spo13 is expressed only in meiotic cells, where it has multiple functions, including the promotion of monopolar chromosome attachment in the first division. Spo13 ubiquitination by the APC depends on an LxExxxN sequence (residues 26-32) that is distinct from previously described destruction sequences of APC substrates. Mutation of one residue, leucine 26, prevented Spo13 ubiquitination by the APC in vitro and stabilized the protein through the meiotic divisions. Analysis of meiotic progression and spore viability of yeast containing the stabilized Spo13 mutant revealed no significant defects, indicating that Spo13 destruction in anaphase I is not essential for meiosis. We propose that Spo13 destruction is one of multiple mechanisms underlying the switch from monopolar to bipolar chromosome attachment between the meiotic divisions.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Genentech Hall,Rm N312B,600 16th St, San Francisco, CA 94158 USA.	David.Morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416	NIGMS NIH HHS [GM53270, R01 GM053270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053270, R37GM053270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Araki M, 2003, EMBO J, V22, P6115, DOI 10.1093/emboj/cdg573; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Castro A, 2003, MOL CELL BIOL, V23, P4126, DOI 10.1128/MCB.23.12.4126-4138.2003; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lee BH, 2002, GENE DEV, V16, P1672, DOI 10.1101/gad.989302; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pfleger CM, 2000, GENE DEV, V14, P655; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Valentin G, 2006, J BIOL CHEM, V281, P2828, DOI 10.1074/jbc.M510626200; Zachariae W, 2004, MOL CELL, V13, P2, DOI 10.1016/S1097-2765(03)00530-6	36	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19710	19715		10.1074/jbc.M701507200	http://dx.doi.org/10.1074/jbc.M701507200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17493939	hybrid			2022-12-27	WOS:000247650600046
J	Gipson, CL; Xin, ZT; Danzy, SC; Parslow, TG; Ly, H				Gipson, Clay L.; Xin, Zhong-Tao; Danzy, Shamika C.; Parslow, Tristram G.; Ly, Hinh			Functional characterization of yeast telomerase RNA dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; IMMUNODEFICIENCY-VIRUS RNA; BICOID MESSENGER-RNA; KISSING-LOOP HAIRPIN; REVERSE-TRANSCRIPTASE; IN-VIVO; CATALYTIC SUBUNIT; GENOMIC RNA; TETRAHYMENA-TELOMERASE; SECONDARY STRUCTURE	Telomerase is the cellular RNA-dependent DNA polymerase (i.e. reverse transcriptase) that uses an integral RNA template to synthesize telomeric DNA repeats at the ends of linear chromosomes. Human telomerase RNA (hTERC) is thought to function as a dimeric complex consisting of two RNAs that interact with each other physically as well as genetically. We show here for the first time that the yeast Saccharomyces cerevisiae telomerase RNA TLC1 likewise forms dimers in vitro. TLC1 dimerization depends on a unique 6-base self-complementary sequence, which closely mimics palindromic sequences that mediate functional dimerization of HIV-1 and other retroviral genomes. We found that dissimilar but comparably located TLC1 palindromes from other sensu stricto yeasts can functionally substitute for that of S. cerevisiae. Yeast cells expressing dimerization-defective TLC1 alleles have shorter telomeres than those with wild-type TLC1. This study, therefore, highlights dimerization as a functionally conserved feature of the RNA templates utilized by reverse transcriptases of both viral and cellular origins.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Div Expt Pathol, Atlanta, GA 30322 USA	Emory University; Emory University	Ly, H (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, 615 Michael St,Whitehead Bldg,Rm105L, Atlanta, GA 30322 USA.	hly@emory.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040317] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-40317] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arai K, 2002, J BIOL CHEM, V277, P8538, DOI 10.1074/jbc.M111068200; Bachand F, 2001, NUCLEIC ACIDS RES, V29, P3385, DOI 10.1093/nar/29.16.3385; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bosoy D, 2003, J BIOL CHEM, V278, P3882, DOI 10.1074/jbc.M210645200; Bryan TM, 2003, MOL BIOL CELL, V14, P4794, DOI 10.1091/mbc.E03-07-0474; Chapon C, 1997, RNA, V3, P1337; Chappell AS, 2004, MOL CELL BIOL, V24, P7720, DOI 10.1128/MCB.24.17.7720-7736.2004; Chen JL, 2004, P NATL ACAD SCI USA, V101, P14683, DOI 10.1073/pnas.0406204101; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chin MPS, 2005, P NATL ACAD SCI USA, V102, P9002, DOI 10.1073/pnas.0502522102; Clever JL, 1996, J VIROL, V70, P5902, DOI 10.1128/JVI.70.9.5902-5908.1996; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Comolli LR, 2002, P NATL ACAD SCI USA, V99, P16998, DOI 10.1073/pnas.262663599; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Doria-Rose NA, 1998, J VIROL, V72, P8073, DOI 10.1128/JVI.72.10.8073-8082.1998; Feng YX, 2000, J VIROL, V74, P10819, DOI 10.1128/JVI.74.22.10819-10821.2000; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; Keppler BR, 2004, BIOCHEMISTRY-US, V43, P334, DOI 10.1021/bi035583e; Laughrea M, 1997, BIOCHEMISTRY-US, V36, P9501, DOI 10.1021/bi970862l; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; Lin J, 2004, P NATL ACAD SCI USA, V101, P14713, DOI 10.1073/pnas.0405879101; Lingner J, 1996, P NATL ACAD SCI USA, V93, P10712, DOI 10.1073/pnas.93.20.10712; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Ly H, 2003, GENE DEV, V17, P1078, DOI 10.1101/gad.1060803; Marie-Egyptienne DT, 2005, NUCLEIC ACIDS RES, V33, P5446, DOI 10.1093/nar/gki848; MARQUET R, 1994, NUCLEIC ACIDS RES, V22, P145, DOI 10.1093/nar/22.2.145; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1; Peng Y, 2001, MOL CELL, V7, P1201, DOI 10.1016/S1097-2765(01)00268-4; Prescott J, 1997, GENE DEV, V11, P528, DOI 10.1101/gad.11.4.528; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Ren XJ, 2003, NUCLEIC ACIDS RES, V31, P6509, DOI 10.1093/nar/gkg871; Rivera MA, 2004, J BIOL CHEM, V279, P53770, DOI 10.1074/jbc.M407768200; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Wagner C, 2004, J BIOL CHEM, V279, P4560, DOI 10.1074/jbc.M306511200; Wang LB, 2002, NUCLEIC ACIDS RES, V30, P4032, DOI 10.1093/nar/gkf513; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Zappulla DC, 2005, NAT STRUCT MOL BIOL, V12, P1072, DOI 10.1038/nsmb1019	48	7	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18857	18863		10.1074/jbc.M700057200	http://dx.doi.org/10.1074/jbc.M700057200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17491007	hybrid			2022-12-27	WOS:000247475300025
J	Liu, J; Xia, JS; Cho, KH; Clapham, DE; Ren, DJ				Liu, Jin; Xia, Jingsheng; Cho, Kwang-Hyun; Clapham, David E.; Ren, Dejian			CatSper beta, a novel transmembrane protein in the CatSper channel complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM MOTILITY; MAMMALIAN SPERM; GENE-EXPRESSION; SODIUM-CHANNELS; MALE-FERTILITY; CA2+ ENTRY; TESTIS; FERTILIZATION; MECHANISMS; EVOLUTION	Four CatSper ion channel subunit genes (CatSpers 1-4) are required for sperm cell hyperactivation and male fertility. The four proteins assemble (presumably as a tetramer) to form a sperm-specific, alkalinization-activated Ca2+-selective channel. We set out to identify proteins associating with CatSper that might help explain its unique role in spermatozoa. Using a transgenic approach, a CatSper1 complex was purified from mouse testis that contained heat shock protein 70-2, a testis-specific chaperone, and CatSper beta, a novel protein with two putative transmembrane-spanning domains. Like the CatSper ion channel subunits, CatSper beta was restricted to testis and localized to the principal piece of the sperm tail. CatSper beta protein is absent in CatSper1(-/-) sperm, suggesting that it is required for trafficking or formation of a stable channel complex. CatSper beta is the first identified auxiliary protein to the CatSper channel.	Childrens Hosp, Howard Hughes Med Inst, Enders 1309, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Ren, DJ (corresponding author), Univ Penn, Dept Biol, 415 S Univ Ave, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428; Cho, Kwang-Hyun/0000-0002-3972-4394				Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Avidan N, 2003, EUR J HUM GENET, V11, P497, DOI 10.1038/sj.ejhg.5200991; BABCOCK DF, 1987, J BIOL CHEM, V262, P15041; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Clapham DE, 2005, PHARMACOL REV, V57, P451, DOI 10.1124/pr.57.4.7; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Eddy EM, 1998, J EXP ZOOL, V282, P261, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;261::AID-JEZ28&gt;3.0.CO;2-V; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hinzpeter A, 2006, AM J PHYSIOL-CELL PH, V290, pC45, DOI 10.1152/ajpcell.00209.2005; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Inaba K, 2002, MOL REPROD DEV, V62, P431, DOI 10.1002/mrd.10131; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jin JL, 2005, BIOL REPROD, V73, P1235, DOI 10.1095/biolreprod.105.045468; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Nikpoor P, 2004, HUM REPROD, V19, P124, DOI 10.1093/humrep/deh043; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Reed RR, 2004, CELL, V116, P329, DOI 10.1016/S0092-8674(04)00047-9; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; WOLF DE, 1990, P NATL ACAD SCI USA, V87, P6893, DOI 10.1073/pnas.87.17.6893; Yanagimachi R., 1994, P189; YU FH, 2004, SCI STKE	38	121	132	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18945	18952		10.1074/jbc.M701083200	http://dx.doi.org/10.1074/jbc.M701083200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17478420	hybrid			2022-12-27	WOS:000247475300036
J	Sloop, KW; Showalter, AD; Cox, AL; Cao, JXC; Siesky, AM; Zhang, HY; Irizarry, AR; Murray, SF; Booten, SL; Finger, EA; Mckay, RA; Monia, BP; Bhanot, S; Michael, MD				Sloop, Kyle W.; Showalter, Aaron D.; Cox, Amy L.; Cao, Julia X. C.; Siesky, Angela M.; Zhang, Hong Yan; Irizarry, Armando R.; Murray, Susan F.; Booten, Sheri L.; Finger, Eleftheria A.; Mckay, Robert A.; Monia, Brett P.; Bhanot, Sanjay; Michael, M. Dodson			Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTISENSE OLIGONUCLEOTIDE INHIBITOR; CHLOROGENIC ACID; MICROSOMAL GLUCOSE-6-PHOSPHATASE; GLUCOSE-PRODUCTION; GENE-THERAPY; MICE LACKING; MOUSE MODEL; METABOLISM; GLUCONEOGENESIS; EXPRESSION	D-Glucose-6-phosphatase is a key regulator of endogenous glucose production, and its inhibition may improve glucose control in type 2 diabetes. Herein, 2'-O-(2-methoxy) ethyl-modified phosphorothioate antisense oligonucleotides (ASOs) specific to the glucose 6-phosphate transporter-1 (G6PT1) enabled reduction of hepatic D-Glu-6-phosphatase activity in diabetic ob/ob mice. Treatment with G6PT1 ASOs decreased G6PT1 expression, reduced G6PT1 activity, blunted glucagon-stimulated glucose production, and lowered plasma glucose concentration in a dose-dependent manner. In contrast to G6PT1 knock-out mice and patients with glycogen storage disease, excess hepatic and renal glycogen accumulation, hyperlipidemia, neutropenia, and elevations in plasma lactate and uric acid did not occur. In addition, hypoglycemia was not observed in animals during extended periods of fasting, and the ability of G6PT1 ASO-treated mice to recover from an exogenous insulin challenge was not impaired. Together, these results demonstrate that effective glucose lowering by G6PT1 inhibitors can be achieved without adversely affecting carbohydrate and lipid metabolism.	Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; Eli Lilly & Co, Lilly Res Labs, Greenfield, IN 46140 USA; ISIS Pharmaceut, Carlsbad, CA 92008 USA	Eli Lilly; Eli Lilly; Isis Pharmaceuticals Inc	Sloop, KW (corresponding author), Lilly Res Labs, Indianapolis, IN 46285 USA.	sloop_kyle_w@lilly.com		Michael, Mervyn/0000-0002-0224-1065				ARION WJ, 1989, METHOD ENZYMOL, V174, P58; ARION WJ, 1980, J BIOL CHEM, V255, P396; ARION WJ, 1975, MOL CELL BIOCHEM, V6, P75, DOI 10.1007/BF01732001; Arion WJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P279, DOI 10.1006/abbi.1997.0563; Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; Bandsma RHJ, 2001, DIABETES, V50, P2591, DOI 10.2337/diabetes.50.11.2591; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; BURCHELL A, 1990, FASEB J, V4, P2978, DOI 10.1096/fasebj.4.12.2168325; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Butler M, 1997, LAB INVEST, V77, P379; Chen LY, 2003, HUM MOL GENET, V12, P2547, DOI 10.1093/hmg/ddg263; Cheung YY, 2007, J CLIN INVEST, V117, P784, DOI 10.1172/JCI30443; Chou JY, 1999, TRENDS ENDOCRIN MET, V10, P104; Chou JY, 2002, EUR J PEDIATR, V161, pS56, DOI 10.1007/s00431-002-1005-x; CORI GT, 1952, J BIOL CHEM, V199, P661; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; DEFRONZO RA, 1989, METABOLISM, V38, P387, DOI 10.1016/0026-0495(89)90129-7; Gerin I, 1997, FEBS LETT, V419, P235, DOI 10.1016/S0014-5793(97)01463-4; Graham MJ, 2001, BIOCHEM PHARMACOL, V62, P297, DOI 10.1016/S0006-2952(01)00669-4; Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360; Herling AW, 1998, AM J PHYSIOL-GASTR L, V274, pG1087, DOI 10.1152/ajpgi.1998.274.6.G1087; Herling AW, 1999, EUR J PHARMACOL, V386, P75, DOI 10.1016/S0014-2999(99)00748-7; Hiraiwa H, 1999, J BIOL CHEM, V274, P5532, DOI 10.1074/jbc.274.9.5532; Igarashi Y, 1980, J Inherit Metab Dis, V2, P45; IGARASHI Y, 1984, BIOCHEM BIOPH RES CO, V119, P593, DOI 10.1016/S0006-291X(84)80290-9; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kurukulasuriya R, 2003, CURR MED CHEM, V10, P99, DOI 10.2174/0929867033368547; LANGE AJ, 1980, J BIOL CHEM, V255, P8381; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lin BC, 1998, J BIOL CHEM, V273, P31656, DOI 10.1074/jbc.273.48.31656; Link James T, 2003, Curr Opin Investig Drugs, V4, P421; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Meyer C, 2004, AM J PHYSIOL-ENDOC M, V287, pE1049, DOI 10.1152/ajpendo.00041.2004; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; NORDLIE RC, 1993, P SOC EXP BIOL MED, V203, P274; Pan CJ, 1999, J BIOL CHEM, V274, P13865, DOI 10.1074/jbc.274.20.13865; Parker JC, 1998, DIABETES, V47, P1630, DOI 10.2337/diabetes.47.10.1630; Radziuk J, 2001, DIABETES-METAB RES, V17, P250, DOI 10.1002/dmrr.217; Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; Shieh JJ, 2003, J BIOL CHEM, V278, P47098, DOI 10.1074/jbc.M309472200; Simon C, 2000, ARCH BIOCHEM BIOPHYS, V373, P418, DOI 10.1006/abbi.1999.1560; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Soler M, 2004, ANTIVIR THER, V9, P953; Staehr P, 2002, DIABETES OBES METAB, V4, P215, DOI 10.1046/j.1463-1326.2002.00177.x; van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; WADDELL ID, 1990, BIOCHEM J, V267, P549, DOI 10.1042/bj2670549; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Yiu WH, 2007, GENE THER, V14, P219, DOI 10.1038/sj.gt.3302869; Zhang H, 2000, NAT BIOTECHNOL, V18, P862, DOI 10.1038/78475; Zingone A, 2000, J BIOL CHEM, V275, P828, DOI 10.1074/jbc.275.2.828; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	57	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19113	19121		10.1074/jbc.M610759200	http://dx.doi.org/10.1074/jbc.M610759200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17478431	hybrid			2022-12-27	WOS:000247475300053
J	Yaghini, FA; Li, F; Malik, KU				Yaghini, Fariborz A.; Li, Fang; Malik, Kafait U.			Expression and mechanism of spleen tyrosine kinase activation by angiotensin II and its implication in protein synthesis in rat vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; CYTOSOLIC PHOSPHOLIPASE A(2); GROWTH-FACTOR RECEPTOR; ARACHIDONIC-ACID; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOTHELIAL-CELLS; IMMUNOGLOBULIN-E; MAST-CELLS; P38 MAPK	Syk, a 72(kDa tyrosine kinase, is involved in development, differentiation, and signal transduction of hematopoietic and some non(hematopoietic cells. This study determined if Syk is expressed in vascular smooth muscle cells (VSMC) and contributes to angiotensin II (Ang II) signaling and protein synthesis. Syk was found in VSMC and was phosphorylated by Ang II through AT1 receptor. Ang II(induced Syk phosphorylation was inhibited by piceatannol and dominant negative but not wild type Syk mutant. Syk phosphorylation by Ang II was attenuated by cytosolic phospholipase A(2) (cPLA(2)) inhibitor pyrrolidine(1 and retrovirus carrying small interfering RNAs (shRNAs) of this enzyme. Arachidonic acid (AA) increased Syk phosphorylation, and AA(and Ang II(induced phosphorylation was diminished by inhibitors of AA metabolism (5,8,11,14(eicosatetraynoic acid) and lipoxygenase (LO; baicalein) but not cyclooxygenase (indomethacin). AA metabolites formed via LO, 5(S)-, 12(S)-, and 15(S)(hydroxyeicosatetraenoic acids, which activate p38 MAPK, increased Syk phosphorylation. p38 MAPK inhibitor SB202190, and dominant negative p38 MAPK mutant attenuated Ang II(and AA(induced Syk phosphorylation. Adenovirus dominant negative c(Src mutant abolished Ang II (and AA(induced Syk phosphorylation and SB202190, and dominant negative p38 MAPK mutant inhibited Ang II(induced c(Src phosphorylation. Syk dominant negative mutant but not epidermal growth factor receptor blocker AG1478 also inhibited Ang II-induced VSMC protein synthesis. These data suggest that Syk expressed in VSMC is activated by Ang II through p38 MAPK-activated c(Src subsequent to cytosolic phospholipase A2 and generation of AA metabolites via LO, and it mediates Ang II-induced protein synthesis independent of epidermal growth factor receptor transactivation (Ang II -> cPLA(2)-> AAmetabolites of LO -> p38 MAPK -> c(Src -> Syk -> protein synthesis).	Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Med, Ctr Vasc Biol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Med, Ctr Connect Tissue Dis, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Malik, KU (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA.	kmalik@utmem.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007641, R01HL079109] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL79109-02, T32 HL07641A] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berk BC, 1997, CIRC RES, V80, P607, DOI 10.1161/01.RES.80.5.607; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; Brogelli L, 2002, J CARDIOVASC PHARM, V39, P739, DOI 10.1097/00005344-200205000-00015; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; CIRILLO M, 1993, ENDOCRINOLOGY, V132, P1921, DOI 10.1210/en.132.5.1921; Deschamps JD, 2006, BIOORGAN MED CHEM, V14, P4295, DOI 10.1016/j.bmc.2006.01.057; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Gold MR, 1999, J IMMUNOL, V163, P1894; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; He JS, 2002, ANTIOXID REDOX SIGN, V4, P509, DOI 10.1089/15230860260196317; Hii CST, 2001, J BIOL CHEM, V276, P27246, DOI 10.1074/jbc.M103250200; HIRASAWA N, 1995, J BIOL CHEM, V270, P10960, DOI 10.1074/jbc.270.18.10960; Inatome R, 2001, BIOCHEM BIOPH RES CO, V286, P195, DOI 10.1006/bbrc.2001.5355; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kalyankrishna S, 2003, J PHARMACOL EXP THER, V304, P761, DOI 10.1124/jpet.102.040949; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; LARRUE J, 1983, BIOCHEM BIOPH RES CO, V112, P242, DOI 10.1016/0006-291X(83)91822-3; Li F, 2005, AM J PHYSIOL-HEART C, V288, pH2306, DOI 10.1152/ajpheart.00571.2004; Li F, 2005, J PHARMACOL EXP THER, V312, P1043, DOI 10.1124/jpet.104.076588; Marji JS, 2002, AM J PHYSIOL-RENAL, V283, pF60, DOI 10.1152/ajprenal.00265.2001; Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684; MCGIFF JC, 1981, ANNU REV PHARMACOL, V21, P479, DOI 10.1146/annurev.pa.21.040181.002403; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Murasawa S, 1998, HYPERTENSION, V32, P668, DOI 10.1161/01.HYP.32.4.668; Muthalif MM, 1998, J PHARMACOL EXP THER, V284, P388; Muthalif MM, 1998, P NATL ACAD SCI USA, V95, P12701, DOI 10.1073/pnas.95.21.12701; Muthalif MM, 2001, J BIOL CHEM, V276, P39653, DOI 10.1074/jbc.M103136200; NATARAJAN R, 1993, P NATL ACAD SCI USA, V90, P4947, DOI 10.1073/pnas.90.11.4947; NEBIGIL C, 1992, J PHARMACOL EXP THER, V260, P849; Parmentier JH, 2006, AM J PHYSIOL-HEART C, V290, pH46, DOI 10.1152/ajpheart.00769.2005; Parmentier JH, 2005, LIFE SCI, V77, P1015, DOI 10.1016/j.lfs.2005.03.002; Parmentier JH, 2001, J BIOL CHEM, V276, P15704, DOI 10.1074/jbc.M011473200; Raeder EMB, 1999, J IMMUNOL, V163, P6785; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; Reddy MA, 2003, HYPERTENSION, V41, P1294, DOI 10.1161/01.HYP.0000069011.18333.08; Reddy MA, 2002, J BIOL CHEM, V277, P9920, DOI 10.1074/jbc.M111305200; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; SCHARENBERG AM, 1995, CHEM IMMUNOL, V61, P72; Seeds MC, 1999, CLIN REV ALLERG IMMU, V17, P5, DOI 10.1007/BF02737594; Serhan CN, 1997, PROSTAG OTH LIPID M, V53, P107, DOI 10.1016/S0090-6980(97)00001-4; Sheffer I, 2001, J IMMUNOL, V167, P475, DOI 10.4049/jimmunol.167.1.475; SHIUE L, 1995, MOL CELL BIOL, V15, P272, DOI 10.1128/MCB.15.1.272; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Takada Y, 2004, J IMMUNOL, V173, P1066, DOI 10.4049/jimmunol.173.2.1066; Tkaczyk C, 2001, CLIN IMMUNOL, V99, P198, DOI 10.1006/clim.2001.4992; Touyz RM, 2001, J HYPERTENS, V19, P441, DOI 10.1097/00004872-200103000-00012; Touyz RM, 2000, PHARMACOL REV, V52, P639; Toyz RM, 2002, BRAZ J MED BIOL RES, V35, P1001, DOI 10.1590/S0100-879X2002000900001; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Uddin MR, 1998, HYPERTENSION, V31, P242, DOI 10.1161/01.HYP.31.1.242; VALLOTTON MB, 1989, AM J PHYSIOL, V257, pE617, DOI 10.1152/ajpendo.1989.257.5.E617; von Willebrand M, 1998, CELL SIGNAL, V10, P407, DOI 10.1016/S0898-6568(97)00139-3; Xu R, 1999, J IMMUNOL, V163, P1110; YANAGI S, 1995, CELL SIGNAL, V7, P185, DOI 10.1016/0898-6568(94)00088-S; Young W, 2000, CIRC RES, V86, P906, DOI 10.1161/01.RES.86.8.906; Zeng ZZ, 2002, J BIOL CHEM, V277, P41213, DOI 10.1074/jbc.M204508200	62	24	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16878	16890		10.1074/jbc.M610494200	http://dx.doi.org/10.1074/jbc.M610494200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17442668	hybrid			2022-12-27	WOS:000246946500020
J	Kusner, DJ; Thompson, CR; Melrose, NA; Pitson, SM; Obeid, LM; Iyer, SS				Kusner, David J.; Thompson, Christopher R.; Melrose, Natalie A.; Pitson, Stuart M.; Obeid, Lina M.; Iyer, Shankar S.			The localization and activity of sphingosine kinase 1 are coordinately regulated with actin cytoskeletal dynamics in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DEPENDENT SIGNAL-TRANSDUCTION; MEDIATED CA2+ MOBILIZATION; PHAGOSOME-LYSOSOME FUSION; PHOSPHOLIPASE-D ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; G-PROTEIN; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM	The physiologic and pathologic functions of sphingosine kinase (SK) require translocation to specific membrane compartments. Wetested the hypothesis that interactions with actin filaments regulate the localization of SK1 to membrane surfaces, including the plasma membrane and phagosome. Macrophage activation is accompanied by a marked increase in association of SK1 with actin filaments. Catalytically-inactive (CI)- and phosphorylation-defective (PD)-SK1 mutants exhibited reductions in plasma membrane translocation, colocalization with cortical actin filaments, membrane ruffling, and lamellipodia formation, compared with wild-type (WT)-SK1. However, translocation of CI- and PD-SK1 to phagosomes were equivalent to WT-SK1. SK1 exhibited constitutive- and stimulus-enhanced association with actin filaments and F-actin-enriched membrane fractions in both intact macrophages and a novel in vitro assay. In contrast, SK1 bound G-actin only under stimulated conditions. Actin inhibitors disrupted SK1 localization and modulated its activity. Conversely, reduction of SK1 levels or activity via RNA interference or specific chemical inhibition resulted in dysregulation of actin filaments. Thus, the localization and activity of SK1 are coordinately regulated with actin dynamics during macrophage activation.	Univ Iowa, Carver Coll Med, Inflammat Program, Div Infect Dis, Iowa City, IA 52245 USA; Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52245 USA; Univ Iowa, Carver Coll Med, Dept Physiol & Biophys, Iowa City, IA 52245 USA; Univ Iowa, Carver Coll Med, Grad Program Immunol, Iowa City, IA 52245 USA; Univ Iowa, Carver Coll Med, Grad Mol Biol, Iowa City, IA 52245 USA; Vet Affairs Med Ctr, Iowa City, IA 52245 USA; Univ Adelaide, Sch Mol & Biomed Sci, Inst Med & Vet Sci, Div Human Immunol,Hanson Inst, Adelaide, SA 5005, Australia; Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Hanson Institute; Institute Medical & Veterinary Science Australia; University of Adelaide; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kusner, DJ (corresponding author), 200 Hawkins Dr,SW54-8GH, Iowa City, IA 52245 USA.	david-kusner@uiowa.edu	Pitson, Stuart/B-9342-2009; Thompson, Christopher/AAB-1361-2021	Pitson, Stuart/0000-0002-9527-2740; obeid, lina/0000-0002-0734-0847	NIAID NIH HHS [R01 AI055916, P01 AI44642-08] Funding Source: Medline; NIGMS NIH HHS [R01 GM062887, R01 GM62302] Funding Source: Medline; PHS HHS [T32] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044642, R01AI055916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887, R01GM062302] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aas V, 2001, CELL COMMUN ADHES, V8, P125, DOI 10.3109/15419060109080712; ALBERTS B, 2004, MOL BIOL CELL, P632; Alemany R, 2000, MOL PHARMACOL, V58, P491, DOI 10.1124/mol.58.3.491; Alemany R, 2001, FEBS LETT, V509, P239, DOI 10.1016/S0014-5793(01)03168-4; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Beaven MA, 1996, CURR BIOL, V6, P798, DOI 10.1016/S0960-9822(02)00598-5; Booth JW, 2001, SEMIN IMMUNOL, V13, P357, DOI 10.1006/smim.2001.0332; CANO ML, 1992, CELL MOTIL CYTOSKEL, V21, P147, DOI 10.1002/cm.970210208; CHAO CP, 1994, J BIOL CHEM, V269, P5849; Choi OH, 1996, NATURE, V380, P634; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Colton T, 1974, STAT MED; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Cuvillier O, 2001, BLOOD, V98, P2828, DOI 10.1182/blood.V98.9.2828; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Deretic V, 1999, MOL MICROBIOL, V31, P1603, DOI 10.1046/j.1365-2958.1999.01279.x; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Funatsu N, 2000, NEUROSCI RES, V36, P311, DOI 10.1016/S0168-0102(99)00125-X; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Hla T, 2000, ANN NY ACAD SCI, V905, P16; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Holzinger A, 2001, METH MOL B, V161, P109; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Itagaki K, 2005, J LEUKOCYTE BIOL, V77, P181, DOI 10.1189/jlb.0704390; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Iyer SS, 1999, J BIOL CHEM, V274, P2350, DOI 10.1074/jbc.274.4.2350; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kaneider NC, 2003, J VIROL, V77, P5535, DOI 10.1128/JVI.77.9.5535-5539.2003; Kaneider NC, 2002, BIOCHEM BIOPH RES CO, V297, P806, DOI 10.1016/S0006-291X(02)02304-5; Katsuma S, 2002, GENES CELLS, V7, P1217, DOI 10.1046/j.1365-2443.2002.00594.x; Kee TH, 2005, CLIN EXP PHARMACOL P, V32, P153, DOI 10.1111/j.1440-1681.2005.04166.x; Kenworthy A, 2002, TRENDS BIOCHEM SCI, V27, P435, DOI 10.1016/S0968-0004(02)02178-3; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kusner DJ, 2003, ARCH BIOCHEM BIOPHYS, V412, P231, DOI 10.1016/S0003-9861(03)00052-3; Kusner DJ, 2002, J BIOL CHEM, V277, P50683, DOI 10.1074/jbc.M209221200; Kusner DJ, 2001, J IMMUNOL, V167, P3308, DOI 10.4049/jimmunol.167.6.3308; Lee S, 2001, J BIOL CHEM, V276, P28252, DOI 10.1074/jbc.M008521200; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; Luna EJ, 1998, METHOD ENZYMOL, V298, P32, DOI 10.1016/S0076-6879(98)98006-5; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; Maekawa S, 1997, BBA-BIOMEMBRANES, V1323, P1, DOI 10.1016/S0005-2736(96)00222-2; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Malik ZA, 2001, J IMMUNOL, V166, P3392, DOI 10.4049/jimmunol.166.5.3392; MAYERZU HD, 1999, FEBS LETT, V461, P217; Melendez A, 1998, CURR BIOL, V8, P210, DOI 10.1016/S0960-9822(98)70085-5; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; Melendez AJ, 2000, GENE, V251, P19, DOI 10.1016/S0378-1119(00)00205-5; Melendez AJ, 2004, J IMMUNOL, V173, P1596, DOI 10.4049/jimmunol.173.3.1596; Nava VE, 2000, FEBS LETT, V473, P81, DOI 10.1016/S0014-5793(00)01510-6; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Olivera A, 2005, J IMMUNOL, V174, P1153, DOI 10.4049/jimmunol.174.3.1153; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; Papakonstanti EA, 2000, MOL MED, V6, P303, DOI 10.1007/BF03401939; Pei ZD, 1996, BIOCHEM BIOPH RES CO, V228, P802, DOI 10.1006/bbrc.1996.1735; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; RENCH KJ, 2003, CANCER RES, V63, P5962; Reynolds HY, 2005, AM J RESP CRIT CARE, V171, P98, DOI 10.1164/rccm.200406-788PP; Rosenfeldt HM, 2001, FASEB J, V15, P2649, DOI 10.1096/fj.01-0523com; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; Swanson JA, 2002, NATURE, V418, P286, DOI 10.1038/418286a; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551; Touret N, 2005, J LEUKOCYTE BIOL, V77, P878, DOI 10.1189/jlb.1104630; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang F, 1999, CANCER RES, V59, P6185; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Xu CB, 2002, ATHEROSCLEROSIS, V164, P237, DOI 10.1016/S0021-9150(02)00100-4; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Yang LB, 1999, J BIOCHEM, V126, P84, DOI 10.1093/oxfordjournals.jbchem.a022440; Yatomi Y, 1996, BIOCHEMISTRY-US, V35, P626, DOI 10.1021/bi9515533; Young KW, 1999, BIOCHEM J, V343, P45, DOI 10.1042/0264-6021:3430045; Young KW, 2003, CELL CALCIUM, V33, P119, DOI 10.1016/S0143-4160(02)00205-1; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	125	22	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23147	23162		10.1074/jbc.M700193200	http://dx.doi.org/10.1074/jbc.M700193200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17519232				2022-12-27	WOS:000248577500017
J	Mueller, GP; Driscoll, WJ				Mueller, Gregory P.; Driscoll, William J.			In vitro synthesis of oleoylglycine by cytochrome c points to a novel pathway for the production of lipid signaling molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION COMMUNICATION; ACID N-ACYLTRANSFERASE; ACYL-COA; INDUCE SLEEP; BRAIN LIPIDS; FATTY-ACIDS; CELL INJURY; RAT-LIVER; MITOCHONDRIA; OLEAMIDE	Long chain fatty acyl glycines represent a new class of signaling molecules whose biosynthetic pathway is unknown. Here we report that cytochrome c catalyzes the formation of oleoylglycine from oleoyl-CoA and glycine, in the presence of hydrogen peroxide. The identity of oleoylglycine product was confirmed by isotope labeling and fragmentation mass spectrometry. Synthesis of oleoylglycine by cytochrome c was dependent upon substrate concentration and time. Other heme-containing proteins, myoglobin and hemoglobin, did not catalyze oleoylglycine synthesis. The functional properties of the reaction closely resemble those observed for the ability of cytochrome c to mediate the synthesis of oleamide from oleoyl-CoA and ammonia, in the presence of hydrogen peroxide (Driscoll, W. J., Chaturvedi., S., and Mueller, G. P. (2007) J. Biol. Chem. 282). The ability of cytochrome c to catalyze the formation of oleoylglycine experimentally indicates the potential importance of cytochrome c as a novel mechanism for the generation of long chain fatty acyl glycine messengers in vivo.	Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Mueller, GP (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gmueller@usuhs.mil			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038050] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS38050-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAFAT ES, 1989, LIFE SCI, V45, P1679, DOI 10.1016/0024-3205(89)90278-6; Barros MH, 2003, FREE RADICAL BIO MED, V35, P179, DOI 10.1016/S0891-5849(03)00307-1; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Boger DL, 1998, P NATL ACAD SCI USA, V95, P4810, DOI 10.1073/pnas.95.9.4810; Bonafe L, 2000, MOL GENET METAB, V69, P302, DOI 10.1006/mgme.2000.2982; Chaturvedi S, 2006, PROSTAG OTH LIPID M, V81, P136, DOI 10.1016/j.prostaglandins.2006.09.001; CONSTANTINIDES PP, 1985, J BIOL CHEM, V260, P7573; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; Driscoll WJ, 2007, J BIOL CHEM, V282, P22353, DOI 10.1074/jbc.M610070200; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Garcia-Dorado D, 2004, CARDIOVASC RES, V61, P386, DOI 10.1016/j.cardiores.2003.11.039; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; HuidobroToro JP, 1996, P NATL ACAD SCI USA, V93, P8078, DOI 10.1073/pnas.93.15.8078; Huitron-Resendiz S, 2001, EXP NEUROL, V172, P235, DOI 10.1006/exnr.2001.7792; Ito A, 2004, CARCINOGENESIS, V25, P2015, DOI 10.1093/carcin/bgh208; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; KASE BF, 1989, J BIOL CHEM, V264, P9220; KASE BF, 1986, BIOCHEM BIOPH RES CO, V138, P167, DOI 10.1016/0006-291X(86)90261-5; KELLEY M, 1994, J BIOCHEM TOXICOL, V9, P153, DOI 10.1002/jbt.2570090307; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; LERNER RA, 1994, P NATL ACAD SCI USA, V91, P9505, DOI 10.1073/pnas.91.20.9505; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; MAWAL YR, 1994, BIOCHEM BIOPH RES CO, V205, P1373, DOI 10.1006/bbrc.1994.2817; Merkler DJ, 1996, ARCH BIOCHEM BIOPHYS, V330, P430, DOI 10.1006/abbi.1996.0272; Merkler DJ, 2004, BIOCHEMISTRY-US, V43, P12667, DOI 10.1021/bi049529p; O'Byrne J, 2003, J BIOL CHEM, V278, P34237, DOI 10.1074/jbc.M300987200; Soltys BJ, 2001, CELL BIOL INT, V25, P331, DOI 10.1006/cbir.2000.0651; Stewart JM, 2000, BIOCHEM CELL BIOL, V78, P675, DOI 10.1139/bcb-78-6-675; Sultana T, 2006, J CHROMATOGR A, V1101, P278, DOI 10.1016/j.chroma.2005.10.027; Wang ZB, 2003, PROTEIN PEPTIDE LETT, V10, P247, DOI 10.2174/0929866033479013; Zhao YG, 2004, BIOCHEM BIOPH RES CO, V317, P980, DOI 10.1016/j.bbrc.2004.03.144; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200	35	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22364	22369		10.1074/jbc.M701801200	http://dx.doi.org/10.1074/jbc.M701801200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17537719	hybrid			2022-12-27	WOS:000248354200014
J	Sun, Q; Weber, CR; Sohail, A; Bernardo, MM; Toth, M; Zhao, H; Turner, JR; Fridman, R				Sun, Qing; Weber, Christopher R.; Sohail, Anjum; Bernardo, M. Margarida; Toth, Marta; Zhao, Huiren; Turner, Jerrold R.; Fridman, Rafael			MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; PRO-MMP-2 ACTIVATION; IV COLLAGENASE; CELL-SURFACE; LIPID RAFTS; MT1-MMP; BINDING; IDENTIFICATION; LOCALIZATION	MMP25 (MT6-MMP) is one of the two glycosylphosphatidylinositol-anchored matrix metalloproteinases (MMPs) that have been suggested to play a role in pericellular proteolysis. However, its role in cancer is unknown, and its biochemical properties are not well established. Here we found a marked increase in MT6-MMP expression within in situ dysplasia and invasive cancer in 61 samples of human colon cancer. Expression of MT6-MMP in HCT-116 human colon cancer cells promoted tumorigenesis in nude mice. Histologically, the MT6-MMP-expressing tumors demonstrated an infiltrative leading edge in contrast to a rounded leading edge in vector control tumors. Biochemical and biosynthesis analyses revealed that MT6-MMP displayed on the cell surface exists as a major form of 120 kDa that likely represents enzyme homodimers linked by disulfide bonds. Upon reduction, a single 57-kDa active MT6-MMP was detected. Interestingly, neither membrane-anchored nor phosphatidylinositol-specific phospholipase C-released MT6-MMPs were found to be associated with tissue inhibitor of metalloproteinases (TIMPs) and did not activate pro-gelatinases (pro-MMP-2 and pro-MMP-9) even in the presence of exogenous TIMP-2 or TIMP-1. A catalytic domain of MT6-MMP was inhibited preferentially by TIMP-1 (K-i = 0.2 nM) over TIMP-2 (K-i = 2.0 nM), because of a slower association rate. These results show that MT6-MMP may play a role in colon cancer and exhibit unique biochemical and structural properties that may regulate proteolytic function at the cell surface.	Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA; Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Chicago; University of Notre Dame	Fridman, R (corresponding author), Wayne State Univ, Dept Pathol, 580 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu	Turner, Jerrold R/A-6895-2009; Turner, Jerrold/H-1502-2019	Turner, Jerrold R/0000-0003-0627-9455; Weber, Christopher/0000-0002-2117-3184; Sohail, Anjum/0000-0001-5567-9645	NATIONAL CANCER INSTITUTE [P30CA014599, R01CA100475, R01CA061986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK094954, P01DK067887, R01DK068271, R01DK061931] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA061986-12, R01 CA100475-04, R01 CA100475, R01 CA61986-11, CA100475, P30 CA014599, P30 CA14599, R01 CA061986] Funding Source: Medline; NIDDK NIH HHS [R01 DK68271, R01 DK061931-06, P01 DK067887, R56 DK094954, R01 DK068271-02, R01 DK61931, R01 DK061931, R01 DK068271] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Bernardo MM, 2002, J BIOL CHEM, V277, P11201, DOI 10.1074/jbc.M111021200; Chabottaux V, 2006, CANCER RES, V66, P5165, DOI 10.1158/0008-5472.CAN-05-3012; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; FUERST TR, 1987, MOL CELL BIOL, V7, P2538, DOI 10.1128/MCB.7.7.2538; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hernandez-Barrantes S, 2002, SEMIN CANCER BIOL, V12, P131, DOI 10.1006/scbi.2001.0421; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P18; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; Matsuda A, 2003, J BIOL CHEM, V278, P36350, DOI 10.1074/jbc.M301509200; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Nie J, 2003, CANCER RES, V63, P6758; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Solomon KR, 1998, BIOCHEM J, V334, P325, DOI 10.1042/bj3340325; Sosne G, 2005, INVEST OPHTH VIS SCI, V46, P2388, DOI 10.1167/iovs.04-1368; STRONGIN AY, 1993, KIDNEY INT, V43, P158, DOI 10.1038/ki.1993.26; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Toth M, 2006, BIOCHEM BIOPH RES CO, V350, P377, DOI 10.1016/j.bbrc.2006.09.052; Velasco G, 2000, CANCER RES, V60, P877; Wallard MJ, 2006, BRIT J CANCER, V94, P569, DOI 10.1038/sj.bjc.6602931; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhuang LY, 2002, CANCER RES, V62, P2227; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	39	50	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21998	22010		10.1074/jbc.M701737200	http://dx.doi.org/10.1074/jbc.M701737200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17513868	Green Accepted, hybrid			2022-12-27	WOS:000248196800047
J	Degrace, P; Demizieux, L; Du, ZY; Gresti, J; Caverot, L; Djaouti, L; Jourdan, T; Moindrot, B; Guilland, JC; Hocquette, JF; Clouet, P				Degrace, Pascal; Demizieux, Laurent; Du, Zhen-yu; Gresti, Joseph; Caverot, Laurent; Djaouti, Louiza; Jourdan, Tony; Moindrot, Bastien; Guilland, Jean-Claude; Hocquette, Jean-Francois; Clouet, Pierre			Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; BUTYROBETAINE HYDROXYLASE INHIBITOR; PROLIFERATOR-ACTIVATED RECEPTORS; LIPOPROTEIN-LIPASE ACTIVITY; GAMMA-BUTYROBETAINE; LINOLEIC-ACID; PALMITOYLTRANSFERASE-I; INSULIN REGULATION; APOLIPOPROTEIN-B; GENE-EXPRESSION	Rats with carnitine deficiency due to trimethylhydrazinium propionate (mildronate) administered at 80 mg/100g body weight per day for 10 days developed liver steatosis only upon fasting. This study aimed to determine whether the transient steatosis resulted from triglyceride accumulation due to the amount of fatty acids preserved through impaired fatty acid oxidation and/or from up-regulation of lipid exchange between liver and adipose tissue. In liver, mildronate decreased the carnitine content by similar to 13-fold and, in fasted rats, lowered the palmitate oxidation rate by 50% in the perfused organ, increased 9-fold the triglyceride content, and doubled the hepatic very low density lipoprotein secretion rate. Concomitantly, triglyceridemia was 13-fold greater than in controls. Hepatic carnitine palmitoyltransferase I activity and palmitate oxidation capacities measured in vitro were increased after treatment. Gene expression of hepatic proteins involved in fatty acid oxidation, triglyceride formation, and lipid uptake were all increased and were associated with increased hepatic free fatty acid content in treated rats. In periepididymal adipose tissue, mildronate markedly increased lipoprotein lipase and hormone-sensitive lipase activities in fed and fasted rats, respectively. On refeeding, carnitine-depleted rats exhibited a rapid decrease in blood triglycerides and free fatty acids, then after similar to 2h, a marked drop of liver triglycerides and a progressive decrease in liver free fatty acids. Data show that up-regulation of liver activities, peripheral lipolysis, and lipoprotein lipase activity were likely essential factors for excess fat deposit and release alternately occurring in liver and adipose tissue of carnitine-depleted rats during the fed/fasted transition.	Univ Bourgogne, Fac Sci, INSERM, UMR 866,Equipe Physiopathol Dyslipidemies, F-21000 Dijon, France; Univ Bourgogne, Fac Med, LPPCE, F-21000 Dijon, France; INRA, Unite Rech Herbivores, F-63122 St Genes Champanelle, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; INRAE	Clouet, P (corresponding author), Univ Bourgogne, Fac Sci, INSERM, UMR 866,Equipe Physiopathol Dyslipidemies, 6 Blvd Gabriel, F-21000 Dijon, France.	pclouet@u-bourgogne.fr	Hocquette, Jean-Francois/I-1034-2019; Degrace, Pascal/AAF-5531-2021	Hocquette, Jean-Francois/0000-0003-2409-3881; Jourdan, Tony/0000-0001-7955-8127; Du, Zhen-Yu/0000-0001-6581-5313				AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Baillet L, 2000, J BIOL CHEM, V275, P36766, DOI 10.1074/jbc.M008265200; BATES EJ, 1977, FEBS LETT, V84, P229, DOI 10.1016/0014-5793(77)80694-7; BEAUFAY H, 1974, J CELL BIOL, V61, P188, DOI 10.1083/jcb.61.1.188; BELFRAGE P, 1969, J LIPID RES, V10, P341; BERGMEYER H, 1974, METHOD ENZYMAT AN, V3, P1128; BORENSZTAJN J, 1975, AM J PHYSIOL, V229, P394, DOI 10.1152/ajplegacy.1975.229.2.394; BRAY GA, 1984, INT J OBESITY, V8, P119; BRONFMAN M, 1979, BIOCHEM BIOPH RES CO, V88, P1030, DOI 10.1016/0006-291X(79)91512-2; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Chen ZJ, 2004, J LIPID RES, V45, P155, DOI 10.1194/jlr.M300275-JLR200; CHIODI P, 1992, BIOCHIM BIOPHYS ACTA, V1127, P81, DOI 10.1016/0005-2760(92)90204-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; CLOUET P, 1995, J NUTR BIOCHEM, V6, P626, DOI 10.1016/0955-2863(95)00123-H; Degrace P, 2004, J NUTR, V134, P861, DOI 10.1093/jn/134.4.861; Degrace P, 2004, MOL CELL BIOCHEM, V258, P171, DOI 10.1023/B:MCBI.0000012853.20116.06; Degrace P, 2003, FEBS LETT, V546, P335, DOI 10.1016/S0014-5793(03)00610-0; Degrace P, 2006, ATHEROSCLEROSIS, V189, P328, DOI 10.1016/j.atherosclerosis.2006.01.012; Demizieux L, 2002, J LIPID RES, V43, P2112, DOI 10.1194/jlr.M200170-JLR200; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garg A, 2002, J CLIN ENDOCR METAB, V87, P3019, DOI 10.1210/jc.87.7.3019; GEELEN MJH, 1980, DIABETES, V29, P1006, DOI 10.2337/diab.29.12.1006; Georges B, 2000, BIOCHEM PHARMACOL, V59, P1357, DOI 10.1016/S0006-2952(00)00265-3; GODBOLE V, 1978, DIABETOLOGIA, V14, P191, DOI 10.1007/BF00429780; Gondret F, 2004, REPROD NUTR DEV, V44, P1, DOI 10.1051/rnd:2004011; GUILLAND JC, 1986, ANN BIOL CLIN-PARIS, V44, P587; HALL M, 1985, BIOCHEM J, V226, P275, DOI 10.1042/bj2260275; HERDT TH, 1983, AM J VET RES, V44, P293; Iverius P H, 1986, Methods Enzymol, V129, P691; KAPLAN ML, 1981, AM J PHYSIOL, V240, pE101, DOI 10.1152/ajpendo.1981.240.2.E101; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; LEWIS JH, 1989, HEPATOLOGY, V9, P679, DOI 10.1002/hep.1840090504; LINDSTED.G, 1967, BIOCHEMISTRY-US, V6, P1271, DOI 10.1021/bi00857a007; LOPES-CARDOZO M, 1972, Biochimica et Biophysica Acta, V283, P1, DOI 10.1016/0005-2728(72)90092-8; Louet JF, 2001, BIOCHEM J, V354, P189, DOI 10.1042/0264-6021:3540189; LUSIS AJ, 1987, J BIOL CHEM, V262, P7594; Mantha L, 1999, AM J PHYSIOL-REG I, V277, pR455, DOI 10.1152/ajpregu.1999.277.2.R455; MCGARRY JD, 1973, J BIOL CHEM, V248, P270; McGarry JD, 1998, AM J CLIN NUTR, V67, p500S, DOI 10.1093/ajcn/67.3.500S; MCGARRY JD, 1976, J LIPID RES, V17, P277; Mensenkamp AR, 2004, J HEPATOL, V40, P599, DOI 10.1016/j.jhep.2003.12.011; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; NIOT I, 1994, LIPIDS, V29, P481, DOI 10.1007/BF02578245; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; PAUL HS, 1992, EUR J BIOCHEM, V203, P599, DOI 10.1111/j.1432-1033.1992.tb16589.x; Peschechera A, 2005, LIFE SCI, V77, P3078, DOI 10.1016/j.lfs.2005.03.029; Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750; PULLINGER CR, 1989, J LIPID RES, V30, P1065; RAYNOLDS MV, 1990, MOL ENDOCRINOL, V4, P1416, DOI 10.1210/mend-4-9-1416; Reid AE, 2001, GASTROENTEROLOGY, V121, P710, DOI 10.1053/gast.2001.27126; ROBINSON IN, 1982, BIOCHEM J, V206, P177, DOI 10.1042/bj2060177; RODBELL M, 1965, ANN NY ACAD SCI, V131, P302, DOI 10.1111/j.1749-6632.1965.tb34798.x; SAGGERSON ED, 1986, BIOCHEM J, V236, P137, DOI 10.1042/bj2360137; SEMENKOVICH CF, 1989, J BIOL CHEM, V264, P9030; SIMKHOVICH BZ, 1988, BIOCHEM PHARMACOL, V37, P195, DOI 10.1016/0006-2952(88)90717-4; Spaniol M, 2003, J LIPID RES, V44, P144, DOI 10.1194/jlr.M200200-JLR200; Spaniol M, 2001, EUR J BIOCHEM, V268, P1876, DOI 10.1046/j.1432-1327.2001.02065.x; Spurway TD, 1997, BIOCHEM J, V323, P119, DOI 10.1042/bj3230119; TOPPING DL, 1972, BIOCHEM J, V126, P295, DOI 10.1042/bj1260295; TSOKO M, 1995, BIOCHEM PHARMACOL, V49, P1403, DOI 10.1016/0006-2952(95)00019-V; Tsoko M, 1998, BIOCHIMIE, V80, P943, DOI 10.1016/S0300-9084(00)88891-4; VEERKAMP JH, 1983, BIOCHIM BIOPHYS ACTA, V753, P399, DOI 10.1016/0005-2760(83)90064-4; VYDELINGUM N, 1983, AM J PHYSIOL, V245, pE121, DOI 10.1152/ajpendo.1983.245.2.E121; WEISSBACH H, 1960, J BIOL CHEM, V235, P1160; Williamson J.R., 1969, METHOD ENZYMOL, V13, P434, DOI 10.1016/0076-687913072-4	67	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20816	20826		10.1074/jbc.M611391200	http://dx.doi.org/10.1074/jbc.M611391200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17496329	Green Published, hybrid			2022-12-27	WOS:000248047500007
J	Shumay, E; Tao, JC; Wang, HY; Malbon, CC				Shumay, Elena; Tao, Jiangchuan; Wang, Hsien-Yu; Malbon, Craig C.			Lysophosphatidic acid regulates trafficking of beta(2)-adrenergic receptors - The G alpha(13)/p115RhoGEF/JNK pathway stimulates receptor internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-MEDIATED PATHWAYS; EMBRYONAL CARCINOMA-CELLS; BETA-ADRENERGIC-RECEPTORS; SIGNAL-TRANSDUCTION; CROSS-REGULATION; P115 RHOGEF; KINASE; ACTIVATION; EXPRESSION; MECHANISMS	Lysophosphatidic acid is an important lipid ligand regulating many aspects of cell function, including proliferation and migration. Operating via heterotrimeric G proteins to downstream effectors, lysophosphatidic acid was shown to regulate the function and trafficking of the G protein-coupled beta(2)-adrenergic receptor. C3 exotoxin, expression of dominant negative RhoA, and inhibition of c-Jun N-terminal kinase blocked the ability of lysophosphatidic acid to sequester the beta(2)-adrenergic receptor, whereas expression of constitutively active G alpha(13), p115RhoGEF, or RhoA mimicked lysophosphatidic acid (LPA) action, stimulating the internalization of the G alpha(s)-coupled beta(2)-adrenergic receptor. This study revealed a novel cross-talk exerted from the LPA/G alpha(13)/p115RhoGEF/RhoA pathway to the beta(2)-adrenergic receptor/G alpha(s)/adenylyl cyclase pathway, attenuating the ability of beta-adrenergic agonists to act following stimulation of cells by LPA as may occur during beta-adrenergic therapy of an inflammatory response.	SUNY Stony Brook, Sch Med, Dept Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Diabet & Metab Dis Res Prog, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Malbon, CC (corresponding author), SUNY Stony Brook, Sch Med, Dept Pharmacol, Stony Brook, NY 11794 USA.	craig@pharm.sunysb.edu	malbon, craig/ABF-3604-2020		NIDDK NIH HHS [DK42510] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Baltensperger K, 1996, J BIOL CHEM, V271, P1061, DOI 10.1074/jbc.271.2.1061; Bhattacharya M, 2004, BIOCHEM SOC T, V32, P1040, DOI 10.1042/BST0321040; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Doronin S, 2002, J BIOL CHEM, V277, P15124, DOI 10.1074/jbc.M108771200; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Fan GF, 2001, J BIOL CHEM, V276, P24005, DOI 10.1074/jbc.M011199200; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Graler MH, 2002, BBA-MOL CELL BIOL L, V1582, P168, DOI 10.1016/S1388-1981(02)00152-X; HADCOCK JR, 1991, J BIOL CHEM, V266, P11915; HADCOCK JR, 1992, J BIOL CHEM, V267, P26017; HADCOCK JR, 1990, J BIOL CHEM, V265, P14784; HADCOCK JR, 1993, J NEUROCHEM, V60, P1, DOI 10.1111/j.1471-4159.1993.tb05816.x; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Jho EH, 1997, J BIOL CHEM, V272, P24468, DOI 10.1074/jbc.272.39.24468; Jho EH, 1997, J BIOL CHEM, V272, P24461, DOI 10.1074/jbc.272.39.24461; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Karoor V, 1996, PROG NEUROBIOL, V48, P555, DOI 10.1016/0301-0082(96)00004-4; Kay LJ, 2005, CHEM IMMUNOL ALLERGY, V87, P145, DOI 10.1159/000087641; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lee YN, 2004, J BIOL CHEM, V279, P54896, DOI 10.1074/jbc.M407581200; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; ROS M, 1988, J BIOL CHEM, V263, P4362; Roumestan C, 2002, J ALLERGY CLIN IMMUN, V109, pS240, DOI 10.1016/S0091-6749(02)81866-8; Shumay E, 2004, J CELL SCI, V117, P593, DOI 10.1242/jcs.00890; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Ueda H, 2001, J BIOL CHEM, V276, P42527, DOI 10.1074/jbc.M102529200; Verhoeckx KCM, 2004, INT IMMUNOPHARMACOL, V4, P1499, DOI 10.1016/j.intimp.2004.07.008; WANG HY, 1991, INT J BIOCHEM, V23, P7; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Witkamp R, 2000, VET QUART, V22, P11, DOI 10.1080/01652176.2000.9695016; Yonemura S, 2002, J CELL SCI, V115, P2569	45	10	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21529	21541		10.1074/jbc.M701998200	http://dx.doi.org/10.1074/jbc.M701998200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17493936	hybrid			2022-12-27	WOS:000248047500080
J	Tanaka, A; Takahashi, H; Shimizu, T				Tanaka, Atsunari; Takahashi, Hiroto; Shimizu, Toru			Critical role of the heme axial ligand, Met(95), in locking catalysis of the phosphodiesterase from Escherichia coli (Ec DOS) toward cyclic diGMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT OXYGEN SENSOR; 3',5'-CYCLIC DIGUANYLIC ACID; C-DI-GMP; REGULATED PHOSPHODIESTERASE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; PAS DOMAINS; BINDING; PROTEIN; 2ND-MESSENGER	Heme-regulated phosphodiesterase from Escherichia coli (Ec DOS) is a gas-sensor enzyme that hydrolyzes cyclic dinucleotide-GMP, and it is activated by O-2 or CO binding to the Fe(II) heme. In contrast to other well known heme-regulated gas-sensor enzymes or proteins, Ec DOS is not specific for a single gas ligand. Because Arg(97) in the heme distal side in Ec DOS interacts with the O-2 molecule and Met(95) serves as the axial ligand on the distal side of the Fe(II) heme-bound PAS domain of Ec DOS, we explored the effect of mutating these residues on the activity and gas specificity of Ec DOS. We found that R97A, R97I, and R97E mutations do not significantly affect regulation of the phosphodiesterase activities of the Fe(II)-CO and Fe(II)-NO complexes. The phosphodiesterase activities of the Fe(II)-O-2 complexes of the mutants could not be detected due to rapid autoxidation and/or low affinity for O2. In contrast, the activities even of the gas-free M95A and M95L mutants were similar to that of the gas-activated wild-type enzyme. Interestingly, the activity of the M95H mutant was partially activated by O-2, CO, and NO. Spectroscopic analysis indicated that the Fe(II) heme is in the 5-coordinated high-spin state in the M95A and M95L mutants but that in the M95H mutant, like wild-type Ec DOS, it is in the 6-coordinated low-spin state. These results suggest that Met(95) coordination to the Fe(II) heme is critical for locking the system and that global structural changes around Met(95) caused by the binding of the external ligands or mutations at Met(95) releases the catalytic lock and activates catalysis.	Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Tohoku University	Shimizu, T (corresponding author), Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	shimizu@tagen.tohoku.ac.jp	Tanaka, Atsunari/F-4950-2013	Shimizu, Toru/0000-0002-3950-5554				Akimoto S, 2003, BIOCHEM BIOPH RES CO, V304, P136, DOI 10.1016/S0006-291X(03)00556-4; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; DeLano W.L, PYMOL MOL GRAPHICS S; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Dunham CM, 2003, BIOCHEMISTRY-US, V42, P7701, DOI 10.1021/bi0343370; El-Mashtoly SF, 2007, J AM CHEM SOC, V129, P3556, DOI 10.1021/ja0669777; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gong WM, 2000, BIOCHEMISTRY-US, V39, P3955, DOI 10.1021/bi992346w; Hirata S, 2003, EUR J BIOCHEM, V270, P4771, DOI 10.1046/j.1432-1033.2003.03879.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; Karaolis DKR, 2005, BIOCHEM BIOPH RES CO, V329, P40, DOI 10.1016/j.bbrc.2005.01.093; KULESEKARA H, 2006, P NATL ACAD SCI USA, V103, P92844; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; Sato A, 2002, J BIOL CHEM, V277, P32650, DOI 10.1074/jbc.M204559200; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Taguchi S, 2004, J BIOL CHEM, V279, P3340, DOI 10.1074/jbc.M301013200; Takahashi H, 2006, CHEM LETT, V35, P970, DOI 10.1246/cl.2006.970; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tanaka A, 2006, BIOCHEMISTRY-US, V45, P2515, DOI 10.1021/bi051989a; Vreede J, 2003, J BIOL CHEM, V278, P18434, DOI 10.1074/jbc.M301701200; Watanabe M, 2002, BIOCHEM BIOPH RES CO, V299, P169, DOI 10.1016/S0006-291X(02)02621-9; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Yoshimura-Suzuki T, 2005, J BACTERIOL, V187, P6678, DOI 10.1128/JB.187.19.6678-6682.2005	34	57	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21301	21307		10.1074/jbc.M701920200	http://dx.doi.org/10.1074/jbc.M701920200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535805	hybrid			2022-12-27	WOS:000248047500058
J	Guerin, ME; Kordulakova, J; Schaeffer, F; Svetlikova, Z; Buschiazzo, A; Giganti, D; Gicquel, B; Mikusova, K; Jackson, M; Alzari, PM				Guerin, Marcelo E.; Kordulakova, Jana; Schaeffer, Francis; Svetlikova, Zuzana; Buschiazzo, Alejandro; Giganti, David; Gicquel, Brigitte; Mikusova, Katarina; Jackson, Mary; Alzari, Pedro M.			Molecular recognition and interfacial catalysis by the essential phosphatidylinositol mannosyltransferase PimA from mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER PROTEIN; ACHOLEPLASMA-LAIDLAWII; GLYCOGEN-PHOSPHORYLASE; GENETIC-REGULATION; CRYSTAL-STRUCTURE; BIOSYNTHESIS; COMPLEX; TUBERCULOSIS; STEP; GLYCOSYLTRANSFERASES	Mycobacterial phosphatidylinositol mannosides (PIMs) and metabolically derived cell wall lipoglycans play important roles in host-pathogen interactions, but their biosynthetic pathways are poorly understood. Here we focus on Mycobacterium smegmatis PimA, an essential enzyme responsible for the initial mannosylation of phosphatidylinositol. The structure of PimA in complex with GDP-mannose shows the two-domain organization and the catalytic machinery typical of GT-B glycosyltransferases. PimA is an amphitrophic enzyme that binds mono-disperse phosphatidylinositol, but its transferase activity is stimulated by high concentrations of non-substrate anionic surfactants, indicating that the early stages of PIM biosynthesis involve lipid-water interfacial catalysis. Based on structural, calorimetric, and mutagenesis studies, we propose a model wherein PimA attaches to the membrane through its N- terminal domain, and this association leads to enzyme activation. Our results reveal a novel mode of phosphatidylinositol recognition and provide a template for the development of potential anti-mycobacterial compounds.	Inst Pasteur, Ubite Biochim Struct, CNRS, URA 2185, F-75724 Paris, France; Inst Pasteur, Unite Genet Mycobacterienne, F-75724 Paris, France; Inst Pasteur, Unite Bioinformat Struct, F-75724 Paris, France; Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Comenius University Bratislava	Alzari, PM (corresponding author), Inst Pasteur, Ubite Biochim Struct, CNRS, URA 2185, 25 Rue Dr Roux, F-75724 Paris, France.	alzari@pasteur.fr	Guerin, Marcelo M/N-7245-2016; Jackson, Mary/D-5345-2017; Kordulakova, Jana/I-3887-2014; Mikusova, Katarina/I-3622-2014; Buschiazzo, Alejandro/W-1095-2018	Guerin, Marcelo M/0000-0001-9524-3184; Jackson, Mary/0000-0002-9212-0258; Kordulakova, Jana/0000-0003-2834-0165; Buschiazzo, Alejandro/0000-0002-2509-6526; Mikusova, Katarina/0000-0002-0100-4877; Alzari, Pedro/0000-0002-4233-1903; Giganti, David/0000-0001-5735-5679	NIAID NIH HHS [AI 64798, R01 AI064798] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Guerin ME, 2005, ACTA CRYSTALLOGR F, V61, P518, DOI 10.1107/S1744309105012364; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HILL DL, 1966, J BIOL CHEM, V241, P895; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Li L, 2003, BIOCHEMISTRY-US, V42, P9677, DOI 10.1021/bi034360l; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mitchell EP, 1996, BIOCHEMISTRY-US, V35, P7341, DOI 10.1021/bi960072w; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Murray D, 2002, CURR TOP MEMBR, V52, P277; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; REBECCHI MJ, 1993, J BIOL CHEM, V268, P1735; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; Schouten A, 2002, EMBO J, V21, P2117, DOI 10.1093/emboj/21.9.2117; Shields D, 1999, CURR OPIN CELL BIOL, V11, P489, DOI 10.1016/S0955-0674(99)80070-2; TAKAYAMA K, 1969, BIOCHIM BIOPHYS ACTA, V176, P196, DOI 10.1016/0005-2760(69)90089-7; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Watanabe R, 1998, EMBO J, V17, P877, DOI 10.1093/emboj/17.4.877; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Yoder MD, 2001, J BIOL CHEM, V276, P9246, DOI 10.1074/jbc.M010131200	51	106	107	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20705	20714		10.1074/jbc.M702087200	http://dx.doi.org/10.1074/jbc.M702087200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17510062	hybrid, Green Published			2022-12-27	WOS:000247819300073
J	Nakano, Y; Kohno, T; Hibi, T; Kohno, S; Baba, A; Mikoshiba, K; Nakajima, K; Hattori, M				Nakano, Yoshimi; Kohno, Takao; Hibi, Terumasa; Kohno, Shiori; Baba, Atsushi; Mikoshiba, Katsuhiko; Nakajima, Kazunori; Hattori, Mitsuharu			The extremely conserved C-terminal region of reelin is not necessary for secretion but is required for efficient activation of downstream signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAJAL-RETZIUS CELLS; BRAIN-DEVELOPMENT; LIPOPROTEIN RECEPTORS; SULFATE PROTEOGLYCANS; LAMINAR ORGANIZATION; HEPARAN-SULFATE; TYROSINE KINASE; MAMMALIAN BRAIN; IN-VIVO; EXPRESSION	Reelin is a very large secreted glycoprotein essential for correct development of the mammalian brain. It is also implicated in higher functions and diseases of human brain. However, whether or not secretion of Reelin is regulated and how Reelin transmits signals remain largely unknown. Reelin protein is composed of an N-terminal F-spondin-like domain, Reelin repeats, and a short and highly basic C-terminal region (CTR). The primary sequence of CTR is almost completely conserved among vertebrates except fishes, indicating its importance. A prevailing idea regarding the function of CTR is that it is required for the secretion of Reelin, although this remains unproven. Here we aimed to clarify the function of Reelin CTR. Neither deleting most of CTR nor replacing CTR with unrelated amino acids affected secretion efficiency, indicating that CTR is not absolutely required for the secretion of Reelin. We also found that Reelin mutants without CTR were less potent in activating the downstream signaling in cortical neurons. Although these mutants were able to bind to the Reelin receptor ectodomain as efficiently as wild-type Reelin, quite interestingly, their ability to bind to the isolated cell membrane bearing Reelin receptors or receptor-expressing cells (including cortical neurons) was much weaker than that of wild-type Reelin. Therefore, it is concluded that the CTR of Reelin is not essential for its secretion but is required for efficient activation of downstream signaling events, presumably via binding to an unidentified "coreceptor" molecule(s) on the cell membrane.	Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Nagoya, Aichi 4678603, Japan; Univ Tokyo, Inst Med Sci, Div Mol Neurobiol, Tokyo 1088639, Japan; RIKEN, Brain Sci Inst, Lab Dev Neurosci, Wako, Saitama 3510198, Japan; Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan; Jikei Univ, Sch Med, Inst DNA Med, Dept Mol Neurobiol, Tokyo 1058641, Japan	Nagoya City University; University of Tokyo; RIKEN; Keio University; Jikei University	Hattori, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe-dori, Nagoya, Aichi 4678603, Japan.	mhattori@phar.nagoya-cu.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Hattori, Mitsuharu/F-3859-2010; Nakajima, Kazunori/L-3396-2013; Hibi, Terumasa/I-3407-2013	Hattori, Mitsuharu/0000-0002-0503-4969; Nakajima, Kazunori/0000-0003-1864-9425; Kohno, Takao/0000-0003-2557-4281; Hibi, Terumasa/0000-0001-9373-9602; Baba, Atsushi/0000-0002-6871-7249				Alcantara S, 1998, J NEUROSCI, V18, P7779; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Cariboni A, 2005, DEVELOPMENT, V132, P4709, DOI 10.1242/dev.02033; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P229, DOI 10.1006/exnr.1999.7019; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Derer P, 2001, J COMP NEUROL, V440, P136, DOI 10.1002/cne.1375; Eastwood SL, 2006, AM J PSYCHIAT, V163, P540, DOI 10.1176/appi.ajp.163.3.540; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Fatemi SH, 2005, MOL PSYCHIATR, V10, P251, DOI 10.1038/sj.mp.4001613; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Ichihara H, 2001, MOL BRAIN RES, V97, P190, DOI 10.1016/S0169-328X(01)00307-2; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Luque JM, 2004, DEV BRAIN RES, V152, P269, DOI 10.1016/j.devbrainres.2004.06.005; Luque JM, 2007, BRAIN RES, V1140, P41, DOI 10.1016/j.brainres.2006.02.056; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 1998, DEVELOPMENT, V125, P3719; SELLECK SB, 2005, SCI STKE, pPE17; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209	41	58	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20544	20552		10.1074/jbc.M702300200	http://dx.doi.org/10.1074/jbc.M702300200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17504759	hybrid			2022-12-27	WOS:000247819300057
J	Pearce, MMP; Wang, Y; Kelley, GG; Wojcikiewicz, RJH				Pearce, Margaret M. P.; Wang, Yuan; Kelley, Grant G.; Wojcikiewicz, Richard J. H.			SPFH2 mediates the endoplasmic reticulum-associated degradation of inositol 1,4,5-trisphosphate receptors and other substrates in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; PROTEIN-DEGRADATION; UBIQUITIN-LIGASE; DOWN-REGULATION; QUALITY-CONTROL; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; REGULATED UBIQUITINATION; P97-UFD1-NPL4 COMPLEX; RAFT ASSOCIATION; DOMAIN PROTEIN	Inositol 1,4,5-trisphosphate (IP3) receptors are endoplasmic reticulum ( ER) membrane calcium channels that, upon activation, become substrates for the ER-associated degradation (ERAD) pathway. Although it is clear that IP3 receptors are polyubiquitinated upon activation and are transferred to the proteasome by a p97-based complex, currently nothing is known about the proteins that initially select activated IP3 receptors for ERAD. Here, we sought to identify novel proteins that associate with and mediate the ERAD of endogenous activated IP3 receptors. SPFH2, an uncharacterized SPFH domain-containing protein, rapidly associated with IP3 receptors in a manner that preceded significant polyubiquitination and the association of p97 and related proteins. SPFH2 was found to be an ER membrane protein largely residing within the ER lumen and in resting and stimulated cells was linked to ERAD pathway components, apparently via endogenous substrates undergoing degradation. Suppression of SPFH2 expression by RNA interference markedly inhibited IP3 receptor polyubiquitination and degradation and the processing of other ERAD substrates. Overall, these studies identify SPFH2 as a key ERAD pathway component and suggest that it may act as a substrate recognition factor.	SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Panning Pearce, Margaret/0000-0002-5846-9632	NIDDK NIH HHS [DK 49194, DK 56294] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194, R01DK056294] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Bosanac I, 2004, BBA-MOL CELL RES, V1742, P89, DOI 10.1016/j.bbamcr.2004.09.016; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sprenger RR, 2006, BIOCHEM J, V400, P401, DOI 10.1042/BJ20060355; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102	64	75	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20104	20115		10.1074/jbc.M701862200	http://dx.doi.org/10.1074/jbc.M701862200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502376	hybrid			2022-12-27	WOS:000247819300011
J	Pestka, S				Pestka, Sidney			The interferons: 50 years after their discovery, there is much more to learn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN-LEUKOCYTE INTERFERON; HUMAN FIBROBLAST INTERFERON; AMINO-ACID-SEQUENCE; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL GENES; MESSENGER-RNA; IFN-GAMMA; PURIFICATION	The interferons (IFNs) and their receptors represent a subset of the class 2 alpha-helical cytokines that have been in chordates for millions of years. This brief review focuses on the discovery and purification of interferons, cloning of human IFN-alpha and IFN-beta, interferon receptors, activities and therapeutic uses of interferons, and the side effects of interferons.	Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Pestka, S (corresponding author), Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA.	Pestka@umdnj.edu			NCI NIH HHS [R01 CA 46465] Funding Source: Medline; NIAID NIH HHS [R01 AI 36450, R01 AI 43369] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036450, R01AI043369] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADOLF GR, 1991, BIOCHEM J, V276, P511, DOI 10.1042/bj2760511; ALLEN G, 1980, NATURE, V287, P408, DOI 10.1038/287408a0; Asokan R, 2006, J IMMUNOL, V177, P383, DOI 10.4049/jimmunol.177.1.383; Berg K, 1981, Methods Enzymol, V78, P487; BOHLEN P, 1975, ANAL BIOCHEM, V67, P438, DOI 10.1016/0003-2697(75)90316-4; Cantell K, 1981, Methods Enzymol, V78, P29; CAVALIERI RL, 1977, P NATL ACAD SCI USA, V74, P4415, DOI 10.1073/pnas.74.10.4415; CAVALIERI RL, 1977, P NATL ACAD SCI USA, V74, P3287, DOI 10.1073/pnas.74.8.3287; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DERYNCK R, 1980, NATURE, V285, P542, DOI 10.1038/285542a0; DIAZ MO, 1994, GENOMICS, V22, P540, DOI 10.1006/geno.1994.1427; Familletti P C, 1981, Methods Enzymol, V78, P387; FAMILLETTI PC, 1981, ANTIMICROB AGENTS CH, V20, P5, DOI 10.1128/AAC.20.1.5; FRIESEN HJ, 1981, ARCH BIOCHEM BIOPHYS, V206, P432, DOI 10.1016/0003-9861(81)90111-9; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; GOEDDEL DV, 1980, NATURE, V287, P411, DOI 10.1038/287411a0; GOEDDEL DV, 1980, NUCLEIC ACIDS RES, V8, P4057, DOI 10.1093/nar/8.18.4057; GREINER JW, 1987, SCIENCE, V235, P895, DOI 10.1126/science.3580039; Hobb D S, 1981, Methods Enzymol, V78, P472; HOBBS DS, 1982, J BIOL CHEM, V257, P4071; HOUGHTON M, 1980, NUCLEIC ACIDS RES, V8, P1913, DOI 10.1093/nar/8.9.1913; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; Klaus W, 1997, J MOL BIOL, V274, P661, DOI 10.1006/jmbi.1997.1396; Krause CD, 2005, PHARMACOL THERAPEUT, V106, P299, DOI 10.1016/j.pharmthera.2004.12.002; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; LABDON JE, 1984, ARCH BIOCHEM BIOPHYS, V232, P422, DOI 10.1016/0003-9861(84)90558-7; LEVY WP, 1980, P NATL ACAD SCI-BIOL, V77, P5102, DOI 10.1073/pnas.77.9.5102; LEVY WP, 1981, P NATL ACAD SCI-BIOL, V78, P6186, DOI 10.1073/pnas.78.10.6186; Maeda S, 1981, Methods Enzymol, V79, P613; MAEDA S, 1980, P NATL ACAD SCI-BIOL, V77, P7010, DOI 10.1073/pnas.77.12.7010; McCandliss R, 1981, Methods Enzymol, V79, P618; McCandliss R, 1981, Methods Enzymol, V79, P51; MILLER DL, 1982, SCIENCE, V215, P689, DOI 10.1126/science.6173922; NAGATA S, 1980, NATURE, V284, P316, DOI 10.1038/284316a0; ORTALDO JR, 1983, J BIOL CHEM, V258, P5011; PESTKA S, 1983, ARCH BIOCHEM BIOPHYS, V221, P1, DOI 10.1016/0003-9861(83)90118-2; PESTKA S, 1985, PHARMACOL THERAPEUT, V29, P299, DOI 10.1016/0163-7258(85)90006-3; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; PESTKA S, 1975, P NATL ACAD SCI USA, V72, P3898, DOI 10.1073/pnas.72.10.3898; PESTKA S, 1983, SCI AM, V249, P36, DOI 10.1038/scientificamerican0883-36; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; PESTKA S, 1986, METHOD ENZYMOL, V119, P3; Pestka S., 2006, INTERFERONS CHARACTE, P113; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; REYNOLDS FH, 1975, P NATL ACAD SCI USA, V72, P4881, DOI 10.1073/pnas.72.12.4881; RUBINSTEIN M, 1978, SCIENCE, V202, P1289, DOI 10.1126/science.725605; RUBINSTEIN M, 1981, ARCH BIOCHEM BIOPHYS, V210, P307, DOI 10.1016/0003-9861(81)90194-6; RUBINSTEIN M, 1979, P NATL ACAD SCI USA, V76, P640, DOI 10.1073/pnas.76.2.640; RUBINSTEIN M, 1979, PEPTIDES STRUCTURE B, P99; SEN GC, 1992, J BIOL CHEM, V267, P5017; STAEHELIN T, 1981, P NATL ACAD SCI-BIOL, V78, P1848, DOI 10.1073/pnas.78.3.1848; STAEHELIN T, 1981, J BIOL CHEM, V256, P9750; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STEIN S, 1973, ARCH BIOCHEM BIOPHYS, V155, P202, DOI 10.1016/S0003-9861(73)80022-0; STEIN S, 1980, P NATL ACAD SCI-BIOL, V77, P5716, DOI 10.1073/pnas.77.10.5716; TANIGUCHI T, 1980, GENE, V10, P11, DOI 10.1016/0378-1119(80)90138-9; THANG MN, 1975, P NATL ACAD SCI USA, V72, P3975, DOI 10.1073/pnas.72.10.3975; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Zoon K C, 1981, Methods Enzymol, V78, P457	65	273	305	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20047	20051		10.1074/jbc.R700004200	http://dx.doi.org/10.1074/jbc.R700004200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502369	hybrid			2022-12-27	WOS:000247819300003
J	Weerachayaphorn, J; Pajor, AM				Weerachayaphorn, Jittima; Pajor, Ana M.			Sodium-dependent extracellular accessibility of Lys-84 in the sodium/dicarboxylate cotransporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONALLY SENSITIVE RESIDUES; NA+/DICARBOXYLATE COTRANSPORTER; GLUTAMATE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; DICARBOXYLATE COTRANSPORTER; SUBSTRATE RECOGNITION; NADC-1; PROTEIN; CATION; HOMOLOG	The N+/dicarboxylate cotransporter transports Na+ with citric acid cycle intermediates such as succinate and citrate. The present study focuses on transmembrane helix 3, which is highly conserved among the members of the SLC13 family. Fifteen amino acids in the extracellular half of transmembrane helix (amino acids 98-112) as well as Lys-84, previously shown to affect substrate affinity, were mutated individually to cysteine and expressed in the human retinal pigment epithelial cell line. Transport specificity ratio analysis shows that determinants for distinguishing succinate and citrate are found at amino acids Lys-84, Glu-101, Trp-103, His-106, and Leu-111. All of the mutants were tested for sensitivity to the membraneimpermeant cysteine-specific reagent (2-sulfonatoethyl) methanethiosulfonate ( MTSES), but only K84C was sensitive to MTSES inhibition. The sensitivity of K84C to MTSES was greatest in the presence of sodium, and the inhibition could be prevented by addition of substrate or replacement of sodium, indicating that the accessibility of Lys-84 changes with conformational state. The substrate protection of MTSES inhibition of K84C appears to occur early in the transport cycle, before the large-scale conformational change associated with translocation of substrate. The results point to a new location for Lys-84 within the substrate access pore of the Na+/dicarboxylate cotransporter, either in a transmembrane helix or a reentrant loop facing a water-filled pore.	Univ Texas, Dept Biochem & Mol Biol, Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Pajor, AM (corresponding author), Univ Texas, Dept Biochem & Mol Biol, Med Branch, Galveston, TX 77555 USA.	ampajor@utmb.edu			NIDDK NIH HHS [R01 DK046269, R01 DK046269-17, DK 46269] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046269] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Fei YJ, 2003, J BIOL CHEM, V278, P6136, DOI 10.1074/jbc.M208763200; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; Joshi AD, 2006, BIOCHEMISTRY-US, V45, P4231, DOI 10.1021/bi052064y; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Kahn ES, 1999, BIOCHEMISTRY-US, V38, P6151, DOI 10.1021/bi9827722; Karlin A, 1998, METHOD ENZYMOL, V293, P123; King Steven C., 2004, BMC Biochemistry, V5, P16, DOI 10.1186/1471-2091-5-16; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; Oshiro N, 2006, BIOCHEMISTRY-US, V45, P2302, DOI 10.1021/bi052328g; Pajor AM, 2000, BIOCHEM J, V350, P677, DOI 10.1042/0264-6021:3500677; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pajor AM, 2005, J BIOL CHEM, V280, P18728, DOI 10.1074/jbc.M501265200; Pajor AM, 1998, J BIOL CHEM, V273, P18923, DOI 10.1074/jbc.273.30.18923; Pajor AM, 1999, BIOCHEM J, V344, P205, DOI 10.1042/0264-6021:3440205; Pajor AM, 1998, BBA-BIOMEMBRANES, V1370, P98, DOI 10.1016/S0005-2736(97)00249-6; Pajor AM, 1998, BIOCHEM J, V331, P257, DOI 10.1042/bj3310257; PAJOR AM, 1995, J BIOL CHEM, V270, P5779, DOI 10.1074/jbc.270.11.5779; Pajor AM, 2001, J BIOL CHEM, V276, P29961, DOI 10.1074/jbc.M011387200; PAK CYC, 1991, AM J KIDNEY DIS, V18, P624, DOI 10.1016/S0272-6386(12)80602-0; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Shlaifer I, 2007, MOL PHARMACOL, V71, P1341, DOI 10.1124/mol.106.032607; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102; WRIGHT SH, 1983, J BIOL CHEM, V258, P5456; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao XZ, 2000, AM J PHYSIOL-RENAL, V279, pF54, DOI 10.1152/ajprenal.2000.279.1.F54; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang FF, 2001, BBA-BIOMEMBRANES, V1511, P80, DOI 10.1016/S0005-2736(00)00385-0; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200	36	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20213	20220		10.1074/jbc.M701113200	http://dx.doi.org/10.1074/jbc.M701113200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17504760	Green Accepted, hybrid			2022-12-27	WOS:000247819300023
J	Miallau, L; Hunter, WN; McSweeney, SM; Leonard, GA				Miallau, Linda; Hunter, William N.; McSweeney, Sean M.; Leonard, Gordon A.			Structures of Staphylococcus aureus D-tagatose-6-phosphate kinase implicate domain motions in specificity and mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GALACTOSE METABOLISM; TAGATOSE 6-PHOSPHATE PATHWAY; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; PHOSPHOGLYCERATE KINASE; PHOSPHORYL TRANSFER; THYMIDYLATE KINASE; ESCHERICHIA-COLI; ADENOSINE KINASE; LACTOSE OPERON	High resolution structures of Staphylococcus aureus D-tagatose-6-phosphate kinase (LacC) in two crystal forms are herein reported. The structures define LacC in apoform, in binary complexes with ADP or the co-factor analogue AMP-PNP, and in a ternary complex with AMP-PNP and D-tagatose-6-phosphate. The tertiary structure of the LacC monomer, which is closely related to other members of the pfkB subfamily of carbohydrate kinases, is composed of a large alpha/beta core domain and a smaller, largely beta "lid." Four extended polypeptide segments connect these two domains. Dimerization of LacC occurs via interactions between lid domains, which come together to form a beta-clasp structure. Residues from both subunits contribute to substrate binding. LacC adopts a closed structure required for phosphoryl transfer only when both substrate and co-factor are bound. A reaction mechanism similar to that used by other phosphoryl transferases is proposed, although unusually, when both substrate and co-factor are bound to the enzyme two Mg2+ ions are observed in the active site. A new motif of amino acid sequence conservation common to the pfkB subfamily of carbohydrate kinases is identified.	Macomol Crystallography Grp, European Synchrotron Radiat Facil, F-38043 Grenoble, France; Univ Dundee, Coll Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland	European Synchrotron Radiation Facility (ESRF); University of Dundee	Leonard, GA (corresponding author), Macomol Crystallography Grp, European Synchrotron Radiat Facil, 6 Rue Jules Horowitz, F-38043 Grenoble, France.	leonard@esrf.fr	Leonard, Gordon/D-2160-2019; Hunter, William/AAE-3947-2019; Miallau, linda/G-9804-2011	Leonard, Gordon/0000-0001-5030-0122; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABELE U, 1995, PROTEIN SCI, V4, P1262, DOI 10.1002/pro.5560040702; Auerbach G, 1997, STRUCTURE, V5, P1475, DOI 10.1016/S0969-2126(97)00297-9; Bettenbrock K, 1999, J BACTERIOL, V181, P225, DOI 10.1128/JB.181.1.225-230.1999; BISSETT DL, 1980, J BIOL CHEM, V255, P8745; BISSETT DL, 1974, J BACTERIOL, V117, P318, DOI 10.1128/JB.117.1.318-320.1974; BORK P, 1993, PROTEIN SCI, V2, P31; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BRUKER, 2000, SMART SAINT SADABS X; Campobasso N, 2000, BIOCHEMISTRY-US, V39, P7868, DOI 10.1021/bi0000061; Cheng G, 2002, STRUCTURE, V10, P225, DOI 10.1016/S0969-2126(02)00708-6; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cook WJ, 2000, PROTEIN SCI, V9, P704; Fioravanti E, 2003, J MOL BIOL, V327, P1077, DOI 10.1016/S0022-2836(03)00202-X; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; GASSNER NC, 1999, ACTA CRYSTALLOGR D, V57, P401; GROVE TM, 1992, J DAIRY SCI, V75, P423, DOI 10.3168/jds.S0022-0302(92)77778-9; Hall DR, 2002, J BIOL CHEM, V277, P22018, DOI 10.1074/jbc.M202464200; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; KOTLARZ D, 1982, METHOD ENZYMOL, V90, P60; LUI JY, 2006, J MOL BIOL, V281, P6601; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Miallau L, 2003, P NATL ACAD SCI USA, V100, P9173, DOI 10.1073/pnas.1533425100; MORSE ML, 1968, J BACTERIOL, V95, P2270, DOI 10.1128/JB.95.6.2270-2274.1968; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohshima N, 2004, J MOL BIOL, V340, P477, DOI 10.1016/j.jmb.2004.04.074; OSKOUIAN B, 1990, J BACTERIOL, V172, P3804, DOI 10.1128/jb.172.7.3804-3812.1990; Ostermann N, 2000, STRUCTURE, V8, P629, DOI 10.1016/S0969-2126(00)00149-0; PAPPU KM, 1994, ARCH BIOCHEM BIOPHYS, V311, P503, DOI 10.1006/abbi.1994.1268; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; ROSEY EL, 1991, J BACTERIOL, V173, P5992, DOI 10.1128/jb.173.19.5992-5998.1991; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; SCHLEIFER KH, 1978, FEMS MICROBIOL LETT, V3, P9, DOI 10.1111/j.1574-6968.1978.tb01873.x; SCHLICTING I, 1996, BIOCHEMISTRY-US, V39, P9290; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Spychala J, 1996, P NATL ACAD SCI USA, V93, P1232, DOI 10.1073/pnas.93.3.1232; STAGNO S, 1980, NEW ENGL J MED, V302, P1073, DOI 10.1056/NEJM198005083021908; VANROOIJEN RJ, 1991, J BIOL CHEM, V266, P7176	47	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19948	19957		10.1074/jbc.M701480200	http://dx.doi.org/10.1074/jbc.M701480200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17459874	hybrid			2022-12-27	WOS:000247650600069
J	Park, KH; Sesti, F				Park, Ki Ho; Sesti, Federico			An arrhythmia susceptibility gene in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; CARDIAC POTASSIUM CURRENT; MINK-RELATED PEPTIDES; K+ CHANNEL; INWARD RECTIFICATION; LANGE-NIELSEN; I-KR; MUTATIONS; SUBUNITS; HERG	kcne are evolutionarily conserved genes that encode accessory subunits of voltage-gated K+ (Kv) channels. Missense mutations in kcne1, kcne2, and kcne3 are linked to congenital and acquired channelopathies in Homo sapiens. Here we show an unique example of conservation of kcne activities at genetic, physiological, functional, and pathophysiological level in Caenorhabditis elegans. Thus, mps-4 is the homologue of kcne1 that operates in human heart and inner ear. Like its KCNE relatives, MPS-4 assembles with a Kv channel, EXP-2, to form a complex that controls pharyngeal muscle contractility. MPS-4 modulates EXP-2 function in a similar fashion as KCNE proteins endow human channels. When defective, MPS-4, can induce abnormal repolarization by mechanisms that resemble the way KCNE proteins are thought to provoke arrhythmia in human heart. Mutation of a conserved aspartate residue associated with human disease (MPS-4-D74N) alters the functional attributes of the C. elegans current. Taken together these data underscore a significant conservation of KCNE activities in different pumps. This implies that C. elegans can develop into a system to study the molecular and genetic basis of KCNE-mediated muscle contractility and disease states.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	sestife@UMDNJ.EDU	Park, Ki Ho/E-8921-2011; Park, Ki Ho/N-8153-2017	Park, Ki Ho/0000-0002-6193-9826	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068581] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM68581] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Anantharam A, 2003, J BIOL CHEM, V278, P11739, DOI 10.1074/jbc.M212751200; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Cai SQ, 2006, CELL BIOCHEM BIOPHYS, V46, P91, DOI 10.1385/CBB:46:1:91; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Davis MW, 1999, SCIENCE, V286, P2501, DOI 10.1126/science.286.5449.2501; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Fleischhauer R, 2000, J NEUROSCI, V20, P511, DOI 10.1523/JNEUROSCI.20-02-00511.2000; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Nicolas MT, 2001, HEARING RES, V153, P132, DOI 10.1016/S0378-5955(00)00268-9; Park KH, 2005, J BIOL CHEM, V280, P21893, DOI 10.1074/jbc.M502732200; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; SAKMANN B, 1995, SINGLE CHANNEL RECOR, V1; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511	32	6	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19799	19807		10.1074/jbc.M701625200	http://dx.doi.org/10.1074/jbc.M701625200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17491013	hybrid			2022-12-27	WOS:000247650600055
J	Terawaki, S; Kitano, K; Hakoshima, T				Terawaki, Shin-ichi; Kitano, Ken; Hakoshima, Toshio			Structural basis for type II membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 24.11 (NEP) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; CD44; RHO; ASSOCIATION; GROWTH; EZRIN; RECOGNITION; INVOLVEMENT; ACTIVATION; MECHANISMS	ERM (Ezrin/Radixin/Moesin) proteins mediate formation of membrane-associated cytoskeletons by simultaneously binding actin filaments and the C-terminal cytoplasmic tails of adhesion molecules (type I membrane proteins). ERM proteins also bind neutral endopeptidase 24.11 (NEP), a type II membrane protein, even though the N-terminal cytoplasmic tail of NEP possesses the opposite peptide polarity to that of type I membrane proteins. Here, we determined the crystal structure of the radixin FERM ( Four point one and ERM) domain complexed with the N-terminal NEP cytoplasmic peptide. In the FERM-NEP complex, the amphipathic region of the peptide forms a beta strand followed by a hairpin that bind to a shallow groove of FERM subdomain C. NEP binding is stabilized by beta-beta interactions and docking of the NEP hairpin into the hydrophobic pocket of subdomain C. Whereas the binding site of NEP on the FERM domain overlaps with the binding site of intercellular adhesion molecule (ICAM)-2, NEP lacks the Motif-1 sequence conserved in ICAM-2 and related adhesion molecules. The NEP hairpin, although lacking the typical inter-chain hydrogen bond but is stabilized by hydrogen bonds with the main chain and side chains of subdomain C, directs the C-terminal basic region of the NEP peptide away from the groove and toward the membrane. The overlap of the binding sites on subdomain C for NEP and Motif-1 adhesion molecules such as CD44 provides the structural basis for the suppression of cell adhesion through interaction between NEP and ERM proteins.	CREST Japan & Technol Agcy, Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan	Japan Science & Technology Agency (JST); Nara Institute of Science & Technology	Hakoshima, T (corresponding author), CREST Japan & Technol Agcy, Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300192, Japan.	hakosima@bs.naist.jp	Terawaki, Shin-ichi/V-7082-2019	Terawaki, Shin-ichi/0000-0002-2859-0589				Albrecht M, 2003, EUR UROL, V44, P415, DOI 10.1016/S0302-2838(03)00322-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHECLER F, 1984, J NEUROCHEM, V43, P1295, DOI 10.1111/j.1471-4159.1984.tb05386.x; Freedland SJ, 2003, PROSTATE, V55, P71, DOI 10.1002/pros.10202; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Hamada K, 2000, ACTA CRYSTALLOGR D, V56, P922, DOI 10.1107/S0907444900006363; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Harrison GM, 2002, INT J ONCOL, V21, P935; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Iwase A, 2004, J BIOL CHEM, V279, P11898, DOI 10.1074/jbc.M212737200; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanus DM, 2003, CLIN CANCER RES, V9, P6307; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papandreou CN, 1998, NAT MED, V4, P50, DOI 10.1038/nm0198-050; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; SHIPP MA, 1991, P NATL ACAD SCI USA, V88, P10662, DOI 10.1073/pnas.88.23.10662; SHIPP MA, 1991, BLOOD, V78, P1834; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; Sumitomo M, 2005, BBA-PROTEINS PROTEOM, V1751, P52, DOI 10.1016/j.bbapap.2004.11.001; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Sun CX, 2002, J CELL SCI, V115, P3991, DOI 10.1242/jcs.00094; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 2002, J CELL SCI, V115, P2569; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	38	36	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19854	19862		10.1074/jbc.M609232200	http://dx.doi.org/10.1074/jbc.M609232200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17459884	hybrid			2022-12-27	WOS:000247650600060
J	Kim, HY				Kim, Hee-Yong			Novel metabolism of docosahexaenoic acid in neural cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							POLYUNSATURATED FATTY-ACIDS; C6 GLIOMA-CELLS; RAT-BRAIN MICROSOMES; NEURONAL APOPTOSIS; PHOSPHATIDYLSERINE BIOSYNTHESIS; SUBSTRATE PREFERENCE; ALZHEIMERS-DISEASE; GENE-EXPRESSION; GLIAL-CELLS; N-3	Long-chain polyunsaturated fatty acids are highly enriched in the nervous system. Docosahexaenoic acid (DHA(2); 22: 6n-3), in particular, is the most abundant polyunsaturated fatty acid in the brain and is concentrated in aminophospholipids of cell membranes. Numerous studies have indicated that this concentration of DHA in the nervous system is essential for optimal neuronal and retinal functions (1). Although the underlying mechanisms of its essential function are still not clearly understood, emerging evidence suggests that unique metabolism of DHA in relation to its incorporation into neuronal membrane phospholipids plays an important role. In this review, biochemical mechanisms for enriching and metabolizing DHA in neural cells are discussed in the context of their biological significance in neuronal function.	NIAAA, Div Intramural Clin & Biol Res, Mol Signalling Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kim, HY (corresponding author), NIAAA, Div Intramural Clin & Biol Res, Mol Signalling Lab, Bethesda, MD 20892 USA.	hykim@nih.gov			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akbar M, 2006, J NEUROSCI RES, V83, P432, DOI 10.1002/jnr.20744; Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Favreliere S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6; GALLI C, 1971, BIOCHIM BIOPHYS ACTA, V248, P449, DOI 10.1016/0005-2760(71)90233-5; Garcia MC, 1998, J NEUROCHEM, V70, P24; Garcia MC, 1997, ALCOHOL CLIN EXP RES, V21, P1465; Garcia MC, 1997, BRAIN RES, V768, P43, DOI 10.1016/S0006-8993(97)00583-0; GORACCI G, 1973, J NEUROCHEM, V20, P1167, DOI 10.1111/j.1471-4159.1973.tb00086.x; GUO M, 2007, IN PRESS J MOL NEURO; Hamilton J, 2000, LIPIDS, V35, P863, DOI 10.1007/S11745-000-0595-x; HARRIS RA, 1984, MOL PHARMACOL, V25, P401; HOLBROOK PG, 1988, J NEUROCHEM, V50, P156, DOI 10.1111/j.1471-4159.1988.tb13243.x; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kalant D, 2004, CURR OPIN LIPIDOL, V15, P309, DOI 10.1097/00041433-200406000-00011; KAMP F, 2006, PROSTAGLANDINS LEUKO, V75, P9; Kevala JH, 2001, ANAL BIOCHEM, V292, P130, DOI 10.1006/abio.2001.5076; Kim HY, 2004, BIOCHEMISTRY-US, V43, P1030, DOI 10.1021/bi035197x; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; KIM HY, 1991, BIOCHEM BIOPH RES CO, V174, P729, DOI 10.1016/0006-291X(91)91478-U; Kim HY, 1999, ADV EXP MED BIOL, V447, P75; Kim HY, 2003, LIPIDS, V38, P453, DOI 10.1007/s11745-003-1083-z; Lammers CH, 1996, J NEUROCHEM, V66, P147; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; MOORE SA, 1990, J NEUROCHEM, V55, P391, DOI 10.1111/j.1471-4159.1990.tb04150.x; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195; MOORE SA, 1991, J NEUROCHEM, V57, P922, DOI 10.1111/j.1471-4159.1991.tb08239.x; Murthy M, 2002, J LIPID RES, V43, P611; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Nourooz-Zadeh J, 1999, J NEUROCHEM, V72, P734, DOI 10.1046/j.1471-4159.1999.0720734.x; Pawlosky RJ, 1997, HEPATOLOGY, V26, P1386; Pereira SL, 2004, BIOCHEM J, V384, P357, DOI 10.1042/BJ20040970; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Rapoport SI, 2001, J LIPID RES, V42, P678; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SAWAZAKI S, 1994, J NEUROCHEM, V62, P2437; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; SUZUKI TT, 1985, J BIOL CHEM, V260, P1394; Uz T, 1999, J NEUROCHEM, V73, P693, DOI 10.1046/j.1471-4159.1999.0730693.x; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; WATANABE T, 1993, EUR J BIOCHEM, V212, P605, DOI 10.1111/j.1432-1033.1993.tb17699.x; Wen ZM, 2007, J NEUROSCI RES, V85, P1568, DOI 10.1002/jnr.21263; Wen ZM, 2004, J NEUROCHEM, V89, P1368, DOI 10.1111/j.1471-4159.2004.02433.x; Williard DE, 2001, J LIPID RES, V42, P1368	57	167	173	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18661	18665		10.1074/jbc.R700015200	http://dx.doi.org/10.1074/jbc.R700015200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17488715	hybrid			2022-12-27	WOS:000247475300002
J	Li, ZY; Yang, J; Gao, X; Lu, JY; Zhang, Y; Wang, KP; Cheng, MB; Wu, NH; Zhang, Y; Wu, ZG; Shen, YF				Li, Zhao-yong; Yang, Jun; Gao, Xin; Lu, Jian-yi; Zhang, Yi; Wang, Kepeng; Cheng, Mo-bin; Wu, Ning-hua; Zhang, Ye; Wu, Zhenguo; Shen, Yu-fei			Sequential recruitment of PCAF and BRG1 contributes to myogenin activation in 12-O-tetradecanoylphorbol-13-acetate-induced early differentiation of rhabdomyosarcoma-derived cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE DIFFERENTIATION; MYOD; CHROMATIN; P38; ACETYLATION; PROGRAM; P300; EXPRESSION; COMPLEXES; PATHWAY	Myogenin and its upstream regulator MyoD are known to be required for myogenic cell differentiation. Although both of them can be expressed in rhabdomyosarcoma-derived RD cells, the cells are unable to undergo full-scale terminal myogenic differentiation. 12-O-Tetradecanoylphorbol-13-acetate (TPA) has been found to be functional in the induction of RD cell differentiation, whereas its mechanism is not fully understood. By using quantitative real-time-based chromatin immunoprecipitation and real-time reverse transcription-PCR-based promoter activity assays, we examined the activation mechanism of the myogenin gene during TPA-induced differentiation of the RD cells. We have shown that a histone acetyltransferase PCAF and ATPase subunit BRG1 of the SWI/SNF chromatin remodeling complex are sequentially recruited to the promoter of the myogenin gene. Both PCAF and BRG1 are also involved in the activation of the myogenin gene. In addition, we have found that the p38 mitogen-activated protein kinase is required for BRG1 recruitment in TPA-mediated myogenin induction. We propose that there are two distinct activation steps for the induction of myogenin in TPA-induced early differentiation of RD cells: 1) an early step that requires PCAF activity to acetylate core histones and MyoD to initiate myogenin gene expression, and 2) a later step that requires p38-dependent activity of the SWI/SNF remodeling complex to provide an open conformation for the induction of myogenin. Our studies reveal an essential role for epigenetic regulation in TPA-induced differentiation of RD cells and provide potential drug targets for future treatment of the rhabdomyosarcoma.	Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol,Dept Biochem & Mol Biol, Beijing 100005, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Hong Kong University of Science & Technology	Wu, ZG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol,Dept Biochem & Mol Biol, Beijing 100005, Peoples R China.	bczgwu@ust.hk; yfshen@ms.imicams.ac.cn	Li, zhao-yong/N-4288-2013; Zhang, Ye/D-5015-2011; Wang, Kepeng/F-8363-2014	Zhang, Ye/0000-0002-3494-7206; Wang, Kepeng/0000-0001-6428-4709; Wu, Zhenguo/0000-0003-3049-8324				AGUANNO S, 1990, CANCER RES, V50, P3377; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BOUCHE M, 1993, EXP CELL RES, V208, P209, DOI 10.1006/excr.1993.1239; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puri PL, 2000, GENE DEV, V14, P574; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xiao L, 2000, CANCER RES, V60, P400; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang JZ, 2006, STEM CELLS, V24, P2661, DOI 10.1634/stemcells.2006-0017; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200	24	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18872	18878		10.1074/jbc.M609448200	http://dx.doi.org/10.1074/jbc.M609448200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17468105	hybrid			2022-12-27	WOS:000247475300027
J	Maas, E; Geissen, M; Groschup, MH; Rost, R; Onodera, T; Schatzl, H; Vorberg, IM				Maas, Elke; Geissen, Markus; Groschup, Martin H.; Rost, Romina; Onodera, Takashi; Schaetzl, Hermann; Vorberg, Ina M.			Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE NEUROBLASTOMA-CELLS; PRP KNOCKOUT MICE; TRANSGENIC MICE; NMR STRUCTURE; AMINO-ACID; SPECIES BARRIER; CULTURED-CELLS; RESISTANT PRP; PROPAGATION; CONVERSION	Expression of the cellular prion protein (PrPC) is crucial for susceptibility to prions. In vivo, ectopic expression of PrPC restores susceptibility to prions and transgenic mice that express heterologous PrP on a PrP knock-out background have been used extensively to study the role of PrP alterations for prion transmission and species barriers. Here we report that prion protein knock-out cells can be rendered permissive to scrapie infection by the ectopic expression of PrP. The system was used to study the influence of sheep PrP-specific residues in mouse PrP on the infection process with mouse adapted scrapie. These studies reveal several critical residues previously not associated with species barriers and demonstrate that amino acid residue alterations at positions known to have an impact on the susceptibility of sheep to sheep scrapie also drastically influence PrPSc formation by mouse-adapted scrapie strain 22L. Furthermore, our data suggest that amino acid polymorphisms located on the outer surfaces of helix 2 and 3 drastically impact conversion efficiency. In conclusion, this system allows for the fast generation of mutant PrPSc that is entirely composed of transgenic PrP and is, thus, ideally suited for testing if artificial PrP molecules can affect prion replication. Transmission of infectivity generated in HpL3-4 cells expressing altered PrP molecules to mice could also help to unravel the potential influence of mutant PrPSc on host cell tropism and strain characteristics in vivo.	Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, D-17493 Greifswald, Germany; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Mol Immunol, Tokyo 113, Japan	Technical University of Munich; Friedrich Loeffler Institute; University of Tokyo	Vorberg, IM (corresponding author), Univ Hamburg, Inst Neuropathol, Martinistr 52, D-20246 Hamburg, Germany.	vorberg@lrz.tum.de	Schatzl, Hermann/G-4958-2011	Schatzl, Hermann/0000-0003-4972-8740				Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; Billeter M, 1997, P NATL ACAD SCI USA, V94, P7281, DOI 10.1073/pnas.94.14.7281; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1993, BRIT MED BULL, V49, P860, DOI 10.1093/oxfordjournals.bmb.a072651; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Glockshuber R, 1997, TRENDS BIOCHEM SCI, V22, P241, DOI 10.1016/S0968-0004(97)01070-0; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Harris B, 2003, CLIO MED, V71, P85; Holscher C, 1998, J VIROL, V72, P1153; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Norstrom EM, 2006, J VIROL, V80, P8521, DOI 10.1128/JVI.00366-06; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Parizek P, 2001, J BIOL CHEM, V276, P44627, DOI 10.1074/jbc.M107458200; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sabuncu E, 2003, J VIROL, V77, P2696, DOI 10.1128/JVI.77.4.2696-2700.2003; Schatzl HM, 1997, J VIROL, V71, P8821; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solassol J, 2003, BRIT MED BULL, V66, P87, DOI 10.1093/bmb/66.1.87; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 2004, J BIOL CHEM, V279, P29218, DOI 10.1074/jbc.M402576200; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Vorberg I, 2001, J VIROL, V75, P10024, DOI 10.1128/JVI.75.21.10024-10032.2001; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; WOLFOROSI L, 2007, J BIOL CHEM, V282, P7465	60	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18702	18710		10.1074/jbc.M701309200	http://dx.doi.org/10.1074/jbc.M701309200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17468101	hybrid			2022-12-27	WOS:000247475300008
J	Shereda, RD; Bernstein, DA; Keck, JL				Shereda, Robert D.; Bernstein, Douglas A.; Keck, James L.			A central role for SSB in Escherichia coli RecQ DNA helicase function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; ACID UNWINDING PROTEIN; BINDING-PROTEIN; REPLICATION FORKS; EXONUCLEASE-I; CRYSTAL-STRUCTURE; POSTREPLICATION REPAIR; GENETIC-RECOMBINATION; TOPOISOMERASE-III; TERMINAL DOMAIN	RecQ DNA helicases are critical components of DNA replication, recombination, and repair machinery in all eukaryotes and bacteria. Eukaryotic RecQ helicases are known to associate with numerous genome maintenance proteins that modulate their cellular functions, but there is little information regarding protein complexes involving the prototypical bacterial RecQ proteins. Here we use an affinity purification scheme to identify three heterologous proteins that associate with Escherichia coli RecQ: SSB (single-stranded DNA-binding protein), exonuclease I, and RecJ exonuclease. The RecQ-SSB interaction is direct and is mediated by the RecQ winged helix subdomain and the C terminus of SSB. Interaction with SSB has important functional consequences for RecQ. SSB stimulates RecQ-mediated DNA unwinding, whereas deletion of the C-terminal RecQ-binding site from SSB produces a variant that blocks RecQ DNA binding and unwinding activities, suggesting that RecQ recognizes both the SSB C terminus and DNA in SSB (.) DNA nucleoprotein complexes. These findings, together with the noted interactions between human RecQ proteins and Replication Protein A, identify SSB as a broadly conserved RecQ-binding protein. These results also provide a simple model that explains RecQ integration into genome maintenance processes in E. coli through its association with SSB.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Med Sci Ctr 550, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	NIGMS NIH HHS [GM068061] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068061] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bennett RJ, 2004, CRIT REV BIOCHEM MOL, V39, P79, DOI 10.1080/10409230490460756; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Bernstein DA, 2003, NUCLEIC ACIDS RES, V31, P2778, DOI 10.1093/nar/gkg376; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CHASE JW, 1984, J BIOL CHEM, V259, P805; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; Han ES, 2006, NUCLEIC ACIDS RES, V34, P1084, DOI 10.1093/nar/gkj503; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Hegde SP, 1996, P NATL ACAD SCI USA, V93, P14468, DOI 10.1073/pnas.93.25.14468; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; Hu JS, 2005, P NATL ACAD SCI USA, V102, P18379, DOI 10.1073/pnas.0509380102; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; IRINO N, 1986, MOL GEN GENET, V205, P298, DOI 10.1007/BF00430442; Ivancic-Bace I, 2005, J BACTERIOL, V187, P1350, DOI 10.1128/JB.187.4.1350-1356.2005; Kitano K, 2007, J BIOL CHEM, V282, P2717, DOI 10.1074/jbc.M610142200; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; KUSHNER SR, 1972, P NATL ACAD SCI USA, V69, P1366, DOI 10.1073/pnas.69.6.1366; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Matsumoto T, 2000, J BIOCHEM, V127, P329, DOI 10.1093/oxfordjournals.jbchem.a022611; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MOLINEUX IJ, 1974, J BIOL CHEM, V249, P6090; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; NAKAYAMA K, 1985, MOL GEN GENET, V200, P266, DOI 10.1007/BF00425434; Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; SAMBROOK J, 2001, MOL CLONING LAB MANU, V3, pA1; Sandigursky M, 1996, RADIAT RES, V145, P619, DOI 10.2307/3579281; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; TSENG YC, 1994, MUTAT RES, V315, P1; UMEZU K, 1994, J BIOL CHEM, V269, P30005; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; UMEZU K, 1993, J MOL BIOL, V230, P1145, DOI 10.1006/jmbi.1993.1231; VALES LD, 1980, J BACTERIOL, V143, P887, DOI 10.1128/JB.143.2.887-896.1980; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; WANG TV, 1985, MOL GEN GENET, V201, P186, DOI 10.1007/BF00425658; WEINER JH, 1975, J BIOL CHEM, V250, P1972; WILLIAMS KR, 1984, J BIOL CHEM, V259, P1804; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189	72	108	110	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19247	19258		10.1074/jbc.M608011200	http://dx.doi.org/10.1074/jbc.M608011200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17483090	hybrid			2022-12-27	WOS:000247475300065
J	Wittkowski, M; Mittelstadt, J; Brandau, S; Reiling, N; Lindner, B; Torrelles, J; Brennan, PJ; Holst, O				Wittkowski, Manon; Mittelstaedt, Jessica; Brandau, Sven; Reiling, Norbert; Lindner, Buko; Torrelles, Jordi; Brennan, Patrick J.; Holst, Otto			Capsular arabinomannans from Mycobacterium avium with morphotype-specific structural differences but identical biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAIN AOYAMA-B; CELL-WALL; MACROPHAGE ACTIVATION; ANTITUMOR ACTIVITIES; INDUCE SECRETION; SURFACE-ANTIGENS; IN-VITRO; TUBERCULOSIS; Z-100; LIPOARABINOMANNAN	The capsules of two colony morphotypes of Mycobacterium avium strain 2151 were investigated, i.e. the virulent smooth-transparent (SmT1) and the nonvirulent smooth-opaque (SmO) types. From both morphotypes we separated a nonacylated arabinomannan (AM) from an acylated polysaccharide fraction by affinity chromatography, of which the AMs were structurally characterized. The AMs from the virulent morphotype, in contrast to that from the nonvirulent form, possessed a larger mannan chain and a shorter arabinan chain. Incubation of murine bone marrow-derived macrophages and human dendritic cells showed that the acylated polysaccharide fractions were potent inducers of tumor necrosis factor-alpha, interleukin-12, and interleukin-10 compared with nonacylated AMs, which led to only a marginal cytokine release. Further in vitro experiments showed that both the acylated polysaccharide fractions and the nonacylated AMs were able to induce in vitro anti-tumor cytotoxicity of human peripheral blood mononuclear cells. Thus, morphotype-specific structural differences in the capsular AMs of M. avium do not correlate with biological activity; however, their acylation is a prerequisite for effective stimulation of murine macrophages and human dendritic cells.	Leibniz Ctr Med & Biosci, Res Ctr, Div Immunotherapy, D-23845 Borstel, Germany; Leibniz Ctr Med & Biosci, Res Ctr, Div Mol Infect Biol, Borstel, Germany; Leibniz Ctr Med & Biosci, Res Ctr, Div Biophys, D-23845 Borstel, Germany; Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; Colorado State University	Holst, O (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr, Div Struct Biochem, D-23845 Borstel, Germany.	oholst@fz-borstel.de	Torrelles, Jordi/E-4204-2011; Lindner, Buko/G-9731-2014; Reiling, Norbert/D-6796-2013	Reiling, Norbert/0000-0001-6673-4291; Brandau, Sven/0000-0002-2702-4163	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018357, R22AI018357, R01AI018357] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 018357] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APPELBERG R, 1995, CLIN EXP IMMUNOL, V101, P308; APPELBERG R, 1993, IMMUNOLOGY, V80, P352; BELISLE JT, 1993, J BIOL CHEM, V268, P10510; Bhatnagar S, 2006, CELL MICROBIOL, V8, P85, DOI 10.1111/j.1462-5822.2005.00602.x; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; Brandau S, 2000, CLIN INFECT DIS, V31, pS94, DOI 10.1086/314068; Brandau S, 2001, EUR UROL, V39, P518, DOI 10.1159/000052497; BRENNAN PJ, 1989, REV INFECT DIS, V11, pS420; CARLSSON SR, 1993, GLYCOBIOLOGY PRACTIC; CHAPMAN GB, 1959, J BACTERIOL, V77, P205, DOI 10.1128/JB.77.2.205-211.1959; CHATTERJEE D, 1992, INFECT IMMUN, V60, P1249, DOI 10.1128/IAI.60.3.1249-1253.1992; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DAFFE M, 1990, J BIOL CHEM, V265, P6734; DAFFE M, 1993, CARBOHYD RES, V249, P383, DOI 10.1016/0008-6215(93)84102-C; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; FREHEL C, 1991, INFECT IMMUN, V59, P2207, DOI 10.1128/IAI.59.6.2207-2214.1991; FURNEY SK, 1992, INFECT IMMUN, V60, P4410, DOI 10.1128/IAI.60.10.4410-4413.1992; Gilleron M, 2005, J BACTERIOL, V187, P854, DOI 10.1128/JB.187.3.854-861.2005; Gilleron M, 1997, J BIOL CHEM, V272, P117; GlatmanFreedman A, 1996, J CLIN MICROBIOL, V34, P2795, DOI 10.1128/JCM.34.11.2795-2802.1996; Guerardel Y, 2003, J BIOL CHEM, V278, P36637, DOI 10.1074/jbc.M305427200; Hamasur B, 2003, VACCINE, V21, P4081, DOI 10.1016/S0264-410X(03)00274-3; HAYASHI Y, 1981, MICROBIOL IMMUNOL, V25, P305, DOI 10.1111/j.1348-0421.1981.tb00032.x; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; KAWAMURA I, 1990, IMMUNOPHARM IMMUNOT, V12, P331, DOI 10.3109/08923979009006467; Kobayashi M, 1997, ANTI-CANCER DRUG, V8, P156, DOI 10.1097/00001813-199702000-00006; KOBAYASHI M, 1994, IMMUNOL LETT, V40, P199, DOI 10.1016/0165-2478(93)00018-9; Lemassu A, 1996, MICROBIOL-UK, V142, P1513, DOI 10.1099/13500872-142-6-1513; MEYLAN PR, 1990, INFECT IMMUN, V58, P2564, DOI 10.1128/IAI.58.8.2564-2568.1990; Navoa JAD, 2003, CLIN DIAGN LAB IMMUN, V10, P88, DOI 10.1128/CDLI.10.1.88-94.2003; Nigou J, 1999, GLYCOCONJUGATE J, V16, P257, DOI 10.1023/A:1007046609341; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; Oka H, 2004, BIOL PHARM BULL, V27, P82, DOI 10.1248/bpb.27.82; Oka H, 2003, BIOL PHARM BULL, V26, P1336; Oka H, 2002, MICROBIOL IMMUNOL, V46, P343, DOI 10.1111/j.1348-0421.2002.tb02705.x; RASTOGI N, 1986, CURR MICROBIOL, V13, P237, DOI 10.1007/BF01568645; RASTOGI N, 1991, RES MICROBIOL, V142, P464, DOI 10.1016/0923-2508(91)90121-P; Reiling N, 2001, IMMUNOBIOLOGY, V204, P558, DOI 10.1078/0171-2985-00093; ROACH TIA, 1993, J IMMUNOL, V150, P1886; Schwebach JR, 2002, INFECT IMMUN, V70, P2566, DOI 10.1128/IAI.70.5.2566-2575.2002; Schwebach JR, 2001, INFECT IMMUN, V69, P5671, DOI 10.1128/IAI.69.9.5671-5678.2001; Shurin MR, 1997, CHEM IMMUNOL, V68, P153; Smith B. J., 2002, PROTEIN PROTOCOLS HD, P237; Tse HM, 2002, J IMMUNOL, V168, P825, DOI 10.4049/jimmunol.168.2.825; VINOGRADOV EV, 1992, EUR J BIOCHEM, V210, P491, DOI 10.1111/j.1432-1033.1992.tb17447.x; WEBER PL, 1979, CARBOHYD RES, V74, P259, DOI 10.1016/S0008-6215(00)84781-3; WHITTAKER DV, 1994, CARBOHYD RES, V253, P247, DOI 10.1016/0008-6215(94)80069-3; Yoshida A, 1997, INFECT IMMUN, V65, P1953, DOI 10.1128/IAI.65.5.1953-1955.1997; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702	50	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19103	19112		10.1074/jbc.M611551200	http://dx.doi.org/10.1074/jbc.M611551200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17459879	hybrid			2022-12-27	WOS:000247475300052
J	Xia, Y; Yu, PB; Sidis, Y; Beppu, H; Bloch, KD; Schneyer, AL; Lin, HY				Xia, Yin; Yu, Paul B.; Sidis, Yisrael; Beppu, Hideyuki; Bloch, Kenneth D.; Schneyer, Alan L.; Lin, Herbert Y.			Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA; IDENTIFICATION; MEMBRANE; INHIBIN; DRAGON; ANTAGONIST; EXPRESSION; PATHWAYS; ELEMENTS; ACTIVIN	Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta superfamily of multifunctional ligands that transduce their signals through type I and II serine/ threonine kinase receptors and intracellular Smad proteins. Recently, we identified the glycosylphosphatidylinositol-anchored repulsive guidance molecules RGMa, DRAGON (RGMb), and hemojuvelin (RGMc) as coreceptors for BMP signaling (Babbit, J. L., Huang, F. W., Wrighting, D. W., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R., Schneyer, A., Woolf, C. J., Andrews, N. C., and Lin, H. Y. (2006) Nat. Genet. 38, 531-539; Babbit, J. L., Zhang, Y., Samad, T. A., Xia, Y., Tang, J., Schneyer, A., Woolf, C. J., and Lin, H. Y. (2005) J. Biol. Chem. 280, 29820-29827; Samad, T. A., Rebbapragada, A., Bell, E., Zhang, Y., Sidis, Y., Jeong, S. J., Campagna, J. A., Perusini, S., Fabrizio, D. A., Schneyer, A. L., Lin, H. Y., Brivanlou, A. H., Attisano, L., and Woolf, C. J. (2005) J. Biol. Chem. 280, 14122-14129). However, the mechanism by which RGM family members enhance BMP signaling remains unknown. Here, we report that RGMa bound to radiolabeled BMP2 and BMP4 with K-d values of 2.4 +/- 0.2 and 1.4 +/- 0.1 nM, respectively. In KGN human ovarian granulosa cells and mouse pulmonary artery smooth muscle cells, BMP2 and BMP4 signaling required BMP receptor type II (BMPRII), but not activin receptor type IIA (ActRIIA) or ActRIIB, based on changes in BMP signaling by small interfering RNA inhibition of receptor expression. In contrast, cells transfected with RGMa utilized both BMPRII and ActRIIA for BMP2 or BMP4 signaling. Furthermore, in BmpRII-null pulmonary artery smooth muscle cells, BMP2 and BMP4 signaling was reduced by inhibition of endogenous RGMa expression, and RGMa-mediated BMP signaling required ActRIIA expression. These findings suggest that RGMa facilitates the use of ActRIIA by endogenous BMP2 and BMP4 ligands that otherwise prefer signaling via BMPRII and that increased utilization of ActRIIA leads to generation of an enhanced BMP signal.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Div Nephrol,Program Membrane Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Reprod Endocrine Unit,Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lin, HY (corresponding author), Richard B Simches Res Ctr, Program Membrane Biol, 185 Cambridge St,CPZN 8216, Boston, MA 02114 USA.	hlin@partners.org	Yu, Paul B./J-7540-2019; Xia, Yin/M-5440-2018	Yu, Paul B./0000-0003-2145-4944; Xia, Yin/0000-0003-0315-7532	NHLBI NIH HHS [K08 HL079943-01A1, K08 HL079943, HL74352] Funding Source: Medline; NIDDK NIH HHS [DK069533, DK076143, DK076158, DK071837] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074352, K08HL079943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069533, R01DK071837] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aspenberg P, 2001, J BONE MINER RES, V16, P497, DOI 10.1359/jbmr.2001.16.3.497; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; del Re E, 2004, J BIOL CHEM, V279, P22765, DOI 10.1074/jbc.M401350200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; LIU F, 1995, MOL CELL BIOL, V15, P3479; Martinez AR, 2004, HAEMATOLOGICA, V89, P1441; Massague J, 2000, GENE DEV, V14, P627; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Welt CK, 1997, J CLIN ENDOCR METAB, V82, P3720, DOI 10.1210/jc.82.11.3720; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; Xia Y, 2005, ENDOCRINOLOGY, V146, P3614, DOI 10.1210/en.2004-1676; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	33	88	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18129	18140		10.1074/jbc.M701679200	http://dx.doi.org/10.1074/jbc.M701679200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17472960	hybrid			2022-12-27	WOS:000247302000019
J	Blanc, G; Font, B; Eichenberger, D; Moreau, C; Ricard-Blum, S; Hulmes, DJS; Moali, C				Blanc, Guillaume; Font, Bernard; Eichenberger, Denise; Moreau, Christophe; Ricard-Blum, Sylvie; Hulmes, David J. S.; Moali, Catherine			Insights into how CUB domains can exert specific functions while sharing a common fold - Conserved and specific features of the CUB1 domain contribute to the molecular basis of procollagen C-proteinase enhancer-1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; MANNAN-BINDING-LECTIN; X-RAY-STRUCTURE; CLEAVAGE; IDENTIFICATION; FAMILY; BMP-1; SPERMADHESINS; COMPLEMENT; ACTIVATION	Procollagen C-proteinase enhancers (PCPE-1 and -2) are extracellular glycoproteins that can stimulate the C-terminal processing of fibrillar procollagens by tolloid proteinases such as bone morphogenetic protein-1. They consist of two CUB domains (CUB1 and -2) that alone account for PCPE-enhancing activity and one C-terminal NTR domain. CUB domains are found in several extracellular and plasma membrane-associated proteins, many of which are proteases. We have modeled the structure of the CUB1 domain of PCPE-1 based on known three dimensional structures of CUB-containing proteins. Sequence alignment shows conserved amino acids, notably two acidic residues (Asp-68 and Asp-109) involved in a putative surface-located calcium binding site, as well as a conserved tyrosine residue (Tyr-67). In addition, three residues (Glu-26, Thr-89, and Phe-90) are found only in PCPE CUB1 domains, in putative surface exposed loops. Among the conserved residues, it was found that mutations of Asp-68 and Asp-109 to alanine almost completely abolished PCPE-1 stimulating activity, whereas mutation of Tyr-67 led to a smaller reduction of activity. Among residues specific to PCPEs, mutation of Glu-26 and Thr-89 had little effect, whereas mutation of Phe-90 dramatically decreased the activity. Changes in activity were paralleled by changes in binding of different PCPE-1 mutants to a mini-procollagen III substrate, as shown by surface plasmon resonance. We conclude that PCPE-stimulating activity requires a calcium binding motif in the CUB1 domain that is highly conserved among CUB-containing proteins but also that PCPEs contain specific sites that could become targets for the development of novel anti-fibrotic therapies.	Univ Lyon 1, CNRS, Inst Biol & Chim Prot, UMR 5086,Inst Fed Rech Biosci Lyon Gerland 128, F-69367 Lyon 7, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Moali, C (corresponding author), Univ Lyon 1, CNRS, Inst Biol & Chim Prot, UMR 5086,Inst Fed Rech Biosci Lyon Gerland 128, 7 Passage Vercors, F-69367 Lyon 7, France.	d.hulmes@ibcp.fr	MOREAU, Christophe/AAC-7912-2020; MOREAU, Christophe J/D-3736-2009	MOREAU, Christophe/0000-0002-5463-9593; MOREAU, Christophe J/0000-0002-5463-9593; MOALI, Catherine/0000-0003-2479-4290; Hulmes, David/0000-0002-0651-1317; RICARD-BLUM, Sylvie/0000-0001-9263-1851				ADAR R, 1986, COLLAGEN REL RES, V6, P267; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Bernocco S, 2001, J BIOL CHEM, V276, P48930, DOI 10.1074/jbc.M108611200; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Canty EG, 2006, J BIOL CHEM, V281, P13258, DOI 10.1074/jbc.M510483200; CHILDS SR, 1994, DEV BIOL, V162, P209, DOI 10.1006/dbio.1994.1079; Christensen EI, 2004, PEDIATR NEPHROL, V19, P714, DOI 10.1007/s00467-004-1494-0; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Davidson G, 2002, DEVELOPMENT, V129, P5587, DOI 10.1242/dev.00154; Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7; DIVITA G, 1992, BIOCHEMISTRY-US, V31, P5791, DOI 10.1021/bi00140a015; Duke-Cohan JS, 2000, ADV EXP MED BIOL, V477, P173; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; FINELLI AL, 1994, DEVELOPMENT, V120, P861; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Ge GX, 2006, J BIOL CHEM, V281, P10786, DOI 10.1074/jbc.M511111200; Ge WT, 2006, J BIOL CHEM, V281, P7406, DOI 10.1074/jbc.M510687200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; Gregory LA, 2004, J BIOL CHEM, V279, P29391, DOI 10.1074/jbc.M402687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; Hooi CSF, 2006, ONCOGENE, V25, P3924, DOI 10.1038/sj.onc.1209418; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; KESSLER E, 1978, ANAL BIOCHEM, V86, P463, DOI 10.1016/0003-2697(78)90770-4; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moschcovich L, 2001, EUR J BIOCHEM, V268, P2991, DOI 10.1046/j.1432-1327.2001.02189.x; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Romero A, 1997, NAT STRUCT BIOL, V4, P783, DOI 10.1038/nsb1097-783; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Sorensen R, 2005, SPRINGER SEMIN IMMUN, V27, P299, DOI 10.1007/s00281-005-0006-z; Steiglitz BM, 2006, MOL CELL BIOL, V26, P238, DOI 10.1128/MCB.26.1.238-249.2006; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Sugiyama T, 2000, BIOCHEMISTRY-US, V39, P15817, DOI 10.1021/bi001583s; TAKAHARA K, 1994, J BIOL CHEM, V269, P26280; Tao ZY, 2005, BLOOD, V106, P4139, DOI 10.1182/blood-2005-05-2029; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; Topfer-Petersen E, 1998, ANDROLOGIA, V30, P217; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu QY, 2003, CURR TOP DEV BIOL, V54, P167, DOI 10.1016/S0070-2153(03)54009-1; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	53	64	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16924	16933		10.1074/jbc.M701610200	http://dx.doi.org/10.1074/jbc.M701610200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17446170	hybrid			2022-12-27	WOS:000246946500025
J	Catlow, K; Ashurst, HL; Varro, A; Dimaline, R				Catlow, Krista; Ashurst, H. Louise; Varro, Andrea; Dimaline, Rod			Identification of a gastrin response element in the vesicular monoamine transporter type 2 promoter and requirement of 20 S proteasome subunits for transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; NUCLEAR-LOCALIZATION; REGULATORY PARTICLE; DEGRADATION; EXPRESSION; ASSOCIATION; RECRUITMENT; ACTIVATION; CELLS; VMAT2	Vesicular monoamine transporter type 2 (VMAT2) is crucial for accumulation of monoamine neurotranmitters into neuronal secretory vesicles and histamine into secretory granules of the enterochromaffin-like cell in the acid-secreting gastric mucosa. Gastric VMAT2 expression is regulated by the antral hormone gastrin acting at the CCK2 receptor. We demonstrate a gastrin response element (-56)ccgccccctc(-47) in the proximal VMAT2 promoter that binds in a gastrin-sensitive manner to nuclear proteins from gastric epithelial cell lines. Mutations within this sequence prevented nuclear protein binding and significantly reduced gastrin-stimulated expression of VMAT2 promoter-reporter constructs in gastric epithelial cells. In a yeast one-hybrid screen of an AR42J cell cDNA library, using the gastrin response element as bait, we identified a beta subunit of the 20 S proteasome, PSMB1, as a potential binding partner. In supershift assays, antibodies to PSMB1 and other proteasome beta subunits disrupted gastrin sensitive nuclear protein binding to the VMAT2 promoter. Moreover, RNA interference of PSMB1 significantly inhibited gastrin-mediated VMAT2 transcription. These data suggest that elements of the 20 S proteasome interact with the VMAT2 promoter to enhance G-protein-coupled receptor-mediated transcription.	Univ Liverpool, Sch Biomed Sci, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Dimaline, R (corresponding author), Univ Liverpool, Sch Biomed Sci, Physiol Lab, Crown St, Liverpool L69 3BX, Merseyside, England.	r.dimaline@liverpool.ac.uk	Varro, Andras/M-2647-2016		Medical Research Council [G8714277, G9900432] Funding Source: Medline; Wellcome Trust [072501/Z/03] Funding Source: Medline; MRC [G9900432, G8714277] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akiyama H, 2005, MATRIX BIOL, V23, P499, DOI 10.1016/j.matbio.2004.10.002; Ashcroft FJ, 2004, BIOCHEM J, V381, P397, DOI 10.1042/BJ20031793; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; BLACK JW, 1987, TRENDS PHARMACOL SCI, V8, P486, DOI 10.1016/0165-6147(87)90044-7; Blackmore CG, 2001, J PHYSIOL-LONDON, V531, P605, DOI 10.1111/j.1469-7793.2001.0605h.x; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Dennis AP, 2005, J STEROID BIOCHEM, V94, P337, DOI 10.1016/j.jsbmb.2004.11.009; DIMALINE R, 1991, FEBS LETT, V281, P20, DOI 10.1016/0014-5793(91)80348-7; Dimaline R, 1996, J PHYSIOL-LONDON, V490, P249, DOI 10.1113/jphysiol.1996.sp021140; DIMALINE R, 1993, AM J PHYSIOL, V264, pG583, DOI 10.1152/ajpgi.1993.264.3.G583; Dockray G, 2005, PFLUG ARCH EUR J PHY, V449, P344, DOI 10.1007/s00424-004-1347-5; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Folco EJ, 1997, BIOCHEM J, V328, P37; Gainetdinov RR, 1998, J NEUROCHEM, V70, P1973; Gerhard M, 2001, ENDOCRINOLOGY, V142, P3663, DOI 10.1210/en.142.8.3663; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Hocker M, 1998, J BIOL CHEM, V273, P34000, DOI 10.1074/jbc.273.51.34000; Kariya S, 2005, J MOL NEUROSCI, V27, P277, DOI 10.1385/JMN:27:3:277; Khan ZE, 2003, GASTROENTEROLOGY, V125, P510, DOI 10.1016/S0016-5085(03)00908-9; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; MERICKEL A, 1995, NEUROPHARMACOLOGY, V34, P1543, DOI 10.1016/0028-3908(95)00148-Y; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Nakamura A, 2006, NEUROSCI LETT, V406, P43, DOI 10.1016/j.neulet.2006.07.050; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Ogiso Y, 2002, CANCER RES, V62, P5008; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; PALMER A, 1994, EUR J CELL BIOL, V64, P163; PETER D, 1994, J BIOL CHEM, V269, P7231; Prinz C, 1999, AM J PHYSIOL-CELL PH, V277, pC845, DOI 10.1152/ajpcell.1999.277.5.C845; Raychowdhury R, 1999, J BIOL CHEM, V274, P20961, DOI 10.1074/jbc.274.30.20961; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730	52	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					17069	17077		10.1074/jbc.M611421200	http://dx.doi.org/10.1074/jbc.M611421200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17442673	hybrid			2022-12-27	WOS:000246946500040
J	Wei, W; Hackmann, K; Xu, HX; Germino, G; Qian, F				Wei, Wen; Hackmann, Karl; Xu, Hangxue; Germino, Gregory; Qian, Feng			Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URCHIN SPERM RECEPTOR; KIDNEY-DISEASE; PLASMA-MEMBRANE; PROTEIN; PKD1; CLEAVAGE; DOMAIN; IDENTIFICATION; ACTIVATION; MUTATIONS	Polycystin-1 (PC1), the PKD1 gene product, plays a critical role in renal tubule diameter control and disruption of its function causes cyst formation in human autosomal dominant polycystic kidney disease. Recent evidence shows that PC1 undergoes cleavage at the juxtamembrane G protein-coupled receptor proteolytic site (GPS), a process likely to be essential for its biological activity. Here we further characterized the proteolytic cleavage of PC1 at the GPS domain. We determined the actual cleavage site to be between leucine and threonine of the tripeptide HLT3049 of human PC1. Cleavage occurs in the early intracellular secretory pathway and requires initial N-glycan attachment but not its subsequent trimming. We provide evidence that the cleavage occurs via a cis-autoproteolytic mechanism involving an ester intermediate as shown for Ntn hydrolases and EMR2.	Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA	Johns Hopkins University	Qian, F (corresponding author), 720 Rutland Ave,Ross Bldg 954, Baltimore, MD 21205 USA.	fqjhupkd@jhmi.edu		Germino, Gregory/0000-0002-3609-5588	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK062199] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Boletta A, 2001, AM J KIDNEY DIS, V38, P1421, DOI 10.1053/ajkd.2001.29282; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Bornstein P, 1977, Methods Enzymol, V47, P132; Butscheid Y, 2006, MOL REPROD DEV, V73, P350, DOI 10.1002/mrd.20410; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Drenth JPH, 2004, GASTROENTEROLOGY, V126, P1819, DOI 10.1053/j.gastro.2004.02.023; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Galindo BE, 2004, DEV GROWTH DIFFER, V46, P53; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2006, CURR OPIN NEPHROL HY, V15, P456, DOI 10.1097/01.mnh.0000232888.65895.e7; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; KOJRO E, 1995, J BIOL CHEM, V270, P6476, DOI 10.1074/jbc.270.12.6476; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Li AR, 2003, GENOMICS, V81, P596, DOI 10.1016/S0888-7543(03)00048-X; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mengerink KJ, 2002, J BIOL CHEM, V277, P943, DOI 10.1074/jbc.M109673200; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 1998, NAT STRUCT BIOL, V5, P249, DOI 10.1038/nsb0498-249; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Ponting CP, 1999, CURR BIOL, V9, pR585, DOI 10.1016/S0960-9822(99)80379-0; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; Stacey M, 2000, TRENDS BIOCHEM SCI, V25, P284, DOI 10.1016/S0968-0004(00)01583-8; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; WILLIAMS JF, 1990, J BIOL CHEM, V265, P8463; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; YU SQ, 2006, J AM SOC NEPHROL, V17, pA89; Yuasa T, 2004, GENOMICS, V84, P126, DOI 10.1016/j.ygeno.2004.02.008	48	74	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21729	21737		10.1074/jbc.M703218200	http://dx.doi.org/10.1074/jbc.M703218200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17525154	hybrid			2022-12-27	WOS:000248196800020
J	Skiniotis, G; Moazed, D; Walz, T				Skiniotis, Georgios; Moazed, Danesh; Walz, Thomas			Acetylated histone tail peptides induce structural rearrangements in the RSC chromatin remodeling complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPY; TILT; RECONSTRUCTION; BROMODOMAINS	Post-translational acetylation of histone tails is often required for the recruitment of ATP-dependent chromatin remodelers, which in turn mobilize nucleosomes on the chromatin fiber. Here we show that the lower lobe of the ATP-dependent chromatin remodeler RSC exists in a dynamic equilibrium and can be found extended away or retracted against the tripartite upper lobe of the complex. Extension of the lower lobe increases the size of a central cavity that has been proposed to be the nucleosome binding site. We show that the presence of acetylated histone 3N-terminal tail peptides stabilizes the lower lobe of RSC in the retracted state, suggesting that domains recognizing the acetylated histone tails reside at the interface between the two lobes. Based on three-dimensional reconstructions, we propose a model for the interaction of RSC with acetylated nucleosomes.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	twalz@hms.harvard.edu		Walz, Thomas/0000-0003-2606-2835; Skiniotis, Georgios/0000-0003-0238-7846				Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Leschziner AE, 2005, STRUCTURE, V13, P267, DOI 10.1016/j.str.2004.12.008; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Verger A, 2004, CELL MOL LIFE SCI, V61, P2154, DOI 10.1007/s00018-004-4176-y; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7	22	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20804	20808		10.1074/jbc.C700081200	http://dx.doi.org/10.1074/jbc.C700081200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535815	hybrid			2022-12-27	WOS:000248047500005
J	Gruber, CW; Cemazar, M; Clark, RJ; Horibe, T; Renda, RF; Anderson, MA; Craik, DJ				Gruber, Christian W.; Cemazar, Masa; Clark, Richard J.; Horibe, Tomohisa; Renda, Rosemary F.; Anderson, Marilyn A.; Craik, David J.			A novel plant protein-disulfide isomerase involved in the oxidative folding of cystine knot defense proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE KALATA B1; C-TERMINAL DOMAIN; FUNCTIONAL-ANALYSIS; FAMILY PROTEINS; ACTIVE-SITES; HUMAN P5; CYCLOTIDES; CHAPERONE; MOTIF; THIOREDOXIN	We have isolated a protein-disulfide isomerase (PDI) from Oldenlandia affinis (OaPDI), a coffee family ( Rubiaceae) plant that accumulates knotted circular proteins called cyclotides. The novel plant PDI appears to be involved in the biosynthesis of cyclotides, since it co-expresses and interacts with the cyclotide precursor protein Oak1. OaPDI exhibits similar isomerase activity but greater chaperone activity than human PDI. Since domain c of OaPDI is predicted to have a neutral pI, we conclude that this domain does not have to be acidic in nature for PDI to be a functional chaperone. Its redox potential of -157 +/- 4 mV supports a role as a functional oxidoreductase in the plant. The mechanism of enzyme-assisted folding of plant cyclotides was investigated by comparing the folding of kalata B1 derivatives in the presence and absence of OaPDI. OaPDI dramatically enhanced the correct oxidative folding of kalata B1 at physiological pH. A detailed investigation of folding intermediates suggested that disulfide isomerization is an important role of the new plant PDI and is an essential step in the production of insecticidal cyclotides.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; La Trobe Univ, Dept Chem, Bundoora, Vic 3086, Australia	University of Queensland; La Trobe University	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Gruber, Christian/C-4406-2011; Clark, Richard J/G-8848-2012; Craik, David/B-1695-2010; Anderson, Marilyn A/A-4259-2012	Clark, Richard J/0000-0002-6807-5426; Craik, David/0000-0003-0007-6796; Anderson, Marilyn A/0000-0002-8257-5128; Gruber, Christian/0000-0001-6060-7048				Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Chang JY, 2006, FEBS LETT, V580, P656, DOI 10.1016/j.febslet.2005.12.064; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; di Luccio E, 2001, BIOCHEM J, V358, P681, DOI 10.1042/0264-6021:3580681; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Gran L., 1970, MEDDELELSER NORSK FA, V12, P173; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Harlow E., 1999, USING ANTIBODIES LAB; HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341; HAYANO T, 1995, GENE, V164, P377, DOI 10.1016/0378-1119(95)00474-K; Horibe T, 2004, J BIOL CHEM, V279, P4604, DOI 10.1074/jbc.M310922200; Houston NL, 2005, PLANT PHYSIOL, V137, P762, DOI 10.1104/pp.104.056507; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Kikuchi M, 2002, J BIOCHEM, V132, P451, DOI 10.1093/oxfordjournals.jbchem.a003242; Kimura T, 2005, BIOCHEM BIOPH RES CO, V331, P224, DOI 10.1016/j.bbrc.2005.03.147; Kimura T, 2004, BIOCHEM J, V382, P169, DOI 10.1042/BJ20040116; Kimura T, 2004, BIOCHEM BIOPH RES CO, V320, P359, DOI 10.1016/j.bbrc.2004.05.178; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; LAMBERT N, 1983, BIOCHEM J, V213, P235, DOI 10.1042/bj2130235; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian R, 2004, J BIOL CHEM, V279, P48830, DOI 10.1074/jbc.M407076200; Trabi M, 2004, J NAT PROD, V67, P806, DOI 10.1021/np034068e; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019	44	102	106	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20435	20446		10.1074/jbc.M700018200	http://dx.doi.org/10.1074/jbc.M700018200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17522051	hybrid			2022-12-27	WOS:000247819300046
J	Jeong, HW; Li, Z; Brown, MD; Sacks, DB				Jeong, Ha-Won; Li, Zhigang; Brown, Matthew D.; Sacks, David B.			IQGAP1 binds Rap1 and modulates its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; SMALL GTPASES; IQ MOTIFS; MYOSIN-V; CDC42; CALMODULIN; PROTEIN; IDENTIFICATION; RAC1; CYTOSKELETON	IQGAP1 is a scaffolding protein involved in multiple fundamental cellular activities, including transcription, cell-cell attachment, and regulation of the cytoskeleton. To function in these pathways, IQGAP1 associates with numerous proteins such as actin, calmodulin, E-cadherin, beta-catenin, CLIP-170, and components of the mitogen-activated protein kinase pathway. Moreover, IQGAP1 binds to active Cdc42 and Rac1 but not RhoA or Ras. Here we show that IQGAP1 also binds to the small GTPase Rap1. In vitro analysis demonstrates a direct interaction between Rap1 and IQGAP1, which is augmented by activation (GTP loading) of Rap1. Cdc42 does not modulate the interaction between Rap1 and IQGAP1. In contrast, the association is eliminated by calmodulin both in the absence and presence of Ca2+. The binding of Rap1 to a point mutant IQGAP1 construct that is unable to interact with calmodulin is 2.5-fold more than to wild type IQGAP1. Consistent with these findings, Rap1 binds to the IQ region of IQGAP1. Confocal microscopy demonstrates that Rap1 and IQGAP1 co-localize at the periphery of human epithelial cells but not in the cytoplasm. The interaction has functional sequelae. Overexpression of IQGAP1 substantially reduces adhesion-mediated activation of Rap1. In addition, Rap1 activation by cAMP is attenuated in cells that overexpress IQGAP1 and enhanced in cells lacking IQGAP1. These findings reveal that the interaction of IQGAP1 with Rap1 differs in several respects from its interaction with other small GTPases. Furthermore, our data suggest that IQGAP1 may link the calmodulin and Rap1 signaling pathways.	Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Sacks, David/0000-0003-3100-0735				Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Baldassa S, 2003, MOL BRAIN RES, V119, P111, DOI 10.1016/j.molbrainres.2003.08.020; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Posern G, 1998, J BIOL CHEM, V273, P24297, DOI 10.1074/jbc.273.38.24297; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660	47	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20752	20762		10.1074/jbc.M700487200	http://dx.doi.org/10.1074/jbc.M700487200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517894	hybrid			2022-12-27	WOS:000247819300077
J	Levine, YC; Li, GK; Michel, T				Levine, Yehoshua C.; Li, Gordon K.; Michel, Thomas			Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells - Evidence for an AMPK -> Rac1 -> Akt -> Endothelial nitric-oxide synthase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-TALK; DIFFERENTIAL REGULATION; SIGNALING PATHWAYS; RNA INTERFERENCE; FATTY-ACID; PHOSPHORYLATION; AKT; ANGIOGENESIS; RECEPTORS; BETA	The endothelial isoform of nitric-oxide synthase (eNOS), a key determinant of vascular homeostasis, is a calcium/calmodulin-dependent phosphoprotein regulated by diverse cell surface receptors. Vascular endothelial growth factor (VEGF) and sphingosine 1-phosphate (S1P) stimulate eNOS activity through Akt/phosphoinositide 3-kinase and calcium-dependent pathways. AMP-activated protein kinase (AMPK) also activates eNOS in endothelial cells; however, the molecular mechanisms linking agonist-mediated AMPK regulation with eNOS activation remain incompletely understood. We studied the role of AMPK in VEGF- and S1P-mediated eNOS activation and found that both agonists led to a striking increase in AMPK phosphorylation in pathways involving the calcium/calmodulin-dependent protein kinase kinase beta. Treatment with tyrosine kinase inhibitors or the phosphoinositide 3-kinase inhibitor wortmannin demonstrated differential effects of VEGF versus S1P. Small interfering RNA (siRNA)-mediated knockdown of AMPK alpha 1 or Akt1 impaired the stimulatory effects of both VEGF and S1P on eNOS activation. AMPK alpha 1 knockdown impaired agonist-mediated Akt phosphorylation, whereas Akt1 knockdown did not affect AMPK activation, thus suggesting that AMPK lies upstream of Akt in the pathway leading from receptor activation to eNOS stimulation. Importantly, we found that siRNA-mediated knockdown of AMPK alpha 1 abrogates agonist-mediated activation of the small GTPase Rac1. Conversely, siRNA-mediated knockdown of Rac1 decreased the agonist-mediated phosphorylation of AMPK substrates without affecting that of AMPK, implicating Rac1 as a molecular link between AMPK and Akt in agonist-mediated eNOS activation. Finally, siRNA-mediated knockdown of caveolin-1 significantly enhanced AMPK phosphorylation, suggesting that AMPK is negatively regulated by caveolin-1. Taken together, these results suggest that VEGF and S1P differentially regulate AMPK and establish a central role for an agonist-modulated AMPK -> Rac1 -> Akt axis in the control of eNOS in endothelial cells.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Michel, T (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	tmichel@research.bwh.harvard.edu			NHLBI NIH HHS [HL 48743, HL 46457] Funding Source: Medline; NIGMS NIH HHS [GM 36259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046457, P01HL048743, R29HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; BALLIGAND JL, 1995, J BIOL CHEM, V270, P14582, DOI 10.1074/jbc.270.24.14582; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Brandes RP, 2003, ANTIOXID REDOX SIGN, V5, P803, DOI 10.1089/152308603770380115; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; GRANT DS, 1994, PATHOL RES PRACT, V190, P854; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; HORS B, 2004, FEBS LETT, V573, P175; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Jozkowicz A, 2004, GROWTH FACTORS, V22, P19, DOI 10.1080/0897719041682863; Kang YJ, 2006, J BIOL CHEM, V281, P26225, DOI 10.1074/jbc.M606800200; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; Kou RQ, 2005, BIOCHEMISTRY-US, V44, P15064, DOI 10.1021/bi0509898; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Mount PF, 2005, AM J PHYSIOL-RENAL, V289, pF1103, DOI 10.1152/ajprenal.00458.2004; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Palanivel R, 2005, ENDOCRINE, V26, P71, DOI 10.1385/ENDO:26:1:071; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rikitake Y, 2002, ARTERIOSCL THROM VAS, V22, P108, DOI 10.1161/hq0102.101843; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sambandam N, 2003, PROG LIPID RES, V42, P238, DOI 10.1016/S0163-7827(02)00065-6; Schulz E, 2005, CIRCULATION, V111, P3473, DOI 10.1161/CIRCULATIONAHA.105.546812; Seebach J, 2005, THROMB HAEMOSTASIS, V94, P620, DOI 10.1160/TH05-01-0015; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soltys CLM, 2006, AM J PHYSIOL-HEART C, V290, pH2472, DOI 10.1152/ajpheart.01206.2005; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang Q, 2006, J BIOL CHEM, V281, P10174, DOI 10.1074/jbc.M513008200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	64	174	182	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20351	20364		10.1074/jbc.M702182200	http://dx.doi.org/10.1074/jbc.M702182200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17519230	hybrid			2022-12-27	WOS:000247819300038
J	Bourguignon, LYW; Gilad, E; Peyrollier, K				Bourguignon, Lilly Y. W.; Gilad, Eli; Peyrollier, Karine			Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-BINDING DOMAIN; CD44 INTERACTION; NUCLEAR TRANSLOCATION; FACTOR RECEPTOR; PROTEIN-KINASE; CYTOSKELETON FUNCTION; CYCLE PROGRESSION; HUMAN-BREAST; RHO GTPASES; PROMOTES	Heregulin (HRG)-induced cell responses are mediated by the ErbB family of tyrosine kinase receptors. In this study we have investigated HRG activation of ErbB2, extracellular signal-regulated kinase (ERK) signaling, and their role in regulating hyaluronan synthase (HAS) activity in human ovarian tumor cells (SK-OV-3.ipl cells). Immunological and biochemical analyses indicate that ErbB2, ErbB3, and ErbB4 are all expressed in SK-OV-3.ipl cells and that ErbB4 (but not ErbB3) is physically linked to ErbB2 following HRG stimulation. Furthermore, our data indicate that the HRG-induced ErbB2(.)ErbB4 complexes stimulate ErbB2 tyrosine kinase, which induces both ERK phosphorylation and kinase activity. The activated ERK then increases the phosphorylation of HAS1, HAS2, and HAS3. Consequently, all three HAS isozymes are activated resulting in hyaluronan (HA) production. Because HRG-mediated HAS isozyme phosphorylation/activation can be effectively blocked by either AG825 (an ErbB2 inhibitor) or thiazolidinedione compound (an ERK blocker), we conclude that ErbB2-ERK signaling and HAS isozyme phosphorylation/HA production are functionally coupled in SK-OV-3.ipl cells. HRG also promotes HA- and CD44-dependent oncogenic events (e. g. CD44-Cdc42 association, p21-activated kinase 1 activation, and p21-activated kinase 1-filamin complex formation) and tumor cell-specific behaviors in an ErbB2-ERK signaling-dependent manner. Finally, we have found that the down-regulation of HAS isozyme expression (by transfecting cells with HAS1/HAS2/HAS3-specific small interfering RNAs) not only inhibits HRG-mediated HAS phosphorylation/ activation and HA production but also impairs CD44-specific Cdc42-PAK1/filamin signaling, cytoskeleton activation and tumor cell behaviors. Taken together, these findings clearly indicate that HRG activation of ErbB2-ERK signaling modulates HAS phosphorylation/activation and HA production leading to CD44-mediated oncogenic events and ovarian cancer progression.	Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med, Endocrine Unit 111N, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med, Endocrine Unit 111N, 4150 Clemen St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu			NCI NIH HHS [R01 CA78633, R01 CA66163] Funding Source: Medline; NIAMS NIH HHS [P01 AR39448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078633, R01CA066163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anttila MA, 2000, CANCER RES, V60, P150; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BAUKNECHT T, 1988, GYNECOL ONCOL, V29, P147, DOI 10.1016/0090-8258(88)90209-0; BERCHUCK A, 1990, CANCER RES, V50, P4087; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P29654, DOI 10.1074/jbc.M403608200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; BOURGUIGNON LYW, 1998, FRONT BIOSCI, V3, P637; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Campiglio M, 1999, J CELL BIOCHEM, V73, P522, DOI 10.1002/(SICI)1097-4644(19990615)73:4<522::AID-JCB10>3.0.CO;2-4; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cook AC, 2006, J BIOL CHEM, V281, P24381, DOI 10.1074/jbc.M602694200; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Fiddes RJ, 1998, ONCOGENE, V16, P2803, DOI 10.1038/sj.onc.1201815; FOX H, 1990, CLIN GYNAECOLOGICAL, P188; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Gilmour LMR, 2002, CLIN CANCER RES, V8, P3933; Gilmour LMR, 2001, CANCER RES, V61, P2169; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HOSKINS WJ, 1993, CANCER, V71, P1534, DOI 10.1002/cncr.2820710420; HUNG MC, 1992, CANCER LETT, V61, P95, DOI 10.1016/0304-3835(92)90166-S; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1999, CANCER RES, V59, P2499; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Itano N, 1998, TRENDS GLYCOSCI GLYC, V10, P23, DOI 10.4052/tigg.10.23; Kosaki R, 1999, CANCER RES, V59, P1141; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; LIAO HX, 1995, J IMMUNOL, V155, P3938; Liu NF, 2001, CANCER RES, V61, P5207; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pegues JC, 1999, INT J ONCOL, V14, P1169; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Riese DJ, 1998, J BIOL CHEM, V273, P11288, DOI 10.1074/jbc.273.18.11288; Riese DJ, 1996, ONCOGENE, V12, P345; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Soltes L, 2006, BIOMACROMOLECULES, V7, P659, DOI 10.1021/bm050867v; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116, DOI 10.1046/j.1523-1747.1998.00093.x; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; TOOLE BP, 1991, CELL BIOL EXTRACELLU, V19, P305; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vijapurkar U, 2003, EXP CELL RES, V284, P291, DOI 10.1016/S0014-4827(02)00040-X; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Weigel PH, 2006, J BIOL CHEM, V281, P36542, DOI 10.1074/jbc.M606529200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Yabushita H, 2004, ONCOL REP, V12, P739; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; ZHANG LR, 1995, CANCER RES, V55, P428; Zhu D, 2000, J CELL PHYSIOL, V183, P182, DOI 10.1002/(SICI)1097-4652(200005)183:2<182::AID-JCP5>3.0.CO;2-O; Zhu D, 1998, CELL MOTIL CYTOSKEL, V39, P209, DOI 10.1002/(SICI)1097-0169(1998)39:3<209::AID-CM4>3.0.CO;2-#	95	128	132	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19426	19441		10.1074/jbc.M610054200	http://dx.doi.org/10.1074/jbc.M610054200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17493932	hybrid			2022-12-27	WOS:000247650600017
J	Eoff, RL; Irimia, A; Angel, KC; Egli, M; Guengerich, P				Eoff, Robert L.; Irimia, Adriana; Angel, Karen C.; Egli, Martin; Guengerich, Peter			Hydrogen bonding of 7,8-dihydro-8-oxodeoxyguanosine with a charged residue in the little finger domain determines miscoding events in Sulfolobus solfataricus DNA polymerase Dpo4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE KINETIC-ANALYSIS; RAY-DIFFRACTION DATA; STEADY-STATE; CRYSTAL-STRUCTURE; NUCLEOTIDE INCORPORATION; REPLICATION FIDELITY; LESION-BYPASS; ERROR-PRONE; Y-FAMILY; ETA	Sulfolobus solfataricus P2 DNA polymerase IV (Dpo4) has been shown to catalyze bypass of 7,8-dihydro-8-oxodeoxyguanosine (8-oxoG) in a highly efficient and relatively accurate manner. Crystal structures have revealed a potential role for Arg332 in stabilizing the anti conformation of the 8-oxoG template base by means of a hydrogen bond or ion-dipole pair, which results in an increased enzymatic efficiency for dCTP insertion and makes formation of a Hoogsteen pair between 8-oxoG and dATP less favorable. Site-directed mutagenesis was used to replace Arg(332) with Ala, Glu, Leu, or His in order to probe the importance of Arg(332) in accurate and efficient bypass of 8-oxoG. The double mutant Ala(331)Ala(332) was also prepared to address the contribution of Arg(331). Transientstate kinetic results suggest that Glu(332) retains fidelity against bypass of 8-oxoG that is similar to wild type Dpo4, a result that was confirmed by tandem mass spectrometric analysis of full-length extension products. A crystal structure of the Dpo4 Glu(332) mutant and 8-oxoG: C pair revealed water-mediated hydrogen bonds between Glu(332) and the O-8 atom of 8-oxoG. The space normally occupied by Arg(332) side chain is empty in the crystal structures of the Ala(332) mutant. Twoother crystal structures show that a Hoogsteen base pair is formed between 8-oxoG andAin the active site of both Glu(332) and Ala(332) mutants. These results support the view that a bond between Arg(332) and 8-oxoG plays a role in determining the fidelity and efficiency of Dpo4-catalyzed bypass of the lesion.	Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, P (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem, 23rd Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			NCI NIH HHS [F32 CA119776] Funding Source: Medline; NIEHS NIH HHS [P30 ES000267, R01 ES010375, P01 ES05355] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355, R01ES010375, P30ES000267] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMES BN, 1979, SCIENCE, V204, P587, DOI 10.1126/science.373122; BOYER PD, 1960, ANNU REV BIOCHEM, V29, P15, DOI 10.1146/annurev.bi.29.070160.000311; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carlson KD, 2005, MOL CELL BIOL, V25, P2169, DOI 10.1128/MCB.25.6.2169-2176.2005; Choi JY, 2006, J BIOL CHEM, V281, P25297, DOI 10.1074/jbc.M605699200; Christian NP, 2001, J AM SOC MASS SPECTR, V12, P744, DOI 10.1016/S1044-0305(01)00228-8; DeLucia AM, 2006, J BIOL CHEM, V281, P27286, DOI 10.1074/jbc.M604393200; Einolf HJ, 2001, J BIOL CHEM, V276, P3764, DOI 10.1074/jbc.M006696200; Einolf HJ, 1998, BIOCHEMISTRY-US, V37, P13300, DOI 10.1021/bi981346d; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; HOWARD AJ, 2000, CRYSTALLOGRAPHIC COM, V7; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Lowe LG, 1996, BIOCHEMISTRY-US, V35, P9840, DOI 10.1021/bi960485x; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; McElhinny SAN, 2007, J BIOL CHEM, V282, P2324, DOI 10.1074/jbc.M609591200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; Wang YL, 2006, PROTEIN SCI, V15, P135, DOI 10.1110/ps.051726906; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	44	61	61	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19831	19843		10.1074/jbc.M702290200	http://dx.doi.org/10.1074/jbc.M702290200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17468100	Green Submitted, hybrid			2022-12-27	WOS:000247650600058
J	Purushothaman, A; Fukuda, J; Mizumoto, S; ten Dam, GB; van Kuppevelt, TH; Kitagawa, H; Mikami, T; Sugahara, K				Purushothaman, Anurag; Fukuda, Junko; Mizumoto, Shuji; ten Dam, Gerdy B.; van Kuppevelt, Toin H.; Kitagawa, Hiroshi; Mikami, Tadahisa; Sugahara, Kazuyuki			Functions of chondroitin sulfate/dermatan sulfate chains in brain development - Critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-ASSOCIATED MOLECULE; OVERSULFATED DERMATAN SULFATE; OUTGROWTH-PROMOTING ACTIVITY; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC PIG BRAIN; NEURITE OUTGROWTH; MONOCLONAL-ANTIBODY; ZETA/RPTP-BETA	Chondroitin sulfate (CS) and dermatan sulfate (DS) have been implicated in the processes of neural development in the brain. In this study, we characterized developmentally regulated brain CS/DS chains using a single chain antibody, GD3G7, produced by the phage display technique. Evaluation of the specificity of GD3G7 toward various glycosaminoglycan preparations showed that this antibody specifically reacted with squid CS-E (rich in the GlcUA beta 1-3GalNAc(4,6-O-sulfate) disaccharide unit E), hagfish CS-H (rich in the IdoUA alpha 1-3GalNAc(4,6-Osulfate) unit iE), and shark skin DS (rich in both E and iE units). In situ hybridization for the expression of N-acetylgalactosamine-4-sulfate 6-O-sulfotransferase in the postnatal mouse brain, which is involved in the biosynthesis of CS/DS-E, showed a widespread expression of the transcript in the developing brain except at postnatal day 7, where strong expression was observed in the external granule cell layer in the cerebellum. The expression switched from the external to internal granule cell layer with development. Immunohistochemical localization of GD3G7 in the mouse brain showed that the epitope was relatively abundant in the cerebellum, hippocampus, and olfactory bulb. GD3G7 suppressed the growth of neurites in embryonic hippocampal neurons mediated by CS-E, suggesting that the epitope is embedded in the neurite outgrowth- promoting motif of CS-E. In addition, a CS-E decasaccharide fraction was found to be the critical minimal structure needed for recognition by GD3G7. Four discrete decasaccharide epitopic sequences were identified. The antibody GD3G7 has broad applications in investigations of CS/DS chains during the central nervous system's development and under various pathological conditions.	Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 658, Japan; Hokkaido Univ, Frontier Res Ctr Post Genom Sci & Technol, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Sapporo, Hokkaido 0010021, Japan; Radboud Univ Nijmegen, Med Ctr, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Kobe Pharmaceutical University; Hokkaido University; Radboud University Nijmegen	Sugahara, K (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 658, Japan.	k-sugar@sci.hokudai.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020; van Kuppevelt, A.H.M.S.M./L-4463-2015; Mizumoto, Shuji/F-8313-2018	Kitagawa, Hiroshi/0000-0002-9307-7079; Mizumoto, Shuji/0000-0002-4641-1505				ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ANNO K, 1971, BIOCHIM BIOPHYS ACTA, V237, P173, DOI 10.1016/0304-4165(71)90046-8; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Engel M, 1996, J COMP NEUROL, V366, P34; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fansson LA, 2000, MATRIX BIOL, V19, P367, DOI 10.1016/S0945-053X(00)00083-4; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinsella MG, 1997, J BIOL CHEM, V272, P318; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; KITAGAWA H, 1995, J BIOCHEM-TOKYO, V117, P1083, DOI 10.1093/oxfordjournals.jbchem.a124810; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; LAFONT F, 1992, DEVELOPMENT, V114, P17; LIAW PC, 2001, J BIOL CHEM, V276, P5228; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Okuda T, 2000, J BIOCHEM, V128, P763, DOI 10.1093/oxfordjournals.jbchem.a022813; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Pons S, 2000, DEVELOPMENT, V127, P333; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; ROSENBERG LC, 1985, J BIOL CHEM, V260, P6304; SAIGO K, 1970, J NEUROCHEM, V17, P633, DOI 10.1111/j.1471-4159.1970.tb00543.x; Salinero O, 2000, J NEUROSCI RES, V60, P87, DOI 10.1002/(SICI)1097-4547(20000401)60:1<87::AID-JNR9>3.0.CO;2-C; Schwartz NB, 2004, GLYCOCONJUGATE J, V21, P329, DOI 10.1023/B:GLYC.0000046278.34016.36; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SMETSERS TF, 2004, J INVEST DERMATOL, V122, P202; Sorrell JM, 1999, HISTOCHEM J, V31, P549; SORRELL JM, 1993, MATRIX, V13, P351, DOI 10.1016/S0934-8832(11)80040-5; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Tsuchida K, 2001, J BIOL CHEM, V276, P37155, DOI 10.1074/jbc.M105818200; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Ueoka C, 1999, GLYCOCONJUGATE J, V16, P291, DOI 10.1023/A:1007022229813; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; WATANABE E, 1995, J BIOL CHEM, V270, P26876, DOI 10.1074/jbc.270.45.26876; Wu AF, 1997, J NEUROSCI, V17, P4987; YAMADA H, 1994, J BIOL CHEM, V269, P10119; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yamauchi S, 1999, J BIOL CHEM, V274, P2456, DOI 10.1074/jbc.274.4.2456; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Zou P, 2003, GLYCOBIOLOGY, V13, P35, DOI 10.1093/glycob/cwg001	77	71	72	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19442	19452		10.1074/jbc.M700630200	http://dx.doi.org/10.1074/jbc.M700630200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500059	hybrid, Green Published			2022-12-27	WOS:000247650600018
J	Zhang, JL; Huang, Y; Qiu, LY; Nickel, J; Sebald, W				Zhang, Jin-Li; Huang, Yi; Qiu, Li-Yan; Nickel, Joachim; Sebald, Walter			von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TWISTED GASTRULATION; BMP RECEPTOR IA; TGF-BETA; MOLECULAR RECOGNITION; CELL-DIFFERENTIATION; STRUCTURAL BASIS; II RECEPTORS; IN-VITRO; CHORDIN; BINDING	Bone morphogenetic protein (BMP) function is regulated in the extracellular space by many modulator proteins, including those containing a von Willebrand factor typeC(VWC) domain. The function of the VWC domain-containing proteins in development and diseases has been extensively studied. The structural basis, however, for the mechanism by which BMP is regulated by these proteins is still poorly understood. By analyzing chordin, CHL2 (chordin-like 2), and CV2 ( crossveinless 2) as well as their individual VWC domains, we show that the VWC domain is a versatile binding module that in its multiple forms and environments can expose a variety of binding specificities. Three of four, two of three, and one of five VWCs from chordin, CHL2, and CV2, respectively, can bind BMPs. Using an array of BMP-2 mutant proteins, it can be demonstrated that the binding competent VWC domains all use a specific subset of BMP-2 binding determinants that overlap with the binding site for the type II receptors (knuckle epitope) or for the type I receptors (wrist epitope). This explains the competition between modulator proteins and receptors for BMP binding and therefore the inhibition of BMP signaling. A subset of VWC domains from CHL2 binds to the Tsg (twisted gastrulation) protein similar to chordin. A stable ternary complex consisting of BMP- 2, CHL2, and Tsg can be formed, thus making CHL2 a more efficient BMP-2 inhibitor. The VWCs of CV2, however, do not interact with Tsg. The present results show that chordin, CHL2, and CV2 regulate BMP-2 signaling by different recognition mechanisms.	Univ Wurzburg, Bioctr, Dept Physiol Chem, D-97074 Wurzburg, Germany	University of Wurzburg	Zhang, JL (corresponding author), Univ Wurzburg, Bioctr, Dept Physiol Chem, D-97074 Wurzburg, Germany.	zhang@biozentrum.uni-wuerzburg.de						Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P3875, DOI 10.1210/en.2005-0053; Gazzerro E, 2006, BONE, V39, P1252, DOI 10.1016/j.bone.2006.06.028; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; Harrison CA, 2006, ENDOCRINOLOGY, V147, P2744, DOI 10.1210/en.2006-0131; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hogan B L, 1996, Harvey Lect, V92, P83; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Jasuja R, 2004, J BIOL CHEM, V279, P51289, DOI 10.1074/jbc.M408129200; Kamimura M, 2004, DEV DYNAM, V230, P434, DOI 10.1002/dvdy.20069; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X; Larrain J, 2001, DEVELOPMENT, V128, P4439; Larrain J, 2000, DEVELOPMENT, V127, P821; Larrain J, 2003, EMBO REP, V4, P813, DOI 10.1038/sj.embor.embor902; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lin JM, 2006, MOL CELL BIOL, V26, P4577, DOI 10.1128/MCB.02127-05; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Nakayama N, 2004, DEVELOPMENT, V131, P229, DOI 10.1242/dev.00901; Nosaka T, 2003, MOL CELL BIOL, V23, P2969, DOI 10.1128/MCB.23.8.2969-2980.2003; O'Connor MB, 2006, DEVELOPMENT, V133, P183; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; Petryk A, 2004, DEV BIOL, V267, P374, DOI 10.1016/j.ydbio.2003.11.015; Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; Schmidl M, 2006, J BIOL CHEM, V281, P31790, DOI 10.1074/jbc.M603419200; Scott IC, 2000, DEV DYNAM, V217, P449, DOI 10.1002/(SICI)1097-0177(200004)217:4<449::AID-DVDY12>3.0.CO;2-8; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tobin JF, 2006, DRUG DISCOV TODAY, V11, P405, DOI 10.1016/j.drudis.2006.03.016; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Watters MR, 2005, SEMIN NEUROL, V25, P278, DOI 10.1055/s-2005-917664; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Wills A, 2006, DEV BIOL, V289, P166, DOI 10.1016/j.ydbio.2005.10.022; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577; Yu K, 2004, GENETICS, V166, P1323, DOI 10.1534/genetics.166.3.1323; Zakin L, 2004, DEVELOPMENT, V131, P413, DOI 10.1242/dev.00946; Zhang DH, 2002, J BONE MINER RES, V17, P293, DOI 10.1359/jbmr.2002.17.2.293	57	84	89	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					20002	20014		10.1074/jbc.M700456200	http://dx.doi.org/10.1074/jbc.M700456200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17483092	hybrid			2022-12-27	WOS:000247650600074
J	Kyzer, S; Ha, KS; Landick, R; Palangat, M				Kyzer, Scotty; Ha, Kook Sun; Landick, Robert; Palangat, Murali			Direct versus limited-step reconstitution reveals key features of an RNA hairpin-stabilized paused transcription complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTACTS NASCENT RNA; POLYMERASE-II; ELONGATION COMPLEXES; STRUCTURAL BASIS; DNA HYBRID; TRANSLOCATION; SITE; BUBBLE; PROCESSIVITY; TERMINATION	We have identified minimal nucleic acid scaffolds capable of reconstituting hairpin-stabilized paused transcription complexes when incubated with RNAP either directly or in a limited step reconstitution assay. Direct reconstitution was achieved using a 29-nucleotide (nt) RNA whose 3'-proximal 9-10 nt pair to template DNA within an 11-nt noncomplementary bubble of a 39-bp duplex DNA; the 5'-proximal 18 nt of RNA forms the his pause RNA hairpin. Limited- step reconstitution was achieved on the same DNAs using a 27-nt RNA that can be 3'-labeled during reconstitution and then extended 2 nt past the pause site to assay transcriptional pausing. Paused complexes formed by either method recapitulated key features of a promoter-initiated, hairpin-stabilized paused complex, including a slow rate of pause escape, resistance to transcript cleavage and pyrophosphorolysis, and enhancement of pausing by the elongation factor NusA. These findings establish that RNA upstream from the pause hairpin and pyrophosphate are not essential for pausing and for NusA action. Reconstitution of the his paused transcription complex provides a valuable tool for future studies of protein-nucleic interactions involved in transcriptional pausing.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.	landick@bact.wisc.edu; palangat@facstaff.wisc.edu	Palangat, Murali/AAK-5445-2021	Palangat, Murali/0000-0002-3327-3844	NIGMS NIH HHS [GM38660, T32 GM07215] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R01GM038660, R29GM038660, T32GM007215] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Landick R, 2001, CELL, V105, P567, DOI 10.1016/S0092-8674(01)00381-6; Landick R, 1996, ESCHERICHIA COLI SAL, P1263; LEE DN, 1990, J BIOL CHEM, V265, P15145; LEE DN, 1992, J MOL BIOL, V228, P759, DOI 10.1016/0022-2836(92)90862-E; LIU K, 1995, J MOL BIOL, V247, P547, DOI 10.1016/S0022-2836(05)80136-6; Milan S, 1999, BIOCHEMISTRY-US, V38, P218, DOI 10.1021/bi9818422; Nedialkov YA, 2003, J BIOL CHEM, V278, P18303, DOI 10.1074/jbc.M301103200; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Ryder AM, 2003, J MOL BIOL, V334, P205, DOI 10.1016/j.jmb.2003.09.039; SHI YB, 1988, J MOL BIOL, V199, P277, DOI 10.1016/0022-2836(88)90314-2; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; TOULOKHONOV I, 2007, IN PRESS MOL CELL; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wilson KS, 1999, J MOL BIOL, V289, P1179, DOI 10.1006/jmbi.1999.2814; Worbs M, 2001, MOL CELL, V7, P1177, DOI 10.1016/S1097-2765(01)00262-3; YANOFSKY C, 1988, J BIOL CHEM, V263, P609; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	37	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19020	19028		10.1074/jbc.M701483200	http://dx.doi.org/10.1074/jbc.M701483200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17502377	hybrid			2022-12-27	WOS:000247475300044
J	Marion, S; Fralish, GB; Laporte, S; Caron, MG; Barak, LS				Marion, Sebastien; Fralish, Gregory B.; Laporte, Stephane; Caron, Marc G.; Barak, Larry S.			N-terminal tyrosine modulation of the endocytic adaptor function of the beta-arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; CYTOPLASMIC DOMAIN; CLATHRIN ADAPTER; SRC; PHOSPHORYLATION; INTERNALIZATION; BETA-ARRESTIN1; ACTIVATION; SEQUENCE	The highly homologous beta-arrestin1 and -2 adaptor proteins play important roles in the function of G protein-coupled receptors. Either beta-arrestin variant can function as a molecular chaperone for clathrin-mediated receptor internalization. This role depends primarily upon two distinct, contiguous C-terminal beta-arrestin motifs recognizing clathrin and the mu-adaptin subunit of AP2. However, a molecular basis is lacking to explain the different endocytic efficacies of the two beta-arrestin isoforms and the observation that beta-arrestin N-terminal substitution mutants can act as dominant negative inhibitors of receptor endocytosis. Despite the near identity of the beta-arrestins throughout their N termini, sequence variability is present at a small number of residues and includes tyrosine to phenylalanine substitutions. Here we show that corresponding N-terminal (Y/F) VTL sequences in beta-arrestin1 and -2 differentially regulate mu-adaptin binding. Our results indicate that the beta-arrestin1 Tyr-54 lessens the interaction with mu-adaptin and moreover is a Src phosphorylation site. Again of endocytic function is obtained with the beta-arrestin1 Y54F substitution, which improves both the beta-arrestin1 interaction with mu-adaptin and the ability to enhance beta 2-adrenergic receptor internalization. These data indicate that beta-arrestin2 utilizes mu-adaptin as an endocytic partner, and that the inability of beta-arrestin1 to sustain a similar degree of interaction with mu-adaptin may result from coordination of Tyr-54 by neighboring residues or its modification by Src kinase. Additionally, these naturally occurring variations in beta-arrestins may also differentially regulate the composition of the signaling complexes organized on the receptor.	Duke Univ, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Caron, MG (corresponding author), Duke Univ, Box 3287, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu; l.barak@cellbio.duke.edu	Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021	Laporte, Stephane/0000-0002-0633-543X; Marion, Sebastien/0000-0002-3302-3845	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM069086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 61365] Funding Source: Medline; NIGMS NIH HHS [GM 069086] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; *DEL SCI, 2002, PYMOL MOL GRAPH SYST; Eng FJ, 1999, MOL BIOL CELL, V10, P35, DOI 10.1091/mbc.10.1.35; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Mundell SJ, 2002, MOL PHARMACOL, V61, P1114, DOI 10.1124/mol.61.5.1114; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; Ohno H, 1998, GENE, V210, P187, DOI 10.1016/S0378-1119(97)00649-5; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Wakeham DE, 2000, TRAFFIC, V1, P393, DOI 10.1034/j.1600-0854.2000.010504.x; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4	38	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18937	18944		10.1074/jbc.M700090200	http://dx.doi.org/10.1074/jbc.M700090200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17456469	hybrid			2022-12-27	WOS:000247475300035
J	Chou, WL; Chuang, LM; Chou, CC; Wang, AHJ; Lawson, JA; FitzGerald, GA; Chang, ZF				Chou, Wen-Ling; Chuang, Lee-Ming; Chou, Chi-Chi; Wang, Andrew H. -J.; Lawson, John A.; FitzGerald, Garret A.; Chang, Zee-Fen			Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E-2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; GENE-EXPRESSION; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; CDNA CLONING; LIGAND; METABOLISM; DEHYDROGENASE; BINDING; OBESITY	This report identifies a novel gene encoding 15-oxoprostaglandin-Delta(13)-reductase (PGR-2), which catalyzes the reaction converting 15-keto-PGE(2) to 13,14-dihydro-15-keto-PGE(2). The expression of PGR-2 is up-regulated in the late phase of 3T3-L1 adipocyte differentiation and predominantly distributed in adipose tissue. Overexpression of PGR-2 in cells decreases peroxisome proliferator-activated receptor gamma ( PPAR gamma)-dependent transcription and prohibits 3T3-L1 adipocyte differentiation without affecting expression of PPAR gamma. Interestingly, we found that 15-keto-PGE(2) can act as a ligand of PPAR gamma to increase coactivator recruitment, thus activating PPAR gamma-mediated transcription and enhancing adipogenesis of 3T3-L1 cells. Overexpression of 15-hydroxyprostaglandin dehydrogenase, which catalyzes the oxidation reaction of PGE(2) to form 15-keto-PGE(2), significantly increased PPAR gamma-mediated transcription in a PGE(2)-dependent manner. Reciprocally, overexpression of wild-type PGR-2, but not the catalytically defective mutant, abolished the effect of 15-keto-PGE(2) on PPAR gamma activation. These results demonstrate a novel link between catabolism of PGE(2) and regulation of ligand-induced PPAR gamma activation.	Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; Natl Core Facilities Proteom Res, Taipei 115, Taiwan; Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; University of Pennsylvania; Pennsylvania Medicine	Chang, ZF (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, No 1,Sec 1,Jen Ai Rd, Taipei 100, Taiwan.	ZFCHANG@ha.mc.ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019; FitzGerald, Garret A/A-4222-2010; Chou, Chi-Chi/X-6053-2019	Chou, Chi-Chi/0000-0002-7862-7757; CHUANG, LEE-MING/0000-0003-0978-2662				ANGGARD E, 1971, ACTA PHYSIOL SCAND, V81, P396, DOI 10.1111/j.1748-1716.1971.tb04914.x; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Ensor CM, 1998, BIOCHEM J, V330, P103, DOI 10.1042/bj3300103; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Glass CK, 2000, GENE DEV, V14, P121; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hori T, 2004, J BIOL CHEM, V279, P22615, DOI 10.1074/jbc.M312655200; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; HYMAN BT, 1982, BIOCHIM BIOPHYS ACTA, V713, P375, DOI 10.1016/0005-2760(82)90256-9; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; RICHELSEN B, 1991, DAN MED BULL, V38, P228; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen O M, 1979, Recent Prog Horm Res, V35, P477; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; Shivanandappa T, 1997, ANAL BIOCHEM, V254, P57, DOI 10.1006/abio.1997.2406; Soukas A, 2000, GENE DEV, V14, P963; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yokomizo T, 1996, J BIOL CHEM, V271, P2844, DOI 10.1074/jbc.271.5.2844	39	73	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18162	18172		10.1074/jbc.M702289200	http://dx.doi.org/10.1074/jbc.M702289200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17449869	Green Published, hybrid			2022-12-27	WOS:000247302000022
J	Pfluger, K; de Lorenzo, V				Pfluger, Katharina; de Lorenzo, Victor			Growth-dependent phosphorylation of the PtsN (EIINtr) protein of Pseudomonas putida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PHOSPHOTRANSFERASE SYSTEM; SIGMA(54) PU PROMOTER; ESCHERICHIA-COLI; TOL PLASMID; ENZYME IIA(NTR); CATABOLITE REPRESSION; GENETIC-EVIDENCE; GENOME SEQUENCE; RNA-POLYMERASE; NITROGEN	The nitrogen-related branch of the phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS) of Pseudomonas putida includes the ptsN gene encoding the EIINtr (PtsN) enzyme. Although the implication of this protein in a variety of cellular functions has been observed in diverse bacteria, the physiological signals that bring about phosphorylation/dephosphorylation of the PtsN protein are not understood. This work documents the phosphorylation status of the EIINtr enzyme of P. putida at various growth stages in distinct media. Culture conditions were chosen to include fructose (the uptake of which is controlled by the PTS) or glucose (a non-PTS sugar in P. putida) in minimal medium with casamino acids, ammonia, or nitrate as alternative nitrogen sources. To quantify the relative ratio of PtsN/PtsN similar to P in live cells, we resorted to the in situ electrophoresis of whole bacteria expressing an E-epitope-tagged EIINtr followed by the fractionation of the thereby released native proteome in a non-denaturing gel. Although the PtsN species phosphorylated in amino acid His(68) was detected under virtually all growth scenarios, the relative levels of the non-phosphorylated form varied dramatically depending on the growth phase and the nutrients available in the medium. The share of phosphorylated PtsN increased along growth in a fashion apparently independent of any trafficking of sugars. The large variations of non-phosphorylated PtsN in different growth conditions, in contrast to the systematic excess of the phosphorylated PtsN form, suggested that the P-free PtsN is the predominant signaling species of the protein.	CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	de Lorenzo, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus de Cantoblanco, E-28049 Madrid, Spain.	vdlorenzo@cnb.uam.es		de Lorenzo, Victor/0000-0002-6041-2731				Aranda-Olmedo I, 2005, APPL ENVIRON MICROB, V71, P4191, DOI 10.1128/AEM.71.8.4191-4198.2005; Aranda-Olmedo I, 2006, APPL ENVIRON MICROB, V72, P7418, DOI 10.1128/AEM.01067-06; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bordo D, 1998, J MOL BIOL, V279, P245, DOI 10.1006/jmbi.1998.1753; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Carmona M, 1999, J BIOL CHEM, V274, P33790, DOI 10.1074/jbc.274.47.33790; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; Cases I, 1999, J BIOL CHEM, V274, P15562, DOI 10.1074/jbc.274.22.15562; Cases I, 1996, MOL MICROBIOL, V19, P7, DOI 10.1046/j.1365-2958.1996.345873.x; Cases I, 2000, J BACTERIOL, V182, P956, DOI 10.1128/JB.182.4.956-960.2000; Cases I, 2001, J BACTERIOL, V183, P5128, DOI 10.1128/JB.183.17.5128-5133.2001; Cases I, 2001, J BACTERIOL, V183, P1032, DOI 10.1128/JB.183.3.1032-1037.2001; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jurado P, 2002, J MOL BIOL, V320, P1, DOI 10.1016/S0022-2836(02)00405-9; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; KOHLER T, 1994, FEMS MICROBIOL LETT, V115, P177, DOI 10.1016/0378-1097(94)90010-8; Lasker M, 1999, PROTEIN SCI, V8, P2177, DOI 10.1110/ps.8.10.2177; Laurie AD, 2003, J BIOL CHEM, V278, P1494, DOI 10.1074/jbc.M209268200; Lee CR, 2007, P NATL ACAD SCI USA, V104, P4124, DOI 10.1073/pnas.0609897104; Lee CR, 2005, MOL MICROBIOL, V58, P334, DOI 10.1111/j.1365-2958.2005.04834.x; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Paustian ML, 2002, J BACTERIOL, V184, P6714, DOI 10.1128/JB.184.23.6714-6720.2002; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Ren JS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-13; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; VALLS M, 2004, PSEUDOMONAS VIRULENC, V2, P289; Velazquez F, 2004, J BACTERIOL, V186, P8267, DOI 10.1128/JB.186.24.8267-8275.2004; VELAZQUEZ F, 2007, IN PRESS J BACTERIOL; Wang GS, 2005, PROTEIN SCI, V14, P1082, DOI 10.1110/ps.041232805; Weinel C, 2002, ENVIRON MICROBIOL, V4, P809, DOI 10.1046/j.1462-2920.2002.00331.x	41	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18206	18211		10.1074/jbc.M611110200	http://dx.doi.org/10.1074/jbc.M611110200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17478425	hybrid			2022-12-27	WOS:000247302000027
J	Deng, X; Yellaturu, C; Cagen, L; Wilcox, HG; Park, EA; Raghow, R; Elam, MB				Deng, Xiong; Yellaturu, Chandrahasa; Cagen, Lauren; Wilcox, Henry G.; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.			Expression of the rat sterol regulatory element-binding protein-1c gene in response to insulin is mediated by increased transactivating capacity of specificity protein 1 (Sp1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X RECEPTOR; NUCLEAR FACTOR-Y; O-GLYCOSYLATION; TRANSCRIPTIONAL ACTIVATION; SYNERGISTIC ACTIVATION; SREBP-1C PROMOTER; CALMODULIN GENE; COACTIVATOR; GLUCOSE; CELLS	The induction of genes involved in lipid biosynthesis by insulin is mediated in part by the sterol regulatory element-binding protein-1c ( SREBP-1c). SREBP-1c is directly regulated by insulin by transcriptional and post-transcriptional mechanisms. Previously, we have demonstrated that the insulin-responsive cis-acting unit of the rat SREBP-1c promoter is composed of several elements that include a sterol regulatory element, two liver X receptor elements, and a number of conserved GC boxes. Here we systematically dissected the role of these GC boxes and report that five bona fide Sp1-binding elements of the SREBP-1c promoter determine its basal and insulin-induced activation. Luciferase expression driven by the rat SREBP-1c promoter was accelerated by ectopic expression of Sp1, and insulin further enhanced the transactivation potential of Sp1. Introduction of a small interfering RNA against Sp1 reduced both basal and insulin-induced activation of the SREBP-1c promoter. We also found that Sp1 interacted with both SREBP-1c and LXR alpha proteins and that insulin promoted these interactions. Chromatin immunoprecipitation studies revealed that insulin facilitated the recruitment of the steroid receptor coactivator-1 to the SREBP-1c promoter. These studies identify a novel mechanism by which maximal activation of the rat SREBP-1c gene expression by insulin is mediated by Sp1 and its enhanced ability to interact with other transcriptional regulatory proteins.	Dept Vet Affairs Med Ctr, Med & Res Serv, Memphis, TN 38104 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Deng, X (corresponding author), Dept Vet Affairs Med Ctr, Med & Res Serv, Memphis, TN 38104 USA.	xdeng@utmem.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059368] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-059368] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; BEYNEN AC, 1979, DIABETES, V28, P828, DOI 10.2337/diabetes.28.9.828; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Elam MB, 2001, J LIPID RES, V42, P2039; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Jackson SM, 1998, J LIPID RES, V39, P767; Jump DB, 2001, J BIOL CHEM, V276, P34419, DOI 10.1074/jbc.M105471200; Jurado LA, 2002, J BIOL CHEM, V277, P27606, DOI 10.1074/jbc.M201429200; Majumdar G, 2006, J BIOL CHEM, V281, P3642, DOI 10.1074/jbc.M511223200; Majumdar G, 2004, DIABETES, V53, P3184, DOI 10.2337/diabetes.53.12.3184; Majumdar G, 2003, AM J PHYSIOL-ENDOC M, V285, pE584, DOI 10.1152/ajpendo.00140.2003; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Oh SY, 2003, J BIOL CHEM, V278, P28410, DOI 10.1074/jbc.M300553200; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Samson SLA, 2002, J MOL ENDOCRINOL, V29, P265, DOI 10.1677/jme.0.0290265; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Schafer D, 1997, FEBS LETT, V417, P325, DOI 10.1016/S0014-5793(97)01314-8; Schweizer M, 2002, BIOCHEM SOC T, V30, P1070, DOI 10.1042/BST0301070; Sekar N, 2004, AM J PHYSIOL-ENDOC M, V287, pE128, DOI 10.1152/ajpendo.00400.2003; SOLOMON SS, 2002, RRD ENDOCRINOL 1, V3, P79; Sone H, 2002, AM J PHYSIOL-ENDOC M, V282, pE222, DOI 10.1152/ajpendo.00189.2001; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; THORNGATE FE, 1994, P NATL ACAD SCI USA, V91, P5392, DOI 10.1073/pnas.91.12.5392; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yellaturu CR, 2005, BIOCHEM BIOPH RES CO, V332, P174, DOI 10.1016/j.bbrc.2005.04.112; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zhang SY, 1997, ARCH BIOCHEM BIOPHYS, V338, P227, DOI 10.1006/abbi.1996.9809; Zheng XL, 2000, J BIOL CHEM, V275, P31747, DOI 10.1074/jbc.M000621200	39	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17517	17529		10.1074/jbc.M702228200	http://dx.doi.org/10.1074/jbc.M702228200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17449871	hybrid			2022-12-27	WOS:000247084500022
J	Guglielmi, KM; Kirchner, E; Holm, GH; Stehle, T; Dermody, TS				Guglielmi, Kristen M.; Kirchner, Eva; Holm, Geoffrey H.; Stehle, Thilo; Dermody, Terence S.			Reovirus binding determinants in junctional adhesion molecule-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ATTACHMENT PROTEIN; CENTRAL-NERVOUS-SYSTEM; IMMUNOGLOBULIN SUPERFAMILY; RHINOVIRUS RECEPTOR; CRYSTAL-STRUCTURE; SIALIC-ACID; SIGMA-1; ADENOVIRUS; IDENTIFICATION; STRAINS	Junctional adhesion molecule-A (JAM-A) serves as a serotype-independent receptor for mammalian orthoreoviruses (reoviruses). The membrane-distal immunoglobulin-like D1 domain of JAM-A is required for homodimerization and binding to reovirus attachment protein sigma 1. We employed a structure-guided mutational analysis of the JAM-A dimer interface to identify determinants of reovirus binding. We purified mutant JAM-A ectodomains for solution-phase and surface plasmon resonance binding studies and expressed mutant forms of full-length JAM-A in Chinese hamster ovary cells to assess reovirus binding and infectivity. Mutation of residues in the JAM-A dimer interface that participate in salt-bridge or hydrogen-bond interactions with apposing JAM-A monomers abolishes the capacity of JAM-A to form dimers. JAM-A mutants incapable of dimer formation form complexes with the sigma 1 head that are indistinguishable from wild-type JAM-A-sigma 1 head complexes, indicating that sigma 1 binds to JAM-A monomers. Residues Glu(61) and Lys(63) of beta-strand C and Leu(72) of beta-strand C' in the dimer interface are required for efficient JAM-A engagement of strain type 3 Dearing sigma 1. Mutation of neighboring residues alters the kinetics of the sigma 1-JAM-A binding interaction. Prototype reovirus strains type 1 Lang and type 2 Jones share similar, although not identical, binding requirements with type 3 Dearing. These results indicate that reovirus engages JAM-A monomers via residues found mainly on beta-strands C and C' of the dimer interface and raise the possibility that the distinct disease phenotypes produced in mice following infection with different strains of reovirus are in part attributable to differences in contacts with JAM-A.	Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany	Vanderbilt University; Vanderbilt University; Vanderbilt University; Eberhard Karls University of Tubingen	Dermody, TS (corresponding author), Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, D7235 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	terry.dermody@vanderbilt.edu	Ogden, Kristen/AAO-9276-2020; Holm, Geoffrey H./C-3188-2009	Ogden, Kristen/0000-0002-2670-4335; 	NIAID NIH HHS [R37 AI38296, F32 AI071440] Funding Source: Medline; NIGMS NIH HHS [T32 GM08554, R01 GM67853] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071440, R37AI038296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554, R01GM067853] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Becker MM, 2001, J VIROL, V75, P1459, DOI 10.1128/JVI.75.3.1459-1475.2001; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Campbell JA, 2005, J VIROL, V79, P7967, DOI 10.1128/JVI.79.13.7967-7978.2005; Chappell JD, 1997, J VIROL, V71, P1834, DOI 10.1128/JVI.71.3.1834-1841.1997; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Cunningham SA, 2000, J BIOL CHEM, V275, P34750, DOI 10.1074/jbc.M002718200; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DeLano W, 2002, PYMOL 0 99; DERMODY TS, 1990, J VIROL, V64, P4842, DOI 10.1128/JVI.64.10.4842-4850.1990; DERMODY TS, 1990, J VIROL, V64, P5173, DOI 10.1128/JVI.64.10.5173-5176.1990; DICHTER MA, 1984, ANN NEUROL, V16, P603, DOI 10.1002/ana.410160512; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; DUNCAN R, 1990, VIROLOGY, V174, P399, DOI 10.1016/0042-6822(90)90093-7; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Forrest JC, 2003, J BIOL CHEM, V278, P48434, DOI 10.1074/jbc.M305649200; FRASER RDB, 1990, J VIROL, V64, P2990, DOI 10.1128/JVI.64.6.2990-3000.1990; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; LERNER AM, 1963, VIROLOGY, V19, P58, DOI 10.1016/0042-6822(63)90024-2; Liu Y, 2000, J CELL SCI, V113, P2363; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MORRISON LA, 1991, P NATL ACAD SCI USA, V88, P3852, DOI 10.1073/pnas.88.9.3852; NIBERT ML, 1990, J VIROL, V64, P2976, DOI 10.1128/JVI.64.6.2976-2989.1990; Nibert ML., 2001, FIELDS VIROLOGY, P1679; Prota AE, 2003, P NATL ACAD SCI USA, V100, P5366, DOI 10.1073/pnas.0937718100; Schelling P, 2007, J BIOL CHEM, V282, P11582, DOI 10.1074/jbc.M610805200; Smelt SC, 2001, J VIROL, V75, P448, DOI 10.1128/JVI.75.1.448-457.2001; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Stehle T, 2004, VIRAL IMMUNOL, V17, P129, DOI 10.1089/0882824041310621; Stehle T, 2003, REV MED VIROL, V13, P123, DOI 10.1002/rmv.379; TARDIEU M, 1983, ANN NEUROL, V13, P602, DOI 10.1002/ana.410130604; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; TOMASSINI JE, 1989, P NATL ACAD SCI USA, V86, P4907, DOI 10.1073/pnas.86.13.4907; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tyler K.L., 2001, FIELDS VIROLOGY, P1729; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WEINER HL, 1977, P NATL ACAD SCI USA, V74, P5744, DOI 10.1073/pnas.74.12.5744; WEINER HL, 1980, J INFECT DIS, V141, P609, DOI 10.1093/infdis/141.5.609; WEINER HL, 1980, J IMMUNOL, V124, P2143; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4	54	40	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17930	17940		10.1074/jbc.M702180200	http://dx.doi.org/10.1074/jbc.M702180200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452315	hybrid			2022-12-27	WOS:000247084500066
J	Lu, ZL; Coetsee, M; White, CD; Millar, RP				Lu, Zhi-Liang; Coetsee, Marla; White, Colin D.; Millar, Robert P.			Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; PHARMACOLOGICAL CHAPERONE ACTION; HORMONE GNRH RECEPTOR; MOLECULAR-BASIS; FUNCTIONAL SELECTIVITY; ADRENERGIC-RECEPTOR; RHODOPSIN-FAMILY; AGONIST BINDING; WILD-TYPE; ACTIVATION	G protein coupled receptors (GPCRs) modulate the majority of physiological processes through specific intermolecular interactions with structurally diverse ligands and activation of differential intracellular signaling. A key issue yet to be resolved is how GPCRs developed selectivity and diversity of ligand binding and intracellular signaling during evolution. We have explored the structural basis of selectivity of naturally occurring gonadotropin-releasing hormones (GnRHs) from different species in the single functional human GnRH receptor. We found that the highly variable amino acids in position 8 of the naturally occurring isoforms of GnRH play a discriminating role in selecting receptor conformational states. The human GnRH receptor has a higher affinity for the cognate GnRH I but a lower affinity for GnRH II and GnRHs from other species possessing substitutions for Arg(8). The latter were partial agonists in the human GnRH receptor. Mutation of Asn(7.45) in transmembrane domain (TM) 7 had no effect on GnRH I affinity but specifically increased affinity for other GnRHs and converted them to full agonists. Using molecular modeling and site-directed mutagenesis, we demonstrated that the highly conserved Asn7.45 makes intramolecular interactions with a highly conserved Cys(6.47) in TM 6, suggesting that disruption of this intramolecular interaction induces a receptor conformational change which allosterically alters ligand specific binding sites and changes ligand selectivity and signaling efficacy. These results reveal GnRH ligand and receptor structural elements for conformational selection, and support co-evolution of GnRH ligand and receptor conformations.	Queens Med Res Inst, MRC, Human Reprod Sci Unit, Ctr Reprod Biol, Edinburgh EH16 4TJ, Midlothian, Scotland; Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Edinburgh; University of Cape Town	Lu, ZL (corresponding author), Queens Med Res Inst, MRC, Human Reprod Sci Unit, Ctr Reprod Biol, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	z.lu@hrsu.mrc.ac.uk	Millar, Robert P/A-4853-2012	Lu, Zhiliang/0000-0002-3442-1415; Millar, Robert P/0000-0003-3606-2708	Medical Research Council [MC_U127685846, U.1276.00.005.00001.01 (85846), MC_U127681325] Funding Source: Medline; MRC [MC_U127681325, MC_U127685846] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Betz SF, 2006, J MED CHEM, V49, P637, DOI 10.1021/jm0506928; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brothers SP, 2004, MOL ENDOCRINOL, V18, P1787, DOI 10.1210/me.2004-0091; Calabro V, 2005, P NATL ACAD SCI USA, V102, P6849, DOI 10.1073/pnas.0409282102; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; COETSEE M, 2006, BIOSCIENCE GLASG UK; Cussac D, 2002, MOL PHARMACOL, V62, P578, DOI 10.1124/mol.62.3.578; Darlison MG, 1999, TRENDS NEUROSCI, V22, P81, DOI 10.1016/S0166-2236(98)01333-2; Davidson JS, 1997, BIOCHEMISTRY-US, V36, P12881, DOI 10.1021/bi971377t; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Favre N, 2005, BIOCHEMISTRY-US, V44, P9990, DOI 10.1021/bi0509853; Fianagan CA, 1999, J BIOL CHEM, V274, P28880, DOI 10.1074/jbc.274.41.28880; Flanagan CA, 2000, BIOCHEMISTRY-US, V39, P8133, DOI 10.1021/bi000085g; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fromme BJ, 2001, MOL PHARMACOL, V60, P1280, DOI 10.1124/mol.60.6.1280; Furse KE, 2003, J MED CHEM, V46, P4450, DOI 10.1021/jm0301437; Gay EA, 2004, MOL PHARMACOL, V66, P97, DOI 10.1124/mol.66.1.97; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Hawtin SR, 2006, J BIOL CHEM, V281, P14604, DOI 10.1074/jbc.M511610200; Hovelmann S, 2002, BIOCHEMISTRY-US, V41, P1129, DOI 10.1021/bi0113162; Janovick JA, 2006, J BIOL CHEM, V281, P8417, DOI 10.1074/jbc.M510601200; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Knollman PE, 2005, J BIOL CHEM, V280, P24506, DOI 10.1074/jbc.M501978200; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 2005, J BIOL CHEM, V280, P29796, DOI 10.1074/jbc.M413520200; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Mamputha S, 2007, MOL ENDOCRINOL, V21, P281, DOI 10.1210/me.2006-0150; Millar R, 2001, P NATL ACAD SCI USA, V98, P9636, DOI 10.1073/pnas.141048498; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Millar RP, 2004, ENDOCRINOLOGY, V145, P3590, DOI 10.1210/en.2004-0461; Milligan G, 2002, NEUROSIGNALS, V11, P29, DOI 10.1159/000057319; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Morgan K, 2006, ENDOCRINOLOGY, V147, P5041, DOI 10.1210/en.2006-0222; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Soderhall JA, 2005, BIOCHEM BIOPH RES CO, V333, P568, DOI 10.1016/j.bbrc.2005.05.142; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Vauquelin G, 2005, FUND CLIN PHARMACOL, V19, P45, DOI 10.1111/j.1472-8206.2005.00319.x; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; ZHOU W, 1994, MOL PHARMACOL, V45, P165	61	41	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17921	17929		10.1074/jbc.M610413200	http://dx.doi.org/10.1074/jbc.M610413200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452338	Green Published, hybrid			2022-12-27	WOS:000247084500065
J	Kebache, S; Ash, J; Annis, MG; Hagan, J; Huber, M; Hassard, J; Stewart, CL; Whiteway, M; Nantel, A				Kebache, Sem; Ash, Josee; Annis, Matthew G.; Hagan, John; Huber, Maria; Hassard, Jennifer; Stewart, Colin L.; Whiteway, Malcolm; Nantel, Andre			Grb10 and active Raf-1 kinase promote bad-dependent cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; PROTEIN-KINASE; ADAPTER PROTEIN; SIGNALING PATHWAYS; C-RAF-1 GENE; PHOSPHORYLATION; APOPTOSIS; DEATH; RECEPTOR; AKT	The proapoptotic protein Bad is a key player in cell survival decisions, and is regulated post-translationally by several signaling networks. We expressed Bad in mouse embryonic fibroblasts to sensitize them to apoptosis, and tested cell lines derived from knock-out mice to establish the significance of the interaction between the adaptor protein Grb10 and the Raf-1 protein kinase in anti-apoptotic signaling pathways targeting Bad. When compared with wild-type cells, both Grb10 and Raf-1 deficient cells exhibit greatly enhanced sensitivity to apoptosis in response to Bad expression. Structure-function analysis demonstrates that, in this cellular model, the SH2, proline-rich, and pleckstrin homology domains of Grb10, as well as its Akt phosphorylation site and consequent binding by 14-3-3, are all necessary for its anti-apoptotic functions. As for Raf-1, its kinase activity, its ability to be phosphorylated by Src on Tyr-340/341 and the binding of its Ras-associated domain to the Grb10 SH2 domain are all necessary to promote cell survival. Silencing the expression of either Grb10 or Raf-1 by small interfering RNAs as well as mutagenesis of specific serine residues on Bad, coupled with signaling inhibitor studies, all indicate that Raf-1 and Grb10 are required for the ability of both the phosphatidylinositol 3-kinase/Akt and MAP kinase pathways to modulate the phosphorylation and inactivation of Bad. Because total Raf-1, ERK,andAktkinaseactivities are not impaired in the absence of Grb10, we propose that this adapter protein creates a subpopulation of Raf-1 with specific anti-apoptotic activity.	Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, Dept Anat, Montreal, PQ H3A 2B2, Canada; McGill Univ, Dept Cell Biol, Montreal, PQ H3A 2B2, Canada; NCI, NIH, Canc & Dev Biol Lab, Ft Detrick, MD 21702 USA	National Research Council Canada; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nantel, A (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	andre.nantel@cnrc-nrc.gc.ca		Hagan, John/0000-0003-0295-4898; Annis, Matthew/0000-0002-8776-004X	NATIONAL CANCER INSTITUTE [Z01BC010377] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Baccarini M, 2002, CELL DEATH DIFFER, V9, P783, DOI 10.1038/sj.cdd.4401070; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cattanach BM, 1998, CYTOGENET CELL GENET, V80, P41, DOI 10.1159/000014955; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Daly RJ, 1996, J BIOL CHEM, V271, P12502, DOI 10.1074/jbc.271.21.12502; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Kulik G, 1998, MOL CELL BIOL, V18, P6711, DOI 10.1128/MCB.18.11.6711; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Le Gall M, 2000, MOL BIOL CELL, V11, P1103, DOI 10.1091/mbc.11.3.1103; Le Mellay V, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-14; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lim MA, 2004, FRONT BIOSCI-LANDMRK, V9, P387, DOI 10.2741/1226; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Mabuchi S, 2002, J BIOL CHEM, V277, P33490, DOI 10.1074/jbc.M204042200; Majewski M, 1999, CANCER RES, V59, P2815; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; MARSHALL M, 1995, MOL REPROD DEV, V42, P493, DOI 10.1002/mrd.1080420418; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Nantel A, 1999, J BIOL CHEM, V274, P35719, DOI 10.1074/jbc.274.50.35719; Nantel A, 1998, J BIOL CHEM, V273, P10475, DOI 10.1074/jbc.273.17.10475; Nantel Andre, 2003, Methods Mol Biol, V218, P269; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oliviero R, 1997, BIOCHEM J, V324, P75, DOI 10.1042/bj3240075; OOI J, 1995, ONCOGENE, V10, P1621; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Pritchard C, 1997, NAT GENET, V16, P214, DOI 10.1038/ng0797-214; Riedel H, 2004, FRONT BIOSCI-LANDMRK, V9, P603, DOI 10.2741/1227; Salomoni P, 1998, J EXP MED, V187, P1995, DOI 10.1084/jem.187.12.1995; Sato S, 2002, J BIOL CHEM, V277, P39360, DOI 10.1074/jbc.M205141200; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Urschel S, 2005, J BIOL CHEM, V280, P16987, DOI 10.1074/jbc.M501477200; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	58	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21873	21883		10.1074/jbc.M611066200	http://dx.doi.org/10.1074/jbc.M611066200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17535812	hybrid			2022-12-27	WOS:000248196800035
J	Kovsan, J; Ben-Romano, R; Souza, SC; Greenberg, AS; Rudich, A				Kovsan, Julia; Ben-Romano, Ronit; Souza, Sandra C.; Greenberg, Andrew S.; Rudich, Assaf			Regulation of adipocyte lipolysis by degradation of the perilipin protein - Nelfinavir enhances lysosome-mediated perilipin proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; DROPLET-ASSOCIATED PROTEINS; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; OXIDATIVE STRESS; POSTTRANSLATIONAL REGULATION; MOLECULAR-MECHANISMS; OBESITY RISK; EXPRESSION; AUTOPHAGY	A decrease in the lipid droplet-associated protein perilipin may constitute a mechanism for enhanced adipocyte lipolysis under nonstimulated (basal) conditions, and increased basal lipolysis has been linked to whole body metabolic dysregulation. Here we investigated whether the lipolytic actions of the human immunodeficiency virus protease inhibitor, nelfinavir, are mediated by decreased perilipin protein content and studied the mechanisms by which it occurs. Time course analysis revealed that the decrease in perilipin protein content preceded the increase in lipolysis. A causative relationship was suggested by demonstrating that nelfinavir potently increased lipolysis in adipocytes derived from mouse embryonal fibroblasts expressing perilipin but not in mouse embryonal fibroblast adipocytes devoid of perilipin and that adenoviral mediated overexpression of perilipin in 3T3-L1 adipocytes blocked the lipolytic actions of nelfinavir. Nelfinavir did not alter mRNA content of perilipin but rather decreased perilipin proteins t(1/2) from >70 to 12 h. Protein degradation of perilipin in both control and nelfinavir-treated adipocytes could be prevented by inhibiting lysosomal proteolysis using leupeptin or NH4Cl but not by the proteasome inhibitor MG-132. We propose that proteolysis of perilipin involving the lysosomal protein degradation machinery may constitute a novel mechanism for enhancing adipocyte lipolysis.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84103 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, S Daniel Abraham Ctr Hlth & Nutr, IL-84103 Beer Sheva, Israel; Tufts Univ, Jean Mayer USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Ben Gurion University; Ben Gurion University; Tufts University; United States Department of Agriculture (USDA)	Rudich, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84103 Beer Sheva, Israel.	rudich@bgu.ac.il		Rudich, Assaf/0000-0002-1366-1444	NIDDK NIH HHS [DK50647] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050647] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aboulaich N, 2006, J BIOL CHEM, V281, P11446, DOI 10.1074/jbc.C500461200; Adler-Wailes DC, 2005, J CLIN ENDOCR METAB, V90, P3251, DOI 10.1210/jc.2004-2194; Arvidsson E, 2004, J INTERN MED, V255, P595, DOI 10.1111/j.1365-2796.2004.01314.x; Ben-Romano R, 2003, AIDS, V17, P23, DOI 10.1097/00002030-200301030-00005; Ben-Romano R, 2004, DIABETOLOGIA, V47, P1107, DOI 10.1007/s00125-004-1408-5; Ben-Romano R, 2006, ANTIVIR THER, V11, P1051; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Corella D, 2005, J CLIN ENDOCR METAB, V90, P5121, DOI 10.1210/jc.2005-0576; Corella D, 2006, DIABETES CARE, V29, P1313, DOI 10.2337/dc06-0045; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Dice J F, 1990, Semin Cell Biol, V1, P449; Ellington AA, 2006, CARCINOGENESIS, V27, P298, DOI 10.1093/carcin/bgi214; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Hadigan C, 2002, METABOLISM, V51, P1143, DOI 10.1053/meta.2002.34704; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Kern PA, 2004, J CLIN ENDOCR METAB, V89, P1352, DOI 10.1210/jc.2003-031388; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Londos C, 1996, INT J OBESITY, V20, pS97; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Moore MN, 2006, MAR ENVIRON RES, V62, pS420, DOI 10.1016/j.marenvres.2006.04.055; Qi L, 2005, J MOL MED, V83, P448, DOI 10.1007/s00109-004-0630-4; Qi L, 2004, OBES RES, V12, P1758, DOI 10.1038/oby.2004.218; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosenstock M, 2001, DIABETOLOGIA, V44, P55, DOI 10.1007/s001250051580; Rudich A, 2001, DIABETES, V50, P1425, DOI 10.2337/diabetes.50.6.1425; Rudich A, 2005, ACTA PHYSIOL SCAND, V183, P75, DOI 10.1111/j.1365-201X.2004.01383.x; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Souza SC, 1998, DIABETES, V47, P691, DOI 10.2337/diabetes.47.4.691; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; van der Valk M, 2001, AIDS, V15, P2093, DOI 10.1097/00002030-200111090-00004; Vincent S, 2004, JAIDS-J ACQ IMM DEF, V37, P1556, DOI 10.1097/00126334-200412150-00003; Wang YX, 2003, OBES RES, V11, P930, DOI 10.1038/oby.2003.128; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200	44	67	69	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21704	21711		10.1074/jbc.M702223200	http://dx.doi.org/10.1074/jbc.M702223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17488708	hybrid			2022-12-27	WOS:000248196800017
J	Rentz, TJ; Poobalarahi, F; Bornstein, P; Sage, EH; Bradshaw, AD				Rentz, Tyler J.; Poobalarahi, Felicitta; Bornstein, Paul; Sage, E. Helene; Bradshaw, Amy D.			SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRICELLULAR PROTEIN SPARC; EHLERS-DANLOS-SYNDROME; NULL MICE; TRANSFORMING GROWTH-FACTOR-BETA-1; FIBRIL ABNORMALITIES; TARGETED DISRUPTION; BINDING-SITES; III COLLAGENS; HUMAN-SKIN; EXPRESSION	A characterization of the factors that control collagen fibril formation is critical for an understanding of tissue organization and the mechanisms that lead to fibrosis. SPARC (secreted protein acidic and rich in cysteine) is a counter-adhesive protein that binds collagens. Herein we show that collagen fibrils in SPARC-null skin from mice 1 month of age were inefficient in fibril aggregation and accumulated in the diameter range of 60-70 nm, a proposed intermediate in collagen fibril growth. In vitro, procollagen I produced by SPARC-null dermal fibroblasts demonstrated an initial preferential association with cell layers, in comparison to that produced by wild-type fibroblasts. However, the collagen I produced by SPARC-null cells was not efficiently incorporated into detergent-insoluble fractions. Coincident with an initial increase in cell association, greater amounts of total collagen I were present as processed forms in SPARC-null versus wild-type cells. Addition of recombinant SPARC reversed collagen I association with cell layers and decreased the processing of procollagen I in SPARC-null cells. Although collagen fibers formed on the surface of SPARC-null fibroblasts earlier than those on wildtype cells, fibers on SPARC-null fibroblasts did not persist. We conclude that SPARC mediates the association of procollagen I with cells, as well as its processing and incorporation into the extracellular matrix.	Med Univ S Carolina, Dept Med, Charleston, SC 29412 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA	Medical University of South Carolina; University of Washington; University of Washington Seattle; Benaroya Research Institute; Virginia Mason Medical Center	Bradshaw, AD (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, 114 Doughty St, Charleston, SC 29425 USA.	bradshad@musc.edu			NIAMS NIH HHS [AR11248] Funding Source: Medline; NIGMS NIH HHS [K01 GM40711] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR011248, R37AR011248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Birk DE, 1997, DEV DYNAM, V208, P291; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Emerson RO, 2006, J CELL BIOCHEM, V98, P701, DOI 10.1002/jcb.20867; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; FLEISCHMAJER R, 1981, P NATL ACAD SCI-BIOL, V78, P7360, DOI 10.1073/pnas.78.12.7360; FLEISCHMAJER R, 1988, J HISTOCHEM CYTOCHEM, V36, P1425, DOI 10.1177/36.11.3049791; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; FRIZELL E, 1995, HEPATOLOGY, V21, P847, DOI 10.1002/hep.1840210335; Gardner H, 1999, J CELL SCI, V112, P263; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; KUHN C, 1995, AM J PATHOL, V147, P1759; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMANDE SR, 1995, J BIOL CHEM, V270, P17858, DOI 10.1074/jbc.270.30.17858; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; Liaw L, 1998, J CLIN INVEST, V101, P1468; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; Pichler RH, 1996, KIDNEY INT, V50, P1978, DOI 10.1038/ki.1996.520; Prockop D.J., 1994, ASSEMBLY COLLAGEN FI; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Ravanti L, 1999, J BIOL CHEM, V274, P2446, DOI 10.1074/jbc.274.4.2446; Sullivan MM, 2006, J BIOL CHEM, V281, P27621, DOI 10.1074/jbc.M510507200; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Tasheva ES, 2002, MOL VIS, V8, P407; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; VUORIO T, 1991, J RHEUMATOL, V18, P247; Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d; Watson RB, 1998, J MOL BIOL, V278, P195, DOI 10.1006/jmbi.1998.1680; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yan Q, 2003, J HISTOCHEM CYTOCHEM, V51, P503, DOI 10.1177/002215540305100412; Yan Q, 2002, J CELL SCI, V115, P2747; Zhou XD, 2006, ARTHRITIS RHEUM-US, V54, P2626, DOI 10.1002/art.21973	50	120	127	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22062	22071		10.1074/jbc.M700167200	http://dx.doi.org/10.1074/jbc.M700167200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17522057	hybrid			2022-12-27	WOS:000248196800053
J	Chen, S; Sanchez-Fernandez, R; Lyver, ER; Dancis, A; Rea, PA				Chen, Sixue; Sanchez-Fernandez, Rocio; Lyver, Elise R.; Dancis, Andrew; Rea, Philip A.			Functional characterization of AtATM1, AtATM2, and AtATM3, a subfamily of Arabidopsis half-molecule ATP-binding cassette transporters implicated in iron homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; PROTEIN; MUTATION; GENE; MEMBRANE; ATM1P	The functional capabilities of one of the smallest subfamilies of ATP-binding cassette transporters from Arabidopsis thaliana, the AtATMs, are described. Designated AtATM1, AtAATM2, and AtATM3, these half-molecule ABC proteins are homologous to the yeast mitochondrial membrane protein ATM1 (ScATM1), which is clearly implicated in the export of mitochondrially synthesized iron/sulfur clusters. Yeast ATM1-deficient (atm1) mutants grow very slowly (have a petite phenotype), are respiration-deficient, accumulate toxic levels of iron in their mitochondria, and show enhanced compensatory high affinity iron uptake. Of the three Arabidopsis ATMs, AtATM3 bears the closest functional resemblance to ScATM1. Heterologously expressed AtATM3 is not only able to complement the yeast atm1 petite phenotype but is also able to suppress the constitutively high capacity for high affinity iron uptake associated with loss of the chromosomal copy of ScATM1, abrogate intra-mitochondrial iron hyperaccumulation, and restore mitochondrial respiratory function and cytochrome c levels. By comparison, AtATM1 only weakly suppresses the atm1 phenotype, and AtATM2 exerts little or no suppressive action but instead is toxic when expressed in this system. The differences between AtATM3 and AtATM1 are maintained after exchanging their target peptides, and these proteins as well as AtATM2 colocalize with the mitochondrial fluor MitoTracker Red when expressed in yeast as GFP fusions. Although its toxicity when heterologously expressed in yeast, except when fused with GFP, precludes the functional analysis of native AtATM2, a common function, mitochondrial export of Fe/S clusters or their precursors for the assembly of cytosolic Fe/S proteins, is inferred for AtATM3 and AtATM1.	Univ Penn, Carolyn Hoff Lynch Biol Lab, Inst Plant Sci, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Rea, PA (corresponding author), Univ Penn, Carolyn Hoff Lynch Biol Lab, Inst Plant Sci, Dept Biol, 433 S Univ Ave, Philadelphia, PA 19104 USA.	parea@sas.upenn.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053953, R01DK053953] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53953] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Babiychuk E, 1997, P NATL ACAD SCI USA, V94, P12722, DOI 10.1073/pnas.94.23.12722; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Garcia O, 2004, J MOL BIOL, V343, P249, DOI 10.1016/j.jmb.2004.07.093; Hanikenne M, 2005, PLANT CELL ENVIRON, V28, P863, DOI 10.1111/j.1365-3040.2005.01335.x; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Lill R, 1999, BIOL CHEM, V380, P1157, DOI 10.1515/BC.1999.147; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; MONDAL AK, 1990, BIOCHEM BIOPH RES CO, V170, P1, DOI 10.1016/0006-291X(90)91232-H; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; REA PA, 2003, ABC PROTEINS BACTERI, P335; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Senbongi H, 1999, MOL GEN GENET, V262, P426; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	26	65	78	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21561	21571		10.1074/jbc.M702383200	http://dx.doi.org/10.1074/jbc.M702383200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17517886	hybrid			2022-12-27	WOS:000248047500083
J	Gershater, MC; Cummins, I; Edwards, R				Gershater, Markus C.; Cummins, Ian; Edwards, Robert			Role of a carboxylesterase in herbicide bioactivation in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; ESTERASE-ACTIVITY; PURIFICATION; XENOBIOTICS; HYDROLASE; FAMILY; WHEAT; GLUCOSYLTRANSFERASE; IDENTIFICATION; METABOLISM	Arabidopsis thaliana contains multiple carboxyesterases (AtCXEs) with activities toward xenobiotics, including herbicide esters that are activated to their phytotoxic acids upon hydrolysis. On the basis of their susceptibility to inhibition by organophosphates, these AtCXEs are all serine hydrolases. Using a trifunctional probe bearing a fluorophosphonate together with biotin and rhodamine to facilitate detection and recovery, four dominant serine hydrolases were identified in the proteome of Arabidopsis. Using a combination of protein purification, capture with the trifunctional probe and proteomics, one of these hydrolases, AtCXE12, was shown to be the major carboxyesterase responsible for hydrolyzing the pro-herbicide methyl-2,4-dichlorophenoxyacetate (2,4-D-methyl) to the phytotoxic acid 2,4-dichlorophenoxyacetic acid. Recombinant expression of the other identified hydrolases showed that AtCXE12 was unique in hydrolyzing 2,4-D-methyl. To determine the importance of AtCXE12 in herbicide metabolism and efficacy, the respective tDNA knock-out (atcxe12) plants were characterized and shown to lack expression of AtCXE12 and have greatly reduced levels of 2,4-D-methyl-hydrolyzing activity. Young atcxe12 seedlings were less sensitive than wild type plants to 2,4-D-methyl, confirming a role for the enzyme in herbicide bioactivation in Arabidopsis.	Univ Durham, Ctr Bioact Chem, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Univ Durham, Ctr Bioact Chem, Durham DH1 3LE, England.	Robert.Edwards@durham.ac.uk		Edwards, Robert/0000-0003-0809-5991				Adam GC, 2002, MOL CELL PROTEOMICS, V1, P828, DOI 10.1074/mcp.T200007-MCP200; Akashi T, 2005, PLANT PHYSIOL, V137, P882, DOI 10.1104/pp.104.056747; Baudouin E, 1997, EUR J BIOCHEM, V248, P700, DOI 10.1111/j.1432-1033.1997.t01-1-00700.x; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Brick DJ, 1995, FEBS LETT, V377, P475, DOI 10.1016/0014-5793(95)01405-5; Cummins I, 2004, PLANT J, V39, P894, DOI 10.1111/j.1365-313X.2004.02174.x; Cummins I, 2001, PHYSIOL PLANTARUM, V113, P477, DOI 10.1034/j.1399-3054.2001.1130406.x; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Edwards R, 2005, ADV BOT RES, V42, P1, DOI 10.1016/S0065-2296(05)42001-7; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fraser CM, 2005, PLANT PHYSIOL, V138, P1136, DOI 10.1104/pp.104.057950; Haslam R, 2001, PESTIC BIOCHEM PHYS, V71, P178, DOI 10.1006/pest.2001.2575; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Kordic S, 2002, ARCH BIOCHEM BIOPHYS, V399, P232, DOI 10.1006/abbi.2002.2772; KRELL HW, 1984, EUR J BIOCHEM, V143, P57, DOI 10.1111/j.1432-1033.1984.tb08339.x; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; Marshall SDG, 2003, J MOL EVOL, V57, P487, DOI 10.1007/s00239-003-2492-8; Nandula VK, 2000, PESTIC BIOCHEM PHYS, V68, P148, DOI 10.1006/pest.2000.2508; Oakeshott JG, 1999, BIOESSAYS, V21, P1031; PREISS U, 1988, PESTIC SCI, V23, P13, DOI 10.1002/ps.2780230103; Rea PA, 1998, ANNU REV PLANT PHYS, V49, P727, DOI 10.1146/annurev.arplant.49.1.727; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; Ruiz-Santaella JP, 2006, PLANTA, V223, P191, DOI 10.1007/s00425-005-0075-1; Sandermann H, 2004, TRENDS PLANT SCI, V9, P406, DOI 10.1016/j.tplants.2004.06.001; Schuler MA, 1996, CRIT REV PLANT SCI, V15, P235, DOI 10.1080/713608134; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Waspi U, 1998, EUR J BIOCHEM, V254, P32, DOI 10.1046/j.1432-1327.1998.2540032.x	31	43	47	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21460	21466		10.1074/jbc.M701985200	http://dx.doi.org/10.1074/jbc.M701985200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17519238	hybrid			2022-12-27	WOS:000248047500073
J	Maksumova, L; Wang, YN; Wong, NKY; Le, HT; Pallen, CJ; Johnson, P				Maksumova, Lola; Wang, Yanni; Wong, Nelson K. Y.; Le, Hoa T.; Pallen, Catherine J.; Johnson, Pauline			Differential function of PTP alpha and PTP alpha Y789F in T cells and regulation of PTP alpha phosphorylation at tyr-789 by CD45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE-ALPHA; SRC-FAMILY KINASES; PROTEIN-KINASE; LIPID RAFTS; PHOSPHOTYROSINE PHOSPHATASE; CYTOPLASMIC DOMAIN; ACTIVATION; LCK; FYN; ADAPTER	CD45 is a major membrane protein tyrosine phosphatase (PTP) expressed in T cells where it regulates the activity of Lck, a Src family kinase important for T cell receptor-mediated activation. PTP alpha is a more widely expressed transmembrane PTP that has been shown to regulate the Src family kinases, Src and Fyn, and is also present in T cells. Here, PTP alpha was phosphorylated at Tyr-789 in CD45(-) T cells but not in CD45(+) T cells suggesting that CD45 could regulate the phosphorylation of PTP alpha at this site. Furthermore, CD45 could directly dephosphorylate PTP alpha in vitro. Expression of PTP alpha and PTP alpha-Y789F in T cells revealed that the mutant had a reduced ability to decrease Fyn and Cbp phosphorylation, to regulate the kinase activity of Fyn, and to restore T cell receptor-induced signaling events when compared with PTP alpha. Conversely, this mutant had an increased ability to prevent Pyk2 phosphorylation and CD44-mediated cell spreading when compared with PTP alpha. These data demonstrate distinct activities of PTP alpha and PTP alpha-Y789F in T cells and identify CD45 as a regulator of PTP alpha phosphorylation at tyrosine 789 in T cells.	Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada; Child & Family Res Inst, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute	Johnson, P (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	pauline@interchange.ubc.ca	Johnson, Pauline/G-9659-2019; Wong, Nelson/S-5526-2016	Johnson, Pauline/0000-0001-7367-4653; Wong, Nelson/0000-0002-7003-6020; Pallen, Catherine/0000-0002-3576-5295				Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Ashwell JD, 1999, IMMUNOL TODAY, V20, P412, DOI 10.1016/S0167-5699(99)01505-4; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; D'Oro U, 1999, J IMMUNOL, V162, P1879; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; DEANS JP, 1992, EUR J IMMUNOL, V22, P661, DOI 10.1002/eji.1830220308; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; Felberg J, 1998, J BIOL CHEM, V273, P17839, DOI 10.1074/jbc.273.28.17839; Filipp D, 2004, J IMMUNOL, V172, P4266, DOI 10.4049/jimmunol.172.7.4266; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HURLEY TR, 1993, MOL CELL BIOL, V13, P1651, DOI 10.1128/MCB.13.3.1651; JOHNSON P, 2000, MOD ASP IMMUNOBIOL, V1, P156; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Li RH, 2001, J BIOL CHEM, V276, P28767, DOI 10.1074/jbc.M100158200; Lim KL, 1998, J BIOL CHEM, V273, P28986, DOI 10.1074/jbc.273.44.28986; Maksumova L, 2005, J IMMUNOL, V175, P7947, DOI 10.4049/jimmunol.175.12.7947; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; NG DHW, 1995, BIOCHEM BIOPH RES CO, V206, P302, DOI 10.1006/bbrc.1995.1042; Ng DHW, 1997, BIOCHEM J, V327, P867; Ng DHW, 1996, J BIOL CHEM, V271, P1295, DOI 10.1074/jbc.271.3.1295; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; OSTERGAARD HL, 1990, J EXP MED, V172, P347, DOI 10.1084/jem.172.1.347; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Stone JD, 1997, J IMMUNOL, V158, P5773; SU J, 1994, J BIOL CHEM, V269, P18731; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	39	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20925	20932		10.1074/jbc.M703157200	http://dx.doi.org/10.1074/jbc.M703157200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17507376	hybrid			2022-12-27	WOS:000248047500018
J	De Lay, NR; Cronan, JE				De lay, Nicholas R.; Cronan, John E.			In vivo functional analyses of the type II Acyl carrier proteins of fatty acid biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PHOSPHOPANTETHEINYL TRANSFERASE; PHOSPHOLIPID-SYNTHESIS; PLASMODIUM-FALCIPARUM; GENE-EXPRESSION; SYNTHASE; RESIDUES; BINDING; REVEAL; MUTANT	Acyl carrier protein (ACP) is a key component of the fatty acid synthesis pathways of both type I and type II synthesis systems. A large number of structure-function studies of various type II ACPs have been reported, but all are in vitro studies that assayed function or interaction of mutant ACPs with various enzymes of fatty acid synthesis or transfer. Hence in these studies functional properties of various mutant ACPs were assayed with only a subset of the many ACP-interacting proteins, which may not give an accurate overall view of the function of these proteins in vivo. This is especially so because Escherichia coli ACP has been reported to interact with several proteins that have no known roles in lipid metabolism. We therefore tested a large number of mutant derivatives of E. coli ACP carrying single amino acid substitutions for their abilities to restore growth to an E. coli strain carrying a temperature-sensitive mutation in acpP, the gene that encodes ACP. Many of these mutant proteins had previously been tested in vitro thus providing data for comparison with our results. We found that several mutant ACPs containing substitutions of ACP residues reported previously to be required for ACP function in vitro support normal growth of the acpP mutant strain. However, several mutant proteins reported to be severely defective in vitro failed to support growth of the acpP strain in vivo ( or supported only weak growth). A collection of ACPs from diverse bacteria and from three eukaryotic organelles was also tested. All of the bacterial ACPs tested restored growth to the E. coli acpP mutant strain except those from two related bacteria, Enterococcus faecalis and Lactococcus lactis. Only one of the three eukaryotic organellar ACPs allowed growth. Strikingly the ACP is that of the apicoplast of Plasmodium falciparum ( the protozoan that causes malaria). The fact that an ACP from a such diverse organism can replace AcpP functionin E. coli suggests that some of the protein-protein interactions detected for AcpP may be not be essential for growth of E.	Univ Illinois, Dept Microbiol, B103 Chem & Life Sci Lab, Urbana, IL 61801 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, B103 Chem & Life Sci Lab, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019	De Lay, Nicholas/0000-0003-2249-7073	NIAID NIH HHS [AI 15650] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEREMAND PD, 1987, ARCH BIOCHEM BIOPHYS, V256, P90, DOI 10.1016/0003-9861(87)90428-0; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cronan JE, 2006, NAT CHEM BIOL, V2, P232, DOI 10.1038/nchembio0506-232; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Cronan JE, 2004, CHEM BIOL, V11, P1601, DOI 10.1016/j.chembiol.2004.11.011; CRONAN JE, 1988, GENE, V70, P161, DOI 10.1016/0378-1119(88)90114-X; CRONAN JE, 1982, J BIOL CHEM, V257, P5013; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; De Lay NR, 2006, MOL MICROBIOL, V61, P232, DOI 10.1111/j.1365-2958.2006.05222.x; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FELL D, 1996, UNDERSTANDING CONTRO; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Flugel RS, 2000, J BIOL CHEM, V275, P959, DOI 10.1074/jbc.275.2.959; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gong H, 2003, BIOCHEM BIOPH RES CO, V302, P35, DOI 10.1016/S0006-291X(03)00108-6; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Gully D, 2006, PROTEOMICS, V6, P282, DOI 10.1002/pmic.200500115; Gully D, 2003, FEBS LETT, V548, P90, DOI 10.1016/S0014-5793(03)00746-4; Heinrich R., 1996, REGULATION CELLULAR; HILL RB, 1995, PROTEIN EXPRES PURIF, V6, P394, DOI 10.1006/prep.1995.1052; Jain NU, 2004, J MOL BIOL, V343, P1379, DOI 10.1016/j.jmb.2004.08.103; JENSEN PR, 1993, EUR J BIOCHEM, V211, P181, DOI 10.1111/j.1432-1033.1993.tb19885.x; JONES PJ, 1987, J BIOL CHEM, V262, P8963; Joshi AK, 1997, BIOCHEMISTRY-US, V36, P2316, DOI 10.1021/bi9626968; Khlebnikov A, 2002, BIOTECHNOL PROGR, V18, P672, DOI 10.1021/bp010141k; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Lu YJ, 2005, J BIOL CHEM, V280, P30342, DOI 10.1074/jbc.M504637200; MARCH JB, 1989, MOL MICROBIOL, V3, P903, DOI 10.1111/j.1365-2958.1989.tb00239.x; Mofid MR, 1999, ACTA CRYSTALLOGR D, V55, P1098, DOI 10.1107/S0907444999003674; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Nichols BP, 1998, J BACTERIOL, V180, P6408; Park SJ, 2003, J BIOCHEM MOL BIOL, V36, P505; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; POLACCO ML, 1981, J BIOL CHEM, V256, P5750; Prigge ST, 2003, BIOCHEMISTRY-US, V42, P1160, DOI 10.1021/bi026847k; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; RAWLINGS M, 1992, J BIOL CHEM, V267, P5751; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; ROCK CO, 1979, J BIOL CHEM, V254, P9778; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SAUER F, 1964, P NATL ACAD SCI USA, V52, P1360, DOI 10.1073/pnas.52.6.1360; SINGER M, 1989, MICROBIOL REV, V53, P1; Smith S, 2006, SCIENCE, V311, P1251, DOI 10.1126/science.1125411; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Srisailam S, 2006, PROTEINS, V64, P800, DOI 10.1002/prot.21016; VAGELOS PR, 1966, FED PROC, V25, P1485; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; Wang HH, 2004, BIOCHEMISTRY-US, V43, P11782, DOI 10.1021/bi0487600; Wang HH, 2004, J BIOL CHEM, V279, P34489, DOI 10.1074/jbc.M403874200; Wildermuth MC, 2000, GENOME BIOL, V1; Witkowski A, 2004, CHEM BIOL, V11, P1667, DOI 10.1016/j.chembiol.2004.09.016; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200	64	60	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20319	20328		10.1074/jbc.M703789200	http://dx.doi.org/10.1074/jbc.M703789200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17522044	hybrid			2022-12-27	WOS:000247819300035
J	Shi, SL; Ge, CH; Luo, Y; Hou, XH; Haltiwanger, RS; Stanley, P				Shi, Shaolin; Ge, Changhui; Luo, Yi; Hou, Xinghua; Haltiwanger, Robert S.; Stanley, Pamela			The threonine that carries fucose, but not fucose, is required for cripto to facilitate nodal signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; THROMBOSPONDIN TYPE-1 REPEATS; MAMMARY EPITHELIAL-CELLS; EMBRYONIC STEM-CELLS; O-LINKED FUCOSE; TGF-BETA SIGNALS; LIGAND-BINDING; MOUSE EMBRYO; PROTEIN O-FUCOSYL-TRANSFERASE-1; VERTEBRATE DEVELOPMENT	Cripto is a membrane-bound co-receptor for Nodal, a member of the transforming growth factor-beta superfamily. Mouse embryos lacking either Cripto or Nodal have the same lethal phenotype at embryonic day 7.5. Previous studies suggest that O-fucosylation of the epidermal growth factor-like (EGF) repeat in Cripto is essential for the facilitation of Nodal signaling. Substitution of Ala for the Thr to which O-fucose is attached led to functional inactivation of both human and mouse Cripto. However, embryos null for protein O-fucosyltransferase 1, the enzyme that adds O-fucose to EGF repeats, do not exhibit a Cripto null phenotype and die at about embryonic day 9.5. This suggested that the loss of O-fucose from the EGF repeat may not have led to the inactivation of Cripto in previous studies. Here we investigate this hypothesis and show the following: 1) protein O-fucosyltransferase 1 is indeed the enzyme that adds O-fucose to Cripto; 2) Pofut1(-/-) embryonic stem cells behave the same as Pofut1(+/+) embryonic stem cells in a Nodal signaling assay; 3) Pofut1(+/+) and Pofut1(+/+) embryoid bodies are indistinguishable in their ability to differentiate into cardiomyocytes; and 4) none of 10 amino acid substitutions at Thr72, including Ser which acquires O-fucose, rescues the activity of mouse Cripto in Nodal signaling assays. Therefore, the Thr to which O-fucose is linked in Cripto plays a key functional role, but O-fucose at Thr72 is not required for Cripto to function in cell-based signaling assays or in vivo. By contrast, we show that O-fucose, and not the Thr to which it is attached, is required in the ligand-binding domain of Notch1 for Notch1 signaling.	Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Yeshiva University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, New York, NY 10461 USA.	stanley@aecom.yu.edu		Stanley, Pamela/0000-0001-5704-3747; Shi, Shaolin/0000-0003-2297-6496	NATIONAL CANCER INSTITUTE [R01CA095022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER; NCI NIH HHS [CA 95022] Funding Source: Medline; NIGMS NIH HHS [R01 GM061126, GM 61126] Funding Source: Medline; PHS HHS [P01 13330] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adamson ED, 2002, J CELL PHYSIOL, V190, P267, DOI 10.1002/jcp.10072; Baldassarre G, 1997, ONCOGENE, V15, P927, DOI 10.1038/sj.onc.1201260; Bianco C, 2005, CURR TOP DEV BIOL, V67, P85, DOI 10.1016/S0070-2153(05)67003-2; Bianco C, 2003, CANCER RES, V63, P1192; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chen CH, 2006, DEVELOPMENT, V133, P319, DOI 10.1242/dev.02210; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; De Santis ML, 1997, CELL GROWTH DIFFER, V8, P1257; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Ebert AD, 1999, CANCER RES, V59, P4502; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; HARRIS RJ, 1992, J BIOL CHEM, V267, P5102; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Kannan S, 1997, J BIOL CHEM, V272, P3330, DOI 10.1074/jbc.272.6.3330; Kenney NJ, 2004, J MAMMARY GLAND BIOL, V9, P133, DOI 10.1023/B:JOMG.0000037158.91940.1c; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Li YX, 2003, DEVELOPMENT, V130, P2829, DOI 10.1242/dev.00498; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Minchiotti G, 2002, GENE, V287, P33, DOI 10.1016/S0378-1119(01)00892-7; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; RAMPAL R, 2007, IN PRESS CURR MOL ME; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schiffer SG, 2001, J BIOL CHEM, V276, P37769; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shen MM, 2003, J CLIN INVEST, V112, P500, DOI 10.1172/JCI200319546; Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Strizzi L, 2004, J CELL PHYSIOL, V201, P266, DOI 10.1002/jcp.20062; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wang Y, 1996, GLYCOBIOLOGY, V6, P837, DOI 10.1093/glycob/6.8.837; Wobus A M, 2002, Methods Mol Biol, V185, P127; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862; Xu CH, 1999, DEVELOPMENT, V126, P483; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	62	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20133	20141		10.1074/jbc.M702593200	http://dx.doi.org/10.1074/jbc.M702593200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17504756	hybrid			2022-12-27	WOS:000247819300014
J	van Kerkhof, P; Putters, J; Strous, GJ				van Kerkhof, Peter; Putters, Joyce; Strous, Ger J.			The ubiquitin ligase SCF(beta TrCP) regulates the degradation of the growth hormone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; PHOSPHORYLATION-DEPENDENT INTERACTION; BETA-TRCP; INDUCED INTERNALIZATION; DESTRUCTION MOTIF; PROTEIN; ENDOCYTOSIS; BINDING; SYSTEM; PATHWAY	SCF ubiquitin ligases play a pivotal role in the regulation of cell division and various signal transduction pathways, which in turn are involved in cell growth, survival, and transformation. SCF( TrCP) recognizes the double phosphorylated DSG Phi XS destruction motif in beta-catenin and I kappa B. We show that the same ligase drives endocytosis and degradation of the growth hormone receptor (GHR) in a ligand-independent fashion. The F-box protein beta-TrCP binds directly and specifically with its WD40 domain to a novel recognition motif, previously designated as the ubiquitin-dependent endocytosis motif. Receptor degradation requires an active neddylation system, implicating ubiquitin ligase activity. GHR-TrCP binding, but not GHR ubiquitination, is necessary for endocytosis. TrCP2 silencing is more effective on GHR degradation and endocytosis than TrCP1, although overexpression of either isoform restores TrCP function in silenced cells. Together, these findings provide direct evidence for a key role of the SCF( TrCP) in the endocytosis and degradation of an important factor in growth, immunity, and life span regulation.	Univ Utrecht, Med Ctr, Inst Biomembranes, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Utrecht University	Strous, GJ (corresponding author), Univ Utrecht, Med Ctr, Inst Biomembranes, Dept Cell Biol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	gstrous@umcutrecht.nl		van Kerkhof, Peter/0000-0002-8954-2230				ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Besnard-Guerin C, 2004, J BIOL CHEM, V279, P788, DOI 10.1074/jbc.M308068200; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; dos Santos GMA, 2001, J BIOL CHEM, V276, P32635, DOI 10.1074/jbc.M103583200; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Mantovani F, 2003, J BIOL CHEM, V278, P42477, DOI 10.1074/jbc.M302799200; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Peters JM, 2003, MOL CELL, V11, P1420, DOI 10.1016/S1097-2765(03)00233-8; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Schantl JA, 2003, BIOCHEM J, V373, P855, DOI 10.1042/BJ20021591; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Strous GJ, 2004, CURR TOP MICROBIOL, V286, P81; Strous GJ, 2002, FEBS LETT, V529, P102, DOI 10.1016/S0014-5793(02)03187-3; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Timsit YE, 2005, BIOCHEM BIOPH RES CO, V328, P550, DOI 10.1016/j.bbrc.2005.01.022; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; van Kerkhof P, 2002, ENDOCRINOLOGY, V143, P1243, DOI 10.1210/en.143.4.1243; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; WATERS M, 1999, GROWTH HORMONE RECEP, P445; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	44	50	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20475	20483		10.1074/jbc.M702610200	http://dx.doi.org/10.1074/jbc.M702610200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17500058	hybrid			2022-12-27	WOS:000247819300050
J	Huang, Y; Zhou, YB; Yang, W; Butters, R; Lee, HW; Li, SY; Castiblanco, A; Brown, EM; Yang, JJ				Huang, Yun; Zhou, Yubin; Yang, Wei; Butters, Robert; Lee, Hsiau-Wei; Li, Shunyi; Castiblanco, Adriana; Brown, Edward M.; Yang, Jenny J.			Identification and dissection of Ca2+-binding sites in the extracellular domain of Ca2+-sensing receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; METABOTROPIC GLUTAMATE-RECEPTOR; EF-HAND PROTEINS; BINDING SITES; LANTHANIDE AFFINITY; STRUCTURAL BASIS; CA2+ BINDING; MUTATIONS; CALMODULIN; DESIGN	Ca2+-sensing receptors (CaSRs) represent a class of receptors that respond to changes in the extracellular Ca2+ concentration ([Ca2+](o)) and activate multiple signaling pathways. A major barrier to advancing our understanding of the role of Ca2+ in regulating CaSRs is the lack of adequate information about their Ca2+-binding locations, which is largely hindered by the lack of a solved three-dimensional structure and rapid off rates due to low Ca2+-binding affinities. In this paper, we have reported the identification of three potential Ca2+-binding sites in a modeled CaSR structure using computational algorithms based on the geometric description and surface electrostatic potentials. Mutation of the predicted ligand residues in the full-length CaSR caused abnormal responses to [Ca2+] o, similar to those observed with naturally occurring activating or inactivating mutations of the CaR, supporting the essential role of these predicted Ca2+-binding sites in the sensing capability of the CaSR. In addition, to probe the intrinsic Ca2+-binding properties of the predicted sequences, we engineered two predicted continuous Ca2+-binding sequences individually into a scaffold protein provided by a non-Ca2+-binding protein, CD2. We report herein the estimation of the metal-binding affinities of these predicted sites in the CaSR by monitoring aromatic-sensitized Tb3+ fluorescence energy transfer. Removing the predicted Ca2+-binding ligands resulted in the loss of or significantly weakened cation binding. The potential Ca2+-binding residues were shown to be involved in Ca2+/Ln(3+) binding by high resolution NMR and site-directed mutagenesis, further validating our prediction of Ca2+-binding sites within the extracellular domain of the CaSR.	Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; Georgia State Univ, Ctr Biotechnol & Drug Design, Dept Chem, Atlanta, GA 30303 USA; Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Univ Plaza, Atlanta, GA 30303 USA.	chejjy@langate.gsu.edu	Zhou, Yubin/D-4748-2011; LEE, HSIAU-WEI/A-1415-2012	Zhou, Yubin/0000-0001-7962-0517; Huang, Yun/0000-0001-5950-9168; Lee, Hsiau-Wei/0000-0002-6060-6341	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052005, R01DK067155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM070555, R01GM062999] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52005, DK67155] Funding Source: Medline; NIGMS NIH HHS [GM62999-1, R21 GM070555, R01 GM062999-05, R01 GM062999, GM070555] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKKE M, 1995, J MOL BIOL, V252, P102, DOI 10.1006/jmbi.1995.0478; Bai M, 1999, INT J MOL MED, V4, P115; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 2004, CELL CALCIUM, V35, P197, DOI 10.1016/j.ceca.2003.10.018; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Breitwieser GE, 2004, CELL CALCIUM, V35, P209, DOI 10.1016/j.ceca.2003.10.013; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Cetani F, 2003, CLIN ENDOCRINOL, V58, P199, DOI 10.1046/j.1365-2265.2003.01696.x; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; DRISCOLL PC, 1993, BIOCHEM SOC T, V21, P947, DOI 10.1042/bst0210947; Dudev T, 2005, J AM CHEM SOC, V127, P4091, DOI 10.1021/ja044404t; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Francesconi A, 2004, J NEUROSCI RES, V75, P472, DOI 10.1002/jnr.10853; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9; HELLINGA HW, 1991, J MOL BIOL, V222, P763, DOI 10.1016/0022-2836(91)90510-D; Higgins D G, 1994, Methods Mol Biol, V25, P307; HIRAOKI T, 1987, J CARDIOVASC PHARM, V10, pS14, DOI 10.1097/00005344-198710001-00004; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hu JX, 2004, J BONE MINER RES, V19, P578, DOI 10.1359/JBMR.040106; Hu JX, 2003, TRENDS ENDOCRIN MET, V14, P282, DOI 10.1016/S1043-2760(03)00104-8; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; Jingami H, 2003, CURR OPIN NEUROBIOL, V13, P271, DOI 10.1016/S0959-4388(03)00067-9; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Malmberg NJ, 2004, BIOCHEMISTRY-US, V43, P16320, DOI 10.1021/bi0482405; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Maurer P, 1996, CURR OPIN CELL BIOL, V8, P609, DOI 10.1016/S0955-0674(96)80101-3; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; Quinn SJ, 2004, J BIOL CHEM, V279, P37241, DOI 10.1074/jbc.M404520200; Sayer JA, 2003, CLIN ENDOCRINOL, V59, P419, DOI 10.1046/j.1365-2265.2003.01869.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; TEPLYAKOV AV, 1990, J MOL BIOL, V214, P261, DOI 10.1016/0022-2836(90)90160-N; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Vetter T, 2002, CURR OPIN NEPHROL HY, V11, P403, DOI 10.1097/00041552-200207000-00006; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093; Yang W, 2005, BIOCHEMISTRY-US, V44, P8267, DOI 10.1021/bi050463n; Yang W, 2005, J AM CHEM SOC, V127, P2085, DOI 10.1021/ja0431307; Yang W, 2003, J AM CHEM SOC, V125, P6165, DOI 10.1021/ja034724x; Ye YM, 2005, J INORG BIOCHEM, V99, P1376, DOI 10.1016/j.jinorgbio.2005.03.011; Ye YM, 2005, J AM CHEM SOC, V127, P3743, DOI 10.1021/ja042786x; Ye YM, 2003, PROTEIN ENG, V16, P429, DOI 10.1093/protein/gzg051; Ye YM, 2001, PROTEIN ENG, V14, P1001, DOI 10.1093/protein/14.12.1001; Zhang XC, 2001, BIOCHEM J, V360, P395, DOI 10.1042/0264-6021:3600395; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200; Zhang ZX, 2001, J BIOL CHEM, V276, P5316, DOI 10.1074/jbc.M005958200; Zonta M, 2003, J PHYSIOL-LONDON, V553, P407, DOI 10.1113/jphysiol.2003.046706	62	81	81	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19000	19010		10.1074/jbc.M701096200	http://dx.doi.org/10.1074/jbc.M701096200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17478419	Green Accepted, hybrid			2022-12-27	WOS:000247475300042
J	Ramanujan, VK; Herman, BA				Ramanujan, V. Krishnan; Herman, Brian A.			Aging process modulates nonlinear dynamics in liver cell metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRACTAL DYNAMICS; CANCER; MITOCHONDRIA; COMPLEXITY; DISEASE; DAMAGE	Regulatory dynamics of energy metabolism in living cells entails a coordinated response of multiple enzyme networks that operate under non-equilibrium conditions. Here we show that mitochondrial dysfunctions associated with the aging process significantly modify nonlinear dynamical signatures in free radical generation/removal, thereby altering energy metabolism in liver cells. We support our data with a plausible biochemical mechanism for modified bioenergetics that involves uncoupling protein-2 that is up-regulated in aged cells as an adaptive response to mitigate increased oxidative stress. Combining high spatial and temporal resolution imaging and bio-energetic measurements, our work provides experimental support to the hypothesis that mitochondria manifest nonlinear dynamical behavior for efficiently regulating energy metabolism in intact cells, and any partial or complete reduction in this behavior would contribute to organ dysfunctions including the aging process and other disease processes.	Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Herman, BA (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	hermanb@uthscsa.edu	Ramanujan, V Krishnan/A-6395-2011; Ramanujan, V Krishnan/O-2831-2014		NATIONAL INSTITUTE ON AGING [R01AG007218] Funding Source: NIH RePORTER; NIA NIH HHS [R01-AG007218-18A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acharya UR, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-24; Ashkenazy Y, 2001, PHYS REV LETT, V86, P1900, DOI 10.1103/PhysRevLett.86.1900; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x; BEZERIANOS A, 1995, CHAOS, V5, P95, DOI 10.1063/1.166104; Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Echtay KS, 2005, BIOFACTORS, V24, P119, DOI 10.1002/biof.5520240114; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Gavrilov Leonid A, 2002, ScientificWorldJournal, V2, P339; Genova ML, 1997, FEBS LETT, V410, P467; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAVLIN S, 1995, CHAOS SOLITON FRACT, V6, P171, DOI 10.1016/0960-0779(95)80025-C; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; KNOOK D, 1986, HDB CELL BIOL AGING, P229; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Mangel M, 2001, J THEOR BIOL, V213, P559, DOI 10.1006/jtbi.2001.2431; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Ramanujan VK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2098753; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Stanley HE, 2002, P NATL ACAD SCI USA, V99, P2561, DOI 10.1073/pnas.022582899; Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769; Vaillancourt DE, 2004, J APPL PHYSIOL, V97, P454, DOI 10.1152/japplphysiol.00244.2004; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X	35	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19217	19226		10.1074/jbc.M700572200	http://dx.doi.org/10.1074/jbc.M700572200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17446172	hybrid			2022-12-27	WOS:000247475300062
J	Tsai, YC; Qi, HY; Liu, LF				Tsai, Yuan-Chin; Qi, Haiyan; Liu, Leroy F.			Protection of DNA ends by telomeric 3 ' G-tail sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; SACCHAROMYCES-CEREVISIAE; IN-VITRO; QUADRUPLEX STRUCTURE; MAMMALIAN TELOMERES; TUMOR-CELLS; YEAST; POT1; CHROMOSOMES; OVERHANG	The extreme ends of eukaryotic chromosomes contain 3' extensions in the form of single-stranded G-rich repeats, referred to as telomeric 3' G-tails or overhangs. Increasing evidence has suggested that telomeric 3' G-tails can adopt a G-quadruplex conformation both in vitro and in vivo. However, the role of G-quadruplexes on the structure and function of telomeric 3' G-tails remains unclear. In the current study, we showed that the human telomeric 3' G-tail sequence protected the duplex DNA ends in cis from being recognized as double strand breaks. This protection is dependent on the G-quadruplex conformation of the 3' G-tail sequence. These results suggest that the ability of telomeric 3' G-tails to adopt the end-protecting G-quadruplex conformation may be one of the reasons for the existence of the evolutionarily conserved G-stretch motifs in telomeric DNA sequences.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Liu, Leroy/0000-0001-9396-763X	NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662] Funding Source: NIH RePORTER; NCI NIH HHS [CA39662, CA102463] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bailey SM, 2004, DNA REPAIR, V3, P225, DOI 10.1016/j.dnarep.2003.10.013; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chang CC, 2006, ANAL CHEM, V78, P2810, DOI 10.1021/ac052218f; Chang CC, 2004, ANAL CHEM, V76, P4490, DOI 10.1021/ac049510s; Churikov D, 2006, MOL CELL BIOL, V26, P6971, DOI 10.1128/MCB.01011-06; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; GIRALDO R, 1994, P NATL ACAD SCI USA, V91, P7658, DOI 10.1073/pnas.91.16.7658; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Gomez D, 2006, CANCER RES, V66, P6908, DOI 10.1158/0008-5472.CAN-06-1581; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hayashi N, 2002, MOL GENET GENOMICS, V267, P806, DOI 10.1007/s00438-002-0712-3; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Knight ZA, 2004, BIOORGAN MED CHEM, V12, P4749, DOI 10.1016/j.bmc.2004.06.022; LIU ZP, 1994, CELL, V77, P1083, DOI 10.1016/0092-8674(94)90447-2; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Qi HY, 2006, CANCER RES, V66, P11808, DOI 10.1158/0008-5472.CAN-06-1225; SCARIA PV, 1992, P NATL ACAD SCI USA, V89, P10336, DOI 10.1073/pnas.89.21.10336; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Stansel RM, 2001, EMBO J, V20, P5532; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wellinger RJ, 1997, EUR J CANCER, V33, P735, DOI 10.1016/S0959-8049(97)00067-1; Yu HQ, 2006, J AM CHEM SOC, V128, P15461, DOI 10.1021/ja064536h; YU HQ, 2006, NUCL ACIDS S SER OXF, V50, P207; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	38	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18786	18792		10.1074/jbc.M702171200	http://dx.doi.org/10.1074/jbc.M702171200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17483095	hybrid			2022-12-27	WOS:000247475300017
J	Veerman, ECI; Valentijn-Benz, M; Nazmi, K; Ruissen, ALA; Walgreen-Weterings, E; van Marle, J; Doust, AB; van't Hof, W; Bolscher, JGM; Amerongen, AVN				Veerman, Enno C. I.; Valentijn-Benz, Marianne; Nazmi, Kamran; Ruissen, Anita L. A.; Walgreen-Weterings, Els; van Marle, Jan; Doust, Alexander B.; van't Hof, Wim; Bolscher, Jan G. M.; Amerongen, Arie V. Nieuw			Energy depletion protects candida albicans against antimicrobial peptides by rigidifying its cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; FLUORESCENCE POLARIZATION; ACTIN POLYMERIZATION; ATP DEPLETION; HISTATIN 5; YEAST; PROTEINS; TARGET; SUSCEPTIBILITY; TRANSLOCATION	Inhibitors of the energy metabolism, such as sodium azide and valinomycin, render yeast cells completely resistant against the killing action of a number of cationic antimicrobial peptides, including the salivary antimicrobial peptide Histatin 5. In this study the Histatin 5-mediated killing of the opportunistic yeast Candida albicans was used as a model system to comprehensively investigate the molecular basis underlying this phenomenon. Using confocal and electron microscopy it was demonstrated that the energy poison azide reversibly blocked the entry of Histatin 5 at the level of the yeast cell wall. Azide treatment hardly induced depolarization of the yeast cell membrane potential, excluding it as a cause of the lowered sensitivity. In contrast, the diminished sensitivity to Histatin 5 of energy-depleted C. albicans was restored by increasing the fluidity of the membrane using the membrane fluidizer benzyl alcohol. Furthermore, rigidification of the membrane by incubation at low temperature or in the presence of the membrane rigidifier Me2SO increased the resistance against Histatin 5, while not affecting the energy charge of the cell. In line, azide induced alterations in the physical state of the interior of the lipid bilayer. These data demonstrate that changes in the physical state of the membrane underlie the increased resistance to antimicrobial peptides.	Acad Ctr Dent Amsterdam, Dept Oral Biochem, NL-1081 BT Amsterdam, Netherlands; Vrije Univ Amsterdam, Acad Ctr Dent, Dept Oral Biochem, NL-1081 BT Amsterdam, Netherlands; Acad Med Ctr, Cent Elect Microscopy, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; Vrije Univ Amsterdam, Dept Phys & Astron, Biophys Sect, NL-1105 AZ Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Veerman, ECI (corresponding author), Acad Ctr Dent Amsterdam, Dept Oral Biochem, Van der Boechorstr 7, NL-1081 BT Amsterdam, Netherlands.	eci.veerman@vumc.nl	Bolscher, Jan/ABF-6102-2021	Bolscher, Jan/0000-0001-5669-6164				Aspedon A, 1996, MICROBIOL-SGM, V142, P3389, DOI 10.1099/13500872-142-12-3389; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Bernstein BW, 2003, J NEUROSCI, V23, P1; Bikker FJ, 2006, CHEM BIOL DRUG DES, V68, P148, DOI 10.1111/j.1747-0285.2006.00424.x; Braet F, 2003, HEPATOLOGY, V38, P394, DOI 10.1053/jhep.2003.50347; Brun S, 2003, ANTIMICROB AGENTS CH, V47, P847, DOI 10.1128/AAC.47.3.847-853.2003; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; den Hertog AL, 2004, BIOCHEM J, V379, P665, DOI 10.1042/BJ20031785; Doctor RB, 1997, AM J PHYSIOL-CELL PH, V272, pC439, DOI 10.1152/ajpcell.1997.272.2.C439; EDDY AA, 1985, BIOCHEM J, V231, P291, DOI 10.1042/bj2310291; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; FLORINECASTEEL K, 1991, FASEB J, V5, P2078, DOI 10.1096/fasebj.5.7.2010060; Gaskova D, 1999, INT J BIOCHEM CELL B, V31, P575, DOI 10.1016/S1357-2725(99)00002-3; Gaskova D, 1998, YEAST, V14, P1189, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1189::AID-YEA320>3.3.CO;2-B; GINSBURG I, 1984, INFLAMMATION, V8, P1, DOI 10.1007/BF00918349; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Haidekker MA, 2004, ANN BIOMED ENG, V32, P531, DOI 10.1023/B:ABME.0000019172.12700.b8; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Hochmuth RM, 1996, BIOPHYS J, V70, P358, DOI 10.1016/S0006-3495(96)79577-2; Hui EKW, 2001, VIROLOGY, V290, P329, DOI 10.1006/viro.2001.1181; KOMOR E, 1979, P NATL ACAD SCI USA, V76, P1814, DOI 10.1073/pnas.76.4.1814; KORDEL M, 1988, J BACTERIOL, V170, P84, DOI 10.1128/jb.170.1.84-88.1988; Korobov VP, 2005, MICROBIOLOGY+, V74, P136, DOI 10.1007/s11021-005-0042-7; Koshlukova SE, 1999, J BIOL CHEM, V274, P18872, DOI 10.1074/jbc.274.27.18872; KOVAC L, 1982, BIOCHIM BIOPHYS ACTA, V721, P341, DOI 10.1016/0167-4889(82)90088-X; KUHRY JG, 1985, BIOCHIM BIOPHYS ACTA, V845, P60, DOI 10.1016/0167-4889(85)90055-2; LEHRER RI, 1988, J CLIN INVEST, V81, P1829, DOI 10.1172/JCI113527; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Li XWS, 2006, J BIOL CHEM, V281, P22453, DOI 10.1074/jbc.M604064200; Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P9799, DOI 10.1021/bi970588v; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Murata Y, 2003, J BIOL CHEM, V278, P33185, DOI 10.1074/jbc.M300450200; Nurko S, 1996, AM J PHYSIOL-RENAL, V270, pF39, DOI 10.1152/ajprenal.1996.270.1.F39; OBRENOVITCH A, 1978, FEBS LETT, V88, P187, DOI 10.1016/0014-5793(78)80170-7; OLSON VL, 1977, CAN J MICROBIOL, V23, P166, DOI 10.1139/m77-024; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; Patra D., 2004, Journal of Applied Spectroscopy, V71, P334, DOI 10.1023/B:JAPS.0000039958.98539.45; PRENDERGAST FG, 1981, BIOCHEMISTRY-US, V20, P7333, DOI 10.1021/bi00529a002; Ruissen ALA, 2002, PEPTIDES, V23, P1391, DOI 10.1016/S0196-9781(02)00076-1; Ruissen ALA, 2001, BIOCHEM J, V356, P361, DOI 10.1042/0264-6021:3560361; Sheikh S, 1997, BIOCHEM BIOPH RES CO, V238, P910, DOI 10.1006/bbrc.1997.7407; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200; van der Kraan MIA, 2005, PEPTIDES, V26, P1537, DOI 10.1016/j.peptides.2005.02.011; VANBLITTERSWIJK WJ, 1988, BIOCHIM BIOPHYS ACTA, V644, P323; Veerman ECI, 2004, BIOCHEM J, V381, P447, DOI 10.1042/BJ20040208; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Yun DJ, 1997, P NATL ACAD SCI USA, V94, P7082, DOI 10.1073/pnas.94.13.7082	53	68	68	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18831	18841		10.1074/jbc.M610555200	http://dx.doi.org/10.1074/jbc.M610555200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17485465	hybrid			2022-12-27	WOS:000247475300022
J	Eto, M; Kirkbride, J; Elliott, E; Lo, SH; Brautigan, DL				Eto, Masumi; Kirkbride, Jason; Elliott, Elizabeth; Lo, Su Hao; Brautigan, David L.			Association of the tensin N-terminal protein-tyrosine phosphatase domain with the alpha isoform of protein phosphatase-1 in focal adhesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; SUBCELLULAR-LOCALIZATION; MYOSIN PHOSPHATASE; MATRIX ADHESIONS; CELL-MIGRATION; PHOSPHORYLATION; PAXILLIN; INHIBITOR; DYNAMICS; MOTILITY	Focal adhesions attach cultured cells to the extracellular matrix, and we found endogenous protein phosphatase-1 alpha-isoform (PP1 alpha) localized in adhesions across the entire area of adherent fibroblasts. However, in fibroblasts migrating into a scrape wound or spreading after replating PP1 alpha did not appear in adhesions near the leading edge but was recruited into other adhesions coincident in time and space with incorporation of tensin. Endogenous tensin and PP1 alpha co-precipitated from cell lysates with isoform-specific PP1 antibodies. Chemical cross-linking of focal adhesion preparations with Lomant's reagent demonstrated molecular proximity of endogenous PP1 alpha and tensin, whereas neither focal adhesion kinase nor vinculin was cross-linked and co-precipitated with PP1 alpha, suggesting distinct spatial subdomains within adhesions. Transient expression of truncated tensin showed the N-terminal 360 residues, which comprise a protein-tyrosine phosphatase domain, alone were sufficient for isoform-selective co-precipitation of co-expressed PP1 alpha. Human prostate cancer PC3 cells are deficient in tensin relative to fibroblasts and have fewer, mostly peripheral adhesions. Transient expression of green fluorescent protein tensin in these cancer cells induced formation of adhesions and recruited endogenous PP1 alpha into those adhesions. Thus, the protein-tyrosine phosphatase domain of tensin exhibits isoform-specific association with PP1 alpha in a restricted spatial region of adhesions that are formed during cell migration.	Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Calif Davis, Dept Orthoped Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Physiol, Philadelphia, PA 19107 USA	University of Virginia; University of Virginia; University of California System; University of California Davis; Jefferson University	Brautigan, DL (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Box 800577,1400 Jerrson Pk Ave, Charlottesville, VA 22908 USA.	db8g@virginia.edu	Eto, Masumi/ABE-4700-2020	Eto, Masumi/0000-0002-0651-5836; Lo, Su Hao/0000-0002-2675-9387	NCI NIH HHS [CA 40042] Funding Source: Medline; NIGMS NIH HHS [GM 56362] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen HY, 2000, BIOCHEM J, V351, P403, DOI 10.1042/0264-6021:3510403; Chen HY, 2003, BIOCHEM J, V370, P1039, DOI 10.1042/BJ20021308; Cohen PTW, 2002, J CELL SCI, V115, P241; Colbran RJ, 2003, METHOD ENZYMOL, V366, P156; DAVIS S, 1991, SCIENCE, V252, P712, DOI 10.1126/science.1708917; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Fresu M, 2001, BIOCHEM J, V358, P407, DOI 10.1042/0264-6021:3580407; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Haynie DT, 1996, PROTEIN SCI, V5, P2643, DOI 10.1002/pro.5560051227; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Kawada M, 1999, BBA-MOL CELL RES, V1452, P209, DOI 10.1016/S0167-4889(99)00126-3; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LO SH, 1994, BIOESSAYS, V16, P817, DOI 10.1002/bies.950161108; Murata K, 1997, MOL BIOL CELL, V8, P663, DOI 10.1091/mbc.8.4.663; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; SHIMA H, 1993, BIOCHEM BIOPH RES CO, V192, P1289, DOI 10.1006/bbrc.1993.1556; Strack S, 1999, J COMP NEUROL, V413, P373; Tanaka J, 1998, BIOCHEMISTRY-US, V37, P16697, DOI 10.1021/bi980782x; Villa-Moruzzi E, 1998, CELL ADHES COMMUN, V5, P297, DOI 10.3109/15419069809040299; Webb DJ, 2003, NAT CELL BIOL, V5, P690, DOI 10.1038/ncb0803-690; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb DJ, 2005, J CELL SCI, V118, P4925, DOI 10.1242/jcs.02563; Webb Donna J., 2004, V294, P3; Young MRI, 2002, INT J CANCER, V100, P276, DOI 10.1002/ijc.10491; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2001, J CELL SCI, V114, P3577	34	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17806	17815		10.1074/jbc.M700944200	http://dx.doi.org/10.1074/jbc.M700944200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17435217	hybrid			2022-12-27	WOS:000247084500054
J	Lanciano, P; Vergnes, A; Grimaldi, S; Guigliarelli, B; Magalon, A				Lanciano, Pascal; Vergnes, Alexandra; Grimaldi, Stephane; Guigliarelli, Bruno; Magalon, Axel			Biogenesis of a respiratory complex is orchestrated by a single accessory protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI NITRATE REDUCTASE; ESCHERICHIA-COLI; MOLYBDENUM COFACTOR; FORMATE DEHYDROGENASE; INHIBITOR BINDING; CATALYTIC SUBUNIT; GENE-PRODUCTS; TAT PATHWAY; NARGHI; EPR	The biogenesis of respiratory complexes is a multistep process that requires finely tuned coordination of subunit assembly, metal cofactor insertion, and membrane-anchoring events. The dissimilatory nitrate reductase of the bacterial anaerobic respiratory chain is a membrane-bound heterotrimeric complex nitrate reductase A ( NarGHI) carrying no less than eight redox centers. Here, we identified different stable folding assembly intermediates of the nitrate reductase complex and analyzed their redox cofactor contents using electron paramagnetic resonance spectroscopy. Upon the absence of the accessory protein NarJ, a global defect in metal incorporation was revealed. In addition to the molybdenum cofactor, we show that NarJ is required for specific insertion of the proximal iron-sulfur cluster ( FS0) within the soluble nitrate reductase ( NarGH) catalytic dimer. Further, we establish that NarJ ensures complete maturation of the b-type cytochrome subunit NarI by a proper timing for membrane anchoring of the NarGH complex. Our findings demonstrate that NarJ has a multifunctional role by orchestrating both the maturation and the assembly steps.	CNRS, Inst Biol Struct & Mircobiol, Unite Bioenerget & Ingn Prot, F-13402 Marseille 09, France; CNRS, Inst Biol Struct & Mircobiol, Lab Chim Bacterienne, F-13402 Marseille 09, France; Univ Aix Marseille 1, F-13402 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Magalon, A (corresponding author), CNRS, Inst Biol Struct & Mircobiol, Unite Bioenerget & Ingn Prot, 31 Chemin Joseph Aiguier, F-13402 Marseille 09, France.	magalon@ibsm.cnrs-mrs.fr	Vergnes, Alexandra/AAM-2842-2020; Grimaldi, Stephane/G-9884-2013; Grimaldi, Stephane/AAF-7138-2020	Grimaldi, Stephane/0000-0002-9559-6112; Magalon, Axel/0000-0002-3375-738X				AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Grimaldi S, 2005, BIOCHEMISTRY-US, V44, P1300, DOI 10.1021/bi048009r; GUIGLIARELLI B, 1992, EUR J BIOCHEM, V207, P61, DOI 10.1111/j.1432-1033.1992.tb17020.x; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; HAGEN WR, 1992, ADV INORG CHEM, V38, P165, DOI 10.1016/S0898-8838(08)60064-1; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kirillova O, 2007, ACTA CRYSTALLOGR D, V63, P348, DOI 10.1107/S0907444906055065; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Magalon A, 2002, J BIOL CHEM, V277, P48199, DOI 10.1074/jbc.M205806200; Magalon A, 1997, J BIOL CHEM, V272, P25652, DOI 10.1074/jbc.272.41.25652; Magalon A, 1998, BIOCHEMISTRY-US, V37, P7363, DOI 10.1021/bi972858f; Magalon A, 1998, J BIOL CHEM, V273, P10851, DOI 10.1074/jbc.273.18.10851; MANDRANDBERTHELOT MA, 1988, J GEN MICROBIOL, V134, P3129; McDevitt CA, 2002, MOL MICROBIOL, V44, P1575, DOI 10.1046/j.1365-2958.2002.02978.x; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Nilavongse A, 2006, MICROBIOL-SGM, V152, P3227, DOI 10.1099/mic.0.29157-0; Olmo-Mira MF, 2004, J BIOL CHEM, V279, P49727, DOI 10.1074/jbc.M406502200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; Potter LC, 1999, BIOCHEM J, V344, P69, DOI 10.1042/0264-6021:3440069; Ray N, 2003, FEBS LETT, V534, P156, DOI 10.1016/S0014-5793(02)03839-5; Rothery RA, 2001, J MOL MICROB BIOTECH, V3, P273; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; Rothery RA, 1999, BIOCHEMISTRY-US, V38, P12747, DOI 10.1021/bi990533o; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; Sargent F, 2002, ARCH MICROBIOL, V178, P77, DOI 10.1007/s00203-002-0434-2; SCHLINDWEIN C, 1990, J BACTERIOL, V172, P6112, DOI 10.1128/jb.172.10.6112-6121.1990; STEWART V, 1991, J BACTERIOL, V173, P4417, DOI 10.1128/JB.173.14.4417-4423.1991; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Vergnes A, 2004, J BIOL CHEM, V279, P41398, DOI 10.1074/jbc.M407087200	40	48	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17468	17474		10.1074/jbc.M700994200	http://dx.doi.org/10.1074/jbc.M700994200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17442677	hybrid			2022-12-27	WOS:000247084500017
J	Wang, RW; Chen, WQ; Cai, ST; Zhang, J; Bolstad, J; Wagenknecht, T; Liu, Z; Chen, SRW				Wang, Ruiwu; Chen, Wenqian; Cai, Shitian; Zhang, Jing; Bolstad, Jeff; Wagenknecht, Terence; Liu, Zheng; Chen, S. R. Wayne			Localization of an NH2-terminal disease-causing mutation hot spot to the "clamp" region in the three-dimensional structure of the cardiac ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; SKELETAL-MUSCLE; CALCIUM-RELEASE; VENTRICULAR-TACHYCARDIA; CRYOELECTRON MICROSCOPY; MALIGNANT HYPERTHERMIA; FKBP12.6 BINDING; SITE; RECONSTRUCTION; RYR2	A region between residues 414 and 466 in the cardiac ryanodine receptor (RyR2) harbors more than half of the known NH2-terminal mutations associated with cardiac arrhythmias and sudden death. To gain insight into the structural basis of this NH2-terminal mutation hot spot, we have determined its location in the three-dimensional structure of RyR2. Green fluorescent protein (GFP), used as a structural marker, was inserted into the middle of this mutation hot spot after Ser-437 in the RyR2 sequence. The resultant GFP-RyR2 fusion protein, RyR(2S437-GFP), was expressed in HEK293 cells and characterized using Ca2+ release, [H-3] ryanodine binding, and single cell Ca2+ imaging studies. These functional analyses revealed that RyR2(S437-GFP) forms a caffeine-and ryanodine-sensitive Ca2+ release channel that possesses Ca2+ and caffeine dependence of activation indistinguishable from that of wild type (wt) RyR2. HEK293 cells expressing RyR2(S437-GFP) displayed a propensity for store overload-induced Ca2+ release similar to that in cells expressing RyR2-wt. The three-dimensional structure of the purified RyR2(S437-GFP) was reconstructed using cryo-electron microscopy and single particle image processing. Subtraction of the three-dimensional reconstructions of RyR2-wt and RyR2(S437-GFP) revealed the location of the inserted GFP, and hence the NH2-terminal mutation hot spot, in a region between domains 5 and 9 in the clamp-shaped structure. This location is close to a previously mapped central disease-causing mutation site located in a region between domains 5 and 6. These results, together with findings from previous studies, suggest that the proposed interactions between the NH2-terminal and central regions of RyR2 are likely to take place between domains 5 and 6 and that the clamp-shaped structure, which shows substantial conformational differences between the closed and open states, is highly susceptible to disease-causing mutations.	New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; New York State Dept Hlth, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; University of Calgary; University of Calgary; State University of New York (SUNY) System	Liu, Z (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	liuz@wadsworth.org; swchen@ucalgary.ca		Liu, Zheng/0000-0001-6952-3406	NCRR NIH HHS [P41 RR001219-21, RR01219, P41 RR001219] Funding Source: Medline; NIAMS NIH HHS [R01 AR040615-15, AR40615, R01 AR040615] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040615] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baker ML, 2002, P NATL ACAD SCI USA, V99, P12155, DOI 10.1073/pnas.182058899; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; Doi Nobuhide, 2002, Methods Mol Biol, V183, P49; Frank J, 2006, 3 DIMENSIONAL ELECT, P71; George CH, 2003, CIRC RES, V93, P531, DOI 10.1161/01.RES.0000091335.07574.86; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Kontula K, 2005, CARDIOVASC RES, V67, P379, DOI 10.1016/j.cardiores.2005.04.027; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Liu Z, 2002, J BIOL CHEM, V277, P46712, DOI 10.1074/jbc.M208124200; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Murayama T, 2007, BIOCHEM J, V402, P349, DOI 10.1042/BJ20061040; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Priori SG, 2005, J CLIN INVEST, V115, P2033, DOI 10.1172/JCI25664; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scoote M, 2004, BIOCHEM BIOPH RES CO, V322, P1286, DOI 10.1016/j.bbrc.2004.08.034; Serysheva I, 2005, J MOL BIOL, V345, P427, DOI 10.1016/j.jmb.2004.10.073; Serysheva II, 1999, BIOPHYS J, V77, P1936, DOI 10.1016/S0006-3495(99)77035-9; Sharma MR, 2002, BIOPHYS J, V82, p644A; Tanna B, 1998, J GEN PHYSIOL, V112, P55, DOI 10.1085/jgp.112.1.55; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; WAGENKNECHT T, 1994, BIOPHYS J, V67, P2286, DOI 10.1016/S0006-3495(94)80714-3; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Wagenknecht T, 1996, BIOPHYS J, V70, P1709, DOI 10.1016/S0006-3495(96)79733-3; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Yano M, 2006, NAT CLIN PRACT CARD, V3, P43, DOI 10.1038/ncpcardio0419; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	42	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17785	17793		10.1074/jbc.M700660200	http://dx.doi.org/10.1074/jbc.M700660200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452324	Green Accepted, hybrid			2022-12-27	WOS:000247084500052
J	Hong, SP; Carlson, M				Hong, Seung-Pyo; Carlson, Marian			Regulation of Snf1 protein kinase in response to environmental stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTINCT SIGNALING PATHWAYS; SHOCK TRANSCRIPTION FACTOR; 3 SNF1-ACTIVATING KINASES; HAPLOID INVASIVE GROWTH; SACCHAROMYCES-CEREVISIAE; YEAST SNF1; GLUCOSE STARVATION; SUBCELLULAR-LOCALIZATION; GLYCOGEN ACCUMULATION; UPSTREAM KINASES	The Saccharomyces cerevisiae Snf1 protein kinase, a member of the Snf1/AMPK (AMP-activated protein kinase) family, has important roles in metabolic control, particularly in response to nutrient stress. Here we have addressed the role of Snf1 in responses to other environmental stresses. Exposure of cells to sodium ion stress, alkaline pH, or oxidative stress caused an increase in Snf1 catalytic activity and phosphorylation of Thr-210 in the activation loop, whereas treatment with sorbitol or heat shock did not. Inhibition of respiratory metabolism by addition of antimycin A to cells also increased Snf1 activity. Analysis of mutants indicated that the kinases Sak1, Tos3, and Elm1, which activate Snf1 in response to glucose limitation, are also required under other stress conditions. Each kinase sufficed for activation in response to stress, but Sak1 had the major role. In sak1 Delta tos3 Delta elm1 Delta cells expressing mammalian Ca2+/calmodulin-dependent protein kinase kinase alpha, Snf1 was activated by both sodium ion and alkaline stress, suggesting that stress signals regulate Snf1 activity by a mechanism that is independent of the upstream kinase. Finally, we showed that Snf1 protein kinase is regulated differently during adaptation of cells to NaCl and alkaline pH with respect to both temporal regulation of activation and subcellular localization. Snf1 protein kinase becomes enriched in the nucleus in response to alkaline pH but not salt stress. Such differences could contribute to specificity of the stress responses.	Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Microbiol, New York, NY 10032 USA	Columbia University; Columbia University	Carlson, M (corresponding author), 701 W 168th,HSC922, New York, NY 10032 USA.	mbc1@columbia.edu	Hong, Raymond/R-6915-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034095, R01GM034095] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034095, GM34095] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Ashrafi K, 2000, GENE DEV, V14, P1872; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Dubacq C, 2004, MOL CELL BIOL, V24, P2560, DOI 10.1128/MCB.24.6.2560-2572.2004; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HARDY TA, 1994, J BIOL CHEM, V269, P27907; Hedbacker K, 2004, MOL CELL BIOL, V24, P8255, DOI 10.1128/MCB.24.18.8255-8263.2004; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Honigberg SM, 1998, MOL CELL BIOL, V18, P4548, DOI 10.1128/MCB.18.8.4548; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim MD, 2005, EUKARYOT CELL, V4, P861, DOI 10.1128/EC.4.5.861-866.2005; Kuchin S, 2002, MOL CELL BIOL, V22, P3994, DOI 10.1128/MCB.22.12.3994-4000.2002; Lin SS, 2003, J BIOL CHEM, V278, P13390, DOI 10.1074/jbc.M212818200; Mayordomo I, 2002, J BIOL CHEM, V277, P35650, DOI 10.1074/jbc.M204198200; McCartney R, 2005, CURR GENET, V47, P335, DOI 10.1007/s00294-005-0576-2; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Orlova M, 2006, EUKARYOT CELL, V5, P1831, DOI 10.1128/EC.00110-06; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Palecek SP, 2002, MOL MICROBIOL, V45, P453, DOI 10.1046/j.1365-2958.2002.03024.x; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Portillo F, 2005, FEBS LETT, V579, P512, DOI 10.1016/j.febslet.2004.12.019; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; THOMPSONJAEGER S, 1991, GENETICS, V129, P697; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; WOODS A, 1994, J BIOL CHEM, V269, P19509; Ye T, 2006, EUKARYOT CELL, V5, P1611, DOI 10.1128/EC.00215-06; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	52	136	141	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16838	16845		10.1074/jbc.M700146200	http://dx.doi.org/10.1074/jbc.M700146200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17438333	hybrid			2022-12-27	WOS:000246946500016
J	Buczynski, MW; Stephens, DL; Bowers-Gentry, RC; Grkovich, A; Deems, RA; Dennis, EA				Buczynski, Matthew W.; Stephens, Daren L.; Bowers-Gentry, Rebecca C.; Grkovich, Andrej; Deems, Raymond A.; Dennis, Edward A.			TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); PLATELET-ACTIVATING-FACTOR; TANDEM MASS-SPECTROMETRY; ARACHIDONIC-ACID RELEASE; MACROPHAGE-LIKE CELLS; GROUP-SPECIFIC ASSAYS; P388D(1) MACROPHAGES; ELECTROSPRAY; INFLAMMATION; METABOLISM	Arachidonic acid is released by phospholipase A(2) and converted into hundreds of distinct bioactive mediators by a variety of cyclooxygenases ( COX), lipoxygenases (LO), and cytochrome P450s. Because of the size and diversity of the eicosanoid class of signaling molecules produced, a thorough and systematic investigation of these biological processes requires the simultaneous quantitation of a large number of eicosanoids in a single analysis. We have developed a robust liquid chromatography/tandem mass spectrometry method that can identify and quantitate over 60 different eicosanoids in a single analysis, and we applied it to agonist-stimulated RAW264.7 murine macrophages. Fifteen different eicosanoids produced through COX and 5-LO were detected either intracellularly or in the media following stimulation with 16 different agonists of Toll-like receptors (TLR), Gprotein-coupled receptors, and purinergic receptors. No significant differences in the COX metabolite profiles were detected using the different agonists; however, we determined that only agonists creating a sustained Ca2+ influx were capable of activating the 5-LO pathway in these cells. Synergy between Ca2+ and TLR pathways was detected and discovered to be independent of NF- kappa B-induced protein synthesis. This demonstrates that TLR induction of protein synthesis and priming for enhanced phospholipase A2-mediated eicosanoid production work through two distinct pathways.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	edennis@ucsd.edu	Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140	NIDDK NIH HHS [T32 DK007202] Funding Source: Medline; NIGMS NIH HHS [GM64611, GM069338] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM064611] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADEREM AA, 1986, CIBA F SYMP, V118, P196, DOI 10.1002/9780470720998.ch13; ADEREM AA, 1986, J EXP MED, V164, P165, DOI 10.1084/jem.164.1.165; ASMIS R, 1994, BIOCHEM J, V298, P543, DOI 10.1042/bj2980543; Balboa MA, 2000, BIOCHEM BIOPH RES CO, V267, P145, DOI 10.1006/bbrc.1999.1964; Balboa MA, 1999, J BIOL CHEM, V274, P36764, DOI 10.1074/jbc.274.51.36764; Balsinde J, 1997, BIOCHEM J, V321, P805, DOI 10.1042/bj3210805; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Baranowski R, 2002, MINI-REV MED CHEM, V2, P135, DOI 10.2174/1389557024605465; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P1259, DOI 10.1161/01.ATV.0000133192.39901.be; Coffey MJ, 2000, J IMMUNOL, V165, P3592, DOI 10.4049/jimmunol.165.7.3592; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; GLASER KB, 1990, J BIOL CHEM, V265, P8658; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; Grkovich A, 2006, J BIOL CHEM, V281, P32978, DOI 10.1074/jbc.M605935200; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Huwiler A, 2001, FASEB J, V15, P7; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Klapisz E, 2000, J LIPID RES, V41, P1680; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Margalit A, 1996, ANAL BIOCHEM, V235, P73, DOI 10.1006/abio.1996.0093; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; Nakamura H, 2006, BIOCHEM PHARMACOL, V71, P850, DOI 10.1016/j.bcp.2005.12.027; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Peters-Golden M, 2003, PROSTAG LEUKOTR ESS, V69, P99, DOI 10.1016/S0952-3278(03)00070-X; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; REINKE M, 1992, AM J PHYSIOL, V262, pE658, DOI 10.1152/ajpendo.1992.262.5.E658; Sacerdoti D, 2003, PROSTAG OTH LIPID M, V72, P51, DOI 10.1016/S1098-8823(03)00077-7; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schaloske RH, 2005, BBA-MOL CELL BIOL L, V1687, P64, DOI 10.1016/j.bbalip.2004.11.005; Seeds MC, 1998, BBA-LIPID LIPID MET, V1394, P224, DOI 10.1016/S0005-2760(98)00111-8; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; SHONO F, 1988, ANAL BIOCHEM, V168, P284, DOI 10.1016/0003-2697(88)90320-X; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spokas EG, 1999, METH MOL B, V120, P213; Takabatake M, 2002, PROSTAG LEUKOTR ESS, V67, P51, DOI 10.1054/plef.2002.0381; Trebino CE, 2005, J BIOL CHEM, V280, P16579, DOI 10.1074/jbc.M412075200; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Yang HC, 1999, ANAL BIOCHEM, V269, P278, DOI 10.1006/abio.1999.4053	55	78	79	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22834	22847		10.1074/jbc.M701831200	http://dx.doi.org/10.1074/jbc.M701831200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17535806	hybrid, Green Published			2022-12-27	WOS:000248354200061
J	Fu, P; Thompson, JA; Bach, LA				Fu, Ping; Thompson, Julian A.; Bach, Leon A.			Promotion of cancer cell migration - An insulin-like growth factor (IGF)-independent action of IGF-binding protein-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR (IGF)-BINDING PROTEIN-3; HEPATIC STELLATE CELLS; N-TERMINAL DOMAIN; P38 MAP KINASE; ALPHA-5-BETA-1 INTEGRIN; AMINO-ACIDS; ACTIVATION; ERK; EXPRESSION; NEUROBLASTOMA	A family of six high affinity IGF-binding proteins (IGFBPs 1-6) plays an important role in modulating IGF activities. Recent studies suggest that some IGFBPs may have IGF-independent effects, including induction of apoptosis and modulation of cell migration. However, very little is known about possible IGF-independent actions of IGFBP-6. We have generated a non-IGF-binding IGFBP-6 mutant by substituting Ala for four amino acid residues (Pro(93)/Leu(94)/Leu(97)/Leu(98)) in its N-domain IGF-binding site. A > 10,000-fold loss of binding affinity for IGF-I and IGF-II was observed using charcoal solution binding assay, BIAcore biosensor, and ligand blotting. Wild-type and mutant IGFBP-6, as well as IGF-II, induced cell migration in RD rhabdomyosarcoma and LIM 1215 colon cancer cells. Cell migration was mediated by the C-domain of IGFBP-6. Transient p38 phosphorylation was observed in RD cells after treatment with IGFBP-6, whereas no change was seen in phospho-ERK1/2 levels. Phospho-JNK was not detected. IGFBP-6-induced cell migration was inhibited by SB203580, an inhibitor of p38 MAPK, and PD98059, an inhibitor of ERK1/2MAPK activation. In contrast, SP600125, a JNK MAPK inhibitor, had no effect on migration. Knockdown of p38 MAPK using short interfering RNA blocked IGFBP-6-induced migration of RD cells. These results indicate that p38 MAPK is involved in IGFBP-6-induced IGF-independent RD cell migration.	Monash Univ, Alfred Med Res & Educ Precinct, Fac Med Nursing & Hlth Sci, Dept Med,Cent & Eastern Clin Sch, Prahran, Vic 3181, Australia; Alfred Hosp, Dept Endocrinol & Diabet, Melbourne, Vic 3004, Australia	Monash University; Florey Institute of Neuroscience & Mental Health	Fu, P (corresponding author), Monash Univ, Alfred Med Res & Educ Precinct, Fac Med Nursing & Hlth Sci, Dept Med,Cent & Eastern Clin Sch, Prahran, Vic 3181, Australia.	ping.fu@med.monash.edu.au		Bach, Leon/0000-0002-9062-1518				Abrass CK, 1997, AM J PHYSIOL-RENAL, V273, pF899, DOI 10.1152/ajprenal.1997.273.6.F899; Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Bach LA, 2005, GROWTH HORM IGF RES, V15, P185, DOI 10.1016/j.ghir.2005.04.001; BACH LA, 1994, ENDOCRINOLOGY, V135, P2168, DOI 10.1210/en.135.5.2168; Berfield AK, 2000, KIDNEY INT, V57, P1991, DOI 10.1046/j.1523-1755.2000.00049.x; Buckway CK, 2001, J CLIN ENDOCR METAB, V86, P4943, DOI 10.1210/jc.86.10.4943; Ceresa BP, 1997, ENDOCRINOLOGY, V138, P4131, DOI 10.1210/en.138.10.4131; Dake BL, 2004, ENDOCRINOLOGY, V145, P3369, DOI 10.1210/en.2003-1667; Duan CM, 1998, J BIOL CHEM, V273, P16836, DOI 10.1074/jbc.273.27.16836; Ewton DZ, 1998, J CELL PHYSIOL, V177, P47, DOI 10.1002/(SICI)1097-4652(199810)177:1<47::AID-JCP5>3.0.CO;2-E; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Fu P, 2007, J CELL BIOCHEM, V100, P58, DOI 10.1002/jcb.20984; Gallicchio MA, 2003, J CELL PHYSIOL, V197, P131, DOI 10.1002/jcp.10352; Gallicchio MA, 2001, INT J CANCER, V94, P645, DOI 10.1002/ijc.1519; Gleeson LM, 2001, J CLIN ENDOCR METAB, V86, P2484, DOI 10.1210/jc.86.6.2484; Grellier P, 1998, CANCER RES, V58, P1670; Headey SJ, 2004, FEBS LETT, V568, P19, DOI 10.1016/j.febslet.2004.04.091; Headey SJ, 2004, J MOL ENDOCRINOL, V33, P377, DOI 10.1677/jme.1.01547; Headey SJ, 2004, MOL ENDOCRINOL, V18, P2740, DOI 10.1210/me.2004-0248; Holt KH, 1996, MOL CELL BIOL, V16, P577; Hong J, 2002, J BIOL CHEM, V277, P10489, DOI 10.1074/jbc.M109604200; Houliston RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1266, DOI 10.1152/ajpcell.2001.281.4.C1266; Hsieh T, 2003, J BIOL CHEM, V278, P42886, DOI 10.1074/jbc.M303835200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; James PL, 1996, J CELL BIOL, V133, P683, DOI 10.1083/jcb.133.3.683; Janulis M, 1999, J BIOL CHEM, V274, P801, DOI 10.1074/jbc.274.2.801; Jiang Q, 2006, J OCUL PHARMACOL TH, V22, P93, DOI 10.1089/jop.2006.22.93; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; Kalus W, 1998, EMBO J, V17, P6558, DOI 10.1093/emboj/17.22.6558; Keeton AB, 2002, J BIOL CHEM, V277, P48565, DOI 10.1074/jbc.M207837200; Kim EJ, 2002, J CELL PHYSIOL, V190, P92, DOI 10.1002/jcp.10045; Kim MS, 2003, CANCER RES, V63, P5454; Lee OH, 2000, BRIT J CANCER, V82, P385; Leventhal PS, 1997, TRENDS ENDOCRIN MET, V8, P1, DOI 10.1016/S1043-2760(96)00202-0; Lewthwaite JC, 2006, J BIOL CHEM, V281, P11011, DOI 10.1074/jbc.M510680200; Marinaro JA, 2000, EUR J BIOCHEM, V267, P5378, DOI 10.1046/j.1432-1327.2000.01575.x; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Neumann GM, 1999, J BIOL CHEM, V274, P14587, DOI 10.1074/jbc.274.21.14587; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Pereira JJ, 2004, CANCER RES, V64, P977, DOI 10.1158/0008-5472.CAN-03-3056; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Puri PL, 2000, GENE DEV, V14, P574; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Scholl FA, 2005, CANCER LETT, V230, P1, DOI 10.1016/j.canlet.2004.12.013; Seurin D, 2002, EUR J CANCER, V38, P2058, DOI 10.1016/S0959-8049(02)00240-X; Silha JV, 2006, ENDOCRINOLOGY, V147, P2112, DOI 10.1210/en.2005-1270; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Sueoka N, 2000, ONCOGENE, V19, P4432, DOI 10.1038/sj.onc.1203813; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; Xie LF, 2005, MOL CELL PROTEOMICS, V4, P1273, DOI 10.1074/mcp.M500032-MCP200; Yan T, 2001, GROWTH HORM IGF RES, V11, P368, DOI 10.1054/ghir.2001.0249; Yan XL, 2004, J BIOL CHEM, V279, P53232, DOI 10.1074/jbc.M409345200; Zeslawski W, 2001, EMBO J, V20, P3638, DOI 10.1093/emboj/20.14.3638	58	54	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22298	22306		10.1074/jbc.M703066200	http://dx.doi.org/10.1074/jbc.M703066200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17519236	hybrid			2022-12-27	WOS:000248354200007
J	Xin, MG; Gao, FQ; May, WS; Flagg, T; Deng, XM				Xin, Meiguo; Gao, Fengqin; May, W. Stratford; Flagg, Tammy; Deng, Xingming			Protein kinase C zeta abrogates the proapoptotic function of bax through phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; PKC-ZETA; PROMOTES SURVIVAL; RAT ADIPOCYTES; APOPTOSIS; ACTIVATION; MITOCHONDRIA; MEMBRANE; TRANSLOCATION; INSULIN	Protein kinase C zeta (PKC zeta) is an atypical PKC isoform that plays an important role in supporting cell survival but the mechanism(s) involved is not fully understood. Bax is a major member of the Bcl-2 family that is required for apoptotic cell death. Because Bax is extensively co-expressed with PKC zeta in both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) cells, it is possible that Bax may act as the downstream target of PKC zeta in regulating survival and chemosensitivity of lung cancer cells. Here we discovered that treatment of cells with nicotine not only enhances PKC zeta activity but also results in Bax phosphorylation and prolonged cell survival, which is suppressed by a PKC zeta specific inhibitor (a myristoylated PKC zeta pseudosubstrate peptide). Purified, active PKC zeta directly phosphorylates Bax in vitro. Overexpression of wild type or the constitutively active A119D but not the dominant negative K281W PKC zeta mutant results in Bax phosphorylation at serine 184. PKC zeta co-localizes and interacts with Bax at the BH3 domain. Specific depletion of PKC zeta by RNA interference blocks nicotine-stimulated Bax phosphorylation and enhances apoptotic cell death. Intriguingly, forced expression of wild type or A119D but not K281W PKC zeta mutant results in accumulation of Bax in cytoplasm and prevents Bax from undergoing a conformational change with prolonged cell survival. Purified PKC zeta can directly dissociate Bax from isolated mitochondria of C2-ceramide-treated cells. Thus, PKC zeta may function as a physiological Bax kinase to directly phosphorylate and interact with Bax, which leads to sequestration of Bax in cytoplasm and abrogation of the proapoptotic function of Bax.	Univ Florida, Shands Canc Ctr, Dept Med, Gainesville, FL 32610 USA; Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Deng, XM (corresponding author), 1376 Mowry Rd,Canc Genet Res Complex,Rm 262,POB 1, Gainesville, FL 32610 USA.	xdeng@ufl.edu			NATIONAL CANCER INSTITUTE [R01CA112183] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA112183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bourbon NA, 2002, J BIOL CHEM, V277, P3286, DOI 10.1074/jbc.M110541200; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Cartron PF, 2005, J BIOL CHEM, V280, P10587, DOI 10.1074/jbc.M409714200; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; DeVries TA, 2004, J BIOL CHEM, V279, P45603, DOI 10.1074/jbc.M407448200; Ding L, 2002, J BIOL CHEM, V277, P35305, DOI 10.1074/jbc.M201460200; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; IKONEN E, 1995, FEBS LETT, V358, P273, DOI 10.1016/0014-5793(94)01444-6; Jin ZH, 2004, J BIOL CHEM, V279, P23837, DOI 10.1074/jbc.M402566200; Jin ZJ, 2005, J BIOL CHEM, V280, P16045, DOI 10.1074/jbc.M413488200; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Krajewska M, 1997, CANCER RES, V57, P1605; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; McJilton MA, 2003, ONCOGENE, V22, P7958, DOI 10.1038/sj.onc.1206795; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Plo I, 2002, J BIOL CHEM, V277, P31407, DOI 10.1074/jbc.M204654200; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Sajan MP, 1999, J BIOL CHEM, V274, P30495, DOI 10.1074/jbc.274.43.30495; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Saxena A, 2004, AM J HEMATOL, V75, P22, DOI 10.1002/ajh.10453; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Smaili SS, 2003, BRAZ J MED BIOL RES, V36, P183, DOI 10.1590/S0100-879X2003000200004; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Villalba M, 2001, J IMMUNOL, V166, P5955, DOI 10.4049/jimmunol.166.10.5955; Wang YM, 1999, J NEUROSCI RES, V55, P293, DOI 10.1002/(SICI)1097-4547(19990201)55:3<293::AID-JNR4>3.3.CO;2-0; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440	46	63	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21268	21277		10.1074/jbc.M701613200	http://dx.doi.org/10.1074/jbc.M701613200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17525161	hybrid			2022-12-27	WOS:000248047500055
J	Hua, GQ; Zhang, QX; Fan, ZS				Hua, Guoqiang; Zhang, Qixiang; Fan, Zusen			Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; ACTIVATED DNASE; MITOCHONDRIA; DEATH; PROTEASE; EXPRESSION; INTERACTS; DISTINCT; FAMILY; HSP90	Natural killer (NK) cells play an important role in innate immunity against virally infected or transformed cells as the first defense line. GranzymeM(GzmM) is an orphan granzyme that is constitutively highly expressed in NK cells and is consistent with NK cell-mediated cytolysis. We recently demonstrated that GzmM induces caspase-dependent apoptosis with DNA fragmentation through direct cleavage of inhibitor of caspase-activated DNase ( ICAD). However, the molecular mechanisms for GzmM-induced apoptosis are unclear. We found GzmM causes mitochondrial swelling and loss of mitochondrial transmembrane potential. Moreover, GzmM initiates reactive oxygen species (ROS) generation and cytochrome c release. Heat shock protein 75 (HSP75, also known as TRAP1) acts as an antagonist of ROS and protects cells from GzmM-mediated apoptosis. GzmM cleaves TRAP1 and abolishes its antagonistic function to ROS, resulting in ROS accumulation. Silencing TRAP1 through RNA interference increases ROS accumulation, whereas TRAP1 overexpression attenuates ROS production. ROS accumulation is in accordance with the release of cytochrome c from mitochondria and enhances GzmM-mediated apoptosis.	Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	fanz@moon.ibp.ac.cn						Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Bots M, 2006, J CELL SCI, V119, P5011, DOI 10.1242/jcs.03239; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen CF, 1996, MOL CELL BIOL, V16, P4691; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fan ZS, 2006, BLOOD, V107, P1342, DOI 10.1182/blood-2005-08-3485; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fan ZS, 2005, CELL MOL IMMUNOL, V2, P259; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Heibein JA, 1999, J IMMUNOL, V163, P4683; Im CN, 2007, J CELL BIOCHEM, V100, P474, DOI 10.1002/jcb.21064; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Johnson H, 2003, BLOOD, V101, P3093, DOI 10.1182/blood-2002-08-2485; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Kempaiah RK, 2006, J NUTR BIOCHEM, V17, P471, DOI 10.1016/j.jnutbio.2005.09.005; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lee YJ, 2005, ONCOGENE, V24, P3715, DOI 10.1038/sj.onc.1208440; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Lu HX, 2006, J IMMUNOL, V177, P1171, DOI 10.4049/jimmunol.177.2.1171; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sayers TJ, 2001, J IMMUNOL, V166, P765, DOI 10.4049/jimmunol.166.2.765; SMYTH MJ, 1992, J BIOL CHEM, V267, P24418; SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574; Suck G, 2005, EXP HEMATOL, V33, P1160, DOI 10.1016/j.exphem.2005.06.024; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; WATERHOUSE J, 2006, CELL DEATH DIFFER, V17, P471; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200	40	152	157	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20553	20560		10.1074/jbc.M703196200	http://dx.doi.org/10.1074/jbc.M703196200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17513296	hybrid			2022-12-27	WOS:000247819300058
J	Sheng, SH; Maarouf, AB; Bruns, JB; Hughey, RP; Kleyman, TR				Sheng, Shaohu; Maarouf, Ahmad B.; Bruns, James B.; Hughey, Rebecca P.; Kleyman, Thomas R.			Functional role of extracellular loop cysteine residues of the epithelial Na+ channel in Na+ self-inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; ALPHA-SUBUNIT; CELL-SURFACE; MUTATIONAL ANALYSIS; HISTIDINE-RESIDUES; DISULFIDE BONDS; GAMMA-SUBUNIT; PORE REGION; YEAST SCO1; AMILORIDE	The epithelial Na+ channel (ENaC) is typically formed by three homologous subunits (alpha, beta, and gamma) that possess a characteristic large extracellular loop (ECL) containing 16 conserved cysteine (Cys) residues. We investigated the functional role of these Cys residues in Na+ self- inhibition, an allosteric inhibition of ENaC activity by extracellular Na+. All 16 Cys residues within alpha and gamma ECLs and selected beta ECL Cys residues were individually mutated to alanine or serine residues. The Na+ self- inhibition response of wild type and mutant channels expressed in Xenopus oocytes was determined by whole cell voltage clamp. Individual mutation of eight alpha (Cys-1, - 4, - 5, - 6, - 7, - 10, - 13, or - 16), one beta (Cys- 7), and nine gamma (Cys-3, - 4, - 6, - 7, - 10, - 11, - 12, - 13, or - 16) residues significantly reduced the magnitude of Na+ self- inhibition. Na+ self- inhibition was eliminated by simultaneous mutations of either the last three alpha ECL Cys residues (Cys- 14, - 15, and - 16) or Cys- 7 within both alpha and gamma ECLs. By analyzing the Na+ self-inhibition responses and the effects of a methanethiosulfonate reagent on channel currents in single and double Cys mutants, we identified five Cys pairs within the alpha ECL (alpha Cys- 1/alpha Cys- 6, alpha Cys-4/zeta Cys-5, alpha Cys-7/alpha Cys-16, alpha Cys-10/alpha Cys-13, and alpha Cys-11/alpha Cys-12) and one pair within the gamma ECL (gamma Cys-7/gamma Cys-16) that likely form intrasubunit disulfide bonds. We conclude that approximately half of the ECL Cys residues in the alpha and gamma ENaC subunits are required to establish the tertiary structure that ensures a proper Na+ self-inhibition response, likely by formation of multiple intrasubunit disulfide bonds.	Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sheng, SH (corresponding author), Univ Pittsburgh, Div Renal & Electrolyte, 3550 Terrace St, Pittsburgh, PA 15261 USA.	shaohu@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	NIDDK NIH HHS [DK 054354] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054354] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abajian C, 2006, J BIOL INORG CHEM, V11, P459, DOI 10.1007/s00775-006-0096-7; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chen L, 2004, AM J PHYSIOL-RENAL, V286, pF1202, DOI 10.1152/ajprenal.00352.2003; Chraibi A, 2003, PFLUG ARCH EUR J PHY, V447, P316, DOI 10.1007/s00424-003-1178-9; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; GARTY H, 1988, PHYSIOL REV, V68, P309, DOI 10.1152/physrev.1988.68.2.309; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Horisberger Jean-Daniel, 2004, Nephron, V96, pp37, DOI 10.1159/000076406; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ismailov II, 1997, J BIOL CHEM, V272, P21075, DOI 10.1074/jbc.272.34.21075; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; TURNHEIM K, 1991, PHYSIOL REV, V71, P429, DOI 10.1152/physrev.1991.71.2.429; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x	45	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20180	20190		10.1074/jbc.M611761200	http://dx.doi.org/10.1074/jbc.M611761200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17522058	hybrid			2022-12-27	WOS:000247819300019
J	Strube, K; de Vries, S; Cramm, R				Strube, Katja; de Vries, Simon; Cramm, Rainer			Formation of a dinitrosyl iron complex by NorA, a nitric oxide-binding Di-iron protein from Ralstonia eutropha H16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ALCALIGENES-EUTROPHUS; RIBONUCLEOTIDE REDUCTASE; S-NITROSOTHIOLS; R2 SUBUNIT; SITE; GENES; OXO; DERIVATIVES; RESISTANCE	In Ralstonia eutropha H16, two genes, norA and norB, form a dicistronic operon that is controlled by the NO-responsive transcriptional regulator NorR. NorB has been identified as a membrane-bound NO reductase, but the physiological function of NorA is unknown. We found that, in a NorA deletion mutant, the promoter activity of the norAB operon was increased 3-fold, indicating that NorA attenuates activation of NorR. NorA shows limited sequence similarity to the oxygen carrier hemerythrin, which contains a di-iron center. Indeed, optical and EPR spectroscopy of purified NorA revealed the presence of a di-iron center, which binds oxygen in a similar way as hemerythrin. Diferrous NorA binds two molecules of NO maximally. Unexpectedly, binding of NO to the diferrous NorA required an external reductant. Two different NorA-NO species could be resolved. A minor species ( up to 20%) showed an S = (1)/(2) EPR signal with g(perpendicular to) = 2.041, and g(parallel to) = 2.018, typical of a paramagnetic dinitrosyl iron complex. The major species was EPR-silent, showing characteristic signals at 420nmand 750nmin the optical spectrum. This species is proposed to represent a novel dinitrosyl iron complex of the form Fe2+ -[NO](2)(2-), i.e. NO is bound as NO-. The NO binding capacity of NorA in conjunction with its high cytoplasmic concentration (20 mu M) suggests that NorA regulates transcription by lowering the free cytoplasmic concentration of NO.	Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Humboldt University of Berlin; Delft University of Technology	Cramm, R (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Chausseestr 117, D-10115 Berlin, Germany.	rainer.cramm@rz.hu-berlin.de		Cramm, Rainer/0000-0002-3630-3885				Andersson K. K., 1995, ADV INORG CHEM, V43, P359; ATTA M, 1994, J AM CHEM SOC, V116, P6429, DOI 10.1021/ja00093a051; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; BOESE M, 1995, J BIOL CHEM, V270, P29244, DOI 10.1074/jbc.270.49.29244; Choi PS, 2006, APPL ENVIRON MICROB, V72, P2200, DOI 10.1128/AEM.72.3.2200-2205.2006; Costanzo S, 2001, INORG CHIM ACTA, V318, P1, DOI 10.1016/S0020-1693(01)00402-9; Cramm R, 1997, J BACTERIOL, V179, P6769, DOI 10.1128/jb.179.21.6769-6777.1997; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; D'Autreaux B, 2004, J AM CHEM SOC, V126, P6005, DOI 10.1021/ja031671a; DEWITT JG, 1991, J AM CHEM SOC, V113, P9219, DOI 10.1021/ja00024a031; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; ENEMARK JH, 1974, COORDIN CHEM REV, V13, P339, DOI 10.1016/S0010-8545(00)80259-3; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FOX BG, 1993, P NATL ACAD SCI USA, V90, P2486, DOI 10.1073/pnas.90.6.2486; GARBETT K, 1969, ARCH BIOCHEM BIOPHYS, V135, P419, DOI 10.1016/0003-9861(69)90559-1; Gomes CM, 2000, BIOCHEMISTRY-US, V39, P16230, DOI 10.1021/bi001844y; GUPTA N, 1995, BIOCHEMISTRY-US, V34, P3310, DOI 10.1021/bi00010a021; Han JY, 1996, INORG CHEM, V35, P4629, DOI 10.1021/ic9515012; HASKIN CJ, 1995, BIOCHEMISTRY-US, V34, P11090, DOI 10.1021/bi00035a014; HUBNER P, 1991, J BACTERIOL, V173, P2993; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Justino MC, 2006, FEMS MICROBIOL LETT, V257, P278, DOI 10.1111/j.1574-6968.2006.00179.x; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Kim CC, 2003, INFECT IMMUN, V71, P3196, DOI 10.1128/IAI.71.6.3196-3205.2003; Klink A, 2007, J BACTERIOL, V189, P2743, DOI 10.1128/JB.01865-06; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; LOWE RH, 1964, BIOCHIM BIOPHYS ACTA, V85, P377, DOI 10.1016/0926-6569(64)90301-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCORMICK JM, 1991, J AM CHEM SOC, V113, P9066, DOI 10.1021/ja00024a007; MCDONALD CC, 1965, J AM CHEM SOC, V87, P3319, DOI 10.1021/ja01093a007; Miller J. H, 1972, EXPT MOL GENETICS; Mizoguchi TJ, 2001, INORG CHEM, V40, P4662, DOI 10.1021/ic010076b; Persson BO, 1996, J BIOL INORG CHEM, V1, P247, DOI 10.1007/s007750050050; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; Raner GM, 1997, BIOCHEMISTRY-US, V36, P7037, DOI 10.1021/bi963041+; REEM RC, 1989, J AM CHEM SOC, V111, P4688, DOI 10.1021/ja00195a024; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; Serres RG, 2004, J AM CHEM SOC, V126, P5138, DOI 10.1021/ja030645+; SHIEMKE AK, 1984, J AM CHEM SOC, V106, P4951, DOI 10.1021/ja00329a054; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Vanin AF, 2004, NITRIC OXIDE-BIOL CH, V10, P60, DOI 10.1016/j.niox.2004.02.005; Vanin AF, 1998, BIOCHEMISTRY-MOSCOW+, V63, P782; Vollack KU, 2001, J BACTERIOL, V183, P2516, DOI 10.1128/JB.183.8.2516-2526.2001; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8; WEIHS V, 1989, ARCH MICROBIOL, V151, P546, DOI 10.1007/BF00454873; Xiong JJ, 2000, BIOCHEMISTRY-US, V39, P5117, DOI 10.1021/bi992796o; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZIMMER D, 1995, J BACTERIOL, V177, P2373, DOI 10.1128/jb.177.9.2373-2380.1995; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZUMFT WG, 1992, EUR J BIOCHEM, V208, P31, DOI 10.1111/j.1432-1033.1992.tb17156.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	60	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20292	20300		10.1074/jbc.M702003200	http://dx.doi.org/10.1074/jbc.M702003200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17507380	hybrid			2022-12-27	WOS:000247819300032
J	Kaneko, R; Tsuji, N; Asanuma, K; Tanabe, H; Kobayashi, D; Watanabe, N				Kaneko, Reiko; Tsuji, Naoki; Asanuma, Koichi; Tanabe, Hiromi; Kobayashi, Daisuke; Watanabe, Naoki			Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor-induced apoptosis in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN SURVIVIN; UP-REGULATION; FARNESYLTRANSFERASE INHIBITORS; SP1 PHOSPHORYLATION; GENE-TRANSCRIPTION; MEVALONATE PATHWAY; ANTIAPOPTOSIS GENE; MULTIPLE-MYELOMA; KINASE-ACTIVITY	3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (HRIs) are widely used to reduce serum cholesterol in patients with hypercholesterolemia. Previous studies have shown that HRIs can induce apoptosis in colon cancer cells. In this study, we investigated the mechanisms underlying the apoptosis-inducing effect of HRIs in greater detail. The HRI lovastatin induced apoptosis in the human colon cancer cell line SW480 by blocking the cholesterol synthesis pathway. Immunoblot analysis of antiapoptotic molecules, including survivin, XIAP, cIAP-1, cIAP-2, Bcl-2, and Bcl-X-L, revealed that only survivin expression was decreased by lovastatin. Survivin down-regulation by RNA interference induced apoptosis, and survivin overexpression rendered the cells resistant to lovastatin-induced growth inhibition. These results indicate that survivin down-regulation contributes substantially to the proapoptotic properties of lovastatin. Farnesyl pyrophosphate and geranylgeranyl pyrophosphate, two downstream intermediates in the cholesterol synthesis pathway, simultaneously reversed survivin down-regulation and the blocking of Ras isoprenylation by lovastatin. Ras isoprenylation is important for the activation of Ras-mediated signaling, including the activation of the phosphatidylinositol 3-kinase (PI3-kinase)/Akt pathway. The PI3-kinase inhibitor down-regulated survivin in SW480 cells. In addition, lovastatin blocked Ras activation and Akt phosphorylation. We conclude that survivin down-regulation is crucial in lovastatin-induced apoptosis in cancer cells and that lovastatin decreases survivin expression by inhibiting Ras-mediated PI3-kinase activation via the blocking of Ras isoprenylation.	Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Chuo Ku, Sapporo, Hokkaido 060, Japan	Sapporo Medical University	Watanabe, N (corresponding author), Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Chuo Ku, S-1,W-16, Sapporo, Hokkaido 060, Japan.	watanabn@sapmed.ac.jp						Adida C, 2000, BRIT J HAEMATOL, V111, P196, DOI 10.1046/j.1365-2141.2000.02328.x; Agarwal B, 1999, GASTROENTEROLOGY, V117, P838, DOI 10.1016/S0016-5085(99)70342-2; Agarwal B, 1999, CLIN CANCER RES, V5, P2223; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Asanuma K, 2004, J IMMUNOL, V172, P3922, DOI 10.4049/jimmunol.172.6.3922; Asanuma K, 2002, JPN J CANCER RES, V93, P1057, DOI 10.1111/j.1349-7006.2002.tb02483.x; Badrichani AZ, 1999, J CLIN INVEST, V103, P543, DOI 10.1172/JCI2517; BENNIS F, 1993, INT J CANCER, V55, P640, DOI 10.1002/ijc.2910550421; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Chen J, 2003, J BIOL CHEM, V278, P486, DOI 10.1074/jbc.M211119200; Endoh T, 2005, EXP CELL RES, V305, P300, DOI 10.1016/j.yexcr.2004.12.014; Fiordalisi JJ, 2003, J BIOL CHEM, V278, P41718, DOI 10.1074/jbc.M305733200; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Holstein SA, 2002, BIOCHEMISTRY-US, V41, P13698, DOI 10.1021/bi026251x; Ikeguchi M, 2002, CLIN CANCER RES, V8, P3131; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Kappler M, 2004, CANCER GENE THER, V11, P186, DOI 10.1038/sj.cgt.7700677; KATO J, 2001, INT J CANCER, V20, P9592; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kawasaki H, 1998, CANCER RES, V58, P5071; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Lu CD, 1998, CANCER RES, V58, P1808; Mahotka C, 1999, CANCER RES, V59, P6097; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Nakamura M, 2004, CANCER SCI, V95, P44, DOI 10.1111/j.1349-7006.2004.tb03169.x; NEWMAN CMH, 1993, BIOCHIM BIOPHYS ACTA, V1155, P79, DOI 10.1016/0304-419X(93)90023-6; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Ozes ON, 1999, NATURE, V401, P82; Pedersen TR, 1996, ARCH INTERN MED, V156, P2085, DOI 10.1001/archinte.156.18.2085; Reisinger K, 2003, J CELL SCI, V116, P225, DOI 10.1242/jcs.00237; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Saitoh Y, 1999, INT J ONCOL, V15, P137; Sarela AI, 2000, GUT, V46, P645, DOI 10.1136/gut.46.5.645; Satoh K, 2001, CANCER, V92, P271, DOI 10.1002/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Tamm I, 1998, CANCER RES, V58, P5315; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Thibault A, 1996, CLIN CANCER RES, V2, P483; VITOLS S, 1994, BLOOD, V84, P2689; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; WACHTERSHAUSER A, J CARCINOGENESIS, V22, P1061; Ye XB, 2002, J BIOL CHEM, V277, P31863, DOI 10.1074/jbc.M205544200; Yoshida H, 2001, INT J ONCOL, V19, P537; Zhu L, 2001, FEBS LETT, V508, P369, DOI 10.1016/S0014-5793(01)03084-8	54	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19273	19281		10.1074/jbc.M610350200	http://dx.doi.org/10.1074/jbc.M610350200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17472962	hybrid			2022-12-27	WOS:000247650600002
J	Pedersen, SF; King, SA; Nygaard, EB; Rigor, RR; Cala, PM				Pedersen, Stine F.; King, Scott A.; Nygaard, Eva B.; Rigor, Robert R.; Cala, Peter M.			NHE1 inhibition by amiloride- and benzoylguanidine-type compounds - Inhibitor binding loci deduced from chimeras of NHE1 homologues with endogenous differences in inhibitor sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; NA+/H+ EXCHANGER NHE1; VOLUME REGULATION; OSMOTIC SHRINKAGE; PH REGULATION; ANTIPORTER; ISOFORM; AFFINITY; DOMAINS; CLONING	The interaction of the ubiquitous Na+/H+ exchanger, NHE1, with its commonly used inhibitors, amiloride- and benzoylguanidine ( Hoechst type inhibitor ( HOE))-type compounds, is incompletely understood. We previously cloned NHE1 from Amphiuma tridactylum (AtNHE1) and Pleuronectes americanus (PaNHE1). Although highly homologous to the amiloride- and HOE-sensitive human NHE1 (hNHE1), AtNHE1 is insensitive to HOE-type and PaNHE1 to both amiloride- and HOE-type compounds. Here we generated chimeras to "knock in" amiloride and HOE sensitivity to PaNHE1, and we thereby identified several NHE1 regions involved in inhibitor interaction. The markedly different inhibitor sensitivities of hNHE1, AtNHE1, and PaNHE1 could not be accounted for by differences in transmembrane (TM) region 9. Replacing TM10 through the C-terminal tail of PaNHE1 with the corresponding region of AtNHE1 partially restored sensitivity to amiloride and the related compound 5'-(N-ethyl-N-isopropyl) amiloride (EIPA) but not to HOE694. This effect was not due to the tail region, but it was dependent on TM10-11, because replacing only this region with that of AtNHE1 also partially restored amiloride and EIPA but not HOE sensitivity. The converse mutant (TM10-11 of AtNHE1 replaced with those of PaNHE1) exhibited even higher amiloride and EIPA sensitivity and was also HOE-sensitive. Replacing an LFFFY motif in TM region 4 of PaNHE1 with the corresponding residues of hNHE1 (VFFLF) or AtNHE1 (TFFLF) greatly increased sensitivity to both amiloride- and HOE-type compounds, despite the fact that AtNHE1 is HOE694- insensitive. Gain of amiloride sensitivity appeared to correlate with increased Na+/H+ exchange rates. It is concluded that regions within TM4 and TM10-11 contribute to amiloride and HOE sensitivity, with both regions imparting partial inhibitor sensitivity to NHE1.	Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; Univ Copenhagen, Dept Mol Biol, DK-2100 Copenhagen, Denmark	University of California System; University of California Davis; University of California System; University of California Davis; University of Copenhagen	Cala, PM (corresponding author), Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, One Shields Ave, Davis, CA 95616 USA.	pmcala@ucdavis.edu	Pedersen, Stine Falsig/O-1133-2019; Pedersen, Stine Falsig/M-8347-2014	Pedersen, Stine Falsig/0000-0002-3044-7714; Pedersen, Stine Falsig/0000-0002-3044-7714; Rigor, Robert/0000-0001-6234-1992	NHLBI NIH HHS [HL-21179] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021179, R37HL021179] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON SE, 1990, AM J PHYSIOL, V259, pC940, DOI 10.1152/ajpcell.1990.259.6.C940; Baumgarth M, 1997, J MED CHEM, V40, P2017, DOI 10.1021/jm960768n; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; BURCKHARDT G, 2002, J NEPHROL, V15, P3; CALA PM, 1977, J GEN PHYSIOL, V69, P537, DOI 10.1085/jgp.69.5.537; CALA PM, 1994, J GEN PHYSIOL, V103, P1035, DOI 10.1085/jgp.103.6.1035; CALA PM, 1980, J GEN PHYSIOL, V76, P683, DOI 10.1085/jgp.76.6.683; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; Holt MEV, 2006, CELL BIOCHEM BIOPHYS, V45, P1, DOI 10.1385/CBB:45:1:1; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; King SA, 2005, FASEB J, V19, pA1585; KINSELLA JL, 1981, AM J PHYSIOL, V241, P374; Lagana A, 2000, J CELL SCI, V113, P3649; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; McLean LA, 1999, AM J PHYSIOL-CELL PH, V276, pC1025, DOI 10.1152/ajpcell.1999.276.5.C1025; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Murphy E, 1999, CIRC RES, V84, P1469; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Noel J, 2003, BIOCHEMISTRY-US, V42, P15361, DOI 10.1021/bi035296a; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Pedersen SF, 2004, J EXP ZOOL PART A, V301A, P569, DOI 10.1002/jez.a.47; Pedersen SF, 2003, AM J PHYSIOL-CELL PH, V284, pC1561, DOI 10.1152/ajpcell.00562.2002; Pedersen SF, 2006, PFLUG ARCH EUR J PHY, V452, P249, DOI 10.1007/s00424-006-0044-y; PEDESIN BK, 1991, INT J SPORTS MED, V1, P25; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Touret N, 2001, BIOCHEMISTRY-US, V40, P5095, DOI 10.1021/bi0025464; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; YUN CHC, 1993, BIOCHEM BIOPH RES CO, V193, P532, DOI 10.1006/bbrc.1993.1656	36	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19716	19727		10.1074/jbc.M701637200	http://dx.doi.org/10.1074/jbc.M701637200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17493937	hybrid			2022-12-27	WOS:000247650600047
J	Tasaki, T; Sohr, R; Xia, Z; Hellweg, R; Hortnagl, H; Varshavsky, A; Kwon, YT				Tasaki, Takafumi; Sohr, Reinhard; Xia, Zanxian; Hellweg, Rainer; Hoertnagl, Heide; Varshavsky, Alexander; Kwon, Yong Tae			Biochemical and genetic studies of UBR3, a ubiquitin ligase with a function in olfactory and other sensory systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; MICE LACKING; CARDIOVASCULAR DEVELOPMENT; PATHWAY; DEGRADATION; RECOGNITION; COMPONENT; PROTEIN; RECEPTORS; APOPTOSIS	Our previous work identified E3 ubiquitin ligases, termed UBR1 - UBR7, that contain the similar to 70-residue UBR box, a motif important for the targeting of N-end rule substrates. In this pathway, specific N-terminal residues of substrates are recognized as degradation signals by UBR box-containing E3s that include UBR1, UBR2, UBR4, and UBR5. The other E3s of this set, UBR3, UBR6, and UBR7, remained uncharacterized. Here we describe the cloning and analyses of mouse UBR3. The similarities of UBR3 to the UBR1 and UBR2 E3s of the N-end rule pathway include the RING and UBR domains. We show that HR6A and HR6B, the E2 enzymes that bind to UBR1 and UBR2, also interact with UBR3. However, in contrast to UBR1 and UBR2, UBR3 does not recognize N-end rule substrates. We also constructed UBR3-lacking mouse strains. In the 129SvImJ background, UBR3(-/-) mice died during embryogenesis, whereas the C57BL/6 background UBR3(-/-) mice exhibited neonatal lethality and suckling impairment that could be partially rescued by litter size reduction. The adult UBR3(-/-) mice had female-specific behavioral anosmia. Cells of the olfactory pathway were found to express beta-galactosidase (LacZ) that marked the deletion/ disruption UBR3(-) allele. The UBR3- specific LacZ expression was also prominent in cells of the touch, vision, hearing, and taste systems, suggesting a regulatory role of UBR3 in sensory pathways, including olfaction. By analogy with functions of the UBR domain in the N-end rule pathway, we propose that the UBR box of UBR3 may recognize small compounds that modulate the targeting, by this E3, of its currently unknown substrates.	Univ Pittsburgh, Ctr Pharmacogenet, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; Univ Med Berlin, Charite, Inst Pharmacol & Toxicol, D-10117 Berlin, Germany; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Med Berlin, Charite, Dept Psychiat & Psychotherapy, D-14050 Berlin, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; California Institute of Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kwon, YT (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Dept Pharmaceut Sci, 3501 Terrace St, Pittsburgh, PA 15261 USA.	yok5@pitt.edu		Hellweg, Rainer/0000-0001-8033-389X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039520, R01DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074000, R01GM069482, R01GM031530] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL083365] Funding Source: Medline; NIDDK NIH HHS [DK39520] Funding Source: Medline; NIGMS NIH HHS [GM69482, GM074000, GM31530] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chourbaji S, 2004, MOL BRAIN RES, V121, P28, DOI 10.1016/j.molbrainres.2003.11.002; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; GUAN XB, 1993, BRAIN RES, V622, P51, DOI 10.1016/0006-8993(93)90800-3; Harlow E., 1999, USING ANTIBODIES LAB; Hellweg R, 1996, NEUROREPORT, V7, P777, DOI 10.1097/00001756-199602290-00023; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Piepponen TP, 2001, J CHROMATOGR B, V757, P277, DOI 10.1016/S0378-4347(01)00156-6; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Sheng J, 2002, EMBO J, V21, P6061, DOI 10.1093/emboj/cdf626; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky AV, 2006, PROTEIN SCI, V15, P647, DOI 10.1110/ps.052012306; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	63	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18510	18520		10.1074/jbc.M701894200	http://dx.doi.org/10.1074/jbc.M701894200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17462990	Green Accepted, Green Submitted, hybrid			2022-12-27	WOS:000247302000056
J	Cook, VM; deHaseth, PL				Cook, Victoria M.; deHaseth, Pieter L.			Strand opening-deficient Escherichia coli RNA polymerase facilitates investigation of closed complexes with promoter DNA - Effects of DNA sequence and temperature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-R PROMOTER; TRANSCRIPTION INITIATION; CONFORMATIONAL-CHANGES; -35 REGIONS; SPACER DNA; START SITE; RECOGNITION; BINDING; HOLOENZYME; ELEMENT	Formation of the strand-separated, open complex between RNA polymerase and a promoter involves several intermediates, the first being the closed complex in which the DNA is fully base-paired. This normally short lived complex has been difficult to study. We have used a mutant Escherichia coli RNA polymerase, deficient in promoter DNA melting, and variants of the P-R promoter of bacteriophage lambda to model the closed complex intermediate at physiologically relevant temperatures. Our results indicate that in the closed complex, RNA polymerase recognizes base pairs as double-stranded DNA even in the region that becomes single-stranded in the open complex. Additionally, a particular base pair in the -35 region engages in an important interaction with the RNA polymerase, and a DNase I-hypersensitive site, pronounced in the promoter DNA of the open complex, was not present. The effect of temperature on closed complex formation was found to be small over the temperature range from 15 to 37 degrees C. This suggests that low temperature complexes of wild type RNA polymerase and promoter DNA may adequately model the closed complex.	Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	deHaseth, PL (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	pld2@case.edu			NIGMS NIH HHS [GM31808] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031808] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AYERS DG, 1989, J MOL BIOL, V207, P749, DOI 10.1016/0022-2836(89)90241-6; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; Burr T, 2000, NUCLEIC ACIDS RES, V28, P1864, DOI 10.1093/nar/28.9.1864; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; DEHASETH P L, 1978, Biochemistry, V17, P1612, DOI 10.1021/bi00602a006; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; KOVACIC RT, 1987, J BIOL CHEM, V262, P13654; Lew CM, 2004, BIOCHEMISTRY-US, V43, P12660, DOI 10.1021/bi0492814; Li XY, 1998, J BIOL CHEM, V273, P23549, DOI 10.1074/jbc.273.36.23549; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; MCCLURE WR, 1980, P NATL ACAD SCI-BIOL, V77, P5634, DOI 10.1073/pnas.77.10.5634; McKane M, 2000, J MOL BIOL, V299, P337, DOI 10.1006/jmbi.2000.3757; MELANCON P, 1983, BIOCHEMISTRY-US, V22, P5169, DOI 10.1021/bi00291a017; MOYLE H, 1991, J BACTERIOL, V173, P1944, DOI 10.1128/jb.173.6.1944-1950.1991; MULLIGAN ME, 1985, J BIOL CHEM, V260, P3529; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Niedziela-Majka A, 2005, J BIOL CHEM, V280, P38219, DOI 10.1074/jbc.M507984200; OZOLINE ON, 1995, NUCLEIC ACIDS RES, V23, P4533, DOI 10.1093/nar/23.22.4533; Panaghie G, 2000, J MOL BIOL, V299, P1217, DOI 10.1006/jmbi.2000.3808; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Roberts CW, 1996, CELL, V86, P495; ROE JH, 1984, J MOL BIOL, V176, P495, DOI 10.1016/0022-2836(84)90174-8; Roy S, 2004, J MOL BIOL, V344, P609, DOI 10.1016/j.jmb.2004.09.070; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; Schroeder LA, 2005, J BIOL CHEM, V280, P17422, DOI 10.1074/jbc.M501281200; Sen R, 2000, J BIOL CHEM, V275, P10899, DOI 10.1074/jbc.275.15.10899; STEFANO JE, 1982, P NATL ACAD SCI-BIOL, V79, P1069, DOI 10.1073/pnas.79.4.1069; Sun L, 2004, J MOL BIOL, V343, P1171, DOI 10.1016/j.jmb.2004.09.025; SZOKE PA, 1987, BIOCHEMISTRY-US, V26, P6188, DOI 10.1021/bi00393a035; Tsujikawa L, 2002, P NATL ACAD SCI USA, V99, P3493, DOI 10.1073/pnas.062487299; WARNE SE, 1993, BIOCHEMISTRY-US, V32, P6134, DOI 10.1021/bi00075a003; Zhang X, 1996, J MOL BIOL, V258, P14, DOI 10.1006/jmbi.1996.0230; Zhi HJ, 2003, METHOD ENZYMOL, V370, P174	40	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21319	21326		10.1074/jbc.M702232200	http://dx.doi.org/10.1074/jbc.M702232200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17507375	hybrid			2022-12-27	WOS:000248047500060
J	Isaacson, RL; Pye, VE; Simpson, P; Meyer, HH; Zhang, XD; Freemont, PS; Matthews, S				Isaacson, Rivka L.; Pye, Valerie E.; Simpson, Peter; Meyer, Hemmo H.; Zhang, Xiaodong; Freemont, Paul S.; Matthews, Steve			Detailed structural insights into the p97-Npl4-Ufd1 interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA ATPASE P97/VCP; CONFORMATIONAL-CHANGES; TRANSCRIPTION FACTOR; MEMBRANE-FUSION; UBIQUITIN; PROTEIN; P97; COMPLEX; P47; DOMAIN	The AAA ATPase, p97, achieves its versatility through binding to a wide range of cofactor proteins that adapt it to different cellular functions. The heterodimer UN (comprising Ufd1 and Npl4) is an adaptor complex that recruits p97 for numerous tasks, many of which involve the ubiquitin pathway. Insights into the structural specificity of p97 for its UN adaptor are currently negligible. Here, we present the solution structure of the Npl4 "ubiquitin-like" domain (UBD), which adopts a beta-grasp fold with a 3(10) helical insert. Moreover we performed a chemical shift perturbation analysis of its binding surface with the p97 N domain. We assigned the backbone amides of the p97 N domain and probed both its reciprocal binding surface with Npl4 UBD and its interaction with the p97-binding region of Ufd1. NMR data recorded on a 400-kDa full-length UN-hexamer p97 complex reveals an identical mode of interaction. We calculated a structural model for the p97 N-Npl4 UBD complex, and a comparison with the p97-p47 adaptor complex reveals subtle differences in p97 adaptor recognition and specificity.	Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; ETH Honggerberg HPM, Inst Biochem, Swiss Fed Sch Technol ETH, CH-8093 Zurich, Switzerland	Imperial College London; Swiss Federal Institutes of Technology Domain; ETH Zurich	Matthews, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Biochem Bldg, London SW7 2AZ, England.	s.j.matthews@imperial.ac.uk	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796; Zhang, Xiaodong/0000-0001-9786-7038; Isaacson, Rivka Leah/0000-0002-9978-8904; Matthews, Steve/0000-0003-0676-0927; Pye, Valerie E/0000-0001-9616-2992; Freemont, Paul/0000-0002-5658-8486; Simpson, Pete/0000-0002-2679-9303	Wellcome Trust [085464, 073908] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; McNeill H, 2004, BIOCHEM J, V384, P391, DOI 10.1042/BJ20041498; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; VIJAYKUMAR S, 1985, P NATL ACAD SCI USA, V82, P3582, DOI 10.1073/pnas.82.11.3582; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	33	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21361	21369		10.1074/jbc.M610069200	http://dx.doi.org/10.1074/jbc.M610069200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17491009	hybrid, Green Accepted			2022-12-27	WOS:000248047500064
J	Southgate, RJ; Neill, B; Prelovsek, O; El-Osta, A; Kamei, Y; Miura, S; Ezaki, O; McLoughlin, TJ; Zhang, W; Unterman, TG; Febbraio, MA				Southgate, Robert J.; Neill, Bronwyn; Prelovsek, Oja; El-Osta, Assam; Kamei, Yasutomi; Miura, Shinji; Ezaki, Osamu; McLoughlin, Thomas J.; Zhang, Wenwei; Unterman, Terry G.; Febbraio, Mark A.			RETRACTED: FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle (Retracted Article. See vol 284, pg 20440, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							FACTOR 4E-BINDING PROTEIN-1; P70 S6 KINASE; GENE-EXPRESSION; MEDIATED PHOSPHORYLATION; TRANSLATION INITIATION; INSULIN-RESISTANCE; NUCLEAR EXCLUSION; TRANSCRIPTION; RAPAMYCIN; BINDING	The mammalian target of rapamycin ( mTOR) is regulated by growth factors to promote protein synthesis. In mammalian skeletal muscle, the Forkhead-O1 transcription factor (FOXO1) promotes catabolism by activating ubiquitin-protein ligases. Using C2C12 mouse myoblasts that stably express inducible FOXO1-ER fusion proteins and transgenic mice that specifically overexpress constitutively active FOXO1 in skeletal muscle (FOXO++/+), we show that FOXO1 inhibits mTOR signaling and protein synthesis. Activation of constitutively active FOXO1 induced the expression of eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) mRNA via binding to the promoter. This resulted in an increased total 4E-BP1 abundance and a reduced 4E-BP1 (Thr-37/46) phosphorylation. The reduction in 4E-BP1 phosphorylation was associated with a reduction in the abundance of Raptor and mTOR proteins, Raptor-associated mTOR, reduced phosphorylation of the downstream protein p70S6 kinase, and attenuated incorporation of [C-14] phenylalanine into protein. The FOXO++/+ mice, characterized by severe skeletal muscle atrophy, displayed similar patterns of mRNA expression and protein abundance to those observed in the constitutively active FOXO1 C2C12 myotubes. These data suggest that FOXO1 may be an important therapeutic target for human diseases where anabolism is impaired.	Univ Illinois, Coll Med, Dept Med, Chicago, IL 60607 USA; Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60607 USA; Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; Baker Heart Res Inst, Cellular & Mol Metab Lab, Melbourne, Vic 3004, Australia; Baker Heart Res Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic 3004, Australia; Natl Inst Hlth & Nutr, Div Clin Nutr, Tokyo 162836, Japan; Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1010062, Japan; Univ Toledo, Dept Kinesiol, Toledo, OH 43608 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; National Institute of Health & Nutrition - Japan; Tokyo Medical & Dental University (TMDU); University System of Ohio; University of Toledo	Unterman, TG (corresponding author), Univ Illinois, Coll Med, Dept Med, Chicago, IL 60607 USA.	unterman@uic.edu; mark.febbraio@baker.edu.au	Febbraio, Mark/AAE-9632-2019; Miura, Shinji/K-6516-2013	Miura, Shinji/0000-0001-8806-9763; El-Osta, Assam/0000-0003-2969-9137; Febbraio, Mark/0000-0002-9296-4418	NIDDK NIH HHS [DK41430] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041430, R29DK041430] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cao Y, 2006, J BIOL CHEM, V281, P40242, DOI 10.1074/jbc.M608116200; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Fadden P, 1997, J BIOL CHEM, V272, P10240; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Franch HA, 2004, AM J PHYSIOL-RENAL, V287, pF700, DOI 10.1152/ajprenal.00440.2003; Gingras AC, 2001, PROG MOLEC, V27, P143; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Pearson R B, 1995, Prog Cell Cycle Res, V1, P21; Price SR, 2003, INT J BIOCHEM CELL B, V35, P617, DOI 10.1016/S1357-2725(02)00385-0; Proud CG, 1997, BIOCHEM J, V328, P329; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Southgate RJ, 2005, FASEB J, V19, P2072, DOI 10.1096/fj.05-3993fje; Stephenson AH, 2004, BIOCHEM BIOPH RES CO, V323, P204, DOI 10.1016/j.bbrc.2004.08.076; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	60	87	91	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21176	21186		10.1074/jbc.M702039200	http://dx.doi.org/10.1074/jbc.M702039200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17510058	hybrid			2022-12-27	WOS:000248047500044
J	Schreiter, ER; Rodriguez, MM; Weichsel, A; Montfort, WR; Bonaventura, J				Schreiter, Eric R.; Rodriguez, Maria M.; Weichsel, Andrzej; Montfort, William R.; Bonaventura, Joseph			S-nitrosylation-induced conformational change in blackfin tuna myoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-FLOW REGULATION; NITRIC-OXIDE; RESOLUTION STRUCTURES; CRYSTAL-STRUCTURES; YELLOWFIN TUNA; NITROSOHEMOGLOBIN; IDENTIFICATION; NITROSATION; COMPLEXES; IRON	S-Nitrosylation is a post-translational protein modification that can alter the function of a variety of proteins. Despite the growing wealth of information that this modification may have important functional consequences, little is known about the structure of the moiety or its effect on protein tertiary structure. Here we report high-resolution x-ray crystal structures of S-nitrosylated and unmodified blackfin tuna myoglobin, which demonstrate that in vitro S-nitrosylation of this protein at the surface-exposed Cys-10 directly causes a reversible conformational change by "wedging" apart a helix and loop. Furthermore, we have demonstrated in solution and in a single crystal that reduction of the S-nitrosylated myoglobin with dithionite results in NO cleavage from the sulfur of Cys-10 and rebinding to the reduced heme iron, showing the reversibility of both the modification and the conformational changes. Finally, we report the 0.95-angstrom structure of ferrous nitrosyl myoglobin, which provides an accurate structural view of the NO coordination geometry in the context of a globin heme pocket.	Univ Puerto Rico, Prot Res Ctr, Dept Chem, Mayaguez, PR 00681 USA; Rutgers State Univ, New Brunswick, NJ USA	University of Puerto Rico; University of Puerto Rico Mayaguez; Rutgers State University New Brunswick	Schreiter, ER (corresponding author), Univ Puerto Rico, Prot Res Ctr, Dept Chem, Mayaguez, PR 00681 USA.	eric_sch@mit.edu	Schreiter, Eric/B-2641-2009	Schreiter, Eric/0000-0002-2864-7469	NCRR NIH HHS [5P20RR016439-05] Funding Source: Medline; NHLBI NIH HHS [HL62969] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062969] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BIRNBAUM GI, 1994, ACTA CRYSTALLOGR D, V50, P283, DOI 10.1107/S0907444993014271; Chan NL, 2004, BIOCHEMISTRY-US, V43, P118, DOI 10.1021/bi030172j; Chan NL, 1998, BIOCHEMISTRY-US, V37, P16459, DOI 10.1021/bi9816711; Cook JA, 1996, ANAL BIOCHEM, V238, P150, DOI 10.1006/abio.1996.0268; Copeland DM, 2006, J INORG BIOCHEM, V100, P1413, DOI 10.1016/j.jinorgbio.2006.04.011; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; GREISS JP, 1879, CHEM BER, V12, P426; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; JAFFREY SR, 2001, SCI STKE PL1; Jentzen W, 1997, J PHYS CHEM B, V101, P1684, DOI 10.1021/jp963142h; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; LANE P, 2001, SCI STKE RE1; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Maes EM, 2005, BIOCHEMISTRY-US, V44, P12690, DOI 10.1021/bi0506573; Mannick JB, 2002, ARCH BIOCHEM BIOPHYS, V408, P1, DOI 10.1016/S0003-9861(02)00490-3; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Marcinek DJ, 2001, AM J PHYSIOL-REG I, V280, pR1123, DOI 10.1152/ajpregu.2001.280.4.R1123; MATHEWS WR, 1993, J PHARMACOL EXP THER, V267, P1529; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; Nims Raymond W., 1995, Methods (Orlando), V7, P48, DOI 10.1006/meth.1995.1007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JKJ, 1997, ANAL BIOCHEM, V249, P61, DOI 10.1006/abio.1997.2159; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; POULOS TL, 2006, CURR OPIN STRUC BIOL, V16, P1; Rayner BS, 2005, J BIOL CHEM, V280, P9985, DOI 10.1074/jbc.M410564200; Roberts SA, 2001, BIOCHEMISTRY-US, V40, P11327, DOI 10.1021/bi0109257; Rovira C, 1997, J PHYS CHEM A, V101, P8914, DOI 10.1021/jp9722115; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; WATTS DA, 1980, J BIOL CHEM, V255, P916; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; Weichsel A, 2007, BIOCHEMISTRY-US, V46, P1219, DOI 10.1021/bi061878r; Williams D. L. H., 2004, NITROSATION REACTION; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; Witting PK, 2001, J BIOL CHEM, V276, P3991, DOI 10.1074/jbc.M005758200; Wyllie GRA, 2003, INORG CHEM, V42, P5722, DOI 10.1021/ic034473t; Yi J, 2005, NITRIC OXIDE-BIOL CH, V12, P261, DOI 10.1016/j.niox.2005.03.005; Zhao YL, 2006, J AM CHEM SOC, V128, P1422, DOI 10.1021/ja057097f	49	54	54	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19773	19780		10.1074/jbc.M701363200	http://dx.doi.org/10.1074/jbc.M701363200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488722	hybrid			2022-12-27	WOS:000247650600052
J	Korber, C; Werner, M; Hoffmann, J; Sager, C; Tietze, M; Schmid, SM; Kott, S; Hollmann, M				Koerber, Christoph; Werner, Markus; Hoffmann, Jutta; Sager, Charlotte; Tietze, Monique; Schmid, Sabine M.; Kott, Sabine; Hollmann, Michael			Stargazin interaction with alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors is critically dependent on the amino acid at the narrow constriction of the ion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; 2 DISTINCT MECHANISMS; LIGAND-BINDING CORE; GLUTAMATE-RECEPTOR; POINT MUTATION; DESENSITIZATION; SUBUNIT; CYCLOTHIAZIDE; DEACTIVATION; PERMEABILITY	The subunit GluR2 of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subfamily of ionotropic glutamate receptors (GluRs) features a single amino acid at the narrow constriction of the pore loop that is altered from glutamine to arginine by RNA editing. This so-called Q/R site has been shown to play an important role in the determination of the electrophysiological properties of AMPA receptor complexes as well as of trafficking to the plasma membrane. The protein stargazin has also been shown to modulate electrophysiological properties and trafficking to the plasma membrane of AMPA receptors. In this study we examined via a series of mutants of the Q/R site of the AMPA receptor GluR1 whether the amino acid at this position has any influence on the modulatory effects mediated by stargazin. To this end, we analyzed current responses of Q/R site mutants upon application of glutamate and kainate and determined the amount of mutant receptor protein in the plasma membrane in Xenopus oocytes. Desensitization kinetics of several mutants were analyzed in HEK293 cells. We found that the stargazin-mediated decrease in receptor desensitization, the slowing of desensitization kinetics, and the kainate efficacy were all dependent on the amino acid at the Q/R site, whereas the stargazin-mediated increase in trafficking toward the plasma membrane remained independent of this amino acid. We propose that the Q/R site modulates the interaction of stargazin with the transmembrane domains of AMPA receptors via an allosteric mechanism and that this modulation leads to the observed differences in the electrophysiological properties of the receptor.	Ruhr Univ Bochum, Dept Biochem Ireceptor Biochem, D-44780 Bochum, Germany; Int Grad Sch Neurosci, D-44780 Bochum, Germany	Ruhr University Bochum	Hollmann, M (corresponding author), Ruhr Univ Bochum, Dept Biochem Ireceptor Biochem, Bldg NC,Level 6,Room 170, D-44780 Bochum, Germany.	Michael.Hollmann@rub.de		Korber, Christoph/0000-0003-1418-9724				Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JAKOWEC M, 1995, NEUROSCIENCE, V4, P893; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Nakagawa T, 2006, BIOL CHEM, V387, P179, DOI 10.1515/BC.2006.024; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Partin KM, 2001, J NEUROSCI, V21, P1939, DOI 10.1523/JNEUROSCI.21-06-01939.2001; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schmidt C, 2006, MOL PHARMACOL, V69, P119, DOI 10.1124/mol.105.016840; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Villmann C, 1997, J NEUROSCI, V17, P7634, DOI 10.1523/jneurosci.17-20-07634.1997; Villmann C, 1999, EUR J NEUROSCI, V11, P1765, DOI 10.1046/j.1460-9568.1999.00594.x; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004	39	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18758	18766		10.1074/jbc.M611182200	http://dx.doi.org/10.1074/jbc.M611182200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17483093	hybrid			2022-12-27	WOS:000247475300014
J	Krishnan, K; Kathiresan, T; Raman, R; Rajini, B; Dhople, VM; Aggrawal, RK; Sharma, Y				Krishnan, Kannan; Kathiresan, Thandavarayan; Raman, Rajeev; Rajini, Bheemreddy; Dhople, Vishnu M.; Aggrawal, Ramesh K.; Sharma, Yogendra			Ubiquitous lens alpha-, beta-, and gamma-crystallins accumulate in anuran cornea as corneal crystallins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARVAL XENOPUS-LAEVIS; ALDEHYDE DEHYDROGENASE; TAU-CRYSTALLIN; ENZYME-CRYSTALLIN; OUTER CORNEA; PROTEINS; REGENERATION; RECRUITMENT; GENE; EPITHELIUM	Corneal epithelium is known to have high levels of some metabolic enzymes such as aldehyde dehydrogenase in mammals, gelsolin in zebrafish, and alpha-enolase in several species. Analogous to lens crystallins, these enzymes and proteins are referred to as corneal crystallins, although their precise function is not established in any species. Although it is known that after lentectomy, the outer cornea undergoes transdifferentiation to regenerate a lens only in anuran amphibians, major proteins expressed in an anuran cornea have not been identified. This study therefore aimed to identify the major corneal proteins in the Indian toad ( Bufo melanostictus) and the Indian frog ( Rana tigrina). Soluble proteins of toad and frog corneas were resolved on two-dimensional gels and identified by matrix-assisted laser desorption ionization time-of-flight/time-of-flight and electrospray ionization quadrupole time-of-flight. We report that anuran cornea is made up of the full complement of ubiquitous lens alpha-, beta-, and gamma-crystallins, mainly localized in the corneal epithelium. In addition, some taxon-specific lens crystallins and novel proteins, such as alpha- or beta-enolase/tau-crystallin, were also identified. Our data present a unique case of the anuran cornea where the same crystallins are used in the lens and in the cornea, thus supporting the earlier idea that crystallins are essential for the visual functions of the cornea as they perform for the lens. High levels of lens alpha-, beta-, and gamma-crystallins have not been reported in the cornea of any species studied so far and may offer a possible explanation for their inability to regenerate a lens after lentectomy. Our data that anuran cornea has an abundant quantity of almost all the lens crystallins are consistent with its ability to form a lens, and this connection is worthy of further studies.	Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sharma, Y (corresponding author), Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	yogendra@ccmb.res.in	Dhople, Vishnu M/J-5377-2014					ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; Agrawal R, 2002, J BIOSCIENCES, V27, P251, DOI 10.1007/BF02704914; Bhat SP, 2004, EXP EYE RES, V79, P809, DOI 10.1016/j.exer.2004.08.020; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bosco L, 1997, DEVELOPMENT, V124, P421; BOSCO L, 1993, DEV GROWTH DIFFER, V35, P257; Call Mindy K., 2005, Anatomical Record Part B:The New Anatomist, V287, P42, DOI 10.1002/ar.b.20084; Cannata SM, 2003, J EXP ZOOL PART A, V299A, P161, DOI 10.1002/jez.a.10275; COOPER DL, 1991, GENE, V98, P201, DOI 10.1016/0378-1119(91)90174-A; COOPER DL, 1993, ADV EXP MED BIOL, V328, P169; CUTHBERTSON RA, 1992, P NATL ACAD SCI USA, V89, P4004, DOI 10.1073/pnas.89.9.4004; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Filoni S, 1982, Acta Embryol Morphol Exp, V3, P15; FILONI S, 1980, J EXP ZOOL, V211, P303, DOI 10.1002/jez.1402110307; FILONI S, 1992, DEV GROWTH DIFFER, V34, P619; FREEMAN G, 1963, J EXP ZOOL, V154, P39, DOI 10.1002/jez.1401540105; FREEMAN J, 1963, J BIOL CHEM, V54, P39; Gopal-Srivastava R, 2000, MECH DEVELOP, V92, P125, DOI 10.1016/S0925-4773(99)00341-X; Henry JJ, 2001, DEV GENES EVOL, V211, P377, DOI 10.1007/s004270100163; Jester JV, 1999, J CELL SCI, V112, P613; Kathiresan T, 2006, FEBS J, V273, P3370, DOI 10.1111/j.1742-4658.2006.05344.x; King G, 1999, ADV EXP MED BIOL, V463, P189; Lampi KJ, 2002, INVEST OPHTH VIS SCI, V43, P216; Mishra AK, 2002, PROTEIN EXPRES PURIF, V25, P59, DOI 10.1006/prep.2001.1609; Mizuno N, 1999, DIFFERENTIATION, V64, P143, DOI 10.1046/j.1432-0436.1999.6430143.x; Piatigorsky J, 2000, J OCUL PHARMACOL TH, V16, P173, DOI 10.1089/jop.2000.16.173; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Piatigorsky J, 1998, PROG RETIN EYE RES, V17, P145, DOI 10.1016/S1350-9462(97)00004-9; Piatigorsky J, 1998, ANN NY ACAD SCI, V842, P7, DOI 10.1111/j.1749-6632.1998.tb09626.x; Piatigorsky J, 2000, J BIOL CHEM, V275, P41064, DOI 10.1074/jbc.M005625200; Piatigorsky J, 2001, CORNEA, V20, P853, DOI 10.1097/00003226-200111000-00015; REEVE JG, 1978, J EMBRYOL EXP MORPH, V48, P205; REYER RW, 1954, Q REV BIOL, V29, P1, DOI 10.1086/399936; Sax CM, 1996, J BIOL CHEM, V271, P33568, DOI 10.1074/jbc.271.52.33568; Shekhawat DS, 2001, J BIOSCIENCES, V26, P571, DOI 10.1007/BF02704755; SINGH SV, 1985, EXP EYE RES, V40, P431, DOI 10.1016/0014-4835(85)90155-1; Sinha D, 1998, Mol Vis, V4, P8; Sun LJ, 1999, J BIOL CHEM, V274, P17334, DOI 10.1074/jbc.274.24.17334; Tomarev SI, 1996, EUR J BIOCHEM, V235, P449, DOI 10.1111/j.1432-1033.1996.00449.x; Uma L, 1996, EXP EYE RES, V63, P117, DOI 10.1006/exer.1996.0098; Wilmarth PA, 2004, INVEST OPHTH VIS SCI, V45, P2705, DOI 10.1167/iovs.04-0131; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Xu YS, 2000, J BIOL CHEM, V275, P24645, DOI 10.1074/jbc.M001159200; ZIESKE JD, 1992, DEV BIOL, V151, P18, DOI 10.1016/0012-1606(92)90209-Y	45	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18953	18959		10.1074/jbc.M609275200	http://dx.doi.org/10.1074/jbc.M609275200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17452334	hybrid			2022-12-27	WOS:000247475300037
J	Chakrabarti, S; Blair, P; Freedman, JE				Chakrabarti, Subrata; Blair, Price; Freedman, Jane E.			CD40-40L signaling in vascular inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; REDOX REGULATION; ENDOTHELIAL-CELLS; P38 MAPK; ACTIVATION; LIGAND; PTEN; PATHWAYS; STRESS; EXPRESSION	Ligation of CD40 in circulating cells or in the vessel wall may promote mononuclear cell recruitment, participate in the weakening of the plaque, and contribute to thrombosis. This process appears to be redox-sensitive, but the precise signaling mechanism by which the interaction between CD40L and its receptor CD40 mediates inflammatory secretion is unclear. Our previous studies have shown that the CD40-CD40L interaction modulates release of reactive oxygen species (ROS) and the current findings demonstrate that in endothelial cells CD40L dose dependently induces intracellular CD40L and MCP1 release in a redox sensitive manner. Pharmacological inhibition of phosphatidylinositol 3-kinase and p38 MAPK as well as adenovirus-mediated inactivation of Akt and p38 MAPK inhibited CD40L effects on endothelial cells. Akt, in particular, appeared to mediate CD40L-induced CD40L synthesis and MCP1 release by endothelial cells in a redox sensitive manner via NF kappa B activation. In addition, using confocal microscopy, exogenous addition of recombinant CD40L or adenoviral mediated CD40L overexpression was found to stimulate nuclear translocation of NF kappa B, which was further augmented by Akt overexpression and inhibited by Akt inactivation. These data support a mechanism whereby redox-sensitive CD40-CD40L interactions induce activation of Akt and p38 MAPK, leading to stimulation of NF kappa B and enhanced synthesis of CD40L and MCP1. Increased CD40L and MCP1 may contribute to the adherence of CD40-positive cells, such as platelets and monocytes, to the vessel wall modulating atherothrombosis.	Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Evans Dept Med, Boston, MA 02118 USA	Boston University	Chakrabarti, S (corresponding author), Boston Univ, Sch Med, 715 Albany St,W507, Boston, MA 02118 USA.	subrata@bu.edu						Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Aggeli IKS, 2006, CELL SIGNAL, V18, P1801, DOI 10.1016/j.cellsig.2006.02.001; Aukrust P, 2004, J AM COLL CARDIOL, V43, P2326, DOI 10.1016/j.jacc.2004.03.023; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Chakrabarti S, 2005, ARTERIOSCL THROM VAS, V25, P2428, DOI 10.1161/01.ATV.0000184765.59207.f3; Cho SH, 2004, FEBS LETT, V560, P7, DOI 10.1016/S0014-5793(04)00112-7; Cipollone F, 2002, CIRCULATION, V106, P399, DOI 10.1161/01.CIR.0000025419.95769.F0; Deregibus MC, 2003, J BIOL CHEM, V278, P18008, DOI 10.1074/jbc.M300711200; Djordjevic T, 2005, FREE RADICAL BIO MED, V38, P616, DOI 10.1016/j.freeradbiomed.2004.09.036; Downes CP, 2004, BIOCHEM SOC T, V32, P338, DOI 10.1042/BST0320338; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Flaherty DM, 2006, J BIOL CHEM, V281, P5058, DOI 10.1074/jbc.M508997200; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Ha YJ, 2004, J IMMUNOL, V172, P231, DOI 10.4049/jimmunol.172.1.231; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Kaur J, 2001, AM J PHYSIOL-HEART C, V281, pH784, DOI 10.1152/ajpheart.2001.281.2.H784; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kikuchi T, 2000, CANCER RES, V60, P6391; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lutgens E, 2002, TRENDS CARDIOVAS MED, V12, P27, DOI 10.1016/S1050-1738(01)00142-6; Mach F, 1998, ATHEROSCLEROSIS, V137, pS89, DOI 10.1016/S0021-9150(97)00309-2; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wagner AH, 2004, ARTERIOSCL THROM VAS, V24, P715, DOI 10.1161/01.ATV.0000122853.99978.b1; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504	38	71	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18307	18317		10.1074/jbc.M700211200	http://dx.doi.org/10.1074/jbc.M700211200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17459878	hybrid			2022-12-27	WOS:000247302000037
J	Fukushima, T; Tezuka, T; Shimomura, T; Nakano, S; Kataoka, H				Fukushima, Tsuyoshi; Tezuka, Tomoaki; Shimomura, Takeshi; Nakano, Shinichi; Kataoka, Hiroaki			Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BINDING; PROGNOSTIC MARKER; CANCER CELLS; PROTEIN-2; PROLIFERATION; MULTIFORME; ACTIVATOR; PATHWAYS; SURVIVAL; INVASION	Glioblastoma multiforme (GBM) is a malignant brain tumor characterized by rapid growth and extensive invasiveness. Overexpression of insulin-like growth factor-binding protein-2 (IGFBP-2) has been reported in GBM. However, it remains to be determined how IGFBP-2 is involved in the progression of GBM. We utilized short hairpin-RNA (shRNA) expression retroviral vectors to inactivate the IGFBP-2 gene permanently in two human GBM cell lines, U251 and YKG-1. The stable knockdown of IGFBP-2 resulted in decreased invasiveness, decreased saturation density of the cells in vitro, and decreased tumorigenicity in nude mice. Transcriptional profiling of both lines revealed several genes that were significantly down-regulated by inactivation of IGFBP-2. One such gene was CD24, which has been implicated in progression of various cancers. Indeed, CD24 was expressed in most GBM cases and the inactivation of CD24 in GBM cells suppressed cellular invasiveness, as was the case for IGFBP-2. Forced overexpression of CD24 led to increased invasiveness of both IGFBP-2-inactivated GBM cell lines and also A172, a human GBM cell line with low endogenous CD24. Further supporting the inter-relationship between IGFBP-2 and CD24, knockdown of IGFBP-2 suppressed the CD24 promoter activity. Moreover, both CD24 promoter activity and in vitro invasiveness were restored in knockdown cells by transfection with an IGFBP-2 expression plasmid. These results indicate that CD24 is modulated by IGFBP-2 and contributes to IGFBP-2 enhanced invasiveness of GBM cells.	Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Miyazaki 8891692, Japan; Miyazaki Univ, Fac Med, Dept Neurosurg, Miyazaki 8891692, Japan; Mitsubishi Pharma Corp, Div Pharmaceut Res, Yokohama, Kanagawa 2270033, Japan	University of Miyazaki; University of Miyazaki; Mitsubishi Tanabe Pharma Corporation	Kataoka, H (corresponding author), Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Miyazaki 8891692, Japan.	mejina@fc.miyazaki-u.ac.jp	Kallioniemi, Olli P/H-5111-2011; Fukushima, Tsuyoshi/K-4270-2019	Kallioniemi, Olli P/0000-0002-3231-0332; Fukushima, Tsuyoshi/0000-0002-9350-777X				Aigner S, 1997, BLOOD, V89, P3385, DOI 10.1182/blood.V89.9.3385; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Boulle N, 1998, J CLIN ENDOCR METAB, V83, P1713, DOI 10.1210/jc.83.5.1713; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; Chakrabarty S, 2006, CANCER BIOL THER, V5, P189, DOI 10.4161/cbt.5.2.2333; Chatterjee S, 2004, INT J UROL, V11, P876, DOI 10.1111/j.1442-2042.2004.00898.x; COHEN P, 1993, J CLIN ENDOCR METAB, V76, P1031, DOI 10.1210/jc.76.4.1031; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fottner C, 2004, HORM METAB RES, V36, P397, DOI 10.1055/s-2004-814563; Fuller GN, 1999, CANCER RES, V59, P4228; HAHNE M, 1994, J EXP MED, V179, P1391, DOI 10.1084/jem.179.4.1391; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Kibbey MM, 2006, MOL PHARMACOL, V69, P833, DOI 10.1124/mol.105.016998; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Kristiansen G, 2004, PROSTATE, V58, P183, DOI 10.1002/pros.10324; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1529, DOI 10.1111/j.1525-1438.2006.00623.x; Lee EJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-7; Lefranc F, 2006, EXPERT REV ANTICANC, V6, P719, DOI 10.1586/14737140.6.5.719; Lim SC, 2005, PATHOL RES PRACT, V201, P479, DOI 10.1016/j.prp.2005.05.004; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Mishra L, 1998, GROWTH HORM IGF RES, V8, P473, DOI 10.1016/S1096-6374(98)80300-6; Miyake H, 2005, ONCOL REP, V13, P341; Miyata S, 2005, CANCER LETT, V227, P83, DOI 10.1016/j.canlet.2005.01.010; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Nuki Yoshitsugu, 2004, Hum Cell, V17, P145; Pass MK, 1998, INT J CANCER, V78, P496, DOI 10.1002/(SICI)1097-0215(19981109)78:4<496::AID-IJC17>3.0.CO;2-4; Schostak M, 2006, BMC Urol, V6, P7, DOI 10.1186/1471-2490-6-7; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002; Smith SC, 2006, CANCER RES, V66, P1917, DOI 10.1158/0008-5472.CAN-05-3855; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Surowiak Pawel, 2005, Polish Journal of Pathology, V56, P69; Uchinokura S, 2006, INT J CANCER, V118, P583, DOI 10.1002/ijc.21362; Wang CC, 2006, CANCER RES, V66, P6756, DOI 10.1158/0008-5472.CAN-06-0185; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200; Wang H, 2003, CANCER RES, V63, P4315; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zhou YH, 2005, NEURO-ONCOLOGY, V7, P485, DOI 10.1215/S1152851704000730	45	74	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18634	18644		10.1074/jbc.M609567200	http://dx.doi.org/10.1074/jbc.M609567200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17475624	hybrid			2022-12-27	WOS:000247302000068
J	Morgunova, E; Saller, S; Haase, I; Cushman, M; Bacher, A; Fischer, M; Ladenstein, R				Morgunova, Ekaterina; Saller, Sabine; Haase, Ilka; Cushman, Mark; Bacher, Adelbert; Fischer, Markus; Ladenstein, Rudolf			Lumazine synthase from Candida albicans as an anti-fungal target enzyme - Structural and biochemical basis for drug design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE ANALYSIS; 3,4-DIHYDROXY-2-BUTANONE 4-PHOSPHATE SYNTHASE; HEAVY RIBOFLAVIN SYNTHASE; BACILLUS-SUBTILIS; BINDING MODE; GENETIC CLASSIFICATION; ANGSTROM RESOLUTION; BIOSYNTHESIS; PROTEIN; INHIBITORS	Lumazine synthase is an enzyme involved in riboflavin biosynthesis in many plants and microorganisms, including numerous human pathogens. The fact that the enzymes of the riboflavin biosynthesis pathway are not present in the human or animal host makes them potential targets for anti-infective agents. The crystal structure of lumazine synthase from Candida albicans was solved by molecular replacement and refined at 2.5-angstrom resolution. The results of crystallographic investigations and sedimentation equilibrium experiments clearly indicated the presence of pentameric assemblies of the enzyme either in crystals or in solution. Isothermal titration calorimetry measurements of the binding reactions of four different inhibitors revealed high affinity for all four compounds with binding constants in the micromolar range. Structural comparison with previously determined structures of the enzyme center dot ligand complexes of other orthologue allowed modeling of the binding of four different inhibitors into the active site of lumazine synthase from Candida albicans.	Karolinska Inst, Novum, Ctr Struct Biochem, S-14157 Huddinge, Sweden; Tech Univ Munich, Lehrstuhl Organ Chem & Biochem, D-85747 Garching, Germany; Univ Hamburg, Inst Biochem & Lebensmittelchem, Abt Lebensmittelchem, D-20146 Hamburg, Germany; Purdue Univ, Sch Pharm & Pharmacal Sci, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA	Karolinska Institutet; Technical University of Munich; University of Hamburg; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Morgunova, E (corresponding author), Karolinska Inst, Novum, Ctr Struct Biochem, Halsovagen 7-9, S-14157 Huddinge, Sweden.	katja.morgunova@biosci.ki.se	Fischer, Markus/AFT-1856-2022; Fischer, Markus/H-2870-2012; Fischer, Markus J./G-9477-2012; Morgunova, Ekaterina/G-2479-2018	Fischer, Markus/0000-0001-7243-4199; Morgunova, Ekaterina/0000-0002-7754-9021	NIGMS NIH HHS [GM51469] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051469] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHER A, 1986, J MOL BIOL, V187, P75, DOI 10.1016/0022-2836(86)90407-9; BACHER A, 1986, CHEM BIOL CLIN ASPEC, V8, P227; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Bourenkov GP, 2006, ACTA CRYSTALLOGR D, V62, P58, DOI 10.1107/S0907444905033998; Braden BC, 2000, J MOL BIOL, V297, P1031, DOI 10.1006/jmbi.2000.3640; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CRESSWELL RM, 1960, J CHEM SOC, P4776, DOI 10.1039/jr9600004776; Cushman M, 2005, J ORG CHEM, V70, P9092, DOI 10.1021/jo056032s; Cushman M, 1999, J ORG CHEM, V64, P3838, DOI 10.1021/jo9821729; Cushman M, 2004, J ORG CHEM, V69, P601, DOI 10.1021/jo030278k; d'Enfert C, 2005, NUCLEIC ACIDS RES, V33, pD353, DOI 10.1093/nar/gki124; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Echt S, 2004, J MOL BIOL, V341, P1085, DOI 10.1016/j.jmb.2004.06.053; Fischer M, 2002, EUR J BIOCHEM, V269, P519, DOI 10.1046/j.0014-2956.2001.02674.x; Gerhardt S, 2002, J MOL BIOL, V318, P1317, DOI 10.1016/S0022-2836(02)00116-X; Graybill JR, 1996, CLIN INFECT DIS, V22, pS166, DOI 10.1093/clinids/22.Supplement_2.S166; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIS K, 1995, J BIOL CHEM, V270, P16788, DOI 10.1074/jbc.270.28.16788; KIS K, 1995, BIOCHEMISTRY-US, V34, P2883, DOI 10.1021/bi00009a019; Klinke S, 2005, J MOL BIOL, V353, P124, DOI 10.1016/j.jmb.2005.08.017; LADENSTEIN R, 1988, J MOL BIOL, V203, P1045, DOI 10.1016/0022-2836(88)90128-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laue T.M., 1992, COMPUTER AIDED INTER; Lu GG, 1999, J APPL CRYSTALLOGR, V32, P365, DOI 10.1107/S0021889898015052; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meining W, 2000, J MOL BIOL, V299, P181, DOI 10.1006/jmbi.2000.3742; Morgunova E, 2005, BIOCHEMISTRY-US, V44, P2746, DOI 10.1021/bi047848a; Morgunova E, 2006, FEBS J, V273, P4790, DOI 10.1111/j.1742-4658.2006.05481.x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mortl S, 1996, J BIOL CHEM, V271, P33201, DOI 10.1074/jbc.271.52.33201; OLTMANNS O, 1969, MOL GEN GENET, V105, P306, DOI 10.1007/BF00277585; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persson K, 1999, PROTEIN SCI, V8, P2355; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; Richter G, 1999, EUR J BIOCHEM, V261, P57, DOI 10.1046/j.1432-1327.1999.00211.x; RITSERT K, 1995, J MOL BIOL, V253, P151, DOI 10.1006/jmbi.1995.0542; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHABERG DR, 1991, AM J MED, V91, pS72, DOI 10.1016/0002-9343(91)90346-Y; SCHOTT K, 1990, J BIOL CHEM, V265, P4204; SEDLMAIER H, 1987, Z NATURFORSCH C, V42, P425; SHAVLOVSKII G M, 1982, Mikrobiologiya, V51, P986; SHAVLOVSKY GM, 1979, GENETIKA+, V15, P1561; STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121; Taylor J.R., 1997, INTRO ERROR ANAL STU, P75; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WARNOCK DW, 1995, J ANTIMICROB CHEMOTH, V36, P73, DOI 10.1093/jac/36.suppl_B.73; Zhang XF, 2003, J MOL BIOL, V328, P167, DOI 10.1016/S0022-2836(03)00186-4; Zhang XF, 2001, J MOL BIOL, V306, P1099, DOI 10.1006/jmbi.2000.4435; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200	54	43	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					17231	17241		10.1074/jbc.M701724200	http://dx.doi.org/10.1074/jbc.M701724200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17446177	hybrid			2022-12-27	WOS:000246946500056
J	Stubbs, KA; Balcewich, M; Mark, BL; Vocadlo, DJ				Stubbs, Keith A.; Balcewich, Misty; Mark, Brian L.; Vocadlo, David J.			Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINIDASE; D-GLUCOSAMINIDASE; CITROBACTER-FREUNDII; O-GLCNACASE; CRYSTAL-STRUCTURE; EXPRESSION; MECHANISM; NAGSTATIN; GENE	The increasing spread of plasmid-borne ampC-ampR operons is of considerable medical importance, since the AmpC beta-lactamases they encode confer high level resistance to many third generation cephalosporins. Induction of AmpC beta-lactamase from endogenous or plasmid-borne ampC-ampR operons is mediated by a catabolic inducer molecule, 1,6-anhydro-Nacetylmuramic acid (MurNAc) tripeptide, an intermediate of the cell wall recycling pathway derived from the peptidoglycan. Here we describe a strategy for attenuating the antibiotic resistance associated with the ampC-ampR operon by blocking the formation of the inducer molecule using small molecule inhibitors of NagZ, the glycoside hydrolase catalyzing the formation of this inducer molecule. The structure of the NagZ-inhibitor complex provides insight into the molecular basis for inhibition and enables the development of inhibitors with 100-fold selectivity for NagZ over functionally related human enzymes. These PUGNAc-derived inhibitors reduce the minimal inhibitory concentration (MIC) values for several clinically relevant cephalosporins in both wild-type and AmpC-hyperproducing strains lacking functional AmpD.	Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Simon Fraser University; University of Manitoba	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014; Stubbs, Keith/H-5909-2014	Vocadlo, David J/0000-0001-6897-5558; Stubbs, Keith/0000-0001-6899-402X; Mark, Brian/0000-0002-7344-1355				AOYAGI T, 1992, J ANTIBIOT, V45, P1404, DOI 10.7164/antibiotics.45.1404; Bagge N, 2002, ANTIMICROB AGENTS CH, V46, P3406, DOI 10.1128/AAC.46.11.3406-3411.2002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnaud G, 1998, ANTIMICROB AGENTS CH, V42, P2352, DOI 10.1128/AAC.42.9.2352; BARTOWSKY E, 1991, MOL MICROBIOL, V5, P1715, DOI 10.1111/j.1365-2958.1991.tb01920.x; BEER D, 1990, HELV CHIM ACTA, V73, P1918, DOI 10.1002/hlca.19900730714; Bradford PA, 1997, ANTIMICROB AGENTS CH, V41, P563, DOI 10.1128/AAC.41.3.563; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; Cheng QM, 2000, J BACTERIOL, V182, P4836, DOI 10.1128/JB.182.17.4836-4840.2000; Chitlaru E, 1996, J BIOL CHEM, V271, P33433, DOI 10.1074/jbc.271.52.33433; DeLano W.L, PYMOL MOL GRAPHICS S; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Doi Y, 2004, ANTIMICROB AGENTS CH, V48, P2652, DOI 10.1128/AAC.48.7.2652-2658.2004; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folkesson A, 2005, CELL MICROBIOL, V7, P147, DOI 10.1111/j.1462-5822.2004.00443.x; Fortineau N, 2001, J ANTIMICROB CHEMOTH, V47, P207, DOI 10.1093/jac/47.2.207; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Heightman TD, 1999, ANGEW CHEM INT EDIT, V38, P750, DOI 10.1002/(SICI)1521-3773(19990315)38:6<750::AID-ANIE750>3.0.CO;2-6; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HOLTJE JV, 1994, FEMS MICROBIOL LETT, V122, P159, DOI 10.1111/j.1574-6968.1994.tb07159.x; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HORSCH M, 1991, EUR J BIOCHEM, V197, P815, DOI 10.1111/j.1432-1033.1991.tb15976.x; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1995, MOL MICROBIOL, V15, P553, DOI 10.1111/j.1365-2958.1995.tb02268.x; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; Kadima TA, 1997, ANTIMICROB AGENTS CH, V41, P2177, DOI 10.1128/AAC.41.10.2177; Kong KF, 2005, ANTIMICROB AGENTS CH, V49, P4567, DOI 10.1128/AAC.49.11.4567-4575.2005; Langaee TY, 2000, ANTIMICROB AGENTS CH, V44, P583, DOI 10.1128/AAC.44.3.583-589.2000; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li CH, 2004, J ANTIMICROB CHEMOTH, V53, P297, DOI 10.1093/jac/dkh057; LINDBERG F, 1987, J BACTERIOL, V169, P1923, DOI 10.1128/jb.169.5.1923-1928.1987; LINDBERG F, 1985, P NATL ACAD SCI USA, V82, P4620, DOI 10.1073/pnas.82.14.4620; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MILLER DJ, 1993, DEVELOPMENT, V118, P1279; Miriagou V, 2004, ANTIMICROB AGENTS CH, V48, P3172, DOI 10.1128/AAC.48.8.3172-3174.2004; Morandi F, 2003, J AM CHEM SOC, V125, P685, DOI 10.1021/ja0288338; Nakae T, 2000, MICROBIOL IMMUNOL, V44, P997, DOI 10.1111/j.1348-0421.2000.tb02595.x; Nakano R, 2004, ANTIMICROB AGENTS CH, V48, P1151, DOI 10.1128/AAC.48.4.1151-1158.2004; NORMARK S, 1994, N COMP BIOC, V27, P485; PARK JT, 1993, J BACTERIOL, V175, P7, DOI 10.1128/JB.175.1.7-11.1993; Pfeifle D, 2000, ANTIMICROB AGENTS CH, V44, P169, DOI 10.1128/AAC.44.1.169-172.2000; Poirel L, 1999, ANTIMICROB AGENTS CH, V43, P769, DOI 10.1128/AAC.43.4.769; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Reisbig MD, 2003, J ANTIMICROB CHEMOTH, V51, P1141, DOI 10.1093/jac/dkg204; Shanmugasundaram B, 2006, CHEM COMMUN, P4372, DOI 10.1039/b612154c; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Stubbs KA, 2006, ORG BIOMOL CHEM, V4, P839, DOI 10.1039/b516273d; Tatsuta K, 1997, B CHEM SOC JPN, V70, P427, DOI 10.1246/bcsj.70.427; TATSUTA K, 1995, TETRAHEDRON LETT, V36, P6721; TATSUTA K, 1995, J ANTIBIOT, V48, P286, DOI 10.7164/antibiotics.48.286; Terinek M, 2005, HELV CHIM ACTA, V88, P10, DOI 10.1002/hlca.200490286; Thomson KS, 1999, ANTIMICROB AGENTS CH, V43, P1393, DOI 10.1128/AAC.43.6.1393; Tondi D, 2005, J AM CHEM SOC, V127, P4632, DOI 10.1021/ja042984o; Uehara T, 2002, J BACTERIOL, V184, P4233, DOI 10.1128/JB.184.15.4233-4239.2002; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456; YEM DW, 1976, J BACTERIOL, V125, P324, DOI 10.1128/JB.125.1.324-331.1976	74	96	99	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21382	21391		10.1074/jbc.M700084200	http://dx.doi.org/10.1074/jbc.M700084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17439950	hybrid			2022-12-27	WOS:000248047500066
J	Wang, CS; Leger, RJS				Wang, Chengshu; Leger, Raymond J. St.			The Metarhizium anisopliae perilipin homolog MPL1 regulates lipid metabolism, appressorial turgor pressure, and virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE LIPOLYSIS; MAGNAPORTHE-GRISEA; DROPLETS; EXPRESSION; PHOSPHORYLATION; MECHANISMS; GENERATION; DROSOPHILA; RESPONSES; PROTEINS	Cells store lipids in droplets. Studies addressing how mammals controllipid-based energy homeostasis have implicated proteins of the PAT domain family, such as perilipin that surrounds the lipid droplets. Perilipin knock-out mice are lean and resistant to obesity. Factors that mediate lipid storage in fungi are still unknown. Here we describe a gene (Mpl1) in the economically important insect fungal pathogen Metarhizium anisopliae that has structural similarities to mammalian perilipins. Consistent with a role in lipid storage, Mpl1 is predominantly expressed when M. anisopliae is engaged in accumulating lipids and ectopically expressed green fluorescent protein-tagged MPL1(Metarhizium perilipin-like protein) localized to lipid droplets. Mutant M. anisopliae lacking MPL1 have thinner hyphae, fewer lipid droplets, particularly in appressoria (specialized infection structures at the end of germ tubes), and a decrease in total lipids. Mpl1 therefore acts in a perilipin-like manner suggesting an evolutionary conserved function in lipid metabolism. However, reflecting general differences between animal and fungal lineages, these proteins have also been selected to cope with different tasks. Thus, turgor generation by Delta Mpl1 appressoria is dramatically reduced indicating that lipid droplets are required for solute accumulation. This was linked with the reduced ability to breach insect cuticle so that Mpl1 is a pathogenicity determinant. Blast searches of fungal genomes revealed that perilipin homologs are found only in pezizomycotinal ascomycetes and occur as single copy genes. Expression of Mpl1 in yeast cells, a fungus that lacks a perilipin-like gene, blocked their ability to mobilize lipids during starvation conditions.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University System of Maryland; University of Maryland College Park	Wang, CS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China.	cswang@sibs.ac.cn; stleger@umd.edu	Wang, Chengshu/A-1656-2011; St. Leger, Raymond/N-3219-2013	Wang, Chengshu/0000-0003-1477-1466; 				Beckman M, 2006, SCIENCE, V311, P1232, DOI 10.1126/science.311.5765.1232; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608; Garcia A, 2004, J BIOL CHEM, V279, P8409, DOI 10.1074/jbc.M311198200; Garcia A, 2003, J BIOL CHEM, V278, P625, DOI 10.1074/jbc.M206602200; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; HWANG CS, 1995, PLANT CELL, V7, P183, DOI 10.1105/tpc.7.2.183; Izard J, 2003, J MICROBIOL METH, V55, P411, DOI 10.1016/S0167-7012(03)00193-3; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Qi L, 2004, CLIN GENET, V66, P299, DOI 10.1111/j.1399-0004.2004.00309.x; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Teixeira L, 2003, MECH DEVELOP, V120, P1071, DOI 10.1016/S0925-4773(03)00158-8; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; Wang CS, 2005, MICROBIOL-SGM, V151, P3223, DOI 10.1099/mic.0.28148-0; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005; Wang ZY, 2005, BIOCHEM SOC T, V33, P384, DOI 10.1042/BST0330384; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	30	144	161	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21110	21115		10.1074/jbc.M609592200	http://dx.doi.org/10.1074/jbc.M609592200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17526497	hybrid			2022-12-27	WOS:000248047500037
J	Matsukuma, KE; Wang, L; Bennett, MK; Osborne, TF				Matsukuma, Karen E.; Wang, Li; Bennett, Mary K.; Osborne, Timothy F.			A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; SMALL HETERODIMER PARTNER; CHICK-EMBRYO HEPATOCYTES; TRANSCRIPTIONAL REGULATION; FEEDBACK-REGULATION; STEROL REGULATION; THYROID-HORMONE; DIFFERENTIAL REGULATION; GENE-TRANSCRIPTION; RESPONSE PATHWAY	Liver X receptor (LXR) activates fatty acid synthase (FAS) gene expression through binding to a DR-4 element in the promoter. We show that a distinct nuclear receptor half-site 21 bases downstream of the DR-4 element is also critical for the response of FAS to LXR but is not involved in LXR binding to DNA. This half-site specifically binds liver receptor homologue-1 (LRH-1) in vitro and in vivo, and we show LRH-1 is required for maximal LXR responsiveness of the endogenous FAS gene as well as from promoter reporter constructs. We also demonstrate that LRH-1 stimulation of the FAS LXR response is blocked by the addition of small heterodimer partner (SHP) and that FAS mRNA is overexpressed in SHP knock-out animals, providing evidence that FAS is an in vivo target of SHP repression. Taken together, these findings identify the first direct lipogenic gene target of LRH-1/SHP repression and provide a mechanistic explanation for bile acid repression of FAS and lipogenesis recently reported by others.	Univ Calif Irvine, Sch Biol Sci, Ctr Diabet Res & Treatment, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Kansas, Med Ctr, Dept Med & Pharmacol, Kansas City, KS 66160 USA	University of California System; University of California Irvine; University of Kansas; University of Kansas Medical Center	Osborne, TF (corresponding author), Univ Calif Irvine, Sch Biol Sci, Ctr Diabet Res & Treatment, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	tim.osborne@uci.edu			NHLBI NIH HHS [HL 48044] Funding Source: Medline; NIDDK NIH HHS [DK 71021] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071021] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Bennett MK, 2004, J BIOL CHEM, V279, P37360, DOI 10.1074/jbc.M404693200; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; CLARKE SD, 1990, J NUTR, V120, P225, DOI 10.1093/jn/120.2.225; Datta S, 2006, J BIOL CHEM, V281, P807, DOI 10.1074/jbc.M511050200; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lu Z, 2001, BBA-MOL CELL BIOL L, V1532, P213, DOI 10.1016/S1388-1981(01)00135-4; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; Luo Y, 2001, J BIOL CHEM, V276, P24767, DOI 10.1074/jbc.M100912200; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Mak PA, 2002, J BIOL CHEM, V277, P31900, DOI 10.1074/jbc.M202993200; Matsukuma KE, 2006, J LIPID RES, V47, P2754, DOI 10.1194/jlr.M600342-JLR200; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Oskouian B, 1996, BIOCHEM J, V317, P257, DOI 10.1042/bj3170257; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Rangan VS, 1996, J BIOL CHEM, V271, P2307, DOI 10.1074/jbc.271.4.2307; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rolland V, 1996, J BIOL CHEM, V271, P21297, DOI 10.1074/jbc.271.35.21297; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; STAPLETON SR, 1990, J BIOL CHEM, V265, P18442; Swinnen JV, 2000, ONCOGENE, V19, P5173, DOI 10.1038/sj.onc.1203889; Venteclef N, 2006, MOL CELL BIOL, V26, P6799, DOI 10.1128/MCB.00579-06; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; WILSON SB, 1986, J BIOL CHEM, V261, P5179; Xiong SB, 1998, P NATL ACAD SCI USA, V95, P12260, DOI 10.1073/pnas.95.21.12260; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102	45	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20164	20171		10.1074/jbc.M702895200	http://dx.doi.org/10.1074/jbc.M702895200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17522048	hybrid			2022-12-27	WOS:000247819300017
J	Zhao, CY; Hamilton, T				Zhao, Chenyang; Hamilton, Thomas			Introns regulate the rate of unstable mRNA decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; NONSENSE-MEDIATED DECAY; 3' UNTRANSLATED REGION; EXON JUNCTION COMPLEX; GENE-EXPRESSION; MAMMALIAN-CELLS; POSTTRANSCRIPTIONAL REGULATION; STABILITY; SEQUENCES; CYTOKINE	The expression of neutrophil-specific chemokines is known to be regulated via adenine-uridine-rich sequence elements in the 3'-untranslated regions of their mRNAs that confer a high degree of mRNA instability. Although the presence of intron sequences in eukaryotic genes is known to enhance expression, the effect of intron content on the rate of mature, translatable mRNA degradation has not been demonstrated. In this study, we have determined the effects of intron content on the rate of decay of the chemokine CXCL1 (KC) mRNA. The half-life of KC mRNA was markedly prolonged when the primary transcript was obtained from a genomic clone containing three introns as compared with the half-life observed with sequence-identical KC mRNA derived from an intron-free cDNA construct. The effect of intron content was achieved with a single intron, and neither the intron sequences nor the intron positions were critical determinants of the outcome. The intron content produced the same effect when expressed in multiple cell types and when the sequences were stably integrated into the genome. The differential decay rates were not a consequence of differential nuclear to cytoplasmic transport. The intron content of the primary transcript did not influence the rate of KC mRNA translation and did not modulate the ability of interleukin-1 stimulation to stabilize the otherwise unstable mRNA. The intron effect on mRNA decay was seen with mRNAs containing two distinct instability determinants. These findings document that intron content marks the mRNA sequence leading to enhanced stability that is particularly evident in short lived ARE-containing mRNAs.	Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hamilton, T (corresponding author), Cleveland Clin Fdn, Dept Immunol NE40, 9500 Euclid Ave, Cleveland, OH 44195 USA.	hamiltt@ccf.org	Hamilton, Thomas A/A-7756-2009	Zhao, Chenyang/0000-0002-4716-2002; Hamilton, Thomas/0000-0002-9817-242X	NCI NIH HHS [CA 39621] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039621] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Armstrong DA, 2004, J LEUKOCYTE BIOL, V75, P641, DOI 10.1189/jlb.0803370; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; Bourdon V, 2001, EMBO REP, V2, P394, DOI 10.1093/embo-reports/kve090; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P4395, DOI 10.1128/MCB.8.10.4395; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Datta S, 2004, J IMMUNOL, V173, P2755, DOI 10.4049/jimmunol.173.4.2755; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mandal P, 2007, J IMMUNOL, V178, P2542, DOI 10.4049/jimmunol.178.4.2542; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Novotny M, 2005, J BIOL CHEM, V280, P30166, DOI 10.1074/jbc.M502280200; OHMORI Y, 1994, BIOCHEM BIOPH RES CO, V198, P590, DOI 10.1006/bbrc.1994.1086; Proudfoot NJ, 2001, EMBO REP, V2, P891, DOI 10.1093/embo-reports/kve207; Rose AB, 2000, PLANT PHYSIOL, V122, P535, DOI 10.1104/pp.122.2.535; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shim J, 2002, MOL CELLS, V14, P323; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tebo JM, 2000, J BIOL CHEM, V275, P12987, DOI 10.1074/jbc.275.17.12987; Tsuruta L, 1998, Int Rev Immunol, V16, P581, DOI 10.3109/08830189809043010; VANOOYEN A, 1979, SCIENCE, V206, P337, DOI 10.1126/science.482942; Wang HF, 2007, BIOCHEM BIOPH RES CO, V354, P203, DOI 10.1016/j.bbrc.2006.12.184; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653	51	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20230	20237		10.1074/jbc.M700180200	http://dx.doi.org/10.1074/jbc.M700180200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17478421	hybrid			2022-12-27	WOS:000247819300025
J	Misra, RS; Russell, JQ; Koenig, A; Hinshaw-Makepeace, JA; Wen, R; Wang, D; Huo, H; Littman, DR; Ferch, U; Ruland, J; Thome, M; Budd, RC				Misra, Ravi S.; Russell, Jennifer Q.; Koenig, Andreas; Hinshaw-Makepeace, Jennifer A.; Wen, Renren; Wang, Demin; Huo, Hairong; Littman, Dan R.; Ferch, Uta; Ruland, Jurgen; Thome, Margot; Budd, Ralph C.			Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappa B adaptors during T cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLICE-INHIBITORY PROTEIN; ANTIGEN RECEPTOR; LYMPHOCYTE-ACTIVATION; SIGNALING COMPLEX; MALT LYMPHOMA; LONG FORM; MEMBRANE MICRODOMAINS; UBIQUITIN LIGASE; KINASE COMPLEX; DEATH	Humans and mice lacking functional caspase-8 in T cells manifest a profound immunodeficiency syndrome due to defective T cell antigen receptor (TCR)-induced NF-kappa B signaling and proliferation. It is unknown how caspase-8 is activated following T cell stimulation, and what is the caspase-8 substrate(s) that is necessary to initiate T cell cycling. We observe that following TCR ligation, a small portion of total cellular caspase-8 and c-FLIPL rapidly migrate to lipid rafts where they associate in an active caspase complex. Activation of caspase-8 in lipid rafts is followed by rapid cleavage of c-FLIPL at a known caspase-8 cleavage site. The active caspase (.) c-FLIP complex forms in the absence of Fas(CD95/APO1) and associates with the NF-kappa B signaling molecules RIP1, TRAF2, and TRAF6, as well as upstream NF-kappa B regulators PKC theta, CARMA1, Bcl-10, and MALT1, which connect to the TCR. The lack of caspase-8 results in the absence of MALT1 and Bcl-10 in the active caspase complex. Consistent with this observation, inhibition of caspase activity attenuates NF-kappa B activation. The current findings define a link among TCR, caspases, and the NF-kappa B pathway that occurs in a sequestered lipid raft environment in T cells.	Univ Vermont, Coll Med, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; Blood Ctr Wisconsin, Blood Res Inst, Dept Microbiol & Mol Genet, Milwaukee, WI 53201 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; Tech Univ Munich, Dept Med Hematol Oncol, Munich, Germany; Univ Lausanne, Inst Biochem, Bil Biomed Res Ctr, CH-1066 Epalinges, Switzerland	University of Vermont; Versiti Blood Center of Wisconsin; Howard Hughes Medical Institute; New York University; New York University; Technical University of Munich; University of Lausanne	Budd, RC (corresponding author), Gieven Med Bldg, Burlington, VT 05405 USA.	ralph.budd@uvm.edu	Huo, Hairong/B-7700-2011; Thome, Margot/F-8167-2011; Wang, Demin/AAX-4449-2020; Ruland, Jürgen/Q-6680-2018	Thome, Margot/0000-0002-5656-2139; Wang, Demin/0000-0001-5549-3795; Ruland, Jürgen/0000-0002-8381-3597	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021905] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036333, P01AI045666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007122] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR021905] Funding Source: Medline; NHLBI NIH HHS [HL073284, R01 HL073284] Funding Source: Medline; NIAID NIH HHS [AI36333, P01 AI045666, AI45666, R01 AI036333] Funding Source: Medline; NIAMS NIH HHS [AR043520, R01 AR043520] Funding Source: Medline; NIEHS NIH HHS [T32 ES007122, 5T32ES007122] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Aouad SM, 2004, J IMMUNOL, V172, P2316, DOI 10.4049/jimmunol.172.4.2316; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Blank N, 2002, J IMMUNOL METHODS, V271, P25, DOI 10.1016/S0022-1759(02)00335-6; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dohrman A, 2005, J IMMUNOL, V175, P311, DOI 10.4049/jimmunol.175.1.311; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fortner KA, 2005, J IMMUNOL, V175, P4374, DOI 10.4049/jimmunol.175.7.4374; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; McLaughlin B, 2004, APOPTOSIS, V9, P111, DOI 10.1023/B:APPT.0000018793.10779.dc; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Millet I, 2000, J BIOL CHEM, V275, P15114, DOI 10.1074/jbc.275.20.15114; Misra RS, 2005, J IMMUNOL, V174, P3999, DOI 10.4049/jimmunol.174.7.3999; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Sebald A, 2005, EUR J IMMUNOL, V35, P318, DOI 10.1002/eji.200425024; Snipas SJ, 2004, BIOL CHEM, V385, P1093, DOI 10.1515/BC.2004.142; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Viola A, 2001, TRENDS IMMUNOL, V22, P322, DOI 10.1016/S1471-4906(01)01938-X; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yang K, 2004, BIOCHEM BIOPH RES CO, V324, P432, DOI 10.1016/j.bbrc.2004.09.070; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	65	64	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19365	19374		10.1074/jbc.M610610200	http://dx.doi.org/10.1074/jbc.M610610200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17462996	Green Accepted, hybrid, Green Submitted			2022-12-27	WOS:000247650600011
J	Mori, T; Wada, T; Suzuki, T; Kubota, Y; Inagaki, N				Mori, Tatsuya; Wada, Tomoe; Suzuki, Takahiro; Kubota, Yoshitsugu; Inagaki, Naoyuki			Singar1, a novel RUN domain-containing protein, suppresses formation of surplus axons for neuronal polarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; GSK-3-BETA; PHOSPHORYLATION; ESTABLISHMENT; CRMP-2; POLARIZATION; REGULATORS; CULTURE; RAT; CAT	Although neuronal functions depend on their robust polarity, the mechanisms that ensure generation and maintenance of only a single axon remain poorly understood. Using highly sensitive two-dimensional electrophoresis-based proteomics, we identified here a novel protein, single axon-related (singar)1/KIAA0871/RPIPx/RUFY3, which contains a RUN domain and is predominantly expressed in the brain. Singar1 expression became up-regulated during polarization of cultured hippocampal neurons and remained at high levels thereafter. Singar1 was diffusely localized in hippocampal neurons and moderately accumulated in growth cones of minor processes and axons. Overexpression of singar1 did not affect normal neuronal polarization but suppressed the formation of surplus axons induced by excess levels of shootin1, a recently identified protein located upstream of phosphoinositide-3-kinase and involved in neuronal polarization. Conversely, reduction of the expression of singar1 and its splicing variant singar2 by RNA interference led to an increase in the population of neurons bearing surplus axons, in a phosphoinositide-3-kinase-dependent manner. Overexpression of singar2 did not suppress the formation of surplus axons induced by shootin1. We propose that singar1 ensures the robustness of neuronal polarity by suppressing formation of surplus axons.	Nara Inst Sci & Technol, Div Signal Transduct, Nara 6300192, Japan; Kagawa Univ, Fac Med, Dept Transfus Med, Kagawa 7600793, Japan	Nara Institute of Science & Technology; Kagawa University	Inagaki, N (corresponding author), Nara Inst Sci & Technol, Div Signal Transduct, Nara 6300192, Japan.	ninagaki@bs.naist.jp		Inagaki, Naoyuki/0000-0002-2664-9196				Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gartner A, 2006, J CELL SCI, V119, P3927, DOI 10.1242/jcs.03159; GOBEL S, 1975, BRAIN RES, V88, P333, DOI 10.1016/0006-8993(75)90395-9; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Inagaki Naoyuki, 2004, Current Proteomics, V1, P35, DOI 10.2174/1570164043488289; Jiang H, 2005, NAT NEUROSCI, V8, P544, DOI 10.1038/nn0505-544; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kukimoto-Niino M, 2006, J BIOL CHEM, V281, P31843, DOI 10.1074/jbc.M604960200; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; MEYER G, 1982, BRAIN RES, V232, P455, DOI 10.1016/0006-8993(82)90288-8; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nomura E, 2004, J MASS SPECTROM, V39, P202, DOI 10.1002/jms.578; Oguri T, 2002, PROTEOMICS, V2, P666, DOI 10.1002/1615-9861(200206)2:6<666::AID-PROT666>3.0.CO;2-V; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; TAKAGI H, 1984, J NEUROCYTOL, V13, P239, DOI 10.1007/BF01148118; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	34	52	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19884	19893		10.1074/jbc.M700770200	http://dx.doi.org/10.1074/jbc.M700770200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17439943	hybrid			2022-12-27	WOS:000247650600063
J	Tittle, RK; Power, JM; Hume, RI				Tittle, Rachel K.; Power, Jamila M.; Hume, Richard I.			A histidine scan to probe the flexibility of the rat P2X(2) receptor zinc-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; ATP-BINDING; MOLECULAR-PROPERTIES; CYSTEINE RESIDUES; AGONIST BINDING; CALCIUM-ENTRY; MODULATION; SUBUNIT; IDENTIFICATION; PURINOCEPTOR	The response of P2X(2) receptors to submaximal concentrations of ATP is potentiated by low levels of extracellular zinc. Histidines 120 and 213 have previously been shown to be essential in binding zinc across an intersubunit binding site. We tested the flexibility of the zinc-binding site by making mutations that had the effect of shifting the two essential histidines up to 13 residues upstream or downstream from their original positions and then testing the ability of the mutated receptors to respond to zinc. Using this method, we were able to explore potential orientations of the two regions relative to one another. Our data are consistent with a moderately flexible zinc-binding site and inconsistent with parallel and anti-parallel orientations of the regions surrounding histidines 120 and 213.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hume, RI (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	rhume@umich.edu	, Richard/AAI-5000-2020	Hume, Richard/0000-0001-9807-112X	NINDS NIH HHS [R01-NS039196, R01 NS039196-07, F31 NS051001] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039196, F31NS051001] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BRANDEN C, 1998, INTRO PROTEIN STRUCT, P13; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Clyne JD, 2003, NEUROPHARMACOLOGY, V44, P403, DOI 10.1016/S0028-3908(02)00406-9; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Ennion S, 2000, J BIOL CHEM, V275, P35656; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Freist W, 1998, FEBS LETT, V434, P61, DOI 10.1016/S0014-5793(98)00958-2; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Kanjhan R, 1999, J COMP NEUROL, V407, P11; Liang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC388, DOI 10.1152/ajpcell.00491.2004; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nakazawa K, 2004, EUR J PHARMACOL, V483, P29, DOI 10.1016/j.ejphar.2003.10.026; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Rong WF, 2003, J NEUROSCI, V23, P11315; Sigel H, 2005, CHEM SOC REV, V34, P875, DOI 10.1039/b505986k; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wildman SS, 1998, BRIT J PHARMACOL, V123, P1214, DOI 10.1038/sj.bjp.0701717; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Yan ZH, 2006, J BIOL CHEM, V281, P32649, DOI 10.1074/jbc.M512791200; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P353, DOI 10.1111/j.1469-7793.1998.353bt.x; Zsembery A, 2004, J BIOL CHEM, V279, P10720, DOI 10.1074/jbc.M313391200	33	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19526	19533		10.1074/jbc.M701604200	http://dx.doi.org/10.1074/jbc.M701604200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17517890	hybrid			2022-12-27	WOS:000247650600027
J	Linster, CL; Gomez, TA; Christensen, KC; Adler, LN; Young, BD; Brenner, C; Clarke, SG				Linster, Carole L.; Gomez, Tara A.; Christensen, Kathryn C.; Adler, Lital N.; Young, Brian D.; Brenner, Charles; Clarke, Steven G.			Arabidopsis VTC2 encodes a GDP-L-galactose phosphorylase, the last unknown enzyme in the Smirnoff-Wheeler pathway to ascorbic acid in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-C; GENETIC-EVIDENCE; BIOSYNTHESIS; MANNOSE; THALIANA; CLONING; IDENTIFICATION; TRANSFERASES; ANTIOXIDANT; PHOSPHATASE	The first committed step in the biosynthesis of L-ascorbate from D-glucose in plants requires conversion of GDP-L-galactose to L-galactose 1-phosphate by a previously unidentified enzyme. Here we show that the protein encoded by VTC2, a gene mutated in vitamin C-deficient Arabidopsis thaliana strains, is a member of the GalT/Apa1 branch of the histidine triad protein superfamily that catalyzes the conversion of GDP-L-galactose to L-galactose 1-phosphate in a reaction that consumes inorganic phosphate and produces GDP. In characterizing recombinant VTC2 from A. thaliana as a specific GDP-L-galactose/GDP-D-glucose phosphorylase, we conclude that enzymes catalyzing each of the ten steps of the Smirnoff-Wheeler pathway from glucose to ascorbate have been identified. Finally, we identify VTC2 homologs in plants, invertebrates, and vertebrates, suggesting that a similar reaction is used widely in nature.	Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Dartmouth Coll Sch Med, Dept Genet, Lebanon, NH 03756 USA; Dartmouth Coll Sch Med, Dept Biochem, Lebanon, NH 03756 USA	University of California System; University of California Los Angeles; Dartmouth College; Dartmouth College	Brenner, C (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	charles.brenner@dartmouth.edu; clarke@mbi.ucla.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Linster, Carole/0000-0001-7143-0719	NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018000] Funding Source: NIH RePORTER; NCI NIH HHS [CA75954, R01 CA075954, R01 CA075954-11] Funding Source: Medline; NIA NIH HHS [R01 AG018000, AG018000] Funding Source: Medline; NIGMS NIH HHS [GM026020, R01 GM026020, R37 GM026020] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; BARBER GA, 1964, BIOCHIM BIOPHYS ACTA, V86, P397, DOI 10.1016/0304-4165(64)90069-8; BAYDOUN EAH, 1988, J PLANT PHYSIOL, V132, P484, DOI 10.1016/S0176-1617(88)80068-3; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Conklin PL, 2000, GENETICS, V154, P847; De Tullio MC, 2004, CELL MOL LIFE SCI, V61, P209, DOI 10.1007/s00018-003-3203-8; ENGLARD S, 1986, ANNU REV NUTR, V6, P365, DOI 10.1146/annurev.nu.06.070186.002053; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; KAGAN RM, 1995, BIOCHEMISTRY-US, V34, P10794, DOI 10.1021/bi00034a012; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Leang K, 2004, J BIOSCI BIOENG, V97, P383, DOI 10.1016/S1389-1723(04)70223-6; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; Moreau R, 1998, P NATL ACAD SCI USA, V95, P10279, DOI 10.1073/pnas.95.17.10279; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272; PIRO G, 1993, PLANTA, V190, P206, DOI 10.1007/BF00196613; PLATEAU P, 1990, J BACTERIOL, V172, P6892, DOI 10.1128/jb.172.12.6892-6899.1990; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; ROBERTS RM, 1971, ARCH BIOCHEM BIOPHYS, V145, P685, DOI 10.1016/S0003-9861(71)80029-2; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Wolucka BA, 2001, P NATL ACAD SCI USA, V98, P14843, DOI 10.1073/pnas.011578198; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	35	127	141	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18879	18885		10.1074/jbc.M702094200	http://dx.doi.org/10.1074/jbc.M702094200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17462988	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000247475300028
J	Steen, M; Kirchberger, T; Guse, AH				Steen, Mareike; Kirchberger, Tanja; Guse, Andreas H.			NAADP mobilizes calcium from the endoplasmic reticular Ca2+ store in T-lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; SEA-URCHIN EGGS; BETA-CELLS; RYANODINE RECEPTORS; PANCREATIC-ACINAR; RELEASE; THAPSIGARGIN; SIGNALS; 2ND-MESSENGER	The target calcium store of nicotinic acid adenine dinucleotide phosphate ( NAADP), the most potent endogenous calcium-mobilizing compound known to date, has been proposed to reside in the lysosomal compartment or in the endo/sarcoplasmic reticulum. This study was performed to test the hypothesis of a lysosomal versus an endoplasmic reticular calcium store sensitive to NAADP in T-lymphocytes. Pretreatment of intact Jurkat T cells with glycyl-phenylalanine 2-naphthylamide largely reduced staining of lysosomes by LysoTracker Red and abolished NAADP-induced Ca2+ signaling. However, the inhibitory effect was not specific since Ca2+ mobilization by D-myoinositol 1,4,5-trisphosphate and cyclic ADP-ribose was abolished, too. Bafilomycin A1, an inhibitor of the lysosomal H+-ATPase, did not block or reduce NAADP-induced Ca2+ signaling, although it effectively prevented labeling of lysosomes by LysoTracker Red. Further, previous T cell receptor/CD3 stimulation in the presence of bafilomycin A1, assumed to block refilling of lysosomal Ca2+ stores, did not antagonize subsequent NAADP-induced Ca2+ signaling. In contrast to bafilomycin A1, emptying of the endoplasmic reticulum by thapsigargin almost completely prevented Ca2+ signaling induced by NAADP. In conclusion, in T-lymphocytes, no evidence for involvement of lysosomes in NAADP-mediated Ca2+ signaling was obtained. The sensitivity of NAADP-induced Ca2+ signaling toward thapsigargin, combined with our recent results identifying ryanodine receptors as the target calcium channel of NAADP (Dammermann, W., and Guse, A. H. (2005) J. Biol. Chem. 280, 21394 - 21399), rather suggest that the target calcium store of NAADP in T cells is the endoplasmic reticulum.	Univ Hamburg, Med Ctr Eppendorf, Ctr Med Expt, Inst Biochem & Mol Biol 1,Calcium Signaling Grp, D-20426 Hamburg, Germany	University of Hamburg	Guse, AH (corresponding author), Univ Hamburg, Med Ctr Eppendorf, Ctr Med Expt, Inst Biochem & Mol Biol 1,Calcium Signaling Grp, Martinistr 52, D-20426 Hamburg, Germany.	guse@uke.uni-hamburg.de						Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Bruzzone S, 2003, J CELL BIOL, V163, P837, DOI 10.1083/jcb.200307016; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; Churamani D, 2005, BIOCHEM J, V386, P497, DOI 10.1042/BJ20041990; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Dickinson GD, 2003, BIOCHEM J, V375, P805, DOI 10.1042/BJ20030672; Docampo R, 1999, PARASITOL TODAY, V15, P443, DOI 10.1016/S0169-4758(99)01531-8; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; GOUY H, 1990, EUR J IMMUNOL, V20, P2269, DOI 10.1002/eji.1830201016; GUSE AH, 1993, BIOCHEM J, V291, P447, DOI 10.1042/bj2910447; Guse AH, 1997, J BIOL CHEM, V272, P8546, DOI 10.1074/jbc.272.13.8546; GUSE AH, 1995, J IMMUNOL, V155, P3353; Harmer AR, 2001, BIOCHEM J, V353, P555, DOI 10.1042/0264-6021:3530555; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kunerth S, 2003, CELL SIGNAL, V15, P783, DOI 10.1016/S0898-6568(03)00015-9; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; MACGREGOR A, 2007, J BIOL CHEM; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Mojzisova A, 2001, PFLUG ARCH EUR J PHY, V441, P674, DOI 10.1007/s004240000465; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	35	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18864	18871		10.1074/jbc.M610925200	http://dx.doi.org/10.1074/jbc.M610925200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17446167	hybrid			2022-12-27	WOS:000247475300026
J	Grybko, MJ; Bartnik, JP; Wurth, GA; Pores-Fernando, AT; Zweifach, A				Grybko, Michael J.; Bartnik, Jakub P.; Wurth, Georjeana A.; Pores-Fernando, Arun T.; Zweifach, Adam			Calcineurin activation is only one calcium-dependent step in cytotoxic T lymphocyte granule exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CYCLOSPORINE-A; CELLS; DEGRANULATION; MECHANISMS; EXPRESSION; INHIBITOR; RECEPTOR; DEPHOSPHORYLATION; IDENTIFICATION	We have tested the idea that calcineurin, a calcium-dependent phosphatase that is critical for activating cytokine gene expression in helper T cells, plays a role in lytic granule exocytosis in cytotoxic T lymphocytes (CTLs). We used TALL-104 human leukemic CTLs as a model. Our results confirm an earlier report (Dutz, J. P., Fruman, D. A., Burakoff, S. J., and Bierer, B. E. (1993) J. Immunol. 150, 2591-2598) that immunosuppressive drugs inhibit exocytosis in CTLs stimulated either via the T cell receptor (TCR) or via TCR-independent soluble agents. Of the two recently reported alternate targets of immunosuppressive drugs (Matsuda, S., Shibasaki, F., Takehana, K., Mori, H., Nishida, E., and Koyasu, S. (2000) EMBO Rep. 1,428-434 and Matsuda, S., and Koyasu, S. (2000) Immunopharmacology 47, 119-125), JNK is not required for lytic granule exocytosis, but we were not able to exclude a role for P38. Exocytosis could be inhibited by expressing GFP fused to a C-terminal fragment of CAIN (cabin 1), but not by expressing VIVIT-GFP. Finally, expressing either full-length or truncated constitutively active mutant calcineurin A enhanced lytic granule exocytosis. However, the mutant calcineurin was unable to support exocytosis when cells were stimulated in the absence of Ca2+ influx. Taken together, our results support the idea that activation of calcineurin is required for lytic granule exocytosis but suggest that it is not the sole Ca(2+-)dependent step.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06268 USA	University of Connecticut	Zweifach, A (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Unit 3125, 91 N Eagleville Rd, Storrs, CT 06268 USA.	adam.zweifach@uconn.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054839] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI054839] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Berg NN, 1998, J IMMUNOL, V161, P2919; BERKE G, 1994, ANNU REV IMMUNOL, V12, P735, DOI 10.1146/annurev.immunol.12.1.735; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; BERREBI G, 1987, P NATL ACAD SCI USA, V84, P1364, DOI 10.1073/pnas.84.5.1364; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; CESANO A, 1992, IN VITRO CELL DEV-AN, V28A, P648; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dieter B, 2002, PFLUG ARCH EUR J PHY, V443, P333, DOI 10.1007/s00424-001-0742-4; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; DUTZ JP, 1993, J IMMUNOL, V150, P2591; Fierro AF, 2004, J BIOL CHEM, V279, P25646, DOI 10.1074/jbc.M400296200; Fowler KT, 2007, J IMMUNOL, V178, P1498, DOI 10.4049/jimmunol.178.3.1498; GOTO S, 1985, J NEUROCHEM, V45, P276, DOI 10.1111/j.1471-4159.1985.tb05504.x; GRIFFITHS GM, 1995, CURR OPIN IMMUNOL, V7, P343, DOI 10.1016/0952-7915(95)80108-1; Groblewski GE, 1998, J BIOL CHEM, V273, P22738, DOI 10.1074/jbc.273.35.22738; GROBLEWSKI GE, 1994, J BIOL CHEM, V269, P15111; Grybko MJ, 2007, J LEUKOCYTE BIOL, V81, P509, DOI 10.1189/jlb.0206109; Hay JC, 2001, EXP CELL RES, V271, P10, DOI 10.1006/excr.2001.5368; HULTSCH T, 1991, P NATL ACAD SCI USA, V88, P6229, DOI 10.1073/pnas.88.14.6229; Im SH, 2004, MOL CELLS, V18, P1; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; LANCKI DW, 1987, J IMMUNOL, V138, P3646; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuda S, 2000, EMBO REP, V1, P428, DOI 10.1093/embo-reports/kvd090; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Pardo J, 2003, INT IMMUNOL, V15, P1441, DOI 10.1093/intimm/dxg141; Pores-Fernando AT, 2005, J PHYSIOL-LONDON, V567, P891, DOI 10.1113/jphysiol.2005.089565; Puente LG, 2000, J IMMUNOL, V165, P6865, DOI 10.4049/jimmunol.165.12.6865; Puente LG, 2006, EUR J IMMUNOL, V36, P1009, DOI 10.1002/eji.200535277; Puente LG, 2005, MOL IMMUNOL, V42, P1177, DOI 10.1016/j.molimm.2004.11.012; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Raufman JP, 1997, BBA-MOL CELL RES, V1357, P73, DOI 10.1016/S0167-4889(97)00023-2; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Shin DW, 2002, BIOPHYS J, V83, P2539, DOI 10.1016/S0006-3495(02)75265-X; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; TAKAYAMA H, 1987, J IMMUNOL METHODS, V104, P183, DOI 10.1016/0022-1759(87)90502-3; TAKAYAMA H, 1987, J EXP MED, V166, P725, DOI 10.1084/jem.166.3.725	46	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18009	18017		10.1074/jbc.M702222200	http://dx.doi.org/10.1074/jbc.M702222200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17478429	hybrid			2022-12-27	WOS:000247302000007
J	Neeli, I; Siddiqi, SA; Siddiqi, S; Mahan, J; Lagakos, WS; Binas, B; Gheyi, T; Storch, J; Mansbach, CM				Neeli, Indira; Siddiqi, Shadab A.; Siddiqi, Shahzad; Mahan, James; Lagakos, William S.; Binas, Bert; Gheyi, Tarun; Storch, Judith; Mansbach, Charles M., II			Liver fatty acid-binding protein initiates budding of pre-chylomicron transport vesicles from intestinal endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; CYTOPLASMIC TRANSPORT; HELICAL DOMAIN; CACO-2 CELLS; COMPLEX; GOLGI; EXPRESSION; SECRETION; MEMBRANES; DELETION	The rate-limiting step in the transit of absorbed dietary fat across the enterocyte is the generation of the pre-chylomicron transport vesicle (PCTV) from the endoplasmic reticulum (ER). This vesicle does not require coatomer-II (COPII) proteins for budding from the ER membrane and contains vesicle-associated membrane protein 7, found in intestinal ER, which is a unique intracellular location for this SNARE protein. We wished to identify the protein(s) responsible for budding this vesicle from ER membranes in the absence of the requirement for COPII proteins. We chromatographed rat intestinal cytosol on Sephacryl S-100 and found that PCTV budding activity appeared in the low molecular weight fractions. Additional chromatographic steps produced a single major and several minor bands on SDS-PAGE. By tandem mass spectroscopy, the bands contained both liver and intestinal fatty acid-binding proteins (L- and I-FABP) as well as four other proteins. Recombinant proteins for each of the six proteins identified were tested for PCTV budding activity; only L-FABP and I-FABP (23% the activity of L-FABP) were active. The vesicles generated by L- FABP were sealed, contained apolipoproteins B48 and AIV, were of the same size as PCTV on Sepharose CL-6B, and by electron microscopy, excluded calnexin and calreticulin but did not fuse with cis- Golgi nor did L-FABP generate COPII-dependent vesicles. Gene-disrupted L-FABP mouse cytosol had 60% the activity of wild type mouse cytosol. We conclude that L- FABP can select cargo for and bud PCTV from intestinal ER membranes.	Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Div Gastroenterol, Memphis, TN 38163 USA; Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Pathobiol, College Stn, TX 77843 USA; Univ Memphis, Dept Chem, Memphis, TN 38152 USA; Vet Affairs Med Ctr, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Rutgers State University New Brunswick; Texas A&M University System; Texas A&M University College Station; University of Memphis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Mansbach, CM (corresponding author), Rutgers State Univ, Dept Nutr Sci, Cook Coll, 96 Lipman Dr, New Brunswick, NJ 08901 USA.	storch@aesop.rutgers.edu; cmansbach@utmem.edu		Storch, Judith/0000-0001-5482-1777	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038760, R01DK038389, R01DK074565, R29DK038389] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38760, DK74565, R01 DK038389, DK38389] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abumrad N, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1693; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; BASS NM, 1985, J BIOL CHEM, V260, P1432; Berk PD, 1999, MOL CELL BIOCHEM, V192, P17, DOI 10.1023/A:1006832001033; BURRIER RE, 1986, BIOCHIM BIOPHYS ACTA, V879, P229; CISTOLA DP, 1989, J BIOL CHEM, V264, P2700; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Corsico B, 2004, BIOCHEMISTRY-US, V43, P3600, DOI 10.1021/bi0357356; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; CULLIS PR, 1985, BIOCH LIPIDS MEMBRAN, P25; Davies JK, 1999, BIOCHEMISTRY-US, V38, P16932, DOI 10.1021/bi991926q; DOLE VP, 1962, PHYSIOL REV, V42, P674, DOI 10.1152/physrev.1962.42.4.674; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Dube N, 2001, J CELL BIOCHEM, V81, P613, DOI 10.1002/jcb.1090; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9; GORDON JI, 1985, J BIOL CHEM, V260, P1995; HAYASHI H, 1990, AM J PHYSIOL, V259, pG709, DOI 10.1152/ajpgi.1990.259.5.G709; Hsu KT, 1996, J BIOL CHEM, V271, P13317, DOI 10.1074/jbc.271.23.13317; HUBSCHER G, 1965, BIOCHEM J, V97, P629, DOI 10.1042/bj0970629; KELER T, 1993, J CELL PHYSIOL, V157, P33, DOI 10.1002/jcp.1041570105; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kumar NS, 1997, AM J PHYSIOL-GASTR L, V273, pG18, DOI 10.1152/ajpgi.1997.273.1.G18; Kumar NS, 1999, AM J PHYSIOL-GASTR L, V276, pG378, DOI 10.1152/ajpgi.1999.276.2.G378; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Luxon BA, 1999, AM J PHYSIOL-GASTR L, V277, pG361, DOI 10.1152/ajpgi.1999.277.2.G361; MANOWITZ NR, 1986, J LIPID RES, V27, P196; Mansbach CM, 1998, J LIPID RES, V39, P963; MANSBACH CM, 1975, J CLIN INVEST, V56, P781, DOI 10.1172/JCI108156; MANSBACH CM, 1995, AM J PHYSIOL-GASTR L, V269, pG144, DOI 10.1152/ajpgi.1995.269.1.G144; MANSBACH CM, 1986, AM J PHYSIOL, V251, pG263, DOI 10.1152/ajpgi.1986.251.2.G263; Mansbach CM, 2000, J LIPID RES, V41, P605; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2005, MOL BIOL CELL, V16, P3719, DOI 10.1091/mbc.E05-03-0262; MISHKIN S, 1972, BIOCHEM BIOPH RES CO, V47, P997, DOI 10.1016/0006-291X(72)90931-X; Murota K, 2005, J NUTR, V135, P1626, DOI 10.1093/jn/135.7.1626; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Poirier H, 1997, AM J PHYSIOL-GASTR L, V273, pG289, DOI 10.1152/ajpgi.1997.273.2.G289; Schachtrup C, 2004, BIOCHEM J, V382, P239, DOI 10.1042/BJ20031340; SCHOELLER C, 1995, CLIN INVEST MED, V18, P380; SHIELDS HM, 1986, J LIPID RES, V27, P549; Siddiqi SA, 2006, J CELL SCI, V119, P943, DOI 10.1242/jcs.02803; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; STORCH J, 1993, MOL CELL BIOCHEM, V123, P45, DOI 10.1007/BF01076474; STORCH J, 1990, J BIOL CHEM, V265, P7827; STREMMEL W, 1988, J CLIN INVEST, V82, P2001, DOI 10.1172/JCI113820; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Thumser AEA, 2000, J LIPID RES, V41, P647; Tisdale EJ, 1997, J CELL BIOL, V137, P581, DOI 10.1083/jcb.137.3.581; Weisiger RA, 1996, HEPATOLOGY, V24, P1288; Wu F, 2001, BIOCHEMISTRY-US, V40, P1976, DOI 10.1021/bi002252i	59	80	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					17974	17984		10.1074/jbc.M610765200	http://dx.doi.org/10.1074/jbc.M610765200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17449472	hybrid			2022-12-27	WOS:000247302000004
J	Szalewska-Palasz, A; Johansson, LUM; Bernardo, LMD; Skarfstad, E; Stec, E; Brannstrom, K; Shingler, V				Szalewska-Palasz, Agnieszka; Johansson, Linda U. M.; Bernardo, Lisandro M. D.; Skarfstad, Eleonore; Stec, Ewa; Brannstrom, Kristoffer; Shingler, Victoria			Properties of RNA polymerase bypass mutants - Implications for the role of ppGpp and its co-factor DksA in controlling transcription dependent on sigma(54)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA(54)-DEPENDENT PO PROMOTER; GUANOSINE TETRAPHOSPHATE PPGPP; ESCHERICHIA-COLI; IN-VIVO; ANGSTROM RESOLUTION; FACTOR COMPETITION; AROMATIC-COMPOUNDS; ALARMONE (P)PPGPP; STRUCTURAL BASIS; INITIATION	The bacterial nutritional and stress alarmone ppGpp and its co-factor DksA directly bind RNA polymerase to regulate its activity at certain sigma(70)-dependent promoters. A number of promoters that are dependent on alternative sigma-factors function poorly in the absence of ppGpp. These include the Pseudomonas-derived sigma(54)-dependent Po promoter and several other sigma(54-)promoters, the transcription from which is essentially abolished in Escherichia coli devoid of ppGpp and DksA. However, ppGpp and DksA have no apparent effect on reconstituted in vitro sigma(54)-transcription, which suggests an indirect mechanism of control. Here we report analysis of five hyper-suppressor mutants within the beta- and beta'-subunits of core RNA polymerase that allow high levels of transcription from the sigma(54)-Po promoter in the absence of ppGpp. Using in vitro transcription and competition assays, we present evidence that these core RNA polymerase mutants are defective in one or both of two properties that could combine to explain their hyper-suppressor phenotypes: (i) modulation of competitive association with sigma-factors to favor sigma(54)-holoenzyme formation over that with sigma(70), and (ii) reduced innate stability of RNA polymerase-promoter complexes, which mimics the essential effects of ppGpp and DksA for negative regulation of stringent sigma(70)-promoters. Both these properties of the mutant holoenzymes support a recently proposed mechanism for regulation of sigma(54)-transcription that depends on the potent negative effects of ppGpp and DksA on transcription from powerful stringent sigma(70)-promoters, and suggests that stringent regulation is a key mechanism by which the activity of alternative sigma-factors is controlled to meet cellular requirements.	Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; Univ Gdansk, Dept Mol Biol, PL-80822 Gdansk, Poland	Umea University; Fahrenheit Universities; University of Gdansk	Shingler, V (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.	victoria.shingler@molbiol.umu.se	Brännström, Kristoffer/D-3648-2009; Brännström, Kristoffer/AAC-1204-2020; Szalewska-Palasz, Agnieszka/AAI-4826-2020	Szalewska-Palasz, Agnieszka/0000-0001-8013-4057; Holmfeldt, Linda/0000-0003-4140-3423; Shingler, Victoria/0000-0002-7349-1678				Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Bremer H., 1996, E COLI SALMONELLA CE, V2, P1553; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Carmona M, 2000, J BACTERIOL, V182, P4711, DOI 10.1128/JB.182.17.4711-4718.2000; CASHEL M, 1974, ANAL BIOCHEM, V57, P100, DOI 10.1016/0003-2697(74)90056-6; CASHEL M, 1996, ESCHERICHIA COLI SAL, V1, P1458; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; ELLIOTT T, 1984, CELL, V36, P211, DOI 10.1016/0092-8674(84)90091-6; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; HERNANDEZ VJ, 1995, J MOL BIOL, V252, P536; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Kvint K, 2000, J BIOL CHEM, V275, P14795, DOI 10.1074/jbc.C000128200; Laurie AD, 2003, J BIOL CHEM, V278, P1494, DOI 10.1074/jbc.M209268200; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Potrykus K, 2002, J BIOL CHEM, V277, P43785, DOI 10.1074/jbc.M208768200; RECORD MT, 1996, ESCHERICHIA COLI SAL, V1, P792; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; SHINGLER V, 1995, MOL MICROBIOL, V17, P505, DOI 10.1111/j.1365-2958.1995.mmi_17030505.x; Sze CC, 2002, J BACTERIOL, V184, P760, DOI 10.1128/JB.184.3.760-770.2002; Sze CC, 1999, MOL MICROBIOL, V31, P1217, DOI 10.1046/j.1365-2958.1999.01264.x; Sze CC, 2001, J BACTERIOL, V183, P2842, DOI 10.1128/JB.183.9.2842-2851.2001; Sze CC, 1996, J BACTERIOL, V178, P3727, DOI 10.1128/jb.178.13.3727-3735.1996; Trautinger BW, 2002, EMBO J, V21, P6944, DOI 10.1093/emboj/cdf654; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	47	45	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18046	18056		10.1074/jbc.M610181200	http://dx.doi.org/10.1074/jbc.M610181200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17456470	Green Submitted, hybrid			2022-12-27	WOS:000247302000011
J	Chang, YF; Martin, SS; Baldwin, EP; Carman, GM				Chang, Yu-Fang; Martin, Shelley S.; Baldwin, Enoch P.; Carman, George M.			Phosphorylation of human CTP synthetase 1 by protein kinase C - Identification of Ser(462) and Thr(455) as major sites of phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE-TRIPHOSPHATE-SYNTHETASE; AFRICAN SLEEPING SICKNESS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CYCLOPENTENYL CYTOSINE; PHOSPHATIDYLCHOLINE SYNTHESIS; 5'-TRIPHOSPHATE SYNTHETASE; LYMPHOBLASTIC-LEUKEMIA; GENE-PRODUCT; MUTATOR GENE	Phosphorylation of human CTP synthetase 1 by mammalian protein kinase C was examined. Using purified Escherichia coli-expressed CTP synthetase 1 as a substrate, protein kinase C activity was time- and dose-dependent and dependent on the concentrations of ATP and CTP synthetase 1. The protein kinase C phosphorylation of the recombinant enzyme was accompanied by a 95-fold increase in CTP synthetase 1 activity. Phosphopeptide mapping and phosphoamino acid analyses showed that CTP synthetase 1 was phosphorylated on multiple serine and threonine residues. The induction of PKC1(R398A)-encoded protein kinase C resulted in a 50% increase for human CTP synthetase 1 phosphorylation in the Saccharomyces cerevisiae ura7 Delta ura8 Delta mutant lacking yeast CTP synthetase activity. Synthetic peptides that contain the protein kinase C motif for Ser(462) and Thr(455) were substrates for mammalian protein kinase C, and S462A and T455A mutations resulted in decreases in the extent of CTP synthetase 1 phosphorylation that occurred in vivo. Phosphopeptide mapping analysis of S. cerevisiae-expressed CTP synthetase 1 mutant enzymes phosphorylated with mammalian protein kinase C confirmed that Ser(462) and Thr(455) were phosphorylation sites. The S. cerevisiae-expressed and purified S462A mutant enzyme exhibited a 2-fold reduction in CTP synthetase 1 activity, whereas the purified T455A mutant enzyme exhibited a 2-fold elevation in CTP synthetase 1 activity ( Choi, M.- G., and Carman, G. M. ( 2006) J. Biol. Chem. 282, 5367-5377). These data indicated that protein kinase C phosphorylation at Ser(462) stimulates human CTP synthetase 1 activity, whereas phosphorylation at Thr(455) inhibits activity.	Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Rutgers State University New Brunswick; University of California System; University of California Davis; University of California System; University of California Davis	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Baldwin, Enoch/0000-0002-1472-0944	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063109, R01GM050679] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-63109, GM-50679, R01 GM050679-14, R01 GM050679, R01 GM063109] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON PM, 1983, BIOCHEMISTRY-US, V22, P3285, DOI 10.1021/bi00282a038; ANTONSSON B, 1994, J BIOL CHEM, V269, P16821; ARONOW B, 1984, J BIOL CHEM, V259, P9035; ARONOW B, 1987, J BIOL CHEM, V262, P5106; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi MG, 2007, J BIOL CHEM, V282, P5367, DOI 10.1074/jbc.M610993200; Choi MG, 2003, J BIOL CHEM, V278, P23610, DOI 10.1074/jbc.M303337200; CHU EHY, 1984, BIOCHEM GENET, V22, P701, DOI 10.1007/BF00485854; CULBERTSON MR, 1975, GENETICS, V80, P23; Dereuddre-Bosquet N, 2004, ANTIVIR RES, V61, P67, DOI 10.1016/j.antiviral.2003.08.002; DESAINTVINCENT BR, 1980, BIOCHIM BIOPHYS ACTA, V610, P352; Endrizzi JA, 2005, BIOCHEMISTRY-US, V44, P13491, DOI 10.1021/bi051282o; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; Fijolek A, 2007, J BIOL CHEM, V282, P11858, DOI 10.1074/jbc.M611580200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goto M, 2004, STRUCTURE, V12, P1413, DOI 10.1016/j.str.2004.05.013; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; HINDENBURG AA, 1985, CANCER RES, V45, P3048; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KANG GJ, 1989, J BIOL CHEM, V264, P713; KAUFMAN ER, 1986, MUTAT RES, V161, P19, DOI 10.1016/0027-5107(86)90096-5; KIZAKI H, 1980, CANCER RES, V40, P3921; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3365, DOI 10.1021/bi00794a008; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P247, DOI 10.1021/bi00752a016; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P241, DOI 10.1021/bi00752a015; LEWIS DA, 1989, BIOCHEMISTRY-US, V28, P8454, DOI 10.1021/bi00447a027; LIEBERMAN I, 1956, J BIOL CHEM, V222, P765; LONG CW, 1967, J BIOL CHEM, V242, P4715; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Mackay HJ, 2003, ENDOCR-RELAT CANCER, V10, P389, DOI 10.1677/erc.0.0100389; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MEUTH M, 1979, P NATL ACAD SCI USA, V76, P6505, DOI 10.1073/pnas.76.12.6505; MEUTH M, 1982, SOMAT CELL GENET, V8, P423, DOI 10.1007/BF01538705; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; Pappas A, 1998, J BIOL CHEM, V273, P15954, DOI 10.1074/jbc.273.26.15954; Pappas A, 1999, BIOCHEMISTRY-US, V38, P16671, DOI 10.1021/bi9920127; Park TS, 2003, J BIOL CHEM, V278, P20785, DOI 10.1074/jbc.M301394200; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; POLITI PM, 1995, CANCER CHEMOTH PHARM, V36, P513, DOI 10.1007/BF00685802; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; THOMAS PE, 1988, BIOCHIM BIOPHYS ACTA, V953, P334, DOI 10.1016/0167-4838(88)90042-8; TRUDEL M, 1984, J BIOL CHEM, V259, P2355; VANDENBERG AA, 1995, EUR J CANCER, V31A, P108, DOI 10.1016/0959-8049(94)00442-8; VANDENBERG AA, 1993, EUR J BIOCHEM, V216, P161; Verschuur AC, 1998, ADV EXP MED BIOL, V431, P667; Verschuur AC, 2000, EUR J CANCER, V36, P627, DOI 10.1016/S0959-8049(00)00021-6; Verschuur AC, 2000, BRIT J HAEMATOL, V110, P161, DOI 10.1046/j.1365-2141.2000.02136.x; VONDERSAAL W, 1985, J BIOL CHEM, V260, P4993; Wadskov-Hansen SLL, 2001, J BIOL CHEM, V276, P38002; WATANABE M, 1994, J BIOL CHEM, V269, P16829; WEBER G, 1980, LIFE SCI, V27, P793, DOI 10.1016/0024-3205(80)90333-1; Weber G, 1978, Adv Enzyme Regul, V17, P1; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; Yang WL, 1996, J BIOL CHEM, V271, P11113, DOI 10.1074/jbc.271.19.11113; YANG WL, 1994, BIOCHEMISTRY-US, V33, P10785, DOI 10.1021/bi00201a028; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; ZHANG H, 1993, CANCER RES, V53, P5714	77	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17613	17622		10.1074/jbc.M702799200	http://dx.doi.org/10.1074/jbc.M702799200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17463002	hybrid, Green Accepted			2022-12-27	WOS:000247084500033
J	Hung, RJ; Chien, HS; Lin, RZ; Lin, CT; Vatsyayan, J; Peng, HL; Chang, HY				Hung, Ruei-Jiun; Chien, Han-Sheng; Lin, Ruei-Zeng; Lin, Ching-Ting; Vatsyayan, Jaya; Peng, Hwei-Ling; Chang, Hwan-You			Comparative analysis of two UDP-glucose dehydrogenases in Pseudomonas aeruginosa PAO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ANTIGEN BIOSYNTHESIS; GROUP-A STREPTOCOCCI; SUGAR INTERCONVERSIONS; POLYACRYLAMIDE GELS; TWITCHING MOTILITY; KEY ENZYME; GENE; LIPOPOLYSACCHARIDE; NUCLEOTIDE; DROSOPHILA	UDP-glucose dehydrogenase (UGDH) catalyzes a two-step NAD(+)-dependent oxidation of UDP-glucose to produce UDPglucuronic acid, which is a common substrate for the biosynthesis of exopolysaccharide. Searching the Pseudomonas aeruginosa PAO1 genome data base for a UGDH has helped identify two open reading frames, PA2022 and PA3559, which may encode a UGDH. To elucidate their enzymatic identity, the two genes were cloned and overexpressed in Escherichia coli, and the recombinant proteins were purified. Both the gene products are active as dimers and are capable of utilizing UDP- glucose as a substrate to generate UDP- glucuronic acid. The Km values of PA2022 and PA3559 for UDP-glucose are similar to 0.1 and 0.4 mM, whereas the K-m values for NAD(+) are 0.5 and 2.0 mM, respectively. Compared with PA3559, PA2022 exhibits broader substrate specificity, utilizing TDP-glucose and UDP-N-acetylglucosamine with one-third the velocity of that with UDP- glucose. The PA2022 mutant and PA2022-PA3559 double mutant, but not the PA3559 mutant, are more susceptible to chloramphenicol, cefotaxime, and ampicillin. The PA3559 mutant, however, shows a reduced resistance to polymyxin B compared with wild type PAO1. Finally, real time PCR analysis indicates that PA3559 is expressed primarily in low concentrations of Mg2+, which contrasts with the constitutive expression of PA2022. Although both the enzymes catalyze the same reaction, their enzymatic properties and gene expression profiles indicate that they play distinct physiological roles in P. aeruginosa, as reflected by different phenotypes displayed by the mutants.	Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 300, Taiwan; Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan	National Tsing Hua University; National Yang Ming Chiao Tung University	Chang, HY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, 101 Kuang Fu Rd,2nd Sec, Hsinchu 300, Taiwan.	hychang@life.nthu.edu.tw						APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Binari RC, 1997, DEVELOPMENT, V124, P2623; BROWN MRW, 1969, BIOCHEM J, V112, P521, DOI 10.1042/bj1120521; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; CRATER DL, 1995, J BIOL CHEM, V270, P18452, DOI 10.1074/jbc.270.31.18452; CROSS AS, 1990, CURR TOP MICROBIOL, V150, P87; DALESSANDRO G, 1977, BIOCHEM J, V162, P281, DOI 10.1042/bj1620281; DARZINS A, 1993, J BACTERIOL, V175, P5934, DOI 10.1128/JB.175.18.5934-5944.1993; DERETIC V, 1987, NUCLEIC ACIDS RES, V15, P4567, DOI 10.1093/nar/15.11.4567; FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627, DOI 10.1128/JCM.28.12.2627-2631.1990; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Gatzeva-Topalova PZ, 2005, STRUCTURE, V13, P929, DOI 10.1016/j.str.2005.03.018; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; HAUSER SC, 1984, J BIOL CHEM, V259, P4527; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hughes JE, 1997, INFECT IMMUN, V65, P4281, DOI 10.1128/IAI.65.10.4281-4287.1997; Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Miller WL, 2004, J BIOL CHEM, V279, P37551, DOI 10.1074/jbc.M404749200; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Princivalle M, 2002, INT J DEV BIOL, V46, P267; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; RODEN L, 1980, BIOCH GLYCOPROTEINS; ROSSMAN MG, 1981, PHILOS T ROY SOC B, V293, P191, DOI 10.1098/rstb.1981.0072; RYLL T, 1991, J CHROMATOGR-BIOMED, V570, P77, DOI 10.1016/0378-4347(91)80202-N; Sambrook J., 2001, MOL CLONING LAB MANU; SCHILLER JG, 1973, BIOCHIM BIOPHYS ACTA, V293, P1, DOI 10.1016/0005-2744(73)90369-0; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Snook CF, 2003, BIOCHEMISTRY-US, V42, P4658, DOI 10.1021/bi027328k; WARREN GH, 1955, J BACTERIOL, V70, P152, DOI 10.1128/JB.70.2.152-157.1955; WARREN GH, 1954, J BACTERIOL, V67, P167, DOI 10.1128/JB.67.2.167-170.1954; WATSON DA, 1990, INFECT IMMUN, V58, P3135, DOI 10.1128/IAI.58.9.3135-3138.1990; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994	40	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17738	17748		10.1074/jbc.M701824200	http://dx.doi.org/10.1074/jbc.M701824200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17442666	hybrid			2022-12-27	WOS:000247084500047
J	Shinohara, M; Shang, WH; Kubodera, M; Harada, S; Mitsushita, J; Kato, M; Miyazaki, H; Sumimoto, H; Kamata, T				Shinohara, Masahiro; Shang, Wei-Hao; Kubodera, Makoto; Harada, Saori; Mitsushita, Junji; Kato, Masayoshi; Miyazaki, Hitoshi; Sumimoto, Hideke; Kamata, Tohru			Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; HYDROGEN-PEROXIDE; CELL-ADHESION; GROWTH; GENERATION; APOPTOSIS; GTPASES; RAC1; TRANSFORMATION; INACTIVATION	Generation of reactive oxygen species ( ROS) by Ras oncogene-induced NADPH oxidase ( Nox) 1 is required for Ras transformation phenotypes including anchorage-independent growth, morphological transformation, and tumorigenesity, but the signaling mechanism downstream of Nox1 remains elusive. Rho is known to be a critical regulator of actin stress fiber formation. Nonetheless, Rho was reported to no longer couple to loss of actin stress fibers in Ras-transformed Swiss3T3 cells despite the elevation of Rho activity. In this study, however, we demonstrate that Rho is inactivated in K-Ras-transformed normal rat kidney cells, and that abrogation of Nox1-generated ROS by Nox1 small interference RNAs or diphenyleneiodonium restores Rho activation, suggesting that Nox1-generated oxidants mediate down-regulation of the Rho activity. This down-regulation involves oxidative inactivation of the low molecular weight protein-tyrosine phosphatase by Nox1-generated ROS and a subsequent elevation in the tyrosine-phosphorylated active form of p190RhoGAP, the direct target of the phosphatase. Furthermore, the decreased Rho activity leads to disruption of both actin stress fibers and focal adhesions in Ras-transformed cells. As for Rac1, Rac1 also appears to participate in the down-regulation of Rho via Nox1. Our discovery defines a mediating role of Nox1-redox signaling for Ras oncogene-induced actin cytoskeletal changes.	Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, Matsumoto, Nagano 3908621, Japan; Univ Tsukuba, Ctr Gene Res, Tsukuba 3058572, Japan; Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan	Shinshu University; University of Tsukuba; Kyushu University	Kamata, T (corresponding author), Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kamatat@sch.md.shinshu-u.ac.jp	Mitsushita, Junji/D-7688-2016	Mitsushita, Junji/0000-0001-9402-4318; Shinohara, Masahiro/0000-0002-5532-1042				Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Brar SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1212, DOI 10.1152/ajpcell.00496.2001; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HUGHES RE, 1997, CELL, P521; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Izawa I, 1998, ONCOGENE, V17, P2863, DOI 10.1038/sj.onc.1202213; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shimizu H, 2001, BIOCHEM BIOPH RES CO, V289, P602, DOI 10.1006/bbrc.2001.6007; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; van Wetering S, 2002, J CELL SCI, V115, P1837; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	38	95	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17640	17648		10.1074/jbc.M609450200	http://dx.doi.org/10.1074/jbc.M609450200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17435218	hybrid			2022-12-27	WOS:000247084500036
J	Beedle, AM; Nienaber, PM; Campbell, KP				Beedle, Aaron M.; Nienaber, Patricia M.; Campbell, Kevin P.			Fukutin-related protein associates with the sarcolemmal dystrophin-glycoprotein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; SUBCELLULAR-LOCALIZATION; SKELETAL-MUSCLE; DYSTROGLYCAN; GLYCOSYLATION; MUTATIONS; GLYCOSYLTRANSFERASE; EXPRESSION	Mutations in fukutin-related protein (FKRP) give rise to mild and more severe forms of muscular dystrophy. FKRP patients have reduced glycosylation of the extracellular protein dystroglycan, and FKRP itself shows sequence similarity to glycosyltransferases, implicating FKRP in the processing of dystroglycan. However, FKRP localization is controversial, and no FKRP complexes are known, so any FKRP-dystroglycan link remains elusive. Here, we demonstrate a novel FKRP localization in vivo; in mouse, both endogenous and recombinant FKRP are present at the sarcolemma. Biochemical analyses revealed that mouse muscle FKRP and dystroglycan co-enrich and co-fractionate, indicating that FKRP coexists with dystroglycan in the native dystrophin-glycoprotein complex. Furthermore, FKRP sedimentation shifts with dystroglycan in disease models involving the dystrophin-glycoprotein complex, and sarcolemmal FKRP immunofluorescence mirrors that of dystroglycan in muscular dystrophy mice, suggesting that FKRP localization may be mediated by dystroglycan. These data offer the first evidence of an FKRP complex in muscle and suggest that FKRP may influence the glycosylation status of dystroglycan from within the sarcolemmal dystrophin-glycoprotein complex.	Univ Iowa, Dept Physiol & Mol Biophys, HHMI, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Dept Physiol & Mol Biophys, HHMI, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Beedle, Aaron M/K-1902-2015; Beedle, Aaron/AAI-7014-2020	Beedle, Aaron M/0000-0002-1019-3235; Campbell, Kevin/0000-0003-2066-5889				Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; BEGOVAC PC, 1994, J BIOL CHEM, V269, P31793; Berger EG, 2002, GLYCOBIOLOGY, V12, p29R, DOI 10.1093/glycob/12.2.29R; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Crosbie RH, 1999, J CELL BIOL, V145, P153, DOI 10.1083/jcb.145.1.153; Dolatshad NF, 2005, EXP CELL RES, V309, P370, DOI 10.1016/j.yexcr.2005.06.017; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 1999, J BIOL CHEM, V274, P26609, DOI 10.1074/jbc.274.37.26609; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; Esapa CT, 2002, HUM MOL GENET, V11, P3319, DOI 10.1093/hmg/11.26.3319; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Ma JY, 1997, J BIOL CHEM, V272, P672; MACLEOD H, 2007, NEUROMUSCUL DISORD; Matsumoto H, 2004, J BIOCHEM, V135, P709, DOI 10.1093/jb/mvh086; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Saito T, 2002, J BIOL CHEM, V277, P17002, DOI 10.1074/jbc.M200521200; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Straub Volker, 2006, Semin Pediatr Neurol, V13, P104, DOI 10.1016/j.spen.2006.06.006; Torelli S, 2005, NEUROMUSCULAR DISORD, V15, P836, DOI 10.1016/j.nmd.2005.09.004; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200	30	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16713	16717		10.1074/jbc.C700061200	http://dx.doi.org/10.1074/jbc.C700061200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17452335	hybrid, Green Submitted			2022-12-27	WOS:000246946500002
J	Sitachitta, N; Lopanik, NB; Mao, Y; Sherman, DH				Sitachitta, Namthip; Lopanik, Nicole B.; Mao, Yingqing; Sherman, David H.			Analysis of a parallel branch in the mitomycin biosynthetic pathway involving the mitN-encoded aziridine N-methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYCOLATOPSIS-MEDITERRANEI S699; GENE-CLUSTER; STREPTOMYCES-VERTICILLATUS; O-METHYLTRANSFERASE; MOLECULAR ANALYSIS; KINETIC MECHANISM; ESCHERICHIA-COLI; PURIFICATION; INDOLOCARBAZOLE; ANTIBIOTICS	Mitomycin C is a natural product with potent alkylating activity, and it is an important anticancer drug and antibiotic. mitN, one of three genes with high similarity to methyltransferases, is located within the mitomycin biosynthetic gene cluster. An inframe deletion in mitN of the mitomycin biosynthetic pathway was generated in Streptomyces lavendulae to produce the DHS5373 mutant strain. Investigation of DHS5373 revealed continued production of mitomycin A and mitomycin C in addition to the accumulation of a new mitomycin analog, 9-epi-mitomycin C. The mitN gene was overexpressed in Escherichia coli, and the histidine-tagged protein (MitN) was purified to homogeneity. Reaction of 9-epi-mitomycin C with MitN in the presence of S-adenosylmethionine yielded mitomycin E showing that the enzyme functions as an aziridine N-methyltransferase. Likewise, MitN was also shown to convert mitomycin A to mitomycin F under the same reaction conditions. We conclude that MitN plays an important role in a parallel biosynthetic pathway leading to the subclass of mitomycins with 9 alpha-stereochemistry but is not involved directly in the biosynthesis of mitomycins A and C.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Minnesota, Microbiol & Biotechnol Inst, Minneapolis, MN 55455 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities	Sherman, DH (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	davidhs@lsi.umich.edu			NATIONAL CANCER INSTITUTE [R01CA081172, F32CA110636] Funding Source: NIH RePORTER; NCI NIH HHS [5F32CA110636, CA/GM81172] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; ANDERSON MG, 1980, J CHEM SOC CHEM COMM, P1277, DOI 10.1039/c39800001277; August PR, 1998, CHEM BIOL, V5, P69, DOI 10.1016/S1074-5521(98)90141-7; BALTZ RH, 1980, DEV IND MICROBIOL, V21, P43; BAUER NJ, 1988, J BIOL CHEM, V263, P15619; BEZANSON GS, 1971, CAN J BIOCHEM CELL B, V49, P911, DOI 10.1139/o71-131; Bradner WT, 2001, CANCER TREAT REV, V27, P35, DOI 10.1053/ctrv.2000.0202; CARTER SK, 1979, MITOMYCIN C CURRENT; DENIS F, 1992, GENE, V111, P115, DOI 10.1016/0378-1119(92)90611-R; Dhar K, 2000, APPL ENVIRON MICROB, V66, P4877, DOI 10.1128/AEM.66.11.4877-4882.2000; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; Gruschow S, 2007, J AM CHEM SOC, V129, P6470, DOI 10.1021/ja0700193; HATA T, 1956, J ANTIBIOT, V9, P141; Hong YS, 2001, BIOTECHNOL LETT, V23, P1765, DOI 10.1023/A:1012496317299; HORNEMAN.U, 1974, J AM CHEM SOC, V96, P320, DOI 10.1021/ja00808a087; HORNEMANN U, 1975, J ANTIBIOT, V28, P841, DOI 10.7164/antibiotics.28.841; HORNEMANN U, 1985, J ORG CHEM, V50, P1301, DOI 10.1021/jo00208a031; Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509; KASAI M, 1995, EXPERT OPIN THER PAT, V5, P757; KONO M, 1990, J ANTIBIOT, V43, P383, DOI 10.7164/antibiotics.43.383; KREUZMAN AJ, 1988, J BIOL CHEM, V263, P15626; LACALLE RA, 1991, GENE, V109, P55, DOI 10.1016/0378-1119(91)90588-3; Lavid N, 2002, PLANT PHYSIOL, V129, P1899, DOI 10.1104/pp.005330; LEFEMINE DV, 1962, J AM CHEM SOC, V84, P3184, DOI 10.1021/ja00875a031; MAO Y, 2000, THESIS U MINNESOTA M, P191; Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4; Mao YQ, 1999, J BACTERIOL, V181, P2199, DOI 10.1128/JB.181.7.2199-2208.1999; MAZODIER P, 1989, J BACTERIOL, V171, P3583, DOI 10.1128/jb.171.6.3583-3585.1989; Meyers CLF, 2004, ANGEW CHEM INT EDIT, V43, P67, DOI 10.1002/anie.200352626; MORTON GO, 1970, J AM CHEM SOC, V92, P2588, DOI 10.1021/ja00711a085; NISHIKOHRI K, 1975, EUR J APPL MICROBIOL, V2, P129; Nishizawa T, 2005, J BACTERIOL, V187, P2084, DOI 10.1128/JB.187.6.2084-2092.2005; Oliynyk M, 2003, MOL MICROBIOL, V49, P1179, DOI 10.1046/j.1365-2958.2003.03571.x; Pacholec M, 2005, BIOCHEMISTRY-US, V44, P14969, DOI 10.1021/bi051599o; SHAFIEE A, 1994, EUR J BIOCHEM, V225, P755, DOI 10.1111/j.1432-1033.1994.00755.x; Spanswick VJ, 1998, GEN PHARMACOL-VASC S, V31, P539, DOI 10.1016/S0306-3623(98)00055-X; TOMASZ M, 1995, CHEM BIOL, V2, P575, DOI 10.1016/1074-5521(95)90120-5; Varoglu M, 2001, J AM CHEM SOC, V123, P6712, DOI 10.1021/ja015646l; Verweij J, 1990, Cancer Chemother Biol Response Modif, V11, P67; WAKAKI S., 1958, ANTIBIOT AND CHEMOTHER, V8, P228; Wang JH, 1999, ARCH BIOCHEM BIOPHYS, V368, P172, DOI 10.1006/abbi.1999.1304; Xu J, 2003, ARCH BIOCHEM BIOPHYS, V411, P277, DOI 10.1016/S0003-9861(03)00004-3; Zhang C, 2006, CHEMBIOCHEM, V7, P795, DOI 10.1002/cbic.200500504	43	13	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20941	20947		10.1074/jbc.M702456200	http://dx.doi.org/10.1074/jbc.M702456200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17507379	hybrid			2022-12-27	WOS:000248047500020
J	Galloux, M; Libersou, S; Morellet, N; Bouaziz, S; Da Costa, B; Ouldali, M; Lepault, J; Delmas, B				Galloux, Marie; Libersou, Sonia; Morellet, Nelly; Bouaziz, Serge; Da Costa, Bruno; Ouldali, Malika; Lepault, Jean; Delmas, Bernard			Infectious bursal disease virus, a non-enveloped virus, possesses a capsid-associated peptide that deforms and perforates biological membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; MATURATION PROCESS; PROTEIN VP3; REOVIRUS; POLYMORPHISM; MICROSCOPY; PARTICLES; PH	Double-stranded RNA (dsRNA) virions constitute transcriptionally competent machines that must translocate across cell membranes to function within the cytoplasm. The entry mechanism of such non-enveloped viruses is not well described. Birnaviruses are unique among dsRNA viruses because they possess a single shell competent for entry. We hereby report how infectious bursal disease virus, an avian birnavirus, can disrupt cell membranes and enter into its target cells. One of its four structural peptides, pep46 (a 46-amino acid amphiphilic peptide) deforms synthetic membranes and induces pores visualized by electron cryomicroscopy, having a diameter of less than 10 nm. Using both biological and synthetic membranes, the pore-forming domain of pep46 was identified as its N terminus moiety (pep22). The N and C termini of pep22 are shown to be accessible during membrane destabilization and pore formation. NMR studies show that pep46 inserted into micelles displays a cis-trans proline isomerization at position 16 that we propose to be associated to the pore formation process. Reverse genetic experiments confirm that the amphiphilicity and proline isomerization of pep46 are both essential to the viral cycle. Furthermore, we show that virus infectivity and its membrane activity ( probably because of the release of pep46 from virions) are controlled differently by calcium concentration, suggesting that entry is performed in two steps, endocytosis followed by endosome permeabilization. Our findings reveal a possible entry pathway of infectious bursal disease virus: in endosomes containing viruses, the lowering of the calcium concentration promotes the release of pep46 that induces the formation of pores in the endosomal membrane.	INRA, Unite Virol Immunol Mol, UR892, F-78350 Jouy En Josas, France; CNRS, INRA, IFR 115, Lab Virol Mol Struct,UMR 2472,UMR 1157, F-91198 Gif Sur Yvette, France; CNRS, INSERM, Unite Pharmacol Chim Genet, U640,UMR 8151, F-75006 Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lepault, J (corresponding author), INRA, Unite Virol Immunol Mol, UR892, F-78350 Jouy En Josas, France.	jean.lepault@vms.cnrs-gif.fr; bernard.delmas@jouy.inra.fr	Lepault, Jean/AAN-8859-2020; Bouaziz, Serge/ABA-8712-2020; bouaziz, serge/C-1401-2014; Ouldali, Malika/AAN-7157-2020	Bouaziz, Serge/0000-0001-7792-8307; morellet, nelly/0000-0001-5076-8884; Ouldali, Malika/0000-0002-7601-6397				ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Agosto MA, 2006, P NATL ACAD SCI USA, V103, P16496, DOI 10.1073/pnas.0605835103; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bong DT, 1999, CHEM BIOL, V6, P473, DOI 10.1016/S1074-5521(99)80065-9; Bottcher B, 1997, J VIROL, V71, P325; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bubeck D, 2005, NAT STRUCT MOL BIOL, V12, P615, DOI 10.1038/nsmb955; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chandran K, 2003, TRENDS MICROBIOL, V11, P374, DOI 10.1016/S0966-842X(03)00178-1; Chevalier C, 2005, J VIROL, V79, P12253, DOI 10.1128/JVI.79.19.12253-12263.2005; Chevalier C, 2002, J VIROL, V76, P2384, DOI 10.1128/JVI.76.5.2384-2392.2002; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; DELMAS B, 2005, BIRNAVIRIDAE; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Gerasimenko O, 2005, CELL CALCIUM, V38, P201, DOI 10.1016/j.ceca.2005.06.025; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Janshoff A, 1999, BIOCHEMISTRY-US, V38, P5328, DOI 10.1021/bi982976i; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; LUZZATI V, 1968, NATURE, V217, P1028, DOI 10.1038/2171028a0; Maia LF, 2006, J BIOL CHEM, V281, P29278, DOI 10.1074/jbc.M604689200; NANDI P, 1992, J VIROL, V66, P3363, DOI 10.1128/JVI.66.6.3363-3367.1992; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pous J, 2005, J GEN VIROL, V86, P2339, DOI 10.1099/vir.0.80942-0; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Tacken MGJ, 2002, J VIROL, V76, P11301, DOI 10.1128/JVI.76.22.11301-11311.2002; WERY JP, 1994, J MOL BIOL, V235, P565, DOI 10.1006/jmbi.1994.1014; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Zhang L, 2006, J VIROL, V80, P12367, DOI 10.1128/JVI.01343-06	35	53	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20774	20784		10.1074/jbc.M701048200	http://dx.doi.org/10.1074/jbc.M701048200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17488723	hybrid, Green Published			2022-12-27	WOS:000247819300079
J	Stahelin, RV; Subramanian, P; Vora, M; Cho, W; Chalfant, CE				Stahelin, Robert V.; Subramanian, Preeti; Vora, Mohsin; Cho, Wonhwa; Chalfant, Charles E.			Ceramide-1-phosphate binds group IVA cytosolic phospholipase a(2) via a novel site in the C2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MEMBRANE-BINDING; CERAMIDE 1-PHOSPHATE; CATALYTIC DOMAIN; KINETIC-ANALYSIS; C-2 DOMAINS; CELL-LINE; ACTIVATION; ALPHA; CA2+	Previously, ceramide-1-phosphate (C1P) was demonstrated to be a potent and specific activator of group IV cytosolic phospholipase A(2)alpha (cPLA(2)alpha) via interaction with the C2 domain. In this study, we hypothesized that the specific interaction site for C1P was localized to the cationic beta-groove (Arg(57), Lys(58), Arg(59)) of the C2 domain of cPLA(2)alpha. In this regard, mutants of this region of cPLA(2)alpha were generated (R57A/K58A/R59A, R57A/R59A, K58A/R59A, R57A/K58A, R57A, K58A, and R59A) and examined for C1P affinity by surface plasmon resonance. The triple mutants (R57A/K58A/R59A), the double mutants (R57A/R59A, K58A/R59A, and R57A/K58A), and the single mutant ( R59A) demonstrated significantly reduced affinity for C1P-containing vesicles as compared with wild-type cPLA(2)alpha. Examining these mutants for enzymatic activity demonstrated that these five mutants of cPLA(2)alpha also showed a significant reduction in the ability of C1P to: 1) increase the V-max of the reaction; and 2) significantly decrease the dissociation constant (K-s(A)) of the reaction as compared with the wild-type enzyme. The mutational effect was specific for C1P as all of the cationic mutants of cPLA(2)alpha demonstrated normal basal activity as well as normal affinities for phosphatidylcholine and phosphatidylinositol-4,5-bisphosphate as compared with wild-type cPLA(2)alpha. This study, for the first time, demonstrates a novel C1P interaction site mapped to the cationic beta-groove of the C2 domain of cPLA(2)alpha.	Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Coll Med, Dept Biochem, Richmond, VA 23298 USA; Univ Illinois, Dept Biochem, Chicago, IL 60607 USA; Indiana Univ, Sch Med, Dept Biochem Mol Biol, South Bend, IN USA; Univ Notre Dame, Walther Ctr Canc Res, Dept Chem & Biochem, South Bend, IN 46617 USA; Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Indiana University System; Indiana University South Bend; University of Notre Dame; Walther Cancer Institute; Hunter Holmes McGuire Veterinary Affairs Medical Center	Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Dept Biochem, 1101 E Marshall St, PO Box 980614, Richmond, VA 23298 USA.	cechalfant@vcu.edu	Stahelin, Robert/L-3567-2019	, Preeti/0000-0002-6062-6158; Stahelin, Robert/0000-0001-5443-7863	NCI NIH HHS [1CO6 RR 17393, CA 117950] Funding Source: Medline; NHLBI NIH HHS [HL 072925] Funding Source: Medline; NIGMS NIH HHS [GM 68849, GM 52598, GM 53987] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA117950] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053987, R01GM068849, R01GM052598] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; BYUN HS, 1994, J ORG CHEM, V59, P6495, DOI 10.1021/jo00100a069; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5734; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5740; Jaud S, 2007, BIOPHYS J, V92, P517, DOI 10.1529/biophysj.106.090704; KATES M, 1986, TECHNIQUES LIPIDOLOG, V3, P114; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; MOREIRA LF, 1995, ANTICANCER RES, V15, P639; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; REYNOLDS LJ, 1993, BIOCHIM BIOPHYS ACTA, V1167, P272, DOI 10.1016/0005-2760(93)90229-3; ROBERTS MF, 1977, P NATL ACAD SCI USA, V74, P1950, DOI 10.1073/pnas.74.5.1950; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; SHARP JD, 1991, J BIOL CHEM, V266, P14850; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; ULEVITCH RJ, 1988, J BIOL CHEM, V263, P3079; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329	49	95	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20467	20474		10.1074/jbc.M701396200	http://dx.doi.org/10.1074/jbc.M701396200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17472963	hybrid			2022-12-27	WOS:000247819300049
J	Watanabe, H; Shionyu, M; Kimura, T; Kimata, K; Watanabe, H				Watanabe, Hiroki; Shionyu, Masafumi; Kimura, Tomoatsu; Kimata, Koji; Watanabe, Hideto			Splicing factor 3b subunit 4 binds BMPR-IA and inhibits osteochondral cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEINS; SPLICEOSOME-ASSOCIATED PROTEIN; ATDC5 CELLS; RECEPTOR; IDENTIFICATION; CHONDROGENESIS; DEGRADATION; SMAD2; P38	Bone morphogenetic protein (BMP)-2/4 play critical roles in early embryogenesis and skeletal development. BMP-2/4 signals conduct into cells via two types of serine/threonine kinase receptors, known as BMPR-I (IA and IB) and BMPR-II. Here we identified splicing factor 3b subunit 4 (SF3b4) as a molecule that interacts with BMPR-IA, using a yeast two-hybrid screening with a human fetal brain cDNA library. Co-immunoprecipitation/ immunoblot analysis confirmed their interaction in mammalian cells. By separation of the cell components, SF3b4 was present in the cell membrane fraction with BMPR-IA as well as in the nucleus. Overexpression of SF3b4 inhibited BMP-2-mediated osteogenic and chondrocytic differentiation of C2C12 and ATDC5 cells, respectively, and the endogenous expression level of SF3b4 decreased during differentiation in ATDC5 cells. By reporter gene assay, SF3b4 suppressed Id reporter gene activity, specific to the Smad1/5/8 pathway, but not TGF beta-mediated reporter gene activity. Biotin labeling of the cell surface proteins followed by their immunoblot revealed that SF3b4 decreased the cell surface BMPRI-A levels. Further analysis by molecular modeling of the intracellular domain of BMPR-IA, coupled with binding studies of its several mutants, indicated that the site(s) for SF3b4 binding is not directly associated with the C-terminal lobe and the activation segment. Taken together, these results suggest that SF3b4, known to be localized in the nucleus and involved in RNA splicing, binds BMPR-IA and specifically inhibits BMP-mediated osteochondral cell differentiation.	Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama 9300194, Japan; Nagahama Inst Biosci & Technol, Fac Biosci, Shiga 5260829, Japan	Aichi Medical University; University of Toyama	Watanabe, H (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp		Shionyu, Masafumi/0000-0002-0431-3456; Watanabe, Hideto/0000-0001-5291-0696				Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; Charng MJ, 1998, J BIOL CHEM, V273, P9365, DOI 10.1074/jbc.273.16.9365; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Imoto S, 2003, J BIOL CHEM, V278, P34253, DOI 10.1074/jbc.M304961200; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Kurozumi K, 1998, GENES CELLS, V3, P257, DOI 10.1046/j.1365-2443.1998.00186.x; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nishanian TG, 2004, BIOCHEM BIOPH RES CO, V323, P91, DOI 10.1016/j.bbrc.2004.08.060; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; RuizLozano P, 1997, DEV DYNAM, V208, P482, DOI 10.1002/(SICI)1097-0177(199704)208:4<482::AID-AJA4>3.0.CO;2-E; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; WAN M, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI DOI 10.1016/J.BBRC.2004.11.067; Warner DR, 2003, FEBS LETT, V539, P167, DOI 10.1016/S0014-5793(03)00155-8; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009	40	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20728	20738		10.1074/jbc.M703292200	http://dx.doi.org/10.1074/jbc.M703292200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17513295	hybrid			2022-12-27	WOS:000247819300075
J	Zoudilova, M; Kumar, P; Ge, L; Wang, P; Bokoch, GM; Defea, KA				Zoudilova, Maria; Kumar, Puneet; Ge, Lan; Wang, Ping; Bokoch, Gary M.; Defea, Kathryn A.			beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ACTIN DYNAMICS; PHOSPHATIDYLINOSITOL 3-KINASE; PARACELLULAR PERMEABILITY; FILAMENT TURNOVER; MAPK ACTIVATION; FACTOR VIIA; LIM-KINASE; ADF/COFILIN; BETA-ARRESTIN-1	beta-Arrestins are pleiotropic molecules that mediate signal desensitization, G-protein-independent signaling, scaffolding of signaling molecules, and chemotaxis. Protease-activated receptor-2 (PAR-2), a G alpha(q/11)-coupled receptor, which has been proposed as a therapeutic target for inflammation and cancer, requires the scaffolding function of beta-arrestins for chemotaxis. We hypothesized that PAR-2 can trigger specific responses by differential activation of two pathways, one through classic G alpha(q)/Ca2+ signaling and one through beta-arrestins, and we proposed that the latter involves scaffolding of proteins involved in cell migration and actin assembly. Here we demonstrate the following. (a) PAR-2 promotes beta-arrestin-dependent dephosphorylation and activation of the actin filament-severing protein (cofilin) independently of G alpha(q)/Ca2+ signaling. (b) PAR-2-evoked cofilin dephosphorylation requires both the activity of a recently identified cofilin-specific phosphatase (chronophin) and inhibition of LIM kinase ( LIMK) activity. ( c) beta-Arrestins can interact with cofilin, LIMK, and chronophin and colocalize with them in membrane protrusions, suggesting that beta-arrestins may spatially regulate their activities. These findings identify cofilin as a novel target of beta-arrestin-dependent scaffolding and suggest that many PAR-2-induced processes may be independent of G alpha(q/11)-protein coupling.	Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Scripps Research Institute	Defea, KA (corresponding author), Univ Calif Riverside, Div Biomed Sci, B605 Stat Rd, Riverside, CA 92521 USA.	kathryn.defea@ucr.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044428, R01GM066151] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 066151, R01 GM 44428, R01 GM066151-04, R01 GM066151] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Al-Ani B, 2002, J PHARMACOL EXP THER, V300, P702, DOI 10.1124/jpet.300.2.702; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bernstein BW, 2000, CELL MOTIL CYTOSKEL, V47, P319, DOI 10.1002/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Bolton SJ, 2003, J LEUKOCYTE BIOL, V74, P60, DOI 10.1189/jlb.0702351; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Chambers LS, 2001, AM J PHYSIOL-LUNG C, V281, pL1369, DOI 10.1152/ajplung.2001.281.6.L1369; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Condeelis JS, 2001, SEMIN CANCER BIOL, V11, P119, DOI 10.1006/scbi.2000.0363; COOPER J A, 1992, P47; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; CRAMER LP, 1994, CURR OPIN CELL BIOL, V6, P82, DOI 10.1016/0955-0674(94)90120-1; Cuffe JE, 2002, J PHYSIOL-LONDON, V539, P209, DOI 10.1113/jphysiol.2001.013159; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Hunt RA, 1999, HYPERTENSION, V34, P603, DOI 10.1161/01.HYP.34.4.603; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KUMAR P, 2007, IN PRESS AM J PHYSL; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; Miki Mari, 2003, Journal of Medical Investigation, V50, P95; Moffatt JD, 2002, AM J RESP CELL MOL, V26, P680, DOI 10.1165/ajrcmb.26.6.4693; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; MUKAI H, 1992, J BIOL CHEM, V267, P16237; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Wang P, 2006, BIOCHEMISTRY-US, V45, P9374, DOI 10.1021/bi0602617; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100	65	113	118	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20634	20646		10.1074/jbc.M701391200	http://dx.doi.org/10.1074/jbc.M701391200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17500066	hybrid			2022-12-27	WOS:000247819300066
J	Bekker-Jensen, S; Fugger, K; Danielsen, JR; Gromova, I; Sehested, M; Celis, J; Bartek, J; Lukas, J; Mailand, N				Bekker-Jensen, Simon; Fugger, Kasper; Danielsen, Jannie Rendtlew; Gromova, Irina; Sehested, Maxwell; Celis, Julio; Bartek, Jiri; Lukas, Jiri; Mailand, Niels			Human Xip1 (C2orf13) is a novel regulator of cellular responses to DNA strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FHA DOMAIN; POLYMERASE-BETA; REPAIR; XRCC1; DAMAGE; POLY(ADP-RIBOSE); CHECKPOINTS; RECOGNITION; MECHANISMS; RETENTION	DNA strand breaks arise continuously as the result of intracellular metabolism and in response to a multitude of genotoxic agents. To overcome such challenges to genomic stability, cells have evolved genome surveillance pathways that detect and repair damaged DNA in a coordinated fashion. Here we identify the previously uncharacterized human protein Xip1 (C2orf13) as a novel component of the checkpoint response to DNA strand breaks. Green fluorescent protein-tagged Xip1 was rapidly recruited to sites of DNA breaks, and this accumulation was dependent on a novel type of zinc finger motif located in the C terminus of Xip1. The initial recruitment kinetics of Xip1 closely paralleled that of XRCC1, a central organizer of single strand break (SSB) repair, and its accumulation was both delayed and sustained when the detection of SSBs was abrogated by inhibition of PARP-1. Xip1 and XRCC1 stably interacted through recognition of CK2 phosphorylation sites in XRCC1 by the Forkhead-associated (FHA) domain of Xip1, and XRCC1 was required to maintain steady-state levels of Xip1. Moreover, Xip1 was phosphorylated on Ser-116 by ataxia telangiectasia-mutated in response to ionizing radiation, further underscoring the potential importance of Xip1 in the DNA damage response. Finally, depletion of Xip1 significantly decreased the clonogenic survival of cells exposed to DNA SSB- or double strand break-inducing agents. Collectively, these findings implicate Xip1 as a new regulator of genome maintenance pathways, which may function to organize DNA strand break repair complexes at sites of DNA damage.	Inst Canc Biol, Ctr Genotox Stress Res, Danish Canc Soc, DK-2100 Copenhagen, Denmark; Inst Canc Biol, Dept Proteom Canc, Danish Canc Soc, DK-2100 Copenhagen, Denmark; Univ Hosp, Dept Pathol, DK-2100 Copenhagen, Denmark	Danish Cancer Society; Danish Cancer Society	Lukas, J (corresponding author), Inst Canc Biol, Ctr Genotox Stress Res, Danish Canc Soc, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jil@cancer.dk	Fugger, Kasper/J-1231-2014; Bartek, Jiri/G-5870-2014	Fugger, Kasper/0000-0001-9811-3983; Lukas, Jiri/0000-0001-9087-506X; Bekker-Jensen, Simon/0000-0002-7308-4597; Gromova, Irina/0000-0003-4357-5958				Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Brem R, 2005, NUCLEIC ACIDS RES, V33, P2512, DOI 10.1093/nar/gki543; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2004, DNA REPAIR, V3, P875, DOI 10.1016/j.dnarep.2004.04.011; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	21	62	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19638	19643		10.1074/jbc.C700060200	http://dx.doi.org/10.1074/jbc.C700060200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17507382	hybrid			2022-12-27	WOS:000247650600038
J	Reyes-Moreno, C; Sharif-Askari, E; Girouard, J; Leveille, C; Jundi, M; Akoum, A; Lapointe, R; Darveau, A; Mourad, W				Reyes-Moreno, Carlos; Sharif-Askari, Ehssan; Girouard, Julie; Leveille, Claire; Jundi, Malek; Akoum, Ali; Lapointe, Rejean; Darveau, Andre; Mourad, Walid			Requirement of oxidation-dependent CD40 homodimers for CD154/CD40 bidirectional signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN B-CELL; LIPID-RAFTS; DENDRITIC CELLS; MEMBRANE RAFTS; RECEPTOR; LIGAND; DOMAIN; CYSTEINE; TRANSLOCATION; STIMULATION	It is well established that the CD154/CD40 interaction is required for T cell-dependent B cell differentiation and maturation. However, the early molecular and structural mechanisms that orchestrate CD154 and CD40 signaling at the T cell/APC contact site are not well understood. We demonstrated that CD40 engagement induces the formation of disulfide-linked (dl) CD40 homodimers that predominantly associate with detergentresistant membrane microdomains. Mutagenesis and biochemical analyses revealed that (a) the integrity of the detergentresistant membranes is necessary for dl-CD40 homodimer formation, (b) the cytoplasmic Cys238 of CD40 is the target for the de novo disulfide oxidation induced by receptor oligomerization, and (c) dl-CD40 homodimer formation is required for CD40-induced interleukin-8 secretion. Stimulation of CD154-positive T cells with staphylococcal enterotoxin E superantigen that mimics nominal antigen in initiating cognate T cell/APC interaction revealed that dl- CD40 homodimer formation is required for interleukin- 2 production by T cells. These findings indicate that dl-CD40 homodimer formation has a physiological role in regulating bidirectional signaling.	Univ Laval, Ctr Hosp, Ctr Rech & Rheumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; Univ Montreal, Hop St Luc, Ctr Hosp, Lab Immunol Cellular & Mol, Montreal, PQ H2X 1P1, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Quebec Trois Rivieres, Dept Biol Chem, Trois Rivieres, PQ G9A 5H7, Canada; Univ Laval, Ctr Rech & Endocrinol Reprod, Quebec City, PQ G1V 4G2, Canada; Univ Montreal, Hop Notre Dame de Bon Secours, Ctr Hosp, Montreal, PQ H2L 4M1, Canada; Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ G1V 4G2, Canada	Laval University; Universite de Montreal; Universite de Montreal; University of Quebec; University of Quebec Trois Rivieres; Laval University; Universite de Montreal; Laval University	Mourad, W (corresponding author), Univ Montreal, Ctr Hosp, Ctr Rech, 264 Blvd Rene Levesque Est, Montreal, PQ H2X 1P1, Canada.	MW.Mourad@umontreal.ca		Mourad, Walid/0000-0002-1859-9387				Akoum A, 2001, MOL HUM REPROD, V7, P859, DOI 10.1093/molehr/7.9.859; Bajorath J, 1997, PROTEINS, V27, P59; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bouillon M, 2003, J BIOL CHEM, V278, P7099, DOI 10.1074/jbc.M211566200; BRAESCHANDERSEN S, 1989, J IMMUNOL, V142, P562; Brenner B, 1997, FEBS LETT, V417, P301, DOI 10.1016/S0014-5793(97)01306-9; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Cheng PC, 2001, J IMMUNOL, V166, P3693, DOI 10.4049/jimmunol.166.6.3693; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Ellmark P, 2003, IMMUNOLOGY, V108, P452, DOI 10.1046/j.1365-2567.2003.01622.x; Eren E, 2006, SCAND J IMMUNOL, V63, P7, DOI 10.1111/j.1365-3083.2006.01700.x; Girouard J, 2005, MOL IMMUNOL, V42, P773, DOI 10.1016/j.molimm.2004.07.048; Giurisato E, 2003, J BIOL CHEM, V278, P6771, DOI 10.1074/jbc.M210758200; Grammer A C, 2000, Adv Immunol, V76, P61; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; GRAZIOLI L, 1994, J BIOL CHEM, V269, P22304; Jones MD, 1997, BIOCHEMISTRY-US, V36, P14914, DOI 10.1021/bi971696k; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kovacs B, 2005, J IMMUNOL, V175, P7848, DOI 10.4049/jimmunol.175.12.7848; KRONING H, 1991, HYBRIDOMA, V10, P651, DOI 10.1089/hyb.1991.10.651; Lee JR, 2003, MOL CELL BIOCHEM, V252, P1, DOI 10.1023/A:1025529704480; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Reyes-Moreno C, 2004, J BIOL CHEM, V279, P7799, DOI 10.1074/jbc.M313168200; Sadra A, 2004, P NATL ACAD SCI USA, V101, P11422, DOI 10.1073/pnas.0403792101; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Stadtman ER, 2002, HUM EXP TOXICOL, V21, P83, DOI 10.1191/0960327102ht215oa; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Wollman EE, 1997, BIOCHEM BIOPH RES CO, V230, P602, DOI 10.1006/bbrc.1996.6015; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; YELLIN MJ, 1991, J IMMUNOL, V147, P3389; Zeyda M, 2006, PROG LIPID RES, V45, P187, DOI 10.1016/j.plipres.2006.01.002	37	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19473	19480		10.1074/jbc.M701076200	http://dx.doi.org/10.1074/jbc.M701076200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17504764	hybrid			2022-12-27	WOS:000247650600021
J	Sal-Man, N; Gerber, D; Bloch, I; Shai, Y				Sal-Man, Neta; Gerber, Doron; Bloch, Itai; Shai, Yechiel			Specificity in transmembrane helix-helix interactions mediated by aromatic residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMERIZATION MOTIF; MEMBRANE-PROTEINS; ALPHA-HELICES; DRIVE ASSOCIATION; AMINO-ACIDS; GXXXG MOTIF; PI-STACKING; IN-VIVO; MODEL; OLIGOMERIZATION	Aromatic residues have been previously shown to mediate the self-assembly of different soluble proteins through pi-pi interactions ( McGaughey, G. B., Gagne, M., and Rappe, A. K. ( 1998) J. Biol. Chem. 273, 15458-15463). However, their role in transmembrane (TM) assembly is not yet clear. In this study, we performed statistical analysis of the frequency of occurrence of aromatic pairs in a bacterial TM data base that provided an initial indication that the appearance of a specific aromatic pattern, Aromatic-XX-Aromatic, is not coincidental, similar to the well characterized QXXS motif. The QXXS motif was previously shown to be both critical and sufficient for stabilizing TM self-assembly. Using the ToxR system, we monitored the dimerization propensities of TM domains that contain mutations of interacting residues to aromatic amino acids and demonstrated that aromatic residues can adequately stabilize self-association. Importantly, we have provided an example of a natural TM domain, the cholera toxin secretion protein EpsM, whose TM self-assembly is mediated by an aromatic motif (WXXW). This is, in fact, the first evidence that aromatic residues are involved in the dimerization of a wild type TM domain. The association mediated by aromatic residues was found to be sensitive to the TM sequence, suggesting that aromatic residue motifs can provide a general means for specificity in TM assembly. Molecular dynamics provided a structural explanation for this backbone sequence sensitivity.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Yechiel.Shai@weizmann.ac.il		Sal-Man, Neta/0000-0002-1109-479X				Abendroth J, 2004, J MOL BIOL, V338, P585, DOI 10.1016/j.jmb.2004.01.064; Arkin IT, 2002, BBA-BIOMEMBRANES, V1565, P347, DOI 10.1016/S0005-2736(02)00580-1; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; Brosig B, 1998, PROTEIN SCI, V7, P1052; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Findeis MA, 1999, BIOCHEMISTRY-US, V38, P6791, DOI 10.1021/bi982824n; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gouldson PR, 2000, NEUROPSYCHOPHARMACOL, V23, pS60, DOI 10.1016/S0893-133X(00)00153-6; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KOLMAR H, 1994, BIOL CHEM H-S, V375, P61; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Li R, 2004, BIOCHEM SOC T, V32, P412, DOI 10.1042/BST0320412; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sal-Man N, 2005, J BIOL CHEM, V280, P27449, DOI 10.1074/jbc.M503095200; Sal-Man N, 2004, BIOCHEMISTRY-US, V43, P2309, DOI 10.1021/bi0356294; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Sun S, 1996, J PHYS CHEM-US, V100, P13348, DOI 10.1021/jp960739o; Tsang S, 1996, J COMPUT BIOL, V3, P185, DOI 10.1089/cmb.1996.3.185; von Heijne G, 1999, Q REV BIOPHYS, V32, P285, DOI 10.1017/S0033583500003541; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	33	91	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19753	19761		10.1074/jbc.M610368200	http://dx.doi.org/10.1074/jbc.M610368200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488729	hybrid			2022-12-27	WOS:000247650600050
J	Veiga, P; Bulbarela-Sampieri, C; Furlan, S; Maisons, A; Chapot-Chartier, MP; Erkelenz, M; Mervelet, P; Noirot, P; Frees, D; Kuipers, OP; Kok, J; Gruss, A; Buist, G; Kulakauskas, S				Veiga, Patrick; Bulbarela-Sampieri, Carmen; Furlan, Sylviane; Maisons, Aurelie; Chapot-Chartier, Marie-Pierre; Erkelenz, Michael; Mervelet, Peggy; Noirot, Philippe; Frees, Dorte; Kuipers, Oscar P.; Kok, Jan; Gruss, Alexandra; Buist, Girbe; Kulakauskas, Saulius			SpxB regulates O-acetylation-dependent resistance of Lactococcus lactis peptidoglycan to hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; CELL-WALL; N-ACETYLGLUCOSAMINIDASE; STAPHYLOCOCCUS-AUREUS; LYSOZYME-RESISTANCE; BACILLUS-SUBTILIS; STRESS TOLERANCE; GENE-EXPRESSION; IDENTIFICATION; PROTEINS	Endogenous peptidoglycan (PG)-hydrolyzing enzymes, the autolysins, are needed to relax the rigid PG sacculus to allow bacterial cell growth and separation. PGs of pathogens and commensal bacteria may also be degraded by hydrolases of animal origin (lysozymes), which act as antimicrobials. The genetic mechanisms regulating PG resistance to hydrolytic degradation were dissected in the Gram-positive bacterium Lactococcus lactis. We found that the ability of L. lactis to counteract PG hydrolysis depends on the degree of acetylation. Overexpression of PG O-acetylase (encoded by oatA) led to bacterial growth arrest, indicating the potential lethality of oatA and a need for its tight regulation. A novel regulatory factor, SpxB (previously denoted as YneH), exerted a positive effect on oatA expression. Our results indicate that SpxB binding to RNA polymerase constitutes a previously missing link in the multistep response to cell envelope stress, provoked by PG hydrolysis with lysozyme. We suggest that the two-component system CesSR responds to this stress by inducing SpxB, thus favoring its interactions with RNA polymerase. Induction of PGO-acetylation by this cascade renders it resistant to hydrolysis.	INRA, Unit Bacteria Lact & Pathogenes Opportun, F-78352 Jouy En Josas, France; INRA, Unit Biochem Bacteria, F-78352 Jouy En Josas, France; Royal Vet & Agr Univ, Dept Vet Pathobiol, DK-1870 Frederiksberg, Denmark; Univ Groningen, Biomol Sci & Biotechnol Inst, Dept Mol Genet, NL-9751 NN Groningen, Netherlands	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; University of Groningen	Kulakauskas, S (corresponding author), INRA, Unit Bacteria Lact & Pathogenes Opportun, F-78352 Jouy En Josas, France.	saulius.kulakauskas@jouy.inra.fr	Kuipers, Oscar/B-6752-2009; Veiga, Patrick/A-9862-2011; Kok, Jan/C-9972-2012	Kuipers, Oscar/0000-0001-5596-7735; Veiga, Patrick/0000-0001-6318-8547; Frees, Dorte/0000-0003-4946-2890; Gruss, Alexandra/0000-0001-7426-5229; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519				ARTHUR M, 1995, GENE, V54, P87; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BRUMFITT W, 1958, NATURE, V181, P1783, DOI 10.1038/1811783a0; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Duwat P, 1999, MOL MICROBIOL, V31, P845, DOI 10.1046/j.1365-2958.1999.01222.x; Foster S.J., 2002, BACILLUS SUBTILIS IT, P21; Frees D, 2001, MOL MICROBIOL, V41, P93, DOI 10.1046/j.1365-2958.2001.02503.x; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Gaspar P, 2004, APPL ENVIRON MICROB, V70, P1466, DOI 10.1128/AEM.70.3.1466-1474.2004; GASSON MJ, 1983, J BACTERIOL, V154, P1; GOODELL EW, 1987, J BACTERIOL, V169, P3861, DOI 10.1128/jb.169.8.3861-3865.1987; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; Huard C, 2004, APPL ENVIRON MICROB, V70, P3493, DOI 10.1128/AEM.70.6.3493-3499.2004; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; Iwamoto K, 2005, MAR BIOTECHNOL, V7, P407, DOI 10.1007/s10126-005-0029-4; James P, 1996, GENETICS, V144, P1425; Jordan S, 2006, J BACTERIOL, V188, P5153, DOI 10.1128/JB.00310-06; Kets EPW, 1996, J BACTERIOL, V178, P6665, DOI 10.1128/jb.178.23.6665-6670.1996; Kramer NE, 2006, ANTIMICROB AGENTS CH, V50, P1753, DOI 10.1128/AAC.50.5.1753-1761.2006; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Leloup L, 1997, APPL ENVIRON MICROB, V63, P2117, DOI 10.1128/AEM.63.6.2117-2123.1997; Lepeuple AS, 1998, APPL ENVIRON MICROB, V64, P4142; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; Masschalck B, 2003, CRIT REV MICROBIOL, V29, P191, DOI 10.1080/713610448; Matsuhashi M., 1994, BACTERIAL CELL WALL, P55; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Noirot-Gros MF, 2002, MOL GENET GENOMICS, V267, P391, DOI 10.1007/s00438-002-0670-9; O'Connell-Motherway M, 2000, MICROBIOL-SGM, V146, P935, DOI 10.1099/00221287-146-4-935; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Shelburne SA, 2005, P NATL ACAD SCI USA, V102, P16037, DOI 10.1073/pnas.0505839102; Shockman GD, 1996, MICROB DRUG RESIST, V2, P95, DOI 10.1089/mdr.1996.2.95; Shockman GD, 1994, NEW COMPREHENSIVE BI, P131; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Sperandio B, 2005, J BACTERIOL, V187, P3762, DOI 10.1128/JB.187.11.3762-3778.2005; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; TAN PST, 1992, FEBS LETT, V306, P9, DOI 10.1016/0014-5793(92)80827-4; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Telkov MV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P414, DOI 10.1134/S0006297906040092; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	66	81	82	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19342	19354		10.1074/jbc.M611308200	http://dx.doi.org/10.1074/jbc.M611308200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17485463	hybrid			2022-12-27	WOS:000247650600009
J	Lella, RK; Sharma, C				Lella, Ravi K.; Sharma, Charu			Eis (enhanced intracellular survival) protein of Mycobacterium tuberculosis disturbs the cross regulation of T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; IFN-GAMMA; EXPRESSION; HELPER; TRANSCRIPTION; REPLICATION; MACROPHAGES; IMMUNOLOGY; ACTIVATION; INDUCTION	The pathogenesis of tuberculosis is complex and its manifestations diverse, reflecting a lifetime of dynamic interactions between mycobacterial virulence factors and the human immune system. The pathogenic mycobacteria have developed strategies to circumvent the major killing mechanisms employed by macrophages and take advantage of the enclosed environment within its host cell to avoid humoral and cell-mediated immune responses. Secretory proteins play a major role in host-pathogen interactions. The eis (Rv2416c) gene has been identified as a secretory protein, and it has been shown that it enhances intracellular survival of Mycobacterium semgmatis in the macrophage cell line. The main aim of this study was to gain insight into the biological role of Eis in the host. Stimulation of T-cells with Eis recombinant protein of Mycobacterium tuberculosis inhibits Con A-mediated T-cell proliferation in vitro. Treatment of T-cells with Eis inhibits ERK1/2, JAK pathway, and subsequent production of tumor necrosis factor-alpha and interleukin-4. On the contrary, there is increased production of interferon-gamma and interleukin- 10, which indicates that immunity in response to Eis treatment is skewed away from a protective T(H)1 response and Eis disturbs the cross regulation of T-cells.	Cent Drug Res Inst, Drug Target Discovery & Dev Div, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Sharma, C (corresponding author), Cent Drug Res Inst, Drug Target Discovery & Dev Div, Lucknow 226001, Uttar Pradesh, India.	chash71@yahoo.com						Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; BOYUM A, 1968, SCAND J CLIN LAB INV, V21, P97; Cappelli G, 2001, INFECT IMMUN, V69, P7262, DOI 10.1128/IAI.69.12.7262-7270.2001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Dahl JL, 2001, INFECT IMMUN, V69, P4295, DOI 10.1128/IAI.69.7.4295-4302.2001; Demissie A, 2006, INFECT IMMUN, V74, P2817, DOI 10.1128/IAI.74.5.2817-2822.2006; DONNELLY RP, 1995, J IMMUNOL, V155, P1420; FERNANDEZBOTRAN R, 1988, J EXP MED, V168, P543, DOI 10.1084/jem.168.2.543; Fietta AM, 2002, CYTOKINE, V19, P242, DOI 10.1006/cyto.2002.1968; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fonseca DPAJ, 2001, INFECT IMMUN, V69, P4839, DOI 10.1128/IAI.69.8.4839-4845.2001; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; GREENBAUM LA, 1988, J IMMUNOL, V140, P1555; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; Jung SB, 2006, INFECT IMMUN, V74, P2686, DOI 10.1128/IAI.74.5.2686-2696.2006; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; KREMER L, 1995, MOL MICROBIOL, V17, P913, DOI 10.1111/j.1365-2958.1995.mmi_17050913.x; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; ORME IM, 1988, INFECT IMMUN, V56, P3310, DOI 10.1128/IAI.56.12.3310-3312.1988; Parra M, 2006, INFECT IMMUN, V74, P786, DOI 10.1128/IAI.74.1.786-789.2006; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3; Roberts EA, 2004, J BACTERIOL, V186, P5410, DOI 10.1128/JB.186.16.5410-5417.2004; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Song CH, 2003, J CLIN IMMUNOL, V23, P194, DOI 10.1023/A:1023309928879; SWARTZ RP, 1988, INFECT IMMUN, V56, P2223, DOI 10.1128/IAI.56.9.2223-2227.1988; Trajkovic V, 2002, INFECT IMMUN, V70, P6558, DOI 10.1128/IAI.70.12.6558-6566.2002; TRAMONTANA JM, 1995, MOL MED, V1, P384, DOI 10.1007/BF03401576; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000	33	35	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18671	18675		10.1074/jbc.C600280200	http://dx.doi.org/10.1074/jbc.C600280200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17449476	hybrid			2022-12-27	WOS:000247475300004
J	Herschkovitz, A; Liu, YF; Ilan, E; Ronen, D; Boura-Halfon, S; Zick, Y				Herschkovitz, Avia; Liu, Yan-Fang; Ilan, Erez; Ronen, Denise; Boura-Halfon, Sigalit; Zick, Yehiel			RETRACTED: Common inhibitory serine sites phosphorylated by IRS-1 kinases, triggered by insulin and inducers of insulin resistance (Retracted article. See vol. 293, pg. 7266, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							RECEPTOR SUBSTRATE-1 IRS-1; KAPPA-B KINASE; INDUCED TYROSINE PHOSPHORYLATION; SKELETAL-MUSCLE; SERINE/THREONINE PHOSPHORYLATION; JUXTAMEMBRANE REGION; SIGNALING PATHWAYS; PROTEIN; ACTIVATION; CERAMIDE	The Insulin Receptor Substrate (IRS) proteins are key players in insulin signal transduction and are the best studied targets of the insulin receptor. Ser/Thr phosphorylation of IRS proteins negatively modulates insulin signaling; therefore, the identification of IRS kinases and their target Ser phosphorylation sites is of physiological importance. Here we show that in Fao rat hepatoma cells, the I kappa B kinase beta (IKK beta) is an IRS-1 kinase activated by selected inducers of insulin resistance, including sphingomyelinase, ceramide, and free fatty acids. Moreover, IKK beta shares a repertoire of seven potential target sites on IRS-1 with protein kinase C zeta( PKC zeta), an IRS-1 kinase activated both by insulin and by inducers of insulin resistance. We further show that mutation of these seven sites (Ser-265, Ser-302, Ser-325, Ser-336, Ser-358, Ser-407, and Ser-408) confers protection from the action of IKK beta and PKC beta when they are overexpressed in Fao cells or primary hepatocytes. This enables the mutated IRS proteins to better propagate insulin signaling. These findings suggest that insulin-stimulated IRS kinases such as PKC zeta overlap with IRS kinases triggered by inducers of insulin resistance, such as IKK beta, to phosphorylate IRS-1 on common Ser sites.	Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual, Inst Biochem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem	Zick, Y (corresponding author), Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel.	yehiel.zick@weizmann.ac.il	Zick, Yehiel/K-1479-2012					Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Berry MN, 2000, BIOCHEM SOC T, V28, P131, DOI 10.1042/bst0280131; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Delahaye L, 1998, ENDOCRINOLOGY, V139, P4911, DOI 10.1210/en.139.12.4911; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Kanety H, 1996, J BIOL CHEM, V271, P9895, DOI 10.1074/jbc.271.17.9895; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Schmitz-Peiffer C, 2000, CELL SIGNAL, V12, P583, DOI 10.1016/S0898-6568(00)00110-8; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; VOLIOVITCH H, 1995, J BIOL CHEM, V270, P18083, DOI 10.1074/jbc.270.30.18083; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812	35	80	83	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18018	18027		10.1074/jbc.M610949200	http://dx.doi.org/10.1074/jbc.M610949200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17446166	hybrid, Green Published			2022-12-27	WOS:000247302000008
J	Yamashita, T; Yao, ZQ; Li, F; Zhang, Q; Badell, IR; Schwarz, EM; Takeshita, S; Wagner, EF; Noda, M; Matsuo, K; Xing, LP; Boyce, BF				Yamashita, Teruhito; Yao, Zhenqiang; Li, Fang; Zhang, Qian; Badell, I. Raul; Schwarz, Edward M.; Takeshita, Sunao; Wagner, Erwin F.; Noda, Masaki; Matsuo, Koichi; Xing, Lianping; Boyce, Brendan F.			NF-kappa B p50 and p52 regulate receptor activator of NF-kappa B ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; T-CELLS; BONE HOMEOSTASIS; KEY REGULATOR; INFLAMMATORY OSTEOLYSIS; OSTEOPROTEGERIN LIGAND; LYMPHOCYTE DEVELOPMENT; GENE-EXPRESSION; NUCLEAR FACTOR; IN-VITRO	Postmenopausal osteoporosis and rheumatoid joint destruction result from increased osteoclast formation and bone resorption induced by receptor activator of NF-kappa B ligand (RANKL) and tumor necrosis factor (TNF). Osteoclast formation induced by these cytokines requires NF-kappa B p50 and p52, c-Fos, and NFATc1 expression in osteoclast precursors. c-Fos induces NFATc1, but the relationship between NF-kappa B and these other transcription factors in osteoclastogenesis remains poorly understood. We report that RANKL and TNF can induce osteoclast formation directly from NF-kappa B p50/p52 double knockout (dKO) osteoclast precursors when either c-Fos or NFATc1 is expressed. RANKL- or TNF-induced c-Fos up-regulation and activation are abolished in dKO cells and in wild-type cells treated with an NF-kappa B inhibitor. c-Fos expression requires concomitant RANKL or TNF treatment to induce NFATc1 activation in the dKO cells. Furthermore, c-Fos expression increases the number and resorptive capacity of wild-type osteoclasts induced by TNF in vitro. We conclude that NF-kappa B controls early osteoclast differentiation from precursors induced directly by RANKL and TNF, leading to activation of c-Fos followed by NFATc1. Inhibition of NF-kappa B should prevent RANKL- and TNF-induced bone resorption.	Univ Rochester, Med Ctr, Dept Pathol, Lab Med, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; Natl Ctr Geriat & Gerontol, Res Inst, D0pt Bone & Joint Dis, Obu 4748522, Japan; Res Inst Mol Pathol, A-1030 Vienna, Austria; Tokyo Med & Dent Univ, Tokyo 1010062, Japan; Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan	University of Rochester; University of Rochester; National Center for Geriatrics & Gerontology; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Tokyo Medical & Dental University (TMDU); Keio University	Boyce, BF (corresponding author), Dept Pathol, Lab Med, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	Brendan_Boyce@urmc.rochester.edu	Matsuo, Koichi/K-5695-2012	Matsuo, Koichi/0000-0002-1490-8955; Wagner, Erwin F/0000-0001-7872-0196	NIAMS NIH HHS [AR43510, AR48697] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, R01AR048697] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyce BF, 2005, J BONE MINER METAB, V23, P11, DOI 10.1007/BF03026317; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Jimi E, 1996, J BIOL CHEM, V271, P4605; Johnson MR, 2000, ANAL BIOCHEM, V278, P175, DOI 10.1006/abio.1999.4461; Kanazawa K, 2005, J BONE MINER RES, V20, P840, DOI 10.1359/JBMR.041225; Kaplan C, 2003, FRONT BIOSCI-LANDMRK, V8, pD1018, DOI 10.2741/1102; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kong YY, 1999, IMMUNOL CELL BIOL, V77, P188, DOI 10.1046/j.1440-1711.1999.00815.x; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; OKeefe RJ, 1997, LAB INVEST, V76, P457; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; RICH GM, 1992, J HEART LUNG TRANSPL, V11, P950; Sato K, 2006, CURR OPIN RHEUMATOL, V18, P419, DOI 10.1097/01.bor.0000231912.24740.a5; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 2001, Novartis Found Symp, V232, P235; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tanabe N, 2005, LIFE SCI, V77, P615, DOI 10.1016/j.lfs.2004.10.079; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Teitelbaum SL, 2000, J BONE MINER METAB, V18, P344, DOI 10.1007/s007740070007; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Udagawa N, 2002, ARTHRITIS RES, V4, P281, DOI 10.1186/ar431; Urushibara M, 2004, ARTHRITIS RHEUM-US, V50, P794, DOI 10.1002/art.20206; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Xing LP, 2005, CURR RHEUMATOL REV, V1, P21, DOI 10.2174/1573397052954127; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Yamashita T, 2002, J BONE MINER RES, V17, pS131; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zhang YH, 2001, J BIOL CHEM, V276, P563, DOI 10.1074/jbc.M008198200; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212	71	316	332	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18245	18253		10.1074/jbc.M610701200	http://dx.doi.org/10.1074/jbc.M610701200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17485464	hybrid			2022-12-27	WOS:000247302000031
J	Hoshino, A; Hirst, JA; Fujii, H				Hoshino, Akemi; Hirst, John A.; Fujii, Hodaka			Regulation of cell proliferation by interleukin-3-induced nuclear translocation of pyruvate kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; CYTOKINE-INDUCIBLE GENE; SIGNAL-TRANSDUCTION; EXPRESSION; PROTEIN; STAT5; TRANSCRIPTION; RAT; DIFFERENTIATION; ERYTHROPOIETIN	Extracellular signaling molecules bound to cell surface receptors can regulate nuclear function with consequences for cell proliferation, differentiation, and function. To regulate nuclear function, signals must be transduced across the nuclear envelope to propagate the signal from the cytoplasm to the nucleus. Therefore, many signaling responses induce the nuclear translocation of transcription factors, kinases, and others. By using inducible translocation trap, a reporter gene-based system to detect inducible nuclear translocation, we found that the M2 isoform of pyruvate kinase, a key enzyme in glycolysis, translocates into the nucleus by interleukin-3, but not by epidermal growth factor, stimulation. The C domain of the M2 isoform of pyruvate kinase was sufficient for interleukin-3-induced nuclear translocation. Interleukin-3-induced nuclear translocation of the M2 isoform of pyruvate kinase was dependent on the activation of Jak2. Overexpression of the M2 isoform of pyruvate kinase protein fused with a nuclear localization signal enhanced cell proliferation in the absence of interleukin-3, suggesting that the nuclear pyruvate kinase plays an important role in cell proliferation.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University	Fujii, H (corresponding author), NYU, Sch Med, Dept Pathol, 550 1st Ave, New York, NY 10016 USA.	hodaka@med.nyu.edu	Fujii, Hodaka/N-9792-2019; Fujii, Hodaka/A-2420-2008	Fujii, Hodaka/0000-0003-1296-4256; Fujii, Hodaka/0000-0003-1296-4256	NIAID NIH HHS [AI059315] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059315] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AZAM M, 1995, EMBO J, V14, P1402, DOI 10.1002/j.1460-2075.1995.tb07126.x; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; DEL PL, 1997, SCIENCE, V278, P687; Fujii H, 2007, BIOCHEM BIOPH RES CO, V354, P825, DOI 10.1016/j.bbrc.2007.01.067; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Hoshino A, 2004, MOL CELL, V15, P153, DOI 10.1016/j.molcel.2004.06.017; Hoshino A, 2007, FEBS LETT, V581, P975, DOI 10.1016/j.febslet.2007.01.083; Hoshino A, 2006, BIOCHEM BIOPH RES CO, V346, P1062, DOI 10.1016/j.bbrc.2006.06.026; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; IMAMURA K, 1982, METHOD ENZYMOL, V90, P150; IZUMI S, 1995, BBA-MOL CELL RES, V1267, P135, DOI 10.1016/0167-4889(95)00071-Y; LONE YC, 1986, FEBS LETT, V195, P97, DOI 10.1016/0014-5793(86)80138-7; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x; MUIRHEAD H, 1990, BIOCHEM SOC T, V18, P193, DOI 10.1042/bst0180193; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PALLARD C, 1995, J BIOL CHEM, V270, P15942, DOI 10.1074/jbc.270.27.15942; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; TREMP GL, 1989, J BIOL CHEM, V264, P19904; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	32	71	78	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17706	17711		10.1074/jbc.M700094200	http://dx.doi.org/10.1074/jbc.M700094200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17446165	hybrid			2022-12-27	WOS:000247084500043
J	Romero, P; Lopez, R; Garcia, E				Romero, Patricia; Lopez, Rubens; Garcia, Ernesto			Key role of amino acid residues in the dimerization and catalytic activation of the autolysin LytA, an important virulence factor in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINE-BINDING DOMAIN; PNEUMOCOCCAL CELL-WALL; TEICHOIC-ACID; CRYSTAL-STRUCTURE; CHIMERIC LYSIN; GENE; AMIDASE; INSIGHTS; PURIFICATION; EXPRESSION	LytA, the main autolysin of Streptococcus pneumoniae, was the first member of the bacterial N-acetylmuramoyl-L-alanine amidase (NAM-amidase) family of proteins to be well characterized. This autolysin degrades the peptidoglycan bonds of pneumococcal cell walls after anchoring to the choline residues of the cell wall teichoic acids via its choline-binding module (ChBM). The latter is composed of seven repeats (ChBRs) of similar to 20 amino acid residues. The translation product of the lytA gene is the low-activity E-form of LytA (a monomer), which can be "converted" (activated) in vitro by choline into the fully active C-form at low temperature. The C-form is a homodimer with a boomerang-like shape. To study the structural requirements for the monomer-to-dimer modification and to clarify whether "conversion" is synonymous with dimerization, the biochemical consequences of replacing four key amino acid residues of ChBR6 and ChBR7 (the repeats involved in dimer formation) were determined. The results obtained with a collection of 21 mutated NAM-amidases indicate that Ile-315 is a key amino acid residue in both LytA activity and folding. Amino acids with a marginal position in the solenoid structure of the ChBM were of minor influence in dimer stability; neither the size, polarity, nor aromatic nature of the replacement amino acids affected LytA activity. In contrast, truncated proteins were drastically impaired in their activity and conversion capacity. The results indicate that dimerization and conversion are different processes, but they do not answer the questions of whether conversion can only be achieved after a dimer formation step.	CSIC, Ctr Invest Biol, Dept Mol Microbiol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Garcia, E (corresponding author), CSIC, Ctr Invest Biol, Dept Mol Microbiol, Ramiro de Maeztu,9, E-28006 Madrid, Spain.	e.garcia@cib.csic.es		Partearroyo Lacaba, Olvido/0000-0002-1692-4481				Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; BRIESE T, 1985, EUR J BIOCHEM, V146, P417, DOI 10.1111/j.1432-1033.1985.tb08668.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buey RM, 2007, J MOL BIOL, V365, P411, DOI 10.1016/j.jmb.2006.09.091; Demarest SJ, 2005, J MOL BIOL, V346, P1197, DOI 10.1016/j.jmb.2004.12.059; DIAZ E, 1992, J BACTERIOL, V174, P5516; Fernandez-Tornero C, 2002, J MOL BIOL, V321, P163, DOI 10.1016/S0022-2836(02)00596-X; Fernandez-Tornero C, 2002, ACTA CRYSTALLOGR D, V58, P556, DOI 10.1107/S0907444902000537; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Fischer W, 2000, RES MICROBIOL, V151, P421, DOI 10.1016/S0923-2508(00)00174-1; GARCIA E, 1988, P NATL ACAD SCI USA, V85, P914, DOI 10.1073/pnas.85.3.914; GARCIA E, 1985, FEMS MICROBIOL LETT, V29, P77; GARCIA E, 1985, MOL GEN GENET, V201, P225, DOI 10.1007/BF00425663; GARCIA JL, 1987, ARCH MICROBIOL, V149, P52, DOI 10.1007/BF00423136; GARCIA JL, 1994, J BACTERIOL, V176, P4066, DOI 10.1128/JB.176.13.4066-4072.1994; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Hermoso JA, 2005, NAT STRUCT MOL BIOL, V12, P533, DOI 10.1038/nsmb940; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; HOLTJE JV, 1976, J BIOL CHEM, V251, P4199; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lopez R, 2004, PNEUMOCCOCUS, P75; LUND E, 1978, METHOD MICROBIOL, V12, P241; Maestro B, 2005, BIOCHEM J, V387, P479, DOI 10.1042/BJ20041194; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOSSER JL, 1970, J BIOL CHEM, V245, P287; Obregon V, 2002, J CLIN MICROBIOL, V40, P2545, DOI 10.1128/JCM.40.7.2545-2554.2002; OTTOLENGHI E, 1962, J EXP MED, V116, P491, DOI 10.1084/jem.116.4.491; Rane L, 1940, J BACTERIOL, V40, P695, DOI 10.1128/JB.40.5.695-704.1940; Romero P, 2004, J BACTERIOL, V186, P8229, DOI 10.1128/JB.186.24.8229-8239.2004; RONDA C, 1987, EUR J BIOCHEM, V164, P621, DOI 10.1111/j.1432-1033.1987.tb11172.x; Saiz JL, 2002, PROTEIN SCI, V11, P1788, DOI 10.1110/ps.4680102; Sambrook J., 2001, MOL CLONING LAB MANU; SANCHEZPUELLES JM, 1990, GENE, V89, P69, DOI 10.1016/0378-1119(90)90207-8; SANCHEZPUELLES JM, 1992, EUR J BIOCHEM, V203, P153, DOI 10.1111/j.1432-1033.1992.tb19840.x; SANCHEZPUELLES JM, 1986, EUR J BIOCHEM, V158, P289, DOI 10.1111/j.1432-1033.1986.tb09749.x; SANCHEZPUELLES JM, 1987, GENE, V61, P13, DOI 10.1016/0378-1119(87)90360-X; Sheehan MM, 1997, MOL MICROBIOL, V25, P717, DOI 10.1046/j.1365-2958.1997.5101880.x; Swiatlo E, 2004, PNEUMOCCOCUS, P49; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TOMASZ A, 1967, SCIENCE, V157, P694, DOI 10.1126/science.157.3789.694; TOMASZ A, 1971, P NATL ACAD SCI USA, V68, P2627, DOI 10.1073/pnas.68.11.2627; Usobiaga P, 1996, J BIOL CHEM, V271, P6832, DOI 10.1074/jbc.271.12.6832; Varea J, 2004, J BIOL CHEM, V279, P43697, DOI 10.1074/jbc.M407067200; Varea J, 2000, J BIOL CHEM, V275, P26842	54	18	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17729	17737		10.1074/jbc.M611795200	http://dx.doi.org/10.1074/jbc.M611795200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17439951	hybrid, Green Published			2022-12-27	WOS:000247084500046
J	Woeller, CF; Anderson, DD; Szebenyi, DME; Stover, PJ				Woeller, Collynn F.; Anderson, Donald D.; Szebenyi, Doletha M. E.; Stover, Patrick J.			Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC SERINE HYDROXYMETHYLTRANSFERASE; ONE-CARBON METABOLISM; DNA POSTREPLICATION REPAIR; SACCHAROMYCES-CEREVISIAE; PROTEIN MODIFICATION; CONJUGATING ENZYME; COLORECTAL-CANCER; MOUSE FIBROBLASTS; SUMO MODIFICATION; GENE-EXPRESSION	Perturbations in folate-mediated one-carbon metabolism increase rates of uracil misincorporation into DNA during replication, impair cellular methylation reactions, and increase risk for neural tube defects and cancer. One-carbon metabolism is compromised by folate deficiency and common genetic polymorphisms. In this study, the mechanism for the preferential partitioning of cytoplasmic serine hydroxymethyltransferase ( cSHMT)-derived methylenetetrahydrofolate to de novo thymidylate biosynthesis was investigated. The cSHMT enzyme was shown to interact with UBC9 and was a substrate for UBC9-catalyzed small ubiquitin-like modifier ( SUMO) modification in vitro. SUMOylated cSHMT was detected in extracts from S phase MCF-7 cells, and cSHMT was shown to localize to the nucleus and nuclear periphery during the S and G(2)/M phases of the cell cycle. A common single nucleotide polymorphism ( L474F-cSHMT) impaired the UBC9-cSHMT interaction and inhibited cSHMT SUMOylation in vitro. The three folate-dependent enzymes that constitute the de novo thymidylate biosynthesis pathway, cSHMT, thymidylate synthase, and dihydrofolate reductase, all contain SUMO modification consensus sequences. Compartmentation of the folate-dependent de novo thymidylate biosynthesis pathway in the nucleus accounts for the preferential partitioning of cSHMT-derived folate-activated one-carbon units into thymidylate biosynthesis; the efficiency of nuclear folate metabolism is likely to be modified by the cSHMT L474F polymorphism.	Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; Cornell Univ, Grad Field Biochem Mol & Cellular Biol, Ithaca, NY 14853 USA; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 315 Savage Hall, Ithaca, NY 14853 USA.	PJS13@cornell.edu	Szebenyi, Marian/GMX-2709-2022; Woeller, Collynn/U-3877-2019	Woeller, Collynn/0000-0001-7197-5057	NIDDK NIH HHS [DK58144] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058144, R37DK058144] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashley C, 2002, GENE, V285, P183, DOI 10.1016/S0378-1119(02)00409-2; Azuma Y, 2002, DEV CELL, V2, P130, DOI 10.1016/S1534-5807(02)00124-7; BARLOWE C K, 1988, Biofactors, V1, P171; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bissoon-Haqqani S, 2006, J HISTOCHEM CYTOCHEM, V54, P19, DOI 10.1369/jhc.5A6642.2005; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; BOORSTEIN RJ, 1983, BIOCHEM BIOPH RES CO, V117, P30, DOI 10.1016/0006-291X(83)91536-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Chu E, 1996, ADV ENZYME REGUL, V36, P143, DOI 10.1016/0065-2571(95)00004-6; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Donnelly JG, 2001, CRIT REV CL LAB SCI, V38, P183, DOI 10.1080/20014091084209; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; GREEN JM, 1988, BIOCHEMISTRY-US, V27, P8014, DOI 10.1021/bi00421a007; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hughes M, 1998, J CELL SCI, V111, P3017; Jang HR, 2005, J NUTR, V135, p2967S, DOI 10.1093/jn/135.12.2967S; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; LOO D, 1994, CELL BIOL LAB HDB, P45; Lydall D, 1997, MOL GEN GENET, V256, P638, DOI 10.1007/s004380050612; Ma J, 1997, CANCER RES, V57, P1098; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Molloy A M, 1999, Haematologica, V84 Suppl EHA-4, P53; NAGARAJAN M, 1989, EXP CELL RES, V181, P289, DOI 10.1016/0014-4827(89)90203-6; NAVALGUND LG, 1980, J BIOL CHEM, V255, P7386; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pastushok L, 2004, ADV PROTEIN CHEM, V69, P279; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; POON PP, 1994, J BIOL CHEM, V269, P8341; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Saitoh N, 2006, EXP CELL RES, V312, P1418, DOI 10.1016/j.yexcr.2006.01.013; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; SCHIRCH V, 1989, ARCH BIOCHEM BIOPHYS, V269, P371, DOI 10.1016/0003-9861(89)90120-3; SCOTT JM, 1981, LANCET, V2, P337; SHIN YS, 1976, BIOCHIM BIOPHYS ACTA, V444, P794; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stempak JM, 2005, CARCINOGENESIS, V26, P981, DOI 10.1093/carcin/bgi037; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; STRONG WB, 1990, J BIOL CHEM, V265, P12149; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Watts FZ, 2004, SEMIN CELL DEV BIOL, V15, P211, DOI 10.1016/j.semcdb.2003.12.002; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Zanetti KA, 2003, J BIOL CHEM, V278, P10142, DOI 10.1074/jbc.M211569200	64	89	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17623	17631		10.1074/jbc.M702526200	http://dx.doi.org/10.1074/jbc.M702526200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17446168	hybrid			2022-12-27	WOS:000247084500034
J	Yoo, HY; Kumagai, A; Shevchenko, A; Shevchenko, A; Dunphy, WG				Yoo, Hae Yong; Kumagai, Akiko; Shevchenko, Anna; Shevchenko, Andrej; Dunphy, William G.			Ataxia-telangiectasia mutated (ATM)-dependent activation of ATR occurs through phosphorylation of TopBP1 by ATM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION CHECKPOINT; DOUBLE-STRAND BREAKS; XENOPUS EGG EXTRACTS; POLYMERASE-ALPHA; PROTEIN; DAMAGE; CHK1; CLASPIN; CHROMATIN; RESPONSES	ATM ( ataxia-telangiectasia mutated) is necessary for activation of Chk1 by ATR ( ATM and Rad3-related) in response to double-stranded DNA breaks ( DSBs) but not to DNA replication stress. TopBP1 has been identified as a direct activator of ATR. We show that ATM regulates Xenopus TopBP1 by phosphorylating Ser-1131 and thereby strongly enhancing association of TopBP1 with ATR. Xenopus egg extracts containing a mutant of TopBP1 that cannot be phosphorylated on Ser-1131 are defective in the ATR-dependent phosphorylation of Chk1 in response to DSBs but not to DNA replication stress. Thus, TopBP1 is critical for the ATM-dependent activation of ATR following production of DSBs in the genome.	CALTECH, Div Cell Biol, Pasadena, CA 91125 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	California Institute of Technology; Max Planck Society	Dunphy, WG (corresponding author), CALTECH, Div Cell Biol, Pasadena, CA 91125 USA.	dunphy@cco.caltech.edu			NIGMS NIH HHS [GM043974, GM070891] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043974, R01GM070891, R37GM043974] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kobayashi T, 2002, J CELL SCI, V115, P3159; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Kumagai A, 2006, CELL CYCLE, V5, P1265, DOI 10.4161/cc.5.12.2834; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Parrilla-Castellar E, 2003, J BIOL CHEM, V278, P45507, DOI 10.1074/jbc.C300418200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Wielsch N, 2006, J PROTEOME RES, V5, P2448, DOI 10.1021/pr060200v; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	31	92	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17501	17506		10.1074/jbc.M701770200	http://dx.doi.org/10.1074/jbc.M701770200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17446169	hybrid, Green Accepted			2022-12-27	WOS:000247084500020
J	O'Shaughnessy, RFL; Welti, JC; Cooke, JC; Avilion, AA; Monks, B; Birnbaum, MJ; Byrne, C				O'Shaughnessy, Ryan F. L.; Welti, Jonathan C.; Cooke, James C.; Avilion, Ariel A.; Monks, Bobby; Birnbaum, Morris J.; Byrne, Carolyn			AKT-dependent HspB1 (hsp27) activity in epidermal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; KINASE-B-GAMMA; BARRIER FUNCTION; HUMAN KERATINOCYTES; PHOSPHOINOSITIDE 3-KINASE; GLUCOSE-HOMEOSTASIS; STRESS-PROTEIN; HAIR FOLLICLE; MICE LACKING; SKIN	AKT activity has been reported in the epidermis associated with keratinocyte survival and differentiation. We show in developing skin that Akt activity associates first with post-proliferative, para-basal keratinocytes and later with terminally differentiated keratinocytes that are forming the fetal stratum corneum. In adult epidermis the dominant Akt activity is in these highly differentiated granular keratinocytes, involved in stratum corneum assembly. Stratum corneum is crucial for protective barrier activity, and its formation involves complex and poorly understood processes such as nuclear dissolution, keratin filament aggregation, and assembly of a multiprotein cell cornified envelope. A key protein in these processes is filaggrin. We show that one target of Akt in granular keratinocytes is HspB1 ( heat shock protein 27). Loss of epidermal HspB1 caused hyperkeratinization and misprocessing of filaggrin. Akt-mediated HspB1 phosphorylation promotes a transient interaction with filaggrin and intracellular redistribution of HspB1. This is the first demonstration of a specific interaction between HspB1 and a stratum corneum protein and indicates that HspB1 has chaperone activity during stratum corneum formation. This work demonstrates a new role for Akt in epidermis.	Barts & London Queen Mary Univ London, Ctr Cutaneous Res, Inst Cell & Mol Sci, London E1 2AT, England; Barts & London Queen Mary Univ London, Canc Res UK Skin Tumour Lab, Inst Cell & Mol Sci, London E1 2AT, England; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of London; Queen Mary University London; Cancer Research UK; University of London; Queen Mary University London; University of Pennsylvania; Howard Hughes Medical Institute	Byrne, C (corresponding author), Queen Mary Univ London, Ctr Cutaneous Res, Inst Cell & Mol Sci, London E1 2AT, England.	c.r.byrne@qmul.ac.uk		Welti, Jonathan/0000-0002-9433-8138; Birnbaum, Morris/0000-0001-9972-8680; O'Shaughnessy, Ryan/0000-0002-3701-0267	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK56886] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adly MA, 2006, J AM ACAD DERMATOL, V54, P811, DOI 10.1016/j.jaad.2005.11.1097; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Boros S, 2006, PROTEINS, V62, P1044, DOI 10.1002/prot.20837; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; CANDI E, 2005, J BIOL CHEM, V31, P31; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; DALE BA, 1978, NATURE, V276, P729, DOI 10.1038/276729a0; Dorion S, 2002, CELL STRESS CHAPERON, V7, P200, DOI 10.1379/1466-1268(2002)007<0200:AOTMAP>2.0.CO;2; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; GANDOUREDWARDS R, 1994, AM J DERMATOPATH, V16, P504, DOI 10.1097/00000372-199410000-00005; Hardman MJ, 1999, J INVEST DERMATOL, V113, P1106, DOI 10.1046/j.1523-1747.1999.00800.x; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Jarnik M, 2002, J INVEST DERMATOL, V118, P102, DOI 10.1046/j.0022-202x.2001.01661.x; Jonak C, 2005, HUM PATHOL, V36, P686, DOI 10.1016/j.humpath.2005.04.009; Jonak C, 2002, BRIT J DERMATOL, V147, P13, DOI 10.1046/j.1365-2133.2002.04667.x; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Laplante AF, 1998, J HISTOCHEM CYTOCHEM, V46, P1291, DOI 10.1177/002215549804601109; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; MCCLAREN M, 1994, J INVEST DERMATOL, V102, P375, DOI 10.1111/1523-1747.ep12371798; Monastirli A, 2005, ACTA DERM-VENEREOL, V85, P389, DOI 10.1080/00015550510032869; Moskowitz DG, 2004, J PEDIATR-US, V145, P82, DOI 10.1016/j.jpeds.2004.03.052; Nozaki J, 1997, PHOTOCHEM PHOTOBIOL, V65, P843, DOI 10.1111/j.1751-1097.1997.tb01932.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pankow S, 2006, J CELL SCI, V119, P4033, DOI 10.1242/jcs.03175; Pasonen-Seppanen S, 2001, HISTOCHEM CELL BIOL, V116, P287, DOI 10.1007/s004180100312; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Presland RB, 2001, EXP CELL RES, V270, P199, DOI 10.1006/excr.2001.5348; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Steinert PM, 2000, J CELL BIOL, V151, pF5, DOI 10.1083/jcb.151.2.F5; Suzuki A, 2003, CANCER RES, V63, P674; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Vertii A, 2006, J BIOL CHEM, V281, P26966, DOI 10.1074/jbc.M602134200; Wong JW, 2000, J INVEST DERMATOL, V115, P427, DOI 10.1046/j.1523-1747.2000.00077.x; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561	46	64	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					17297	17305		10.1074/jbc.M610386200	http://dx.doi.org/10.1074/jbc.M610386200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17439945	hybrid			2022-12-27	WOS:000246946500063
J	Pedram, A; Razandi, M; Sainson, RCA; Kim, JK; Hughes, CC; Levin, ER				Pedram, Ali; Razandi, Mahnaz; Sainson, Richard C. A.; Kim, Jin K.; Hughes, Christopher C.; Levin, Ellis R.			A conserved mechanism for steroid receptor translocation to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ESTROGEN-RECEPTOR; BINDING-SITES; ALPHA; PALMITOYLATION; IDENTIFICATION; LOCALIZATION; INTEGRATION; ACTIVATION; CELLS	Multiple steroid receptors (SR) have been proposed to localize to the plasma membrane. Some structural elements for membrane translocation of the estrogen receptor alpha( ER alpha) have been described, but the mechanisms relevant to other steroid receptors are entirely unknown. Here, we identify a highly conserved 9 amino acid motif in the ligand binding domains (E domains) of human/mouse ER alpha and ER beta, progesterone receptors A and B, and the androgen receptor. Mutation of the phenylalanine or tyrosine at position -2, cysteine at position 0, and hydrophobic isoleucine/leucine or leucine/leucine combinations at positions +5/6, relative to cysteine, significantly reduced membrane localization, MAP and PI 3-kinase activation, thymidine incorporation into DNA, and cell viability, stimulated by specific SR ligands. The localization sequence mediated palmitoylation of each SR, which facilitated caveolin-1 association, subsequent membrane localization, and steroid signaling. Palmitoylation within the E domain is therefore a crucial modification for membrane translocation and function of classical sex steroid receptors.	Univ Calif Irvine, Long Beach Vet Affairs Med Ctr, Med Serv 111 1, Long Beach, CA 90822 USA; Vet Affairs Med Ctr, Div Endocrinol, Long Beach, CA 90822 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Levin, ER (corresponding author), Univ Calif Irvine, Long Beach Vet Affairs Med Ctr, Med Serv 111 1, 5901 E 7th St, Long Beach, CA 90822 USA.	ellis.levin@med.va.gov	Levin, Ellis/J-5402-2013		NATIONAL CANCER INSTITUTE [R01CA100366] Funding Source: NIH RePORTER; NCI NIH HHS [CA-100366] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Basu J, 2004, CURR SCI INDIA, V87, P212; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Chambliss KL, 2002, MOL ENDOCRINOL, V16, P938, DOI 10.1210/me.16.5.938; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; HAGVE TA, 1987, BIOCHIM BIOPHYS ACTA, V917, P333, DOI 10.1016/0005-2760(87)90138-X; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; JENSEN EV, 1962, RECENT PROG HORM RES, V18, P387; Kelly MJ, 1999, TRENDS ENDOCRIN MET, V10, P369, DOI 10.1016/S1043-2760(99)00190-3; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kousteni S, 2002, SCIENCE, V298, P843, DOI 10.1126/science.1074935; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; PIETRAS RJ, 1975, NATURE, V253, P357, DOI 10.1038/253357a0; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Skildum A, 2005, MOL ENDOCRINOL, V19, P327, DOI 10.1210/me.2004-0306; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Tian JD, 2000, P NATL ACAD SCI USA, V97, P14358, DOI 10.1073/pnas.250492197; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	33	340	351	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22278	22288		10.1074/jbc.M611877200	http://dx.doi.org/10.1074/jbc.M611877200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17535799	hybrid			2022-12-27	WOS:000248354200005
J	Lyons, TR; Thorburn, J; Ryan, PW; Thorburn, A; Anderson, SM; Kassenbrock, CK				Lyons, Traci R.; Thorburn, Jackie; Ryan, Philip W.; Thorburn, Andrew; Anderson, Steven M.; Kassenbrock, C. Kenneth			Regulation of the pro-apoptotic scaffolding protein POSH by Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; NF-KAPPA-B; GROWTH-FACTOR; NEGATIVE REGULATION; SIGNALING PATHWAY; SURVIVAL SIGNALS; JNK ACTIVATION; CELL-SURVIVAL; KINASE-B; PHOSPHORYLATION	POSH (Plenty of SH3 domains) binds to activated Rac and promotes apoptosis by acting as a scaffold to assemble a signal transduction pathway leading from Rac to JNK activation. Overexpression of POSH induces apoptosis in a variety of cell types, but apoptosis can be prevented by co-expressing the pro-survival protein kinase Akt. We report here that POSH is a direct substrate for phosphorylation by Akt in vivo and in vitro, and we identify a major site of Akt phosphorylation as serine 304 of POSH, which lies within the Rac-binding domain. We further show that phosphorylation of POSH results in a decreased ability to bind activated Rac, as does phosphomimetic S304D and S304E mutation of POSH. S304D mutant POSH also shows a strongly reduced ability to induce apoptosis. These findings identify a novel mechanism by which Akt promotes cell survival.	Univ Colorado, Dept Pathol, Denver, CO 80202 USA; Univ Colorado, Dept Pharmacol, Denver, CO 80202 USA; Colorado State Univ, Ft Collins, CO 80523 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Colorado State University	Kassenbrock, CK (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pathol, Mailstop 8104,POB 6511, Aurora, CO 80045 USA.	Ken.Kassenbrock@uchsc.edu			NCI NIH HHS [CA111421] Funding Source: Medline; NIDDK NIH HHS [DK063674] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063674] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; BELLACOSA A, 1993, ONCOGENE, V8, P745; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen PL, 2002, PROTEIN EXPRES PURIF, V24, P481, DOI 10.1006/prep.2001.1599; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Figueroa C, 2003, J BIOL CHEM, V278, P47922, DOI 10.1074/jbc.M307357200; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Hui L, 2005, BRAIN RES, V1052, P1, DOI 10.1016/j.brainres.2005.05.043; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kim GH, 2006, CELL SIGNAL, V18, P553, DOI 10.1016/j.cellsig.2005.05.026; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2006, METHOD ENZYMOL, V406, P479, DOI 10.1016/S0076-6879(06)06036-8; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Yao R, 1996, ONCOGENE, V13, P343; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhang QG, 2005, J NEUROCHEM, V95, P784, DOI 10.1111/j.1471-4159.2005.03435.x	35	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21987	21997		10.1074/jbc.M704321200	http://dx.doi.org/10.1074/jbc.M704321200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17535800	hybrid			2022-12-27	WOS:000248196800046
J	Takaine, M; Mabuchi, I				Takaine, Masak; Mabuchi, Issei			Properties of actin from the fission yeast Schizosaccharomyces pombe and interaction with fission yeast profilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN EGGS; F-ACTIN; ARP2/3 COMPLEX; DICTYOSTELIUM-DISCOIDEUM; CAPPING PROTEIN; DEPOLYMERIZING PROTEIN; MODULATING PROTEINS; THIN-FILAMENTS; FORMIN CDC12P; MYOSIN-I	The fission yeast Schizosaccharomyces pombe serves as a model system for studying role of actin cytoskeleton, since it has simple actin cytoskeletons and is genetically tractable. In contrast, biochemical approaches using this organism are still developing; fission yeast actin has so far not been isolated in its native form and characterized, and therefore, biochemical assays of fission yeast actin-binding proteins (ABPs) or myosin have been performed using rabbit skeletal muscle actin that may interact with the fission yeast ABPs in a manner different from fission yeast actin. Here, we report a novel method for isolating functionally active actin from fission yeast cells. The highly purified fission yeast actin polymerized with kinetics somewhat different from those of muscle actin and forms filaments that are structurally indistinguishable from skeletal muscle actin filaments. The fission yeast actin was a significantly weaker activator of Mg2+-ATPase of HMM of skeletal muscle myosin than muscle actin. The fission yeast profilin Cdc3 suppressed polymerization of fission yeast actin more effectively than that of muscle actin and showed an affinity for fission yeast actin higher than for muscle actin. The establishment of purification of fission yeast actin will enable reconstruction of physiologically relevant interactions between the actin and fission yeast ABPs or myosins and contribute to clarification of function of actin cytoskeleton in various cellular activities.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Div Biol,Meguro Ku, Tokyo 1538902, Japan	University of Tokyo; University of Tokyo	Mabuchi, I (corresponding author), Gakushuin Univ, Sch Sci, Inst Biomol Sci, Dept Chem,Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	issei.mabuchi@gakushuin.ac.jp	Takaine, Masakatsu/U-1277-2019	Takaine, Masakatsu/0000-0002-1279-9505				Arai R, 2002, J CELL SCI, V115, P887; Arai R, 1998, EUR J CELL BIOL, V76, P288, DOI 10.1016/S0171-9335(98)80007-1; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; BOOYSE FM, 1973, J BIOL CHEM, V248, P4083; BRENNER SL, 1979, J BIOL CHEM, V254, P9982; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; CHANG F, 1997, J CELL BIOL, V137, P69; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; CRAIG R, 1980, J MOL BIOL, V140, P35, DOI 10.1016/0022-2836(80)90355-1; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; GORDON DJ, 1977, J BIOL CHEM, V252, P8300; GREER C, 1982, MOL CELL BIOL, V2, P1270, DOI 10.1128/MCB.2.10.1270; Hanson J., 1963, Journal of Molecular Biology, V6, P46; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAL AA, 1985, J BIOL CHEM, V260, P132; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Lindberg U, 1979, Methods Achiev Exp Pathol, V8, P143; Llorca O, 1998, J BIOL CHEM, V273, P10091, DOI 10.1074/jbc.273.17.10091; LOAD M, 2004, J CELL BIOL, V167, P315; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MABUCHI I, 1985, J CELL BIOL, V100, P375, DOI 10.1083/jcb.100.2.375; MABUCHI I, 1982, J BIOCHEM-TOKYO, V92, P1439, DOI 10.1093/oxfordjournals.jbchem.a134068; MABUCHI I, 1982, BIOMED RES-TOKYO, V3, P465, DOI 10.2220/biomedres.3.465; MABUCHI I, 1980, J BIOCHEM-TOKYO, V87, P785, DOI 10.1093/oxfordjournals.jbchem.a132808; MABUCHI I, 1981, BIOMED RES, V1, P417; MARKS J, 1985, EUR J CELL BIOL, V39, P27; McCollum D, 1996, EMBO J, V15, P6438, DOI 10.1002/j.1460-2075.1996.tb01035.x; MERTINS P, 1987, NUCLEIC ACIDS RES, V15, P7369, DOI 10.1093/nar/15.18.7369; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; Mossakowska M, 1996, J MUSCLE RES CELL M, V17, P383, DOI 10.1007/BF00123355; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakano K, 2006, MOL BIOL CELL, V17, P1933, DOI 10.1091/mbc.E05-09-0900; Nakano K, 2001, MOL BIOL CELL, V12, P3515, DOI 10.1091/mbc.12.11.3515; NEFSKY B, 1992, EUR J BIOCHEM, V206, P949, DOI 10.1111/j.1432-1033.1992.tb17005.x; Nitsch M, 1998, NAT STRUCT BIOL, V5, P855, DOI 10.1038/2296; OBRIEN EJ, 1975, J MOL BIOL, V99, P461, DOI 10.1016/S0022-2836(75)80138-0; Oda T, 2005, BIOPHYS J, V88, P2727, DOI 10.1529/biophysj.104.047753; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143, DOI 10.1093/oxfordjournals.jbchem.a135365; Orlova A, 1997, J MOL BIOL, V271, P235, DOI 10.1006/jmbi.1997.1163; OZAKI K, 1984, J CELL BIOL, V98, P1919, DOI 10.1083/jcb.98.6.1919; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Ren HY, 1997, PLANT CELL, V9, P1445, DOI 10.1105/tpc.9.8.1445; SHUSTER CB, 1995, J CELL BIOL, V128, P837, DOI 10.1083/jcb.128.5.837; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; SPUDICH JA, 1974, J BIOL CHEM, V249, P6013; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SPUDICH JA, 1972, COLD SPRING HARB SYM, V37, P585; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P3654, DOI 10.1021/bi00258a020; SUTOH K, 1986, BIOCHEMISTRY-US, V25, P435, DOI 10.1021/bi00350a024; SUTOH K, 1989, BIOCHEMISTRY-US, V28, P102, DOI 10.1021/bi00427a015; Toya M, 2001, GENES CELLS, V6, P187, DOI 10.1046/j.1365-2443.2001.00414.x; TSENG PCH, 1982, J CELL BIOL, V94, P213, DOI 10.1083/jcb.94.1.213; UYEMURA DG, 1978, J BIOL CHEM, V253, P9088; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; WOOLLEY DE, 1972, ARCH BIOCHEM BIOPHYS, V150, P519, DOI 10.1016/0003-9861(72)90070-7; YOUNG DM, 1964, J BIOL CHEM, V239, P2822; ZECHEL K, 1980, EUR J BIOCHEM, V110, P343, DOI 10.1111/j.1432-1033.1980.tb04873.x	72	17	17	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21683	21694		10.1074/jbc.M611371200	http://dx.doi.org/10.1074/jbc.M611371200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17533155	hybrid			2022-12-27	WOS:000248196800015
J	Martens, GA; Vervoort, A; Van de Casteele, M; Stange, G; Hellemans, K; Van Thi, HV; Schuit, F; Pipeleers, D				Martens, Geert A.; Vervoort, Annelies; Van de Casteele, Mark; Stange, Geert; Hellemans, Karine; Van Thi, Hong Vien; Schuit, Frans; Pipeleers, Daniel			Specificity in beta cell expression of (L)-3-Hydroxyacyl-CoA dehydrogenase, short chain, and potential role in down-regulating insulin release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE; SECRETION; OXIDATION; COA; HYPERINSULINISM; DEFICIENCY; ISLETS; ENZYME; L-3-HYDROXYACYL-COENZYME; ADAPTATION	A loss-of-function mutation of the mitochondrial beta-oxidation enzyme L-3-hydroxyacyl-CoA dehydrogenase, short chain (HADHSC), has been associated with hyperinsulinemic hypoglycemia in man. It is still unclear whether loss of glucose homeostasis in these patients (partly) results from a dysregulation of beta cells. This study examines HADHSC expression in purified rat beta cells and investigates whether its selective suppression elevates insulin release. Beta cells expressed the highest levels of HADHSC mRNA and protein of all examined tissues, including those with high rates of mitochondrial beta-oxidation. On the other hand, beta cells expressed relatively low levels of other beta-oxidation enzymes (acyl-CoA dehydrogenase short, medium, and long chain and acetyl-coenzyme A acyltransferase 2). HADHSC expression was sequence-specifically silenced by RNA interference, and the effects were examined on glucose-stimulated insulin secretion following 48-72 h of suppression. In both rat beta cells and in the beta cell line INS1 832-13, HADHSC silencing resulted in elevated insulin release at low and at high glucose concentrations, which appeared not to be caused by increased rates of glucose metabolism or an inhibition in fatty acid oxidation. These data indicate that the normal beta cell phenotype is characterized by a high expression of HADHSC and a low expression of other beta-oxidation enzymes. Down-regulation of HADHSC causes an elevated secretory activity suggesting that this enzyme protects against inappropriately high insulin levels and hypoglycemia.	Free Univ Brussels VUB, Diabet Res Ctr, B-1090 Brussels, Belgium; Free Univ Brussels ULB, Brugmann Hosp, Pediat Lab, B-1020 Brussels, Belgium; Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, B-3000 Louvain, Belgium	Vrije Universiteit Brussel; Universite Libre de Bruxelles; KU Leuven	Pipeleers, D (corresponding author), Free Univ Brussels VUB, Diabet Res Ctr, Laarbeeklaan 103, B-1090 Brussels, Belgium.	Daniel.Pipeleers@vub.ac.be	Hellemans, Karine/B-7573-2013; Martens, Geert A./F-6920-2015; Martens, Geert/ABA-6297-2020; stange, geert m/C-1092-2009	Hellemans, Karine/0000-0001-9306-4369; Martens, Geert A./0000-0003-1208-6289; Martens, Geert/0000-0003-1208-6289; stange, geert m/0000-0003-3148-1372; Pipeleers, Daniel/0000-0002-6440-2485; Van De Casteele, mark/0000-0002-8594-9260				AGREN A, 1977, DIABETES METAB, V3, P169; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bennett MJ, 1996, PEDIATR RES, V39, P185, DOI 10.1203/00006450-199601000-00031; Bennett MJ, 1999, PEDIATR DEVEL PATHOL, V2, P337, DOI 10.1007/s100249900132; Cavedon CT, 2005, CLIN CHEM, V51, P745, DOI 10.1373/clinchem.2004.043646; Clayton PT, 2001, BIOCHEM SOC T, V29, P298, DOI 10.1042/BST0290298; Clayton PT, 2001, J CLIN INVEST, V108, P457; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x; Gremlich S, 2005, ENDOCRINOLOGY, V146, P375, DOI 10.1210/en.2004-0667; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hussain K, 2005, J PEDIATR-US, V146, P706, DOI 10.1016/j.jpeds.2005.01.032; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Lalloyer F, 2006, DIABETES, V55, P1605, DOI 10.2337/db06-0016; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lehtihet M, 2003, AM J PHYSIOL-ENDOC M, V285, pE438, DOI 10.1152/ajpendo.00057.2003; Liang X, 2001, BIOCHEM SOC T, V29, P279, DOI 10.1042/BST0290279; Ling ZD, 1996, DIABETES, V45, P1774, DOI 10.2337/diabetes.45.12.1774; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; Martens GA, 2006, ENDOCRINOLOGY, V147, P5196, DOI 10.1210/en.2006-0580; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Molven A, 2004, DIABETES, V53, P221, DOI 10.2337/diabetes.53.1.221; Papeleu Peggy, 2006, Methods Mol Biol, V320, P229; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; SCHUIT FC, 1991, BIOCHEM BIOPH RES CO, V178, P1182, DOI 10.1016/0006-291X(91)91017-7; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Tordjman K, 2002, J LIPID RES, V43, P936; VANSCHRAVENDIJK CFH, 1992, J BIOL CHEM, V267, P21344; Vredendaal PJCM, 1996, BIOCHEM BIOPH RES CO, V223, P718, DOI 10.1006/bbrc.1996.0961; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	41	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21134	21144		10.1074/jbc.M700083200	http://dx.doi.org/10.1074/jbc.M700083200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17491019	hybrid			2022-12-27	WOS:000248047500040
J	Andriopoulos, B; Hegedusch, S; Mangin, J; Riedel, HD; Hebling, U; Wang, J; Pantopoulos, K; Mueller, S				Andriopoulos, Bill; Hegeduesch, Stephan; Mangin, Julia; Riedel, Hans-Dieter; Hebling, Ulrike; Wang, Jian; Pantopoulos, Kostas; Mueller, Sebastian			Sustained hydrogen peroxide induces iron uptake by transferrin receptor-1 independent of the iron regulatory protein/iron-responsive element network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC VIRAL-HEPATITIS; OXIDATIVE STRESS; GENE-MUTATIONS; K562 CELLS; INFLAMMATION; TRANSLATION; ACTIVATION; PHOSPHORYLATION; METABOLISM; HEPCIDIN	Local and systemic inflammatory conditions are characterized by the intracellular deposition of excess iron, which may promote tissue damage via Fenton chemistry. Because the Fenton reactant H2O2 is continuously released by inflammatory cells, a tight regulation of iron homeostasis is required. Here, we show that exposure of cultured cells to sustained low levels of H2O2 that mimic its release by inflammatory cells leads to upregulation of transferrin receptor 1 (TfR1), the major iron uptake protein. The increase in TfR1 results in increased transferrin-mediated iron uptake and cellular accumulation of the metal. Although iron regulatory protein 1 is transiently activated by H2O2, this response is not sufficient to stabilize TfR1 mRNA and to repress the synthesis of the iron storage protein ferritin. The induction of TfR1 is also independent of transcriptional activation via hypoxia-inducible factor 1 alpha or significant protein stabilization. In contrast, pulse experiments with S-35-labeled methionine/cysteine revealed an increased rate of TfR1 synthesis in cells exposed to sustained low H2O2 levels. Our results suggest a novel mechanism of iron accumulation by sustained H2O2, based on the translational activation of TfR1, which could provide an important (patho) physiological link between iron metabolism and inflammation.	Harvard Univ, Sch Med, Beth Israel Med Ctr, Boston, MA 02115 USA; Univ Heidelberg, Salem Med Ctr, Dept Internal Med, D-69121 Heidelberg, Germany; Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ruprecht Karls University Heidelberg; Lady Davis Institute; McGill University; McGill University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mueller, S (corresponding author), Harvard Univ, Sch Med, Beth Israel Med Ctr, 330 Brookline Ave, Boston, MA 02115 USA.	smueller@bidmc.harvard.edu	Pantopoulos, Kostas/A-9668-2008	Pantopoulos, Kostas/0000-0002-2305-0057				BelAiba RS, 2004, BIOL CHEM, V385, P249, DOI 10.1515/BC.2004.019; Bonkovsky HL, 2003, ALCOHOL, V30, P137, DOI 10.1016/S0741-8329(03)00127-7; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; CARTWRIGHT GE, 1946, J CLIN INVEST, V25, P65, DOI 10.1172/JCI101690; Casano LM, 2001, PLANT PHYSIOL, V125, P1450, DOI 10.1104/pp.125.3.1450; Cobelens PM, 2007, CELL SIGNAL, V19, P269, DOI 10.1016/j.cellsig.2006.06.009; Coronella-Wood J, 2004, J BIOL CHEM, V279, P33567, DOI 10.1074/jbc.M404013200; FREIREICH EJ, 1957, BLOOD, V12, P972, DOI 10.1182/blood.V12.11.972.972; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Haque S, 1996, HUM PATHOL, V27, P1277, DOI 10.1016/S0046-8177(96)90337-8; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HIRAYAMA M, 1993, HEPATOLOGY, V18, P874, DOI 10.1002/hep.1840180420; Kang KR, 2001, EXP MOL MED, V33, P198, DOI 10.1038/emm.2001.33; Kasvosve I, 2006, CLIN CHIM ACTA, V371, P130, DOI 10.1016/j.cca.2006.02.034; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kazemi-Shirazi L, 1999, GASTROENTEROLOGY, V116, P127, DOI 10.1016/S0016-5085(99)70236-2; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; KONDO H, 1988, HEPATOLOGY, V8, P32, DOI 10.1002/hep.1840080108; KONIJN AM, 1994, BAIL CL HAE, V7, P829, DOI 10.1016/S0950-3536(05)80127-1; Kotamraju S, 2002, J BIOL CHEM, V277, P17179, DOI 10.1074/jbc.M111604200; LASKEY J, 1988, EXP CELL RES, V176, P87, DOI 10.1016/0014-4827(88)90123-1; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; LUCIANI N, 1995, BIOCHIMIE, V77, P182, DOI 10.1016/0300-9084(96)88123-5; MacCallum PR, 2006, J GEN VIROL, V87, P3251, DOI 10.1099/vir.0.82051-0; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; Mueller S, 2000, CANCER RES, V60, P156; Mueller S, 1997, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P338; Mueller S, 2000, FREE RADICAL BIO MED, V29, P410, DOI 10.1016/S0891-5849(00)00261-6; Mueller S, 2005, BIOFACTORS, V24, P171, DOI 10.1002/biof.5520240121; MUELLER S, 1995, J BIOLUM CHEMILUM, V10, P229, DOI 10.1002/bio.1170100406; Mueller S, 1997, BLOOD, V90, P4973, DOI 10.1182/blood.V90.12.4973.4973_4973_4978; Mueller S, 2002, METHOD ENZYMOL, V348, P324, DOI 10.1016/S0076-6879(02)48651-X; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Mueller S, 2006, GASTROENTEROLOGY, V130, P2229, DOI 10.1053/j.gastro.2006.05.006; Mutze S, 2003, J BIOL CHEM, V278, P40542, DOI 10.1074/jbc.M307159200; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; O'Loghlen A, 2003, ARCH BIOCHEM BIOPHYS, V417, P194, DOI 10.1016/S0003-9861(03)00368-0; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Piperno A, 1998, HEPATOLOGY, V28, P1105, DOI 10.1002/hep.510280427; QUASTEL MR, 1966, BLOOD-J HEMATOL, V28, P738, DOI 10.1182/blood.V28.5.738.738; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Riedel HD, 1999, BLOOD, V94, P3915, DOI 10.1182/blood.V94.11.3915.423k27_3915_3921; Riggio O, 1997, AM J GASTROENTEROL, V92, P1298; Rost D, 2007, J HEPATOL, V46, P482, DOI 10.1016/j.jhep.2006.09.025; Roy CN, 2005, CURR OPIN HEMATOL, V12, P107, DOI 10.1097/00062752-200503000-00001; Roy CN, 2004, NAT GENET, V36, P481, DOI 10.1038/ng1350; SCHAFER KH, 1942, Z GES EXP MED, V110, P678; Shenberger JS, 2002, AM J RESP CELL MOL, V27, P250, DOI 10.1165/ajrcmb.27.2.4785; Sureda A, 2005, FREE RADICAL RES, V39, P817, DOI 10.1080/10715760500164045; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Upton RL, 2003, EUR RESPIR J, V22, P335, DOI 10.1183/09031936.03.00075302; VOLLAND W, 1940, KLIN WOCHENSCHR, V19, P1242; Wang J, 2005, BIOCHEM J, V392, P383, DOI 10.1042/BJ20050492; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061; [No title captured]	62	39	40	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20301	20308		10.1074/jbc.M702463200	http://dx.doi.org/10.1074/jbc.M702463200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517884	hybrid			2022-12-27	WOS:000247819300033
J	Kitatani, K; Idkowiak-Baldys, J; Hannun, YA				Kitatani, Kazuyuki; Idkowiak-Baldys, Jolanta; Hannun, Yusuf A.			Mechanism of inhibition of sequestration of protein kinase C alpha/beta II by ceramide - Roles of ceramide-activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C alpha/beta II on threonine 638/641	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER-CELLS; PHOSPHOLIPASE-D; BETA-II; RECYCLING ENDOSOMES; SIGNAL-TRANSDUCTION; SR PROTEINS; IN-VIVO; DEPHOSPHORYLATION; PHOSPHORYLATION; AUTOPHOSPHORYLATION	Sustained activation of protein kinase C (PKC) isoenzymes alpha and beta II leads to their translocation to a perinuclear region and to the formation of the pericentrion, a PKC-dependent subset of recycling endosomes. In MCF-7 human breast cancer cells, the action of the PKC activator 4 beta-phorbol-12-myristate-13-acetate (PMA) evokes ceramide formation, which in turn prevents PKC alpha/beta II translocation to the pericentrion. In this study we investigated the mechanisms by which ceramide negatively regulates this translocation of PKC alpha/beta II. Upon PMA treatment, HEK-293 cells displayed dual phosphorylation of PKC alpha/beta II at carboxyl-terminal sites (Thr638/641 and Ser-657/660), whereas in MCF-7 cells PKC alpha/beta II were phosphorylated at Ser-657/660 but not Thr-638/641. Inhibition of ceramide synthesis by fumonisin B1 overcame the defect in PKC phosphorylation and restored translocation of PKC alpha/beta II to the pericentrion. To determine the involvement of ceramide-activated protein phosphatases in PKC regulation, we employed small interference RNA to silence individual Ser/Thr protein phosphatases. Knockdown of isoforms alpha or beta of the catalytic subunits of protein phosphatase 1 not only increased phosphorylation of PKC alpha/beta II at Thr-638/641 but also restored PKC alpha/beta II translocation to the pericentrion. Mutagenesis approaches in HEK-293 cells revealed that mutation of either Thr-641 or Ser-660 to Ala in PKC beta II abolished sequestration of PKC, implying the indispensable roles of phosphorylation of PKC alpha/beta II at those sites for their translocation to the pericentrion. Reciprocally, a point mutation of Thr-641 to Glu, which mimics phosphorylation, in PKC beta II overcame the inhibitory effects of ceramide on PKC translocation in PMA-stimulated MCF-7 cells. Therefore, the results demonstrate a novel role for carboxyl-terminal phosphorylation of PKC alpha/beta II in the translocation of PKC to the pericentrion, and they disclose specific regulation of PKC autophosphorylation by ceramide through the activation of specific isoforms of protein phosphatase 1.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,PO Box 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 43707] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; BORNER C, 1989, J BIOL CHEM, V264, P13902; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Bourbon NA, 2000, J BIOL CHEM, V275, P35617, DOI 10.1074/jbc.M007346200; CAZAUBON SM, 1993, J BIOL CHEM, V268, P17559; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chen CC, 2001, MOL PHARMACOL, V59, P493, DOI 10.1124/mol.59.3.493; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; Feng X, 2000, J BIOL CHEM, V275, P17024, DOI 10.1074/jbc.275.22.17024; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; FLINT AJ, 1990, SCIENCE, V249, P408, DOI 10.1126/science.2377895; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Galadari S, 2001, EXP MOL MED, V33, P240, DOI 10.1038/emm.2001.39; Garzotto M, 1998, CANCER RES, V58, P2260; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Hu TH, 2004, J BIOL CHEM, V279, P35702, DOI 10.1074/jbc.M402372200; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kitatani K, 2004, CELL SIGNAL, V16, P967, DOI 10.1016/j.cellsig.2004.02.003; Kitatani K, 2001, ARCH BIOCHEM BIOPHYS, V395, P208, DOI 10.1006/abbi.2001.2573; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kowluru A, 1997, FEBS LETT, V418, P179, DOI 10.1016/S0014-5793(97)01379-3; Lee JY, 2000, J BIOL CHEM, V275, P29290, DOI 10.1074/jbc.M000170200; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; Lesage B, 2005, FEBS LETT, V579, P5626, DOI 10.1016/j.febslet.2005.09.033; Levade T, 2001, CIRC RES, V89, P957, DOI 10.1161/hh2301.100350; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Mora A, 2002, CELL SIGNAL, V14, P557, DOI 10.1016/S0898-6568(01)00282-0; Nakamura Y, 1996, J IMMUNOL, V156, P256; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; ORR JW, 1994, J BIOL CHEM, V269, P27715; PEARS C, 1992, BIOCHEM J, V283, P515, DOI 10.1042/bj2830515; Prevostel C, 2000, J CELL SCI, V113, P2575; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Suchard SJ, 1997, BLOOD, V89, P2139, DOI 10.1182/blood.V89.6.2139; Venable ME, 1996, J BIOL CHEM, V271, P24800, DOI 10.1074/jbc.271.40.24800; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	65	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20647	20656		10.1074/jbc.M609162200	http://dx.doi.org/10.1074/jbc.M609162200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17504762	hybrid			2022-12-27	WOS:000247819300067
J	Kosoy, A; Calonge, TM; Outwin, EA; O'Connell, MJ				Kosoy, Ana; Calonge, Teresa M.; Outwin, Emily A.; O'Connell, Matthew J.			Fission yeast Rnf4 homologs are required for DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING FINGER PROTEIN; DAMAGE CHECKPOINT; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; KINASE CHK1; RECOMBINATION; PHOSPHORYLATION; HELICASE; SNURF; CDC2	We describe two RING finger proteins in the fission yeast Schizosaccharomyces pombe, Rfp1 and Rfp2. Weshow that these proteins function redundantly in DNA repair. Rfp1 was isolated as a Chk1-interacting protein in a two-hybrid screen and has high amino acid sequence similarity to Rfp2. Deletion of either gene does not cause a phenotype, but a double deletion ( rfp1 Delta rfp2 Delta) showed poor viability and defects in cell cycle progression. These cells are also sensitive to DNA-damaging agents, although they maintained normal checkpoint signaling to Chk1. Rfp1 and Rfp2 are most closely related to human Rnf4, and we showed that Rnf4 can substitute functionally for Rfp1 and/or Rfp2. The double mutants also showed significantly increased levels of protein SUMOylation, and we identified an S. pombe Ulp2/Smt4 homolog that, when overexpressed, reduced SUMO levels and suppressed the DNA damage sensitivity of rfp1 Delta rfp2 Delta cells.	Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	O'Connell, MJ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	matthew.oconnell@mssm.edu			NATIONAL CANCER INSTITUTE [R01CA100076, R56CA100076] Funding Source: NIH RePORTER; NCI NIH HHS [CA 100076] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALKHODAIRY F, 1995, J CELL SCI, V108, P475; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Calonge TM, 2006, GENETICS, V174, P113, DOI 10.1534/genetics.106.060970; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chen L, 1999, GENE DEV, V13, P675, DOI 10.1101/gad.13.6.675; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Fedele M, 2000, J BIOL CHEM, V275, P7894, DOI 10.1074/jbc.275.11.7894; FORSBURG SL, 1991, ANNU REV CELL BIOL, V7, P227, DOI 10.1146/annurev.cb.07.110191.001303; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Haghnazari E, 2004, NUCLEIC ACIDS RES, V32, P4257, DOI 10.1093/nar/gkh717; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hakli M, 2001, J BIOL CHEM, V276, P23653, DOI 10.1074/jbc.M009891200; Harvey SH, 2004, MOL CELL BIOL, V24, P662, DOI 10.1128/MCB.24.2.662-674.2004; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Hutchins JRA, 2000, FEBS LETT, V466, P91, DOI 10.1016/S0014-5793(99)01763-9; Jacquiau HR, 2005, J BIOL CHEM, V280, P23566, DOI 10.1074/jbc.M500947200; James P, 1996, GENETICS, V144, P1425; Krien MJE, 1998, J CELL SCI, V111, P967; Krien MJE, 2002, EMBO J, V21, P1713, DOI 10.1093/emboj/21.7.1713; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Lee KM, 2006, DNA REPAIR, V5, P138, DOI 10.1016/j.dnarep.2005.08.003; LEHMANN AR, 1991, MUTAT RES, V250, P205, DOI 10.1016/0027-5107(91)90177-P; Liu HY, 2002, J BIOL CHEM, V277, P2637, DOI 10.1074/jbc.M109016200; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Lyngso C, 2000, J BIOL CHEM, V275, P26144, DOI 10.1074/jbc.M003405200; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; O'Connell MJ, 2005, J CELL SCI, V118, P1, DOI 10.1242/jcs.01626; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; PERO R, 2001, J BIOL CHEM; Raleigh JM, 2000, J CELL SCI, V113, P1727; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Saville B, 2002, J BIOL CHEM, V277, P2485, DOI 10.1074/jbc.M109021200; Strunnikov AV, 2001, GENETICS, V158, P95; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Verkade HM, 1998, MOL GEN GENET, V260, P426, DOI 10.1007/s004380050913; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Watts FZ, 2006, DNA REPAIR, V5, P399, DOI 10.1016/j.dnarep.2005.11.002	48	62	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20388	20394		10.1074/jbc.M702652200	http://dx.doi.org/10.1074/jbc.M702652200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502373	hybrid			2022-12-27	WOS:000247819300041
J	Schindler, C; Levy, DE; Decker, T				Schindler, Christian; Levy, David E.; Decker, Thomas			JAK-STAT signaling: From interferons to cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IFN-GAMMA; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; TRANSACTIVATION DOMAIN; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; DNA-BINDING; ACTIVATION; KINASE; COACTIVATOR		Columbia Univ, Dept Microbiol, New York, NY 10032 USA; Columbia Univ, Dept Med, New York, NY 10032 USA; NYU, Sch Med, New York, NY 10016 USA; Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, A-1030 Vienna, Austria	Columbia University; Columbia University; New York University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Schindler, C (corresponding author), Columbia Univ, Dept Microbiol, New York, NY 10032 USA.	cws4@columbia.edu	Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019	Levy, David/0000-0002-7320-7788	Austrian Science Fund (FWF) [F 2803] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; DECKER T, 2003, SIGNAL TRANSDUCERS A, P207; Delhommeau F, 2006, CELL MOL LIFE SCI, V63, P2939, DOI 10.1007/s00018-006-6272-7; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Komyod W, 2005, J BIOL CHEM, V280, P21700, DOI 10.1074/jbc.C400606200; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Lau JF, 2003, MOL CELL BIOL, V23, P620, DOI 10.1128/MCB.23.2.620-628.2003; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Litterst CM, 2002, J BIOL CHEM, V277, P36052, DOI 10.1074/jbc.M203556200; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; McBride Kevin M, 2003, Sci STKE, V2003, pRE13; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Miyoshi K, 2001, GENOMICS, V71, P150, DOI 10.1006/geno.2000.6433; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nakahira M, 2007, IMMUNITY, V26, P163, DOI 10.1016/j.immuni.2007.01.010; Nusinzon I, 2005, J INTERF CYTOK RES, V25, P745, DOI 10.1089/jir.2005.25.745; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schmerer M, 2006, BLOOD, V108, P2989, DOI 10.1182/blood-2006-05-022137; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Song L, 2006, BLOOD, V108, P3237, DOI 10.1182/blood-2006-04-020271; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Wang DM, 2000, EMBO J, V19, P392, DOI 10.1093/emboj/19.3.392; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Watford WT, 2006, IMMUNITY, V25, P695, DOI 10.1016/j.immuni.2006.10.007; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; Yang J, 2005, CANCER RES, V65, P939; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	68	899	972	3	102	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20059	20063		10.1074/jbc.R700016200	http://dx.doi.org/10.1074/jbc.R700016200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502367	hybrid			2022-12-27	WOS:000247819300005
J	Varfaj, F; Wakabayashi, H; Fay, PJ				Varfaj, Fatbardha; Wakabayashi, Hironao; Fay, Philip J.			Residues surrounding Arg(336) and Arg(562) contribute to the disparate rates of proteolysis of factor VIIIa catalyzed by activated protein C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR XA; PROCOAGULANT ACTIVITY; HEMOPHILIA-A; FACTOR-IXA; FACTOR-V; INACTIVATION; SPECIFICITY; THROMBIN; SUBUNIT; SITE	Activated ProteinC(APC) inactivates factor VIIIa by cleavage at Arg(336) and Arg(562) within the A1 and A2 subunits, respectively, with reaction at the former site occurring at a rate similar to 25-fold faster than the latter. Recombinant factor VIII variants possessing mutations within the P4-P3' sequences were used to determine the contributions of these residues to the disparate cleavage rates at the two P1 sites. Specific activity values for 336(P4-P3') 562, 336(P4-P2) 562, and 336(P1'-P3') 562 mutants, where indicated residues surrounding the Arg336 site were replaced with those surrounding Arg562, were similar to wild type (WT) factor VIII; whereas 562(P4-P3') 336 and 562(P4-P2) 336 mutants showed specific activity values < 1% the WT value. Inactivation rates for the 336 site mutants were reduced similar to 6-11-fold compared with WT factor VIIIa, and approached values attributed to cleavage at Arg562. Cleavage rates at Arg336 were reduced similar to 100- fold for 336(P1'-P3') 562, and similar to 9-16-fold for 336(P4-P2) 562 and 336( P1'-P3') 562 mutants. Inhibition kinetics revealed similar affinities of APC for WT factor VIIIa and 336(P4-P3') 562 variant. Alternatively, the 562(P4-P3') 336 variant showed a modest increase in cleavage rate (similar to 4-fold) at Arg562 compared with WT, whereas these rates were increased by similar to 27- and 6-fold for 562(P4-P3') 336 and 562(P4-P2) 336, respectively, using the factor VIII procofactor form as substrate. Thus the P4-P3' residues surrounding Arg336 and Arg562 make significant contributions to proteolysis rates at each site, apparently independent of binding affinity. Efficient cleavage at Arg336 by APC is attributed to favorable P4-P3' residues at this site, whereas cleavage at Arg562 can be accelerated following replacement with more optimal P4-P3' residues.	Univ Rochester, Sch Med, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Sch Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			NHLBI NIH HHS [HL 76213, HL 38199] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, R01HL076213] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansong C, 2006, J THROMB HAEMOST, V4, P842, DOI 10.1111/j.1538-7836.2006.01831.x; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; FOSTER PA, 1988, J CLIN INVEST, V82, P123, DOI 10.1172/JCI113559; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; KALAFATIS M, 1995, ARTERIOSCL THROM VAS, V15, P2181, DOI 10.1161/01.ATV.15.12.2181; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KemballCook G, 1997, NUCLEIC ACIDS RES, V25, P128, DOI 10.1093/nar/25.1.128; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; Manithody C, 2003, BLOOD, V101, P4802, DOI 10.1182/blood-2003-01-0126; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Nogami K, 2005, BLOOD, V105, P4362, DOI 10.1182/blood-2004-10-3939; Nogami K, 2003, J BIOL CHEM, V278, P1634, DOI 10.1074/jbc.M209811200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Rezaie AR, 2002, BIOCHEMISTRY-US, V41, P12179, DOI 10.1021/bi0261443; Rosenblum MEK, 2002, J BIOL CHEM, V277, P11664, DOI 10.1074/jbc.M200037200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Varfaj F, 2006, BIOCHEM J, V396, P355, DOI 10.1042/BJ20060117; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	31	14	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20264	20272		10.1074/jbc.M701327200	http://dx.doi.org/10.1074/jbc.M701327200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17519239	hybrid			2022-12-27	WOS:000247819300029
J	Niu, XL; Li, JX; Hakim, ZS; Rojas, M; Runge, MS; Madamanchi, NR				Niu, Xi-Lin; Li, Juxiang; Hakim, Zeenat S.; Rojas, Mauricio; Runge, Marschall S.; Madamanchi, Nageswara R.			Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; TRANSGENIC MICE; BETA-CATENIN; TARGETED OVEREXPRESSION; GENE-EXPRESSION; ADIPOSE-TISSUE; IGF-I; RECEPTOR; LAR; PHOSPHORYLATION	Increase in the expression of leukocyte antigen-related (LAR) protein causes insulin resistance, an important contributor to atherosclerosis. However, the function of LAR in atherosclerosis is not known. To address whether LAR is important in the response of vascular cells to atherogenic stimuli, we investigated cell proliferation, migration, and insulin-like growth factor-1 receptor (IGF-1R) signaling in wild-type and LAR(-/-) mouse vascular smooth muscle cells (VSMC) treated with IGF-1. Absence of LAR significantly enhanced proliferation and migration of VSMC compared with wild-type cells after IGF-1 treatment. U0126 and LY249002, specific inhibitors of MAPK/ERK kinase (MEK) and phosphoinositide 3-kinase, respectively, inhibited IGF-1-induced DNA synthesis and migration in both wild-type and LAR(-/-) VSMC. IGF-1 markedly enhanced IGF-1R phosphorylation in both wild-type and LAR(-/-) VSMC, but the phosphorylation was 90% higher in knock-out cells compared with wild-type cells. Absence of LAR enhanced phosphorylation of insulin receptor substrate-1 and insulin receptor substrate-1-associated phosphoinositide 3-kinase activity in VSMC treated with IGF-1. IGF-1-induced phosphorylation of ERK1/2 also increased significantly in LAR(-/-) VSMC compared with wild-type cells. Furthermore, LAR directly binds to IGF-1R in glutathione S-transferase-LAR pull-down and IGF-1R immunoprecipitation experiments and recombinant LAR dephosphorylates IGF-1R in vitro. Neointima formation in response to arterial injury and IGF-1R phosphorylation in neointima increased significantly in LAR(-/-) mice compared with wildtype mice. A significant decrease in body weight, fasting insulin, and IGF-1 levels were observed in LAR(-/-) mice compared with wild-type mice. Together, these data indicate that LAR regulates IGF-1R signaling in VSMC and dysregulation of this phosphatase may lead to VSMC hyperplasia.	Univ N Carolina, Chapel Hill, NC 27599 USA; Univ N Carolina, Cardiovasc Biol Ctr, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Madamanchi, NR (corresponding author), Univ N Carolina, 7312B Med Biomol Res Bldg, Chapel Hill, NC 27599 USA.	nrmadama@med.unc.edu		Madamanchi, Nageswara/0000-0003-0590-0908	NHLBI NIH HHS [HL-57352] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057352] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmad F, 1997, METABOLISM, V46, P1140, DOI 10.1016/S0026-0495(97)90206-7; Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; AHMAD F, 1995, J CLIN INVEST, V95, P2806, DOI 10.1172/JCI117985; Ahmad F, 1997, J BIOL CHEM, V272, P448; ARNQVIST HJ, 1995, METABOLISM, V44, P58, DOI 10.1016/0026-0495(95)90222-8; Avena R, 1999, AM J SURG, V178, P156, DOI 10.1016/S0002-9610(99)00150-6; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Bayes-Genis A, 2000, CIRC RES, V86, P125, DOI 10.1161/01.RES.86.2.125; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Channon KM, 1996, CARDIOVASC RES, V32, P962; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Delafontaine P, 1996, J CLIN INVEST, V97, P139, DOI 10.1172/JCI118381; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Force T, 2004, CIRCULATION, V109, P1196, DOI 10.1161/01.CIR.0000118538.21306.A9; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; Henricks DM, 1998, BIOL REPROD, V59, P330, DOI 10.1095/biolreprod59.2.330; Huang J, 2005, ARTERIOSCL THROM VAS, V25, P354, DOI 10.1161/01.ATV.0000151619.54108.a5; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; KHORSANDI MJ, 1992, J CLIN INVEST, V90, P1926, DOI 10.1172/JCI116070; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Kundu AK, 2003, CELL STRUCT FUNCT, V28, P255, DOI 10.1247/csf.28.255; LEE JP, 1992, PROTEIN SCI, V1, P1353, DOI 10.1002/pro.5560011015; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Mander A, 2005, FEBS LETT, V579, P3024, DOI 10.1016/j.febslet.2005.04.057; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; MYERS MG, 1994, J BIOL CHEM, V269, P28783; Nichols TC, 1999, CIRC RES, V85, P1040; Patel VA, 2001, CIRC RES, V88, P895, DOI 10.1161/hh0901.090305; RAINES EW, 1993, BRIT HEART J, V69, pS30; Rao GN, 1999, J BIOL CHEM, V274, P12925, DOI 10.1074/jbc.274.18.12925; Ren JM, 1998, DIABETES, V47, P493, DOI 10.2337/diabetes.47.3.493; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Scheidegger KJ, 1999, J BIOL CHEM, V274, P3522, DOI 10.1074/jbc.274.6.3522; Sidawy AN, 1996, J VASC SURG, V23, P308, DOI 10.1016/S0741-5214(96)70275-6; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; Uglow EB, 2003, CIRC RES, V92, P1314, DOI 10.1161/01.RES.0000079027.44309.53; van Huijsduijnen RH, 1998, GENE, V225, P1; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Wang XS, 2002, ARTERIOSCL THROM VAS, V22, P884, DOI 10.1161/01.ATV.0000022201.18709.A1; Werner H, 1997, CRIT REV ONCOGENESIS, V8, P71, DOI 10.1615/CritRevOncog.v8.i1.40; Wright MB, 2000, ARTERIOSCL THROM VAS, V20, P1189, DOI 10.1161/01.ATV.20.5.1189; Yeo TT, 1997, J NEUROSCI RES, V47, P348, DOI 10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y; Zabolotny JM, 2001, P NATL ACAD SCI USA, V98, P5187, DOI 10.1073/pnas.071050398; Zhu BH, 2001, ENDOCRINOLOGY, V142, P3598, DOI 10.1210/en.142.8.3598	54	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19808	19819		10.1074/jbc.M610452200	http://dx.doi.org/10.1074/jbc.M610452200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500057	hybrid, Green Published			2022-12-27	WOS:000247650600056
J	Kim, YM; Ramirez, JA; Mick, JE; Giebler, HA; Yan, JP; Nyborg, JK				Kim, Young-Mi; Ramirez, Julita A.; Mick, Jeanne E.; Giebler, Holli A.; Yan, Jian-Ping; Nyborg, Jennifer K.			Molecular characterization of the tax-containing HTLV-1 enhancer complex reveals a prominent role for CREB phosphorylation in tax transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LEUKEMIA-VIRUS; TRANSCRIPTIONAL ACTIVATOR TAX; BINDING-PROTEIN CREB; TYPE-1 TAX; KIX DOMAIN; COACTIVATOR CBP; T-LYMPHOCYTES; KINASE-A; DNA; RECRUITMENT	Transcriptional activation of human T-cell leukemia virus type 1 (HTLV-1) is mediated by the viral oncoprotein Tax, which utilizes cellular transcriptional machinery to perform this function. The viral promoter carries three cyclic AMP-response elements (CREs), which are recognized by the cellular transcription factor cAMP-response element-binding protein (CREB). Tax binds to GC-rich sequences that immediately flank the CREs. The coactivator CREB-binding protein (CBP)/p300 binds to this promoter-bound ternary complex, which promotes the initiation of HTLV-1 transcription. Protein kinase A phosphorylation of CREB at serine 133 facilitates transcription from cellular CREs by recruiting CBP/p300 via its KIX domain. However, it remains controversial whether CREB phosphorylation plays a role in Tax transactivation. In this study, we biochemically characterized the quaternary complex formed by Tax, CREB, KIX, and the viral CRE by examining the individual molecular interactions that contribute to Tax stabilization in the complex. Our data show KIX, Ser(133)-phosphorylated CREB, and vCRE DNA are all required for stable Tax incorporation into the complex in vitro. Consonant with a fundamental role for CREB phosphorylation in Tax recruitment to the complex, we found that CREB is highly phosphorylated in a panel of HTLV-1-infected human T-cell lines. Significantly, we show that Tax is directly responsible for promoting elevated levels of CREB phosphorylation. Together, these data support a model in which Tax promotes CREB phosphorylation in vivo to ensure availability for Tax transactivation. Because pCREB has been implicated in leukemogenesis, enhancement of CREB phosphorylation by the virus may play a role in the etiology of adult T-cell leukemia.	Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Nyborg, JK (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Jennifer.Nyborg@ColoState.edu			NCI NIH HHS [R01 CA055035, CA55035-S1, R01 CA055035-14, CA55035, R01 CA055035-14S1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA055035, R01CA055035] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akagi T, 1997, ONCOGENE, V14, P2071, DOI 10.1038/sj.onc.1201045; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; FRANKLIN AA, 1993, J BIOL CHEM, V268, P21225; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Iwanaga Y, 1999, J VIROL, V73, P1271, DOI 10.1128/JVI.73.2.1271-1277.1999; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; KADISON P, 1990, J VIROL, V64, P2141, DOI 10.1128/JVI.64.5.2141-2148.1990; Kashanchi F, 1998, J BIOL CHEM, V273, P34646, DOI 10.1074/jbc.273.51.34646; Kimzey AL, 1998, J BIOL CHEM, V273, P13768, DOI 10.1074/jbc.273.22.13768; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lemasson I, 2006, J BIOL CHEM, V281, P13075, DOI 10.1074/jbc.M512193200; Lenzmeier BA, 1999, J MOL BIOL, V291, P731, DOI 10.1006/jmbi.1999.2969; Lenzmeier BA, 1998, MOL CELL BIOL, V18, P721, DOI 10.1128/MCB.18.2.721; Lundblad JR, 1998, J BIOL CHEM, V273, P19251, DOI 10.1074/jbc.273.30.19251; Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27; POTEAT HT, 1989, J VIROL, V63, P1604, DOI 10.1128/JVI.63.4.1604-1611.1989; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Riou P, 2000, J BIOL CHEM, V275, P10551, DOI 10.1074/jbc.275.14.10551; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Rousset R, 1996, NATURE, V381, P328, DOI 10.1038/381328a0; Scoggin KES, 2001, MOL CELL BIOL, V21, P5520, DOI 10.1128/MCB.21.16.5520-5530.2001; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Shankar DB, 2004, LEUKEMIA LYMPHOMA, V45, P265, DOI 10.1080/1042819031000151095; SMITH MR, 1991, J CLIN INVEST, V88, P1038, DOI 10.1172/JCI115364; TAN TH, 1989, J VIROL, V63, P3761, DOI 10.1128/JVI.63.9.3761-3768.1989; Trevisan R, 2006, EXP CELL RES, V312, P1390, DOI 10.1016/j.yexcr.2006.01.009; Trevisan R, 2004, EXP CELL RES, V299, P57, DOI 10.1016/j.yexcr.2004.05.024; Turgeman H, 1998, FEBS LETT, V428, P183, DOI 10.1016/S0014-5793(98)00513-4; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Vendel AC, 2003, BIOCHEMISTRY-US, V42, P12481, DOI 10.1021/bi0353023; Yan JP, 1998, J MOL BIOL, V281, P395, DOI 10.1006/jmbi.1998.1951; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445	36	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18750	18757		10.1074/jbc.M700391200	http://dx.doi.org/10.1074/jbc.M700391200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17449469	hybrid			2022-12-27	WOS:000247475300013
J	Cai, SQ; Sesti, F				Cai, Shi-Qing; Sesti, Federico			A new mode of regulation of N-type inactivation in a Caenorhabditis elegans voltage-gated potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-TYPE POTASSIUM; C-TYPE INACTIVATION; SHAKER K-CHANNELS; BETA-SUBUNIT; METHIONINE OXIDATION; IK(A) CHANNELS; PHOSPHORYLATION; DOMAIN; PORE; ELIMINATION	N-type inactivation in voltage-gated K+ (Kv) channels is a widespread means to modulate neuronal excitability and signaling. Here we have shown a novel mechanism of N-type inactivation in a Caenorhabditis elegans Kv channel. The N-terminal sequence of KVS-1 contains a domain of 22 amino acids that resembles the inactivation ball in A-type channels, which is preceded by a domain of eighteen amino acids. Wild type KVS-1 currents can be described as A-type; however, their kinetics are significantly ( similar to 5-fold) slower. When the putative inactivation ball is deleted, the current becomes non-inactivating. Inactivation is restored in non-inactivating channels by diffusion of the missing inactivation domain in the cytoplasm. Deletion of the domain in front of the ball speeds inactivation kinetics similar to 5-fold. We conclude that KVS-1 is the first example of a novel type of Kv channel simultaneously possessing an N-inactivating ball preceded by an N inactivation regulatory domain (NIRD) that acts to slow down inactivation through steric mechanisms.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	sestife@UMDNJ.EDU			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068581] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM68581-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amberg GC, 2003, AM J PHYSIOL-CELL PH, V284, pC583, DOI 10.1152/ajpcell.00301.2002; Antz C, 1999, NAT STRUCT BIOL, V6, P146; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; Ciorba MA, 1999, FEBS LETT, V442, P48, DOI 10.1016/S0014-5793(98)01616-0; Ciorba MA, 1997, P NATL ACAD SCI USA, V94, P9932, DOI 10.1073/pnas.94.18.9932; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; Fawcett GL, 2006, J BIOL CHEM, V281, P30725, DOI 10.1074/jbc.M605814200; Finol-Urdaneta RK, 2006, J GEN PHYSIOL, V128, P133, DOI 10.1085/jgp.200609498; HAGIWARA S, 1961, J PHYSIOL-LONDON, V155, P470, DOI 10.1113/jphysiol.1961.sp006640; Heinemann SH, 1995, FEBS LETT, V377, P383, DOI 10.1016/0014-5793(95)01377-6; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Kondoh S, 1997, J BIOL CHEM, V272, P19333, DOI 10.1074/jbc.272.31.19333; Kwak YG, 1999, J BIOL CHEM, V274, P13928, DOI 10.1074/jbc.274.20.13928; Leicher T, 1998, J BIOL CHEM, V273, P35095, DOI 10.1074/jbc.273.52.35095; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Nitabach MN, 2002, J NEUROSCI, V22, P7913; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Rasmusson RL, 1997, ADV EXP MED BIOL, V430, P29; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; TSENGCRANK J, 1993, J GEN PHYSIOL, V102, P1057, DOI 10.1085/jgp.102.6.1057; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	38	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18597	18601		10.1074/jbc.M702079200	http://dx.doi.org/10.1074/jbc.M702079200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17488718	hybrid			2022-12-27	WOS:000247302000064
J	Dey, S; Hu, ZQ; Xu, XL; Sacchettini, JC; Grant, GA				Dey, Sanghamitra; Hu, Zhiqin; Xu, Xiao Lan; Sacchettini, James C.; Grant, Gregory A.			The effect of hinge mutations on effector binding and domain rotation in Escherichia coli D-3-phosphoglycerate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END PRODUCT INHIBITION; MODULATED ALLOSTERIC REGULATION; PHOSPHOGLYCERATE DEHYDROGENASE; SERINE BIOSYNTHESIS; HYBRID TETRAMERS; SERA GENE; MECHANISM; COOPERATIVITY; RESIDUES; PURIFICATION	D-3-Phosphoglycerate dehydrogenase (EC 1.1.1.95) from Escherichia coli contains two Gly-Gly sequences that have been shown previously to have the characteristics of hinge regions. One of these, Gly(336)-Gly(337), is found in the loop between the substrate binding domain and the regulatory domain. Changing these glycine residues to valine affected the sensitivity of the enzyme to inhibition by L-serine but not the extent of inhibition. The decrease in sensitivity was caused primarily by a decrease in the affinity of the enzyme for L-serine. These mutations also affected the domain rotation of the subunits in response to L-serine binding. A major conclusion of this study was that it defines a minimal limit on the necessary conformational changes leading to inhibition of enzyme activity. That is, some of the conformational differences seen in the native enzyme upon L-serine binding are not critical for inhibition, whereas others are maintained and may play important roles in inhibition and cooperativity. The structure of G336V demonstrates that the minimal effect of L-serine binding leading to inhibition of enzyme activity requires a domain rotation of approximately only 6 in just two of the four subunits of the enzyme that are oriented diagonally across from each other in the tetramer. Moreover the structures show that both pairs of Asn(190) to Asn(190) hydrogen bonds across the subunit interfaces are necessary for activity. These observations are consistent with the half-the-sites activity, flip-flop mechanism proposed for this and other similar enzymes and suggest that the Asn(190) hydrogen bonds may function in the conformational transition between alternate half-the-site active forms of the enzyme.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Washington University (WUSTL); Washington University (WUSTL); Texas A&M University System; Texas A&M University College Station	Grant, GA (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Box 8103, St Louis, MO 63110 USA.	ggrant@wustl.edu	Dey, Sanghamitra/AAV-7921-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056676] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56676] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AlRabiee R, 1996, J BIOL CHEM, V271, P23235, DOI 10.1074/jbc.271.38.23235; AlRabiee R, 1996, J BIOL CHEM, V271, P13013, DOI 10.1074/jbc.271.22.13013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; ELL JE, 1988, PROTEINS ENZYMES, P465; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Grant GA, 2000, BIOCHEMISTRY-US, V39, P7316, DOI 10.1021/bi000218y; Grant GA, 2005, BIOCHEMISTRY-US, V44, P16844, DOI 10.1021/bi051681j; Grant GA, 2004, METHOD ENZYMOL, V380, P106; Grant GA, 1999, PROTEIN SCI, V8, P2501; Grant GA, 1996, PROTEIN SCI, V5, P34; Grant GA, 2000, ARCH BIOCHEM BIOPHYS, V375, P171, DOI 10.1006/abbi.1999.1652; Grant GA, 2004, J BIOL CHEM, V279, P13452, DOI 10.1074/jbc.M313593200; Grant GA, 2003, J BIOL CHEM, V278, P18170, DOI 10.1074/jbc.M213050200; Grant GA, 2001, J BIOL CHEM, V276, P17844, DOI 10.1074/jbc.M009957200; Grant GA, 1998, J BIOL CHEM, V273, P22389, DOI 10.1074/jbc.273.35.22389; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Kantardjieff KA, 2002, ACTA CRYSTALLOGR D, V58, P735, DOI 10.1107/S0O907444901019588; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LAZDUNSKI M, 1972, CURRENT TOPICS CELLU, V6, P267; Leslie A.G.W., 1992, JT CCP4 ESF EAMCB NE, V26; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILO J, 1994, J BIOL CHEM, V269, P27840; Philo JS, 2000, METHOD ENZYMOL, V321, P100; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; ROSENBLO.J, 1968, J BIOL CHEM, V243, P2099; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHUDSON M, 1995, FORBES MEDIA CRITIC, V2, P76; SCHULLER DJ, 1989, J BIOL CHEM, V264, P2645; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2090; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996; [No title captured]	41	13	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18418	18426		10.1074/jbc.M701174200	http://dx.doi.org/10.1074/jbc.M701174200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17459882	hybrid			2022-12-27	WOS:000247302000048
J	Dul, BE; Walworth, NC				Dul, Barbara E.; Walworth, Nancy C.			The plant homeodomain fingers of fission yeast Msc1 exhibit E3 ubiquitin ligase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; DNA-REPAIR; CONJUGATING ENZYME; PHD FINGER; FUNCTIONAL HOMOLOG; HISTONE H3K4ME3; PROTEIN; GENE; BINDING; RAD6	The DNA damage checkpoint pathway governs how cells regulate cell cycle progression in response to DNA damage. A screen for suppressors of a fission yeast chk1 mutant defective in the checkpoint pathway identified a novel Schizosaccharomyces pombe protein, Msc1. Msc1 contains 3 plant homeodomain (PHD) finger motifs, characteristically defined by a C4HC3 consensus similar to RING finger domains. PHD finger domains in viral proteins and in the cellular protein kinase MEKK1 (mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1) have been implicated as ubiquitin E3 protein ligases that affect protein stability. The close structural relationship of PHD fingers to RING fingers suggests that other PHD domain-containing proteins might share this activity. We show that each of the three PHD fingers of Msc1 can act as ubiquitin E3 ligases, reporting for the first time that PHD fingers from a nuclear protein exhibit E3 ubiquitin ligase activity. The function of the PHD fingers of Msc1 is needed to rescue the DNA damage sensitivity of a chk1 Delta strain. Msc1 co-precipitates Rhp6, the S. pombe homologue of the human ubiquitin-conjugating enzyme Ubc2. Strikingly, deletion of msc1 confers complete suppression of the slow growth phenotype, UV and hydroxyurea sensitivities of an rhp6 deletion strain and restores deficient histone H3 methylation observed in the rhp6 Delta mutant. We speculate that the target of the E3 ubiquitin ligase activity of Msc1 is likely to be a chromatin-associated protein.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Joint Grad Program Cellular & Mol Pharmacol, Newark, NJ 07103 USA; Rutgers State Univ, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Walworth, NC (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	walworna@umdnj.edu		Walworth, Nancy/0000-0001-5940-8236	NIGMS NIH HHS [R01 GM53194] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053194] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Catteau A, 2004, INT J ONCOL, V25, P5; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Edmondson DG, 1998, METHODS, V15, P355, DOI 10.1006/meth.1998.0639; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jacobson S, 1999, CURR OPIN GENET DEV, V9, P175, DOI 10.1016/S0959-437X(99)80027-6; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; LEGGETT DS, 1995, DNA CELL BIOL, V14, P883, DOI 10.1089/dna.1995.14.883; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu HY, 2002, J BIOL CHEM, V277, P2637, DOI 10.1074/jbc.M109016200; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; REYNOLDS P, 1990, EMBO J, V9, P1423, DOI 10.1002/j.1460-2075.1990.tb08258.x; Scheel H, 2003, TRENDS CELL BIOL, V13, P285, DOI 10.1016/S0962-8924(03)00102-8; SCHINDLER U, 1993, PLANT J, V4, P137, DOI 10.1046/j.1365-313X.1993.04010137.x; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Singh J, 1998, MOL CELL BIOL, V18, P5511, DOI 10.1128/MCB.18.9.5511; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang SW, 2002, J CELL SCI, V115, P587; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249	46	31	31	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18397	18406		10.1074/jbc.M700729200	http://dx.doi.org/10.1074/jbc.M700729200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17456468	hybrid			2022-12-27	WOS:000247302000046
J	Furuya, K; Ozaki, T; Hanamoto, T; Hosoda, M; Hayashi, S; Barker, PA; Takano, K; Matsumoto, M; Nakagawara, A				Furuya, Kazushige; Ozaki, Toshinori; Hanamoto, Takayuki; Hosoda, Mitsuchika; Hayashi, Syunji; Barker, Philip A.; Takano, Kunio; Matsumoto, Masahiko; Nakagawara, Akira			Stabilization of p73 by nuclear I kappa B kinase-alpha mediates cisplatin-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACLITAXEL-INDUCED APOPTOSIS; DEPENDENT GENE-EXPRESSION; ABL TYROSINE KINASE; DNA-DAMAGE; IKK-ALPHA; C-ABL; REGULATES P73; MICE LACKING; CELL-DEATH; SIGNALING PATHWAY	In response to DNA damage, p53 and its homolog p73 have a function antagonistic to NF-kappa B in deciding cell fate. Here, we show for the first time that p73, but not p53, is stabilized by physical interaction with nuclear I kappa B kinase (IKK)-alpha to enhance cisplatin (CDDP)-induced apoptosis. CDDP caused a significant increase in the amounts of nuclear IKK-alpha and p73 alpha in human osteosarcoma-derived U2OS cells. Ectopic expression of IKK-alpha prolonged the half-life of p73 by inhibiting its ubiquitination and thereby enhancing its transactivation and pro-apoptotic activities. Consistent with these results, small interfering RNA-mediated knockdown of endogenous IKK-alpha inhibited the CDDP-mediated accumulation of p73 alpha. The kinase-deficient mutant form of IKK-alpha interacted with p73 alpha, but failed to stabilize it. Furthermore, CDDP-mediated accumulation of endogenous p73 alpha was not detected in mouse embryonic fibroblasts (MEFs) prepared from IKK-alpha-deficient mice, and CDDP sensitivity was significantly decreased in IKK-alpha-deficient MEFs compared with wild-type MEFs. Thus, our results strongly suggest that the nuclear IKK-alpha-mediated accumulation of p73 alpha is one of the novel molecular mechanisms to induce apoptotic cell death in response to CDDP, which may be particularly important in killing tumor cells with p53 mutation.	Canc Ctr Res Inst, Div Biochem, Chiba 2608717, Japan; Univ Yamanashi, Sch Med, Dept Surg 2, Yamaguchi 4093898, Japan; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of Yamanashi; McGill University	Nakagawara, A (corresponding author), Canc Ctr Res Inst, Div Biochem, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp	Hosoda, Mitsuchika/A-7534-2012					Agami R, 1999, NATURE, V399, P809; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bayon Y, 2003, MOL CELL BIOL, V23, P1061, DOI 10.1128/MCB.23.3.1061-1074.2003; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Ben-Yehoyada M, 2003, J BIOL CHEM, V278, P34475, DOI 10.1074/jbc.M301051200; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Chang NS, 2002, J BIOL CHEM, V277, P10323, DOI 10.1074/jbc.M106607200; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Cusack JC, 2001, CANCER RES, V61, P3535; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Fujioka S, 2004, J BIOL CHEM, V279, P27549, DOI 10.1074/jbc.M313435200; Gong JG, 1999, NATURE, V399, P806; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hehner SP, 1998, J BIOL CHEM, V273, P18117, DOI 10.1074/jbc.273.29.18117; Hellin AC, 1998, ONCOGENE, V16, P1187, DOI 10.1038/sj.onc.1201638; Hollstein M, 1997, Recent Results Cancer Res, V143, P369; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang Y, 2002, MOL PHARMACOL, V61, P105, DOI 10.1124/mol.61.1.105; Huang Y, 2000, CANCER RES, V60, P4426; Ikawa S, 1999, CELL DEATH DIFFER, V6, P1154, DOI 10.1038/sj.cdd.4400631; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V354, P892, DOI 10.1016/j.bbrc.2007.01.057; NICKERSON JA, 1992, J CELL BIOL, V116, P977, DOI 10.1083/jcb.116.4.977; Ohtsuka T, 2003, ONCOGENE, V22, P1678, DOI 10.1038/sj.onc.1206306; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Stiewe T, 2002, CANCER RES, V62, P3598; SUN XG, 1995, MOL CELL BIOL, V15, P4489; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; VAN AD, 1996, SCIENCE, V274, P787; Verma UN, 2004, J BIOL CHEM, V279, P3509, DOI 10.1074/jbc.M309300200; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wan YSY, 2003, IMMUNITY, V18, P331, DOI 10.1016/S1074-7613(03)00053-0; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WU HY, 1994, J BIOL CHEM, V269, P20067; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000	67	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18365	18378		10.1074/jbc.M610522200	http://dx.doi.org/10.1074/jbc.M610522200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452332	hybrid			2022-12-27	WOS:000247302000043
J	Marino, G; Salvador-Montoliu, N; Fueyo, A; Knecht, E; Mizushima, N; Lopez-Otin, C				Marino, Guillermo; Salvador-Montoliu, Natalia; Fueyo, Antonio; Knecht, Erwin; Mizushima, Noboru; Lopez-Otin, Carlos			RETRACTED: Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/Autophagin-3 (Retracted article. See vol. 294, pg. 1435, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							CELL-DEATH; CONJUGATION SYSTEM; CANCER; DEGRADATION; PROTEINS; GABARAP; GATE-16; INHIBITION; PROTEASE; PATHWAYS	Atg4C/autophagin-3 is a member of a family of cysteine proteinases proposed to be involved in the processing and delipidation of the mammalian orthologues of yeast Atg8, an essential component of an ubiquitin-like modification system required for execution of autophagy. To date, the in vivo role of the different members of this family of proteinases remains unclear. To gain further insights into the functional relevance of Atg4 orthologues, we have generated mutant mice deficient in Atg4C/autophagin-3. These mice are viable and fertile and do not display any obvious abnormalities, indicating that they are able to develop the autophagic response required during the early neonatal period. However, Atg4C(-/-)-starved mice show a decreased autophagic activity in the diaphragm as assessed by immunoblotting studies and by fluorescence microscopic analysis of samples from Atg4C(-/-) GFP-LC3 transgenic mice. In addition, animals deficient in Atg4C show an increased susceptibility to develop fibrosarcomas induced by chemical carcinogens. Based on these results, we propose that Atg4C is not essential for autophagy development under normal conditions but is required for a proper autophagic response under stressful conditions such as prolonged starvation. We also propose that this enzyme could play an in vivo role in events associated with tumor progression.	Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; Univ Oviedo, Inst Univ Oncol, Dept Biol Funct, E-33006 Oviedo, Spain; Ctr Invest Prinipe Felipe, Lab Biol Celular, E-46013 Valencia, Spain; Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan; Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; Japan Sci & Technol Agcy, SORST, Kawguchi 3320012, Japan	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Tokyo Metropolitan Institute of Medical Science; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	clo@uniovi.es	Knecht, Erwin/K-2432-2014; Fueyo, Antonio/ABH-3243-2020; Mizushima, Noboru/C-3635-2009; Knecht, Erwin/A-9366-2014; marino, guillermo/HGB-8664-2022	Knecht, Erwin/0000-0002-7208-3832; Fueyo, Antonio/0000-0002-7121-9398; Mizushima, Noboru/0000-0002-6258-6444; 				Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Everitt AB, 2004, J BIOL CHEM, V279, P21701, DOI 10.1074/jbc.M312806200; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Fuertes G, 2003, INT J BIOCHEM CELL B, V35, P651, DOI 10.1016/S1357-2725(02)00382-5; Furuta S, 2004, ONCOGENE, V23, P3898, DOI 10.1038/sj.onc.1207539; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kim R, 2006, EJSO-EUR J SURG ONC, V32, P269, DOI 10.1016/j.ejso.2005.12.006; Kim R, 2005, ONCOL REP, V14, P595; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; KISEN GO, 1993, CARCINOGENESIS, V14, P2501, DOI 10.1093/carcin/14.12.2501; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Manzanedo C, 2004, BEHAV BRAIN RES, V150, P73, DOI 10.1016/S0166-4328(03)00225-0; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2003, INT J BIOCHEM CELL B, V35, P553, DOI 10.1016/S1357-2725(02)00343-6; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nagler DK, 2003, BIOL CHEM, V384, P837, DOI 10.1515/BC.2003.094; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; SCHWARZE PE, 1985, EXP CELL RES, V157, P15, DOI 10.1016/0014-4827(85)90148-X; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weng LP, 1999, CANCER RES, V59, P5808; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	66	329	351	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18573	18583		10.1074/jbc.M701194200	http://dx.doi.org/10.1074/jbc.M701194200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17442669	hybrid			2022-12-27	WOS:000247302000062
J	Nishimura, H; Myles, DG; Primakoff, P				Nishimura, Hitoshi; Myles, Diana G.; Primakoff, Paul			Identification of an ADAM2-ADAM3 complex on the surface of mouse testicular germ cells and cauda epididymal sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; FERTILIN-ALPHA; MICE; EXPRESSION; PROTEINS; ADAM3; LOCALIZATION; PENETRATION; CYRITESTIN; MEMBRANE	Male mice lacking ADAM2 (fertilin beta) or ADAM3 (cyritestin) are infertile; cauda epididymal sperm (mature sperm) from these mutant mice cannot bind to the egg zona pellucida. ADAM3 is barely present in Adam2-null sperm, despite normal levels of this protein in Adam2-null testicular germ cells (TGCs; sperm precursor cells). Here, we have explored the molecular basis for the loss of ADAM3 in Adam2-null TGCs to clarify the biosynthetic and functional linkage of ADAM2 and ADAM3. A small portion of total ADAM3 was found present on the surface of wild-type and Adam2(-/-) TGCs at similar levels. In the Adam2-null TGCs, however, surface-localized ADAM3 exhibited an increased amount of an endoglycosidase H-resistant form that may be related to instability of ADAM3. Moreover, we found a complex between ADAM2 and ADAM3 on the surface of TGCs and sperm. The intracellular chaperone calnexin was a component of the testicular ADAM2-ADAM3 complex. Our findings suggest that the association with ADAM2 is a key element for stability of ADAM3 in epididymal sperm. The presence of the ADAM2-ADAM3 complex in sperm also suggests a potential role of ADAM2 with ADAM3 in sperm binding to the egg zona pellucida.	Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95618 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95618 USA	University of California System; University of California Davis; University of California System; University of California Davis	Primakoff, P (corresponding author), Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, 1 Shields Ave, Davis, CA 95618 USA.	pdprimakoff@ucdavis.edu			NICHD NIH HHS [HD-16580] Funding Source: Medline; PHS HHS [U54-29125] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016580, R01HD016580] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cho CH, 2000, DEV BIOL, V222, P289, DOI 10.1006/dbio.2000.9703; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Claassens OE, 1998, HUM REPROD, V13, P3139, DOI 10.1093/humrep/13.11.3139; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Kim E, 2006, J BIOL CHEM, V281, P5634, DOI 10.1074/jbc.M510558200; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Kim E, 2004, J REPROD DEVELOP, V50, P571, DOI 10.1262/jrd.50.571; Kim E, 2003, BIOCHEM BIOPH RES CO, V304, P313, DOI 10.1016/S0006-291X(03)00588-6; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2002, GENE, V291, P67, DOI 10.1016/S0378-1119(02)00540-1; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; PHELPS BM, 1990, J CELL BIOL, V111, P1839, DOI 10.1083/jcb.111.5.1839; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Schlondorff J, 1999, J CELL SCI, V112, P3603; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; Stein KK, 2006, PROTEOMICS, V6, P3533, DOI 10.1002/pmic.200500845; Stein KK, 2005, BIOL REPROD, V73, P1032, DOI 10.1095/biolreprod.105.040972; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yanagimachi R., 1994, P189	26	41	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17900	17907		10.1074/jbc.M702268200	http://dx.doi.org/10.1074/jbc.M702268200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17439939	hybrid			2022-12-27	WOS:000247084500063
J	Pandey, MK; Sandur, SK; Sung, B; Sethi, G; Kunnumakkara, AB; Aggarwal, BB				Pandey, Manoj K.; Sandur, Santosh K.; Sung, Bokyung; Sethi, Gautam; Kunnumakkara, Ajaikumar B.; Aggarwal, Bharat B.			Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappa B and NF-kappa B-regulated gene expression through direct inhibition of I kappa B alpha kinase beta on cysteine 179 residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; RHUS-VERNICIFLUA STOKES; TRANSCRIPTIONAL REGULATION; CELL-GROWTH; CONSTITUTIVE ACTIVATION; PLANT POLYPHENOLS; INDUCE APOPTOSIS; TYROSINE KINASE; DOWN-REGULATION; TNF-ALPHA	Although butein (3,4,2', 4'-tetrahydroxychalcone) is known to exhibit anti-inflammatory, anti-cancer, and anti-fibrogenic activities, very little is known about its mechanism of action. Because numerous effects modulated by butein can be linked to interference with the NF-kappa B pathway, we investigated in detail the effect of this chalcone on NF-kappa B activity. As examined by DNA binding, we found that butein suppressed tumor necrosis factor (TNF)-induced NF-kappa B activation in a dose-and time-dependent manner; suppressed the NF-kappa B activation induced by various inflammatory agents and carcinogens; and inhibited the NF-kappa B reporter activity induced by TNFR1, TRADD, TRAF2, NIK, TAK1/ TAB1, and IKK-beta. We also found that butein blocked the phosphorylation and degradation of I kappa B alpha by inhibiting I kappa B alpha kinase (IKK) activation. We found the inactivation of IKK by butein was direct and involved cysteine residue 179. This correlated with the suppression of phosphorylation and the nuclear translocation of p65. In this study, butein also inhibited the expression of the NF-kappa B-regulated gene products involved in anti-apoptosis (IAP2, Bcl-2, and Bcl-xL), proliferation (cyclin D1 and c-Myc), and invasion (COX-2 and MMP-9). Suppression of these gene products correlated with enhancement of the apoptosis induced by TNF and chemotherapeutic agents; and inhibition of cytokine-induced cellular invasion. Overall, our results indicated that antitumor and anti-inflammatory activities previously assigned to butein may be mediated in part through the direct inhibition of IKK, leading to the suppression of the NF-kappa B activation pathway.	Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Aggarwal, BB (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Kunnumakkara, Ajaikumar/AAH-5214-2019; Pandey, Manoj K/K-9706-2015; Sung, Bokyung/AAX-5697-2021; Sethi, Gautam/F-2372-2011; Kunnumakkara, Ajaikumar/H-8566-2012; Aggarwal, Bharat B/G-3388-2013	Kunnumakkara, Ajaikumar/0000-0001-9121-6816; Pandey, Manoj K/0000-0002-2767-2929; Sethi, Gautam/0000-0002-8677-8475; Kunnumakkara, Ajaikumar/0000-0001-9121-6816; 	NCI NIH HHS [CA016672-32, P01 CA91844, P50 CA97007] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA097007, P01CA091844, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; AIZU E, 1986, CARCINOGENESIS, V7, P1809, DOI 10.1093/carcin/7.11.1809; ALBINI A, 1987, CANCER RES, V47, P3239; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Cheng ZJ, 1998, BBA-LIPID LIPID MET, V1392, P291, DOI 10.1016/S0005-2760(98)00043-5; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DUYAO MP, 1992, J BIOL CHEM, V267, P16288; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayashi K, 1996, EUR J PHARMACOL, V316, P297, DOI 10.1016/S0014-2999(96)00689-9; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Iwashita K, 2000, BIOSCI BIOTECH BIOCH, V64, P1813, DOI 10.1271/bbb.64.1813; Jang HS, 2005, BBA-GEN SUBJECTS, V1726, P309, DOI 10.1016/j.bbagen.2005.08.010; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Jeon KI, 2003, EXP MOL MED, V35, P61, DOI 10.1038/emm.2003.9; Kang DG, 2004, BIOL PHARM BULL, V27, P366, DOI 10.1248/bpb.27.366; Kang DK, 2003, BIOL PHARM BULL, V26, P1345, DOI 10.1248/bpb.26.1345; Kang HM, 2004, NAT PROD RES, V18, P349, DOI 10.1080/14786410310001622022; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khatib S, 2005, BIOORGAN MED CHEM, V13, P433, DOI 10.1016/j.bmc.2004.10.010; Kim NY, 2001, PHARMACOL TOXICOL, V88, P261, DOI 10.1034/j.1600-0773.2001.d01-114.x; KUPPUSAMY UR, 1992, BIOCHEM PHARMACOL, V44, P1307, DOI 10.1016/0006-2952(92)90531-M; Lee JC, 2004, FOOD CHEM TOXICOL, V42, P1383, DOI 10.1016/j.fct.2004.03.012; Lee JC, 2002, BBA-GEN SUBJECTS, V1570, P181, DOI 10.1016/S0304-4165(02)00196-4; Lee SH, 2004, BIOCHEM BIOPH RES CO, V323, P125, DOI 10.1016/j.bbrc.2004.08.063; Lee SH, 2003, PLANTA MED, V69, P990, DOI 10.1055/s-2003-45143; Lee SH, 2006, BIOCHEM PHARMACOL, V72, P1322, DOI 10.1016/j.bcp.2006.08.004; Lim SS, 2001, J PHARM PHARMACOL, V53, P653, DOI 10.1211/0022357011775983; Liotta L A, 1982, Cancer Metastasis Rev, V1, P277, DOI 10.1007/BF00124213; Manna SK, 2000, J IMMUNOL, V165, P4927, DOI 10.4049/jimmunol.165.9.4927; Na HK, 2006, MOL CARCINOGEN, V45, P368, DOI 10.1002/mc.20225; NELSEN B, 1988, MOL CELL BIOL, V8, P3526, DOI 10.1128/MCB.8.8.3526; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Park MH, 2005, BIOCHEMISTRY-US, V44, P8326, DOI 10.1021/bi050156h; RAMANATHAN R, 1992, CANCER LETT, V62, P217, DOI 10.1016/0304-3835(92)90099-H; REDDY SAG, 1994, J BIOL CHEM, V269, P25369; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; SAMOSZUK M, 2005, BMC COMPLEM ALTERN M, V5, P1; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Selvam C, 2004, PHYTOTHER RES, V18, P582, DOI 10.1002/ptr.1492; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shishodia S, 2003, CANCER RES, V63, P4375; Simeonidis S, 1999, P NATL ACAD SCI USA, V96, P49, DOI 10.1073/pnas.96.1.49; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; SOGAWA S, 1994, BIOL PHARM BULL, V17, P251; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; Takano-Ishikawa Y, 2003, PHYTOTHER RES, V17, P1224, DOI 10.1002/ptr.1371; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; THEVENIN C, 1990, New Biologist, V2, P793; THIYAGARAJAH P, 1991, BIOCHEM PHARMACOL, V41, P669, DOI 10.1016/0006-2952(91)90065-D; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang Y, 2005, LIFE SCI, V77, P39, DOI 10.1016/j.lfs.2004.12.014; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Woo SW, 2003, J PHARM PHARMACOL, V55, P347, DOI 10.1211/002235702658; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yang EB, 1998, BIOCHEM BIOPH RES CO, V245, P435, DOI 10.1006/bbrc.1998.8452; Yang EB, 2001, BBA-PROTEIN STRUCT M, V1550, P144, DOI 10.1016/S0167-4838(01)00276-X; YIT CC, 1994, CANCER LETT, V82, P65, DOI 10.1016/0304-3835(94)90147-3; YU SM, 1995, EUR J PHARMACOL, V280, P69, DOI 10.1016/0014-2999(95)00190-V; Zhang K, 1997, BIOCHEM J, V325, P417, DOI 10.1042/bj3250417; ZHANG K, 1994, BIOCHEM PHARMACOL, V47, P2063, DOI 10.1016/0006-2952(94)90082-5; Zhang K, 1996, BIOCHEM PHARMACOL, V52, P1631, DOI 10.1016/S0006-2952(96)00570-9; Zhang K, 1997, BIOCHEM PHARMACOL, V54, P1047, DOI 10.1016/S0006-2952(97)00315-8; Zhang K, 2003, LIFE SCI, V72, P2629, DOI 10.1016/S0024-3205(03)00173-5; Zhu LL, 2003, ANAL CHEM, V75, P6381, DOI 10.1021/ac026371a	80	155	161	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17340	17350		10.1074/jbc.M700890200	http://dx.doi.org/10.1074/jbc.M700890200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17439942	hybrid			2022-12-27	WOS:000247084500004
J	Kopriva, S; Fritzemeier, K; Wiedemann, G; Reski, R				Kopriva, Stanislav; Fritzemeier, Kai; Wiedemann, Gertrud; Reski, Ralf			The putative moss 3 '-phosphoadenosine-5 '-phosphosulfate reductase is a novel form of adenosine-5 '-phosphosulfate reductase without an iron-sulfur cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE 5'-PHOSPHOSULFATE REDUCTASE; PREDICTING SUBCELLULAR-LOCALIZATION; PHYSCOMITRELLA-PATENS; SULFATE REDUCTASE; PAPS REDUCTASE; APS REDUCTASE; ASSIMILATION; METABOLISM	Sulfate assimilation provides reduced sulfur for synthesis of the amino acids cysteine and methionine and for a range of other metabolites. Sulfate has to be activated prior to reduction by adenylation to adenosine 5'-phosphosulfate (APS). In plants, algae, and many bacteria, this compound is reduced to sulfite by APS reductase (APR); in fungi and some cyanobacteria and gamma-proteobacteria, a second activation step, phosphorylation to 3'-phosphoadenosine 5'-phosphosulfate ( PAPS), is necessary before reduction to sulfite by PAPS reductase (PAPR). We found previously that the moss Physcomitrella patens is unique among these organisms in possessing orthologs of both APR and PAPR genes (Koprivova, A., Meyer, A. J., Schween, G., Herschbach, C., Reski, R., and Kopriva, S. ( 2002) J. Biol. Chem. 277, 32195-32201). To assess the function of the two enzymes, we compared their biochemical properties by analysis of purified recombinant proteins. APR from Physcomitrella is very similar to the well characterized APRs from seed plants. On the other hand, we found that the putative PAPR preferentially reduces APS. Sequence analysis, analysis of UV-visible spectra, and determination of iron revealed that this new APR, named PpAPR-B, does not contain the FeS cluster, which was previously believed to determine the substrate specificity of the otherwise relatively similar enzymes. The lack of the FeS cluster in PpAPR-B catalysis is connected with a lower turnover rate but higher stability of the protein. These findings show that APS reduction without the FeS cluster is possible and that plant sulfate assimilation is predominantly dependent on reduction of APS.	John Innes Inst, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; Univ Freiburg, Fac Biol, Plant Biochem Sect, D-79104 Freiburg, Germany; Univ Freiburg, Fac Biol, Plant Biotechnol Sect, D-79104 Freiburg, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Freiburg; University of Freiburg	Kopriva, S (corresponding author), John Innes Inst, Dept Metab Biol, Coloney Lane, Norwich NR4 7UH, Norfolk, England.	stanislav.kopriva@bbsrc.ac.uk	Reski, Ralf/A-8817-2008; Kopriva, Stanislav/C-7401-2013	Kopriva, Stanislav/0000-0002-7416-6551; Wiedemann, Gertrud/0000-0002-2259-1011; Reski, Ralf/0000-0002-5496-6711				Berndt C, 2004, J BIOL CHEM, V279, P7850, DOI 10.1074/jbc.M309332200; Bick JA, 1998, P NATL ACAD SCI USA, V95, P8404, DOI 10.1073/pnas.95.14.8404; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Carroll KS, 2005, BIOCHEMISTRY-US, V44, P14647, DOI 10.1021/bi051344a; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; HOGLUND A, 2006, P PAC S BIOC, V11, P16; Hohe A, 2002, PLANT CELL REP, V20, P1135, DOI 10.1007/s00299-002-0463-y; Horton P, 2006, P 4 AS PAC BIOINF C; Kiessling J, 2000, J CELL BIOL, V151, P945, DOI 10.1083/jcb.151.4.945; Kim SK, 2004, BIOCHEMISTRY-US, V43, P13478, DOI 10.1021/bi048811t; Kim SK, 2007, BIOCHEMISTRY-US, V46, P591, DOI 10.1021/bi0618971; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kopriva S, 2004, J EXP BOT, V55, P1775, DOI 10.1093/jxb/erh185; Kopriva S, 2006, ANN BOT-LONDON, V97, P479, DOI 10.1093/aob/mcl006; Kopriva S, 2002, J BIOL CHEM, V277, P21786, DOI 10.1074/jbc.M202152200; Kopriva S, 2001, J BIOL CHEM, V276, P42881, DOI 10.1074/jbc.M107424200; Koprivova A, 2002, J BIOL CHEM, V277, P32195, DOI 10.1074/jbc.M204971200; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lang D, 2005, PLANT BIOLOGY, V7, P238, DOI 10.1055/s-2005-837578; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; LI JY, 1991, BIOCHEM J, V274, P355, DOI 10.1042/bj2740355; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Penning TM, 2001, CHEM REV, V101, P3027, DOI 10.1021/cr000049n; RESKI R, 1985, PLANTA, V165, P354, DOI 10.1007/BF00392232; ROTHER S, 1994, J PLANT PHYSIOL, V143, P72, DOI 10.1016/S0176-1617(11)82099-7; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; SCHWENN JD, 1988, ARCH MICROBIOL, V150, P313, DOI 10.1007/BF00408300; Stumpe M, 2006, BBA-MOL CELL BIOL L, V1761, P301, DOI 10.1016/j.bbalip.2006.03.008; Tomita T, 2006, BIOSCI BIOTECH BIOCH, V70, P2230, DOI 10.1271/bbb.60170; Weber M, 2000, EUR J BIOCHEM, V267, P3647, DOI 10.1046/j.1432-1327.2000.01394.x	35	31	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22930	22938		10.1074/jbc.M702522200	http://dx.doi.org/10.1074/jbc.M702522200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17519237	hybrid			2022-12-27	WOS:000248354200070
J	Hildebrand, ME; David, LS; Hamid, J; Mulatz, K; Garcia, E; Zamponi, GW; Snutch, TP				Hildebrand, Michael E.; David, Laurence S.; Hamid, Jawed; Mulatz, Kirk; Garcia, Esperanza; Zamponi, Gerald W.; Snutch, Terrance P.			Selective inhibition of Cav3.3 T-type calcium channels by G alpha(q/11)-coupled muscarinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHILDHOOD ABSENCE EPILEPSY; RETICULAR THALAMIC NEURONS; CA2+ CHANNELS; OLFACTORY-BULB; FUNCTIONAL-CHARACTERIZATION; GRANULE CELLS; GENE FAMILY; BETA-GAMMA; RAT-BRAIN; MODULATION	T-type calcium channels play critical roles in controlling neuronal excitability, including the generation of complex spiking patterns and the modulation of synaptic plasticity, although the mechanisms and extent to which T-type Ca2+ channels are modulated by G-protein-coupled receptors (GPCRs) remain largely unexplored. To examine specific interactions between T-type Ca2+ channel subtypes and muscarinic acetylcholine receptors (mAChRS), the Cav3.1 (alpha(1G)), Cav3.2 (alpha(1H)), and Cav3.3 (alpha(1I)) T-type Ca2+ channels were co-expressed with the M1 G alpha(q/11)-coupled mAChR. Perforated patch recordings demonstrate that activation of M1 receptors has a strong inhibitory effect on Cav3.3 T-type Ca2+ currents but either no effect or a moderate stimulating effect on Cav3.1 and Cav3.2 peak current amplitudes. This differential modulation was observed for both rat and human T-type Ca2+ channel variants. The inhibition of Cav3.3 channels by M1 receptors is reversible, use-independent, and associated with a concomitant increase in inactivation kinetics. Loss-of-function experiments with genetically encoded antagonists of G alpha and G beta gamma proteins and gain-of-function experiments with genetically encoded G alpha subtypes indicate that M1 receptor-mediated inhibition of Cav3.3 occurs through G alpha(q/11). This is supported by experiments showing that activation of the M3 and M5 G alpha(q/11)-coupled mAChRs also causes inhibition of Cav3.3 currents, although G alpha(i)-coupled mAChRs (M2 and M4) have no effect. Examining Cav3.1-Cav3.3 chimeric channels demonstrates that two distinct regions of the Cav3.3 channel are necessary and sufficient for complete M1 receptor-mediated channel inhibition and represent novel sites not previously implicated in T-type channel modulation.	Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	University of British Columbia; University of Calgary	Snutch, TP (corresponding author), Univ British Columbia, Michael Smith Labs, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	snutch@msl.ubc.ca	Hildebrand, Michael E/J-9102-2012; Snutch, Terrance P/L-3464-2019	Hildebrand, Michael E/0000-0002-6845-8013; Snutch, Terrance P/0000-0001-5182-1296; Zamponi, Gerald W./0000-0002-0644-9066				ALLEN TGJ, 1993, J PHYSIOL-LONDON, V466, P173; Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Bannister RA, 2002, BIOPHYS J, V83, P3256, DOI 10.1016/S0006-3495(02)75327-7; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Castillo PE, 1999, J NEUROSCI, V19, P9180; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2001, EMBO J, V20, P7033, DOI 10.1093/emboj/20.24.7033; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Chevalier M, 2006, EUR J NEUROSCI, V23, P2321, DOI 10.1111/j.1460-9568.2006.04761.x; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; Dippel E, 1996, P NATL ACAD SCI USA, V93, P1391, DOI 10.1073/pnas.93.4.1391; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Egger V, 2003, J NEUROSCI, V23, P7551; FISHER R, 1990, J NEUROPHYSIOL, V64, P1291, DOI 10.1152/jn.1990.64.4.1291; FRASER DD, 1991, J NEUROSCI, V11, P2812; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hildebrand M.E., 2006, DRUG DISCOVERY TODAY, V3, P335; HILDEBRAND ME, 2005, BIOPH SOC 49 ANN M L; HOGGER P, 1995, J BIOL CHEM, V270, P7405; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Joksovic PM, 2006, J PHYSIOL-LONDON, V574, P415, DOI 10.1113/jphysiol.2006.110395; Joksovic PM, 2005, J PHYSIOL-LONDON, V566, P125, DOI 10.1113/jphysiol.2005.086579; Kammermeier PJ, 2000, J NEUROSCI, V20, P5623, DOI 10.1523/JNEUROSCI.20-15-05623.2000; Khosravani H, 2005, ANN NEUROL, V57, P745, DOI 10.1002/ana.20458; Khosravani H, 2004, J BIOL CHEM, V279, P9681, DOI 10.1074/jbc.C400006200; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Lee JH, 1999, J NEUROSCI, V19, P1912; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LEVEY AI, 1994, NEUROSCIENCE, V63, P207, DOI 10.1016/0306-4522(94)90017-5; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Melliti K, 2000, J NEUROSCI, V20, P7167; Mittman S, 1999, NEUROSCI LETT, V269, P121, DOI 10.1016/S0304-3940(99)00319-5; Monteil A, 2000, J BIOL CHEM, V275, P16530, DOI 10.1074/jbc.C000090200; Murbartian J, 2004, J NEUROPHYSIOL, V92, P3399, DOI 10.1152/jn.00498.2004; Murbartian J, 2002, FEBS LETT, V528, P272, DOI 10.1016/S0014-5793(02)03341-0; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Peloquin JB, 2006, EPILEPSIA, V47, P655, DOI 10.1111/j.1528-1167.2006.00482.x; Pemberton KE, 2000, PFLUG ARCH EUR J PHY, V440, P452, DOI 10.1007/s004240000303; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Plummer KL, 1999, J COMP NEUROL, V404, P408; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Santi CM, 2002, J NEUROSCI, V22, P396, DOI 10.1523/JNEUROSCI.22-02-00396.2002; SCHWARZ RD, 1993, LIFE SCI, V52, P465, DOI 10.1016/0024-3205(93)90303-K; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Talley EM, 1999, J NEUROSCI, V19, P1895; THOMPSON SM, 1991, J PHYSIOL-LONDON, V439, P671, DOI 10.1113/jphysiol.1991.sp018687; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200; TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; Wan XD, 1996, ENDOCRINOLOGY, V137, P2514, DOI 10.1210/en.137.6.2514; WEI J, 1994, J NEUROCHEM, V63, P815; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yunker AMR, 2003, NEUROSCIENCE, V117, P321, DOI 10.1016/S0306-4522(02)00936-3; Zamponi Gerald W, 2002, Mol Interv, V2, P476, DOI 10.1124/mi.2.8.476	65	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21043	21055		10.1074/jbc.M611809200	http://dx.doi.org/10.1074/jbc.M611809200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535809	Green Published, hybrid			2022-12-27	WOS:000248047500031
J	Wei, F; Scholer, HR; Atchison, ML				Wei, Fang; Schoeler, Hans R.; Atchison, Michael L.			Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; POU DIMER CONFIGURATION; TRANSCRIPTION FACTOR; SUMO-1 MODIFICATION; MAMMALIAN EMBRYO; PROTEIN SUMO-1; UBIQUITIN; GENE; OCT-3/4; DOMAIN	Transcription factor Oct4 is a master regulator affecting the fate of pluripotent stem cells and germ cell precursors. Oct4 expression is tightly regulated, and small changes in expression level can have dramatic effects on differentiation or oncogenesis. Post-translational modifications including phosphorylation and ubiquitination have been reported to regulate Oct4 transcriptional activity. Here we show that Oct4 is a target for small ubiquitin-related modifier (SUMO)-1 modification in vivo and in vitro. Sumoylation of Oct4 occurs at a single lysine, Lys(118), located at the end of the amino-terminal transactivation domain and next to the Pit1-Oct-Unc86 (POU) DNA binding domain. SUMO-1 and Oct4 colocalize at several promoter sequences in vivo, and a fraction of Oct4 molecules colocalized with SUMO-1 in nuclear aggregates. Sumoylation of Oct4 led to significantly increased Oct4 stability and increased DNA binding. In addition, SUMO-1 cotransfection led to augmented Oct4 transactivation potential that was reduced when the Oct4 sumoylation target site was mutated. Therefore, sumoylation of Oct4 results in increased stability, DNA binding, and transactivation and provides an important mechanism to regulate Oct4 activity.	Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Dept Anim Biol, Philadelphia, PA 19104 USA; Max Planck Inst Mol Biomed, D-48149 Munster, Germany	University of Pennsylvania; Max Planck Society	Atchison, ML (corresponding author), Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	atchison@vet.upenn.edu	, HS/AAB-4434-2019	, HS/0000-0003-2643-5136	NICHD NIH HHS [HD042011] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042011] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brehm A, 1997, MOL CELL BIOL, V17, P154, DOI 10.1128/MCB.17.1.154; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hodawadekar S, 2006, J IMMUNOL, V177, P6165, DOI 10.4049/jimmunol.177.9.6165; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yeom YI, 1996, DEVELOPMENT, V122, P881; YEOM YI, 1991, MECH DEVELOP, V35, P171	38	136	141	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21551	21560		10.1074/jbc.M611041200	http://dx.doi.org/10.1074/jbc.M611041200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17525163	hybrid			2022-12-27	WOS:000248047500082
J	Gand, A; Antoine, M; Boschi-Muller, S; Branlant, G				Gand, Adeline; Antoine, Mathias; Boschi-Muller, Sandrine; Branlant, Guy			Characterization of the amino acids involved in substrate specificity of methionine sulfoxide reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; CATALYTIC MECHANISM; KINETIC CHARACTERIZATION; CRYSTAL-STRUCTURE; OXIDATION; ENZYME; MSRA	Methionine sulfoxide reductases (Msrs) are ubiquitous enzymes that catalyze the thioredoxin-dependent reduction of methionine sulfoxide ( MetSO) back to methionine. In vivo, Msrs are essential in protecting cells against oxidative damages on proteins and in the virulence of some bacteria. There exists two structurally unrelated classes of Msrs. MsrAs are stereo-specific toward the S epimer on the sulfur of the sulfoxide, whereas MsrBs are specific toward the R isomer. Both classes of Msrs display a similar catalytic mechanism of sulfoxide reduction by thiols via the sulfenic acid chemistry and a better affinity for protein-bound MetSO than for free MetSO. Recently, the role of the amino acids implicated in the catalysis of the reductase step of Neisseria meningitidis MsrA was determined. In the present study, the invariant amino acids potentially involved in substrate binding, i.e. Phe-52, Trp-53, Asp-129, His-186, Tyr-189, and Tyr-197, were substituted. The catalytic parameters under steady-state conditions and of the reductase step of the mutated MsrAs were determined and compared with those of the wild type. Altogether, the results support the presence of at least two binding subsites. The first one, whose contribution is major in the efficiency of the reductase step and in which the is an element of-methyl group of MetSO binds, is the hydrophobic pocket formed by Phe-52 and Trp-53, the position of the indole ring being stabilized by interactions with His-186 and Tyr-189. The second subsite composed of Asp-129 and Tyr-197 contributes to the binding of the main chain of the substrate but to a lesser extent.	Nancy Univ, Fac Sci & Tech, CNRS, UHP 7567, F-54506 Vandoeuvre Les Nancy, France; Nancy Univ, Fac Sci & Tech, Unite Mixte Rech, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine	Branlant, G (corresponding author), Nancy Univ, Fac Sci & Tech, CNRS, UHP 7567, Bld des Aiguillettes,BP 239, F-54506 Vandoeuvre Les Nancy, France.	Guy.Branlant@maem.uhp-nancy.fr		Boschi, Sandrine/0000-0001-8962-4749				Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; Antoine M, 2006, J BIOL CHEM, V281, P39062, DOI 10.1074/jbc.M608844200; Balta B, 2006, J PHYS CHEM A, V110, P7628, DOI 10.1021/jp0573036; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701; CHIPOT C, 1993, J PHYS CHEM-US, V97, P9788, DOI 10.1021/j100140a042; Coudevylle N, 2007, J MOL BIOL, V366, P193, DOI 10.1016/j.jmb.2006.11.042; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Gruez A, 2004, J MOL BIOL, V343, P29, DOI 10.1016/j.jmb.2004.08.030; Guillot R, 2001, ACTA CRYSTALLOGR B, V57, P567, DOI 10.1107/S0108768101007212; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Neiers F, 2004, J BIOL CHEM, V279, P42462, DOI 10.1074/jbc.M407464200; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Tsou LK, 2002, J AM CHEM SOC, V124, P14917, DOI 10.1021/ja026721a; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	25	13	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20484	20491		10.1074/jbc.M702350200	http://dx.doi.org/10.1074/jbc.M702350200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17500063	Green Published, hybrid			2022-12-27	WOS:000247819300051
J	Tang, GL; Cheng, YQ; Shen, B				Tang, Gong-Li; Cheng, Yi-Qiang; Shen, Ben			Chain initiation in the leinamycin-producing hybrid nonribosomal peptide/polyketide synthetase from streptomyces atroolivaceus S-140 - Discrete, monofunctional adenylation enzyme and peptidyl carrier protein that directly load D-Alanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; IN-VITRO RECONSTITUTION; POLYKETIDE SYNTHASE; CYCLIC PEPTIDE; BIOCHEMICAL-CHARACTERIZATION; VERTICILLUS ATCC15003; NATURAL-PRODUCTS; VIBRIO-CHOLERAE; IDENTIFICATION; SIDEROPHORE	Nonribosomal peptide natural products are biosynthesized from amino acid precursors by nonribosomal peptide synthetases (NRPSs), which are organized into modules. For a typical NRPS initiation module, an adenylation (A) domain activates an amino acid and installs it onto a peptidyl carrier protein (PCP) domain as a thioester; an elongation module, which has a condensation (C) domain located between every consecutive pair of A and PCP domains, catalyzes the formation of the peptide bond between the upstream aminoacyl/peptidyl-S-PCP and the free amino group of the downstream aminoacyl-S-PCP. D-Amino acid constituents in peptide natural products usually arise from the L-enantiomers through the action of integral epimerization (E) domains of an NRPS. The biosynthetic gene cluster for leinamycin, a hybrid nonribosomal peptide/polyketide containing a D-alanine moiety, does not encode a typical NRPS initiation module with the expected A-PCP-E domains; instead, it has only an A protein (LnmQ) and a PCP (LnmP), both of which are encoded by separate genes. Here we show the results of biochemical experiments as follows: (i) we demonstrate that LnmQ directly activates D-alanine as D-alaninyl-AMP and installs it onto LnmP to generate a D-alaninyl-S-PCP intermediate; (ii) we confirm that aminoacylation of LnmP by LnmQ in trans is the result of specific communication between the separate A and PCP proteins; and (iii) we reveal that leinamycin production can be improved by supplementation of exogenous D-alanine in the fermentation broth of Streptomyces atroolivaceous S-140. These findings unveil an unprecedented NRPS initiation module structure that is characterized by a discrete D-alanine-specific A protein and a PCP.	Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; Univ Wisconsin, Div Pharmaceut Sci, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu		Cheng, Eric/0000-0001-9336-2593	NATIONAL CANCER INSTITUTE [U19CA113297, R01CA106150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051687] Funding Source: NIH RePORTER; NCI NIH HHS [CA 106150, CA 113297, U19 CA113297] Funding Source: Medline; NIAID NIH HHS [AI 51687] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Belshaw PJ, 1999, SCIENCE, V284, P486, DOI 10.1126/science.284.5413.486; Billman-Jacobe H, 1999, MOL MICROBIOL, V33, P1244, DOI 10.1046/j.1365-2958.1999.01572.x; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Chen HW, 2001, BIOCHEMISTRY-US, V40, P11651, DOI 10.1021/bi0115434; Chen HW, 2001, CHEM BIOL, V8, P899, DOI 10.1016/S1074-5521(01)00064-3; Cheng YQ, 2000, J BIOL CHEM, V275, P4906, DOI 10.1074/jbc.275.7.4906; Cheng YQ, 2002, J BACTERIOL, V184, P7013, DOI 10.1128/JB.184.24.7013-7024.2002; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Chiu HT, 2001, P NATL ACAD SCI USA, V98, P8548, DOI 10.1073/pnas.151246498; Christiansen G, 2003, J BACTERIOL, V185, P564, DOI 10.1128/JB.185.2.564-572.2003; COSMINA P, 1993, MOL MICROBIOL, V8, P821, DOI 10.1111/j.1365-2958.1993.tb01629.x; Doekel S, 2000, CHEM BIOL, V7, P373, DOI 10.1016/S1074-5521(00)00118-6; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Du LC, 1999, CHEM BIOL, V6, P507, DOI 10.1016/S1074-5521(99)80083-0; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Ehmann DE, 2000, P NATL ACAD SCI USA, V97, P2509, DOI 10.1073/pnas.040572897; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; HARA M, 1989, J ANTIBIOT, V42, P333, DOI 10.7164/antibiotics.42.333; HOFFMANN K, 1994, J BIOL CHEM, V269, P12710; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Jacobsen JR, 1997, SCIENCE, V277, P367, DOI 10.1126/science.277.5324.367; Jiang WL, 2003, J AM CHEM SOC, V125, P1877, DOI 10.1021/ja0212314; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15513, DOI 10.1021/bi001651a; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15522, DOI 10.1021/bi0016523; Linne U, 2004, METHOD ENZYMOL, V388, P293; Lombo F, 2006, CHEMBIOCHEM, V7, P366, DOI 10.1002/cbic.200500325; Marsden AFA, 1998, SCIENCE, V279, P199, DOI 10.1126/science.279.5348.199; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Patel HM, 2001, BIOCHEMISTRY-US, V40, P9023, DOI 10.1021/bi010519n; Pootoolal J, 2002, P NATL ACAD SCI USA, V99, P8962, DOI 10.1073/pnas.102285099; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; RUSNAK F, 1989, BIOCHEMISTRY-US, V28, P6827, DOI 10.1021/bi00443a008; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Schmoock G, 2005, J BIOL CHEM, V280, P4339, DOI 10.1074/jbc.M411026200; Schoenafinger G, 2006, J AM CHEM SOC, V128, P7406, DOI 10.1021/ja0611240; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tang GL, 2006, J NAT PROD, V69, P387, DOI 10.1021/np050467t; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; Thomas MG, 2002, CHEM BIOL, V9, P171, DOI 10.1016/S1074-5521(02)00100-X; TURGAY K, 1992, MOL MICROBIOL, V6, P529, DOI 10.1111/j.1365-2958.1992.tb01498.x; Walsh CT, 2002, CHEMBIOCHEM, V3, P125; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; WEBER G, 1994, CURR GENET, V26, P120, DOI 10.1007/BF00313798; Xia ZP, 2001, J ORG CHEM, V66, P3459, DOI 10.1021/jo005783l	55	44	49	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20273	20282		10.1074/jbc.M702814200	http://dx.doi.org/10.1074/jbc.M702814200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502372	hybrid			2022-12-27	WOS:000247819300030
J	Hong, J; Doebele, RC; Lingen, MW; Quilliam, LA; Tang, WJ; Rosner, MR				Hong, Jia; Doebele, Robert C.; Lingen, Mark W.; Quilliam, Lawrence A.; Tang, Wei-Jen; Rosner, Marsha Rich			Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; CYCLIC-AMP; LETHAL FACTOR; BARRIER FUNCTION; ANGIOGENESIS; EXPRESSION; KINASE; ACTIVATION; RECEPTOR; PATHWAY	Angiogenesis involves the assembly of endothelial cells into capillaries from a pre-existing vasculature. Because abnormal angiogenesis is a hallmark of many cancers, it is critical to find factors that control this process. Endothelial cells are enriched in the anthrax receptor; we therefore determined the effect of anthrax edema toxin ( ET), an adenylyl cyclase, on chemotaxis. cAMP generated by ET does not block proliferation or survival but causes cytoskeletal changes and inhibits chemotaxis by primary human microvascular endothelial cells (HMVECs). These effects are due to the action of a downstream cAMP effector, Epac, a guanine nucleotide exchange-activating protein for Rap1 (RAP1-GEF). ET induces transcription of Epac-related activators of Rap1, Epac2 (RapGEF4), and MR-GEF/RapGEF5. Similar to ET, activated Epac or Rap1 induces cytoskeletal changes and blocks chemotaxis in human endothelial cells. These results identify Epac and Rap1 as key regulators of signaling cascades leading to endothelial cell chemotaxis.	Univ Chicago, Gordon Ctr Integrat Sci, Dept Canc Res, Chicago, IL 60637 USA; Univ Chicago, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Rosner, MR (corresponding author), Univ Chicago, Gordon Ctr Integrat Sci, Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	m-rosner@uchicago.edu	Doebele, Robert C./I-8230-2019; Quilliam, Lawrence/Q-4987-2019; Quilliam, Lawrence/B-6447-2015	Doebele, Robert C./0000-0001-6728-6857; Tang, Wei-Jen/0000-0002-8267-8995	NCI NIH HHS [CA108647, R01 CA108647, R01 CA108647-03, CA112310, CA109278] Funding Source: Medline; NHLBI NIH HHS [HL-07605] Funding Source: Medline; NIGMS NIH HHS [GM53459, GM62548] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112310, R01CA109278, R01CA108647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062548, R01GM053459] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Cline EI, 2002, CANCER RES, V62, P7143; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Gupta K, 2005, POSTGRAD MED J, V81, P236, DOI 10.1136/pgmj.2004.023309; Hong J, 2005, BIOCHEM BIOPH RES CO, V335, P850, DOI 10.1016/j.bbrc.2005.07.132; HOOVER DL, 1994, INFECT IMMUN, V62, P4432, DOI 10.1128/IAI.62.10.4432-4439.1994; Ichiba T, 1999, FEBS LETT, V457, P85, DOI 10.1016/S0014-5793(99)01012-1; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Kuo WL, 2004, J BIOL CHEM, V279, P23073, DOI 10.1074/jbc.M313696200; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Li LM, 2002, MOL CELL BIOL, V22, P1203, DOI 10.1128/MCB.22.4.1203-1217.2002; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Lingen MW, 2003, METH MOLEC MED, V78, P337; Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Ribatti D, 2005, BRIT J HAEMATOL, V128, P303, DOI 10.1111/j.1365-2141.2004.05291.x; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Soelaiman S, 2003, J BIOL CHEM, V278, P25990, DOI 10.1074/jbc.M301232200; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Volpert OV, 2000, CANCER METAST REV, V19, P87, DOI 10.1023/A:1026560618302; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200	39	51	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19781	19787		10.1074/jbc.M700128200	http://dx.doi.org/10.1074/jbc.M700128200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17491018	hybrid			2022-12-27	WOS:000247650600053
J	Nassir, F; Wilson, B; Han, XL; Gross, RW; Abumrad, NA				Nassir, Fatiha; Wilson, Brody; Han, Xianlin; Gross, Richard W.; Abumrad, Nada A.			CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE MEMBRANE-PROTEIN; INSULIN-RESISTANCE; CLASS-B; APOBEC-1(-/-) MICE; LIPID ABSORPTION; CRUDE EXTRACTS; SR-BI; TRANSPORT; BINDING; IDENTIFICATION	CD36, a membrane protein that facilitates fatty acid uptake, is highly expressed in the intestine on the luminal surface of enterocytes. Cd36 null (Cd36(-/-)) mice exhibit impaired chylomicron secretion but no overall lipid absorption defect. Because chylomicron production is most efficient proximally we examined whether CD36 function is important for proximal lipid absorption. CD36 levels followed a steep decreasing gradient along three equal-length, proximal to distal intestinal segments (S1-S3). Enterocytes isolated from the small intestines of Cd36(-/-) mice, when compared with wild type counterparts, exhibited reduced uptake of fatty acid (50%) and cholesterol (60%) in S1. The high affinity fatty acid uptake component was missing in Cd36(-/-) cells. Fatty acid incorporation into triglyceride and triglyceride secretion were also reduced in Cd36(-/-) S1 enterocytes. In vivo, proximal absorption was monitored using mass spectrometry from oleic acid enrichment of S1 lipids, 90 min (active absorption) and 5 h (steady state) after intragastric olive oil (70% triolein). Oleate enrichment was 50% reduced at 90 min in Cd36(-/-) tissue consistent with defective uptake whereas no differences were measured at 5 h. In Cd36(-/-) S1, mRNA for L-fabp, Dgat1, and apoA-IV was reduced. Protein levels for FATP4, SR-BI, and NPC1L1 were similar, whereas those for apoB48 and apoA-IV were significantly lower. A large increase in NPC1L1 was observed in Cd36(-/-) S2 and S3. The findings support the role of CD36 in proximal absorption of dietary fatty acid and cholesterol for optimal chylomicron formation, whereas CD36-independent mechanisms predominate in distal segments.	Washington Univ, Dept Med, Div Nutr Sci, St Louis, MO 63110 USA; Washington Univ, Dept Med, Div Bioorgan Chem, St Louis, MO 63110 USA; Washington Univ, Dept Med, Div Mol Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Nassir, F (corresponding author), Washington Univ, Sch Med, Campus Box 8031, St Louis, MO 63110 USA.	fnassir@im.wustl.edu; nabumrad@wustl.edu		Nassir, Fatiha/0000-0002-3653-3621	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33301, P30 DK056341-06, P30 DK056341-07, P30 DK056341, DK 600220] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abumrad N, 1998, J LIPID RES, V39, P2309; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Aitman TJ, 2001, LANCET, V357, P651, DOI 10.1016/S0140-6736(00)04149-0; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Altmann SW, 2002, BBA-MOL CELL BIOL L, V1580, P77, DOI 10.1016/S1388-1981(01)00190-1; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Besnard P, 2002, MOL CELL BIOCHEM, V239, P139, DOI 10.1023/A:1020505512364; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Chen M, 2001, AM J PHYSIOL-ENDOC M, V281, pE916, DOI 10.1152/ajpendo.2001.281.5.E916; CHOW SL, 1979, J LIPID RES, V20, P349; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Febbraio M, 2002, MOL CELL BIOCHEM, V239, P193, DOI 10.1023/A:1020515210972; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Furuhashi M, 2003, DIABETES CARE, V26, P471, DOI 10.2337/diacare.26.2.471; Goudriaan JR, 2002, MOL CELL BIOCHEM, V239, P199, DOI 10.1023/A:1020575412789; GREENWALT DE, 1992, BLOOD, V80, P1105; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; HARMON CM, 1992, BIOCHEM SOC T, V20, P811, DOI 10.1042/bst0200811; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; Ho SP, 2001, AM J PHYSIOL-CELL PH, V281, pC1106, DOI 10.1152/ajpcell.2001.281.4.C1106; HOFMANN AF, 1964, J CLIN INVEST, V43, P247, DOI 10.1172/JCI104909; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; KASHIWAGI H, 1994, BLOOD, V83, P3545; Kolleck I, 2002, BIOCHEMISTRY-US, V41, P6369, DOI 10.1021/bi015980u; Kronenberg A, 1998, THROMB HAEMOSTASIS, V79, P1021; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; Lammert F, 2005, GASTROENTEROLOGY, V129, P718, DOI [10.1053/j.gastro.2004.11.017, 10.1016/j.gastro.2004.11.017]; Llaverias G, 2005, MOL CELL BIOCHEM, V273, P185, DOI 10.1007/s11010-005-0624-8; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Meegalla RL, 2002, BIOCHEM BIOPH RES CO, V298, P317, DOI 10.1016/S0006-291X(02)02466-X; Mu HL, 2005, PROG LIPID RES, V44, P430, DOI 10.1016/j.plipres.2005.09.002; Murota K, 2005, J NUTR, V135, P1626, DOI 10.1093/jn/135.7.1626; Nassir F, 2004, J LIPID RES, V45, P1649, DOI 10.1194/jlr.M300505-JLR200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Prieto R M, 1996, Eur J Med Res, V1, P355; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; SALLEE VL, 1978, J LIPID RES, V19, P207; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; STREMMEL W, 1988, J CLIN INVEST, V82, P2001, DOI 10.1172/JCI113820; Tanaka T, 2001, J LIPID RES, V42, P751; THOMSON ABR, 1980, AM J PHYSIOL, V239, pG372, DOI 10.1152/ajpgi.1980.239.5.G372; Trotter PJ, 1996, J LIPID RES, V37, P336; Watanabe K, 1998, Ann Nucl Med, V12, P261; WESTERGAARD H, 1976, J CLIN INVEST, V58, P97, DOI 10.1172/JCI108465; Xie Y, 2003, AM J PHYSIOL-GASTR L, V285, pG735, DOI 10.1152/ajpgi.00202.2003; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	62	198	205	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19493	19501		10.1074/jbc.M703330200	http://dx.doi.org/10.1074/jbc.M703330200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17507371	hybrid			2022-12-27	WOS:000247650600023
J	Taurin, S; Hogarth, K; Sandbo, N; Yau, DM; Dulin, NO				Taurin, Sebastien; Hogarth, Kyle; Sandbo, Nathan; Yau, Douglas M.; Dulin, Nickolai O.			G beta gamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; PHOSPHOLIPASE-C; RECEPTOR; GENE; EXPRESSION; SUBUNITS; RELEASE; PATHWAY; PKA; STIMULATION	Endothelin-1 (ET1) is a vasoactive peptide that stimulates hypertrophy of vascular smooth muscle cells (VSMC) through diverse signaling pathways mediated by G(q)/G(i)/G(13) heterotrimeric G proteins. We have found that ET1 stimulates the activity of cAMP-dependent protein kinase (PKA) in VSMC as profoundly as the G(s)-linked beta-adrenergic agonist, isoproterenol (ISO), but in a transient manner. PKA activation by ET1 was mediated by type-A ET1 receptors (ETA) and recruited an autocrine signaling mechanism distinct from that of ISO, involving G(i)-coupled beta gamma subunits of heterotrimeric G proteins, extracellular signal-regulated kinases ERK1/2, cyclooxygenase COX-1 ( but not COX-2) and prostacyclin receptors. In the functional studies, inhibition of PKA or COX-1 attenuated ET1-induced VSMC hypertrophy, suggesting the positive role of PKA in this response to ET1. Furthermore, we found that ET1 stimulates a G beta gamma-mediated, PKA-dependent phosphorylation and inactivation of glycogen synthase kinase-3 (GSK3), an enzyme that regulates cell growth. Together, this study describes that (i) PKA can be transiently activated by G(i)-coupled agonists such as ET1 by an autocrine mechanism involving G beta gamma/calcium/ERK/COX1/prostacyclin signaling, and (ii) this PKA activation promotes VSMC hypertrophy, at least in part, through PKA-dependent phosphorylation and inhibition of GSK3.	Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Dulin, NO (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ndulin@medicine.bsd.uchicago.edu		Taurin, Sebastien/0000-0003-2167-5253	NHLBI NIH HHS [HL071755] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071755] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI M, 1991, BIOCHEM BIOPH RES CO, V180, P1265, DOI 10.1016/S0006-291X(05)81332-4; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; CHUA BHL, 1992, AM J PHYSIOL, V262, pE412, DOI 10.1152/ajpendo.1992.262.4.E412; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Demoliou-Mason CD, 1998, BIOL SIGNAL RECEPT, V7, P90; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Dulin NO, 2001, J BIOL CHEM, V276, P20827, DOI 10.1074/jbc.C100195200; Dulin NO, 2001, BIOCHEM J, V357, P587, DOI 10.1042/0264-6021:3570587; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FILEP JG, 1991, BIOCHEM BIOPH RES CO, V177, P171, DOI 10.1016/0006-291X(91)91964-E; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Graves LM, 1996, J BIOL CHEM, V271, P505, DOI 10.1074/jbc.271.1.505; GRIENDLING KK, 1989, J BIOL CHEM, V264, P8237; Hogarth DK, 2004, AM J PHYSIOL-CELL PH, V287, pC449, DOI 10.1152/ajpcell.00547.2003; IIJIMA K, 1991, J CARDIOVASC PHARM, V17, pS146, DOI 10.1097/00005344-199100177-00040; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lum H, 1999, AM J PHYSIOL-CELL PH, V277, pC580, DOI 10.1152/ajpcell.1999.277.3.C580; MIURA K, 1989, EUR J PHARMACOL, V170, P91, DOI 10.1016/0014-2999(89)90139-8; MORELAND S, 1994, BRIT J PHARMACOL, V112, P704, DOI 10.1111/j.1476-5381.1994.tb13133.x; RAKUGI H, 1989, BIOCHEM BIOPH RES CO, V160, P924, DOI 10.1016/0006-291X(89)92523-0; RESINK TJ, 1988, BIOCHEM BIOPH RES CO, V157, P1360, DOI 10.1016/S0006-291X(88)81025-8; Roberts NA, 2005, BRIT J PHARMACOL, V145, P477, DOI 10.1038/sj.bjp.0706210; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; SAKAMOTO A, 1991, BIOCHEM BIOPH RES CO, V178, P656, DOI 10.1016/0006-291X(91)90158-4; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Soltow QA, 2006, MED SCI SPORT EXER, V38, P840, DOI 10.1249/01.mss.0000218142.98704.66; WAGNERMANN C, 1991, AM J PHYSIOL, V260, pC763, DOI 10.1152/ajpcell.1991.260.4.C763; Wu R, 2005, HYPERTENSION, V45, P1139, DOI 10.1161/01.HYP.0000164572.92049.29; Yamboliev IA, 1998, PULM PHARMACOL THER, V11, P205, DOI 10.1006/pupt.1998.0139; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	43	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19518	19525		10.1074/jbc.M702655200	http://dx.doi.org/10.1074/jbc.M702655200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17513863	hybrid			2022-12-27	WOS:000247650600026
J	Baldock, PA; Allison, SJ; Lundberg, P; Lee, NJ; Slack, K; Lin, EJD; Enriquez, RF; McDonald, MM; Zhang, L; During, MJ; Little, DG; Eisman, JA; Gardiner, EM; Yulyaningsih, E; Lin, S; Sainsbury, A; Herzog, H				Baldock, Paul A.; Allison, Susan J.; Lundberg, Pernilla; Lee, Nicola J.; Slack, Katy; Lin, En-Ju D.; Enriquez, Ronaldo F.; McDonald, Michelle M.; Zhang, Lei; During, Matthew J.; Little, David G.; Eisman, John A.; Gardiner, Edith M.; Yulyaningsih, Ernie; Lin, Shu; Sainsbury, Amanda; Herzog, Herbert			Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOTHALAMIC Y2 RECEPTORS; NEUROPEPTIDE-Y; INSULIN-SECRETION; ADIPOSE-TISSUE; KNOCKOUT MICE; NORMAL RATS; CYCLIC-AMP; LEPTIN; CELLS; MASS	The importance of neuropeptide Y (NPY) and Y2 receptors in the regulation of bone and energy homeostasis has recently been demonstrated. However, the contributions of the other Y receptors are less clear. Here we show that Y1 receptors are expressed on osteoblastic cells. Moreover, bone and adipose tissue mass are elevated in Y1(-/-) mice with a generalized increase in bone formation on cortical and cancellous surfaces. Importantly, the inhibitory effects of NPY on bone marrow stromal cells in vitro are absent in cells derived from Y1(-/-) mice, indicating a direct action of NPY on bone cells via this Y receptor. Interestingly, in contrast to Y2 receptor or germ line Y1 receptor deletion, conditional deletion of hypothalamic Y1 receptors in adult mice did not alter bone homeostasis, food intake, or adiposity. Furthermore, deletion of both Y1 and Y2 receptors did not produce additive effects in bone or adiposity. Thus Y1 receptor pathways act powerfully to inhibit bone production and adiposity by nonhypothalamic pathways, with potentially direct effects on bone tissue through a single pathway with Y2 receptors.	Univ Queensland, Sch Med, Brisbane, Qld 4000, Australia; St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Program, Neurosci Res Program, Sydney, NSW 2010, Australia; Umea Univ, Dept Oral Cell Biol, S-90187 Umea, Sweden; Childrens Hosp Westmead, Dept Orthopaed Res & Biotechnol, Sydney, NSW 2000, Australia; Univ Auckland, Dept Mol Med & Pathol, Auckland 1001, New Zealand; Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia	University of Queensland; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Umea University; University of Sydney; University of Auckland; University of Queensland	Herzog, H (corresponding author), Univ Lund Hosp, Stem Cell Inst, Lab Neural Stem Cell Biol, S-22184 Lund, Sweden.	h.herzog@garvan.org.au	/B-2038-2013; /A-4361-2010; /E-2900-2010; /A-6021-2011; McDonald, Michelle/AAD-4760-2019; Herzog, Herbert/B-8294-2008; /B-6258-2012; During, Matthew/AAC-1388-2020; Eisman, John A/C-2886-2014; Salis, Amanda/A-3187-2011; Baldock, Paul/B-3840-2012	/0000-0001-7766-6095; /0000-0003-2110-2017; McDonald, Michelle/0000-0002-3928-2506; Salis, Amanda/0000-0001-9176-1574; lin, shu/0000-0002-4239-2028; , Herbert/0000-0002-1713-1029				Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2006, J BONE MINER RES, V21, P1618, DOI 10.1359/JBMR.060714; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; BJURHOLM A, 1992, J BONE MINER RES, V7, P1011; BJURHOLM A, 1988, ACTA PHYSIOL SCAND, V134, P451, DOI 10.1111/j.1748-1716.1988.tb08515.x; BOONEKAMP PM, 1984, P K NED AKAD B PHYS, V87, P371; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CUSIN I, 1990, ENDOCRINOLOGY, V127, P3246, DOI 10.1210/endo-127-6-3246; DUMONT Y, 1990, EUR J PHARMACOL, V191, P501, DOI 10.1016/0014-2999(90)94189-5; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gardiner EM, 2000, FASEB J, V14, P1908, DOI 10.1096/fj.99-1075com; Howell OW, 2005, J NEUROCHEM, V93, P560, DOI 10.1111/j.1471-4159.2005.03057.x; INSEL TR, 1989, PHYSIOL BEHAV, V45, P1033, DOI 10.1016/0031-9384(89)90234-5; Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031; Kalariti N, 2004, IN VIVO, V18, P621; Koteja P, 2003, PHYSIOL BEHAV, V80, P375, DOI 10.1016/j.physbeh.2003.09.001; Kushi A, 1998, P NATL ACAD SCI USA, V95, P15659, DOI 10.1073/pnas.95.26.15659; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; MOLTZ JH, 1985, PEPTIDES, V6, P1155, DOI 10.1016/0196-9781(85)90443-7; Morgan DG, 1998, DIABETOLOGIA, V41, P1482, DOI 10.1007/s001250051095; MURZI E, 1991, BRAIN RES BULL, V26, P321, DOI 10.1016/0361-9230(91)90001-Z; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; PETTERSSON M, 1987, CELL TISSUE RES, V248, P43, DOI 10.1007/BF01239960; Pralong FP, 2002, FASEB J, V16, P712, DOI 10.1096/fj.01-0754fje; Sainsbury A, 2006, DIABETES, V55, P19; Sainsbury A, 1997, DIABETES, V46, P209, DOI 10.2337/diabetes.46.2.209; Sainsbury A, 2003, MOL CELL BIOL, V23, P5225, DOI 10.1128/MCB.23.15.5225-5233.2003; Sainsbury A, 1997, DIABETOLOGIA, V40, P1269, DOI 10.1007/s001250050820; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; Sainsbury A, 2002, DIABETES, V51, P3420, DOI 10.2337/diabetes.51.12.3420; Siu WS, 2003, J BONE MINER METAB, V21, P316, DOI 10.1007/s00774-003-0427-5; Standridge M, 2000, FASEB J, V14, P455, DOI 10.1096/fasebj.14.3.455; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; WAHLESTEDT C, 1990, ANN NY ACAD SCI, V611, P7	39	153	166	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19092	19102		10.1074/jbc.M700644200	http://dx.doi.org/10.1074/jbc.M700644200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17491016	hybrid, Green Published			2022-12-27	WOS:000247475300051
J	Delaine, C; Alvino, CL; McNeil, KA; Mulhern, TD; Gauguin, L; De Meyts, P; Jones, EY; Brown, J; Wallace, JC; Forbes, BE				Delaine, Carlie; Alvino, Clair L.; McNeil, Kerrie A.; Mulhern, Terrance D.; Gauguin, Lisbeth; De Meyts, Pierre; Jones, E. Yvonne; Brown, James; Wallace, John C.; Forbes, Briony E.			A novel binding site for the human insulin-like growth factor-II (IGF-II)/mannose 6-phosphate receptor on IGF-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION; FUSION PROTEINS; LIGAND-BINDING; CROSS-LINKING; LOW-AFFINITY; B-DOMAIN; EXPRESSION; LOCALIZATION; MUTATIONS; RESIDUES	The mammalian insulin-like growth factor (IGF)-II/cation-independent mannose 6-phosphate receptor (IGF2R) binds IGF-II with high affinity. By targeting IGF-II to lysosomal degradation, it plays a role in the maintenance of correct IGF-II levels in the circulation and in target tissues. Loss of IGF2R function is associated with tumor progression; therefore, the IGF2R is often referred to as a tumor suppressor. The interaction between IGF2R and IGF-II involves domains 11 and 13 of the 15 extracellular domains of the receptor. Recently, a hydrophobic binding region was identified on domain 11 of the IGF2R. In contrast, relatively little is known about the residues of IGF-II that are involved in IGF2R binding and the determinants of IGF2R specificity for IGF-II over the structurally related IGF-I. Using a series of novel IGF-II analogues and surface plasmon resonance assays, this study revealed a novel binding surface on IGF-II critical for IGF2R binding. The hydrophobic residues Phe19 and Leu53 are critical for IGF2R binding, as are residues Thr16 and Asp52. Furthermore, Thr16 was identified as playing a major role in determining why IGF-II, but not IGF-I, binds with high affinity to the IGF2R.	Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem, Melbourne, Vic 3010, Australia; Hagedorn Res Lab, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; Univ Oxford, Canc Res UK Receptor Struct Res Grp, Div Struct Biol, Oxford, England	University of Adelaide; University of Melbourne; Novo Nordisk; Hagedorn Research Institute; Cancer Research UK; University of Oxford	Forbes, BE (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	briony.forbes@adelaide.edu.au	Forbes, Briony/R-1838-2019; Mulhern, Terrence/A-1206-2007; Jones, Yvonne/J-2293-2016; , John/AAP-5150-2020; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Mulhern, Terrence/0000-0002-1609-7498; Forbes, Briony/0000-0003-4360-9927; De Meyts, Pierre/0000-0001-6214-0824	NCRR NIH HHS [P41 RR-01081] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Brown J, 2002, EMBO J, V21, P1054, DOI 10.1093/emboj/21.5.1054; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; DAVIS SJ, 1990, J MOL BIOL, V213, P7, DOI 10.1016/S0022-2836(05)80116-0; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; Devi GR, 1999, CANCER RES, V59, P4314; Forbes BE, 2001, GROWTH FACTORS, V19, P163, DOI 10.3109/08977190109001084; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; GARMROUDI F, 1994, J BIOL CHEM, V269, P26944; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gill R, 1999, PROTEIN ENG, V12, P297, DOI 10.1093/protein/12.4.297; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; HODGSON DR, 1995, EUR J BIOCHEM, V233, P299, DOI 10.1111/j.1432-1033.1995.299_1.x; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; Lien S, 2001, BIOTECHNOL BIOENG, V74, P335, DOI 10.1002/bit.1124; Linnell J, 2001, J BIOL CHEM, V276, P23986, DOI 10.1074/jbc.M100700200; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Mazor O, 2002, ANAL BIOCHEM, V301, P75, DOI 10.1006/abio.2001.5475; MILNER SJ, 1995, BIOCHEM J, V308, P865, DOI 10.1042/bj3080865; OH Y, 1991, BIOCHEM J, V278, P249, DOI 10.1042/bj2780249; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Reddy ST, 2004, J BIOL CHEM, V279, P38658, DOI 10.1074/jbc.M407474200; Roche P, 2006, PROTEINS, V64, P758, DOI 10.1002/prot.21035; ROTH BV, 1991, BIOCHEM BIOPH RES CO, V181, P907, DOI 10.1016/0006-291X(91)91277-J; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; Scott CD, 2004, HORM METAB RES, V36, P261, DOI 10.1055/s-2004-814477; Shooter GK, 1996, J MOL ENDOCRINOL, V17, P237, DOI 10.1677/jme.0.0170237; SOOS MA, 1992, J BIOL CHEM, V267, P12955; STANLEY P, 1981, MOL CELL BIOL, V1, P687, DOI 10.1128/MCB.1.8.687; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Yandell CA, 1999, J BIOL CHEM, V274, P27076, DOI 10.1074/jbc.274.38.27076; Zaccheo OJ, 2006, J MOL BIOL, V359, P403, DOI 10.1016/j.jmb.2006.03.046	41	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18886	18894		10.1074/jbc.M700531200	http://dx.doi.org/10.1074/jbc.M700531200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17475626	hybrid			2022-12-27	WOS:000247475300029
J	Dinkla, K; Nitsche-Schmitz, DP; Barroso, V; Reissmann, S; Johansson, HM; Frick, IM; Rohde, M; Chhatwal, GS				Dinkla, Katrin; Nitsche-Schmitz, D. Patric; Barroso, Vanessa; Reissmann, Silvana; Johansson, Helena M.; Frick, Inga-Maria; Rohde, Manfred; Chhatwal, Gursharan S.			Identification of a streptococcal octapeptide motif involved in acute rheumatic fever	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-DISEASE; M-PROTEIN; FOG; PATHOGENESIS; PHARYNGITIS; INFECTIONS; ANTIGENS; CHAIN; LINKS	Acute rheumatic fever is a serious autoimmune sequela of pharyngitis caused by certain group A streptococci. One mechanism applied by streptococcal strains capable of causing acute rheumatic fever is formation of an autoantigenic complex with human collagen IV. In some geographic regions with a high incidence of acute rheumatic fever pharyngeal carriage of group C and group G streptococci prevails. Examination of such strains revealed the presence of M-like surface proteins that bind human collagen. Using a peptide array and recombinant proteins with targeted amino acid substitutions, we could demonstrate that formation of collagen complexes during streptococcal infections depends on an octapeptide motif, which is present in collagen binding M and M-like proteins of different beta-hemolytic streptococcal species. Mice immunized with streptococcal proteins that contain the collagen binding octapeptide motif developed high serum titers of anti-collagen antibodies. In sera of rheumatic fever patients such a collagen autoimmune response was accompanied by specific reactivity against the collagen-binding proteins, linking the observed effect to clinical cases. Taken together, the data demonstrate that the identified octapeptide motif through its action on collagen plays a crucial role in the pathogenesis of rheumatic fever. Eradication of streptococci that express proteins with the collagen binding motif appears advisable for controlling rheumatic fever.	Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; Lund Univ, Dept Clin Sci, S-22184 Lund, Sweden	Helmholtz Association; Helmholtz-Center for Infection Research; Lund University	Chhatwal, GS (corresponding author), Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Inhoffenstr 7, D-38124 Braunschweig, Germany.	gsc@helmholtz-hzi.de		Linge, Helena/0000-0002-8919-0300				Afek A, 1999, LUPUS, V8, P502, DOI 10.1191/096120399678840873; Ahmed J, 2003, Bangladesh Med Res Counc Bull, V29, P113; BARACCO GJ, 2006, GRAM POSITIVE PATHOG, P223; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carapetis JR, 1997, ADV EXP MED BIOL, V418, P233; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; CUNNINGHAM MW, 1989, J IMMUNOL, V143, P2677; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Ellis NMJ, 2005, J IMMUNOL, V175, P5448, DOI 10.4049/jimmunol.175.8.5448; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Haidan A, 2000, LANCET, V356, P1167, DOI 10.1016/S0140-6736(00)02765-3; HARTAS J, 1995, MICROB PATHOGENESIS, V18, P345, DOI 10.1006/mpat.1995.0031; Johansson HM, 2004, MICROBIOL-SGM, V150, P4211, DOI 10.1099/mic.0.27269-0; Kaplan EL, 2006, CLIN INFECT DIS, V43, P690, DOI 10.1086/506944; Kaplan EL, 2005, HEART, V91, P3, DOI 10.1136/hrt.2004.034744; Kumar Rajesh, 2002, Indian Heart J, V54, P54; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; MAJEED HA, 1986, ZBL BAKT-INT J MED M, V262, P346; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; McDonald MI, 2006, CLIN INFECT DIS, V43, P683, DOI 10.1086/506938; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Nitsche-Schmitz DP, 2007, J BIOL CHEM, V282, P17530, DOI 10.1074/jbc.M702612200; POTTER EV, 1978, J PEDIATR-US, V92, P325, DOI 10.1016/S0022-3476(78)80036-5; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Saxena Anita, 2002, Curr Treat Options Cardiovasc Med, V4, P309, DOI 10.1007/s11936-002-0011-7; SIMPSON WJ, 1987, MICROB PATHOGENESIS, V3, P339, DOI 10.1016/0882-4010(87)90004-0; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; Stollerman G H, 1990, Adv Intern Med, V35, P1; Tontsch D, 2000, CLIN EXP IMMUNOL, V121, P270, DOI 10.1046/j.1365-2249.2000.01283.x; Veasy LG, 2004, PEDIATRICS, V113, pE168, DOI 10.1542/peds.113.3.e168; WANNAMAKER LW, 1973, CIRCULATION, V48, P9, DOI 10.1161/01.CIR.48.1.9; WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease, 2001, WHO TECHN REP SER, V923; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767	37	45	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18686	18693		10.1074/jbc.M701047200	http://dx.doi.org/10.1074/jbc.M701047200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17452321	hybrid			2022-12-27	WOS:000247475300006
J	Haacke, A; Hartl, FU; Breuer, P				Haacke, Annette; Hartl, F. Ulrich; Breuer, Peter			Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTONS-DISEASE; TRANSGENIC MICE; CELL-DEATH; CASPASE CLEAVAGE; NEURODEGENERATIVE DISORDERS; INTRANUCLEAR INCLUSIONS; PROTEIN AGGREGATION; MUTANT HUNTINGTIN; WILD-TYPE; FRAGMENTS	The formation of intraneuronal inclusions is a common feature of neurodegenerative polyglutamine disorders, including Spinocerebellar ataxia type 3. The mechanism that triggers inclusion formation in these typically late onset diseases has remained elusive. However, there is increasing evidence that proteolytic fragments containing the expanded polyglutamine segment are critically required to initiate the aggregation process. We analyzed ataxin-3 proteolysis in neuroblastoma cells and in vitro and show that calcium-dependent calpain proteases generate aggregation-competent ataxin-3 fragments. Co-expression of the highly specific cellular calpain inhibitor calpastatin abrogated fragmentation and the formation of inclusions in cells expressing pathological ataxin-3. These findings suggest a critical role of calpains in the pathogenesis of Spinocerebellar ataxia type 3.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Am Klopferspitz 18, D-82152 Martinsried, Germany.	u.hartl@biochem.mpg.de; breuer@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019					Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Ellerby LM, 1999, J BIOL CHEM, V274, P8730, DOI 10.1074/jbc.274.13.8730; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; LIU CM, 1978, J BIOL CHEM, V253, P5892; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Miyashita T, 1997, J BIOL CHEM, V272, P29238, DOI 10.1074/jbc.272.46.29238; MouattPrigent A, 1996, NEUROSCIENCE, V73, P979, DOI 10.1016/0306-4522(96)00100-5; Namura S, 2002, NEUROBIOL DIS, V11, P147, DOI 10.1006/nbdi.2002.0532; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Samara C, 2003, AGEING RES REV, V2, P451, DOI 10.1016/S1568-1637(03)00032-1; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vig PJS, 2000, J NEUROL SCI, V174, P100, DOI 10.1016/S0022-510X(00)00262-8; Villa PG, 1998, J CELL SCI, V111, P713; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200	40	73	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18851	18856		10.1074/jbc.M611914200	http://dx.doi.org/10.1074/jbc.M611914200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17488727	hybrid			2022-12-27	WOS:000247475300024
J	Paul, S; Gable, K; Dunn, TM				Paul, Shilpi; Gable, Kenneth; Dunn, Teresa M.			A six-membrane-spanning topology for yeast and arabidopsis Tsc13p, the enoyl reductases of the microsomal fatty acid elongating system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; TRANSMEMBRANE TOPOLOGY; LIPID RAFTS; GENE FAMILY; IDENTIFICATION; GLYCOSYLATION; BIOSYNTHESIS; SUPPRESSORS; COMPONENT; ENCODES	The very long chain fatty acids are crucial building blocks of essential lipids, most notably the sphingolipids. These elongated fatty acids are synthesized by a system of enzymes that are organized in a complex within the endoplasmic reticulum membrane. Although several of the components of the elongase complex have recently been identified, little is known about how these proteins are organized within the membrane or about how they interact with one another during fatty acid elongation. In this study the topology of Tsc13p, the enoyl reductase of the elongase system, was investigated. The N and C termini of Tsc13p reside in the cytoplasm, and six putative membrane-spanning domains were identified by insertion of glycosylation and factor Xa cleavage sites at various positions. The N-terminal domain including the first membrane-spanning segment contains sufficient information for targeting to the endoplasmic reticulum membrane. Studies of the Arabidopsis Tsc13p protein revealed a similar topology. Highly conserved domains of the Tsc13p proteins that are likely to be important for enzymatic activity lie on the cytosolic face of the endoplasmic reticulum, possibly partially embedded within the membrane.	Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20184 USA	Uniformed Services University of the Health Sciences - USA	Dunn, TM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, 4301 Jones Bridge Rd, Bethesda, MD 20184 USA.	tdunn@usuhs.mil		PAUL, SHILPI/0000-0001-5075-2081				Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Beaudoin F, 2000, P NATL ACAD SCI USA, V97, P6421, DOI 10.1073/pnas.110140197; Beaudoin F, 2002, J BIOL CHEM, V277, P11481, DOI 10.1074/jbc.M111441200; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Gable K, 2004, J EXP BOT, V55, P543, DOI 10.1093/jxb/erh061; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257; Han GS, 2002, J BIOL CHEM, V277, P35440, DOI 10.1074/jbc.M205620200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee S, 2006, NUCLEIC ACIDS RES, V34, pW99, DOI 10.1093/nar/gkl351; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Paul S, 2006, J BIOL CHEM, V281, P9018, DOI 10.1074/jbc.M507723200; POULOS A, 1995, LIPIDS, V30, P1, DOI 10.1007/BF02537036; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; Sherman F., 1986, METHODS YEAST GENETI; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toke DA, 1996, J BIOL CHEM, V271, P18413, DOI 10.1074/jbc.271.31.18413; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhang XM, 2003, MOL VIS, V9, P301; ZHAO C, 1994, J BIOL CHEM, V269, P21480; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	36	16	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19237	19246		10.1074/jbc.M701774200	http://dx.doi.org/10.1074/jbc.M701774200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17463005	hybrid			2022-12-27	WOS:000247475300064
J	Robin, E; Guzy, RD; Loor, G; Iwase, H; Waypa, GB; Marks, JD; Hoek, TLV; Schumacker, PT				Robin, Emmanuel; Guzy, Robert D.; Loor, Gabriel; Iwase, Hirotaro; Waypa, Gregory B.; Marks, Jeremy D.; Hoek, Terry L. Vanden; Schumacker, Paul T.			Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL GENERATION; REDOX GENE-THERAPY; MYOCARDIAL-ISCHEMIA; FLUORESCENT PROTEIN; CARDIAC MYOCYTES; RABBIT HEART; NITRIC-OXIDE; COMPLEX-III; OXYGEN; INJURY	Ischemia-reperfusion injury induces oxidant stress, and the burst of reactive oxygen species (ROS) production after reperfusion of ischemic myocardium is sufficient to induce cell death. Mitochondrial oxidant production may begin during ischemia prior to reperfusion because reducing equivalents accumulate and promote superoxide production. We utilized a ratiometric redox-sensitive protein sensor (heat shock protein 33 fluorescence resonance energy transfer (HSP-FRET)) to assess oxidant stress in cardiomyocytes during simulated ischemia. HSP-FRET consists of the cyan and yellow fluorescent protein fluorophores linked by the cysteine-containing regulatory domain from bacterial HSP-33. During ischemia, ROS-mediated oxidation of HSP-FRET was observed, along with a decrease in cellular reduced glutathione levels. These findings were corroborated by measurements using redox-sensitive green fluorescent protein, another protein thiol ratiometric sensor, which became 93% oxidized by the end of simulated ischemia. However, cell death did not occur during ischemia, indicating that this oxidant stress is not sufficient to induce death before reperfusion. However, interventions that attenuate ischemic oxidant stress, including antioxidants or scavengers of residual O-2 that attenuate/prevent ROS generation during ischemia, abrogated cell death during simulated reperfusion. These findings reveal that, in isolated cardiomyocytes, sublethal H2O2 generation during simulated ischemia regulates cell death during simulated reperfusion, which is mediated by the reperfusion oxidant burst.	Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Surg, Chicago, IL 60637 USA	Northwestern University; University of Chicago; University of Chicago	Schumacker, PT (corresponding author), Northwestern Univ, Dept Pediat, 303 E Chicago Ave, Chicago, IL 60611 USA.	p-schumacker@northwestern.edu	Marks, Jeremy/W-2087-2019	Marks, Jeremy/0000-0002-2644-5257; Robin, Emmanuel/0000-0003-3422-5622; Waypa, Gregory/0000-0002-6179-4209; Guzy, Robert/0000-0001-8420-6177; Schumacker, Paul T/0000-0001-9591-2034	NHLBI NIH HHS [R01 HL079650, HL079650, HL35440, HL66315, R01 HL066315, HL32646] Funding Source: Medline; NINDS NIH HHS [R01 NS056313-01A1, R01 NS056313] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R55HL032646, R01HL079650, R01HL032646, R01HL035440, R01HL066315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056313] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Bai JX, 2001, J BIOL CHEM, V276, P4315, DOI 10.1074/jbc.M008895200; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Chen ZY, 2000, FREE RADICAL BIO MED, V29, P589, DOI 10.1016/S0891-5849(00)00363-4; DEBOER LWV, 1983, P NATL ACAD SCI-BIOL, V80, P5784, DOI 10.1073/pnas.80.18.5784; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Eaton P, 2002, J MOL CELL CARDIOL, V34, P1549, DOI 10.1006/jmcc.2002.2108; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Jain M, 2004, CIRCULATION, V109, P898, DOI 10.1161/01.CIR.0000112605.43318.CA; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Janssens S, 2004, CIRC RES, V94, P1256, DOI 10.1161/01.RES.0000126497.38281.23; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Levraut J, 2003, AM J PHYSIOL-HEART C, V284, pH549, DOI 10.1152/ajpheart.00708.2002; Liochev SI, 2001, J BIOL CHEM, V276, P35253, DOI 10.1074/jbc.M104237200; Lo LW, 1996, ANAL BIOCHEM, V236, P153, DOI 10.1006/abio.1996.0144; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; McDonald MC, 1999, FREE RADICAL BIO MED, V27, P493, DOI 10.1016/S0891-5849(99)00100-8; MISRA HP, 1972, J BIOL CHEM, V247, P188; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; REIMER KA, 1979, LAB INVEST, V40, P633; SCHONHEIT K, 1995, BBA-MOL BASIS DIS, V1271, P335, DOI 10.1016/0925-4439(95)00052-6; Shao ZH, 2007, AM J PHYSIOL-HEART C, V292, pH1995, DOI 10.1152/ajpheart.01312.2005; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Van den Berg A, 2000, INT J CANCER, V86, P548, DOI 10.1002/(SICI)1097-0215(20000515)86:4<548::AID-IJC17>3.0.CO;2-A; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Vanden Hoek TL, 2003, AM J PHYSIOL-HEART C, V284, pH141, DOI 10.1152/ajpheart.00132.2002; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Vergely C, 2003, ARCH BIOCHEM BIOPHYS, V420, P209, DOI 10.1016/j.abb.2003.07.007; Vergely C, 2001, FREE RADICAL RES, V35, P475, DOI 10.1080/10715760100301491; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698; Zwacka RM, 1998, HUM GENE THER, V9, P1381, DOI 10.1089/hum.1998.9.9-1381; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; Zweier JL, 1998, TRANSPL P, V30, P4228, DOI 10.1016/S0041-1345(98)01399-2	47	115	119	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19133	19143		10.1074/jbc.M701917200	http://dx.doi.org/10.1074/jbc.M701917200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17488710	hybrid			2022-12-27	WOS:000247475300055
J	Izawa, K; Kitaura, J; Yamanishi, Y; Matsuoka, T; Oki, T; Shibata, F; Kumagai, H; Nakajima, H; Maeda-Yamamoto, M; Hauchins, JP; Tybulewicz, VLJ; Takai, T; Kitamura, T				Izawa, Kumi; Kitaura, Jiro; Yamanishi, Yoshinori; Matsuoka, Takayuki; Oki, Toshihiko; Shibata, Fumi; Kumagai, Hidetoshi; Nakajima, Hideaki; Maeda-Yamamoto, Mari; Hauchins, Jeffrey P.; Tybulewicz, Victor L. J.; Takai, Toshiyuki; Kitamura, Toshio			Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; IMMUNOGLOBULIN-LIKE RECEPTORS; MAST-CELL ACTIVATION; FC-EPSILON-RI; TYROSINE KINASE; MYELOID CELLS; CMRF-35-LIKE MOLECULE-1; GENE SUPERFAMILY; DENDRITIC CELLS; IMMUNE-SYSTEM	The leukocyte mono-Ig-like receptor (LMIR) belongs to a new family of paired immunoreceptors. In this study, we analyzed activating receptor LMIR4/CLM-5 as a counterpart of inhibitory receptor LMIR3/CLM-1. LMIR4 is expressed in myeloid cells, including granulocytes, macrophages, and mast cells, whereas LMIR3 is more broadly expressed. The association of LMIR4 with Fc receptor-gamma among immunoreceptor tyrosine-based activation motif-bearing molecules was indispensable for LMIR4-mediated functions of bone marrow-derived mast cells, but dispensable for its surface expression. Cross-linking of LMIR4 led to Lyn- and Syk-dependent activation of bone marrow-derived mast cells, resulting in cytokine production and degranulation, whereas that of LMIR3 did not. The triggering of LMIR4 and TLR4 synergistically caused robust cytokine production in accordance with enhanced activation of ERK, whereas the co-ligation of LMIR4 and LMIR3 dramatically abrogated cytokine production. Notably, intraperitoneal administration of lipopolysaccharide strikingly up-regulated LMIR3 and down-regulated LMIR4, whereas that of granulocyte colony-stimulating factor up-regulated both LMIR3 and LMIR4 in granulocytes. Cross-linking of LMIR4 in bone marrow granulocytes also resulted in their activation, which was enhanced by lipopolysaccharide. Collectively, these results suggest that the innate immune system is at least in part regulated by the qualitative and quantitative balance of the paired receptors LMIR3 and LMIR4.	Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, Tokyo 1088639, Japan; Natl Agr Res Org, Natl Inst Vegetable & Tea Sci, Shizuoka 4288501, Japan; R&D Syst Inc, Minneapolis, MN 55413 USA; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; MRC National Institute for Medical Research; Tohoku University	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp	Kitamura, Toshio/AAA-2071-2021	Maeda-Yamamoto, Mari/0000-0002-4494-7509; Tybulewicz, Victor/0000-0003-2439-0798	MRC [MC_U117527252] Funding Source: UKRI; Medical Research Council [MC_U117527252] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Clark GJ, 2001, TISSUE ANTIGENS, V57, P415, DOI 10.1034/j.1399-0039.2001.057005415.x; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P718, DOI 10.1002/jlb.66.5.718; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Costello PS, 1996, ONCOGENE, V13, P2595; DAISH A, 1993, IMMUNOLOGY, V79, P55; Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; EISEMAN E, 1992, NATURE, V355, P78; Fujimoto M, 2006, INT IMMUNOL, V18, P1499, DOI 10.1093/intimm/dxl083; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; Green BJ, 1998, INT IMMUNOL, V10, P891, DOI 10.1093/intimm/10.7.891; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Katz HR, 2002, CURR OPIN IMMUNOL, V14, P698, DOI 10.1016/S0952-7915(02)00400-4; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; King RG, 2006, J IMMUNOL, V176, P6012, DOI 10.4049/jimmunol.176.10.6012; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kojima T, 1999, NAT BIOTECHNOL, V17, P487, DOI 10.1038/8666; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Lu-Kuo JM, 1999, J BIOL CHEM, V274, P5791, DOI 10.1074/jbc.274.9.5791; Luo K, 2001, BIOCHEM BIOPH RES CO, V287, P35, DOI 10.1006/bbrc.2001.5539; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Oki T, 2006, J IMMUNOL, V176, P52, DOI 10.4049/jimmunol.176.1.52; Ono M, 1999, J BIOL CHEM, V274, P30288, DOI 10.1074/jbc.274.42.30288; Pereira S, 2001, J IMMUNOL, V166, P4115, DOI 10.4049/jimmunol.166.6.4115; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Toyama-Sorimachi N, 2005, J IMMUNOL, V174, P4621, DOI 10.4049/jimmunol.174.8.4621; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Uehara T, 2001, J CLIN INVEST, V108, P1041, DOI 10.1172/JCI200112195; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	56	49	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					17997	18008		10.1074/jbc.M701100200	http://dx.doi.org/10.1074/jbc.M701100200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17438331	hybrid			2022-12-27	WOS:000247302000006
J	Tate, JJ; Cooper, TG				Tate, Jennifer J.; Cooper, Terrance G.			Stress-responsive Gln3 localization in Saccharomyces cerevisiae is separable from and can overwhelm nitrogen source regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RSP5-BUL1/2 UBIQUITIN LIGASE; TOR SIGNALING NETWORK; CELL-GROWTH CONTROL; HEAVY-METAL ION; CATABOLITE REPRESSION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; CARBON STARVATION; 2A PHOSPHATASES	Intracellular localization of Saccharomyces cerevisiae GATA family transcription activator, Gln3, is used as a downstream readout of rapamycin-inhibited Tor1,2 control of Tap42 and Sit4 activities. Gln3 is cytoplasmic in cells provided with repressive nitrogen sources such as glutamine and is nuclear in cells growing with a derepressive nitrogen source such as proline or those treated with rapamycin or methionine sulfoximine (Msx). Although gross Gln3-Myc(13) phosphorylation levels in wild type cells do not correlate with nitrogen source-determined intracellular Gln3-Myc(13) localization, the phosphorylation levels are markedly influenced by several environmental perturbations. Msx treatment increases Snf1-independent Gln3-Myc(13) phosphorylation, whereas carbon starvation increases both Snf1-dependent and - independent Gln3-Myc(13) phosphorylation. Here we demonstrate that a broad spectrum of environmental stresses ( temperature, osmotic, and oxidative) increase Gln3-Myc(13) phosphorylation. In parallel, these stresses elicit rapid (< 5 min for NaCl) Gln3-Myc(13) relocalization from the nucleus to the cytoplasm. The response of Gln3-Myc(13) localization to stressful conditions can completely overwhelm its response to nitrogen source quality or inhibitor-generated disruption of the Tor1,2 signal transduction pathway. Adding NaCl to cells cultured under conditions in which Gln3-Myc(13) is normally nuclear, i.e. proline-grown, nitrogen-starved, Msx-, caffeine-, and rapamycin-treated wild type cells, or ure2 Delta cells, results in its prompt relocalization to the cytoplasm. Together these data identify a major new level of regulation to which Gln3 responds, and adds a new dimension to mechanistic studies of the regulation of this transcription factor.	Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA.	tcooper@utmem.edu		Cooper, Terrance G./0000-0002-7651-9963	NIGMS NIH HHS [R01 GM035642, GM-35642] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COURCHESNE WE, 1988, J BACTERIOL, V170, P708, DOI 10.1128/jb.170.2.708-713.1988; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Feller A, 2006, J BIOL CHEM, V281, P28546, DOI 10.1074/jbc.M605551200; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Masuda CA, 2000, J BIOL CHEM, V275, P30957, DOI 10.1074/jbc.M004869200; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Mendizabal I, 2001, MOL GENET GENOMICS, V265, P801, DOI 10.1007/s004380100474; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Proft M, 1999, MOL CELL BIOL, V19, P537; Rai R, 2005, YEAST, V22, P343, DOI 10.1002/yea.1215; Rai R, 2003, J BIOL CHEM, V278, P12826, DOI 10.1074/jbc.M212186200; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Rohde JR, 2004, MOL CELL BIOL, V24, P8332, DOI 10.1128/MCB.24.19.8332-8341.2004; Schluter Michael, 2005, Am Heart Hosp J, V3, P182, DOI 10.1111/j.1541-9215.2005.04407.x; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Soliman GA, 2005, CURR OPIN LIPIDOL, V16, P317, DOI 10.1097/01.mol.0000169352.35642.06; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; THOMAS G, 2004, CURR TOP MICROBIOL I, V279; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, ANNU REV GENET, V38, P681, DOI 10.1146/annurev.genet.38.072902.092200; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Withee JL, 1998, GENETICS, V149, P865; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239	51	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18467	18480		10.1074/jbc.M609550200	http://dx.doi.org/10.1074/jbc.M609550200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17439949	hybrid, Green Accepted			2022-12-27	WOS:000247302000053
J	Wakamatsu, K; Ogita, H; Okabe, N; Irie, K; Tanaka-Okamoto, M; Ishizaki, H; Ishida-Yamamoto, A; Iizuka, H; Miyoshi, J; Takai, Y				Wakamatsu, Kotaro; Ogita, Hisakazu; Okabe, Noriko; Irie, Kenji; Tanaka-Okamoto, Miki; Ishizaki, Hiroyuki; Ishida-Yamamoto, Akemi; Iizuka, Hajime; Miyoshi, Jun; Takai, Yoshimi			Up-regulation of loricrin expression by cell adhesion molecule nectin-1 through Rap1-ERK signaling in keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTIONS; BARRIER FUNCTION; ECTODERMAL DYSPLASIA; ADHERENS JUNCTIONS; EPIDERMAL BARRIER; CLEFT LIP/PALATE; E-CADHERIN; PROTEIN; SKIN; ROLES	Nectin is an immunoglobulin-like cell-cell adhesion molecule, which plays essential roles in the initial step of formation of adherens junctions and tight junctions. We demonstrate here the role of nectin-1 in the epidermis using nectin-1(-/-) mice. Newborn nectin-1(-/-) pups showed shiny and slightly reddish skin; the amount of loricrin, one of the differentiation markers and also a major component of cornified cell envelopes, was markedly reduced in the epidermis of nectin-1(-/-) mice. The amounts of repetin and SPRRP, other components of cornified cell envelopes, were markedly elevated probably due to a compensatory mechanism to overcome the impaired expression of loricrin. However, cornified cells from nectin-1(-/-) mice were sensitive to mechanical stress. Moreover, Ca2+ induced activation of ERK through Rap1 and expression of loricrin were reduced in primary cultured nectin-1(-/-) keratinocytes; in turn, the inhibition of ERK activation reduced the amount of loricrin in wild-type keratinocytes. These results indicate that nectin-1 plays a key role in the expression of loricrin in the epidermis.	Osaka Univ, Grad Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka 5378511, Japan; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Asahikawa Medical College	Takai, Y (corresponding author), Osaka Univ, Grad Sch Med, Fac Med, Dept Mol Biol & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ytakai@molbio.med.osaka-u.ac.jp	Wakamatsu, Kazumasa/AAZ-5877-2020; Ogita, Hisakazu/AAE-4416-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Tanaka-Okamoto, Miki/0000-0002-6429-7662; Ogita, Hisakazu/0000-0001-6750-1668				AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; ELIAS PM, 1977, ANAT RECORD, V189, P577, DOI 10.1002/ar.1091890404; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Fukuhara A, 2002, ONCOGENE, V21, P7642, DOI 10.1038/sj.onc.1205875; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Inagaki M, 2006, GENES CELLS, V11, P1125, DOI 10.1111/j.1365-2443.2006.01006.x; Jarnik M, 2002, J INVEST DERMATOL, V118, P102, DOI 10.1046/j.0022-202x.2001.01661.x; Kobayashi T, 1998, J DERMATOL SCI, V17, P108, DOI 10.1016/S0923-1811(97)00081-9; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643; Matsushima H, 2003, BRIT J DERMATOL, V148, P755, DOI 10.1046/j.1365-2133.2003.05225.x; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Ogita H, 2006, IUBMB LIFE, V58, P334, DOI 10.1080/15216540600719622; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Okabe N, 2004, DEV BIOL, V273, P244, DOI 10.1016/j.ydbio.2004.05.034; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Sakai S, 2003, J INVEST DERMATOL, V120, P79, DOI 10.1046/j.1523-1747.2003.12006.x; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 2004, CURR OPIN CELL BIOL, V16, P513, DOI 10.1016/j.ceb.2004.07.007; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Seo HR, 2004, EXP MOL MED, V36, P292, DOI 10.1038/emm.2004.40; Shimizu K, 2003, J BIOCHEM, V134, P631, DOI 10.1093/jb/mvg198; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; STEVEN AC, 1994, J CELL SCI, V107, P693; Suzuki K, 1998, AM J HUM GENET, V63, P1102, DOI 10.1086/302072; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525	45	23	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18173	18181		10.1074/jbc.M611159200	http://dx.doi.org/10.1074/jbc.M611159200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17472964	hybrid			2022-12-27	WOS:000247302000023
J	Deval, J; D'Abramo, CM; Zhao, ZJ; McCormick, S; Coutsinos, D; Hess, S; Kvaratskhelia, M; Gotte, M				Deval, Jerome; D'Abramo, Claudia M.; Zhao, Zhuojun; McCormick, Suzanne; Coutsinos, Dimitrios; Hess, Sonja; Kvaratskhelia, Mamuka; Gotte, Matthias			High resolution footprinting of the hepatitis C virus polymerase NS5B in complex with RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO INITIATION; HIV-1 REVERSE-TRANSCRIPTASE; REPLICATION-PROTEIN-A; VIRAL-RNA; CRYSTAL-STRUCTURE; NONNUCLEOSIDE INHIBITORS; BINDING; SITE; DNA; MODULATION	The nucleic acid binding channel of the hepatitis C virus RNA polymerase remains to be defined. Here we employed complementary footprinting techniques and show that the enzyme binds to a newly synthesized duplex of approximately seven to eight base pairs. Comparative analysis of surface topologies of free enzyme versus the nucleoprotein complex revealed certain lysines and arginines that are protected from chemical modification upon RNA binding. The protection pattern helps to define the trajectory of the nucleic acid substrate. Lys(81), Lys(98), Lys(100), Lys(106), Arg(158), Arg(386), and Arg(394) probably interact with the bound RNA. The selective protection of amino acids of the arginine-rich region in helix T points to RNA-induced conformational rearrangements. Together, these findings suggest that RNA-protein interaction through the entire substrate binding channel can modulate intradomain contacts at the C terminus.	McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada; Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; NIDDK, NIH, Bethesda, MD 20892 USA	McGill University; McGill University; McGill University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca	Hess, Sonja/K-4842-2013	Hess, Sonja/0000-0002-5904-9816	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062520] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI062520] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Biswal BK, 2006, J MOL BIOL, V361, P33, DOI 10.1016/j.jmb.2006.05.074; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cai ZH, 2005, J VIROL, V79, P11607, DOI 10.1128/JVI.79.18.11607-11617.2005; Choi HB, 2003, EXP MOL MED, V35, P475, DOI 10.1038/emm.2003.62; D'Abramo CM, 2004, J MOL BIOL, V337, P1, DOI 10.1016/j.jmb.2004.01.030; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; HAUSEN P, 1970, EUR J BIOCHEM, V14, P278, DOI 10.1111/j.1432-1033.1970.tb00287.x; Hirano M, 2003, J BIOL CHEM, V278, P5109, DOI 10.1074/jbc.M207629200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Kvaratskhelia M, 2002, P NATL ACAD SCI USA, V99, P15988, DOI 10.1073/pnas.252550199; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; Lai VCH, 2003, J VIROL, V77, P2295, DOI 10.1128/JVI.77.3.2295-2300.2003; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Makeyev EV, 2000, EMBO J, V19, P6275, DOI 10.1093/emboj/19.22.6275; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Ranjith-Kumar CT, 2004, J VIROL, V78, P12207, DOI 10.1128/JVI.78.22.12207-12217.2004; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	37	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16907	16916		10.1074/jbc.M701973200	http://dx.doi.org/10.1074/jbc.M701973200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17449464	hybrid			2022-12-27	WOS:000246946500023
J	McCloskey, DT; Doherty, L; Dai, YP; Miller, L; Hume, JR; Yamboliev, IA				McCloskey, Diana T.; Doherty, Lynda; Dai, Yan-Ping; Miller, Lisa; Hume, Joseph R.; Yamboliev, Ilia A.			Hypotonic activation of short ClC3 isoform is modulated by direct interaction between its cytosolic C-terminal tail and subcortical actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL REGULATION; VOLUME REGULATION; CBS DOMAINS; PHOSPHORYLATION; CELLS; CIC-2; IDENTIFICATION; CYTOSKELETON; EXPRESSION; MUTATIONS	Short ClC3 isoform (sClC3) functions as a volume-sensitive outwardly rectifying anion channel (VSOAC) in some cell types. In previous studies, we have shown that the hypotonic activation of sClC3 is linked to cell swelling-mediated remodeling of the actin cytoskeleton. In the present study, we have tested the hypothesis that the cytosolic tails of sClC3 bind to actin directly and that binding modulates the hypotonic activation of the channel. Co-sedimentation assays in vitro demonstrated a strong binding between the glutathione S-transferase-fused cytosolic C terminus of sClC3 (GST-sClC3-CT) to filamentous actin (F-actin) but not to globular monomeric actin (G-actin). The GST-fused N terminus (GST-sClC3-NT) exhibited low binding affinity to both G-and F-actin. Co-sedimentation experiments with progressively truncated GST-sClC3-CT indicated that the F-actin binding region is located between amino acids 690 and 760 of sClC3. Two synthetic peptides mapping basic clusters of the cytosolic sClC3-CT (CTP2, isoleucine 716 to leucine 734; and CTP3, proline 688 to proline 709) prevented binding of GST-sClC3-CT to F-actin in vitro. Dialysis into NIH/3T3 cells of these two peptides (but not of synthetic peptide CTP1 (isoleucine 737 to glutamine 748)) reduced the maximal current density by 60 and 38%, respectively. Based on these results, we have concluded that, by direct interaction with subcortical actin filaments, sClC3 contributes to the hypotonic stress-induced VSOACs in NIH/3T3 cells.	Univ Nevada, Reno Sch Med, Dept Pharmacol, Reno, NV 89557 USA; Univ Nevada, Reno Sch Med, Ctr Biomed Res Excellence, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Yamboliev, IA (corresponding author), Univ Nevada, Reno Sch Med, Dept Pharmacol, MS 318, Reno, NV 89557 USA.	iyamboliev@medicine.nevada.edu			NCRR NIH HHS [P21RR 15581] Funding Source: Medline; NHLBI NIH HHS [HL49254] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015581] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049254, R01HL049254] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmed N, 2000, BIOCHEM J, V352, P789, DOI 10.1042/0264-6021:3520789; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Britton FC, 2005, J BIOL CHEM, V280, P25871, DOI 10.1074/jbc.M502826200; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Do CW, 2005, INVEST OPHTH VIS SCI, V46, P948, DOI 10.1167/iovs.04-1004; Duan D, 2000, CIRC RES, V86, pE63, DOI 10.1161/01.RES.86.4.e63; Duan D, 1999, J GEN PHYSIOL, V113, P57, DOI 10.1085/jgp.113.1.57; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Furukawa T, 2002, J PHYSIOL-LONDON, V540, P883; Furukawa T, 1998, AM J PHYSIOL-CELL PH, V274, pC500, DOI 10.1152/ajpcell.1998.274.2.C500; Greenwood IA, 2004, J PHYSIOL-LONDON, V557, P343, DOI 10.1113/jphysiol.2004.063750; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hatton WJ, 2002, BIOPHYS J, V82, p242A; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Henson JH, 1999, MICROSC RES TECHNIQ, V47, P155, DOI 10.1002/(SICI)1097-0029(19991015)47:2<155::AID-JEMT7>3.0.CO;2-T; Hermoso M, 2002, J BIOL CHEM, V277, P40066, DOI 10.1074/jbc.M205132200; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jin NG, 2003, AM J PHYSIOL-GASTR L, V285, pG938, DOI 10.1152/ajpgi.00470.2002; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Lemonnier L, 2004, CANCER RES, V64, P4841, DOI 10.1158/0008-5472.CAN-03-3223; LEVITAN I, 1995, J MEMBRANE BIOL, V147, P283; Li SJ, 2006, J BIOCHEM, V139, P813, DOI 10.1093/jb/mvj099; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Nagasaki M, 2000, J PHYSIOL-LONDON, V523, P705, DOI 10.1111/j.1469-7793.2000.00705.x; Pedersen SF, 1999, EXP CELL RES, V252, P63, DOI 10.1006/excr.1999.4615; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Rossow CF, 2006, ACTA PHYSIOL, V187, P5, DOI 10.1111/j.1748-1716.2006.01550.x; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vessey JP, 2004, BIOCHEM CELL BIOL, V82, P708, DOI 10.1139/O04-107; Wang GX, 2005, J MEMBRANE BIOL, V208, P15, DOI 10.1007/s00232-005-0815-y; Wang GX, 2004, AM J PHYSIOL-HEART C, V287, pH533, DOI 10.1152/ajpheart.00228.2003; Wang GX, 2003, AM J PHYSIOL-HEART C, V285, pH1453, DOI 10.1152/ajpheart.00244.2003; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Weylandt KH, 2001, J BIOL CHEM, V276, P17461, DOI 10.1074/jbc.M011667200; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x; Zheng YJ, 2002, J BIOL CHEM, V277, P32268, DOI 10.1074/jbc.M202105200; Zhong JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1627, DOI 10.1152/ajpcell.00152.2001; Zhou JG, 2005, J BIOL CHEM, V280, P7301, DOI 10.1074/jbc.M412813200	47	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16871	16877		10.1074/jbc.M700379200	http://dx.doi.org/10.1074/jbc.M700379200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17442672	hybrid			2022-12-27	WOS:000246946500019
J	Meares, GP; Jope, RS				Meares, Gordon P.; Jope, Richard S.			Resolution of the nuclear localization mechanism of glycogen synthase kinase-3 - Functional effects in apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; CELL-SURVIVAL; PHOSPHORYLATION; 3-BETA; GSK3; SUPPRESSION; IDENTIFICATION; ACTIVATION; PROTEIN	Mechanisms regulating the nuclear localization of glycogen synthase kinase-3 beta (GSK3 beta) remained enigmatic despite the crucial regulation by nuclear GSK3 beta of important cellular functions. These include regulation of gene expression, cell cycle progression, and apoptosis, achieved by the phosphorylation by GSK3 of nuclear substrates (e.g. numerous transcription factors). We resolved this mechanism by identifying a bipartite nuclear localization sequence (NLS) that is necessary for the nuclear accumulation of GSK3 beta and is sufficient to drive yellow fluorescent protein into the nucleus. Despite the NLS, most GSK3 beta is cytosolic, sequestered in protein complexes that, although still mobile in the cytosol, block the NLS. Conditions promoting nuclear translocation of GSK3 beta release it from cytosolic complexes, allowing the NLS to direct nuclear import. Using this information to prepare a nucleus-excluded active GSK3 construct, we found that the antiapoptotic effect of GSK3 beta in tumor necrosis factor-induced apoptosis is mediated by cytosolic, not nuclear, GSK3 beta. Identification of a GSK3 beta NLS allows new strategies to decipher and manipulate its subcellular actions regulating gene expression and apoptosis and its involvement in diseases.	Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Jope, RS (corresponding author), Univ Alabama Birmingham, Dept Psychiat, 7th Ave S,SC1057, Birmingham, AL 35294 USA.	jope@uab.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155	NIA NIH HHS [R01 AG021045, AG021045] Funding Source: Medline; NIMH NIH HHS [R01 MH038752, R01 MH038752-23] Funding Source: Medline; NINDS NIH HHS [R01 NS037768, R01 NS037768-04, R01 NS037768-09, NS37768] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021045] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dingwall C, 1998, CURR BIOL, V8, pR922, DOI 10.1016/S0960-9822(98)00010-4; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Liao XB, 2003, MOL CANCER THER, V2, P1215; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Nair R, 2003, NUCLEIC ACIDS RES, V31, P397, DOI 10.1093/nar/gkg001; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Woodgett J. R., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P281, DOI 10.2174/1568008033340153; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	35	90	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16989	17001		10.1074/jbc.M700610200	http://dx.doi.org/10.1074/jbc.M700610200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17438332	Green Accepted, hybrid			2022-12-27	WOS:000246946500032
J	Mason, JM; Hagemann, UB; Arndt, KM				Mason, Jody M.; Hagemann, Urs B.; Arndt, Katja M.			Improved stability of the Jun-Fos activator protein-1 coiled coil motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLOW CIRCULAR-DICHROISM; FREE-ENERGY CHANGES; LEUCINE-ZIPPER; EMPIRICAL PARAMETERS; TRANSITION-STATES; FOLDING PROBLEM; IN-VIVO; LINEAR EXTRAPOLATION; 2-STATE TRANSITION; ESCHERICHIA-COLI	Two c-Jun leucine zipper variants that bind with high affinity to c-Fos have been selected using semirational design combined with protein-fragment complementation assays (JunW) or phage display selection (JunW(Ph1)). Enriched winners differ from each other in only two of ten semi-randomized positions, with Delta Tm values of 28 degrees C and 37 degrees C over wild-type. cFos-JunW, cFos-JunW(Ph1), and two intermediate mutants (cFos-JunW(Q21R) and cFos-JunW(E23K)) display biphasic kinetics in the folding direction, indicating the existence of a folding intermediate. The first reaction phase is fast and concentration-dependent, showing that the intermediate is readily populated and dimeric. The second phase is independent of concentration and is exponential. In contrast, in the unfolding direction, all molecules display two-state kinetics. Collectively this implies a transition state between unfolded helices and dimeric intermediate that is readily traversed in both directions. We demonstrate that the added stability of cFos-JunW(Ph1) relative to cFos-JunW is achieved via a combination of kinetic rate changes; cFos-JunW(E23K) has an increased initial dimerization rate, prior to the major transition state barrier while cFos-JunW(Q21R) displays a decreased unfolding rate. The former implies that improved hydrophobic burial and helix-stabilizing mutations exert their effect on the initial, rapid, monomer-collision event. In contrast, electrostatic interactions exert their effect late in the folding pathway. Although our focus is the leucine zipper region of the oncogenic transcription factor Activator Protein-1, coiled coils are ubiquitous and highly specific in their recognition of partners. Consequently, generating kinetic-based rules to predict and engineer their stability is of major significance in peptide-based drug design and nano-biotechnology.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany	University of Freiburg	Mason, JM (corresponding author), Univ Freiburg, Inst Biol 3, Schaenzlestr 1, D-79104 Freiburg, Germany.	jody@biologie.uni-freiburg.de; katja@biologie.uni-freiburg.de	Mason, Jody/W-8204-2019; Mason, Jody/A-9329-2011	Mason, Jody/0000-0002-4118-1958; Mason, Jody/0000-0002-4118-1958; Arndt, Katja/0000-0001-9220-0920				ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9; Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Bosshard HR, 2001, BIOCHEMISTRY-US, V40, P3544, DOI 10.1021/bi002161l; Bunagan MR, 2006, BIOCHEMISTRY-US, V45, P10981, DOI 10.1021/bi0606142; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Dragan AI, 2002, J MOL BIOL, V321, P891, DOI 10.1016/S0022-2836(02)00699-X; Du H, 1998, PHOTOCHEM PHOTOBIOL, V68, P141, DOI 10.1562/0031-8655(1998)068<0141:PACADA>2.3.CO;2; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; GITTELMAN MS, 1990, BIOCHEMISTRY-US, V29, P7011, DOI 10.1021/bi00482a009; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Ibarra-Molero B, 2004, J MOL BIOL, V336, P989, DOI 10.1016/j.jmb.2003.12.069; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jelesarov I, 1998, BIOCHEMISTRY-US, V37, P7539, DOI 10.1021/bi972977v; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Knappenberger JA, 2002, J MOL BIOL, V321, P1, DOI 10.1016/S0022-2836(02)00592-2; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; Lu CH, 2005, ONCOGENE, V24, P6516, DOI 10.1038/sj.onc.1208905; Ludes-Meyers JH, 2001, ONCOGENE, V20, P2771, DOI 10.1038/sj.onc.1204377; MANN CJ, 1993, BIOCHEMISTRY-US, V32, P5282, DOI 10.1021/bi00071a002; Mason JM, 2005, J BIOL CHEM, V280, P40494, DOI 10.1074/jbc.M509281200; Mason JM, 2002, BIOCHEMISTRY-US, V41, P12093, DOI 10.1021/bi026398o; Mason JM, 2007, BIOCHEMISTRY-US, V46, P4804, DOI 10.1021/bi602506p; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Meisner WK, 2004, P NATL ACAD SCI USA, V101, P15639, DOI 10.1073/pnas.0404895101; Meisner WK, 2004, P NATL ACAD SCI USA, V101, P13478, DOI 10.1073/pnas.0404057101; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; MO JM, 1991, P NATL ACAD SCI USA, V88, P916, DOI 10.1073/pnas.88.3.916; Moran LB, 1999, P NATL ACAD SCI USA, V96, P10699, DOI 10.1073/pnas.96.19.10699; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; Myers JK, 1999, J MOL BIOL, V289, P205, DOI 10.1006/jmbi.1999.2747; PACE CN, 1979, BIOCHEMISTRY-US, V18, P288, DOI 10.1021/bi00569a008; Parker MJ, 1998, BIOCHEMISTRY-US, V37, P2538, DOI 10.1021/bi972459k; Pelletier JN, 1999, NAT BIOTECHNOL, V17, P683, DOI 10.1038/10897; Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885; Ryadnov MG, 2003, J AM CHEM SOC, V125, P9388, DOI 10.1021/ja0352045; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sosnick TR, 1996, PROTEINS, V24, P427; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Wang T, 2005, BIOPHYS J, V89, P4180, DOI 10.1529/biophysj.105.068809; WENDT H, 1994, J AM CHEM SOC, V116, P6973, DOI 10.1021/ja00094a077; WENDT H, 1995, BIOCHEMISTRY-US, V34, P4097, DOI 10.1021/bi00012a028; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	54	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23015	23024		10.1074/jbc.M701828200	http://dx.doi.org/10.1074/jbc.M701828200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17483489	hybrid			2022-12-27	WOS:000248577500004
J	Kremer, W; Kachel, N; Kuwata, K; Akasaka, K; Kalbitzer, HR				Kremer, Werner; Kachel, Norman; Kuwata, Kazuo; Akasaka, Kazuyuki; Kalbitzer, Hans Robert			Species-specific differences in the intermediate states of human and Syrian hamster prion protein detected by high pressure NMR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVITY SAPPHIRE CELLS; CONFORMATION; REVEALS; SHIFTS	Human (huPrP) and Syrian hamster (ShaPrP) prion proteins have barriers for mutual infectivity, although they fold into almost an identical structure. The pressure responses of huPrP and ShaPrP characterized by high pressure NMR spectroscopy show differences in their excited states, as monitored by pressure-induced chemical shifts and intensity changes of individual residues in the N-15/H-1 HSQC spectra. Both proteins fluctuate rapidly between two well folded (native) conformations N-1 and N-2 and less frequently between N and the excited states I-1 and I-2 with local disorder that may present structural intermediates on the way to PrPSc. These four structural states can be observed in the hamster and human PrP. At ambient pressure, less than 5 molecules of 10,000 are in the intermediate state I-2. From the structural point of view, the different states are mutually different, particularly in positions strategically important for generating species barriers for infection. The results point to the notion that excited state conformers are important for infection and that their structural differences may crucially determine species barriers for infection.	Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany; Gifu Univ, Ctr Emerging Infect Dis, Gifu 5008705, Japan; Kinki Univ, Sch Biol Oriented Sci & Technol, Dept Biotechnol Sci, Wakayama 6496493, Japan	University of Regensburg; Gifu University; Kindai University (Kinki University)	Kalbitzer, HR (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.	hans-robert.kalbitzer@biologie.uni-regensburg.de		Kalbitzer, Hans Robert/0000-0002-6514-2355				Akasaka K, 1999, PROTEIN SCI, V8, P1946, DOI 10.1110/ps.8.10.1946; Akasaka K, 2001, BIOCHEMISTRY-US, V40, P8665, DOI 10.1021/bi010312u; Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z; Arnold MR, 2003, J MAGN RESON, V161, P127, DOI 10.1016/S1090-7807(02)00179-9; Arnold MR, 2002, BIOPHYS CHEM, V96, P129, DOI 10.1016/S0301-4622(02)00018-2; Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200; Chen SG, 2002, NEURON, V34, P854, DOI 10.1016/S0896-6273(02)00736-5; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Horiuchi M, 1999, STRUCTURE, V7, pR231, DOI 10.1016/S0969-2126(00)80049-0; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kremer W, 2004, SPECTROSC-INT J, V18, P271, DOI 10.1155/2004/407619; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Li H, 1998, BIOCHEMISTRY-US, V37, P1167, DOI 10.1021/bi972288j; Maurer T, 2004, J BACTERIOL, V186, P5906, DOI 10.1128/JB.186.17.5906-5918.2004; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Price WE, 1997, PRACT APPR CHEM SER, P225; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799; YAMADA H, 1974, REV SCI INSTRUM, V45, P640, DOI 10.1063/1.1686703; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1999, Q REV BIOPHYS, V32, P309, DOI 10.1017/S0033583500003553	31	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22689	22698		10.1074/jbc.M701884200	http://dx.doi.org/10.1074/jbc.M701884200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17519231	hybrid			2022-12-27	WOS:000248354200046
J	Renna, M; Caporaso, MG; Bonatti, S; Kaufman, RJ; Remondelli, P				Renna, Maurizio; Caporaso, Maria Gabriella; Bonatti, Stefano; Kaufman, Randal J.; Remondelli, Paolo			Regulation of ERGIC-53 gene transcription in response to endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-Y; LECTIN ERGIC-53; MESSENGER-RNA; FACTOR YY1; PROTEIN; ELEMENT; ATF6; INDUCTION; IDENTIFICATION; RECEPTOR	Accumulation of unfolded proteins within the endoplasmic reticulum (ER) activates the unfolded protein response, also known as the ER stress response. We previously demonstrated that ER stress induces transcription of the ER Golgi intermediate compartment protein ERGIC-53. To investigate the molecular events that regulate unfolded protein response-mediated induction of the gene, we have analyzed the transcriptional regulation of ERGIC-53. We found that the ERGIC-53 promoter contains a single cis-acting element that mediates induction of the gene by thapsigargin and other ER stress-causing agents. This ER stress response element proved to retain a novel structure and to be highly conserved in mammalian ERGIC-53 genes. The ER stress response element identified contains a 5 '-end CCAAT sequence that constitutively binds NFY/CBF and, 9 nucleotides away, a 3 '-end region (5 '-CCCTGTTGGCCATC- 3 ') that is equally important for ER stress-mediated induction of the gene. This sequence is the binding site for endogenous YY1 at the 5 '-CCCTGTTGG-3 ' part and for undefined factors at the CCATC 3 '-end. ATF6 alpha-YY1, but not XBP1, interacted with the ERGIC-53 regulatory region and activated ERGIC-53 ER stress response element-dependent transcription. A molecular model for the transcriptional regulation of the ERGIC-53 gene is proposed.	Univ Salerno, Dipartimento Sci Farmaceut, I-84034 Fisciano Salerno, Italy; Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; Univ Michigan, Ctr Med, Dept Biol Chem & Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Salerno; University of Naples Federico II; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Remondelli, P (corresponding author), Univ Salerno, Dipartimento Sci Farmaceut, Via Ponte Don Melillo, I-84034 Fisciano Salerno, Italy.	premondelli@unisa.it	Remondelli, Paolo/X-7805-2019	REMONDELLI, Paolo/0000-0002-3698-3497	NHLBI NIH HHS [HL52173, HL057346] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdelrahim M, 2005, J BIOL CHEM, V280, P16508, DOI 10.1074/jbc.C500030200; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHAO CCK, 1992, NUCLEIC ACIDS RES, V20, P6481, DOI 10.1093/nar/20.24.6481; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hauri HP, 2000, J CELL SCI, V113, P587; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57; Klumperman J, 1998, J CELL SCI, V111, P3411; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li WW, 1997, MOL CELL BIOL, V17, P54, DOI 10.1128/MCB.17.1.54; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Moussalli M, 1999, J BIOL CHEM, V274, P32539, DOI 10.1074/jbc.274.46.32539; Nyfeler B, 2003, BIOCHEM BIOPH RES CO, V304, P599, DOI 10.1016/S0006-291X(03)00634-X; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Renna M, 2006, INT J BIOCHEM CELL B, V38, P2040, DOI 10.1016/j.biocel.2006.05.016; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Spatuzza C, 2004, J BIOL CHEM, V279, P42535, DOI 10.1074/jbc.M401860200; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; Wang Y, 2000, J BIOL CHEM, V275, P27013; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153	45	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31							22499	10.1074/jbc.M703778200	http://dx.doi.org/10.1074/jbc.M703778200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17535801	hybrid			2022-12-27	WOS:000248354200028
J	Kashkina, E; Anikin, M; Brueckner, F; Lehmann, E; Kochetkov, SN; McAllister, WT; Cramer, P; Temiakov, D				Kashkina, Ekaterina; Anikin, Michael; Brueckner, Florian; Lehmann, Elisabeth; Kochetkov, Sergey N.; McAllister, William T.; Cramer, Patrick; Temiakov, Dmitry			Multisubunit RNA polymerases melt only a single DNA base pair downstream of the active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II ELONGATION COMPLEX; STRUCTURAL BASIS; NUCLEOTIDE INCORPORATION; 2-AMINOPURINE FLUORESCENCE; TEMPLATE-STRAND; TRANSCRIPTION; INITIATION; BUBBLE; NTP; TRANSLOCATION	To extend the nascent transcript, RNA polymerases must melt the DNA duplex downstream from the active site to expose the next acceptor base for substrate binding and incorporation. A number of mechanisms have been proposed to account for the manner in which the correct substrate is selected, and these differ in their predictions as to how far the downstream DNA is melted. Using fluorescence quenching experiments, we provide evidence that cellular RNA polymerases from bacteria and yeast melt only one DNA base pair downstream from the active site. These data argue against a model in which multiple NTPs are lined up downstream of the active site.	Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA; Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; Univ Munich, Ctr Integrated Prot Sci, Dept Chem & Biochem, D-81377 Munich, Germany	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Munich; University of Munich	Temiakov, D (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA.	d.temiakov@umdnj.edu	Kochetkov, Sergey N./O-1065-2013	Kochetkov, Sergey/0000-0002-7443-6961	NIGMS NIH HHS [R01 GM038147, GM38147, R01 GM038147-15A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Batada NN, 2004, P NATL ACAD SCI USA, V101, P17361, DOI 10.1073/pnas.0408168101; Datta K, 2006, J MOL BIOL, V360, P800, DOI 10.1016/j.jmb.2006.05.053; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Hariharan C, 2006, BIOCHEMISTRY-US, V45, P2836, DOI 10.1021/bi051644s; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Mandal SS, 2002, BIOCHEMISTRY-US, V41, P4399, DOI 10.1021/bi015723p; Martin CT, 2003, METHOD ENZYMOL, V371, P13; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Temiakov D, 2003, ACTA CRYSTALLOGR D, V59, P185, DOI 10.1107/S0907444902019777; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	27	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21578	21582		10.1074/jbc.C700098200	http://dx.doi.org/10.1074/jbc.C700098200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17526498	Green Published, hybrid			2022-12-27	WOS:000248196800002
J	Mullany, LK; Nelsen, CJ; Hanse, EA; Goggin, MM; Anttila, CK; Peterson, M; Bitterman, PB; Raghavan, A; Crary, GS; Albrecht, JH				Mullany, Lisa K.; Nelsen, Christopher J.; Hanse, Eric A.; Goggin, Melissa M.; Anttila, Chelsea K.; Peterson, Mark; Bitterman, Peter B.; Raghavan, Arvind; Crary, Gretchen S.; Albrecht, Jeffrey H.			Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR P21; RIBOSOMAL-PROTEIN S6; HEPATOCYTE PROLIFERATION; SIGNALING PATHWAY; IN-VIVO; REGENERATING LIVER; ENDOTHELIAL-CELLS; GENE-EXPRESSION; ORGAN GROWTH; PROGRESSION	The control of hepatocyte growth is relevant to the processes of liver regeneration, development, metabolic homeostasis, and cancer. A key component of growth control is the protein kinase Akt, which acts downstream of mitogens and nutrients to affect protein translation and cell cycle progression. In this study, we found that transient transfection of activated Akt triggered a 3-4-fold increase in liver size within days but only minimal hepatocyte proliferation. Akt-induced liver growth was associated with marked up-regulation of cyclin E but not cyclin D1. Analysis of liver polyribosomes demonstrated that the post-transcriptional induction of cyclin E was associated with increased translational efficiency of this mRNA, suggesting that cell growth promotes expression of this protein through a translational mechanism that is distinct from the cyclin D-E2F pathway. Treatment of Akt-transfected mice with rapamycin only partially inhibited liver growth and did not prevent the induction of cyclin E protein, indicating that target of rapamycin activity is not necessary for this response. In the enlarged livers, cyclin E-Cdk2 complexes were present in high abundance but were inactive due to increased binding of p21 to these complexes. Akt transfection of p21(-/-) mice promoted liver growth, activation of Cdk2, and enhanced hepatocyte proliferation. In conclusion, growth promotes cyclin E expression through a novel translational mechanism in the liver, suggesting a new link between cell growth and the cell cycle machinery. Furthermore, p21 suppresses proliferation in the overgrown livers and may play a role in preventing cell cycle progression in response to organ size homeostatic mechanisms.	Hennepin Cty Med Ctr G5, Div Gastroenterol, Minneapolis, MN 55415 USA; Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; Hennepin Cty Med Ctr, Dept Pathol, Minneapolis, MN 55415 USA	Hennepin County Medical Center; Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center	Albrecht, JH (corresponding author), Hennepin Cty Med Ctr G5, Div Gastroenterol, 701 Pk Ave, Minneapolis, MN 55415 USA.	albre010@umn.edu		BITTERMAN, PETER/0000-0002-7995-7117; Raghavan, Arvind/0000-0002-2959-3626; Hanse, Eric/0000-0002-1234-0198	NIDDK NIH HHS [DK54921] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054921] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; Boylan JM, 2001, J BIOL CHEM, V276, P44457, DOI 10.1074/jbc.M103457200; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Crary GS, 1998, HEPATOLOGY, V28, P738, DOI 10.1002/hep.510280320; Derenzini M, 2005, J CELL PHYSIOL, V202, P483, DOI 10.1002/jcp.20144; Edgar Bruce A., 2004, VVolume 42, P23; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; FRANCAVILLA A, 1992, HEPATOLOGY, V15, P871, DOI 10.1002/hep.1840150520; FRANCAVILLA A, 1992, TRANSPLANTATION, V53, P496; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Goggin MM, 2004, HEPATOLOGY, V40, P537, DOI 10.1002/hep.20338; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Hui TT, 2002, AM J SURG, V183, P457, DOI 10.1016/S0002-9610(02)00822-X; Jaime M, 2002, HEPATOLOGY, V35, P1063, DOI 10.1053/jhep.2002.32678; Jiang YP, 2001, J BIOL CHEM, V276, P10943, DOI 10.1074/jbc.M007758200; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; Li S, 2003, J BIOL CHEM, V278, P3015, DOI 10.1074/jbc.M208821200; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Luedde T, 2003, HEPATOLOGY, V37, P833, DOI 10.1053/jhep.2003.50136; Malstrom S, 2001, P NATL ACAD SCI USA, V98, P14967, DOI 10.1073/pnas.231467698; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Morita Tomoyuki, 2002, J Hepatobiliary Pancreat Surg, V9, P352, DOI 10.1007/s005340200039; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nelsen CJ, 2003, J BIOL CHEM, V278, P25853, DOI 10.1074/jbc.M302360200; Nelsen CJ, 2003, J BIOL CHEM, V278, P3656, DOI 10.1074/jbc.M209374200; Nelsen CJ, 2001, CANCER RES, V61, P8564; Nelsen CJ, 2001, ONCOGENE, V20, P1825, DOI 10.1038/sj.onc.1204248; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Prober DA, 2001, CURR OPIN GENET DEV, V11, P19, DOI 10.1016/S0959-437X(00)00151-9; Rickheim DG, 2002, HEPATOLOGY, V36, P30, DOI 10.1053/jhep.2002.33996; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; STEER CJ, 1995, FASEB J, V9, P1396, DOI 10.1096/fasebj.9.14.7589980; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Wagayama H, 2001, DIGEST DIS SCI, V46, P2074, DOI 10.1023/A:1011977923941; Wells WA, 2002, J CELL BIOL, V158, P1156, DOI 10.1083/jcb.200209042; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Zhang H, 2007, MOL CELL, V25, P175, DOI 10.1016/j.molcel.2007.01.008	62	42	45	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21244	21252		10.1074/jbc.M702110200	http://dx.doi.org/10.1074/jbc.M702110200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17517888	hybrid			2022-12-27	WOS:000248047500052
J	Bharadwaj, AG; Rector, K; Simpson, MA				Bharadwaj, Alamelu G.; Rector, Katherine; Simpson, Melanie A.			Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; HYAL1 HYALURONIDASE; CARCINOMA-CELLS; PERICELLULAR MATRIX; EXPRESSION; CANCER; CD44; ACID; GENE; INHIBITION	Prostate cancer progression can be predicted in human tumor biopsies by abundant hyaluronan ( HA) and its processing enzyme, the hyaluronidase HYAL1. Accumulation of HA is dictated by the balance between expression levels of HA synthases, the enzymes that produce HA polymers, and hyaluronidases, which process polymers to oligosaccharides. Aggressive prostate tumor cells express 20-fold higher levels of the hyaluronan synthase HAS3, but the mechanistic relevance of this correlation has not been determined. We stably overexpressed HAS3 in prostate tumor cells. Adhesion to extracellular matrix and cellular growth kinetics in vitro were significantly reduced. Slow growth in culture was restored either by exogenous addition of hyaluronidase or by stable HYAL1 coexpression. Coexpression did not improve comparably slow growth in mice, however, suggesting that excess hyaluronan production by HAS3 may alter the balance required for induced tumor growth. To address this, we used a tetracycline-inducible HAS3 expression system in which hyaluronan production could be experimentally controlled. Adjusting temporal parameters of hyaluronan production directly affected growth rate of the cells. Relief from growth suppression in vitro but not in vivo by enzymatic removal of HA effectively uncoupled the respective roles of hyaluronan in growth and angiogenesis, suggesting that growth mediation is less critical to establishment of the tumor than early vascular development. Collectively results also imply that HA processing by elevated HYAL1 expression in invasive prostate cancer is a requirement for progression.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Simpson, MA (corresponding author), Univ Nebraska, Dept Biochem, N241 Beadle Ctr,1901 Vine St, Lincoln, NE 68588 USA.	msimpson2@unl.edu			NATIONAL CANCER INSTITUTE [R01CA106584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 106584] Funding Source: Medline; NCRR NIH HHS [P20 RR 018759] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aaltomaa S, 2002, UROL INT, V69, P266, DOI 10.1159/000066123; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Asteriou T, 2006, MATRIX BIOL, V25, P166, DOI 10.1016/j.matbio.2005.11.005; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Bullard KM, 2003, INT J CANCER, V107, P739, DOI 10.1002/ijc.11475; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Csoka TB, 1998, GENOMICS, V48, P63, DOI 10.1006/geno.1997.5158; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; DEKLERK DP, 1984, J UROLOGY, V131, P1008, DOI 10.1016/S0022-5347(17)50750-8; Delpech B, 1997, J INTERN MED, V242, P41, DOI 10.1046/j.1365-2796.1997.00172.x; Dube B, 2001, BBA-MOL CELL RES, V1538, P283, DOI 10.1016/S0167-4889(01)00079-9; Ekici S, 2004, INT J CANCER, V112, P121, DOI 10.1002/ijc.20368; Enegd B, 2002, NEUROSURGERY, V50, P1311, DOI 10.1097/00006123-200206000-00023; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; FUJIMOTO T, 1989, J PEDIATR SURG, V24, P550, DOI 10.1016/S0022-3468(89)80504-4; Gakunga P, 1997, DEVELOPMENT, V124, P3987; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hughes C, 2005, J CLIN PATHOL, V58, P673, DOI 10.1136/jcp.2002.003954; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Itano N, 1999, CANCER RES, V59, P2499; Kosaki R, 1999, CANCER RES, V59, P1141; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Laurent T. C., 1996, IMMUNOL CELL BIOL, V74, pA1, DOI [10.1038/icb.1996.32, DOI 10.1038/ICB.1996.32]; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; LEES VC, 1995, LAB INVEST, V73, P259; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Liu NF, 2001, CANCER RES, V61, P5207; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lokeshwar VB, 2005, CANCER RES, V65, P2243, DOI 10.1158/0008-5472.CAN-04-2805; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Lokeshwar VB, 1996, CANCER RES, V56, P651; Lopez MV, 2006, MOL CANCER THER, V5, P2503, DOI 10.1158/1535-7163.MCT-06-0286; Mio K, 2002, MATRIX BIOL, V21, P31, DOI 10.1016/S0945-053X(01)00185-8; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Nardini M, 2004, GENE EXPR PATTERNS, V4, P303, DOI 10.1016/j.modgep.2003.10.006; Patel S, 2002, INT J CANCER, V97, P416, DOI 10.1002/ijc.1638; Posey JT, 2003, CANCER RES, V63, P2638; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Simpson MA, 2001, J BIOL CHEM, V276, P17949, DOI 10.1074/jbc.M010064200; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stern R, 2005, PATHOL BIOL, V53, P372, DOI 10.1016/j.patbio.2004.12.021; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; van Bokhoven A, 2001, CANCER RES, V61, P6340; Ward JA, 2003, AM J PATHOL, V162, P1403, DOI 10.1016/S0002-9440(10)64273-3; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WELSH CF, 1995, J CELL PHYSIOL, V164, P605, DOI 10.1002/jcp.1041640319; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; Xu L, 2002, J BIOL CHEM, V277, P11368, DOI 10.1074/jbc.M108347200; Zeng CX, 1998, INT J CANCER, V77, P396; ZHANG LR, 1995, CANCER RES, V55, P428	79	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20561	20572		10.1074/jbc.M702964200	http://dx.doi.org/10.1074/jbc.M702964200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502371	hybrid			2022-12-27	WOS:000247819300059
J	Maskrey, BH; Bermudez-Fajardo, A; Morgan, AH; Stewart-Jones, E; Dioszeghy, V; Taylor, GW; Baker, PRS; Coles, B; Coffey, MJ; Kuhn, H; O'Donnell, VB				Maskrey, Benjamin H.; Bermudez-Fajardo, Alexandra; Morgan, Alwena H.; Stewart-Jones, Esther; Dioszeghy, Vincent; Taylor, Graham W.; Baker, Paul R. S.; Coles, Barbara; Coffey, Marcus J.; Kuehn, Hartmut; O'Donnell, Valerie B.			Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER EPITHELIAL-CELLS; 15-HYDROXYEICOSATETRAENOIC ACID; 12(S)-HYDROXYEICOSATETRAENOIC ACID; SELECTIVE INCORPORATION; SIGNALING PATHWAY; GLYCOPROTEIN-VI; RECEPTOR-GAMMA; KNOCKOUT MICE; FATTY-ACIDS; PHOSPHOLIPIDS	12/15-Lipoxygenase (LOX) mediates immune-regulatory activities not accounted for by its known free acid eicosanoids, suggesting that additional lipids may be generated by activated cells. To characterize novel LOX-derived lipids, a lipidomic approach was utilized. Ionophore-activated interleukin-4-treated human peripheral monocytes generated up to 10-fold more esterified 15-hydroxyeicosatetraenoic acid (15-HETE) than free in a phosphatidylinositol 3-kinase- and protein kinase C-sensitive manner. Precursor scanning electrospray ionization/tandem spectroscopy form/z 319 ( HETE, [M-H](-)) showed 4 ions at m/z 738, 764, 766, and 782 that were identified using tandem spectroscopy and MS3 as specific diacyl and plasmalogen 15-HETE phosphatidylethanolamines. Using (H2O)-O-18 water, the compounds were shown to form by direct oxidation of endogenous phosphatidylethanolamine (PE) by 15-LOX, with PE being the preferred phospholipid pool containing 15-HETE. Similarly, human platelets generated 4 analogous PE lipids that contained 12-HETE and increased significantly in response to ionophore, collagen, or convulxin. These products were retained in the cells, in contrast to free acids, which are primarily secreted. Precursor scanning of platelet extracts for the major platelet-derived prostanoid, thromboxane B2 (m/z 369.2), did not reveal PE esters, indicating that this modification is restricted to the LOX pathway. In summary, we show formation of PE-esterified HETEs in immune cells that may contribute to LOX signaling in inflammation.	Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales; UCL Royal Free Univ, Sch Med, Ctr Amyloidosis & Acute Phase Proteins, London NW3 2PF, England; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; Humboldt Univ, Inst Biochem, D-10117 Berlin, Germany	Cardiff University; University of London; University College London; UCL Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Humboldt University of Berlin	O'Donnell, VB (corresponding author), Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	o-donnellvb@cardiff.ac.uk	O'Donnell, Valerie/C-6948-2012; Taylor, Graham Walter/R-4811-2019	Taylor, Graham Walter/0000-0002-9672-8463; Bermudez-Fajardo, Alexandra/0000-0001-8889-5635; /0000-0003-4089-8460	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALPERT SE, 1993, AM J RESP CELL MOL, V8, P273, DOI 10.1165/ajrcmb/8.3.273; Anning PB, 2005, AM J PATHOL, V166, P653, DOI 10.1016/S0002-9440(10)62287-0; Arai M, 1997, EUR J BIOCHEM, V244, P513, DOI 10.1111/j.1432-1033.1997.00513.x; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; BRASH AR, 1987, BIOCHEMISTRY-US, V26, P5465, DOI 10.1021/bi00391a038; BRASH AR, 1986, PROSTAG LEUKOTR ESS, V23, P149, DOI 10.1016/0262-1746(86)90178-2; BREZINSKI ME, 1990, P NATL ACAD SCI USA, V87, P6248, DOI 10.1073/pnas.87.16.6248; Brinckmann R, 1998, BLOOD, V91, P64, DOI 10.1182/blood.V91.1.64.64_64_74; Coffey MJ, 2004, FEBS LETT, V576, P165, DOI 10.1016/j.febslet.2004.09.007; Coffey MJ, 2004, CIRC RES, V94, P1598, DOI 10.1161/01.RES.0000132281.78948.65; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; DUGAN LL, 1986, J CHROMATOGR, V378, P317, DOI 10.1016/S0378-4347(00)80728-8; GIRTON RA, 1994, KIDNEY INT, V45, P972, DOI 10.1038/ki.1994.131; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; KENNETT FF, 1984, BIOCHIM BIOPHYS ACTA, V804, P301, DOI 10.1016/0167-4889(84)90133-2; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; KUHN H, 1994, J LIPID RES, V35, P1749; KUHN H, 1987, EUR J BIOCHEM, V169, P593, DOI 10.1111/j.1432-1033.1987.tb13650.x; LEGRAND AB, 1991, J BIOL CHEM, V266, P7570; Legrand AB, 1996, BBA-LIPID LIPID MET, V1301, P150, DOI 10.1016/0005-2760(96)00015-X; MARINETTI GV, 1982, CHEM PHYS LIPIDS, V31, P169, DOI 10.1016/0009-3084(82)90042-1; Middleton MK, 2006, J IMMUNOL, V176, P265, DOI 10.4049/jimmunol.176.1.265; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Murphy R. C, 2002, MASS SPECTROMETRY PH; Pace-Asciak CR, 1999, ADV EXP MED BIOL, V447, P123; PAPAYIANNI A, 1995, KIDNEY INT, V47, P1295, DOI 10.1038/ki.1995.184; PAWLOWSKI NA, 1982, J EXP MED, V155, P1653, DOI 10.1084/jem.155.6.1653; Profita M, 1999, AM J RESP CELL MOL, V20, P61, DOI 10.1165/ajrcmb.20.1.3151; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; SERHAN CN, 1991, ADV PROSTAG THROMB L, V21, P105; Shankaranarayanan P, 2003, J IMMUNOL, V170, P887, DOI 10.4049/jimmunol.170.2.887; Shappell SB, 2001, CANCER RES, V61, P497; SHEN XY, 1988, BIOCHEMISTRY-US, V27, P996, DOI 10.1021/bi00403a024; STENSON WF, 1983, PROSTAGLANDINS, V26, P253, DOI 10.1016/0090-6980(83)90093-X; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; URSINI F, 1995, METHOD ENZYMOL, V252, P28; Vernhet L, 1997, LIFE SCI, V61, P1667, DOI 10.1016/S0024-3205(97)00772-8; Vernhet L, 1996, J LIPID MEDIAT CELL, V13, P233, DOI 10.1016/0929-7855(95)00050-X; WALLUKAT G, 1994, J BIOL CHEM, V269, P29055; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhao L, 2002, J BIOL CHEM, V277, P35350, DOI 10.1074/jbc.M205738200	44	113	114	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20151	20163		10.1074/jbc.M611776200	http://dx.doi.org/10.1074/jbc.M611776200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17519227	hybrid			2022-12-27	WOS:000247819300016
J	Nakanishi-Matsui, M; Kashiwagi, S; Ubukata, T; Iwamoto-Kihara, A; Wada, Y; Futai, M				Nakanishi-Matsui, Mayumi; Kashiwagi, Sachiko; Ubukata, Toshiharu; Iwamoto-Kihara, Atsuko; Wada, Yoh; Futai, Masamitsu			Rotational catalysis of Escherichia coli ATP synthase F-1 sector - Stochastic fluctuation and a key domain of the beta subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; TORQUE GENERATION; EPSILON-SUBUNIT; GAMMA-SUBUNIT; F-ATPASE; C-RING; F-1-ATPASE; MUTANT; F1-ATPASE; SITE	A complex of gamma, is an element of, and c subunits rotates in ATP synthase (FoF(1)) coupled with proton transport. A gold bead connected to the gamma subunit of the Escherichia coli F-1 sector exhibited stochastic rotation, confirming a previous study (Nakanishi-Matsui, M., Kashiwagi, S., Hosokawa, H., Cipriano, D. J., Dunn, S. D., Wada, Y., and Futai, M. (2006) J. Biol. Chem. 281, 4126 - 4131). A similar approach was taken for mutations in the beta subunit key region; consistent with its bulk phase ATPase activities, F1 with the Ser-174 to Phe substitution (beta S174F) exhibited a slower single revolution time ( time required for 360 degree revolution) and paused almost 10 times longer than the wild type at one of the three 120 positions during the stepped revolution. The pause positions were probably not at the "ATP waiting" dwell but at the "ATP hydrolysis/ product release" dwell, since the ATP concentration used for the assay was similar to 30-fold higher than the Km value for ATP. A beta Gly-149 to Ala substitution in the phosphate binding P-loop suppressed the defect of beta S174F. The revertant (beta G149A/beta S174F) exhibited similar rotation to the wild type, except that it showed long pauses less frequently. Essentially the same results were obtained with the Ser-174 to Leu substitution and the corresponding revertant beta G149A/beta S174L. These results indicate that the domain between beta-sheet 4 (beta Ser-174) and P-loop (beta Gly-149) is important to drive rotation.	Microbial Chem Res Ctr, Microbial Chem Res Fdn, Futai Special Lab, Tokyo 1410021, Japan; Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Iwate 0283694, Japan; Nagahama Inst Biosci & Technol, Dept Biosci, Shiga 5260829, Japan; Osaka Univ, Inst Sci, Dept Biol Sci, Ibaraki 5670041, Japan	Iwate Medical University; Osaka University	Futai, M (corresponding author), Microbial Chem Res Ctr, Microbial Chem Res Fdn, Futai Special Lab, Tokyo 1410021, Japan.	futaim@iwate-med.ac.jp						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Futai M., 2004, HDB ATPASES BIOCH CE, P237; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Hosokawa H, 2005, J BIOL CHEM, V280, P23797, DOI 10.1074/jbc.M502650200; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Iko Y, 2001, J BIOL CHEM, V276, P47508, DOI 10.1074/jbc.M108803200; IWAMOTO A, 1993, J BIOL CHEM, V268, P3156; IWAMOTO A, 1991, J BIOL CHEM, V266, P16350; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; KANAZAWA H, 1980, J BIOCHEM-TOKYO, V88, P695, DOI 10.1093/oxfordjournals.jbchem.a133022; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Masaike T, 2000, J EXP BIOL, V203, P1; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2006, IUBMB LIFE, V58, P318, DOI 10.1080/15216540600702255; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OMOTE H, 1994, J BIOL CHEM, V269, P10265; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	35	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20698	20704		10.1074/jbc.M700551200	http://dx.doi.org/10.1074/jbc.M700551200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517893	hybrid			2022-12-27	WOS:000247819300072
J	Noriega-Lopez, L; Tovar, AR; Gonzalez-Granillo, M; Hernandez-Pando, R; Escalante, B; Santillan-Doherty, P; Torres, N				Noriega-Lopez, Lilia; Tovar, Armando R.; Gonzalez-Granillo, Marcela; Hernandez-Pando, Rogelio; Escalante, Bruno; Santillan-Doherty, Patricio; Torres, Nimbe			Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; BETA-CELL HYPERPLASIA; PEROXISOME PROLIFERATOR; TYROSINE KINASE; INDUCED OBESITY; GLUCOSE; RELEASE; ISLETS; LIVER; LIPOTOXICITY	Obesity is frequently associated with the consumption of high carbohydrate/fat diets leading to hyperinsulinemia. We have demonstrated that soy protein (SP) reduces hyperinsulinemia, but it is unclear by which mechanism. Thus, the purpose of the present work was to establish whether SP stimulates insulin secretion to a lower extent and/or reduces insulin resistance, and to understand its molecular mechanism of action in pancreatic islets of rats with diet-induced obesity. Long-term consumption of SP in a high fat (HF) diet significantly decreased serum glucose, free fatty acids, leptin, and the insulin: glucagon ratio compared with animals fed a casein HF diet. Hyperglycemic clamps indicated that SP stimulated insulin secretion to a lower extent despite HF consumption. Furthermore, there was lower pancreatic islet area and insulin, SREBP-1, PPAR alpha, and GLUT-2 mRNA abundance in comparison with rats fed the casein HF diet. Euglycemic-hyperinsulinemic clamps showed that the SP diet prevented insulin resistance despite consumption of a HF diet. Incubation of pancreatic islets with isoflavones reduced insulin secretion and expression of PPAR alpha. Addition of amino acids resembling the plasma concentration of rats fed casein stimulated insulin secretion; a response that was reduced by the presence of isoflavones, whereas the amino acid pattern resembling the plasma concentration of rats fed SP barely stimulated insulin release. Infusion of isoflavones during the hyperglycemic clamps did not stimulate insulin secretion. Therefore, isoflavones as well as the amino acid pattern seen after SP consumption stimulated insulin secretion to a lower extent, decreasing PPAR gamma, GLUT-2, and SREBP-1 expression, and ameliorating hyperinsulinemia observed during obesity.	Inst Nacl Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City 14000, DF, Mexico; Inst Nacl Nutr Salvador Zubiran, Dept Cirugia Expt, Mexico City 14000, DF, Mexico; Inst Nacl Nutr Salvador Zubiran, Dept Patol Expt, Mexico City 14000, DF, Mexico; CINVESTAV, Dept Biomed Mol, Mexico City 07360, DF, Mexico; Univ Iberoamer, Mexico City 01219, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Iberoamericana Ciudad de Mexico	Torres, N (corresponding author), Inst Nacl Nutr Salvador Zubiran, Dept Fisiol Nutr, Vasco de Quiroga No 15, Mexico City 14000, DF, Mexico.	nimbet@quetzal.innsz.mx	Torres, Nimbe/AAI-4340-2020; Torres, Nimbe/AAY-8821-2020	Torres, Nimbe/0000-0002-1741-0984; Hernandez-Pando, Rogelio/0000-0003-1292-3833; Noriega, Lilia G./0000-0003-2156-9872; Gonzalez Granillo, Marcela Alejandra/0000-0002-9046-2692				Ascencio C, 2004, J NUTR, V134, P522, DOI 10.1093/jn/134.3.522; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; BLACHIER F, 1989, BIOCHIM BIOPHYS ACTA, V1013, P144, DOI 10.1016/0167-4889(89)90042-6; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Bray G, 1998, AM J CLIN NUTR, V67, P1; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Dobbins RL, 2002, DIABETES, V51, P1825, DOI 10.2337/diabetes.51.6.1825; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gu LW, 2006, J NUTR, V136, P1215, DOI 10.1093/jn/136.5.1215; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Hensrud DD, 2001, OBES RES, V9, p348S, DOI 10.1038/oby.2001.141; HIRIART M, 1991, ENDOCRINOLOGY, V128, P3193, DOI 10.1210/endo-128-6-3193; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; ITOH Y, 2005, HEPATOL RES; Jia DM, 2004, METABOLISM, V53, P405, DOI 10.1016/j.metabol.2003.10.006; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; KOOPMANS SJ, 1992, BIOCHIM BIOPHYS ACTA, V1115, P230, DOI 10.1016/0304-4165(92)90059-4; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; KRAEGEN EW, 1983, AM J PHYSIOL, V245, pE1, DOI 10.1152/ajpendo.1983.245.1.E1; Lavigne C, 2001, AM J PHYSIOL-ENDOC M, V281, pE62, DOI 10.1152/ajpendo.2001.281.1.E62; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; MALAISSE WJ, 1973, DIABETOLOGIA, V9, P167, DOI 10.1007/BF01219778; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matsui J, 2004, DIABETES, V53, P2844, DOI 10.2337/diabetes.53.11.2844; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; MILNER RDG, 1970, J ENDOCRINOL, V47, P347, DOI 10.1677/joe.0.0470347; Ness-Abramof R, 2006, ENDOCRINE, V29, P5, DOI 10.1385/ENDO:29:1:5; Reaven Gerald M, 2003, Curr Atheroscler Rep, V5, P364, DOI 10.1007/s11883-003-0007-0; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SANCHEZ A, 1991, MED HYPOTHESES, V36, P27, DOI 10.1016/0306-9877(91)90160-Z; Sandberg MB, 2005, MOL CELL ENDOCRINOL, V240, P94, DOI 10.1016/j.mce.2005.05.005; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Sugden MC, 2004, DIABETES, V53, pS71, DOI 10.2337/diabetes.53.2007.S71; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Torres N, 2006, FUTURE LIPIDOL, V1, P331, DOI 10.2217/17460875.1.3.331; Torres N, 2006, J NUTR BIOCHEM, V17, P365, DOI 10.1016/j.jnutbio.2005.11.005; Tovar AR, 2005, J LIPID RES, V46, P1823, DOI 10.1194/jlr.M500067-JLR200; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; VERSPOHL EJ, 1995, CELL SIGNAL, V7, P505, DOI 10.1016/0898-6568(95)00020-P; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhao YF, 2005, J MOL ENDOCRINOL, V35, P49, DOI 10.1677/jme.1.01779; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; Zhou YT, 1998, P NATL ACAD SCI USA, V95, P8898, DOI 10.1073/pnas.95.15.8898; ZU Z, 2006, ACTA BIOCH BIOPH SIN, V38, P1	56	92	95	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20657	20666		10.1074/jbc.M701045200	http://dx.doi.org/10.1074/jbc.M701045200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17507381	hybrid			2022-12-27	WOS:000247819300068
J	Henriksson, LM; Unge, T; Carlsson, J; Aqvist, J; Mowbray, SL; Jones, TA				Henriksson, Lena M.; Unge, Torsten; Carlsson, Jens; Aqvist, Johan; Mowbray, Sherry L.; Jones, T. Alwyn			Structures of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase provide new insights into catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-MEVALONATE PATHWAY; 5-PHOSPHATE REDUCTOISOMERASE; ISOPRENOID BIOSYNTHESIS; CRYSTAL-STRUCTURE; NONMEVALONATE PATHWAY; 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE; ISOPENTENYL DIPHOSPHATE; FOSMIDOMYCIN; ENZYME; BOND	Isopentenyl diphosphate is the precursor of various isoprenoids that are essential to all living organisms. It is produced by the mevalonate pathway in humans but by an alternate route in plants, protozoa, and many bacteria. 1-Deoxy-D-xylulose-5-phosphate reductoisomerase catalyzes the second step of this non-mevalonate pathway, which involves an NADPH-dependent rearrangement and reduction of 1-deoxy-D-xylulose 5-phosphate to form 2-C-methyl-D-erythritol 4-phosphate. The use of different pathways, combined with the reported essentiality of the enzyme makes the reductoisomerase a highly promising target for drug design. Here we present several high resolution structures of the Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase, representing both wild type and mutant enzyme in various complexes with Mn2+, NADPH, and the known inhibitor fosmidomycin. The asymmetric unit corresponds to the biological homodimer. Although crystal contacts stabilize an open active site in the B molecule, the A molecule displays a closed conformation, with some differences depending on the ligands bound. An inhibition study with fosmidomycin resulted in an estimated IC50 value of 80 nM. The double mutant enzyme (D151N/E222Q) has lost its ability to bind the metal and, thereby, also its activity. Our structural information complemented with molecular dynamics simulations and free energy calculations provides the framework for the design of new inhibitors and gives new insights into the reaction mechanism. The conformation of fosmidomycin bound to the metal ion is different from that reported in a previously published structure and indicates that a rearrangement of the intermediate is not required during catalysis.	Uppsala Univ, Biomed Ctr, Dept Mol & Cell Biol, S-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Jones, TA (corresponding author), Uppsala Univ, Biomed Ctr, Dept Mol & Cell Biol, S-75124 Uppsala, Sweden.	Alwyn@xray.bmc.uu.se	Mowbray, Sherry L/D-2141-2013	Carlsson, Jens/0000-0003-4623-2977				AQVIST J, 1993, CHEM REV, V93, P2523, DOI 10.1021/cr00023a010; AQVIST J, 1909, COMPUTATIONAL APPROA, P341; Argyrou A, 2004, BIOCHEMISTRY-US, V43, P4375, DOI 10.1021/bi049974k; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjelic S, 2006, BIOCHEMISTRY-US, V45, P7709, DOI 10.1021/bi060131y; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dhiman RK, 2005, J BACTERIOL, V187, P8395, DOI 10.1128/JB.187.24.8395-8402.2005; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Haemers T, 2006, BIOORG MED CHEM LETT, V16, P1888, DOI 10.1016/j.bmcl.2005.12.082; Harris M, 2001, ACTA CRYSTALLOGR D, V57, P1201, DOI 10.1107/S0907444901007697; Henriksson LM, 2006, ACTA CRYSTALLOGR D, V62, P807, DOI 10.1107/S0907444906019196; Hoeffler JF, 2002, EUR J BIOCHEM, V269, P4446, DOI 10.1046/j.1432-1033.2002.03150.x; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kuzuyama T, 2000, J BIOL CHEM, V275, P19928, DOI 10.1074/jbc.M001820200; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P4509, DOI 10.1016/S0040-4039(98)00802-8; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lell B, 2003, ANTIMICROB AGENTS CH, V47, P735, DOI 10.1128/AAC.47.2.735-738.2003; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Mac Sweeney A, 2005, J MOL BIOL, V345, P115, DOI 10.1016/j.jmb.2004.10.030; MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017; Marelius J, 1998, J MOL GRAPH MODEL, V16, P213, DOI 10.1016/S1093-3263(99)00012-1; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Missinou MA, 2002, LANCET, V360, P1941, DOI 10.1016/S0140-6736(02)11860-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Proteau PJ, 1999, ORG LETT, V1, P921, DOI 10.1021/ol990839n; Radykewicz T, 2000, FEBS LETT, V465, P157, DOI 10.1016/S0014-5793(99)01743-3; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reuter K, 2002, J BIOL CHEM, V277, P5378, DOI 10.1074/jbc.M109500200; Ricagno S, 2004, BBA-PROTEINS PROTEOM, V1698, P37, DOI 10.1016/j.bbapap.2003.10.006; Rodriguez-Concepcion M, 2000, FEBS LETT, V473, P328, DOI 10.1016/S0014-5793(00)01552-0; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Sem DS, 2004, CHEM BIOL, V11, P185, DOI 10.1016/j.chembio.2004.02.012; SHIGI Y, 1989, J ANTIMICROB CHEMOTH, V24, P131, DOI 10.1093/jac/24.2.131; Spurgeon SL, 1981, BIOSYNTHESIS ISOPREN, P1; Steinbacher S, 2003, J BIOL CHEM, V278, P18401, DOI 10.1074/jbc.M300993200; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Warshel A, 1991, COMPUTER MODELING CH; Yajima S, 2004, J AM CHEM SOC, V126, P10824, DOI 10.1021/ja040126m; Yajima S, 2002, J BIOCHEM, V131, P313, DOI 10.1093/oxfordjournals.jbchem.a003105; Zeidler J, 1998, Z NATURFORSCH C, V53, P980	59	69	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19905	19916		10.1074/jbc.M701935200	http://dx.doi.org/10.1074/jbc.M701935200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17491006	hybrid			2022-12-27	WOS:000247650600065
J	Horsman, GP; Bhowmik, S; Seah, SYK; Kumar, P; Bolin, JT; Eltis, LD				Horsman, Geoff P.; Bhowmik, Shiva; Seah, Stephen Y. K.; Kumar, Pravindra; Bolin, Jeffrey T.; Eltis, Lindsay D.			The tautomeric half-reaction of BphD, a C-C bond hydrolase - Kinetic and structural evidence supporting a key role for histidine 265 of the catalytic triad	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-HYDROXY-6-KETO-NONA-2,4-DIENE-1,9-DIOIC ACID 5,6-HYDROLASE; MICROBIAL-DEGRADATION; POLYCHLORINATED-BIPHENYLS; SERINE HYDROLASE; MECHANISM; ENZYMES; MHPC; CRYSTALLOGRAPHY; IDENTIFICATION; INTERMEDIATE	BphD of Burkholderia xenovorans LB400 catalyzes an unusual C-C bond hydrolysis of 2-hydroxy-6-oxo-6-phenyl-hexa-2,4-dienoic acid ( HOPDA) to afford benzoic acid and 2-hydroxy-2,4-pentadienoic acid (HPD). An enol-keto tautomerization has been proposed to precede hydrolysis via a gemdiol intermediate. The role of the canonical catalytic triad (Ser-112, His-265, Asp-237) in mediating these two half-reactions remains unclear. We previously reported that the BphD-catalyzed hydrolysis of HOPDA (lambda(max) is 434 nm for the free enolate) proceeds via an unidentified intermediate with a red-shifted absorption spectrum (lambda(max) is 492 nm) (Horsman, G. P., Ke, J., Dai, S., Seah, S. Y. K., Bolin, J. T., and Eltis, L. D. ( 2006) Biochemistry 45, 11071-11086). Here we demonstrate that the S112A variant generates and traps a similar intermediate (lambda(max) is 506 nm) with a similar rate, 1/tau similar to 500 s(-1). The crystal structure of the S112A: HOPDA complex at 1.8-angstrom resolution identified this intermediate as the keto tautomer, (E)-2,6-dioxo-6-phenyl-hex-3- enoate. This keto tautomer did not accumulate in either the H265A or the S112A/H265A double variants, indicating that His-265 catalyzes tautomerization. Consistent with this role, the wild type and S112A enzymes catalyzed tautomerization of the product HPD, whereas H265A variants did not. This study thus identifies a keto intermediate, and demonstrates that the catalytic triad histidine catalyzes the tautomerization half-reaction, expanding the role of this residue from its purely hydrolytic function in other serine hydrolases. Finally, the S112A: HOPDA crystal structure is more consistent with hydrolysis occurring via an acyl-enzyme intermediate than a gem- diol intermediate as solvent molecules have poor access to C6, and the closest ordered water is 7 angstrom away.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Life Sci Inst, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Purdue Univ, Ctr Canc, Markey Ctr Struct Biol, Dept Biol Sci, W Lafayette, IN 47907 USA	University of British Columbia; University of British Columbia; University of British Columbia; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Eltis, LD (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 1365-2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Horsman, Geoff/AAQ-2349-2020; KUMAR, PRAVINDRA/AAF-2859-2020; Eltis, Lindsay D/J-8272-2015	Horsman, Geoff/0000-0002-2023-2349; KUMAR, PRAVINDRA/0000-0003-2128-7736; Eltis, Lindsay D/0000-0002-6774-8158				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bugg TDH, 2004, BIOORG CHEM, V32, P367, DOI 10.1016/j.bioorg.2004.05.005; DIAZ E, 1995, J BIOL CHEM, V270, P6403, DOI 10.1074/jbc.270.11.6403; DORDINE RL, 1994, BIOCHEMISTRY-US, V33, P12635, DOI 10.1021/bi00208a014; Dunn G, 2005, J MOL BIOL, V346, P253, DOI 10.1016/j.jmb.2004.11.033; Fleming SM, 2000, BIOCHEMISTRY-US, V39, P1522, DOI 10.1021/bi9923095; FOX MA, 1994, ORGANIC CHEM, P204; Furukawa K, 2003, TRENDS BIOTECHNOL, V21, P187, DOI 10.1016/S0167-7799(03)00054-4; Fushinobu S, 2002, PROTEIN SCI, V11, P2184, DOI 10.1110/ps.0209602; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Henderson IMJ, 1997, BIOCHEMISTRY-US, V36, P12252, DOI 10.1021/bi971116j; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Horsman GP, 2006, BIOCHEMISTRY-US, V45, P11071, DOI 10.1021/bi0611098; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lam WWY, 1997, BIOCHEMISTRY-US, V36, P12242, DOI 10.1021/bi971115r; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li C, 2005, J MOL BIOL, V346, P241, DOI 10.1016/j.jmb.2004.11.032; Li JJ, 2007, ORG BIOMOL CHEM, V5, P507, DOI 10.1039/b615605c; Li JJ, 2006, BIOCHEMISTRY-US, V45, P12461, DOI 10.1021/bi0612519; Li JJ, 2005, CHEM COMMUN, P130, DOI 10.1039/b415491f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nandhagopal N, 2001, J MOL BIOL, V309, P1139, DOI 10.1006/jmbi.2001.4737; Nerdinger S, 1999, CHEM COMMUN, P2259, DOI 10.1039/a907279i; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seah SYK, 1998, J BIOL CHEM, V273, P22943, DOI 10.1074/jbc.273.36.22943; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; Sekharan S, 2007, ANGEW CHEM INT EDIT, V46, P269, DOI 10.1002/anie.200603306; Speare DM, 2004, ORG BIOMOL CHEM, V2, P2942, DOI 10.1039/b410322j; Speare DM, 2002, CHEM COMMUN, P2304, DOI 10.1039/b208168g; Takahashi Y, 2003, BIOCHEMISTRY-US, V42, P6025, DOI 10.1021/bi020629+; Tian T, 2006, ANGEW CHEM INT EDIT, V45, P7763, DOI 10.1002/anie.200602720; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Williams DH., 1995, SPECTROSCOPIC METHOD, P14; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	39	32	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19894	19904		10.1074/jbc.M702237200	http://dx.doi.org/10.1074/jbc.M702237200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17442675	hybrid			2022-12-27	WOS:000247650600064
J	Arrecubieta, C; Lee, MH; Macey, A; Foster, TJ; Lowy, FD				Arrecubieta, Carlos; Lee, Mei-Ho; Macey, Alistair; Foster, Timothy J.; Lowy, Franklin D.			SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; FOREIGN-BODY INFECTIONS; CELL-SURFACE; EXTRACELLULAR-MATRIX; LACTOCOCCUS-LACTIS; MOLECULAR-BASIS; CLUMPING FACTOR; AUREUS; FIBRONECTIN; ADHERENCE	Staphylococcus epidermidis is the leading cause of device-related infections. These infections require an initial colonization step in which S. epidermidis adheres to the implanted material. This process is usually mediated by specific bacterial surface proteins and host factors coating the foreign device. Some of these surface proteins belong to the serine-aspartate repeat (Sdr) family, which includes adhesins from Staphyloccus aureus and S. epidermidis. Using a heterologous expression system in Lactococcus lactis to overcome possible staphylococcal adherence redundancy we observed that one of these Sdr proteins, SdrF, mediates binding to type I collagen when present on the lactococcal cell surface. We used lactococcal recombinant strains, a protein-protein interaction assay and Western ligand blot analysis to demonstrate that this process occurs via the B domain of SdrF and both the alpha 1 and alpha 2 chains of type I collagen. It was also found that a single B domain repeat of S. epidermidis 9491 retains the capacity to bind to type I collagen. We demonstrated that the putative ligand binding N-terminal A domain does not bind to collagen which suggests that SdrF might be a multiligand adhesin. Antibodies directed against the B domain significantly reduce in vitro adherence of S. epidermidis to immobilized collagen.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Med, Div Infect Dis, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland	Columbia University; Columbia University; Columbia University; Trinity College Dublin	Lowy, FD (corresponding author), Trinity Coll Dublin, Moyne Inst Prevent Med, Dublin 2, Ireland.	fl189@columbia.edu	Lee, Mei-Ho/ABA-1514-2021	Lee, Mei-Ho/0000-0001-9206-6805	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077096] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 077096-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acil Y, 1997, J CHROMATOGR A, V758, P313, DOI 10.1016/S0021-9673(96)00729-7; Andreola F, 2004, J BIOL CHEM, V279, P3434, DOI 10.1074/jbc.M305832200; Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0; Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P597, DOI 10.1128/AAC.33.5.597; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Heimberger T S, 1989, Infect Dis Clin North Am, V3, P221; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Ingham KC, 2004, J BIOL CHEM, V279, P42945, DOI 10.1074/jbc.M406984200; Josefsson E, 1998, J BIOL CHEM, V273, P31145, DOI 10.1074/jbc.273.47.31145; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; MARTIN MA, 1989, ANN INTERN MED, V110, P9, DOI 10.7326/0003-4819-110-1-9; McCrea KW, 2000, MICROBIOL-SGM, V146, P1535, DOI 10.1099/00221287-146-7-1535; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; NI ED, 1998, MOL MICROBIOL, V30, P245; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Pei L, 1999, INFECT IMMUN, V67, P4525, DOI 10.1128/IAI.67.9.4525-4530.1999; PETERS G, 1988, J ANTIMICROB CHEMOTH, V21, P139, DOI 10.1093/jac/21.suppl_C.139; PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Simon D, 2005, CLIN INFECT DIS, V40, P1108, DOI 10.1086/428728; von Eiff C, 1999, INFECTION, V27, pS7, DOI 10.1007/BF02561610; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; WELLS JM, 1993, J APPL BACTERIOL, V74, P629, DOI 10.1111/j.1365-2672.1993.tb05195.x; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	42	64	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18767	18776		10.1074/jbc.M610940200	http://dx.doi.org/10.1074/jbc.M610940200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17472965	hybrid			2022-12-27	WOS:000247475300015
J	Guizzetti, M; Chen, J; Oram, JF; Tsuji, R; Dao, K; Moller, T; Costa, LG				Guizzetti, Marina; Chen, Jing; Oram, John F.; Tsuji, Ryozo; Dao, Khoi; Moeller, Thomas; Costa, Lucio G.			Ethanol induces cholesterol efflux and up-regulates ATP-binding cassette cholesterol transporters in fetal astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED PHOSPHOINOSITIDE METABOLISM; LEMLI-OPITZ-SYNDROME; APOLIPOPROTEIN-E; ALCOHOL SYNDROME; SONIC HEDGEHOG; CELL-DEATH; DEVELOPMENTAL NEUROTOXICITY; MUSCARINIC RECEPTORS; NEURITE OUTGROWTH; RETINOIC ACID	Cholesterol plays an important role during brain development, since it is involved in glial cell proliferation, neuronal survival and differentiation, and synaptogenesis. Astrocytes produce large amounts of brain cholesterol and produce and release lipoproteins containing apoE that can extract cholesterol from CNS cells for elimination. We hypothesized that some of the deleterious effects of ethanol in the developing brain may be due to the disruption of cholesterol homeostasis in astrocytes. This study investigates the effect of ethanol on cholesterol efflux mediated by ATP-binding cassette (ABC) cholesterol transporters. In fetal rat astrocytes in culture, ethanol caused a concentration-dependent increase in cholesterol efflux and increased the levels of ABCA1 starting at 25mM. Similar effects of ethanol on cholesterol efflux and ABCA1 were also observed in fetal human astrocytes. In addition, ABCA1 levels were increased in the brains of 7-day-old pups treated for 3 days with 2, 4, or 6 g/kg ethanol. Ethanol also increased apoE release from fetal rat astrocytes, and conditioned medium prepared from ethanol-treated astrocytes extracted more cholesterol than conditioned medium from untreated cells. In addition, ethanol increased the levels of another cholesterol transporter, ABCG1. Ethanol did not affect cholesterol synthesis and reduced the levels of intracellular cholesterol in rat astrocytes. Retinoic acid, which induces teratogenic effects similarly to ethanol, also caused up-regulation of ABCA1 and ABCG1.	Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98105 USA; Univ Washington, Dept Med, Seattle, WA 98105 USA; Univ Washington, Dept Neurol, Seattle, WA 98105 USA; Sumitomo Chem Co Ltd, Environm Hlth Lab, Osaka 554, Japan; Univ Parma, Dept Human Anat Pharmacol & Forens Med, I-43100 Parma, Italy	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Sumitomo Chem Co Ltd; University of Parma	Guizzetti, M (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE No100, Seattle, WA 98105 USA.	marinag@u.washington.edu			NIAAA NIH HHS [AA015443, AA08154] Funding Source: Medline; NICHD NIH HHS [HD00836] Funding Source: Medline; NIEHS NIH HHS [P30ES07033] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015443, R01AA008154] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Ahlgren SC, 2002, P NATL ACAD SCI USA, V99, P10476, DOI 10.1073/pnas.162356199; Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P400, DOI 10.1093/alcalc/35.4.400; Astley SJ, 1999, TERATOLOGY, V59, P163, DOI 10.1002/(SICI)1096-9926(199903)59:3<163::AID-TERA8>3.0.CO;2-8; BALDUINI W, 1989, J PHARMACOL EXP THER, V250, P541; BALDUINI W, 1990, BRAIN RES, V512, P248, DOI 10.1016/0006-8993(90)90633-M; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Blader P, 1998, DEV BIOL, V201, P185, DOI 10.1006/dbio.1998.8995; BOCHELEN D, 1995, J NEUROCHEM, V65, P2194; CASTELLI WP, 1977, LANCET, V2, P153; Cohen MM, 2002, AM J MED GENET, V109, P1, DOI 10.1002/ajmg.10258; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Costet P, 2003, MOL CELL BIOL, V23, P7756, DOI 10.1128/MCB.23.21.7756-7766.2003; DAVIES DL, 1981, NEUROSCI LETT, V26, P49, DOI 10.1016/0304-3940(81)90424-9; Dehart DB, 1997, AM J MED GENET, V68, P328, DOI 10.1002/(SICI)1096-8628(19970131)68:3<328::AID-AJMG15>3.0.CO;2-V; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; Fan QW, 2002, J NEUROCHEM, V80, P178, DOI 10.1046/j.0022-3042.2001.00686.x; Guizzetti M, 2005, MED HYPOTHESES, V64, P563, DOI 10.1016/j.mehy.2004.05.019; Guizzetti M, 2004, J NEUROCHEM, V90, P646, DOI 10.1111/j.1471-4159.2004.02541.x; Guizzetti M, 1996, J NEUROCHEM, V67, P2236; Guizzetti M, 1996, EUR J PHARMACOL, V297, P265, DOI 10.1016/0014-2999(95)00746-6; Guizzetti M, 2001, NEUROREPORT, V12, P1639, DOI 10.1097/00001756-200106130-00025; Guizzetti Marina, 1997, Frontiers in Bioscience, V2, pE93; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; INOMATA K, 1987, INT J DEV NEUROSCI, V5, P455, DOI 10.1016/0736-5748(87)90023-2; Jurevics HA, 1997, J LIPID RES, V38, P723; Karten B, 2006, J BIOL CHEM, V281, P4049, DOI 10.1074/jbc.M508915200; Kim WS, 2007, J BIOL CHEM, V282, P2851, DOI 10.1074/jbc.M607831200; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Kotter K, 1999, J NEUROCHEM, V73, P2517, DOI 10.1046/j.1471-4159.1999.0732517.x; KUGE T, 1993, ENVIRON RES, V62, P99, DOI 10.1006/enrs.1993.1094; LaDu MJ, 1998, J NEUROCHEM, V70, P2070; Lanoue L, 1997, AM J MED GENET, V73, P24; Lusa S, 2003, J BIOL CHEM, V278, P19844, DOI 10.1074/jbc.M212503200; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Michikawa M, 1999, J NEUROCHEM, V72, P2278, DOI 10.1046/j.1471-4159.1999.0722278.x; Nowaczyk MJM, 1999, CAN MED ASSOC J, V161, P165; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Porter FD, 2003, CURR OPIN PEDIATR, V15, P607, DOI 10.1097/00008480-200312000-00011; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Soscia SJ, 2006, CELL MOL LIFE SCI, V63, P2039, DOI 10.1007/s00018-006-6208-2; SRIVASTAVA LM, 1994, ALCOHOL ALCOHOLISM, V29, P11; STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; SULIK KK, 1988, DEVELOPMENT, V103, P213; Tachikawa M, 2005, J NEUROCHEM, V95, P294, DOI 10.1111/j.1471-4159.2005.03369.x; Tsuji R, 2003, NEUROREPORT, V14, P1395, DOI 10.1097/01.wnr.0000071763.92388.41; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wang YT, 2005, J BIOL CHEM, V280, P35896, DOI 10.1074/jbc.M506210200; Yagle K, 2001, GLIA, V35, P111, DOI 10.1002/glia.1076; Yanni PA, 2000, DEV BRAIN RES, V120, P233, DOI 10.1016/S0165-3806(00)00015-8	61	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18740	18749		10.1074/jbc.M702398200	http://dx.doi.org/10.1074/jbc.M702398200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17478430	hybrid			2022-12-27	WOS:000247475300012
J	Mokranjac, D; Berg, A; Adam, A; Neupert, W; Hell, K				Mokranjac, Dejana; Berg, Annette; Adam, Alexander; Neupert, Walter; Hell, Kai			Association of the Tim14 center dot Tim16 subcomplex with the TIM23 translocase is crucial for function of the mitochondrial protein import motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PREPROTEIN TRANSLOCASE; PRESEQUENCE TRANSLOCASE; SACCHAROMYCES-CEREVISIAE; DYNAMIC INTERACTION; YEAST MITOCHONDRIA; J-DOMAIN; HSP70; COMPLEX; MATRIX	Tim14 and Tim16 are essential components of the import motor of the mitochondrial TIM23 preprotein translocase. Tim14 contains a J domain in the matrix space that is anchored in the inner membrane by a transmembrane segment. Tim16 is a J-related protein with a moderately hydrophobic segment at its N terminus. The J and J-like domains function in the regulation of the ATPase activity of the Hsp70 chaperone of the import motor. We report here on the role of the hydrophobic segments of Tim16 and Tim14 in the TIM23 translocase. Yeast cells lacking the hydrophobic N-terminal segment in either Tim16 or Tim14 are viable but show growth defects and decreased import rates of matrix-targeted preproteins into mitochondria. The interaction of the Tim14 center dot Tim16 complex with the core complex of the TIM23 translocase is destabilized in these cells. In particular, the N-terminal domain of Tim16 is crucial for the interaction of the Tim14 center dot Tim16 complex with the TIM23 preprotein translocase. Deletion of hydrophobic segments in both, Tim16 and Tim14, is lethal. We conclude that import into the matrix space of mitochondria requires association of the co-chaperones Tim16 and Tim14 with the TIM23 preprotein translocase.	Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany	University of Munich	Hell, K (corresponding author), Univ Munich, Inst Physiol Chem, Butenantstr 5, D-81377 Munich, Germany.	hell@med.uni-muenchen.de		Mokranjac, Dejana/0000-0002-4005-6979				Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; BERTHOLD J, 1995, CELL, V81, P1085, DOI 10.1016/S0092-8674(05)80013-3; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; FOELSCH H, 1996, EMBO J, V15, P479; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HORST M, 1995, EMBO J, V14, P2293, DOI 10.1002/j.1460-2075.1995.tb07223.x; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; KRONIDOU NG, 1994, P NATL ACAD SCI USA, V91, P12818, DOI 10.1073/pnas.91.26.12818; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; MAARSE AC, 1992, EMBO J, V11, P3619, DOI 10.1002/j.1460-2075.1992.tb05446.x; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Milisav I, 2001, J BIOL CHEM, V276, P25856, DOI 10.1074/jbc.M102132200; Mokranjac D, 2005, J BIOL CHEM, V280, P31608, DOI 10.1074/jbc.M502397200; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; NAKAI M, 1994, BIOCHEM BIOPH RES CO, V200, P435, DOI 10.1006/bbrc.1994.1468; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; NEUPERT W, 2007, ANNU REV BIOCHEM, V76, P609; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; SCHERER PE, 1992, P NATL ACAD SCI USA, V89, P11930, DOI 10.1073/pnas.89.24.11930; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; SIKORSKI RS, 1989, GENETICS, V122, P19; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2005, MOL CELL BIOL, V25, P7449, DOI 10.1128/MCB.25.17.7449-7458.2005; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	44	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18037	18045		10.1074/jbc.M701895200	http://dx.doi.org/10.1074/jbc.M701895200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452317	hybrid			2022-12-27	WOS:000247302000010
J	Richman, JG; Kanemitsu-Parks, M; Gaidarov, I; Cameron, JS; Griffin, P; Zheng, H; Guerra, NC; Cham, L; Maciejewski-Lenoir, D; Behan, DP; Boatman, D; Chen, RP; Skinner, P; Ornelas, P; Waters, MG; Wright, SD; Semple, G; Connolly, DT				Richman, Jeremy G.; Kanemitsu-Parks, Martha; Gaidarov, Ibragim; Cameron, Jill S.; Griffin, Peter; Zheng, Hong; Guerra, Nuvia C.; Cham, Linda; Maciejewski-Lenoir, Dominique; Behan, Dominic P.; Boatman, Doug; Chen, Ruoping; Skinner, Philip; Ornelas, Pricilla; Waters, M. Gerard; Wright, Samuel D.; Semple, Graeme; Connolly, Daniel T.			Nicotinic acid receptor agonists differentially activate downstream effectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; FREE FATTY ACIDS; PUMA-G; MOLECULAR-IDENTIFICATION; PROSTAGLANDIN D-2; LANGERHANS CELLS; ADIPOSE TISSUE; CHOLESTEROL; EFFICACY; NIACIN	Nicotinic acid remains the most effective therapeutic agent for the treatment and prevention of atherosclerosis resulting from low high density lipoprotein cholesterol. The therapeutic actions of nicotinic acid are mediated by GPR109A, a G(i) protein-coupled receptor, expressed primarily on adipocytes, Langerhans cells, and macrophage. Unfortunately, a severe, cutaneous flushing side effect limits its use and patient compliance. The mechanism of high density lipoprotein elevation is not clearly established but assumed to be influenced by an inhibition of lipolysis in the adipose. The flushing side effect appears to be mediated by the release of prostaglandin D2 from Langerhans cells in the skin. We hypothesized that the signal transduction pathways mediating the anti-lipolytic and prostaglandin D2/flushing pathways are distinct and that agonists may be identified that are capable of selectively eliciting the therapeutic, anti-lipolytic pathway while avoiding the activation of the parallel flush-inducing pathway. We have identified a number of GPR109A pyrazole agonists that are capable of fully inhibiting lipolysis in vitro and in vivo and not only fail to elicit a flushing response but can antagonize the ability of nicotinic acid to elicit a flush response in vivo. In contrast to flushing agonists, exposure of cells expressing GPR109A to the non-flushing agonists fails to induce internalization of the receptor or to activate ERK 1/2 mitogen- activated protein kinase phosphorylation.	Arena Pharmaceut Inc, San Diego, CA 92121 USA; Merck Res Labs, Div Cardiovasc Dis, Rahway, NJ 07065 USA	Merck & Company	Richman, JG (corresponding author), Arena Pharmaceut Inc, 6166 Nancy Ridge Dr, San Diego, CA 92121 USA.	jrichman@arenapharm.com						[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Backstrom JR, 1999, NEUROPSYCHOPHARMACOL, V21, pS77, DOI 10.1038/sj.npp.1395329; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; CARLSON LA, 1965, ANN NY ACAD SCI, V131, P119, DOI 10.1111/j.1749-6632.1965.tb34784.x; CARLSON LA, 1962, ACTA MED SCAND, V172, P641; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; CARLSON LA, 1963, ACTA MED SCAND, V173, P719; CARLSON LA, 1965, J ATHEROSCLER RES, V20, P436; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Hiatt JG, 1999, AM J MANAG CARE, V5, P437; Jin FY, 1997, ARTERIOSCL THROM VAS, V17, P2020, DOI 10.1161/01.ATV.17.10.2020; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Lorenzen A, 2001, MOL PHARMACOL, V59, P349, DOI 10.1124/mol.59.2.349; Maciejewski-Lenoir D, 2006, J INVEST DERMATOL, V126, P2637, DOI 10.1038/sj.jid.5700586; MCKENNEY JM, 1994, JAMA-J AM MED ASSOC, V271, P672, DOI 10.1001/jama.271.9.672; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Roelen H, 1996, J MED CHEM, V39, P1463, DOI 10.1021/jm950267m; Sakai T, 2001, ARTERIOSCL THROM VAS, V21, P1783, DOI 10.1161/hq1001.096624; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tan CM, 2002, P NATL ACAD SCI USA, V99, P12471, DOI 10.1073/pnas.122368499; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; van Herk T, 2003, J MED CHEM, V46, P3945, DOI 10.1021/jm030888c; van Schaick EA, 1998, BRIT J PHARMACOL, V124, P607, DOI 10.1038/sj.bjp.0701868; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200	28	82	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18028	18036		10.1074/jbc.M701866200	http://dx.doi.org/10.1074/jbc.M701866200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452318	hybrid			2022-12-27	WOS:000247302000009
J	Matsumoto, K; Yu, ST; Jia, YZ; Ahmed, MR; Viswakarma, N; Sarkar, J; Kashireddy, PV; Rao, MS; Karpus, W; Gonzalez, FJ; Reddy, JK				Matsumoto, Kojiro; Yu, Songtao; Jia, Yuzhi; Ahmed, Mohamed R.; Viswakarma, Navin; Sarkar, Joy; Kashireddy, Papreddy V.; Rao, M. Sambasiva; Karpus, William; Gonzalez, Frank J.; Reddy, Janardan K.			Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPAR alpha ligand-induced liver tumor development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-LIVER; PARTIAL-HEPATECTOMY; NUCLEAR RECEPTORS; PROTEIN; EXPRESSION; MECHANISM; CAR; PBP; HEPATOTOXICITY; INTERACTS	Disruption of the gene encoding for the transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP/TRAP220/DRIP205/Med1) in the mouse results in embryonic lethality. Here, we have reported that targeted disruption of the Pbp/Pparbp gene in hepatocytes (Pbp(Delta Liv)) impairs liver regeneration with low survival after partial hepatectomy. Analysis of cell cycle progression suggests a defective exit from quiescence, reduced BrdUrd incorporation, and diminished entry into G(2)/M phase in Pbp(Delta Liv) hepatocytes after partial hepatectomy. Pbp(Delta Liv) hepatocytes failed to respond to hepatocyte growth factor/scatter factor, implying that hepatic PBP deficiency affects c-met signaling. Pbp gene disruption also abolishes primary mitogen-induced liver cell proliferative response. Striking abrogation of CCl4-induced hepatocellular proliferation and hepatotoxicity occurred in Pbp(Delta Liv) mice pretreated with phenobarbital due to lack of expression of xenobiotic metabolizing enzymes necessary for CCl4 activation. Pbp(Delta Liv) mice, chronically exposed to Wy-14,643, a PPAR alpha ligand, revealed a striking proliferative response and clonal expansion of a few Pbp(fl/fl) hepatocytes that escaped Cre-mediated gene deletion in Pbp(Delta Liv) livers, but no proliferative expansion of PBP null hepatocytes was observed. In these Pbp(Delta Liv) mice, none of the Wy-14,643-induced hepatic adenomas and hepatocellular carcinomas was derived from PBP Delta Liv hepatocytes; all liver tumors developing in Pbp(Delta Liv) mice maintained non-recombinant Pbp alleles and retained PBP expression. These studies provide direct evidence in support of a critical role of PBP/TRAP220 in liver regeneration, induction of hepatotoxicity, and hepatocarcinogenesis.	Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; Canc Res Ctr, Lab Metab, NIH, Bethesda, MD 20892 USA	Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA	Reddy, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	jkreddy@northwestern.edu			NCI NIH HHS [CA104578] Funding Source: Medline; NIGMS NIH HHS [GM23750] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC005708, Z01BC005708, R01CA104578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023750, R01GM023750] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Costa RH, 2005, HEPATOLOGY, V42, P1004, DOI 10.1002/hep.20953; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Guo DS, 2006, BIOCHEM BIOPH RES CO, V347, P485, DOI 10.1016/j.bbrc.2006.06.129; Higgins GM, 1931, ARCH PATHOL, V12, P186; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jia YZ, 2005, P NATL ACAD SCI USA, V102, P12531, DOI 10.1073/pnas.0506000102; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kitamura K, 2005, DEV GROWTH DIFFER, V47, P537; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Leu JI, 2003, J CLIN INVEST, V111, P129, DOI 10.1172/JCI200316712; Locker J, 2003, HEPATOLOGY, V38, P314, DOI 10.1053/jhep.2003.50299; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Oliver JR, 2005, EXP BIOL MED, V230, P61; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; RAO MS, 1987, CARCINOGENESIS, V8, P631; Reddy JK, 2006, AD DEV BIOL, V16, P389, DOI 10.1016/S1574-3349(06)16012-3; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reddy JK, 2004, AM J PATHOL, V164, P2305, DOI 10.1016/S0002-9440(10)63787-X; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Sherr CJ, 2000, CANCER RES, V60, P3689; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Togo S, 2004, J HEPATOL, V40, P464, DOI 10.1016/j.jhep.2003.11.005; VANDEWOUDE GF, 1997, CIBA F SYMP, V212, P130; Yamazaki Y, 2005, WORLD J GASTROENTERO, V11, P5966, DOI 10.3748/wjg.v11.i38.5966; YU S, 2007, IN PRESS BIOCH BIOPH; Yu ST, 2004, BIOCHIMIE, V86, P743, DOI 10.1016/j.biochi.2004.09.015; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zhang YQ, 1997, BBA-GENE STRUCT EXPR, V1354, P204, DOI 10.1016/S0167-4781(97)00085-7; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	37	38	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					17053	17060		10.1074/jbc.M701956200	http://dx.doi.org/10.1074/jbc.M701956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17438330	hybrid			2022-12-27	WOS:000246946500038
J	Meur, G; Parker, AKT; Gergely, FV; Taylor, CW				Meur, Gargi; Parker, Andrew K. T.; Gergely, Fanni V.; Taylor, Colin W.			Targeting and retention of type 1 ryanodine receptors to the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; MUSCLE SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; MEMBRANE RETENTION; PROTEIN; TOPOLOGY; EXPRESSION; SIGNAL; ASSOCIATION; REGION	Most ryanodine receptors and their relatives, inositol 1,4,5-trisphosphate receptors, are expressed in the sarcoplasmic or endoplasmic reticulum (ER), where they mediate Ca2+ release. We expressed fragments of ryanodine receptor type 1 (RyR1) in COS cells alone or fused to intercellular adhesion molecule-1 (ICAM-1), each tagged with yellow fluorescent protein, and used confocal imaging and glycoprotein analysis to identify the determinants of ER targeting and retention. Single transmembrane domains (TMD) of RyR1 taken from the first (TMD1-TMD2) or last (TMD5-TMD6) pair were expressed in the ER membrane. TMD3-TMD4 was expressed in the outer mitochondrial membrane. The TMD outer pairs (TMD1-TMD2 and TMD5-TMD6) retained ICAM-1, a plasma membrane-targeted protein, within the ER membrane. TMD1 alone provided a strong ER retention signal and TMD6 a weaker signal, but the other single TMD were unable to retain ICAM-1 in the ER. We conclude that TMD1 provides the first and sufficient signal for ER targeting of RyR1. The TMD outer pairs include redundant ER retention signals, with TMD1 providing the strongest signal.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	; Taylor, Colin/G-2447-2010	Meur, Gargi/0000-0002-8466-2997; Taylor, Colin/0000-0001-7771-1044; Gergely, Fanni/0000-0002-2441-8095	Biotechnology and Biological Sciences Research Council [BB/C005201/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Balshaw D, 1999, P NATL ACAD SCI USA, V96, P3345, DOI 10.1073/pnas.96.7.3345; Bhat MB, 2002, J BIOL CHEM, V277, P8597, DOI 10.1074/jbc.M107609200; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; CHEN SRW, 1993, BIOCHEMISTRY-US, V32, P3743, DOI 10.1021/bi00065a029; Dalbey R.E., 2002, PROTEIN TARGETING TR; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Du GG, 2004, J BIOL CHEM, V279, P37566, DOI 10.1074/jbc.M406637200; Du GG, 2001, J BIOL CHEM, V276, P31760, DOI 10.1074/jbc.M102751200; Dulhunty AF, 2003, CLIN EXP PHARMACOL P, V30, P713, DOI 10.1046/j.1440-1681.2003.03904.x; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Galvan DL, 1999, J BIOL CHEM, V274, P29483, DOI 10.1074/jbc.274.41.29483; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; George CH, 2004, MOL BIOL CELL, V15, P2627, DOI 10.1091/mbc.E03-09-0688; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Huh YH, 2005, FEBS LETT, V579, P2597, DOI 10.1016/j.febslet.2005.03.076; LEE HC, 2002, CYCLIC ADPRIBOSE NAA; LEE S, 2000, JPL OPTICAL COMMUNIC, V2000, P1; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Ma JJ, 2004, CELL BIOCHEM BIOPHYS, V40, P207, DOI 10.1385/CBB:40:2:207; Marius P, 2006, CELL CALCIUM, V39, P65, DOI 10.1016/j.ceca.2005.09.010; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; Moonga BS, 2002, AM J PHYSIOL-RENAL, V282, pF921, DOI 10.1152/ajprenal.00045.2000; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Parker AKT, 2004, J BIOL CHEM, V279, P23797, DOI 10.1074/jbc.M402098200; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Sayers LG, 1997, BIOCHEM J, V323, P273, DOI 10.1042/bj3230273; Serysheva I, 2005, J MOL BIOL, V345, P427, DOI 10.1016/j.jmb.2004.10.073; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TAKESHIMA H, 1993, FEBS LETT, V322, P105, DOI 10.1016/0014-5793(93)81547-D; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Treves S, 2002, CELL CALCIUM, V31, P1, DOI 10.1054/ceca.2001.0252; Tunwell REA, 1996, BIOCHEM J, V318, P477, DOI 10.1042/bj3180477; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Xiao BL, 2002, J BIOL CHEM, V277, P41778, DOI 10.1074/jbc.M208210200; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	47	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23096	23103		10.1074/jbc.M702457200	http://dx.doi.org/10.1074/jbc.M702457200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17526491	hybrid			2022-12-27	WOS:000248577500012
J	Lee, GH; Kim, HK; Chae, SW; Kim, DS; Ha, KC; Cuddy, M; Kress, C; Reed, JC; Kim, HR; Chae, HJ				Lee, Geum-Hwa; Kim, Hyun-Kyung; Chae, Soo-Wan; Kim, Do-Sung; Ha, Ki-Chan; Cuddy, Mike; Kress, Christina; Reed, John C.; Kim, Hyung-Ryong; Chae, Han-Jung			Bax inhibitor-1 regulates endoplasmic reticulum stress-associated reactive oxygen species and heme oxygenase-1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; PANCREATIC BETA-CELLS; INDUCED APOPTOSIS; OXIDATIVE STRESS; GENE-EXPRESSION; YEAST; RAT; ER; PROTECTION; INDUCTION	The Bax inhibitor-1 ( BI-1) is an anti-apoptotic protein that is located in endoplasmic reticulum (ER) membranes and protects cells from ER stress-induced apoptosis. The ER is associated with generation of reactive oxygen species (ROS) through oxidative protein folding. This study examined the role of BI-1 in the regulation of ER stress-induced accumulation of ROS and expression of unfolded protein response-associated proteins. BI-1 reduced the expression levels of glucose response protein 78, C/EBP homologous protein, phospho-eukaryotic initiation factor 2 alpha, IRE1 alpha, XBP-1, and phospho-JNK and inhibited the cleavage of ATF-6 alpha p-90, leading to the inhibition of ROS. Although ROS scavengers offer some protection against ER stress-induced apoptosis, the expression of pro-apoptotic ER stress proteins was not affected. This study shows that the response of unfolded proteins is followed by ROS accumulation under ER stress, which is regulated in BI-1 cells. The mechanism for these BI-1-associated functions involves the expression of heme oxygenase-1 (HO-1) through nuclear factor erythroid 2-related factor 2. In BI-1 cells, the transfection of HO-1 small interfering RNA completely abolished the BI-1-induced protection. The endogenous expression of HO-1 through ER stress-initiated ROS is believed to be as a protection signal. In conclusion, these observations suggest that BI-1 can inhibit the ER stress proteins as well as the accumulation of ROS, thereby protecting the cells. Moreover, HO-1 plays an important role in the BI-1-associated protection against ER stress.	Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Iksan 570749, Chonbuk, South Korea; Wonkwang Univ, Sch Dent, Wonkwang Biomat Implant Res Inst, Iksan 570749, Chonbuk, South Korea; Chonbuk Natl Univ, Sch Med, Dept Pharmacol, Jeonju 561182, Chonbuk, South Korea; Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561182, Chonbuk, South Korea; Chonbuk Hosp, Clin Trial Ctr Funct Foods, Jeonju, Chonbuk, South Korea; Burnham Inst Med Res, La Jolla, CA USA	Wonkwang University; Wonkwang University; Jeonbuk National University; Jeonbuk National University; Sanford Burnham Prebys Medical Discovery Institute	Chae, HJ (corresponding author), Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Iksan 570749, Chonbuk, South Korea.	hjchae@chonbuk.ac.kr		Chae, Han-Jung/0000-0003-4190-9889				Ahmad A, 2005, J BIOL CHEM, V280, P32090, DOI 10.1074/jbc.M501426200; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Chae HJ, 2000, ENDOCRINOLOGY, V141, P2904, DOI 10.1210/en.141.8.2904; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Clark JE, 2000, BIOCHEM J, V348, P615, DOI 10.1042/0264-6021:3480615; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gavilan MP, 2006, NEUROBIOL AGING, V27, P973, DOI 10.1016/j.neurobiolaging.2005.05.010; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hoetzel A, 2001, HEPATOLOGY, V33, P925, DOI 10.1053/jhep.2001.23431; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JANSCO G, 2007, ANN NY ACAD SCI, V1095, P251; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kessel D, 2005, CELL DEATH DIFFER, V12, P502, DOI 10.1038/sj.cdd.4401579; Kim DS, 2005, BIOCHEM PHARMACOL, V70, P1066, DOI 10.1016/j.bcp.2005.06.026; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; OWUER ED, 2002, BIOCHEM PHARMACOL, V64, P765; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Rottenberg H, 1998, BBA-MOL CELL RES, V1404, P393, DOI 10.1016/S0167-4889(98)00088-3; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Ueda K, 2005, EUR J ENDOCRINOL, V153, P167, DOI 10.1530/eje.1.01945; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	34	88	94	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21618	21628		10.1074/jbc.M700053200	http://dx.doi.org/10.1074/jbc.M700053200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17526500	hybrid			2022-12-27	WOS:000248196800008
J	Banuelos, S; Omaetxebarria, MJ; Ramos, I; Larsen, MR; Arregi, I; Jensen, ON; Arizmendi, JM; Prado, A; Muga, A				Banuelos, Sonia; Omaetxebarria, Miren J.; Ramos, Isbaal; Larsen, Martin R.; Arregi, Igor; Jensen, Ole N.; Arizmendi, Jesus M.; Prado, Adelina; Muga, Arturo			Phosphorylation of both nucleoplasmin domains is required for activation of its chromatin decondensation activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; HISTONE CHAPERONES; NUCLEAR CHAPERONES; CRYSTAL-STRUCTURE; SPERM CHROMATIN; PROTEINS; DNA; BINDING; CORE; CONFORMATION	Nucleoplasmin (NP) is a histone chaperone involved in nucleosome assembly, chromatin decondensation at fertilization, and apoptosis. To carry out these activities NP has to interact with different types of histones, an interaction that is regulated by phosphorylation. Here we have identified a number of phosphorylated residues by mass spectrometry and generated mutants in which these amino acids are replaced by Asp to mimic the effect of phosphorylation. Our results show that, among the eight phosphoryl groups experimentally detected, four are located at the flexible N terminus, and the rest are found at the tail domain, flanking the nuclear localization signal. Phosphorylation-mimicking mutations render a recombinant protein as active in chromatin decondensation as hyperphosphorylated NP isolated from Xenopus laevis eggs. Comparison of mutants in which the core and tail domains of the protein were independently or simultaneously "activated" indicates that activation or phosphorylation of both protein domains is required for NP to efficiently extract linker-type histones from chromatin.	Univ Basque Country, CSIC, Unidad Biofis, E-48080 Bilbao, Spain; Univ Basque Country, Fac Ciencias & Tecnol, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Southern Denmark	Muga, A (corresponding author), Univ Basque Country, CSIC, Unidad Biofis, POB 644, E-48080 Bilbao, Spain.	gbpmuvia@lg.ehu.es	Muga, Arturo/N-1174-2014; Jensen, Ole N/J-1763-2012; Bañuelos, Sonia/N-9128-2019; Omaetxebarria, Miren Josu/AAB-5667-2019; Larsen, Martin Rossel/F-1411-2015	Muga, Arturo/0000-0003-0345-6882; Jensen, Ole N/0000-0003-1862-8528; Bañuelos, Sonia/0000-0002-1399-381X; Larsen, Martin Rossel/0000-0001-6203-0123; Arizmendi, Jesus M/0000-0002-1412-4042				Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Banuelos S, 2003, J MOL BIOL, V334, P585, DOI 10.1016/j.jmb.2003.09.067; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; COTTEN M, 1986, BIOCHEMISTRY-US, V25, P5063, DOI 10.1021/bi00366a014; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; Dingwall C, 1990, Semin Cell Biol, V1, P11; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Gillespie PJ, 2000, NUCLEIC ACIDS RES, V28, P472, DOI 10.1093/nar/28.2.472; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hierro A, 2002, BIOCHEMISTRY-US, V41, P6408, DOI 10.1021/bi020002r; Hierro A, 2001, EUR J BIOCHEM, V268, P1739; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; Kjellstrom S, 2004, ANAL CHEM, V76, P5109, DOI 10.1021/ac0400257; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Leno GH, 1996, J BIOL CHEM, V271, P7253, DOI 10.1074/jbc.271.13.7253; Lohka MJ, 1998, METHOD CELL BIOL, V53, P367; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Lu ZG, 2005, P NATL ACAD SCI USA, V102, P2778, DOI 10.1073/pnas.0405374102; Matsumoto K, 1999, MOL CELL BIOL, V19, P6940; Mowen K, 2000, MOL CELL BIOL, V20, P7273, DOI 10.1128/MCB.20.19.7273-7281.2000; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Namboodiri VMH, 2003, STRUCTURE, V11, P175, DOI 10.1016/S0969-2126(03)00007-8; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; Prado A, 2004, BIOCHEM CELL BIOL, V82, P437, DOI 10.1139/O04-042; Ramos I, 2005, BIOCHEMISTRY-US, V44, P8274, DOI 10.1021/bi050386w; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shintomi K, 2005, P NATL ACAD SCI USA, V102, P8210, DOI 10.1073/pnas.0500822102; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Tholey A, 1999, BIOPHYS J, V76, P76, DOI 10.1016/S0006-3495(99)77179-1; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; VANCUROVA I, 1995, J CELL SCI, V108, P779; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	39	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21213	21221		10.1074/jbc.M702842200	http://dx.doi.org/10.1074/jbc.M702842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17510054	hybrid			2022-12-27	WOS:000248047500048
J	Bedard, J; Kubis, S; Bimanadham, S; Jarvis, P				Bedard, Jocelyn; Kubis, Sybille; Bimanadham, Sarat; Jarvis, Paul			Functional similarity between the chloroplast translocon component, Tic40, and the human co-chaperone, Hsp70-interacting protein (Hip)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ENVELOPE MEMBRANE; MOLECULAR-CHAPERONE; IN-VIVO; ARABIDOPSIS-THALIANA; IMPORT MACHINERY; HSP90; HOP; COCHAPERONE; PLASTIDS; HSP70	Tic40 is a component of the protein import apparatus of the inner envelope of chloroplasts, but its role in the import mechanism has not been clearly defined. The C terminus of Tic40 shares weak similarity with the C-terminal Sti1 domains of the mammalian Hsp70-interacting protein (Hip) and Hsp70/Hsp90-organizing protein (Hop) co-chaperones. Additionally, Tic40 may possess a tetratricopeptide repeat (TPR) protein-protein interaction domain, another characteristic feature of Hip/Hop co-chaperones. To investigate the functional importance of different parts of the Tic40 protein and to determine whether the homology between Tic40 and co-chaperones is functionally significant, different Tic40 deletion and Tic40:Hip fusion constructs were generated and assessed for complementation activity in the Arabidopsis Tic40 knock-out mutant, tic40. Interestingly, all Tic40 deletion constructs failed to complement tic40, indicating that each part removed is essential for Tic40 function; these included a construct lacking the Sti1-like domain (Delta Sti1), a second lacking a central region, including the putative TPR domain (Delta TPR), and a third lacking the predicted transmembrane anchor region. Moreover, the Delta Sti1 and Delta TPR constructs caused strong dominant-negative, albino phenotypes in tic40 transformants, indicating that the truncated Tic40 proteins interfere with the residual chloroplast protein import that occurs in tic40 plants. Remarkably, the Tic40:Hip fusion constructs showed that the Sti1 domain of human Hip is functionally equivalent to the Sti1-like region of Tic40, strongly suggesting a co-chaperone role for the Tic40 protein. Supporting this notion, yeast two-hybrid and bimolecular fluorescence complementation assays demonstrated the in vivo interaction of Tic40 with Tic110, a protein believed to recruit stromal chaperones to protein import sites.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Jarvis, P (corresponding author), Univ Leicester, Dept Biol, Univ Rd, Leicester LE1 7RH, Leics, England.	rpj3@le.ac.uk						Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Bedard J, 2005, J EXP BOT, V56, P2287, DOI 10.1093/jxb/eri243; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Bruce BD, 1997, EUR J BIOCHEM, V245, P738, DOI 10.1111/j.1432-1033.1997.00738.x; Cao DS, 2003, PLANT J, V33, P107, DOI 10.1046/j.1365-313X.2003.016011.x; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Chou ML, 2003, EMBO J, V22, P2970, DOI 10.1093/emboj/cdg281; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; HOHFELD J, 1995, CELL, V83, P589; Inaba T, 2005, PLANT CELL, V17, P1482, DOI 10.1105/tpc.105.030700; Inaba T, 2003, J BIOL CHEM, V278, P38617, DOI 10.1074/jbc.M306367200; Irmer H, 1997, J BIOL CHEM, V272, P2230; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; Ko K, 2004, FUNCT PLANT BIOL, V31, P285, DOI 10.1071/FP03195; KO K, 1995, J BIOL CHEM, V270, P28601, DOI 10.1074/jbc.270.48.28601; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; Kubis S, 2004, PLANT CELL, V16, P2059, DOI 10.1105/tpc.104.023309; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Li M, 2006, J CELL BIOL, V175, P249, DOI 10.1083/jcb.200605162; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Nelson GM, 2003, CELL STRESS CHAPERON, V8, P125, DOI 10.1379/1466-1268(2003)008<0125:COTCDR>2.0.CO;2; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Prapapanich V, 1996, MOL CELL BIOL, V16, P6200; Reumann S, 2005, MOL MEMBR BIOL, V22, P73, DOI 10.1080/09687860500041916; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Stahl T, 1999, J BIOL CHEM, V274, P37467, DOI 10.1074/jbc.274.52.37467; Velten M, 2002, J BIOL CHEM, V277, P259, DOI 10.1074/jbc.M106881200; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Webb MA, 2001, CELL STRESS CHAPERON, V6, P247, DOI 10.1379/1466-1268(2001)006<0247:OIATOT>2.0.CO;2; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; WU CB, 1994, J BIOL CHEM, V269, P32264	48	51	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21404	21414		10.1074/jbc.M611545200	http://dx.doi.org/10.1074/jbc.M611545200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535810	hybrid			2022-12-27	WOS:000248047500068
J	Huang, MS; Morony, S; Lu, JX; Zhang, Z; Bezouglaia, O; Tseng, W; Tetradis, S; Demer, LL; Tintut, Y				Huang, Michael S.; Morony, Sean; Lu, Jinxiu; Zhang, Zina; Bezouglaia, Olga; Tseng, Wendy; Tetradis, Sotirios; Demer, Linda L.; Tintut, Yin			Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; LOW-DENSITY-LIPOPROTEIN; MARROW STROMAL CELLS; NF-KAPPA-B; OXIDIZED PHOSPHOLIPIDS; IN-VIVO; VASCULAR CALCIFICATION; POSTMENOPAUSAL WOMEN; DIFFERENTIATION; ERK	Cardiovascular disease, such as atherosclerosis, has been associated with reduced bone mineral density and fracture risk. A major etiologic factor in atherogenesis is believed to be oxidized phospholipids. We previously found that these phospholipids inhibit spontaneous osteogenic differentiation of marrow stromal cells, suggesting that they may account for the clinical link between atherosclerosis and osteoporosis. Currently, anabolic agents that promote bone formation are increasingly used as a new treatment for osteoporosis. It is not known, however, whether atherogenic phospholipids alter the effects of bone anabolic agents, such as bone morphogenetic protein (BMP)-2 and parathyroid hormone (PTH). Therefore we investigated the effects of oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (ox-PAPC) on osteogenic signaling induced by BMP-2 and PTH in MC3T3-E1 cells. Results showed that ox-PAPC attenuated BMP-2 induction of osteogenic markers alkaline phosphatase and osteocalcin. Ox-PAPC also inhibited both spontaneous and BMP-induced expression of PTH receptor. Consistently, pretreatment of cells with ox-PAPC inhibited PTH-induced cAMP production and expression of immediate early genes Nurr1 and IL-6. Results from immunofluorescence and Western blot analyses showed that inhibitory effects of ox-PAPC on BMP-2 signaling were associated with inhibition of SMAD 1/5/8 but not p38-MAPK activation. These effects appear to be due to ox-PAPC activation of the ERK pathway, as the ERK inhibitor PD98059 reversed ox-PAPC inhibitory effects on BMP-2-induced alkaline phosphatase activity, osteocalcin expression, and SMAD activation. These results suggest that atherogenic lipids inhibit osteogenic signaling induced by BMP-2 and PTH, raising the possibility that hyperlipidemia and atherogenic phospholipids may interfere with anabolic therapy.	Univ Calif Los Angeles, Sch Dent, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Dent, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Dent, Dept Mol Cellular Integrat Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Dent, Div Diagnost & Surg Sci, Los Angeles, CA 90095 USA; Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Amgen	Tintut, Y (corresponding author), Univ Calif Los Angeles, Sch Dent, Dept Med, CHS BH 307,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ytintut@mednet.ucla.edu	Demer, Linda L/I-5770-2013	Demer, Linda L/0000-0002-9618-6895	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK076009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL081202, R01 HL081202] Funding Source: Medline; NIDDK NIH HHS [DK076009-01, R21 DK076009, R21 DK076009-01, R21 DK076009-02] Funding Source: Medline; NIGMS NIH HHS [T32 GM065823] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abedin M, 2006, CIRC RES, V98, P727, DOI 10.1161/01.RES.0000216009.68958.e6; Bagger YZ, 2006, J INTERN MED, V259, P598, DOI 10.1111/j.1365-2796.2006.01640.x; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Barengolts EI, 1998, CALCIFIED TISSUE INT, V62, P209, DOI 10.1007/s002239900419; Chae HJ, 2002, IMMUNOPHARM IMMUNOT, V24, P31, DOI 10.1081/IPH-120003401; Chan GK, 2003, ENDOCRINOLOGY, V144, P5511, DOI 10.1210/en.2003-0273; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; Date T, 2004, J ORTHOP SCI, V9, P503, DOI 10.1007/s00776-004-0815-2; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0; Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Jie KSG, 1996, CALCIFIED TISSUE INT, V59, P352, DOI 10.1007/s002239900139; JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P257; Ju WJ, 2000, J BONE MINER RES, V15, P1889, DOI 10.1359/jbmr.2000.15.10.1889; Kadl A, 2002, VASC PHARMACOL, V38, P219, DOI 10.1016/S1537-1891(02)00172-6; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kono SJ, 2007, BONE, V40, P68, DOI 10.1016/j.bone.2006.07.024; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lou J, 2000, BIOCHEM BIOPH RES CO, V268, P757, DOI 10.1006/bbrc.2000.2210; MA YF, 1995, J BONE MINER RES, V10, P496; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Orozco P, 2004, EUR J EPIDEMIOL, V19, P1105, DOI 10.1007/s10654-004-1706-8; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Parhami F, 1999, J BONE MINER RES, V14, P2067, DOI 10.1359/jbmr.1999.14.12.2067; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; Pirih FQ, 2003, BIOCHEM BIOPH RES CO, V306, P144, DOI 10.1016/S0006-291X(03)00931-8; Pirih FQ, 2005, BIOCHEM BIOPH RES CO, V332, P494, DOI 10.1016/j.bbrc.2005.04.132; RODAN GA, 1992, BONE S1, V13, P3; Shao JS, 2003, J BIOL CHEM, V278, P50195, DOI 10.1074/jbc.M308825200; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Tintut Y, 2004, ARTERIOSCL THROM VAS, V24, pE6, DOI 10.1161/01.ATV.0000112023.62695.7f; Tintut Y, 2002, J BIOL CHEM, V277, P14221, DOI 10.1074/jbc.M111551200; Urist MR, 1997, CONNECT TISSUE RES, V36, P9, DOI 10.3109/03008209709160210; Velardez MO, 2001, MOL CELL ENDOCRINOL, V172, P7, DOI 10.1016/S0303-7207(00)00399-3; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yamaguchi T, 2002, ENDOCR J, V49, P211, DOI 10.1507/endocrj.49.211	42	32	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21237	21243		10.1074/jbc.M701341200	http://dx.doi.org/10.1074/jbc.M701341200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17522049	hybrid, Green Accepted			2022-12-27	WOS:000248047500051
J	Zhang, W; Zitron, E; Homme, MK; Kihm, L; Morath, C; Scherer, D; Hegge, S; Thomas, D; Schmitt, CP; Zeier, M; Katus, H; Karle, C; Schwenger, V				Zhang, Wei; Zitron, Edgar; Hoemme, Meike; Kihm, Lars; Morath, Christian; Scherer, Daniel; Hegge, Stephan; Thomas, Dierk; Schmitt, Claus P.; Zeier, Martin; Katus, Hugo; Karle, Christoph; Schwenger, Vedat			Aquaporin-1 channel function is positively regulated by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; WATER PERMEABILITY; IN-VITRO; ALPHA; PROLONGATION; ACTIVATION	Aquaporin-1 (AQP1) channels contribute to osmotically induced water transport in several organs including the kidney and serosal membranes such as the peritoneum and the pleura. In addition, AQP1 channels have been shown to conduct cationic currents upon stimulation by cyclic nucleotides. To date, the short term regulation of AQP1 function by other major intracellular signaling pathways has not been studied. In the present study, we therefore investigated the regulation of AQP1 by protein kinase C. AQP1 wild type channels were expressed in Xenopus oocytes. Water permeability was assessed by hypotonic challenges. Activation of protein kinase C (PKC) by 1-oleoyl-2-acetyl-sn-glycerol (OAG) induced a marked increase of AQP1-dependent water permeability. This regulation was abolished in mutated AQP1 channels lacking both consensus PKC phosphorylation sites Thr(157) and Thr(239) (termed AQP1 Delta PKC). AQP1 cationic currents measured with double-electrode voltage clamp were markedly increased after pharmacological activation of PKC by either OAG or phorbol 12-myristate 13-acetate. Deletion of either Thr(157) or Thr(239) caused a marked attenuation of PKC-dependent current increases, and deletion of both phosphorylation sites in AQP1 Delta PKC channels abolished the effect. In vitro phosphorylation studies with synthesized peptides corresponding to amino acids 154-168 and 236-250 revealed that both Thr(157) and Thr(239) are phosphorylated by PKC. Upon stimulation by cyclic nucleotides, AQP1 wild type currents exhibited a strong activation. This regulation was not affected after deletion of PKC phosphorylation sites in AQP1 Delta PKC channels. In conclusion, this is the first study to show that PKC positively regulates both water permeability and ionic conductance of AQP1 channels. This new pathway of AQP1 regulation is independent of the previously described cyclic nucleotide pathway and may contribute to the PKC stimulation of AQP1-modulated processes such as endothelial permeability, angiogenesis, and urine concentration.	Univ Heidelberg Hosp, Dept Cardiol, D-69120 Heidelberg, Germany; Univ Heidelberg Hosp, Dept Paediat, D-69120 Heidelberg, Germany; Univ Heidelberg Hosp, Dept Nephrol, D-69120 Heidelberg, Germany; Univ Heidelberg Hosp, Dept Parasitol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Zitron, E (corresponding author), Med Univ Hosp Heidelberg, Dept Cardiol, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	edgar.zitron@med.uni-heidelberg.de	Thomas, Dierk/ABA-4706-2021; Morath, Christian/ABC-5091-2021; Thomas, Dierk/V-3940-2017	Thomas, Dierk/0000-0002-5687-7843; 				Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Anthony TL, 2000, MOL PHARMACOL, V57, P576, DOI 10.1124/mol.57.3.576; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Belge H, 2006, NEPHROL DIAL TRANSPL, V21, P2069, DOI 10.1093/ndt/gfl162; Boassa D, 2006, J NEUROSCI, V26, P7811, DOI 10.1523/JNEUROSCI.0525-06.2006; Boassa Daniela, 2003, BMC Physiol, V3, P12, DOI 10.1186/1472-6793-3-12; Bokhari SM, 2006, J INVEST DERMATOL, V126, P460, DOI 10.1038/sj.jid.5700071; Chang YS, 2000, MICROVASC RES, V59, P265, DOI 10.1006/mvre.1999.2225; Dang L, 2005, CLIN EXP PHARMACOL P, V32, P771, DOI 10.1111/j.1440-1681.2005.04266.x; Devuyst O, 2005, BIOL CELL, V97, P667, DOI 10.1042/BC30040132; GARCIA NH, 1994, J CLIN INVEST, V93, P2572, DOI 10.1172/JCI117268; Han ZQ, 1998, J BIOL CHEM, V273, P6001, DOI 10.1074/jbc.273.11.6001; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Karle CA, 2002, CIRCULATION, V106, P1493, DOI 10.1161/01.CIR.0000029747.53262.5C; Kiesecker C, 2006, J MOL MED, V84, P46, DOI 10.1007/s00109-005-0707-8; Ni J, 2006, KIDNEY INT, V69, P1518, DOI 10.1038/sj.ki.5000285; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saparov SM, 2001, J BIOL CHEM, V276, P31515, DOI 10.1074/jbc.M104267200; Siflinger-Birnboim A, 2003, AM J PHYSIOL-LUNG C, V284, pL435, DOI 10.1152/ajplung.00106.2002; Tsunoda SP, 2004, J BIOL CHEM, V279, P11364, DOI 10.1074/jbc.M310881200; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Ware JA, 1999, ANGIOGENESIS AND CARDIOVASCULAR DISEASE, P30; Witchel HJ, 2002, J PHARMACOL TOX MET, V48, P65, DOI 10.1016/S1056-8719(03)00041-8; Yao LJ, 2004, AM J PHYSIOL-RENAL, V287, pF299, DOI 10.1152/ajprenal.00274.2003; Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216; Yool AJ, 2002, NEWS PHYSIOL SCI, V17, P68, DOI 10.1152/nips.01372.2001; Yu J, 2006, STRUCTURE, V14, P1411, DOI 10.1016/j.str.2006.07.006; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001; Zitron E, 2005, CIRCULATION, V111, P835, DOI 10.1161/01.CIR.0000155617.54749.09; Zitron E, 2004, CARDIOVASC RES, V63, P520, DOI 10.1016/j.cardiores.2004.02.015	34	73	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20933	20940		10.1074/jbc.M703858200	http://dx.doi.org/10.1074/jbc.M703858200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17522053	hybrid			2022-12-27	WOS:000248047500019
J	Oshiro, N; Takahashi, R; Yoshino, KI; Tanimura, K; Nakashima, A; Eguchi, S; Miyamoto, T; Hara, K; Takehana, K; Avruch, J; Kikkawa, U; Yonezawa, K				Oshiro, Noriko; Takahashi, Rinako; Yoshino, Ken-ichi; Tanimura, Keiko; Nakashima, Akio; Eguchi, Satoshi; Miyamoto, Takafumi; Hara, Kenta; Takehana, Kenji; Avruch, Joseph; Kikkawa, Ushio; Yonezawa, Kazuyoshi			The proline-rich akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; REPRESSOR PHAS-I; PROTEIN-KINASE; TUBEROUS SCLEROSIS; SIGNALING PATHWAYS; BINDING PARTNER; CELL-SURVIVAL; GROWTH-FACTOR; EIF-4E BP1; AMINO-ACID	The proline-rich Akt substrate of 40 kilodaltons (PRAS40) was identified as a raptor-binding protein that is phosphorylated directly by mammalian target of rapamycin ( mTOR) complex 1 (mTORC1) but not mTORC2 in vitro, predominantly at PRAS40 (Ser(183)). The binding of S6K1 and 4E-BP1 to raptor requires a TOR signaling (TOS) motif, which contains an essential Phe followed by four alternating acidic and small hydrophobic amino acids. PRAS40 binding to raptor was severely inhibited by mutation of PRAS40 (Phe(129) to Ala). Immediately carboxyl-terminal to Phe(129) are two small hydrophobic amino acid followed by two acidic residues. PRAS40 binding to raptor was also abolished by mutation of the majormTORC1phosphorylation site, Ser(183), to Asp. PRAS40 (Ser(183)) was phosphorylated in intact cells; this phosphorylation was inhibited by rapamycin, by 2- deoxyglucose, and by overexpression of the tuberous sclerosis complex heterodimer. PRAS40 ( Ser183) phosphorylation was also inhibited reversibly by withdrawal of all or of only the branched chain amino acids; this inhibition was reversed by overexpression of the Rheb GTPase. Over-expressed PRAS40 suppressed the phosphorylation of S6K1 and 4E-BP1 at their rapamycin-sensitive phosphorylation sites, and reciprocally, overexpression of S6K1 or 4E-BP1 suppressed phosphorylation of PRAS40 (Ser(183)) and its binding to raptor. RNA interference-induced depletion of PRAS40 enhanced the amino acid-stimulated phosphorylation of both S6K1 and 4E-BP1. These results establish PRAS40 as a physiological mTORC1 substrate that contains a variant TOS motif. Moreover, they indicate that the ability of raptor to bind endogenous substrates is limiting for the activity of mTORC1 in vivo and is therefore a potential locus of regulation.	Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; Kobe Univ, Sch Med, Dept Internal & Geriatr Med, Kobe, Hyogo 6500017, Japan; Ajinomoto Co Inc, Pharmaceut Res Labs, Kawasaki, Kanagawa 2108681, Japan; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Dept Mol Biol & Diabet Unit, Boston, MA 02114 USA	Kobe University; Kobe University; Ajinomoto Co Inc; Harvard University; Harvard Medical School; Massachusetts General Hospital	Avruch, J (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	avruch@molbio.mgh.harvard.edu	Miyamoto, Takafumi/T-6950-2019	Miyamoto, Takafumi/0000-0001-9363-2864	NCI NIH HHS [R01 CA073818, CA 73818] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561, P30 DK040561-12, R37 DK017776, DK 17776] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R37DK017776, R01DK017776] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chern JJ, 2002, DEVELOPMENT, V129, P4005; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DUMONT FJ, 1990, J IMMUNOL, V144, P251; Ess KC, 2004, GLIA, V46, P28, DOI 10.1002/glia.10324; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harthill JE, 2002, BIOCHEM J, V368, P565, DOI 10.1042/BJ20020838; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Huang B, 2005, ACTA PHARMACOL SIN, V26, P1253, DOI 10.1111/j.1745-7254.2005.00184.x; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Nascimento EBM, 2006, DIABETES, V55, P3221, DOI 10.2337/db05-1390; Nishiuma T, 1998, BIOCHEM BIOPH RES CO, V252, P440, DOI 10.1006/bbrc.1998.9671; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Saito A, 2006, STROKE, V37, P513, DOI 10.1161/01.STR.0000198826.56611.a2; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Sakakibara K, 2005, J BIOL CHEM, V280, P15029, DOI 10.1074/jbc.M410538200; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; Singh A, 2006, DEVELOPMENT, V133, P4771, DOI 10.1242/dev.02686; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamaguchi Y, 2006, J BIOL CHEM, V281, P31627, DOI 10.1074/jbc.M606992200; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7	49	251	259	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20329	20339		10.1074/jbc.M702636200	http://dx.doi.org/10.1074/jbc.M702636200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517883	Green Accepted, hybrid			2022-12-27	WOS:000247819300036
J	Oueslati, M; Hermosilla, R; Schonenberger, E; Oorschot, V; Beyermann, M; Wiesner, B; Schmidt, A; Klumperman, J; Rosenthal, W; Schulein, R				Oueslati, Morad; Hermosilla, Ricardo; Schoenenberger, Eva; Oorschot, Viola; Beyermann, Michael; Wiesner, Burkhard; Schmidt, Antje; Klumperman, Judith; Rosenthal, Walter; Schuelein, Ralf			Rescue of a nephrogenic diabetes insipidus-causing vasopressin V-2 receptor mutant by cell-penetrating peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; V2 RECEPTOR; SURFACE EXPRESSION; SECRETORY PATHWAY; INTERMEDIATE COMPARTMENT; INTRACELLULAR-TRANSPORT; EPITHELIAL-CELLS; PROTEIN; DEGRADATION	Mutant membrane proteins are frequently retained in the early secretory pathway by a quality control system, thereby causing disease. An example are mutants of the vasopressin V-2 receptor (V2R) leading to nephrogenic diabetes insipidus. Transport-defective V(2)Rs fall into two classes: those retained exclusively in the endoplasmic reticulum ( ER) and those reaching post-ER compartments such as the ER/Golgi intermediate compartment. Although numerous chemical or pharmacological chaperones that rescue the transport of ER-retained membrane proteins are known, substances acting specifically in post-ER compartments have not been described as yet. Using the L62P (ER-retained) and Y205C ( reaching post-ER compartments) mutants of the V2R as a model, we show here that the cell-penetrating peptide penetratin and its synthetic analog KLAL rescue the transport of the Y205C mutant. In contrast, the location of the L62P mutant is not influenced by either peptide because the peptides are unable to enter the ER. We also show data indicating that the peptide-mediated transport rescue is associated with an increase in cytosolic Ca2+ concentrations. Thus, we describe a new class of substances influencing protein transport specifically in post-ER compartments.	Leibniz Inst Mol Pharmakol, D-13125 Berlin, Germany; Charite Univ Med Berlin, Inst Pharmakol, D-14195 Berlin, Germany; Univ Med Ctr, Biomembrane Inst, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Utrecht University; Utrecht University Medical Center	Schulein, R (corresponding author), Leibniz Inst Mol Pharmakol, Robert-Rossle-Strasse 10, D-13125 Berlin, Germany.	schuelein@fmp-berlin.de	Horstmann, Britta/C-2154-2008					Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Beyermann M, 1996, J MED CHEM, V39, P3324, DOI 10.1021/jm960116z; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hauri HP, 2000, J CELL SCI, V113, P587; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Klussmann E, 2000, REV PHYSIOL BIOCH P, V141, P33, DOI 10.1007/BFb0119577; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; Lotti LV, 1996, EXP CELL RES, V227, P323, DOI 10.1006/excr.1996.0281; Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Oksche A, 1998, FEBS LETT, V424, P57, DOI 10.1016/S0014-5793(98)00140-9; Oksche A, 1998, J MOL MED, V76, P326, DOI 10.1007/s001090050224; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Palokangas H, 1998, MOL BIOL CELL, V9, P3561, DOI 10.1091/mbc.9.12.3561; PASYK EA, 1995, J BIOL CHEM, V270, P12347, DOI 10.1074/jbc.270.21.12347; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Saliba RS, 2002, J CELL SCI, V115, P2907; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Schulein R, 1996, J BIOL CHEM, V271, P28844, DOI 10.1074/jbc.271.46.28844; Schulein R, 2004, REV PHYSIOL BIOCH P, V151, P45, DOI 10.1007/s10254-004-0022-8; Schulein R, 2000, FEBS LETT, V466, P101, DOI 10.1016/S0014-5793(99)01764-0; Schulein R, 1996, BIOCHEM J, V313, P611, DOI 10.1042/bj3130611; Schulein R, 2001, J BIOL CHEM, V276, P8384, DOI 10.1074/jbc.M007045200; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Young HS, 2001, J MOL BIOL, V308, P231, DOI 10.1006/jmbi.2001.4558	38	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20676	20685		10.1074/jbc.M611530200	http://dx.doi.org/10.1074/jbc.M611530200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17491025	hybrid			2022-12-27	WOS:000247819300070
J	Shahid, G; Hussain, T				Shahid, Gulnar; Hussain, Tahir			GRK2 negatively regulates glycogen synthesis in mouse liver FL83B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN INSULIN-RECEPTOR; PLASMA-MEMBRANES; SKELETAL-MUSCLE; PHOSPHORYLATION; KINASE; SUBSTRATE-1; TRANSLOCATION; ADIPOCYTES; ACTIVATION	G-protein-coupled receptor (GPCR) kinases (GRKs) are serine/threonine kinases that desensitize agonist-occupied classical GPCRs. Although the insulin receptor (IR) is a tyrosine kinase receptor, the IR also couples to G-proteins and utilizes G-protein signaling components. The present study was designed to test the hypothesis that GRK2 negatively regulates IR signaling. FL83B cells, derived from mouse liver, were treated with insulin and membrane translocation of GRK2 was determined using immunofluoresecence and Western blotting. Insulin caused an increase in the translocation of GRK-2 from cytosol to the plasma membrane. To determine the role of GRK2 in IR signaling, GRK2 was selectively down-regulated (similar to by 90%) in FL83B cells using a small interfering RNA technique. Basal as well as insulin-induced glycogen synthesis ( measured by D-[(UC)-C-14] glucose incorporation) was increased in GRK2-deficient cells compared with control cells. Similarly, GRK2 deficiency increased the basal and insulin-stimulated phosphorylation of Ser(21) in glycogen synthase kinase-3 alpha. Insulin-induced tyrosine phosphorylation of the IR was similar in control and GRK2-deficient cells. Basal and insulin-stimulated phosphorylation of Tyr(612) in insulin receptor subunit 1 was significantly increased while phosphorylation of Ser(307) was decreased in GRK2-deficient FL83B cells compared with control cells. Chronic insulin treatment ( 24 h) in control cells caused an increase in GRK2 (56%) and a decrease in IR (50%) expression associated with the absence of an increase in glycogen synthesis, suggesting impairment of IR function. However, chronic insulin treatment (24 h) did not decrease IR expression or impair IR effects on glycogen synthesis in GRK2-deficient cells. We conclude that (i) GRK2 negatively regulates basal and insulin-stimulated glycogen synthesis via a post-IR signaling mechanism, and (ii) GRK2 may contribute to reduced IR expression and function during chronic insulin exposure.	Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA	University of Houston System; University of Houston	Hussain, T (corresponding author), Univ Houston, Sci & Res Bldg 2,4800 Calhoun, Houston, TX 77204 USA.	thussain2@uh.edu						Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Green A, 1997, AM J PHYSIOL-ENDOC M, V273, pE254, DOI 10.1152/ajpendo.1997.273.2.E254; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; HESS SL, 1991, J CELL BIOCHEM, V45, P374, DOI 10.1002/jcb.240450411; Iaccarino G, 2003, ASSAY DRUG DEV TECHN, V1, P347, DOI 10.1089/154065803321204484; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; KAHN CR, 1988, J CLIN INVEST, V82, P1151, DOI 10.1172/JCI113711; Kanzaki M, 2000, J BIOL CHEM, V275, P7167, DOI 10.1074/jbc.275.10.7167; KASUGA M, 1982, J BIOL CHEM, V257, P9891; Korsheninnikova E, 2002, DIABETES-METAB RES, V18, P209, DOI 10.1002/dmrr.272; KriegerBrauer HI, 1997, J BIOL CHEM, V272, P10135; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; PILCH PF, 1980, J BIOL CHEM, V255, P1722; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; Tennagels N, 2001, BIOCHEM BIOPH RES CO, V282, P387, DOI 10.1006/bbrc.2001.4589; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Trivedi M, 2005, AM J PHYSIOL-RENAL, V289, pF298, DOI 10.1152/ajprenal.00362.2004; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Usui I, 2004, EMBO J, V23, P2821, DOI 10.1038/sj.emboj.7600297; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609	33	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20612	20620		10.1074/jbc.M700744200	http://dx.doi.org/10.1074/jbc.M700744200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517892	hybrid			2022-12-27	WOS:000247819300064
J	Tran, TH; Andreka, P; Rodrigues, CO; Webster, KA; Bishopric, NH				Tran, Thanh H.; Andreka, Peter; Rodrigues, Claudia O.; Webster, Keith A.; Bishopric, Nanette H.			Jun kinase delays caspase-9 activation by interaction with the apoptosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; CARDIAC MYOCYTE APOPTOSIS; DEATH PROTEASE CASPASE-9; CYTOCHROME-C RELEASE; HEAT-SHOCK-PROTEIN; T-CELL-ACTIVATION; APAF-1 APOPTOSOME; OXIDATIVE STRESS; NITRIC-OXIDE; MEDIATED OLIGOMERIZATION	Activation of c-Jun N-terminal kinase 1/2 (JNK) can delay oxidant-induced cell death, but the mechanism is unknown. We found that oxidant stress of cardiac myocytes activated both JNK and mitochondria-dependent apoptosis and that expression of JNK inhibitory mutants accelerated multiple steps in this pathway, including the cleavage and activation of caspases-3 and -9 and DNA internucleosomal cleavage, without affecting the rate of cytochrome c release; JNK inhibition also increased caspase-3 and -9 cleavage in a cell-free system. On activation by GSNO or H2O2, JNK formed a stable association with oligomeric Apaf-1 in a similar to 1.4-2.0 mDa pre-apoptosome complex. Formation of this complex could be triggered by addition of cytochrome c and ATP to the cell-free cytosol. JNK inhibition abrogated JNK-Apaf-1 association and accelerated the association of procaspase-9 and Apaf-1 in both intact cells and cell-free extracts. We conclude that oxidant-activated JNK associates with Apaf-1 and cytochrome c in a catalytically inactive complex. We propose that this interaction delays formation of the active apoptosome, promoting cell survival during short bursts of oxidative stress.	Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA; Gottsegen Hungarian Inst Cardiol, Budapest, Hungary; Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Med & Pediat, Miami, FL 33136 USA	University of Miami; University of Miami	Bishopric, NH (corresponding author), Dept Mol & Cellular Pharmacol, PO Box 016189, Miami, FL 33101 USA.	n.bishopric@miami.edu		Webster, Keith A/0000-0002-6431-3642	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044578, R01HL071094] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 71094, R01 HL 44578] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams JW, 2000, CIRC RES, V87, P1180, DOI 10.1161/01.RES.87.12.1180; Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Andreka P, 2001, CIRC RES, V88, P305, DOI 10.1161/01.RES.88.3.305; Angelastro JM, 2001, J BIOL CHEM, V276, P12190, DOI 10.1074/jbc.M009523200; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Beem E, 2004, AM J PHYSIOL-CELL PH, V287, pC664, DOI 10.1152/ajpcell.00232.2003; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; BISHOPRIC NH, 1991, P NATL ACAD SCI USA, V88, P2132, DOI 10.1073/pnas.88.6.2132; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Boluyt MO, 2003, AM J PHYSIOL-HEART C, V285, pH2639, DOI 10.1152/ajpheart.00596.2003; Borutaite V, 2003, FREE RADICAL BIO MED, V35, P1457, DOI 10.1016/j.freeradbiomed.2003.08.003; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Clerk A, 2002, BIOCHEM J, V368, P101, DOI 10.1042/BJ20021083; Clerk A, 1998, BIOCHEM J, V333, P581, DOI 10.1042/bj3330581; Communal C, 2002, J CARD FAIL, V8, P86, DOI 10.1054/jcaf.2002.32755; Czerski L, 2004, J MOL CELL CARDIOL, V37, P643, DOI 10.1016/j.yjmcc.2004.04.016; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Dreskin SC, 2001, J IMMUNOL, V166, P5646, DOI 10.4049/jimmunol.166.9.5646; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Engelbrecht A-M, 2004, BASIC RES CARDIOL, V99, P338, DOI 10.1007/s00395-004-0478-3; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Flesch M, 2001, CIRCULATION, V104, P2273, DOI 10.1161/hc4401.099449; Han H, 2004, AM J PHYSIOL-HEART C, V286, pH2169, DOI 10.1152/ajpheart.00199.2003; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Ing DJ, 1999, CIRC RES, V84, P21; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Krumenacker JS, 2005, AM J PHYSIOL-CELL PH, V289, pC778, DOI 10.1152/ajpcell.00057.2005; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Laderoute KR, 1997, CIRC RES, V80, P336, DOI 10.1161/01.RES.80.3.336; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Nishitai G, 2004, J BIOL CHEM, V279, P1621, DOI 10.1074/jbc.M310335200; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Park JH, 2001, J CELL BIOCHEM, V82, P326, DOI 10.1002/jcb.1163; Petrich BG, 2004, J BIOL CHEM, V279, P15330, DOI 10.1074/jbc.M314142200; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Pinsky DJ, 1997, CIRC RES, V81, P372, DOI 10.1161/01.RES.81.3.372; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Remondino A, 2003, CIRC RES, V92, P136, DOI 10.1161/01.RES.0000054624.03539.B4; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Sadoshima J, 2002, J CLIN INVEST, V110, P271, DOI 10.1172/JCI200214938; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Sanna MG, 2002, J BIOL CHEM, V277, P30454, DOI 10.1074/jbc.M203312200; Sanna MG, 1998, P NATL ACAD SCI USA, V95, P6015, DOI 10.1073/pnas.95.11.6015; Seye CI, 2004, CARDIOVASC RES, V64, P144, DOI 10.1016/j.cardiores.2004.05.016; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Tachibana H, 2006, BIOCHEM BIOPH RES CO, V343, P1060, DOI 10.1016/j.bbrc.2006.03.065; Takatani T, 2004, AM J PHYSIOL-CELL PH, V287, pC949, DOI 10.1152/ajpcell.00042.2004; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Twiddy D, 2004, J BIOL CHEM, V279, P19665, DOI 10.1074/jbc.M311388200; Ueda Ryuji, 2003, Medical Electron Microscopy, V36, P41, DOI 10.1007/s007950300005; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Von Ahsen O, 2000, CELL DEATH DIFFER, V7, P1192, DOI 10.1038/sj.cdd.4400782; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	90	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20340	20350		10.1074/jbc.M702210200	http://dx.doi.org/10.1074/jbc.M702210200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17483091	hybrid			2022-12-27	WOS:000247819300037
J	Drosatos, K; Sanoudou, D; Kypreos, KE; Kardassis, D; Zannis, VI				Drosatos, Konstantinos; Sanoudou, Despina; Kypreos, Kyriakos E.; Kardassis, Dimitris; Zannis, Vassilis I.			A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; LOW-DENSITY-LIPOPROTEIN; NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASES; CARBOXY-TERMINAL DOMAIN; APOLIPOPROTEIN-E; DNA-BINDING; IN-VIVO; V-JUN; 3T3-L1 PREADIPOCYTES	c-Jun is a transcription factor activated by phosphorylation by the stress-activated protein kinase/c-Jun N-terminal kinase pathway in response to extracellular signals and cytokines. We show that adenovirus-mediated gene transfer of the dominant negative form of c-Jun (dn-c-Jun)in C57BL/6 mice increased greatly apoE hepatic mRNA and plasma levels, increased plasma cholesterol, triglyceride, and very low density lipoprotein levels, and resulted in the accumulation of discoidal high density lipoprotein particles. A similar but more severe phenotype was generated by overexpression of the mouse apoE in C57BL/6 mice, suggesting that dyslipidemia induced by dn-c-Jun was the result of apoE overexpression. Unexpectedly, infection of apoE(-/-) mice with adenovirus expressing dn-c-Jun reduced plasma cholesterol by 70%, suggesting that dn-c-Jun affected other genes that control plasma cholesterol levels. To identify these genes, we performed whole genome expression analysis (34,000 genes) of isolated livers from two groups of five apoE(-/-) mice, infected with adenoviruses expressing either the dn-c-Jun or the green fluorescence protein. Bioinformatic analysis and Northern blotting validation revealed that dn-c-Jun increased 40-fold the apoE mRNA and reduced by 70% the Scd-1 (stearoyl-CoA-desaturase 1) mRNA. The involvement of Scd-1 in lowering plasma cholesterol was confirmed by restoration of high cholesterol levels of apoE(-/-) mice following coinfection with adenoviruses expressing dn-c-Jun and Scd-1. In conclusion, dn-c-Jun appears to trigger two opposing events in mice that affect plasma cholesterol and triglyceride levels as follows: one results in apoE overexpression and triggers dyslipidemia and the other results in inhibition of Scd-1 and offsets dyslipidemia.	Univ Crete, Sch Med, Dept Basic Sci, GR-71110 Iraklion, Greece; Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Greece; Acad Athens, Fdn Biomed Res, Ctr Basic Res, Div Mol Biol, GR-11527 Athens, Greece; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Biochem, Boston, MA 02118 USA	University of Crete; Foundation for Research & Technology - Hellas (FORTH); Academy of Athens; Boston University; Boston University	Zannis, VI (corresponding author), 700 Albany St,W509, Boston, MA 02118 USA.	vzannis@bu.edu	KYPREOS, KYRIAKOS/AAN-4485-2020; Drosatos, Konstantinos/H-9153-2013; Kypreos, Kyriakos/AAG-1745-2020; Sanoudou, Despina/AAD-8139-2019	Drosatos, Konstantinos/0000-0003-0903-834X; Kypreos, Kyriakos/0000-0001-6784-2710; Sanoudou, Despina/0000-0003-3704-1941; Zannis, Vassilis/0000-0002-1295-7155	NHLBI NIH HHS [R01 HL068216, R01 HL033952, HL33952, R01 HL048739, HL48739, R01 HL068216-05A1, R01 HL048739-11] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068216, R01HL033952, R01HL048739] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; Ahmad M, 1998, J BIOL CHEM, V273, P4616, DOI 10.1074/jbc.273.8.4616; ALANI R, 1991, MOL CELL BIOL, V11, P6286, DOI 10.1128/MCB.11.12.6286; ANGEL P, 1989, New Biologist, V1, P35; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; Beers A, 2006, BIOCHEMISTRY-US, V45, P2408, DOI 10.1021/bi0518040; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1989, ONCOGENE, V4, P123; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; CHAJEKSHAUL T, 1989, BIOCHIM BIOPHYS ACTA, V1001, P316, DOI 10.1016/0005-2760(89)90116-1; CHANG DJ, 1990, J BIOL CHEM, V265, P9496; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; De Cesaris P, 1999, J BIOL CHEM, V274, P28978, DOI 10.1074/jbc.274.41.28978; Dewberry R, 2000, ARTERIOSCL THROM VAS, V20, P2394, DOI 10.1161/01.ATV.20.11.2394; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; FAZIO S, 1993, J CLIN INVEST, V92, P1497, DOI 10.1172/JCI116728; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; Hadman M, 1998, ONCOGENE, V16, P655, DOI 10.1038/sj.onc.1201574; Hadzopoulou-Cladaras M, 1998, BIOCHEMISTRY-US, V37, P14078, DOI 10.1021/bi9804176; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heinemann FS, 1998, MOL BIOL CELL, V9, P3445, DOI 10.1091/mbc.9.12.3445; HIRAI SI, 1990, ONCOGENE, V5, P39; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Ioroi T, 2003, J PHARMACOL SCI, V91, P145; Isoda K, 2004, ARTERIOSCL THROM VAS, V24, P1068, DOI 10.1161/01.ATV.0000127025.48140.a3; KAESTNER KH, 1989, J BIOL CHEM, V264, P14755; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kypreos KE, 2005, J BIOL CHEM, V280, P6276, DOI 10.1074/jbc.M413458200; Kypreos KE, 2003, BIOCHEMISTRY-US, V42, P9841, DOI 10.1021/bi0271796; Kypreos KE, 2001, BIOCHEMISTRY-US, V40, P6027, DOI 10.1021/bi002414a; Kypreos KE, 2001, FASEB J, V15, P1598, DOI 10.1096/fj.00-0882fje; Kypreos KE, 2001, J BIOL CHEM, V276, P19778, DOI 10.1074/jbc.M100418200; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Li XP, 2003, BIOCHEMISTRY-US, V42, P10406, DOI 10.1021/bi027093c; Marculescu R, 2002, DIABETES, V51, P3582, DOI 10.2337/diabetes.51.12.3582; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Metzler B, 2000, AM J PATHOL, V156, P1875, DOI 10.1016/S0002-9440(10)65061-4; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Miyazaki M, 2003, J BIOL CHEM, V278, P33904, DOI 10.1074/jbc.M304724200; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Murphy N, 2002, ATHEROSCLEROSIS, V163, P69, DOI 10.1016/S0021-9150(01)00755-9; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; POMBO CM, 1994, J BIOL CHEM, V269, P26546; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Sanoudou D, 2005, PHYSIOL GENOMICS, V21, P131, DOI 10.1152/physiolgenomics.00259.2004; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Shin M, 2002, BBA-MOL CELL RES, V1589, P311, DOI 10.1016/S0167-4889(02)00195-7; Singh NN, 2006, ARTERIOSCL THROM VAS, V26, P1323, DOI 10.1161/01.ATV.0000220383.19192.55; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; STRUHL K, 1988, NATURE, V332, P649, DOI 10.1038/332649a0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	66	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19556	19564		10.1074/jbc.M700986200	http://dx.doi.org/10.1074/jbc.M700986200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17456467	hybrid, Green Accepted			2022-12-27	WOS:000247650600030
J	Gusarova, V; Seo, J; Sullivan, ML; Watkins, SC; Brodsky, JL; Fisher, EA				Gusarova, Viktoria; Seo, Jeongmin; Sullivan, Mara L.; Watkins, Simon C.; Brodsky, Jeffrey L.; Fisher, Edward A.			Golgi-associated maturation of very low density lipoproteins involves conformational changes in apolipoprotein B, but is not dependent on apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; PHYSIOLOGICAL RELEVANCE; TRANSFER PROTEIN; RAT HEPATOCYTES; APO-B; SECRETION; TRIGLYCERIDE; OCCURS; TRIACYLGLYCEROL	The major protein component in secreted very low density lipoproteins (VLDL) is apoB, and it is established that these particles can reach sizes approaching 100 nm. We previously employed a cell-free system to investigate the nature of the vesicles in which this large cargo exits the endoplasmic reticulum (ER) (Gusarova, V., Brodsky, J. L., and Fisher, E. A. (2003) J. Biol. Chem. 278, 48051-48058). We found that apoB-containing lipoproteins exit the ER as dense lipid-protein complexes regardless of the final sizes of the particles and that further expansion occurs via post-ER lipidation. Here, we focused on maturation in the Golgi apparatus. In three separate approaches, we found that VLDL maturation (as assessed by changes in buoyant density) was associated with conformational changes in apoB. In addition, as the size of VLDL expanded, apoE concentrated in a subclass of Golgi microsomes or Golgi-derived vesicles that co-migrated with apoB-containing microsomes or vesicles, respectively. A relationship between apoB and apoE was further confirmed in co-localization studies by immunoelectron microscopy. These combined results are consistent with previous suggestions that apoE is required for VLDL maturation. To our surprise, however, we observed robust secretion of mature VLDL when apoE synthesis was inhibited in either rat hepatoma cells or apoE(-/-) mouse primary hepatocytes. We conclude that VLDL maturation in the Golgi involves apoB conformational changes and that the expansion of the lipoprotein does not require apoE; rather, the increase in VLDL surface area favors apoE binding.	NYU, Sch Med, Dept Med, Leon Charney Div Cardiol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, Marc & Bell Program Vasc Biol, New York, NY 10016 USA; Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	New York University; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fisher, EA (corresponding author), NYU, Sch Med, Dept Med, 550 1St Ave, New York, NY 10016 USA.	edward.fisher@med.nyu.edu	Watkins, Simon/ABG-2590-2021; Adiels, Martin/C-9278-2011; Fisher, Edward/ABE-7469-2020	Watkins, Simon/0000-0003-4092-1552; Fisher, Edward/0000-0001-9802-143X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58541] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; Asp L, 2000, J BIOL CHEM, V275, P26285, DOI 10.1074/jbc.M003520200; BAMBERGER MJ, 1990, P NATL ACAD SCI USA, V87, P2390, DOI 10.1073/pnas.87.7.2390; BAMBERGER MJ, 1988, J BIOL CHEM, V263, P11868; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOREN J, 1994, J BIOL CHEM, V269, P25879; DAHAN S, 1994, J CELL BIOL, V127, P1859, DOI 10.1083/jcb.127.6.1859; Du XB, 1998, J CELL BIOL, V141, P585, DOI 10.1083/jcb.141.3.585; FAZIO S, 1995, ARTERIOSCL THROM VAS, V15, P593, DOI 10.1161/01.ATV.15.5.593; Fazio S, 2000, TRENDS CARDIOVAS MED, V10, P23, DOI 10.1016/S1050-1738(00)00033-5; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; HAMILTON RL, 1990, J LIPID RES, V31, P1589; Hasty AH, 1999, J LIPID RES, V40, P1529; HAVEL RJ, 2001, METABOLIC MOL BASES, P2705; Heimann K, 1999, J BIOL CHEM, V274, P10743, DOI 10.1074/jbc.274.16.10743; HIGGINS JA, 1988, FEBS LETT, V232, P405, DOI 10.1016/0014-5793(88)80780-4; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Kummrow E, 2002, J LIPID RES, V43, P2155, DOI 10.1194/jlr.M200249-JLR200; Mancias JD, 2005, TRAFFIC, V6, P278, DOI 10.1111/j.1600-0854.2005.00279.x; Maugeais C, 2000, J LIPID RES, V41, P1673; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; RUSINOL A, 1993, J BIOL CHEM, V268, P3555; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Swift LL, 2003, J LIPID RES, V44, P1841, DOI 10.1194/jlr.M300276-JLR200; Swift LL, 2001, J BIOL CHEM, V276, P22965, DOI 10.1074/jbc.M100172200; SWIFT LL, 1980, J CLIN INVEST, V66, P415, DOI 10.1172/JCI109871; Thorngate FE, 2000, ARTERIOSCL THROM VAS, V20, P1939, DOI 10.1161/01.ATV.20.8.1939; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; WANG HX, 1993, J CLIN INVEST, V91, P1380, DOI 10.1172/JCI116340; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Wientgen H, 2004, ARTERIOSCL THROM VAS, V24, P1460, DOI 10.1161/01.ATV.0000134297.61979.3c; WILCOX HG, 1987, J LIPID RES, V28, P351; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Zhu MY, 2005, METABOLISM, V54, P1309, DOI 10.1016/j.metabol.2005.04.019	48	51	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19453	19462		10.1074/jbc.M700475200	http://dx.doi.org/10.1074/jbc.M700475200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500069	hybrid			2022-12-27	WOS:000247650600019
J	Franchi, L; Kanneganti, TD; Dubyak, GR; Nunez, G				Franchi, Luigi; Kanneganti, Thirumala-Devi; Dubyak, George R.; Nunez, Gabriel			Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(7) RECEPTOR; IL-1-BETA-CONVERTING ENZYME; IL-1-BETA SECRETION; MICE DEFICIENT; INTERLEUKIN-1-BETA; ATP; RELEASE; INFLAMMASOME; MATURATION; INFECTION	Interleukin-1 beta (IL-1 beta) is a pro-inflammatory cytokine that plays an important role in host defense and inflammatory diseases. The maturation and secretion of IL-1 beta are mediated by caspase-1, a protease that processes pro-IL-1 beta into biologically active IL-1 beta. The activity of caspase-1 is controlled by the inflammasome, a multiprotein complex formed by NLR proteins and the adaptor ASC, that induces the activation of caspase-1. The current model proposes that changes in the intracellular concentration of K+ potentiate caspase-1 activation induced by the recognition of bacterial products. However, the roles of P2X7 receptor and intracellular K+ in IL-1 beta secretion induced by bacterial infection remain unknown. Here we show that, in response to Toll-like receptor agonists such as lipopolysaccharide or infection with extracellular bacteria Staphylococcus aureus and Escherichia coli, efficient caspase-1 activation is only triggered by addition of ATP, a signal that promotes caspase-1 activation through depletion of intracellular K+ caused by stimulation of the purinergic P2X7 receptor. In contrast, activation of caspase-1 that relies on cytosolic sensing of flagellin or intracellular bacteria did not require ATP stimulation or depletion of cytoplasmic K+. Consistently, caspase-1 activation induced by intracellular Salmonella or Listeria was unimpaired in macrophages deficient in P2X7 receptor. These results indicate that, unlike caspase-1 induced by Toll-like receptor agonists and ATP, activation of the inflammasome by intracellular bacteria and cytosolic flagellin proceeds normally in the absence of P2X7 receptor-mediated cytoplasmic K+ perturbations.	Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA; Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Case Western Reserve University	Nunez, G (corresponding author), Univ Michigan, Sch Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	bclx@umich.ed	Nuñez, Gabriel/A-7160-2014; Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Dubyak, George/0000-0001-9720-4226	NIAID NIH HHS [AI063331, AI064748] Funding Source: Medline; NIAMS NIH HHS [AR051790] Funding Source: Medline; NIGMS NIH HHS [GM36387] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, R37AI063331, R56AI063331, R01AI064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036387] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; BUISMAN HP, 1988, P NATL ACAD SCI USA, V85, P7988, DOI 10.1073/pnas.85.21.7988; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cheneval D, 1998, J BIOL CHEM, V273, P17846, DOI 10.1074/jbc.273.28.17846; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Laliberte RE, 1997, J LEUKOCYTE BIOL, V62, P227, DOI 10.1002/jlb.62.2.227; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	52	256	259	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18810	18818		10.1074/jbc.M610762200	http://dx.doi.org/10.1074/jbc.M610762200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17491021	hybrid			2022-12-27	WOS:000247475300020
J	Murthy, N; Ollagnier-de-Choudens, S; Sanakis, Y; Abdel-Ghany, SE; Rousset, C; Ye, H; Fontecave, M; Pilon-Smits, EAH; Pilon, M				Murthy, Narayana; Ollagnier-de-Choudens, Sandrine; Sanakis, Yiannis; Abdel-Ghany, Salah E.; Rousset, Carine; Ye, Hong; Fontecave, Marc; Pilon-Smits, Elizabeth A. H.; Pilon, Marinus			Characterization of Arabidopsis thaliana SufE2 and SufE3 - Functions in chloroplast iron-sulfur cluster assembly and NAD synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; CYSTEINE DESULFURASE CPNIFS; ESCHERICHIA-COLI; SCAFFOLD PROTEIN; QUINOLINATE SYNTHETASE; AZOTOBACTER-VINELANDII; BIOGENESIS; FERREDOXIN; NIFS; BIOSYNTHESIS	In this study we characterize two novel chloroplast SufE- like proteins from Arabidopsis thaliana. Other SufE- like proteins, including the previously described A. thaliana CpSufE, participate in sulfur mobilization for Fe-S biosynthesis through activation of cysteine desulfurization by NifS-like proteins. In addition to CpSufE, the Arabidopsis genome encodes two other proteins with SufE domains, SufE2 and SufE3. SufE2 has plastid targeting information. Purified recombinant SufE2 could activate the cysteine desulfurase activity of CpNifS 40-fold. SufE2 expression was flower-specific and high in pollen; we therefore hypothesize that SufE2 has a specific function in pollen Fe-S cluster biosynthesis. SufE3, also a plastid targeted protein, was expressed at low levels in all major plant organs. The mature SufE3 contains two domains, one SufE- like and one with similarity to the bacterial quinolinate synthase, NadA. Indeed SufE3 displayed both SufE activity (stimulating CpNifS cysteine desulfurase activity 70-fold) and quinolinate synthase activity. The full-length protein was shown to carry a highly oxygen-sensitive (4Fe-4S) cluster at its NadA domain, which could be reconstituted by its own SufE domain in the presence of CpNifS, cysteine and ferrous iron. Knock-out of SufE3 in Arabidopsis is embryo-lethal. We conclude that SufE3 is the NadA enzyme of A. thaliana, involved in a critical step during NAD biosynthesis.	Colorado State Univ, Program Mol Plant Biol, Dept Biol, Ft Collins, CO 80523 USA; CNRS, Inst Rech Technol & Sci Vivant, CEA, UMR UJF 5249, F-38054 Grenoble, France; CNRS, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Metaux, F-38054 Grenoble, France; NCSR Demokritos, Inst Mat Sci, Athens, Greece	Colorado State University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); National Centre of Scientific Research "Demokritos"	Pilon, M (corresponding author), Colorado State Univ, Program Mol Plant Biol, Dept Biol, Ft Collins, CO 80523 USA.	pilon@lamar.colostate.edu	Pilon-Smits, Elizabeth/AAN-4117-2020	Pilon-Smits, Elizabeth/0000-0003-1205-8798; Ollagnier de Choudens, Sandrine/0000-0002-0080-6659				Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cicchillo RM, 2005, J AM CHEM SOC, V127, P7310, DOI 10.1021/ja051369x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Johnson DC, 2005, BIOCHEM SOC T, V33, P90, DOI 10.1042/BST0330090; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Katoh A, 2006, PLANT PHYSIOL, V141, P851, DOI 10.1104/pp.106.081091; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; LEMAIR ESD, 2005, PHOTOSYNTH RES, V79, P305; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Leon S, 2002, BIOCHEM J, V366, P557, DOI 10.1042/BJ20020322; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Moller SG, 2001, GENE DEV, V15, P90, DOI 10.1101/gad.850101; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; NASU S, 1982, J BIOL CHEM, V257, P626; Ollagnier-de Choudens S, 2005, FEBS LETT, V579, P3737, DOI 10.1016/j.febslet.2005.05.065; Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Pilon-Smits EAH, 2002, PLANT PHYSIOL, V130, P1309, DOI 10.1104/pp.010280; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; SUN DX, 1993, J BACTERIOL, V175, P1423, DOI 10.1128/JB.175.5.1423-1432.1993; SUZUKI S, 1991, PLANT PHYSIOL, V97, P375, DOI 10.1104/pp.97.1.375; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; TAKAHASHI Y, 1986, P NATL ACAD SCI USA, V83, P2434, DOI 10.1073/pnas.83.8.2434; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Van Hoewyk D, 2007, P NATL ACAD SCI USA, V104, P5686, DOI 10.1073/pnas.0700774104; WISE RR, 2005, STRUCTURE FUNCTION P, P3; Wu G, 2002, J BIOL INORG CHEM, V7, P526, DOI 10.1007/s00775-001-0330-2; Xu XM, 2006, EMBO J, V25, P900, DOI 10.1038/sj.emboj.7600968; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yabe T, 2006, BIOCHEM BIOPH RES CO, V340, P1047, DOI 10.1016/j.bbrc.2005.12.104; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Ye H, 2006, J BIOL CHEM, V281, P8958, DOI 10.1074/jbc.M512737200; Ye H, 2005, PLANTA, V220, P602, DOI 10.1007/s00425-004-1388-1; Ye H, 2006, NEW PHYTOL, V171, P285, DOI 10.1111/j.1469-8137.2006.01751.x; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	57	60	64	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18254	18264		10.1074/jbc.M701428200	http://dx.doi.org/10.1074/jbc.M701428200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452319	hybrid			2022-12-27	WOS:000247302000032
J	Nagae, M; Tsuchiya, A; Katayama, T; Yamamoto, K; Wakatsuki, S; Kato, R				Nagae, Masamichi; Tsuchiya, Atsuko; Katayama, Takane; Yamamoto, Kenji; Wakatsuki, Soichi; Kato, Ryuichi			Structural basis of the catalytic reaction mechanism of novel 1,2-alpha-L-fucosidase from Bifidobacterium bifidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-FUCOSIDASE; SUBSTRATE-ASSISTED CATALYSIS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; INSIGHTS; ADHESION; GLYCOSIDASES; COMPLEX; ENZYME; PHOSPHORYLASE	1,2-alpha-L-Fucosidase (AfcA), which hydrolyzes the glycosidic linkage of Fuc alpha 1-2Gal via an inverting mechanism, was recently isolated from Bifidobacterium bifidum and classified as the first member of the novel glycoside hydrolase family 95. To better understand the molecular mechanism of this enzyme, we determined the x-ray crystal structures of the AfcA catalytic (Fuc) domain in unliganded and complexed forms with deoxyfuconojirimycin ( inhibitor), 2'-fucosyllactose ( substrate), and L-fucose and lactose ( products) at 1.12 - 2.10 angstrom resolution. The AfcA Fuc domain is composed of four regions, an N-terminal beta region, a helical linker, an (alpha/alpha)(6) helical barrel domain, and a C-terminal beta region, and this arrangement is similar to bacterial phosphorylases. In the complex structures, the ligands were buried in the central cavity of the helical barrel domain. Structural analyses in combination with mutational experiments revealed that the highly conserved Glu(566) probably acts as a general acid catalyst. However, no carboxylic acid residue is found at the appropriate position for a general base catalyst. Instead, a water molecule stabilized by Asn(423) in the substrate-bound complex is suitably located to perform a nucleophilic attack on the C1 atom of L-fucose moiety in 2'-fucosyllactose, and its location is nearly identical near the O1 atom of beta-L-fucose in the products-bound complex. Based on these data, we propose and discuss a novel catalytic reaction mechanism of AfcA.	Photon Factory, Struct Biol Res Ctr, Inst Mat Struct Sci, High Energy Accelerator Res Org, Tsukuba, Ibaraki 305, Japan; Kyoto Univ, Grad Sch Biostudies, Div Integrat Life Sci, Sakyo Ku, Kyoto 606, Japan; Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 921, Japan	High Energy Accelerator Research Organization (KEK); Kyoto University; Ishikawa Prefecture University	Kato, R (corresponding author), Photon Factory, Struct Biol Res Ctr, Inst Mat Struct Sci, High Energy Accelerator Res Org, Tsukuba, Ibaraki 305, Japan.	ryuichi.kato@kek.jp		Katayama, Takane/0000-0003-4009-7874; Wakatsuki, Soichi/0000-0001-5896-7968; Nagae, Masamichi/0000-0002-5470-3807; Kato, Ryuichi/0000-0003-2087-2896				AbdelAleem H, 1996, INT J GYNECOL OBSTET, V55, P273, DOI 10.1016/S0020-7292(96)02770-1; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERNET MF, 1993, APPL ENVIRON MICROB, V59, P4121, DOI 10.1128/AEM.59.12.4121-4128.1993; Brameld KA, 1998, J AM CHEM SOC, V120, P3571, DOI 10.1021/ja972282h; COHENFORD MA, 1989, ANAL BIOCHEM, V177, P172, DOI 10.1016/0003-2697(89)90035-3; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; FEIZI T, 1991, TRENDS BIOCHEM SCI, V16, P84, DOI 10.1016/0968-0004(91)90038-W; Femia AP, 2002, CARCINOGENESIS, V23, P1953, DOI 10.1093/carcin/23.11.1953; Fernandez-Rodriguez J, 2000, CANCER DETECT PREV, V24, P143; FLEET GWJ, 1985, J CHEM SOC CHEM COMM, P841, DOI 10.1039/c39850000841; FUKUDA M, 1995, BIOORGAN MED CHEM, V3, P207, DOI 10.1016/0968-0896(95)00014-8; GIBSON GR, 1994, J APPL BACTERIOL, V77, P412, DOI 10.1111/j.1365-2672.1994.tb03443.x; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Heikinheimo P, 2003, J MOL BIOL, V327, P631, DOI 10.1016/S0022-2836(03)00172-4; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; Hosono J, 1998, J SURG ONCOL, V67, P77, DOI 10.1002/(SICI)1096-9098(199802)67:2<77::AID-JSO2>3.0.CO;2-I; Ishizuka H, 1999, INTERNAL MED, V38, P927, DOI 10.2169/internalmedicine.38.927; Kamitori S, 1999, J MOL BIOL, V287, P907, DOI 10.1006/jmbi.1999.2647; Katayama T, 2005, J BIOSCI BIOENG, V99, P457, DOI 10.1263/jbb.99.457; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LARSON G, 1988, J BIOL CHEM, V263, P10790; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mizuno M, 2004, J BIOL CHEM, V279, P10575, DOI 10.1074/jbc.M310771200; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Ouwehand A., 2002, European Journal of Nutrition, V41; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PODOLSKY DK, 1985, J BIOL CHEM, V260, P8262; Rapoport E, 1999, GLYCOBIOLOGY, V9, P1337, DOI 10.1093/glycob/9.12.1337; Roujeinikova A, 2001, J MOL BIOL, V312, P119, DOI 10.1006/jmbi.2001.4944; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sevcik J, 1998, ACTA CRYSTALLOGR D, V54, P854, DOI 10.1107/S0907444998002005; SINCOTT ML, 1990, CHEM REV, V90, P1171; Song JF, 2002, ANAL BIOCHEM, V304, P126, DOI 10.1006/abio.2001.5589; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	62	92	93	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18497	18509		10.1074/jbc.M702246200	http://dx.doi.org/10.1074/jbc.M702246200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17459873	hybrid			2022-12-27	WOS:000247302000055
J	Yamada, S; Tomoeda, M; Ozawa, Y; Yoneda, S; Terashima, Y; Ikezawa, K; Ikegawa, S; Saito, M; Toyosawa, S; Murakami, S				Yamada, Satoru; Tomoeda, Miki; Ozawa, Yasuhiro; Yoneda, Shinya; Terashima, Yoshimitsu; Ikezawa, Kazuhiko; Ikegawa, Shiro; Saito, Masahiro; Toyosawa, Satoru; Murakami, Shinya			PLAP-1/asporin, a novel negative regulator of periodontal ligament mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; LEUCINE-RICH REPEATS; GROWTH-FACTOR-BETA; OSTEOBLAST DIFFERENTIATION; MATRIX MINERALIZATION; DECORIN-BINDING; CELLS; BIGLYCAN; EXPRESSION; ASPORIN	Periodontal ligament-associated protein-1 (PLAP-1)/asporin is a recently identified novel member of the small leucine-rich repeat proteoglycan family. PLAP-1/asporin is involved in chondrogenesis, and its involvement in the pathogenesis of osteoarthritis has been suggested. We report that PLAP-1/asporin is also expressed specifically and predominantly in the periodontal ligament (PDL) and that it negatively regulates the mineralization of PDL cells. In situ hybridization analysis revealed that PLAP-1/asporin was expressed specifically not only in the PDL of an erupted tooth but also in the dental follicle, which is the progenitor tissue of the PDL during tooth development. Overexpression of PLAP-1/asporin in mouse PDL-derived clone cells interfered with both naturally and bone morphogenetic protein 2 (BMP-2)-induced mineralization of the PDL cells. On the other hand, knockdown of PLAP-1/asporin transcript levels by RNA interference enhanced BMP-2-induced differentiation of PDL cells. Furthermore co-immuno-precipitation assays showed a direct interaction between PLAP1/asporin and BMP- 2 in vitro, and immunohistochemistry staining revealed the co-localization of PLAP-1/asporin and BMP- 2 at the cellular level. These results suggest that PLAP-1/asporin plays a specific role(s) in the periodontal ligament as a negative regulator of cytodifferentiation and mineralization probably by regulating BMP- 2 activity to prevent the periodontal ligament from developing non-physiological mineralization such as ankylosis.	Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Dent, Dept Oral Pathol, Suita, Osaka 5650871, Japan; RIKEN, Single Nucleotide Polymorphisms Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; Kanagawa Dent Coll, Div Operat Dent & Endodont, Dept Oral Med, Yokosuka, Kanagawa 2388580, Japan	Osaka University; Osaka University; RIKEN; Kanagawa Dental College	Murakami, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ipshinya@dent.osaka-u.ac.jp	Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147; Murakami, Shinya/0000-0002-5230-452X				ARCEO N, 1991, J PERIODONTOL, V62, P499, DOI 10.1902/jop.1991.62.8.499; Bartold PM, 2006, PERIODONTOL 2000, V40, P164, DOI 10.1111/j.1600-0757.2005.00139.x; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bosshardt DD, 1996, ANAT RECORD, V245, P267; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; CHO MI, 1992, CALCIFIED TISSUE INT, V50, P459, DOI 10.1007/BF00296778; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; Duarte WR, 2003, J BONE MINER RES, V18, P493, DOI 10.1359/jbmr.2003.18.3.493; Duarte WR, 1999, BIOCHEM BIOPH RES CO, V255, P416, DOI 10.1006/bbrc.1999.0214; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Iida A, 2006, J HUM GENET, V51, P151, DOI 10.1007/s10038-005-0337-6; Ikegawa S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1992; Ishihara K, 1999, BBA-MOL CELL RES, V1451, P48, DOI 10.1016/S0167-4889(99)00090-7; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kobayashi M, 1999, J DENT RES, V78, P1624, DOI 10.1177/00220345990780100701; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lekic P, 1996, ANAT REC, V245, P327; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; Mochida Y, 2003, BIOCHEM BIOPH RES CO, V305, P6, DOI 10.1016/S0006-291X(03)00693-4; Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saito M, 2005, J BONE MINER RES, V20, P50, DOI 10.1359/jbmr.041006; Saito Y, 2002, J CELL SCI, V115, P4191, DOI 10.1242/jcs.00098; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Stander M, 1999, CELL TISSUE RES, V296, P221, DOI 10.1007/s004410051283; Sulochana KN, 2005, J BIOL CHEM, V280, P27935, DOI 10.1074/jbc.M414320200; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Yamada S, 2006, J DENT RES, V85, P447, DOI 10.1177/154405910608500510; Yamada S, 2001, GENE, V275, P279, DOI 10.1016/S0378-1119(01)00683-7; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004; Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441	37	148	155	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23070	23080		10.1074/jbc.M611181200	http://dx.doi.org/10.1074/jbc.M611181200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17522060	hybrid			2022-12-27	WOS:000248577500009
J	Kobayashi, S; Mao, K; Zheng, HQ; Wang, XJ; Patterson, C; O'Connell, TD; Liang, QR				Kobayashi, Satoru; Mao, Kai; Zheng, Hanqiao; Wang, Xuejun; Patterson, Cam; O'Connell, Timothy D.; Liang, Qiangrong			Diminished GATA4 protein levels contribute to hyperglycemia-induced cardiomyocyte injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC CARDIOMYOPATHY; INDUCED APOPTOSIS; CELL-DEATH; VENTRICULAR MYOCYTES; CARDIAC MYOCYTES; UBIQUITIN LIGASE; GENE-EXPRESSION; VITAMIN-E; IN-VITRO; HYPERTROPHY	Hyperglycemia is an independent risk factor for diabetic heart failure. However, the mechanisms that mediate hyperglycemia-induced cardiac damage remain poorly understood. The transcription factor GATA4 is essential for cardiac homeostasis, and its protein levels are dramatically reduced in the heart in response to diverse pathologic stresses. In this study, we investigated if hyperglycemia affects GATA4 expression in cardiomyocytes and if enhancing GATA4 signaling could attenuate hyperglycemia-induced cardiomyocyte injury. In cultured rat cardiomyocytes, high glucose (HG, 25 or 40 mM) markedly reduced GATA4 protein levels as compared with normal glucose (NG, 5.5 mM). Equal amount of mannitol did not affect GATA4 protein expression (NG, 100 +/- 12%; mannitol, 97 +/- 8%, versus HG, 43 +/- 16%, p < 0.05). The GATA4 mRNA content, either steady-state or polysome-associated, remained unchanged. HG-induced GATA4 reduction was reversed by MG262, a specific proteasome inhibitor. HG did not activate the ubiquitin proteasome system (UPS) in cardiomyocytes as indicated by a UPS reporter, nor did it increase the peptidase activities or protein expression of the proteasomal subunits. However, the mRNA levels of ubiquitin-protein isopeptide ligase (E3) carboxyl terminus of Hsp70-interacting protein (CHIP) were markedly increased in HG-treated cardiomyocytes. CHIP overexpression promoted GATA4 protein degradation, whereas small interfering RNA-mediated CHIP knockdown prevented HG-induced GATA4 depletion. Moreover, overexpression of GATA4 blocked HG-induced cardiomyocyte death. Also, GATA4 protein levels were diminished in the hearts of streptozotocin and db/db diabetic mice (44 +/- 7% and 67 +/- 13% of control, p < 0.05), which correlated with increased CHIPmRNA abundance. In summary, increased GATA4 protein degradation may be an important mechanism that contributes to hyperglycemic cardiotoxicity.	Univ S Dakota Sanford Sch Med, Sanford Res, Inst Cardiovasc Res, Sioux Falls, SD 57105 USA; Univ N Carolina, Sch Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA	Sanford Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Liang, QR (corresponding author), Univ S Dakota Sanford Sch Med, Sanford Res, Inst Cardiovasc Res, Sioux Falls, SD 57105 USA.	qliang@usd.edu	Wang, Xuejun/AAT-9490-2021; Wang, Xuejun/K-8874-2013; O'Connell, Timothy/D-5048-2013	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072166] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR017662] Funding Source: Medline; NHLBI NIH HHS [R01 HL085629, R01 HL072166] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aasum E, 2003, DIABETES, V52, P434, DOI 10.2337/diabetes.52.2.434; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BELL DSH, 1995, DIABETES CARE, V18, P708, DOI 10.2337/diacare.18.5.708; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; Chagnon F, 2005, CIRC RES, V96, P1095, DOI 10.1161/01.RES.0000168327.22888.4d; Cooper ME, 2004, AM J HYPERTENS, V17, p31S, DOI 10.1016/j.amjhyper.2004.08.021; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dong X, 2004, AM J PHYSIOL-HEART C, V287, pH1417, DOI 10.1152/ajpheart.01233.2003; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Fiordaliso F, 2000, LAB INVEST, V80, P513, DOI 10.1038/labinvest.3780057; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Kakita T, 2001, CIRC RES, V88, P1239, DOI 10.1161/hh1201.091794; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P841, DOI 10.1016/j.yjmcc.2005.07.019; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li LH, 2006, CIRCULATION, V113, P535, DOI 10.1161/CIRCULATIONAHA.105.568402; Li YW, 2006, LAB INVEST, V86, P32, DOI 10.1038/labinvest.3700367; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; Malhotra A, 2005, MOL CELL BIOCHEM, V268, P169, DOI 10.1007/s11010-005-3858-6; Maulik N, 1999, CIRCULATION, V100, P369; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Phelps M, 2005, J BIOL CHEM, V280, P16651, DOI 10.1074/jbc.M412334200; Pierce GN, 1997, CARDIOVASC RES, V34, P41, DOI 10.1016/S0008-6363(97)00010-2; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Shizukuda Y, 2002, AM J PHYSIOL-HEART C, V282, pH1625, DOI 10.1152/ajpheart.00783.2001; Suzuki YJ, 2004, J MOL CELL CARDIOL, V37, P1195, DOI 10.1016/j.yjmcc.2004.09.009; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Zhang CL, 2005, AM J PHYSIOL-HEART C, V288, pH2836, DOI 10.1152/ajpheart.01122.2004	42	43	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21945	21952		10.1074/jbc.M703048200	http://dx.doi.org/10.1074/jbc.M703048200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17525155	hybrid			2022-12-27	WOS:000248196800042
J	Methot, N; Rubin, J; Guay, D; Beaulieu, C; Ethier, D; Reddy, TJ; Riendeau, D; Percival, MD				Methot, Nathalie; Rubin, Joel; Guay, Daniel; Beaulieu, Christian; Ethier, Diane; Reddy, T. Jagadeeswar; Riendeau, Denis; Percival, M. David			Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-I; NEUTROPHIL ELASTASE; PROMYELOCYTIC LEUKEMIA; MOLECULAR-CLONING; LUNG-DISEASE; RAT LIVER; DIFFERENTIATION; PROTEINASE-3; CYSTEINE; CELLS	Cathepsin C is a cysteine protease required for the activation of several pro-inflammatory serine proteases and, as such, is of interest as a therapeutic target. In cathepsin C-deficient mice and humans, the N-terminal processing and activation of neutrophil elastase, cathepsin G, and proteinase-3 is abolished and is accompanied by a reduction of protein levels. Pharmacologically, the consequence of cathepsin C inhibition on the activation of these serine proteases has not been described, due to the lack of stable and non-toxic inhibitors and the absence of appropriate experimental cell systems. Using novel reversible peptide nitrile inhibitors of cathepsin C, and cell-based assays with U937 and EcoM-G cells, we determined the effects of pharmacological inhibition of cathepsin C on serine protease activity. We show that indirect and complete inhibition of neutrophil elastase, cathepsin G, and proteinase-3 is achievable in intact cells with selective and non-cytotoxic cathepsin C inhibitors, at concentrations similar to 10-fold higher than those required to inhibit purified cathepsin C. The concentration of inhibitor needed to block processing of these three serine proteases was similar, regardless of the cell system used. Importantly, cathepsin C inhibition must be sustained to maintain serine protease inhibition, because removal of the reversible inhibitors resulted in the activation of pro-enzymes in intact cells. These findings demonstrate that near complete inhibition of multiple serine proteases can be achieved with cathepsin Cinhibitors and that cathepsin C inhibition represents a viable but challenging approach for the treatment of neutrophil-based inflammatory diseases.	Merck Res Labs, Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Kirkland, PQ H9H 3L1, Canada; Merck Res Labs, Merck Frosst Ctr Therapeut Res, Dept Med Chem, Kirkland, PQ H9H 3L1, Canada	Merck & Company; Merck & Company	Percival, MD (corresponding author), Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, 16711 Trans Canada Hwy, Montreal, PQ H9H 2L1, Canada.	david_percival@merck.com						Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bondebjerg J, 2005, BIOORGAN MED CHEM, V13, P4408, DOI 10.1016/j.bmc.2005.04.048; Bondebjerg J, 2006, BIOORG MED CHEM LETT, V16, P3614, DOI 10.1016/j.bmcl.2006.01.102; BORIES D, 1989, CELL, V59, P959, DOI 10.1016/0092-8674(89)90752-6; BOUMA JMW, 1966, BIOCHIM BIOPHYS ACTA, V113, P350, DOI 10.1016/S0926-6593(66)80074-7; BRANTLY ML, 1988, AM REV RESPIR DIS, V138, P327, DOI 10.1164/ajrccm/138.2.327; Cairns JA, 2005, PULM PHARMACOL THER, V18, P55, DOI 10.1016/j.pupt.2004.09.032; Campbell EJ, 2000, J IMMUNOL, V165, P3366, DOI 10.4049/jimmunol.165.6.3366; COFFEY JW, 1968, J BIOL CHEM, V243, P3255; Conese Massimo, 2003, J Cyst Fibros, V2, P129, DOI 10.1016/S1569-1993(03)00063-8; DAVIES P, 1991, ANN NY ACAD SCI, V624, P219; de Haar Susanne F, 2004, Hum Mutat, V23, P524, DOI 10.1002/humu.9243; Falgueyret JP, 2004, ANAL BIOCHEM, V335, P218, DOI 10.1016/j.ab.2004.09.005; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; Garwicz D, 2005, HAEMATOLOGICA, V90, P38; GULLBERG U, 1995, J BIOL CHEM, V270, P12912, DOI 10.1074/jbc.270.21.12912; Henningsson F, 2003, BIOL CHEM, V384, P1527, DOI 10.1515/BC.2003.169; Hu Y, 2005, ARTHRITIS RHEUM-US, V52, P2553, DOI 10.1002/art.21192; ISHIDOH K, 1991, J BIOL CHEM, V266, P16312; Kam CM, 2004, ARCH BIOCHEM BIOPHYS, V427, P123, DOI 10.1016/j.abb.2004.04.011; Koehl C, 2003, J BIOL CHEM, V278, P12609, DOI 10.1074/jbc.M210074200; Kohri K, 2002, AM J PHYSIOL-LUNG C, V283, pL531, DOI 10.1152/ajplung.00455.2001; Korver GE, 2001, INT IMMUNOPHARMACOL, V1, P21, DOI 10.1016/S0162-3109(00)00267-8; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; MCDONALD JK, 1969, J BIOL CHEM, V244, P234; McGuire MJ, 1997, BBA-GENE STRUCT EXPR, V1351, P267, DOI 10.1016/S0167-4781(97)00021-3; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; MCGUIRE MJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P280, DOI 10.1016/0003-9861(92)90519-3; Methot N, 2004, J BIOL CHEM, V279, P27905, DOI 10.1074/jbc.M400247200; Mezyk-Kopec R, 2005, BIOL CHEM, V386, P801, DOI 10.1515/BC.2005.094; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Pham CTN, 1997, J BIOL CHEM, V272, P10695, DOI 10.1074/jbc.272.16.10695; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; RABILLOUD T, 1992, ELECTROPHORESIS, V13, P429, DOI 10.1002/elps.1150130190; Rao NV, 1996, J BIOL CHEM, V271, P2972, DOI 10.1074/jbc.271.6.2972; Rao NV, 1997, J BIOL CHEM, V272, P10260; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Robichaud J, 2003, J MED CHEM, V46, P3709, DOI 10.1021/jm0301078; SALVESEN G, 1990, BIOCHEMISTRY-US, V29, P5304, DOI 10.1021/bi00474a013; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Sheth PD, 2003, BIOCHEM PHARMACOL, V66, P2251, DOI 10.1016/j.bcp.2003.08.002; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Sykes DB, 2003, LEUKEMIA LYMPHOMA, V44, P1187, DOI 10.1080/1042819031000090273; Sykes DB, 2001, BLOOD, V98, P2308, DOI 10.1182/blood.V98.8.2308; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Tran TV, 2002, ARCH BIOCHEM BIOPHYS, V403, P160, DOI 10.1016/S0003-9861(02)00217-5; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; WALKER RI, 1980, REV INFECT DIS, V2, P282; Witko-Sarsat V, 2002, J BIOL CHEM, V277, P47338, DOI 10.1074/jbc.M202789200; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200	57	62	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20836	20846		10.1074/jbc.M702615200	http://dx.doi.org/10.1074/jbc.M702615200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535802	hybrid			2022-12-27	WOS:000248047500009
J	Rogaeva, A; Ou, XM; Jafar-Nejad, H; Lemonde, S; Albert, PR				Rogaeva, Anastasia; Ou, Xiao-Ming; Jafar-Nejad, Hamed; Lemonde, Sylvie; Albert, Paul R.			Differential repression by Freud-1/CC2D1A at a polymorphic site in the dopamine-D2 receptor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN IMMUNOPRECIPITATION; TRANSCRIPTION FACTOR; MENTAL-RETARDATION; MAJOR DEPRESSION; PROMOTER REGION; D-2 RECEPTORS; SCHIZOPHRENIA; D2; BINDING; FAMILY	Freud-1/CC2D1A is a transcriptional repressor of the serotonin-1A receptor gene and was recently genetically linked to non-syndromic mental retardation. To identify new Freud-1 gene targets, data base mining for Freud-1 recognition sequences was done. A highly homologous intronic element (D2-DRE) was identified in the human dopamine-D2 receptor (DRD2) gene, and the role of Freud-1 in regulating the gene at this site was assessed. Recombinant Freud-1 bound specifically to the D2-DRE, and a major protein-D2-DRE complex was identified in nuclear extracts that was super-shifted using Freud-1-specific antibodies. Endogenous Freud-1 binding to the D2-DRE in cells was detected using chromatin immunoprecipitation. The D2-DRE conferred strong repressor activity in transcriptional reporter assays that was dependent on the Freud-1 recognition sequence. In three different human cell lines, the level of Freud-1 protein was inversely related to DRD2 expression. Knockdown of endogenous Freud-1 using small interfering RNA resulted in an up-regulation of DRD2 RNA and binding sites, demonstrating a crucial role for Freud-1 in DRD2 regulation. A previously uncharacterized single nucleotide A/G polymorphism (rs2734836) was located adjacent to the D2-DRE and conferred allele-specific Freud-1 binding and repression, with the major G-allele having reduced activity. These studies demonstrate a key role for Freud-1 to regulate DRD2 expression and provide the first mechanistic insights into its transcriptional regulation. Allele-specific regulation of DRD2 expression by Freud-1 may possibly associate with psychiatric disorders or mental retardation.	Univ Ottawa, Ottawa Hlth Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ So Calif, Dept Pharm, Los Angeles, CA 90033 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Southern California; Baylor College of Medicine	Albert, PR (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst Neurosci, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	palbert@uottawa.ca	Albert, Paul/E-4804-2010; Jafar-Nejad, Hamed/B-9216-2008	Albert, Paul/0000-0002-1809-3554; 				Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Adell A, 2004, NEUROSCI BIOBEHAV R, V28, P415, DOI 10.1016/j.neubiorev.2004.05.001; Ainscough JFX, 2000, DEVELOPMENT, V127, P3923; Albert PR, 2004, NEUROSCIENTIST, V10, P575, DOI 10.1177/1073858404267382; Arinami T, 1997, HUM MOL GENET, V6, P577, DOI 10.1093/hmg/6.4.577; Ausio J, 2003, CLIN GENET, V64, P83, DOI 10.1034/j.1399-0004.2003.00124.x; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Bobb AJ, 2005, AM J MED GENET B, V134B, P67, DOI 10.1002/ajmg.b.30142; Caballero IM, 2005, HUM MOL GENET, V14, pR19, DOI 10.1093/hmg/ddi102; Czesak M, 2006, J NEUROSCI, V26, P1864, DOI 10.1523/JNEUROSCI.2643-05.2006; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Fan GP, 2005, CELL RES, V15, P255, DOI 10.1038/sj.cr.7290294; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; Ghahremani MH, 1999, J BIOL CHEM, V274, P9238, DOI 10.1074/jbc.274.14.9238; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P7558, DOI 10.1073/pnas.121635798; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kushwaha N, 2006, MOL PHARMACOL, V69, P1518, DOI 10.1124/mol.105.019844; Lemonde S, 2004, J NEUROCHEM, V88, P857, DOI 10.1046/j.1471-4159.2003.02223.x; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANSOUR A, 1990, J NEUROSCI, V10, P2587; MINOWA T, 1992, BIOCHEMISTRY-US, V31, P8389, DOI 10.1021/bi00151a001; MINOWA T, 1994, J BIOL CHEM, V269, P11656; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Noble E P, 2000, Pharmacogenomics, V1, P309, DOI 10.1517/14622416.1.3.309; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogbourne S, 1998, BIOCHEM J, V331, P1; Ou XM, 2000, J BIOL CHEM, V275, P8161, DOI 10.1074/jbc.275.11.8161; Ou XM, 2003, J NEUROSCI, V23, P7415; Parsey RV, 2006, NEUROPSYCHOPHARMACOL, V31, P1745, DOI 10.1038/sj.npp.1300992; Parsey RV, 2006, BIOL PSYCHIAT, V59, P106, DOI 10.1016/j.biopsych.2005.06.016; ROGAEVA A, 2007, IN PRESS J NEUROSCI; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Seeman P, 2000, P NATL ACAD SCI USA, V97, P7673, DOI 10.1073/pnas.97.14.7673; Seeman P, 2005, P NATL ACAD SCI USA, V102, P3513, DOI 10.1073/pnas.0409766102; Storring JM, 1999, J NEUROCHEM, V72, P2238, DOI 10.1046/j.1471-4159.1999.0722238.x; VALDENAIRE O, 1994, EUR J BIOCHEM, V220, P577, DOI 10.1111/j.1432-1033.1994.tb18658.x; Wang J, 2005, J NEUROCHEM, V93, P474, DOI 10.1111/j.1471-4159.2005.03051.x; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Yajima S, 1997, J NEUROSCI, V17, P8657; Yajima S, 1998, DNA CELL BIOL, V17, P471, DOI 10.1089/dna.1998.17.471	46	30	32	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20897	20905		10.1074/jbc.M610038200	http://dx.doi.org/10.1074/jbc.M610038200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535813	hybrid			2022-12-27	WOS:000248047500015
J	Wayne, GJ; Deng, SJ; Amour, A; Borman, S; Matico, R; Carter, HL; Murphy, G				Wayne, Gareth J.; Deng, Su-Jun; Amour, Augustin; Borman, Satty; Matico, Rosalie; Carter, H. Luke; Murphy, Gillian			TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED-CHANGES; EXTRACELLULAR-MATRIX; CHONDROITIN SULFATE; ARTICULAR-CARTILAGE; TISSUE INHIBITOR; KERATAN SULFATE; METALLOPROTEINASES; CLEAVAGE; FAMILY; BINDING	ADAMTS-4 (aggrecanase-1) is a glutamyl endopeptidase capable of generating catabolic fragments of aggrecan analogous to those released from articular cartilage during degenerative joint diseases such as osteoarthritis. Efficient aggrecanase activity requires the presence of sulfated glycosaminoglycans attached to the aggrecan core protein, implying the contribution of substrate recognition/binding site(s) to ADAMTS-4 activity. In this study, we developed a sensitive fluorescence resonance energy transfer peptide assay with a K-m in the 10 mu M range and utilized this assay to demonstrate that inhibition of full-length ADAMTS-4 by full-length TIMP-3 (a physiological inhibitor of metalloproteinases) is enhanced in the presence of aggrecan. Our data indicate that this interaction is mediated largely through the binding of glycosaminoglycans (specifically chondroitin 6-sulfate) of aggrecan to binding sites in the thrombospondin type 1 motif and spacer domains of ADAMTS-4 to form a complex with an improved binding affinity for TIMP-3 over free ADAMTS-4. The results of this study therefore indicate that the cartilage environment can modulate the function of enzyme-inhibitor systems and could have relevance for therapeutic approaches to aggrecanase modulation.	Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; GlaxoSmithKline Inc, Harlow CM19 5AW, Essex, England; GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline Inc, Stevenage SG1 2NY, Herts, England; GlaxoSmithKline Inc, King Of Prussia, PA 19406 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Murphy, G (corresponding author), Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	gm290@cam.ac.uk		Matico, Rosalie/0000-0003-2341-3767				Alvarez-Iglesias M, 2005, LAB INVEST, V85, P1440, DOI 10.1038/labinvest.3700340; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Brown GM, 1998, J BIOL CHEM, V273, P26408, DOI 10.1074/jbc.273.41.26408; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; Deng SJ, 2004, J VIROL, V78, P2637, DOI 10.1128/JVI.78.5.2637-2641.2003; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Lauder RM, 2001, BIOCHEM J, V358, P523, DOI 10.1042/0264-6021:3580523; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; MACPHERSON JL, 1997, J MED CHEM, V40, P2525; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Poon CJ, 2005, J BIOL CHEM, V280, P23615, DOI 10.1074/jbc.M412145200; POPE A, 2001, DRUG DISCOV TODAY, V4, P350; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Pratta MA, 2000, J BIOL CHEM, V275, P39096, DOI 10.1074/jbc.M006201200; Roughley PJ, 2001, ARTHRITIS RES, V3, P342, DOI 10.1186/ar326; Segel I. H., 1993, ENZYME KINETICS, P793; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	29	52	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20991	20998		10.1074/jbc.M610721200	http://dx.doi.org/10.1074/jbc.M610721200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17470431	hybrid			2022-12-27	WOS:000248047500025
J	Gunawardena, RW; Fox, SR; Siddiqui, H; Knudsen, ES				Gunawardena, Ranjaka W.; Fox, Sejal R.; Siddiqui, Hasan; Knudsen, Erik S.			SWI/SNF activity is required for the repression of deoxyribonucleotide triphosphate metabolic enzymes via the recruitment of mSin3B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; CHROMATIN REMODELING FACTOR; CELL-CYCLE CONTROL; TRANSCRIPTIONAL REPRESSION; POCKET PROTEINS; DNA-DAMAGE; IN-VIVO; E2F; FAMILY; COMPLEXES	The SWI/SNF chromatin remodeling complex plays a critical role in the coordination of gene expression with physiological stimuli. The synthetic enzymes ribonucleotide reductase, dihydrofolate reductase, and thymidylate synthase are coordinately regulated to ensure appropriate deoxyribonucleotide triphosphate levels. Particularly, these enzymes are actively repressed as cells exit the cell cycle through the action of E2F transcription factors and the retinoblastoma tumor suppressor/p107/p130 family of pocket proteins. This process is found to be highly dependent on SWI/SNF activity as cells deficient in BRG-1 and Brm subunits fail to repress these genes with activation of pocket proteins, and this deficit in repression can be complemented, via the ectopic expression of BRG-1. The failure to repress transcription does not involve a blockade in the association of E2F or pocket proteins p107 and p130 with promoter elements. Rather, the deficit in repression is due to a failure to mediate histone deacetylation of ribonucleotide reductase, dihydrofolate reductase, and thymidylate synthase promoters in the absence of SWI/SNF activity. The basis for this is found to be a failure to recruit mSin3B and histone deacetylase proteins to promoters. Thus, the coordinate repression of deoxyribonucleotide triphosphate metabolic enzymes is dependent on the action of SWI/SNF in facilitating the assembly of repressor complexes at the promoter.	Univ Cincinnati, Coll Med, Dept Cell & Canc Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Knudsen, ES (corresponding author), 3125 Eden Ave, Cincinnati, OH 45267 USA.	erik.Knudsen@uc.edu			NCI NIH HHS [CA 104213] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104213] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Angus SP, 2003, MOL CELL BIOL, V23, P8172, DOI 10.1128/MCB.23.22.8172-8188.2003; Angus SP, 2002, EXP CELL RES, V276, P201, DOI 10.1006/excr.2002.5510; Angus SP, 2002, J BIOL CHEM, V277, P44376, DOI 10.1074/jbc.M205911200; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Belotserkovskaya R, 1999, CRIT REV EUKAR GENE, V9, P221, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.70; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Gunawardena RW, 2004, J BIOL CHEM, V279, P29278, DOI 10.1074/jbc.M400395200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Imbalzano AN, 2005, CANCER CELL, V7, P294, DOI 10.1016/j.ccr.2005.04.001; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; KASAHARA Y, 1993, MUTAT RES, V319, P143, DOI 10.1016/0165-1218(93)90073-M; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; LAURENT BC, 1990, MOL CELL BIOL, V10, P5616, DOI 10.1128/MCB.10.11.5616; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Mayhew CN, 2004, ONCOGENE, V23, P4107, DOI 10.1038/sj.onc.1207503; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nakayama Norisuke, 2006, Gastric Cancer, V9, P185, DOI 10.1007/s10120-006-0371-x; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Nicolas E, 2003, MOL CELL BIOL, V23, P1614, DOI 10.1128/MCB.23.5.1614-1622.2003; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Rastogi S, 2006, MOL CELL BIOL, V26, P4161, DOI 10.1128/MCB.02142-05; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Reisman DN, 2003, CANCER RES, V63, P560; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Strobeck MW, 2000, ONCOGENE, V19, P1857, DOI 10.1038/sj.onc.1203510; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Takahashi Y, 2000, GENE DEV, V14, P804; Taylor-Harding B, 2004, MOL CELL BIOL, V24, P9124, DOI 10.1128/MCB.24.20.9124-9136.2004; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Un F, 2006, ANTICANCER RES, V26, P2761; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; WANG JYJ, 1994, ADV CANCER RES, V64, P25, DOI 10.1016/S0065-230X(08)60834-9; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854	72	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20116	20123		10.1074/jbc.M701406200	http://dx.doi.org/10.1074/jbc.M701406200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17510060	hybrid			2022-12-27	WOS:000247819300012
J	Liu, G; Kawaguchi, H; Ogasawara, T; Asawa, Y; Kishimoto, J; Takahashi, T; Chung, UI; Yamaoka, H; Asato, H; Nakamura, K; Takato, T; Hoshi, K				Liu, Guangyao; Kawaguchi, Hiroshi; Ogasawara, Toru; Asawa, Yukiyo; Kishimoto, Junji; Takahashi, Tsuguharu; Chung, Ung-il; Yamaoka, Hisayo; Asato, Hirotaka; Nakamura, Kozo; Takato, Tsuyoshi; Hoshi, Kazuto			Optimal combination of soluble factors for tissue engineering of permanent cartilage from cultured human chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROGENIC CELL-LINE; GROWTH-FACTOR-I; THYROID-HORMONE; PARATHYROID-HORMONE; GENE-EXPRESSION; DIFFERENTIATION; COLLAGEN; INSULIN; PLATE; PROLIFERATION	Since permanent cartilage has poor self-regenerative capacity, its regeneration from autologous human chondrocytes using a tissue engineering techniquemaygreatly benefit the treatment of various skeletal disorders. However, the conventional autologous chondrocyte implantation is insufficient both in quantity and in quality due to two major limitations: dedifferentiation during a long term culture for multiplication and hypertrophic differentiation by stimulation for the redifferentiation. To overcome the limitations, this study attempted to determine the optimal combination in primary human chondrocyte cultures under a serum-free condition, from among 12 putative chondrocyte regulators. From the exhaustive 2(12) = 4,096 combinations, 256 were selected by fractional factorial design, and bone morphogenetic protein-2 and insulin (BI) were statistically determined to be the most effective combination causing redifferentiation of the dedifferentiated cells after repeated passaging. We further found that the addition of triiodothyronine (T3) prevented the BI-induced hypertrophic differentiation of redifferentiated chondrocytes via the suppression of Akt signaling. The implant formed by the human chondrocytes cultured in atelocollagen and poly(L-latic acid) scaffold under the BI + T3 stimulation consisted of sufficient hyaline cartilage with mechanical properties comparable with native cartilage after transplantation in nude mice, indicating that BI + T3 is the optimal combination to regenerate a clinically practical permanent cartilage from autologous chondrocytes.	Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Dept Cartilage & Bone Regenerat,Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Dept Sensory & Motor Syst Med & Clin Bioinformat, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Hoshi, K (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Dept Cartilage & Bone Regenerat,Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	pochi-tky@umin.net	Ogasawara, Toru/I-1629-2014	Ogasawara, Toru/0000-0002-2996-081X				Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Aoyagi R, 2004, JPN J APPL PHYS 1, V43, P3204, DOI 10.1143/JJAP.43.3204; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; BALLOCK RT, 1994, J CELL BIOL, V126, P1311, DOI 10.1083/jcb.126.5.1311; Bassett JHD, 2003, TRENDS ENDOCRIN MET, V14, P356, DOI 10.1016/S1043-2760(03)00144-90; Berling T, 2003, IEEE T SOFTWARE ENG, V29, P769, DOI 10.1109/TSE.2003.1232283; BOHME K, 1992, J CELL BIOL, V116, P1035, DOI 10.1083/jcb.116.4.1035; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chung Ung-il, 2000, P355; CRABB ID, 1992, CALCIFIED TISSUE INT, V50, P61, DOI 10.1007/BF00297299; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; FUJIMOTO R, 2003, IHI ENG REV, V36, P168; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; GRIGORIADIS AE, 1989, ENDOCRINOLOGY, V125, P2103, DOI 10.1210/endo-125-4-2103; Grunder T, 2004, OSTEOARTHR CARTILAGE, V12, P559, DOI 10.1016/j.joca.2004.04.001; Hidaka K, 2001, INT J BIOCHEM CELL B, V33, P1094, DOI 10.1016/S1357-2725(01)00067-X; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; JOHNSON L F, 1991, Journal of Burn Care and Rehabilitation, V12, P306, DOI 10.1097/00004630-199107000-00005; KATO Y, 1984, J CELL PHYSIOL, V120, P354, DOI 10.1002/jcp.1041200314; Kim J S, 1996, MED DEVICE DIAGN IND, V18, P78; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lei JX, 2003, AM J PHYSIOL-LUNG C, V285, pL762, DOI 10.1152/ajplung.00376.2002; Li Jun, 2003, J Orthop Sci, V8, P829, DOI 10.1007/s00776-003-0719-6; MACKINTOSH D, 1988, BIOCHIM BIOPHYS ACTA, V964, P295, DOI 10.1016/0304-4165(88)90029-3; Malinin TI, 1997, TRANSPLANT P, V29, P2037, DOI 10.1016/S0041-1345(97)00220-0; Maor G, 1999, ENDOCRINOLOGY, V140, P1901, DOI 10.1210/en.140.4.1901; Miura M, 2002, J BONE MINER RES, V17, P443, DOI 10.1359/jbmr.2002.17.3.443; MONSONEGO E, 1995, MOL CELL ENDOCRINOL, V114, P35, DOI 10.1016/0303-7207(95)03639-O; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947; OHLSSON C, 1993, MOL CELL ENDOCRINOL, V91, P167, DOI 10.1016/0303-7207(93)90269-P; Okubo Y, 2003, BIOCHEM BIOPH RES CO, V306, P186, DOI 10.1016/S0006-291X(03)00912-4; Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003; Rodd C, 2004, CALCIFIED TISSUE INT, V75, P214, DOI 10.1007/s00223-004-0197-7; SCHWARTZ Z, 1988, J BIOL CHEM, V263, P6023; Shamma A, 2000, INT J ONCOL, V16, P261; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; STEVENS RL, 1981, J BIOL CHEM, V256, P2045; Takahashi T, 2005, CELL TRANSPLANT, V14, P683, DOI 10.3727/000000005783982675; Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004; Ushida T, 2002, CELL TRANSPLANT, V11, P489; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; WROBLEWSKI J, 1995, J BONE MINER RES, V10, P735; Yasuda T, 2002, ARTHRITIS RHEUM, V46, P138, DOI 10.1002/1529-0131(200201)46:1<138::AID-ART10051>3.0.CO;2-K; Zerega B, 1999, J BONE MINER RES, V14, P1281, DOI 10.1359/jbmr.1999.14.8.1281	47	79	93	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20407	20415		10.1074/jbc.M608383200	http://dx.doi.org/10.1074/jbc.M608383200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17493933	hybrid			2022-12-27	WOS:000247819300043
J	Meesapyodsuk, D; Reed, DW; Covello, PS; Qiu, X				Meesapyodsuk, Dauenpen; Reed, Darwin W.; Covello, Patrick S.; Qiu, Xiao			Primary structure, regioselectivity, and evolution of the membrane-bound fatty acid desaturases of Claviceps purpurea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; ACYL-LIPID DESATURASE; SACCHAROMYCES-CEREVISIAE; HISTIDINE-RESIDUES; GENE; EXPRESSION; TOPOLOGY; SPECIFICITY; IDENTIFICATION; PREDICTION	Two cDNAs with sequence similarity to fatty acid desaturase genes were isolated from the phytopathogenic fungus, Claviceps purpurea. The predicted amino acid sequences of the corresponding genes, named CpDes12 and CpDesX, share 87% identity. Phylogenetic analysis indicates that CpDes12 and CpDesX arose by gene duplication of an ancestral Delta(12)-desaturase gene after the divergence of Nectriaceae and Clavicipitaceae. Functional expression of CpDes12 and CpDesX in yeast ( Saccharomyces cerevisiae) indicated that CpDes12 is primarily a "Delta(12)"-desaturase, whereas CpDesX is a novel desaturase catalyzing "Delta(12)," "Delta(15)," and "omega(3)" types of desaturation with omega(3) activity predominating. CpDesX sequentially desaturates both 16:1-9c and 18:1-9c to give 16: 3-9c, 12c, 15c and 18: 3-9c, 12c, 15c, respectively. In addition, it could also act as an omega(3)-desaturase converting omega(6)-polyunsaturates 18: 3-6c, 9c, 12c, 20: 3-8c, 11c, 14c, and 20: 4-5c, 8c, 11c, 14c to their omega(3) counterparts 18: 4 - 6c, 9c, 12c, 15c, 20: 4 8c, 11c, 14c, 17c, and 20: 5 - 5c, 8c, 11c, 14c, 17c, respectively. By using reciprocal site-directed mutagenesis, we demonstrated that two residues (isoleucine at 152 and alanine at 206) are critical in defining the catalytic specificity of these enzymes and the C-terminal amino acid sequence (residues 302 - 477) was also found to be important. These data provide insights into the nature of regio-selectivity in membrane-bound fatty acid desaturases and the relevant structural determinants. The authors suggest that the regio-selectivity of such enzymes may be best understood by considering the relative importance of more than one regioselective preference. In this view, CpDesX is designated as a v + 3(omega(3)) desaturase, which primarily references an existing double bond (v + 3 regioselectivity) and secondarily shows preference for omega(3) desaturation.	Univ Saskatchewan, Dept Appl Microbiol & Food Sci, Saskatoon, SK S7N 5A8, Canada; Bioriginal Food & Sci Corp, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada	University of Saskatchewan	Qiu, X (corresponding author), Univ Saskatchewan, Dept Appl Microbiol & Food Sci, 51 Campus Dr, Saskatoon, SK S7N 5A8, Canada.	xiao.qiu@usask.ca		Reed, Darwin/0000-0001-8038-8647				Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; AVELANGEMACHEREL MH, 1995, FEBS LETT, V361, P111, DOI 10.1016/0014-5793(95)00163-4; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Cahoon EB, 2004, J BIOL CHEM, V279, P12495, DOI 10.1074/jbc.M314329200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Diaz AR, 2002, J BIOL CHEM, V277, P48099, DOI 10.1074/jbc.M208960200; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fujimori K, 1997, FEBS LETT, V413, P226, DOI 10.1016/S0014-5793(97)00846-6; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; HITZ WD, 1994, PLANT PHYSIOL, V105, P635, DOI 10.1104/pp.105.2.635; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Libisch B, 2000, BIOCHEM BIOPH RES CO, V279, P779, DOI 10.1006/bbrc.2000.4023; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; LUTHRIA DL, 1993, LIPIDS, V28, P561, DOI 10.1007/BF02536089; MANTLE PG, 1976, J GEN MICROBIOL, V93, P321, DOI 10.1099/00221287-93-2-321; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Mey G, 2002, MOL PLANT MICROBE IN, V15, P303, DOI 10.1094/MPMI.2002.15.4.303; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Reed DW, 2000, PLANT PHYSIOL, V122, P715, DOI 10.1104/pp.122.3.715; Sakuradani E, 2005, APPL MICROBIOL BIOT, V66, P648, DOI 10.1007/s00253-004-1760-x; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Schwartzbeck JL, 2001, PHYTOCHEMISTRY, V57, P643, DOI 10.1016/S0031-9422(01)00081-4; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; YADAV NS, 1993, PLANT PHYSIOL, V103, P467, DOI 10.1104/pp.103.2.467; Zhang S, 2007, FEBS LETT, V581, P315, DOI 10.1016/j.febslet.2006.12.031	36	47	57	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20191	20199		10.1074/jbc.M702196200	http://dx.doi.org/10.1074/jbc.M702196200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17510052	hybrid			2022-12-27	WOS:000247819300020
J	Shi, XH; Ma, YQ; Tu, Y; Chen, K; Wu, S; Fukuda, K; Qin, J; Plow, EF; Wu, CY				Shi, Xiaohua; Ma, Yan-Qing; Tu, Yizeng; Chen, Ka; Wu, Shan; Fukuda, Koichi; Qin, Jun; Plow, Edward F.; Wu, Chuanyue			The MIG-2/integrin interaction strengthens cell-matrix adhesion and modulates cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; INTEGRIN ACTIVATION; CYTOPLASMIC DOMAIN; FIBRONECTIN RECEPTOR; SHAPE MODULATION; BINDING-PROTEIN; FOCAL ADHESIONS; TALIN; MIGRATION; MIGFILIN	Integrin-mediated cell-matrix adhesion plays an important role in control of cell behavior. We report here that MIG-2, a widely expressed focal adhesion protein, interacts with beta 1 and beta 3 integrin cytoplasmic domains. Integrin binding is mediated by a single site within the MIG-2 FERM domain. Functionally, the MIG-2/integrin interaction recruits MIG-2 to focal adhesions. Furthermore, using alpha IIb beta 3 integrin-expressing Chinese hamster ovary cells, a well described model system for integrin activation, we show that MIG-2 promotes integrin activation and enhances cell-extracellular matrix adhesion. Although MIG-2 is expressed in many cell types, it is deficient in certain colon cancer cells. Expression of MIG-2, but not of an integrin binding-defective MIG-2 mutant, in MIG-2-null colon cancer cells strengthened cell-matrix adhesion, promoted focal adhesion formation, and reduced cell motility. These results suggest that the MIG-2/integrin interaction is an important element in the cellular control of integrin-mediated cell-matrix adhesion and that loss of this interaction likely contributes to high motility of colon cancer cells.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, 707B Scaife Hall, 3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu	Qin, Jun/D-5559-2009	Qin, Jun/0000-0002-2647-9270	NHLBI NIH HHS [HL 073311] Funding Source: Medline; NIDDK NIH HHS [DK 54639] Funding Source: Medline; NIGMS NIH HHS [GM 65188] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUER JS, 1992, J CELL BIOL, V116, P477, DOI 10.1083/jcb.116.2.477; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; DeLano W.L, PYMOL MOL GRAPHICS S; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gkretsi V, 2005, J CELL SCI, V118, P697, DOI 10.1242/jcs.01638; Guo L, 2002, FASEB J, V16, P1298, DOI 10.1096/fj.02-0089fje; Hemler M E, 1995, Curr Opin Hematol, V2, P61; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; KOLLS J, 1994, P NATL ACAD SCI USA, V91, P215, DOI 10.1073/pnas.91.1.215; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li J, 1999, J CELL BIOL, V147, P1391, DOI 10.1083/jcb.147.7.1391; Liu SC, 2000, J CELL SCI, V113, P3563; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; MCCLAY DR, 2003, CURRENT PROTOCOLS CE, V1; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; ROUSSEL A, 1991, TURBO FRUDO SILICON; Schaller MD, 2000, J CELL BIOL, V150, pF9, DOI 10.1083/jcb.150.1.F9; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Su AI, 2001, CANCER RES, V61, P7388; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; YAMADA KM, 2003, CURRENT PROTOCOLS CE, V1; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200; Zhang YJ, 2002, J BIOL CHEM, V277, P318, DOI 10.1074/jbc.M108257200	51	141	145	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20455	20466		10.1074/jbc.M611680200	http://dx.doi.org/10.1074/jbc.M611680200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17513299	hybrid			2022-12-27	WOS:000247819300048
J	Christensen, B; Kazanecki, CC; Petersen, TE; Rittling, SR; Denhardt, DT; Sorensen, ES				Christensen, Brian; Kazanecki, Christian C.; Petersen, Torben E.; Rittling, Susan R.; Denhardt, David T.; Sorensen, Esben S.			Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION SITES; GLYCINE-ASPARTIC ACID; IN-VITRO; CASEIN KINASE; HYDROXYAPATITE FORMATION; OSTEOCLAST ADHESION; BONE SIALOPROTEIN; MASS-SPECTROMETRY; PHOSPHORYLATION; EXPRESSION	Osteopontin (OPN) is a highly modified integrin-binding protein found in all body fluids. Expression of OPN is strongly correlated with poor prognosis in many different human cancers, suggesting an important but poorly understood role for this protein in tumorigenesis and metastasis. The protein exists in a number of different isoforms differing in the degree of post-translational modifications that are likely to exhibit different functional properties. This study examines for the first time the post-translational modifications of OPN from transformed cells and the effects of these modifications on cell biology. We have characterized the complete phosphorylation and glycosylation patterns of OPN expressed by murineras-transformed fibroblasts(FbOPN) and differentiating osteoblasts (ObOPN) by a combination of mass spectrometric analyses and Edman degradation. Mass spectrometric analysis showed masses of 34.9 and 35.9 kDa for FbOPN and ObOPN, respectively. Enzymatic dephosphorylation, sequence, and mass analyses demonstrated that FbOPN contains approximately four phosphate groups distributed over 16 potential phosphorylation sites, whereas ObOPN contains similar to 21 phosphate groups distributed over 27 sites. Five residues are O-glycosylated in both isoforms. These residues are fully modified in FbOPN, whereas onesite is partially glycosylated in ObOPN. Although both forms of OPN mediated robust integrin-mediated adhesion of mouse ras-transformed fibroblasts, the less phosphorylated FbOPN mediated binding of MDA-MD-435 human tumor cells almost 6-fold more than the heavy phosphorylated ObOPN. These results strongly support the hypothesis that the degree of phosphorylation of OPN produced by different cell types can regulate its function.	Univ Aarhus, Dept Mol Biol, Protein Chem Lab, DK-8000 Aarhus C, Denmark; Rutgers State Univ, Dept Cell Biol & Neurosci, Nelson Labs, Piscataway, NJ USA; Forsyth Inst, Boston, MA USA	Aarhus University; Rutgers State University New Brunswick; Harvard University; Forsyth Institute	Sorensen, ES (corresponding author), Univ Aarhus, Dept Mol Biol, Protein Chem Lab, Sci Pk,Gustav Wields Vej 10C, DK-8000 Aarhus C, Denmark.	ess@mb.au.dk		Sorensen, Esben Skipper/0000-0002-7050-3354	NIDDK NIH HHS [DK067685] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067685] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Shami R, 2005, J CELL BIOCHEM, V94, P1218, DOI 10.1002/jcb.20379; Annan RS, 1996, ANAL CHEM, V68, P3413, DOI 10.1021/ac960221g; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Carlinfante G, 2003, CLIN EXP METASTAS, V20, P437, DOI 10.1023/A:1025419708343; CHANG PL, 1991, CANCER RES, V51, P2144; Chellaiah MA, 2003, J BIOL CHEM, V278, P29086, DOI 10.1074/jbc.M211074200; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; D'Alonzo RC, 2002, J BIOL CHEM, V277, P24788, DOI 10.1074/jbc.M202604200; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Hoyer JR, 2001, KIDNEY INT, V60, P77, DOI 10.1046/j.1523-1755.2001.00772.x; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Katagiri YU, 1999, CANCER RES, V59, P219; Katayama Y, 1998, J CELL PHYSIOL, V176, P179, DOI 10.1002/(SICI)1097-4652(199807)176:1<179::AID-JCP19>3.3.CO;2-M; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; NEMIR M, 1989, J BIOL CHEM, V264, P18202; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Razzouk S, 2002, BONE, V30, P40, DOI 10.1016/S8756-3282(01)00637-8; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Safran JB, 1998, J BIOL CHEM, V273, P29935, DOI 10.1074/jbc.273.45.29935; Salih E, 1997, J BIOL CHEM, V272, P13966, DOI 10.1074/jbc.272.21.13966; Shanmugam V, 1997, BIOCHEMISTRY-US, V36, P5729, DOI 10.1021/bi961687w; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sodek J, 2006, J DENT RES, V85, P404, DOI 10.1177/154405910608500503; SODEK J, 1995, ANN NY ACAD SCI, V760, P223, DOI 10.1111/j.1749-6632.1995.tb44633.x; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wu Y, 2000, BRIT J CANCER, V83, P156; XUAN JW, 1995, J CELL BIOCHEM, V57, P680, DOI 10.1002/jcb.240570413; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	45	114	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19463	19472		10.1074/jbc.M703055200	http://dx.doi.org/10.1074/jbc.M703055200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500062	hybrid			2022-12-27	WOS:000247650600020
J	Ikegami, A; Yoshimura, N; Motohashi, K; Takahashi, S; Romano, PGN; Hisabori, T; Takamiya, K; Masuda, T				Ikegami, Akinori; Yoshimura, Naho; Motohashi, Ken; Takahashi, Shigekazu; Romano, Patrick G. N.; Hisabori, Toru; Takamiya, Ken-ichiro; Masuda, Tatsuru			The CHLI1 subunit of Arabidopsis thaliana magnesium chelatase is a target protein of the chloroplast thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING CUCUMBER CHLOROPLASTS; MG-CHELATASE; ATPASE ACTIVITY; RHODOBACTER-SPHAEROIDES; PLASTIDIAL THIOREDOXINS; CHLOROPHYLL SYNTHESIS; ESCHERICHIA-COLI; EXPRESSION; SYSTEM; ENZYME	Insertion of magnesium into protoporphyrin IX by magnesium chelatase is a key step in the chlorophyll biosynthetic pathway, which takes place in plant chloroplasts. ATP hydrolysis by the CHLI subunit of magnesium chelatase is an essential component of this reaction, and the activity of this enzyme is a primary determinant of the rate of magnesium insertion into the chlorophyll molecule ( tetrapyrrole ring). Higher plant CHLI contains highly conserved cysteine residues and was recently identified as a candidate protein in a proteomic screen of thioredoxin target proteins (Balmer, Y., Koller, A., del Val, G., Manieri, W., Schurmann, P., and Buchanan, B. B.( 2003) Proc. Natl. Acad. Sci. U. S. A. 100,370-375). To study the thioredoxin-dependent regulation of magnesium chelatase, we first investigated the effect of thioredoxin on the ATPase activity of CHLI1, a major isoform of CHLI in Arabidopsis thaliana. The ATPase activity of recombinant CHLI1 was found to be fully inactivated by oxidation and easily recovered by thioredoxin-assisted reduction, suggesting that CHLI1 is a target protein of thioredoxin. Moreover, we identified one crucial disulfide bond located in the C-terminal helical domain of CHLI1 protein, which may regulate the binding of the nucleotide to the N-terminal catalytic domain. The redox state of CHLI was also found to alter in a light-dependent manner in vivo. Moreover, we successfully observed stimulation of the magnesium chelatase activity in isolated chloroplasts by reduction. Our findings strongly suggest that chlorophyll biosynthesis is subject to chloroplast biogenesis regulation networks to coordinate them with the photosynthetic pathways in chloroplasts.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; Japan Sci & Technol Corp, ATP Syst Project, Yokohama, Kanagawa 2260026, Japan; Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; Univ Tokyo, Grad Sch Arts & Sci, Tokyo 153, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; University of Tokyo	Masuda, T (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan.	ctmasuda@mail.ecc.u-tokyo.ac.jp	Masuda, Tatsuru/E-7942-2013; Motohashi, Ken/I-4970-2019; Hisabori, Toru/E-5205-2014	Masuda, Tatsuru/0000-0002-1585-5832; Motohashi, Ken/0000-0002-8414-2836; Hisabori, Toru/0000-0003-2046-0277				Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; FUESLER T P, 1984, Plant Physiology (Rockville), V74, P928; FUESLER TP, 1984, PLANT PHYSIOL, V75, P662, DOI 10.1104/pp.75.3.662; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; Gibson LCD, 1996, PLANT PHYSIOL, V111, P61, DOI 10.1104/pp.111.1.61; GLAZER AN, 1975, CHEM MODIFICATION PR, P21; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; Hosoya-Matsuda N, 2005, J BIOL CHEM, V280, P840, DOI 10.1074/jbc.M411493200; Jensen PE, 2000, BIOCHEM J, V352, P435, DOI 10.1042/0264-6021:3520435; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1996, MOL GEN GENET, V250, P383; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; KONCZ C, 1990, EMBO J, V9, P1337, DOI 10.1002/j.1460-2075.1990.tb08248.x; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; Motohashi K, 1997, FEBS LETT, V412, P633, DOI 10.1016/S0014-5793(97)00847-8; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; Nakayama M, 1998, PLANT CELL PHYSIOL, V39, P275, DOI 10.1093/oxfordjournals.pcp.a029368; NAKAYAMA M, 1995, BIOCHEM BIOPH RES CO, V215, P422, DOI 10.1006/bbrc.1995.2481; Neuwald AF, 1999, GENOME RES, V9, P27; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Reid JD, 2003, BIOCHEMISTRY-US, V42, P6912, DOI 10.1021/bi034082q; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Rissler HM, 2002, PLANT PHYSIOL, V128, P770, DOI [10.1104/pp.010625, 10.1104/pp0010625]; Schurmann P, 2000, ANNU REV PLANT PHYS, V51, P371, DOI 10.1146/annurev.arplant.51.1.371; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; WALKER CJ, 1991, P NATL ACAD SCI USA, V88, P5789, DOI 10.1073/pnas.88.13.5789; WALKER CJ, 1991, PLANT PHYSIOL, V95, P1189, DOI 10.1104/pp.95.4.1189; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x; Yano H, 2001, P NATL ACAD SCI USA, V98, P4794, DOI 10.1073/pnas.071041998	45	109	116	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19282	19291		10.1074/jbc.M703324200	http://dx.doi.org/10.1074/jbc.M703324200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17472958	hybrid			2022-12-27	WOS:000247650600003
J	Barlic, J; Zhang, Y; Murphy, PM				Barlic, Jana; Zhang, Yuan; Murphy, Philip M.			Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNF alpha-NF kappa B-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FRACTALKINE RECEPTOR CX(3)CR1; AMERICAN-HEART-ASSOCIATION; NECROSIS-FACTOR-ALPHA; GENETIC RISK-FACTOR; OXIDIZED LDL; ENDOTHELIAL-CELLS; ATHEROSCLEROTIC LESIONS; HISTOLOGICAL CLASSIFICATION; MOLECULE EXPRESSION	Recent genetic evidence has implicated the adhesive chemokine CX3CL1 and its leukocyte receptor CX3CR1 in atherosclerosis. We previously proposed a mechanism involving foam cell anchorage to vascular smooth muscle cells because: 1) CX3CL1 and CX3CR1 are expressed by both cell types in mouse and human atherosclerotic lesions; 2) foam cells are reduced in lesions in cx3cr1(-/-) apoE(-/-) mice; and 3) proatherogenic lipids ( oxidized low density lipoprotein [oxLDL] and oxidized linoleic acid derivatives) induce adhesion of primary human macrophages to primary human coronary artery smooth muscle cells (CASMCs) in vitro in a macrophage CX3CR1-dependent manner. Here we analyze this concept further by testing whether atherogenic lipids regulate expression and function of CX3CL1 and CX3CR1 on CASMCs. We found that both oxLDL and oxidized linoleic acid derivatives indirectly up-regulated CASMC CX3CL1 at both the protein and mRNA levels through an autocrine feedback loop involving tumor necrosis factor alpha production and NF-kappa B signaling. Oxidized lipids also up-regulated CASMC CX3CR1 but through a different mechanism. Oxidized lipid stimulation also increased adhesion of macrophages to CASMCs when CASMCs were stimulated prior to assay, and a synergistic pro-adhesive effect was observed when both cell types were prestimulated. Selective inhibition with a CX3CL1-specific blocking antibody indicated that adhesion was strongly CASMC CX3CL1-dependent. These findings support the hypothesis that CX3CR1 and CX3CL1 mediate heterotypic anchorage of foam cells to CASMCs in the context of atherosclerosis and suggest that this chemokine/chemokine receptor pair may be considered as a pro-inflammatory target for therapeutic intervention in atherosclerotic cardiovascular disease.	NIH, NIAID, Mol Signalling Sect, Lab Mol Immunol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Murphy, PM (corresponding author), NIH, Bldg 10,Rm 11N113,9000 Rockville Pike, Bethesda, MD 20892 USA.	pmm@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000615, ZIAAI000615] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amberger A, 1997, CELL STRESS CHAPERON, V2, P94, DOI 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2; Barlic J, 2006, CIRCULATION, V114, P807, DOI 10.1161/CIRCULATIONAHA.105.602359; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Damas JK, 2005, ARTERIOSCL THROM VAS, V25, P2567, DOI 10.1161/01.ATV.0000190672.36490.7b; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Dwivedi A, 2001, BIOCHEM BIOPH RES CO, V284, P239, DOI 10.1006/bbrc.2001.4955; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Ghilardi G, 2004, STROKE, V35, P1276, DOI 10.1161/01.STR.0000128528.56009.d4; GLAVIND J, 1951, EXPERIENTIA, V7, P464, DOI 10.1007/BF02168696; Han KH, 2000, J CLIN INVEST, V106, P793, DOI 10.1172/JCI10052; HARLAND WA, 1973, BIOCHIM BIOPHYS ACTA, V316, P378, DOI 10.1016/0005-2760(73)90076-3; Heermeier K, 2001, J AM SOC NEPHROL, V12, P456, DOI 10.1681/ASN.V123456; Holm T, 2003, J THROMB HAEMOST, V1, P257, DOI 10.1046/j.1538-7836.2003.00065.x; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Imaizumi Tadaatsu, 2004, J Atheroscler Thromb, V11, P15; Jira W, 1998, CHEM PHYS LIPIDS, V91, P1, DOI 10.1016/S0009-3084(97)00095-9; Lei ZB, 2002, CARDIOVASC RES, V53, P524, DOI 10.1016/S0008-6363(01)00491-6; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Ludwig A, 2002, J IMMUNOL, V168, P604, DOI 10.4049/jimmunol.168.2.604; MacKenzie CJ, 2007, CELL SIGNAL, V19, P75, DOI 10.1016/j.cellsig.2006.06.001; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Murphy PM, 2002, PHARMACOL REV, V54, P227, DOI 10.1124/pr.54.2.227; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Ollivier W, 2003, CYTOKINE, V21, P303, DOI 10.1016/S1043-4666(03)00112-1; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schecter AD, 2003, MICROCIRCULATION, V10, P265, DOI 10.1038/sj.mn.7800192; Sizemore N, 2004, P NATL ACAD SCI USA, V101, P7994, DOI 10.1073/pnas.0401593101; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; STARY HC, 1992, VIRCHOWS ARCH A, V421, P277, DOI 10.1007/BF01660974; Takei A, 2001, ATHEROSCLEROSIS, V154, P79, DOI 10.1016/S0021-9150(00)00465-2; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Tobe M, 2003, BIOORGAN MED CHEM, V11, P609, DOI 10.1016/S0968-0896(02)00338-3; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Voisard R, 2001, BMC Mol Biol, V2, P7, DOI 10.1186/1471-2199-2-7; Voisard R, 1998, CORONARY ARTERY DIS, V9, P737, DOI 10.1097/00019501-199809110-00006; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; Yeh M, 2001, ARTERIOSCL THROM VAS, V21, P1585, DOI 10.1161/hq1001.097027; Zeiffer U, 2004, CIRC RES, V94, P776, DOI 10.1161/01.RES.0000121105.72718.5C	55	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19167	19176		10.1074/jbc.M701642200	http://dx.doi.org/10.1074/jbc.M701642200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17456471	hybrid			2022-12-27	WOS:000247475300058
J	Brusselmans, K; Timmermans, L; Van de Sande, T; Van Veldhoven, PP; Guan, GM; Shechter, I; Claessens, F; Verhoeven, G; Swinnen, JV				Brusselmans, Koen; Timmermans, Leen; Van de Sande, Tine; Van Veldhoven, Paul P.; Guan, Guimin; Shechter, Ishaiahu; Claessens, Frank; Verhoeven, Guido; Swinnen, Johannes V.			Squalene synthase, a determinant of raft-associated cholesterol and modulator of cancer cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; LOVASTATIN-INDUCED APOPTOSIS; LIPOGENIC GENE-EXPRESSION; LIPID RAFTS; PROTEIN GERANYLGERANYLATION; TRANSCRIPTIONAL REGULATION; SEQUENCE ELEMENTS; INHIBITION; GROWTH; ANDROGENS	Several cues for cell proliferation, migration, and survival are transmitted through lipid rafts, membrane microdomains enriched in sphingolipids and cholesterol. Cells obtain cholesterol from the circulation but can also synthesize cholesterol de novo through the mevalonate/ isoprenoid pathway. This pathway, however, has several branches and also produces non-sterol isoprenoids. Squalene synthase (SQS) is the enzyme that determines the switch toward sterol biosynthesis. Here we demonstrate that in prostate cancer cells SQS expression is enhanced by androgens, channeling intermediates of the mevalonate/ isoprenoid pathway toward cholesterol synthesis. Interestingly, the resulting increase in de novo synthesis of cholesterol mainly affects the cholesterol content of lipid rafts, while leaving non-raft cholesterol levels unaffected. Conversely, RNA interference-mediated SQS inhibition results in a decrease of raft-associated cholesterol. These data show that SQS activity and de novo cholesterol synthesis are determinants of membrane microdomain-associated cholesterol in cancer cells. Remarkably, SQS knock down also attenuates proliferation and induces death of prostate cancer cells. Similar effects are observed when cancer cells are treated with the chemical SQS inhibitor zaragozic acid A. Importantly, although the anti-tumor effect of statins has previously been attributed to inhibition of protein isoprenylation, the present study shows that specific inhibition of the cholesterol biosynthesis branch of the mevalonate/isoprenoid pathway also induces cancer cell death. These findings significantly underscore the importance of de novo cholesterol synthesis for cancer cell biology and suggest that SQS is a potential novel target for antineoplastic intervention.	LEGENDO, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Div Pharmacol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Div Biochem, B-3000 Louvain, Belgium; Uniformed Serv Univ Hlth Sci, Sch Med, Dept Surg, Bethesda, MD 20814 USA	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Uniformed Services University of the Health Sciences - USA	Swinnen, JV (corresponding author), LEGENDO, Herestr 49,bos 902, B-3000 Louvain, Belgium.	Johan.Swinnen@med.kuleuven.be	, Van Veldhoven Paul/U-6359-2019; Claessens, Frank/M-8565-2016; Swinnen, Johannes V/AAA-2214-2022	, Van Veldhoven Paul/0000-0002-4478-2564; Claessens, Frank/0000-0002-8676-7709; Swinnen, Johannes V/0000-0002-7720-5077				Andela VB, 2003, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/01.blo.0000093846.72468.66; Bang B, 2005, EXP DERMATOL, V14, P266, DOI 10.1111/j.0906-6705.2005.00283.x; BAXTER A, 1992, J BIOL CHEM, V267, P11705; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Bosland M C, 2000, J Natl Cancer Inst Monogr, P39; BROWN MS, 1973, FED PROC, V32, P2168; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Brusselmans K, 2003, INT J CANCER, V106, P856, DOI 10.1002/ijc.11317; De Schrijver E, 2003, CANCER RES, V63, P3799; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Denoyelle C, 2003, CELL SIGNAL, V15, P327, DOI 10.1016/S0898-6568(02)00124-9; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guan GM, 1998, J BIOL CHEM, V273, P12526, DOI 10.1074/jbc.273.20.12526; Guan GM, 1997, J BIOL CHEM, V272, P10295; GUAN GM, 1995, J BIOL CHEM, V270, P21958, DOI 10.1074/jbc.270.37.21958; HAEFFNER EW, 1984, CANCER RES, V44, P2668; Hager MH, 2006, CURR OPIN CLIN NUTR, V9, P379, DOI 10.1097/01.mco.0000232896.66791.62; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heemers H, 2001, MOL ENDOCRINOL, V15, P1817, DOI 10.1210/me.15.10.1817; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Khanzada UK, 2006, ONCOGENE, V25, P877, DOI 10.1038/sj.onc.1209117; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Marcelli M, 1998, CANCER RES, V58, P76; Marques RB, 2005, INT J CANCER, V117, P221, DOI 10.1002/ijc.21201; Muck AO, 2004, INT J CLIN PHARM TH, V42, P695; PEREZSALA D, 1994, BIOCHEM BIOPH RES CO, V199, P1209, DOI 10.1006/bbrc.1994.1359; Sato R, 1995, CELL STRUCT FUNCT, V20, P421, DOI 10.1247/csf.20.421; Sebti SM, 2005, CANCER CELL, V7, P297, DOI 10.1016/j.ccr.2005.04.005; SHECHTER I, 1992, J BIOL CHEM, V267, P8628; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPECTOR AA, 1985, J LIPID RES, V26, P1015; SUMI S, 1992, GASTROENTEROLOGY, V103, P982, DOI 10.1016/0016-5085(92)90032-T; Swinnen JV, 2004, J STEROID BIOCHEM, V92, P273, DOI 10.1016/j.jsbmb.2004.10.013; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Swinnen JV, 1996, ENDOCRINOLOGY, V137, P4468, DOI 10.1210/en.137.10.4468; Swinnen JV, 1997, CANCER RES, V57, P1086; Tansey TR, 2000, BBA-MOL CELL BIOL L, V1529, P49, DOI 10.1016/S1388-1981(00)00137-2; Ukomadu C, 2003, J BIOL CHEM, V278, P43586, DOI 10.1074/jbc.M307194200; Willard NR, 2002, CELL MOL LIFE SCI, V59, P1771, DOI 10.1007/PL00012505; Xia Z, 2001, LEUKEMIA, V15, P1398, DOI 10.1038/sj.leu.2402196; Zhong WB, 2003, ENDOCRINOLOGY, V144, P3852, DOI 10.1210/en.2003-0098; Zhuang LY, 2005, J CLIN INVEST, V115, P959	49	77	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18777	18785		10.1074/jbc.M611763200	http://dx.doi.org/10.1074/jbc.M611763200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17483544	hybrid			2022-12-27	WOS:000247475300016
J	Lundberg, P; Allison, SJ; Lee, NJ; Baldock, PA; Brouard, N; Rost, S; Enriquez, RF; Sainsbury, A; Lamghari, M; Simmons, P; Eisman, JA; Gardiner, EM; Herzog, H				Lundberg, Pernilla; Allison, Susan J.; Lee, Nicola J.; Baldock, Paul A.; Brouard, Nathalie; Rost, Stephanie; Enriquez, Ronaldo F.; Sainsbury, Amanda; Lamghari, Meriem; Simmons, Paul; Eisman, John A.; Gardiner, Edith M.; Herzog, Herbert			Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; MOUSE CALVARIAL OSTEOBLASTS; BETA-ADRENERGIC RECEPTORS; MARROW STROMAL CELLS; GENE-RELATED PEPTIDE; NEUROPEPTIDE-Y; TYROSINE-HYDROXYLASE; OSTEOGENIC CELLS; MESSENGER-RNAS; SUBSTANCE-P	Germ line or hypothalamus-specific deletion of Y2 receptors in mice results in a doubling of trabecular bone volume. However, the specific mechanism by which deletion of Y2 receptors increases bone mass has not yet been identified. Here we show that cultured adherent bone marrow stromal cells from Y2(-/-) mice also demonstrate increased mineralization in vitro. Isolation of two populations of progenitor cell types, an immature mesenchymal stem cell population and a more highly differentiated population of progenitor cells, revealed a greater number of the progenitor cells within the bone of Y2(-/-) mice. Analysis of Y receptor transcripts in cultured stromal cells from wild-type mice revealed high levels of Y1 but not Y2, Y4, Y5, or y6 receptor mRNA. Interestingly, germ line Y2 receptor deletion causes Y1 receptor down-regulation in stromal cells and bone tissue possibly due to the lack of feedback inhibition of NPY release and subsequent overstimulation of Y1 receptors. Furthermore, deletion of Y1 receptors resulted in increased bone mineral density in mice. Together, these findings indicate that the greater number of mesenchymal progenitors and the altered Y1 receptor expression within bone cells in the absence of Y2 receptors are a likely mechanism for the greater bone mineralization in vivo and in vitro, opening up potential new treatment avenues for osteoporosis.	St Vincents Hosp, Garvan Inst Med Res, Neurosci Res Program, Darlinghurst, NSW 2010, Australia; St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Res Program, Darlinghurst, NSW 2010, Australia; Peter MacCallum Canc Inst, Stem Cell Res Lab, Melbourne, Vic 8006, Australia; Univ Queensland, Princess Alexandra Hosp, Diamantina, Brisbane, Qld 4102, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Peter Maccallum Cancer Center; University of Queensland	Lundberg, P (corresponding author), Umea Univ, Dept Odontol, Sect Oral Cell Biol, S-90187 Umea, Sweden.	pernilla.lundberg@odont.umu.se; h.herzog@garvan.org.au	Lamghari, Meriem/K-2159-2013; Baldock, Paul/B-3840-2012; Herzog, Herbert/B-8294-2008; /E-2900-2010; /B-2038-2013; Salis, Amanda/A-3187-2011; Eisman, John A/C-2886-2014	Lamghari, Meriem/0000-0002-2500-4548; /0000-0001-7766-6095; Salis, Amanda/0000-0001-9176-1574; , Herbert/0000-0002-1713-1029				AHMED M, 1994, REGUL PEPTIDES, V51, P179, DOI 10.1016/0167-0115(94)90063-9; AHMED M, 1993, SPINE, V18, P268, DOI 10.1097/00007632-199302000-00016; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; BERESFORD JN, 1992, J CELL SCI, V102, P341; BJURHOLM A, 1991, INT ORTHOP, V15, P325; BJURHOLM A, 1992, J BONE MINER RES, V7, P1011; BJURHOLM A, 1988, J AUTONOM NERV SYST, V25, P119, DOI 10.1016/0165-1838(88)90016-1; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Cornish J, 1999, J BONE MINER RES, V14, P1302, DOI 10.1359/jbmr.1999.14.8.1302; Denes A, 2005, NEUROSCIENCE, V134, P947, DOI 10.1016/j.neuroscience.2005.03.060; ERICSSON A, 1987, P NATL ACAD SCI USA, V84, P5585, DOI 10.1073/pnas.84.16.5585; Goto T, 1998, CELL TISSUE RES, V293, P87, DOI 10.1007/s004410051100; HILL EL, 1991, NEUROSCIENCE, V44, P747, DOI 10.1016/0306-4522(91)90094-5; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kellenberger S, 1998, BONE, V22, P471, DOI 10.1016/S8756-3282(98)00026-X; King PJ, 2000, EUR J PHARMACOL, V396, pR1, DOI 10.1016/S0014-2999(00)00230-2; Kitano Y, 2000, EXP HEMATOL, V28, P1460, DOI 10.1016/S0301-472X(00)00551-8; Lin S, 2005, NEUROPEPTIDES, V39, P21, DOI 10.1016/j.npep.2004.10.002; LINDBLAD BE, 1994, ACTA ORTHOP SCAND, V65, P629, DOI 10.3109/17453679408994619; Lundberg P, 1999, REGUL PEPTIDES, V85, P47, DOI 10.1016/S0167-0115(99)00069-5; Lundberg P, 2000, BONE, V27, P803, DOI 10.1016/S8756-3282(00)00394-X; Lundberg P, 2001, ENDOCRINOLOGY, V142, P339, DOI 10.1210/en.142.1.339; Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102; MOORE RE, 1993, BONE MINER, V23, P301, DOI 10.1016/S0169-6009(08)80105-5; Mori T, 1999, BIOCHEM BIOPH RES CO, V262, P418, DOI 10.1006/bbrc.1999.1220; MULLINS MW, 1993, REGUL PEPTIDES, V49, P65, DOI 10.1016/0167-0115(93)90385-L; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sainsbury A, 2003, MOL CELL BIOL, V23, P5225, DOI 10.1128/MCB.23.15.5225-5233.2003; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Short B, 2003, ARCH MED RES, V34, P565, DOI 10.1016/j.arcmed.2003.09.007; Sisask G, 1996, J AUTONOM NERV SYST, V59, P27, DOI 10.1016/0165-1838(95)00139-5; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6; VANVLASSELAER P, 1994, BLOOD, V84, P753, DOI 10.1182/blood.V84.3.753.bloodjournal843753; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3	46	114	125	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19082	19091		10.1074/jbc.M609629200	http://dx.doi.org/10.1074/jbc.M609629200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17491022	Green Published, hybrid			2022-12-27	WOS:000247475300050
J	Shukla, K; Kim, J; Blundell, J; Powell, CM				Shukla, Kajal; Kim, James; Blundell, Jacqueline; Powell, Craig M.			Learning-induced glutamate receptor phosphorylation resembles that induced by long term potentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY FRACTION; DEPENDENT PROTEIN-KINASE; SYNAPTIC PLASTICITY; AMPA RECEPTORS; GLUR1 SUBUNIT; MICE LACKING; REGULATORY PHOSPHORYLATION; FIELD POTENTIALS; RAT FOREBRAIN; MUTANT MICE	Long term potentiation and long term depression of synaptic responses in the hippocampus are thought to be critical for certain forms of learning and memory, although until recently it has been difficult to demonstrate that long term potentiation or long term depression occurs during hippocampus-dependent learning. Induction of long term potentiation or long term depression in hippocampal slices in vitro modulates phosphorylation of the alpha-amino-3-hydrozy-5-methylisoxazole-4-propionic acid subtype of glutamate receptor subunit GluR1 at distinct phosphorylation sites. In long term potentiation, GluR1 phosphorylation is increased at the Ca2+/calmodulin-dependent protein kinase and protein kinase C site serine 831, whereas in long term depression, phosphorylation of the protein kinase A site serine 845 is decreased. Indeed, phosphorylation of one or both of these sites is required for long term synaptic plasticity and for certain forms of learning and memory. Here we demonstrate that training in a hippocampus-dependent learning task, contextual fear conditioning is associated with increased phosphorylation of GluR1 at serine 831 in the hippocampal formation. This increased phosphorylation is specific to learning, has a similar time course to that in long term potentiation, and like memory and long term potentiation, is dependent on N-methyl-D- aspartate receptor activation during training. Furthermore, the learning-induced increase in serine 831 phosphorylation is present at synapses and is in heteromeric complexes with the glutamate receptor subunit GluR2. These data indicate that a biochemical correlate of long term potentiation occurs at synapses in receptor complexes in a final, downstream, postsynaptic effector of long term potentiation during learning in vivo, further strengthening the link between long term potentiation and memory.	Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Powell, CM (corresponding author), Univ Texas, SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	craig.powell@utsouthwestern.edu		Powell, Craig/0000-0001-5451-2165	NIMH NIH HHS [K08 MH065975-03, K08 MH065975-04, K08 MH065975, MH65975, K08 MH065975-05] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065975] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Allen PB, 2000, J NEUROSCI, V20, P3537, DOI 10.1523/JNEUROSCI.20-10-03537.2000; Andersen P, 1996, J PHYSIOLOGY-PARIS, V90, P349, DOI 10.1016/S0928-4257(97)87917-X; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BANNERMAN DM, 1994, J NEUROSCI, V14, P7404; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bevilaqua LR, 2005, NEUROSCIENCE, V136, P397, DOI 10.1016/j.neuroscience.2005.08.007; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Bordi F, 1996, NEUROPHARMACOLOGY, V35, P1557, DOI 10.1016/S0028-3908(96)00101-3; Cammarota M, 1998, EUR J NEUROSCI, V10, P2669, DOI 10.1046/j.1460-9568.1998.t01-1-00254.x; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GREEN EJ, 1990, J NEUROSCI, V10, P1455; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 2005, P NATL ACAD SCI USA, V102, P9365, DOI 10.1073/pnas.0503777102; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Hunt CA, 1996, J NEUROSCI, V16, P1380; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jouvenceau A, 2003, EUR J NEUROSCI, V18, P1279, DOI 10.1046/j.1460-9568.2003.02831.x; Jun KS, 1998, LEARN MEMORY, V5, P317; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; Kjoller C, 2000, NEUROCHEM INT, V37, P7, DOI 10.1016/S0197-0186(00)00008-5; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; Mayford M, 1997, CURR BIOL, V7, pR580, DOI 10.1016/S0960-9822(06)00287-9; MCNAUGHTON BL, 1986, J NEUROSCI, V6, P563; Meiri N, 1998, P NATL ACAD SCI USA, V95, P15037, DOI 10.1073/pnas.95.25.15037; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MITSUNO K, 1994, PHYSIOL BEHAV, V55, P633, DOI 10.1016/0031-9384(94)90037-X; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Norman ED, 2000, J NEUROCHEM, V74, P192, DOI 10.1046/j.1471-4159.2000.0740192.x; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Pavlov I, 2002, MOL CELL NEUROSCI, V20, P330, DOI 10.1006/mcne.2002.1104; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; POWELL CM, 1994, J BIOL CHEM, V269, P27958; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Roberson ED, 1996, LEARN MEMORY, V3, P1, DOI 10.1101/lm.3.1.1; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; SHARP PE, 1985, BRAIN RES, V339, P361, DOI 10.1016/0006-8993(85)90105-2; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, COLD SPRING HARB SYM, V57, P527, DOI 10.1101/SQB.1992.057.01.058; Soderling TR, 1996, NEUROCHEM INT, V28, P359, DOI 10.1016/0197-0186(95)00098-4; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sweatt JD, 2001, CURR BIOL, V11, pR391, DOI 10.1016/S0960-9822(01)00216-0; Sweatt JD, 1999, LEARN MEMORY, V6, P399, DOI 10.1101/lm.6.5.399; Sweatt JD, 2003, MECH MEMORY; Thiels E, 2000, J NEUROSCI, V20, P7199; Tonegawa S, 1996, COLD SPRING HARB SYM, V61, P225; Villacres EC, 1998, J NEUROSCI, V18, P3186; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	97	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18100	18107		10.1074/jbc.M702906200	http://dx.doi.org/10.1074/jbc.M702906200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17472959	hybrid, Green Accepted			2022-12-27	WOS:000247302000016
J	Tian, C; Chikayama, E; Tsuboi, Y; Kuromori, T; Shinozaki, K; Kikuchi, J; Hirayama, T				Tian, Chunjie; Chikayama, Eisuke; Tsuboi, Yuuri; Kuromori, Takashi; Shinozaki, Kazuo; Kikuchi, Jun; Hirayama, Takashi			Top-down phenomics of Arabidopsis thaliana - Metabolic profiling by one- and two-dimensional nuclear magnetic resonance spectroscopy and transcriptome analysis of albino mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL GENOMICS; NONMEVALONATE PATHWAY; GENE-EXPRESSION; DRAFT SEQUENCE; NITROGEN; BIOSYNTHESIS; CYTOKININ; REVEALS; SYSTEMS; LEAVES	Elucidating the function of each gene in a genome is important for understanding the whole organism. We previously constructed 4000 disruptant mutants of Arabidopsis by insertion of Ds transposons. Here, we describe a top-down phenomics approach based on metabolic profiling that uses one-dimensional H-1 and two-dimensional H-1, C-13 NMR analyses and transcriptome analysis of albino mutant lines of Arabidopsis. One-dimensional H-1 NMR metabolic fingerprinting revealed global metabolic changes in the albino mutants, notably a decrease in aromatic metabolites and changes in aliphatic metabolites. NMRmeasurements of plants fed with C-13(6)-glucose showed that the albino lines had dramatically different C-13-labeling patterns and increased levels of several (am)ino acids, especially Asn and Gln. Microarray analysis of one of the albino lines revealed a unique expression profile and showed that changes in the expression of genes encoding metabolic enzymes did not correspond with changes in the levels of metabolites. Collectively, these results suggest that albino mutants lose the normal carbon/nitrogen balance, presumably mainly through lack ofphotosynthesis. Our study offers an idea of how much the metabolite network is affected by chloroplast function in plants and shows the effectiveness of NMR-based metabolic analysis for metabolite profiling. On the basis of these findings, we propose that future investigations of plant systems biology combine transcriptomic, metabolomic, and phenomic analyses of gene disruptant lines.	RIKEN, Wako Inst, Lab Environm Mol Biol, Wako, Saitama 351, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan; RIKEN, Plant Sci Ctr, Gene Discovery Res Grp, Yokohama, Kanagawa 230, Japan; CREST, Japan Sci & Technol Agcy, Kawaguchi 3320012, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 464, Japan	RIKEN; Yokohama City University; RIKEN; Japan Science & Technology Agency (JST); Nagoya University	Kikuchi, J (corresponding author), RIKEN, Yokohama Inst, 1-7-22 Suehiro, Yokohama, Kanagawa 2300045, Japan.	kikuchi@psc.riken.jp; hirayama@gsc.riken.jp	HIRAYAMA, Takashi/B-2496-2011; Kuromori, Takashi/G-7862-2013; Kikuchi, Jun/O-4725-2019; Shinozaki, Kazuo/G-4202-2013; Kikuchi, Jun/M-5512-2015	HIRAYAMA, Takashi/0000-0002-3868-2380; Kuromori, Takashi/0000-0003-3232-7262; Kikuchi, Jun/0000-0002-6809-394X; Shinozaki, Kazuo/0000-0002-6317-9867; Kikuchi, Jun/0000-0002-6809-394X				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Alonso JM, 2006, NAT REV GENET, V7, P524, DOI 10.1038/nrg1893; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; Dixon RA, 2006, J AGR FOOD CHEM, V54, P8984, DOI 10.1021/jf061218t; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Fellermeier M, 2001, EUR J BIOCHEM, V268, P6302, DOI 10.1046/j.0014-2956.2001.02585.x; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Fritz C, 2006, PLANT CELL ENVIRON, V29, P2055, DOI 10.1111/j.1365-3040.2006.01580.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glawischnig E, 2001, PLANT PHYSIOL, V125, P1178, DOI 10.1104/pp.125.3.1178; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hsieh MH, 2006, PLANTA, V223, P779, DOI 10.1007/s00425-005-0140-9; Hsieh MH, 2005, PLANT PHYSIOL, V138, P641, DOI 10.1104/pp.104.058735; Hughes TR, 2004, CURR OPIN MICROBIOL, V7, P546, DOI 10.1016/j.mib.2004.08.015; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ishii N, 2005, METABOLOMICS, V1, P29, DOI 10.1007/s11306-005-1105-5; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaiser WM, 2000, PLANTA, V210, P801, DOI 10.1007/s004250050682; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kikuchi J, 2006, BIOTECH AGR FOREST, V57, P93; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; KIKUCHI J, 2006, METABOLOMICS METHODS, P273; Kolbe A, 2006, PLANT PHYSIOL, V141, P412, DOI 10.1104/pp.106.081208; Kuromori T, 2004, PLANT J, V37, P897, DOI 10.1111/j.1365.313X.2004.02009.x; Kuromori T, 2006, PLANT J, V47, P640, DOI 10.1111/j.1365-313X.2006.02808.x; LAM HM, 1995, PLANT CELL, V7, P887, DOI 10.1105/tpc.7.7.887; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Liang YS, 2006, PHYTOCHEMISTRY, V67, P2503, DOI 10.1016/j.phytochem.2006.08.018; Morgenthal K, 2006, BIOSYSTEMS, V83, P108, DOI 10.1016/j.biosystems.2005.05.017; Mori H, 2004, J BIOCHEM MOL BIOL, V37, P83; Muskett PR, 2003, PLANT PHYSIOL, V132, P506, DOI 10.1104/pp.102.016535; Oliver SG, 2006, PHILOS T R SOC B, V361, P477, DOI 10.1098/rstb.2005.1805; Oswald O, 2001, P NATL ACAD SCI USA, V98, P2047, DOI 10.1073/pnas.021449998; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rastogi R, 1997, PLANT MOL BIOL, V34, P465, DOI 10.1023/A:1005842812321; Ratcliffe RG, 2001, ANNU REV PLANT PHYS, V52, P499, DOI 10.1146/annurev.arplant.52.1.499; Ratcliffe RG, 2006, PLANT J, V45, P490, DOI 10.1111/j.1365-313X.2005.02649.x; Roberts JKM, 2000, TRENDS PLANT SCI, V5, P30, DOI 10.1016/S1360-1385(99)01515-0; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakakibara H, 2006, TRENDS PLANT SCI, V11, P440, DOI 10.1016/j.tplants.2006.07.004; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; SEKIYAMA Y, 2007, IN PRESS PHYTOCHEMIS; Sherameti I, 2002, J BIOL CHEM, V277, P46594, DOI 10.1074/jbc.M202924200; Smith D, 1996, PLANT J, V10, P721, DOI 10.1046/j.1365-313X.1996.10040721.x; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Sweetlove LJ, 2003, PLANT PHYSIOL, V132, P420, DOI 10.1104/pp.103.022004; Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; Takei K, 2001, PLANT CELL PHYSIOL, V42, P85, DOI 10.1093/pcp/pce009; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Verbruggen N, 1996, P NATL ACAD SCI USA, V93, P8787, DOI 10.1073/pnas.93.16.8787; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Ward JL, 2003, PHYTOCHEMISTRY, V62, P949, DOI 10.1016/S0031-9422(02)00705-7; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	68	46	51	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18532	18541		10.1074/jbc.M700549200	http://dx.doi.org/10.1074/jbc.M700549200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17468106	hybrid			2022-12-27	WOS:000247302000058
J	Santos, SG; Campbell, EC; Lynch, S; Wong, V; Antoniou, AN; Powis, SJ				Santos, Susana G.; Campbell, Elaine C.; Lynch, Sarah; Wong, Vincent; Antoniou, Antony N.; Powis, Simon J.			Major histocompatibility complex class I-ERp57-tapasin interactions within the peptide-loading complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; DEPENDENT REDUCTASE ERP57; ENDOPLASMIC-RETICULUM; OXIDOREDUCTASE ERP57; HEAVY-CHAIN; CELL-LINE; MOLECULES; TAPASIN; HLA-B27; TAP	The endoplasmic reticulum-located multimolecular peptide-loading complex functions to load optimal peptides onto major histocompatibility complex ( MHC) class I molecules for presentation to CD8(+) T lymphocytes. Two oxidoreductases, ERp57 and protein-disulfide isomerase, are known to be components of the peptide-loading complex. Within the peptide-loading complex ERp57 is normally found disulfide-linked to tapasin, through one of its two thioredoxin-like redox motifs. We describe here a novel trimeric complex that disulfide links together MHC class I heavy chain, ERp57 and tapasin, and that is found in association with the transporter associated with antigen processing peptide transporter. The trimeric complex normally represents a small subset of the total ERp57-tapasin pool but can be significantly increased by altering intracellular oxidizing conditions. Direct mutation of a conserved structural cysteine residue implicates an interaction between ERp57 and the MHC class I peptide-binding groove. Taken together, our studies demonstrate for the first time that ERp57 directly interacts with MHC class I molecules within the peptide-loading complex and suggest that ERp57 and protein-disulfide isomerase act in concert to regulate the redox status of MHC class I during antigen presentation.	Univ St Andrews, Bute Med Sch, St Andrews KY16 9TS, Fife, Scotland; Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England	University of St Andrews; University of Southampton	Powis, SJ (corresponding author), Univ St Andrews, Bute Med Sch, St Andrews KY16 9TS, Fife, Scotland.	sjp10@st-andrews.ac.uk	Santos, Susana G/L-9351-2013	Santos, Susana G/0000-0002-8604-2978; Williams, Sarah/0000-0003-1574-3328; Antoniou, Antony/0000-0002-6536-7781; Powis, Simon/0000-0003-4218-2984				Allen RL, 1999, J IMMUNOL, V162, P5045; Antoniou AN, 2004, J BIOL CHEM, V279, P8895, DOI 10.1074/jbc.M311757200; Antoniou AN, 2003, ANTIOXID REDOX SIGN, V5, P375, DOI 10.1089/152308603768295104; Antoniou AN, 2003, CURR OPIN IMMUNOL, V15, P75, DOI 10.1016/S0952-7915(02)00010-9; Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; Deverson EV, 2001, GENES IMMUN, V2, P48, DOI 10.1038/sj.gene.6363727; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Jessop CE, 2004, BIOCHEM SOC T, V32, P655, DOI 10.1042/BST0320655; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lindquist JA, 2001, FASEB J, V15, P1448, DOI 10.1096/fj.00-0720fje; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; Mear JP, 1999, J IMMUNOL, V163, P6665; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Park B, 2003, J IMMUNOL, V170, P961, DOI 10.4049/jimmunol.170.2.961; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Paulsson KM, 2004, FASEB J, V18, P31, DOI 10.1096/fj.03-0846rev; Paulsson KM, 2001, INT IMMUNOL, V13, P1063, DOI 10.1093/intimm/13.8.1063; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Powis SJ, 1997, EUR J IMMUNOL, V27, P2744, DOI 10.1002/eji.1830271040; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Tran TM, 2004, J IMMUNOL, V172, P5110, DOI 10.4049/jimmunol.172.8.5110; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	32	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17587	17593		10.1074/jbc.M702212200	http://dx.doi.org/10.1074/jbc.M702212200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17459881	hybrid			2022-12-27	WOS:000247084500030
J	Davidson, WS; Thompson, TB				Davidson, W. Sean; Thompson, Thomas B.			The structure of apolipoprotein A-I in high density lipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LIPID-FREE STRUCTURE; C-TERMINAL DOMAIN; APOA-I; ANTIINFLAMMATORY PROPERTIES; CRYSTAL-STRUCTURE; CONFORMATION; HELIX; FLUORESCENCE; ORIENTATION; MODELS		Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Davidson, WS (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA.	Sean.Davidson@UC.edu		Thompson, Thomas/0000-0002-7041-5047; Davidson, William/0000-0003-2756-2989				Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; Curtiss LK, 2000, BIOCHEMISTRY-US, V39, P5712, DOI 10.1021/bi992902m; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Duffy D, 2006, CIRCULATION, V113, P1140, DOI 10.1161/CIRCULATIONAHA.105.593855; Fang YL, 2003, BIOCHEMISTRY-US, V42, P6881, DOI 10.1021/bi034152t; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gorshkova IN, 2006, BIOCHEMISTRY-US, V45, P1242, DOI 10.1021/bi051669r; Groen AK, 2004, ANN MED, V36, P135, DOI 10.1080/07853890310020635; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Gursky O, 2007, PROTEIN PEPTIDE LETT, V14, P171, DOI 10.2174/092986607779816023; JONAS A, 1990, J BIOL CHEM, V265, P22123; Klon AE, 2002, BIOCHEMISTRY-US, V41, P10895, DOI 10.1021/bi020315m; Koppaka V, 1999, J BIOL CHEM, V274, P14541, DOI 10.1074/jbc.274.21.14541; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; LEROY A, 1994, BBA-LIPID LIPID MET, V1212, P285, DOI 10.1016/0005-2760(94)90202-X; Li HH, 2000, J BIOL CHEM, V275, P37048, DOI 10.1074/jbc.M005336200; Li HH, 2002, J BIOL CHEM, V277, P39093, DOI 10.1074/jbc.M206770200; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MISHRA VK, 1994, J BIOL CHEM, V269, P7185; Narayanaswami V, 2004, J BIOL CHEM, V279, P14273, DOI 10.1074/jbc.M313318200; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Panagotopulos SE, 2001, J BIOL CHEM, V276, P42965, DOI 10.1074/jbc.M106462200; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Schneeweis LA, 2005, BIOCHEMISTRY-US, V44, P12525, DOI 10.1021/bi050872j; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Silva RAGD, 2007, J BIOL CHEM, V282, P9713, DOI 10.1074/jbc.M610380200; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; WALD JH, 1990, J BIOL CHEM, V265, P20044; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	52	154	163	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22249	22253		10.1074/jbc.R700014200	http://dx.doi.org/10.1074/jbc.R700014200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17526499	hybrid			2022-12-27	WOS:000248354200002
J	Jones, PM; George, AM				Jones, Peter M.; George, Anthony M.			Nucleotide-dependent allostery within the ABC transporter ATP-binding cassette - A computational study of the MJ0796 dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ACTIVE-SITE; CONFORMATIONAL-CHANGES; DOMAIN MOVEMENTS; MOTOR DOMAIN; PROTEINS; SUBUNIT; ARCHITECTURE	ATP-binding cassette transporters perform energy-dependent transmembrane solute trafficking in all organisms. These proteins often mediate cellular resistance to therapeutic drugs and are involved in a range of human genetic diseases. Enzymological studies have implicated a helical subdomain within the ATP-binding cassette nucleotide-binding domain in coupling ATP hydrolysis to solute transport in the transmembrane domains. Consistent with this, structural and computational analyses have indicated that the helical subdomain undergoes nucleotide-dependent movement relative to the core of the nucleotide-binding domain fold. Here we use theoretical methods to examine the allosteric nucleotide dependence of helical subdomain transitions to further elucidate its role in interactions between the transmembrane and nucleotide-binding domains. Unrestrained 30-ns molecular dynamics simulations of the ATP-bound, ADP-bound, and apo states of the MJ0796 monomer support the idea that interaction of a conserved glutamine residue with the catalytic metal mediates the rotation of the helical subdomain in response to nucleotide binding and hydrolysis. Simulations of the nucleotide-binding domain dimer revealed that ATP hydrolysis induces a large transition of one helical subdomain, resulting in an asymmetric conformation of the dimer not observed previously. A coarse-grained elastic network analysis supports this finding, revealing the existence of corresponding dynamic modes intrinsic to the contact topology of the protein. The implications of these findings for the coupling of ATP hydrolysis to conformational changes in the transmembrane domains required for solute transport are discussed in light of recent whole transporter structures.	Univ Technol Sydney, Fac Sci, Dept Med & Mol Biosci, Broadway, NSW 2007, Australia	University of Technology Sydney	George, AM (corresponding author), Univ Technol Sydney, Fac Sci, Dept Med & Mol Biosci, POB 123, Broadway, NSW 2007, Australia.	tony.george@uts.edu.au		George, Anthony/0000-0003-4691-8960				AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bianchet MA, 1997, J BIOENERG BIOMEMBR, V29, P503, DOI 10.1023/A:1022443209010; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Campbell JD, 2005, FEBS LETT, V579, P4193, DOI 10.1016/j.febslet.2005.06.027; Campbell JD, 2004, BIOPHYS J, V87, P3703, DOI 10.1529/biophysj.104.046870; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kurashima-Ito K, 2006, J BIOMOL NMR, V35, P53, DOI 10.1007/s10858-006-9000-6; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liao JL, 2004, BIOPHYS J, V87, P1369, DOI 10.1529/biophysj.103.038653; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu PQ, 1999, J BIOL CHEM, V274, P18310, DOI 10.1074/jbc.274.26.18310; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Lu WC, 2006, PROTEINS, V62, P152, DOI 10.1002/prot.20743; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mazumder-Shivakumar D, 2004, P NATL ACAD SCI USA, V101, P14379, DOI 10.1073/pnas.0406002101; Ose T, 2004, PROTEINS, V57, P635, DOI 10.1002/prot.20206; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Senior AE, 1998, ACTA PHYSIOL SCAND, V163, P213; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; Wriggers W, 1997, PROTEINS, V29, P1; Yang LW, 2005, BIOINFORMATICS, V21, P2978, DOI 10.1093/bioinformatics/bti469; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	55	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22793	22803		10.1074/jbc.M700809200	http://dx.doi.org/10.1074/jbc.M700809200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17485460	hybrid			2022-12-27	WOS:000248354200057
J	Lee, WS; Choi, KS; Riddell, J; Ip, C; Ghosh, D; Park, JH; Park, YM				Lee, WeonSup; Choi, Kyoung-Soo; Riddell, Jonah; Ip, Clement; Ghosh, Debashis; Park, Jong-Hoon; Park, Young-Mee			Human peroxiredoxin 1 and 2 are not duplicate proteins - The unique presence of Cys(83) in Prx1 underscores the structural and functional differences between Prx1 and Prx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER CELLS; 2-CYS PEROXIREDOXIN; OXIDATIVE STRESS; THIOREDOXIN PEROXIDASE; CRYSTAL-STRUCTURE; SITE CYSTEINE; I EXPRESSION; ANTIOXIDANT; FAMILY; PAG	Human peroxiredoxins 1 and 2, also known as Prx1 and Prx2, are more than 90% homologous in their amino acid sequences. Prx1 and Prx2 are elevated in various cancers and are shown to influence diverse cellular processes. Although their growth regulatory role has traditionally been attributed to the peroxidase activity, the physiological significance of this function is unclear because the proteins are highly susceptible to inactivation by H2O2. A chaperone activity appears to emerge when their peroxidase activity is lost. Structural studies suggest that they may form a homodimer or doughnut-shaped homodecamer. However, little information is available whether human Prx1 and Prx2 are duplicative in structure and function. We noted that Prx1 contains a cysteine (Cys(83)) at the putative dimer-dimer interface, which is absent in Prx2. We studied the role of Cys(83) in regulating the peroxidase and chaperone activities of Prx1, because the redox status of Cys(83) might influence the oligomeric structure and consequently the functions of Prx1. We show that Prx1 is more efficient as a molecular chaperone, whereas Prx2 is better suited as a peroxidase enzyme. Substituting Cys(83) with Ser(83) (Prx1C83S) results in dramatic changes in the structural and functional characteristics of Prx1 in a direction similar to those of Prx2. Here we also report the first crystal structure of human Prx1 and the presence of the Cys(83)-Cys(83) bond at the dimer-dimer interface of decameric Prx1. These findings are consistent with the hypothesis that human Prx1 and Prx2 possess unique functions and regulatory mechanisms and that Cys(83) bestows a distinctive identity to Prx1.	Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Canc Prevent, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Pharmaol & Therapeut, Buffalo, NY 14263 USA; Hauptman Woodward Med Res Inst, Dept Biol Struct, Buffalo, NY 14203 USA; Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Hauptman Woodward Medical Research Institute; Sookmyung Women's University	Park, YM (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	young-mee.park@roswellpark.org			NATIONAL CANCER INSTITUTE [R01CA105500, P30CA016056, R01CA111846, R01CA109480] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY009412, R01EY009412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062794] Funding Source: NIH RePORTER; NCI NIH HHS [CA109480, CA111846, CA16056, CA105500] Funding Source: Medline; NEI NIH HHS [EY09412] Funding Source: Medline; NIGMS NIH HHS [GM62794] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chang JW, 2005, FEBS LETT, V579, P2873, DOI 10.1016/j.febslet.2005.04.028; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Chung YM, 2001, ANTICANCER RES, V21, P1129; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Ghosh D, 2001, J BIOL CHEM, V276, P11159, DOI 10.1074/jbc.M008831200; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; ISHII T, 1993, J BIOL CHEM, V268, P18633; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; KAWAI S, 1994, J BIOCHEM-TOKYO, V115, P641, DOI 10.1093/oxfordjournals.jbchem.a124388; Kim HJ, 2003, CELL BIOL TOXICOL, V19, P285, DOI 10.1023/B:CBTO.0000004952.07979.3d; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Kinnula VL, 2004, FEBS LETT, V569, P1, DOI 10.1016/j.febslet.2004.05.045; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Lee K, 2002, BIOCHEM BIOPH RES CO, V296, P337, DOI 10.1016/S0006-291X(02)00801-X; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lehtonen ST, 2004, INT J CANCER, V111, P514, DOI 10.1002/ijc.20294; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Noh DY, 2001, ANTICANCER RES, V21, P2085; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SH, 2000, CLIN CANCER RES, V6, P4915; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Pasta SY, 2004, MOL VIS, V10, P655; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; Qi YJ, 2005, PROTEOMICS, V5, P2960, DOI 10.1002/pmic.200401175; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Sarafian TA, 1999, J NEUROSCI RES, V56, P206, DOI 10.1002/(SICI)1097-4547(19990415)56:2<206::AID-JNR1>3.0.CO;2-X; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; SHAU HY, 1994, BIOCHEM BIOPH RES CO, V199, P83, DOI 10.1006/bbrc.1994.1197; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; Trujillo M, 2006, J BIOL CHEM, V281, P20555, DOI 10.1074/jbc.M601008200; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1; Yanagawa T, 1999, CANCER LETT, V145, P127, DOI 10.1016/S0304-3835(99)00243-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yoo YD, 2002, EXP MOL MED, V34, P273, DOI 10.1038/emm.2002.38; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	53	116	126	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22011	22022		10.1074/jbc.M610330200	http://dx.doi.org/10.1074/jbc.M610330200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17519234	hybrid			2022-12-27	WOS:000248196800048
J	Lu, JI; Qian, J; Keppler, D; Cardoso, WV				Lue, Jining; Qian, Jun; Keppler, Daniel; Cardoso, Wellington V.			Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT PROTEIN-B; CATHEPSIN-H; CYSTEINE PROTEINASES; EPITHELIAL-CELLS; MICE DEFICIENT; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; INHIBITION; PROTEASES	During lung development, signaling by Fgf10 (fibroblast growth factor 10) and its receptor Fgfr2b is critical for induction of a gene network that controls proliferation, differentiation, and branching of the epithelial tubules. The downstream events triggered by Fgf10-Fgfr2b signaling during this process are still poorly understood. In a global screen for transcriptional targets of Fgf10, we identified Ctsh (cathepsin H), a gene encoding a lysosomal cysteine protease of the papain family, highly up-regulated in the developing lung epithelium. Here we show that among other cathepsin genes present in the lung, Ctsh is the only family member selectively induced by Fgf10 in the lung epithelium. We provide evidence that, during branching morphogenesis, epithelial expression of Ctsh overlaps temporally and spatially with that of Bmp4 (bone morphogenetic protein 4), another target of Fgf10. Moreover, we show that Ctsh controls the availability of mature Bmp4 protein in the embryonic lung and that inhibiting Ctsh activity leads to a marked accumulation of Bmp4 protein and disruption of branching morphogenesis. Tightly controlled levels of Bmp4 signaling are critical for patterning of the distal lung epithelium. Our study suggests a potentially novel posttranscriptional mechanism in which Ctsh rapidly removes Bmp4 from forming buds to limit Bmp4 action. The presence of both Ctsh and Bmp4 or Bmp4 signaling activity in other developing structures, such as the kidney, yolk sac, and choroid plexus, suggests a possible general role of Ctsh in regulating Bmp4 proteolysis in different morphogenetic events.	Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Cellular Biol & Anat, Shreveport, LA 71130 USA; Louisiana State Univ, Hlth Sci Ctr, Sch Med, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Boston University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Cardoso, WV (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 715 Albany St, Boston, MA 02118 USA.	wcardoso@bu.edu	Keppler, Daniel/B-4309-2012	Cardoso, Wellington/0000-0002-2550-3697	NHLBI NIH HHS [R01 HL67129, P01 HL47049] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067129, P01HL047049] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANGLIKER H, 1989, BIOCHEM J, V262, P63, DOI 10.1042/bj2620063; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Buhling F, 2002, DEV DYNAM, V225, P14, DOI 10.1002/dvdy.10134; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Constam DB, 2000, GENE DEV, V14, P1146; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cui YZ, 2001, GENE DEV, V15, P2797; Desai TJ, 2004, DEV BIOL, V273, P402, DOI 10.1016/j.ydbio.2004.04.039; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Flentke GR, 2004, DEV DYNAM, V229, P886, DOI 10.1002/dvdy.10489; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Guttentag S, 2003, AM J RESP CELL MOL, V28, P69, DOI 10.1165/rcmb.2002-0111OC; Hyatt BA, 2002, DEV DYNAM, V225, P153, DOI 10.1002/dvdy.10145; ISHII Y, 1991, J HISTOCHEM CYTOCHEM, V39, P461, DOI 10.1177/39.4.2005374; Jortikka L, 1997, CELL SIGNAL, V9, P47, DOI 10.1016/S0898-6568(96)00094-0; KOMINAMI E, 1988, FEBS LETT, V231, P225, DOI 10.1016/0014-5793(88)80736-1; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Lu J, 2004, DEV BIOL, V273, P418, DOI 10.1016/j.ydbio.2004.05.035; Lu JN, 2005, J BIOL CHEM, V280, P4834, DOI 10.1074/jbc.M410714200; Malpel S, 2000, DEVELOPMENT, V127, P3057; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V260, P712, DOI 10.1016/0003-9861(88)90500-0; Nomura Y, 1999, BIOCHEM BIOPH RES CO, V254, P388, DOI 10.1006/bbrc.1998.9941; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SAN SB, 1986, FEBS LETT, V201, P251; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; SHAW E, 1994, METHOD ENZYMOL, V244, P649; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; VRLJICAK P, 2004, AM J PHYSIOL, V286, pF265; Waghray A, 2002, J BIOL CHEM, V277, P11533, DOI 10.1074/jbc.M109557200; Weaver M, 2000, DEVELOPMENT, V127, P2695; Weaver M, 1999, DEVELOPMENT, V126, P4005; WILCOX D, 1992, BIOCHEM J, V285, P495, DOI 10.1042/bj2850495; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Yayoi Y, 2001, ARCH HISTOL CYTOL, V64, P89, DOI 10.1679/aohc.64.89; Zhang T, 2000, IMMUNOLOGY, V100, P13, DOI 10.1046/j.1365-2567.2000.00000.x; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	55	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22176	22184		10.1074/jbc.M700063200	http://dx.doi.org/10.1074/jbc.M700063200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17500053	hybrid			2022-12-27	WOS:000248196800063
J	Sharma, M; George, AA; Singh, BN; Sahoo, NC; Rao, KVS				Sharma, Manish; George, Anuja A.; Singh, Badri N.; Sahoo, Naresh C.; Rao, Kanury V. S.			Regulation of transcript elongation through cooperative and ordered recruitment of cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; C-TERMINAL DOMAIN; PROXIMAL REGION; PHOSPHORYLATION; ACTIVATION; PROMOTER; GENE	We studied the regulation of murine CD80, a gene whose basal transcriptional status was characterized by the presence of a stalled RNA polymerase II complex on the promoter-proximal region. Stimulus-induced activation of productive elongation involved a complex interplay of regulated events that included a synergy between ordered cofactor recruitment. This cascade of recruitments was initiated through the engagement of transcription factor NF-kappa B, leading to the temporal association of histone acetyltransferases and the consequent selective acetylation of a transcription start site downstream nucleosome. This in turn culminated into the nucleosomal association of Brd4-associated P-TEFb, a protein complex containing kinase specific for serine 2 of Rbp 1, the largest subunit of the carboxyl-terminal domain of RNA polymerase II. The consequent phosphorylation of serine 2 residues in CTD by CDK9 in the P-TEFb complex then facilitated escape of polymerase II into the productive elongation phase. Thus, the cooperative mechanisms that integrate between independent pathways characterize regulation of the elongation step of transcription, thereby providing another level at which specificity of gene regulation can be achieved.	Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rao, KVS (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	kanury@icgeb.res.in	George, Anuja/C-5963-2017; Singh, Badri/P-5848-2015	George, Anuja/0000-0003-2643-6307; Singh, Badri/0000-0002-6100-7092				BORRIELLO F, 1994, J IMMUNOL, V153, P5038; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Donepudi M, 2001, J IMMUNOL, V166, P6491, DOI 10.4049/jimmunol.166.11.6491; George AA, 2006, EMBO J, V25, P811, DOI 10.1038/sj.emboj.7600966; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Marshall RM, 2006, FRONT BIOSCI-LANDMRK, V11, P2598, DOI 10.2741/1994; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schwartz BE, 2003, MOL CELL BIOL, V23, P6876, DOI 10.1128/MCB.23.19.6876-6886.2003; SELVAKUMAR A, 1993, IMMUNOGENETICS, V38, P292, DOI 10.1007/BF00188807; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shilatifard A, 1998, FASEB J, V12, P1437, DOI 10.1096/fasebj.12.14.1437; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7	22	16	18	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20887	20896		10.1074/jbc.M701420200	http://dx.doi.org/10.1074/jbc.M701420200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17535807	hybrid			2022-12-27	WOS:000248047500014
J	Um, JH; Yang, ST; Yamazaki, S; Kang, H; Viollet, B; Foretz, M; Chung, JH				Um, Jee Hyun; Yang, Shutong; Yamazaki, Shin; Kang, Hyeog; Viollet, Benoit; Foretz, Marc; Chung, Jay H.			Activation of 5 '-AMP-activated kinase with diabetes drug metformin induces casein kinase I epsilon (CKI epsilon)-dependent degradation of clock protein mPer2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN GENE-EXPRESSION; PHOSPHORYLATION; FIBROBLASTS; MAMMALS; FAMILY; LIVER; MICE; TAU; CKI	Metformin is one of the most commonly used first line drugs for type II diabetes. Metformin lowers serum glucose levels by activating 5'-AMP-activated kinase (AMPK), which maintains energy homeostasis by directly sensing the AMP/ATP ratio. AMPK plays a central role in food intake and energy metabolism through its activities in central nervous system and peripheral tissues. Since food intake and energy metabolism is synchronized to the light-dark (LD) cycle of the environment, we investigated the possibility that AMPK may affect circadian rhythm. We discovered that the circadian period of Rat-1 fibroblasts treated with metformin was shortened by 1 h. One of the regulators of the period length is casein kinase I epsilon (CKI epsilon), which by phosphorylating and inducing the degradation of the circadian clock component, mPer2, shortens the period length. AMPK phosphorylates Ser-389 of CKI epsilon, resulting in increased CKI epsilon activity and degradation of mPer2. In peripheral tissues, injection of metformin leads to mPer2 degradation and a phase advance in the circadian expression pattern of clock genes in wild-type mice but not in AMPK alpha 2 knock-out mice. We conclude that metformin and AMPK have a previously unrecognized role in regulating the circadian rhythm.	NHLBI, Natl Inst Hlth, Lab Biochem Genet, Bethesda, MD 20892 USA; Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Inst Cochin, Dept Endocrinol Metab & Canc, F-75014 Paris, France; INSERM, U567, F-75014 Paris, France; CNRS, UMR 8104, F-75014 Paris, France; Univ Paris 05, Fac Med Rene Descartes, UM 3, F-75014 Paris, France; Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chung, JH (corresponding author), NHLBI, Natl Inst Hlth, Lab Biochem Genet, Bldg 10,Rm 7D14,10 Ctr Dr, Bethesda, MD 20892 USA.	chungj@nhlbi.nih.gov	Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; kang, hyeog/0000-0001-8935-1103	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002243, ZIAHL002243] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Consoli A, 2004, DIABETES METAB, V30, P509, DOI 10.1016/S1262-3636(07)70148-9; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; GAO G, 1995, BBA-MOL CELL RES, V1266, P73, DOI 10.1016/0167-4889(94)00222-Z; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; JUNIEN JL, 1979, ARCH INT PHARMACOD T, V241, P165; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Keesler GA, 2000, NEUROREPORT, V11, P951, DOI 10.1097/00001756-200004070-00011; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	27	159	164	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20794	20798		10.1074/jbc.C700070200	http://dx.doi.org/10.1074/jbc.C700070200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17525164	hybrid			2022-12-27	WOS:000248047500003
J	Fisher, TS; Lo Surdo, P; Pandit, S; Mattu, M; Santoro, JC; Wisniewski, D; Cummings, RT; Calzetta, A; Cubbon, RM; Fischer, PA; Tarachandani, A; De Francesco, R; Wright, SD; Sparrow, CP; Carfi, A; Sitlani, A				Fisher, Timothy S.; Lo Surdo, Paola; Pandit, Shilpa; Mattu, Marco; Santoro, Joseph C.; Wisniewski, Doug; Cummings, Richard T.; Calzetta, Alessandra; Cubbon, Rose M.; Fischer, Paul A.; Tarachandani, Anil; De Francesco, Raffaele; Wright, Samuel D.; Sparrow, Carl P.; Carfi, Andrea; Sitlani, Ayesha			Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PCSK9 GENE; FAMILIAL HYPERCHOLESTEROLEMIA; MOLECULAR-INTERACTIONS; HUMAN FIBROBLASTS; ADAPTER PROTEIN; PROPROTEIN; MUTATIONS; MICE; CHOLESTEROL	Mutations within PCSK9 (proprotein convertase subtilisin/kexin type 9) are associated with dominant forms of familial hyper- and hypocholesterolemia. Although PCSK9 controls low density lipoprotein (LDL) receptor (LDLR) levels post-transcriptionally, several questions concerning its mode of action remain unanswered. We show that purified PCSK9 protein added to the medium of human endothelial kidney 293, HepG2, and Chinese hamster ovary cell lines decreases cellular LDL uptake in a dose-dependent manner. Using this cell-based assay of PCSK9 activity, we found that the relative potencies of several PCSK9 missense mutants (S127R and D374Y, associated with hypercholesterolemia, and R46L, associated with hypocholesterolemia) correlate with LDL cholesterol levels in humans carrying such mutations. Notably, we found that in vitro wild-type PCSK9 binds LDLR with an similar to 150-fold higher affinity at an acidic endosomal pH (K-D = 4.19 nM) compared with a neutral pH (K-D = 628 nM). We also demonstrate that wild-type PCSK9 and mutants S127R and R46L are internalized by cells to similar levels, whereas D374Y is more efficiently internalized, consistent with their affinities for LDLR at neutral pH. Finally, we show that LDL diminishes PCSK9 binding to LDLR in vitro and partially inhibits the effects of secreted PCSK9 on LDLR degradation in cell culture. Together, the results of our biochemical and cell- based experiments suggest a model in which secreted PCSK9 binds to LDLR and directs the trafficking of LDLR to the lysosomes for degradation.	Dept Cardiovasc Dis, Merck Res Labs, Rahway, NJ 07065 USA; Dept Infect Dis, Merck Res Labs, Rahway, NJ 07065 USA; Dept Target Validat, Merck Res Labs, Rahway, NJ 07065 USA; IRBM, I-00040 Pomezia, Italy	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Sitlani, A (corresponding author), Dept Cardiovasc Dis, Merck Res Labs, Rahway, NJ 07065 USA.	ayesha_sitlani@merck.com	Wisniewski, Douglas/AAT-9198-2021; De Francesco, Raffaele/J-6003-2012	De Francesco, Raffaele/0000-0001-8754-5123				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BASU SK, 1978, J BIOL CHEM, V253, P3852; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cooper MA, 2003, ANAL BIOANAL CHEM, V377, P834, DOI 10.1007/s00216-003-2111-y; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Grozdanov PN, 2006, BIOCHEM CELL BIOL, V84, P80, DOI 10.1139/O05-155; HAVEKES L, 1983, BIOCHEM J, V214, P951, DOI 10.1042/bj2140951; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; Karlsson R, 2004, J MOL RECOGNIT, V17, P151, DOI 10.1002/jmr.660; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; MATHIS G, 1995, CLIN CHEM, V41, P1391; MATHIS G, 1993, CLIN CHEM, V39, P1953; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; MIYAKE Y, 1989, J BIOL CHEM, V264, P16584; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; NIGON F, 1991, J LIPID RES, V32, P1741; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SERDAH N, 2006, BIOL CHEM, V387, P871; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Sun XM, 2005, HUM MOL GENET, V14, P1161, DOI 10.1093/hmg/ddi128; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	46	154	183	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20502	20512		10.1074/jbc.M701634200	http://dx.doi.org/10.1074/jbc.M701634200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17493938	hybrid			2022-12-27	WOS:000247819300053
J	Lin, WJ; Duffy, A; Chen, CY				Lin, Wei-Jye; Duffy, Aaron; Chen, Ching-Yi			Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCESSING BODIES; DECAPPING ENZYME; POLY(A)-BINDING PROTEIN; MAMMALIAN EXOSOME; BINDING PROTEIN; GENE-EXPRESSION; MEDIATED DECAY; GW BODIES; DEGRADATION; TURNOVER	Eukaryotic mRNAs can be degraded in either decapping/5'-to-3' or 3'-to-5' direction after deadenylation. In yeast and mammalian cells, decay factors involved in the 5'-to-3' decay pathway are concentrated in cytoplasmic processing bodies (P bodies). The mechanistic steps and localization of mammalianm RNA decay are still not completely understood. Here, we investigate functions of human mRNA decay enzymes in AU-rich element (ARE)-mediated mRNA decay (AMD) and find that the deadenylase, poly(A) ribonuclease PARN, and enzymes involved in the 5'-to-3' and 3'-to-5' decay pathways are required for AMD. The ARE-containing reporter mRNA accumulates in discrete cytoplasmic granular structures, which are distinct from P bodies and stress granules. These granules consist of poly(A)-specific ribonuclease, exosome subunits, and decay-promoting ARE-binding proteins. Inhibition of AMD increases accumulation of ARE-mRNA in these granules. We refer to these structures as cytoplasmic exosome granules and suggest that some AMD may occur in these granules.	Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Chen, CY (corresponding author), Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	cchen@uab.edu	Lin, Wei-Jye/AGW-1054-2022	Lin, Wei-Jye/0000-0002-6057-7325	NIGMS NIH HHS [GM68758] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068758] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brouwer R, 2001, J BIOL CHEM, V276, P6177, DOI 10.1074/jbc.M007603200; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Murray EL, 2007, MOL CELL BIOL, V27, P2791, DOI 10.1128/MCB.01445-06; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Raijmakers R, 2003, J BIOL CHEM, V278, P30698, DOI 10.1074/jbc.M302488200; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477	46	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19958	19968		10.1074/jbc.M702281200	http://dx.doi.org/10.1074/jbc.M702281200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17470429	hybrid			2022-12-27	WOS:000247650600070
J	Vincent, C; Maridonneau-Parini, I; Le Clainche, C; Gounon, P; Labrousse, A				Vincent, Claire; Maridonneau-Parini, Isabelle; Le Clainche, Christophe; Gounon, Pierre; Labrousse, Arnaud			Activation of p61Hck triggers WASp- and Arp2/3-dependent actin-comet tail biogenesis and accelerates lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT BARBED ENDS; N-WASP; TYROSINE KINASE; PLASMA-MEMBRANE; ENDOSOMAL MEMBRANES; SECRETORY GRANULES; HUMAN MACROPHAGES; ARP2/3 COMPLEX; F-ACTIN; MOTILITY	Secretory lysosomes exist in few cell types, but various mechanisms are involved to ensure their mobilization within the cytoplasm. In phagocytes, lysosome exocytosis is a regulated phenomenon at least in part under the control of the phagocyte-specific and lysosome-associated Src-kinase p61Hck (hematopoietic cell kinase). We show here that p61Hck activation triggered polymerization of actin at the membrane of lysosomes, which resulted in F-actin structures similar to comet tails observed on endocytic vesicles. We correlated this actin-comet biogenesis to a 35% acceleration of p61Hck-lysosomes in cells, which was dependent on actin polymerization and required an intact microtubular network. It was possible to initiate the formation of actin tails on p61Hck-positive lysosomes and on p61Hck-associated latex beads incubated in human phagocyte cytosolic extracts. The in vitro reconstitution on beads indicated that other lysosomal proteins were dispensable in this mechanism. The de novo actin polymerization process was functionally dependent on the kinase activity of Hck, WASp, the Arp2/3 complex, and Cdc42 but not Rac or Rho. Thus, we identified p61Hck as the first lysosomal protein able to recruit the molecular machinery responsible for actin tail formation. Altogether, our results suggest a new mechanism for lysosome motility involving p61Hck, actin-comet tail biogenesis, and the microtubule network.	Inst Pharmacol & Biol Struct, CNRS, UMR5089, F-31077 Toulouse, France; CNRS, Lab Enzymol & Biochem Struct, F-91198 Gif Sur Yvette, France; Fac Sci, Ctr Commun Microscopy, F-06108 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Maridonneau-Parini, I (corresponding author), Inst Pharmacol & Biol Struct, CNRS, UMR5089, 205 Route de Narbonne, F-31077 Toulouse, France.	Isabelle.Maridonneau-Parini@ipbs.fr	Le Clainche, Christophe/A-4782-2015; Maridonneau-Parini, Isabelle/F-1985-2011	Le Clainche, Christophe/0000-0001-5659-677X; Labrousse, Arnaud/0000-0002-6525-6627; Maridonneau-Parini, Isabelle/0000-0003-0189-0976				Astarie-Dequeker C, 2002, J CELL SCI, V115, P81; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Boldogh IR, 2001, P NATL ACAD SCI USA, V98, P3162, DOI 10.1073/pnas.051494698; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; Bossi G, 2002, IMMUNOL REV, V189, P152, DOI 10.1034/j.1600-065X.2002.18913.x; Boyer L, 2006, J CELL BIOL, V173, P809, DOI 10.1083/jcb.200509009; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Carreno S, 2002, J BIOL CHEM, V277, P21007, DOI 10.1074/jbc.M201212200; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cougoule C, 2005, TRAFFIC, V6, P682, DOI 10.1111/j.1600-0854.2005.00307.x; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fehrenbacher KL, 2003, TRENDS CELL BIOL, V13, P472, DOI 10.1016/S0962-8924(03)00174-0; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Goding CR, 2007, INT J BIOCHEM CELL B, V39, P275, DOI 10.1016/j.biocel.2006.10.003; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; GOUNON P, 2002, MOL CELLULAR MICROBI, P531; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Kaksonen M, 2000, J CELL SCI, V113, P4421; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kjeken R, 2004, MOL BIOL CELL, V15, P345, DOI 10.1091/mbc.e03-05-0334; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Ma L, 1998, J CELL BIOL, V140, P1125; MARCHAND JB, 1995, J CELL BIOL, V130, P331, DOI 10.1083/jcb.130.2.331; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Park SJ, 2005, EMBO J, V24, P1557, DOI 10.1038/sj.emboj.7600586; Poincloux R, 2006, EUR J CELL BIOL, V85, P327, DOI 10.1016/j.ejcb.2005.09.012; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Scott MP, 2002, J BIOL CHEM, V277, P28238, DOI 10.1074/jbc.M202783200; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Welch H, 1997, J BIOL CHEM, V272, P102; Zhang FL, 2002, CELL MOTIL CYTOSKEL, V53, P81, DOI 10.1002/cm.10058	51	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19565	19574		10.1074/jbc.M701501200	http://dx.doi.org/10.1074/jbc.M701501200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500055	hybrid			2022-12-27	WOS:000247650600031
J	Yuan, CJ; Sato, M; Lanier, SM; Smrcka, AV				Yuan, Chujun; Sato, Motohiko; Lanier, Stephen M.; Smrcka, Alan V.			Signaling by a non-dissociated complex of G protein beta gamma and alpha subunits stimulated by a receptor-independent activator of G protein signaling, AGS8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; YEAST G-PROTEIN; AMINO-TERMINUS; CELLS; REARRANGEMENT; DETERMINANTS; INHIBITION; MECHANISMS; EFFECTORS; BINDING	Accumulating evidence suggests that heterotrimeric G protein activation may not require G protein subunit dissociation. Results presented here provide evidence for a subunit dissociation-independent mechanism for G protein activation by a receptor-independent activator of G protein signaling, AGS8. AGS8 is a member of the AGS group III family of AGS proteins thought to activate G protein signaling primarily through interactions with G beta gamma subunits. Results are presented demonstrating that AGS8 binds to the effector and alpha subunit binding "hot spot" on G beta gamma yet does not interfere with G alpha subunit binding to G beta gamma or phospholipase C beta 2 activation. AGS8 stimulates activation of phospholipase C beta 2 by heterotrimeric G alpha beta gamma and forms a quaternary complex with G alpha(i1), G beta(1)gamma(2), and phospholipase C beta 2. AGS8 rescued phospholipase C beta binding and regulation by an inactive beta subunit with a mutation in the hot spot (beta(1)(W99A)gamma(2)) that normally prevents binding and activation of phospholipase C beta 2. This demonstrates that, in the presence of AGS8, the hot spot is not used for G beta gamma interactions with phospholipase C beta 2. Mutation of an alternate binding site for phospholipase C beta 2 in the amino- terminal coiled- coil region of G beta gamma prevented AGS8- dependent phospholipase C binding and activation. These data implicate a mechanism for AGS8, and potentially other G beta gamma binding proteins, for directing G beta gamma signaling through alternative effector activation sites on G beta gamma in the absence of subunit dissociation.	Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 236, Japan; Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	University of Rochester; Yokohama City University; University of Rochester; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Smrcka, AV (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Alan_Smrcka@urmc.rochester.edu		Lanier, Stephen/0000-0002-2740-7607	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060286, R01GM053536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM060286, GM053536] Funding Source: Medline; NIMH NIH HHS [MH55391] Funding Source: Medline; NINDS NIH HHS [NS24821] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; DENKER BM, 1992, J BIOL CHEM, V267, P6272; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HARTMAN IVJ, 1999, J BIOL CHEM, V271, P22591; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Klein S, 2000, P NATL ACAD SCI USA, V97, P3219, DOI 10.1073/pnas.050015797; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEBERER E, 1992, EMBO J, V11, P4805, DOI 10.1002/j.1460-2075.1992.tb05586.x; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Levitzki A, 2002, CHEMBIOCHEM, V3, P815, DOI 10.1002/1439-7633(20020902)3:9<815::AID-CBIC815>3.0.CO;2-E; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; NEER EJ, 1988, J BIOL CHEM, V263, P8996; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Ugur O, 2005, MOL PHARMACOL, V68, P720, DOI 10.1124/mol.104.010306; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Yoshikawa DM, 2001, J BIOL CHEM, V276, P11246, DOI 10.1074/jbc.M006073200	39	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19938	19947		10.1074/jbc.M700396200	http://dx.doi.org/10.1074/jbc.M700396200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17446173	hybrid			2022-12-27	WOS:000247650600068
J	Vos, A; Dekker, N; Distel, B; Leunissen, JAM; Hochstenbach, F				Vos, Alina; Dekker, Nick; Distel, Ben; Leunissen, Jack A. M.; Hochstenbach, Frans			Role of the synthase domain of Ags1p in cell wall alpha-glucan biosynthesis in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COLI GLYCOGEN-SYNTHASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; BACTERIAL GLYCOGEN; SCHIZOSACCHAROMYCES-POMBE; ASPERGILLUS-FUMIGATUS; PHYLOGENETIC TREES; CRYSTAL-STRUCTURE; CHITIN SYNTHASE	The cell wall is important for maintenance of the structural integrity and morphology of fungal cells. Besides beta-glucan and chitin, alpha-glucan is a major polysaccharide in the cell wall of many fungi. In the fission yeast Schizosaccharomyces pombe, cell wall alpha-glucan is an essential component, consisting mainly of (1,3)-alpha-glucan with similar to 10% (1,4)-linked alpha-glucose residues. The multidomain protein Ags1p is required for alpha-glucan biosynthesis and is conserved among cell wall alpha-glucan-containing fungi. One of its domains shares amino acid sequence motifs with (1,4)-alpha-glucan synthases such as bacterial glycogen synthases and plant starch synthases. Whether Ags1p is involved in the synthesis of the (1,4)-alpha-glucan constituent of cell wall alpha-glucan had remained unclear. Here, we show that overexpression of Ags1p in S. pombe cells results in accumulation of (1,4)-alpha-glucan. To determine whether the synthase domain of Ags1p is responsible for this activity, we overexpressed Ags1p-E1526A, which carries a mutation in a putative catalytic residue of the synthase domain, but observed no accumulation of (1,4)-alpha-glucan. Compared with wild-type Ags1p, this mutant Ags1p showed a markedly reduced ability to complement the cell lysis phenotype of the temperature-sensitive ags1-1 mutant. Therefore, we conclude that, in S. pombe, the production of (1,4)-alpha-glucan by the synthase domain of Ags1p is important for the biosynthesis of cell wall alpha-glucan.	Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; Univ Wageningen & Res Ctr, Lab Bioinformat, NL-6700 ET Wageningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Wageningen University & Research	Hochstenbach, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	f.hochstenbach@amc.uva.nl	Hochstenbach, Frans/B-5232-2008					Alako BTF, 2006, NUCLEIC ACIDS RES, V34, pW104, DOI 10.1093/nar/gkl171; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BAILEY JM, 1961, J BIOL CHEM, V236, P969; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Beauvais A, 2005, APPL ENVIRON MICROB, V71, P1531, DOI 10.1128/AEM.71.3.1531-1538.2005; BULAWA CE, 1986, CELL, V46, P213, DOI 10.1016/0092-8674(86)90738-5; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; CHENG C, 1995, MOL CELL BIOL, V15, P6632; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Cid E, 2002, FEBS LETT, V528, P5, DOI 10.1016/S0014-5793(02)03313-6; Cos T, 1998, EUR J BIOCHEM, V256, P419, DOI 10.1046/j.1432-1327.1998.2560419.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Dekker N, 2006, FEBS LETT, V580, P3099, DOI 10.1016/j.febslet.2006.04.061; Dijkgraaf GJP, 2002, YEAST, V19, P671, DOI 10.1002/yea.866; Felsenstein J., 2002, PHYLIP PHYLOGENY INF; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FOX J, 1976, BIOCHEMISTRY-US, V15, P849, DOI 10.1021/bi00649a019; FURUKAWA K, 1993, J BIOL CHEM, V268, P23837; FURUKAWA K, 1994, J BIOL CHEM, V269, P868; GRUN CH, 2004, GLYCOBIOLOGY, V15, P1; Hochstenbach F, 1998, P NATL ACAD SCI USA, V95, P9161, DOI 10.1073/pnas.95.16.9161; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAMES PG, 1990, CARBOHYD RES, V198, P23, DOI 10.1016/0008-6215(90)84273-W; JOHNSTON IR, 1965, BIOCHEM J, V96, P659, DOI 10.1042/bj0960659; Kartsonis NA, 2003, DRUG RESIST UPDATE, V6, P197, DOI 10.1016/S1368-7646(03)00064-5; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Lomako J, 2004, BBA-GEN SUBJECTS, V1673, P45, DOI 10.1016/j.bbagen.2004.03.017; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PALUMBO G, 1987, LIPIDS, V22, P201, DOI 10.1007/BF02537303; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ugalde JE, 2003, P NATL ACAD SCI USA, V100, P10659, DOI 10.1073/pnas.1534787100; Yep A, 2004, J BIOL CHEM, V279, P8359, DOI 10.1074/jbc.M312686200	48	19	21	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18969	18979		10.1074/jbc.M605147200	http://dx.doi.org/10.1074/jbc.M605147200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17472966	hybrid			2022-12-27	WOS:000247475300039
J	Liu, JY; Seibold, SA; Rieke, CJ; Song, I; Cukier, RI; Smith, WL				Liu, Jiayan; Seibold, Steve A.; Rieke, Caroline J.; Song, Inseok; Cukier, Robert I.; Smith, William L.			Prostaglandin endoperoxide H synthases - Peroxidase hydroperoxide specificity and cyclooxygenase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; POLYUNSATURATED FATTY-ACIDS; MANGANO PROTOPORPHYRIN-IX; SITE-DIRECTED MUTAGENESIS; HIGHER OXIDATION-STATES; COMPOUND-I; SUBCELLULAR-LOCALIZATION; PRODUCTIVE CONFORMATION; HORSERADISH-PEROXIDASE; INACTIVATION KINETICS	The cyclooxygenase (COX) activity of prostaglandin endoperoxide H synthases (PGHSs) converts arachidonic acid and O-2 to prostaglandin G(2) (PGG(2)). PGHS peroxidase (POX) activity reduces PGG(2) to PGH(2). The first step in POX catalysis is formation of an oxyferryl heme radical cation (Compound I), which undergoes intramolecular electron transfer forming Intermediate II having an oxyferryl heme and a Tyr-385 radical required for COX catalysis. PGHS POX catalyzes heterolytic cleavage of primary and secondary hydroperoxides much more readily than H2O2, but the basis for this specificity has been unresolved. Several large amino acids form a hydrophobic "dome" over part of the heme, but when these residues were mutated to alanines there was little effect on Compound I formation from H2O2 or 15-hydroperoxyeicosatetraenoic acid, a surrogate substrate for PGG(2). Ab initio calculations of heterolytic bond dissociation energies of the peroxyl groups of small peroxides indicated that they are almost the same. Molecular Dynamics simulations suggest that PGG(2) binds the POX site through a peroxyl-iron bond, a hydrogen bond with His-207 and van der Waals interactions involving methylene groups adjoining the carbon bearing the peroxyl group and the protoporphyrin IX. We speculate that these latter interactions, which are not possible with H2O2, are major contributors to PGHS POX specificity. The distal Gln-203 four residues removed from His-207 have been thought to be essential for Compound I formation. However, Q203V PGHS-1 and PGHS-2 mutants catalyzed heterolytic cleavage of peroxides and exhibited native COX activity. PGHSs are homodimers with each monomer having a POX site and COX site. Cross-talk occurs between the COX sites of adjoining monomers. However, no cross-talk between the POX and COX sites of monomers was detected in a PGHS-2 heterodimer comprised of a Q203R monomer having an inactive POX site and a G533A monomer with an inactive COX site.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Michigan State University; Michigan State University; University of Michigan System; University of Michigan	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 Med Sci Res Bldg III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@umich.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM68848] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI S, 1993, BIOCHEMISTRY-US, V32, P241, DOI 10.1021/bi00052a031; BACH RD, 1994, J AM CHEM SOC, V116, P5379, DOI 10.1021/ja00091a049; Bakovic M, 1996, J BIOL CHEM, V271, P2048, DOI 10.1074/jbc.271.4.2048; BENECKY MJ, 1993, BIOCHEMISTRY-US, V32, P11929, DOI 10.1021/bi00095a024; BRASH AR, 1991, J BIOL CHEM, V266, P22926; CAPDEVILA JH, 1995, BIOCHEMISTRY-US, V34, P3325, DOI 10.1021/bi00010a023; Case DA, 2002, AMBER SIMULATION SOF; Chen W, 1999, J BIOL CHEM, V274, P20301, DOI 10.1074/jbc.274.29.20301; Chubb AJ, 2006, BIOCHEMISTRY-US, V45, P811, DOI 10.1021/bi051973k; Cremer D., 1983, CHEM PEROXIDES; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; DEGRAY JA, 1992, J BIOL CHEM, V267, P23583; DEMONTELLANO PO, 1995, CYTOCHROME P450 STRU, P49; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; DIX TA, 1985, J BIOL CHEM, V260, P5351; ERMAN JE, 1989, BIOCHEMISTRY-US, V28, P7992, DOI 10.1021/bi00446a004; FRISCH MJ, 2001, GAUSSIAN 98; Girotti AW, 1998, J LIPID RES, V39, P1529; GRAFF G, 1982, METHOD ENZYMOL, V86, P386; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; HEMLER ME, 1978, BIOCHEM BIOPH RES CO, V85, P1325, DOI 10.1016/0006-291X(78)91148-8; HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4430, DOI 10.1021/bi00067a036; HSI LC, 1995, BIOCHEM BIOPH RES CO, V207, P652, DOI 10.1006/bbrc.1995.1237; Huyett JE, 1998, INORG CHEM, V37, P1361, DOI 10.1021/ic9703639; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; Kelley SO, 1999, MET IONS BIOL SYST, V36, P211; KULMACZ RJ, 1985, PROSTAGLANDINS, V29, P175, DOI 10.1016/0090-6980(85)90200-X; KULMACZ RJ, 1990, BIOCHEMISTRY-US, V29, P8760, DOI 10.1021/bi00489a037; KULMACZ RJ, 1983, PROSTAGLANDINS, V25, P531, DOI 10.1016/0090-6980(83)90025-4; KULMACZ RJ, 1986, ARCH BIOCHEM BIOPHYS, V249, P273, DOI 10.1016/0003-9861(86)90003-2; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Kulmacz RJ, 2003, PROG LIPID RES, V42, P377, DOI 10.1016/S0163-7827(03)00023-7; Kulmacz RJ, 2005, BIOCHEM BIOPH RES CO, V338, P25, DOI 10.1016/j.bbrc.2005.08.030; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Landino LM, 1997, J BIOL CHEM, V272, P21565, DOI 10.1074/jbc.272.34.21565; Landino LM, 1996, BIOCHEMISTRY-US, V35, P2637, DOI 10.1021/bi952546h; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; Lu GQ, 1999, J BIOL CHEM, V274, P16162, DOI 10.1074/jbc.274.23.16162; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; OHKI S, 1979, J BIOL CHEM, V254, P829; OTTO JC, 1995, ADV PROSTAG THROMB L, V23, P29; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Poulos TL, 1996, J BIOL INORG CHEM, V1, P356, DOI 10.1007/s007750050064; Putter J, 1975, METHOD ENZYMAT AN, P685; REDDY ST, 1994, J BIOL CHEM, V269, P15473; RodriguezLopez JN, 1997, J BIOL CHEM, V272, P5469, DOI 10.1074/jbc.272.9.5469; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; SCHULZ CE, 1984, BIOCHEMISTRY-US, V23, P4743, DOI 10.1021/bi00315a033; Seibold SA, 2000, BIOCHEMISTRY-US, V39, P6616, DOI 10.1021/bi0002333; Seibold SA, 2004, J PHYS CHEM B, V108, P9297, DOI 10.1021/jp049844l; Shitashige M, 1998, BBA-LIPID LIPID MET, V1389, P57, DOI 10.1016/S0005-2760(97)00129-X; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Smith T, 2000, ARCH BIOCHEM BIOPHYS, V375, P195, DOI 10.1006/abbi.1999.1659; SMITH W L, 1981, Progress in Lipid Research, V20, P103, DOI 10.1016/0163-7827(81)90020-5; SMITH WL, 1972, BIOCHEMISTRY-US, V11, P3276, DOI 10.1021/bi00767a024; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3; STRIEDER S, 1992, J BIOL CHEM, V267, P13870; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Swinney DC, 1997, J BIOL CHEM, V272, P12393, DOI 10.1074/jbc.272.19.12393; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; TSAI AL, 1992, J BIOL CHEM, V267, P17753; Tsai AL, 1997, J BIOL CHEM, V272, P8885; Witting PK, 2001, J BIOL CHEM, V276, P16540, DOI 10.1074/jbc.M011707200; Wu G, 1999, J BIOL CHEM, V274, P9231, DOI 10.1074/jbc.274.14.9231; Wu G, 2003, BIOCHEMISTRY-US, V42, P13772, DOI 10.1021/bi035415m; Wu G, 2001, J BIOL CHEM, V276, P19879, DOI 10.1074/jbc.M100628200; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; 2003, MOL OPERATING ENV	81	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18233	18244		10.1074/jbc.M701235200	http://dx.doi.org/10.1074/jbc.M701235200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17462992	hybrid			2022-12-27	WOS:000247302000030
J	Reineke, EL; Liu, H; Lam, M; Liu, Y; Kao, HY				Reineke, Erin L.; Liu, Heng; Lam, Minh; Liu, Yu; Kao, Hung-Ying			Aberrant association of promyelocytic leukemia protein-retinoic acid receptor-alpha with coactivators contributes to its ability to regulate gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PML-RAR-ALPHA; NUCLEAR HORMONE-RECEPTORS; LIGAND-BINDING DOMAIN; TRANSCRIPTIONAL COACTIVATOR; FUSION PROTEIN; PML/RAR-ALPHA; RXR-ALPHA; N-COR; MEDIATED TRANSACTIVATION; T(1517) TRANSLOCATION	The aberrant association of promyelocytic leukemia proteinretinoic acid receptor-alpha (PML-RAR alpha) with corepressor complexes is generally thought to contribute to the ability of PML-RAR alpha to regulate transcription. We report here that PML-RAR alpha acquires aberrant association with coactivators. We show that endogenous PML-RAR alpha interacts with the histone acetyltransferases CBP, p300, and SRC-1 in a hormone-independent manner, an association not seen for RAR alpha. This hormone-independent coactivator binding activity requires an intact ligand-binding domain and the NR box of the coactivators. Confocal microscopy studies demonstrate that exogenous PML-RAR alpha sequesters and colocalizes with coactivators. These observations correlate with the ability of PML-RAR alpha to attenuate the transcription activation of the Notch signaling downstream effector, CBF1, and of the glucocorticoid receptor. This includes attenuation of the glucocorticoid-induced leucine zipper (GILZ) and FLJ25390 target genes of the endogenous glucocorticoid receptor. Furthermore, treatment of NB4 cells with all-trans-retinoic acid, which promotes PML-RAR alpha degradation, resulted in increased activation of GILZ. On the basis of these findings, we propose a model in which the hormone-independent association between PML-RAR alpha and coactivators contributes to its ability to regulate gene expression.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Ctr Comprehens Canc, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu			NCI NIH HHS [P30 CA43703-12, T32 CA059366-11] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA043703, T32CA059366] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Arnould C, 1999, HUM MOL GENET, V8, P1741, DOI 10.1093/hmg/8.9.1741; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Carbone R, 2006, MOL CELL BIOL, V26, P1288, DOI 10.1128/MCB.26.4.1288-1296.2006; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chan IT, 2006, BLOOD, V108, P1708, DOI 10.1182/blood-2006-04-015040; Chattopadhyay A, 2006, ONCOGENE, V25, P2223, DOI 10.1038/sj.onc.1209252; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; DANIEL MT, 1993, BLOOD, V82, P1858; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dong S, 2003, ONCOGENE, V22, P858, DOI 10.1038/sj.onc.1206182; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Hauksdottir H, 2001, CELL GROWTH DIFFER, V12, P85; Hayashi R, 2004, EUR J PHARMACOL, V500, P51, DOI 10.1016/j.ejphar.2004.07.011; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HOLLENBERG SM, 1989, CANCER RES, V49, pS2292; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; JANSEN JH, 1995, P NATL ACAD SCI USA, V92, P7401, DOI 10.1073/pnas.92.16.7401; Jones PL, 2001, J BIOL CHEM, V276, P8807, DOI 10.1074/jbc.C000879200; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2003, J BIOL CHEM, V278, P7366, DOI 10.1074/jbc.M207569200; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; Khan MM, 2004, J BIOL CHEM, V279, P11814, DOI 10.1074/jbc.M312121200; Kogan SC, 2000, BLOOD, V95, P1541, DOI 10.1182/blood.V95.5.1541.005k28_1541_1550; LAVAU C, 1994, LEUKEMIA, V8, P1615; Lengfelder E, 2005, CRIT REV ONCOL HEMAT, V56, P261, DOI 10.1016/j.critrevonc.2004.08.009; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin RJ, 2000, MOL CELL, V5, P821, DOI 10.1016/S1097-2765(00)80322-6; Liu H, 2004, J BIOL CHEM, V279, P45208, DOI 10.1074/jbc.M408033200; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Meani N, 2005, ONCOGENE, V24, P3358, DOI 10.1038/sj.onc.1208498; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Minucci S, 2001, ONCOGENE, V20, P3110, DOI 10.1038/sj.onc.1204336; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Ng APP, 2006, CANCER RES, V66, P9903, DOI 10.1158/0008-5472.CAN-06-0002; ONATE SA, 1995, SCIENCE, V270, P1354; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Raelson JV, 1996, BLOOD, V88, P2826, DOI 10.1182/blood.V88.8.2826.bloodjournal8882826; Redner RL, 1996, BLOOD, V87, P882, DOI 10.1182/blood.V87.3.882.bloodjournal873882; Rego EM, 2006, ONCOGENE, V25, P1974, DOI 10.1038/sj.onc.1209216; ROUSSELOT P, 1994, ONCOGENE, V9, P545; Schulman IG, 1996, MOL CELL BIOL, V16, P3807; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Warrell RP, 1998, JNCI-J NATL CANCER I, V90, P1621, DOI 10.1093/jnci/90.21.1621; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wells RA, 1997, NAT GENET, V17, P109, DOI 10.1038/ng0997-109; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626	63	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18584	18596		10.1074/jbc.M700330200	http://dx.doi.org/10.1074/jbc.M700330200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17475621	hybrid			2022-12-27	WOS:000247302000063
J	Vunta, H; Davis, F; Palempalli, UD; Bhat, D; Arner, RJ; Thompson, JT; Peterson, DG; Reddy, CC; Prabhu, KS				Vunta, Hema; Davis, Faith; Palempalli, Umamaheswari D.; Bhat, Deepa; Arner, Ryan J.; Thompson, Jerry T.; Peterson, Devin G.; Reddy, C. Channa; Prabhu, K. Sandeep			The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta(12,14)-prostaglandin J(2) in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	9th International Symposium on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Related Diseases	2004	San Francisco, CA				NF-KAPPA-B; ACTIVATED RECEPTOR-GAMMA; PROSTATE-CANCER; GENE-TRANSCRIPTION; SERUM SELENIUM; UP-REGULATION; DNA-BINDING; PPAR-GAMMA; SYNTHASE; CELLS	Selenium is an essential micronutrient that suppresses the redox-sensitive transcription factor NF-kappa B-dependent pro-inflammatory gene expression. To understand the molecular mechanisms underlying the anti-inflammatory property of selenium, we examined the activity of a key kinase of the NF-kappa B cascade, I kappa B- kinase beta (IKK beta) subunit, as a function of cellular selenium status in murine primary bone marrow- derived macrophages and RAW264.7 macrophage-like cell line. In vitro kinase assays revealed that selenium supplementation decreased the activity of IKK beta in lipopolysaccharide (LPS)-treated macrophages. Stimulation by LPS of selenium-supplemented macrophages resulted in a time-dependent increase in 15-deoxy-Delta(12,14)- prostaglandin J(2) (15d- PGJ(2)) formation, an endogenous inhibitor of IKK beta activity. Further analysis revealed that inhibition of IKK beta activity in selenium-supplemented cells correlated with the Michael addition product of 15d- (P)GJ(2) with Cys-179 of IKK beta, while the formation of such an adduct was significantly decreased in the selenium-deficient macrophages. In addition, anti-inflammatory activities of selenium were also mediated by the 15d-PGJ(2)-dependent activation of the peroxisome proliferator-activated nuclear receptor-gamma in macrophages. Experiments using specific cyclooxygenase (COX) inhibitors and genetic knockdown approaches indicated that COX-1, and not the COX-2 pathway, was responsible for the increased synthesis of 15dP-GJ(2) in selenium-supplemented macrophages. Taken together, our results suggest that selenium supplementation increases the production of 15d- PGJ(2) as an adaptive response to protect cells against oxidative stress-induced pro-inflammatory gene expression. More specifically, modification of protein thiols by 15d- PGJ(2) represents a previously undescribed code for redox regulation of gene expression by selenium.	Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Prabhu, KS (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, 115 William L Henning Bldg, University Pk, PA 16802 USA.	ksp4@psu.edu	Bhat, Deepa/HIR-7867-2022					Allan CB, 1999, ANNU REV NUTR, V19, P1, DOI 10.1146/annurev.nutr.19.1.1; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bailey ST, 2005, NAT IMMUNOL, V6, P966, DOI 10.1038/ni1005-966; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Breedlove HA, 2006, BREAST CANCER RES TR, V97, P225, DOI 10.1007/s10549-005-9012-z; BURK RF, 1990, PHARMACOL THERAPEUT, V45, P383, DOI 10.1016/0163-7258(90)90073-B; Carcamo JM, 2002, BIOCHEMISTRY-US, V41, P12995, DOI 10.1021/bi0263210; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P1259, DOI 10.1161/01.ATV.0000133192.39901.be; Cole Suzanne B, 2005, Nutr Clin Pract, V20, P662, DOI 10.1177/0115426505020006662; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Foster HD, 2004, MED HYPOTHESES, V62, P549, DOI 10.1016/j.mehy.2003.12.009; Gasparian AV, 2002, MOL CANCER THER, V1, P1079; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hartikainen H, 2005, J TRACE ELEM MED BIO, V18, P309, DOI 10.1016/j.jtemb.2005.02.009; Ikeda Y, 2000, J BIOL CHEM, V275, P33142, DOI 10.1074/jbc.M002319200; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim IY, 1997, P NATL ACAD SCI USA, V94, P12904, DOI 10.1073/pnas.94.24.12904; Klein EA, 2004, ANN NY ACAD SCI, V1031, P234, DOI 10.1196/annals.1331.023; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; Moskovitz J, 2003, P NATL ACAD SCI USA, V100, P7486, DOI 10.1073/pnas.1332607100; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Prabhu KS, 2005, J BIOL CHEM, V280, P19895, DOI 10.1074/jbc.M502621200; PRESTON AM, 1991, PROG FOOD NUTR SCI, V15, P183; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rojas Armando, 2006, Current Vascular Pharmacology, V4, P277, DOI 10.2174/157016106777698441; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rouzer CA, 2005, J LIPID RES, V46, P1027, DOI 10.1194/jlr.M500006-JLR200; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Sonn GA, 2005, PROSTATE CANCER P D, V8, P304, DOI 10.1038/sj.pcan.4500825; Spector A, 2000, J OCUL PHARMACOL TH, V16, P193, DOI 10.1089/jop.2000.16.193; SPEER CP, 1989, MONATSSCHR KINDERH, V137, P390; Tamura T, 2002, METHOD ENZYMOL, V347, P297; Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Vogt TM, 2003, INT J CANCER, V103, P664, DOI 10.1002/ijc.10866; Zamamiri-Davis F, 2002, FREE RADICAL BIO MED, V32, P890, DOI 10.1016/S0891-5849(02)00775-X	46	166	173	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					17964	17973		10.1074/jbc.M703075200	http://dx.doi.org/10.1074/jbc.M703075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	179PK	17439952	hybrid			2022-12-27	WOS:000247302000003
J	Wang, JL; Shen, WH; Jin, YJ; Brandt-Rauf, PW; Yin, YX				Wang, Jianli; Shen, Wen Hong; Jin, Yan J.; Brandt-Rauf, Paul W.; Yin, Yuxin			A molecular link between E2F-1 and the MAPK cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRANSCRIPTION FACTOR; GENE-PRODUCT; CELL-PROLIFERATION; PROTEIN-KINASES; P53; GROWTH; INHIBITION; EXPRESSION; PHOSPHATASES	Transcription factor E2F-1 mediates apoptosis and suppresses tumorigenesis. The mechanisms by which E2F-1 functions in these processes are largely unclear. We report here that E2F-1 acts as a transcriptional regulator of MKP-2 ( MAPK phosphatase-2), a dual specificity protein phosphatase (DUSP4) with stringent substrate specificity for MAPKs. We show that E2F-1 is required for the cellular apoptotic response to oxidative damage. MKP-2 is greatly increased following oxidative stress, and E2F-1 is necessary for that induction. We found that E2F-1 is physically associated with the MKP-2 promoter and can transactivate the promoter of the MKP-2 gene. Specifically, E2F-1 binds to a perfect palindromic motif in the MKP-2 promoter. Finally, we show that this E2F-1/MKP-2 pathway mediates apoptosis under oxidative stress and that MKP-2 suppresses tumor formation in nude mice. Our findings demonstrate that E2F-1 is a transcriptional activator of MKP-2 and that MKP-2 is an essential cell death mediator in the E2F-1 pathway. Characterization of MKP-2 as a cell death mediator may lead to the development of new strategies for cancer treatment.	Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA	Columbia University; Columbia University	Yin, YX (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, New York, NY 10032 USA.	yy151@columbia.edu		SHEN, WEN/0000-0002-5830-6518	NATIONAL CANCER INSTITUTE [R01CA102447] Funding Source: NIH RePORTER; NCI NIH HHS [R0 CA102447] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Connolly EM, 2002, BRIT J CANCER, V87, P231, DOI 10.1038/sj.bjc.6600462; Denchi EL, 2005, EMBO REP, V6, P661, DOI 10.1038/sj.embor.7400452; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Giardina C, 1998, BBA-MOL CELL RES, V1401, P277, DOI 10.1016/S0167-4889(97)00140-7; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; GUAN KL, 1994, CELL SIGNAL, V6, P581, DOI 10.1016/0898-6568(94)90041-8; Harris RE, 1996, EPIDEMIOLOGY, V7, P203, DOI 10.1097/00001648-199603000-00017; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Husain SS, 2001, LIFE SCI, V69, P3045, DOI 10.1016/S0024-3205(01)01411-4; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Kundu N, 2002, CANCER RES, V62, P2343; Lala PK, 1997, INT J CANCER, V73, P371, DOI 10.1002/(SICI)1097-0215(19971104)73:3<371::AID-IJC12>3.0.CO;2-G; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Maiyar AC, 1996, J BIOL CHEM, V271, P12414, DOI 10.1074/jbc.271.21.12414; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Nevins JR, 1997, METHOD ENZYMOL, V283, P205; NEVINS JR, 1992, SCIENCE, V258, P424; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; PAN HC, 1995, GENE DEV, V9, P2157, DOI 10.1101/gad.9.17.2157; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Shen WH, 2004, J BIOL CHEM, V279, P7438, DOI 10.1074/jbc.M310264200; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzuki Y, 1996, IMMUNOLOGY, V87, P396, DOI 10.1046/j.1365-2567.1996.431546.x; Theodosiou A, 2002, GENOME BIOL, V3; WEINBERG RA, 1995, ANN NY ACAD SCI, V758, P331, DOI 10.1111/j.1749-6632.1995.tb24838.x; Weinberg RA, 1996, CELL, V85, P457, DOI 10.1016/S0092-8674(00)81244-1; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; YEE AS, 1987, EMBO J, V6, P2061, DOI 10.1002/j.1460-2075.1987.tb02471.x; Yin YX, 1999, MOL CARCINOGEN, V24, P15, DOI 10.1002/(SICI)1098-2744(199901)24:1<15::AID-MC3>3.3.CO;2-P; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; Zhao RB, 2000, GENE DEV, V14, P981; Zhu JW, 1999, CELL GROWTH DIFFER, V10, P829; ZHU L, 1994, COLD SPRING HARB SYM, V59, P75, DOI 10.1101/SQB.1994.059.01.011	71	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18521	18531		10.1074/jbc.M610538200	http://dx.doi.org/10.1074/jbc.M610538200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452331	hybrid			2022-12-27	WOS:000247302000057
J	Nonaka, M; Ma, BY; Ohtani, M; Yamamoto, A; Murata, M; Totani, K; Ito, Y; Miwa, K; Nogami, W; Kawasaki, N; Kawasaki, T				Nonaka, Motohiro; Ma, Bruce Yong; Ohtani, Misato; Yamamoto, Akitsugu; Murata, Masayuki; Totani, Kiichiro; Ito, Yukishige; Miwa, Keiko; Nogami, Wataru; Kawasaki, Nobuko; Kawasaki, Toshisuke			Subcellular localization and physiological significance of intracellular mannan-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; RAT-LIVER; LECTIN ERGIC-53; QUALITY-CONTROL; HIV TYPE-1; TRANSPORT; RECEPTOR	Mannan-binding protein (MBP) is a C-type mammalian lectin specific for mannose and N-acetylglucosamine. MBP is mainly synthesized in the liver and occurs naturally in two forms, serum MBP (S-MBP) and intracellular MBP (I-MBP). S-MBP activates complement in association with MBP-associated serine proteases via the lectin pathway. Despite our previous study (Mori, K., Kawasaki, T., and Yamashina, I. (1984) Arch. Biochem. Biophys. 232, 223 -233), the subcellular localization of I-MBP and its functional implication have not been clarified yet. Here, as an extension of our previous studies, we have demonstrated that the expression of human MBP cDNA reproduces native MBP differentiation of S-MBP and I-MBP in human hepatoma cells. I-MBP shows distinct accumulation in cytoplasmic granules, and is predominantly localized in the endoplasmic reticulum (ER) and involved in COPII vesicle-mediated ER-to-Golgi transport. However, the subcellular localization of either a mutant (C236S/ C244S) I-MBP, which lacks carbohydrate-binding activity, or the wild-type I-MBP in tunicamycin-treated cells shows an equally diffuse cytoplasmic distribution, suggesting that the unique accumulation of I-MBP in the ER and COPII vesicles is mediated by an N-glycan-lectin interaction. Furthermore, the binding of I-MBP with glycoprotein intermediates occurs in the ER, which is carbohydrate-and pH-dependent, and is affected by glucose-trimmed high-mannose-type oligosaccharides. These results strongly indicate that I-MBP may function as a cargo transport lectin facilitating ER-to-Golgi traffic in glycoprotein quality control.	Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5258577, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; Nagahama Inst Biosci & Technol, Dept Biosci, Shiga 5260829, Japan; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	Ritsumeikan University; Kyoto University; University of Tokyo	Kawasaki, T (corresponding author), Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5258577, Japan.	byma@fc.ritsumei.ac.jp; tkawasak@fc.ritsumei.ac.jp	Ito, Yukishige/M-5119-2014	Ito, Yukishige/0000-0001-6251-7249				Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Fullekrug J, 1999, J CELL SCI, V112, P2813; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Hart ML, 2003, J GEN VIROL, V84, P353, DOI 10.1099/vir.0.18734-0; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; KAWASAKI N, 1983, J BIOCHEM, V94, P937, DOI 10.1093/oxfordjournals.jbchem.a134437; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; Ma BY, 2004, BIOCHEM BIOPH RES CO, V317, P60, DOI 10.1016/j.bbrc.2004.03.012; Ma Y, 1997, J BIOCHEM-TOKYO, V122, P810; Ma Y, 1999, P NATL ACAD SCI USA, V96, P371, DOI 10.1073/pnas.96.2.371; MIZUNO Y, 1981, J BIOL CHEM, V256, P4247; MORI K, 1988, ARCH BIOCHEM BIOPHYS, V264, P647, DOI 10.1016/0003-9861(88)90331-1; MORI K, 1984, ARCH BIOCHEM BIOPHYS, V232, P223, DOI 10.1016/0003-9861(84)90538-1; OKA S, 1988, ARCH BIOCHEM BIOPHYS, V260, P257, DOI 10.1016/0003-9861(88)90448-1; Saifuddin M, 2000, J GEN VIROL, V81, P949, DOI 10.1099/0022-1317-81-4-949; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; Totani K, 2005, ANGEW CHEM INT EDIT, V44, P7950, DOI 10.1002/anie.200502723; Weisz OA, 2003, INT REV CYTOL, V226, P259, DOI 10.1016/S0074-7696(03)01005-2; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; YAMAMOTO A, 1991, CELL STRUCT FUNCT, V16, P419, DOI 10.1247/csf.16.419; Ying HY, 2004, AIDS RES HUM RETROV, V20, P327, DOI 10.1089/088922204322996563	35	22	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17908	17920		10.1074/jbc.M700992200	http://dx.doi.org/10.1074/jbc.M700992200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17442667	hybrid			2022-12-27	WOS:000247084500064
J	Luan, Y; Yu, XP; Xu, K; Ding, B; Yu, J; Huang, Y; Yang, N; Lengyel, P; Di Cesare, PE; Liu, CJ				Luan, Yi; Yu, Xiu-Ping; Xu, Ke; Ding, Bo; Yu, Jin; Huang, Yan; Yang, Ning; Lengyel, Peter; Di Cesare, Paul E.; Liu, Chuan-Ju			The retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the Cbfa1 transcription factor thereby increasing its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; BEATING CARDIAC MYOCYTES; INDUCIBLE 204 GENE; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; MYOBLAST DIFFERENTIATION; OSTEOCALCIN GENE; BETA INTERACTS; INTERFERON; EXPRESSION	Bone formation requires the coordinated activity of numerous proteins including the transcription factor core-binding factor alpha 1 (Cbfa1). Deregulation of Cbfa1 results in metabolic bone diseases including osteoporosis and osteopetrosis. The retinoblastoma protein (pRb) that is required for osteogenesis binds Cbfa1. We reported earlier that the p200 family protein p204, which is known to be involved in the differentiation of skeletal muscle myotubes, cardiac myocytes, and macrophages, also serves as a cofactor of Cbfa1 and promotes osteogenesis. In this study we established that suppression of p204 expression by an adenovirus construct encoding p204 antisense RNA inhibited osteoblast-specific gene activation by Cbfa1 in an osteogenesis assay involving the pluripotent C2C12 mesenchymal cell line. Using protein-protein interaction assays we established that Cbfa1, pRb, and p204 form a ternary complex in which pRb serves as a linker connecting p204 and Cbfa1. Chromatin immunoprecipitation assays revealed the binding of such a p204-pRbCbfa1 transcription factor complex to the promoter of the osteocalcin gene. The pRb requirement of the stimulation of Cbfa1 activity by p204 was established in experiments involving p204 mutants lacking one or two pRb binding (LXCXE) motifs. Such mutants failed to enhance the Cbfa1-dependent transactivation of gene expression as well as osteogenesis. Furthermore, as revealed in reporter gene and in vitro osteogenesis assays p204 synergized with pRb in the stimulation of Cbfa1-dependent gene activation and osteoblast differentiation.	NYU, Med Ctr, Dept Orthoped Surg, New York, NY 10003 USA; Shandong Univ, Sch Med, Inst Pathogen Biol, Shandong 250012, Peoples R China; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med & Cardiol, New Haven, CT 06520 USA; Univ Calif Davis, Med Ctr, Dept Orthoped Surg, Sacramento, CA 95817 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; Shandong University; Yale University; Yale University; University of California System; University of California Davis; New York University	Liu, CJ (corresponding author), NYU, Med Ctr, Dept Orthoped Surg, Rm 1608,HJD,301 E 17th St, New York, NY 10003 USA.	chuanju.liu@med.nyu.edu	Liu, Chuan-ju/AAT-8165-2021	Xu, Ke Kate/0000-0002-2453-4475; liu, chuanju/0000-0002-7181-8032	NIAID NIH HHS [AI-12320] Funding Source: Medline; NIAMS NIH HHS [AR052022, AR050620, R03 AR052022-02, R03 AR052022, R21 AR052676-02, R21 AR052676, R21 AR052676-01A1, R03 AR052022-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012320, R01AI012320, R21AI012320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR052022, R21AR052676] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Abboud SL, 2002, ENDOCRINOLOGY, V143, P1942, DOI 10.1210/en.143.5.1942; Asefa B, 2006, FEBS LETT, V580, P1205, DOI 10.1016/j.febslet.2006.01.032; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; CHOUBEY D, 1992, J CELL BIOL, V116, P1333, DOI 10.1083/jcb.116.6.1333; CHOUBEY D, 1989, J BIOL CHEM, V264, P17182; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Dauffy J, 2006, J LEUKOCYTE BIOL, V79, P173, DOI 10.1189/jlb.0205083; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Ding B, 2006, J BIOL CHEM, V281, P14882, DOI 10.1074/jbc.M511747200; Ding B, 2006, J BIOL CHEM, V281, P14893, DOI 10.1074/jbc.M511748200; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Eliazer S, 2003, MOL CELL BIOL, V23, P482, DOI 10.1128/MCB.23.2.482-492.2003; Gribaudo G, 1999, FEBS LETT, V456, P31, DOI 10.1016/S0014-5793(99)00916-3; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hertel L, 2000, ONCOGENE, V19, P3598, DOI 10.1038/sj.onc.1203697; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lembo M, 1998, ONCOGENE, V16, P1543, DOI 10.1038/sj.onc.1201677; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; LI WW, 1995, P NATL ACAD SCI USA, V92, P10436, DOI 10.1073/pnas.92.22.10436; Liu CJ, 2000, MOL CELL BIOL, V20, P7024, DOI 10.1128/MCB.20.18.7024-7036.2000; Liu CJ, 1999, EMBO J, V18, P2845, DOI 10.1093/emboj/18.10.2845; Liu CJ, 2005, J BIOL CHEM, V280, P2788, DOI 10.1074/jbc.M412604200; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Mundlos S, 1997, FASEB J, V11, P227, DOI 10.1096/fasebj.11.4.9068611; Munz B, 2002, MOL CELL BIOL, V22, P5879, DOI 10.1128/MCB.22.16.5879-5886.2002; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takayanagi H, 2005, IMMUNOL REV, V208, P181, DOI 10.1111/j.0105-2896.2005.00337.x; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang WF, 2004, DEV BIOL, V270, P364, DOI 10.1016/j.ydbio.2004.03.003; Wang WF, 2002, DEV DYNAM, V224, P79, DOI 10.1002/dvdy.10089; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Xie WF, 2000, MATRIX BIOL, V19, P501, DOI 10.1016/S0945-053X(00)00087-1; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	62	40	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16860	16870		10.1074/jbc.M610943200	http://dx.doi.org/10.1074/jbc.M610943200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17439944	hybrid			2022-12-27	WOS:000246946500018
J	Ku, SY; Yip, P; Cornell, KA; Riscoe, MK; Behr, JB; Guillerm, G; Howell, PL				Ku, Shao-Yang; Yip, Patrick; Cornell, Kenneth A.; Riscoe, Michael K.; Behr, Jean-Bernard; Guillerm, Georges; Howell, P. Lynne			Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SALVAGE PATHWAY; CRYSTAL-STRUCTURE; METHYLTHIORIBOSE KINASE; PROTEIN; ENZYME; PHOSPHATE; 5-METHYLTHIOADENOSINE; REFINEMENT; MECHANISMS; ALIGNMENT	The methionine salvage pathway is ubiquitous in all organisms, but metabolic variations exist between bacteria and mammals. 5-Methylthioribose (MTR) kinase is a key enzyme in methionine salvage in bacteria and the absence of a mammalian homolog suggests that it is a good target for the design of novel antibiotics. The structures of the apo-form of Bacillus subtilis MTR kinase, as well as its ADP, ADP-PO4, AMPPCP, and AMPPCP-MTR complexes have been determined. MTR kinase has a bilobal eukaryotic protein kinase fold but exhibits a number of unique features. The protein lacks the DFG motif typically found at the beginning of the activation loop and instead coordinates magnesium via a DXE motif (Asp(250)-Glu(252)). In addition, the glycine-rich loop of the protein, analogous to the "Gly triad" in protein kinases, does not interact extensively with the nucleotide. The MTR substrate binding site consists of Asp(233) of the catalytic HGD motif, a novel twin arginine motif (Arg(340)/Arg(341)), and a semi-conserved W-loop, which appears to regulate MTR binding specificity. No lobe closure is observed for MTR kinase upon substrate binding. This is probably because the enzyme lacks the lobe closure/inducing interactions between the C-lobe of the protein and the ribosyl moiety of the nucleotide that are typically responsible for lobe closure in protein kinases. The current structures suggest that MTR kinase has a dissociative mechanism.	Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada; Boise State Univ, Dept Chem, Boise, ID 83725 USA; Portland State Univ, Dept Chem, Portland, OR 97207 USA; Vet Affairs Med Ctr, Med Res Serv, Portland, OR 97201 USA; Univ Reims, CNRS, UMR URCA 6519, F-51687 Reims 2, France	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Idaho; Boise State University; Portland State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne	Howell, PL (corresponding author), Hosp Sick Children, Res Inst, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Breton C, 1998, J BIOCHEM, V123, P1000; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Cornell KA, 1996, BIOCHEM J, V317, P285, DOI 10.1042/bj3170285; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRO AJ, 1978, J BIOL CHEM, V253, P6021; FERRO AJ, 1983, METHOD ENZYMOL, V94, P361; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; GIANOTTI AJ, 1990, J BIOL CHEM, V265, P831; GURANOWSKI A, 1983, PLANT PHYSIOL, V71, P932, DOI 10.1104/pp.71.4.932; Hayward S, 2004, J MOL BIOL, V339, P1001, DOI 10.1016/j.jmb.2004.04.004; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Ku SY, 2007, ACTA CRYSTALLOGR D, V63, P493, DOI 10.1107/S0907444907006592; Ku SY, 2004, ACTA CRYSTALLOGR D, V60, P116, DOI 10.1107/S0907444903022042; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JG, 2001, GLYCOBIOLOGY, V11, P217, DOI 10.1093/glycob/11.3.217; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murphy BA, 2002, J BACTERIOL, V184, P2314, DOI 10.1128/JB.184.8.2314-2318.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parang K, 2001, NAT STRUCT BIOL, V8, P37; PEGG AE, 1969, BIOCHEM J, V115, P241, DOI 10.1042/bj1150241; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RISCOE MK, 1988, ANTIMICROB AGENTS CH, V32, P1904, DOI 10.1128/AAC.32.12.1904; Sauter M, 2004, PLANT PHYSIOL, V136, P4061, DOI 10.1104/pp.104.053587; SCHLENK F, 1973, BIOCHIM BIOPHYS ACTA, V320, P357, DOI 10.1016/0304-4165(73)90316-4; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2001, BMC Microbiol, V1, P15, DOI 10.1186/1471-2180-1-15; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; SUFRIN JR, 1995, ANTIMICROB AGENTS CH, V39, P2511, DOI 10.1128/AAC.39.11.2511; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thompson PR, 2002, BIOCHEMISTRY-US, V41, P7001, DOI 10.1021/bi0256680; TOWER PA, 1993, J GEN MICROBIOL, V139, P1027, DOI 10.1099/00221287-139-5-1027; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	56	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22195	22206		10.1074/jbc.M611045200	http://dx.doi.org/10.1074/jbc.M611045200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17522047	hybrid			2022-12-27	WOS:000248196800065
J	Fialcowitz-White, EJ; Brewer, BY; Ballin, JD; Willis, CD; Toth, EA; Wilson, GM				Fialcowitz-White, Elizabeth J.; Brewer, Brandy Y.; Ballin, Jeff D.; Willis, Chris D.; Toth, Eric A.; Wilson, Gerald M.			Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNA-destabilizing sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; FLUORESCENCE ANISOTROPY; ESCHERICHIA-COLI; DNA INTERACTIONS; MAMMALIAN-CELLS; GENE-EXPRESSION; POLY(A) TAIL; ELEMENTS; STABILITY; ALPHA	The RNA-binding factor HuR is a ubiquitously expressed member of the Hu protein family that binds and stabilizes mRNAs containing AU-rich elements (AREs). Huproteins share a common domain organization of two tandemly arrayed RNA recognition motifs (RRMs) near the N terminus, followed by a basic hinge domain and a third RRM near the C terminus. In this study, we engineered recombinant wild-type and mutant HuR proteins lacking affinity tags to characterize their ARE-binding properties. Using combinations of electrophoretic mobility shift and fluorescence anisotropy-based binding assays, we show that HuR can bind ARE substrates as small as 13 nucleotides with low nanomolar affinity, but forms cooperative oligomeric protein complexes on ARE substrates of at least 18 nucleotides in length. Analyses of deletion mutant proteins indicated that RRM3 does not contribute to high affinity recognition of ARE substrates, but is required for cooperative assembly of HuR oligomers on RNA. Finally, the hinge domain between RRM2 and RRM3 contributes significant binding energy to HuR center dot ARE complex formation in an ARE length-dependent manner. The hinge does not enhance RNA-binding activity by increased ion pair formation despite extensive positive charge within this region, and it does not thermodynamically stabilize protein folding. Together, the results define distinct roles for the HuR hinge and RRM3 domains in formation of cooperative HuR center dot ARE complexes in solution.	Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, GM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	gwils001@umaryland.edu	Wilson, Gerald/AAF-3874-2019; Ballin, Jeff D/AAC-3869-2022; Ballin, Jeff/D-3752-2011	Ballin, Jeff D/0000-0002-2712-130X; Ballin, Jeff/0000-0002-2712-130X; Willis, Chris/0000-0002-6639-6568; Wilson, Gerald/0000-0002-1273-7507	NCI NIH HHS [R01 CA102428-04, R01 CA102428] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; DRAPER DE, 1995, ANNU REV BIOCHEM, V64, P593, DOI 10.1146/annurev.bi.64.070195.003113; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P12121, DOI 10.1021/bi980743l; FRANKEL AD, 1991, CELL, V67, P1041, DOI 10.1016/0092-8674(91)90282-4; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gouble A, 2000, ONCOGENE, V19, P5377, DOI 10.1038/sj.onc.1203910; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Inoue M, 2000, NUCLEIC ACIDS RES, V28, P1743, DOI 10.1093/nar/28.8.1743; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Lu JY, 2004, J BIOL CHEM, V279, P12974, DOI 10.1074/jbc.M310433200; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; Manyusa S, 1999, BIOCHEMISTRY-US, V38, P9533, DOI 10.1021/bi990550d; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; MISRA VK, 1995, P NATL ACAD SCI USA, V92, P4691, DOI 10.1073/pnas.92.10.4691; Mobarak CD, 2000, MOL BIOL CELL, V11, P3191, DOI 10.1091/mbc.11.9.3191; Nabors LB, 2001, CANCER RES, V61, P2154; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Tudyka T, 1997, PROTEIN SCI, V6, P2180; Wang WG, 2004, J BIOL CHEM, V279, P48376, DOI 10.1074/jbc.M409014200; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilson GM, 1999, METHODS, V17, P74, DOI 10.1006/meth.1998.0709; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200	55	75	77	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20948	20959		10.1074/jbc.M701751200	http://dx.doi.org/10.1074/jbc.M701751200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17517897	hybrid, Green Accepted			2022-12-27	WOS:000248047500021
J	Laxalt, AM; Raho, N; ten Have, A; Lamattina, L				Laxalt, Ana M.; Raho, Nicolas; ten Have, Arjen; Lamattina, Lorenzo			Nitric Oxide is critical for inducing phosphatidic acid accumulation in xylanase-elicited tomato cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PLANT-DISEASE RESISTANCE; LATERAL ROOT-FORMATION; CULTURED RICE CELLS; PHOSPHOLIPASE-D; ABSCISIC-ACID; HYDROGEN-PEROXIDE; SIGNALING PATHWAYS; OXIDATIVE BURST; NADPH OXIDASE	Nitric Oxide (NO) is a second messenger related to development and (a) biotic stress responses in plants. We have studied the role of NO in signaling during plant defense responses upon xylanase elicitation. Treatment of tomato cell cultures with the fungal elicitor xylanase resulted in a rapid and dose-dependent NO accumulation. We have demonstrated that NO is required for the production of the lipid second messenger phosphatidic acid (PA) via the activation of the phospholipase C (PLC) and diacylglycerol kinase (DGK) pathway. Defense-related responses downstream of PA were studied. PA and, correspondingly, xylanase were shown to induce reactive oxygen species production. Scavenging of NO or inhibition of either the PLC or the DGK enzyme diminished xylanase-induced reactive oxygen species production. Xylanase-induced PLD beta 1 and PR1 mRNA levels decreased when NO or PA production were compromised. Finally, we have shown that NO and PA are involved in the induction of cell death by xylanase. Treatment with NO scavenger cPTIO, PLC inhibitor U73122, or DGK inhibitor R59022 diminished xylanase-induced cell death. On the basis of biochemical and pharmacological experimental results, we have shown that PLC/DGK-derived PA represents a novel downstream component of NO signaling cascade during plant defense.	Univ Nacl Mar del Plata, Inst Invest Biol, RA-7600 Mar Del Plata, Argentina	National University of Mar del Plata	Laxalt, AM (corresponding author), Univ Nacl Mar del Plata, Inst Invest Biol, CC 1245, RA-7600 Mar Del Plata, Argentina.	amlaxalt@mdp.edu.ar	Have, Arjen ten/J-2524-2014; Have, Arjen ten/N-3934-2019	Have, Arjen ten/0000-0001-6210-5017; Have, Arjen ten/0000-0001-6210-5017				Andersson MX, 2006, PLANT J, V47, P947, DOI 10.1111/j.1365-313X.2006.02844.x; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Anthony RG, 2006, J BIOL CHEM, V281, P37536, DOI 10.1074/jbc.M607341200; BAILEY BA, 1990, PLANT PHYSIOL, V94, P1849, DOI 10.1104/pp.94.4.1849; Bargmann BOR, 2006, PLANT J, V45, P358, DOI 10.1111/j.1365-313X.2005.02631.x; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; Brune B, 1998, EUR J PHARMACOL, V351, P261, DOI 10.1016/S0014-2999(98)00274-X; Chen J, 2007, PROTOPLASMA, V230, P13, DOI 10.1007/s00709-006-0195-x; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Clark D, 2000, MOL PLANT MICROBE IN, V13, P1380, DOI 10.1094/MPMI.2000.13.12.1380; Clementi E, 1998, BIOCHEM PHARMACOL, V55, P713, DOI 10.1016/S0006-2952(97)00375-4; CLEMENTI E, 1995, MOL PHARMACOL, V47, P517; Correa-Aragunde N, 2006, J EXP BOT, V57, P581, DOI 10.1093/jxb/erj045; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; Creus CM, 2005, PLANTA, V221, P297, DOI 10.1007/s00425-005-1523-7; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; de Pinto MC, 2006, PLANT J, V48, P784, DOI 10.1111/j.1365-313X.2006.02919.x; de Pinto MC, 2002, PLANT PHYSIOL, V130, P698, DOI 10.1104/pp.005629; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Del Rio LA, 2004, PHYTOCHEMISTRY, V65, P783, DOI 10.1016/j.phytochem.2004.02.001; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Durner J, 1999, CURR OPIN PLANT BIOL, V2, P369, DOI 10.1016/S1369-5266(99)00007-2; Elbaz M, 2002, CELL DEATH DIFFER, V9, P726, DOI 10.1038/sj.cdd.4401030; Farmer PK, 1999, BBA-PROTEIN STRUCT M, V1434, P6, DOI 10.1016/S0167-4838(99)00166-1; FELIX G, 1991, PLANT PHYSIOL, V97, P19, DOI 10.1104/pp.97.1.19; Garcia-Mata C, 2003, P NATL ACAD SCI USA, V100, P11116, DOI 10.1073/pnas.1434381100; GARVEY EP, 1994, J BIOL CHEM, V269, P26669; Gerber Isak B, 2003, Methods Cell Sci, V25, P115; Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Kumar D, 2000, MOL PLANT MICROBE IN, V13, P347, DOI 10.1094/MPMI.2000.13.3.347; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lamotte O, 2004, PLANT PHYSIOL, V135, P516, DOI 10.1104/pp.104.038968; Lanteri ML, 2006, J EXP BOT, V57, P1341, DOI 10.1093/jxb/erj109; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Laxalt AM, 2001, PLANT J, V26, P237, DOI 10.1046/j.1365-313X.2001.01023.x; Lee S, 2001, PLANT J, V26, P479, DOI 10.1046/j.1365-313x.2001.01037.x; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lum HK, 2002, NITRIC OXIDE-BIOL CH, V6, P205, DOI 10.1006/niox.2001.0395; McPhail LC, 1999, BBA-MOL CELL BIOL L, V1439, P277, DOI 10.1016/S1388-1981(99)00100-6; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Moise AR, 2002, J VIROL, V76, P1578, DOI 10.1128/JVI.76.4.1578-1587.2002; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Munnik T, 1996, J BIOL CHEM, V271, P15708, DOI 10.1074/jbc.271.26.15708; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Neill SJ, 2002, PLANT PHYSIOL, V128, P13, DOI 10.1104/pp.010707; Pagnussat GC, 2004, PLANT PHYSIOL, V135, P279, DOI 10.1104/pp.103.038554; Pagnussat GC, 2003, PLANT PHYSIOL, V132, P1241, DOI 10.1104/pp.103.022228; Pagnussat GC, 2002, PLANT PHYSIOL, V129, P954, DOI 10.1104/pp.004036; Palicz A, 2001, J BIOL CHEM, V276, P3090, DOI 10.1074/jbc.M007759200; Park J, 2004, PLANT PHYSIOL, V134, P129, DOI 10.1104/pp.103.031393; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Romero-Puertas MC, 2004, CELL MICROBIOL, V6, P795, DOI 10.1111/j.1462-5822.2004.00428.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Sang YM, 2001, PLANT PHYSIOL, V126, P1449, DOI 10.1104/pp.126.4.1449; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; VANKAN JAL, 1992, PLANT MOL BIOL, V20, P513, DOI 10.1007/BF00040610; Walia M, 2003, AM J PHYSIOL-CELL PH, V284, pC649, DOI 10.1152/ajpcell.00405.2002; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Yamaguchi T, 2004, PLANT CELL PHYSIOL, V45, P1261, DOI 10.1093/pcp/pch150; Yano A, 1998, MOL PLANT MICROBE IN, V11, P115, DOI 10.1094/MPMI.1998.11.2.115; Zhang WH, 2005, BBA-MOL CELL BIOL L, V1736, P1, DOI 10.1016/j.bbalip.2005.07.004; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zonia Laura, 2006, V39, P207	79	92	96	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21160	21168		10.1074/jbc.M701212200	http://dx.doi.org/10.1074/jbc.M701212200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17491015	hybrid			2022-12-27	WOS:000248047500042
J	de Weerd, NA; Samarajiwa, SA; Hertzog, PJ				de Weerd, Nicole A.; Samarajiwa, Shamith A.; Hertzog, Paul J.			Type I interferon receptors: Biochemistry and biological functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ALPHA-RECEPTOR; GENE-CLUSTER; CRYSTAL-STRUCTURE; LIGAND-BINDING; SUBUNIT IFNAR1; HEPATITIS-C; BETA; EXPRESSION; CELLS; ASSOCIATION		Monash Univ, Monash Inst Med Res, Ctr Funct Genom & Human Dis, Clayton, Vic 3168, Australia	Monash University	Hertzog, PJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Funct Genom & Human Dis, Clayton, Vic 3168, Australia.	paul.hertzog@med.monash.edu.au	Hertzog, Paul J/I-7053-2013; Samarajiwa, Shamith/B-1601-2013; Yang, Chen/G-1379-2010; Hertzog, Paul J/G-6734-2013; de Weerd, Nicole/X-5886-2019	Hertzog, Paul J/0000-0002-1373-8472; Samarajiwa, Shamith/0000-0003-1046-0601; Hertzog, Paul J/0000-0002-1373-8472; de Weerd, Nicole/0000-0002-7985-189X				ABRAMOVICH C, 1994, FEBS LETT, V338, P295, DOI 10.1016/0014-5793(94)80287-4; Ambrus JL, 2003, CANCER, V98, P2730, DOI 10.1002/cncr.11843; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Chill JH, 2003, STRUCTURE, V11, P791, DOI 10.1016/S0969-2126(03)00120-5; COHEN B, 1995, MOL CELL BIOL, V15, P4208; Cook JR, 1996, J BIOL CHEM, V271, P13448, DOI 10.1074/jbc.271.23.13448; Diop G, 2006, BIOMED PHARMACOTHER, V60, P569, DOI 10.1016/j.biopha.2006.08.002; Domanski P, 1997, J BIOL CHEM, V272, P26388, DOI 10.1074/jbc.272.42.26388; Eid P, 2000, EUR CYTOKINE NETW, V11, P560; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; FERNANDEZBOTRAN R, 1991, FASEB J, V5, P2567, DOI 10.1096/fasebj.5.11.1868981; Frodsham AJ, 2006, P NATL ACAD SCI USA, V103, P9148, DOI 10.1073/pnas.0602800103; Gazziola C, 2005, INT J ONCOL, V26, P129; GHISLAIN J, 1994, J IMMUNOL, V153, P3655; Han CS, 2001, P NATL ACAD SCI USA, V98, P6138, DOI 10.1073/pnas.111139598; Hardy MP, 2003, MAMM GENOME, V14, P105, DOI 10.1007/s00335-002-2225-0; Hardy MP, 2002, BIOCHEM J, V365, P355, DOI 10.1042/BJ20020105; Hardy MP, 2001, BLOOD, V97, P473, DOI 10.1182/blood.V97.2.473; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Kierstein S, 2006, GENES IMMUN, V7, P667, DOI 10.1038/sj.gene.6364345; Kola I, 1997, HUM MOL GENET, V6, P1713, DOI 10.1093/hmg/6.10.1713; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; LANGER JA, 1988, IMMUNOL TODAY, V9, P393, DOI 10.1016/0167-5699(88)91241-8; Lewerenz M, 1998, J MOL BIOL, V282, P585, DOI 10.1006/jmbi.1998.2026; Leyva L, 2005, J NEUROIMMUNOL, V163, P165, DOI 10.1016/j.jneuroim.2005.02.010; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; LUTFALLA G, 1995, EMBO J, V14, P5100, DOI 10.1002/j.1460-2075.1995.tb00192.x; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; McKenna SD, 2004, J INTERF CYTOK RES, V24, P119, DOI 10.1089/107999004322813363; Mizukoshi E, 1999, HEPATOLOGY, V30, P1325, DOI 10.1002/hep.510300516; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; NOVICK D, 1992, FEBS LETT, V314, P445, DOI 10.1016/0014-5793(92)81523-O; Owczarek CM, 1997, J BIOL CHEM, V272, P23865, DOI 10.1074/jbc.272.38.23865; Piehler J, 1999, J MOL BIOL, V294, P223, DOI 10.1006/jmbi.1999.3230; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Runkel L, 2000, BIOCHEMISTRY-US, V39, P2538, DOI 10.1021/bi991631c; Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056; Saleh AZM, 2004, ONCOGENE, V23, P7076, DOI 10.1038/sj.onc.1207955; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Tough DF, 1999, IMMUNOL REV, V170, P39, DOI 10.1111/j.1600-065X.1999.tb01327.x; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; UZE G, 1995, J INTERF CYTOK RES, V15, P3, DOI 10.1089/jir.1995.15.3; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Yan H, 1996, MOL CELL BIOL, V16, P2074; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416	58	291	311	6	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20053	20057		10.1074/jbc.R700006200	http://dx.doi.org/10.1074/jbc.R700006200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502368	hybrid			2022-12-27	WOS:000247819300004
J	Goto, K; Kamiya, Y; Imamura, T; Miyazono, K; Miyazawa, K				Goto, Kouichiro; Kamiya, Yuto; Imamura, Takeshi; Miyazono, Kohei; Miyazawa, Keiji			Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; GERMLINE MUTATIONS; SIGNAL-TRANSDUCTION; JUVENILE POLYPOSIS; CRYSTAL-STRUCTURE; C2C12 MYOBLASTS; FAMILY-MEMBERS; MESSENGER-RNA; DOMAIN; IDENTIFICATION	The inhibitory Smads, Smad6 and Smad7, play pivotal roles in negative regulation of transforming growth factor-beta (TGF-beta) family signaling as feedback molecules as well as mediators of cross-talk with other signaling pathways. Whereas Smad7 acts as a ubiquitous inhibitor of Smad signaling, Smad6 has been shown to effectively inhibit bone morphogenetic protein (BMP) signaling but only weakly TGF-beta/activin signaling. In the present study, we have found that Smad6 inhibits signaling from the activin receptor-like kinase (ALK)-3/6 subgroup in preference to that from the ALK-1/2 subgroup of BMP type I receptors. The difference is attributable to the interaction of Smad6 with these BMP type I receptors. The amino acid residues responsible for Smad6 sensitivity of ALK-3 were identified as Arg-238, Phe-264, Thr-265, and Ala-269, which map to the N-terminal lobe of the ALK-3 kinase domain. Although Smad6 regulates BMP signaling through multiple mechanisms, our findings suggest that interaction with type I receptors is a critical step in the function of Smad6.	Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan	University of Tokyo; Japanese Foundation for Cancer Research	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan.	miyazono-ind@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014					Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Aoki H, 2001, J CELL SCI, V114, P1483; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bai ST, 2002, J BIOL CHEM, V277, P4176, DOI 10.1074/jbc.M105105200; Bitzer M, 2000, GENE DEV, V14, P187; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Ebisawa T, 1999, J CELL SCI, V112, P3519; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Namiki M, 1997, J BIOL CHEM, V272, P22046, DOI 10.1074/jbc.272.35.22046; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Takase M, 1998, BIOCHEM BIOPH RES CO, V244, P26, DOI 10.1006/bbrc.1998.8200; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	48	111	115	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20603	20611		10.1074/jbc.M702100200	http://dx.doi.org/10.1074/jbc.M702100200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17493940	hybrid			2022-12-27	WOS:000247819300063
J	Jang, SI; Lee, EJ; Hart, PS; Ramaswami, M; Pallos, D; Hart, TC				Jang, Shyh-Ing; Lee, Eun-Jin; Hart, P. Suzanne; Ramaswami, Mukundhan; Pallos, Debora; Hart, Thomas C.			Germ line gain of function with SOS1 mutation in hereditary gingival fibromatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; EPIDERMAL-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; EARLY GENE-PRODUCTS; MAP KINASE; SIGNAL-TRANSDUCTION; EGF RECEPTOR; PC12 CELLS; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTORS	Mutation of human SOS1 is responsible for hereditary gingival fibromatosis type 1, a benign overgrowth condition of the gingiva. Here, we investigated molecular mechanisms responsible for the increased rate of cell proliferation in gingival fibroblasts caused by mutant SOS1 in vitro. Using ectopic expression of wild-type and mutant SOS1 constructs, we found that truncated SOS1 could localize to the plasma membrane, without growth factor stimuli, leading to sustained activation of Ras/MAPK signaling. Additionally, we observed an increase in the magnitude and duration of ERK signaling in hereditary gingival fibromatosis gingival fibroblasts that was associated with phosphorylation of retinoblastoma tumor suppressor protein and the up-regulation of cell cycle regulators, including cyclins C, D, and E and the E2F/DP transcription factors. These factors promote cell cycle progression from G1 to S phase, and their up-regulation may underlie the increased gingival fibroblast proliferation observed. Selective depletion of wild-type and mutant SOS1 through small interfering RNA demonstrates the link between mutation of SOS1, ERK signaling, cell proliferation rate, and the expression levels of Egr-1 and proliferating cell nuclear antigen. These findings elucidate the mechanisms for gingival overgrowth mediated by SOS1 gene mutation in humans.	NIH, NIDCR, Sect Human & Craniofacial Genet, Bethesda, MD 20892 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Taubate, Dept Dent, Periodont Res & Grad Studies Div, BR-12020 Sao Paulo, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Universidade de Taubate	Hart, TC (corresponding author), NIH, NIDCR, Sect Human & Craniofacial Genet, Bldg 10, Bethesda, MD 20892 USA.	thart@mail.nih.gov	Pallos, Debora/AAW-5258-2021; Pallos, Debora/H-7844-2012	Pallos, Debora/0000-0001-7426-1041; Lee, Eun-Jin/0000-0001-5718-542X	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000711, Z01DE000711] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Gorlin RJ, 2001, SYNDROMES HEAD NECK, P847; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Gudas JM, 1999, MOL CELL BIOL, V19, P612; Guerrero C, 1996, ONCOGENE, V12, P1097; Hart TC, 2002, AM J HUM GENET, V70, P943, DOI 10.1086/339689; Hart TC, 1998, AM J HUM GENET, V62, P876, DOI 10.1086/301797; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Jang SI, 2005, J CELL SCI, V118, P781, DOI 10.1242/jcs.01647; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; KARLOVICH CA, 1995, SCIENCE, V268, P576, DOI 10.1126/science.7725106; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lee EJ, 2006, J DENT RES, V85, P1050, DOI 10.1177/154405910608501115; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu W, 1999, J CELL SCI, V112, P2409; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; NIMNUAL A, 2002, SCI STKE, pPE36, DOI DOI 10.1126/STKE.2002.145; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rojas JM, 1996, ONCOGENE, V12, P2291; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; WANG W, 1995, NAT GENET, V10, P294, DOI 10.1038/ng0795-294; WITKOP C J JR, 1971, Birth Defects Original Article Series, V7, P210	57	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20245	20255		10.1074/jbc.M701609200	http://dx.doi.org/10.1074/jbc.M701609200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17510059	hybrid			2022-12-27	WOS:000247819300027
J	Geyer, J; Doring, B; Meerkamp, K; Ugele, B; Bakhiya, N; Fernandes, CF; Godoy, JR; Glatt, H; Petzinger, E				Geyer, Joachim; Doering, Barbara; Meerkamp, Kerstin; Ugele, Bernhard; Bakhiya, Nadiya; Fernandes, Carla F.; Godoy, Jose R.; Glatt, Hansruedi; Petzinger, Ernst			Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID COTRANSPORTER; STEROID-HORMONE BIOSYNTHESIS; MEMBRANE-PROTEIN STRUCTURE; SUBSTRATE-SPECIFICITY; TOPOLOGY PREDICTION; RAT; ILEAL; IDENTIFICATION; LOCALIZATION; EXPRESSION	We have cloned human sodium-dependent organic anion transporter ( SOAT) cDNA, which consists of 1502 bp and encodes a 377-amino acid protein. SOAT shows 42% sequence identity to the ileal apical sodium-dependent bile acid transporter ASBT and 33% sequence identity to the hepatic Na+/taurocholate- cotransporting polypeptide NTCP. Immunoprecipitation of a SOAT-FLAG-tagged protein revealed a glycosylated form at 46 kDa that decreased to 42 kDa after PNGase F treatment. SOAT exhibits a seven-transmembrane domain topology with an outside-to-inside orientation of the N-terminal and C-terminal ends. SOAT mRNA is most highly expressed in testis. Relatively high SOAT expression was also detected in placenta and pancreas. We established a stable SOAT-HEK293 cell line that showed sodium-dependent transport of dehydroepiandrosterone sulfate, estrone-3-sulfate, and pregnenolone sulfate with apparent Km values of 28.7, 12.0, and 11.3 mu M, respectively. Although bile acids, such as taurocholic acid, cholic acid, and chenodeoxycholic acid, were not substrates of SOAT, the sulfoconjugated bile acid taurolithocholic acid-3-sulfate was transported by SOAT-HEK293 cells in a sodium-dependent manner and showed competitive inhibition of SOAT transport with an apparent K-i value of 0.24 mu M. Several nonsteroidal organosulfates also strongly inhibited SOAT, including 1-(omega-sulfooxyethyl) pyrene, bromosulfophthalein, 2- and 4-sulfooxymethylpyrene, and alpha-naphthylsulfate. Among these inhibitors, 2- and 4-sulfooxymethylpyrene were competitive inhibitors of SOAT, with apparent Ki values of 4.3 and 5.5 mu M, respectively, and they were also transported by SOAT-HEK293 cells.	Univ Giessen, Inst Pharmacol & Toxicol, D-35392 Giessen, Germany; Univ Munich, Univ Hosp, D-80337 Munich, Germany; German Inst Human Nutr, Dept Nutr Toxicol, D-14558 Nuthetal, Germany	Justus Liebig University Giessen; University of Munich; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Geyer, J (corresponding author), Univ Giessen, Inst Pharmacol & Toxicol, Frankfurter Str 107, D-35392 Giessen, Germany.	joachim.m.geyer@vetmed.uni-giessen.de	Godoy, Jose/ABF-3804-2020; Geyer, Joachim/AAQ-4593-2021	Glatt, Hansruedi/0000-0001-6053-0562				ALBRECHT ED, 1990, ENDOCR REV, V11, P124, DOI 10.1210/edrv-11-1-124; ALCALAY M, 1988, NUCLEIC ACIDS RES, V16, P9527, DOI 10.1093/nar/16.20.9527; ANANTHANARAYANAN M, 1994, AM J PHYSIOL-GASTR L, V267, pG637, DOI 10.1152/ajpgi.1994.267.4.G637; Bakhiya N, 2006, J AM SOC NEPHROL, V17, P1414, DOI 10.1681/ASN.2005080801; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Baringhaus KH, 1999, J LIPID RES, V40, P2158; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Craddock AL, 1998, AM J PHYSIOL-GASTR L, V274, pG157, DOI 10.1152/ajpgi.1998.274.1.G157; Dawson Paul A., 1995, Current Opinion in Lipidology, V6, P109, DOI 10.1097/00041433-199504000-00009; DEPERETTI E, 1983, J CLIN ENDOCR METAB, V57, P550, DOI 10.1210/jcem-57-3-550; Enders N., 1993, POLYCYCLIC AROMATIC, V3, P887; Engst W, 1999, CARCINOGENESIS, V20, P1777, DOI 10.1093/carcin/20.9.1777; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Geyer J, 2004, BIOCHEM BIOPH RES CO, V316, P300, DOI 10.1016/j.bbrc.2004.02.048; Glatt H, 2000, CHEM-BIOL INTERACT, V129, P141, DOI 10.1016/S0009-2797(00)00202-7; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hagenbuch B, 1996, SEMIN LIVER DIS, V16, P129, DOI 10.1055/s-2007-1007226; HAGENBUCH B, 1990, J BIOL CHEM, V265, P5357; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hata S, 2003, AM J PHYSIOL-GASTR L, V285, pG829, DOI 10.1152/ajpgi.00352.2002; Hess Rex A, 2003, Reprod Biol Endocrinol, V1, P52, DOI 10.1186/1477-7827-1-52; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kobayashi Y, 2005, J BIOL CHEM, V280, P32332, DOI 10.1074/jbc.M504246200; Kramer W, 2006, CURR MED CHEM, V13, P997, DOI 10.2174/092986706776361003; Kramer W, 1999, J LIPID RES, V40, P1604; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUSS E, 1994, EXP CLIN ENDOCRINOL, V102, P135, DOI 10.1055/s-0029-1211276; Labrie F, 2001, FRONT NEUROENDOCRIN, V22, P185, DOI 10.1006/frne.2001.0216; Lazaridis KN, 2000, P NATL ACAD SCI USA, V97, P11092, DOI 10.1073/pnas.200325297; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mareninova O, 2005, BIOCHEMISTRY-US, V44, P13702, DOI 10.1021/bi051291x; Marin Jose J G, 2005, Ann Hepatol, V4, P70; Miller WL, 1998, CLIN PERINATOL, V25, P799, DOI 10.1016/S0095-5108(18)30084-8; NAKAGAWA M, 1990, J LIPID RES, V31, P1089; Pasquier C, 1999, PROTEIN ENG, V12, P631, DOI 10.1093/protein/12.8.631; Persson B, 1996, PROTEIN SCI, V5, P363; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Schroeder A, 1998, AM J PHYSIOL-GASTR L, V274, pG370, DOI 10.1152/ajpgi.1998.274.2.G370; SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722; Srivastava A, 2004, CANCER EPIDEM BIOMAR, V13, P49, DOI 10.1158/1055-9965.EPI-03-0133; STIEGER B, 1994, GASTROENTEROLOGY, V107, P1781, DOI 10.1016/0016-5085(94)90821-4; Strauss JF, 1996, BIOL REPROD, V54, P303, DOI 10.1095/biolreprod54.2.303; Suzuki T, 2003, MOL ENDOCRINOL, V17, P1203, DOI 10.1210/me.2002-0304; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ugele B, 1999, J STEROID BIOCHEM, V71, P203, DOI 10.1016/S0960-0760(99)00138-7; Ugele B, 2003, AM J PHYSIOL-ENDOC M, V284, pE390, DOI 10.1152/ajpendo.00257.2002; WATKINS JB, 1983, J PEDIATR GASTR NUTR, V2, P365, DOI 10.1097/00005176-198305000-00027; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; Weinman SA, 1997, YALE J BIOL MED, V70, P331; WONG MH, 1995, J BIOL CHEM, V270, P27228, DOI 10.1074/jbc.270.45.27228; WONG MH, 1994, J BIOL CHEM, V269, P1340; Zhang EY, 2004, BIOCHEMISTRY-US, V43, P11380, DOI 10.1021/bi049270a	55	76	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19728	19741		10.1074/jbc.M702663200	http://dx.doi.org/10.1074/jbc.M702663200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17491011	hybrid			2022-12-27	WOS:000247650600048
J	Gross, SA; Wissenbach, U; Philipp, SE; Freichel, M; Cavalie, A; Flockerzi, V				Gross, Stefan Alfred; Wissenbach, Ulrich; Philipp, Stephan Ernst; Freichel, Marc; Cavalie, Adolfo; Flockerzi, Veit			Murine ORAI2 splice variants form functional Ca2+ release-activated Ca2+ (CRAC) channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORE; STIM1; SUBUNIT; IDENTIFICATION; MODULATION; TERMINUS; PROTEIN; SENSOR; GENES; PORE	The stimulation of membrane receptors coupled to the phopholipase C pathway leads to activation of the Ca2+ release-activated Ca2+ ( CRAC) channels. Recent evidence indicates that ORAI1 is an essential pore subunit of CRAC channels. STIM1 is additionally required for CRAC channel activation. The present study focuses on the genomic organization, tissue expression pattern, and functional properties of the murine ORAI2. Additionally, we report the cloning of the murine ORAI1, ORAI3, and STIM1. Two chromosomal loci were identified for the murine orai2 gene, one containing an intronless gene and a second locus that gives rise to the splice variants ORAI2 long (ORAI2L) and ORAI2 short (ORAI2S). Northern blots revealed a prominent expression of the ORAI2 variants in the brain, lung, spleen, and intestine, while ORAI1, ORAI3, and STIM1 appeared to be near ubiquitously expressed in mice tissues. Specific antibodies detected ORAI2 in RBL 2H3 but not in HEK 293 cells, whereas both cell lines appeared to express ORAI1 and STIM1 proteins. Co-expression experiments with STIM1 and either ORAI1 or ORAI2 variants showed that ORAI2L and ORAI2S enhanced substantially CRAC current densities in HEK 293 but were ineffective in RBL 2H3 cells, whereas ORAI1 strongly amplified CRAC currents in both cell lines. Thus, the capability of ORAI2 variants to form CRAC channels depends strongly on the cell background. Additionally, CRAC channels formed by ORAI2S were strongly sensitive to inactivation by internal Ca2+. When co-expressed with STIM1 and ORAI1, ORAI2S apparently plays a negative dominant role in the formation of CRAC channels.	Univ Saarland, Inst Expt & Klin Pharmacol & Toxicol, D-66421 Homburg, Germany	Saarland University	Cavalie, A (corresponding author), Univ Saarland, Campus Homburg,bldg 46, D-66421 Homburg, Germany.	ptacav@uks.eu	Philipp, Stephan/AAR-7519-2020	Philipp, Stephan/0000-0003-1959-9167				Aneiros E, 2005, J IMMUNOL, V174, P119, DOI 10.4049/jimmunol.174.1.119; BELFORT M, 1993, SCIENCE, V262, P1009, DOI 10.1126/science.7694364; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; GRUSKIN KD, 1987, P NATL ACAD SCI USA, V84, P1605, DOI 10.1073/pnas.84.6.1605; GWACK Y, 2007, IN PRESS J BIOL CHEM, V282; HARA Y, 1992, P NATL ACAD SCI USA, V89, P3280, DOI 10.1073/pnas.89.8.3280; Held B, 2002, J PHYSIOL-LONDON, V539, P459, DOI 10.1113/jphysiol.2001.012745; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kang MG, 2003, J BIOL CHEM, V278, P21315, DOI 10.1074/jbc.R300004200; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	29	84	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19375	19384		10.1074/jbc.M701962200	http://dx.doi.org/10.1074/jbc.M701962200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17463004	hybrid			2022-12-27	WOS:000247650600012
J	Leng, YM; Cao, C; Ren, J; Huang, L; Chen, DS; Ito, M; Kufe, D				Leng, Yumei; Cao, Cheng; Ren, Jian; Huang, Lei; Chen, Dongshu; Ito, Masaki; Kufe, Donald			Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; GROWTH-FACTOR RECEPTOR; BETA-CATENIN; APOPTOTIC RESPONSE; GENE-TRANSCRIPTION; SURVIVAL RESPONSE; OXIDATIVE STRESS; TANDEM REPEATS; PROTEIN IMPORT; PORE COMPLEX	The MUC1 heterodimeric transmembrane protein is aberrantly overexpressed by most human carcinomas. The MUC1 C-terminal subunit (MUC1-C) is devoid of a classical nuclear localization signal and is targeted to the nucleus by an unknown mechanism. The present results demonstrate that MUC1-C associates with importin beta and not importin alpha. The results also show that, like importin beta, MUC1-C binds to Nup62 ( nucleoporin p62). MUC1-C binds directly to the Nup62 central domain and indirectly to the Nup62 C-terminal alpha-helical coiled-coil domain. We demonstrate that MUC1-C forms oligomers and that oligomerization is necessary for binding to Nup62. The MUC1-C cytoplasmic domain contains a CQC motif that when mutated to AQA abrogates oligomerization and binding to Nup62. Stable expression of MUC1 with the CQC -> AQA mutations was associated with targeting to the cell membrane and cytosol and attenuation of nuclear localization. The results further show that expression of MUC1(CQC-AQA) attenuates MUC1-induced (i) transcriptional coactivation, (ii) anchorage-independent growth, and (iii) tumorigenicity. These findings indicate that the MUC1-C oncoprotein is imported to the nucleus by a pathway involving Nup62.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu	Cao, Cheng/GNP-6156-2022	Huang, Lei/0000-0002-4851-4807	NATIONAL CANCER INSTITUTE [R01CA097098] Funding Source: NIH RePORTER; NCI NIH HHS [CA97098] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE M, 1989, CANCER RES, V49, P2834; Angeline M, 2003, VIROLOGY, V317, P13, DOI 10.1016/j.virol.2003.08.024; CARMOFONSECA M, 1991, EUR J CELL BIOL, V55, P17; CORDES V, 1991, EUR J CELL BIOL, V55, P31; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang L, 2003, CANCER BIOL THER, V2, P702; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2003, MOL CANCER RES, V1, P765; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, BIOCHEM BIOPH RES CO, V281, P440, DOI 10.1006/bbrc.2001.4383; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; MERLO GR, 1989, CANCER RES, V49, P6966; Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835; Pemberton LF, 1996, J BIOL CHEM, V271, P2332, DOI 10.1074/jbc.271.4.2332; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; STARR CM, 1991, BIOESSAYS, V13, P145, DOI 10.1002/bies.950130309; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suh EK, 2003, EXP CELL RES, V290, P447, DOI 10.1016/S0014-4827(03)00370-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yin L, 2004, J BIOL CHEM, V279, P45721, DOI 10.1074/jbc.M408027200; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; ZRIHANLICHT S, 1994, EUR J BIOCHEM, V224, P787, DOI 10.1111/j.1432-1033.1994.00787.x	52	113	125	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19321	19330		10.1074/jbc.M703222200	http://dx.doi.org/10.1074/jbc.M703222200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500061	hybrid			2022-12-27	WOS:000247650600007
J	Sakai, H; Tanaka, Y; Tanaka, M; Ban, N; Yamada, K; Matsumura, Y; Watanabe, D; Sasaki, M; Kita, T; Inagaki, N				Sakai, Hiromichi; Tanaka, Yukiko; Tanaka, Makoto; Ban, Nobuhiro; Yamada, Katsuya; Matsumura, Yoshihiro; Watanabe, Daisuke; Sasaki, Mayumi; Kita, Toru; Inagaki, Nobuya			ABCA2 deficiency results in abnormal sphingolipid metabolism in mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; FATAL SURFACTANT DEFICIENCY; THIN-LAYER CHROMATOGRAPHY; HIGH-DENSITY-LIPOPROTEIN; CENTRAL-NERVOUS-SYSTEM; BETA-GALACTOSIDASE; KNOCKOUT MICE; RAT-BRAIN; CELLULAR CHOLESTEROL; TANGIER-DISEASE	ABCA2, a member of the ATP-binding cassette (ABC) transporter family, is localized mainly to late endosome/lysosomes of oligodendrocytes in brain, but the physiological role and function of ABCA2 are unknown. In this study, we generated mutant mice (ABCA2-null) by targeting the abca2 gene. ABCA2-null mice exhibited a phenotype including lower pregnancy rate and body weight, shorter latency period on the balance beam, and sensitization to environmental stress compared with wild type mice but no abnormality in the cytoarchitectonic and compact myelin structure or oligodendroglial differentiation. Lipid analysis of brain from 11 days to 64 weeks of age revealed significant accumulation of gangliosides along with reduced sphingomyelin (SM) from 4 weeks to 64 weeks of age and accumulation of cerebrosides and sulfatides at 64 weeks of age in ABCA2- null mice compared with wild type mice. In addition, a significant accumulation of the major ganglioside GM1 and reduced SM was detected in the myelin fraction of ABCA2-null brain. Comparison of ABCA2- null and wild type mice revealed weak ABCA2 immunoreactivity in some large pyramidal cells of wild type brain. These results suggest that ABCA2 is involved in the intracellular metabolism of sphingolipids in the brain, particularly SM and gangliosides in oligodendrocytes and certain neurons.	Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto 606, Japan; Akita Univ, Sch Med, Dept Physiol, Akita 010, Japan; Kyoto Univ, Grad Sch Med, Dept Geriatr Med, Kyoto 606, Japan; Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 606, Japan; Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto 606, Japan; Kyoto Univ, Grad Sch Med, Core Res Evolut Sci & Technol, Japan Sci & Technol Agcy, Kyoto 606, Japan	Kyoto University; Akita University; Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Inagaki, N (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Physiol, Hirosaki, Aomori 036, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp	Sakai, Hiromichi/K-8457-2019; Yamada, Katsuya/E-8720-2013	Matsumura, Yoshihiro/0000-0002-3108-0440; Inagaki, Nobuya/0000-0001-8261-2593				Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Allikmets R, 2000, AM J HUM GENET, V67, P793, DOI 10.1086/303100; ANDO S, 1987, J CHROMATOGR, V405, P125, DOI 10.1016/S0021-9673(01)81754-4; Ban N, 2005, BIOCHEM J, V389, P577, DOI 10.1042/BJ20050159; Broccardo C, 1999, BBA-BIOMEMBRANES, V1461, P395, DOI 10.1016/S0005-2736(99)00170-4; Broccardo C, 2006, J NEUROCHEM, V97, P345, DOI 10.1111/j.1471-4159.2006.03714.x; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; LAUTER CJ, 1962, J LIPID RES, V3, P136; LEDEEN RW, 1973, J NEUROCHEM, V21, P829, DOI 10.1111/j.1471-4159.1973.tb07527.x; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Mack JT, 2007, MOL CELL BIOL, V27, P44, DOI 10.1128/MCB.01824-06; Matsuda J, 1997, BRAIN DEV-JPN, V19, P19, DOI 10.1016/S0387-7604(96)00077-0; Matsuda J, 1997, GLYCOCONJUGATE J, V14, P729, DOI 10.1023/A:1018573518127; MIETTINEN T, 1959, ACTA CHEM SCAND, V13, P856, DOI 10.3891/acta.chem.scand.13-0856; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; Tanaka Y, 2003, J COMP NEUROL, V455, P353, DOI 10.1002/cne.10493; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang Y, 2005, J NEUROL SCI, V232, P59, DOI 10.1016/j.jns.2005.01.016; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Yoshida I, 2004, BIOCHEM BIOPH RES CO, V323, P547, DOI 10.1016/j.bbrc.2004.08.133; YU RK, 1975, J NEUROCHEM, V25, P229, DOI 10.1111/j.1471-4159.1975.tb06957.x; Zhao LX, 2000, BIOCHEM J, V350, P865, DOI 10.1042/0264-6021:3500865; Zhou CJ, 2002, J COMP NEUROL, V451, P334, DOI 10.1002/cne.10354; Zhou CJ, 2001, J NEUROSCI, V21, P849, DOI 10.1523/JNEUROSCI.21-03-00849.2001; ZILLES K, 1995, RAT NERVOUS SYSTEM, V2, P649	41	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19692	19699		10.1074/jbc.M611056200	http://dx.doi.org/10.1074/jbc.M611056200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488728	hybrid			2022-12-27	WOS:000247650600044
J	Sharma, N; Lopez, DI; Nyborg, JK				Sharma, Neelam; Lopez, Dinaida I.; Nyborg, Jennifer K.			DNA binding and phosphorylation induce conformational alterations in the kinase-inducible domain of CREB - Implications for the mechanism of transcription function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-RESPONSE ELEMENT; VIRUS TYPE-1 PROMOTER; GENOME-WIDE ANALYSIS; PROTEIN CREB; KIX DOMAIN; TAX TRANSACTIVATION; MOLECULAR-MECHANISM; ACTIVATION DOMAINS; COMPLEX-FORMATION; CYCLIC-AMP	CREB-mediated activation of target gene transcription is stimulated by protein kinase A (PKA) phosphorylation at serine 133. This is followed by recruitment of the coactivators CREB-binding protein (CBP) or p300. Conversely, the decline in expression during the attenuation phase is linked to CREB dephosphorylation by nuclear phosphatases. The CREB bZIP domain, which promotes dimerization and promoter binding, as well as the kinase-inducible domain (KID), which interacts with the KIX domain of CBP/p300, are both largely unstructured in solution and become more structured once bound to their respective ligands. In this study, we biochemically characterize DNA- and phosphorylation-induced conformational alterations in CREB that may play a role in its transcriptionally poised, activated state. We find that sequence-specific DNA binding of pCREB renders the protein resistant to serine 133 dephosphorylation by protein phosphatase 1. Paradoxically, CREB bound to DNA and chromatin is efficiently phosphorylated by PKA, indicating that the KID region exists in a different conformation depending on its phosphorylation state. Consistent with this observation, we find that phosphorylation of DNA-bound CREB promotes an alternate conformation characterized by an apparent increase in the size or asymmetry of the complex and a qualitative change in proteolytic sensitivity. Together, our data indicate that DNA binding promotes a global conformational change in CREB that alters the structure of KID. PKA phosphorylation of KID in the DNA-bound state induces a phosphatase-resistant conformation that may prolong transcriptional activity.	Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Nyborg, JK (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Jennifer.Nyborg@ColoState.edu			NCI NIH HHS [R01 CA080002-09, CA 80002, R01 CA080002] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080002] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; BRAUWEILER A, 1995, J BIOL CHEM, V270, P12814, DOI 10.1074/jbc.270.21.12814; BULGER M, 1994, GENE CHROMOSOME ANAL, V5; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COHEN P, 1989, J BIOL CHEM, V264, P21435; DYNAN WS, 1987, GENETIC ENG PRINCIPL, V9, P75; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; FRANKLIN AA, 1993, J BIOL CHEM, V268, P21225; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Johnson KM, 2004, METHOD ENZYMOL, V380, P207; Konesky KL, 2006, J VIROL, V80, P10542, DOI 10.1128/JVI.00631-06; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Mayr BM, 2005, J BIOL CHEM, V280, P15103, DOI 10.1074/jbc.M414144200; MERINO A, 1989, J BIOL CHEM, V264, P21266; Mestas SP, 1999, NAT STRUCT BIOL, V6, P613; Mick JE, 2000, AIDS RES HUM RETROV, V16, P1597, DOI 10.1089/08892220050193010; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Parker D, 1996, MOL CELL BIOL, V16, P694; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; QUINN PG, 1993, J BIOL CHEM, V268, P16999; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Richards JP, 1996, J BIOL CHEM, V271, P13716, DOI 10.1074/jbc.271.23.13716; RUPPERT S, 1992, EMBO J, V11, P1503, DOI 10.1002/j.1460-2075.1992.tb05195.x; SANTIAGORIVERA ZI, 1993, PROTEIN SCI, V2, P1461, DOI 10.1002/pro.5560020910; SCHONTHAL AH, 1998, FRONT BIOSCI, V3, P1262; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Scoggin KES, 2001, MOL CELL BIOL, V21, P5520, DOI 10.1128/MCB.21.16.5520-5530.2001; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Smal C, 2004, BIOCHEM PHARMACOL, V68, P95, DOI 10.1016/j.bcp.2004.02.031; Usukura J, 2000, GENES CELLS, V5, P515, DOI 10.1046/j.1365-2443.2000.00345.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Votavova H, 1997, J BIOMOL STRUCT DYN, V15, P587, DOI 10.1080/07391102.1997.10508968; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; WEIH F, 1990, GENE DEV, V4, P1437, DOI 10.1101/gad.4.8.1437; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu XL, 1998, J BIOL CHEM, V273, P20820, DOI 10.1074/jbc.273.33.20820; YACIUK P, 1991, MOL CELL BIOL, V11, P5389, DOI 10.1128/MCB.11.11.5389; YAMAMOTO KK, 1990, CELL, V60, P611, DOI 10.1016/0092-8674(90)90664-Z; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	58	24	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19872	19883		10.1074/jbc.M701435200	http://dx.doi.org/10.1074/jbc.M701435200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17491014	hybrid			2022-12-27	WOS:000247650600062
J	Cao, W; Xi, XY; Hao, ZY; Li, WJ; Kong, Y; Cui, LX; Ma, C; Ba, DN; He, W				Cao, Wei; Xi, Xueyan; Hao, Zhiyong; Li, Wenjing; Kong, Yan; Cui, Lianxian; Ma, Chi; Ba, Denian; He, Wei			RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-RELATED MOLECULES; CD8(+) T-CELLS; NKG2D RECEPTOR; MALIGNANT DISEASES; GLYCOPROTEIN UL16; CUTTING EDGE; LIGANDS; ENGAGEMENT; EXPRESSION; MICA	UL16-binding proteins (ULBPs, also termed as retinoic acid early transcripts, encoded by RAET1 genes), a family of ligands for NKG2D in humans, are frequently expressed by tumor cells and mediate cytotoxicities of natural killer (NK) cells and CD8(+) alpha beta T cells to tumor cells. ULBP1, ULBP2, ULBP3, and RAET1L link to membrane through glycosylphosphatidylinositol, whereas RAET1E and RAET1G contain transmembrane and cytoplasmic domains. Proteolytic cleavage of ULBP2 produces truncated and soluble forms that may counteract NKG2D-mediated tumor immune surveillance. In this study, we report that RAET1E can produce a soluble, 35-kDa protein (termed as RAET1E2) lacking the transmembrane region by selective splicing in tumor cells. The expressions of both RAET1E2 transcripts and protein can be found in different tumor cells and tissues. Preincubation of NK-92 cells, a human NK cell line, with culture supernatants from tumor cell lines expressing RAET1E2 or RAET1E2 gene-transfected COS-7 cells resulted in decreased expression of NKG2D on NK-92 cells. Furthermore, incubation of NK-92 cells with recombinant RAET1E2 protein also decreased the surface expression of NKG2D and resulted in marked reduction in cytotoxicities to MGC-803, HepG2, or K562 tumor cells. Taken together, our data provide strong evidence for an immune escape mechanism of tumors via alternative splicing of ULBP RNA to generate a free soluble ULBP protein, RAET1E2, that may impair NKG2D-mediated NK cell cytotoxicity to tumors.	Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Dept Immunol,Natl Key Lab MMB, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	He, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Dept Immunol,Natl Key Lab MMB, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	heweiimu@public.bta.net.cn	Li, Wenjing/G-3551-2012					Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; Cao W, 2004, IMMUNOBIOLOGY, V209, P283, DOI 10.1016/j.imbio.2004.04.008; Cao We, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P242; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Dhanji S, 2004, BLOOD, V104, P2116, DOI 10.1182/blood-2004-01-0150; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Holdenrieder S, 2006, INT J CANCER, V118, P684, DOI 10.1002/ijc.21382; Holdenrieder S, 2006, CANCER IMMUNOL IMMUN, V55, P1584, DOI 10.1007/s00262-006-0167-1; JAN CN, 2003, BIOCHEM BIOPH RES CO, V305, P129; Kubin M, 2001, EUR J IMMUNOL, V31, P1428, DOI 10.1002/1521-4141(200105)31:5<1428::AID-IMMU1428>3.0.CO;2-4; Maasho K, 2005, J IMMUNOL, V174, P4480, DOI 10.4049/jimmunol.174.8.4480; Maccalli C, 2003, EUR J IMMUNOL, V33, P2033, DOI 10.1002/eji.200323909; Marten A, 2006, INT J CANCER, V119, P2359, DOI 10.1002/ijc.22186; Markiewicz MA, 2005, J IMMUNOL, V175, P2825, DOI 10.4049/jimmunol.175.5.2825; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Nitahara A, 2006, J INVEST DERMATOL, V126, P1052, DOI 10.1038/sj.jid.5700112; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Rolle A, 2003, J IMMUNOL, V171, P902, DOI 10.4049/jimmunol.171.2.902; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Song H, 2006, CELL IMMUNOL, V239, P22, DOI 10.1016/j.cellimm.2006.03.002; Spreu J, 2006, J IMMUNOL, V177, P3143, DOI 10.4049/jimmunol.177.5.3143; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671; Sutherland CL, 2001, IMMUNOL REV, V181, P185, DOI 10.1034/j.1600-065X.2001.1810115.x; Sutherland CL, 2006, BLOOD, V108, P1313, DOI 10.1182/blood-2005-11-011320; Vales-Gomez Mar, 2003, BMC Immunol, V4, P4, DOI 10.1186/1471-2172-4-4; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; Yokoyama WM, 2002, NATURE, V419, P679, DOI 10.1038/419679a; Zhou H, 2006, BLOOD, V107, P3251, DOI 10.1182/blood-2005-10-4231; Zhou H, 2005, P NATL ACAD SCI USA, V102, P10846, DOI 10.1073/pnas.0502208102	41	60	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18922	18928		10.1074/jbc.M702504200	http://dx.doi.org/10.1074/jbc.M702504200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17470428	hybrid			2022-12-27	WOS:000247475300033
J	Goenka, S; Cho, SH; Boothby, M				Goenka, Shreevrat; Cho, Sung Hoon; Boothby, Mark			Collaborator of stat6 (CoaSt6)-associated poly(ADP-ribose) polymerase activity modulates stat6-dependent gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL LYMPHOMAS; ACTIVATION; COACTIVATOR; EXPRESSION; PARP-1; DNA; IDENTIFICATION; SPECIFICITY; INHIBITION; MECHANISM	The transcription factor Stat6 plays a critical role in interleukin-4-dependent gene activation. To mediate this function, Stat6 recruits canonical transcriptional co-activators including the histone acetyl transferases CREB-binding protein and NCoA-1 and other proteins such as a p100 co-factor. However, much remains unknown regarding the constituents of Stat6 enhancer complexes, and the exact molecular events that modulate Stat6-dependent gene activation are not fully understood. Recently, we identified a novel co-factor, CoaSt6 (collaborator of Stat6), which associates with Stat6 and enhances its transcriptional activity. Sequence homologies place CoaSt6 in a superfamily of poly(ADP-ribosyl) polymerase (PARP)-like proteins. We have demonstrated here that PARP enzymatic activity is associated with CoaSt6, and this function of CoaSt6 can append ADP-ribose to itself and p100. Further, we show that a catalytically inactive mutant of CoaSt6 was unable to enhance Stat6-mediated transcription of a test promoter. Consistent with these findings, chemical inhibition of PARP activity blocked interleukin-4-dependent transcription from target promoters in vivo. Taken together, we have identified a CoaSt6-associated PARP activity and provided evidence for a role of poly(ADP ribosyl)ation in Stat-mediated transcriptional responses involving a novel PARP.	Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Med, Div Rheumatol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Goenka, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.	shreevrat.goenka@vanderbilt.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071735] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071735] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Aguiar RCT, 2000, BLOOD, V96, P4328, DOI 10.1182/blood.V96.13.4328.h8004328_4328_4334; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Goenka S, 1999, J IMMUNOL, V163, P4663; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Goenka S, 2003, J BIOL CHEM, V278, P50362, DOI 10.1074/jbc.M305854200; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Juszczynski P, 2006, MOL CELL BIOL, V26, P5348, DOI 10.1128/MCB.02351-05; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Litterst CM, 2001, J BIOL CHEM, V276, P45713, DOI 10.1074/jbc.M108132200; Lu XQ, 2005, BLOOD, V105, P2924, DOI 10.1182/blood-2004-10-3820; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MATHIS G, 1987, BIOCHEM BIOPH RES CO, V143, P1049, DOI 10.1016/0006-291X(87)90358-5; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; PEHRSON JR, 1992, SCIENCE, V257, P1398; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; REALINI CA, 1992, J BIOL CHEM, V267, P18858; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; TONG X, 1995, MOL CELL BIOL, V15, P4735; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463	38	64	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18732	18739		10.1074/jbc.M611283200	http://dx.doi.org/10.1074/jbc.M611283200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17478423	hybrid			2022-12-27	WOS:000247475300011
J	Tampellini, D; Magrane, J; Takahashi, RH; Li, F; Lin, MT; Almeida, CG; Gouras, GK				Tampellini, Davide; Magrane, Jordi; Takahashi, Reisuke H.; Li, Feng; Lin, Michael T.; Almeida, Claudia G.; Gouras, Gunnar K.			Internalized antibodies to the A beta domain of APP reduce neuronal A beta and protect against synaptic alterations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; INTRANEURONAL A-BETA-42 ACCUMULATION; ALZHEIMERS-DISEASE; INTRACELLULAR ACCUMULATION; TRANSGENIC MODEL; PLAQUE-FORMATION; MEMORY LOSS; IMMUNIZATION; PEPTIDE; ENDOCYTOSIS	Immunotherapy against beta-amyloid peptide (A beta) is a leading therapeutic direction for Alzheimer disease (AD). Experimental studies in transgenic mouse models of AD have demonstrated that A beta immunization reduces A beta plaque pathology and improves cognitive function. However, the biological mechanisms by which A beta antibodies reduce amyloid accumulation in the brain remain unclear. We provide evidence that treatment of AD mutant neuroblastoma cells or primary neurons with A beta antibodies decreases levels of intracellular A beta. Antibody-mediated reduction in cellular A beta appears to require that the antibody binds to the extracellular A beta domain of the amyloid precursor protein (APP) and be internalized. In addition, treatment with A beta antibodies protects against synaptic alterations that occur in APP mutant neurons.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	Cornell University	Gouras, GK (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 525 E 68th St, New York, NY 10021 USA.	gkgouras@med.cornell.edu	Magrané, Jordi/AAJ-2967-2020; Gouras, Gunnar/B-3021-2010; de Almeida, Cláudia Guimas/AAN-8935-2020	Magrané, Jordi/0000-0002-6785-2166; Gouras, Gunnar/0000-0002-5500-6325; de Almeida, Cláudia Guimas/0000-0001-9384-2896; Tampellini, Davide/0000-0003-3188-0293	NIA NIH HHS [AG028174] Funding Source: Medline; NINDS NIH HHS [NS045677] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG028174] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Arbel M, 2005, P NATL ACAD SCI USA, V102, P7718, DOI 10.1073/pnas.0502427102; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Das P, 2003, J NEUROSCI, V23, P8532; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Goldsbury C, 2006, TRAFFIC, V7, P873, DOI 10.1111/j.1600-0854.2006.00434.x; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holtzman DM, 2002, ADV DRUG DELIVER REV, V54, P1603, DOI 10.1016/S0169-409X(02)00158-8; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Lemere CA, 2003, NEUROBIOL DIS, V14, P10, DOI 10.1016/S0969-9961(03)00044-5; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Shie FS, 2003, NEUROREPORT, V14, P123, DOI 10.1097/00001756-200301200-00023; Solomon Beka, 2004, Current Alzheimer Research, V1, P149, DOI 10.2174/1567205043332126; Tabira T, 2002, FRONT BIOSCI-LANDMRK, V7, pA44, DOI 10.2741/tabira; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Wilcock DM, 2004, NEUROBIOL DIS, V15, P11, DOI 10.1016/j.nbd.2003.09.015; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Yamazaki T, 1996, J CELL SCI, V109, P999; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650	63	102	104	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18895	18906		10.1074/jbc.M700373200	http://dx.doi.org/10.1074/jbc.M700373200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17468102	hybrid			2022-12-27	WOS:000247475300030
J	Wright, DC; Geiger, PC; Han, DH; Jones, TE; Holloszy, JO				Wright, David C.; Geiger, Paige C.; Han, Dong-Ho; Jones, Terry E.; Holloszy, John O.			Calcium induces increases in peroxisome proliferator-activated receptor gamma coactivator-1 alpha and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; BIOCHEMICAL ADAPTATIONS; GENE-EXPRESSION; EXERCISE; PGC-1-ALPHA; NUCLEAR; PGC-1; ALPHA	Previous studies have shown that raising cytosolic calcium in myotubes induces increases in peroxisome proliferator-activated receptor gamma coactivator-1 alpha expression and mitochondrial biogenesis. This finding suggests that the increases in cytosolic calcium in skeletal muscle during exercise may mediate the exercise-induced increase in mitochondria. The initial aim of this study was to determine whether raising calcium in skeletal muscle induces the same adaptations as in myotubes. We found that treatment of rat epitrochlearis muscles with a concentration of caffeine that raises cytosolic calcium to a concentration too low to cause contraction induces increases in peroxisome proliferator-activated receptor gamma coactivator-1 alpha expression and mitochondrial biogenesis. Our second aim was to elucidate the pathway by which calcium induces these adaptations. Raising cytosolic calcium has been shown to activate calcium/calmodulin-dependent protein kinase in muscle. In the present study raising cytosolic calcium resulted in increases in phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor-2, which were blocked by the calcium/calmodulin-dependent protein kinase inhibitor KN93 and by the p38 mitogen-activated protein kinase inhibitor SB202190. The increases in peroxisome proliferator-activated receptor gamma coactivator-1 alpha expression and mitochondrial biogenesis were also prevented by inhibiting p38 activation. We interpret these findings as evidence that p38 mitogen-activated protein kinase is downstream of calcium/calmodulin-dependent protein kinase in a signaling pathway by which increases in cytosolic calcium lead to increases in peroxisome proliferator-activated receptor gamma coactivator-1 alpha expression and mitochondrial biogenesis in muscle.	Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Holloszy, JO (corresponding author), Washington Univ, Sch Med, Div Geriatr & Nutr Sci, Campus Box 8113,4566 Scott Ave, St Louis, MO 63110 USA.	jhollosz@im.wustl.edu		Wright, David/0000-0003-3867-8901	NIA NIH HHS [AG00425, AG00078] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-06, DK070425, P30 DK056341, P30 DK056341-07] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, F32DK070425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG000425, R56AG000425, R37AG000425] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373; BIANCHI CP, 1961, J GEN PHYSIOL, V44, P845, DOI 10.1085/jgp.44.5.845; BOOTH FW, 1977, J BIOL CHEM, V252, P416; BOOTH FW, 1997, HDB PHYSL 12, P1075; Boppart MD, 2000, J PHYSIOL-LONDON, V526, P663, DOI 10.1111/j.1469-7793.2000.00663.x; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chan MHS, 2004, FASEB J, V18, P1785, DOI 10.1096/fj.03-1039fje; Chin ER, 2004, P NUTR SOC, V63, P279, DOI 10.1079/PNS2004335; CONSTABLE SH, 1987, AM J PHYSIOL, V253, pC316, DOI 10.1152/ajpcell.1987.253.2.C316; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Elzi DJ, 2001, AM J PHYSIOL-CELL PH, V281, pC350; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Freyssenet D, 1999, J BIOL CHEM, V274, P9305, DOI 10.1074/jbc.274.14.9305; Geiger PC, 2005, AM J PHYSIOL-ENDOC M, V288, pE782, DOI 10.1152/ajpendo.00477.2004; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; LAWRENCE JC, 1983, AM J PHYSIOL, V244, pC348, DOI 10.1152/ajpcell.1983.244.5.C348; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOLE PA, 1971, J CLIN INVEST, V50, P2323, DOI 10.1172/JCI106730; Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com; Ojuka EO, 2002, AM J PHYSIOL-ENDOC M, V283, pE1040, DOI 10.1152/ajpendo.00242.2002; OSCAI LB, 1971, J BIOL CHEM, V246, P6968; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; RODNICK KJ, 1992, AM J PHYSIOL, V262, pC9, DOI 10.1152/ajpcell.1992.262.1.C9; Rose AJ, 2006, J PHYSIOL-LONDON, V574, P889, DOI 10.1113/jphysiol.2006.111757; Rose AJ, 2003, J PHYSIOL-LONDON, V553, P303, DOI 10.1113/jphysiol.2003.054171; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Terada S, 2006, AM J PHYSIOL-ENDOC M, V290, pE607, DOI 10.1152/ajpendo.00430.2005; Terada S, 2003, J APPL PHYSIOL, V94, P1813, DOI 10.1152/japplphysiol.00780.2002; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wright DC, 2004, AM J PHYSIOL-ENDOC M, V287, pE305, DOI 10.1152/ajpendo.00082.2004; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YOUN JH, 1991, AM J PHYSIOL, V260, pC555, DOI 10.1152/ajpcell.1991.260.3.C555; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	62	207	216	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18793	18799		10.1074/jbc.M611252200	http://dx.doi.org/10.1074/jbc.M611252200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17488713	hybrid			2022-12-27	WOS:000247475300018
J	Yang, WY; Devaiah, SP; Pan, XQ; Isaac, G; Welti, R; Wang, XM				Yang, Wenyu; Devaiah, Shivakumar P.; Pan, Xiangqing; Isaac, Giorgis; Welti, Ruth; Wang, Xuemin			AtPLAI is an acyl hydrolase involved in basal jasmonic acid production and Arabidopsis resistance to Botrytis cinerea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOUND-INDUCED ACCUMULATION; PHOSPHOLIPASE D-ALPHA; LEUCINE-RICH REPEAT; METHYL JASMONATE; PROTEINASE-INHIBITORS; SALICYLIC-ACID; TOBACCO-LEAVES; PATATIN; EXPRESSION; GENE	Intracellular phospholipase A(2) (PLA(2)) plays an important role in regulating oxylipin biosynthesis in mammals, but the molecular and biochemical nature of intracellular PLA2 is not well understood in plants. Arabidopsis thaliana gene At1g61850 (AtPLAI) encodes a 140-kDa protein that is most similar to mammalian calcium-independent PLA(2), and additionally contains leucine-rich repeats and Armadillo repeats. AtPLAI hydrolyzes phospholipids at both the sn-1 and sn-2 positions, but prefers galactolipids to phospholipids as substrates. Profiling of lipid species altered in response to the necrotrophic fungus Botrytis cinerea revealed decreases in the levels of phosphatidylglycerol and digalactosyldiacylglycerol, suggesting that hydrolysis of plastidic polar lipids might provide precursors for pathogen-induced jasmonic acid (JA) production. Disruption of AtPLAI by T-DNA insertion reduced the basal level of JA, but did not impede pathogen-induced production of JA, free linolenic acid, or hydrolysis of plastidic lipids. Still, AtPLAI-deficient plants exhibited more damage than wild type plants after B. cinerea infection, and pretreatment of plants with methyl jasmonate alleviated pathogen damage to the mutant plants. The study shows that AtPLAI is an acyl hydrolase, rather than a specific phospholipase A. AtPLAI is involved in basal JA production and Arabidopsis resistance to the necrotrophic fungus B. cinerea.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; Kansas State Univ, Div Biol, Kansas Lipodom Res Ctr, Manhattan, KS 66506 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center; Kansas State University	Wang, XM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	wangxue@umsl.edu	Wang, Xuemin/M-2853-2013	wang, xuemin/0000-0002-6251-6745; Welti, Ruth/0000-0003-4373-2538	NCRR NIH HHS [P20RR16475] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDREWS DL, 1988, BIOCHEM J, V252, P199, DOI 10.1042/bj2520199; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Chandra S, 1996, PLANT PHYSIOL, V110, P979, DOI 10.1104/pp.110.3.979; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dhondt S, 2000, PLANT J, V23, P431, DOI 10.1046/j.1365-313x.2000.00802.x; Dhondt S, 2002, PLANT J, V32, P749, DOI 10.1046/j.1365-313X.2002.01465.x; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; GUNDLACH H, 1992, P NATL ACAD SCI USA, V89, P2389, DOI 10.1073/pnas.89.6.2389; Harms K, 1998, PLANT PHYSIOL, V118, P1057, DOI 10.1104/pp.118.3.1057; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Hisamatsu Y, 2005, J NAT PROD, V68, P600, DOI 10.1021/np0495938; Holk A, 2002, PLANT PHYSIOL, V130, P90, DOI 10.1104/pp.006288; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; KAUSS H, 1986, PLANT PHYSIOL, V80, P7, DOI 10.1104/pp.80.1.7; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; La Camera S, 2005, PLANT J, V44, P810, DOI 10.1111/j.1365-313X.2005.02578.x; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; LIECHTI R, 2006, SCI STKE, V322; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Maleck K, 1999, TRENDS PLANT SCI, V4, P215, DOI 10.1016/S1360-1385(99)01415-6; MASON HS, 1992, PLANT PHYSIOL, V98, P859, DOI 10.1104/pp.98.3.859; MASON HS, 1990, PLANT CELL, V2, P569, DOI 10.1105/tpc.2.6.569; Mueller MJ, 1997, PHYSIOL PLANTARUM, V100, P653, DOI 10.1034/j.1399-3054.1997.1000329.x; Narusaka Y, 2003, PLANT CELL PHYSIOL, V44, P1246, DOI 10.1093/pcp/pcg138; Narvaez-Vasquez J, 1999, PLANT CELL, V11, P2249, DOI 10.1105/tpc.11.11.2249; Pappan K, 2004, J BIOL CHEM, V279, P47833, DOI 10.1074/jbc.M402789200; Pieterse CMJ, 2006, MULTIGENIC AND INDUCED SYSTEMIC RESISTANCE IN PLANTS, P166, DOI 10.1007/0-387-23266-4_8; Prins TW, 2000, FUNGAL PATHOLOGY, P33; Rietz S, 2004, PLANTA, V219, P743, DOI 10.1007/s00425-004-1275-9; ROY S, 1995, PLANT SCI, V107, P17, DOI 10.1016/0168-9452(95)04086-A; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; Ryu SB, 1998, BBA-LIPID LIPID MET, V1393, P193, DOI 10.1016/S0005-2760(98)00048-4; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Stelmach BA, 2001, J BIOL CHEM, V276, P28628; Stelmach BA, 2001, J BIOL CHEM, V276, P12832, DOI 10.1074/jbc.M010743200; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Viehweger K, 2002, PLANT CELL, V14, P1509, DOI 10.1105/tpc.002329; Viehweger K, 2006, PLANT CELL, V18, P1510, DOI 10.1105/tpc.105.035121; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wanjie SW, 2005, LIPIDS, V40, P773, DOI 10.1007/s11745-005-1439-4; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Welti R, 2005, FUNCTIONAL LIPIDOMIC, P307; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Young ND, 2000, CURR OPIN PLANT BIOL, V3, P285, DOI 10.1016/S1369-5266(00)00081-9; Zien CA, 2001, BBA-MOL CELL BIOL L, V1530, P236, DOI 10.1016/S1388-1981(01)00091-9	65	102	104	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18116	18128		10.1074/jbc.M700405200	http://dx.doi.org/10.1074/jbc.M700405200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17475618	hybrid, Green Published			2022-12-27	WOS:000247302000018
J	Houston, CM; Lee, HHC; Hosie, AM; Moss, SJ; Smart, TG				Houston, Catriona M.; Lee, Henry H. C.; Hosie, Alastair M.; Moss, Stephen J.; Smart, Trevor G.			Identification of the sites for CaMK-II-dependent phosphorylation of GABA(A) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; PROTEIN-KINASE-C; VASCULAR SMOOTH-MUSCLE; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; TYROSINE PHOSPHORYLATION; A RECEPTOR; INTRACELLULAR DOMAINS; SYNAPTIC-TRANSMISSION; COUPLED RECEPTORS	Phosphorylation can affect both the function and trafficking of GABA(A) receptors with significant consequences for neuronal excitability. Serine/threonine kinases can phosphorylate the intracellular loops between M3-4 of GABA(A) receptor beta and gamma subunits thereby modulating receptor function in heterologous expression systems and in neurons (1, 2). Specifically, CaMK-II has been demonstrated to phosphorylate the M3 -4 loop of GABAA receptor subunits expressed as GST fusion proteins (3, 4). It also increases the amplitude of GABAA receptor-mediated currents in a number of neuronal cell types (5 -7). To identify which substrate sites CaMK-II might phosphorylate and the consequent functional effects, we expressed recombinant GABAA receptors in NG108-15 cells, which have previously been shown to support CaMK-II modulation of GABAA receptors containing the beta 3 subunit (8). We now demonstrate that CaMK-II mediates its effects on alpha 1 beta 3 receptors via phosphorylation of Ser(383) within the M3-4 domain of the beta subunit. Ablation of beta 3 subunit phosphorylation sites for CaMK-II revealed that for alpha beta gamma receptors, CaMK-II has a residual effect on GABA currents that is not mediated by previously identified sites of CaMK-II phosphorylation. This residual effect is abolished by mutation of tyrosine phosphorylation sites, Tyr(365) and Tyr(367), on the gamma 2S subunit, and by the tyrosine kinase inhibitor genistein. These results suggested that CaMK-II is capable of directly phosphorylating GABAA receptors and activating endogenous tyrosine kinases to phosphorylate the gamma 22 subunit in NG108-15 cells. These findings were confirmed in a neuronal environment by expressing recombinant GABAA receptors in cerebellar granule neurons.	UCL, Dept Pharmacol, London WC1E 6BT, England; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of London; University College London; University of Pennsylvania	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk	Lee, Henry/GVS-2114-2022; Lee, Henry HC/S-6014-2016	Lee, Henry HC/0000-0003-4975-7330	MRC [G0601529] Funding Source: UKRI; Medical Research Council [G0601529] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aguayo LG, 1998, PFLUG ARCH EUR J PHY, V435, P382, DOI 10.1007/s004240050527; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1418; Boxall AR, 1998, EUR J NEUROSCI, V10, P2; Boxall AR, 2000, J PHYSIOL-LONDON, V524, P677, DOI 10.1111/j.1469-7793.2000.00677.x; Brandon NJ, 2001, NEUROPHARMACOLOGY, V41, P745, DOI 10.1016/S0028-3908(01)00121-6; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Churn SB, 2002, J NEUROCHEM, V82, P1065, DOI 10.1046/j.1471-4159.2002.01032.x; Churn SB, 1998, BRAIN RES, V809, P68, DOI 10.1016/S0006-8993(98)00834-8; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Fan RS, 2005, J BIOL CHEM, V280, P24212, DOI 10.1074/jbc.M500716200; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101; Ginnan R, 2004, AM J PHYSIOL-CELL PH, V286, pC1281, DOI 10.1152/ajpcell.00202.2003; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Guo J, 2004, NEUROSCI LETT, V355, P177, DOI 10.1016/j.neulet.2003.10.076; Heidinger V, 2002, J NEUROSCI, V22, P5452; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Houston CM, 2006, EUR J NEUROSCI, V24, P2504, DOI 10.1111/j.1460-9568.2006.05145.x; Huang CC, 1999, J PHYSIOL-LONDON, V520, P783, DOI 10.1111/j.1469-7793.1999.00783.x; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lin YF, 1996, MOL PHARMACOL, V50, P185; Lo RKH, 2004, MOL PHARMACOL, V65, P1427, DOI 10.1124/mol.65.6.1427; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Ma XH, 2003, J NEUROSCI, V23, P1159, DOI 10.1523/JNEUROSCI.23-04-01159.2003; Magoski NS, 2005, J NEUROSCI, V25, P8037, DOI 10.1523/JNEUROSCI.1903-05.2005; MCDONALD BJ, 1994, J BIOL CHEM, V269, P18111; McDonald BJ, 1997, NEUROPHARMACOLOGY, V36, P1377, DOI 10.1016/S0028-3908(97)00111-1; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MOSS SJ, 1995, NATURE, V377, P344, DOI 10.1038/377344a0; MOSS SJ, 1992, J BIOL CHEM, V267, P14470; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; MOSS SJ, 1991, NEUROSCI LETT, V123, P265, DOI 10.1016/0304-3940(91)90947-R; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; SUZUKITAKEUCHI E, 1992, PROTEIN EXPRES PURIF, V3, P160; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; VALENZUELA CF, 1995, MOL BRAIN RES, V31, P165, DOI 10.1016/0169-328X(95)00048-W; WANG RA, 1995, J NEUROPHYSIOL, V73, P2099, DOI 10.1152/jn.1995.73.5.2099; Wang Y, 2003, J AM SOC NEPHROL, V14, P28, DOI 10.1097/01.ASN.0000043180.18456.47; Wei J, 2004, NEUROSCIENCE, V127, P637, DOI 10.1016/j.neuroscience.2004.05.056; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	60	38	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17855	17865		10.1074/jbc.M611533200	http://dx.doi.org/10.1074/jbc.M611533200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17442679	hybrid			2022-12-27	WOS:000247084500059
J	Ivanisevic, L; Zheng, WH; Woo, SB; Neet, KE; Saragovi, HU				Ivanisevic, Ljubica; Zheng, WenHua; Woo, Sang B.; Neet, Kenneth E.; Saragovi, H. Uri			TrkA receptor "Hot spots" for binding of NT-3 as a heterologous ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; IMMUNOGLOBULIN-LIKE DOMAINS; EXTRACELLULAR DOMAIN; NEUROTROPHIN RECEPTORS; SYMPATHETIC NEURONS; CRYSTAL-STRUCTURE; P75; ACTIVATION; NGF; SURVIVAL	Neurotrophins signal via Trk tyrosine kinase receptors. Nerve growth factor (NGF) is the cognate ligand for TrkA, the brain-derived neurotrophic factor for TrkB, and NT-3 for TrkC. NT-3 also binds TrkA as a lower affinity heterologous ligand. Because neurotrophin-3 (NT-3) interactions with TrkA are biologically relevant, we aimed to define the TrkA "hot spot" functional docking sites of NT-3. The Trk extracellular domain consists of two cysteine-rich subdomains (D1 and D3), flanking a leucine-rich subdomain (D2), and two immunoglobulin-like subdomains IgC1(D4) and IgC2(D5). Previously, the D5 subdomain was defined as the primary ligand-binding site of neurotrophins for their cognate receptors (e.g. NGF binds and activates through TRKA-D5 hot spots). Here binding studies with truncated and chimeric extracellular subdomains show that TRKA-D5 also includes an NT-3 docking and activation hot spot (site 1), and competition studies show that the NGF and NT-3 hot spots on TRKA-D5 are distinct but partially overlapping. In addition, ligand binding studies provide evidence for an NT-3-binding/allosteric site on TRKA-D4 (site 2). NT-3 docking on sites 1 and/ or 2 partially blocks NGF binding. Functional survival studies showed that sites 1 and 2 regulate TrkA activation. NT-3 docking on both sites 1 and 2 affords full agonism, which can be additive with NGF activation of Trk. However, NT-3 docking solely on site 1 is partially agonistic but noncompetitively antagonizes NGF binding and activation of Trk. This study demonstrates that Trk signaling is more complex than previously thought because it involves several receptor subdomains and hot spots.	Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Abbott Pk, IL 60064 USA; McGill Univ, Oncol Canc Ctr, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3T 1E2, Canada; McGill Univ, Lady Davis Inst Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	Rosalind Franklin University Medical & Science; McGill University; McGill University; Lady Davis Institute; McGill University	Neet, KE (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Abbott Pk, IL 60064 USA.	Kenneth.neet@rosalindfranklin.edu; uri.saragovi@mcgill.ca			NATIONAL CANCER INSTITUTE [R01CA082642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036700, R01NS038569, R01NS024380] Funding Source: NIH RePORTER; NCI NIH HHS [CA82642] Funding Source: Medline; NINDS NIH HHS [NS36700, R01NS38569, NS24380] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; Banfield MJ, 2001, STRUCTURE, V9, P1191, DOI 10.1016/S0969-2126(01)00681-5; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; EIDE FF, 1993, EXP NEUROL, V121, P200, DOI 10.1006/exnr.1993.1087; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Holden PH, 1997, NAT BIOTECHNOL, V15, P668, DOI 10.1038/nbt0797-668; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LeSauteur L, 1996, J NEUROSCI, V16, P1308; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MacDonald JIS, 1996, MOL CELL NEUROSCI, V7, P371, DOI 10.1006/mcne.1996.0027; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Mischel PS, 2002, BIOPHYS J, V83, P968, DOI 10.1016/S0006-3495(02)75222-3; Mufson EJ, 1997, EXP NEUROL, V146, P91, DOI 10.1006/exnr.1997.6504; PEREZ P, 1995, MOL CELL NEUROSCI, V6, P97, DOI 10.1006/mcne.1995.1010; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Ryden M, 1996, J BIOL CHEM, V271, P5623, DOI 10.1074/jbc.271.10.5623; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; Saragovi HU, 2002, CURR PHARM DESIGN, V8, P2201, DOI 10.2174/1381612023393215; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Urfer R, 1998, J BIOL CHEM, V273, P5829, DOI 10.1074/jbc.273.10.5829; URFER R, 1995, EMBO J, V14, P2795, DOI 10.1002/j.1460-2075.1995.tb07279.x; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Woo SB, 1998, PROTEIN SCI, V7, P1006; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200	34	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16754	16763		10.1074/jbc.M701996200	http://dx.doi.org/10.1074/jbc.M701996200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17439940	hybrid			2022-12-27	WOS:000246946500007
J	Panee, J; Stoytcheva, ZR; Liu, W; Berry, MJ				Panee, Jun; Stoytcheva, Zoia R.; Liu, Wanyu; Berry, Marla J.			Selenoprotein H is redox-sensing high mobility group family DNA-binding protein that up-regulates genes involved in glutathione synthesis and phase II detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; TARGET TISSUES; SUBUNIT GENE; CELL-DEATH; SELENIUM; EXPRESSION; ASSAY	Selenoprotein His a recently identified member of the selenoprotein family whose function is not fully known. Previous studies from our laboratory and others showed that Drosophila melanogaster selenoprotein H is essential for viability and antioxidant defense. In this study we investigated the function of human selenoprotein H in murine hippocampal HT22 cells engineered to stably overexpress the protein. After treatment of cells with L-buthionine-(S, R)-sulfoximine to deplete glutathione, selenoprotein H-overexpressing cells exhibited higher levels of total glutathione, total antioxidant capacities, and glutathione peroxidase enzymatic activity than did vector control cells. Overexpression of selenoprotein H also up-regulated the mRNA levels of endogenous selenoprotein H, glutamylcysteine synthetase heavy and light chains, and glutathione S-transferases Alpha 2, Alpha 4, and Omega 1. The amino acid sequence of selenoprotein H contains four putative nuclear localization sequences and an AT-hook motif, a small DNA-binding domain first identified in high mobility group proteins. Chromatin immunoprecipitation using a green fluorescent protein-selenoprotein H fusion revealed binding to sequences containing heat shock and/or stress response elements. Thus, selenoprotein His a redox-responsive DNA-binding protein of the AT-hook family and functions in regulating expression levels of genes involved in de novo glutathione synthesis and phase II detoxification in response to redox status.	Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Hawaii System	Berry, MJ (corresponding author), 651 Ilalo St,BSB 222, Honolulu, HI 96813 USA.	mberry@hawaii.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040302] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS40302] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; Ben Jilani KE, 2007, INT J BIOL SCI, V3, P198; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Kwon SY, 2003, MOL CELL BIOL, V23, P8495, DOI 10.1128/MCB.23.23.8495-8504.2003; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pellegrini N, 1999, METHOD ENZYMOL, V299, P379; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Takamura Y, 2006, AM J PHYSIOL-CELL PH, V290, pC554, DOI 10.1152/ajpcell.00398.2005; Wild AC, 2000, FREE RADICAL RES, V32, P281, DOI 10.1080/10715760000300291; Zafar KS, 2003, J NEUROCHEM, V84, P438, DOI 10.1046/j.1471-4159.2003.01531.x	21	83	84	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2007	282	33					23759	23765		10.1074/jbc.M702267200	http://dx.doi.org/10.1074/jbc.M702267200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	199HK	17526492	hybrid			2022-12-27	WOS:000248686600004
J	Bartoov-Shifman, R; Ridner, G; Bahar, K; Rubins, N; Walker, MD				Bartoov-Shifman, Reut; Ridner, Gabriela; Bahar, Keren; Rubins, Nir; Walker, Michael D.			Regulation of the gene encoding GPR40, a fatty acid receptor expressed selectively in pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; BINDING PROTEINS; PROMOTER; TRANSCRIPTION; LINE; TUMOR; MICE; PDX1	GPR40 is a G protein-coupled receptor expressed preferentially in pancreatic beta cells. It is activated by long-chain fatty acids and has been implicated in mediating physiological and pathological effects of long-chain fatty acids on beta cells. We mapped the GPR40 transcription start site to a location 1044 bp upstream of the translation start site. This permitted definition of the GPR40 core promoter and the organization of the gene, which comprises a 24-bp non-coding exon, a 698-bp intron and a 4402-bp second exon, containing the entire protein coding sequence. Sequence analysis of the GPR40 locus revealed three evolutionarily conserved regions upstream to the translation start site (HR1-HR3). DNase I-hypersensitive sites were present in the HR2 and HR3 regions in beta cells but not in non-beta cells. The 5 '-flanking region of the GPR40 gene was capable of directing transcriptional activity selectively in beta cells. An important component of this is attributable to the HR2 region, which showed strong beta cell-specific enhancer activity. Systematic mutagenesis of HR2 revealed several important sub-regions. Mutagenesis of sub-regions 4-5, and 9 reduced transcriptional activity by similar to 60 and 40%, respectively. These sub-regions can bind the beta cellspecific transcription factors PDX1 and BETA2, respectively, both in vitro and in vivo. Thus, cell-specific expression of the GPR40 gene involves a characteristic chromatin organization of the locus and is controlled at the transcriptional level through HR2, a potent beta cell-specific enhancer.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, POB 26, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il						Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; ARONHEIM A, 1991, NUCLEIC ACIDS RES, V19, P3893, DOI 10.1093/nar/19.14.3893; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Deryckere F, 1996, GENE, V175, P35, DOI 10.1016/0378-1119(96)00117-5; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Flodgren E, 2007, BIOCHEM BIOPH RES CO, V354, P240, DOI 10.1016/j.bbrc.2006.12.193; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Glick E, 2000, J BIOL CHEM, V275, P2199, DOI 10.1074/jbc.275.3.2199; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; HUTTON JC, 1990, BIOCHEM SOC T, V18, P122, DOI 10.1042/bst0180122; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; KADESCH T, 1992, IMMUNOL TODAY, V13, P31, DOI 10.1016/0167-5699(92)90201-H; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Liberzon A, 2004, NUCLEIC ACIDS RES, V32, P54, DOI 10.1093/nar/gkh156; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; PARK CW, 1992, J BIOL CHEM, V267, P15642; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Poitout V, 2003, TRENDS ENDOCRIN MET, V14, P201, DOI 10.1016/S1043-2760(03)00086-9; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; Rutter GA, 2003, CURR BIOL, V13, pR403, DOI 10.1016/S0960-9822(03)00322-1; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	42	34	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23561	23571		10.1074/jbc.M702115200	http://dx.doi.org/10.1074/jbc.M702115200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17525159	hybrid			2022-12-27	WOS:000248577500058
J	Choi, CS; Savage, DB; Kulkarni, A; Yu, XX; Liu, ZX; Morino, K; Kim, S; Distefano, A; Samuel, VT; Neschen, S; Zhang, DY; Wang, A; Zhang, XM; Kahn, M; Cline, GW; Pandey, SK; Geisler, JG; Bhanot, S; Monia, BP; Shulman, GI				Choi, Cheol Soo; Savage, David B.; Kulkarni, Ameya; Yu, Xing Xian; Liu, Zhen-Xiang; Morino, Katsutaro; Kim, Sheene; Distefano, Alberto; Samuel, Varman T.; Neschen, Susanne; Zhang, Dongyan; Wang, Amy; Zhang, Xian-Man; Kahn, Mario; Cline, Gary W.; Pandey, Sanjay K.; Geisler, John G.; Bhanot, Sanjay; Monia, Brett P.; Shulman, Gerald I.			Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; GLUCOSE-METABOLISM; MONOACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; RECEPTOR SUBSTRATE-1; OBESITY RESISTANCE; TREATMENT STRATEGY; LIVER	Nonalcoholic fatty liver disease (NAFLD) is a major contributing factor to hepatic insulin resistance in type 2 diabetes. Diacylglycerol acyltransferase (Dgat), of which there are two iso-forms (Dgat1 and Dgat2), catalyzes the final step in triglyceride synthesis. We evaluated the metabolic impact of pharmacological reduction of DGAT1 and -2 expression in liver and fat using antisense oligonucleotides (ASOs) in rats with diet-induced NAFLD. Dgat1 and Dgat2 ASO treatment selectively reduced DGAT1 and DGAT2 mRNA levels in liver and fat, but only Dgat2 ASO treatment significantly reduced hepatic lipids (diacylglycerol and triglyceride but not long chain acyl CoAs) and improved hepatic insulin sensitivity. Because Dgat catalyzes triglyceride synthesis from diacylglycerol, and because we have hypothesized that diacylglycerol accumulation triggers fat-induced hepatic insulin resistance through protein kinase C-is an element of activation, we next sought to understand the paradoxical reduction in diacylglycerol in Dgat2 ASO-treated rats. Within 3 days of starting Dgat2 ASO therapy in high fat-fed rats, plasma fatty acids increased, whereas hepatic lysophosphatidic acid and diacylglycerol levels were similar to those of control rats. These changes were associated with reduced expression of lipogenic genes (SREBP1c, ACC1, SCD1, and mtGPAT) and increased expression of oxidative/thermogenic genes ( CPT1 and UCP2). Taken together, these data suggest that knocking down Dgat2 protects against fat-induced hepatic insulin resistance by paradoxically lowering hepatic diacylglycerol content and protein kinase C-is an element of activation through decreased SREBP1c-mediated lipogenesis and increased hepatic fatty acid oxidation.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Isis Pharmaceut, Carlsbad, CA 92008 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Isis Pharmaceuticals Inc; Howard Hughes Medical Institute; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, TAC S269,POB 9812, New Haven, CT 06536 USA.	gerald.shulman@yale.edu	MORINO, KATSUTARO/I-3207-2019; Adiels, Martin/C-9278-2011; Shulman, Gerald I./P-7176-2019; Distefano, Alberto/AAD-8638-2019; O'Rahilly, Stephen/ABF-6509-2020	MORINO, KATSUTARO/0000-0003-2420-3817; Shulman, Gerald I./0000-0003-1529-5668; Distefano, Alberto/0000-0003-2842-9119; O'Rahilly, Stephen/0000-0003-2199-4449; Savage, David Bousfield/0000-0002-7857-7032	NIDDK NIH HHS [R01 DK-40936, R01 DK040936, P30 DK-45735] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK040936] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2938, DOI 10.1172/JCI118001; Cooney GJ, 2002, ANN NY ACAD SCI, V967, P196; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; JUMP DB, 1994, J LIPID RES, V35, P1076; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; LEHNER R, 1993, J BIOL CHEM, V268, P8781; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Neschen S, 2002, AM J PHYSIOL-ENDOC M, V282, pE395, DOI 10.1152/ajpendo.00414.2001; OHSHIMA K, 1984, AM J PHYSIOL, V246, pE193, DOI 10.1152/ajpendo.1984.246.2.E193; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; SHMUELI E, 1993, J INTERN MED, V234, P397, DOI 10.1111/j.1365-2796.1993.tb00761.x; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Streeper RS, 2006, AM J PHYSIOL-ENDOC M, V291, pE388, DOI 10.1152/ajpendo.00621.2005; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	50	282	302	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22678	22688		10.1074/jbc.M704213200	http://dx.doi.org/10.1074/jbc.M704213200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17526931	hybrid			2022-12-27	WOS:000248354200045
J	Jin, MH; Yuan, Q; Li, SH; Travis, GH				Jin, Minghao; Yuan, Quan; Li, Songhua; Travis, Gabriel H.			Role of LRAT on the retinoid isomerase activity and membrane association of Rpe65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE VISUAL CYCLE; PIGMENT EPITHELIUM; PROTEIN PALMITOYLATION; VITAMIN-A; LECITHIN; ACYLTRANSFERASE; ESTERS; ISOMEROHYDROLASE; SUBSTRATE; ISOMERIZATION	Absorption of a photon by a vertebrate opsin pigment induces 11-cis to all-trans isomerization of its retinaldehyde chromophore. Restoration of light sensitivity to the bleached opsin requires chemical re-isomerization of the chromophore via an enzyme pathway called the visual cycle. The retinoid isomerase in this pathway is Rpe65, a membrane-associated protein in the retinal pigment epithelium (RPE) with no predicted membrane-spanning segments. It has been suggested that Rpe65 is S-palmitoylated by lecithin: retinol acyl transferase (LRAT) on Cys(231), Cys(329), and Cys(330), and that this palmitoylation is required for isomerase activity and the association of Rpe65 with membranes. Here we show that the affinity of Rpe65 for membranes is similar in wild-type and lrat(-/-) mice. The isomerase activity of Rpe65 is also similar in both strains when all-trans-retinyl palmitate is used as substrate. With all-trans-retinol substrate, isomerase activity is present in wild-type but undetectable in RPE homogenates from lrat(-/-) mice. Substitution of Cys231, Cys(329), and Cys(330) with Ser or Ala did not affect the affinity of Rpe65 for membranes. Further, these Cys residues are not palmitoylated in Rpe65 by mass spectrometric analysis. Global inhibition of protein palmitoylation by 2-bromopalmitate did not affect the solubility or isomerase activity of Rpe65. Finally, we show that soluble and membrane-associated Rpe65 possesses similar isomerase specific activities. These results indicate that LRAT is not required for isomerase activity beyond synthesis of retinyl-ester substrate, and that the association of Rpe65 with membranes is neither dependent upon LRAT nor the result of S-palmitoylation. The affinity of Rpe65 for membranes is probably an intrinsic feature of this protein.	Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	travis@jsei.ucla.edu	Travis, Gabriel Harvey/AIF-1062-2022; yuan, quan/GZM-5597-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; 	NEI NIH HHS [R01 EY011713-14, R01 EY015844, R01 EY011713, R01 EY011713-15, R01 EY011713-16, R01 EY015844-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011713, R01EY015844] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; DRIESSEN CAGG, 1995, INVEST OPHTH VIS SCI, V36, P1988; Felius J, 2002, ARCH OPHTHALMOL-CHIC, V120, P55; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P11824, DOI 10.1021/bi035227w; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P5809, DOI 10.1021/bi0341004; Guo H, 2006, J THEOR BIOL, V242, P117, DOI 10.1016/j.jtbi.2006.02.005; HO MTP, 1989, J BIOL CHEM, V264, P17759; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; JACKSON CS, 2002, CURRENT PROTOCOLS PR, V2; JIMENEZ CR, 2002, CURRENT PROTOCOLS PR, V2; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; RANDO RR, 1991, BIOCHEMISTRY-US, V30, P595, DOI 10.1021/bi00217a001; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Ruegg U T, 1977, Methods Enzymol, V47, P111; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; Tsilou E, 1997, ARCH BIOCHEM BIOPHYS, V346, P21, DOI 10.1006/abbi.1997.0276; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Xue LL, 2006, BIOCHEMISTRY-US, V45, P10710, DOI 10.1021/bi060897y; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016	31	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20915	20924		10.1074/jbc.M701432200	http://dx.doi.org/10.1074/jbc.M701432200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17504753	Green Accepted, hybrid			2022-12-27	WOS:000248047500017
J	Payne, VA; Au, WS; Gray, SL; Nora, ED; Rahman, SM; Sanders, R; Hadaschik, D; Friedman, JE; O'Rahilly, S; Rochford, JJ				Payne, Victoria A.; Au, Wo-Shing; Gray, Sarah L.; Nora, Edoardo Dalla; Rahman, Shaikh M.; Sanders, Rebecca; Hadaschik, Dirk; Friedman, Jacob E.; O'Rahilly, Stephen; Rochford, Justin J.			Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/Enhancer-binding protein ss(C/EBP ss) and C/EBP alpha during adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; MICE LACKING; 3T3-L1 PREADIPOCYTES; HEPATIC STEATOSIS; GENE-EXPRESSION; ADIPOSE-TISSUE; PPAR-GAMMA; IN-VITRO; BETA; ACTIVATION	Diacylglycerol acyltransferase 2 (DGAT2) catalyzes the final step of triacylglycerol (TG) synthesis. Despite the existence of an alternative acyltransferase (DGAT1), mice lacking DGAT2 have a severe deficiency of TG in adipose tissue, indicating a nonredundant role for this enzyme in adipocyte TG synthesis. We have studied the regulation of DGAT2 expression during adipogenesis. In both isolated murine preadipocytes and 3T3-L1 cells the temporal pattern of DGAT2 expression closely mimicked that of genes whose expression is regulated by CAAT/enhancer-binding protein beta (C/EBP beta). Inhibition of C/EBP beta expression in differentiating preadipocytes reduced DGAT2 expression, and electrophoretic mobility shift assay and chromatin immunoprecipitation experiments identified a promoter element in the DGAT2 gene that is likely to mediate this effect. The importance of C/EBP beta in adipocyte expression of DGAT2 was confirmed by the finding of reduced DGAT2 expression in the adipose tissue of C/EBP beta-null animals. However, DGAT2 expression is maintained at high levels during the later stages of adipogenesis, when C/EBP beta levels decline. We show that, at these later stages of differentiation, C/EBP alpha is capable of substituting for C/EBP beta at the same promoter element. These observations provide novel insight into the transcriptional regulation of DGAT2 expression. Moreover, they further refine the complex and serial roles of the C/EBP family of transcription factors in inducing and maintaining the metabolic properties of mature adipocytes.	Univ Cambridge, Dept Clin Biochem, Addenbrookes Hosp, Cambridge CB2 2QR, England; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Rochford, JJ (corresponding author), Univ Cambridge, Dept Clin Biochem, Addenbrookes Hosp, Box 232,Level 4,Hills Rd, Cambridge CB2 2QR, England.	jjr30@cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Rahman, Shaikh Mizanoor/GLN-7518-2022; Nora, Edoardo Dalla/AAA-8938-2019	O'Rahilly, Stephen/0000-0003-2199-4449; Rahman, Shaikh Mizanoor/0000-0002-4879-2663; dalla nora, edoardo/0000-0003-2583-4776; Rochford, Justin/0000-0002-5020-4939	British Heart Foundation [FS/05/092/19519] Funding Source: Medline; NIDDK NIH HHS [R01 DK059767, DK059767] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0600717B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059767] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Camp HS, 2002, TRENDS MOL MED, V8, P442, DOI 10.1016/S1471-4914(02)02396-1; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Jitrapakdee S, 2005, J BIOL CHEM, V280, P27466, DOI 10.1074/jbc.M503836200; Lane MD, 1996, INT J OBESITY, V20, pS91; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Magre J, 2003, DIABETES, V52, P1573, DOI 10.2337/diabetes.52.6.1573; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yamamoto H, 2002, J CELL SCI, V115, P3601, DOI 10.1242/jcs.00044; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	44	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21005	21014		10.1074/jbc.M702871200	http://dx.doi.org/10.1074/jbc.M702871200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17504763	Green Accepted, hybrid			2022-12-27	WOS:000248047500027
J	Sandelin, E; Nordlund, A; Andersen, PM; Marklund, SSL; Oliveberg, M				Sandelin, Erik; Nordlund, Anna; Andersen, Peter M.; Marklund, Stefan S. L.; Oliveberg, Mikael			Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALS-LINKED SOD1; CU,ZN-SUPEROXIDE DISMUTASE; AGGREGATION; MUTANTS; DISEASE; DATABASE; DESTABILIZATION; STABILITY; RESIDUES; DEFECTS	We provide bioinformatical evidence that protein charge plays a key role in the disease mechanism of amyotrophic lateral sclerosis (ALS). Analysis of 100 ALS-associated mutations in copper/zinc superoxide dismutase (SOD1) shows that these are site-selective with a preference to decrease the proteins' net repulsive charge. For each SOD1 monomer this charge is normally -6. Because biomolecules as a rule maintain net negative charge to assure solubility in the cellular interior, the result lends support to the hypothesis of protein aggregation as an initiating event in the ALS pathogenesis. The strength of the preferential reduction of repulsive charge is higher in SOD1 associated ALS than in other inherited protein disorders.	Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University	Oliveberg, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	mikael.oliveberg@dbb.su.se						Andersen PM, 2004, ANN NEUROL, V55, P298, DOI 10.1002/ana.10850; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Antonarakis SE, 2000, EUR J PEDIATR, V159, pS173, DOI 10.1007/PL00014395; Assfalg M, 2003, J MOL BIOL, V330, P145, DOI 10.1016/S0022-2836(03)00533-3; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bendotti C, 2004, J NEUROPATH EXP NEUR, V63, P113, DOI 10.1093/jnen/63.2.113; Brown A, 1998, NUCLEIC ACIDS RES, V26, P259, DOI 10.1093/nar/26.1.259; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chung J, 2003, BIOCHEM BIOPH RES CO, V312, P873, DOI 10.1016/j.bbrc.2003.11.008; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gunasekaran K, 1996, J MOL BIOL, V264, P191, DOI 10.1006/jmbi.1996.0633; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Kwok CJ, 2002, HUM MUTAT, V19, P217, DOI 10.1002/humu.10036; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Liochev SI, 2003, FREE RADICAL BIO MED, V34, P1383, DOI 10.1016/S0891-5849(03)00153-9; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Morrison BM, 1998, J COMP NEUROL, V391, P64, DOI 10.1002/(SICI)1096-9861(19980202)391:1<64::AID-CNE6>3.0.CO;2-P; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200	49	58	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21230	21236		10.1074/jbc.M700765200	http://dx.doi.org/10.1074/jbc.M700765200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17513298	hybrid			2022-12-27	WOS:000248047500050
J	Benanti, EL; Chivers, PT				Benanti, Erin L.; Chivers, Peter T.			The N-terminal arm of the Helicobacter pylori Ni2+-dependent transcription factor NikR is required for specific DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI NIKR; NICKEL-RESPONSIVE REGULATOR; CRYSTAL-STRUCTURE; HYDROGENASE ISOENZYMES; OPERATOR COMPLEX; ACID RESISTANCE; UREASE ACTIVITY; MNT REPRESSOR; METAL-BINDING; BETA-SHEETS	The Ni2+-dependent transcription factor NikR is widespread among microbes. The two experimentally characterized NikR orthologs, from Helicobacter pylori and Escherichia coli, display vastly different regulatory capabilities in response to increased intracellular Ni2+. Here, we demonstrate that the nine-residue N-terminal arm present in H. pylori NikR plays a critical role in the expanded regulatory capabilities of this NikR family member. Specifically, the N-terminal arm is required to inhibit NikR binding to low affinity and nonspecific DNA sequences and is also linked to a cation requirement for NikR binding to the nixA promoter. Site-directed mutagenesis and arm-truncation variants of NikR indicate that two residues, Asp-7 and Asp-8, are linked to the cation requirement for binding. Pro-4 and Lys-6 are required for maximal DNA binding affinity of the full-length protein to both the nixA and ureA promoters. The N-terminal arm is highly variable among NikR family members, and these results suggest that it is an adaptable structural feature that can tune the regulatory capabilities of NikR to the nickel physiology of the microbe in which it is found.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Chivers, PT (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	chivers@wustl.edu		Chivers, Peter/0000-0002-8779-1452				Abraham LO, 2006, J INORG BIOCHEM, V100, P1005, DOI 10.1016/j.jinorgbio.2005.10.014; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Bauerfeind P, 1997, GUT, V40, P25, DOI 10.1136/gut.40.1.25; Belzer C, 2005, MICROBIOL-SGM, V151, P3989, DOI 10.1099/mic.0.28188-0; Berggrun A, 2000, J MOL BIOL, V301, P959, DOI 10.1006/jmbi.2000.4007; Berggrun A, 2001, P NATL ACAD SCI USA, V98, P2301, DOI 10.1073/pnas.041612198; BLASER MJ, 1990, J INFECT DIS, V161, P626, DOI 10.1093/infdis/161.4.626; Bloom SL, 2004, BIOCHEMISTRY-US, V43, P10029, DOI 10.1021/bi049404k; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Carrington PE, 2003, NAT STRUCT BIOL, V10, P126, DOI 10.1038/nsb890; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Chivers PT, 1999, PROTEIN SCI, V8, P2494, DOI 10.1110/ps.8.11.2494; Chivers PT, 2005, J MOL BIOL, V348, P597, DOI 10.1016/j.jmb.2005.03.017; Chivers PT, 2000, J BIOL CHEM, V275, P19735, DOI 10.1074/jbc.M002232200; Chivers PT, 2002, CHEM BIOL, V9, P1141, DOI 10.1016/S1074-5521(02)00241-7; Contreras M, 2003, MOL MICROBIOL, V49, P947, DOI 10.1046/j.1365-2958.2003.03621.x; Cowan JA, 1998, CHEM REV, V98, P1067, DOI 10.1021/cr960436q; Davis GS, 2006, INFECT IMMUN, V74, P6811, DOI 10.1128/IAI.01188-06; De Pina K, 1999, J BACTERIOL, V181, P670, DOI 10.1128/JB.181.2.670-674.1999; Delany I, 2005, J BACTERIOL, V187, P7703, DOI 10.1128/JB.187.22.7703-7715.2005; Dian C, 2006, J MOL BIOL, V361, P715, DOI 10.1016/j.jmb.2006.06.058; Dias AV, 2005, J BIOL INORG CHEM, V10, P605, DOI 10.1007/s00775-005-0008-2; Dosanjh NS, 2007, BIOCHEMISTRY-US, V46, P2520, DOI 10.1021/bi062092w; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; Ernst FD, 2005, INFECT IMMUN, V73, P7252, DOI 10.1128/IAI.73.11.7252-7258.2005; Ernst FD, 2006, INFECT IMMUN, V74, P6821, DOI 10.1128/IAI.01196-06; FOX JG, 1990, GASTROENTEROLOGY, V99, P352, DOI 10.1016/0016-5085(90)91016-Y; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; KNIGHT KL, 1989, P NATL ACAD SCI USA, V86, P797, DOI 10.1073/pnas.86.3.797; Leitch S, 2007, J AM CHEM SOC, V129, P5085, DOI 10.1021/ja068505y; Maier RJ, 2007, BIOMETALS, V20, P655, DOI 10.1007/s10534-006-9061-8; Maroney MJ, 1999, CURR OPIN CHEM BIOL, V3, P188, DOI 10.1016/S1367-5931(99)80032-5; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Nguyen CC, 1995, FEBS LETT, V377, P98, DOI 10.1016/0014-5793(95)01344-X; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAUMANN BE, 1995, NAT STRUCT BIOL, V2, P1115, DOI 10.1038/nsb1295-1115; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; RAUMANN BE, 1994, CURR OPIN STRUC BIOL, V4, P36, DOI 10.1016/S0959-440X(94)90057-4; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Schreiter ER, 2003, NAT STRUCT BIOL, V10, P794, DOI 10.1038/nsb985; Schreiter ER, 2006, P NATL ACAD SCI USA, V103, P13676, DOI 10.1073/pnas.0606247103; Scott DR, 2002, GASTROENTEROLOGY, V123, P187, DOI 10.1053/gast.2002.34218; Scott DR, 1998, GASTROENTEROLOGY, V114, P58, DOI 10.1016/S0016-5085(98)70633-X; SEGAL ED, 1992, INFECT IMMUN, V60, P1883, DOI 10.1128/IAI.60.5.1883-1889.1992; Shirai M, 1999, GENE, V239, P351, DOI 10.1016/S0378-1119(99)00389-3; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Stingl K, 2005, INT J MED MICROBIOL, V295, P307, DOI 10.1016/j.ijmm.2005.06.006; TULLIUS TD, 1987, METHOD ENZYMOL, V155, P537; van Vliet AHM, 2004, INFECT IMMUN, V72, P766, DOI 10.1128/IAI.72.2.766-773.2004; van Vliet AHM, 2002, INFECT IMMUN, V70, P2846, DOI 10.1128/IAI.70.6.2846-2852.2002; VERSHON AK, 1987, J MOL BIOL, V195, P311, DOI 10.1016/0022-2836(87)90652-8; Wang SC, 2004, BIOCHEMISTRY-US, V43, P10018, DOI 10.1021/bi049405c; WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222; WU LF, 1989, MOL MICROBIOL, V3, P1709, DOI 10.1111/j.1365-2958.1989.tb00156.x; WU LF, 1991, GENE, V107, P37; ZINONI F, 1984, ARCH MICROBIOL, V139, P299, DOI 10.1007/BF00408370	68	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20365	20375		10.1074/jbc.M702982200	http://dx.doi.org/10.1074/jbc.M702982200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17522054	hybrid			2022-12-27	WOS:000247819300039
J	Fries, T; Betz, C; Sohn, K; Caesar, S; Schlenstedt, G; Bailer, SM				Fries, Thomas; Betz, Christian; Sohn, Kai; Caesar, Stefanie; Schlenstedt, Gabriel; Bailer, Susanne M.			A novel conserved nuclear localization signal is recognized by a group of yeast importins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEINS; MAMMALIAN-CELLS; TRANSPORT; EXPORT; BETA; HISTONES; RECEPTOR; KARYOPHERINS; COMPLEXES; PATHWAY	Nucleo-cytoplasmic transport of proteins is mostly mediated by specific interaction between transport receptors of the importin beta family and signal sequences present in their cargo. While several signal sequences, in particular the classical nuclear localization signal (NLS) recognized by the heterodimeric importin alpha/beta complex are well known, the signals recognized by other importin beta-like transport receptors remain to be characterized in detail. Here we present the systematic analysis of the nuclear import of Saccharomyces cerevisiae Asr1p, a nonessential alcohol-responsive Ring/PHD finger protein that shuttles between nucleus and cytoplasm but accumulates in the nucleus upon alcohol stress. Nuclear import of Asr1p is constitutive and mediated by its C-terminal domain. A short sequence comprising residues 243-280 is sufficient and necessary for active targeting to the nucleus. Moreover, the nuclear import signal is conserved from yeast to mammals. In vitro, the nuclear localization signal of Asr1p directly interacts with the importins Kap114p, Kap95p, Pse1p, Kap123p, or Kap104p, interactions that are sensitive to the presence of RanGTP. In vivo, these importins cooperate in nuclear import. Interestingly, the same importins mediate nuclear transport of histone H2A. Based on mutational analysis and sequence comparison with a region mediating nuclear import of histone H2A, we identified a ;novel type of NLS with the consensus sequence R/KxxL(x)(n)V/YxxV/IxK/RxxxK/R that is recognized by five yeast importins and connects them into a highly efficient network for nuclear import of proteins.	Univ Saarland, D-66421 Homburg, Germany; Fraunhofer Inst Grenzflachen & Bioverfahrenstech, D-70569 Stuttgart, Germany	Saarland University; Fraunhofer Gesellschaft	Bailer, SM (corresponding author), Univ Saarland, D-66421 Homburg, Germany.	dr.susanne.bailer@med-rz.uni-saarland.de						Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; Betz C, 2004, J BIOL CHEM, V279, P28174, DOI 10.1074/jbc.M401595200; Caesar S, 2006, MOL CELL BIOL, V26, P3170, DOI 10.1128/MCB.26.8.3170-3180.2006; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Greiner M, 2004, EUR J CELL BIOL, V83, P511, DOI 10.1078/0171-9335-00418; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Koepp DM, 1996, J CELL BIOL, V133, P1163, DOI 10.1083/jcb.133.6.1163; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Maurer P, 2001, MOL BIOL CELL, V12, P539, DOI 10.1091/mbc.12.3.539; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Solsbacher J, 1998, MOL CELL BIOL, V18, P6805, DOI 10.1128/MCB.18.11.6805; Strom AC, 2001, GENOME BIOL, V2; Sullivan SA, 2000, NUCLEIC ACIDS RES, V28, P320, DOI 10.1093/nar/28.1.320; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207	30	22	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19292	19301		10.1074/jbc.M700217200	http://dx.doi.org/10.1074/jbc.M700217200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17485461	hybrid			2022-12-27	WOS:000247650600004
J	Izquierdo, JM; Valcarcel, J				Izquierdo, Jose M.; Valcarcel, Juan			Two isoforms of the T-cell intracellular antigen 1 (TIA-1) splicing factor display distinct splicing regulation activities - Control of TIA-1 isoform ratio by TIA-1-related protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; BINDING PROTEINS TIA-1; U1 SNRNP; TRANSLATIONAL SILENCER; STRESS GRANULES; 5'-SPLICE SITES; RICH ELEMENT; IDENTIFICATION; EXPRESSION; DISEASE	TIA-1 (T-cell Intracellular Antigen 1) and TIAR (TIA-1-related protein) are RNA-binding proteins involved in the regulation of alternative pre-mRNA splicing and other aspects of RNA metabolism. Various isoforms of these proteins exist in mammals. For example, TIA- 1 presents two major isoforms (TIA-1a and TIA-1b) generated by alternative splicing of exon 5 that differ by eleven amino acids exclusive of the TIA-1a isoform. Here we show that the relative expression of TIA-1 and TIAR isoforms varies in different human tissues and cell lines, suggesting distinct functional properties and regulated isoform expression. We report that whereas TIA-1 isoforms show similar subcellular distribution and RNA binding, TIA-1b displays enhanced splicing stimulatory activity compared with TIA-1a, both in vitro and in vivo. Interestingly, TIAR depletion from HeLa and mouse embryonic fibroblasts results in an increased ratio of TIA-1b/a expression, suggesting that TIAR regulates the relative expression of TIA-1 isoforms. Taken together, the results reveal distinct functional properties of TIA-1 isoforms and the existence of a regulatory network that controls isoform expression.	Univ Autonoma Madrid, Fac Sci, CBMSO, Dept Mol Biol, Madrid 28049, Spain; Univ Pompeu Fabra, Inst Catalana Rec & Study Avancats, Barcelona 08003, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); ICREA; Pompeu Fabra University	Izquierdo, JM (corresponding author), Univ Autonoma Madrid, Fac Sci, CBMSO, Dept Mol Biol, Modulo C-V,Lab 230,Cantoblanco, Madrid 28049, Spain.	jmizquierdo@cbm.uam.es	Valcarcel, Juan/O-9814-2014	Valcarcel, Juan/0000-0001-5398-3571	ICREA Funding Source: Custom	ICREA(ICREA)		Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Beck ARP, 1996, NUCLEIC ACIDS RES, V24, P3829, DOI 10.1093/nar/24.19.3829; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Discenza MT, 2004, PHYSIOL GENOMICS, V16, P287, DOI 10.1152/physiolgenomics.00164.2003; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hastie ND, 2001, CELL, V106, P391, DOI 10.1016/S0092-8674(01)00469-X; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Isquierdo JM, 2006, BIOCHEM BIOPH RES CO, V348, P703, DOI 10.1016/j.bbrc.2006.7.114; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; Izquierdo JM, 2006, GENE DEV, V20, P1679, DOI 10.1101/gad.1449106; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KAJITA Y, 1995, J BIOL CHEM, V270, P22167, DOI 10.1074/jbc.270.38.22167; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; KAWAKAMI A, 1994, J IMMUNOL, V152, P4937; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Koloteva-Levine N, 2002, FEBS LETT, V523, P73, DOI 10.1016/S0014-5793(02)02938-1; Lal A, 2006, MOL CELL, V22, P117, DOI 10.1016/j.molcel.2006.03.016; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Le Guiner C, 2003, J BIOL CHEM, V278, P10465, DOI 10.1074/jbc.M212378200; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; MAGAN S, 2006, J MOL BIOL, V356, P1073; MANZANMAMCZARZ K, 2006, MOL CELL BIOL, V26, P2716; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Soares LMM, 2006, EMBO J, V25, P923, DOI 10.1038/sj.emboj.7601023; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; TAUPIN JL, 1995, P NATL ACAD SCI USA, V92, P1629, DOI 10.1073/pnas.92.5.1629; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yu Q, 2003, J BIOL CHEM, V278, P1579, DOI 10.1074/jbc.M203526200; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zhu H, 2003, MOL CELL BIOL, V23, P5959, DOI 10.1128/MCB.23.17.5959-5971.2003; Zhu H, 2006, MOL BIOL CELL, V17, P5105, DOI 10.1091/mbc.E06-02-0099; Zuccato E, 2004, J BIOL CHEM, V279, P16980, DOI 10.1074/jbc.M313439200	69	52	53	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19410	19417		10.1074/jbc.M700688200	http://dx.doi.org/10.1074/jbc.M700688200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488725	hybrid			2022-12-27	WOS:000247650600015
J	Maa, MC; Lee, JC; Chen, YJ; Chen, YJ; Lee, YC; Wang, ST; Huang, CC; Chow, NH; Leu, TH				Maa, Ming-Chei; Lee, Jenq-Chang; Chen, Yen-Jen; Chen, Yun-Ju; Lee, Yuch-Ching; Wang, Shan-Tair; Huang, Ching-Chung; Chow, Nan-Haw; Leu, Tzeng-Horng			EPS8 facilitates cellular growth and motility of colon cancer cells by increasing the expression and activity of focal adhesion kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAT3 ACTIVATION; MAXIMAL ACTIVATION; FACTOR RECEPTOR; C-SRC; PROTEIN; TYROSINE; PHOSPHORYLATION; BINDING; OVEREXPRESSION; TRANSFORMATION	In an attempt to study the role of Eps8 in human carcinogenesis, we observe that ectopic overexpression of Eps8 in SW480 cells (low Eps8 expression) increases cell proliferation. By contrast, expressing eps8 small interference RNA in SW620 and WiDr cells (high Eps8 expression) reduces their proliferation rate. Interestingly, attenuation of Eps8 decreases Src Pi-Tyr-416, Shc Pi-Tyr-317, and serum-induced FAK Pi-Tyr-397 and Pi-Tyr-861. Remarkably, by virtue of mammalian target of rapamycin/STAT3 Pi-Ser-727, Eps8 modulates FAK expression required for cell proliferation. Within 62% of colorectal tumor specimens examined, > 2-fold enhancement of Eps8 as compared with their normal counterparts is observed, especially for those from the advanced stage. In agreement with the modulation of FAK by Eps8, the concomitant expression of these two proteins in tumor specimens is observed. Notably, Eps8 attenuation also impedes the motility of SW620 and WiDr cells, which can be rescued by ectopically expressed FAK. This finding discloses the indispensability of Eps8 and FAK in cell locomotion. These results provide a novel mechanism for Eps8-mediated FAK expression and activation in colon cancer cells.	China Med Univ, Inst Med Sci, Taichung 40402, Taiwan; Natl Cheng Kung Univ, Dept Surg, Tainan 70101, Taiwan; Natl Cheng Kung Univ, Inst Basic Med Sci, Dept Pharmacol, Tainan 70101, Taiwan; Natl Cheng Kung Univ, Inst Basic Med Sci, Dept Publ Hlth, Tainan 70101, Taiwan; Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan 70101, Taiwan; Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Leu, TH (corresponding author), China Med Univ, Inst Med Sci, Taichung 40402, Taiwan.	tzengleu@mail.ncku.edu.tw						Agochiya M, 1999, ONCOGENE, V18, P5646, DOI 10.1038/sj.onc.1202957; Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Baisden JM, 2001, ONCOGENE, V20, P6607, DOI 10.1038/sj.onc.1204802; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; DEVOR BB, 1993, BIOCHEM BIOPH RES CO, V190, P1084, DOI 10.1006/bbrc.1993.1160; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Gallo R, 1997, ONCOGENE, V15, P1929, DOI 10.1038/sj.onc.1201344; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hecker TP, 2004, ONCOGENE, V23, P3962, DOI 10.1038/sj.onc.1207541; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lee JC, 2005, MOL CARCINOGEN, V43, P207, DOI 10.1002/mc.20117; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Leu TH, 2004, J BIOL CHEM, V279, P9875, DOI 10.1074/jbc.M309884200; Leu TH, 2003, FRONT BIOSCI-LANDMRK, V8, pS28, DOI 10.2741/980; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Maa MC, 1999, BBA-MOL CELL RES, V1450, P341, DOI 10.1016/S0167-4889(99)00069-5; Maa MC, 2001, ONCOGENE, V20, P106, DOI 10.1038/sj.onc.1204069; Matoskova B, 1996, ONCOGENE, V12, P2679; OWENS LV, 1995, CANCER RES, V55, P2752; Parker SL, 1996, CA-CANCER J CLIN, V46, P5, DOI 10.3322/canjclin.46.1.5; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamamoto D, 2003, CELL SIGNAL, V15, P575, DOI 10.1016/S0898-6568(02)00142-0; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555	49	62	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19399	19409		10.1074/jbc.M610280200	http://dx.doi.org/10.1074/jbc.M610280200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17496330	hybrid			2022-12-27	WOS:000247650600014
J	Davis, ML; Thoden, JB; Holden, HM				Davis, Melissa L.; Thoden, James B.; Holden, Hazel M.			The X-ray structure of dTDP-4-keto-6-deoxy-D-glucose-3,4-ketoisomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-LAYER; CUPIN SUPERFAMILY; BIOSYNTHESIS; PROTEINS; BACTERIA; EVOLUTION; GENES	The repeating unit of the glycan chain in the S-layer of the bacterium Aneurinibacillus thermoaerophilus L420-91(T) is composed of four alpha-D-rhamnose molecules and two 3-acetamido3,6- dideoxy-alpha-D-galactose moieties (abbreviated as Fucp3NAc). Formation of the glycan layer requires nucleotide-activated sugars as the donor molecules. Whereas the enzymes involved in the synthesis of GDP-rhamnose have been well characterized, less is known regarding the structures and enzymatic mechanisms of the enzymes required for the production of dTDP-Fucp3NAc. One of the enzymes involved in the biosynthesis of dTDP-Fucp3NAc is a 3,4-ketoisomerase, hereafter referred to as FdtA. Here we describe the first three-dimensional structure of this sugar isomerase complexed with dTDP and solved to 1.5 A resolution. The FdtA dimer assumes an almost jellyfish-like appearance with the sole alpha-helices representing the tentacles. Formation of the FdtA dimer represents a classical example of domain swapping whereby beta-strands 2 and 3 from one subunit form part of a beta-sheet in the second subunit. The active site architecture of FdtA is characterized by a cluster of three histidine residues, two of which, His(49) and His(51), appear to be strictly conserved in the amino acid sequences deposited to date. Site-directed mutagenesis experiments, enzymatic assays, and x-ray crystallographic analyses suggest that His(49) functions as an active site base.			Holden, HM (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.	Hazel_Holden@biochem.wisc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047814, R56DK047814] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Claus H, 2005, CAN J MICROBIOL, V51, P731, DOI 10.1139/W05-093; DeLano W.L., 2003, PYMOL REFERENCE MANU; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Garduno R, 2000, CAN J MICROBIOL, V46, P660, DOI 10.1139/cjm-46-7-660; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; He XM, 2002, CURR OPIN CHEM BIOL, V6, P590, DOI 10.1016/S1367-5931(02)00367-8; He XMM, 2002, ANNU REV BIOCHEM, V71, P701, DOI 10.1146/annurev.biochem.71.110601.135339; Johnson D. A., 1999, COMPREHENSIVE NATURA, P311; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KOSMA P, 1995, GLYCOCONJUGATE J, V12, P99, DOI 10.1007/BF00731875; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Melancon CE, 2007, BIOCHEMISTRY-US, V46, P577, DOI 10.1021/bi061907y; Michalopoulos I, 2004, NUCLEIC ACIDS RES, V32, pD251, DOI 10.1093/nar/gkh060; Novotny R, 2003, GLYCOCONJUGATE J, V20, P435, DOI 10.1023/B:GLYC.0000038290.74944.65; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Sabet M, 2003, MICROBIOL-SGM, V149, P3617, DOI 10.1099/mic.0.26535-0; Sambrook J., 2001, MOL CLONING LAB MANU; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schaffer C, 2001, BIOCHIMIE, V83, P591, DOI 10.1016/S0300-9084(01)01299-8; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Trefzer A, 1999, NAT PROD REP, V16, P283, DOI 10.1039/a804431g; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012	31	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19227	19236		10.1074/jbc.M702529200	http://dx.doi.org/10.1074/jbc.M702529200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17459872	hybrid			2022-12-27	WOS:000247475300063
J	Hou, ZB; Li, Q; He, LS; Lim, HY; Fu, XR; Cheung, NS; Qi, DX; Qi, RZ				Hou, Zhibo; Li, Qing; He, Lisheng; Lim, Hui-Ying; Fu, Xinrong; Cheung, Nam Sang; Qi, Donna X.; Qi, Robert Z.			Microtubule association of the neuronal p35 activator of Cdk5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; PHOSPHORYLATION; IDENTIFICATION; CLEAVAGE; DEFECTS; P25	Cdk5 and its neuronal activator p35 play an important role in neuronal migration and proper development of the brain cortex. We show that p35 binds directly to alpha/beta-tubulin and microtubules. Microtubule polymers but not the alpha/beta-tubulin heterodimer block p35 interaction with Cdk5 and therefore inhibit Cdk5-p35 activity. p25, a neurotoxin-induced and truncated form of p35, does not have tubulin and microtubule binding activities, and Cdk5-p25 is inert to the inhibitory effect of microtubules. p35 displays strong activity in promoting microtubule assembly and inducing formation of microtubule bundles. Furthermore, microtubules stabilized by p35 are resistant to cold-induced disassembly. In cultured cortical neurons, a significant proportion of p35 localizes to microtubules. When microtubules were isolated from rat brain extracts, p35 co-assembled with microtubules, including cold-stable microtubules. Together, these findings suggest that p35 is a microtubule-associated protein that modulates microtubule dynamics. Also, microtubules play an important role in the control of Cdk5 activation.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Inst Mol & Cell Biol, Singapore 138673, Singapore; Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Hong Kong University of Science & Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk		Lim, Hui-Ying/0000-0001-8084-6337				Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; BAAS PW, 1994, J CELL SCI, V107, P135; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; GASKIN F, 1982, METHOD ENZYMOL, V85, P433; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lim ACB, 2004, J BIOL CHEM, V279, P4433, DOI 10.1074/jbc.M310563200; Lim ACB, 2004, J BIOL CHEM, V279, P46668, DOI 10.1074/jbc.M404760200; Lim ACB, 2003, NEUROSIGNALS, V12, P230, DOI 10.1159/000074625; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Qi Z, 1998, FEBS LETT, V423, P227, DOI 10.1016/S0014-5793(98)00096-9; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tang DM, 1997, J BIOL CHEM, V272, P12318, DOI 10.1074/jbc.272.19.12318; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; TURNER PF, 1984, J CELL BIOL, V99, P940, DOI 10.1083/jcb.99.3.940; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6	28	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18666	18670		10.1074/jbc.C700052200	http://dx.doi.org/10.1074/jbc.C700052200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17491008	hybrid, Green Published			2022-12-27	WOS:000247475300003
J	Shalbuyeva, N; Brustovetsky, T; Brustovetsky, N				Shalbuyeva, Natalia; Brustovetsky, Tatiana; Brustovetsky, Nickolay			Lithium desensitizes brain mitochondria to calcium, antagonizes permeability transition, and diminishes cytochrome c release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; CEREBELLAR GRANULE CELLS; CA-2&-INDUCED MEMBRANE TRANSITION; GLYCOGEN-SYNTHASE KINASE-3; CYCLOSPORINE-A; CYCLOPHILIN-D; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; STRIATAL NEURONS; GLUTAMATE EXCITOTOXICITY	Among the numerous effects of lithium on intracellular targets, its possible action on mitochondria remains poorly explored. In the experiments with suspension of isolated brain mitochondria, replacement of KCl by LiCl suppressed mitochondrial swelling, depolarization, and a release of cytochrome c induced by a single Ca2+ bolus. Li+ robustly protected individual brain mitochondria loaded with rhodamine 123 against Ca2+- induced depolarization. In the experiments with slow calcium infusion, replacement of KCl by LiCl in the incubation medium increased resilience of synaptic and nonsynaptic brain mitochondria as well as resilience of liver and heart mitochondria to the deleterious effect of Ca2+. In LiCl medium, mitochondria accumulated larger amounts of Ca2+ before they lost the ability to sequester Ca2+. However, lithium appeared to be ineffective if mitochondria were challenged by Sr2+ instead of Ca2+. Cyclosporin A, sanglifehrin A, and Mg2+, inhibitors of the mitochondrial permeability transition (mPT), increased mitochondrial Ca2+ capacity in KCl medium but failed to do so in LiCl medium. This suggests that the mPT might be a common target for Li+ and mPT inhibitors. In addition, lithium protected mitochondria against high Ca2+ in the presence of ATP, where cyclosporin A was reported to be ineffective. SB216763 and SB415286, inhibitors of glycogen synthase kinase-3 beta, which is implicated in regulating reactive oxygen species-induced mPT in cardiac mitochondria, did not increase Ca2+ capacity of brain mitochondria. Altogether, these findings suggest that Li+ desensitizes mitochondria to elevated Ca2+ and diminishes cytochrome c release from brain mitochondria by antagonizing the Ca2+-induced mPT.	Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Brustovetsky, N (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,Med Sci Bldg,Rm 549, Indianapolis, IN 46202 USA.	nbrous@iupui.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050131] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS 050131] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bambrick LL, 2006, J BIOENERG BIOMEMBR, V38, P43, DOI 10.1007/s10863-006-9004-7; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1993, J BIOL CHEM, V268, P1005; BERNARDI P, 1982, FEBS LETT, V139, P9, DOI 10.1016/0014-5793(82)80475-4; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Brocard JB, 2001, J PHYSIOL-LONDON, V531, P793, DOI 10.1111/j.1469-7793.2001.0793h.x; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; BROWN MR, 2006, J BIOL CHEM; Brustovetsky N, 2003, J NEUROCHEM, V84, P196, DOI 10.1046/j.1471-4159.2003.01545.x; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Brustovetsky T, 2005, J PHYSIOL-LONDON, V568, P47, DOI 10.1113/jphysiol.2005.091199; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; CARAFOLI E, 1965, BIOCHIM BIOPHYS ACTA, V97, P88, DOI 10.1016/0304-4165(65)90272-2; Castilho RF, 1998, J NEUROSCI, V18, P10277; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chinopoulos C, 2004, J NEUROCHEM, V91, P471, DOI 10.1111/j.1471-4159.2004.02732.x; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Czyz A, 2002, J NEUROCHEM, V81, P379, DOI 10.1046/j.1471-4159.2002.00851.x; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; GEAR ARL, 1968, J BIOL CHEM, V243, P3953; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; HUTSON SM, 1976, J BIOL CHEM, V251, P5251; Isaev NK, 1996, FEBS LETT, V392, P143, DOI 10.1016/0014-5793(96)00804-6; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Karkanias NB, 1999, J NEUROPHYSIOL, V81, P1506, DOI 10.1152/jn.1999.81.4.1506; KHODOROV B, 1995, FEBS LETT, V371, P249, DOI 10.1016/0014-5793(95)00894-F; Kiedrowski L, 1999, MOL PHARMACOL, V56, P619, DOI 10.1124/mol.56.3.619; KIEDROWSKI L, 1992, MOL PHARMACOL, V41, P779; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Layden BT, 2005, BBA-MOL BASIS DIS, V1741, P339, DOI 10.1016/j.bbadis.2005.07.004; LEQUOC K, 1988, ARCH BIOCHEM BIOPHYS, V265, P249, DOI 10.1016/0003-9861(88)90125-7; Mansson R, 2007, NEUROBIOL DIS, V25, P198, DOI 10.1016/j.nbd.2006.09.008; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; MURPHY SN, 1987, J NEUROSCI, V7, P4145; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Nieminen AL, 1996, NEUROSCIENCE, V75, P993; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Peng TI, 1998, EXP NEUROL, V149, P1, DOI 10.1006/exnr.1997.6599; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; ROTTENBERG H, 1989, FEBS LETT, V247, P483, DOI 10.1016/0014-5793(89)81396-1; Sarti Paolo, 2003, Ital J Biochem, V52, P37; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Sattler R, 1998, J NEUROCHEM, V71, P2349; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; SHERMAN WR, 1981, J NEUROCHEM, V36, P1947, DOI 10.1111/j.1471-4159.1981.tb10819.x; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SNYDER SH, 1995, NAT MED, V1, P32, DOI 10.1038/nm0195-32; Srinivasan C, 1999, LIPIDS, V34, P1211, DOI 10.1007/s11745-999-0474-5; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; TSUZUKI K, 1994, MOL BRAIN RES, V26, P37, DOI 10.1016/0169-328X(94)90071-X; Vercesi AE, 1997, BIOSCIENCE REP, V17, P43, DOI 10.1023/A:1027335217774; Vergun O, 2005, BBA-BIOENERGETICS, V1709, P127, DOI 10.1016/j.bbabio.2005.07.006; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Vergun O, 2003, BIOPHYS J, V85, P3358, DOI 10.1016/S0006-3495(03)74755-9; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; WERTH JL, 1994, J NEUROSCI, V14, P348; White RJ, 1996, J NEUROSCI, V16, P5688; YAMAGUCHI K, 1990, J PHYSIOL-LONDON, V420, P185, DOI 10.1113/jphysiol.1990.sp017907; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	84	45	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18057	18068		10.1074/jbc.M702134200	http://dx.doi.org/10.1074/jbc.M702134200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17485418	hybrid			2022-12-27	WOS:000247302000012
J	Liu, M; Li, DW; Aneja, R; Joshi, HC; Xie, SB; Zhang, C; Zhou, J				Liu, Min; Li, Dengwen; Aneja, Ritu; Joshi, Harish C.; Xie, Songbo; Zhang, Chao; Zhou, Jun			PO2-dependent differential regulation of multidrug resistance 1 gene expression by the c-jun NH2-terminal Kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; MDR1 GENE; HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; CELLULAR-RESPONSE; PROMOTER ACTIVITY; BINDING-PROTEIN; CANCER-CELLS	Hypoxia-induced multidrug resistance 1 ( MDR1) gene expression is known to be mediated by c-Jun NH2-terminal kinase ( JNK) activation. However, the molecular mechanisms underlying this action of JNK remain elusive. On the contrary, there has been increasing evidence for a negative correlation of JNK activity with MDR1 expression under normoxic conditions. Here, we present evidence that the JNK pathway represses MDR1 expression in normoxia and activates MDR1 expression in hypoxia. Our data show that JNK pathway-induced MDR1 repression in normoxia is mediated by increased c-Jun binding to activator protein 1 site, located in the MDR1 promoter, and requires the activity of histone deacetylase 5. In contrast, JNK pathway-induced MDR1 activation in hypoxia is independent of the activator protein 1 site. Rather, this action is dependent on increased hypoxia-inducible factor 1 ( HIF1) binding to the hypoxia response element in the MDR1 promoter, which is promoted by the interaction of HIF1 alpha with c-Jun in the nucleus and requires the activity of the p300/CBP ( CREB-binding protein) coactivator.	Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, Minist Educ, Tianjin 300071, Peoples R China; Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Nankai University; Nankai University; Emory University	Zhou, J (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn	Zhou, Jun/D-4654-2017; Xie, Songbo/AAD-9850-2020	Zhou, Jun/0000-0001-7858-8260; 				Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Baker EK, 2004, CANCER BIOL THER, V3, P819, DOI 10.4161/cbt.3.9.1101; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Brown JM, 1998, CANCER RES, V58, P1408; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Comerford KM, 2002, CANCER RES, V62, P3387; CORNWELL MM, 1993, J BIOL CHEM, V268, P19505; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; IKEGUCHI M, 1991, DNA CELL BIOL, V10, P639, DOI 10.1089/dna.1991.10.639; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; Kang CD, 2000, EXP CELL RES, V256, P300, DOI 10.1006/excr.2000.4807; Lecureur V, 2001, ONCOGENE, V20, P303, DOI 10.1038/sj.onc.1204065; Ledoux S, 2003, CANCER RES, V63, P7284; Li ZH, 1997, CANCER LETT, V119, P177, DOI 10.1016/S0304-3835(97)00267-X; Liu M, 2006, J BIOL CHEM, V281, P18090, DOI 10.1074/jbc.M601324200; Miao ZH, 2003, CANCER RES, V63, P4527; Ogretmen B, 1999, BIOCHEMISTRY-US, V38, P2189, DOI 10.1021/bi982236+; Ohga T, 1998, J BIOL CHEM, V273, P5997, DOI 10.1074/jbc.273.11.5997; Osborn MT, 1996, J BIOL CHEM, V271, P30950, DOI 10.1074/jbc.271.48.30950; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; STRAUSS BE, 1995, BIOCHEM BIOPH RES CO, V217, P333, DOI 10.1006/bbrc.1995.2781; UEDA K, 1987, J BIOL CHEM, V262, P17432; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Zhou J, 2006, CANCER RES, V66, P445, DOI 10.1158/0008-5472.CAN-05-1779; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200	32	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17581	17586		10.1074/jbc.M702206200	http://dx.doi.org/10.1074/jbc.M702206200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452336	hybrid			2022-12-27	WOS:000247084500029
J	Schlaepfer, DD; Hou, SH; Lim, ST; Tomar, A; Yu, HG; Lim, YM; Hanson, DA; Uryu, SA; Molina, J; Mitra, SK				Schlaepfer, David D.; Hou, Shihe; Lim, Ssang-Taek; Tomar, Alok; Yu, Honggang; Lim, Yangmi; Hanson, Dan A.; Uryu, Sean A.; Molina, John; Mitra, Satyajit K.			Tumor necrosis factor-alpha stimulates focal adhesion kinase activity required for mitogen-activated kinase-associated interleukin 6 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES APOPTOSIS; CELL MOTILITY; GROWTH-FACTOR; DEATH-DOMAIN; FAK; INFLAMMATION; CANCER; PHOSPHORYLATION; METASTASIS	Focal adhesion kinase (FAK) is a cytoplasmic protein-tyrosine kinase that promotes cell migration, survival, and gene expression. Here we show that FAK signaling is important for tumor necrosis factor-alpha (TNF alpha)-induced interleukin 6 (IL-6) mRNA and protein expression in breast (4T1), lung (A549), prostate (PC-3), and neural (NB-8) tumor cells by FAK short hairpin RNA knockdown and by comparisons of FAK-null (FAK(-/)-) and FAK(+/+) mouse embryo fibroblasts. FAK promoted TNF alpha-stimulated MAPK activation needed for maximal IL-6 production. FAK was not required for TNF alpha-mediated nuclear factor-kappa beta or c-Jun N-terminal kinase activation. TNF alpha-stimulated FAK catalytic activation and IL-6 production were inhibited by FAK N-terminal but not FAK C-terminal domain overexpression. Analysis of FAK(-/)-fibroblasts stably reconstituted with wild type or various FAK point mutants showed that FAK catalytic activity, Tyr-397 phosphorylation, and the Pro-712/713 proline-rich region of FAK were required for TNF alpha-stimulated MAPK activation and IL-6 production. Constitutively activated MAPK kinase-1 (MEK1) expression in FAK(-/)-and A549 FAK short hairpin RNA-expressing cells rescued TNF alpha-stimulated IL-6 production. Inhibition of Src protein-tyrosine kinase activity or mutation of Src phosphorylation sites on FAK (Tyr-861 or Tyr-925) did not affect TNF alpha-stimulated IL-6 expression. Moreover, analyses of Src(-/-), Yes(-/-), and Fyn(-/)-fibroblasts showed that Src expression was inhibitory to TNF alpha-stimulated IL-6 production. These studies provide evidence for a novel Src-independent FAK to MAPK signaling pathway regulating IL-6 expression with potential importance to inflammation and tumor progression.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Schlaepfer, DD (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dschlaep@scripps.edu		Lim, Steve/0000-0003-0323-8607	NATIONAL CANCER INSTITUTE [R29CA075240, R01CA102310, R01CA075240, R01CA087038] Funding Source: NIH RePORTER; NCI NIH HHS [CA102310, CA75240, CA87038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Bachelot T, 2003, BRIT J CANCER, V88, P1721, DOI 10.1038/sj.bjc.6600956; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; Funakoshi-Tago M, 2003, J BIOL CHEM, V278, P29359, DOI 10.1074/jbc.M213115200; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; Hsia DA, 2005, MOL CELL BIOL, V25, P9700, DOI 10.1128/MCB.25.21.9700-9712.2005; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Ilic D, 1998, J CELL BIOL, V143, P547; ILLC D, 1995, NATURE, V377, P539; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Lim YM, 2004, J BIOL CHEM, V279, P29060, DOI 10.1074/jbc.M401183200; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Mitra SK, 2006, ONCOGENE, V25, P5969, DOI 10.1038/sj.onc.1209588; Mitra SK, 2006, ONCOGENE, V25, P4429, DOI 10.1038/sj.onc.1209482; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mon NN, 2006, CANCER RES, V66, P6778, DOI 10.1158/0008-5472.CAN-05-4159; Neff L, 2003, J BIOL CHEM, V278, P27721, DOI 10.1074/jbc.M212065200; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; TAKAHASHI R, 2006, BIOCHIM BIOPHYS ACTA, V1770, P518; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Watanabe Y, 2003, KIDNEY INT, V64, P431, DOI 10.1046/j.1523-1755.2003.00122.x; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393; Zhang HFM, 2006, AM J PHYSIOL-CELL PH, V290, pC1310, DOI 10.1152/ajpcell.00450.2005	38	44	46	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17450	17459		10.1074/jbc.M610672200	http://dx.doi.org/10.1074/jbc.M610672200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17438336	hybrid			2022-12-27	WOS:000247084500015
J	Stevens, HC; Nichols, JW				Stevens, Haley C.; Nichols, J. Wylie			The proton electrochemical gradient across the plasma membrane of yeast is necessary for phospholipid flip	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSLOCASE; LABELED PHOSPHATIDYLCHOLINE; TRANSPORT; ASYMMETRY; IDENTIFICATION	Recently, two members of the P4 family of P-type ATPases, Dnf1p and Dnf2p, were shown to be necessary for the internalization ( flip) of fluorescent, 7-nitrobenz-2-oxa-1,3-diazol-4-yl( NBD)-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae. In the current study, we have demonstrated that ATP hydrolysis is not sufficient for phospholipid flip in the absence of the proton electrochemical gradient across the plasma membrane. This requirement was demonstrated by two independent means. First, collapse of the plasma membrane proton electrochemical gradient by the protonophore, carbonyl cyanide m-chlorophenylhydrazone ( CCCP) almost completely blocked NBD-phospholipid flip while only moderately reducing the cytosolic ATP concentration. Second, strains with point mutations in PMA1, which encodes the plasma membrane proton pump that generates the proton electrochemical gradient, are defective in NBD-PC flip, whereas their cytosolic ATP content is actually increased. These results establish that the proton electrochemical gradient is required for NBD-phospholipid flip across the plasma membrane of yeast and raise the question whether it contributes an additional required driving force or whether it functions as a regulatory signal.	Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Nichols, JW (corresponding author), Emory Univ, Sch Med, Dept Physiol, 615 Michael St,605G Whitehead, Atlanta, GA 30322 USA.	wylie.nichols@emory.edu			NIGMS NIH HHS [GM64770] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064770] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Elvington SM, 2005, J BIOL CHEM, V280, P40957, DOI 10.1074/jbc.M507926200; FOX TD, 1991, METHODS ENZYMOLOGY, V194, P149; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Grant AM, 2001, TRAFFIC, V2, P37, DOI 10.1034/j.1600-0854.2001.020106.x; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Ikeda M, 2006, BIOL PHARM BULL, V29, P1542, DOI 10.1248/bpb.29.1542; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; MCLAUGHLIN SGA, 1980, PHYSIOL REV, V60, P825, DOI 10.1152/physrev.1980.60.3.825; MORIYAMA Y, 1991, ARCH BIOCHEM BIOPHYS, V286, P252, DOI 10.1016/0003-9861(91)90037-J; Moye-Rowley WS, 2005, GENE, V354, P15, DOI 10.1016/j.gene.2005.03.019; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; SERRANO R, 1977, EUR J BIOCHEM, V80, P97, DOI 10.1111/j.1432-1033.1977.tb11861.x; Serrano R, 1991, MOL CELLULAR BIOL YE, P523; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663; Yamaji-Hasegawa A, 2006, BIOL PHARM BULL, V29, P1547, DOI 10.1248/bpb.29.1547	28	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17563	17567		10.1074/jbc.M700454200	http://dx.doi.org/10.1074/jbc.M700454200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452326	hybrid			2022-12-27	WOS:000247084500027
J	Chew, EH; Hagen, T				Chew, Eng-Hui; Hagen, Thilo			Substrate-mediated regulation of cullin neddylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASES; COP9 SIGNALOSOME; NEDD8 MODIFICATION; CONJUGATING ENZYMES; STRUCTURAL BASIS; COMPLEX; SCF; PROTEIN; CUL1; RECOGNITION	Cullin-based E3 ligases are a large family of multi-subunit ubiquitin ligases with diverse cellular functions, including the regulation of the cell cycle, of the DNA damage response, and of various transcription factors. These ligases are composed of one of six mammalian cullin homologs (Cul1, Cul2, Cul3, Cul4a, Cul4b, and Cul5), the Ring finger containing protein Roc1/Rbx1, and cullin homolog-specific adaptor and substrate recognition subunits. To be active, cullin-based ligases require the covalent modification of a conserved lysine residue in the cullin protein with the ubiquitin-like protein Nedd8. We show in this study that in intact cells Cul1 neddylation is dependent on binding to adaptor proteins and substrate recognition subunits. Mutant Cul1 that is unable to recruit adaptor and substrate recognition subunits exhibits markedly reduced neddylation, and inhibiting binding of adaptor and substrate recognition subunits to wild type Cul1 reduces Nedd8 modification. This regulatory mechanism also extends to other cullin-based E3 ligases, including Cul2, Cul3, and Cul4a. The regulation of cullin neddylation by adaptor proteins and substrate recognition subunits in cells was found to be independent of both CAND1 and the COP9 signalosome, two negative regulators of cullin Nedd8 modification. Using hypoxia-inducible factor-1 alpha (HIF-1 alpha), a substrate of the Elongin B/C-Cul2-VHL ligase, we demonstrate the critical role of substrate binding to promote Cul2 neddylation in a manner that does not require substrate ubiquitination but may involve a conformational change. These findings suggest a mechanism through which availability of substrate recognition subunits and substrates can regulate the ubiquitin ligase activity.	Univ Nottingham, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England	University of Nottingham	Hagen, T (corresponding author), Univ Nottingham, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England.	thilo.hagen@nottingham.ac.uk	Chew, Eng Hui/D-8975-2016	Chew, Eng Hui/0000-0002-2615-8987				Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sufan RI, 2006, NEOPLASIA, V8, P956, DOI 10.1593/neo.06520; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Wada H, 1999, J BIOL CHEM, V274, P36025, DOI 10.1074/jbc.274.50.36025; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	32	68	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					17032	17040		10.1074/jbc.M701153200	http://dx.doi.org/10.1074/jbc.M701153200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17439941	hybrid			2022-12-27	WOS:000246946500036
J	Swiercz, R; Cheng, DH; Kim, D; Bedford, MT				Swiercz, Rafal; Cheng, Donghang; Kim, Daehoon; Bedford, Mark T.			Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE N-METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; MOUSE DEVELOPMENT; HELA-CELLS; PRMT3; METHYLATION; N-METHYLTRANSFERASE-3; OLIGOMERIZATION; DROSOPHILA; MEMBRANE	PRMT3 is a type I arginine methyltransferase that resides in the cytoplasm. A large proportion of this cystosolic PRMT3 is found associated with ribosomes. It is tethered to the ribosomes through its interaction with rpS2, which is also its substrate. Here we show that mouse embryos with a targeted disruption of PRMT3 are small in size but survive after birth and attain a normal size in adulthood, thus displaying Minute-like characteristics. The ribosome protein rpS2 is hypomethylated in the absence of PRMT3, demonstrating that it is a bona fide, in vivo PRMT3 substrate that cannot be modified by other PRMTs. Finally, the levels 40 S, 60 S, and 80 S monosomes and polyribosomes are unaffected by the loss of PRMT3, but there are additional as yet unidentified proteins that co-fractionate with ribosomes that are also dedicated PRMT3 substrates.	Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Bedford, MT (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	Bedford, Mark T/E-7856-2011		NCI NIH HHS [CA016672] Funding Source: Medline; NIEHS NIH HHS [ES07784] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BEDFORD MT, 2006, FAMILY PROTEIN ARGIN, P31; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; CHANG FN, 1978, BIOCHIM BIOPHYS ACTA, V518, P89, DOI 10.1016/0005-2787(78)90118-1; CHANG FN, 1976, ARCH BIOCHEM BIOPHYS, V172, P627, DOI 10.1016/0003-9861(76)90117-X; CRAMTON SE, 1994, GENETICS, V137, P1039; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Ikenaka K, 2006, NEUROSCIENCE, V141, P1971, DOI 10.1016/j.neuroscience.2006.05.022; JOHNSON SP, 1987, MOL CELL BIOL, V7, P1338, DOI 10.1128/MCB.7.4.1338; Joyner AL, 1994, GENE TARGETING PRACT; Kim J, 2004, J BIOL CHEM, V279, P25339, DOI 10.1074/jbc.M402544200; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yoshimoto T, 2006, EXP CELL RES, V312, P2040, DOI 10.1016/j.yexcr.2006.03.001; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	27	94	97	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16917	16923		10.1074/jbc.M609778200	http://dx.doi.org/10.1074/jbc.M609778200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17439947	hybrid			2022-12-27	WOS:000246946500024
J	Nicolae, C; Ko, YP; Miosge, N; Niehoff, A; Studer, D; Enggist, L; Hunziker, EB; Paulsson, M; Wagener, R; Aszodi, A				Nicolae, Claudia; Ko, Ya-Ping; Miosge, Nicolai; Niehoff, Anja; Studer, Daniel; Enggist, Lukas; Hunziker, Ernst B.; Paulsson, Mats; Wagener, Raimund; Aszodi, Attila			Abnormal collagen fibrils in cartilage of matrilin-1/matrilin-3-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; HUMAN ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX; A-DOMAIN; MATRILIN-3 MUTATION; MOLECULAR-STRUCTURE; TISSUE DISTRIBUTION; EXPRESSION; SKELETAL	Matrilins are oligomeric extracellular matrix adaptor proteins mediating interactions between collagen fibrils and other matrix constituents. All four matrilins are expressed in cartilage and mutations in the human gene encoding matrilin-3 (MATN3) are associated with different forms of chondrodysplasia. Surprisingly, however, Matn3-null as well as Matn1-and Matn2-null mice do not show an overt skeletal phenotype, suggesting a dominant negative pathomechanism for the human disorders and redundancy/compensation among the family members in the knock-out situation. Here, we show that mice lacking both matrilin-1 and matrilin-3 develop an apparently normal skeleton, but exhibit biochemical and ultrastructural abnormalities of the knee joint cartilage. At the protein level, an altered SDS-PAGE band pattern and a clear up-regulation of the homotrimeric form of matrilin-4 were evident in newborn Matn1/Matn3 and Matn1 knock-out mice, but not in Matn3-null mice. The ultrastructure of the cartilage matrix after conventional chemical fixation was grossly normal; however, electron microscopy of high pressure frozen and freeze-substituted samples, revealed two consistent observations: 1) moderately increased collagen fibril diameters throughout the epiphysis and the growth plate in both single and double mutants; and 2) increased collagen volume density in Matn1(-/-)/Matn3(-/-) and Matn3(-/-) mice. Taken together, our results demonstrate that matrilin-1 and matrilin-3 modulate collagen fibrillogenesis in cartilage and provide evidence that biochemical compensation might exist between matrilins.	Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; Univ Cologne, Fac Med, Ctr Mol Med, D-50931 Cologne, Germany; Univ Gottingen, Dept Prosthodont, D-37075 Gottingen, Germany; German Sport Univ Cologne, Inst Biomech & Orthopaed, D-50933 Cologne, Germany; Univ Bern, Dept Anat, CH-3010 Bern, Switzerland; Univ Bern, ITI Res Inst Dental & Skeletal Biol, CH-3010 Bern, Switzerland	Max Planck Society; University of Cologne; University of Cologne; University of Gottingen; German Sport University Cologne; University of Bern; University of Bern	Aszodi, A (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18A, D-82152 Martinsried, Germany.	aszodi@biochem.mpg.de	Studer, Daniel/F-8581-2012; Niehoff, Anja/K-6626-2015; Miosge, Nicolai/E-3244-2010; Hunziker, Ernst B/GYA-1015-2022	Niehoff, Anja/0000-0002-4165-0929; Nicolae, Claudia/0000-0003-4933-5496				Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Aszodi A, 1999, MOL CELL BIOL, V19, P7841; Aszodi A, 1998, J CELL BIOL, V143, P1399, DOI 10.1083/jcb.143.5.1399; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Aszodi A, 1996, EUR J BIOCHEM, V236, P970, DOI 10.1111/j.1432-1033.1996.00970.x; ASZODI A, 1994, MATRIX BIOL, V14, P181, DOI 10.1016/0945-053X(94)90007-8; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Borochowitz ZU, 2004, J MED GENET, V41, P366, DOI 10.1136/jmg.2003.013342; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200; GLUER CC, 1995, EUR J RADIOL, V20, P173, DOI 10.1016/0720-048X(95)00651-6; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Hauser N, 1996, J BIOL CHEM, V271, P32247, DOI 10.1074/jbc.271.50.32247; HAUSER N, 1994, J BIOL CHEM, V269, P25747; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; HUNZIKER EB, 1989, J PHYSIOL-LONDON, V414, P55, DOI 10.1113/jphysiol.1989.sp017676; Hunziker EB, 1997, MICROSC RES TECHNIQ, V37, P271; Jackson GC, 2004, J MED GENET, V41, P52, DOI 10.1136/jmg.2003.011429; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Klatt AR, 2002, MATRIX BIOL, V21, P289, DOI 10.1016/S0945-053X(02)00006-9; Klatt AR, 2001, J BIOL CHEM, V276, P17267, DOI 10.1074/jbc.M100587200; Ko YP, 2004, MOL CELL BIOL, V24, P1691, DOI 10.1128/MCB.24.4.1691-1699.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loughlin J, 2000, ARTHRITIS RHEUM, V43, P1423, DOI 10.1002/1529-0131(200006)43:6<1423::AID-ANR31>3.0.CO;2-4; LOUGHLIN J, 1994, HUM GENET, V94, P698; Mabuchi Akihiko, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9286; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Mates L, 2004, MATRIX BIOL, V23, P195, DOI 10.1016/j.matbio.2004.05.003; Meulenbelt I, 1997, ARTHRITIS RHEUM, V40, P1760, DOI 10.1002/art.1780401006; Min JL, 2006, ANN RHEUM DIS, V65, P1060, DOI 10.1136/ard.2005.045153; Miosge N, 1999, LAB INVEST, V79, P1591; Mostert AK, 2003, AM J MED GENET A, V120A, P490, DOI 10.1002/ajmg.a.20034; Okimura A, 1997, ARTHRITIS RHEUM, V40, P1029, DOI 10.1002/art.1780400606; Opolka A, 2007, MATRIX BIOL, V26, P85, DOI 10.1016/j.matbio.2006.09.010; Otten C, 2005, J MED GENET, V42, P774, DOI 10.1136/jmg.2004.029462; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; Pullig O, 2007, ANN RHEUM DIS, V66, P279, DOI 10.1136/ard.2006.058263; Pullig O, 2002, OSTEOARTHR CARTILAGE, V10, P253, DOI 10.1053/joca.2001.0508; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; van der Weyden L, 2006, AM J PATHOL, V169, P515, DOI 10.2353/ajpath.2006.050981; Wagener R, 1998, FEBS LETT, V438, P165, DOI 10.1016/S0014-5793(98)01293-9; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307	55	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22163	22175		10.1074/jbc.M610994200	http://dx.doi.org/10.1074/jbc.M610994200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17502381	hybrid			2022-12-27	WOS:000248196800062
J	Nascimento, FD; Hayashi, MAF; Kerkis, A; Oliveira, V; Oliveira, EB; Radis-Baptista, G; Nader, HB; Yamane, T; Tersariol, ILD; Kerkis, I				Nascimento, Fabio Dupart; Hayashi, Mirian A. F.; Kerkis, Alexandre; Oliveira, Vitor; Oliveira, Eduardo B.; Radis-Baptista, Gandhi; Nader, Helena Bonciani; Yamane, Tetsuo; Tersariol, Ivarne Luis dos Santos; Kerkis, Irina			Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENETRATING PEPTIDES; INTRACELLULAR DELIVERY; PROTEIN TRANSDUCTION; ENDOTHELIAL-CELLS; HELA-CELLS; CHLORIDE; TRANSLOCATION; TAT; MECHANISM; ENDOCYTOSIS	Recently we have shown that crotamine, a toxin from the South American rattlesnake Crotalus durissus terrificus venom, belongs to the family of cell-penetrating peptides. Moreover, crotamine was demonstrated to be a marker of centrioles, of cell cycle, and of actively proliferating cells. Herein we show that this toxin at non-toxic concentrations is also capable of binding electrostatically to plasmid DNA forming DNA-peptide complexes whose stabilities overcome the need for chemical conjugation for carrying nucleic acids into cells. Interestingly, crotamine demonstrates cell specificity and targeted delivery of plasmid DNA into actively proliferating cells both in vitro and in vivo, which distinguishes crotamine from other known natural cell-penetrating peptides. The mechanism of crotamine penetration and cargo delivery into cells was also investigated, showing the involvement of heparan sulfate proteoglycans in the uptake phase, which is followed by endocytosis and peptide accumulation within the acidic endosomal vesicles. Finally, the permeabilization of endosomal membranes induced by crotamine results in the leakage of the vesicles contents to the cell cytosol.	Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, BR-08780210 Mogi Das Cruzes, SP, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, BR-04044020 Sao Paulo, Brazil; Inst Butantan, Ctr Toxinol Aplicada, BR-05503900 Sao Paulo, Brazil; Clin & Ctr Pesquisa Reprod Humana Roger Abdelmass, BR-01431000 Sao Paulo, Brazil; Univ Cidade Sao Paulo, Lab Neurociencias, BR-03071000 Sao Paulo, Brazil; Univ Sao Paulo, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, Brazil; Univ Fed Pernambuco, Ctr Ciencias Biol, BR-50732970 Recife, PE, Brazil; Univ Sao Paulo, IPEN CNEN SP, BR-05508000 Sao Paulo, Brazil; Inst Butantan, Genet Lab, BR-05503900 Sao Paulo, Brazil	Universidade de Mogi das Cruzes; Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan; Universidade Cidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Pernambuco; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo; Instituto Butantan	Tersariol, ILD (corresponding author), Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Predio I,Sala 1S-15,Av Dr Candido Xavier de Almei, BR-08780210 Mogi Das Cruzes, SP, Brazil.	ivarne@umc.br; ikerkis@butantan.gov.br	Nascimento, Fabio D/A-5115-2010; Hayashi, Mirian/ABG-2663-2020; RADIS-BAPTISTA, GANDHI/J-4991-2019; Oliveira, Vitor/AAT-5981-2020; RADIS-BAPTISTA, GANDHI/H-9574-2016; Nascimento, Fabio Dupart/ABB-8295-2020; Oliveira, Vitor/L-3709-2013; Kerkis, Irina/AAD-1006-2019; Nader, Helena Bonciani/D-9253-2012; Hayashi, Mirian/C-7458-2012; Dos Santos Tersariol, Ivarne Luis/G-4042-2012	Nascimento, Fabio D/0000-0001-6672-3373; RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; Nascimento, Fabio Dupart/0000-0001-6672-3373; Oliveira, Vitor/0000-0002-4662-1377; Hayashi, Mirian/0000-0001-6437-4923; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; NADER, HELENA/0000-0002-7569-2166				ANDERSON RGW, 1984, P NATL ACAD SCI-BIOL, V81, P4838, DOI 10.1073/pnas.81.15.4838; Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; BAE HR, 1990, NATURE, V348, P637, DOI 10.1038/348637a0; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Brunk UT, 1999, REDOX REP, V4, P3, DOI 10.1179/135100099101534675; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; Coeytaux E, 2003, J BIOL CHEM, V278, P18110, DOI 10.1074/jbc.M300248200; Conrad H. E., 1998, HEPARIN BINDING PROT; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Eguchi A, 2001, J BIOL CHEM, V276, P26204, DOI 10.1074/jbc.M010625200; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Fadel V, 2005, TOXICON, V46, P759, DOI 10.1016/j.toxicon.2005.07.018; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Foerg C, 2005, BIOCHEMISTRY-US, V44, P72, DOI 10.1021/bi048330+; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Futaki S, 2002, INT J PHARM, V245, P1, DOI 10.1016/S0378-5173(02)00337-X; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Henriques ST, 2005, BIOCHEMISTRY-US, V44, P10189, DOI 10.1021/bi0502644; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; KENZIE DL, 2000, J BIOL CHEM, V275, P9970; Kerkis A, 2006, IUBMB LIFE, V58, P7, DOI 10.1080/15216540500494508; Kerkis A, 2004, FASEB J, V18, P1407, DOI 10.1096/fj.03-1459fje; Kilk K, 2005, J CONTROL RELEASE, V103, P511, DOI 10.1016/j.jconrel.2004.12.006; LAURE CJ, 1975, H-S Z PHYSIOL CHEM, V356, P213; Letoha T, 2003, J MOL RECOGNIT, V16, P272, DOI 10.1002/jmr.637; LEWIS RS, 1988, TRENDS NEUROSCI, V11, P214, DOI 10.1016/0166-2236(88)90129-4; Liang Y, 1997, J CELL BIOL, V139, P851, DOI 10.1083/jcb.139.4.851; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630; Magzoub M, 2005, BIOCHEMISTRY-US, V44, P14890, DOI 10.1021/bi051356w; McKenzie DL, 2000, BIOCONJUGATE CHEM, V11, P901, DOI 10.1021/bc000056i; Moreira CR, 2004, BBA-GEN SUBJECTS, V1673, P178, DOI 10.1016/j.bbagen.2004.04.014; MOZHAEVA G N, 1973, Neuroscience and Behavioral Physiology, V6, P228, DOI 10.1007/BF01190346; Neuringer IP, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-6; Nicastro G, 2003, EUR J BIOCHEM, V270, P1969, DOI 10.1046/j.1432-1033.2003.03563.x; OLSON ST, 1991, J BIOL CHEM, V266, P6353; Pellegrin P, 1997, FEBS LETT, V418, P101, DOI 10.1016/S0014-5793(97)01339-2; Pimenta DC, 2002, BIOCHEM J, V366, P435, DOI 10.1042/BJ20020023; Porcionatto MA, 1998, J CELL BIOCHEM, V70, P563, DOI 10.1002/(SICI)1097-4644(19980915)70:4<563::AID-JCB12>3.0.CO;2-I; Pusch M, 1999, J PHYSIOL-LONDON, V515, P341, DOI 10.1111/j.1469-7793.1999.341ac.x; Radis-Baptista G, 1999, TOXICON, V37, P973, DOI 10.1016/S0041-0101(98)00226-8; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; ROBBINS E, 1963, J CELL BIOL, V18, P237, DOI 10.1083/jcb.18.2.237; Rojas M, 1998, NAT BIOTECHNOL, V16, P370, DOI 10.1038/nbt0498-370; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; Smith A, 2001, COLD SPRING HARBOR M, P205; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Sukoyan MA, 2002, BRAZ J MED BIOL RES, V35, P535, DOI 10.1590/S0100-879X2002000500004; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vives E, 2005, J CONTROL RELEASE, V109, P77, DOI 10.1016/j.jconrel.2005.09.032; WHITAKER M, 1990, DEVELOPMENT, V108, P525; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604; Zimmermann P, 2005, DEV CELL, V9, P721, DOI 10.1016/j.devcel.2005.10.011; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	72	83	91	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21349	21360		10.1074/jbc.M604876200	http://dx.doi.org/10.1074/jbc.M604876200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17491023	hybrid			2022-12-27	WOS:000248047500063
J	Ashibe, B; Hirai, T; Higashi, K; Sekimizu, K; Motojima, K				Ashibe, Bunichiro; Hirai, Toshitake; Higashi, Kyoichiro; Sekimizu, Kazuhisa; Motojima, Kiyoto			Dual subcellular localization in the endoplasmic reticulum and peroxisomes and a vital role in protecting against oxidative stress of fatty aldehyde dehydrogenase are achieved by alternative splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-ALPHA; SJOGREN-LARSSON-SYNDROME; PHYTANIC ACID; RAT-LIVER; MAMMALIAN PEROXISOMES; MOLECULAR-CLONING; HUMAN FIBROBLASTS; GENE-EXPRESSION; PPAR-ALPHA; METABOLISM	Fatty aldehyde dehydrogenase ( FALDH, ALDH3A2) is thought to be involved in the degradation of phytanic acid, a saturated branched chain fatty acid derived from chlorophyll. However, the identity, subcellular distribution, and physiological roles of FALDH are unclear because several variants produced by alternative splicing are present in varying amounts at different subcellular locations. Subcellular fractionation experiments do not provide a clear-cut conclusion because of the incomplete separation of organelles. We established human cell lines heterologously expressing mouse FALDH from each cDNA without tagging under the control of an inducible promoter and detected the variant FALDH proteins using a mouse FALDH specific antibody. One variant, FALDH-V, was exclusively detected in peroxisomal membranes. Human FALDH-V with an amino-terminal Myc sequence also localized to peroxisomes. The most dominant form, FALDH-N, and other variants examined, however, were distributed in the endoplasmic reticulum. A gas chromatography-mass spectrometry-based analysis of metabolites in FALDH-expressing cells incubated with phytol or phytanic acid showed that FALDH-V, not FALDH-N, is the key aldehyde dehydrogenase in the degradation pathway and that it protects peroxisomes from oxidative stress. In contrast, both FALDHs had a protective effect against oxidative stress induced by a model aldehyde for lipid peroxidation, dodecanal. These results suggest that FALDH variants are produced by alternative splicing and share an important role in protecting against oxidative stress in an organelle-specific manner.	Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan	Meiji Pharmaceutical University; University of Tokyo	Motojima, K (corresponding author), Meiji Pharmaceut Univ, Dept Biochem, Noshio 2-522-1, Tokyo 2048588, Japan.	motojima@my-pharm.ac.jp						ALEXSON SEH, 1985, J CELL BIOL, V101, P294, DOI 10.1083/jcb.101.1.294; Barbier O, 2003, J BIOL CHEM, V278, P13975, DOI 10.1074/jbc.M300749200; Chai ZL, 2003, ENDOCRINOLOGY, V144, P2084, DOI 10.1210/en.2002-221030; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; DeLaurenzi V, 1996, NAT GENET, V12, P52; Demozay D, 2004, J BIOL CHEM, V279, P6261, DOI 10.1074/jbc.M312062200; Foulon V, 1999, P NATL ACAD SCI USA, V96, P10039, DOI 10.1073/pnas.96.18.10039; FOWLER ME, 1983, J WILDLIFE DIS, V19, P34, DOI 10.7589/0090-3558-19.1.34; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; GHOSH MK, 1986, ANAL BIOCHEM, V159, P169, DOI 10.1016/0003-2697(86)90323-4; Gloerich J, 2007, J LIPID RES, V48, P77, DOI 10.1194/jlr.M600050-JLR200; Gloerich J, 2006, MOL GENET METAB, V89, P111, DOI 10.1016/j.ymgme.2006.05.009; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Heim M, 2002, FASEB J, V16, P718, DOI 10.1096/fj.01-0816fje; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Honsho M, 2001, J BIOL CHEM, V276, P9375, DOI 10.1074/jbc.M003304200; Jansen GA, 2001, BIOCHEM BIOPH RES CO, V283, P674, DOI 10.1006/bbrc.2001.4835; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Komen JC, 2004, J LIPID RES, V45, P1341, DOI 10.1194/jlr.M400064-JLR200; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Lin ZL, 2000, MOL GENET METAB, V71, P496, DOI 10.1006/mgme.2000.3084; MASAKI R, 1994, J CELL BIOL, V126, P1407, DOI 10.1083/jcb.126.6.1407; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; MITCHELL DY, 1989, ARCH BIOCHEM BIOPHYS, V269, P11, DOI 10.1016/0003-9861(89)90081-7; MIYAUCHI K, 1991, J BIOL CHEM, V266, P19536; Motojima K, 2006, FEBS J, V273, P292, DOI 10.1111/j.1742-4658.2005.05060.x; Motojima K, 2004, EUR J BIOCHEM, V271, P4141, DOI 10.1111/j.1432-1033.2004.04352.x; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; OWEN JB, 1992, J AGR SCI, V119, P151, DOI 10.1017/S0021859600014052; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; Rizzo WB, 2001, CHEM-BIOL INTERACT, V130, P297, DOI 10.1016/S0009-2797(00)00273-8; Rizzo WB, 2000, BBA-MOL BASIS DIS, V1535, P1, DOI 10.1016/S0925-4439(00)00077-6; Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1; van den Brink DM, 2006, CELL MOL LIFE SCI, V63, P1752, DOI 10.1007/s00018-005-5463-y; van den Brink DM, 2005, J BIOL CHEM, V280, P26838, DOI 10.1074/jbc.M501861200; Vasiliou V, 1996, DNA CELL BIOL, V15, P235, DOI 10.1089/dna.1996.15.235; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Verhoeven NM, 1998, FEBS LETT, V429, P225, DOI 10.1016/S0014-5793(98)00574-2; Vizeacoumar FJ, 2006, J BIOL CHEM, V281, P14805, DOI 10.1074/jbc.M601808200; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Willemsen MAAP, 2001, J NEUROL SCI, V183, P61, DOI 10.1016/S0022-510X(00)00474-3; Zomer AWM, 2000, J LIPID RES, V41, P1801	45	58	58	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20763	20773		10.1074/jbc.M611853200	http://dx.doi.org/10.1074/jbc.M611853200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17510064	hybrid			2022-12-27	WOS:000247819300078
J	Clausen, JD; McIntosh, DB; Anthonisen, AN; Woolley, DG; Vilsen, B; Andersen, JP				Clausen, Johannes D.; McIntosh, David B.; Anthonisen, Anne Nyholm; Woolley, David G.; Vilsen, Bente; Andersen, Jens Peter			ATP-binding modes and functionally important interdomain bonds of sarcoplasmic reticulum Ca2+-ATPase revealed by mutation of glycine 438, glutamate 439, and arginine 678	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED PHOSPHORYLATION LOOP; ALKALI-METAL SALTS; CALCIUM-PUMP; ADENOSINE-TRIPHOSPHATASE; CATALYTIC SITE; ACTIVE-SITE; REACTION-MECHANISM; CRYSTAL-STRUCTURE; KINETIC EVIDENCE; DOMAIN RESIDUES	ATP binds to sarcoplasmic reticulum Ca2+-ATPase both in a phosphorylating ( catalytic) mode and in a nonphosphorylating ( modulatory) mode, the latter leading to acceleration of phosphoenzyme turnover (Ca2E1P -> E2P and E2P -> E-2 reactions) and Ca2+ binding (E-2 -> Ca2E1). In some of the Ca2+-ATPase crystal structures, Arg(678) and Glu(439) seem to be involved in the binding of nucleotide or an associated Mg2+ ion. We have replaced Arg(678), Glu(439), and Gly(438) with alanine to examine their importance for the enzyme cycle and the modulatory effects of ATP and MgATP. The results point to the key role of Arg678 in nucleotide binding and to the importance of interdomain bonds Glu(439)-Ser(186) and Arg(678)-Asp(203) in stabilizing the E2P and E-2 intermediates, respectively. Mutation of Arg(678) had conspicuous effects on ATP/MgATP binding to the E-1 form and ADP binding to Ca2E1P, as well as ATP/MgATP binding in modulatory modes to E2P and E-2, whereas the effects on ATP/MgATPacceleration of the Ca2E1P -> E2P transition were small, suggesting that the nucleotide that accelerates Ca2E1P -> E2P binds differently from that modulating the E2P -> E-2 and E-2 -> Ca2E1 reactions. Mutation of Glu(439) hardly affected nucleotide binding to E-1, Ca2E1P, and E-2, but it led to disruption of the modulatory effect of ATP on E2P 3 E2 and acceleration of the latter reaction, indicating that ATP normally modulates E2P -> E-2 by interfering with the interaction between Glu(439) and Ser(186). Gly(438) seems to be important for this interaction as well as for nucleotide binding, probably because of its role in formation of the helix containing Glu(439) and Thr(441).	Univ Aarhus, Inst Physiol & Biophys, Dept Physiol, DK-8000 Aarhus C, Denmark; Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, ZA-7925 Cape Town, South Africa	Aarhus University; University of Cape Town	Andersen, JP (corresponding author), Univ Aarhus, Inst Physiol & Biophys, Dept Physiol, Ole Worms Alle 1160, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Vilsen, Bente/0000-0002-4727-9382; Andersen, Jens Peter/0000-0003-0654-4300				ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; BISHOP JE, 1987, J BIOL CHEM, V262, P4658; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; CABLE MB, 1985, BIOCHEMISTRY-US, V24, P5612, DOI 10.1021/bi00341a049; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clausen JD, 2006, J BIOL CHEM, V281, P9471, DOI 10.1074/jbc.M512371200; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Clausen JD, 2001, J BIOL CHEM, V276, P35741, DOI 10.1074/jbc.M105434200; COLL RJ, 1991, BIOCHEMISTRY-US, V30, P1456, DOI 10.1021/bi00220a002; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; FORGE V, 1993, J BIOL CHEM, V268, P10953; GUILLAIN F, 1981, J BIOL CHEM, V256, P6140; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Hua SM, 2002, BIOCHEMISTRY-US, V41, P11405, DOI 10.1021/bi026181u; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LUND S, 1988, J BIOL CHEM, V263, P1654; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 2004, J BIOL CHEM, V279, P32515, DOI 10.1074/jbc.M403242200; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; MCINTOSH DB, 1992, J BIOL CHEM, V267, P22328; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; MINTZ E, 1995, J BIOL CHEM, V270, P27160, DOI 10.1074/jbc.270.45.27160; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2357; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Montigny C, 2004, J BIOL CHEM, V279, P43971, DOI 10.1074/jbc.M407142200; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; ROSS DC, 1987, J BIOL CHEM, V262, P2042; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SEEBREGTS CJ, 1989, J BIOL CHEM, V264, P2043; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1458; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; STAHL N, 1984, BIOCHEMISTRY-US, V23, P5389, DOI 10.1021/bi00318a002; Strugatsky D, 2005, BIOCHEMISTRY-US, V44, P15961, DOI 10.1021/bi051921v; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VERJOVSKIALMEIDA S, 1979, J BIOL CHEM, V254, P18; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762	56	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20686	20697		10.1074/jbc.M702365200	http://dx.doi.org/10.1074/jbc.M702365200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17504757	hybrid			2022-12-27	WOS:000247819300071
J	Li, JF; Nebenfuhr, A				Li, Jian-Feng; Nebenfuehr, Andreas			Organelle targeting of myosin XI is mediated by two globular tail subdomains with separate cargo binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PLANT MYOSIN; YEAST VACUOLE; CELLS; ACTIN; DOMAIN; LOCALIZATION; MITOCHONDRIA; MEMBRANE; MOVEMENT	Myosin XI are actin-based molecular motors that are thought to drive organelle movements in plants, analogous to myosin V in animals and fungi. Similar domain structure of these myosins suggests that binding to organelles may occur via the globular tail domain in both types of motors, even though sequence similarity is low. To address this hypothesis, we developed a structure homology model for the globular tail of MYA1, a myosin XI from Arabidopsis, based on the known structure of yeast myosin V (Myo2p) globular tail. This model suggested an interaction between two subdomains of the globular tail which was verified by yeast two-hybrid assay and by in vivo bimolecular fluorescence complementation (BiFC). Interface mapping demonstrated that this subdomain interaction depends critically on the C terminus of helix H6 as well as three specific residues in helices H3 and H15, consistent with the structural prediction. The reconstituted globular tails of several Arabidopsis myosin XIs in BiFC assays targeted to peroxisomes in plant cells, identifying this domain as sufficient for cargo binding. Unlike myosin V, either subdomain of myosin XI alone was targeting-competent and responsible for association with different organelles. In addition, our data suggest that organelle binding is regulated by an allosteric interaction between two tail subdomains. We conclude that the globular tail of myosin XI shares a similar structure with that of myosin V, but has evolved plant-specific cargo binding mechanisms.	Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Nebenfuhr, A (corresponding author), Univ Tennessee, M407 Walters Life Sci, Knoxville, TN 37996 USA.	nebenfuehr@utk.edu	Li, Jian-Feng/H-4307-2011	Nebenfuhr, Andreas/0000-0002-4997-2180				Bezanilla M, 2003, J MOL EVOL, V57, P229, DOI 10.1007/s00239-003-2469-7; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; Colosimo A, 1999, BIOTECHNIQUES, V26, P870, DOI 10.2144/99265bm15; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fehrenbacher KL, 2003, TRENDS CELL BIOL, V13, P472, DOI 10.1016/S0962-8924(03)00174-0; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Hamada S, 2006, J PLANT RES, V119, P105, DOI 10.1007/s10265-005-0249-8; Hashimoto K, 2005, PLANT CELL PHYSIOL, V46, P782, DOI 10.1093/pcp/pci085; Higaki T, 2006, PLANT CELL PHYSIOL, V47, P839, DOI 10.1093/pcp/pcj056; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jedd G, 2002, PLANT CELL PHYSIOL, V43, P384, DOI 10.1093/pcp/pcf045; Jiang SY, 2004, PLANT CELL PHYSIOL, V45, P590, DOI 10.1093/pcp/pch061; Kashiyama T, 2000, J BIOCHEM-TOKYO, V127, P1065, DOI 10.1093/oxfordjournals.jbchem.a022699; KINKEMA M, 1994, J MOL BIOL, V239, P591, DOI 10.1006/jmbi.1994.1400; Korn ED, 2000, P NATL ACAD SCI USA, V97, P12559, DOI 10.1073/pnas.230441597; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Liebe S, 1995, BIOL CELL, V85, P207, DOI 10.1016/0248-4900(96)85282-8; Liu LY, 2001, CELL MOTIL CYTOSKEL, V48, P130, DOI 10.1002/1097-0169(200102)48:2<130::AID-CM1004>3.3.CO;2-P; Molchan TM, 2002, PLANTA, V214, P683, DOI 10.1007/s004250100672; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pashkova N, 2005, EUKARYOT CELL, V4, P787, DOI 10.1128/EC.4.4.787-798.2005; Pashkova N, 2005, J CELL BIOL, V168, P359, DOI 10.1083/jcb.200407146; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; REDDY AS, 2001, GENOME BIOL, V2, DOI 10.1186/GB-2001-2-7-RESEARCH0024; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Romagnoli S, 2007, PLANT CELL PHYSIOL, V48, P345, DOI 10.1093/pcp/pcm001; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; Tang FS, 2003, NATURE, V422, P87, DOI 10.1038/nature01453; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Van Gestel K, 2002, J EXP BOT, V53, P659, DOI 10.1093/jexbot/53.369.659; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang ZY, 2004, CELL MOTIL CYTOSKEL, V57, P218, DOI 10.1002/cm.10168; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; YOKOTA E, 1994, PROTOPLASMA, V177, P153, DOI 10.1007/BF01378989; YOKOTA E, 1995, PROTOPLASMA, V185, P178, DOI 10.1007/BF01272858	43	72	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20593	20602		10.1074/jbc.M700645200	http://dx.doi.org/10.1074/jbc.M700645200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17500056	hybrid			2022-12-27	WOS:000247819300062
J	Nagano, Y; Mavrakis, KJ; Lee, KL; Fujii, T; Koinuma, D; Sase, H; Yuki, K; Isogaya, K; Saitoh, M; Imamura, T; Episkopou, V; Miyazono, K; Miyazawa, K				Nagano, Yoshiko; Mavrakis, Konstantinos J.; Lee, Kian Leong; Fujii, Tomoko; Koinuma, Daizo; Sase, Hitoshi; Yuki, Keiko; Isogaya, Kazunobu; Saitoh, Masao; Imamura, Takeshi; Episkopou, Vasso; Miyazono, Kohei; Miyazawa, Keiji			Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; ANAPHASE-PROMOTING COMPLEX; SMAD PROTEINS; TRANSCRIPTIONAL REPRESSION; PROGNOSTIC MARKER; UBIQUITIN LIGASE; TGF; EXPRESSION; RECEPTOR; GENE	Transforming growth factor-beta (TGF-beta) signaling is controlled by a variety of regulators that target either signaling receptors or activated Smad complexes. Among the negative regulators, Smad7 antagonizes TGF-beta signaling mainly through targeting the signaling receptors, whereas SnoN and c-Ski repress signaling at the transcriptional level through inactivation of Smad complexes. We previously found that Arkadia is a positive regulator of TGF-beta signaling that induces ubiquitin-dependent degradation of Smad7 through its C-terminal RING domain. We report here that Arkadia induces degradation of SnoN and c-Ski in addition to Smad7. Arkadia interacts with SnoN and c-Ski in their free forms as well as in the forms bound to Smad proteins, and constitutively down-regulates levels of their expression. Arkadia thus appears to effectively enhance TGF-beta signaling through simultaneous down-regulation of two distinct types of negative regulators, Smad7 and SnoN/c-Ski, and may play an important role in determining the intensity of TGF-beta family signaling in target cells.	Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; Imperial Coll Sch Med, Hammersmith Hosp, Mammalian Neurogenesis Med Res Council, London W12 0NN, England; Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Tokyo 1358550, Japan	University of Tokyo; Imperial College London; Japanese Foundation for Cancer Research	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan.	miyazono-ind@umin.ac.jp	LEE, Kian Leong/E-3584-2013; MIYAZAWA, KEIJI/I-9713-2014; Episkopou, Vasso/E-2952-2010; Koinuma, Daizo/Y-8716-2018	LEE, Kian Leong/0000-0002-0443-2746; Koinuma, Daizo/0000-0001-5611-2122; FUJII, Tomoko/0000-0003-3854-4081	MRC [MC_U120074332] Funding Source: UKRI; Medical Research Council [MC_U120074332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Briones-Orta MA, 2006, BIOCHEM BIOPH RES CO, V341, P889, DOI 10.1016/j.bbrc.2006.01.041; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buess M, 2004, NEOPLASIA, V6, P207, DOI 10.1593/neo.03442; da Graca LS, 2004, DEVELOPMENT, V131, P435, DOI 10.1242/dev.00922; Denissova NG, 2004, J BIOL CHEM, V279, P28143, DOI 10.1074/jbc.M404961200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kobayashi N, 2007, GENES CELLS, V12, P375, DOI 10.1111/j.1365-2443.2007.01052.x; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; MIYAZONO K, 2006, SMAD SIGNAL TRANSDUC, V5, P277; Mizuide M, 2003, J BIOL CHEM, V278, P531, DOI 10.1074/jbc.C200596200; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Nagata M, 2006, GENES CELLS, V11, P1267, DOI 10.1111/j.1365-2443.2006.01018.x; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Nishihara A, 1999, J BIOL CHEM, V274, P28716, DOI 10.1074/jbc.274.40.28716; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Reed JA, 2001, CANCER RES, V61, P8074; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Tajima Y, 2003, J BIOL CHEM, V278, P10716, DOI 10.1074/jbc.M212663200; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tewari M, 2004, MOL CELL, V13, P469, DOI 10.1016/S1097-2765(04)00033-4; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Zhang F, 2003, CANCER RES, V63, P5005; Zhang ST, 2006, CELL CYCLE, V5, P2787, DOI 10.4161/cc.5.23.3523; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	61	126	129	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20492	20501		10.1074/jbc.M701294200	http://dx.doi.org/10.1074/jbc.M701294200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17510063	hybrid			2022-12-27	WOS:000247819300052
J	Pedmale, UV; Liscum, E				Pedmale, Ullas V.; Liscum, Emmanuel			Regulation of phototropic signaling in Arabidopsis via phosphorylation state changes in the phototropin 1-interacting protein NPH3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT; PHOSPHATASE 2A; OKADAIC ACID; CELL-CYCLE; UBIQUITIN LIGASES; GUARD-CELLS; KINASE; DOMAIN; BINDING; TRANSDUCTION	Phototropism, or the directional growth ( curvature) of various organs toward or away from incident light, represents a ubiquitous adaptive response within the plant kingdom. This response is initiated through the sensing of directional blue light (BL) by a small family of photoreceptors known as the phototropins. Of the two phototropins present in the model plant Arabidopsis thaliana, phot1 (phototropin 1) is the dominant receptor controlling phototropism. Absorption of BL by the sensory portion of phot1 leads, as in other plant phototropins, to activation of a C-terminal serine/threonine protein kinase domain, which is tightly coupled with phototropic responsiveness. Of the five phot1-interacting proteins identified to date, only one, NPH3 (non-phototropic hypocotyl 3), is essential for all phot1-dependent phototropic responses, yet little is known about how phot1 signals through NPH3. Here, we show that, in dark-grown seedlings, NPH3 exists as a phosphorylated protein and that BL stimulates its dephosphorylation. phot1 is necessary for this response and appears to regulate the activity of a type 1 protein phosphatase that catalyzes the reaction. The abrogation of both BL-dependent dephosphorylation of NPH3 and development of phototropic curvatures by protein phosphatase inhibitors further suggests that this post-translational modification represents a crucial event in phot1-dependent phototropism. Given that NPH3 may represent a core component of a CUL3-based ubiquitin-protein ligase (E3), we hypothesize that the phosphorylation state of NPH3 determines the functional status of such an E3 and that differential regulation of this E3 is required for normal phototropic responsiveness.	Univ Missouri, Christopher S Bond Life Sci Ctr, Div Biol Sci, Columbus, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Liscum, E (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Div Biol Sci, Columbus, MO 65211 USA.	liscume@missouri.edu		Liscum, Emmanuel/0000-0002-8672-9315				ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Allende-Vega N, 2005, MOL CELL BIOCHEM, V274, P85, DOI 10.1007/s11010-005-3074-4; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bouly JP, 2003, EUR J BIOCHEM, V270, P2921, DOI 10.1046/j.1432-1033.2003.03691.x; Celaya RB, 2005, PHOTOCHEM PHOTOBIOL, V81, P73, DOI 10.1562/2004-08-22-IR-282.1; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christopher DA, 1997, PLANT PHYSIOL, V113, P1273, DOI 10.1104/pp.113.4.1273; Cohen PTW, 2002, J CELL SCI, V115, P241; DeLong A, 2006, CURR OPIN PLANT BIOL, V9, P470, DOI 10.1016/j.pbi.2006.07.015; Deruere J, 1999, PLANT J, V20, P389, DOI 10.1046/j.1365-313x.1999.00607.x; Emi T, 2005, PLANT PHYSIOL, V138, P1615, DOI 10.1104/pp.104.052639; ERDODI F, 1995, AM J PHYSIOL-CELL PH, V269, pC1176, DOI 10.1152/ajpcell.1995.269.5.C1176; Esmon CA, 2005, INT J DEV BIOL, V49, P665, DOI 10.1387/ijdb.052028ce; Esmon CA, 2006, P NATL ACAD SCI USA, V103, P236, DOI 10.1073/pnas.0507127103; Fankhauser C, 2000, SEMIN CELL DEV BIOL, V11, P467, DOI 10.1006/scdb.2000.0201; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haga K, 2005, PLANT CELL, V17, P103, DOI 10.1105/tpc.104.028357; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Iino M, 2001, PHOTOMOVEMENT, V1, P659, DOI DOI 10.1016/S1568-461X(01)80027-2; Inada S, 2004, PLANT CELL, V16, P887, DOI 10.1105/tpc.019901; Jackson LP, 2006, MOL CELL BIOL, V26, P2456, DOI 10.1128/MCB.26.6.2456-2466.2006; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kim DH, 2002, PLANT CELL, V14, P3043, DOI 10.1105/tpc.005306; Kimura M, 2006, CURR OPIN PLANT BIOL, V9, P503, DOI 10.1016/j.pbi.2006.07.003; Kinoshita T, 1997, PLANT CELL PHYSIOL, V38, P1281, DOI 10.1093/oxfordjournals.pcp.a029117; Kinoshita T, 2003, PLANT PHYSIOL, V133, P1453, DOI 10.1104/pp.103.029629; Kong SG, 2006, PLANT J, V45, P994, DOI 10.1111/j.1365-313X.2006.02667.x; Krek W, 2003, NAT CELL BIOL, V5, P950, DOI 10.1038/ncb1103-950; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; Lasceve G, 1999, PLANT PHYSIOL, V120, P605, DOI 10.1104/pp.120.2.605; Lebrin F, 1999, MOL CELL BIOCHEM, V191, P207, DOI 10.1023/A:1006888228156; LI YM, 1993, BIOCHEM PHARMACOL, V46, P1435, DOI 10.1016/0006-2952(93)90109-A; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Liscum E, 1996, PLANT PHYSIOL, V112, P291, DOI 10.1104/pp.112.1.291; LISCUM E, 2002, ARABIDOPSIS BOOK, P1; Loyet KM, 2005, MOL CELL PROTEOMICS, V4, P235, DOI 10.1074/mcp.R400011-MCP200; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Matsuoka D, 2007, PHOTOCHEM PHOTOBIOL, V83, P122, DOI 10.1562/2006-03-29-RA-861; McCluskey Adam, 2001, Mini-Reviews in Medicinal Chemistry, V1, P43, DOI 10.2174/1389557013407205; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Mizoguchi T, 2006, INT REV CYTOL, V250, P47, DOI 10.1016/S0074-7696(06)50002-6; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; Motchoulski A, 1999, SCIENCE, V286, P961, DOI 10.1126/science.286.5441.961; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; Phee BK, 2006, PROTEOMICS, V6, P3671, DOI 10.1002/pmic.200500222; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rawn DFK, 2005, J CHROMATOGR A, V1080, P148, DOI 10.1016/j.chroma.2005.05.035; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Salomon M, 2003, BIOCHEMISTRY-US, V42, P4217, DOI 10.1021/bi027324f; Shalitin D, 2003, PLANT CELL, V15, P2421, DOI 10.1105/tpc.013011; Shalitin D, 2002, NATURE, V417, P763, DOI 10.1038/nature00815; SHEEN J, 1993, EMBO J, V12, P3497, DOI 10.1002/j.1460-2075.1993.tb06024.x; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Smith RD, 1996, ANNU REV PLANT PHYS, V47, P101, DOI 10.1146/annurev.arplant.47.1.101; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stowe-Evans EL, 2001, PLANT PHYSIOL, V126, P826, DOI 10.1104/pp.126.2.826; Stowe-Evans EL, 1998, PLANT PHYSIOL, V118, P1265, DOI 10.1104/pp.118.4.1265; Takemiya A, 2006, P NATL ACAD SCI USA, V103, P13549, DOI 10.1073/pnas.0602503103; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Wang HY, 2005, CURR TOP DEV BIOL, V68, P227, DOI 10.1016/S0070-2153(05)68008-8; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Whippo CW, 2004, PLANT CELL ENVIRON, V27, P1223, DOI 10.1111/j.1365-3040.2004.01227.x; Whippo CW, 2003, PLANT PHYSIOL, V132, P1499, DOI 10.1104/pp.102.018481; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; ZHUO S, 1993, J BIOL CHEM, V268, P17754	92	112	125	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19992	20001		10.1074/jbc.M702551200	http://dx.doi.org/10.1074/jbc.M702551200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17493935	hybrid			2022-12-27	WOS:000247650600073
J	Medel, YFF; Gardner, PD				Fuentes Medel, Yuly F.; Gardner, Paul D.			Transcriptional repression by a conserved intronic sequence in the nicotinic receptor alpha 3 subunit gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; CENTRAL-NERVOUS-SYSTEM; FRONTAL-LOBE EPILEPSY; MESSENGER-RNA LEVELS; 4 SUBUNIT GENE; ACETYLCHOLINE-RECEPTOR; REGULATORY ELEMENTS; ALPHA-3 GENE; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL REGULATION	The genes encoding the nicotinic acetylcholine receptor alpha 3, alpha 5, and beta 4 subunits are genomically clustered. These genes are co-expressed in a variety of cells in the peripheral and central nervous systems. Their gene products assemble in a number of stoichiometries to generate several nicotinic receptor subtypes that have distinct pharmacological and physiological properties. Signaling through these receptors is critical for a variety of fundamental biological processes. Despite their importance, the transcriptional mechanisms underlying their coordinated expression remain to be completely elucidated. By using a bioin-formatics approach, we identified a highly conserved intronic sequence within the fifth intron of the alpha 3 subunit gene. Reporter gene analysis demonstrated that this sequence, termed "alpha 3 intron 5," inhibits the transcriptional activities of the alpha 3 and beta 4 subunit gene promoters. This repressive activity is position- and orientation-independent. Importantly, repression occurs in a cell type-specific manner, being present in cells that do not express the receptor genes or expresses them at very low levels. Electrophoretic mobility shift assays demonstrate that nuclear proteins specifically interact with alpha 3 intron 5 at two distinct sites. We propose that this intronic repressor element is important for the restricted expression patterns of the nicotinic receptor alpha 3 and beta 4 subunit genes.	Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester	Gardner, PD (corresponding author), Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA.	paul.gardner@umassmed.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030243] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30243] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benfante R, 2007, J BIOL CHEM, V282, P13290, DOI 10.1074/jbc.M608616200; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; BESSIS A, 1993, NUCLEIC ACIDS RES, V21, P2185, DOI 10.1093/nar/21.9.2185; Bigger CB, 1996, J BIOL CHEM, V271, P32842, DOI 10.1074/jbc.271.51.32842; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; BOULTER J, 1990, J BIOL CHEM, V265, P4472; Boyd RT, 1996, NEUROSCI LETT, V208, P73, DOI 10.1016/0304-3940(96)12561-1; Boyd RT, 1997, CRIT REV TOXICOL, V27, P299, DOI 10.3109/10408449709089897; BOYD RT, 1994, J NEUROBIOL, V25, P960, DOI 10.1002/neu.480250806; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Campos-Caro A, 1999, J BIOL CHEM, V274, P4693, DOI 10.1074/jbc.274.8.4693; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; De Fusco M, 2000, NAT GENET, V26, P275; DEVAY P, 1994, DEV BIOL, V162, P56, DOI 10.1006/dbio.1994.1066; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Du Q, 1997, J BIOL CHEM, V272, P14990, DOI 10.1074/jbc.272.23.14990; Ebihara M, 2002, GENE, V298, P101, DOI 10.1016/S0378-1119(02)00925-3; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; FINKBEINER S, 2001, SCI STKE, pPE1; Flora A, 2000, EUR J PHARMACOL, V393, P85, DOI 10.1016/S0014-2999(00)00040-6; Flores CM, 1996, J NEUROSCI, V16, P7892; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Fornasari D, 1997, MOL PHARMACOL, V51, P250, DOI 10.1124/mol.51.2.250; FORNASARI D, 1998, NEURONAL NICOTINIC R, P25; Francis N, 2002, J BIOL CHEM, V277, P6511, DOI 10.1074/jbc.M105616200; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; FRANK E, 1993, NEURON, V10, P779, DOI 10.1016/0896-6273(93)90194-V; Fyodorov D, 1996, MOL CELL BIOL, V16, P5004; Fyodorov D, 1998, J NEUROBIOL, V34, P151, DOI 10.1002/(SICI)1097-4695(19980205)34:2<151::AID-NEU5>3.0.CO;2-1; Genzen JR, 2001, J NEUROPHYSIOL, V86, P1773, DOI 10.1152/jn.2001.86.4.1773; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Groves AK, 1999, CURR TOP DEV BIOL, V43, P221; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; HU MJ, 1995, J BIOL CHEM, V270, P4497, DOI 10.1074/jbc.270.19.11619; Isacson O, 2002, TRENDS NEUROSCI, V25, P79, DOI 10.1016/S0166-2236(02)02037-4; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; King SL, 2003, J NEUROSCI, V23, P3837; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Lena C, 1997, CURR OPIN NEUROBIOL, V7, P674, DOI 10.1016/S0959-4388(97)80088-8; LEVEY MS, 1995, NEURON, V14, P153, DOI 10.1016/0896-6273(95)90249-X; LIPTON SA, 1988, SCIENCE, V239, P1293, DOI 10.1126/science.3344435; Liu Q, 1999, J NEUROSCI, V19, P9747; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lustig LR, 2001, GENOMICS, V73, P272, DOI 10.1006/geno.2000.6503; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Matter JM, 1998, J PHYSIOLOGY-PARIS, V92, P245, DOI 10.1016/S0928-4257(98)80027-2; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; McDonough J, 1997, J NEUROSCI, V17, P2273; McDonough J, 2000, J BIOL CHEM, V275, P28962, DOI 10.1074/jbc.M004181200; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Melnikova IN, 2000, NEUROPHARMACOLOGY, V39, P2615, DOI 10.1016/S0028-3908(00)00125-8; Melnikova IN, 2001, J BIOL CHEM, V276, P19040, DOI 10.1074/jbc.M010735200; Milton NGN, 1996, BIOCHEM J, V317, P419, DOI 10.1042/bj3170419; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Perl O, 2003, FASEB J, V17, P1948, DOI 10.1096/fj.03-0104fje; Perry EK, 2001, ALCOHOL, V24, P63, DOI 10.1016/S0741-8329(01)00130-6; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Picciotto MR, 2002, J NEUROSCI, V22, P3338; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Record M T Jr, 1985, Adv Biophys, V20, P109; Richardson CE, 2001, GASTROENTEROLOGY, V121, P350, DOI 10.1053/gast.2001.26320; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; RUST G, 1994, EUR J NEUROSCI, V6, P478, DOI 10.1111/j.1460-9568.1994.tb00290.x; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schuller HM, 2000, EUR J PHARMACOL, V393, P265, DOI 10.1016/S0014-2999(00)00094-7; Sher E, 1998, ANN NY ACAD SCI, V841, P606, DOI 10.1111/j.1749-6632.1998.tb10993.x; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Teaktong T, 2003, GLIA, V41, P207, DOI 10.1002/glia.10132; Terzano S, 2000, J BIOL CHEM, V275, P41495, DOI 10.1074/jbc.M006197200; Thiel G, 2004, EUR J BIOCHEM, V271, P2855, DOI 10.1111/j.1432-1033.2004.04174.x; Valor LM, 2003, J BIOL CHEM, V278, P37249, DOI 10.1074/jbc.M307043200; Valor LM, 2002, J BIOL CHEM, V277, P8866, DOI 10.1074/jbc.M110454200; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; Wang NS, 2002, PROG NEUROBIOL, V68, P341, DOI 10.1016/S0301-0082(02)00106-5; Watkins S S, 2000, Nicotine Tob Res, V2, P19; WHITEHOUSE PJ, 1988, ARCH NEUROL-CHICAGO, V45, P722, DOI 10.1001/archneur.1988.00520310028012; WinzerSerhan UH, 1997, J COMP NEUROL, V386, P540, DOI 10.1002/(SICI)1096-9861(19971006)386:4<540::AID-CNE2>3.0.CO;2-2; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Xu XH, 2006, MOL CELL BIOL, V26, P5636, DOI 10.1128/MCB.00456-06; YANG XD, 1994, J BIOL CHEM, V269, P10252; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; Yang XD, 1997, J NEUROBIOL, V32, P311, DOI 10.1002/(SICI)1097-4695(199703)32:3<311::AID-NEU5>3.0.CO;2-A; Zhou YF, 1998, J NEUROBIOL, V34, P164, DOI 10.1002/(SICI)1097-4695(19980205)34:2<164::AID-NEU6>3.0.CO;2-0; Zoli M, 1998, J NEUROSCI, V18, P4461	97	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19062	19070		10.1074/jbc.M702354200	http://dx.doi.org/10.1074/jbc.M702354200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17504758	hybrid			2022-12-27	WOS:000247475300048
J	Yabuta, N; Okada, N; Ito, A; Hosomi, T; Nishihara, S; Sasayama, Y; Fujimori, A; Okuzaki, D; Zhao, H; Ikawa, M; Okabe, M; Nojima, H				Yabuta, Norikazu; Okada, Nobuhiro; Ito, Akihiko; Hosomi, Toshiya; Nishihara, Souichi; Sasayama, Yuya; Fujimori, Azumi; Okuzaki, Daisuke; Zhao, Hanjun; Ikawa, Masahito; Okabe, Masaru; Nojima, Hiroshi			Lats2 is an essential mitotic regulator required for the coordination of cell division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA TUMOR-SUPPRESSOR; PUTATIVE PROTEIN-KINASE; AURORA-A KINASE; CENTROSOME DUPLICATION; BUDDING YEAST; HUMAN HOMOLOG; PROMOTES APOPTOSIS; TETRAPLOIDY CHECKPOINT; DOWN-REGULATION; MOB1 PROTEIN	Tumor suppressor Lats2 is a member of the conserved Dbf2 kinase family. It localizes to the centrosome and has been implicated in regulation of the cell cycle and apoptosis. However, the in vivo function of this kinase remains unclear. Here, we show that complete disruption of the gene encoding Lats2 in mice causes developmental defects in the nervous system and embryonic lethality. Furthermore, mutant cells derived from total LATS2-knock-out embryos exhibit mitotic defects including centrosome fragmentation and cytokinesis defects, followed by nuclear enlargement and multinucleation. We show that the Mob1 family, a regulator of mitotic exit, associates with Lats2 to induce its activation. We also show that the complete LATS2-knock-out cells exhibit an acceleration of exit from mitosis and marked down-regulation of critical mitotic regulators. These results suggest that Lats2 plays an essential mitotic role in coordinating accurate cytokinesis completion, governing the stabilization of other mitotic regulators.	Osaka Univ, Res Inst Microbial Dis, Dept Mol Genet, Suita, Osaka 5650871, Japan; Kobe Univ, Grad Sch Med, Div Surg Pathol, Chuo Ku, Kobe, Hyogo 650, Japan; Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan	Osaka University; Kobe University; Osaka University	Nojima, H (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Mol Genet, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	snj-0212@biken.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020; ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	Okuzaki, Daisuke/0000-0002-4552-783X; ikawa, masahito/0000-0001-9859-6217; Okada, Nobuhiro/0000-0002-0434-6039; Okabe, Masaru/0000-0002-0803-9044				Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Bosl WJ, 2005, CELL, V121, P325, DOI 10.1016/j.cell.2005.04.006; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Duensing S, 2005, CELL BIOL INT, V29, P352, DOI 10.1016/j.cellbi.2005.03.005; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Frenz LM, 2000, J CELL SCI, V113, P3399; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hori T, 2000, ONCOGENE, V19, P3101, DOI 10.1038/sj.onc.1203659; Hou MC, 2004, MOL CELL BIOL, V24, P3262, DOI 10.1128/MCB.24.8.3262-3276.2004; Hou MC, 2003, J CELL SCI, V116, P125, DOI 10.1242/jcs.00206; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; JOHNSTON LH, 1990, MOL CELL BIOL, V10, P1358, DOI 10.1128/MCB.10.4.1358; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Ke HN, 2004, EXP CELL RES, V298, P329, DOI 10.1016/j.yexcr.2004.04.031; Komarnitsky SI, 1998, MOL CELL BIOL, V18, P2100, DOI 10.1128/MCB.18.4.2100; Kramer A, 2004, CELL CYCLE, V3, P1390, DOI 10.4161/cc.3.11.1252; Kuninaka S, 2007, ONCOGENE, V26, P2395, DOI 10.1038/sj.onc.1210042; Kuninaka S, 2005, ONCOGENE, V24, P5287, DOI 10.1038/sj.onc.1208682; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mrkobrada S, 2006, J MOL BIOL, V362, P430, DOI 10.1016/j.jmb.2006.07.007; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nishiyama Y, 1999, FEBS LETT, V459, P159, DOI 10.1016/S0014-5793(99)01224-7; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Ponchon L, 2004, J MOL BIOL, V337, P167, DOI 10.1016/j.jmb.2004.01.010; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Saavedra HI, 2003, CANCER CELL, V3, P333, DOI 10.1016/S1535-6108(03)00083-7; Salimova E, 2000, J CELL SCI, V113, P1695; Salisbury JL, 1999, BIOL CELL, V91, P451, DOI 10.1016/S0248-4900(99)80086-0; Seshan A, 2004, CURR OPIN CELL BIOL, V16, P41, DOI 10.1016/j.ceb.2003.11.003; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Sparks CA, 1999, J CELL BIOL, V146, P777, DOI 10.1083/jcb.146.4.777; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stavridi ES, 2003, STRUCTURE, V11, P1163, DOI 10.1016/S0969-2126(03)00182-5; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; TOYN JH, 1991, GENE, V104, P63, DOI 10.1016/0378-1119(91)90465-N; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang Q, 2006, P NATL ACAD SCI USA, V103, P6512, DOI 10.1073/pnas.0601682103; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; XU TA, 1995, DEVELOPMENT, V121, P1053; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817	85	123	126	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19259	19271		10.1074/jbc.M608562200	http://dx.doi.org/10.1074/jbc.M608562200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17478426	hybrid			2022-12-27	WOS:000247475300066
J	Masuda, K; Ouchida, R; Hikida, M; Kurosaki, T; Yokoi, M; Masutani, C; Seki, M; Wood, RD; Hanaoka, F; O-Wang, J				Masuda, Keiji; Ouchida, Rika; Hikida, Masaki; Kurosaki, Tomohiro; Yokoi, Masayuki; Masutani, Chikahide; Seki, Mineaki; Wood, Richard D.; Hanaoka, Fumio; O-Wang, Jiyang			DNA polymerases eta and theta function in the same genetic pathway to generate mutations at A/T during somatic hypermutation of Ig genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS SWITCH RECOMBINATION; EMBRYONIC LETHALITY; TRANSLESION SYNTHESIS; IMMUNOGLOBULIN GENES; V(D)J RECOMBINATION; ANTIBODY DIVERSITY; MICE DEFICIENT; ZETA; ERROR; MOUSE	Somatic hypermutation of the Ig genes requires the activity of multiple DNA polymerases to ultimately introduce mutations at both A/T and C/G base pairs. Mice deficient for DNA polymerase eta (POLH) exhibited an similar to 80% reduction of the mutations at A/T, whereas absence of polymerase theta( POLQ) resulted in similar to 20% reduction of both A/T and C/G mutations. To investigate whether the residual A/T mutations observed in the absence of POLH are generated by POLQ and how these two polymerases might cooperate or compete with each other to generate A/T mutations, here we have established mice deficient for both POLH and POLQ. Polq(-/-) Polh(-/-) mice, however, did not show a further decrease of A/T mutations as compared with Polh(-/-) mice, suggesting that POLH and POLQ function in the same genetic pathway in the generation of these mutations. Frequent misincorporation of nucleotides, in particular opposite template T, is a known feature of POLH, but the efficiency of extension beyond the misincorporation differs significantly depending on the nature of the mispairing. Remarkably, we found that POLQ catalyzed extension more efficiently than POLH from all types of mispaired termini opposite A or T. Moreover, POLQ was able to extend mispaired termini generated by POLH albeit at a relatively low efficiency. These results reveal genetic and biochemical interactions between POLH and POLQ and suggest that POLQ might cooperate with POLH to generate some of the A/T mutations during the somatic hypermutation of Ig genes.	RIKEN, Yokohama Inst, Lab Immune Divers, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; RIKEN, Yokohama Inst, Lab Lymphocyte Differentiat, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, SORST, Suita, Osaka 5650871, Japan; Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA	RIKEN; RIKEN; Osaka University; Japan Science & Technology Agency (JST); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O-Wang, J (corresponding author), RIKEN, Yokohama Inst, Lab Immune Divers, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan.	oh@rcai.riken.jp	Masutani, Chikahide/I-6160-2014; Kurosaki, Tomohiro/D-1306-2009; Wood, Richard D/M-6319-2018	Kurosaki, Tomohiro/0000-0002-6352-304X; Wood, Richard D/0000-0002-9495-6892; Yokoi, Masayuki/0000-0001-9727-0258; Masutani, Chikahide/0000-0002-8600-8227	NCI NIH HHS [CA101980] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA101980] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Diaz M, 2001, J IMMUNOL, V167, P327, DOI 10.4049/jimmunol.167.1.327; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kajiwara K, 2001, GENES CELLS, V6, P99, DOI 10.1046/j.1365-2443.2001.00410.x; Martomo SA, 2006, DNA REPAIR, V5, P392, DOI 10.1016/j.dnarep.2005.12.006; Martomo SA, 2005, P NATL ACAD SCI USA, V102, P8656, DOI 10.1073/pnas.0501852102; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Masuda K, 2005, P NATL ACAD SCI USA, V102, P13986, DOI 10.1073/pnas.0505636102; Masuda K, 2006, DNA REPAIR, V5, P1384, DOI 10.1016/j.dnarep.2006.06.006; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Shimizu T, 2005, IMMUNOL LETT, V98, P259, DOI 10.1016/j.imlet.2004.11.022; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Zan H, 2005, EMBO J, V24, P3757, DOI 10.1038/sj.emboj.7600833; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X	45	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17387	17394		10.1074/jbc.M611849200	http://dx.doi.org/10.1074/jbc.M611849200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17449470	hybrid			2022-12-27	WOS:000247084500008
J	Pearce, G; Siems, WF; Bhattacharya, R; Chen, YC; Ryan, CA				Pearce, Gregory; Siems, William F.; Bhattacharya, Ramcharan; Chen, Yu-Chi; Ryan, Clarence A.			Three hydroxyproline-rich glycopeptides derived from a single petunia polyprotein precursor activate defensin I, a pathogen defense response gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANTS; PEPTIDES; LOCALIZATION; ARABIDOPSIS; COMPONENTS; IMMUNITY; RECEPTOR; HORMONES; ANIMALS; SYSTEM	Hydroxyproline-rich glycopeptides (HypSys peptides) are recently discovered 16 -20-amino acid defense signals in tobacco and tomato leaves that are derived from cell wall-associated precursors. The peptides are powerful wound signals that activate the expression of defensive genes in tobacco and tomato leaves in response to herbivore attacks. We have isolated a cDNA from petunia (Petunia hybrida) leaves encoding a putative protein of 214 amino acids that is a homolog of tobacco and tomato HypSys peptide precursors and is inducible by wounding and MeJA. The deduced protein contains a leader sequence and four predicted proline-rich peptides of 18-21 amino acids. Three of the four peptides were isolated from leaves, and each peptide contained hydroxylated prolines and glycosyl residues. Each of the peptides has a -GR-motif at its N terminus, indicating that it may be the substrate site for a processing enzyme. The peptides were active in a petunia suspension culture bioassay at nanomolar concentrations, but they did not induce the expression of defense genes that are directed against herbivores, as found in tobacco and tomato leaves. They did, however, activate expression of defensin 1, a gene associated with inducible defense responses against pathogens.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Washington State Univ, Dept Chem, Pullman, WA 99164 USA; Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India	Washington State University; Washington State University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB)	Ryan, CA (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	cabudryan@hotmail.com						Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boller T, 2005, CURR OPIN CELL BIOL, V17, P116, DOI 10.1016/j.ceb.2005.02.007; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Ferris PJ, 2001, BIOCHEMISTRY-US, V40, P2978, DOI 10.1021/bi0023605; Howe GA, 1999, GENETICS, V153, P1411; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; MCGURL B, 1992, SCIENCE, V255, P1570, DOI 10.1126/science.1549783; Menezes H, 2002, COMP BIOCHEM PHYS C, V132, P1, DOI 10.1016/S1532-0456(02)00043-1; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Narvaez-Vasquez J, 2005, P NATL ACAD SCI USA, V102, P12974, DOI 10.1073/pnas.0505248102; Narvaez-Vasquez J, 2004, PLANTA, V218, P360, DOI 10.1007/s00425-003-1115-3; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Parker JE, 2003, TRENDS PLANT SCI, V8, P245, DOI 10.1016/S1360-1385(03)00105-5; Pearce G, 2003, J BIOL CHEM, V278, P30044, DOI 10.1074/jbc.M304159200; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PEARCE G, 1993, PLANT PHYSIOL, V102, P639, DOI 10.1104/pp.102.2.639; Pearce G, 2001, NATURE, V411, P817, DOI 10.1038/35081107; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Ren F, 2006, PLANT SCI, V171, P286, DOI 10.1016/j.plantsci.2006.04.001; ROCHAGRANADOS MC, 2005, PLANTA, V222, P794, DOI DOI 10.1007/S00425-005-0024-Z; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Ryan CA, 2002, P NATL ACAD SCI USA, V99, P6519, DOI 10.1073/pnas.112196499; RYAN CA, 2004, ENCY BIOL CHEM, V3, P381; Scheer JM, 2002, P NATL ACAD SCI USA, V99, P9585, DOI 10.1073/pnas.132266499; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103	29	43	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17777	17784		10.1074/jbc.M701543200	http://dx.doi.org/10.1074/jbc.M701543200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17449475	hybrid			2022-12-27	WOS:000247084500051
J	Torres, MP; Borchers, CH				Torres, Matthew P.; Borchers, Christoph H.			Mitotic phosphorylation of the anaphase-promoting complex inhibitory subunit Mnd2 is necessary for efficient progression through meiosis I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE STABILIZES; TUMOR-SUPPRESSOR RASSF1A; CELL-CYCLE; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; SUBSTRATE RECOGNITION; DEPENDENT PROTEOLYSIS; MASS-SPECTROMETRY; UBIQUITIN LIGASE; MITOSIS	The yeast anaphase-promoting complex (APC) subunit Mnd2 is necessary for maintaining sister chromatid cohesion in prophase I of meiosis by inhibiting premature ubiquitination and subsequent degradation of substrates by the APC(Ama1) ubiquitin ligase. In a proteomics screen for post-translational modifications on the APC, we discovered that Mnd2 is phosphorylated during mitosis in a cell cycle-dependent manner. We identified and characterized the sites of mitotic Mnd2 phosphorylation during the cell cycle. Collective mutation of Mnd2 phosphorylation sites to alanine had no effect on vegetative growth but a striking effect (> 85% reduction) on the percentage of tetrad-forming cells compared with the wild type strain. Similar to the MND2 deletion strain, cells harboring the alanine mutant that did not form spores arrested after premeiotic S phase with a single undivided nucleus and low levels of the APCAma1 meiotic substrate, Clb5, relative to wild type cells. In contrast, collective mutation of Mnd2 phosphorylation sites to aspartic acid resulted in partial suppression of the sporulation defect. No differences were observed in the binding between each Mnd2 isoform and the APC in vitro. However, in vivo, we observed a gradient in the abundance of APC-associated Mnd2 in each strain that was proportional to the observed differences in sporulation and Clb5 levels. Taken together, these data suggest that mitotic phosphorylation of Mnd2 is necessary for APC-mediated progression beyond the first meiotic nuclear division.	Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8Z 7X8, Canada; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of Victoria; University of North Carolina; University of North Carolina Chapel Hill	Borchers, CH (corresponding author), Univ Victoria, Proteom Ctr, Vancouver Isl Technol Pk,3101-4464 Markham St, Victoria, BC V8Z 7X8, Canada.	christoph@proteincentre.com	BORCHERS, Christoph/U-5964-2019	Torres, Matthew/0000-0001-7296-4536				Bardin AJ, 2003, MOL CELL BIOL, V23, P5018, DOI 10.1128/MCB.23.14.5018-5030.2003; Bashir T, 2003, ADV CANCER RES, V88, P101, DOI 10.1016/S0065-230X(03)88305-7; Blanco MA, 2001, J CELL SCI, V114, P2135; Borchers C, 2000, ANAL CHEM, V72, P1163, DOI 10.1021/ac990937m; CHEN M, 1989, J BIOL CHEM, V264, P14282; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Eckerdt F, 2005, J BIOL CHEM, V280, P36575, DOI 10.1074/jbc.M504548200; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; LAHAVBARATZ S, 1995, P NATL ACAD SCI USA, V92, P9303, DOI 10.1073/pnas.92.20.9303; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Page AM, 2005, GENETICS, V170, P1045, DOI 10.1534/genetics.104.040105; Parker Carol E., 2005, V301, P117; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Rudner AD, 2000, J CELL BIOL, V149, P1361, DOI 10.1083/jcb.149.7.1361; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V260, P193, DOI 10.1006/bbrc.1999.0884; Song MS, 2004, CELL CYCLE, V3, P574; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Torres MP, 2005, J PROTEOME RES, V4, P1628, DOI 10.1021/pr050129d; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhou Y, 2003, BIOCHEM J, V374, P349, DOI 10.1042/BJ20030600	53	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17351	17362		10.1074/jbc.M610841200	http://dx.doi.org/10.1074/jbc.M610841200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17459880	hybrid, Green Published			2022-12-27	WOS:000247084500005
J	Zederbauer, M; Furtmuller, PG; Bellei, M; Stampler, J; Jakopitsch, C; Battistuzzi, G; Moguilevsky, N; Obinger, C				Zederbauer, Martina; Furtmueller, Paul G.; Bellei, Marzia; Stampler, Johanna; Jakopitsch, Christa; Battistuzzi, Gianantonio; Moguilevsky, Nicole; Obinger, Christian			Disruption of the aspartate to heme ester linkage in human myeloperoxidase - Impact on ligand binding, redox chemistry, and interconversion of redox intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; HUMAN RECOMBINANT MYELOPEROXIDASE; SITE-DIRECTED MUTAGENESIS; EOSINOPHIL PEROXIDASE; HYDROGEN-PEROXIDE; COMPOUND-I; ANGSTROM RESOLUTION; LACTOPEROXIDASE; THIOCYANATE; MUTANTS	In human heme peroxidases the prosthetic group is covalently attached to the protein via two ester linkages between conserved glutamate and aspartate residues and modified methyl groups on pyrrole rings A and C. Here, monomeric recombinant myeloperoxidase (MPO) and the variants D94V and D94N were produced in Chinese hamster ovary cell lines. Disruption of the Asp(94) to heme ester bond decreased the one-electron reduction potential E '(0) [Fe(III)/ Fe(II)] from 1 to -55 mV at pH 7.0 and 25 C, whereas the kinetics of binding of low spin ligands and of compound I formation was unaffected. By contrast, in both variants rates of compound I reduction by chloride and bromide (but not iodide and thiocyanate) were substantially decreased compared with the wild-type protein. Bimolecular rates of compound II (but not compound I) reduction by ascorbate and tyrosine were slightly diminished in D94V and D94N. The presented biochemical and biophysical data suggest that the Asp94 to heme linkage is no precondition for the autocatalytic formation of the other two covalent links found in MPO. The findings are discussed with respect to the known active site structure of MPO and its complexes with ligands.	BOKU Univ Nat Resources & Appl Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria; Univ Modena, Dept Chem, I-41100 Modena, Italy; Univ Namur, Technol Transfer Off, B-5000 Namur, Belgium	University of Natural Resources & Life Sciences, Vienna; Universita di Modena e Reggio Emilia; University of Namur	Obinger, C (corresponding author), BOKU Univ Nat Resources & Appl Life Sci, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	Furtmüller, Paul G./Y-5819-2018; Battistuzzi, Gianantonio/L-7183-2015; Obinger, Christian/AAV-3173-2021	Furtmüller, Paul G./0000-0002-1199-2469; Battistuzzi, Gianantonio/0000-0003-4716-5745; Jakopitsch, Christa/0000-0002-5855-2057; Obinger, Christian/0000-0002-7133-3430				Arnhold J, 2003, REDOX REP, V8, P179, DOI 10.1179/135100003225002664; Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogioni S, 2006, J RAMAN SPECTROSC, V37, P263, DOI 10.1002/jrs.1442; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; Colas C, 2004, J BIOL CHEM, V279, P24131, DOI 10.1074/jbc.M401687200; Colas C, 2002, J BIOL CHEM, V277, P7191, DOI 10.1074/jbc.M109523200; DAIVASU H, 2000, J MOL EVOL, V31, P433; Davey CA, 1996, BIOCHEMISTRY-US, V35, P10967, DOI 10.1021/bi960577m; DOLPHIN D, 1971, P NATL ACAD SCI USA, V68, P614, DOI 10.1073/pnas.68.3.614; Dunforb HB, 1999, HEME PEROXIDASES, P349; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; Ferrari RP, 1997, J INORG BIOCHEM, V68, P17, DOI 10.1016/S0162-0134(97)00003-2; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2000, FEBS LETT, V484, P139, DOI 10.1016/S0014-5793(00)02143-8; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2005, J INORG BIOCHEM, V99, P1220, DOI 10.1016/j.jinorgbio.2005.02.021; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HOOGLAND H, 1988, BIOCHIM BIOPHYS ACTA, V955, P337, DOI 10.1016/0167-4838(88)90213-0; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; JACQUET A, 1991, ARCH BIOCHEM BIOPHYS, V291, P132, DOI 10.1016/0003-9861(91)90115-Y; JACQUET A, 1994, BIOCHEM BIOPH RES CO, V202, P73, DOI 10.1006/bbrc.1994.1895; Jantschko W, 2002, ARCH BIOCHEM BIOPHYS, V398, P12, DOI 10.1006/abbi.2001.2674; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Kooter IM, 1999, J BIOL CHEM, V274, P26794, DOI 10.1074/jbc.274.38.26794; Kooter IM, 1997, J BIOL INORG CHEM, V2, P191, DOI 10.1007/s007750050124; Kooter IM, 1999, EUR J BIOCHEM, V264, P211, DOI 10.1046/j.1432-1327.1999.00606.x; Kooter IM, 1997, J AM CHEM SOC, V119, P11542, DOI 10.1021/ja9725460; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; SMULEVICH G, 1995, BIOCHEMISTRY-US, V34, P13485, DOI 10.1021/bi00041a028; Suriano G, 2001, BIOORG MED CHEM LETT, V11, P2827, DOI 10.1016/S0960-894X(01)00533-9; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; TAYLOR KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P635, DOI 10.1006/abbi.1995.1083; Wang JG, 2006, ARCH BIOCHEM BIOPHYS, V445, P256, DOI 10.1016/j.abb.2005.10.008; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	50	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					17041	17052		10.1074/jbc.M610685200	http://dx.doi.org/10.1074/jbc.M610685200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17438335	hybrid			2022-12-27	WOS:000246946500037
J	Ono, N; Nakashima, K; Schipani, E; Hayata, T; Ezura, Y; Soma, K; Kronenberg, HM; Noda, M				Ono, Noriaki; Nakashima, Kazuhisa; Schipani, Ernestina; Hayata, Tadayoshi; Ezura, Yoichi; Soma, Kunimichi; Kronenberg, Henry M.; Noda, Masaki			Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; EXPRESSION; PROTEIN; MARROW; OSTEOCLASTOGENESIS; OSTEOPOROSIS; INHIBITION; ACTIVATION; TIBIA; MASS	Multiple signaling pathways participate in the regulation of bone remodeling, and pathological negative balance in the regulation results in osteoporosis. However, interactions of signaling pathways that act comprehensively in concert to maintain bone mass are not fully understood. We investigated roles of parathyroid hormone receptor ( PTH/PTHrP receptor) signaling in osteoblasts in unloading-induced bone loss using transgenic mice. Hind limb unloading by tail suspension reduced bone mass in wild-type mice. In contrast, signaling by constitutively active PTH/PTHrP receptor ( caPPR), whose expression was regulated by the osteoblast-specific Col1a1 promoter ( Col1a1-caPPR), suppressed unloading-induced reduction in bone mass in these transgenic mice. In Col1a1-caPPR transgenic ( Tg) mice, hind limb unloading suppressed bone formation parameters in vivo and mineralized nodule formation in vitro similarly to those observed in wild-type mice. In addition, serum osteocalcin levels and mRNA expression levels of type I collagen, Runx2 and Osterix in bone were suppressed by unloading in both wild-type mice and Tg mice. However, in contrast to unloading-induced enhancement of bone resorption parameters in wild-type mice, Col1a1-caPPR signaling suppressed, rather than enhanced, osteoclast number and osteoclast surface as well as urinary deoxypyridinoline excretion upon unloading. Col1a1-caPPR signaling also suppressed mRNA expression levels of RANK and c-fms in bone upon unloading. Although the M-CSF and monocyte chemoattractant protein 1 ( MCP-1) mRNA levels were enhanced in control Tg mice, these levels were suppressed in unloaded Tg mice. These results indicated that constitutive activation of PTH/PTHrP receptor signaling in osteoblastic cells suppresses unloading-induced bone loss specifically through the regulation of osteoclastic activity.	Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, 21st Century Ctr Excellence Program Frontier Res, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Dept Orthodont Sci, Grad Sch, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, ABJS Integrated Act Initiat JSPS Core Core Progra, Tokyo 1010062, Japan; Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo 1010062, Japan; Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Noda, M (corresponding author), Chiyada Ku,2-3-10 Kanda Surugadai, Tokyo, Japan.	noda.mph@mri.tmd.ac.jp	Hayata, Tadayoshi/AAE-9712-2021; Ezura, Yoichi/L-9485-2016	Nakashima, Kazuhisa/0000-0003-0491-2149	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE022564] Funding Source: NIH RePORTER; NIDCR NIH HHS [K99 DE022564] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bikle DD, 1999, J BONE MINER METAB, V17, P233, DOI 10.1007/s007740050090; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Dossing DA, 2005, J CELL BIOCHEM, V95, P1029, DOI 10.1002/jcb.20470; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Graves DT, 1999, HISTOL HISTOPATHOL, V14, P1347, DOI 10.14670/HH-14.1347; Halloran BP, 1997, J BONE MINER RES, V12, P1068, DOI 10.1359/jbmr.1997.12.7.1068; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Itoh K, 2000, J BONE MINER RES, V15, P1766, DOI 10.1359/jbmr.2000.15.9.1766; Kodama Y, 1997, J BONE MINER RES, V12, P1058, DOI 10.1359/jbmr.1997.12.7.1058; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Kostenuik PJ, 1999, J BONE MINER RES, V14, P21, DOI 10.1359/jbmr.1999.14.1.21; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Murray TM, 2005, ENDOCR REV, V26, P78, DOI 10.1210/er.2003-0024; Partridge NC, 2006, ANN NY ACAD SCI, V1068, P187, DOI 10.1196/annals.1346.024; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; SCHIPANI E, 1996, NEW ENGL J MED, V348, P618; Tanaka S, 2004, J BONE MINER RES, V19, P1813, DOI 10.1359/JBMR.040808; ZHU JF, 1994, J BONE MINER RES, V9, P1123	26	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2007	282	35					25509	25516		10.1074/jbc.M610782200	http://dx.doi.org/10.1074/jbc.M610782200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	204AB	17500070	Green Accepted, hybrid			2022-12-27	WOS:000249014100037
J	Thomas, SR; Terentis, AC; Cai, H; Takikawa, O; Levina, A; Lay, PA; Freewan, M; Stocker, R				Thomas, Shane R.; Terentis, Andrew C.; Cai, Hong; Takikawa, Osamu; Levina, Aviva; Lay, Peter A.; Freewan, Mohammed; Stocker, Roland			Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN CATABOLISM; INTERFERON-GAMMA; DENDRITIC CELLS; KYNURENINE PATHWAY; SPECTRAL CHARACTERIZATION; CRYSTAL-STRUCTURE; HEME ENVIRONMENT; CARBON-MONOXIDE; EXPRESSION; METABOLISM	The heme protein indoleamine 2,3-dioxygenase (IDO) is induced by the proinflammatory cytokine interferon-gamma (IFN gamma) and plays an important role in the immune response by catalyzing the oxidative degradation of L-tryptophan (Trp) that contributes to immune suppression and tolerance. Here we examined the mechanism by which nitric oxide (NO) inhibits human IDO activity. Exposure of IFN gamma-stimulated human monocyte-derived macrophages (MDM) to NO donors had no material impact on IDO mRNA or protein expression, yet exposure of MDM or transfected COS-7 cells expressing active human IDO to NO donors resulted in reversible inhibition of IDO activity. NO also inhibited the activity of purified recombinant human IDO (rhIDO) in a reversible manner and this correlated with NO binding to the heme of rhIDO. Optical absorption and resonance Raman spectroscopy identified NO-inactivated rhIDO as a ferrous iron (Fe-II)-NO-Trp adduct. Stopped-flow kinetic studies revealed that NO reacted most rapidly with Fe-II rhIDO in the presence of Trp. These findings demonstrate that NO inhibits rhIDO activity reversibly by binding to the active site heme to trap the enzyme as an inactive nitrosyl-Fe-II enzyme adduct with Trp bound and O-2 displaced. Reversible inhibition by NO may represent an important mechanism in controlling the immune regulatory actions of IDO.	Univ New S Wales, Fac Med, Ctr Vasc Res, Sydney, NSW 2052, Australia; Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Aichi 4748522, Japan; Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	University of New South Wales Sydney; State University System of Florida; Florida Atlantic University; National Center for Geriatrics & Gerontology; University of Sydney	Thomas, SR (corresponding author), Univ New S Wales, Fac Med, Ctr Vasc Res, Sydney, NSW 2052, Australia.	shane.thomas@unsw.edu.au	Terentis, Andrew/N-9188-2019; Stocker, Roland/AAV-4489-2021; Lay, Peter A/B-4698-2014	Terentis, Andrew/0000-0001-6137-8275; Lay, Peter A/0000-0002-3232-2720; Levina, Aviva/0000-0002-7311-3263				ABUSOUD HM, 1995, J BIOL CHEM, V270, P22997, DOI 10.1074/jbc.270.39.22997; Aitken JB, 2004, BIOCHEMISTRY-US, V43, P4892, DOI 10.1021/bi049645s; AlberatiGiani D, 1997, J IMMUNOL, V159, P419; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247; CHRISTEN S, 1994, J CLIN INVEST, V93, P2149, DOI 10.1172/JCI117211; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Fujigaki H, 2006, J IMMUNOL, V176, P372, DOI 10.4049/jimmunol.176.1.372; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; HIRATA F, 1977, J BIOL CHEM, V252, P4637; Hortelano S, 2003, J IMMUNOL, V171, P6059, DOI 10.4049/jimmunol.171.11.6059; Hucke C, 2004, INFECT IMMUN, V72, P2723, DOI 10.1128/IAI.72.5.2723-2730.2004; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; Khan S, 1997, J CELL SCI, V110, P2315; Konan KV, 1996, J BIOL CHEM, V271, P19140, DOI 10.1074/jbc.271.32.19140; Littlejohn TK, 2000, PROTEIN EXPRES PURIF, V19, P22, DOI 10.1006/prep.2000.1214; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Orabona C, 2005, J IMMUNOL, V174, P6582, DOI 10.4049/jimmunol.174.11.6582; Samelson-Jones BJ, 2006, BIOCHEMISTRY-US, V45, P8527, DOI 10.1021/bi060143j; Sanni LA, 1998, AM J PATHOL, V152, P611; SONO M, 1986, BIOCHEMISTRY-US, V25, P6089, DOI 10.1021/bi00368a038; SONO M, 1980, J BIOL CHEM, V255, P1339; SONO M, 1989, J BIOL CHEM, V264, P1616; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; SUGIMOTO H, 2006, P NATL ACAD SCI US; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; Terwel D, 2000, EUR J PHARMACOL, V400, P19, DOI 10.1016/S0014-2999(00)00379-4; Thomas DD, 2003, ANTIOXID REDOX SIGN, V5, P307, DOI 10.1089/152308603322110887; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; Wang J., 1996, METHODS NITRIC OXIDE, P427; Wang JL, 2003, J BIOL CHEM, V278, P2341, DOI 10.1074/jbc.M211131200; Zegarra-Moran O, 2004, J IMMUNOL, V173, P542, DOI 10.4049/jimmunol.173.1.542; Zhang Y, 2007, BIOCHEMISTRY-US, V46, P145, DOI 10.1021/bi0620095	43	82	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2007	282	33					23778	23787		10.1074/jbc.M700669200	http://dx.doi.org/10.1074/jbc.M700669200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	199HK	17535808	hybrid			2022-12-27	WOS:000248686600006
J	Baker, DJ; Wuenschell, G; Xia, LQ; Termini, J; Bates, SE; Riggs, AD; O'Connor, TR				Baker, David J.; Wuenschell, Gerald; Xia, Liqun; Termini, John; Bates, Steven E.; Riggs, Arthur D.; O'Connor, Timothy R.			Nucleotide excision repair eliminates unique DNA-protein cross-links from mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TOPOISOMERASE-I; PYRIMIDINE DIMERS; ACTIVE GENE; FPG PROTEIN; DAMAGE; MECHANISM; METHYLTRANSFERASE; ADDUCT; BASE	DNA- protein cross-links (DPCs) present a formidable obstacle to cellular processes because they are "superbulky" compared with the majority of chemical adducts. Elimination of DPCs is critical for cell survival because their persistence can lead to cell death or halt cell cycle progression by impeding DNA and RNA synthesis. To study DPC repair, we have used DNA methyltransferases to generate unique DPC adducts in oligodeoxyribonucleotides or plasmids to monitor both in vitro excision and in vivo repair. We show that HhaI DNA methyltransferase covalently bound to an oligodeoxyribonucleotide is not efficiently excised by using mammalian cell-free extracts, but protease digestion of the full-length HhaI DNA methyltransferase-DPC yields a substrate that is efficiently removed by a process similar to nucleotide excision repair (NER). To examine the repair of that unique DPC, we have developed two plasmid-based in vivo assays for DPC repair. One assay shows that in nontranscribed regions, DPC repair is greater than 60% in 6 h. The other assay based on host cell reactivation using a green fluorescent protein demonstrates that DPCs in transcribed genes are also repaired. Using Xpg-deficient cells (NER-defective) with the in vivo host cell reactivation assay and a unique DPC indicates that NER has a role in the repair of this adduct. We also demonstrate a role for the 26 S proteasome in DPC repair. These data are consistent with a model for repair in which the polypeptide chain of a DPC is first reduced by proteolysis prior to NER.	City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	O'Connor, TR (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	toconnor@coh.org		Riggs, Arthur/0000-0002-8184-5288; O'Connor, Timothy/0000-0001-5848-3592	NIGMS NIH HHS [GM59219] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059219] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; ASUBEL FM, 1992, SHORT PROTOCOLS MOL; BAKER DJ, 1993, BIOCHEM BIOPH RES CO, V196, P864, DOI 10.1006/bbrc.1993.2329; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Barker S, 2005, ANAL BIOCHEM, V344, P204, DOI 10.1016/j.ab.2005.06.039; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bates SE, 2005, NUCLEIC ACIDS RES, V33, P2475, DOI 10.1093/nar/gki542; Biggerstaff M, 1999, METH MOL B, V113, P357; BLOW DM, 1974, ENZYMES, P185; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; CALDECOTT K, 1991, MUTAT RES, V255, P111, DOI 10.1016/0921-8777(91)90046-R; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHENG X, 1993, COLD SPRING HARB SYM, V58, P331, DOI 10.1101/SQB.1993.058.01.039; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Costa M, 1997, J TOXICOL ENV HEALTH, V50, P433, DOI 10.1080/00984109708984000; DODSON ML, 1993, BIOCHEMISTRY-US, V32, P8284, DOI 10.1021/bi00083a032; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Emri G, 2004, EXP DERMATOL, V13, P305, DOI 10.1111/j.0906-6705.2004.00157.x; ERICKSON LC, 1980, CANCER RES, V40, P4216; FORNACE AJ, 1982, CANCER RES, V42, P145; FORNACE AJ, 1979, CANCER RES, V39, P704; GANTT R, 1984, CANCER RES, V44, P1809; GANTT R, 1987, MUTAT RES, V183, P75, DOI 10.1016/0167-8817(87)90048-4; GAO SW, 1994, SCIENCE, V263, P1438, DOI 10.1126/science.8128226; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Giri I, 2002, BIOCHEMISTRY-US, V41, P5462, DOI 10.1021/bi012116t; Gowher H, 2004, CANCER BIOL THER, V3, P1062, DOI 10.4161/cbt.3.11.1308; Guengerich FP, 2002, CHEM RES TOXICOL, V15, P793, DOI 10.1021/tx0200055; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; HARRIS TM, 1990, J PHARMACEUT BIOMED, V8, P195, DOI 10.1016/0731-7085(90)80027-M; Hazra TK, 2001, NUCLEIC ACIDS RES, V29, P1967, DOI 10.1093/nar/29.9.1967; Hohl M, 2003, J BIOL CHEM, V278, P19500, DOI 10.1074/jbc.M213155200; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; JELINSKY SA, 1995, BIOCHEMISTRY-US, V34, P13545, DOI 10.1021/bi00041a034; Karle IL, 2004, P NATL ACAD SCI USA, V101, P1433, DOI 10.1073/pnas.0307305101; KAYSEN J, 1986, CANCER RES, V46, P4534; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kohn KW, 2000, CELL BIOCHEM BIOPHYS, V33, P175, DOI 10.1385/CBB:33:2:175; KUMAR S, 1992, BIOCHEMISTRY-US, V31, P8648, DOI 10.1021/bi00151a035; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Larsen AK, 2001, CANCER RES, V61, P2961; LECLERC JE, 1991, P NATL ACAD SCI USA, V88, P9685, DOI 10.1073/pnas.88.21.9685; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; McCullough AK, 2001, BIOCHEMISTRY-US, V40, P561, DOI 10.1021/bi002404+; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Merk O, 2000, MUTAT RES-GEN TOX EN, V471, P71, DOI 10.1016/S1383-5718(00)00110-8; Minko IG, 2005, BIOCHEMISTRY-US, V44, P3000, DOI 10.1021/bi0478805; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; Parsons JL, 2005, FEBS J, V272, P5753, DOI 10.1111/j.1742-4658.2005.04962.x; PODDEVIN B, 1993, MOL PHARMACOL, V44, P767; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Raymond AC, 2005, J BIOL CHEM, V280, P22029, DOI 10.1074/jbc.M502148200; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; Reardon JT, 1997, NUCLEIC ACIDS RES, V25, P1015, DOI 10.1093/nar/25.5.1015; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; REARDON JT, 1991, NUCLEIC ACIDS RES, V19, P4623, DOI 10.1093/nar/19.17.4623; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; RODRIGUEZ H, 1993, BIOCHEMISTRY-US, V32, P1759, DOI 10.1021/bi00058a009; Sambrook J., 2001, MOL CLONING LAB MANU; Sankpal UT, 2002, CRIT REV BIOCHEM MOL, V37, P167, DOI 10.1080/10409230290771492; Saparbaev M, 2002, ENVIRON MOL MUTAGEN, V39, P10, DOI 10.1002/em.10041; Sastry S, 1998, J BIOL CHEM, V273, P9942, DOI 10.1074/jbc.273.16.9942; Shivji MKK, 1999, METH MOL B, V113, P373; Sidorkina OM, 2000, J BIOL CHEM, V275, P9924, DOI 10.1074/jbc.275.14.9924; Smela ME, 2002, P NATL ACAD SCI USA, V99, P6655, DOI 10.1073/pnas.102167699; SMITH SS, 1992, P NATL ACAD SCI USA, V89, P4744, DOI 10.1073/pnas.89.10.4744; Speit G, 2002, MUTAGENESIS, V17, P183, DOI 10.1093/mutage/17.3.183; Speit G, 2000, MUTAGENESIS, V15, P85, DOI 10.1093/mutage/15.1.85; STARY A, 1992, MUTAT RES, V272, P101, DOI 10.1016/0165-1161(92)90038-N; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; SZYMKOWSKI DE, 1993, P NATL ACAD SCI USA, V90, P9823, DOI 10.1073/pnas.90.21.9823; TCHOU J, 1995, J BIOL CHEM, V270, P11671, DOI 10.1074/jbc.270.19.11671; Topcu Z, 2001, J CLIN PHARM THER, V26, P405, DOI 10.1046/j.1365-2710.2001.00368.x; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Vladu B, 2000, MOL PHARMACOL, V57, P243; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wang HX, 2001, MOL BIOTECHNOL, V19, P133, DOI 10.1385/MB:19:2:133; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; ZHAO XD, 1995, BIOCHEMISTRY-US, V34, P1386, DOI 10.1021/bi00004a033; Zhitkovich A, 1998, ENVIRON HEALTH PERSP, V106, P969, DOI 10.2307/3434139; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	91	86	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31							22592	10.1074/jbc.M702856200	http://dx.doi.org/10.1074/jbc.M702856200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17507378	hybrid			2022-12-27	WOS:000248354200037
J	Thuerauf, DJ; Marcinko, M; Belmont, PJ; Glembotski, CC				Thuerauf, Donna J.; Marcinko, Marie; Belmont, Peter J.; Glembotski, Christopher C.			Effects of the isoform-specific characteristics of ATF6 alpha and ATF6 beta on endoplasmic reticulum stress response gene expression and cell viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR ATF6; NF-Y CBF; DNA-BINDING; HETEROLOGOUS PROTEINS; IN-VIVO; ELEMENT; ACTIVATION; PROTEOLYSIS; DOMAIN	The endoplasmic reticulum (ER)-transmembrane proteins, ATF6 alpha and ATF6 beta, are cleaved during the ER stress response (ERSR). The resulting N-terminal fragments ( N-ATF6 alpha and N-ATF6 beta) have conserved DNA-binding domains and divergent transcriptional activation domains. N-ATF6 alpha and N-ATF6 beta translocate to the nucleus, bind to specific regulatory elements, and influence expression of ERSR genes, such as glucose-regulated protein 78 (GRP78), that contribute to resolving the ERSR, thus, enhancing cell viability. We previously showed that N-ATF6 alpha is a rapidly degraded, strong transcriptional activator, whereas beta is a slowly degraded, weak activator. In this study we explored the molecular basis and functional impact of these isoform-specific characteristics in HeLa cells. Mutants in the transcriptional activation domain or DNA-binding domain of N-ATF6 alpha exhibited loss of function and increased expression, the latter of which suggested decreased rates of degradation. Fusing N-ATF6 alpha to the mutant estrogen receptor generated N-ATF6 alpha-MER, which, without tamoxifen exhibited loss-of- function and high expression, but in the presence of tamoxifen N-ATF6 alpha- MER exhibited gain-of-function and low expression. N-ATF6 beta conferred loss-of-function and high expression to N-ATF6 alpha, suggesting that ATF6 beta is an endogenous inhibitor of ATF6 alpha. In vitro DNA binding experiments showed that recombinant N-ATF6 beta inhibited the binding of recombinant N-ATF6 alpha to an ERSR element from the GRP78 promoter. Moreover, siRNA-mediated knock-down of endogenous ATF6 beta increased GRP78 promoter activity and GRP78 gene expression, as well as augmenting cell viability. Thus, the relative levels of ATF6 alpha and -beta, may contribute to regulating the strength and duration of ATF6-dependent ERSR gene induction and cell viability.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Heart, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Glembotski, CC (corresponding author), San Diego State Univ, Dept Biol, 5300 Campanile Dr, San Diego, CA 92182 USA.	cglembotski@sciences.sdsu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL75573] Funding Source: Medline; NINDS NIH HHS [NS025037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Corton JC, 1998, J BIOL CHEM, V273, P13776, DOI 10.1074/jbc.273.22.13776; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu CY, 2003, J CELL SCI, V116, P1861, DOI 10.1242/jcs.00408; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Pal B, 2007, MOL BIOL CELL, V18, P426, DOI 10.1091/mbc.E06-04-0304; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Picard Didier, 1993, Trends in Cell Biology, V3, P278, DOI 10.1016/0962-8924(93)90057-8; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Spear E, 2001, TRAFFIC, V2, P515, DOI 10.1034/j.1600-0854.2001.20801.x; Tanaka M, 1996, P NATL ACAD SCI USA, V93, P4311, DOI 10.1073/pnas.93.9.4311; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; Thuerauf DJ, 2002, J BIOL CHEM, V277, P20734, DOI 10.1074/jbc.M201749200; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Wang Y, 2000, J BIOL CHEM, V275, P27013; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	36	107	116	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22865	22878		10.1074/jbc.M701213200	http://dx.doi.org/10.1074/jbc.M701213200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17522056	hybrid			2022-12-27	WOS:000248354200064
J	Bao, JJ; Ma, XF; Liu, CY; Adelstein, RS				Bao, Jianjun; Ma, Xuefei; Liu, Chengyu; Adelstein, Robert S.			Replacement of nonmuscle myosin II-B with II-A rescues brain but not cardiac defects in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY CHAIN-B; DILATED CARDIOMYOPATHY; MOLECULAR-MECHANISMS; NERVOUS-SYSTEM; HEART-FAILURE; MESSENGER-RNA; CELL-ADHESION; CYTOKINESIS; EXPRESSION; ISOFORMS	The purpose of these studies was to learn whether one isoform of nonmuscle myosin II, specifically nonmuscle myosin II-A, could functionally replace a second one, nonmuscle myosin II-B, in mice. To accomplish this, we used homologous recombination to ablate nonmuscle myosin heavy chain (NMHC) II-B by inserting cDNA encoding green fluorescent protein (GFP)NMHC II-A into the first coding exon of the Myh10 gene, thereby placing GFP-NMHC II-A under control of the endogenous II-B promoter. Similar to B-/B- mice, most B-a*/B-a* mice died late in embryonic development with structural cardiac defects and impaired cytokinesis of the cardiac myocytes. However, unlike B-/B- mice, 15 B-a*/B-a* mice of 172 F2 generation mice survived embryonic lethality but developed a dilated cardiomyopathy as adults. Surprisingly none of the B-a*/B-a* mice showed evidence for hydrocephalus that is always found in B-/B- mice. Rescue of this defect was due to proper localization and function of GFP-NMHC II-A in place of NMHC II-B in a cell-cell adhesion complex in the cells lining the spinal canal. Restoration of the integrity and adhesion of these cells prevents protrusion of the underlying cells into the spinal canal where they block circulation of the cerebral spinal fluid. However, abnormal migration of facial and pontine neurons found in NMHC II-B mutant and ablated mice persisted in B-a*/B-a* mice. Thus, although NMHC II-A can substitute for NMHC II-B to maintain integrity of the spinal canal, NMHC II-B plays an isoform-specific role during cytokinesis in cardiac myocytes and in migration of the facial and pontine neurons.	NIH, Mol Cardiol Lab, Bethesda, MD 20892 USA; NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Adelstein, RS (corresponding author), NIH, Mol Cardiol Lab, Bldg 10,Rm 8N202,10 Ctr Dr MSC 1762, Bethesda, MD 20892 USA.	adelster@nhlbi.nih.gov		Adelstein, Robert/0000-0002-8683-2144	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004216, ZIAHL004216] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; CONRAD AH, 1995, CELL MOTIL CYTOSKEL, V31, P93, DOI 10.1002/cm.970310203; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Ma XF, 2004, MOL BIOL CELL, V15, P2568, DOI 10.1091/mbc.E03-11-0836; Ma XF, 2007, MOL BIOL CELL, V18, P2305, DOI 10.1091/mbc.E07-01-0073; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; MURAKAMI N, 1993, DEV BIOL, V157, P19, DOI 10.1006/dbio.1993.1108; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sellers J. R., 1999, MYOSINS; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; Simerly C, 1998, MOL BIOL CELL, V9, P2509, DOI 10.1091/mbc.9.9.2509; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; Takeda K, 2000, CELL MOTIL CYTOSKEL, V46, P59, DOI 10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q; Takeda K, 2003, CIRC RES, V93, P330, DOI 10.1161/01.RES.0000089256.00309.CB; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Tullio AN, 2001, J COMP NEUROL, V433, P62, DOI 10.1002/cne.1125; Uren D, 2000, J CLIN INVEST, V105, P663, DOI 10.1172/JCI8199; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617	42	68	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22102	22111		10.1074/jbc.M702731200	http://dx.doi.org/10.1074/jbc.M702731200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17519229	hybrid			2022-12-27	WOS:000248196800057
J	Geething, NC; Spudich, JA				Geething, Nathan C.; Spudich, James A.			Identification of a minimal myosin Va binding site within an intrinsically unstructured domain of melanophilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-GENETIC DISSECTION; NATIVELY UNFOLDED PROTEINS; MELANOSOME DISTRIBUTION; UNCONVENTIONAL MYOSIN; REGION MUTATIONS; DISORDER; RECEPTOR; SLAC2-A/MELANOPHILIN; MELANOCYTES; TRANSPORT	Myosin V is a molecular motor that transports a variety of cellular cargo, including organelles, vesicles, and messenger RNA. The proper peripheral distribution of melanosomes, a dense pigment-containing organelle, is dependent on actin and the activity of myosin Va. The recruitment of myosin Va to the melanosome and proper transport of the melanosome requires melanophilin, which directly binds to myosin Va and is tethered to the melanosome membrane via Rab27a. Here we use highly purified proteins to demonstrate that the globular tail domain of myosin Va binds directly to an intrinsically unstructured domain of melanophilin. The myosin Va binding domain of melanophilin lacks stable secondary structure, and H-1 NMR measurements indicate that the protein is unfolded. This domain is extremely sensitive to mild proteolysis and has a hydrodynamic radius that is consistent with a random coil-like polypeptide. We show that myosin Va binding does not induce the global folding of melanophilin. Truncations of melanophilin were utilized to define a short peptide sequence (26 residues) within melanophilin that is critical for myosin Va binding. We demonstrate that a peptide corresponding to these residues binds directly to the globular tail domain with the same affinity as melanophilin. Wediscuss the possible implications of protein intrinsic disorder in recruitment and maintenance of myosin Va on melanosome membranes.	Stanford Univ, Dept Biochem, Stanford, CA 94041 USA	Stanford University	Spudich, JA (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94041 USA.	jspudich@stanford.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01 AR42895] Funding Source: Medline; NIGMS NIH HHS [R01 GM033289] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin RL, 2000, P NATL ACAD SCI USA, V97, P12391, DOI 10.1073/pnas.97.23.12391; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Gill AC, 2000, EMBO J, V19, P5324, DOI 10.1093/emboj/19.20.5324; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; Huang JD, 1998, GENETICS, V148, P1951; Huang JD, 1998, GENETICS, V148, P1963; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Smallcombe SH, 1995, J MAGN RESON SER A, V117, P295, DOI 10.1006/jmra.1995.0759; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x; TANFORD C, 1966, J BIOL CHEM, V241, P1921; Tang FS, 2003, NATURE, V422, P87, DOI 10.1038/nature01453; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wei Q, 1997, J MUSCLE RES CELL M, V18, P517, DOI 10.1023/A:1018659117569; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028	46	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21518	21528		10.1074/jbc.M701932200	http://dx.doi.org/10.1074/jbc.M701932200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17513864	hybrid			2022-12-27	WOS:000248047500079
J	Dang, W; Kagalwala, MN; Bartholomew, B				Dang, Weiwei; Kagalwala, Mohamedi N.; Bartholomew, Blaine			The Dpb4 subunit of ISW2 is anchored to extranucleosomal DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; YEAST SWI/SNF COMPLEX; SACCHAROMYCES-CEREVISIAE; HISTONE OCTAMER; POLYMERASE-EPSILON; IN-VIVO; NUCLEOSOME; BINDING; TRANSCRIPTION; DISRUPTION	Histone fold proteins Dpb4 and Dls1 are components of the yeast ISW2 chromatin remodeling complex that resemble the smaller subunits of the CHRAC (Chromatin Accessibility Complex) complex found in Drosophila and humans. DNA photoaffinity labeling found that the Dpb4 subunit contacts extranucleosomal DNA 37-53 bp away from the entry/exit site of the nucleosome. Binding of Dpb4 to Isw2 and Itc2, the two largest subunits of ISW2, was found to require Dls1. Even after remodeling and nucleosome movement, Dpb4 tends to remain bound to its original binding site and likely serves as an anchor point for ISW2 on DNA. In vitro, only minor differences can be detected in the nucleosome binding and mobilization properties of ISW2 with or without Dpb4 and Dls1. Changes in the contacts of the largest subunit Itc1 with extranucleosomal DNA have, however, been found upon deletion of the Dpb4 and Dls1 dimer that may affect the nucleosome spacing properties of ISW2.	So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; University of Texas System; UTMD Anderson Cancer Center; Southern Illinois University System; Southern Illinois University	Bartholomew, B (corresponding author), Univ Penn, Wistar Inst, Inst Human Gene Therapy, 3601 Spruce St,Rm 204, Philadelphia, PA 19104 USA.	bbartholomew@siumed.edu		Dang, Weiwei/0000-0002-6931-4636				Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Brachmann CB, 1998, YEAST, V14, P115; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guschin D, 2000, J BIOL CHEM, V275, P35248, DOI 10.1074/jbc.M006041200; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Iida T, 2004, MOL CELL BIOL, V24, P217, DOI 10.1128/MCB.24.1.217-227.2004; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; McConnell AD, 2004, MOL CELL BIOL, V24, P2605, DOI 10.1128/MCB.24.7.2605-2613.2004; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Sengupta SM, 1999, METHODS, V19, P434, DOI 10.1006/meth.1999.0880; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; TULLIUS TD, 1987, METHOD ENZYMOL, V155, P537; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	35	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19418	19425		10.1074/jbc.M700640200	http://dx.doi.org/10.1074/jbc.M700640200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17491017	hybrid			2022-12-27	WOS:000247650600016
J	Hyde, R; Cwiklinski, EL; MacAulay, K; Taylor, PM; Hundal, HS				Hyde, Russell; Cwiklinski, Emma L.; MacAulay, Katrina; Taylor, Peter M.; Hundal, Harinder S.			Distinct sensor pathways in the hierarchical control of SNAT2, a putative amino acid transceptor, by amino acid availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEM-A; TRANSPORT SYSTEM; ADAPTIVE REGULATION; GENE-EXPRESSION; PLASMA-MEMBRANE; MECHANISM; ACTIVATION; PERMEASE; CELLS; ATA2	Mammalian nutrient sensors are novel targets for therapeutic intervention in disease states such as insulin resistance and muscle wasting; however, the proteins responsible for this important task are largely uncharacterized. Toaddress this issue we have dissected an amino acid (AA) sensor/effector regulon that controls the expression of the System A amino acid transporter-SNAT2-in mammalian cells, a paradigm nutrient-responsive process, and found evidence for the convergence of at least two sensor/effector pathways. During AA withdrawal, JNK is activated and induces the expression of SNAT2 in L6 myotubes by stimulating an intronic nutrient-sensitive domain. A sensor for large neutral AA (e.g. Tyr, Gln) inhibits JNK activation and SNAT2 up-regulation. Additionally, shRNA and transporter chimeras demonstrate that SNAT2 provides a repressive signal for gene transcription during AA sufficiency, thus echoing AA sensing by transceptor (transporter-receptor) orthologues in yeast (Gap1/Ssy1) and Drosophila (PATH). Furthermore, the SNAT2 protein is stabilized during AA withdrawal.	Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Mol Physiol, Dundee DD1 5EH, Scotland	University of Dundee	Hundal, HS (corresponding author), Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Mol Physiol, Dundee DD1 5EH, Scotland.	h.s.hundal@dundee.ac.uk	Taylor, Peter M/A-4667-2010; Hundal, Hari/A-8990-2008	Hundal, Hari/0000-0002-7621-4932	Biotechnology and Biological Sciences Research Council [C19477] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Asola MR, 2002, EUR J NUCL MED MOL I, V29, P1485, DOI 10.1007/s00259-002-0921-3; Bain PJ, 2002, J NUTR, V132, P3023, DOI 10.1093/jn/131.10.3023; Baird FE, 2006, BIOCHEM J, V397, P369, DOI 10.1042/BJ20060026; Bevington A, 2002, EUR J CLIN INVEST, V32, P590, DOI 10.1046/j.1365-2362.2002.01038.x; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; BRACY DS, 1986, J BIOL CHEM, V261, P1514; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; GAZZOLA GC, 1981, J BIOL CHEM, V256, P3191; Gazzola RF, 2001, FEBS LETT, V490, P11; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; HEATON JH, 1977, J BIOL CHEM, V252, P2900; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; HUNDAL HS, 1989, J PHYSIOL-LONDON, V408, P93, DOI 10.1113/jphysiol.1989.sp017449; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Ling R, 2001, BBA-BIOMEMBRANES, V1512, P15, DOI 10.1016/S0005-2736(01)00310-8; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MOFFETT J, 1984, MOL CELL BIOL, V4, P799, DOI 10.1128/MCB.4.4.799; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Zorzano A, 2000, BIOCHEM J, V349, P667, DOI 10.1042/bj3490667	44	91	96	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19788	19798		10.1074/jbc.M611520200	http://dx.doi.org/10.1074/jbc.M611520200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488712	hybrid			2022-12-27	WOS:000247650600054
J	Kramer, DK; Al-Khalili, L; Guigas, B; Leng, Y; Garcia-Roves, PM; Krook, A				Kraemer, David Kitz; Al-Khalili, Lubna; Guigas, Bruno; Leng, Ying; Garcia-Roves, Pablo M.; Krook, Anna			Role of AMP kinase and PPAR delta in the regulation of lipid and glucose metabolism in human skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-DELTA; SINGLE NUCLEOTIDE POLYMORPHISMS; PROTEIN-KINASE; GENE-EXPRESSION; FATTY-ACIDS; COMPLEX I; ALPHA; PHOSPHORYLATION; TRANSPORT; OBESITY	The peroxisome proliferator-activated receptor (PPAR)delta has been implicated in the regulation of lipid metabolism in skeletal muscle. Furthermore, activation of PPAR delta has been proposed to improve insulin sensitivity and reduce glucose levels in animal models of type 2 diabetes. We recently demonstrated that the PPAR delta agonist GW501516 activates AMP-activated protein kinase ( AMPK) and stimulates glucose uptake in skeletal muscle. However, the underlying mechanism remains to be clearly identified. In this study, we first confirmed that incubation of primary cultured human muscle cells with GW501516 induced AMPK phosphorylation and increased fatty acid transport and oxidation and glucose uptake. Using small interfering RNA, we have demonstrated that PPAR delta expression is required for the effect of GW501516 on the intracellular accumulation of fatty acids. Furthermore, we have shown that the subsequent increase in fatty acid oxidation induced by GW501516 is dependenton both PPAR delta and AMPK. Concomitant with these metabolic changes, we provide evidence that GW501516 increases the expression of key genes involved inlipid metabolism(FABP3, CPT1, and PDK4) by a PPAR delta-dependent mechanism. Finally, we have also demonstrated that the GW501516-mediated increase in glucose uptake requires AMPK but not PPAR alpha. In conclusion, the PPAR delta agonist GW501516 promotes changes in lipid/glucose metabolism and gene expression in human skeletal muscle cells by PPAR delta- and AMPK-dependent and -independent mechanisms.	Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Mol Med, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Surg, SE-17177 Stockholm, Sweden; Univ Catholique Louvain, Sch Med, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; Inst Cellular Pathol, B-1200 Brussels, Belgium	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Krook, A (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China.	Anna.Krook@ki.se	Roves, Pablo Garcia/A-7113-2015; Krook, Anna/K-1192-2015; Guigas, Bruno/M-2515-2015; Garcia-Roves, Pablo M./X-4585-2018	Krook, Anna/0000-0002-0891-0258; Guigas, Bruno/0000-0002-8856-5799; Garcia-Roves, Pablo M./0000-0002-8371-2067				Al-Khalili L, 2004, AM J PHYSIOL-CELL PH, V286, pC1410, DOI 10.1152/ajpcell.00444.2003; Al-Khalili L, 2004, ACTA PHYSIOL SCAND, V180, P395, DOI 10.1111/j.1365-201X.2004.01259.x; Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Andrulionyte L, 2006, DIABETES, V55, P2148, DOI 10.2337/db05-1629; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Brunmair B, 2006, DIABETOLOGIA, V49, P2713, DOI 10.1007/s00125-006-0357-6; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Johnson TE, 2005, TOXICOL APPL PHARM, V208, P210, DOI 10.1016/j.taap.2005.03.004; Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7; Kramer DK, 2006, ACTA PHYSIOL, V188, P207, DOI 10.1111/j.1748-1716.2006.01620.x; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Leff T, 2003, BIOCHEM SOC T, V31, P224; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lopez-Soriano J, 2006, ENDOCR REV, V27, P318, DOI 10.1210/er.2005-0012; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Luquet S, 2005, BBA-MOL BASIS DIS, V1740, P313, DOI 10.1016/j.bbadis.2004.11.011; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Scatena R, 2004, IUBMB LIFE, V56, P477, DOI 10.1080/15216540400008416; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Terada S, 2006, AM J PHYSIOL-ENDOC M, V290, pE607, DOI 10.1152/ajpendo.00430.2005; Vanttinen M, 2005, DIABETES, V54, P3587, DOI 10.2337/diabetes.54.12.3587; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zimmerman AW, 2001, BIOCHEM J, V360, P159, DOI 10.1042/0264-6021:3600159	45	140	146	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19313	19320		10.1074/jbc.M702329200	http://dx.doi.org/10.1074/jbc.M702329200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500064	Green Published, hybrid			2022-12-27	WOS:000247650600006
J	Qin, YP; Su, SC; Farrand, SK				Qin, Yinping; Su, Shengchang; Farrand, Stephen K.			Molecular basis of transcriptional antiactivation - TraM disrupts the TraR-DNA complex through stepwise interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMID CONJUGAL TRANSFER; QUORUM-SENSING ANTIACTIVATOR; AGROBACTERIUM-TUMEFACIENS; REGULATOR TRAR; CRYSTAL-STRUCTURE; AZOTOBACTER-VINELANDII; INHIBIT ACTIVATION; GENE-EXPRESSION; PROTEIN; AUTOINDUCER	Conjugative transfer of Agrobacterium Ti plasmids is regulated by TraR, a quorum-sensing activator. Quorum dependence requires TraM, which binds to and inactivates TraR. In this study, we showed that TraR and TraM form a 151-kDa stable complex composed of two TraR and two TraM dimers both in vitro and in vivo. When interacted with TraR bound to tra box DNA, wild-type TraM formed a nucleoprotein complex of 77 kDa composed of one dimer of each protein and DNA. The complex converted to the 151-kDa species with concomitant release of DNA with a half-life of 1.6 h. TraR in the complex still retained tightly bound autoinducer. From these results, we conclude that TraM interacts in a two-step process with DNA-TraR to form a large, stable antiactivation complex. Mutagenesis identified residues of TraR important for interacting with TraM. These residues form two patches, possibly defining the binding interfaces. Consistent with this interpretation, comparison of the trypsin-digested polypeptides of TraR and of TraM with that of the TraR-TraM complex revealed that a tryptic site at position 177 of TraR around these patches is accessible on free TraR but is blocked by TraM in the complex. From these genetic and structural considerations, we constructed three-dimensional models of the complex that shed light on the mechanism of TraM-mediated inhibition of TraR and on TraM-mediated destabilization of the TraR- DNA complex.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Farrand, SK (corresponding author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave, Urbana, IL 61801 USA.	stephenf@uiuc.edu			NIGMS NIH HHS [R01GM52465] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052465] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANGELOSI GA, 1991, METHOD ENZYMOL, V204, P384; Chahla M, 2003, BIOCHEMISTRY-US, V42, P3812, DOI 10.1021/bi0271143; Chen GZ, 2006, J BACTERIOL, V188, P8244, DOI 10.1128/JB.00954-06; Chen GZ, 2004, MOL MICROBIOL, V52, P1641, DOI 10.1111/j.1365-2958.2004.04110.x; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Danino VE, 2003, MOL MICROBIOL, V50, P511, DOI 10.1046/j.1365-2958.2003.03699.x; Fuqua C, 1996, J BACTERIOL, V178, P435, DOI 10.1128/jb.178.2.435-440.1996; FUQUA C, 1995, J BACTERIOL, V177, P1367, DOI 10.1128/jb.177.5.1367-1373.1995; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Ghrist AC, 2001, MICROBIOL-SGM, V147, P2215, DOI 10.1099/00221287-147-8-2215; Grabbe R, 2003, EUR J BIOCHEM, V270, P1555, DOI 10.1046/j.1432-1033.2003.03520.x; He XS, 2003, J BACTERIOL, V185, P809, DOI 10.1128/JB.185.3.809-822.2003; Hwang IY, 1999, MOL MICROBIOL, V34, P282, DOI 10.1046/j.1365-2958.1999.01595.x; HWANG IY, 1994, P NATL ACAD SCI USA, V91, P4639, DOI 10.1073/pnas.91.11.4639; HWANG IY, 1995, J BACTERIOL, V177, P449, DOI 10.1128/jb.177.2.449-458.1995; Little R, 2003, J BIOL CHEM, V278, P28711, DOI 10.1074/jbc.M301992200; Luo ZQ, 2000, J BIOL CHEM, V275, P7713, DOI 10.1074/jbc.275.11.7713; Luo ZQ, 2003, J BIOL CHEM, V278, P13173, DOI 10.1074/jbc.M210035200; Luo ZQ, 1999, P NATL ACAD SCI USA, V96, P9009, DOI 10.1073/pnas.96.16.9009; Luo ZQ, 2001, MOL PLANT MICROBE IN, V14, P98, DOI 10.1094/MPMI.2001.14.1.98; Marketon MM, 2002, J BACTERIOL, V184, P3466, DOI 10.1128/JB.184.13.3466-3475.2002; Martinez-Argudo I, 2004, P NATL ACAD SCI USA, V101, P16316, DOI 10.1073/pnas.0405312101; Miller J.H., 1972, EXPT MOL GENETICS; Nakano MM, 2002, MOL MICROBIOL, V44, P1341, DOI 10.1046/j.1365-2958.2002.02963.x; Piper KR, 2000, J BACTERIOL, V182, P1080, DOI 10.1128/JB.182.4.1080-1088.2000; PIPER KR, 1993, NATURE, V362, P448, DOI 10.1038/362448a0; Qin YP, 2000, EMBO J, V19, P5212, DOI 10.1093/emboj/19.19.5212; Qin YP, 2004, MOL MICROBIOL, V53, P1471, DOI 10.1111/j.1365-2958.2004.04216.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Su SC, 2006, MICROBIOL-SGM, V152, P1197, DOI 10.1099/mic.0.28657-0; Swiderska A, 2001, J BIOL CHEM, V276, P49449, DOI 10.1074/jbc.M107881200; Vannini A, 2004, J BIOL CHEM, V279, P24291, DOI 10.1074/jbc.M401855200; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	39	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19979	19991		10.1074/jbc.M703332200	http://dx.doi.org/10.1074/jbc.M703332200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17475619	hybrid			2022-12-27	WOS:000247650600072
J	Su, JL; Yang, CY; Zhao, M; Kuo, ML; Yen, ML				Su, Jen-Liang; Yang, Ching-Yao; Zhao, Ming; Kuo, Min-Liang; Yen, Men-Luh			Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; BREAST-CANCER CELLS; ESTROGEN-RECEPTOR; TRANSCRIPTION FACTOR; IN-VITRO; INHIBITION; PATHWAY; GROWTH; EXPRESSION; APOPTOSIS	Osteoporosis is a major public health problem and the most obvious preventive strategy, hormone replacement therapy, has lost favor due to recent findings of the Women's Health Initiative regarding increased risks of breast cancer and cardiovascular disease. Resveratrol, a naturally occurring compound possessing estrogenic activity, is thought to have considerable potential for therapy of osteoporosis. In the present study, resveratrol was found to exhibit bone-protective effects equivalent to those exerted by ;hormone replacement therapy and decrease the risk of breast cancer in the in vivo and in vitro models. Forkhead proteins were found to be essential for both effects of resveratrol. The bone-protective effect was attributable to induction of bone morphogenetic protein-2 through Src kinase-dependent estrogen receptor activation and FOXA1 is required for resveratrol-induced estrogen receptor-dependent bone morphogenetic protein-2 expression. The tumor suppressive effects of resveratrol were the consequence of Akt inactivation mediated FOXO3a nuclear accumulation and activation. Resveratrol is therefore anticipated to be highly effective in management of postmenopausal osteoporosis without an increased risk of breast cancer.	China Med Univ, Coll Med, Grad Inst Canc Biol, Taichung 404, Taiwan; China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; Asia Univ, Dept Biotechnol & Bioinformat, Taichung 41354, Taiwan; Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Traumatol, Taipei 100, Taiwan; Vanderbilt Univ, Vanderbilt Ctr Bone Biol, Dept Med, Div Clin Pharmacol, Nashville, TN 37232 USA; Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Coll Med, Dept Primary Care Med, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 100, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Vanderbilt University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Yen, ML (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Primary Hlth Care Med, No 7,Chung Shan S Rd, Taipei, Taiwan.	ntu88447004.tw@yahoo.com.tw	Kuo, Min-Liang/C-4872-2009	YEN, MEN-LUH/0000-0003-3800-3664; YANG, CHING-YAO/0000-0001-6312-3719; KUO, MIN-LIANG/0000-0002-7139-0144				Abrams KL, 2004, J BIOL CHEM, V279, P15916, DOI 10.1074/jbc.M313531200; Anderson HC, 2000, J HISTOCHEM CYTOCHEM, V48, P1493, DOI 10.1177/002215540004801106; Andreou V, 2004, J PERIODONTOL, V75, P939, DOI 10.1902/jop.2004.75.7.939; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Boissy P, 2005, CANCER RES, V65, P9943, DOI 10.1158/0008-5472.CAN-05-0651; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Couzin J, 2003, SCIENCE, V302, P1136, DOI 10.1126/science.302.5648.1136; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Delmas D, 2006, CURR DRUG TARGETS, V7, P423, DOI 10.2174/138945006776359331; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kumar R, 2005, CANCER RES, V65, P2511, DOI 10.1158/0008-5472.CAN-05-0189; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Li Y, 2006, APPL BIOCHEM BIOTECH, V135, P181, DOI 10.1385/ABAB:135:3:181; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsumoto A, 2001, J PERIODONTAL RES, V36, P175, DOI 10.1034/j.1600-0765.2001.360306.x; Mizutani K, 2000, J NUTR SCI VITAMINOL, V46, P78, DOI 10.3177/jnsv.46.78; Mundy GR, 2006, AM J CLIN NUTR, V83, p427S; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ray PS, 1999, FREE RADICAL BIO MED, V27, P160, DOI 10.1016/S0891-5849(99)00063-5; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Su JL, 2005, CARCINOGENESIS, V26, P1, DOI 10.1093/carcin/bgh220; Turgeman G, 2002, J CELL BIOCHEM, V86, P461, DOI 10.1002/jcb.10231; Van Der Horst G, 2002, BONE, V31, P661, DOI 10.1016/S8756-3282(02)00903-1; Wietzke JA, 2005, MOL CELL ENDOCRINOL, V230, P59, DOI 10.1016/j.mce.2004.11.001; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yen ML, 2005, MOL PHARMACOL, V68, P1061, DOI 10.1124/mol.104.010082; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05; Zhou SH, 2003, MOL ENDOCRINOL, V17, P56, DOI 10.1210/me.2002-0210	50	86	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19385	19398		10.1074/jbc.M702452200	http://dx.doi.org/10.1074/jbc.M702452200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17513867	hybrid			2022-12-27	WOS:000247650600013
J	Cabello-Verrugio, C; Brandan, E				Cabello-Verrugio, Claudio; Brandan, Enrique			A novel modulatory mechanism of transforming growth factor-ss signaling through decorin and LRP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; RECEPTOR-RELATED PROTEIN; HUMAN MESANGIAL CELLS; TGF-BETA SIGNALS; PROTEOGLYCAN DECORIN; TYROSINE PHOSPHORYLATION; MYOBLAST DIFFERENTIATION; EPITHELIAL-CELLS; EXPRESSION; INHIBITION	Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that signals to the nucleus through cell surface transmembrane receptors with serine/threonine kinase activity and cytoplasmic effectors, including Smad proteins. Here we describe two novel modulators of this pathway, lipoprotein-receptor related protein (LRP-1) and decorin. Decorin null (Dcn null) myoblasts showed a diminished TGF-beta response that is restored by decorin re-expression. Importantly, this reactivation occurs without changes in the binding to TGF-beta receptors, Smad protein phosphorylation, or Smad-4 nuclear translocation. In wild type myoblasts, inhibition of decorin binding to LRP-1 and depletion of LRP-1 inhibited TGF-beta response to levels similar to those observed in Dcn null myoblasts. Re-expression of decorin in Dcn null myoblasts cannot restore TGF-beta response if the Smad pathway or phosphatidylinositol 3-kinase activity is inhibited, suggesting that this LRP-1-decorin modulatory pathway requires activation of the Smad pathway by TGF-beta and involves phosphatidylinositol 3-kinase activity. This work unveils a new regulatory mechanism for TGF-beta signaling by decorin and LRP-1.	Pontificia Univ Catolica Chile, Fac Biol Sci, Ctr Regulat Cellular & Pathol, Millinnium Inst Fundamental & Appl Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Brandan, E (corresponding author), Pontificia Univ Catolica Chile, Fac Biol Sci, Ctr Regulat Cellular & Pathol, Millinnium Inst Fundamental & Appl Biol, Santiago, Chile.	ebrandan@bio.puc.cl	Cabello-Verrugio, Claudio/AAD-1454-2020; Brandan, Enrique/A-7063-2017	Cabello-Verrugio, Claudio/0000-0001-7273-2102; Brandan, Enrique/0000-0002-6820-5059				Abdel-Wahab N, 2002, BIOCHEM J, V362, P643, DOI 10.1042/0264-6021:3620643; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BRANDAN E, 1991, EUR J CELL BIOL, V55, P209; Brandan E, 1996, EUR J CELL BIOL, V71, P170; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Casar JC, 2004, DEV BIOL, V268, P358, DOI 10.1016/j.ydbio.2003.12.025; Costacurta A, 2002, J CLIN LAB ANAL, V16, P178, DOI 10.1002/jcla.10038; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; FLORINI JR, 1986, J BIOL CHEM, V261, P6509; Gray PC, 2001, MOL CELL ENDOCRINOL, V180, P47, DOI 10.1016/S0303-7207(01)00515-9; Hausser H, 1998, ARCH BIOCHEM BIOPHYS, V349, P363, DOI 10.1006/abbi.1997.0471; HAUSSER H, 1992, J BIOL CHEM, V267, P11559; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Huang SS, 2004, FASEB J, V18, P1719, DOI 10.1096/fj.04-1872fje; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Imamichi Y, 2005, BIOL CHEM, V386, P225, DOI 10.1515/BC.2005.028; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Ishitobi M, 2000, NEUROREPORT, V11, P4033, DOI 10.1097/00001756-200012180-00026; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Larrain J, 1998, J BIOL CHEM, V273, P32288, DOI 10.1074/jbc.273.48.32288; Larrain J, 1997, EXP CELL RES, V234, P405, DOI 10.1006/excr.1997.3648; Leal SM, 1999, J BIOL CHEM, V274, P6711, DOI 10.1074/jbc.274.10.6711; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Lopez-Casillas F, 2003, J BIOL CHEM, V278, P382, DOI 10.1074/jbc.M208520200; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsumoto-Ida M, 2006, AM J PHYSIOL-HEART C, V290, pH709, DOI 10.1152/ajpheart.00186.2005; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; Ohashi N, 2005, FEBS LETT, V579, P2557, DOI 10.1016/j.febslet.2005.03.069; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Rodriguez-Barbero A, 2006, KIDNEY INT, V70, P901, DOI 10.1038/sj.ki.5001626; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; Stander M, 1998, GENE THER, V5, P1187, DOI 10.1038/sj.gt.3300709; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; Tseng WF, 2004, FEBS LETT, V562, P71, DOI 10.1016/S0014-5793(04)00185-1; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Ungefroren H, 2003, J BIOL CHEM, V278, P11041, DOI 10.1074/jbc.M300035200; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	61	101	103	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18842	18850		10.1074/jbc.M700243200	http://dx.doi.org/10.1074/jbc.M700243200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17485468	hybrid			2022-12-27	WOS:000247475300023
J	Sun, SY; Liu, XG; Zou, W; Yue, P; Marcus, AI; Khuri, FR				Sun, Shi-Yong; Liu, Xiangguo; Zou, Wei; Yue, Ping; Marcus, Adam I.; Khuri, Fadlo R.			The farnesyltransferase inhibitor lonafarnib induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL TRANSFERASE INHIBITOR; ENDOPLASMIC-RETICULUM STRESS; SYNTHETIC RETINOID CD437; RECEPTOR-SELECTIVE RETINOIDS; LUNG-CARCINOMA CELLS; DEATH RECEPTORS; UP-REGULATION; PHASE-I; ANTITUMOR-ACTIVITY; TRANSGENIC MICE	Pre-clinical studies have demonstrated that farnesyltransferase inhibitors (FTIs) induce growth arrest or apoptosis in various human cancer cells independently of Ras mutations. However, the underlying mechanism remains unknown. Death receptor 5 (DR5) is a pro-apoptotic protein involved in mediating the extrinsic apoptotic pathway. Its role in FTI-induced apoptosis has not been reported. In this study, we investigated the modulation of DR5 by the FTI lonafarnib and the involvement of DR5 up-regulation in FTI-induced apoptosis. Lonafarnib activated caspase-8 and its downstream caspases, whereas the caspase-8-specific inhibitor benzyloxycarbonyl-Ile-Glu(methoxy)-Thr-Asp(methoxy)-fluoromethyl ketone or small interfering RNA abrogated lonafarnib-induced apoptosis, indicating that lonafarnib induces caspase-8-dependent apoptosis. Lonafarnib up-regulated DR5 expression, increased cell-surface DR5 distribution, and enhanced tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Overexpression of a dominant-negative Fas-associated death domain mutant or silencing of DR5 expression using small interfering RNA attenuated lonafarnib-induced apoptosis. These results indicate a critical role of the DR5-mediated extrinsic apoptotic pathway in lonafarnib-induced apoptosis. By analyzing the DR5 promoter, we found that lonafarnib induced a CCAAT/enhancer-binding protein homologous protein (CHOP)-dependent transactivation of the DR5 promoter. Lonafarnib increased CHOP expression, whereas silencing of CHOP expression abrogated lonafarnib-induced DR5 expression. These results thus indicate that lonafarnib induces CHOP-dependent DR5 up-regulation. We conclude that CHOP-dependent DR5 up-regulation contributes to lonafarnib-induced apoptosis.	Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Sun, SY (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, 1365-C Clifton Rd,C3088, Atlanta, GA 30322 USA.	shi-yong.sun@emoryhealthcare.org	Liu, Xiangguo/G-1091-2010; Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Liu, Xiangguo/0000-0002-1879-3817				Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Adjei AA, 2000, CANCER RES, V60, P1871; Adjei AA, 2001, CLIN CANCER RES, V7, P1438; Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Awada A, 2002, EUR J CANCER, V38, P2272, DOI 10.1016/S0959-8049(02)00379-9; Beaupre DM, 2004, MOL CANCER THER, V3, P179; Beaupre DM, 2003, LEUKEMIA LYMPHOMA, V44, P2123, DOI 10.1080/1042819031000116652; Bohnke A, 2004, INT J RADIAT BIOL, V80, P53, DOI 10.1080/09553000310001642902; Brunner TB, 2003, CANCER RES, V63, P5656; CHINNAIYAN AM, 1995, CELL, V81, P512; Chun KH, 2003, CANCER RES, V63, P4796; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Du W, 1999, CANCER RES, V59, P4208; Edamatsu H, 2000, ONCOGENE, V19, P3059, DOI 10.1038/sj.onc.1203625; Feldkamp MM, 2001, CANCER RES, V61, P4425; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hoover RR, 2002, BLOOD, V100, P1068, DOI 10.1182/blood.V100.3.1068; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Khuri FR, 2004, CLIN CANCER RES, V10, P2968, DOI 10.1158/1078-0432.CCR-03-0412; Kim ES, 2005, CANCER, V104, P561, DOI 10.1002/cncr.21188; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; Lebowitz PF, 1998, ONCOGENE, V17, P1439, DOI 10.1038/sj.onc.1202175; Liu M, 1998, CANCER RES, V58, P4947; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Marcus AI, 2006, CANCER RES, V66, P8838, DOI 10.1158/0008-5472.CAN-06-0699; Marzo I, 2004, LEUKEMIA, V18, P1599, DOI 10.1038/sj.leu.2403469; Meng RD, 2001, EXP CELL RES, V262, P154, DOI 10.1006/excr.2000.5073; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Nakajima A, 2003, MOL CANCER THER, V2, P219; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; PFAHL M, 1990, METHOD ENZYMOL, V189, P256; Reichert A, 2001, BLOOD, V97, P1399, DOI 10.1182/blood.V97.5.1399; Sebti SM, 2005, CANCER CELL, V7, P297, DOI 10.1016/j.ccr.2005.04.005; Sharma S, 2002, ANN ONCOL, V13, P1067, DOI 10.1093/annonc/mdf173; Sheikh MS, 1998, CANCER RES, V58, P1593; Shi B, 2000, CANCER CHEMOTH PHARM, V46, P387, DOI 10.1007/s002800000170; Smalley KSM, 2003, INT J CANCER, V105, P165, DOI 10.1002/ijc.11064; Sun SY, 2000, CANCER RES, V60, P6537; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 2000, CLIN CANCER RES, V6, P1563; Sun SY, 2004, CANCER BIOL THER, V3, P1092, DOI 10.4161/cbt.3.11.1176; Sun SY, 1997, CANCER RES, V57, P4931; Sun SY, 2000, ONCOGENE, V19, P4513, DOI 10.1038/sj.onc.1203810; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wen LP, 1998, CELL DEATH DIFFER, V5, P729, DOI 10.1038/sj.cdd.4400409; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238	51	45	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18800	18809		10.1074/jbc.M611438200	http://dx.doi.org/10.1074/jbc.M611438200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17493934	hybrid			2022-12-27	WOS:000247475300019
J	Ammons, MCB; Siemsen, DW; Nelson-Overton, LK; Quinn, MT; Gauss, KA				Ammons, Mary Cloud B.; Siemsen, Daniel W.; Nelson-Overton, Laura K.; Quinn, Mark T.; Gauss, Katherine A.			Binding of pleomorphic adenoma gene-like 2 to the tumor necrosis factor (TNF)-alpha-responsive region of the NCF2 promoter regulates p67(phox) expression and NADPH oxidase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; SUPEROXIDE-PRODUCTION; CYTOSOLIC COMPONENT; GENE-EXPRESSION; FAMILY-MEMBERS; PLAG FAMILY; IN-VITRO; ACTIVATION; P47(PHOX); SUMOYLATION	NCF2, the gene encoding the NADPH oxidase cytosolic component p67(phox), is up-regulated by TNF-alpha, and we recently mapped a region in the NCF2 promoter that was required for this TNF-alpha-dependent response. Because this TNF-alpha-responsive region (TRR) lacked recognizable transcription factor binding elements, we performed studies to identify factors involved in regulating NCF2 via the TRR. Using the TRR sequence as bait in a yeast one-hybrid screen, we identified the zinc finger transcription factor Pleomorphic Adenoma Gene-Like 2 (PLAGL2) as a candidate regulator of NCF2 expression. PLAGL2-specific antibodies were generated that detected the native and SUMO1-modified forms of endogenous PLAGL2. EMSA and DNA-binding protein affinity purification analyses demonstrated specific binding of in vitro-translated as well as endogenously expressed PLAGL2 to the TRR, and chromatin immunoprecipitation assays demonstrated enhanced binding of endogenous PLAGL2 to the TRR in vivo with TNF-alpha treatment. Knockdown of PLAGL2 protein inhibited up-regulation of NCF2 transcript, p67phox protein expression, and subsequent superoxide production in response to TNF-alpha. Furthermore, relative levels of native and SUMO1-modified endogenous PLAGL2 protein were modulated in a time-dependant manner in response to TNF-alpha treatment. These data clearly identify PLAGL2 as a novel regulator of NCF2 gene expression as well as NADPH oxidase activity and contribute to a greater understanding of the transcriptional regulation of NCF2.	Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Gauss, KA (corresponding author), Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA.	kgauss@montana.edu		Quinn, Mark/0000-0001-8114-5073; Ammons, Mary Cloud/0000-0002-9717-0844	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042426] Funding Source: NIH RePORTER; NCRR NIH HHS [RR020185] Funding Source: Medline; NIAMS NIH HHS [AR42426, R01 AR042426] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Baugh J A, 2001, Curr Opin Drug Discov Devel, V4, P635; BEUTLER B, 1995, J INVEST MED, V43, P227; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bylund J, 2005, ADV EXP MED BIOL, V568, P67; CASSATELLA MA, 1991, J BIOL CHEM, V266, P22079; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Dang PMC, 2000, BIOCHEMISTRY-US, V39, P3069, DOI 10.1021/bi9919807; DeLeo FR, 1996, J BIOL CHEM, V271, P17013, DOI 10.1074/jbc.271.29.17013; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; Furukawa T, 2001, ONCOGENE, V20, P4718, DOI 10.1038/sj.onc.1204647; Gauss KA, 2005, J LEUKOCYTE BIOL, V77, P267, DOI 10.1189/jlb.0604329; Gorzalczany Y, 2002, J BIOL CHEM, V277, P18605, DOI 10.1074/jbc.M202114200; GrazianiBowering GM, 1997, J IMMUNOL METHODS, V207, P157, DOI 10.1016/S0022-1759(97)00114-2; Hensen K, 2002, CANCER RES, V62, P1510; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hilgarth Roland S., 2005, V301, P329; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Hua J, 2000, J LEUKOCYTE BIOL, V68, P216; JUTILA MA, 1992, J EXP MED, V175, P1565, DOI 10.1084/jem.175.6.1565; Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; Landrette SF, 2005, BLOOD, V105, P2900, DOI 10.1182/blood-2004-09-3630; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LEVY R, 1991, J IMMUNOL, V147, P3066; Liu GQ, 2004, COMPUT SYST SCI ENG, V19, P39; Mizrahi A, 2006, J LEUKOCYTE BIOL, V79, P881, DOI 10.1189/jlb.1005553; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; NEWBURGER PE, 1991, J BIOL CHEM, V266, P16171; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Paclet MH, 2000, BIOCHEMISTRY-US, V39, P9302, DOI 10.1021/bi000483j; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Skalnik DG, 2002, GENE, V284, P1, DOI 10.1016/S0378-1119(02)00387-6; Smith RM, 1996, J CLIN INVEST, V98, P977, DOI 10.1172/JCI118882; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Van Dyck F, 2004, J BIOL CHEM, V279, P36121, DOI 10.1074/jbc.M401753200; Voz ML, 2000, CANCER RES, V60, P106; Weissmann G, 2004, JCR-J CLIN RHEUMATOL, V10, pS26, DOI 10.1097/01.rhu.0000130687.75646.44; Yang MCW, 2005, AM J RESP CELL MOL, V32, P35, DOI 10.1165/rcmb.2003-0422OC; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Zheng G, 2005, J BIOL CHEM, V280, P40773, DOI 10.1074/jbc.M504334200	45	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17941	17952		10.1074/jbc.M610618200	http://dx.doi.org/10.1074/jbc.M610618200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17462995	hybrid			2022-12-27	WOS:000247084500067
J	Deschenes, J; Bourdeau, V; White, JH; Mader, S				Deschenes, Julie; Bourdeau, Veronique; White, John H.; Mader, Sylvie			Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; RESPONSE ELEMENTS; TARGET GENES; EXPRESSION; IDENTIFICATION; PROLIFERATION; RESISTANCE; TAMOXIFEN; THERAPY	Estrogen receptors activate transcription in part through direct interactions with specific DNA motifs, called estrogen response elements (EREs). Here we show that the strong and sustained induction of the gene regulated in breast cancer 1 (GREB1), a gene of unknown function that has been previously suggested to play a role in the effects of estradiol on breast cancer cell proliferation (Rae, J. M., Johnson, M. D., Scheys, J. O., Cordero, K. E., Larios, J. M., and Lippman, M. E. (2005) Breast Cancer Res. Treat 92, 141-149), is mediated by binding of estrogen receptor alpha(ER alpha) to three consensus EREs spread over similar to 20 kb of upstream flanking sequences. In addition to ER alpha, coactivator SRC-3, acetylated histones and phosphorylated RNA polymerase II (P-polII) were detected on all three EREs in the presence of estrogen, while basal recruitment of ER alpha and P-polII was observed only on the proximal element. Chromatin loops were formed between each ERE and the GREB1 transcriptional start site in the presence of estrogen but not of a total antiestrogen. Furthermore, estradiol induced physical association between EREs, suggesting that these elements function as a potent multipartite enhancer to regulate GREB1 transcription.	Univ Montreal, IRIC, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3A 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A4, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University	Mader, S (corresponding author), Univ Montreal, IRIC, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	sylvie.mader@umontreal.ca	white, john h/N-9782-2013	white, john h/0000-0002-4785-2687				Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Button K, 2005, TRANSPORT POLICY, V12, P47, DOI 10.1016/j.tranpol.2004.09.003; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Ghosh MG, 2000, CANCER RES, V60, P6367; Howell A, 2004, J CLIN ONCOL, V22, P1605, DOI 10.1200/JCO.2004.02.112; Hui R, 2002, CANCER RES, V62, P6916; Jordan VC, 2001, JNCI-J NATL CANCER I, V93, P2, DOI 10.1093/jnci/93.1.2; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marks JR, 1997, ONCOGENE, V14, P115, DOI 10.1038/sj.onc.1200808; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; O'Regan RM, 2002, LANCET ONCOL, V3, P207, DOI 10.1016/S1470-2045(02)00711-8; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Rocha W, 2005, MOL PHARMACOL, V68, P1852, DOI 10.1124/mol.105.014514; Sanchez R, 2002, BIOESSAYS, V24, P244, DOI 10.1002/bies.10066; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Vega VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r82	33	79	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17335	17339		10.1074/jbc.C700030200	http://dx.doi.org/10.1074/jbc.C700030200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17463000	hybrid			2022-12-27	WOS:000247084500003
J	Gruber, F; Oskolkova, O; Leitner, A; Mildner, M; Mlitz, V; Lengauer, B; Kadl, A; Mrass, P; Kronke, G; Binder, BR; Bochkov, VN; Leitinger, N; Tschachler, E				Gruber, Florian; Oskolkova, Olga; Leitner, Alexander; Mildner, Michael; Mlitz, Veronika; Lengauer, Barbara; Kadl, Alexandra; Mrass, Paul; Kroenke, Gerhard; Binder, Bernd R.; Bochkov, Valery N.; Leitinger, Norbert; Tschachler, Erwin			Photooxidation generates biologically active phospholipids that induce heme oxygenase-1 in skin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATION-SPECIFIC EPITOPES; TANDEM MASS-SPECTROMETRY; ULTRAVIOLET-A RADIATION; 32-KDA STRESS PROTEIN; OXIDIZED PHOSPHOLIPIDS; SINGLET OXYGEN; APOPTOTIC CELLS; UVA RADIATION; MONOCLONAL AUTOANTIBODIES	Heme oxygenase-1 (HO-1) is a key enzyme in the cellular response to tissue injury and oxidative stress. HO-1 enzymatic activity results in the formation of the cytoprotective metabolites CO and biliverdin. In the skin, HO-1 is strongly induced after long wave ultraviolet radiation (UVA-1). Here we show that UVA-1 irradiation generates oxidized phospholipids derived from 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (PAPC) that mediate the expression of HO-1 in skin cells. Using EO6 antibodies that recognize oxidized phospholipids, we show that UVA-1 irradiation of dermal fibroblasts generates oxidation-specific epitopes. Irradiation of arachidonatecontaining phospholipids with UVA-1 led to formation of defined lipid oxidation products including epoxyisoprostane-phosphatidylcholine that induced HO-1 expression in dermal fibroblasts, in keratinocytes, and in a three-dimensional epidermal equivalent model. In addition, we demonstrate that the oxidation of PAPC by UVA-1 is a singlet oxygen-dependent mechanism. Together, we present a novel mechanism of UVA-1- induced HO-1 expression that is mediated by the generation of biologically active phospholipid oxidation products. Because UVA-1 irradiation is a mainstay treatment of several inflammatory skin diseases, structural identification of UVA-1-generated biomolecules with HO-1-inducing capacity should lead to the development of drugs that could substitute for irradiation.	Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; Med Univ Vienna, Dept Dermatol, A-1090 Vienna, Austria; Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; Univ Vienna, Dept Analyt Chem & Food Chem, A-1090 Vienna, Austria; CERIES, F-92200 Neuilly sur Seine, France	University of Virginia; Medical University of Vienna; Medical University of Vienna; University of Vienna	Leitinger, N (corresponding author), Univ Virginia, Cardiovasc Res Ctr, POB 801394, Charlottesville, VA 22908 USA.	nl2q@virginia.edu	Leitner, Alexander/U-1601-2019; Krönke, Gerhard/C-6615-2014; Kadl, Alexandra/AAV-3395-2021	Leitner, Alexander/0000-0003-4126-0725; Krönke, Gerhard/0000-0002-7566-4325; Tschachler, Erwin/0000-0002-0248-1798; Gruber, Florian/0000-0003-1094-5641; Mildner, Michael/0000-0002-6892-925X; Oskolkova, Olga/0000-0001-9443-8705	NHLBI NIH HHS [R01 HL084422-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084422] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BasuModak S, 1996, FREE RADICAL BIO MED, V20, P887, DOI 10.1016/0891-5849(95)02182-5; BASUMODAK S, 1993, CANCER RES, V53, P4505; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Bochkov VN, 2003, J MOL MED, V81, P613, DOI 10.1007/s00109-003-0467-2; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; BOSE B, 1994, J PHOTOCH PHOTOBIO B, V23, P119, DOI 10.1016/1011-1344(94)06995-6; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; DALLASTA V, 1994, J BIOL CHEM, V269, P10485; Dissemond J, 2003, BRIT J DERMATOL, V149, P341, DOI 10.1046/j.1365-2133.2003.05457.x; Furnkranz A, 2004, CURR PHARM DESIGN, V10, P915, DOI 10.2174/1381612043452929; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Grether-Beck S, 2000, EMBO J, V19, P5793, DOI 10.1093/emboj/19.21.5793; Grether-Beck S, 2000, METHOD ENZYMOL, V319, P280; GretherBeck S, 1996, P NATL ACAD SCI USA, V93, P14586, DOI 10.1073/pnas.93.25.14586; GretherBeck S, 1997, BIOL CHEM, V378, P1231; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P101, DOI 10.1161/hq0102.101525; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kadl A, 2002, VASC PHARMACOL, V38, P219, DOI 10.1016/S1537-1891(02)00172-6; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; KEYSE SM, 1987, J BIOL CHEM, V262, P14821; Klotz LO, 2000, METHOD ENZYMOL, V319, P130; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Krutmann J, 2000, J DERMATOL SCI, V23, pS22, DOI 10.1016/S0923-1811(99)00077-8; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Li RS, 2006, CIRC RES, V98, P642, DOI 10.1161/01.RES.0000207394.39249.fc; Mang R, 2005, PHOTODERMATOL PHOTO, V21, P103, DOI 10.1111/j.1600-0781.2005.00146.x; Marathe GK, 2005, J BIOL CHEM, V280, P35448, DOI 10.1074/jbc.M503811200; Matroule JY, 2000, METHOD ENZYMOL, V319, P119; McIntyre TM, 1999, J BIOL CHEM, V274, P25189, DOI 10.1074/jbc.274.36.25189; Mildner M, 1999, PHOTOCHEM PHOTOBIOL, V70, P674, DOI 10.1562/0031-8655(1999)070<0674:UAURDR>2.3.CO;2; Morita A, 1997, J EXP MED, V186, P1763, DOI 10.1084/jem.186.10.1763; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reis A, 2005, BIOMED CHROMATOGR, V19, P129, DOI 10.1002/bmc.429; Reis A, 2004, J MASS SPECTROM, V39, P1513, DOI 10.1002/jms.751; Reis A, 2004, RAPID COMMUN MASS SP, V18, P2849, DOI 10.1002/rcm.1686; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924; Ryter SW, 1998, FREE RADICAL BIO MED, V24, P1520, DOI 10.1016/S0891-5849(97)00461-9; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2000, FREE RADICAL BIO MED, V28, P1751, DOI 10.1016/S0891-5849(00)00233-1; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Szegedi A, 2005, RHEUMATOLOGY, V44, P925, DOI 10.1093/rheumatology/keh643; Tyrrell RM, 1997, METHODS, V11, P313, DOI 10.1006/meth.1996.0425; Tyrrell RM, 2004, ANTIOXID REDOX SIGN, V6, P835, DOI 10.1089/1523086041798033; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Williams SD, 2000, J LIPID RES, V41, P1585; Zhang QW, 2005, J BIOL CHEM, V280, P73, DOI 10.1074/jbc.M409795200	58	52	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16934	16941		10.1074/jbc.M702523200	http://dx.doi.org/10.1074/jbc.M702523200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17449870	hybrid, Green Published			2022-12-27	WOS:000246946500026
J	Brooks, CL; Li, M; Gu, W				Brooks, Christopher L.; Li, Muyang; Gu, Wei			Mechanistic studies of MDM2-mediated ubiquitination in p53 regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; RING-FINGER DOMAIN; C-TERMINAL DOMAIN; NUCLEAR EXPORT; DNA-BINDING; MDM2; DEGRADATION; PROTEIN; MONOUBIQUITINATION; ONCOPROTEIN	As a central regulator for cell cycle arrest, apoptosis, and cellular senescence, p53 requires multiple layers of regulatory control to ensure correct temporal and spatial functions. It is well accepted that Mdm2-mediated ubiquitination plays a crucial role in p53 regulation. In addition to proteasome-mediated degradation, ubiquitination of p53 by Mdm2 acts a key signal for its nuclear export. Nuclear export has previously been thought to require the disassociation of the p53 tetramer and exposure of the intrinsic nuclear export signal. To elucidate the molecular mechanism of degradation-independent repression on p53 by Mdm2, we have developed a two-step approach to purify ubiquitinated forms of p53 induced by Mdm2 from human cells. Surprisingly, however, we found that ubiquitination has no effect on the tetramerization/oligomerization of p53, arguing against this seemingly well accepted model. Moreover, nuclear export of p53 alone is not sufficient to completely abolish p53 activity. Ubiquitination-mediated repression of p53 by Mdm2 acts at least, in part, through inhibiting the sequence-specific DNA binding activity. Thus, our results have important implications regarding the mechanisms by which Mdm2 acts on p53.	Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu		Brooks, Christopher/0000-0003-3487-6644	NCI NIH HHS [R01 CA098821, R01 CA131439, P01 CA097403, R01 CA129627, R01 CA104843, R01 CA085533] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085533, P01CA097403, R01CA104843, R01CA131439, R01CA098821, R01CA129627] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Caron De Fromentel Claude, 1992, Genes Chromosomes and Cancer, V4, P1; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Middeler G, 1997, ONCOGENE, V14, P1407, DOI 10.1038/sj.onc.1200949; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175	49	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22804	22815		10.1074/jbc.M700961200	http://dx.doi.org/10.1074/jbc.M700961200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17500067	hybrid, Green Accepted			2022-12-27	WOS:000248354200058
J	Driscoll, WJ; Chaturvedi, S; Mueller, GP				Driscoll, William J.; Chaturvedi, Shalini; Mueller, Gregory P.			Oleamide synthesizing activity from rat kidney - Identification as cytochrome C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID AMIDES; SECRETORY GRANULES; BRAIN LIPIDS; SLEEP; BIOSYNTHESIS; ACYLTRANSFERASE; COMMUNICATION; OLEOYLGLYCINE; CARDIOLIPIN; GENERATION	Oleamide (cis-9-octadecenamide) is the prototype member of an emerging class of lipid signaling molecules collectively known as the primary fatty acid amides. Current evidence suggests that oleamide participates in the biochemical mechanisms underlying the drive to sleep, thermoregulation, and antinociception. Despite the potential importance of oleamide in these physiologic processes, the biochemical pathway for its synthesis in vivo has not been established. We report here the discovery of an oleamide synthetase found in rat tissues using [C-14]oleoyl-CoA and ammonium ion. Hydrogen peroxide was subsequently found to be a required cofactor. The enzyme displayed temperature and pH optima in the physiologic range, a remarkable resistance to proteolysis, and specificity for long-chain acyl-CoA substrates. The reaction demonstrated Michaelis-Menten kinetics with a K-m for oleoyl-CoA of 21 mu M. Proteomic, biochemical, and immunologic analyses were used to identify the source of the oleamide synthesizing activity as cytochrome c. This identification was based upon peptide mass fingerprinting of isolated synthase protein, a tight correlation between enzymatic activity and immunoreactivity for cytochrome c, and identical functional properties shared by the tissue-derived synthetase and commercially obtained cytochrome c. The ability of cytochrome c to catalyze the formation of oleamide experimentally raises the possibility that cytochrome c may mediate oleamide biosynthesis in vivo.	Uniformed Serv Univ Hlth Sci, F Edward Herbert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Mueller, GP (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Herbert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	gmueller@usuhs.mil			NINDS NIH HHS [R01 NS38050-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAFAT ES, 1989, LIFE SCI, V45, P1679, DOI 10.1016/0024-3205(89)90278-6; Barros MH, 2003, FREE RADICAL BIO MED, V35, P179, DOI 10.1016/S0891-5849(03)00307-1; Bisogno T, 1997, BIOCHEM BIOPH RES CO, V239, P473, DOI 10.1006/bbrc.1997.7431; Bisogno T, 2002, CURR PHARM DESIGN, V8, P533, DOI 10.2174/1381612023395655; BISSWANGER H, 2002, ENZYME KINETICS PRIN, P55; Boger DL, 1998, P NATL ACAD SCI USA, V95, P4810, DOI 10.1073/pnas.95.9.4810; Boger DL, 1998, CURR PHARM DESIGN, V4, P303; Chaturvedi S, 2006, PROSTAG OTH LIPID M, V81, P136, DOI 10.1016/j.prostaglandins.2006.09.001; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; DENNIS SC, 1977, BIOCHEM J, V168, P521, DOI 10.1042/bj1680521; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Fedorova I, 2001, J PHARMACOL EXP THER, V299, P332; Garcia-Dorado D, 2002, CARDIOVASC RES, V55, P456, DOI 10.1016/S0008-6363(02)00441-8; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HuidobroToro JP, 1996, P NATL ACAD SCI USA, V93, P8078, DOI 10.1073/pnas.93.15.8078; Huitron-Resendiz S, 2001, EXP NEUROL, V172, P235, DOI 10.1006/exnr.2001.7792; IDE T, 1995, LIPIDS, V30, P755, DOI 10.1007/BF02537803; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kim NH, 2004, B KOREAN CHEM SOC, V25, P1889; LANOUE KF, 1983, J BIOL CHEM, V258, P1726; LERNER RA, 1994, P NATL ACAD SCI USA, V91, P9505, DOI 10.1073/pnas.91.20.9505; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Merkler DJ, 1996, ARCH BIOCHEM BIOPHYS, V330, P430, DOI 10.1006/abbi.1996.0272; Merkler DJ, 2004, BIOCHEMISTRY-US, V43, P12667, DOI 10.1021/bi049529p; Mueller GP, 2007, J BIOL CHEM, V282, P22364, DOI 10.1074/jbc.M701801200; Muth E, 2004, BBA-PROTEINS PROTEOM, V1699, P263, DOI 10.1016/j.bbapap.2004.03.007; Power GW, 1997, LIPIDS, V32, P31, DOI 10.1007/s11745-997-0005-4; Ripps H, 2002, EXP EYE RES, V74, P327, DOI 10.1006/exer.2002.1155; Satriano J, 2004, AMINO ACIDS, V26, P321, DOI 10.1007/s00726-004-0078-4; Soltys BJ, 2001, CELL BIOL INT, V25, P331, DOI 10.1006/cbir.2000.0651; STEWART JM, 2002, BIOCH CELL BIOL, V78, P675; Sugiura T, 1996, BIOCHEM MOL BIOL INT, V40, P931; Watkins PA, 1997, PROG LIPID RES, V36, P55, DOI 10.1016/S0163-7827(97)00004-0; YAMASHIT.S, 1973, EUR J BIOCHEM, V38, P25, DOI 10.1111/j.1432-1033.1973.tb03028.x; YET SF, 1995, BIOCHEMISTRY-US, V34, P7303, DOI 10.1021/bi00022a003; Zhao YG, 2004, BIOCHEM BIOPH RES CO, V317, P980, DOI 10.1016/j.bbrc.2004.03.144; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200	42	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22353	22363		10.1074/jbc.M610070200	http://dx.doi.org/10.1074/jbc.M610070200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17496328	hybrid			2022-12-27	WOS:000248354200013
J	Li, YW; Wang, ZW; Kong, D; Murthy, S; Dou, QP; Sheng, S; Reddy, GPV; Sarkar, FH				Li, Yiwei; Wang, Zhiwei; Kong, Dejuan; Murthy, Shalini; Dou, Q. Ping; Sheng, Shijie; Reddy, G. Prem Veer; Sarkar, Fazlul H.			Regulation of FOXO3a/beta-catenin/GSK-3 beta signaling by 3,3 '-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ANDROGEN RECEPTOR; BETA-CATENIN; BREAST-CANCER; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; AKT PATHWAY; KAPPA-B; SURVIVAL; PHOSPHORYLATION	Previous studies from our laboratory have shown anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane (DIM) through regulation of Akt and androgen receptor (AR) in prostate cancer cells. However, the mechanism by which DIM regulates Akt and AR signaling pathways has not been fully investigated. It has been known that FOXO3a and glycogen synthase kinase-3 beta (GSK-3 beta), two targets of activated Akt, interact with beta-catenin, regulating cell proliferation and apoptotic cell death. More importantly, FOXO3a, GSK-3 beta, and beta-catenin are all AR coregulators and regulate the activity of AR, mediating the development and progression of prostate cancers. Here, we investigated the molecular effects of B-DIM, a formulated DIM with higher bioavailability, on Akt/FOXO3a/GSK-3 beta/beta-catenin/AR signaling in hormone-sensitive LNCaP and hormone-insensitive C4-2B prostate cancer cells. We found that B-DIM significantly inhibited the phosphorylation of Akt and FOXO3a and increased the phosphorylation of beta-catenin, leading to the inhibition of cell growth and induction of apoptosis. We also found that B-DIM significantly inhibited beta-catenin nuclear translocation. By electrophoretic mobility shift and chromatin immunoprecipitation assays, we found that B-DIM inhibited FOXO3a binding to the promoter of AR and promoted FOXO3a binding to the p27(KIP1) promoter, resulting in the alteration of AR and p27(KIP1) expression, the inhibition of cell proliferation, and the induction of apoptosis in both androgen-sensitive and -insensitive prostate cancer cells. These results suggest that B-DIM-induced cell growth inhibition and apoptosis induction are partly mediated through the regulation of Akt/FOXO3a/GSK-3 beta/beta-catenin/AR signaling. Therefore, B-DIM could be a promising non-toxic agent for possible treatment of hormone-sensitive but most importantly hormone-refractory prostate cancers.	Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA; Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Henry Ford Health System; Henry Ford Hospital	Sarkar, FH (corresponding author), 740 Hudson Webber Canc Res Ctr, 4100 John Rd, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	Wang, Zhiwei/A-6809-2011	Murthy, Shalini/0000-0001-5517-9894; Dou, Qingping/0000-0002-6465-1473	NCI NIH HHS [5R01CA108535] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108535] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderton MJ, 2004, DRUG METAB DISPOS, V32, P632, DOI 10.1124/dmd.32.6.632; Bhuiyan MMR, 2006, CANCER RES, V66, P10064, DOI 10.1158/0008-5472.CAN-06-2011; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P107, DOI 10.2174/156720206776875830; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Firestone GL, 2003, J NUTR, V133, p2448S, DOI 10.1093/jn/133.7.2448S; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hong CB, 2002, CARCINOGENESIS, V23, P1297, DOI 10.1093/carcin/23.8.1297; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kuemmerle JF, 2005, AM J PHYSIOL-GASTR L, V288, pG101, DOI 10.1152/ajpgi.00032.2004; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Nachshon-Kedmi M, 2003, FOOD CHEM TOXICOL, V41, P745, DOI 10.1016/S0278-6915(03)00004-8; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Rosas M, 2006, J LEUKOCYTE BIOL, V80, P186, DOI 10.1189/jlb.1105636; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; Terry S, 2006, J CELL BIOCHEM, V99, P402, DOI 10.1002/jcb.20983; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Truica CI, 2000, CANCER RES, V60, P4709; Wen Y, 2000, CANCER RES, V60, P6841; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	43	102	105	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21542	21550		10.1074/jbc.M701978200	http://dx.doi.org/10.1074/jbc.M701978200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17522055	hybrid			2022-12-27	WOS:000248047500081
J	Liu, XW; Wu, B; Szary, J; Kofoed, EM; Schaufele, F				Liu, Xiaowei; Wu, Bo; Szary, Jaroslaw; Kofoed, Eric M.; Schaufele, Fred			Functional sequestration of transcription factor activity by repetitive DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-ALPHA; ESTROGEN-RECEPTOR ACTIVATION; PITUITARY-CELL NUCLEUS; GENE-EXPRESSION; C/EBP-ALPHA; CENTROMERIC HETEROCHROMATIN; SATELLITE DNA; LIVING CELLS; PIT-1; LOCALIZATION	Higher eukaryote genomes contain repetitive DNAs, often concentrated in transcriptionally inactive heterochromatin. Although repetitive DNAs are not typically considered as regulatory elements that directly affect transcription, they can contain binding sites for some transcription factors. Here, we demonstrate that binding of the transcription factor CCAAT/enhancer-binding protein alpha (C/EBP alpha) to the mouse major alpha-satellite repetitive DNA sequesters C/EBP alpha in the transcriptionally inert pericentromeric heterochromatin. We find that this sequestration reduces the transcriptional capacity of C/EBP alpha. Functional sequestration of C/EBP alpha was demonstrated by experimentally reducing C/EBP alpha binding to the major alpha-satellite DNA, which elevated the concentration of C/EBP alpha in the non-heterochromatic subcompartment of the cell nucleus. The reduction in C/EBP alpha binding to alpha-satellite DNA was induced by the co-expression of the transcription factor Pit-1, which removes C/EBP alpha from the heterochromatic compartment, and by the introduction of an altered-specificity mutation into C/EBP alpha that reduces binding to alpha-satellite DNA but permits normal binding to sites in some gene promoters. In both cases the loss of alpha-satellite DNA binding coincided with an elevation in the binding of C/EBP alpha to a promoter and an increased transcriptional output from that promoter. Thus, the binding of C/EBP alpha to this highly repetitive DNA reduced the amount of C/EBP alpha available for binding to and regulation of this promoter. The functional sequestration of some transcription factors through binding to repetitive DNAs may represent an underappreciated mechanism controlling transcription output.	Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schaufele, F (corresponding author), Univ Calif San Francisco, Ctr Diabet, S-1230,513 Parnassus, San Francisco, CA 94143 USA.	freds@diabetes.ucsf.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054345] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK054345, DK-54345, R01 DK054345-07] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blattes R, 2006, EMBO J, V25, P2397, DOI 10.1038/sj.emboj.7601125; Brown K, 1999, CRIT REV EUKAR GENE, V9, P203, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.50; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chuang FM, 1997, MOL ENDOCRINOL, V11, P1332, DOI 10.1210/me.11.9.1332; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Corry GN, 2005, BIOCHEM CELL BIOL, V83, P535, DOI 10.1139/O05-062; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Day RN, 2003, MOL ENDOCRINOL, V17, P333, DOI 10.1210/me.2002-0136; Day RN, 2001, METHODS, V25, P4, DOI 10.1006/meth.2001.1211; DeFranco DB, 2002, MOL ENDOCRINOL, V16, P1449, DOI 10.1210/me.16.7.1449; Demarco IA, 2006, MOL CELL BIOL, V26, P8087, DOI 10.1128/MCB.02410-05; Enwright JF, 2003, MOL ENDOCRINOL, V17, P209, DOI 10.1210/me.2001-0222; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Francastel C, 2001, P NATL ACAD SCI USA, V98, P12120, DOI 10.1073/pnas.211444898; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Inoue Y, 2004, J BIOL CHEM, V279, P44740, DOI 10.1074/jbc.M405177200; Isogai Y, 2003, CURR OPIN CELL BIOL, V15, P296, DOI 10.1016/S0955-0674(03)00052-8; Jacob KK, 1999, ENDOCRINOLOGY, V140, P4542, DOI 10.1210/en.140.10.4542; Janssen S, 2000, MOL CELL, V6, P1013, DOI 10.1016/S1097-2765(00)00100-3; Janssen S, 2000, MOL CELL, V6, P999, DOI 10.1016/S1097-2765(00)00099-X; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; JOSEPH A, 1989, EXP CELL RES, V183, P494, DOI 10.1016/0014-4827(89)90408-4; Komeili A, 2000, CURR OPIN CELL BIOL, V12, P355, DOI 10.1016/S0955-0674(00)00100-9; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kummalue T, 2003, J LEUKOCYTE BIOL, V74, P464, DOI 10.1189/jlb.1202622; Lamb JC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-214; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Liu WQ, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-6; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Perrod S, 2003, CELL MOL LIFE SCI, V60, P2303, DOI 10.1007/s00018-003-3246-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilipuk GP, 2003, J BIOL CHEM, V278, P35668, DOI 10.1074/jbc.M305182200; Platero JS, 1998, J CELL BIOL, V140, P1297; Schaufele F, 1999, MOL ENDOCRINOL, V13, P935, DOI 10.1210/me.13.6.935; Schaufele F, 2003, J BIOL CHEM, V278, P10578, DOI 10.1074/jbc.M207466200; Schaufele F, 1996, J BIOL CHEM, V271, P21484, DOI 10.1074/jbc.271.35.21484; Schaufele F, 2001, MOL ENDOCRINOL, V15, P1665, DOI 10.1210/me.15.10.1665; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Shestakova EA, 2004, NUCLEIC ACIDS RES, V32, P4390, DOI 10.1093/nar/gkh737; STEPHANOVA E, 1988, EXP CELL RES, V179, P545, DOI 10.1016/0014-4827(88)90292-3; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Vandromme M, 1996, TRENDS BIOCHEM SCI, V21, P59, DOI 10.1016/S0968-0004(96)80182-4; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200	52	38	38	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20868	20876		10.1074/jbc.M702547200	http://dx.doi.org/10.1074/jbc.M702547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17526489	Green Accepted, hybrid			2022-12-27	WOS:000248047500012
J	Mckee, KK; Harrison, D; Capizzi, S; Yurchenco, PD				Mckee, Karen K.; Harrison, David; Capizzi, Stephanie; Yurchenco, Peter D.			Role of laminin terminal globular domains in basement membrane assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIDOGEN-BINDING-SITE; ALPHA-CHAIN; LAMININ-GAMMA-1; AGGREGATION; STABILITY; LETHALITY; ABLATION; NETWORK; IV	Laminins contribute to basement membrane assembly through interactions of their N- and C-terminal globular domains. To further analyze this process, recombinant laminin-111 heterotrimers with deletions and point mutations were generated by recombinant expression and evaluated for their ability to self-assemble, interact with nidogen-1 and type IV collagen, and form extracellular matrices on cultured Schwann cells by immunofluorescence and electron microscopy. Wild-type laminin and laminin without LG domains polymerized in contrast to laminins with deleted alpha 1-, beta 1-, or gamma 1-LN domains or with duplicated beta 1- or alpha 1-LN domains. Laminins with a full complement of LN and LG domains accumulated on cell surfaces substantially above those lacking either LN or LG domains and formed a lamina densa. Accumulation of type IV collagen onto the cell surface was found to require laminin with separate contributions arising from the presence of laminin LN domains, nidogen-1, and the nidogen-binding site in laminin. Collectively, the data support the hypothesis that basement membrane assembly depends on laminin self-assembly through formation of alpha-, beta-, and gamma-LN domain complexes and LG-mediated cell surface anchorage. Furthermore, type IV collagen recruitment into the laminin extracellular matrices appears to be mediated through a nidogen bridge with a lesser contribution arising from a direct interaction with laminin.	Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Yurchenco, PD (corresponding author), Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, 675 Hoes Lane, Piscataway, NJ 08854 USA.	yurchenc@umdnj.edu		Yurchenco, Peter/0000-0003-0387-2317	NIDDK NIH HHS [R37 DK036425, R37-DK36425] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK036425] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Bose K, 2006, J BIOL CHEM, V281, P39620, DOI 10.1074/jbc.M607886200; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; FUJIWARA S, 1984, EUR J BIOCHEM, V143, P145, DOI 10.1111/j.1432-1033.1984.tb08353.x; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Huang CC, 2003, DEVELOPMENT, V130, P3343, DOI 10.1242/dev.00481; KALB E, 1991, J BIOL CHEM, V266, P19047; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; PAULSSON M, 1988, J BIOL CHEM, V263, P5425; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; RUBEN GC, 1994, MICROSC RES TECHNIQ, V28, P13, DOI 10.1002/jemt.1070280104; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Tsiper MV, 2002, J CELL SCI, V115, P1005; Willem M, 2002, DEVELOPMENT, V129, P2711; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636	36	133	136	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21437	21447		10.1074/jbc.M702963200	http://dx.doi.org/10.1074/jbc.M702963200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17517882	hybrid			2022-12-27	WOS:000248047500071
J	Peng, ZM; Peng, L; Fan, YX; Zandi, E; Shertzer, HG; Xia, Y				Peng, Zhimin; Peng, Li; Fan, Yunxia; Zandi, Ebrahim; Shertzer, Howard G.; Xia, Ying			A critical role for I kappa B kinase beta in metallothionein-1 expression and protection against arsenic toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; CELL-LINES; RESPONSIVE ELEMENT; TNF-ALPHA; ACTIVATION; APOPTOSIS; TRIOXIDE; INDUCTION; PROTEIN	Arsenic is a widespread environmental toxic agent that has been shown to cause diverse tissue and cell damage and at the same time to be an effective anti-cancer therapeutic agent. The objective of this study is to explore the signaling mechanisms involved in arsenic toxicity. We show that the I kappa B kinase beta (IKK beta) plays a crucial role in protecting cells from arsenic toxicity. Ikk beta(-/-) mouse 3T3 fibroblasts have decreased expression of antioxidant genes, such as metallothionein 1 (Mt1). In contrast to wild type and IKK beta- reconstituted Ikk beta(-/-) cells, IKK beta-null cells display a marked increase in arsenic-induced reactive oxygen species (ROS) accumulation, which leads to activation of the MKK4-c-Jun NH2-terminal kinase (JNK) pathway, c-Jun phosphorylation, and apoptosis. Pretreatment with the antioxidant N-acetylcysteine (NAC) and expression of MT1 in the Ikk beta(-/-) cells prevented JNK activation; moreover, NAC pretreatment, MT1expression, MKK4 ablation, and JNK inhibition all protected cells from death induced by arsenic. Our data show that two signaling pathways appear to be important for modulating arsenic toxicity. First, the IKK-NF-kappa B pathway is crucial for maintaining cellular metallothionein-1 levels to counteract ROS accumulation, and second, when this pathway fails, excessive ROS leads to activation of the MKK4-JNK pathway, resulting in apoptosis.	Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	University System of Ohio; University of Cincinnati; University of Southern California	Xia, Y (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, 123 E Shields St, Cincinnati, OH 45267 USA.	xiay@email.uc.edu	peng, zhimin/B-4536-2010		NEI NIH HHS [R01 EY015227] Funding Source: Medline; NIEHS NIH HHS [ES11798] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011798] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akao Y, 1998, BRIT J HAEMATOL, V102, P1055, DOI 10.1046/j.1365-2141.1998.00869.x; Andela VB, 2005, FEBS LETT, V579, P6814, DOI 10.1016/j.febslet.2005.11.018; ANDERSEN RD, 1987, MOL CELL BIOL, V7, P3574, DOI 10.1128/MCB.7.10.3574; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bashir S, 2006, BASIC CLIN PHARMACOL, V98, P38, DOI 10.1111/j.1742-7843.2006.pto_170.x; Bi YY, 2004, BIOCHEM J, V380, P695, DOI 10.1042/BJ20031677; Campagne MV, 2000, J NEUROSCI, V20, P5200, DOI 10.1523/JNEUROSCI.20-14-05200.2000; Chen F, 2003, CANCER RES, V63, P7689; Das S, 2005, TOXICOL APPL PHARM, V204, P18, DOI 10.1016/j.taap.2004.08.010; Del Razo LM, 2001, TOXICOL APPL PHARM, V177, P132, DOI 10.1006/taap.2001.9291; Ding W, 2005, MOL CELL BIOCHEM, V279, P105, DOI 10.1007/s11010-005-8227-y; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Felix K, 2005, J BIOCHEM MOL TOXIC, V19, P67, DOI 10.1002/jbt.20062; Gupta S, 2003, MOL CANCER THER, V2, P711; Haas AF, 1998, FREE RADICAL BIO MED, V25, P998, DOI 10.1016/S0891-5849(98)00135-X; Haga N, 2005, CANCER SCI, V96, P825, DOI 10.1111/j.1349-7006.2005.00114.x; Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103; Iwama K, 2001, INT J CANCER, V92, P518, DOI 10.1002/ijc.1220; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kann S, 2005, TOXICOL SCI, V87, P365, DOI 10.1093/toxsci/kfi253; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liao VHC, 2005, BIOMETALS, V18, P519, DOI 10.1007/s10534-005-2996-3; Liu J, 2001, TOXICOL SCI, V61, P314, DOI 10.1093/toxsci/61.2.314; Lynn S, 2000, CIRC RES, V86, P514, DOI 10.1161/01.RES.86.5.514; Mathas S, 2003, BLOOD, V102, P1028, DOI 10.1182/blood-2002-04-1154; Munshi NC, 2002, INT J HEMATOL, V76, P340, DOI 10.1007/BF03165281; Murgo AJ, 2001, ONCOLOGIST, V6, P22, DOI 10.1634/theoncologist.6-suppl_2-22; Nesnow S, 2002, CHEM RES TOXICOL, V15, P1627, DOI 10.1021/tx025598y; Nikaido M, 2003, ENVIRON TOXICOL, V18, P306, DOI 10.1002/tox.10129; Nishigori C, 2004, ANTIOXID REDOX SIGN, V6, P561, DOI 10.1089/152308604773934314; Nishina H, 1999, DEVELOPMENT, V126, P505; NORDENSON I, 1991, HUM HERED, V41, P71, DOI 10.1159/000153979; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Pi JB, 2002, ENVIRON HEALTH PERSP, V110, P331, DOI 10.1289/ehp.02110331; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Santra A, 2000, Indian J Gastroenterol, V19, P112; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; Shumilla JA, 1999, J BIOL CHEM, V274, P36207, DOI 10.1074/jbc.274.51.36207; Soignet SL, 2001, ONCOLOGIST, V6, P11; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Sun XC, 2006, TOXICOL IN VITRO, V20, P1139, DOI 10.1016/j.tiv.2006.02.008; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Woo SY, 2006, PEDIATR HEMAT ONCOL, V23, P231, DOI 10.1080/08880010500506818; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yan W, 2007, BIOCHEM BIOPH RES CO, V355, P1038, DOI 10.1016/j.bbrc.2007.02.064; Zhang W, 1998, LEUKEMIA, V12, P1383, DOI 10.1038/sj.leu.2401112; Zheng X, 2005, BIOCHEM BIOPH RES CO, V329, P95, DOI 10.1016/j.bbrc.2005.01.105	52	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21487	21496		10.1074/jbc.M702510200	http://dx.doi.org/10.1074/jbc.M702510200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17526490	hybrid			2022-12-27	WOS:000248047500076
J	Escusa, S; Laporte, D; Massoni, A; Boucherie, H; Dautant, A; Daignan-Fornier, B				Escusa, Stephanie; Laporte, Damien; Massoni, Aurelie; Boucherie, Helian; Dautant, Alain; Daignan-Fornier, Bertrand			Skp1-Cullin-F-box-dependent degradation of Aah1p requires its interaction with the F-box protein Saf1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASES; DEPENDENT DEGRADATION; ADENOSINE-DEAMINASE; ADENINE DEAMINASE; CRYSTAL-STRUCTURE; YEAST; SCF; COMPLEXES; SYSTEM	When yeast cells enter into quiescence in response to nutrient limitation, the adenine deaminase Aah1p is specifically degraded via a process requiring the F-box protein Saf1p and components of the Skp1-Cullin-F-box complex. In this paper, we show that Saf1p interacts with both Aah1p and Skp1p. Interaction with Skp1p, but not with Aah1p, requires the F-box domain of Saf1p. Based on deletion and point mutations, we further demonstrate that the F-box domain of Saf1p is critical for degradation of Aah1p. We also establish that overexpression of Saf1p in proliferating cells is sufficient to trigger the degradation of Aah1p. Using this property and a two-dimensional protein gel approach, we found that Saf1p has a small number of direct targets. Finally, we isolated and characterized several point mutations in Aah1p, which increase its stability during quiescence. The majority of the mutated residues are located in two distinct exposed regions in the Aah1p three-dimensional model structure. Two hybrid experiments strongly suggest that these domains are directly involved in interaction with Saf1p. Importantly, we obtained a mutation in Aah1p that does not affect the protein interaction with Saf1p but abolishes Aah1p degradation. Because this mutated residue is an exposed lysine in the Aah1p three-dimensional model, we propose that it is likely to be a major ubiquitylation site. All together, our data strongly argue for Saf1p being a bona fide Skp1-Cullin-F-box subunit.	Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Daignan-Fornier, B (corresponding author), Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, 1 Rue Camille Saint-Saens, F-33076 Bordeaux, France.	B.Daignan-Fornier@ibgc.u-bordeaux2.fr						BOUCHERIE H, 2006, YEAST PROTOCOLS, P47; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Durfee T, 1999, YEAST, V15, P1761, DOI 10.1002/(SICI)1097-0061(199912)15:16<1761::AID-YEA494>3.0.CO;2-C; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Escusa S, 2006, MOL MICROBIOL, V60, P1014, DOI 10.1111/j.1365-2958.2006.05153.x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Louvet O, 1997, BIOTECHNIQUES, V23, P816, DOI 10.2144/97235bm11; Nishimoto T, 1999, BIOCHEM BIOPH RES CO, V262, P571, DOI 10.1006/bbrc.1999.1252; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Perrot M, 1999, ELECTROPHORESIS, V20, P2280, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2280::AID-ELPS2280>3.3.CO;2-H; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Ribard C, 2003, J MOL BIOL, V334, P1117, DOI 10.1016/j.jmb.2003.10.005; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; SIKORSKI RS, 1989, GENETICS, V122, P19; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	30	11	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20097	20103		10.1074/jbc.M702425200	http://dx.doi.org/10.1074/jbc.M702425200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517885	hybrid			2022-12-27	WOS:000247819300010
J	Kuwata, H; Fujimoto, C; Yoda, E; Shimbara, S; Nakatani, Y; Hara, S; Murakami, M; Kudo, I				Kuwata, Hiroshi; Fujimoto, Chikako; Yoda, Emiko; Shimbara, Satoko; Nakatani, Yoshihito; Hara, Shuntaro; Murakami, Makoto; Kudo, Ichiro			A novel role of group VIB calcium-independent phospholipase A(2) (iPLA(2)gamma) in the inducible expression of group IIA secretory PLA(2) in rat fibroblastic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; MECHANISM-BASED DISCRIMINATION; NEUROPATHY TARGET ESTERASE; SMOOTH-MUSCLE-CELLS; GROUP-V; PROSTAGLANDIN PRODUCTION; BROMOENOL LACTONE; MESANGIAL CELLS; GROUP-X; GENE	Group IIA secretory phospholipase A(2) (sPLA(2)-IIA) is a prototypic sPLA(2) enzyme that may play roles in modification of eicosanoid biosynthesis as well as antibacterial defense. In several cell types, inducible expression of sPLA(2) by pro-inflammatory stimuli is attenuated by group IVA cytosolic PLA(2) (cPLA(2)alpha) inhibitors such as arachidonyl trifluoromethylketone, leading to the proposal that prior activation of cPLA(2)alpha is required for de novo induction of sPLA(2). However, because of the broad specificity of several cPLA(2)alpha inhibitors used so far, a more comprehensive approach is needed to evaluate the relevance of this ambiguous pathway. Here, we provide evidence that the induction of sPLA(2)-IIA by pro-inflammatory stimuli requires group VIB calcium-independent PLA(2) (iPLA(2)gamma), rather than cPLA(2)alpha, in rat fibroblastic 3Y1 cells. Results with small interfering RNA unexpectedly showed that the cytokine induction of sPLA2-IIA in cPLA(2)alpha knockdown cells, in which cPLA(2)alpha protein was undetectable, was similar to that in replicate control cells. By contrast, knockdown of iPLA(2)gamma, another arachidonyl trifluoromethyl ketone-sensitive intracellular PLA(2), markedly reduced the cytokine- induced expression of sPLA(2)-IIA. Supporting this finding, the R-enantiomer of bromoenol lactone, an iPLA(2)gamma inhibitor, suppressed the cytokine- induced sPLA2-IIA expression, whereas (S)-bromoenol lactone, an iPLA(2)beta inhibitor, failed to do so. Moreover, lipopolysaccharide- stimulated sPLA(2)-IIA expression was also abolished by knockdown of iPLA(2)gamma. These findings open new insight into a novel regulatory role of iPLA(2)gamma in stimulus- coupled sPLA(2)-IIA expression.	Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 142, Japan; Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 113, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Showa University; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Kudo, I (corresponding author), Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 142, Japan.	ichi-ku@pharm.showa-u.ac.jp						ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2001, J BIOL CHEM, V276, P21854, DOI 10.1074/jbc.M010201200; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Beck S, 2003, J BIOL CHEM, V278, P29799, DOI 10.1074/jbc.M211763200; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Couturier C, 1999, J BIOL CHEM, V274, P23085, DOI 10.1074/jbc.274.33.23085; CROWL RM, 1991, J BIOL CHEM, V266, P2647; Guidet B, 1996, INFECTION, V24, P103, DOI 10.1007/BF01713312; Hamaguchi K, 2003, BBA-MOL CELL BIOL L, V1635, P37, DOI 10.1016/j.bbalip.2003.10.004; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Herbert SP, 2006, J BIOL CHEM, V281, P35709, DOI 10.1074/jbc.M600699200; Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kessen UA, 2005, J LIPID RES, V46, P2488, DOI 10.1194/jlr.M500325-JLR200; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; KOMADA M, 1989, J BIOCHEM-TOKYO, V106, P545, DOI 10.1093/oxfordjournals.jbchem.a122890; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Kuwata H, 2000, J IMMUNOL, V165, P4024, DOI 10.4049/jimmunol.165.7.4024; Kuwata H, 2005, J BIOL CHEM, V280, P25830, DOI 10.1074/jbc.M500168200; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Kuwata H, 2004, BBA-MOL CELL BIOL L, V1686, P15, DOI 10.1016/j.bbalip.2004.07.002; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Menschikowski M, 2006, PROSTAG OTH LIPID M, V79, P1, DOI 10.1016/j.prostaglandins.2005.10.005; Menschikowski M, 1995, ATHEROSCLEROSIS, V118, P173, DOI 10.1016/0021-9150(95)05604-1; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; MURAKAMI M, 1990, BIOCHIM BIOPHYS ACTA, V1043, P34, DOI 10.1016/0005-2760(90)90107-9; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; OKA S, 1991, J BIOL CHEM, V266, P9956; OUZUMI N, 1997, NATURE, V390, P618; PFEILSCHIFTER J, 1993, J CLIN INVEST, V92, P2516, DOI 10.1172/JCI116860; Piris-Gimenez A, 2005, J IMMUNOL, V175, P6786, DOI 10.4049/jimmunol.175.10.6786; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Quistad GB, 2003, P NATL ACAD SCI USA, V100, P7983, DOI 10.1073/pnas.1232473100; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tay HK, 2004, J BIOL CHEM, V279, P22505, DOI 10.1074/jbc.M308788200; Uozumi N, 2002, PROSTAG OTH LIPID M, V68-9, P59, DOI 10.1016/S0090-6980(02)00021-7; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; WEISS J, 1994, J BIOL CHEM, V269, P26331; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yang JY, 2003, FEBS LETT, V546, P247, DOI 10.1016/S0014-5793(03)00581-7; Yoshimoto T, 2002, PROSTAG OTH LIPID M, V68-9, P245, DOI 10.1016/S0163-7827(97)00002-7	64	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20124	20132		10.1074/jbc.M611883200	http://dx.doi.org/10.1074/jbc.M611883200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17475622	hybrid			2022-12-27	WOS:000247819300013
J	Manya, H; Suzuki, T; Akasaka-Manya, K; Ishida, H; Mizuno, M; Suzuki, Y; Inazu, T; Dohmae, N; Endo, T				Manya, Hiroshi; Suzuki, Takehiro; Akasaka-Manya, Keiko; Ishida, Hide-Ki; Mizuno, Mamoru; Suzuki, Yasushi; Inazu, Toshiyuki; Dohmae, Naoshi; Endo, Tamao			Regulation of mammalian protein O-mannosylation - Preferential amino acid sequence for O-mannose modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DYSTROGLYCAN; C-MANNOSYLATION; GLYCOSYLATION; MUTATIONS; FUCOSE; FUCOSYLATION; REGION; YEAST; POMT1	O-Mannosyl glycans are important in muscle and brain development. Protein O-mannosyltransferase (POMT) catalyzes the initial step of O-mannosyl glycan biosynthesis. To understand which serine (Ser) and threonine (Thr) residues POMT recognizes for mannosylation, we prepared a series of synthetic peptides based on a mucin-like domain in alpha-dystroglycan (alpha-DG), one of the best known O-mannosylated proteins in mammals. In alpha-DG, the mucin-like domain spans amino acid residues 316 to 489. Two similar peptide sequences, corresponding to residues 401-420 and 336-355, respectively, were strongly mannosylated by POMT, whereas other peptides from alpha-DG and peptides of various mucin tandem repeat regions were poorly mannosylated. Peptides 401-420 and 336-355 contained four and six Ser and Thr residues, respectively. Substitution of Ala residues for the Ser or Thr residues showed that Thr-414 of peptide 401-420 and Thr-351 of peptide 336-355 were prominently modified by O-mannosylation. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and Edman degradation analysis of the mannosylated peptide 401-420 indicated that Thr-414 was the Thr residue that was most prominently modified by O-mannosylation and that O-mannosylation occurred sequentially rather than at random. Based on these results, we propose a preferred amino acid sequence for mammalian O-mannose modification.	Fdn Res Aging & Promot Human Welfare, Tokyo Metropolitan Inst Gerontol, Glycobiol Res Grp, Itabashi Ku, Tokyo 173, Japan; RIKEN, Biomol Characterizat Team, Wako, Saitama 351, Japan; Tokyo Chem Ind Co Ltd, Kita Ku, Tokyo 114, Japan; Noguchi Inst, Res Dept, Itabashi Ku, Tokyo 173, Japan; Tokai Univ, Sch Engn, Inst Glycotechnol, Dept Appl Chem, Kanagawa 2591292, Japan	Tokyo Metropolitan Institute of Gerontology; RIKEN; Tokai University	Endo, T (corresponding author), Fdn Res Aging & Promot Human Welfare, Tokyo Metropolitan Inst Gerontol, Glycobiol Res Grp, Itabashi Ku, 35-2 Sakaecho, Tokyo 173, Japan.	endo@tmig.or.jp	Suzuki, Takehiro/B-3210-2013; Inazu, Toshiyuki/R-1966-2019; Dohmae, Naoshi/C-2040-2011	Dohmae, Naoshi/0000-0002-5242-9410; Manya, Hiroshi/0000-0003-1573-9177				Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x; Chiba A, 1997, J BIOL CHEM, V272, P2156; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; Endo T, 2004, GLYCOCONJUGATE J, V21, P3, DOI 10.1023/B:GLYC.0000043740.26062.2c; Endo T, 1999, BBA-GEN SUBJECTS, V1473, P237, DOI 10.1016/S0304-4165(99)00182-8; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Takahashi S, 2001, GLYCOBIOLOGY, V11, P37, DOI 10.1093/glycob/11.1.37; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vosseller K, 2001, BIOCHIMIE, V83, P575, DOI 10.1016/S0300-9084(01)01295-0; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yamada H, 1996, J NEUROCHEM, V66, P1518; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	29	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20200	20206		10.1074/jbc.M702369200	http://dx.doi.org/10.1074/jbc.M702369200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502374	hybrid			2022-12-27	WOS:000247819300021
J	Ryder, JW; Lau, KS; Kamm, KE; Stull, JT				Ryder, Jeffrey W.; Lau, Kim S.; Kamm, Kristine E.; Stull, James T.			Enhanced skeletal muscle contraction with myosin light chain phosphorylation by a calmodulin-sensing kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTACT-CELLS; ACTIVATION; POTENTIATION; MOUSE; CA2+/CALMODULIN; STIMULATION; PERFORMANCE; INCREASES; KINETICS; TENSION	Repetitive low frequency stimulation results in potentiation of twitch force development in fast-twitch skeletal muscle due to myosin regulatory light chain (RLC) phosphorylation by Ca2+/ calmodulin (CaM)-dependent skeletal muscle myosin light chain kinase (skMLCK). We generated transgenic mice that express an skMLCK CaM biosensor in skeletal muscle to determine whether skMLCK or CaM is limiting to twitch force potentiation. Three transgenic mouse lines exhibited up to 22-fold increases in skMLCK protein expression in fast-twitch extensor digitorum longus muscle containing type IIa and IIb fibers, with comparable expressions in slow-twitch soleus muscle containing type I and IIa fibers. The high expressing lines showed a more rapid RLC phosphorylation and force potentiation in extensor digitorum longus muscle with low frequency electrical stimulation. Surprisingly, overexpression of skMLCK in soleus muscle did not recapitulate the fast-twitch potentiation response despite marked enhancement of both fast-twitch and slow-twitch RLC phosphorylation. Analysis of calmodulin binding to the biosensor showed a frequency-dependent activation to a maximal extent of 60%. Because skMLCK transgene expression is 22-fold greater than the wild-type kinase, skMLCK rather than calmodulin is normally limiting for RLC phosphorylation and twitch force potentiation. The kinase activation rate (10.6 s(-1)) was only 3.6-fold slower than the contraction rate, whereas the inactivation rate (2.8 s(-1)) was 12-fold slower than relaxation. The slower rate of kinase inactivation in vivo with repetitive contractions provides a biochemical memory via RLC phosphorylation. Importantly, RLC phosphorylation plays a prominent role in skeletal muscle force potentiation of fast-twitch type IIb but not type I or IIa fibers.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Stull, JT (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			NHLBI NIH HHS [HL 26043, T32 HL 007360, HL 29043] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029043, R01HL026043, T32HL007360, R37HL026043] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agbulut O, 2007, J BIOL CHEM, V282, P10465, DOI 10.1074/jbc.M610418200; Baudry S, 2007, J APPL PHYSIOL, V102, P1394, DOI 10.1152/japplphysiol.01254.2006; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; BOWMAN BF, 1992, J BIOL CHEM, V267, P5346; Childers MK, 2004, MUSCLE NERVE, V29, P313, DOI 10.1002/mus.10517; Clarkson PM, 2005, J APPL PHYSIOL, V99, P564, DOI 10.1152/japplphysiol.00130.2005; CLOSE R, 1968, J PHYSIOL-LONDON, V197, P461, DOI 10.1113/jphysiol.1968.sp008570; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; CROW MT, 1982, J BIOL CHEM, V257, P2121; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; GALLINA C, 1997, TUTELA, V1, P16; Geguchadze R, 2004, FEBS LETT, V557, P121, DOI 10.1016/S0014-5793(03)01456-X; Gorselink M, 2002, AM J PHYSIOL-ENDOC M, V282, pE348, DOI 10.1152/ajpendo.00085.2001; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KLUG GA, 1982, J BIOL CHEM, V257, P4688; KRARUP C, 1981, J PHYSIOL-LONDON, V311, P355, DOI 10.1113/jphysiol.1981.sp013589; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; Maier LS, 2006, J MOL CELL CARDIOL, V41, P451, DOI 10.1016/j.yjmcc.2006.04.020; MANNING DR, 1982, AM J PHYSIOL, V242, pC234, DOI 10.1152/ajpcell.1982.242.3.C234; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; MOORE RL, 1985, J CELL PHYSIOL, V125, P301, DOI 10.1002/jcp.1041250219; MOORE RL, 1984, AM J PHYSIOL, V247, pC462, DOI 10.1152/ajpcell.1984.247.5.C462; Muscat George E. O., 1992, Gene Expression, V2, P111; NUNNALLY MH, 1985, J BIOL CHEM, V260, P1020; Patel JR, 1998, BIOPHYS J, V74, P360, DOI 10.1016/S0006-3495(98)77793-8; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Sale DG, 2002, EXERC SPORT SCI REV, V30, P138, DOI 10.1097/00003677-200207000-00008; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; STULL JT, 1977, BIOCHEM BIOPH RES CO, V77, P1078, DOI 10.1016/S0006-291X(77)80088-0; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P414, DOI 10.1073/pnas.87.1.414; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Totsuka Y, 2003, J APPL PHYSIOL, V95, P720, DOI 10.1152/japplphysiol.00946.2002; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; WESTWOOD SA, 1984, BIOCHEM J, V218, P841, DOI 10.1042/bj2180841; Yang YH, 1998, J STRUCT BIOL, V122, P139, DOI 10.1006/jsbi.1998.3979; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	42	80	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20447	20454		10.1074/jbc.M702927200	http://dx.doi.org/10.1074/jbc.M702927200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17504755	hybrid			2022-12-27	WOS:000247819300047
J	Li, J; Pan, GJ; Cui, K; Liu, YW; Xu, SB; Pei, DQ				Li, Jun; Pan, Guangjin; Cui, Kai; Liu, Yuwen; Xu, Shaobin; Pei, Duanqing			A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PLURIPOTENCY; NANOG; OCT4; ENHANCER; ANOPHTHALMIA; ELEMENTS; RENEWAL; COMPLEX	SOX2 plays an important role in early embryogenesis by cooperating with OCT4 in regulating gene expression in fertilized eggs, yet the precise mechanism through which SOX2 accomplishes this important function remains poorly understood. Here, we describe the identification of two nuclear localization signals (NLS) in SOX2 and the generation of a dominant-negative mutant (Dmu-mSox2) by mutating these two NLS in its high mobility group domain. Characterization of this mutant demonstrated that SOX2 shuttles between the cytoplasm and nucleus using these two NLS. The mutant has lost its ability to interact with OCT4, but remains competent to interact with wild-type SOX2. Functionally, Dmu-mSox2 is inactive and unable to cooperate with OCT4 in transactivating target promoters bearing its binding sites. However, Dmu-mSox2 is able to inhibit the activity of wild- type SOX2 and subsequently suppress the activity of downstream genes such as Oct4 and Nanog. When stably expressed in embryonic stem (ES) cells, DmumSox2 triggered progressive doublings of cell ploidy (> 8N), leading to differentiation into the trophectoderm lineage. Knockdown of Sox2 by small interfering RNA also induced trophectoderm differentiation and polyploid formation in mouse ES cells. These results suggest that SOX2 maintains stem cell pluripotency by shuttling between the nucleus and cytoplasm in cooperation with OCT4 to prevent trophectoderm differentiation and polyploid formation in ES cells.	Tsinghua Univ, Sch Med, Inst Pharmacol, Dept Biol Sci & Biotechnol,State Key Lab Biomembr, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Med, Inst Biomed, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Pei, DQ (corresponding author), Tsinghua Univ, Sch Med, Inst Pharmacol, Dept Biol Sci & Biotechnol,State Key Lab Biomembr, Beijing 100084, Peoples R China.	pei_duanqing@gibh.ac.cn	zhou, xingru/G-4442-2012					Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Constantinescu S, 2003, J CELL MOL MED, V7, P103, DOI 10.1111/j.1582-4934.2003.tb00209.x; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fraidenraich D, 1998, DEV BIOL, V204, P197, DOI 10.1006/dbio.1998.9053; Kishi M, 2000, DEVELOPMENT, V127, P791; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Smith A, 2005, CELL, V123, P757, DOI 10.1016/j.cell.2005.11.012; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	25	71	75	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19481	19492		10.1074/jbc.M702056200	http://dx.doi.org/10.1074/jbc.M702056200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17507372	hybrid			2022-12-27	WOS:000247650600022
J	Uchida, Y; Nakano, SI; Gomi, F; Takahashi, H				Uchida, Yoko; Nakano, Shun-ichirou; Gomi, Fujiya; Takahashi, Hiroshi			Differential regulation of basic helix-loop-helix factors Mash1 and Olig2 by beta-amyloid accelerates both differentiation and death of cultured neural stem/progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; STEM-CELLS; TRANSCRIPTION FACTOR; PROGENITOR CELLS; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; CORTICAL-NEURONS; MOUSE MODEL; BRAIN	Despite increased neurogenic differentiation markers in the hippocampal CA1 in Alzheimer disease, neurons are not replaced in CA1 and the neocortex in the disease. beta-Amyloid (A beta) might cause deterioration of the brain microenvironment supporting neurogenesis and the survival of immature neurons. To test this possibility, we examined whether A beta alters the expression of cell fate determinants in cerebral cortical cultures and in an Alzheimer disease mouse model (PrP-APPSW). Upregulation of Mash1 and down-regulation of Olig2 were found in cerebral cortical cultures treated with A beta-(1-42). Mash1 was expressed in nestin-positive immature cells. The majority of Mash1-positive cells in untreated cortical culture co-expressed Olig2. A beta increased the proportion of Olig2-negative/Mash1-positive cells. A decrease in Olig2+ cells was also observed in the cerebral cortex of adult PrP-APPSW mice. Cotransfection experiments with Mash1 cDNA and Olig2 siRNA revealed that overexpression of Mash1 in neurosphere cells retaining Olig2 expression enhanced neural differentiation but accelerated death of Olig2-depleted cells. Growth factor deprivation, which down-regulated Olig2, accelerated death of Mash1-overexpressing neurosphere cells. We conclude that cooperation between Mash1 and Olig2 is necessary for neural stem/progenitor cells to develop into fully mature neurons and that downregulation of Olig2 by A beta in Mash1-overexpressing cells switches the cell fate to death. Maintaining Olig2 expression in differentiating cells could have therapeutic potential.	Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Disorders, Gene Express Res Grp, Itabashi Ku, Tokyo 173, Japan; Mitsubishi Kagaku Inst Life Sci, Tokyo 194, Japan	Tokyo Metropolitan Institute of Gerontology; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Uchida, Y (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Disorders, Gene Express Res Grp, Itabashi Ku, 35-2 Sakaecho, Tokyo 173, Japan.	57uchida@tmig.or.jp						Becker M, 2007, P NATL ACAD SCI USA, V104, P1691, DOI 10.1073/pnas.0610180104; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Calafiore M, 2006, NEUROBIOL AGING, V27, P606, DOI 10.1016/j.neurobiolaging.2005.03.019; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Elliott RC, 2001, NEUROSCIENCE, V106, P79, DOI 10.1016/S0306-4522(01)00198-1; Furusho M, 2006, DEV BIOL, V293, P348, DOI 10.1016/j.ydbio.2006.01.031; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; HARDY J, 1997, TRENDS NEUROSCI, V20, P164; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mazur-Kolecka B, 2006, NEUROBIOL AGING, V27, P1181, DOI 10.1016/j.neurobiolaging.2005.07.006; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Torii MA, 1999, DEVELOPMENT, V126, P443; Uchida Y, 2003, J BIOL CHEM, V278, P366, DOI 10.1074/jbc.M210091200; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Wen PH, 2002, NEUROBIOL DIS, V10, P8, DOI 10.1006/nbdi.2002.0490; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	36	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19700	19709		10.1074/jbc.M703099200	http://dx.doi.org/10.1074/jbc.M703099200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488716	hybrid			2022-12-27	WOS:000247650600045
J	Zhu, SC; Wang, W; Clarke, DC; Liu, XD				Zhu, Songcheng; Wang, Wei; Clarke, David C.; Liu, Xuedong			Activation of Mps1 promotes transforming growth factor-beta-independent Smad signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; EPITHELIAL-CELLS; CENTROSOME DUPLICATION; MITOTIC CHECKPOINT; RECEPTOR; KINASE; PHOSPHORYLATION; PROTEINS; NUCLEUS; TRANSDUCTION	The primary intracellular mediators of TGF-beta signaling are the Smad proteins. Phosphorylation of R-Smad at the C-terminal SSXS motif by the activated TGF-beta type I receptor kinase triggers a conformation change in R-Smad and facilitates complex formation between R- Smad and Smad4, which shuttle into the nucleus where they interact with DNA and other transcription factors to regulate gene expression. In an attempt to identify proteins interacting with activated Smad signaling complex, we discovered that Mps1, a protein kinase that plays important roles in normal mitotic progression and mitotic checkpoint signaling, co-purifies with this complex. We demonstrated that Smad2 and Smad3 but not Smad4 are substrates of Mps1 in vitro and in vivo. Mps1 phosphorylates Smad2 and Smad3 at the SSXS motif in their C-terminal regions in vitro and in vivo. Disruption of microtubule networks by nocodazole activates Mps1 and promotes TGF-beta-independent activation of Smad signaling. We found that Mps1 is involved in turning on Smad signaling by phosphorylating R-Smads. Our results reveal a novel functional link between Mps1 and Smads in a non-canonical Smad signaling pathway.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA.	Xuedong.Liu@colorado.edu	Clarke, Dave/AAF-7278-2019	Clarke, David/0000-0002-1520-5426; LIU, XUEDONG/0000-0001-7209-4964	NATIONAL CANCER INSTITUTE [R01CA095527] Funding Source: NIH RePORTER; NCI NIH HHS [CA095527, R01 CA095527] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; LAIHO M, 1990, J BIOL CHEM, V265, P18518; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Murphy SJ, 2004, MOL BIOL CELL, V15, P2853, DOI 10.1091/mbc.E04-02-0097; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Piek E, 1999, J CELL SCI, V112, P4557; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Schutte M, 1996, CANCER RES, V56, P2527; Shi MJ, 2001, INT IMMUNOL, V13, P733, DOI 10.1093/intimm/13.6.733; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; WRANA JL, 1992, COLD SPRING HARB SYM, V57, P81, DOI 10.1101/SQB.1992.057.01.011; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	46	50	51	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18327	18338		10.1074/jbc.M700636200	http://dx.doi.org/10.1074/jbc.M700636200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452325	hybrid			2022-12-27	WOS:000247302000039
J	Ziesche, E; Bachmann, M; Kleinert, H; Pfeilschifter, J; Muhl, H				Ziesche, Elisabeth; Bachmann, Malte; Kleinert, Hartmut; Pfeilschifter, Josef; Muehl, Heiko			The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NO SYNTHASE; T-CELL; POSTTRANSCRIPTIONAL REGULATION; SIGNAL TRANSDUCERS; BINDING-PROTEIN; IL-22; STAT3; CYTOKINE; ACTIVATION	Inducible nitric-oxide synthase (iNOS) has been identified as a marker and mediator of disease in human colonic inflammation and carcinogenesis. Accordingly, identification of mediators that trigger iNOS in colon carcinoma/epithelial cells is an important topic of current research. Here we demonstrate that interleukin (IL)-22, a newly described member of the IL-10 cytokine family, potently synergizes with interferon (IFN)-gamma for iNOS expression in human DLD-1 colon carcinoma cells. Detection of both IL-22 receptor chains and STAT3 phosphorylation proved robust IL-22 responsiveness of these cells. Short interfering RNA technology identified STAT3 as being crucial for up-regulation of iNOS. Compared with IFN gamma, STAT1 phosphorylation by IL-22 was insufficient. IL-22 did not stabilize IL-1 beta/tumor necrosis factor-alpha/IFN gamma-induced iNOS mRNA. IL-22 also failed to amplify expression of the prototypic IFN gamma-inducible parameters IL-18-binding protein and CXCL-10, indicating that IL-22 is not a general amplifier of IFN gamma functions. This assumption is furthermore supported by the observation that IL-22 was unable to enhance cellular activation of the pro-inflammatory transcription factor nuclear factor-kappa B. In contrast, IL-22 increased iNOS promoter activation as detected by using DLD-1 cells stably transfected with a corresponding 16-kb promoter construct (pNOS2(16)-Luc). IL-22 likewise enhanced iNOS in Caco-2 colon carcinoma cells. With IL-22 we introduce a novel potent determinant of iNOS expression in human colon carcinoma/epithelial cells. Considering the eminent functions of STAT3 and iNOS in inflammation and carcinogenesis, IL-22 may represent a novel target for immunotherapeutic intervention.	Univ Frankfurt Klinikum, Pharmazentrum Frankfurt, ZAFES, D-60590 Frankfurt, Germany; Johannes Gutenberg Univ Mainz, Dept Pharmacol, D-55101 Mainz, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Johannes Gutenberg University of Mainz	Muhl, H (corresponding author), Univ Frankfurt Klinikum, Pharmazentrum Frankfurt, ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	H.Muehl@em.uni-frankfurt.de	Kleinert, Hartmut/M-2988-2018	Kleinert, Hartmut/0000-0003-2202-3548; Muhl, Heiko/0000-0002-0429-0127				Ambs S, 1998, NAT MED, V4, P1371, DOI 10.1038/3957; Ambs S, 1998, CANCER RES, V58, P334; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; ANDRADE SP, 1992, BRIT J PHARMACOL, V107, P1092, DOI 10.1111/j.1476-5381.1992.tb13412.x; Beck KF, 1999, J EXP BIOL, V202, P645; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Chavez AM, 1999, GUT, V44, P659, DOI 10.1136/gut.44.5.659; Cianchi F, 2003, AM J PATHOL, V162, P793, DOI 10.1016/S0002-9440(10)63876-X; Corvinus FM, 2005, NEOPLASIA, V7, P545, DOI 10.1593/neo.04571; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Fechir M, 2005, MOL PHARMACOL, V67, P2148, DOI 10.1124/mol.104.008763; Frank S, 1999, FASEB J, V13, P2002, DOI 10.1096/fasebj.13.14.2002; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Hellmuth M, 2004, FEBS LETT, V563, P98, DOI 10.1016/S0014-5793(04)00275-3; Hellmuth M, 2002, CARCINOGENESIS, V23, P1273, DOI 10.1093/carcin/23.8.1273; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hofseth LJ, 2003, FREE RADICAL BIO MED, V34, P955, DOI 10.1016/S0891-5849(02)01363-1; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; JENKINS DC, 1994, BRIT J CANCER, V70, P847, DOI 10.1038/bjc.1994.409; Kanda N, 2007, ENDOCRINOLOGY, V148, P2317, DOI 10.1210/en.2006-1639; Kankuri E, 2001, J PHARMACOL EXP THER, V298, P1128; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleinert H, 1998, BRIT J PHARMACOL, V123, P1716, DOI 10.1038/sj.bjp.0701782; Kleinert H, 1998, BRIT J PHARMACOL, V125, P193, DOI 10.1038/sj.bjp.0702039; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Ma XT, 2004, WORLD J GASTROENTERO, V10, P1569, DOI 10.3748/wjg.v10.i11.1569; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Muhl H, 2003, BIOCHEM BIOPH RES CO, V310, P677, DOI 10.1016/j.bbrc.2003.09.039; Muhl H, 2000, FREE RADICAL BIO MED, V29, P969, DOI 10.1016/S0891-5849(00)00389-0; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rao CV, 1999, CARCINOGENESIS, V20, P641, DOI 10.1093/carcin/20.4.641; Salzman AL, 1996, AM J PHYSIOL-GASTR L, V270, pG565, DOI 10.1152/ajpgi.1996.270.4.G565; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHERMAN PA, 1993, BIOCHEMISTRY-US, V32, P11600, DOI 10.1021/bi00094a017; Siegert A, 2002, BRIT J CANCER, V86, P1310, DOI 10.1038/sj.bjc.6600224; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; SUNITHA I, 1994, CLIN EXP METASTAS, V12, P143, DOI 10.1007/BF01753981; Szabo C, 2003, CRIT CARE MED, V31, pS39, DOI 10.1097/00003246-200301001-00006; Szaleczky E, 2000, J CLIN GASTROENTEROL, V30, P47, DOI 10.1097/00004836-200001000-00008; Takahashi M, 2006, NITRIC OXIDE-BIOL CH, V14, P130, DOI 10.1016/j.niox.2005.07.004; Tedeschi E, 2003, J PHARMACOL EXP THER, V307, P254, DOI 10.1124/jpet.103.054460; Van Buren G, 2006, EXPERT OPIN THER TAR, V10, P689, DOI 10.1517/14728222.10.5.689; Wang EZ, 1999, NITRIC OXIDE-BIOL CH, V3, P244, DOI 10.1006/niox.1999.0230; WEINBERG JB, 1995, BLOOD, V86, P1184; Whittington HA, 2004, AM J RESP CELL MOL, V31, P220, DOI 10.1165/rcmb.2003-0285OC; Witteck A, 2003, EXP CELL RES, V287, P106, DOI 10.1016/S0014-4827(03)00129-0; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200	67	93	94	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2007	282	22					16006	16015		10.1074/jbc.M611040200	http://dx.doi.org/10.1074/jbc.M611040200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	172HH	17438334	hybrid			2022-12-27	WOS:000246794300009
J	Hunter, GA; Zhang, JS; Ferreira, GC				Hunter, Gregory A.; Zhang, Junshun; Ferreira, Gloria C.			Transient kinetic studies support refinements to the chemical and kinetic mechanisms of aminolevulinate synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL-PHOSPHATE ENZYMES; 5-AMINOLEVULINATE SYNTHASE; 8-AMINO-7-OXONONANOATE SYNTHASE; REACTION SPECIFICITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SWISS-MODEL; BIOSYNTHESIS; CATALYSIS; COFACTOR	5-Aminolevulinate synthase catalyzes the pyridoxal 5'- phosphate-dependent condensation of glycine and succinyl-CoA to produce carbon dioxide, CoA, and 5-aminolevulinate, in a reaction cycle involving the mechanistically unusual successive cleavage of two amino acid substrate alpha-carbon bonds. Single and multiple turnover rapid scanning stopped-flow experiments have been conducted from pH 6.8-9.2 and 5-35 degrees C, and the results, interpreted within the framework of the recently solved crystal structures, allow refined characterization of the central kinetic and chemical steps of the reaction cycle. Quinonoid intermediate formation occurs with an apparent pK(a) of 7.7 +/- 0.1, which is assigned to His-207 acid-catalyzed decarboxylation of the alpha-amino-beta-ketoadipate intermediate to form an enol that is in rapid equilibrium with the 5-aminolevulinate-bound quinonoid species. Quinonoid intermediate decay occurs in two kinetic steps, the first of which is acid-catalyzed with a pKa of 8.1 +/- 0.1, and is assigned to protonation of the enol by Lys-313 to generate the product-bound external aldimine. The second step of quinonoid decay defines k(cat) and is relatively pH-independent and is assigned to opening of the active site loop to allow ALA dissociation. The data support important refinements to both the chemical and kinetic mechanisms and indicate that 5-aminolevulinate synthase operates under the stereoelectronic control predicted by Dunathan's hypothesis.	Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Hunter, GA (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	ghunter@health.usf.edu; gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	NIDDK NIH HHS [R01 DK063191, DK63191] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063191] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKHTAR M, 1976, PHILOS T ROY SOC B, V273, P117, DOI 10.1098/rstb.1976.0005; Alexeev D, 2006, ORG BIOMOL CHEM, V4, P1209, DOI 10.1039/b517922j; Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Bottomley SS, 2004, WINTROBES CLIN HEMAT, P1011; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; COREY EJ, 1956, J AM CHEM SOC, V78, P6269, DOI 10.1021/ja01605a013; DUNATHAN HC, 1971, ADV ENZYMOL RAMB, V35, P79; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Ferreira GC, 2002, CELL MOL BIOL, V48, P827; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; Fogle EJ, 2005, BIOCHEMISTRY-US, V44, P16392, DOI 10.1021/bi051475b; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Kerbarh O, 2006, CHEM COMMUN, P60, DOI 10.1039/b511837a; KIKUCHI G, 1958, J BIOL CHEM, V233, P1214; MCDONALD IK, 1995, PROTEIN ENG, V8, P217, DOI 10.1093/protein/8.3.217; NANDI DL, 1978, J BIOL CHEM, V253, P8872; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Schulze JO, 2006, J MOL BIOL, V358, P1212, DOI 10.1016/j.jmb.2006.02.064; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; TSAI MD, 1978, BIOCHEMISTRY-US, V17, P3183, DOI 10.1021/bi00609a002; WEISS B, 1963, J BIOL CHEM, V238, P1953; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; ZAMAN Z, 1973, BIOCHEM J, V135, P257, DOI 10.1042/bj1350257; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200	31	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23025	23035		10.1074/jbc.M609330200	http://dx.doi.org/10.1074/jbc.M609330200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17485466	hybrid			2022-12-27	WOS:000248577500005
J	Khan, S; Bijker, MS; Weterings, JJ; Tanke, HJ; Adema, GJ; van Hall, T; Drijfhout, JW; Melief, CJM; Overkleeft, HS; van der Marel, GA; Filippov, DV; van der Burg, SH; Ossendorp, F				Khan, Selina; Bijker, Martijn S.; Weterings, Jimmy J.; Tanke, Hans J.; Adema, Gosse J.; van Hall, Thorbald; Drijfhout, Jan W.; Melief, Cornelis J. M.; Overkleeft, Hermen S.; van der Marel, Gijsbert A.; Filippov, Dmitri V.; van der Burg, Sjoerd H.; Ossendorp, Ferry			Distinct uptake mechanisms but similar intracellular processing of two different Toll-like receptor ligand-peptide conjugates in dendritic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIDED CROSS-PRESENTATION; IMMUNOSTIMULATORY DNA; ANTIGEN PRESENTATION; CPG-DNA; PROTEIN; RECOGNITION; INHIBITORS; EXPRESSION; RESPONSES; IMMUNITY	Covalent conjugation of Toll-like receptor ligands (TLR-L) to synthetic antigenic peptides strongly improves antigen presentation in vitro and T lymphocyte priming in vivo. These molecularly well defined TLR-L-peptide conjugates, constitute an attractive vaccination modality, sharing the peptide antigen and a defined adjuvant in one single molecule. We have analyzed the intracellular trafficking and processing of two TLR-L conjugates in dendritic cells (DCs). Long synthetic peptides containing an ovalbumin cytotoxic T-cell epitope were chemically conjugated to two different TLR-Ls the TLR2 ligand, Pam(3)CysSK(4) (Pam) or the TLR9 ligand CpG. Rapid and enhanced uptake of both types of TLR-L-conjugated peptide occurred in DCs. Moreover, TLR-L conjugation greatly enhanced antigen presentation, a process that was dependent on endosomal acidification, proteasomal cleavage, and TAP translocation. The uptake of the CpG similar to conjugate was independent of endosomally-expressed TLR9 as reported previously. Unexpectedly, we found that Pam similar to conjugated peptides were likewise internalized independently of the expression of cell surface-expressed TLR2. Further characterization of the uptake mechanisms revealed that TLR2-L employed a different uptake route than TLR9-L. Inhibition of clathrin- or caveolin-dependent endocytosis greatly reduced uptake and antigen presentation of the Pam-conjugate. In contrast, internalization and antigen presentation of CpG similar to conjugates was independent of clathrin- coated pits but partly dependent on caveolae formation. Importantly, in contrast to the TLR-independent uptake of the conjugates, TLR expression and downstream TLR signaling was required for dendritic cell maturation and for priming of naive CD8(+) T-cells. Together, our data show that targeting to two distinct TLRs requires distinct uptake mechanism but follows similar trafficking and intracellular processing pathways leading to optimal antigen presentation and T-cell priming.	Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; Radboud Univ Nijmegen Med Ctr, Immunol Lab, NL-6500 HB Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen	Ossendorp, F (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, POB 9600, NL-2300 RC Leiden, Netherlands.	f.a.ossendorp@lumc.nl	van der Burg, Sjoerd H/T-1875-2017; Drijfhout, Jan Wouter/ABA-6318-2021; Adema, G.J./H-8007-2014; Filippov, Dmitri/J-7612-2017; van Hall, Thorbald/Y-5651-2018	van der Burg, Sjoerd H/0000-0002-6556-0354; Drijfhout, Jan Wouter/0000-0003-4808-5296; Filippov, Dmitri/0000-0002-6978-7425; van Hall, Thorbald/0000-0002-9115-558X; Overkleeft, Herman/0000-0001-6976-7005				Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; BRADLEY JR, 1993, J IMMUNOL, V150, P5544; Chan WC, 2000, PRACT APPROACH SER, V222, P41; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; GRANDAS A, 2003, CURRENT PROTOCOLS NU; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Heit A, 2003, J IMMUNOL, V170, P2802, DOI 10.4049/jimmunol.170.6.2802; Heit A, 2005, J IMMUNOL, V174, P4373, DOI 10.4049/jimmunol.174.7.4373; Horner AA, 2001, J IMMUNOL, V167, P1584, DOI 10.4049/jimmunol.167.3.1584; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Kaisho T, 2004, MICROBES INFECT, V6, P1388, DOI 10.1016/j.micinf.2004.08.019; Kaisho T, 2001, ACTA ODONTOL SCAND, V59, P124, DOI 10.1080/000163501750266701; KALINA M, 1991, J HISTOCHEM CYTOCHEM, V39, P1337, DOI 10.1177/39.10.1658127; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; LJUNGGREN HG, 1995, INT IMMUNOL, V7, P975, DOI 10.1093/intimm/7.6.975; Matyszak MK, 2000, EUR J IMMUNOL, V30, P1233, DOI 10.1002/(SICI)1521-4141(200004)30:4<1233::AID-IMMU1233>3.0.CO;2-F; Maurer T, 2002, EUR J IMMUNOL, V32, P2356, DOI 10.1002/1521-4141(200208)32:8<2356::AID-IMMU2356>3.0.CO;2-Z; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; NANDI PK, 1981, BIOCHEMISTRY-US, V20, P6706, DOI 10.1021/bi00526a028; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Riezman H, 1997, CELL, V91, P731, DOI 10.1016/S0092-8674(00)80461-4; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Shirota H, 2001, J IMMUNOL, V167, P66, DOI 10.4049/jimmunol.167.1.66; Sin N, 1999, BIOORG MED CHEM LETT, V9, P2283, DOI 10.1016/S0960-894X(99)00376-5; Steinman RM, 1999, HUM IMMUNOL, V60, P562, DOI 10.1016/S0198-8859(99)00030-0; STUKART MJ, 1984, J IMMUNOL, V133, P24; TANAKA K, 1986, J BIOL CHEM, V261, P5197; TANAKA K, 1989, J CELL PHYSIOL, V139, P34, DOI 10.1002/jcp.1041390107; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Zeng WG, 2002, J IMMUNOL, V169, P4905, DOI 10.4049/jimmunol.169.9.4905	51	141	145	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21145	21159		10.1074/jbc.M701705200	http://dx.doi.org/10.1074/jbc.M701705200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17462991	hybrid, Green Published			2022-12-27	WOS:000248047500041
J	Moin, SM; Panteva, M; Jameel, S				Moin, Syed Mohammad; Panteva, Milena; Jameel, Shahid			The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; RAT-BRAIN HEXOKINASE; CYTOCHROME-C RELEASE; RECOMBINANT YEAST MITOCHONDRIA; PERMEABILITY TRANSITION; COLORIMETRIC ASSAY; VIRAL-HEPATITIS; APOPTOSIS; EXPRESSION; BINDING	The biology and pathogenesis of hepatitis E virus are poorly understood due to the lack of an in vitro culture or infection models. The viral Orf3 protein activates the cellular mitogen-activated protein kinase pathway and is likely to modulate the host cell environment for efficient viral replication. We screened for cellular genes whose transcription was differentially up-regulated in an Orf3-expressing stable cell line (ORF3/4). The gene for mitochondrial voltage-dependent anion channel (VDAC) was one such candidate. The up-regulation of VDAC in ORF3/4 cells was confirmed by Northern and Western blotting in various cell lines. Transfection of ORF3/4 cells with an ORF3-specific small interfering RNA led to a reduction in VDAC protein levels. VDAC is a critical mitochondrial outer membrane protein, and its overexpression results in apoptosis. Surprisingly, Orf3-expressing cells were protected against staurosporine-induced cell death by preservation of mitochondrial potential and membrane integrity. A small interfering RNA-mediated reduction in Orf3 and VDAC levels also made cells sensitive to staurosporine. Chemical cross-linking showed Orf3-expressing cells to contain higher levels of oligomeric VDAC. These cells also contained higher levels of hexokinase I that directly interacted with VDAC. This interaction is known to preserve mitochondrial potential and prevent cytochrome c release. We report here the first instance of a viral protein promoting cell survival through such a mechanism.	Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Jameel, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India.	shahid@icgeb.res.in		Mechkarska, Milena/0000-0001-8882-0975; Moin, Syed/0000-0001-8789-9167	Wellcome Trust [063171] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Aflalo C, 1998, J BIOENERG BIOMEMBR, V30, P245, DOI 10.1023/A:1020544803475; Agrawal N, 2000, CURR SCI INDIA, V79, P711; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; ARORA KK, 1988, J BIOL CHEM, V263, P17422; Azoulay-Zohar H, 2000, EUR J BIOCHEM, V267, P2973; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Beutner G, 1998, BBA-BIOMEMBRANES, V1368, P7, DOI 10.1016/S0005-2736(97)00175-2; Bour S, 2000, Adv Pharmacol, V48, P75; Boya P, 2003, BIOCHEM BIOPH RES CO, V304, P575, DOI 10.1016/S0006-291X(03)00630-2; Boya P, 2001, EMBO J, V20, P4325, DOI 10.1093/emboj/20.16.4325; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; Brown GC, 2003, SCIENCE, V299, P838, DOI 10.1126/science.1082028; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; CARMICHAEL J, 1987, CANCER RES, V47, P936; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Downward J, 2003, NATURE, V424, P896, DOI 10.1038/424896a; EMERSON SU, 2004, 8 ICTV, P851; Emerson SU, 2006, J VIROL, V80, P10457, DOI 10.1128/JVI.00892-06; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; Graff J, 2005, J VIROL, V79, P6680, DOI 10.1128/JVI.79.11.6680-6689.2005; Graff J, 2006, J VIROL, V80, P5919, DOI 10.1128/JVI.00046-06; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Jameel S, 1996, J VIROL, V70, P207, DOI 10.1128/JVI.70.1.207-216.1996; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; KRAWCZYNSKI K, 1993, HEPATOLOGY, V17, P932, DOI 10.1002/hep.1840170525; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martinou JC, 2000, NAT CELL BIOL, V2, pE41, DOI 10.1038/35004069; Mishra RN, 2005, ANAL BIOCHEM, V345, P149, DOI 10.1016/j.ab.2005.07.029; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAYAK NC, 1989, J GASTROEN HEPATOL, V4, P345, DOI 10.1111/j.1440-1746.1989.tb00846.x; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; PURCELL RH, 1988, VIRAL HEPATITIS LIVE, P131; Rahmani Z, 2000, J VIROL, V74, P2840, DOI 10.1128/JVI.74.6.2840-2846.2000; RAMALINGASWAMI V, 1988, LANCET, V1, P571; REMPEL A, 1994, BBA-GENE STRUCT EXPR, V1219, P660, DOI 10.1016/0167-4781(94)90225-9; Roy AK, 2004, J BIOL CHEM, V279, P28345, DOI 10.1074/jbc.M400457200; Rucker E, 2004, J VIROL, V78, P12689, DOI 10.1128/JVI.78.22.12689-12693.2004; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Sebastian S, 1997, BIOCHEM BIOPH RES CO, V235, P389, DOI 10.1006/bbrc.1997.6797; Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x; Skulachev VP, 1996, FEBS LETT, V397, P7, DOI 10.1016/0014-5793(96)00989-1; Steffens CM, 2001, AIDS, V15, pS21, DOI 10.1097/00002030-200100005-00004; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Tyagi S, 2004, J BIOL CHEM, V279, P29308, DOI 10.1074/jbc.M402017200; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; VISTICA DT, 1991, CANCER RES, V51, P2515; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; XIE GC, 1990, ARCH BIOCHEM BIOPHYS, V276, P285, DOI 10.1016/0003-9861(90)90040-6; XIE GC, 1988, ARCH BIOCHEM BIOPHYS, V267, P803, DOI 10.1016/0003-9861(88)90090-2; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zafrullah M, 1999, J VIROL, V73, P4074, DOI 10.1128/JVI.73.5.4074-4082.1999; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	65	59	62	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21124	21133		10.1074/jbc.M701696200	http://dx.doi.org/10.1074/jbc.M701696200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17488721	Green Accepted, hybrid			2022-12-27	WOS:000248047500039
J	Jia, ZZ; Moulson, CL; Pei, ZT; Miner, JH; Watkins, PA				Jia, Zhenzhen; Moulson, Casey L.; Pei, Zhengtong; Miner, Jeffrey H.; Watkins, Paul A.			Fatty acid transport protein 4 is the principal very long chain fatty Acyl-CoA synthetase in skin fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR UPTAKE; CLONING; EXPRESSION; PLASMA; ROLES; MOUSE; MECHANISM; RELEVANCE; MAMMALS; FAMILY	Fatty acid transport protein 4 (FATP4) is a fatty acyl-CoA synthetase that preferentially activates very long chain fatty acid substrates, such as C24: 0, to their CoA derivatives. To gain better insight into the physiological functions of FATP4, we established dermal fibroblast cell lines from FATP4-deficient wrinklefree mice and wild type (w.t.) mice. FATP4-/- fibroblasts had no detectable FATP4 protein by Western blot. Compared with w.t. fibroblasts, cells lacking FATP4 had an 83% decrease in C24: 0 activation. Peroxisomal degradation of C24: 0 was reduced by 58%, and rates of C24: 0 incorporation into major phospholipid species (54-64% decrease), triacylglycerol (64% decrease), and cholesterol esters ( 58% decrease) were significantly diminished. Because these lipid metabolic processes take place in different subcellular organelles, we used immunofluorescence and Western blotting of subcellular fractions to investigate the distribution of FATP4 protein and measured enzyme activity in fractions from w.t. and FATP4(-/-) fibroblasts. FATP4 protein and acyl-CoA synthetase activity localized to multiple organelles, including mitochondria, peroxisomes, endoplasmic reticulum, and the mitochondria-associated membrane fraction. We conclude that in murine skin fibroblasts, FATP4 is the major enzyme producing very long chain fatty acid-CoA for lipid metabolic pathways. Although FATP4 deficiency primarily affected very long chain fatty acid metabolism, mutant fibroblasts also showed reduced uptake of a fluorescent long chain fatty acid and reduced levels of long chain polyunsaturated fatty acids. FATP4-deficient cells also contained abnormal neutral lipid droplets. These additional defects indicate that metabolic abnormalities in these cells are not limited to very long chain fatty acids.	Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Washington University (WUSTL)	Watkins, PA (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.	watkins@kennedykrieger.org		Watkins, Paul A./0000-0002-3246-1405	NIAMS NIH HHS [AR 49269] Funding Source: Medline; NICHD NIH HHS [HD 10981] Funding Source: Medline; NINDS NIH HHS [NS 37355] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037355] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Bonen A, 2002, MOL CELL BIOCHEM, V239, P181, DOI 10.1023/A:1020511125085; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; CONIGLIO JG, 1994, PROG LIPID RES, V33, P387, DOI 10.1016/0163-7827(94)90024-8; DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hamilton JA, 2002, MOL CELL BIOCHEM, V239, P17, DOI 10.1023/A:1020542220599; Hamilton JA, 2001, J MOL NEUROSCI, V16, P99, DOI 10.1385/JMN:16:2-3:99; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagerstedt SA, 2001, MOL GENET METAB, V73, P38, DOI 10.1006/mgme.2001.3170; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; MOORE SA, 1995, J LIPID RES, V36, P2433; Morita YS, 2000, SCIENCE, V288, P140, DOI 10.1126/science.288.5463.140; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser HW, 1991, TECHNIQUES DIAGNOSTI, P177; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Pei ZT, 2003, J BIOL CHEM, V278, P47070, DOI 10.1074/jbc.M310075200; POULOS A, 1995, LIPIDS, V30, P1, DOI 10.1007/BF02537036; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schmuth M, 2005, J INVEST DERMATOL, V125, P1174, DOI 10.1111/j.0022-202X.2005.23934.x; Sprecher H, 1999, LIPIDS, V34, pS153, DOI 10.1007/BF02562271; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Steinberg SJ, 2000, J BIOL CHEM, V275, P35162, DOI 10.1074/jbc.M006403200; Steinberg SJ, 1999, MOL GENET METAB, V68, P32, DOI 10.1006/mgme.1999.2883; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; STEWART ME, 1991, ADV LIPID RES, V24, P263; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; Watkins PA, 1997, PROG LIPID RES, V36, P55, DOI 10.1016/S0163-7827(97)00004-0; WATKINS PA, 1995, AM J HUM GENET, V57, P292; Wertz PW, 2000, ACTA DERM-VENEREOL, P7	49	84	87	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20573	20583		10.1074/jbc.M700568200	http://dx.doi.org/10.1074/jbc.M700568200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17522045	hybrid			2022-12-27	WOS:000247819300060
J	Maruyama, M; Hattori, A; Goto, Y; Ueda, M; Maeda, M; Fujiwara, H; Tsujimoto, M				Maruyama, Masato; Hattori, Akira; Goto, Yoshikuni; Ueda, Masamichi; Maeda, Michiyuki; Fujiwara, Hiroshi; Tsujimoto, Masafumi			Laeverin/aminopeptidase Q, a novel bestatin-sensitive leucine aminopeptidase belonging to the M1 family of aminopeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-REGULATED AMINOPEPTIDASE; PROTEIN-COUPLED RECEPTOR; HAMSTER OVARY CELLS; C-TERMINAL DOMAIN; OXYTOCINASE SUBFAMILY; TRIMS PRECURSORS; MATERNAL SERUM; ANGIOTENSIN-IV; EXPRESSION; IDENTIFICATION	Laeverin/aminopeptidase Q (APQ) is a cell surface protein specifically expressed on human embryo-derived extravillous trophoblasts that invades the uterus during placentation. The cDNA cloning of Laeverin/APQ revealed that the sequence encodes a protein with 990 amino acid residues, and Laeverin/APQ contains the HEXXHX18E gluzincin motif, which is characteristic of the M1 family of aminopeptidases, although the exopeptidase motif of the family, GAMEN, is uniquely substituted for the HAMEN sequence. In this study, we expressed a recombinant human Laeverin/APQ using a baculovirus expression system, purified to homogeneity, and characterized its enzymatic properties. It was found that Laeverin/APQ had a broad substrate specificity toward synthetic substrate, although it showed a preference for Leu-4-methylcoumaryl-7-amide. Searching natural substrates, we found that Laeverin/ APQ was able to cleave the N-terminal amino acid of several peptides such as angiotensin III, kisspeptin-10, and endokinin C, which are abundantly expressed in the placenta. In contrast to the case with other M1 aminopeptidases, bestatin inhibited the aminopeptidase activity of Laeverin/ APQ much more effectively than other known aminopeptidase inhibitors. These results indicate that Laeverin/ APQis a novel bestatin-sensitive leucine aminopeptidase and suggest that the enzyme plays important roles in human placentation by regulating biological activity of key peptides at the embryo- maternal interface.	RIKEN, Lab Cellular Biochem, Wako, Saitama 351, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 606, Japan; Redox Biosci Inc, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Fac Med, Dept Obstet & Gynecol, Sakyo Ku, Kyoto 606, Japan	RIKEN; Kyoto University; Kyoto University	Hattori, A (corresponding author), RIKEN, Lab Cellular Biochem, 2-1 Hirosawa, Wako, Saitama 351, Japan.	ahattori@riken.jp	FUJIWARA, Hiroshi/J-8401-2015	FUJIWARA, Hiroshi/0000-0003-3098-9406				Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; DANIELSEN EM, 1990, BIOCHEMISTRY-US, V29, P305, DOI 10.1021/bi00453a042; Fujiwara H, 2004, BIOCHEM BIOPH RES CO, V313, P962, DOI 10.1016/j.bbrc.2003.12.024; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Haas CS, 2006, ARTHRITIS RHEUM-US, V54, P2047, DOI 10.1002/art.21953; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Hattori A, 2000, J BIOCHEM-TOKYO, V128, P755, DOI 10.1093/oxfordjournals.jbchem.a022812; HOOPER NM, 1994, FEBS LETT, V31, P1; Ito N, 2004, BIOCHEM BIOPH RES CO, V314, P1008, DOI 10.1016/j.bbrc.2003.12.183; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Laustsen PG, 2001, EUR J BIOCHEM, V268, P98, DOI 10.1046/j.1432-1327.2001.01848.x; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; Matsumoto H, 2001, EUR J BIOCHEM, V268, P3259, DOI 10.1046/j.1432-1327.2001.02221.x; Miyashita H, 2002, BLOOD, V99, P3241, DOI 10.1182/blood.V99.9.3241; Nomura S, 2005, BBA-PROTEINS PROTEOM, V1751, P19, DOI 10.1016/j.bbapap.2005.04.006; Ofner LD, 2002, BIOCHEM J, V362, P191, DOI 10.1042/0264-6021:3620191; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; OKUYAMA T, 1991, CLIN CHIM ACTA, V196, P207, DOI 10.1016/0009-8981(91)90074-M; Osada T, 1999, J NEUROSCI, V19, P6068, DOI 10.1523/JNEUROSCI.19-14-06068.1999; Page NM, 2004, CELL MOL LIFE SCI, V61, P1652, DOI 10.1007/s00018-004-4035-x; Page NM, 2003, P NATL ACAD SCI USA, V100, P6245, DOI 10.1073/pnas.0931458100; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Rogi T, 1996, J BIOL CHEM, V271, P56, DOI 10.1074/jbc.271.1.56; Rozenfeld R, 2004, J BIOL CHEM, V279, P43285, DOI 10.1074/jbc.M404369200; SAFAVI A, 1995, J NEUROCHEM, V65, P389; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schomburg L, 1999, EUR J BIOCHEM, V265, P415, DOI 10.1046/j.1432-1327.1999.00753.x; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tobler AR, 1997, J NEUROCHEM, V68, P889; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Turner AJ, 2004, HDB PROTEOLYTIC ENZY, V1, P289; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Vonnahme KA, 2004, BIOL REPROD, V70, P132, DOI 10.1095/biolreprod.103.020412; WATANABE Y, 1995, BIOL CHEM H-S, V376, P397, DOI 10.1515/bchm3.1995.376.7.397; WU Q, 1991, P NATL ACAD SCI USA, V88, P676, DOI 10.1073/pnas.88.2.676; Xia Y, 2002, J BIOL CHEM, V277, P24601, DOI 10.1074/jbc.M201369200; Yamahara N, 2000, LIFE SCI, V66, P1401, DOI 10.1016/S0024-3205(00)00451-3; Yamamoto N, 2002, HUM MUTAT, V19, P251, DOI 10.1002/humu.10047; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	49	34	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20088	20096		10.1074/jbc.M702650200	http://dx.doi.org/10.1074/jbc.M702650200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17525158	hybrid			2022-12-27	WOS:000247819300009
J	Melkonian, KA; Maier, KC; Godfrey, JE; Rodgers, M; Schroer, TA				Melkonian, Karin A.; Maier, Kerstin C.; Godfrey, Jamie E.; Rodgers, Michael; Schroer, Trina A.			Mechanism of dynamitin-mediated disruption of dynactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEIN; MOLECULAR CHARACTERIZATION; CYTOPLASMIC DYNEIN; IN-VITRO; COMPLEX; TRANSPORT; COMPONENT; SUBUNIT; REVEALS; PURIFICATION	Dynamitin is a commonly used inhibitor of cytoplasmic dynein-based motility in living cells. Dynamitin does not inhibit dynein directly but instead acts by causing disassembly of dynactin, a multiprotein complex required for dynein-based movement. In dynactin, dynamitin is closely associated with the subunits p150(Glued) and p24, which together form the shoulder and projecting arm structures of the dynactin molecule. In this study, we explore the way in which exogenous dynamitin effects dynactin disruption. We find that pure, recombinant dynamitin is an elongated protein with a strong propensity for self-assembly. Titration experiments reveal that free dynamitin binds dynactin before it causes release of subunits. When dynamitin is added to dynactin at an equimolar ratio of exogenous dynamitin subunits to endogenous dynamitin subunits (1 x = 4 mol of exogenous dynamitin per mole of dynactin), exogenous dynamitin exchanges with endogenous dynamitin, and partial release of p150(Glued) is observed. When added in vast excess (>= 25 x; 100 mol of exogenous dynamitin per mole of dynactin), recombinant dynamitin causes complete release of both p150(Glued) subunits, two dynamitins and one p24, but not other dynactin subunits. Our data suggest that dynamitin mediates disruption of dynactin by binding to endogenous dynamitin subunits. This binding destabilizes the shoulder structure that links the p150(Glued) arm to the Arp1 filament and leads to subunit release.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Schroer, TA (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	schroer@jhu.edu		Schroer, Trina/0000-0002-5065-1835	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044589, R56GM044589] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044589, GM44589] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; COHN EJ, 1943, PROTEINS AMINO ACIDS, V370; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Demeler B, 1998, BIOPHYS J, V74, P444, DOI 10.1016/S0006-3495(98)77802-6; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Hodgkinson JL, 2005, P NATL ACAD SCI USA, V102, P3667, DOI 10.1073/pnas.0409506102; Holleran EA, 1998, INT REV CYTOL, V182, P69, DOI 10.1016/S0074-7696(08)62168-3; Imai H, 2006, J MOL BIOL, V359, P833, DOI 10.1016/j.jmb.2006.03.071; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LESSARD JL, 1988, CELL MOTIL CYTOSKEL, V10, P349, DOI 10.1002/cm.970100302; Pfister KK, 1998, CELL MOTIL CYTOSKEL, V41, P154, DOI 10.1002/(SICI)1097-0169(1998)41:2<154::AID-CM6>3.0.CO;2-E; POLLARD TD, 1984, J CELL BIOL, V99, P1970, DOI 10.1083/jcb.99.6.1970; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; van Holde K. E., 1998, PRINCIPLE PHYS BIOCH, P192; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wittmann T, 1999, METHOD CELL BIOL, V61, P137	34	58	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19355	19364		10.1074/jbc.M700003200	http://dx.doi.org/10.1074/jbc.M700003200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17449914	hybrid			2022-12-27	WOS:000247650600010
J	Rydziel, S; Stadmeyer, L; Zanotti, S; Durant, D; Smerdel-Ramoya, A; Canalis, E				Rydziel, Sheila; Stadmeyer, Lisa; Zanotti, Stefano; Durant, Deena; Smerdel-Ramoya, Anna; Canalis, Ernesto			Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MORPHOGENETIC-PROTEIN; MARROW STROMAL CELLS; TWISTED-GASTRULATION; SIGNALING PATHWAYS; BMP ANTAGONIST; BETA-CATENIN; TGF-BETA; OSTEOCALCIN GENE; STEM-CELLS; IN-VITRO	Nephroblastoma overexpressed (Nov), a member of the Cyr 61, connective tissue growth factor, Nov (CCN) family of proteins, is expressed by osteoblasts, but its function in cells of the osteoblastic lineage is not known. We investigated the effects of Nov overexpression by transducing murine ST-2 stromal and MC3T3 osteoblastic cells with a retroviral vector where Nov is under the control of the cytomegalovirus promoter. We also examined the skeletal phenotype of transgenic mice expressing Nov under the control of the human osteocalcin promoter. Overexpression of Nov in ST-2 cells inhibited the appearance of mineralized nodules and decreased alkaline phosphatase activity and osteocalcin mRNA levels. Nov overexpression inhibited the effect of bone morphogenetic protein (BMP)-2 on the phosphorylation of Smad 1/5/8; on the transactivation of 12xSBE-Oc-pGL3, a BMP/Smad signaling reporter construct, and of Wnt 3 on cytoplasmic beta-catenin levels; and on the transactivation of the Wnt/beta- catenin signaling reporter construct 16xTCF-Luc. Nov overexpression did not activate Notch or transforming growth factor beta signaling. Glutathione S-transferase pulldown assays demonstrated direct Nov-BMP interactions. Nov transgenic mice exhibited osteopenia. In conclusion, Nov binds BMP-2 and antagonizes BMP-2 and Wnt activity, and its overexpression inhibits osteoblastogenesis and causes osteopenia.	St Francis Hosp & Med Ctr, Med Ctr, Dept Res, Hartford, CT 06105 USA	Saint Francis Hospital & Medical Center	Canalis, E (corresponding author), St Francis Hosp & Med Ctr, Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	ecanalis@stfranciscare.org	Zanotti, Stefano/C-6006-2009		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR021707, R01AR021707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR21707, R01 AR021707] Funding Source: Medline; NIDDK NIH HHS [DK45227] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Calhabeua F, 2006, EXP CELL RES, V312, P1876, DOI 10.1016/j.yexcr.2006.02.027; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Frenkel B, 1997, ENDOCRINOLOGY, V138, P2109, DOI 10.1210/en.138.5.2109; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P3875, DOI 10.1210/en.2005-0053; Gazzerro E, 1999, ENDOCRINOLOGY, V140, P562, DOI 10.1210/en.140.2.562; Gazzerro E, 2006, BONE, V39, P1252, DOI 10.1016/j.bone.2006.06.028; Gellhaus A, 2004, J BIOL CHEM, V279, P36931, DOI 10.1074/jbc.M404073200; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; HARRIS SE, 1994, J BONE MINER RES, V9, P389; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafont J, 2005, J BONE MINER RES, V20, P2213, DOI 10.1359/JBMR.050818; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Nosaka T, 2003, MOL CELL BIOL, V23, P2969, DOI 10.1128/MCB.23.8.2969-2980.2003; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Pereira RC, 2000, J CELL PHYSIOL, V182, P239, DOI 10.1002/(SICI)1097-4652(200002)182:2<239::AID-JCP13>3.0.CO;2-W; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sims NA, 1997, MOL ENDOCRINOL, V11, P1695, DOI 10.1210/me.11.11.1695; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200	70	58	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19762	19772		10.1074/jbc.M700212200	http://dx.doi.org/10.1074/jbc.M700212200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500060	hybrid			2022-12-27	WOS:000247650600051
J	Mies, F; Spriet, C; Heliot, L; Sariban-Sohraby, S				Mies, Frederique; Spriet, Corentin; Heliot, Laurent; Sariban-Sohraby, Sarah			Epithelial Na+ channel stimulation by n-3 fatty acids requires proximity to a membrane-bound A-kinase-anchoring protein complexed with protein kinase A and phosphodiesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID; LIVING CELLS; CA2+ CURRENT; CAMP; CURRENTS; ACTIVATION; PHOSPHORYLATION; AQUAPORIN-2; INHIBITION; TRANSPORT	Essential polyunsatured fatty acids have been shown to modulate enzymes, channels and transporters, to interact with lipid bilayers and to affect metabolic pathways. We have previously shown that eicosapentanoic acid (EPA, C20:5, n-3) activates epithelial sodium channels (ENaCs) in a cAMP-dependent manner involving stimulation of cAMP-dependent protein kinase (PKA). In the present study, we explored further the mechanism of EPA stimulation of ENaC in A6 cells. Fluorescence resonance energy transfer experiments confirmed activation of PKA by EPA. Consistent with our previous studies, EPA had no further stimulatory effect on amiloride-sensitive transepithelial current (I-Na) in the presence of CPT-cAMP. Thus, we investigated the effect of EPA on cellular pathways which produce cAMP. EPA did not stimulate adenylate cyclase activity or total cellular cAMP accumulation. However, membrane-bound phosphodiesterase activity was inhibited by EPA from 2.46 pmol/mg of protein/min to 1.3 pmol/mg of protein/min. To investigate the potential role of an A-kinase-anchoring protein (AKAP), we used HT31, an inhibitor of the binding between PKA and AKAPs as well as cerulenin, an inhibitor of myristoylation and palmitoylation. Both agents prevented the stimulatory effect of EPA and CPT-cAMP on I-Na and drastically decreased the amount of PKA in the apical membrane. Colocalization experiments in A6 cells cotransfected with fluorescently labeled ENaC beta subunit and PKA regulatory subunit confirmed the close proximity of the two proteins and the membrane anchorage of PKA. Last, in A6 cells transfected with a dead mutant of Sgk, an enzyme which up-regulates ENaCs, EPA did not stimulate Na+ current. Our results suggest that stimulation of ENaCs by EPA occurs via SGK in membrane-bound compartments containing an AKAP, activated PKA, and a phosphodiesterase.	Univ Libre Bruxelles, Dept Phys, B-1070 Brussels, Belgium; Interdisciplinary Res Inst, Biophoton Cellulaire Fonctionnelle, F-59021 Lille, France	Universite Libre de Bruxelles	Sariban-Sohraby, S (corresponding author), NIH, Bldg 31,Rm 6A22, Bethesda, MD 20892 USA.	sohrabys@nei.nih.gov	Spriet, Corentin/ABE-4215-2021	Spriet, Corentin/0000-0002-5805-3426				Ali S, 1998, P NATL ACAD SCI USA, V95, P10274, DOI 10.1073/pnas.95.17.10274; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Bengrine A, 2007, FASEB J, V21, P1189, DOI 10.1096/fj.06-6046com; Bringmann A, 2001, GRAEF ARCH CLIN EXP, V239, P859, DOI 10.1007/s004170100372; Camuzeaux B, 2005, BIOCHEM BIOPH RES CO, V332, P1107, DOI 10.1016/j.bbrc.2005.05.057; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Faletti CJ, 2002, AM J PHYSIOL-CELL PH, V282, pC494, DOI 10.1152/ajpcell.00408.2001; Ferrier GR, 2002, CARDIOVASC RES, V54, P601, DOI 10.1016/S0008-6363(02)00275-4; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Henn V, 2005, BIOCHEM SOC T, V33, P1316, DOI 10.1042/BST0331316; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hong MP, 2004, BRAIN RES, V1008, P81, DOI 10.1016/j.brainres.2004.02.033; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Leaf A, 1998, Curr Opin Clin Nutr Metab Care, V1, P225, DOI 10.1097/00075197-199803000-00014; Leaf A, 1999, J NUTR BIOCHEM, V10, P440, DOI 10.1016/S0955-2863(99)00034-0; Liu LW, 2000, J PHYSIOL-LONDON, V525, P391, DOI 10.1111/j.1469-7793.2000.00391.x; MATSUMOTO PS, 1993, AM J PHYSIOL, V264, pC246, DOI 10.1152/ajpcell.1993.264.1.C246; Mies F, 2004, AM J PHYSIOL-RENAL, V287, pF850, DOI 10.1152/ajprenal.00078.2004; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Rychkov GY, 2005, BIOCHEM J, V385, P551, DOI 10.1042/BJ20041604; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Schonfeld P, 2004, J BIOENERG BIOMEMBR, V36, P241, DOI 10.1023/B:JOBB.0000031975.72350.c6; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Tibbs VC, 1998, J BIOL CHEM, V273, P25783, DOI 10.1074/jbc.273.40.25783; Trotter KW, 1999, J CELL BIOL, V147, P1481, DOI 10.1083/jcb.147.7.1481; Waharte F, 2006, CYTOM PART A, V69A, P299, DOI 10.1002/cyto.a.20240; WARRIE RS, 2005, AM J PHYSIOL, V289, pC455; Wells J N, 1977, Adv Cyclic Nucleotide Res, V8, P119; Wu P, 2004, P NATL ACAD SCI USA, V101, P17634, DOI 10.1073/pnas.0407649101; Xiao YF, 2004, BIOCHEM BIOPH RES CO, V321, P116, DOI 10.1016/j.bbrc.2004.06.114	39	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18339	18347		10.1074/jbc.M611160200	http://dx.doi.org/10.1074/jbc.M611160200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17478424	hybrid			2022-12-27	WOS:000247302000040
J	Vingtdeux, V; Hamdane, M; Loyens, A; Gele, P; Drobeck, H; Begard, S; Galas, MC; Delacourte, A; Beauvillain, JC; Buee, L; Sergeant, N				Vingtdeux, Valerie; Hamdane, Malika; Loyens, Anne; Gele, Patrick; Drobeck, Herve; Begard, Severine; Galas, Marie-Christine; Delacourte, Andre; Beauvillain, Jean-Claude; Buee, Luc; Sergeant, Nicolas			Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE COMPLEX; VACUOLAR H+-ATPASE; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; TERMINAL FRAGMENTS; BETA-SECRETASE; PROTEOMIC ANALYSIS; TRANSGENIC MICE; LIPID RAFTS; EXOSOMES	Amyloid precursor protein (APP) metabolism is central to the pathogenesis of Alzheimer disease. We showed recently that the amyloid intracellular domain (AICD), which is released by gamma-secretase cleavage of APP C-terminal fragments (CTFs), is strongly increased in cells treated with alkalizing drugs (Vingtdeux, V., Hamdane, M., Begard, S., Loyens, A., Delacourte, A., Beauvillain, J.- C., Buee, L., Marambaud, P., and Sergeant, N. (2007) Neurobiol. Dis. 25, 686-696). Herein, we aimed to determine the cell compartment in which AICD accumulates. We show that APP-CTFs and AICD are present in multivesicular structures. Multivesicular bodies contain intraluminal vesicles (known as exosomes) when released in the extracellular space. We demonstrate that APP, APP-CTFs, and AICD are integrated and secreted within exosomes in differentiated neuroblastoma and primary neuronal culture cells. Together with recent data showing that amyloid-beta is also found in exosomes, our data show that multivesicular bodies are essential organelles for APP metabolism and that all APP metabolites can be secreted in the extracellular space.	Univ Lille 2, Ctr Rech Jean Pierre Aubert, INSERM, U837, F-59045 Lille, France; Univ Lille 2, Ctr Rech Jean Pierre Aubert, Inst Med Predict & Rech Rheapeut, Fac Med, F-59045 Lille, France; Univ Lille 1, CNRS, Inst Pasteur, UMR 8161, F-59021 Lille, France; Univ Lille 1, CNRS, Inst Biol, UMR 8161, F-59021 Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Sergeant, N (corresponding author), INSERM, U837, Jean Pierre Auabert Res Ctr, 1,Place de Verdun, F-59045 Lille, France.	sergeant@lille.inserm.fr	Sergeant, Nicolas/O-5467-2017; Galas, Marie-Christine/AAL-9812-2020; BUEE, Luc/B-3126-2010; Vingtdeux, Valerie/C-2463-2012	Sergeant, Nicolas/0000-0003-1448-124X; BUEE, Luc/0000-0002-6261-4230; Vingtdeux, Valerie/0000-0003-4550-503X; Hamdane, Malika/0000-0001-7971-8696; Galas, Marie-Christine/0000-0002-3766-7103				Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Chen TY, 2006, BIOCHEM BIOPH RES CO, V342, P266, DOI 10.1016/j.bbrc.2006.01.156; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; Efthimiopoulos S, 1996, P NATL ACAD SCI USA, V93, P8046, DOI 10.1073/pnas.93.15.8046; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; Johnstone RM, 2005, BLOOD CELL MOL DIS, V34, P214, DOI 10.1016/j.bcmd.2005.03.002; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SchraderFischer G, 1996, BRAIN RES, V716, P91, DOI 10.1016/0006-8993(96)00002-9; Segura E, 2005, BLOOD CELL MOL DIS, V35, P89, DOI 10.1016/j.bcmd.2005.05.003; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Sergeant N, 2002, J NEUROCHEM, V81, P663, DOI 10.1046/j.1471-4159.2002.00901.x; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tezapsidis N, 1998, BIOCHEMISTRY-US, V37, P1274, DOI 10.1021/bi9714159; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; vanDeurs B, 1996, EUR J CELL BIOL, V69, P343; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verbeek MM, 2002, J HISTOCHEM CYTOCHEM, V50, P681, DOI 10.1177/002215540205000509; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vingtdeux V, 2005, NEUROBIOL DIS, V20, P625, DOI 10.1016/j.nbd.2005.05.004; Vingtdeux V, 2007, NEUROBIOL DIS, V25, P686, DOI 10.1016/j.nbd.2006.09.019; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	58	144	146	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18197	18205		10.1074/jbc.M609475200	http://dx.doi.org/10.1074/jbc.M609475200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17468104	hybrid			2022-12-27	WOS:000247302000026
J	Thakurta, AG; Selvanathan, SP; Patterson, AD; Gopal, G; Dhar, R				Thakurta, Anjan G.; Selvanathan, Saravana P.; Patterson, Andrew D.; Gopal, Ganesh; Dhar, Ravi			The nuclear export signal of splicing factor Uap56p interacts with nuclear pore-associated protein Rae1p for mRNA export in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION FACTOR-4A; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; COMPLEX; HOMOLOG; TRANSCRIPTION; MACHINERY; MEX67P; YRA1P; SUB2P	Mammalian UAP56 or its homolog Sub2p in Saccharomyces cerevisiae are members of the ATP-dependent RNA helicase family and are required for splicing and nuclear export of mRNA. Previously we showed that in Schizosaccharomyces pombe Uap56p is critical for mRNA export. It links the mRNA adapter Mlo3p, a homolog of Yra1p in S. cerevisiae or Aly in mammals, to nuclear pore-associated mRNA export factor Rae1p. In this study we show that, in contrast to S. cerevisiae, Uap56p in S. pombe is not required for pre-mRNA splicing. The putative RNA helicase function of Uap56p is not required for mRNA export. However, the RNA-binding motif of Uap56p is critical for nuclear export of mRNA. Within Uap56p we identified nuclear import and export signals that may allow it to shuttle between the nucleus and the cytoplasm. Wefound that Uap56p interacts with Rae1p directly via its nuclear export signal, and this interaction is critical for the nuclear export activity of Uap56p as well as for exporting mRNA. RNA binding and the ability to shuttle between the nucleus and cytoplasm are important features of mRNA export carriers such as HIV-Rev. Our results suggest that Uap56p could function similarly as an export carrier of mRNA in S. pombe.	NCI, Basic Res Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; NCI, Metab Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; NIGMS, Pharmacol Res Associate Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)	Dhar, R (corresponding author), NCI, Basic Res Lab, Canc Res Ctr, NIH, Bldg 37,Rm 5016,37 Convent Dr,9000 Rockville Pike, Bethesda, MD 20892 USA.	dharr@mail.nih.gov	Patterson, Andrew/ABF-1575-2020; Patterson, Andrew/G-3852-2012	Patterson, Andrew/0000-0003-2073-0070; Patterson, Andrew/0000-0003-2073-0070	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alfa C., 1993, EXPT FISSION YEAST; AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kaufer NF, 2000, NUCLEIC ACIDS RES, V28, P3003, DOI 10.1093/nar/28.16.3003; Kiesler E, 2002, CURR BIOL, V12, P859, DOI 10.1016/S0960-9822(02)00840-0; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Kozak L, 2002, J BIOL CHEM, V277, P33580, DOI 10.1074/jbc.M205415200; Kunzler M, 1998, FEBS LETT, V433, P185, DOI 10.1016/S0014-5793(98)00892-8; Lei EP, 2002, GENE DEV, V16, P2761, DOI 10.1101/gad.1032902; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Partridge JF, 2000, GENE DEV, V14, P783; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SCHMID SR, 1991, MOL CELL BIOL, V11, P3463, DOI 10.1128/MCB.11.7.3463; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Thakurta AG, 2004, J BIOL CHEM, V279, P17434, DOI 10.1074/jbc.M309731200; Thakurta AG, 2005, EMBO J, V24, P2512, DOI 10.1038/sj.emboj.7600713; Thakurta AG, 2002, MOL BIOL CELL, V13, P2571, DOI 10.1091/mbc.E01-11-0133; Whalen WA, 1999, GENETICS, V152, P827; Yoon JH, 2000, MOL CELL BIOL, V20, P8767, DOI 10.1128/MCB.20.23.8767-8782.2000; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	33	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17507	17516		10.1074/jbc.M609727200	http://dx.doi.org/10.1074/jbc.M609727200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17449473	hybrid			2022-12-27	WOS:000247084500021
J	Waxman, EA; Baconguis, I; Lynch, DR; Robinson, MB				Waxman, Elisa A.; Baconguis, Isabelle; Lynch, David R.; Robinson, Michael B.			N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; DIFFERENTIAL SYNAPTIC LOCALIZATION; CELL-SURFACE EXPRESSION; GLYCINE TRANSPORTER; HIPPOCAMPAL CA1; NMDA RECEPTORS; POSTSYNAPTIC DENSITY-95; MEDIATED RESPONSES; MACAQUE MONKEY	The neuronal transporter excitatory amino acid carrier 1 ( EAAC1) is enriched in perisynaptic regions, where it may regulate synaptic spillover of glutamate. In this study we examined potential interactions between EAAC1 and ionotropic glutamate receptors. N-Methyl-D-aspartate ( NMDA) receptor subunits NR1, NR2A, and NR2B, but not the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunit GluR2, were co-immunoprecipitated with EAAC1 from neuron-enriched hippocampal cultures. A similar interaction was observed in C6 glioma and human embryonic kidney cells after co-transfection with Myc epitope-tagged EAAC1 and NMDA receptor subunits. Co-transfection of C6 glioma with the combination of NR1 and NR2 subunits dramatically increased ( similar to 3-fold) the amount of Myc-EAAC1 that can be labeled with a membrane-impermeable biotinylating reagent. In hippocampal cultures, brief ( 5 min), robust ( 100 mu M NMDA, 10 mu M glycine) activation of the NMDA receptor decreased biotinylated EAAC1 to similar to 50% of control levels. This effect was inhibited by an NMDA receptor antagonist, intracellular or extracellular calcium chelators, or hypertonic sucrose. Glutamate, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid with cyclothiazide, and thapsigargin mimicked the effects of NMDA. These studies suggest that NMDA receptors interact with EAAC1, facilitate cell surface expression of EAAC1 under basal conditions, and control internalization of EAAC1 upon activation. ThisNMDAreceptor-dependent regulation of EAAC1 provides a novel mechanism that may shape excitatory signaling during synaptic plasticity and/or excitotoxicity.	Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Lynch, DR (corresponding author), Childrens Hosp Philadelphia, Dept Pharmacol, 502 Abramson Bldg,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	lynch@pharm.med.upenn.edu	Baconguis, Isabelle/AAH-3790-2021	Baconguis, Isabelle/0000-0002-5440-2289; Waxman, Elisa/0000-0003-4562-7969	NINDS NIH HHS [NS39011, NS45986] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS045986, R01NS039011, R01NS045986] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amara S G, 1998, Adv Pharmacol, V42, P164; Ambrosio AF, 2000, EUR J NEUROSCI, V12, P2021, DOI 10.1046/j.1460-9568.2000.00091.x; ANEGAWA NJ, 1995, J NEUROCHEM, V64, P2004; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BECKMAN ML, 2005, 35 ANN M SOC NEUR NO; BENVENISTE H, 1989, J CEREBR BLOOD F MET, V9, P629, DOI 10.1038/jcbfm.1989.90; Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Brustovetsky T, 2004, EXP NEUROL, V189, P222, DOI 10.1016/j.expneurol.2004.03.021; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen L, 2003, J NEUROPHYSIOL, V89, P691, DOI 10.1152/jn.00680.2002; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; Cubelos B, 2005, J NEUROCHEM, V95, P1047, DOI 10.1111/j.1471-4159.2005.03438.x; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dong YN, 2006, J NEUROCHEM, V99, P206, DOI 10.1111/j.1471-4159.2006.04096.x; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; Gebhardt C, 2002, J CEREBR BLOOD F MET, V22, P569, DOI 10.1097/00004647-200205000-00008; Gonzalez MI, 2002, MOL PHARMACOL, V62, P901, DOI 10.1124/mol.62.4.901; Grant ER, 1997, J BIOL CHEM, V272, P647; Guillet B, 2002, NEUROCHEM INT, V40, P661, DOI 10.1016/S0197-0186(01)00110-3; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hanley JG, 2000, J BIOL CHEM, V275, P840, DOI 10.1074/jbc.275.2.840; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harney SC, 2006, J NEUROSCI, V26, P1128, DOI 10.1523/JNEUROSCI.2753-05.2006; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; He Y, 2001, NEUROSCI LETT, V311, P161, DOI 10.1016/S0304-3940(01)02180-2; He Y, 2000, J COMP NEUROL, V418, P255; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Huang CC, 2006, J NEUROCHEM, V96, P179, DOI 10.1111/j.1471-4159.2005.03527.x; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Jensen JB, 1998, NEUROCHEM INT, V32, P505, DOI 10.1016/S0197-0186(97)00130-7; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lynch DR, 2001, CURR DRUG TARGETS, V2, P215, DOI 10.2174/1389450013348434; LYNCH DR, 1994, MOL PHARMACOL, V45, P540; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin Sally, 1999, Cell Biochemistry and Biophysics, V30, P89, DOI 10.1007/BF02737886; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mitani A, 1998, J CEREBR BLOOD F MET, V18, P1088, DOI 10.1097/00004647-199810000-00005; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Najimi M, 2005, BBA-BIOMEMBRANES, V1668, P195, DOI 10.1016/j.bbamem.2004.12.008; Najimi M, 2002, FEBS LETT, V523, P224, DOI 10.1016/S0014-5793(02)02981-2; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; O'Donnell LA, 2006, J NEUROSCI, V26, P981, DOI 10.1523/JNEUROSCI.4617-05.2006; Okada T, 1999, EUR J NEUROSCI, V11, P1085, DOI 10.1046/j.1460-9568.1999.00516.x; Palos TP, 1996, MOL BRAIN RES, V37, P297, DOI 10.1016/0169-328X(95)00331-L; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Robinson MB, 1998, NEUROCHEM INT, V33, P479, DOI 10.1016/S0197-0186(98)00055-2; Roettger V, 1996, NEUROSCIENCE, V75, P677, DOI 10.1016/0306-4522(96)00314-4; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Sheldon AL, 2006, J BIOL CHEM, V281, P4876, DOI 10.1074/jbc.M504983200; Sims KD, 1999, CRIT REV NEUROBIOL, V13, P169, DOI 10.1615/CritRevNeurobiol.v13.i2.30; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Supplisson S, 1997, J NEUROSCI, V17, P4580; Tovar KR, 1999, J NEUROSCI, V19, P4180; Toyoda H, 2005, EUR J NEUROSCI, V22, P485, DOI 10.1111/j.1460-9568.2005.04236.x; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; WILCOX KS, 1994, SYNAPSE, V18, P128, DOI 10.1002/syn.890180206; Yang YX, 2004, J NEUROCHEM, V88, P1361, DOI 10.1046/j.1471-4159.2003.02279.x; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zuo ZY, 2005, J EXP BIOL, V208, P2063, DOI 10.1242/jeb.01595	82	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17594	17607		10.1074/jbc.M702278200	http://dx.doi.org/10.1074/jbc.M702278200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17459877	hybrid			2022-12-27	WOS:000247084500031
J	Wu, R; Kausar, H; Johnson, P; Montoya-Durango, DE; Merchant, M; Rane, MJ				Wu, Rui; Kausar, Hina; Johnson, Paul; Montoya-Durango, Diego E.; Merchant, Michael; Rane, Madhavi J.			Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HEAT-SHOCK-PROTEIN-70 INHIBITS APOPTOSIS; C-DEPENDENT ACTIVATION; CELL-SURVIVAL PATHWAY; P38 MAP KINASE; CYTOCHROME-C; ACTIN REORGANIZATION; NEGATIVE REGULATION; APAF-1 APOPTOSOME; HUMAN NEUTROPHILS	We have shown previously that Akt exists in a signal complex with p38 MAPK, MAPK-activated protein kinase-2 (MK2), and heat shock protein 27 (Hsp27) and MK2 phosphorylates Akt on Ser-473. Additionally, dissociation of Hsp27 from Akt, prior to Akt activation, induced polymorphonuclear leukocyte (PMN) apoptosis. However, the role of Hsp27 in regulating Akt activation was not examined. This study tested the hypothesis that Hsp27 regulates Akt activation and promotes cell survival by scaffolding MK2 to the Akt signal complex. Here we show that loss of Akt/Hsp27 interaction by anti-Hsp27 antibody treatment resulted in loss of Akt/MK2 interaction, loss of Akt-Ser-473 phosphorylation, and induced PMN apoptosis. Transfection of myristoylated Akt (AktCA) in HK-11 cells induced Akt-Ser-473 phosphorylation, activation, and Hsp27-Ser-82 phosphorylation. Co-transfection of AktCA with Hsp27 short interfering RNA, but not scrambled short interfering RNA, silenced Hsp27 expression, without altering Akt expression in HK-11 cells. Silencing Hsp27 expression inhibited Akt/MK2 interaction, inhibited Akt phosphorylation and Akt activation, and induced HK-11 cell death. Deletion mutagenesis studies identified acidic linker region (amino acids 117-128) on Akt as an Hsp27 binding region. Deletion of amino acids 117-128 on Akt resulted in loss of its interaction with Hsp27 and MK2 but not with Hsp90 as demonstrated by immunoprecipitation and glutathione S-transferase pulldown studies. Co-transfection studies demonstrated that constitutively activeMK2(MK2EE) phosphorylated Aktwt (wild type) on Ser-473 but failed to phosphorylate Akt(Delta 117-128) mutant in transfixed cells. These studies collectively define a novel role of Hsp27 in regulating Akt activation and cellular apoptosis by mediating interaction between Akt and its upstream activator MK2.	Univ Louisville, Dept Med, Louisville, KY 40202 USA; Univ Louisville, Dept Biochem, Louisville, KY 40202 USA; Univ Louisville, Dept Mol Biol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Rane, MJ (corresponding author), Univ Louisville, Dept Med, 570 S Preston St,Baxter 1 Bldg S 102C, Louisville, KY 40202 USA.	mjrane01@gwise.louisville.edu	Merchant, Michael/F-7109-2013; Merchant, Michael L/N-7444-2013	Merchant, Michael L/0000-0003-4128-4057	NIAID NIH HHS [1 R56 AI059165-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059165] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414; Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bruey JM, 2000, ONCOGENE, V19, P4855, DOI 10.1038/sj.onc.1203850; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Cappellini A, 2005, APOPTOSIS, V10, P141, DOI 10.1007/s10495-005-6069-4; Chang-Liao KS, 2001, ELEC SOC S, V2001, P1; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Chauhan D, 2003, BLOOD, V102, P3379, DOI 10.1182/blood-2003-05-1417; de Graauw M, 2005, J BIOL CHEM, V280, P29885, DOI 10.1074/jbc.M412708200; Efthymiou CA, 2004, BASIC RES CARDIOL, V99, P392, DOI 10.1007/s00395-004-0483-6; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Garrido C, 1996, EUR J BIOCHEM, V237, P653, DOI 10.1111/j.1432-1033.1996.0653p.x; Garrido C, 1998, CANCER RES, V58, P5495; Garrido C, 1997, CANCER RES, V57, P2661; Gozal E, 2005, AM J PHYSIOL-CELL PH, V288, pC535, DOI 10.1152/ajpcell.00270.2004; Hansen RK, 2001, BIOCHEM BIOPH RES CO, V282, P186, DOI 10.1006/bbrc.2001.4548; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Khundmiri SJ, 2005, J AM SOC NEPHROL, V16, P2598, DOI 10.1681/ASN.2004121049; Klein JB, 2001, CELL SIGNAL, V13, P335, DOI 10.1016/S0898-6568(01)00151-6; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lee YJ, 2005, J BIOL CHEM, V280, P18108, DOI 10.1074/jbc.M501131200; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Nakajima K, 2005, LIFE SCI, V77, P96, DOI 10.1016/j.lfs.2004.12.017; Okamoto CT, 1999, AM J PHYSIOL-CELL PH, V277, pC1029; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Piotrowicz RS, 1998, FASEB J, V12, P1481, DOI 10.1096/fasebj.12.14.1481; Pivovarova AV, 2005, BIOCHEM BIOPH RES CO, V331, P1548, DOI 10.1016/j.bbrc.2005.04.077; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schepers H, 2005, EXP HEMATOL, V33, P660, DOI 10.1016/j.exphem.2005.03.009; Sheth K, 2001, J SURG RES, V99, P129, DOI 10.1006/jsre.2000.6100; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Son GH, 2005, BIOCHEM BIOPH RES CO, V338, P1751, DOI 10.1016/j.bbrc.2005.10.152; Souza K, 2001, MOL MED, V7, P767, DOI 10.1007/BF03401967; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; VENKATAKRISHNAN CD, 2006, AM J PHYSIOL, V291, pH2980; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Zhang QS, 2001, INT J ONCOL, V19, P1057; Zhang SXL, 2003, FASEB J, V17, P1709, DOI 10.1096/fj.02-1111fje; Zheng CL, 2006, J BIOL CHEM, V281, P37215, DOI 10.1074/jbc.M603622200	60	113	123	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21598	21608		10.1074/jbc.M611316200	http://dx.doi.org/10.1074/jbc.M611316200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17510053	hybrid			2022-12-27	WOS:000248196800006
J	Beinrohr, L; Harmat, V; Dobo, J; Lorincz, Z; Gal, P; Zavodszky, P				Beinrohr, Laszlo; Harmat, Veronika; Dobo, Jozsef; Loerincz, Zsolt; Gal, Peter; Zavodszky, Peter			C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; HUMAN-COMPLEMENT; DEXTRAN SULFATE; HUMAN C1-INHIBITOR; CRYSTAL-STRUCTURES; SYSTEM PROTEASES; C1BAR INHIBITOR; TERNARY COMPLEX; FACTOR XIA; IN-VIVO	C1 inhibitor, a member of the serpin family, is a major down-regulator of inflammatory processes in blood. Genetic deficiency of C1 inhibitor results in hereditary angioedema, a dominantly inheritable, potentially lethal disease. Here we report the first crystal structure of the serpin domain of human C1 inhibitor, representing a previously unreported latent form, which explains functional consequences of several naturally occurring mutations, two of which are discussed in detail. The presented structure displays a novel conformation with a seven-stranded beta-sheet A. The unique conformation of the C-terminal six residues suggests its potential role as a barrier in the active-latent transition. On the basis of surface charge pattern, heparin affinity measurements, and docking of a heparin disaccharide, a heparin binding site is proposed in the contact area of the serpin-proteinase encounter complex. We show how polyanions change the activity of the C1 inhibitor by a novel "sandwich" mechanism, explaining earlier reaction kinetic and mutagenesis studies. These results may help to improve therapeutic C1 inhibitor preparations used in the treatment of hereditary angioedema, organ transplant rejection, and heart attack.	Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary; Eotvos Lorand Univ, Hungarian Acad Sci, Inst Chem, Lab Struct Chem & Biol, H-1117 Budapest, Hungary; Eotvos Lorand Univ, Hungarian Acad Sci, Inst Chem, Protein Modeling Grp, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences	Beinrohr, L (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, Karolina Ut 29, H-1113 Budapest, Hungary.	lbeinrohr@enzim.hu; gal@enzim.hu; zxp@enzim.hu	Zavodszky, Peter/C-1214-2008; Dobo, Jozsef/C-7331-2014; Harmat, Veronika/B-8033-2016; Gal, Peter/B-5886-2011	Harmat, Veronika/0000-0002-1866-9904; Dobo, Jozsef/0000-0001-9187-8502				AULAK KS, 1993, J BIOL CHEM, V268, P18088; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bos I.G.A.C., 2003, C1 INHIBITOR POTENTI; Bos IGA, 2003, J BIOL CHEM, V278, P29463, DOI 10.1074/jbc.M302977200; Bos IGA, 2002, IMMUNOBIOLOGY, V205, P518, DOI 10.1078/0171-2985-00151; Bos IGAC, 2001, INT IMMUNOPHARMACOL, V1, P1583, DOI 10.1016/S1567-5769(01)00073-X; Bowen T, 2004, J ALLERGY CLIN IMMUN, V114, P629, DOI 10.1016/j.jaci.2004.06.043; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Cai SH, 2003, J IMMUNOL, V171, P4786, DOI 10.4049/jimmunol.171.9.4786; Caldwell EEO, 1999, ARCH BIOCHEM BIOPHYS, V361, P215, DOI 10.1006/abbi.1998.0996; Caliezi C, 2000, PHARMACOL REV, V52, P91; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; CAUGHMAN GB, 1982, MOL IMMUNOL, V19, P287, DOI 10.1016/0161-5890(82)90342-X; COUTINHO M, 1994, J IMMUNOL, V153, P3648; Cumming SA, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e114; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; ELDERING E, 1995, J BIOL CHEM, V270, P2579, DOI 10.1074/jbc.270.6.2579; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; GADEK JE, 1980, NEW ENGL J MED, V302, P542, DOI 10.1056/NEJM198003063021002; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gozzo AJ, 2003, BRAZ J MED BIOL RES, V36, P1055, DOI 10.1590/S0100-879X2003000800011; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Huntington JA, 2003, STRUCTURE, V11, P205, DOI 10.1016/S0969-2126(02)00944-9; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Im H, 2002, J BIOL CHEM, V277, P46347, DOI 10.1074/jbc.M207682200; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; Jin L, 2005, J BIOL CHEM, V280, P4704, DOI 10.1074/jbc.M411309200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalmar L, 2005, HUM MUTAT, V25, P1, DOI 10.1002/humu.20112; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Liu DX, 2003, J IMMUNOL, V171, P2594, DOI 10.4049/jimmunol.171.5.2594; Mauron T, 1998, THROMB HAEMOSTASIS, V80, P82, DOI 10.1055/s-0037-1615143; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUIJENS JH, 1989, J CLIN INVEST, V84, P443, DOI 10.1172/JCI114185; ODERMATT E, 1981, FEBS LETT, V131, P283, DOI 10.1016/0014-5793(81)80385-7; PATSTON PA, 1995, FEBS LETT, V368, P401, DOI 10.1016/0014-5793(95)00694-5; PERKINS SJ, 1990, J MOL BIOL, V214, P751, DOI 10.1016/0022-2836(90)90290-3; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P9427, DOI 10.1021/bi060820+; SIM RB, 1980, BIOCHIM BIOPHYS ACTA, V612, P433, DOI 10.1016/0005-2744(80)90126-6; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; van Doorn MBA, 2005, J ALLERGY CLIN IMMUN, V116, P876, DOI 10.1016/j.jaci.2005.05.019; Wuillemin WA, 1996, J BIOL CHEM, V271, P12913, DOI 10.1074/jbc.271.22.12913; Wuillemin WA, 1997, J IMMUNOL, V159, P1953; Zahedi R, 2001, J IMMUNOL, V167, P1500, DOI 10.4049/jimmunol.167.3.1500; Zhao MM, 1998, J BIOL CHEM, V273, P31153, DOI 10.1074/jbc.273.47.31153; Zhou AW, 1999, BLOOD, V94, P3388, DOI 10.1182/blood.V94.10.3388.422k20_3388_3396	60	79	83	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21100	21109		10.1074/jbc.M700841200	http://dx.doi.org/10.1074/jbc.M700841200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17488724	hybrid			2022-12-27	WOS:000248047500036
J	Donmez, I; Rajagopal, V; Jeong, YJ; Patel, SS				Donmez, Ilker; Rajagopal, Vaishnavi; Jeong, Yong-Joo; Patel, Smita S.			Nucleic acid unwinding by hepatitis C virus and bacteriophage T7 helicases is sensitive to base pair stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI UVRD; HEXAMERIC HELICASE; GENE-4 PROTEIN; IN-VITRO; THERMODYNAMIC PARAMETERS; HCVNS3 HELICASE; MECHANISM; REPLICATION; TRANSLOCATION	Helicases are motor enzymes that convert the chemical energy of NTP hydrolysis into mechanical force for motion and nucleic acid strand separation. Within the cell, helicases process a range of nucleic acid sequences. It is not known whether this composite rate of moving and opening the strands of nucleic acids depends on the base sequence. Our presteady state kinetic studies of helicases from two classes, the ring-shaped T7 helicase and two forms of non-ring-shaped hepatitis C virus (HCV) helicase, show that both the unwinding rate and processivity depend on the sequence and decrease as the nucleic acid stability increases. The DNA unwinding activity of T7 helicase and the RNA unwinding activity of HCV helicases decrease steeply with increasing base pair stability. On the other hand, the DNA unwinding activity of HCV helicases is less sensitive to base pair stability. These results predict that helicases will fall into a spectrum of modest to high sensitivity to base pair stability depending on their biological role in the cell. Modeling of the dependence provided the degree of the active involvement of helicase in base pair destabilization during the unwinding process and distinguished between passive and active mechanisms of unwinding.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea	Rutgers State University New Brunswick; Rutgers State University Medical Center; Kookmin University	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	patelss@umdnj.edu	Rajagopal, Vaishnavi/E-5272-2012		NIGMS NIH HHS [GM55310] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Betterton MD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011904; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CHEN YZ, 1992, J BIOMOL STRUCT DYN, V10, P415, DOI 10.1080/07391102.1992.10508656; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Cunningham EL, 2005, CURR OPIN STRUC BIOL, V15, P68, DOI 10.1016/j.sbi.2005.01.003; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; FAIRFIELD FR, 1983, J BIOMOL STRUCT DYN, V1, P715, DOI 10.1080/07391102.1983.10507477; FELSENFE.G, 1967, ANNU REV BIOCHEM, V36, P407, DOI 10.1146/annurev.bi.36.070167.002203; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; He ZG, 2004, J BIOL CHEM, V279, P22190, DOI 10.1074/jbc.M401100200; Howe AYM, 1999, PROTEIN SCI, V8, P1332, DOI 10.1110/ps.8.6.1332; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Levin M.K., 2003, MOL MOTORS, P179; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1993, J BIOL CHEM, V268, P10668; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8	55	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21116	21123		10.1074/jbc.M702136200	http://dx.doi.org/10.1074/jbc.M702136200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17504766	hybrid			2022-12-27	WOS:000248047500038
J	Grotenbreg, GM; Nicholson, MJ; Fowler, KD; Wilbuer, K; Octavio, L; Yang, MX; Chakraborty, AK; Ploegh, HL; Wucherpfennig, KW				Grotenbreg, Gijsbert M.; Nicholson, Melissa J.; Fowler, Kevin D.; Wilbuer, Kathrin; Octavio, Leah; Yang, Maxine; Chakraborty, Arup K.; Ploegh, Hidde L.; Wucherpfennig, Kai W.			Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HLA-DR MOLECULES; RESTRICTED ANTIGEN PRESENTATION; MYELIN BASIC-PROTEIN; INVARIANT CHAIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MHC MOLECULES; BINDING; DISSOCIATION; EXPRESSION	DM catalyzes the exchange of peptides bound to Class II major histocompatibility complex (MHC) molecules. Because the dissociation and association components of the overall reaction are difficult to separate, a detailed mechanism of DM catalysis has long resisted elucidation. UV irradiation of DR molecules loaded with a photocleavable peptide (caged Class II MHC molecules) enabled synchronous and verifiable evacuation of the peptide-binding groove and tracking of early binding events in real time by fluorescence polarization. Empty DR molecules generated by photocleavage rapidly bound peptide but quickly resolved into species with substantially slower binding kinetics. DM formed a complex with empty DR molecules that bound peptide with even faster kinetics than empty DR molecules just having lost their peptide cargo. Mathematical models demonstrate that the peptide association rate of DR molecules is substantially higher in the presence of DM. We therefore unequivocally establish that DM contributes directly to peptide association through formation of a peptide-loading complex between DM and empty Class II MHC. This complex rapidly acquires a peptide analogous to the MHC class I peptide-loading complex.	Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; MIT, Dept Chem Engn, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Wucherpfennig, KW (corresponding author), 44 Binney St, Boston, MA 02115 USA.	Kai_Wucherpfennig@dfci.harvard.edu			NIAID NIH HHS [R01 AI057493, P01 AI045757, P01 AI071195] Funding Source: Medline; NIH HHS [DP1 OD001022] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057493, P01AI071195, P01AI045757] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; Busch R, 1998, J BIOL CHEM, V273, P27557, DOI 10.1074/jbc.273.42.27557; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lennon-Dumenil AM, 2002, CURR OPIN IMMUNOL, V14, P15, DOI 10.1016/S0952-7915(01)00293-X; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Nanda NK, 2000, J EXP MED, V192, P781, DOI 10.1084/jem.192.6.781; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Rich JD, 2003, J IMMUNOL, V171, P853, DOI 10.4049/jimmunol.171.2.853; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Weber DA, 2001, J IMMUNOL, V167, P5167, DOI 10.4049/jimmunol.167.9.5167; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wu SH, 1996, MOL IMMUNOL, V33, P371, DOI 10.1016/0161-5890(95)00159-X; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398	42	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21425	21436		10.1074/jbc.M702844200	http://dx.doi.org/10.1074/jbc.M702844200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17525157	hybrid, Green Accepted			2022-12-27	WOS:000248047500070
J	McNeil, HP; Adachi, R; Stevens, RL				McNeil, H. Patrick; Adachi, Roberto; Stevens, Richard L.			Mast cell-restricted tryptases: Structure and function in inflammation and pathogen defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHONDROITIN SULFATE PROTEOGLYCAN; HUMAN BETA-TRYPTASE; SUBSTRATE-SPECIFICITY; BACTERIAL-INFECTIONS; SYSTEMIC-ANAPHYLAXIS; TRICHINELLA-SPIRALIS; PROTEASE INHIBITORS; ENDOTHELIAL-CELLS; GRANULE PROTEASES; MOLECULAR-CLONING	Mast cells (MCs) are highly specialized immune cells present in mammals and in lower organisms that predate the development of adaptive immunity. The strong evolutionary pressure to retain MCs for > 500 million years suggests critical roles for these cells in our survival. In support of this conclusion, no human has been identified to date that lacks MCs, despite the adverse roles of MCs in systemic anaphylaxis and varied inflammatory disorders. MCs express numerous lineage-restricted neutral proteases, and four members of the chromosome 17A3.3 family of tryptases are preferentially expressed in mouse MCs. The anatomical location of MCs at host-environment interfaces has raised the possibility that some of these enzymes are evolutionally conserved because they are needed for combating infectious organisms. Here we review recent insights into the structure and function of MC tryptases in inflammation and host defense against bacteria and other infectious organisms.	Univ New S Wales, Liverpool Hosp, Dept Rheumatol, Sydney, NSW 2052, Australia; Univ New S Wales, S Western Sydney Clin Sch, Sydney, NSW 2052, Australia; Univ Texas, MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; Inst Biosci & Technol, Ctr Lung Inflammat & Infect, Houston, TX 77030 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Liverpool Hospital; University of New South Wales Sydney; University of New South Wales Sydney; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McNeil, HP (corresponding author), Univ New S Wales, Liverpool Hosp, Dept Rheumatol, Sydney, NSW 2052, Australia.	p.mcneil@unsw.edu.au; rstevens@rics.bwh.harvard.edu		McNeil, Hugh Patrick/0000-0003-4336-2960; Adachi, Roberto/0000-0002-0146-0768	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL036110] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Badge RM, 2000, HUM MOL GENET, V9, P1239, DOI 10.1093/hmg/9.8.1239; BOURDON MA, 1985, P NATL ACAD SCI USA, V82, P1321, DOI 10.1073/pnas.82.5.1321; Brubaker JO, 2001, CELL MOL BIOL, V47, P637; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Compton SJ, 1998, J IMMUNOL, V161, P1939; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Ehrlich P, 1878, THESIS U LEIPZIG GER; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fukuoka Y, 2004, BIOCHEMISTRY-US, V43, P10757, DOI 10.1021/bi049486c; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; HARTMANN T, 1992, AM J PHYSIOL, V262, pL528, DOI 10.1152/ajplung.1992.262.5.L528; He SH, 1998, BRIT J PHARMACOL, V125, P1491, DOI 10.1038/sj.bjp.0702223; Huang C, 2000, J BIOL CHEM, V275, P351, DOI 10.1074/jbc.275.1.351; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Jippo T, 2003, J EXP MED, V197, P1417, DOI 10.1084/jem.20022157; JOHNSON DA, 1992, PROTEIN SCI, V1, P370; Kinoshita M, 2005, ARTERIOSCL THROM VAS, V25, P1858, DOI 10.1161/01.ATV.0000174797.71708.97; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; LANE DA, 1992, ADV EXP MED BIOL, V313, P1; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; Morii E, 2004, BLOOD, V104, P1656, DOI 10.1182/blood-2004-01-0247; Morii E, 1996, BLOOD, V88, P2488, DOI 10.1182/blood.V88.7.2488.bloodjournal8872488; Mullaly SC, 2007, EUR J IMMUNOL, V37, P224, DOI 10.1002/eji.200636405; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; RAZIN E, 1982, J BIOL CHEM, V257, P7229; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; SALI A, 1993, J BIOL CHEM, V268, P9023; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; Selwood T, 2002, BIOCHEMISTRY-US, V41, P3329, DOI 10.1021/bi015662v; Soto D, 2002, CLIN EXP ALLERGY, V32, P1000, DOI 10.1046/j.1365-2222.2002.01416.x; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; STEVENS RL, 1986, J IMMUNOL, V137, P291; STEVENS RL, 1988, J BIOL CHEM, V263, P7287; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; VANDERSLICE P, 1989, BIOCHEMISTRY-US, V28, P4148, DOI 10.1021/bi00436a004; Wang HW, 2002, J IMMUNOL, V169, P5145, DOI 10.4049/jimmunol.169.9.5145; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong GW, 2002, J BIOL CHEM, V277, P41906, DOI 10.1074/jbc.M205868200; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784	61	81	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20785	20789		10.1074/jbc.R700017200	http://dx.doi.org/10.1074/jbc.R700017200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17504754	hybrid			2022-12-27	WOS:000248047500001
J	Tu, AW; Luo, K				Tu, Andrea W.; Luo, Kunxin			Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor ss response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; DNA-BINDING; TARGETED DISRUPTION; SNON ONCOPROTEIN; MH1 DOMAIN; PROTEINS; TRANSCRIPTION; ACTIVATION; CBP; PHOSPHORYLATION	Transforming growth factor beta (TGF beta) signals primarily through the Smad proteins to regulate cell growth, differentiation, and extracellular matrix production. Post-translational modifications, such as phosphorylation, play an important role in the regulation of the Smad proteins. TGF beta signaling results in the phosphorylation of Smad2 and Smad3 that then oligomerize with Smad4 and translocate into the nucleus to initiate transcription of TGF beta target genes. The initiation of transcription is significantly enhanced by the direct interaction of the Smad complex with p300/CBP (CREB-binding protein), a co-activator with intrinsic acetyltransferase activity. However, how p300/CBP enhances transcription through this interaction is not entirely understood. In this report, we show that Smad2, but not the highly homologous Smad3, can be acetylated by p300/CBP in a ligand-dependent manner. At least three lysine residues, Lys(19), Lys(20), and Lys(39), are required for efficient acetylation of Smad2, as mutations altering these lysines abolished Smad2 acetylation in vivo. This acetylation event is required for the ability of Smad2 to mediate activin and TGF beta signaling. Mutation of the three key lysine residues did not alter the stability of Smad2 or the ability of Smad2 to form a complex with Smad4 on promoter DNA, but it prevented nuclear accumulation of Smad2 and subsequent TGF beta and activin responses. Thus, our studies reveal a novel mechanism of modulating Smad2 activity and localization through protein acetylation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Luo, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall,Mail Code 3204, Berkeley, CA 94720 USA.	kluo@berkeley.edu			NIDDK NIH HHS [DK067074] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067074] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Chan HM, 2001, J CELL SCI, V114, P2363; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Heyer J, 1999, P NATL ACAD SCI USA, V96, P12595, DOI 10.1073/pnas.96.22.12595; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liberati NT, 2001, J BIOL CHEM, V276, P22595, DOI 10.1074/jbc.M010778200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Nishihara A, 1999, J BIOL CHEM, V274, P28716, DOI 10.1074/jbc.274.40.28716; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Simonsson M, 2005, J BIOL CHEM, V280, P21797, DOI 10.1074/jbc.M503134200; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	49	63	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21187	21196		10.1074/jbc.M700085200	http://dx.doi.org/10.1074/jbc.M700085200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17478422	hybrid			2022-12-27	WOS:000248047500045
J	van Straaten, KE; Barends, TRM; Dijkstra, BW; Thunnissen, AMWH				van Straaten, Karin E.; Barends, Thomas R. M.; Dijkstra, Bauke W.; Thunnissen, Andy-Mark W. H.			Structure of Escherichia coli lytic transglycosylase MltA with bound chitohexaose - Implications for peptidoglycan binding and cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; CRYSTAL-STRUCTURE; LYSOZYME; DOMAIN; PURIFICATION; REFINEMENT; MECHANISMS; DISTORTION; FAMILIES; REVEALS	Crystal structures of an inactive mutant (D308A) of the lytic transglycosylase MltA from Escherichia coli have been determined in two different apo-forms, as well as in complex with the substrate analogue chitohexaose. The chitohexaose binds with all six saccharide residues in the active site groove, with an intact glycosidic bond at the bond cleavage center. Its binding induces a large reorientation of the two structural domains in MltA, narrowing the active site groove and allowing tight interactions of the oligosaccharide with residues from both domains. The structures identify residues in MltA with key roles in the binding and recognition of peptidoglycan and confirm that Asp-308 is the single catalytic residue, acting as a general acid/base. Moreover, the structures suggest that catalysis involves a high energy conformation of the scissile glycosidic linkage and that the putative oxocarbenium ion intermediate is stabilized by the dipole moment of a nearby alpha-helix.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands	University of Groningen	Thunnissen, AMWH (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	a.m.w.h.thunnissen@rug.nl	Dijkstra, Bauke W./H-4308-2019; Thunnissen, Andy-Mark/A-1777-2010	Dijkstra, Bauke W./0000-0001-9731-6586; Thunnissen, Andy-Mark/0000-0002-1915-9850				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barends TRM, 2005, ACTA CRYSTALLOGR D, V61, P613, DOI 10.1107/S0907444905005743; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DAVIES GJ, 1993, NATURE, V365, P362, DOI 10.1038/365362a0; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; HOLTJE JV, 1995, ARCH MICROBIOL, V164, P243, DOI 10.1007/s002030050261; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Kraft AR, 1998, J BACTERIOL, V180, P3441, DOI 10.1128/JB.180.13.3441-3447.1998; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell AJ, 2006, J MOL BIOL, V359, P122, DOI 10.1016/j.jmb.2006.03.023; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; ROMEIS T, 1993, FEMS MICROBIOL LETT, V111, P141; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; URSINUS A, 1994, J BACTERIOL, V176, P338, DOI 10.1128/JB.176.2.338-343.1994; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; van Asselt EJ, 1999, STRUCT FOLD DES, V7, P1167, DOI 10.1016/S0969-2126(00)80051-9; van Asselt EJ, 2000, BIOCHEMISTRY-US, V39, P1924, DOI 10.1021/bi992161p; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; van Straaten KE, 2004, ACTA CRYSTALLOGR D, V60, P758, DOI 10.1107/S0907444904002574; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200	38	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21197	21205		10.1074/jbc.M701818200	http://dx.doi.org/10.1074/jbc.M701818200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17502382	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000248047500046
J	Heuts, DPHM; van Hellemond, EW; Janssen, DB; Fraaije, MW				Heuts, Dominic P. H. M.; van Hellemond, Erik W.; Janssen, Dick B.; Fraaije, Marco W.			Discovery, characterization, and kinetic analysis of an alditol oxidase from streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLYL-ALCOHOL OXIDASE; OXIDATION-REDUCTION; OXIDOREDUCTASE; FLAVINYLATION; FLAVOPROTEINS; REACTIVITY; MECHANISM; FAMILY	A gene encoding an alditol oxidase was found in the genome of Streptomyces coelicolor A3(2). This newly identified oxidase, AldO, was expressed at extremely high levels in Escherichia coli when fused to maltose-binding protein. AldO is a soluble monomeric flavoprotein with subunits of 45.1 kDa, each containing a covalently bound FAD cofactor. From sequence alignments with other flavoprotein oxidases, it was found that AldO contains a conserved histidine (His46) that is typically involved in covalent FAD attachment. Covalent FAD binding is not observed in the H46A AldO mutant, confirming its role in covalent attachment of the flavin cofactor. Steady-state kinetic analyses revealed that wild-type AldO is active with several polyols. The alditols xylitol (K-m = 0.32 mM, k(cat) = 13 s(-1)) and sorbitol (K-m = 1.4 mM, k(cat) = 17 s(-1)) are the preferred substrates. From pre-steady-state kinetic analyses, using xylitol as substrate, it can be concluded that AldO mainly follows a ternary complex kinetic mechanism. Reduction of the flavin cofactor by xylitol occurs at a relatively high rate ( 99 s(-1)), after which a second kinetic event is observed, which is proposed to represent ring closure of the formed aldehyde product, yielding the hemiacetal of D-xylose. Reduced AldO readily reacts with molecular oxygen (1.7 x 105 M-1 s(-1)), which confirms that the enzyme represents a true flavoprotein oxidase.	Univ Groningen, Biomol Sci & Biotechnol Inst, Biochem Lab, NL-9747 AG Groningen, Netherlands	University of Groningen	Fraaije, MW (corresponding author), Univ Groningen, Biomol Sci & Biotechnol Inst, Biochem Lab, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl	Fraaije, Marco/E-8421-2014	Fraaije, Marco/0000-0001-6346-5014				Bertram R, 2004, J BACTERIOL, V186, P1362, DOI 10.1128/JB.186.5.1362-1373.2004; DEJONG E, 1992, EUR J BIOCHEM, V208, P651; Federico R, 1997, BIOCHEM BIOPH RES CO, V240, P150, DOI 10.1006/bbrc.1997.7630; Forneris F, 2006, ACTA CRYSTALLOGR F, V62, P1298, DOI 10.1107/S1744309106051128; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Fraaije MW, 1997, APPL ENVIRON MICROB, V63, P435, DOI 10.1128/AEM.63.2.435-439.1997; Fraaije MW, 1997, J BIOL CHEM, V272, P18111, DOI 10.1074/jbc.272.29.18111; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; FRAAIJE MW, 1999, FLAVINS FLAVOPROTEIN, P881; Hiraga K, 1997, BIOSCI BIOTECH BIOCH, V61, P1699, DOI 10.1271/bbb.61.1699; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; HUANG CY, 1983, CONT ENZYME KINETICS, P54; Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4; MASSEY V, 1977, J BIOL CHEM, V252, P5612; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MASSEY V, 1969, J BIOL CHEM, V244, P3999; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; PORTER DJT, 1977, J BIOL CHEM, V252, P4464; Rand T, 2006, FEBS J, V273, P2693, DOI 10.1111/j.1742-4658.2006.05285.x; SCHOPFER LM, 1988, BIOCHEMISTRY-US, V27, P6599, DOI 10.1021/bi00417a059; Stevens RC, 2000, STRUCTURE, V8, pR177, DOI 10.1016/S0969-2126(00)00193-3; van Hellemond EW, 2006, ADV APPL MICROBIOL, V60, P17, DOI 10.1016/S0065-2164(06)60002-6; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Wu XL, 2001, BIOCHEMISTRY-US, V40, P12886, DOI 10.1021/bi011244e; Xu F, 2001, EUR J BIOCHEM, V268, P1136, DOI 10.1046/j.1432-1327.2001.01982.x; Yamashita M, 2000, J BIOSCI BIOENG, V89, P350, DOI 10.1016/S1389-1723(00)88958-6	26	63	67	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20283	20291		10.1074/jbc.M610849200	http://dx.doi.org/10.1074/jbc.M610849200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517896	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000247819300031
J	Morimoto, S; Tanaka, Y; Sasaki, K; Tanaka, H; Fukamizu, T; Shoyama, Y; Shoyama, Y; Taura, F				Morimoto, Satoshi; Tanaka, Yumi; Sasaki, Kaori; Tanaka, Hiroyuki; Fukamizu, Tomohide; Shoyama, Yoshinari; Shoyama, Yukihiro; Taura, Futoshi			Identification and characterization of cannabinoids that induce cell death through mitochondrial permeability transition in Cannabis leaf cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLING MARIJUANA PSYCHOACTIVITY; ACID SYNTHASE; CYTOCHROME-C; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; ENDONUCLEASE-G; PORE; INVOLVEMENT; PROTEASES; CALCIUM	Cannabinoids are secondary metabolites stored in capitatesessile glands on leaves of Cannabis sativa. We discovered that cell death is induced in the leaf tissues exposed to cannabinoid resin secreted from the glands, and identified cannabichromenic acid ( CBCA) and Delta(1)-tetrahydrocannabinolic acid ( THCA) as unique cell death mediators from the resin. These cannabinoids effectively induced cell death in the leaf cells or suspension-cultured cells of C. sativa, whereas pretreatment with the mitochondrial permeability transition (MPT) inhibitor cyclosporin A suppressed this cell death response. Examinations using isolated mitochondria demonstrated that CBCA and THCA mediate opening of MPT pores without requiring Ca2+ and other cytosolic factors, resulting in high amplitude mitochondrial swelling, release of mitochondrial proteins ( cytochrome c and nuclease), and irreversible loss of mitochondrial membrane potential. Therefore, CBCA and THCA are considered to cause serious damage to mitochondria through MPT. The mitochondrial damage was also confirmed by a marked decrease of ATP level in cannabinoid-treated suspension cells. These features are in good accord with those of necrotic cell death, whereas DNA degradation was also observed in cannabinoid-mediated cell death. However, the DNA degradation was catalyzed by nuclease(s) released from mitochondria during MPT, indicating that this reaction was not induced via a caspase-dependent apoptotic pathway. Furthermore, the inhibition of the DNA degradation only slightly blocked the cell death induced by cannabinoids. Based on these results, we conclude that CBCA and THCA have the ability to induce necrotic cell death via mitochondrial dysfunction in the leaf cells of C. sativa.	Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan	Kyushu University	Morimoto, S (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan.	morimoto@phar.kyushu-u.ac.jp; taura@phar.kyushu-u.ac.jp						Arpagaus S, 2002, J BIOL CHEM, V277, P1780, DOI 10.1074/jbc.M109416200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Balk J, 2003, PLANT J, V34, P573, DOI 10.1046/j.1365-313X.2003.01748.x; BERNARDI P, 1993, J BIOL CHEM, V268, P1005; Casolo V, 2005, J EXP BOT, V56, P997, DOI 10.1093/jxb/eri093; Curtis MJ, 2002, PLANT J, V29, P295, DOI 10.1046/j.0960-7412.2001.01213.x; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Feeney M, 2003, IN VITRO CELL DEV-PL, V39, P578, DOI 10.1079/IVP2003454; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Gechev TS, 2005, J CELL BIOL, V168, P17, DOI 10.1083/jcb.200409170; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greenberg JT, 1996, P NATL ACAD SCI USA, V93, P12094, DOI 10.1073/pnas.93.22.12094; HAMMOND CT, 1977, AM J BOT, V64, P1023, DOI 10.2307/2442258; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Ishihara Y, 2006, J BIOL CHEM, V281, P6726, DOI 10.1074/jbc.M510382200; JACOBS EE, 1960, J BIOL CHEM, V235, P531; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; KUSHIMA H, 1980, CHEM PHARM BULL, V28, P594; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lemasters JJ, 1999, AM J PHYSIOL-GASTR L, V276, pG1, DOI 10.1152/ajpgi.1999.276.1.G1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; McCaskill D, 1999, NAT BIOTECHNOL, V17, P31, DOI 10.1038/5202; MECHOULAM R, 1970, SCIENCE, V168, P1159, DOI 10.1126/science.168.3936.1159; Mlejnek P, 2003, PLANT CELL ENVIRON, V26, P1723, DOI 10.1046/j.1365-3040.2003.01090.x; Morimoto S, 1997, J NAT PROD, V60, P854, DOI 10.1021/np970210y; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Sirikantaramas S, 2005, PLANT CELL PHYSIOL, V46, P1578, DOI 10.1093/pcp/pci166; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Sun YL, 1999, CELL MOL LIFE SCI, V55, P310, DOI 10.1007/s000180050293; TAURA F, 1995, J AM CHEM SOC, V117, P9766, DOI 10.1021/ja00143a024; Taura F, 1996, J BIOL CHEM, V271, P17411, DOI 10.1074/jbc.271.29.17411; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; TURNER JC, 1977, AM J BOT, V64, P687, DOI 10.2307/2441721; Vacca RA, 2006, PLANT PHYSIOL, V141, P208, DOI 10.1104/pp.106.078683; Virolainen E, 2002, ANN BOT-LONDON, V90, P509, DOI 10.1093/aob/mcf221; Wang Y, 2006, J INTEGR PLANT BIOL, V48, P433, DOI 10.1111/j.1744-7909.2006.00219.x; Woltering EJ, 2002, PLANT PHYSIOL, V130, P1764, DOI 10.1104/pp.006338; Woltering EJ, 2004, TRENDS PLANT SCI, V9, P469, DOI 10.1016/j.tplants.2004.08.001	45	55	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20739	20751		10.1074/jbc.M700133200	http://dx.doi.org/10.1074/jbc.M700133200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17513301	hybrid			2022-12-27	WOS:000247819300076
J	Yin, CF; Khan, JA; Swapna, GVT; Ertekin, A; Krug, RM; Tong, L; Montelione, GT				Yin, Cuifeng; Khan, Javed A.; Swapna, G. V. T.; Ertekin, Asli; Krug, Robert M.; Tong, Liang; Montelione, Gaetano T.			Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; ANTIVIRAL RESPONSES; BETA-INTERFERON; SYSTEM; KINASE; CELLS	Influenza A viruses cause a highly contagious respiratory disease in humans and are responsible for periodic widespread epidemics with high mortality rates. The influenza A virus NS1 protein (NS1A) plays a key role in countering host antiviral defense and in virulence. The 73-residue N-terminal domain of NS1A (NS1A-(1-73)) forms a symmetric homodimer with a unique six-helical chain fold. It binds canonical A-form double-stranded RNA ( dsRNA). Mutational inactivation of this dsRNA binding activity of NS1A highly attenuates virus replication. Here, we have characterized the unique structural features of the dsRNA binding surface of NS1A-(1-73) using NMR methods and describe the 2.1-angstrom x-ray crystal structure of the corresponding dsRNA binding domain from human influenza B virus NS1B-(15 93). These results identify conserved dsRNA binding surfaces on both NS1A-(1-73) and NS1B-(15-93) that are very different from those indicated in earlier "working models" of the complex between dsRNA and NS1A-(1-73). The combined NMR and crystallographic data reveal highly conserved surface tracks of basic and hydrophilic residues that interact with dsRNA. These tracks are structurally complementary to the polyphosphate backbone conformation of A-form dsRNA and run at an similar to 45 degrees angle relative to the axes of helices alpha 2/alpha 2'. At the center of this dsRNA binding epitope, and common to NS1 proteins from influenza A and B viruses, is a deep pocket that includes both hydrophilic and hydrophobic amino acids. This pocket provides a target on the surface of the NS1 protein that is potentially suitable for the development of antiviral drugs targeting both influenza A and B viruses.	Rutgers State Univ, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, NE Struct Genom Consortium, Piscataway, NJ 08854 USA; Rutgers State Univ, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Columbia Univ, NE Struct Genom Consortium, Dept Biol & Biochem, New York, NY 10027 USA; Univ Texas, Inst Cell & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University; University of Texas System; University of Texas Austin	Krug, RM (corresponding author), Rutgers State Univ, New Brunswick, NJ 08903 USA.	rkrug@mail.utexas.edu; ltong@columbia.edu; guy@cabm.rutgers.edu		Tong, Liang/0000-0002-0563-6468; Montelione, Gaetano/0000-0002-9440-3059	NIAID NIH HHS [AI 49475, AI 11772] Funding Source: Medline; NIGMS NIH HHS [U54 GM 074958] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI011772, R01AI011772, R01AI049475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074958] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baran MC, 2006, PROTEINS, V62, P843, DOI 10.1002/prot.20840; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Chien CY, 2004, BIOCHEMISTRY-US, V43, P1950, DOI 10.1021/bi030176o; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Dauber B, 2006, J VIROL, V80, P11667, DOI 10.1128/JVI.01142-06; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donelan NR, 2004, J VIROL, V78, P11574, DOI 10.1128/JVI.78.21.11574-11582.2004; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GODDARD T, 2000, SPARKY NMR ANAL SOFT; HATADA E, 1992, J GEN VIROL, V73, P3325, DOI 10.1099/0022-1317-73-12-3325; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Liu JS, 1997, NAT STRUCT BIOL, V4, P896, DOI 10.1038/nsb1197-896; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; MONTELIONE GT, 1999, BIOL MAGN RESON, V17, P81; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2005, ADV VIRUS RES, V65, P121, DOI 10.1016/S0065-3527(05)65004-X; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Qian XY, 1995, RNA, V1, P948; Reid AH, 2001, MICROBES INFECT, V3, P81, DOI 10.1016/S1286-4579(00)01351-4; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang WR, 1996, VIROLOGY, V223, P41, DOI 10.1006/viro.1996.0453; Wright P., 2001, FIELDS VIROLOGY; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Yuan WM, 2002, VIROLOGY, V304, P291, DOI 10.1006/viro.2002.1663	40	77	83	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20584	20592		10.1074/jbc.M611619200	http://dx.doi.org/10.1074/jbc.M611619200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17475623	hybrid			2022-12-27	WOS:000247819300061
J	Tesz, GJ; Guilherme, A; Guntur, KVP; Hubbard, AC; Tang, XQ; Chawla, A; Czech, MP				Tesz, Gregory J.; Guilherme, Adilson; Guntur, Kalyani V. P.; Hubbard, Andrea C.; Tang, Xiaoqing; Chawla, Anil; Czech, Michael P.			Tumor necrosis factor alpha (TNF alpha) stimulates Map4k4 expression through TNF alpha receptor 1 signaling to c-Jun and activating transcription factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; TYROSINE KINASE-ACTIVITY; NCK-INTERACTING KINASE; PROTEIN-KINASE; GENE-EXPRESSION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; PPAR-GAMMA; ADIPOCYTE; OBESITY	Tumor necrosis factor alpha (TNF alpha) is a cytokine secreted by macrophages and adipocytes that contributes to the low grade inflammation and insulin resistance observed in obesity. TNF alpha signaling decreases peroxisome proliferator-activated receptor gamma and glucose transporter isoform 4 (GLUT4) expression in adipocytes, impairing insulin action, and this is mediated in part by the yeast Ste20 protein kinase ortholog Map4k4. Here we show that Map4k4 expression is selectively up-regulated by TNF alpha, whereas the expression of the protein kinases JNK1/2, ERK1/2, p38 stress-activated protein kinase, and mitogen-activated protein kinase kinases 4/7 shows little or no response. Furthermore, the cytokines interleukin 1 beta (IL-1 beta) and IL-6 as well as lipopolysaccharide fail to increase Map4k4 mRNA levels in cultured adipocytes under conditions where TNF alpha elicits a 3-fold effect. Using agonistic and antagonistic antibodies and small interfering RNA ( siRNA) against TNF alpha receptor 1 (TNFR1) and TNF alpha receptor 2 (TNFR2), we show that TNFR1, but not TNFR2, mediates the increase in Map4k4 expression. TNFR1, but not TNFR2, also mediates a potent effect of TNF alpha on the phosphorylation of JNK1/2 and p38 stress-activated protein kinase and their downstream transcription factor substrates c-Jun and activating transcription factor 2 (ATF2). siRNA-based depletion of c-Jun and ATF2 attenuated TNF alpha action on Map4k4 mRNA expression. Consistent with this concept, the phosphorylation of ATF2 along with the expression and phosphorylation of c-Jun by TNF alpha signaling was more robust and prolonged compared with that of IL-1 beta, which failed to modulate Map4k4. These data reveal that TNF alpha selectively stimulates the expression of a key component of its own signaling pathway, Map4k4, through a TNFR1-dependent mechanism that targets the transcription factors c-Jun and ATF2.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Suite 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030898, R37DK030898] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK30898] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Aouadi M, 2006, STEM CELLS, V24, P1399, DOI 10.1634/stemcells.2005-0398; Asschert JGW, 1999, INT J CANCER, V81, P236, DOI 10.1002/(SICI)1097-0215(19990412)81:2<236::AID-IJC12>3.0.CO;2-R; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Chainy GBN, 1996, J IMMUNOL, V157, P2410; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Demir AY, 2005, CELL TISSUE RES, V322, P299, DOI 10.1007/s00441-005-0002-6; Eder J, 1997, TRENDS PHARMACOL SCI, V18, P319, DOI 10.1016/S0165-6147(97)01097-3; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Haridas V, 1998, J IMMUNOL, V160, P3152; HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kyosseva SV, 2004, INT REV NEUROBIOL, V59, P201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Mracek T, 2004, CYTOKINE, V26, P9, DOI 10.1016/j.cyto.2003.12.001; Nishigaki K, 2003, J BIOL CHEM, V278, P13520, DOI 10.1074/jbc.M208601200; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; SCOTT LM, 1992, BLOOD, V80, P1725; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Skolnik Edward Y., 1996, Cytokine and Growth Factor Reviews, V7, P161, DOI 10.1016/1359-6101(96)00021-4; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Willaime-Morawek S, 2003, NEUROSCIENCE, V119, P387, DOI 10.1016/S0306-4522(02)00996-X; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Xu HY, 2001, FEBS LETT, V506, P97, DOI 10.1016/S0014-5793(01)02889-7; Xue YZ, 2001, DEVELOPMENT, V128, P1559; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zerbini LF, 2003, CANCER RES, V63, P2206; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	56	65	81	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19302	19312		10.1074/jbc.M700665200	http://dx.doi.org/10.1074/jbc.M700665200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17500068	hybrid			2022-12-27	WOS:000247650600005
J	Hartl, L; Kubicek, CP; Seiboth, B				Hartl, Lukas; Kubicek, Christian P.; Seiboth, Bernhard			Induction of the gal pathway and cellulase genes involves no transcriptional inducer function of the galactokinase in Hypocrea jecorina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; D-GALACTOSE; KLUYVEROMYCES-LACTIS; LACTOSE METABOLISM; EXPRESSION; GROWTH; TRANSFORMATION	The Saccharomyces cerevisiae galactokinase ScGal1, a key enzyme for D-galactose metabolism, catalyzes the conversion of D-galactose to D-galactose 1-phosphate, whereas its catalytically inactive paralogue, ScGal3, activates the transcription of the GAL pathway genes. In Kluyveromyces lactis the transcriptional inducer function and the galactokinase activity are encoded by a single bifunctional KlGal1. Here, we investigated the cellular function of the single galactokinase GAL1 in the multicellular ascomycete Hypocrea jecorina ( = Trichoderma reesei) in the induction of the gal genes and of the galactokinase-dependent induction of the cellulase genes by lactose (1,4-O-beta-D-galactopyranosyl-D- glucose). A comparison of the transcriptional response of a strain deleted in the gal1 gene ( no putative transcriptional inducer and no galactokinase activity), a strain expressing a catalytically inactive GAL1 version ( no galactokinase activity but a putative inducer function), and a strain expressing the Escherichia coli galK ( no putative transcriptional inducer but galactokinase activity) showed that, in contrast to the two yeasts, both the GAL1 protein and the galactokinase activity are fully dispensable for induction of the Leloir pathway gene gal7 by D-galactose and that only the galactokinase activity is required for cellulase induction by lactose. The data document a fundamental difference in the mechanisms by which yeasts and multicellular fungi respond to the presence of D-galactose, showing that the Gal1/Gal3-Gal4 - Gal80- dependent regulatory circuit does not operate in multicellular fungi.	Vienna Univ Technol, Inst Chem Engn, Res Area Gene Technol& Appl Biochem, Mol Biotechnol Grp, A-1060 Vienna, Austria	Technische Universitat Wien	Hartl, L (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Area Gene Technol& Appl Biochem, Mol Biotechnol Grp, Getreidemark 9-166, A-1060 Vienna, Austria.	lhartl@mail.zserv.tuwien.ac.at						BHAT PJ, 1990, GENETICS, V125, P281; Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; Fekete E, 2004, ARCH MICROBIOL, V181, P35, DOI 10.1007/s00203-003-0622-8; Fekete E, 2002, ARCH MICROBIOL, V179, P7, DOI 10.1007/s00203-002-0491-6; Fekete E, 2007, MICROBIOL-SGM, V153, P507, DOI 10.1099/mic.0.2006/001602-0; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Grun CH, 2005, GLYCOBIOLOGY, V15, P245, DOI 10.1093/glycob/cwi002; Kainuma M, 2001, YEAST, V18, P533, DOI 10.1002/yea.708; Karaffa L, 2006, MICROBIOL-SGM, V152, P1507, DOI 10.1099/mic.0.28719-0; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; MEYER J, 1991, MOL CELL BIOL, V11, P5454, DOI 10.1128/MCB.11.11.5454; Penttila M., 2004, Handbook of fungal biotechnology, P413; Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154; ROBERTS CF, 1970, BIOCHIM BIOPHYS ACTA, V201, P267, DOI 10.1016/0304-4165(70)90301-6; Rubio-Texeira M, 2005, FEMS YEAST RES, V5, P1115, DOI 10.1016/j.femsyr.2005.05.003; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Schaffrath R, 2000, FUNGAL GENET BIOL, V30, P173, DOI 10.1006/fgbi.2000.1221; Seiboth B, 2004, MOL MICROBIOL, V51, P1015, DOI 10.1046/j.1365-2958.2003.03901.x; Seiboth B, 2002, GENE, V295, P143, DOI 10.1016/S0378-1119(02)00834-X; Seiboth B, 2002, MOL GENET GENOMICS, V267, P124, DOI 10.1007/s00438-002-0654-9; Seiboth Bernhard, 2007, Fungal Biology Reviews, V21, P42, DOI 10.1016/j.fbr.2007.02.006; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZACHARIAE W, 1993, MOL CELL BIOL, V13, P3058, DOI 10.1128/MCB.13.5.3058	27	32	34	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18654	18659		10.1074/jbc.M700955200	http://dx.doi.org/10.1074/jbc.M700955200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452322	hybrid			2022-12-27	WOS:000247302000070
J	Bowzard, JB; Cheng, D; Peng, J; Kahn, RA				Bowzard, J. Bradford; Cheng, Dongmei; Peng, Junmin; Kahn, Richard A.			ELMOD2 is an Arl2 GTPase-activating protein that also acts on Arfs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; BINDING PROTEINS; RAS SUPERFAMILY; DOWNSTREAM ACTIVATION; GENOMIC ANALYSIS; COFACTOR-D; FAMILY; GENE; GAP; HYDROLYSIS	Regulatory GTPases in the Ras superfamily employ a cycle of alternating GTP binding and hydrolysis, controlled by guanine nucleotide exchange factors and GTPase-activating proteins ( GAPs), as essential features of their actions in cells. Studies of these GAPs and guanine nucleotide exchange factors have provided important insights into our understanding of GTPase signaling and biology. Within the Ras superfamily, the Arf family is composed of 30 members in mammals, including 22 Arf-like ( Arl) proteins. Much less is known about the mechanisms of cell regulation by Arls than by Arfs. We report the purification from bovine testis of an Arl2 GAP and its identity as ELMOD2, a protein with no previously described function. ELMOD2 is one of six human proteins that contain an ELMO domain, and a second member, ELMOD1, was also found to have Arl2 GAP activity. Surprisingly, ELMOD2 also exhibited GAP activity against Arf proteins even though it does not contain the canonical Arf GAP sequence signature. The broader specificity of ELMOD2, as well as the previously described role for ELMO1 and ELMO2 in linking Arf6 and Rac1 signaling, suggests that ELMO family members may play a more general role in integrating signaling pathways controlled by Arls and other GTPases.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Emory University; Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Peng, Junmin/N-2614-2018; Kahn, Richard/ABD-2666-2020	Peng, Junmin/0000-0003-0472-7648; Kahn, Richard/0000-0002-0259-0601	NIA NIH HHS [AG025688] Funding Source: Medline; NIGMS NIH HHS [GM24680, GM067465, R01 GM090158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andreev J, 1999, MOL CELL BIOL, V19, P2338; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bowzard JB, 2005, METHOD ENZYMOL, V404, P453, DOI 10.1016/S0076-6879(05)04040-1; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P4357, DOI 10.1021/bi00288a002; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Cassel D, 2003, PROTEINS CELL REG, V1, P137; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Ding M, 1996, J BIOL CHEM, V271, P24005, DOI 10.1074/jbc.271.39.24005; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; FEUERSTEIN J, 1987, J BIOL CHEM, V262, P8455; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hodgson U, 2006, AM J HUM GENET, V79, P149, DOI 10.1086/504639; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Jacques KM, 2002, J BIOL CHEM, V277, P47235, DOI 10.1074/jbc.M208875200; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Katoh H, 2006, BRAIN RES, V1073, P103, DOI 10.1016/j.brainres.2005.12.085; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Liu K, 1998, J BIOL CHEM, V273, P10087, DOI 10.1074/jbc.273.17.10087; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Luo RB, 2005, CURR BIOL, V15, P2164, DOI 10.1016/j.cub.2005.10.065; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Okai T, 2004, J CELL SCI, V117, P4705, DOI 10.1242/jcs.01347; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Petrocca F, 2006, CANCER RES, V66, P10287, DOI 10.1158/0008-5472.CAN-06-2289; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Seewald MJ, 2003, MOL CELL BIOL, V23, P8124, DOI 10.1128/MCB.23.22.8124-8136.2003; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; STEARNS T, 1990, GENETICS, V124, P251; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; WEISS O, 1989, J BIOL CHEM, V264, P21066; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	65	58	63	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17568	17580		10.1074/jbc.M701347200	http://dx.doi.org/10.1074/jbc.M701347200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452337	hybrid			2022-12-27	WOS:000247084500028
J	DeHaven, WI; Smyth, JT; Boyles, RR; Putney, JW				DeHaven, Wayne I.; Smyth, Jeremy T.; Boyles, Rebecca R.; Putney, James W., Jr.			Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CURRENT I-CRAC; CA2+ CHANNELS; STORE DEPLETION; PROTEIN-KINASE; T-LYMPHOCYTES; CELLS; INFLUX; STIM1; JURKAT; INACTIVATION	The recent discoveries of Stim1 and Orai proteins have shed light on the molecular makeup of both the endoplasmic reticulum Ca2+ sensor and the calcium release-activated calcium ( CRAC) channel, respectively. In this study, we investigated the regulation of CRAC channel function by extracellular Ca2+ for channels composed primarily of Orai1, Orai2, and Orai3, by coexpressing these proteins together with Stim1, as well as the endogenous channels in HEK293 cells. As reported previously, Orai1 or Orai2 resulted in a substantial increase in CRAC current ( I-crac), but Orai3 failed to produce any detectable Ca2+ selective currents. However, sodium currents measured in the Orai3-expressing HEK293 cells were significantly larger in current density than Stim1-expressing cells. Moreover, upon switching to divalent free external solutions, Orai3 currents were considerably more stable than Orai1 or Orai2, indicating that Orai3 channels undergo a lesser degree of depotentiation. Additionally, the difference between depotentiation from Ca2+ and Ba2+ or Mg2+ solutions was significantly less for Orai3 than for Orai1 or -2. Nonetheless, the Na+ currents through Orai1, Orai2, and Orai3, as well as the endogenous store-operated Na+ currents in HEK293 cells, were all inhibited by extracellular Ca2+ with a half-maximal concentration of similar to 20 mu M. We conclude that Orai1, -2, and -3 channels are similarly inhibited by extracellular Ca2+, indicating similar affinities for Ca2+ within the selectivity filter. Orai3 channels appeared to differ from Orai1 and -2 in being somewhat resistant to the process of Ca2+ depotentiation.	NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Putney, JW (corresponding author), NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	putney@niehs.nih.gov	Putney, James W/F-7247-2019	Putney, James W/0000-0002-3379-4789; Boyles, Rebecca/0000-0003-0073-6854	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090087, ZIAES090087] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; Christian EP, 1996, J MEMBRANE BIOL, V150, P63, DOI 10.1007/s002329900030; Fasolato C, 1998, PFLUG ARCH EUR J PHY, V436, P69, DOI 10.1007/s004240050605; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Lewis RS, 1996, SOC GEN PHY, V51, P241; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Su ZC, 2004, BIOPHYS J, V86, P805, DOI 10.1016/S0006-3495(04)74156-9; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; Zweifach A, 1996, J GEN PHYSIOL, V107, P597, DOI 10.1085/jgp.107.5.597	28	194	199	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17548	17556		10.1074/jbc.M611374200	http://dx.doi.org/10.1074/jbc.M611374200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452328	hybrid			2022-12-27	WOS:000247084500025
J	Kumagai, K; Kawano, M; Shinkai-Ouchi, F; Nishijima, M; Hanada, K				Kumagai, Keigo; Kawano, Miyuki; Shinkai-Ouchi, Fumiko; Nishijima, Masahiro; Hanada, Kentaro			Interorganelle trafficking of ceramide is regulated by phosphorylation-dependent cooperativity between the PH and START domains of CERT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; ENDOPLASMIC-RETICULUM; SERINE PALMITOYLTRANSFERASE; SPHINGOMYELIN SYNTHESIS; GOODPASTURE ANTIGEN; BINDING-PROTEIN; GOLGI; TRANSPORT; LOCALIZATION; RESISTANT	The synthesis and transport of lipids are essential events for membrane biogenesis. However, little is known about how intracellular trafficking of lipids is regulated. Ceramide is synthesized at the endoplasmic reticulum (ER) and transported by the ceramide transfer protein CERT to the Golgi apparatus, where it is converted to sphingomyelin. CERT has a phosphoinositidebinding pleckstrin homology (PH) domain for Golgi-targeting and a lipid transfer START domain for intermembrane transfer of ceramide. We here show that CERT receives multiple phosphorylations at a serine-repeat motif, a possibe site for casein kinase I, and that the phosphorylation down-regulates the ER-to-Golgi transport of ceramide. In vitro assays show that the phosphorylation induces an autoinhibitory interaction between the PH and START domains and consequently inactivates both the phosphoinositide binding and ceramide transfer activities of CERT. Loss of sphingomyelin and cholesterol from cells causes dephosphorylation of CERT to activate it. The cooperative control of functionally distinct domains of CERT is a novel molecular event to regulate the intracellular trafficking of ceramide.	Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	National Institute of Infectious Diseases (NIID); Japan Science & Technology Agency (JST)	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	hanak@nih.go.jp	Kumagai, Keigo/AAG-1385-2021; Shinkai-ouchi, Fumiko/E-3207-2010	Shinkai-ouchi, Fumiko/0000-0002-0095-941X; Hanada, Kentaro/0000-0003-1383-2781; Kumagai, Keigo/0000-0002-1663-2905; KAWANO-KAWADA, Miyuki/0000-0002-1168-9291				Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Kuyama H, 2003, RAPID COMMUN MASS SP, V17, P1493, DOI 10.1002/rcm.1078; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mogelsvang S, 2004, TRAFFIC, V5, P338, DOI 10.1111/j.1398-9219.2004.00186.x; Mohammadi A, 2001, J LIPID RES, V42, P1062; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Yanagisawa Y, 2006, J PATHOL, V209, P464, DOI 10.1002/path.2012; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200	31	86	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17758	17766		10.1074/jbc.M702291200	http://dx.doi.org/10.1074/jbc.M702291200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17442665	hybrid			2022-12-27	WOS:000247084500049
J	Bei, L; Lu, Y; Bellis, SL; Zhou, W; Horvath, E; Eklund, EA				Bei, Ling; Lu, YuFeng; Bellis, Susan L.; Zhou, Wei; Horvath, Elizabeth; Eklund, Elizabeth A.			Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta 3 integrin during myeloid differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEMATOPOIETIC-CELLS; BONE-MARROW-CELLS; DNA-BINDING; FIBRONECTIN RECEPTORS; VITRONECTIN RECEPTOR; INTERFERON-GAMMA; EXPRESSION; PROTEINS; FAMILY; BETA-1-INTEGRIN	Transcription of the ITGB3 gene, which encodes beta 3 integrin, increases during myeloid differentiation. alpha v beta 3 integrin mediates adhesion to fibronectin or vitronectin and regulates various aspects of the inflammatory response in mature phagocytes. In these studies, we found that the homeodomain transcription factor HoxA10 interacted with a specific ITGB3 cis element and activated transcription of this gene during myeloid differentiation. We also found that increased fibronectin adhesion in differentiating myeloid cells was dependent upon this HoxA10-induced increase in beta 3 integrin expression. We determined that activation of ITGB3 transcription required a HoxA10 domain that was not identical to the "hexapeptide" that mediates interaction of Hox and Pbx proteins. This activation domain was also not identical to a previously identified HoxA10 repression domain that mediates interaction with transcriptional co-repressors. Instead, this HoxA10 activation domain had homology to "PQ" protein-protein interaction domains that have been described previously in other transcription factors. Consistent with this, we found that the HoxA10 PQ-like domain recruited the CREB-binding protein (CBP) to the ITGB3 promoter. This was associated with an increase in local histone acetylation in vivo. In immature myeloid cells, we previously determined that HoxA10 repressed transcription of the CYBB and NCF2 genes, which encode the phagocyte oxidase proteins gp91(PHOX) and p67(PHOX), respectively. Therefore, our studies indicated that HoxA10 either activates or represses gene transcription at various points during myelopoiesis. Our studies also suggested that HoxA10 is a bifunctional protein that is involved in dynamic regulation of multiple aspects of phagocyte phenotype and function.	Northwestern Univ, Dept Med, Feinberg Sch, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Jesse Brown Vet Hlth Adm Hosp, Chicago, IL 60612 USA; Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Alabama System; University of Alabama Birmingham	Eklund, EA (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch, 710 N Fairbanks Ct,Olson 8524, Chicago, IL 60611 USA.	e-eklund@northwestern.edu						ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Bhatia R, 2002, EXP HEMATOL, V30, P324, DOI 10.1016/S0301-472X(01)00799-8; Bruyninckx WJ, 2001, BLOOD, V97, P3251, DOI 10.1182/blood.V97.10.3251; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Daftary GS, 2002, MOL ENDOCRINOL, V16, P571, DOI 10.1210/me.16.3.571; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 2002, J BIOL CHEM, V277, P36878, DOI 10.1074/jbc.M203917200; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Eklund EA, 2006, CURR OPIN HEMATOL, V13, P67, DOI 10.1097/01.moh.0000208467.63861.d6; FADOK VA, 1992, J IMMUNOL, V149, P4029; GARCIAVILLA M, 1994, BLOOD, V83, P668; HILL HR, 1993, INFECT IMMUN, V61, P2334, DOI 10.1128/IAI.61.6.2334-2339.1993; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; KLINGEMANN HG, 1989, BLOOD, V74, P1348; LARRICK JW, 1980, J IMMUNOL, V125, P6; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Lu YF, 2003, J BIOL CHEM, V278, P47792, DOI 10.1074/jbc.M305885200; NEWBURGER PE, 1988, P NATL ACAD SCI USA, V85, P5215, DOI 10.1073/pnas.85.14.5215; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; VERFAILLIE CM, 1991, J EXP MED, V174, P693, DOI 10.1084/jem.174.3.693; Wall CD, 1997, BLOOD CELL MOL DIS, V23, P361, DOI 10.1006/bcmd.1997.0153; Yan SR, 1999, CELL IMMUNOL, V195, P119, DOI 10.1006/cimm.1999.1524	37	43	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16846	16859		10.1074/jbc.M609744200	http://dx.doi.org/10.1074/jbc.M609744200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17439948	hybrid			2022-12-27	WOS:000246946500017
J	Hurd, TR; Prime, TA; Harbour, ME; Lilley, KS; Murphy, MP				Hurd, Thomas R.; Prime, Tracy A.; Harbour, Michael E.; Lilley, Kathryn S.; Murphy, Michael P.			Detection of reactive oxygen species-sensitive thiol proteins by redox difference gel electrophoresis - Implications for mitochondrial redox signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSPORT CHAIN; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; S-NITROSYLATION; NITRIC-OXIDE; COMPLEX-I; GLUTATHIONYLATION; DISULFIDE; CELLS; GENERATION	Reactive oxygen species (ROS) produced by the mitochondrial respiratory chain can be a redox signal, but whether they affect mitochondrial function is unclear. Here we show that low levels of ROS from the respiratory chain under physiological conditions reversibly modify the thiol redox state of mitochondrial proteins involved in fatty acid and carbohydrate metabolism. As these thiol modifications were specific and occurred without bulk thiol changes, we first had to develop a sensitive technique to identify the small number of proteins modified by endogenous ROS. In this technique, redox difference gel electrophoresis, control, and redox-challenged samples are labeled with different thiol-reactive fluorescent tags and then separated on the same two-dimensional gel, enabling the sensitive detection of thiol redox modifications by changes in the relative fluorescence of the two tags within a single protein spot, followed by protein identification by mass spectrometry. Thiol redox modification affected enzyme activity, suggesting that the reversible modification of enzyme activity by ROS from the respiratory chain may be an important and unexplored mode of mitochondrial redox signaling.	MRC, Dunn Human Nutr Unit, Cambridge CB2 0XY, England; Univ Cambridge, Dept Biochem, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Murphy, MP (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-dunn.cam.ac.uk	Murphy, Michael P/C-2120-2009; Lilley, Kathryn/ABF-5787-2020	Murphy, Michael P/0000-0003-1115-9618; Lilley, Kathryn/0000-0003-0594-6543	Medical Research Council [MC_U105663148, MC_U105663142] Funding Source: Medline; MRC [MC_U105663142, MC_U105663148] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akerboom T P, 1981, Methods Enzymol, V77, P373; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Beltran B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chappell J. B., 1972, SUBCELLULAR COMPONEN, P77; Chen K, 2004, J BIOL CHEM, V279, P35079, DOI 10.1074/jbc.M404859200; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; ELLMAN G, 1979, ANAL BIOCHEM, V93, P98, DOI 10.1016/S0003-2697(79)80122-0; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HUCHO F, 1972, Archives of Biochemistry and Biophysics, V151, P328, DOI 10.1016/0003-9861(72)90504-8; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; KALOUSEK F, 1980, J BIOL CHEM, V255, P60; Karp NA, 2004, PROTEOMICS, V4, P1421, DOI 10.1002/pmic.200300681; KIL JS, 2005, J BIOL CHEM, V280, P10486; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Korge P, 2006, AM J PHYSIOL-HEART C, V291, pH1436, DOI 10.1152/ajpheart.01292.2005; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; PETTIT FH, 1982, P NATL ACAD SCI-BIOL, V79, P3945, DOI 10.1073/pnas.79.13.3945; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Shaw J, 2003, PROTEOMICS, V3, P1181, DOI 10.1002/pmic.200300439; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Svensson LT, 1998, BIOCHEM J, V329, P601, DOI 10.1042/bj3290601; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	53	119	122	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22040	22051		10.1074/jbc.M703591200	http://dx.doi.org/10.1074/jbc.M703591200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17525152	hybrid			2022-12-27	WOS:000248196800051
J	Ruiz-Ederra, J; Zhang, H; Verkman, AS				Ruiz-Ederra, Javier; Zhang, Hua; Verkman, A. S.			Evidence against functional interaction between aquaporin-4 water channels and Kir4.1 potassium channels in retinal muller cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNEL; ALPHA-SYNTROPHIN; GLIAL-CELLS; MICE; EXPRESSION; LACKING; MEMBRANE; BRAIN; K-AB-2/KIR4.1; LOCALIZATION	Indirect evidence suggests that the Muller/glial cell water channel aquaporin-4 (AQP4) modulates K+ channel function of the closely associated Kir4.1 protein. We used patch clamp to compare Kir4.1 K+ channel function in freshly isolated Muller cells from retinas of wild-type (+/+) and AQP4 knock-out (-/-) mice. Immunocytochemistry showed a comparable Kir4.1 protein expression pattern in Muller cells from +/+ and -/- retinas, with greatest expression at their end feet. Osmotic water permeability was >4-fold reduced in -/- than in +/+ Muller cells. Resting membrane potential did not differ significantly in +/+ versus -/- Muller cells (-64 +/- 1 versus -64 +/- 1 mV, S. E., n = 24). Whole-cell K+ currents recorded with a micropipette inserted into the cell soma were Ba2+-sensitive and showed no significant differences in magnitude in +/+ versus -/- Muller cells (1.3 +/- 0.1 versus 1.2 +/- 0.1 nA at -160 mV) or in inwardly rectifying current- voltage relationships. Spatially resolved K+ currents generated by pulsed K+ injections along Muller cell bodies were also comparable in +/+ versus -/- Muller cells. Single-channel cell-attached patch clamp showed comparable unitary conductance, current- voltage data, and open probability in +/+ versus -/- Muller cells. Thus, contrary to the generally accepted view, our results provide direct evidence against functionally significant AQP4 modulation of Muller cell Kir4.1 K+ channel function.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med & Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med & Physiol, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	verkman@itsa.ucsf.edu	Ederra, Javier Ruiz/H-9687-2017	Ederra, Javier Ruiz/0000-0001-8486-8592	NEI NIH HHS [EY13574] Funding Source: Medline; NHLBI NIH HHS [HL59198, HL73856] Funding Source: Medline; NIBIB NIH HHS [EB00415] Funding Source: Medline; NIDDK NIH HHS [DK72517, DK35124] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; CHAO TI, 1994, PFLUG ARCH EUR J PHY, V426, P51, DOI 10.1007/BF00374670; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; Connors NC, 2006, GLIA, V53, P124, DOI 10.1002/glia.20271; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; Ishii M, 1997, J NEUROSCI, V17, P7725; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Kusaka S, 1999, J PHYSIOL-LONDON, V520, P373, DOI 10.1111/j.1469-7793.1999.00373.x; Kusaka S, 1997, J PHYSIOL-LONDON, V500, P593, DOI 10.1113/jphysiol.1997.sp022045; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Newman EA, 1996, J NEUROSCI, V16, P159; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Solessio E, 2000, J NEUROPHYSIOL, V83, P418, DOI 10.1152/jn.2000.83.1.418; Tada Y, 1998, JPN J PHYSIOL, V48, P71, DOI 10.2170/jjphysiol.48.71; TAKUMI T, 1995, J BIOL CHEM, V270, P16339, DOI 10.1074/jbc.270.27.16339; Takumi Y, 1998, EUR J NEUROSCI, V10, P3584, DOI 10.1046/j.1460-9568.1998.00360.x	31	87	94	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21866	21872		10.1074/jbc.M703236200	http://dx.doi.org/10.1074/jbc.M703236200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17525153	hybrid			2022-12-27	WOS:000248196800034
J	Aoyagi, H; Hasegawa, M; Tamaoka, A				Aoyagi, Hirofumi; Hasegawa, Masato; Tamaoka, Akira			Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L Tau but not wild-type Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; MICROTUBULE-BINDING REGION; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; FTDP-17 MUTATIONS; PROTEIN-TAU; ALPHA-SYNUCLEIN; SULFATED GLYCOSAMINOGLYCANS; MONOCLONAL-ANTIBODIES; PHOSPHORYLATION SITES	Frontotemporal dementia and parkinsonism linked to chromosome 17 ( FTDP-17), an autosomal, dominantly inherited neurodegenerative disorder caused by tau gene mutations, is neuropathologically characterized by intraneuronal filamentous inclusions of hyperphosphorylated tau protein. Biochemical and immunocytochemical analyses have shown that only mutant tau is deposited in patients harboring P301L missense mutation, whereas both wild-type and mutant tau are deposited in patients harboring R406W mutation (Miyasaka, T., Morishima-Kawashima, M., Ravid, R., Kamphorst, W., Nagashima, K., and Ihara, Y. (2001) J. Neuropathol. Exp. Neurol. 60, 872-884 and Miyasaka, T., Morishima-Kawashima, M., Ravid, R., Heutink, P., van Swieten, J. C., Nagashima, K., and Ihara, Y. ( 2001) Am. J. Pathol. 158, 373-379). Here we have tested the nucleation ability of monomeric tau and the seeding ability of fibrillogenic nuclei obtained from bacterially expressed human tau. P301L mutant tau showed a higher nucleation ability than wild-type tau, whereas R406W mutant tau shows similar ability to wild-type tau. Surprisingly, fibrillogenic nuclei composed of P301L mutant tau enhanced the assembly of P301L mutant tau into filaments but did not promote filament formation from wild- type tau. In contrast, nuclei composed of R406W mutant tau supported filament formation from both wild- type tau and R406W mutant tau, as did nuclei composed of wild- type tau. Proteolytic analyses indicated that the substructure of nuclei composed of P301L mutant tau was different from that of nuclei composed of wild- type or R406W mutant tau. Thus, the interaction between fibrillogenic nuclei and monomeric protein appears to play an important role in the mechanism of tau filament assembly.	Eisai & Co Ltd, Discovery Res Labs, Tsukuba, Ibaraki, Japan; Tokyo Inst Psychiat, Dept Mol Neurobiol, Tokyo Metropolitan Org Med Res, Setagaya Ku, Tokyo 1568585, Japan; Univ Tsukuba, Inst Clin Med, Dept Neurol, Tsukuba, Ibaraki 305, Japan	Eisai Co Ltd; Tokyo Institute of Psychiatry; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba	Hasegawa, M (corresponding author), Eisai & Co Ltd, Discovery Res Labs, 5-1-3 Tokodai, Tsukuba, Ibaraki, Japan.	masato@prit.go.jp						Arrasate M, 1999, FEBS LETT, V446, P199, DOI 10.1016/S0014-5793(99)00210-0; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Bird TD, 1999, BRAIN, V122, P741, DOI 10.1093/brain/122.4.741; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hasegawa M, 1996, FEBS LETT, V384, P25, DOI 10.1016/0014-5793(96)00271-2; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; ISHIGURO K, 1991, NEUROSCI LETT, V128, P195, DOI 10.1016/0304-3940(91)90259-V; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Rizzu P, 2000, HUM MOL GENET, V9, P3075, DOI 10.1093/hmg/9.20.3075; Saito Y, 2002, NEUROLOGY, V58, P811, DOI 10.1212/WNL.58.5.811; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; van Swieten JC, 1999, ANN NEUROL, V46, P617, DOI 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	46	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20309	20318		10.1074/jbc.M611876200	http://dx.doi.org/10.1074/jbc.M611876200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17526496	hybrid			2022-12-27	WOS:000247819300034
J	Drake, EJ; Cao, J; Qu, J; Shah, MB; Straubinger, RM; Gulick, AM				Drake, Eric J.; Cao, Jin; Qu, Jun; Shah, Manish B.; Straubinger, Robert M.; Gulick, Andrew M.			The 1.8 A crystal structure of PA2412, an MbtH-like protein from the pyoverdine cluster of Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; MYCOBACTERIUM-TUBERCULOSIS; SIDEROPHORE BIOSYNTHESIS; STREPTOMYCES-COELICOLOR; ESCHERICHIA-COLI; MASS-SPECTROMETRY; IDENTIFICATION; ENTEROBACTIN; ANTIBIOTICS; EXPRESSION	Many bacteria use nonribosomal peptide synthetase (NRPS) proteins to produce peptide antibiotics and siderophores. The catalytic domains of the NRPS proteins are usually linked in large multidomain proteins. Often, additional proteins are coexpressed with NRPS proteins that modify the NRPS peptide products, ensure the availability of substrate building blocks, or play a role in the import or export of the NRPS product. Many NRPS clusters include a small protein of similar to 80 amino acids with homology to the MbtH protein of mycobactin synthesis in Mycobacteria tuberculosis; no function has been assigned to these proteins. Pseudomonas aeruginosa utilizes an NRPS cluster to synthesize the siderophore pyoverdine. The pyoverdine peptide contains a dihydroxyquinoline-based chromophore, as well as two formyl-N-hydroxyornithine residues, which are involved in iron binding. The pyoverdine cluster contains four modular NRPS enzymes and 10 - 15 additional proteins that are essential for pyoverdine production. Coexpressed with the pyoverdine synthetic enzymes is a 72-amino acid MbtH-like family member designated PA2412. We have determined the three-dimensional structure of the PA2412 protein and describe here the structure and the location of conserved regions. Additionally, we have further analyzed a deletion mutant of the PA2412 protein for growth and pyoverdine production. Our results demonstrate that PA2412 is necessary for the production or secretion of pyoverdine at normal levels. The PA2412 deletion strain is able to use exogenously produced pyoverdine, showing that there is no defect in the uptake or utilization of the iron-pyoverdine complex.	Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Dept Pharmaceut Sci, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gulick, AM (corresponding author), Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	gulick@hwi.buffalo.edu	Shah, Manish/H-6158-2011	Gulick, Andrew/0000-0003-4238-7453; Shah, Manish/0000-0001-8593-6446	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021221, S10RR014592, S10RR023650, S10RR024521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068440] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR 021221, S10 RR024521-01A1, S10 RR 023650, S10 RR023650, S10 RR014592-01, S10 RR024521, S10 RR021221-01, S10 RR 014592, S10 RR021221, S10 RR023650-01, S10 RR021221-010002] Funding Source: Medline; NIGMS NIH HHS [R01 GM068440, GM 068440] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans SP, 1999, J MOL BIOL, V291, P661, DOI 10.1006/jmbi.1999.2971; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Fuchs R, 2001, CURR ORG CHEM, V5, P265, DOI 10.2174/1385272013375562; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Gulick AM, 2002, ACTA CRYSTALLOGR D, V58, P306, DOI 10.1107/S0907444901018832; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kilz S, 1999, J MASS SPECTROM, V34, P281, DOI 10.1002/(SICI)1096-9888(199904)34:4<281::AID-JMS750>3.0.CO;2-M; LaBaer J, 2004, GENOME RES, V14, P2190, DOI 10.1101/gr.2482804; Lauer B, 2000, EUR J BIOCHEM, V267, P1698, DOI 10.1046/j.1432-1327.2000.01162.x; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Lin H, 2005, J AM CHEM SOC, V127, P11075, DOI 10.1021/ja0522027; Magarvey NA, 2006, ANTIMICROB AGENTS CH, V50, P2167, DOI 10.1128/AAC.01545-05; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Miethke M, 2006, FEBS J, V273, P409, DOI 10.1111/j.1742-4658.2005.05077.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Rayment I, 2002, STRUCTURE, V10, P147, DOI 10.1016/S0969-2126(02)00711-6; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Renders N, 2001, INFECT GENET EVOL, V1, P29, DOI 10.1016/S1567-1348(01)00004-1; RUSNAK F, 1991, BIOCHEMISTRY-US, V30, P2916, DOI 10.1021/bi00225a027; Somu RV, 2006, J MED CHEM, V49, P31, DOI 10.1021/jm051060o; Stegmann E, 2006, FEMS MICROBIOL LETT, V262, P85, DOI 10.1111/j.1574-6968.2006.00368.x; Stintzi A, 1999, J BACTERIOL, V181, P4118, DOI 10.1128/JB.181.13.4118-4124.1999; Sundlov JA, 2006, ACTA CRYSTALLOGR D, V62, P734, DOI 10.1107/S0907444906015824; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Van Roey P, 2002, NAT STRUCT BIOL, V9, P806, DOI 10.1038/nsb853; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Wilderman PJ, 2001, INFECT IMMUN, V69, P5385, DOI 10.1128/IAI.69.9.5385-5394.2001; Wolpert M, 2007, MICROBIOL-SGM, V153, P1413, DOI 10.1099/mic.0.2006/002998-0; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	45	53	54	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20425	20434		10.1074/jbc.M611833200	http://dx.doi.org/10.1074/jbc.M611833200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502378	hybrid			2022-12-27	WOS:000247819300045
J	Hong, E; Lee, HM; Ko, H; Kim, DU; Jeon, BY; Jung, J; Shin, J; Lee, SA; Kim, Y; Jeon, YH; Cheong, C; Cho, HS; Lee, W				Hong, Eunmi; Lee, Hyang Mi; Ko, Hyunsook; Kim, Dong-Uk; Jeon, Byoung-Young; Jung, Jinwon; Shin, Joon; Lee, Sung-Ah; Kim, Yangmee; Jeon, Young Ho; Cheong, Chaejoon; Cho, Hyun-Soo; Lee, Weontae			Structure of an atypical orphan response regulator protein supports a new phosphorylation-independent regulatory mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURE DETERMINATION; 2-COMPONENT SIGNAL-TRANSDUCTION; RNA-POLYMERASE INTERACTION; DNA-BINDING DOMAIN; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL ACTIVATOR; STRUCTURE REFINEMENT; CHEMICAL-SHIFT; NMR	Two-component signal transduction systems, commonly found in prokaryotes, typically regulate cellular functions in response to environmental conditions through a phosphorylation-dependent process. A new type of response regulator, hp1043 (HP-RR) from Helicobacterpylori, hasbeenrecentlyidentified. HP-RR is essential for cell growth and does not require the well known phosphorelay scheme. Unphosphorylated HP-RR binds specifically to its own promoter (P-1043) and autoregulates the promoter of the tlpB gene (P-tlpB). We have determined the structure of HP-RR by NMR and x-ray crystallography, revealing a symmetrical dimer with two functional domains. The molecular topology resembles that of the OmpR/PhoB subfamily, however, the symmetrical dimer is stable even in the unphosphorylated state. The dimer interface, formed by three secondary structure elements (alpha 4-beta 5-alpha 5), resembles that of the active, phosphorylated forms of ArcA and PhoB. Several conserved residues of the HP-RR dimeric interface deviate from the OmpR/PhoB subfamily, although there are similar salt bridges and hydrophobic patches within the interface. Our findings reveal how a new type of response regulator protein could function as a cell growth-associated regulator in the absence of post-translational modification.	Yonsei Univ, Dept Biochem, HTSD NMR & Applicat NRL, Seoul 120749, South Korea; Yonsei Univ, Protien Network Res ctr, Dept Biol, Seoul, South Korea; Konkuk Univ, Dept Biosci & Biotechnol, Div Biosci & Biotechnol, Seoul 363883, South Korea; Korea Basic Sci Inst, Magnet Resonance Team, Chungbuk 363883, South Korea	Yonsei University; Yonsei University; Konkuk University; Korea Basic Science Institute (KBSI)	Cho, HS (corresponding author), Yonsei Univ, Coll Sci, Dept Biochem, 134 Shinchon-Dong, Seoul 120749, South Korea.	hscho8@yonsei.ac.kr; wlee@spin.yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021; Jung, Jinwon/F-6038-2010; kim, yangmee/D-8297-2011; Jeon, Young Ho/F-4483-2011; Cheong, Chaejoon/GWC-3135-2022	Jung, Jinwon/0000-0002-7981-3316; Lee, Weontae/0000-0003-2347-1262				Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Baikalov I, 1998, BIOCHEMISTRY-US, V37, P3665, DOI 10.1021/bi972365a; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beier D, 2000, J BACTERIOL, V182, P2068, DOI 10.1128/JB.182.8.2068-2076.2000; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Boucher PE, 1997, J BACTERIOL, V179, P1755, DOI 10.1128/jb.179.5.1755-1763.1997; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Delany I, 2002, J BACTERIOL, V184, P4800, DOI 10.1128/JB.184.17.4800-4810.2002; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Eisenbach M, 1996, MOL MICROBIOL, V20, P903, DOI 10.1111/j.1365-2958.1996.tb02531.x; Goddard T.D., 2004, SPARKY 3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Halkides CJ, 2000, BIOCHEMISTRY-US, V39, P5280, DOI 10.1021/bi9925524; Hong EM, 2004, J BIOMOL NMR, V28, P85, DOI 10.1023/B:JNMR.0000012833.26132.f5; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee HM, 2006, BBA-PROTEINS PROTEOM, V1764, P989, DOI 10.1016/j.bbapap.2005.10.024; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; Liu W, 1997, J BACTERIOL, V179, P6302, DOI 10.1128/jb.179.20.6302-6310.1997; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Muller S, 2007, MICROBIOL RES, V162, P1, DOI 10.1016/j.micres.2006.01.003; Okamura H, 2000, J MOL BIOL, V295, P1225, DOI 10.1006/jmbi.1999.3379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelton JG, 1999, J MOL BIOL, V292, P1095, DOI 10.1006/jmbi.1999.3140; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Simonovic M, 2001, J BIOL CHEM, V276, P28637, DOI 10.1074/jbc.C100295200; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Zu T, 1996, MOL MICROBIOL, V21, P557, DOI 10.1111/j.1365-2958.1996.tb02564.x	49	48	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20667	20675		10.1074/jbc.M609104200	http://dx.doi.org/10.1074/jbc.M609104200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17491010	hybrid			2022-12-27	WOS:000247819300069
J	Wood, A; Garg, P; Burgers, PMJ				Wood, Adam; Garg, Parie; Burgers, Peter M. J.			A ubiquitin-binding motif in the translesion DNA polymerase Rev1 mediates its essential functional interaction with ubiquitinated proliferating cell nuclear antigen in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-THYMINE DIMER; REPLICATION FACTOR-C; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; POL-ETA; IN-VIVO; PROTEIN INTERACTS; CLAMP LOADERS; ABASIC SITES; PCNA	During normalDNAreplication, the proliferating cell nuclear antigen (PCNA) enhances the processivity of DNA polymerases at the replication fork. When DNA damage is encountered, PCNA is monoubiquitinated on Lys-164 by the Rad6-Rad18 complex as the initiating step of translesion synthesis. DNA damage bypass by the translesion synthesis polymerase Rev1 is enhanced by the presence of ubiquitinated PCNA. Here we have carried out a mutational analysis of Rev1, and we have identified the functional domain in the C terminus of Rev1 that mediates interactions with PCNA. We show that a unique motif within this domain binds the ubiquitin moiety of ubiquitinated PCNA. Point mutations within this ubiquitin-binding motif of Rev1 (L821A, P822A, I825A) abolish its functional interaction with ubiquitinated PCNA in vitro and strongly attenuate damage-induced mutagenesis in vivo. Taken together, these studies suggest a specific mechanism by which the interaction between Rev1 and ubiquitinated PCNA is stabilized during the DNA damage response.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032431, GM 032431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Garg P, 2005, CELL CYCLE, V4, P221; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Haracska L, 2003, MOL CELL BIOL, V23, P1453, DOI 10.1128/MCB.23.4.1453-1459.2003; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Hochegger H, 2004, BIOESSAYS, V26, P151, DOI 10.1002/bies.10403; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Lehmann AR, 2003, CELL CYCLE, V2, P300, DOI 10.4161/cc.2.4.407; LEMONTT JF, 1971, GENETICS, V68, P21; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Northam MR, 2006, EMBO J, V25, P4316, DOI 10.1038/sj.emboj.7601320; Otsuka C, 2005, MUTAT RES-FUND MOL M, V578, P79, DOI 10.1016/j.mrfmmm.2005.03.005; Pessoa-Brandao L, 2004, GENETICS, V167, P1597, DOI 10.1534/genetics.103.021675; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; QUAH SK, 1980, GENETICS, V96, P819; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zhao B, 2004, NUCLEIC ACIDS RES, V32, P3984, DOI 10.1093/nar/gkh710; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	54	92	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20256	20263		10.1074/jbc.M702366200	http://dx.doi.org/10.1074/jbc.M702366200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17517887	hybrid			2022-12-27	WOS:000247819300028
J	Wu, HY; Hsu, FC; Gleichman, AJ; Baconguis, I; Coulter, DA; Lynch, DR				Wu, Hai-Yan; Hsu, Fu-Chun; Gleichman, Amy J.; Baconguis, Isabelle; Coulter, Douglas A.; Lynch, David R.			Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; NMDA-RECEPTOR; TYROSINE PHOSPHORYLATION; GLUTAMATE RECEPTORS; SURFACE EXPRESSION; EPSILON-2 SUBUNIT; MUTANT MICE; CELL-DEATH; PROTEIN; KINASE	Cleavage of the intracellular carboxyl terminus of the N-methyl-D-aspartate ( NMDA) receptor 2 subunit (NR2) by calpain regulates NMDA receptor function and localization. Here, we show that Fyn-mediated phosphorylation of NR2B controls calpain-mediated NR2B cleavage. In cultured neurons, calpain-mediated NR2B cleavage is significantly attenuated by blocking NR2B phosphorylation of Tyr-1336, but not Tyr-1472, via inhibition of Src family kinase activity or decreasing Fyn levels by small interfering RNA. In HEK cells, mutation of Tyr1336 eliminates the potentiating effect of Fyn on calpain-mediated NR2B cleavage. The potentiation of NR2B cleavage by Fyn is limited to cell surface receptors and is associated with calpain translocation to plasma membranes during NMDA receptor activation. Finally, reducing full-length NR2B by calpain does not decrease extrasynaptic NMDA receptor function, and truncated NR1/2B receptors similar to those generated by calpain have electrophysiological properties matching those of wild-type receptors. Thus, the Fyn-controlled regulation of NMDA receptor cleavage by calpain may play critical roles in controlling NMDA receptor properties during synaptic plasticity and excitotoxicity.	Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lynch, DR (corresponding author), Childrens Hosp Philadelphia, Div Neurol, 502 Abramson Bldg, Philadelphia, PA 19104 USA.	lynch@pharm.med.upenn.edu	Baconguis, Isabelle/AAH-3790-2021	Baconguis, Isabelle/0000-0002-5440-2289; Coulter, Douglas/0000-0002-1486-119X; Gleichman, Amy/0000-0003-1029-4471	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS045986, R01NS032403, R01NS045986, R01NS038572, R37NS032403] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS038572-09, R01 NS038572, R01 NS032403-09, NS 45986, R37 NS032403-14, R56 NS045986, R37 NS032403, R01 NS032403, R01 NS045986] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANEGAWA NJ, 1995, J NEUROCHEM, V64, P2004; Araujo IM, 2005, NEUROREPORT, V16, P393; ARIYOSHI H, 1993, BIOCHEM MOL BIOL INT, V30, P63; Cheung HH, 2001, J NEUROCHEM, V78, P524, DOI 10.1046/j.1471-4159.2001.00433.x; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Dong YN, 2006, J NEUROCHEM, V99, P206, DOI 10.1111/j.1471-4159.2006.04096.x; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; Grant ER, 1997, J BIOL CHEM, V272, P647; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Gurd JW, 1997, J NEUROCHEM, V69, P623; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; HANKE JH, 1996, I BIOL CHEM, V271, P695; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kalia LV, 2003, NEUROPHARMACOLOGY, V45, P720, DOI 10.1016/S0028-3908(03)00313-7; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lynch DR, 2001, CURR DRUG TARGETS, V2, P215, DOI 10.2174/1389450013348434; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Lynch DR, 2001, EUR J PHARMACOL, V416, P185, DOI 10.1016/S0014-2999(01)00868-8; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; PONTREMOLI S, 1989, BIOCHEM BIOPH RES CO, V160, P737, DOI 10.1016/0006-291X(89)92495-9; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Sala C, 1999, P NATL ACAD SCI USA, V96, P335, DOI 10.1073/pnas.96.2.335; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sims KD, 2000, J BIOL CHEM, V275, P5228, DOI 10.1074/jbc.275.7.5228; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Yaka R, 2003, J NEUROSCI, V23, P3623; Yang M, 2001, J NEUROCHEM, V77, P580, DOI 10.1046/j.1471-4159.2001.00255.x; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634	48	69	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20075	20087		10.1074/jbc.M700624200	http://dx.doi.org/10.1074/jbc.M700624200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17526495	hybrid, Green Accepted			2022-12-27	WOS:000247819300008
J	Fujimura, T; Esteban, R				Fujimura, Tsutomu; Esteban, Rosa			Interactions of the RNA polymerase with the viral genome at the 5 '- and 3 '-ends contribute to 20S RNA narnavirus persistence in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED RNA; BIPARTITE 3'-CIS-ACTING SIGNAL; INFLUENZA-VIRUS POLYMERASE; 23 S RNA; SACCHAROMYCES-CEREVISIAE; IN-VIVO; 20-S RNA; ENCAPSIDATION SIGNAL; POLIOVIRUS RNA; REPLICATION	20S RNA narnavirus is a positive strand RNA virus found in the yeast Saccharomyces cerevisiae. The viral genome (2514 nucleotides) only encodes a single protein (p91), the RNA-dependent RNA polymerase and does not have capsid proteins to form intracellular virions. The genomic RNA has no 3' poly(A) tail and perhaps no cap structure at the 5'-end; thus resembling an intermediate of mRNA degradation. The virus, however, escapes the host surveillance and replicates in the yeast cytoplasm persistently. The viral genome is not naked but exists in the form of a ribonucleoprotein complex with p91 in a 1:1 stoichiometry. Here we investigated interactions between p91 and the viral genome. Our results indicate that p91 directly or indirectly interacts with theRNAat the 5'- and 3'-end regions and to a lesser extent at a central part. The 3'-end site is identical to or overlaps with the 3'-cis signal for replication identified previously. The 5'-site is at the second stem loop structure from the 5'-end ( nucleotides 72-104), and this structure also contains a cis signal for replication. Analysis of mutants in the structure revealed a tight correlation between replication and formation of complexes. These results highlight the importance of ribonucleoprotein complexes for the viral life cycle. We will discuss implications of these findings especially on how the virus escapes from mRNA degradation pathways and resides in the cytoplasm persistently despite the lack of a protective capsid.	Univ Salamanca, Inst Microbiol Bioquim, CSIC, Dept Genet & Microbiol, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Fujimura, T (corresponding author), Univ Salamanca, Inst Microbiol Bioquim, CSIC, Avda Campo Charro S-N, Salamanca 37007, Spain.	tfujimura@usal.es	Fujimura, Tsutomu/K-5807-2014; Esteban, Rosa/K-4356-2014	Fujimura, Tsutomu/0000-0002-9457-6769; Esteban, Rosa/0000-0001-6804-7209				AHMED R, 1999, PERSISTENT VIRAL INF; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Barton DJ, 2001, EMBO J, V20, P1439, DOI 10.1093/emboj/20.6.1439; ESTEBAN LM, 1994, J BIOL CHEM, V269, P29771; ESTEBAN R, 1989, EMBO J, V8, P947, DOI 10.1002/j.1460-2075.1989.tb03456.x; Esteban R, 2005, J BIOL CHEM, V280, P33725, DOI 10.1074/jbc.M506546200; Esteban R., 2006, RECENT ADV RNA VIRUS, P171; Fujimura T, 2005, J BIOL CHEM, V280, P7398, DOI 10.1074/jbc.M412048200; FUJIMURA T, 1990, CELL, V62, P819, DOI 10.1016/0092-8674(90)90125-X; Fujimura T, 2004, J BIOL CHEM, V279, P44219, DOI 10.1074/jbc.M408530200; Fujimura T, 2004, J BIOL CHEM, V279, P13215, DOI 10.1074/jbc.M313797200; Fujimura T, 2000, J BIOL CHEM, V275, P37118, DOI 10.1074/jbc.M005245200; GARCIACUELLAR MP, 1995, J BIOL CHEM, V270, P20084, DOI 10.1074/jbc.270.34.20084; GARCIACUELLAR MP, 1996, IN VITRO REPLICATION; Herold J, 2001, MOL CELL, V7, P581, DOI 10.1016/S1097-2765(01)00205-2; KADOWAKI K, 1971, J BACTERIOL, V105, P826, DOI 10.1128/JB.105.3.826-830.1971; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; MATSUMOTO Y, 1990, P NATL ACAD SCI USA, V87, P7628, DOI 10.1073/pnas.87.19.7628; MATSUMOTO Y, 1991, J BIOL CHEM, V266, P12779; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Rodriguez-Cousino N, 1998, J BIOL CHEM, V273, P20363, DOI 10.1074/jbc.273.32.20363; RODRIGUEZCOUSINO N, 1991, J BIOL CHEM, V266, P12772; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Solorzano A, 2000, J BIOL CHEM, V275, P26428, DOI 10.1074/jbc.M002281200; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; TOHE A, 1978, J BACTERIOL, V136, P1002, DOI 10.1128/JB.136.3.1002-1007.1978; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; WEJKSNORA PJ, 1978, J BACTERIOL, V134, P246, DOI 10.1128/JB.134.1.246-260.1978; WESOLOWSKI M, 1984, MOL CELL BIOL, V4, P181, DOI 10.1128/MCB.4.1.181; WICKNER RB, 2000, VIRUS TAXONOMY, P651; WIDNER WR, 1991, MOL CELL BIOL, V11, P2905, DOI 10.1128/MCB.11.5.2905; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; ZUKER M, 1999, ALGORITHMS THERMODYN	34	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19011	19019		10.1074/jbc.M702432200	http://dx.doi.org/10.1074/jbc.M702432200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17478418	hybrid			2022-12-27	WOS:000247475300043
J	Pillinger, MH; Marjanovic, N; Kim, SY; Lee, YC; Scher, JU; Roper, J; Abeles, AM; Izmirly, PI; Axelrod, M; Pillinger, MY; Tolani, S; Dinsell, V; Abramson, SB; Blaser, MJ				Pillinger, Michael H.; Marjanovic, Nada; Kim, Seok-Yong; Lee, Yong-Chan; Scher, Jose U.; Roper, Jatin; Abeles, Aryeh M.; Izmirly, Peter I.; Axelrod, Matthew; Pillinger, Mara Y.; Tolani, Sonia; Dinsell, Victoria; Abramson, Steven B.; Blaser, Martin J.			Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PATHWAY; VIRULENCE FACTOR CAGA; P38 MAP KINASE; FACTOR-KAPPA-B; MATRIX METALLOPROTEINASES; PATHOGENICITY ISLAND; IN-VITRO; MATRIX-METALLOPROTEINASE-9 EXPRESSION; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX	Because the mechanisms of Helicobacter pylori-induced gastric injury are incompletely understood, we examined the hypothesis that H. pylori induces matrix metalloproteinase-1 (MMP-1) secretion, with potential to disrupt gastric stroma. We further tested the role of CagA, an H. pylori virulence factor, in MMP-1 secretion. Co-incubation of AGS cells with Tx30a, an H. pylori strain lacking the cagA virulence gene, stimulated MMP-1 secretion, confirming cagA-independent secretion. Co-incubation with strain 147C (cagA(+)) resulted in CagA translocation into AGS cells and increased MMP-1 secretion relative to Tx30a. Transfection of cells with the recombinant 147C cagA gene also induced MMP-1 secretion, indicating that CagA can independently stimulate MMP-1 secretion. Co-incubation with strain 147A, containing a cagA gene that lacks an EPIYA tyrosine phosphorylation motif, as well as transfection with 147A cagA, yielded an MMP-1 secretion intermediate between no treatment and 147C, indicating that CagA tyrosine phosphorylation regulates cellular signaling in this model system. H. pylori induced activation of the MAP kinase ERK, with CagA-independent (early) and dependent (later) components. MEK inhibitors UO126 and PD98059 inhibited both CagA-independent and -dependent MMP-1 secretion, whereas p38 inhibition enhanced MMP-1 secretion and ERK activation, suggesting p38 negative regulation of MMP-1 and ERK. These data indicate H. pylori effects on host epithelial MMP-1 expression via ERK, with p38 playing a potential regulatory role.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; New York Harbor Helathcare Syst, Dept Vet Affairs, Med Serv, New York, NY 10010 USA; NYU, Hosp Joint Dis, Dept Rheumatol, New York, NY 10003 USA; Chungbuk Natl Univ, Coll Med, Dept Microbiol, Cheongju 361763, South Korea; Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea	New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Chungbuk National University; Yonsei University; Yonsei University Health System	Pillinger, MH (corresponding author), New York Harbor Healthcare Syst, 423 E 23rd St, New York, NY 10010 USA.	michael.pillinger@med.nyu.edu	Abeles, Aryeh M./AAD-1874-2019	Pillinger, Michael/0000-0003-3168-1542; Pillinger, Mara/0000-0002-6692-5407; Abramson, Steven/0000-0002-0668-6344; Roper, Jatin/0000-0002-8851-1352; Dinsell, Victoria/0000-0002-5067-3698; Abeles, Aryeh/0000-0003-2940-7114	NIAMS NIH HHS [R01-AR47206-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM63270] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Aras RA, 2003, J INFECT DIS, V188, P486, DOI 10.1086/377098; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; BARRANCO SC, 1983, CANCER RES, V43, P1703; Bebb JR, 2003, GUT, V52, P1408, DOI 10.1136/gut.52.10.1408; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; Bou-Gharios G, 2004, CELL PROLIFERAT, V37, P207, DOI 10.1111/j.1365-2184.2004.00306.x; Brauchle M, 2000, EXP CELL RES, V258, P135, DOI 10.1006/excr.2000.4913; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; COBB MH, 1994, SEMIN CANCER BIOL, V5, P261; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Crawford HC, 2003, GASTROENTEROLOGY, V125, P1125, DOI 10.1016/S0016-5085(03)01206-X; CREWS CM, 1992, P NATL ACAD SCI USA, V89, P8205, DOI 10.1073/pnas.89.17.8205; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cunnane G, 2001, ARTHRITIS RHEUM-US, V44, P1744, DOI 10.1002/1529-0131(200108)44:8<1744::AID-ART309>3.0.CO;2-K; Danese S, 2004, GASTROENTEROLOGY, V126, P369, DOI 10.1053/j.gastro.2003.06.007; Ding XZ, 2001, BIOCHEM BIOPH RES CO, V282, P447, DOI 10.1006/bbrc.2001.4595; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Foster ML, 2000, DRUG NEWS PERSPECT, V13, P488; GILLESSEN A, 1993, SCAND J GASTROENTERO, V28, P688, DOI 10.3109/00365529309098273; Gooz M, 2001, AM J PHYSIOL-GASTR L, V281, pG823, DOI 10.1152/ajpgi.2001.281.3.G823; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; Honda M, 1996, GUT, V39, P444, DOI 10.1136/gut.39.3.444; Huntington JT, 2004, J BIOL CHEM, V279, P33168, DOI 10.1074/jbc.M405102200; Johansson N, 2000, J CELL SCI, V113, P227; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kalmes A, 1999, FEBS LETT, V444, P71, DOI 10.1016/S0014-5793(99)00034-4; Keates S, 1999, J IMMUNOL, V163, P5552; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kim SY, 2006, CELL MICROBIOL, V8, P97, DOI 10.1111/j.1462-5822.2005.00603.x; Kitoh T, 2004, J GASTROENTEROL, V39, P434, DOI 10.1007/s00535-003-1316-3; Kobayashi N, 2001, J PHYSIOL PHARMACOL, V52, P195; Koyama S, 2004, SCAND J GASTROENTERO, V39, P1046, DOI 10.1080/00365520410003245; Krueger S, 2006, J BIOL CHEM, V281, P2868, DOI 10.1074/jbc.m511053200; Kundu P, 2006, J BIOL CHEM, V281, P34651, DOI 10.1074/jbc.M604574200; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; Lin B, 2001, J INFECT DIS, V184, P174, DOI 10.1086/322000; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; Menges M, 2000, Z GASTROENTEROL, V38, P887, DOI 10.1055/s-2000-10300; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Mitsuno Y, 2001, GUT, V49, P18, DOI 10.1136/gut.49.1.18; Mori N, 2003, GASTROENTEROLOGY, V124, P983, DOI 10.1053/gast.2003.50152; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Moss SF, 2001, CANCER RES, V61, P1406; Murray GI, 1998, GUT, V43, P791, DOI 10.1136/gut.43.6.791; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Nomura AMY, 2002, J INFECT DIS, V186, P1138, DOI 10.1086/343808; Nomura AMY, 2002, AM J EPIDEMIOL, V155, P1054, DOI 10.1093/aje/155.11.1054; Numazawa S, 2003, J BIOCHEM, V133, P599, DOI 10.1093/jb/mvg077; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; OKADA Y, 1995, LAB INVEST, V72, P311; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Peek RM, 1995, LAB INVEST, V73, P760; Pelletier JP, 2003, ARTHRITIS RHEUM-US, V48, P1582, DOI 10.1002/art.11014; Perides G, 1999, J NEUROSCI RES, V58, P779, DOI 10.1002/(SICI)1097-4547(19991215)58:6&lt;779::AID-JNR5&gt;3.0.CO;2-L; Pillinger MH, 1996, J BIOL CHEM, V271, P12049, DOI 10.1074/jbc.271.20.12049; Pillinger MH, 2005, J BIOL CHEM, V280, P9973, DOI 10.1074/jbc.M413522200; Pillinger MH, 2004, BRIT J PHARMACOL, V142, P973, DOI 10.1038/sj.bjp.0705864; Pillinger MH, 2003, J IMMUNOL, V171, P6080, DOI 10.4049/jimmunol.171.11.6080; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; Reunanen N, 2002, J BIOL CHEM, V277, P32360, DOI 10.1074/jbc.M204296200; Rutter JL, 1998, CANCER RES, V58, P5321; SaarialhoKere UK, 1996, AM J PATHOL, V148, P519; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259; Seo JH, 2004, LAB INVEST, V84, P49, DOI 10.1038/labinvest.3700010; Shahin M, 2001, MICROSC RES TECHNIQ, V53, P396, DOI 10.1002/jemt.1108; Sharma SA, 1998, J IMMUNOL, V160, P2401; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Slomiany BL, 2001, J PHYSIOL PHARMACOL, V52, P185; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wessler S, 2000, J BIOL CHEM, V275, P3629, DOI 10.1074/jbc.275.5.3629; Wroblewski LE, 2002, BIOCHEM J, V365, P873, DOI 10.1042/BJ20020068; Zhao ZH, 2003, J INFECT DIS, V188, P1098, DOI 10.1086/379039; Zhu YL, 2005, ONCOGENE, V24, P3886, DOI 10.1038/sj.onc.1208551	89	53	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18722	18731		10.1074/jbc.M703022200	http://dx.doi.org/10.1074/jbc.M703022200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17475625	hybrid			2022-12-27	WOS:000247475300010
J	Ambrosio, ALB; Dias, SMG; Polikarpov, I; Zurier, RB; Burstein, SH; Garratt, RC				Ambrosio, Andre L. B.; Dias, Sandra M. G.; Polikarpov, Igor; Zurier, Robert B.; Burstein, Sumner H.; Garratt, Richard C.			Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIAL AGONIST; PPAR; ALPHA; DESIGN; SELECTIVITY; CRYSTALLOGRAPHY; RECRUITMENT; EXPRESSION; MOLECULE; PATHWAYS	Ajulemic acid (AJA) is a synthetic analog of THC-11-oic acid, a metabolite of tetrahydrocannabinol (THC), the major active ingredient of the recreational drug marijuana derived from the plant Cannabis sativa. AJA has potent analgesic and anti-inflammatory activity in vivo, but without the psychotropic action of THC. However, its precise mechanism of action remains unknown. Biochemical studies indicate that AJA binds directly and selectively to the isotype gamma of the peroxisome proliferator-activated receptor (PPAR gamma) suggesting that this may be a pharmacologically relevant receptor for this compound and a potential target for drug development in the treatment of pain and inflammation. Here, we report the crystal structure of the ligand binding domain of the gamma isotype of human PPAR in complex with ajulemic acid, determined at 2.8-angstrom resolution. Our results show a binding mode that is compatible with other known partial agonists of PPAR, explaining their moderate activation of the receptor, as well as the structural basis for isotype selectivity, as observed previously in vitro. The structure also provides clues to the understanding of partial agonism itself, suggesting a rational approach to the design of molecules capable of activating the receptor at levels that avoid undesirable side effects.	Univ Sao Paulo, Inst Fis, Ctr Biotechnol Mol Estrutural, BR-13560970 Sao Paulo, Brazil; Cornell Univ, Ctr Vet Med, Ithaca, NY 14853 USA; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Universidade de Sao Paulo; Cornell University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Garratt, RC (corresponding author), Univ Sao Paulo, Inst Fis, Ctr Biotechnol Mol Estrutural, BR-13560970 Sao Paulo, Brazil.	ala48@cornell.edu; richard@if.sc.usp.br	Polikarpov, Igor/D-2575-2012; Ambrosio, Andre/AAB-1178-2020; garratt, richard c/F-6921-2011; Dias, Sandra/AAB-7042-2019; Ambrosio, Andre/C-9089-2012	Ambrosio, Andre/0000-0002-9515-930X; garratt, richard/0000-0002-2016-3179; Polikarpov, Igor/0000-0001-9496-4174	NIAID NIH HHS [U19 AI056362] Funding Source: Medline; NIDA NIH HHS [R01 DA13691] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013691] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Albers M, 2006, J BIOL CHEM, V281, P4920, DOI 10.1074/jbc.M510101200; Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; Bouaboula M, 2005, EUR J PHARMACOL, V517, P174, DOI 10.1016/j.ejphar.2005.05.032; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; BURSTEIN S, 1981, DRUG METAB DISPOS, V9, P94; BURSTEIN S, 1972, SCIENCE, V176, P422, DOI 10.1126/science.176.4033.422; BURSTEIN S, 1987, EXPERIENTIA, V43, P402, DOI 10.1007/BF01940427; BURSTEIN SH, 1970, NATURE, V225, P87, DOI 10.1038/225087a0; Burstein SH, 2004, LIFE SCI, V75, P1513, DOI 10.1016/j.lfs.2004.04.010; BURSTEIN SH, 1971, CHEM-BIOL INTERACT, V3, P316, DOI 10.1016/0009-2797(71)90078-0; Cobb JE, 1998, J MED CHEM, V41, P5055, DOI 10.1021/jm980414r; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; de la Lastra CA, 2004, CURR PHARM DESIGN, V10, P3505; Dyson A, 2005, PAIN, V116, P129, DOI 10.1016/j.pain.2005.03.037; Ebdrup S, 2003, J MED CHEM, V46, P1306, DOI 10.1021/jm021027r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Haffner CD, 2004, J MED CHEM, V47, P2010, DOI 10.1021/jm030565g; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Johnson BA, 2000, J MOL BIOL, V298, P187, DOI 10.1006/jmbi.2000.3636; Karst M, 2003, JAMA-J AM MED ASSOC, V290, P1757, DOI 10.1001/jama.290.13.1757; Klaholz BP, 2000, ACTA CRYSTALLOGR D, V56, P933, DOI 10.1107/S090744490000634X; Klaholz BP, 2000, J MOL BIOL, V302, P155, DOI 10.1006/jmbi.2000.4032; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; KLEYWEGT GJ, 1997, CCP4 ESF EACBM NEWSL, V34, P5; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Liu JL, 2003, MOL PHARMACOL, V63, P983, DOI 10.1124/mol.63.5.983; Lu IL, 2006, J MED CHEM, V49, P2703, DOI 10.1021/jm051129s; Mahindroo N, 2006, J MED CHEM, V49, P1212, DOI 10.1021/jm0510373; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; Mitchell VA, 2005, NEUROSCI LETT, V382, P231, DOI 10.1016/j.neulet.2005.03.019; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; O'Sullivan SE, 2005, BIOCHEM BIOPH RES CO, V337, P824, DOI 10.1016/j.bbrc.2005.09.121; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Ostberg T, 2004, J BIOL CHEM, V279, P41124, DOI 10.1074/jbc.M401552200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Rockwell CE, 2006, MOL PHARMACOL, V70, P101, DOI 10.1124/mol.105.019117; Sauerberg P, 2002, J MED CHEM, V45, P789, DOI 10.1021/jm010964g; Shi GQ, 2005, J MED CHEM, V48, P4457, DOI 10.1021/jm0502135; Sung B, 2004, J GERONTOL A-BIOL, V59, P997; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a	62	50	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18625	18633		10.1074/jbc.M702538200	http://dx.doi.org/10.1074/jbc.M702538200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17462987	hybrid			2022-12-27	WOS:000247302000067
J	Viswakarma, N; Yu, S; Naik, S; Kashireddy, P; Matsumoto, K; Sarkar, J; Surapureddi, S; Jia, Y; Rao, MS; Reddy, JK				Viswakarma, Navin; Yu, Songtao; Naik, Swati; Kashireddy, Papreddy; Matsumoto, Kojiro; Sarkar, Joy; Surapureddi, Sailesh; Jia, Yuzhi; Rao, M. Sambasiva; Reddy, Janardan K.			Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alpha-like effector A, in mouse liver by peroxisome proliferator-activated receptor alpha and gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA OXIDASE; GENE-EXPRESSION; DEFICIENT MICE; RESPONSE ELEMENTS; RETINOIC ACID; TARGET GENES; PPAR-GAMMA; FAMILY; METABOLISM; OBESITY	Cidea ( cell death-inducing DNA fragmentation factor alpha-like effector A), a member of a novel family of proapoptotic proteins, is expressed abundantly in the brown adipose tissue of the mouse. Although Cidea mRNA is not detectable in the mouse liver, we now show that peroxisome proliferator-activated receptor ( PPAR) alpha ligandsWy-14,643 and ciprofibrate increase the Cidea mRNA level in a PPAR alpha-dependent manner, whereas Cidea induction in liver by PPAR gamma overexpression is PPAR alpha independent. Increase in Cidea mRNA content in liver did not alter the expression of uncoupling protein 1 (Ucp1) gene, which regulates thermogenesis, lipolysis, and conservation of energy. Although Cidea is considered to be a proapoptotic factor, Cidea induction in liver did not result in increased apoptosis. To elucidate the mechanism by which PPAR alpha and PPAR gamma regulate Cidea gene expression in the liver, we analyzed the promoter region of the Cidea gene. Three putative peroxisome proliferator response elements (PPREs) are found in the Cidea gene promoter. Transactivation, gel-shift, and chromatin immunoprecipitation assays indicated that the proximal PPRE in Cidea gene (Cidea-PPRE1 at - 680/ - 668) is functional for both PPAR alpha and -gamma. We conclude that Cidea is a novel target gene for both PPAR alpha and -gamma in the liver where these two transcription factors utilize the same PPRE region for dual regulation. The induction of Cidea in liver with these PPAR alpha and -gamma agonists suggests a possible role for Cidea in energy metabolism and a less likely role in hepatocyte apoptosis.	Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.	jkreddy@northwestern.edu			NCI NIH HHS [CA104578] Funding Source: Medline; NIGMS NIH HHS [GM23750] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023750, R37GM023750] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Cherkaoui-Malki M, 2001, GENE EXPRESSION, V9, P291, DOI 10.3727/000000001783992533; CHU RY, 1995, J BIOL CHEM, V270, P29636; Da L, 2006, BIOCHEM J, V393, P779, DOI 10.1042/BJ20051027; Danielsson C, 1997, J CELL BIOCHEM, V66, P552, DOI 10.1002/(SICI)1097-4644(19970915)66:4<552::AID-JCB14>3.0.CO;2-D; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hasmall SC, 2000, MUTAT RES-FUND MOL M, V448, P193, DOI 10.1016/S0027-5107(99)00236-5; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Lin SC, 2004, TRENDS MOL MED, V10, P434, DOI 10.1016/j.molmed.2004.07.005; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Meyer K, 2003, CARCINOGENESIS, V24, P975, DOI 10.1093/carcin/bgg040; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Reddy JK, 2006, AD DEV BIOL, V16, P389, DOI 10.1016/S1574-3349(06)16012-3; Reddy JK, 2004, AM J PATHOL, V164, P2305, DOI 10.1016/S0002-9440(10)63787-X; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; Reed JC, 2003, GENOME RES, V13, P1376, DOI 10.1101/gr.1053803; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; SHAH YM, 2007, MOL CELL BIOL; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1; YU S, 2007, BIOCH BIOPHYS ACTA; Yu ST, 2004, BIOCHIMIE, V86, P743, DOI 10.1016/j.biochi.2004.09.015; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	47	77	83	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18613	18624		10.1074/jbc.M701983200	http://dx.doi.org/10.1074/jbc.M701983200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17462989	hybrid			2022-12-27	WOS:000247302000066
J	Lin, YF; Yang, JB; Rosen, BP				Lin, Yung-Feng; Yang, Jianbo; Rosen, Barry P.			ArsD residues Cys(12), Cys(13), and Cys(18) form an As(III)-binding site required for arsenic metallochaperone activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; PROTEIN INTERACTIONS; COPPER TRAFFICKING; ATPASE; CHAPERONE; METALLOACTIVATION; RESISTANCE; REPRESSOR; PUMP	The ArsA ATPase is the catalytic subunit of the ArsAB pump encoded by the arsRDABC operon of Escherichia coli plasmid R773. ArsD is a metallochaperone that delivers As(III) to ArsA, increasing its affinity for As(III), thus conferring resistance to environmental concentrations of arsenic. R773 ArsD is a homodimer with three vicinal cysteine pairs, Cys(12)-Cys(13), Cys(112)-Cys(113), and Cys(119)-Cys(120), in each subunit. Each vicinal pair binds As(III) or Sb(III). Alignment of the primary sequence of homologues of ArsD indicates that only the first vicinal cysteine pair, Cys(12)-Cys(13), and an additional cysteine, Cys(18), are conserved. The effect of cysteine-to-alanine substitutions and truncations were examined. By yeast two-hybrid analysis, nearly all of the ArsD mutants were able to interact with wild type ArsD, indicating that the mutations do not interfere with dimerization. ArsD mutants with alanines substituting for Cys(112), Cys(113), Cys(119), or Cys(120) individually or in pairs or truncations lacking the vicinal pairs retained ability to interact with ArsA and to activate its ATPase activity. Cells expressing these mutants retained ArsD-enhanced As(III) efflux and resistance. In contrast, mutants with substitutions of conserved Cys(12), Cys(13), or Cys(18), individually or in pairs, were unable to activate ArsA or to enhance the activity of the ArsAB pump. We propose that ArsD residues Cys(12), Cys(13), and Cys(18), but not Cys(112), Cys(113), Cys(119), or Cys(120), are required for delivery of As(III) to and activation of the ArsAB pump.	Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA	Wayne State University	Rosen, BP (corresponding author), Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA.	brosen@med.wayne.edu	Yang, Jianbo/G-1254-2013; Lin, Yung-Feng/H-3289-2019	Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055425, R37GM055425] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abernathy CO, 2003, J NUTR, V133, p1536S, DOI 10.1093/jn/133.5.1536S; Arnesano F, 2004, STRUCTURE, V12, P669, DOI 10.1016/j.str.2004.03.006; Bhattacharjee H, 1996, J BIOL CHEM, V271, P24465, DOI 10.1074/jbc.271.40.24465; BHATTACHARJEE H, 1995, J BIOL CHEM, V270, P11245, DOI 10.1074/jbc.270.19.11245; Bhattacharjee H, 2000, BIOMETALS, V13, P281, DOI 10.1023/A:1009200215328; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chen YX, 1997, J BIOL CHEM, V272, P14257, DOI 10.1074/jbc.272.22.14257; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Freeman LEB, 2004, AM J EPIDEMIOL, V160, P679, DOI 10.1093/aje/kwh267; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HSU CM, 1989, J BIOL CHEM, V264, P17349; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Li JX, 2000, MOL MICROBIOL, V35, P361, DOI 10.1046/j.1365-2958.2000.01696.x; Li S, 2002, J BIOL CHEM, V277, P25992, DOI 10.1074/jbc.M201619200; Li S, 2001, MOL MICROBIOL, V41, P687, DOI 10.1046/j.1365-2958.2001.02546.x; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; ROSEN BP, 1984, BIOCHEM BIOPH RES CO, V124, P760, DOI 10.1016/0006-291X(84)91023-4; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Ruan X, 2006, J BIOL CHEM, V281, P9925, DOI 10.1074/jbc.M600125200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Wimmer R, 1999, J BIOL CHEM, V274, P22597, DOI 10.1074/jbc.274.32.22597; WU JH, 1993, MOL MICROBIOL, V8, P615, DOI 10.1111/j.1365-2958.1993.tb01605.x; Zhou T, 2000, EMBO J, V19, P1	36	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2007	282	23					16783	16791		10.1074/jbc.M700886200	http://dx.doi.org/10.1074/jbc.M700886200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	174MN	17439954	hybrid			2022-12-27	WOS:000246946500010
J	Crichlow, GV; Cheng, KF; Dabideen, D; Ochani, M; Aljabari, B; Pavlov, VA; Miller, EJ; Lolis, E; Al-Abed, Y				Crichlow, Gregg V.; Cheng, Kai Fan; Dabideen, Darrin; Ochani, Mahendar; Aljabari, Bayan; Pavlov, Valentin A.; Miller, Edmund J.; Lolis, Elias; Al-Abed, Yousef			Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MIF; SEPTIC SHOCK; TAUTOMERASE ACTIVITY; CRYSTAL-STRUCTURE; SEPSIS; PATHOGENESIS; ENDOTOXEMIA; DISCOVERY; CYTOKINE; SURVIVAL	Pharmacophores are chemical scaffolds upon which changes in chemical moieties (R-groups) at specific sites are made to identify a combination of R-groups that increases the therapeutic potency of a small molecule inhibitor while minimizing adverse effects. We developed a pharmacophore based on a carbonyloxime (OXIM) scaffold for macrophage migration inhibitory factor (MIF), a protein involved in the pathology of sepsis, to validate that inhibition of a catalytic site could produce therapeutic benefits. We studied the crystal structures of MIF.OXIM-based inhibitors and found two opposite orientations for binding to the active site that were dependent on the chemical structures of an R-group. One orientation was completely unexpected based on previous studies with hydroxyphenylpyruvate and (S, R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1). We further confirmed that the unexpected binding mode targets MIF in cellular studies by showing that one compound, OXIM-11, abolished the counter-regulatory activity of MIF on anti-inflammatory glucocorticoid action. OXIM-11 treatment of mice, initiated 24 h after the onset of cecal ligation and puncture-induced sepsis, significantly improved survival when compared with vehicle-treated controls, confirming that inhibition of the MIF catalytic site could produce therapeutic effects. The crystal structures of the MIF inhibitor complexes provide insight for further structure-based drug design efforts.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Feinstein Inst Med Res, Med Chem Lab, Manhasset, NY 11030 USA; Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA; Feinstein Inst Med Res, Lab Cardiopulm Res, Manhasset, NY 11030 USA	Yale University; Northwell Health; Northwell Health; Northwell Health	Lolis, E (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	elias.lolis@yale.edu; yalabed@nshs.edu		Pavlov, Valentin/0000-0002-1994-2853; Lolis, Elias/0000-0002-7902-7868	NATIONAL CANCER INSTITUTE [T32CA009085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065029] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09085, T32 CA009085] Funding Source: Medline; NHLBI NIH HHS [R01 HL081655, HL081655] Funding Source: Medline; NIAID NIH HHS [R01 AI065029, AI065029, R01 AI065029-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Bacher M, 1997, AM J PATHOL, V150, P235; Beishuizen A, 2001, J CLIN ENDOCR METAB, V86, P2811, DOI 10.1210/jc.86.6.2811; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Calandra T, 2001, J CHEMOTHERAPY, V13, P173, DOI 10.1179/joc.2001.13.Supplement-2.173; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; Dabideen DR, 2007, J MED CHEM, V50, P1993, DOI 10.1021/jm061477+; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nicoletti F, 2005, J NEUROIMMUNOL, V168, P168, DOI 10.1016/j.jneuroim.2005.07.019; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Sakuragi Tohru, 2007, Surg Infect (Larchmt), V8, P29, DOI 10.1089/sur.2006.031; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Xue CB, 1997, J MED CHEM, V40, P2064, DOI 10.1021/jm960799i	30	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23089	23095		10.1074/jbc.M701825200	http://dx.doi.org/10.1074/jbc.M701825200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17526494	Green Accepted, hybrid			2022-12-27	WOS:000248577500011
J	Izem, L; Morton, RE				Izem, Lahoucine; Morton, Richard E.			Possible role for intracellular cholesteryl ester transfer protein in adipocyte lipid metabolism and storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LIPOPROTEIN-DEFICIENT PLASMA; MEDIATES SELECTIVE UPTAKE; HUMAN ADIPOSE-TISSUE; GENE-EXPRESSION; MONOCLONAL-ANTIBODIES; DENSITY-LIPOPROTEINS; EXCHANGE PROTEIN; MESSENGER-RNA; AMINO-ACIDS	Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester (CE) and triglyceride (TG) between lipoproteins in plasma. However, short term suppression of CETP biosynthesis in cells alters cellular cholesterol homeostasis, demonstrating an intracellular role for CETP as well. The consequences of chronic CETP deficiency in lipid-storing cells normally expressing have not been reported. Here, SW872 adipocytes stably expressing antisense CETP cDNA and synthesizing 20% of normal CETP were created. CETP-deficient cells had 4-fold more CE but an similar to 3-fold decrease in cholesterol biosynthesis. This phenotype of cholesterol overload is consistent with the observed 45% reduction in low density lipoprotein receptor and 2.5-fold increase in ABCA1 levels. However, cholesterol mass in CETP-deficient adipocytes was actually reduced. Strikingly, CETP- deficient adipocytes stored <50% of normal TG, principally reflecting reduced synthesis. The hydrolysis of cellular CE and TG in CETP- deficient cells was reduced by >50%, although hydrolase/lipase activity was increased 3-fold. Notably, the incorporation of recently synthesized CE and TG into lipid storage droplets in CETP- deficient cells was just 40% of control, suggesting that these lipids are inefficiently transported to droplets where the hydrolase/lipase resides. The capacity of cellular CETP to transport CE and TG into storage droplets was directly demonstrated in vitro. Overall, chronic CETP deficiency disrupts lipid homeostasis and compromises the TG storage function of adipocytes. Inefficient CETP-mediated translocation of CE and TG from the endoplasmic reticulum to their site of storage may partially explain these defects. These studies in adipocytic cells strongly support a novel role for CETP in intracellular lipid transport and storage.	Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Morton, RE (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	mortonr@ccf.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060934] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60934] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1992, INT J CLIN LAB RES, V21, P264, DOI 10.1007/BF02591657; Benoist F, 1997, J BIOL CHEM, V272, P23572, DOI 10.1074/jbc.272.38.23572; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Bruce C, 1998, CURR OPIN STRUC BIOL, V8, P426, DOI 10.1016/S0959-440X(98)80118-8; Bruce C, 1998, ANNU REV NUTR, V18, P297, DOI 10.1146/annurev.nutr.18.1.297; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CLAY MA, 1989, BIOCHIM BIOPHYS ACTA, V1002, P173, DOI 10.1016/0005-2760(89)90284-1; DRAYNA D, 1987, NATURE, V327, P632, DOI 10.1038/327632a0; Dugail I, 2003, HORM METAB RES, V35, P204, DOI 10.1055/s-2003-39475; Edwards PA, 2002, J LIPID RES, V43, P2; FAUST RA, 1990, BIOCHIM BIOPHYS ACTA, V1042, P404, DOI 10.1016/0005-2760(90)90171-S; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; GAMBLE W, 1978, J LIPID RES, V19, P1068; Gauthier A, 2005, ARTERIOSCL THROM VAS, V25, P2177, DOI 10.1161/01.ATV.0000183613.13929.13; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; Hajjar D P, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P45; HASHIMOTO S, 1984, BIOCHEM BIOPH RES CO, V120, P586, DOI 10.1016/0006-291X(84)91295-6; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HESLER CB, 1988, J BIOL CHEM, V263, P5020; HESLER CB, 1987, J BIOL CHEM, V262, P2275; Huang ZP, 2003, AM J PHYSIOL-ENDOC M, V284, pE1210, DOI 10.1152/ajpendo.00453.2002; INAZU A, 1992, BIOCHEMISTRY-US, V31, P2352, DOI 10.1021/bi00123a021; Izem L, 2001, J BIOL CHEM, V276, P26534, DOI 10.1074/jbc.M103624200; JIANG XC, 1991, J BIOL CHEM, V266, P4631; JIANG XC, 1995, BIOCHEMISTRY-US, V34, P7258, DOI 10.1021/bi00021a042; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; KRAEMER FB, 1993, J LIPID RES, V34, P663; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; KRAUSE BR, 1981, P SOC EXP BIOL MED, V167, P407, DOI 10.3181/00379727-167-41188; KRAUSE BR, 1984, J LIPID RES, V25, P97; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Large V, 1998, J LIPID RES, V39, P1688; Le Lay S, 2003, J LIPID RES, V44, P1499, DOI 10.1194/jlr.M200466-JLR200; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MENDEZ AJ, 1986, ANAL BIOCHEM, V156, P386, DOI 10.1016/0003-2697(86)90269-1; MILLER KW, 1983, J BIOL CHEM, V258, P3772; MILLER KW, 1983, BIOCHEMISTRY-US, V22, P443, DOI 10.1021/bi00271a030; Mora S, 2002, DIABETES-METAB RES, V18, P345, DOI 10.1002/dmrr.321; MORTON RE, 1982, J LIPID RES, V23, P1058; MORTON RE, 1990, EXPERIENTIA, V46, P552, DOI 10.1007/BF01939693; MORTON RE, 1983, J BIOL CHEM, V258, P1751; MORTON RE, 1988, J LIPID RES, V29, P1367; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; PATTNAIK NM, 1978, BIOCHIM BIOPHYS ACTA, V530, P428, DOI 10.1016/0005-2760(78)90163-7; PATTNAIK NM, 1979, J BIOL CHEM, V254, P2782; Roy P, 1996, J LIPID RES, V37, P22; Sawada S, 1999, ATHEROSCLEROSIS, V146, P291, DOI 10.1016/S0021-9150(99)00152-5; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Walczak R, 2002, J LIPID RES, V43, P177; WANG S, 1992, J BIOL CHEM, V267, P17487; WANG SK, 1995, J BIOL CHEM, V270, P612, DOI 10.1074/jbc.270.2.612; Yang TP, 1996, J BIOL CHEM, V271, P12603, DOI 10.1074/jbc.271.21.12603; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; Zhang ZY, 2001, ATHEROSCLEROSIS, V159, P67, DOI 10.1016/S0021-9150(01)00490-7; Zhou HW, 2006, J LIPID RES, V47, P2011, DOI 10.1194/jlr.M600153-JLR200	60	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					21856	21865		10.1074/jbc.M701075200	http://dx.doi.org/10.1074/jbc.M701075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17522050	hybrid			2022-12-27	WOS:000248196800033
J	Tamehiro, N; Shigemoto-Mogami, Y; Kakeya, T; Okuhira, K; Suzuki, K; Sato, R; Nagao, T; Nishimaki-Mogami, T				Tamehiro, Norimasa; Shigemoto-Mogami, Yukari; Kakeya, Tomoshi; Okuhira, Kei-ichiro; Suzuki, Kazuhiro; Sato, Ryuichiro; Nagao, Taku; Nishimaki-Mogami, Tomoko			Sterol regulatory element-binding protein-2-and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression - Mechanism underlying the unique response to cellular cholesterol status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-MEDIATED RELEASE; CASSETTE; EFFLUX; LXR; MICE; LIGANDS; STATINS; OVEREXPRESSION; IDENTIFICATION	ABC transporter A1 (ABCA1) mediates and rate-limits biogenesis of high density lipoprotein (HDL), and hepatic ABCA1 plays a major role in regulating plasma HDL levels. HDL generation is also responsible for release of cellular cholesterol. In peripheral cells ABCA1 is up-regulated by the liver X receptor (LXR) system when cell cholesterol increases. However, cholesterol feeding has failed to show a significant increase in hepatic ABCA1 gene expression, and its expression is up-regulated by statins (3-hydroy-3-methylglutaryl-CoA reductase inhibitors), suggesting distinct regulation. In this study we investigated the mechanism of regulation of the rat hepatic ABCA1 gene and identified two major ABCA1 transcripts and two corresponding promoter regions. Compactin activated the novel liver-type promoter in rat hepatoma McARH7777 cells by binding the sterol regulatory element-binding protein-2 (SREBP-2). In contrast, compactin repressed the previously identified peripheral-type promoter in an LXR-responsive element-dependent but not E-box-dependent manner. Thus, compactin increased the liver-type transcript and decreased the peripheral-type transcript. The same two transcripts were also dominant in human and mouse livers, whereas the intestine contains only the peripheral-type transcript. Treatment of rats with pravastatin and a bile acid binding resin (colestimide), which is known to activate SREBP-2 in the liver, caused a reduction in the hepatic cholesterol level and the same differential responses in vivo, leading to increases in hepatic ABCA1 mRNA and protein and plasma HDL levels. We conclude that the dual promoter system driven by SREBP-2 and LXR regulates hepatic ABCA1 expression and may mediate the unique response of hepatic ABCA1 gene expression to cellular cholesterol status.	Natl Inst Hlth Sci, Div Biosignaling, Setagaya Ku, Tokyo 1588501, Japan; Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	National Institute of Health Sciences - Japan; University of Tokyo	Nishimaki-Mogami, T (corresponding author), Natl Inst Hlth Sci, Div Biosignaling, Setagaya Ku, Kamiyoga 1-18-1, Tokyo 1588501, Japan.	mogami@nihs.go.jp						Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; BRESLOW JL, 1985, ANNU REV BIOCHEM, V54, P699, DOI 10.1146/annurev.biochem.54.1.699; Brewer HB, 2004, ARTERIOSCL THROM VAS, V24, P387, DOI 10.1161/01.ATV.0000121505.88326.d2; Brewer HB, 2003, AM J CARDIOL, V92, p23K, DOI 10.1016/S0002-9149(03)00779-3; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Costet P, 2000, J BIOL CHEM, V275, P28240; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Edwards PA, 2002, J LIPID RES, V43, P2; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; FIELDING CJ, 1995, J LIPID RES, V36, P211; GLOMSET JA, 1968, J LIPID RES, V9, P155; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Hoekstra M, 2005, J HEPATOL, V42, P400, DOI 10.1016/j.jhep.2004.11.032; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Maejima T, 2004, BIOCHEM BIOPH RES CO, V324, P835, DOI 10.1016/j.bbrc.2004.09.122; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Misawa K, 2003, J BIOL CHEM, V278, P36176, DOI 10.1074/jbc.M302387200; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nishimaki-Mogami T, 2004, J LIPID RES, V45, P1538, DOI 10.1194/jlr.M400102-JLR200; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Ragozin S, 2005, ARTERIOSCL THROM VAS, V25, P1433, DOI 10.1161/01.ATV.0000166616.86723.d0; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 1997, P NATL ACAD SCI USA, V94, P12354, DOI 10.1073/pnas.94.23.12354; Singaraja RR, 2006, CIRCULATION, V114, P1301, DOI 10.1161/CIRCULATIONAHA.106.621433; Singaraja RR, 2005, J LIPID RES, V46, P2061, DOI 10.1194/jlr.M500133-JLR200; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Sone H, 2004, BIOCHEM BIOPH RES CO, V316, P790, DOI 10.1016/j.bbrc.2004.02.121; Suzuki S, 2004, ARTERIOSCL THROM VAS, V24, P519, DOI 10.1161/01.ATV.0000117178.94087.ba; Tamehiro N, 2005, FEBS LETT, V579, P5299, DOI 10.1016/j.febslet.2005.08.054; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Tsujita M, 2005, J LIPID RES, V46, P154, DOI 10.1194/jlr.M400402-JLR200; Vrecer M, 2003, INT J CLIN PHARM TH, V41, P567; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wellington CL, 2003, J LIPID RES, V44, P1470, DOI 10.1194/jlr.M300110-JLR200; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yang XP, 2002, J LIPID RES, V43, P297; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200	52	82	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21090	21099		10.1074/jbc.M701228200	http://dx.doi.org/10.1074/jbc.M701228200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17526932	hybrid			2022-12-27	WOS:000248047500035
J	Blackwell, JS; Wilkinson, ST; Mosammaparast, N; Pemberton, LF				Blackwell, Jeffrey S., Jr.; Wilkinson, Sarah T.; Mosammaparast, Nima; Pemberton, Lucy F.			Mutational analysis of H3 and H4N termini reveals distinct roles in nuclear import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B HISTONE ACETYLTRANSFERASES; NUCLEOSOME CORE PARTICLE; DNA-REPLICATION; CELL-CYCLE; IN-VITRO; S-PHASE; YEAST; ACETYLATION; CHROMATIN; DEPOSITION	Core histones H3 and H4 are rapidly imported into the nucleus by members of the karyopherin (Kap)/importin family. We showed that H3 and H4 interact with Kap123p, histone acetyltransferase-B complex (HAT-B), and Asf1p in cytosol. In vivo analysis indicated that Kap123p is required for H3-mediated import, whereas H4 utilizes multiple Kaps including Kap123p. The evolutionary conservation of H3 and H4 cytoplasmic acetylation led us to analyze the role of acetylation in nuclear transport. We determined that lysine 14 is critical for H3 NLS function in vivo and demonstrated that mutation of H3 lysine 14 to the acetylation-mimic glutamine decreased association with Kap123p in vitro. Several lysines in the H4 NLS are important for its function. We showed that mutation of key lysines to glutamine resulted in a greater import defect than mutation to arginine, suggesting that positive charge promotes NLS function. Lastly we determined that six of ten N-terminal acetylation sites in H3 and H4 can be mutated to arginine, indicating that deposition acetylation is not absolutely necessary in vivo. However, the growth defect of these mutants suggests that acetylation does play an important role in import. These findings suggest a model where cytosolic histones bind import karyopherins prior to acetylation. Other factors are recruited to this complex such as HAT-B and Asf1p; these factors in turn promote acetylation. Acetylation may be important for modulating the interaction with transport factors and may play a role in the release of histones from karyopherins in the nucleus.	Univ Virginia, Hlth Sci Ctr, Ctr Cell Signalling, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Pemberton, LF (corresponding author), Univ Virginia, Hlth Sci Ctr, Ctr Cell Signalling, Dept Microbiol, Box 800577, Charlottesville, VA 22908 USA.	lfp2n@virginia.edu			NIGMS NIH HHS [R01 GM 65385] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065385] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Glowczewski L, 2004, MOL CELL BIOL, V24, P10180, DOI 10.1128/MCB.24.23.10180-10192.2004; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Ling XF, 1996, GENE DEV, V10, P686, DOI 10.1101/gad.10.6.686; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; MORGAN BA, 1991, MOL CELL BIOL, V11, P4111, DOI 10.1128/MCB.11.8.4111; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Ruiz-Garcia AB, 1998, J BIOL CHEM, V273, P12599, DOI 10.1074/jbc.273.20.12599; RUIZCARRILLO A, 1975, SCIENCE, V190, P117, DOI 10.1126/science.1166303; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Sherman F., 1986, METHODS YEAST GENETI; Sklenar Amy R., 2004, BMC Biochemistry, V5, P11, DOI 10.1186/1471-2091-5-11; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TSUBOTA T, 2007, CELL; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; Verreault A, 2000, GENE DEV, V14, P1430; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207	39	61	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20142	20150		10.1074/jbc.M701989200	http://dx.doi.org/10.1074/jbc.M701989200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17507373	hybrid			2022-12-27	WOS:000247819300015
J	Balasubramanian, K; Mirnikjoo, B; Schroit, AJ				Balasubramanian, Krishnakumar; Mirnikjoo, Banafsheh; Schroit, Alan J.			Regulated externalization of phosphatidylserine at the cell surface - Implications for apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; PLASMA-MEMBRANE; TRANSBILAYER MOVEMENT; CALCIUM; DEATH; ERYTHROCYTES; MITOCHONDRIA; CLEARANCE; TRANSPORT; PROTEIN	The regulated loss of plasma membrane phosphatidylserine ( PS) asymmetry is critical to many biological processes. In particular, the appearance of PS at the cell surface, a hallmark of apoptosis, prepares the dying cell for engulfment and elimination by phagocytes. While it is well established that PS externalization is regulated by activation of a calcium-dependent phospholipid scramblase activity in concert with inactivation of the aminophospholipid translocase, there is no evidence indicating that these processes are triggered and regulated by apoptotic regulatory mechanisms. Using a novel model system, we show that PS externalization is inducible, reversible, and independent of cytochrome c release, caspase activation, and DNA fragmentation. Additional evidence is presented indicating that the outward movement of plasma membrane PS requires sustained elevation in cytosolic Ca2+ in concert with inactivation of the aminophospholipid translocase and is inhibited by calcium channel blockers.	Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Schroit, AJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aschroit@mdanderson.org			NIGMS NIH HHS [GM70964] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam-Klages S, 2005, IMMUNOL RES, V33, P149, DOI 10.1385/IR:33:2:149; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bevers EM, 1998, LUPUS, V7, pS126, DOI 10.1177/096120339800700228; CONNOR J, 1992, J BIOL CHEM, V267, P19412; CONNOR J, 1988, BIOCHEMISTRY-US, V27, P848, DOI 10.1021/bi00403a002; de Jong K, 2002, BIOCHEMISTRY-US, V41, P12562, DOI 10.1021/bi025882o; Dekkers DWC, 1998, BIOCHEMISTRY-US, V37, P14833, DOI 10.1021/bi981011w; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P504, DOI 10.1006/bbrc.1999.1820; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Jacobson J, 2004, MOL CELL BIOCHEM, V256, P209, DOI 10.1023/B:MCBI.0000009869.29827.df; JAIN SK, 1981, BIOCHIM BIOPHYS ACTA, V642, P46, DOI 10.1016/0005-2736(81)90136-X; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kuhtrelber WM, 2003, J MOL ENDOCRINOL, V31, P373, DOI 10.1677/jme.0.0310373; KURATA M, 1994, COMP BIOCHEM PHYS B, V109, P305, DOI 10.1016/0305-0491(94)90014-0; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; MASON RP, 1989, MOL PHARMACOL, V36, P634; MASON RP, 1992, MOL PHARMACOL, V41, P315; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Moosmang S, 2005, PHARMACOL THERAPEUT, V106, P347, DOI 10.1016/j.pharmthera.2004.12.003; Moreau C, 1997, MOL MEMBR BIOL, V14, P5, DOI 10.3109/09687689709048163; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9; Sheu SS, 1999, J PHYSIOL-LONDON, V518, P577, DOI 10.1111/j.1469-7793.1999.0577p.x; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; SLEIGHT RG, 1984, J CELL BIOL, V99, P742, DOI 10.1083/jcb.99.2.742; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; Thomas JA, 2001, EXP GERONTOL, V36, P1519, DOI 10.1016/S0531-5565(01)00137-1; vanEngeland M, 1997, EXP CELL RES, V235, P421, DOI 10.1006/excr.1997.3738; WERTH JL, 1994, J NEUROSCI, V14, P348; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Young HS, 2004, J MEMBRANE BIOL, V198, P55, DOI 10.1007/s00232-004-0666-y; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	41	138	143	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18357	18364		10.1074/jbc.M700202200	http://dx.doi.org/10.1074/jbc.M700202200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17470427	hybrid			2022-12-27	WOS:000247302000042
J	Simard, CF; Bergeron, MJ; Frenette-Cotton, R; Carpentier, GA; Pelchat, ME; Caron, L; Isenring, P				Simard, Charles F.; Bergeron, Marc J.; Frenette-Cotton, Rachelle; Carpentier, Gabriel A.; Pelchat, Marie-Eve; Caron, Luc; Isenring, Paul			Homooligomeric and heterooligomeric associations between K+-Cl- cotransporter isoforms and between K+-Cl- and Na+-K+-Cl- cotransporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; KCL COTRANSPORTER; STRUCTURAL UNIT; RABBIT KIDNEY; KCC4; LOCALIZATION; RAT; TRANSPORT; DEAFNESS	Little is known regarding the quaternary structure of cation-Cl- cotransporters (CCCs) except that the Na+-dependent CCCs can exist as homooligomeric units. Given that each of the CCCs exhibits unique functional properties and that several of these carriers coexist in various cell types, it would be of interest to determine whether the four K+-Cl- cotransporter (KCC) isoforms and their splice variants can also assemble into such units and, more importantly, whether they can form heterooligomers by interacting with each other or with the secretory Na+- K+-Cl- cotransporter (NKCC1). In the present work, we have addressed these questions by conducting two groups of analyses: 1) yeast two-hybrid and pull-down assays in which CCC-derived protein segments were used as both bait and prey and 2) coimmunoprecipitation and functional studies of intact CCCs coexpressed in Xenopus laevis oocytes. Through a combination of such analyses, we have found that KCC2 and KCC4 could adopt various oligomeric states (in the form of KCC2- KCC2, KCC4-KCC4, KCC2-KCC4, and even KCC4-NKCC1 complexes), that their carboxyl termini were probably involved in carrier assembly, and that the KCC4-NKCC1 oligomers, more specifically, could deploy unique functional features. Through additional coimmunoprecipitation studies, we have also found that KCC1 and KCC3 had the potential of assembling into various types of CCC-CCC oligomers as well, although the interactions uncovered were not characterized as extensively, and the protein segments involved were not identified in yeast two-hybrid assays. Taken together, these findings could change our views on how CCCs operate or are regulated in animal cells by suggesting, in particular, that cation-Cl- cotransport achieves higher levels of functional diversity than foreseen.	Univ Laval, Fac Med, Dept Med, Nephrol Res Grp,Hotel Dieu Quebec Res Inst, Quebec City, PQ G1R 2J6, Canada	Laval University	Isenring, P (corresponding author), Hotel Dieu Quebec Inst, 10 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	paul.isenring@crhdq.ulaval.ca						Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Bergeron MJ, 2003, AM J PHYSIOL-RENAL, V285, pF68, DOI 10.1152/ajprenal.00032.2003; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Brunet GM, 2005, J GEN PHYSIOL, V126, P325, DOI 10.1085/jgp.200509334; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Crable SC, 2005, EXP HEMATOL, V33, P624, DOI 10.1016/j.exphem.2005.02.006; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Gagnon E, 2005, J BIOL CHEM, V280, P32555, DOI 10.1074/jbc.M505511200; Gagnon E, 2004, J BIOL CHEM, V279, P5648, DOI 10.1074/jbc.M311218200; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; Hiki K, 1999, J BIOL CHEM, V274, P10661, DOI 10.1074/jbc.274.15.10661; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ichinose Mayuri, 1999, Journal of the American Society of Nephrology, V10, p34A; Immink RGH, 2002, P NATL ACAD SCI USA, V99, P2416, DOI 10.1073/pnas.042677699; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Jansens Annemieke, 2003, Methods Mol Biol, V232, P133; Karadsheh MF, 2004, NEUROSCIENCE, V123, P381, DOI 10.1016/j.neuroscience.2003.10.004; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC299, DOI 10.1152/ajpcell.1998.274.2.C299; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Misri S, 2006, EXP EYE RES, V83, P1287, DOI 10.1016/j.exer.2006.07.006; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Riechmann JL, 1999, MOL CELL BIOL, V19, P8505; Roussa E, 2002, HISTOCHEM CELL BIOL, V117, P335, DOI 10.1007/s00418-002-0393-3; Simard CF, 2004, J BIOL CHEM, V279, P40769, DOI 10.1074/jbc.M406458200; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Velazquez H, 2003, AM J PHYSIOL-RENAL, V285, pF49, DOI 10.1152/ajprenal.00389.2002; Vu TQ, 2000, J NEUROSCI, V20, P1414; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	46	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18083	18093		10.1074/jbc.M607811200	http://dx.doi.org/10.1074/jbc.M607811200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17462999	hybrid			2022-12-27	WOS:000247302000014
J	Zhang, DW; Lagace, TA; Garuti, R; Zhao, Z; McDonald, M; Horton, JD; Cohen, JC; Hobbs, HH				Zhang, Da-Wei; Lagace, Thomas A.; Garuti, Rita; Zhao, Zhenze; McDonald, Meghan; Horton, Jay D.; Cohen, Jonathan C.; Hobbs, Helen H.			Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat a of low density lipoprotein receptor decreases receptor recycling and increases degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; CALCIUM-BINDING; CYTOPLASMIC DOMAIN; DIFFERENT PROTEINS; HUMAN-FIBROBLASTS; FACTOR PRECURSOR; EGF DOMAINS; PCSK9 GENE	Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes degradation of hepatic low density lipoprotein receptors ( LDLR), the major route of clearance of circulating cholesterol. Gain-of-function mutations in PCSK9 cause hypercholesterolemia and premature atherosclerosis, whereas loss-of-function mutations result in hypocholesterolemia and protection from heart disease. Recombinant human PCSK9 binds the LDLR on the surface of cultured hepatocytes and promotes degradation of the receptor after internalization. Here we localized the site of binding of PCSK9 within the extracellular domain of the LDLR and determined the fate of the receptor after PCSK9 binding. Recombinant human PCSK9 interacted in a sequence-specific manner with the first epidermal growth factor-like repeat (EGF-A) in the EGF homology domain of the human LDLR. Similar binding specificity was observed between PCSK9 and purified EGF-A. Binding to EGF-A was calcium-dependent and increased dramatically with reduction in pH from 7 to 5.2. The addition of PCSK9, but not heat-inactivated PCSK9, to the medium of cultured hepatocytes resulted in redistribution of the receptor from the plasma membrane to lysosomes. These data are consistent with a model in which PCSK9 binding to EGF-A interferes with an acid-dependent conformational change required for receptor recycling. As a consequence, the LDLR is rerouted from the endosome to the lysosome where it is degraded.	SW Texas State Univ, Dept Mol Genet & Int Med, Dallas, TX 75390 USA; SW Texas State Univ, Donal W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; SW Texas State Univ, Howard Hughes Inst, Dallas, TX 75390 USA	Texas State University System; Texas State University San Marcos; Texas State University System; Texas State University San Marcos; Howard Hughes Medical Institute; Texas State University System; Texas State University San Marcos	Cohen, JC (corresponding author), SW Texas State Univ, Dept Mol Genet, 5323 Harry Hlines Blvd, Dallas, TX 75390 USA.	Jonathan.cohen@utsouthwestern.edu; Helen.hobbs@utsouthwestern.edu	Zhao, Zhenze/AAW-5870-2020; Zhang, Dawei/ABD-8990-2022	Zhang, Dawei/0000-0001-8279-8041	NHLBI NIH HHS [P01HL-20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; BEISIEGEL U, 1981, J BIOL CHEM, V256, P4071; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Boswell EJ, 2004, J BIOL CHEM, V279, P30611, DOI 10.1074/jbc.M401412200; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; CASSIO D, 1991, J CELL BIOL, V115, P1397, DOI 10.1083/jcb.115.5.1397; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; Dinchuk JE, 2000, J BIOL CHEM, V275, P39543, DOI 10.1074/jbc.M006753200; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; ESSER V, 1988, J BIOL CHEM, V263, P13282; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Malby S, 2001, BIOCHEMISTRY-US, V40, P2555, DOI 10.1021/bi002322l; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Saha S, 2001, STRUCTURE, V9, P451, DOI 10.1016/S0969-2126(01)00606-2; SAKAI J, 1994, J BIOL CHEM, V269, P2173; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; STENFLO J, 1988, J BIOL CHEM, V263, P21; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; SUNNERHAGEN MS, 1993, J BIOL CHEM, V268, P23339; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; TOKIWA G, 1994, NATURE, V371, P342, DOI 10.1038/371342a0; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; VANDERWESTHUYZEN DR, 1991, BIOCHEM J, V277, P677, DOI 10.1042/bj2770677; VANDRIEL IR, 1987, J BIOL CHEM, V262, P16127; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Zhang DW, 2006, J BIOL CHEM, V281, P4507, DOI 10.1074/jbc.M512277200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	54	589	658	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18602	18612		10.1074/jbc.M702027200	http://dx.doi.org/10.1074/jbc.M702027200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452316	hybrid			2022-12-27	WOS:000247302000065
J	Tafesse, FG; Huitema, K; Hermansson, M; van der Poel, S; van den Dikkenberg, J; Uphoff, A; Somerharju, P; Holthuis, JCM				Tafesse, Fikadu Geta; Huitema, Klazien; Hermansson, Martin; van der Poel, Selene; van den Dikkenberg, Joep; Uphoff, Andreas; Somerharju, Pentti; Holthuis, Joost C. M.			Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL PHOSPHORYLCERAMIDE SYNTHASE; HAMSTER OVARY CELLS; GOLGI-APPARATUS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; RAT-LIVER; SPHINGOLIPIDS; CERAMIDE; DIACYLGLYCEROL; BIOSYNTHESIS	Sphingomyelin ( SM) is a vital component of cellular membranes in organisms ranging from mammals to protozoa. Its production involves the transfer of phosphocholine from phosphatidylcholine to ceramide, yielding diacylglycerol in the process. The mammalian genome encodes two known SM synthase ( SMS) isoforms, SMS1 and SMS2. However, the relative contributions of these enzymes to SM production in mammalian cells remained to be established. Here we show that SMS1 and SMS2 are co-expressed in a variety of cell types and function as the key Golgi- and plasma membrane-associated SM synthases in human cervical carcinoma HeLa cells, respectively. RNA interference-mediated depletion of either SMS1 or SMS2 caused a substantial decrease in SM production levels, an accumulation of ceramides, and a block in cell growth. Although SMS-depleted cells displayed a reduced SM content, external addition of SM did not restore growth. These results indicate that the biological role of SM synthases goes beyond formation of SM.	Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands; Univ Helsinki, Inst Biomed, Dept Biochem, FIN-00014 Helsinki, Finland	Utrecht University; Utrecht University; Finland National Institute for Health & Welfare; University of Helsinki	Holthuis, JCM (corresponding author), Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	j.c.holthuis@chem.uu.nl	Hermansson, Martin/B-7854-2008; Holthuis, Joost/AAL-9157-2020	Hermansson, Martin/0000-0003-3387-8365; Tafesse, Fikadu/0000-0002-8575-4164; Holthuis, Joost/0000-0001-8912-1586				Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Burger KNJ, 1996, J CELL BIOL, V133, P15, DOI 10.1083/jcb.133.1.15; CHAM BE, 1976, J LIPID RES, V17, P176; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FISHMAN JB, 1986, J BIOL CHEM, V261, P1896; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; GAMBLE W, 1978, J LIPID RES, V19, P1068; Guillen N, 2007, GENE, V388, P117, DOI 10.1016/j.gene.2006.10.013; HAMPTON RY, 1989, SCIENCE, V246, P1050, DOI 10.1126/science.2555921; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hermansson M, 2005, J NEUROCHEM, V95, P609, DOI 10.1111/j.1471-4159.2005.03376.x; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Itoh M, 2003, CLIN CANCER RES, V9, P415; Lee NPY, 2007, J ENDOCRINOL, V192, P17, DOI 10.1677/JOE-06-0002; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; MUEHLENBERG BA, 1972, CAN J BIOCHEM CELL B, V50, P166, DOI 10.1139/o72-022; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; NAOI M, 1974, ANAL BIOCHEM, V58, P571, DOI 10.1016/0003-2697(74)90226-7; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Riboni L, 2001, J BIOL CHEM, V276, P12797, DOI 10.1074/jbc.M011570200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	39	156	167	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17537	17547		10.1074/jbc.M702423200	http://dx.doi.org/10.1074/jbc.M702423200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17449912	Green Published, hybrid			2022-12-27	WOS:000247084500024
J	Wu, J; Tao, Y; Zhang, ML; Howard, MH; Gutteridge, S; Ding, JP				Wu, Jian; Tao, Yong; Zhang, Meilan; Howard, Michael H.; Gutteridge, Steven; Ding, Jianping			Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; CRYPTOCOCCUS-NEOFORMANS; ESSENTIAL ENZYME; PROTEIN; TRANSFERASE; ACETYLTRANSFERASES; BENZOFURANS; ACYLATION; CATALYSIS; SYNTHASE	Protein N-myristoylation catalyzed by myristoyl-CoA:protein N-myristoyltransferase (NMT) plays an important role in a variety of critical cellular processes and thus is an attractive target for development of antifungal drugs. We report here three crystal structures of Saccharomyces cerevisiae NMT: in binary complex with myristoyl-CoA (MYA) alone and in two ternary complexes involving MYA and two different non-peptidic inhibitors. In all three structures, the majority of the N-terminal region, absent in all previously reported structures, forms a well defined motif that is located in the vicinity of the peptide substrate-binding site and is involved in the binding of MYA. The Ab loop, which might be involved in substrate recognition, adopts an open conformation, whereas a loop of the N-terminal region (residues 22-24) that covers the top of the substrate-binding site is in the position occupied by the Ab loop when in the closed conformation. Structural comparisons with other NMTs, together with mutagenesis data, suggest that the N-terminal region of NMT plays an important role in the binding of both MYA and peptide substrate, but not in subsequent steps of the catalytic mechanism. The two inhibitors occupy the peptide substrate-binding site and interact with the protein through primarily hydrophobic contacts. Analyses of the inhibitor-enzyme interactions provide valuable information for further improvement of antifungal inhibitors targeting NMT.	DuPont Co Inc, Stine Haskell Res Ctr, Newark, DE 19714 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	DuPont; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Gutteridge, S (corresponding author), DuPont Co Inc, Stine Haskell Res Ctr, 1090 Elkton Rd, Newark, DE 19714 USA.	Gutteridge@usa.dupont.com; jpding@sibs.ac.cn		ding, jian ping/0000-0001-7029-7346				Ashrafi K, 1998, J BIOL CHEM, V273, P25864, DOI 10.1074/jbc.273.40.25864; Bhatnagar RS, 1998, NAT STRUCT BIOL, V5, P1091, DOI 10.1038/4202; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Devadas B, 1998, J MED CHEM, V41, P996, DOI 10.1021/jm980001q; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; DURONIO RJ, 1992, P NATL ACAD SCI USA, V89, P4129, DOI 10.1073/pnas.89.9.4129; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Farazi TA, 2001, BIOCHEMISTRY-US, V40, P6335, DOI 10.1021/bi0101401; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; GORDON JI, 1991, J BIOL CHEM, V266, P8647; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gunaratne RS, 2000, BIOCHEM J, V348, P459, DOI 10.1042/0264-6021:3480459; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawasaki K, 2003, BIOORG MED CHEM LETT, V13, P87, DOI 10.1016/S0960-894X(02)00844-2; KNOLL LJ, 1995, METHOD ENZYMOL, V250, P405; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LODGE JK, 1994, J BIOL CHEM, V269, P2996; LODGE JK, 1994, P NATL ACAD SCI USA, V91, P12008, DOI 10.1073/pnas.91.25.12008; Lodge JK, 1997, MICROBIOL-UK, V143, P357, DOI 10.1099/00221287-143-2-357; Lodge JK, 1998, J BIOL CHEM, V273, P12482, DOI 10.1074/jbc.273.20.12482; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Masubuchi M, 2001, BIOORG MED CHEM LETT, V11, P1833, DOI 10.1016/S0960-894X(01)00319-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLSON EN, 1985, J BIOL CHEM, V260, P3784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panethymitaki C, 2006, BIOCHEM J, V396, P277, DOI 10.1042/BJ20051886; PESECKIS SM, 1994, J BIOL CHEM, V269, P30888; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; RUDNICK DA, 1992, J BIOL CHEM, V267, P23852; RUDNICK DA, 1993, ADV ENZYMOL RAMB, V67, P375; RUDNICK DA, 1991, J BIOL CHEM, V266, P9732; Selvakumar P, 2002, INT J MOL MED, V10, P493; Sikorski JA, 1997, BIOPOLYMERS, V43, P43, DOI 10.1002/(SICI)1097-0282(1997)43:1&lt;43::AID-BIP5&gt;3.0.CO;2-0; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Sogabe S, 2002, CHEM BIOL, V9, P1119, DOI 10.1016/S1074-5521(02)00240-5; Takamune N, 2002, FEBS LETT, V527, P138, DOI 10.1016/S0014-5793(02)03199-X; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; WEINBURG RA, 1995, MOL MICROBIOL, V16, P241, DOI 10.1111/j.1365-2958.1995.tb02296.x; Weston SA, 1998, NAT STRUCT BIOL, V5, P213, DOI 10.1038/nsb0398-213; Zhang LT, 1996, J BIOL CHEM, V271, P33131, DOI 10.1074/jbc.271.51.33131	48	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22185	22194		10.1074/jbc.M702696200	http://dx.doi.org/10.1074/jbc.M702696200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17513302	hybrid			2022-12-27	WOS:000248196800064
J	Kurup, S; Wijnhoven, TJM; Jenniskens, GJ; Kimata, K; Habuchi, H; Li, J; Lindahl, U; van Kuppevelt, TH; Spillmann, D				Kurup, Sindhulakshmi; Wijnhoven, Tessa J. M.; Jenniskens, Guido J.; Kimata, Koji; Habuchi, Hiroko; Li, Jin-ping; Lindahl, Ulf; van Kuppevelt, Toin H.; Spillmann, Dorothe			Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION; STRUCTURAL DIVERSITY; IDURONIC ACID; DOMAINS; IDENTIFICATION; BINDING; DEPOLYMERIZATION; HETEROGENEITY; BIOSYNTHESIS; PROTEIN	Heparan sulfates (HS) are linear carbohydrate chains, covalently attached to proteins, that occur on essentially all cell surfaces and in extracellular matrices. HS chains show extensive structural heterogeneity and are functionally important during embryogenesis and in homeostasis due to their interactions with various proteins. Phage display antibodies have been developed to probe HS structures, assess the availability of protein-binding sites, and monitor structural changes during development and disease. Here we have characterized two such antibodies, AO4B08 and HS4E4, previously noted for partly differential tissue staining. AO4B08 recognized both HS and heparin, and was found to interact with an ubiquitous, N-, 2-O-, and 6-O-sulfated saccharide motif, including an internal 2-O-sulfate group. HS4E4 turned out to preferentially recognize low-sulfated HS motifs containing iduronic acid, and N-sulfated as well as N-acetylated glucosamine residues. Contrary to AO4B08, HS4E4 did not bind highly O-sulfated structures such as found in heparin.	Uppsala Univ, Ctr Biomed, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan	Uppsala University; Radboud University Nijmegen; Aichi Medical University	Spillmann, D (corresponding author), Uppsala Univ, Ctr Biomed, Dept Med Biochem & Microbiol, POB 582, SE-75123 Uppsala, Sweden.	Dorothe.Spillmann@imbim.uu.se	van Kuppevelt, A.H.M.S.M./L-4463-2015					BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Feyzi E, 1997, J BIOL CHEM, V272, P5518, DOI 10.1074/jbc.272.9.5518; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; JACOBSSON I, 1979, BIOCHEM J, V179, P77, DOI 10.1042/bj1790077; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2002, EMBO J, V21, P6303, DOI 10.1093/emboj/cdf638; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; KUSCHE M, 1991, BIOCHEM J, V275, P151, DOI 10.1042/bj2750151; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; LINKER A, 1973, CARBOHYD RES, V29, P41, DOI 10.1016/S0008-6215(00)82069-8; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MacRae IJ, 1998, J BIOL CHEM, V273, P28583, DOI 10.1074/jbc.273.44.28583; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Safaiyan F, 2000, BIOCHEMISTRY-US, V39, P10823, DOI 10.1021/bi000411s; Sedita J, 2004, DEV DYNAM, V231, P782, DOI 10.1002/dvdy.20173; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3943, DOI 10.1021/bi00663a006; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960	33	67	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21032	21042		10.1074/jbc.M702073200	http://dx.doi.org/10.1074/jbc.M702073200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17517889	Green Published, hybrid			2022-12-27	WOS:000248047500030
J	Nguyen, TLA; de Walque, S; Veithen, E; Dekoninck, A; Martinelli, V; de Launoit, Y; Burny, A; Harrod, R; Van Lint, C				Nguyen, Thi Lien-Anh; de Walque, Stephane; Veithen, Emmanuelle; Dekoninck, Ann; Martinelli, Valerie; de Launoit, Yvan; Burny, Arsene; Harrod, Robert; Van Lint, Carine			Transcriptional regulation of the bovine leukemia virus promoter by the cyclic AMP-response element modulator tau isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; PROTEIN-KINASE-C; CAMP-INDUCED TRANSCRIPTION; MALE GERM-CELLS; BINDING PROTEIN; IN-VIVO; GENE-EXPRESSION; B-LYMPHOCYTES; TRANSACTIVATOR PROTEIN; GENOMIC INTEGRATION	Bovine leukemia virus (BLV) expression is controlled at the transcriptional level through three Tax(BLV)- responsive elements (TxREs) responsive to the viral transactivator Tax(BLV). The cAMP-responsive element (CRE)-binding protein (CREB) has been shown to interact with CRE-like sequences present in the middle of each of these TxREs and to play critical transcriptional roles in both basal and Tax(BLV)-transactivated BLV promoter activity. In this study, we have investigated the potential involvement of the cAMP-response element modulator (CREM) in BLV transcriptional regulation, and we have demonstrated that CREM proteins were expressed in BLV-infected cells and bound to the three BLV TxREs in vitro. Chromatin immuno-precipitation assays using BLV-infected cell lines demonstrated in the context of chromatin that CREM proteins were recruited to the BLV promoter TxRE region in vivo. Functional studies, in the absence of TaxBLV, indicated that ectopic CREM tau protein had a CRE-dependent stimulatory effect on BLV promoter transcriptional activity. Cross-link of the B-cell receptor potentiated CREM tau transactivation of the viral promoter. Further experiments supported the notion that this potentiation involved CREM tau Ser-117 phosphorylation and recruitment of CBP/p300 to the BLV promoter. Although CREB and TaxBLV synergistically transactivated the BLV promoter, CREM tau repressed this Tax(BLV)/CREB synergism, suggesting that a modulation of the level of TaxBLV transactivation through opposite actions of CREB and CREM tau could facilitate immune escape and allow tumor development.	Univ Libre Bruxelles, Mol Virol Lab, Inst Biol & Med Mol, B-6041 Gosselies, Belgium; Univ Lille 1, Inst Biol Lille, CNRS, UMR 8117, F-59021 Lille, France; Univ Lille 1, Inst Pasteur Lille, CNRS, UMR 8117, F-59021 Lille, France; So Methodist Univ, Mol Virol Lab, Dept Biol Sci, Dallas, TX 75275 USA; Fonds Natl Rech Sci, Bern, Switzerland	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Southern Methodist University	Van Lint, C (corresponding author), Univ Libre Bruxelles, Mol Virol Lab, Inst Biol & Med Mol, Rue Profs Jeener & Brachet 12, B-6041 Gosselies, Belgium.	cvlint@ulb.ac.be						Adam E, 1996, J VIROL, V70, P1990, DOI 10.1128/JVI.70.3.1990-1999.1996; ADAM E, 1994, J VIROL, V68, P5845, DOI 10.1128/JVI.68.9.5845-5853.1994; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Bodor J, 1995, FEBS LETT, V377, P413, DOI 10.1016/0014-5793(95)01299-0; Bodor J, 1996, P NATL ACAD SCI USA, V93, P3536, DOI 10.1073/pnas.93.8.3536; Calomme C, 2004, J VIROL, V78, P13848, DOI 10.1128/JVI.78.24.13848-13864.2004; Calomme C, 2002, J BIOL CHEM, V277, P8775, DOI 10.1074/jbc.M107441200; Daniel PB, 2000, ENDOCRINOLOGY, V141, P3923, DOI 10.1210/en.141.11.3923; DE CD, 1999, TRENDS BIOCHEM SCI, V24, P281; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; De Cesare D, 2000, J ENDOCRINOL INVEST, V23, P592, DOI 10.1007/BF03343781; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; DERSE D, 1987, J VIROL, V61, P2462, DOI 10.1128/JVI.61.8.2462-2471.1987; DERSE D, 1986, SCIENCE, V231, P1437, DOI 10.1126/science.3006241; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FOULKES NS, 1993, NATURE, V362, P264, DOI 10.1038/362264a0; Gellersen B, 2002, MOL HUM REPROD, V8, P965, DOI 10.1093/molehr/8.11.965; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; GUPTA P, 1982, SCIENCE, V215, P405, DOI 10.1126/science.6276975; HAGMEYER BM, 1995, BIOESSAYS, V17, P621, DOI 10.1002/bies.950170708; Harnett MA, 2005, IMMUNOL LETT, V98, P33, DOI 10.1016/j.imlet.2004.11.002; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; KATOH I, 1989, EMBO J, V8, P497, DOI 10.1002/j.1460-2075.1989.tb03403.x; Kerkhofs P, 1996, J VIROL, V70, P2170, DOI 10.1128/JVI.70.4.2170-2177.1996; KETTMANN R, 1980, P NATL ACAD SCI-BIOL, V77, P2577, DOI 10.1073/pnas.77.5.2577; KETTMANN R, 1982, P NATL ACAD SCI-BIOL, V79, P2465, DOI 10.1073/pnas.79.8.2465; KETTMANN R, 1980, LEUKEMIA RES, V4, P509, DOI 10.1016/0145-2126(80)90062-4; KISSTOTH E, 1993, NUCLEIC ACIDS RES, V21, P3677, DOI 10.1093/nar/21.16.3677; KISTLER MK, 1994, BIOL REPROD, V51, P1322, DOI 10.1095/biolreprod51.6.1322; LAGARIAS DM, 1989, J VIROL, V63, P2099, DOI 10.1128/JVI.63.5.2099-2107.1989; Lamas M, 1996, PHILOS T R SOC B, V351, P561, DOI 10.1098/rstb.1996.0055; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Laurance ME, 1997, J BIOL CHEM, V272, P2646, DOI 10.1074/jbc.272.5.2646; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Merezak C, 2002, J VIROL, V76, P5034, DOI 10.1128/JVI.76.10.5034-5042.2002; Monaco L, 2004, INT J ANDROL, V27, P322, DOI 10.1111/j.1365-2605.2004.00494.x; MURAKAMI K, 1994, VIROLOGY, V202, P458, DOI 10.1006/viro.1994.1362; Muthusamy N, 1998, J BIOL CHEM, V273, P22841, DOI 10.1074/jbc.273.35.22841; Newbound GC, 2000, J MED VIROL, V62, P286, DOI 10.1002/1096-9071(200010)62:2<286::AID-JMV22>3.3.CO;2-P; Nguyen TLA, 2004, J BIOL CHEM, V279, P35025, DOI 10.1074/jbc.M404081200; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; PONGUBALA JMR, 1995, J BIOL CHEM, V270, P10304, DOI 10.1074/jbc.270.17.10304; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; SUN ZM, 1995, J BIOL CHEM, V270, P29507, DOI 10.1074/jbc.270.49.29507; Swart JM, 2000, J IMMUNOL, V164, P2311, DOI 10.4049/jimmunol.164.5.2311; TAYLOR JA, 1993, LAB INVEST, V69, P340; TSUKIYAMA K, 1987, ARCH VIROL, V96, P89, DOI 10.1007/BF01310992; Twizere JC, 2000, J VIROL, V74, P9895, DOI 10.1128/JVI.74.21.9895-9902.2000; Van den Broeke A, 1999, J VIROL, V73, P1054, DOI 10.1128/JVI.73.2.1054-1065.1999; Van den Broeke A, 2001, J VIROL, V75, P1095, DOI 10.1128/JVI.75.3.1095-1103.2001; van der Stoep N, 2002, J IMMUNOL, V169, P5061, DOI 10.4049/jimmunol.169.9.5061; VANLINT C, 1994, J VIROL, V68, P2632, DOI 10.1128/JVI.68.4.2632-2648.1994; WALKER WH, 1994, P NATL ACAD SCI USA, V91, P12423, DOI 10.1073/pnas.91.26.12423; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; WILLEMS L, 1987, EMBO J, V6, P3385, DOI 10.1002/j.1460-2075.1987.tb02661.x; WILLEMS L, 1992, P NATL ACAD SCI USA, V89, P3957, DOI 10.1073/pnas.89.9.3957; WILLEMS L, 1992, J VIROL, V66, P766, DOI 10.1128/JVI.66.2.766-772.1992; WILLEMS L, 1990, EMBO J, V9, P1577, DOI 10.1002/j.1460-2075.1990.tb08277.x; Willems L, 2000, AIDS RES HUM RETROV, V16, P1787, DOI 10.1089/08892220050193326; Xie HJ, 1996, CELL IMMUNOL, V169, P264, DOI 10.1006/cimm.1996.0117; XIE HJ, 1995, J IMMUNOL, V154, P1717; ZANDOMENI RO, 1994, J INFECT DIS, V170, P787, DOI 10.1093/infdis/170.4.787; ZANDOMENI RO, 1992, J GEN VIROL, V73, P1915, DOI 10.1099/0022-1317-73-8-1915; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P12262, DOI 10.1073/pnas.93.22.12262	76	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20854	20867		10.1074/jbc.M703060200	http://dx.doi.org/10.1074/jbc.M703060200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17526487	hybrid			2022-12-27	WOS:000248047500011
J	Land, SC; Tee, AR				Land, Stephen C.; Tee, Andrew R.			Hypoxia-inducible factor 1 alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TUBEROUS SCLEROSIS; TRANSCRIPTIONAL ACTIVATION; BINDING PARTNER; GENE-PRODUCTS; PATHWAY; IDENTIFICATION; EXPRESSION; RHEB	Tumors that form as a result of heightened mammalian target of rapamycin ( mTOR) signaling are highly vascularized. This process of angiogenesis is regulated through hypoxia-inducible factor (HIF)-mediated transcription of angiogenic factors. It is recognized that inhibition of mTOR with rapamycin can diminish the process of angiogenesis. Our work shows that activation of mTOR by Ras homologue enriched in brain ( Rheb) overexpression potently enhances the activity of HIF1 alpha and vascular endothelial growth factor (VEGF)-A secretion during hypoxia, which is reversed with rapamycin. Mutants of Rheb, which do not bind guanine nucleotide (D60K, D60V, N119I, and D122N) and are unable to activate mTOR, inhibit the activity of HIF when overexpressed. We show that regulatory associated protein of mTOR ( Raptor) interacts with HIF1 alpha and requires an mTOR signaling (TOS) motif located in the N terminus of HIF1 alpha. Furthermore, a mutant of HIF1 alpha lacking this TOS motif dominantly impaired HIF activity during hypoxia and was unable to bind to the co-activator CBP/p300. Rapamycin treatments do not affect the stability of HIF1 alpha and modulate HIF activity via a Von Hippel-Lindau (VHL)-independent mechanism. We demonstrate that the high levels of HIF activity in cells devoid of TSC2 can be reversed by treatments with rapamycin or the readdition of TSC2. Our work explains why human cancers with aberrant mTOR signaling are prone to angiogenesis and suggests that inhibition of mTOR with rapamycin might be a suitable therapeutic strategy.	Univ Cardiff Wales, Coll Med, Inst Med Genet, Cardiff CF14 4XN, Wales; Univ Dundee, Ninewells Hosp, Sch Med, Div Maternal & Child Hlth Sci, Dundee DD1 9SY, Scotland	Cardiff University; University of Dundee	Tee, AR (corresponding author), Univ Cardiff Wales, Coll Med, Inst Med Genet, Heath Park, Cardiff CF14 4XN, Wales.	TeeA@cardiff.ac.uk		Land, Stephen/0000-0001-9216-5969; Tee, Andrew/0000-0002-5577-4631	Worldwide Cancer Research [06-0914] Funding Source: Medline	Worldwide Cancer Research		Baba M, 2003, ONCOGENE, V22, P2728, DOI 10.1038/sj.onc.1206373; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; El-Hashemite N, 2003, CANCER RES, V63, P5173; Gomez-Manzano C, 2003, ANN NEUROL, V53, P109, DOI 10.1002/ana.10396; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kotsuji-Maruyama T, 2002, J DERMATOL, V29, P713, DOI 10.1111/j.1346-8138.2002.tb00208.x; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rapisarda A, 2002, CANCER RES, V62, P4316; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Woo KJ, 2006, BIOCHEM BIOPH RES CO, V343, P8, DOI 10.1016/j.bbrc.2006.02.116; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	41	370	391	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20534	20543		10.1074/jbc.M611782200	http://dx.doi.org/10.1074/jbc.M611782200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502379	hybrid			2022-12-27	WOS:000247819300056
J	North, BJ; Verdin, E				North, Brian J.; Verdin, Eric			Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CDC14A PHOSPHATASE; PROTEIN DEACETYLASES; CHROMOSOME SEGREGATION; HISTONE DEACETYLASE; TUBULIN DEACETYLASE; SIR2-LIKE PROTEINS; CELL-CYCLE; GENE; EXIT; HOMOLOGY	Sirtuins are evolutionarily conserved NAD(+)-dependent deacetylases and ADP-ribosyltransferases involved in the regulation of cell division, apoptosis, DNA damage repair, genomic silencing, and longevity. Recent studies have focused on identifying target substrates for human sirtuin enzymatic activity, but little is known about processes that directly regulate their function. Here, we demonstrate that SIRT2 is phosphorylated both in vitro and in vivo on serine 368 by the cell-cycle regulator, cyclin-dependent kinase 1, and dephosphorylated by the phosphatases CDC14A and CDC14B. Overexpression of SIRT2 mediates a delay in cellular proliferation that is dependent on serine 368 phosphorylation. Furthermore, mutation of serine 368 reduces hyperploidy in cells under mitotic stress due to microtubule poisons.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183				Afshar G, 1999, GENE, V234, P161, DOI 10.1016/S0378-1119(99)00162-6; Bae NS, 2004, J BIOCHEM, V135, P695, DOI 10.1093/jb/mvh084; Bembenek J, 2003, FRONT BIOSCI, V8, pD1275, DOI 10.2741/1128; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; North BJ, 2005, METHODS, V36, P338, DOI 10.1016/j.ymeth.2005.03.004; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Yang YH, 2000, GENOMICS, V69, P355, DOI 10.1006/geno.2000.6360; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978	26	117	122	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19546	19555		10.1074/jbc.M702990200	http://dx.doi.org/10.1074/jbc.M702990200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17488717	hybrid			2022-12-27	WOS:000247650600029
J	Suemori, A; Iwakura, M				Suemori, Akio; Iwakura, Masahiro			A systematic and comprehensive combinatorial approach to simultaneously improve the activity, reaction specificity, and thermal stability of p-hydroxybenzoate hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; SITE-DIRECTED MUTAGENESIS; AMINO-ACID OXIDASE; PROTOCATECHUATE 3,4-DIOXYGENASE; 4-HYDROXYBENZOATE HYDROXYLASE; PSEUDOMONAS-FLUORESCENS; HALOARCULA-MARISMORTUI; SUBSTRATE-SPECIFICITY; HALOPHILIC ARCHAEON; CRYSTAL-STRUCTURE	We have simultaneously improved the activity, reaction specificity, and thermal stability of p-hydroxybenzoate hydroxylase by means of systematic and comprehensive combinatorial mutagenesis starting from available single mutations. Introduction of random mutations at the positions of four cysteine and eight methionine residues provided 216 single mutants as stably expressed forms in Escherichia coli host cells. Four characteristics, hydroxylase activity toward p-hydroxybenzoate (main activity), protocatechuate-dependent NADPH oxidase activity (sub-activity), ratio of sub-activity to main activity (reaction specificity), and thermal stability, of the purified mutants were determined. To improve the above characteristics for diagnostic use of the enzyme, 11 single mutations (C152V, C211I, C332A, M52V, M52Q, M110L, M110I, M213G, M213L, M276Q, and M349A) were selected for further combinatorial mutagenesis. All possible combinations of the mutations provided 18 variants with double mutations and further combinatorial mutagenesis provided 6 variants with triple mutations and 9 variants with quadruple mutations with the simultaneously improved four properties.	Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Iwakura, M (corresponding author), Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	masa-iwakura@aist.go.jp						ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ASHIHARA Y, 1983, J BIOCHEM-TOKYO, V94, P11, DOI 10.1093/oxfordjournals.jbchem.a134318; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bertani I, 2001, MICROBIOL-SGM, V147, P1611, DOI 10.1099/00221287-147-6-1611; Bornscheuer UT, 2001, CURR OPIN CHEM BIOL, V5, P137, DOI 10.1016/S1367-5931(00)00182-4; Buchan A, 2000, APPL ENVIRON MICROB, V66, P4662, DOI 10.1128/AEM.66.11.4662-4672.2000; Buchan A, 2004, APPL ENVIRON MICROB, V70, P1658, DOI 10.1128/AEM.70.3.1658-1668.2004; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Campanella L, 2006, J PHARMACEUT BIOMED, V42, P94, DOI 10.1016/j.jpba.2006.03.020; Chelius D, 2000, BIOCHEMISTRY-US, V39, P9687, DOI 10.1021/bi000274z; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Deka RC, 2003, COMB CHEM HIGH T SCR, V6, P1; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EMERSON D, 1994, ARCH MICROBIOL, V161, P445, DOI 10.1007/s002030050081; Endelman JB, 2004, PROTEIN ENG DES SEL, V17, P589, DOI 10.1093/protein/gzh067; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; ENTSCH B, 1988, GENE, V71, P279, DOI 10.1016/0378-1119(88)90044-3; Fairley DJ, 2002, APPL ENVIRON MICROB, V68, P6246, DOI 10.1128/AEM.68.12.6246-6255.2002; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; Fu WJ, 1999, EXTREMOPHILES, V3, P45, DOI 10.1007/s007920050098; Garcia MT, 2005, FEMS MICROBIOL ECOL, V54, P97, DOI 10.1016/j.femsec.2005.03.009; Hamamatsu N, 2005, PROTEIN ENG DES SEL, V18, P265, DOI 10.1093/protein/gzi028; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.mi.46.100192.003025; Harris JL, 1998, CURR OPIN CHEM BIOL, V2, P127, DOI 10.1016/S1367-5931(98)80044-6; HARTNETT C, 1990, J BACTERIOL, V172, P956, DOI 10.1128/jb.172.2.956-966.1990; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Iwabata H, 2005, FEMS MICROBIOL LETT, V243, P393, DOI 10.1016/j.femsle.2004.12.030; Iwakura M, 2006, J BIOL CHEM, V281, P13234, DOI 10.1074/jbc.M508823200; Jestin JL, 2005, RES MICROBIOL, V156, P961, DOI 10.1016/j.resmic.2005.09.004; Ju SS, 2000, FEMS MICROBIOL LETT, V186, P215, DOI 10.1016/S0378-1097(00)00151-8; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Larsson AK, 2004, PROTEIN ENG DES SEL, V17, P49, DOI 10.1093/protein/gzh005; Li TP, 2003, PROTEIN ENG, V16, P323, DOI 10.1093/protein/gzg044; Mattevi A, 1998, BIOPHYS CHEM, V70, P217, DOI 10.1016/S0301-4622(97)00126-9; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; Noivirt O, 2005, PROTEIN ENG DES SEL, V18, P247, DOI 10.1093/protein/gzi029; OREN A, 1990, INT J SYST BACTERIOL, V40, P209, DOI 10.1099/00207713-40-2-209; Overhage J, 1999, APPL ENVIRON MICROB, V65, P951; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Quinn JA, 2001, GENE, V264, P77, DOI 10.1016/S0378-1119(00)00599-0; Sacchi S, 2004, PROTEIN ENG DES SEL, V17, P517, DOI 10.1093/protein/gzh064; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; SCHREUDER HA, 1988, J MOL BIOL, V199, P637, DOI 10.1016/0022-2836(88)90307-5; Seibold B, 1996, EUR J BIOCHEM, V239, P469, DOI 10.1111/j.1432-1033.1996.0469u.x; SHUMAN B, 1993, J BIOL CHEM, V268, P17057; Slusarczyk H, 2000, EUR J BIOCHEM, V267, P1280, DOI 10.1046/j.1432-1327.2000.01123.x; Suemori A, 2001, BIOTECHNOL LETT, V23, P489, DOI 10.1023/A:1010345807073; Suen WC, 2004, PROTEIN ENG DES SEL, V17, P133, DOI 10.1093/protein/gzh017; Urgun-Demirtas M, 2006, CRIT REV BIOTECHNOL, V26, P145, DOI 10.1080/07388550600842794; VANBERKEL W, 1992, EUR J BIOCHEM, V210, P411; VANBERKEL WJH, 1984, EUR J BIOCHEM, V145, P245; VANDERBOLT FJT, 1994, PROTEIN ENG, V7, P801, DOI 10.1093/protein/7.6.801; Wattiau P, 2001, RES MICROBIOL, V152, P861, DOI 10.1016/S0923-2508(01)01269-4; WHITESTE.RH, 1970, BIOCHEM BIOPH RES CO, V38, P882, DOI 10.1016/0006-291X(70)90803-X; WONG CM, 1994, MICROBIOL-SGM, V140, P2775, DOI 10.1099/00221287-140-10-2775; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Zhao HM, 1997, CURR OPIN STRUC BIOL, V7, P480, DOI 10.1016/S0959-440X(97)80110-8	66	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19969	19978		10.1074/jbc.M610320200	http://dx.doi.org/10.1074/jbc.M610320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17462997	hybrid			2022-12-27	WOS:000247650600071
J	Zou, GZ; de Leeuw, E; Li, C; Pazgier, M; Li, CQ; Zeng, PY; Lu, WY; Lubkowski, J; Lu, WY				Zou, Guozhang; de Leeuw, Erik; Li, Chong; Pazgier, Marzena; Li, Changqing; Zeng, Pengyun; Lu, Wei-Yue; Lubkowski, Jacek; Lu, Wuyuan			Toward understanding the cationicity of defensins - Arg and Lys versus their noncoded analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-DEFENSINS; HUMAN BETA-DEFENSINS; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-3; HOST-DEFENSE; AMINO-ACIDS; ANTIBACTERIAL ACTIVITY; MAMMALIAN DEFENSINS; HUMAN-NEUTROPHILS; MESSENGER-RNA	Human defensins are a family of small antimicrobial proteins found predominantly in leukocytes and epithelial cells that play important roles in the innate and adaptive immune defense against microbial infection. The most distinct molecular feature of defensins is cationicity, manifested by abundant Arg and/or Lys residues in their sequences. Sequence analysis indicates that Arg is strongly selected over Lys in alpha-defensins but not in alpha-defensins. To understand this Arg/Lys disparity in defensins, we chemically synthesized human alpha-defensin 1 (HNP1) and several HNP1 analogs where three Arg residues were replaced by each of the following six alpha-amino acids: Lys, ornithine (Orn), diaminobutyric acid ( Dab), diaminopropionic acid (Dap), N, N-dimethyl-Lys ((diMe)Lys), and homo-Arg ((homo)Arg). In addition, we prepared human alpha-defensin 1 (hBD1) and (Lys3 -> Arg)hBD1 in which all four Lys residues were substituted for Arg. Bactericidal activity assays revealed the following. 1) Arg-containing HNP1 and (Lys3 -> Arg)hBD1 are functionally better than Lys-HNP1 and hBD1, respectively; the difference between Arg and Lys is more evident in the alpha-defensin than in the beta-defensin and is more evident at low salt concentrations than at high salt concentrations. 2) For HNP1, the Arg/Lys disparity is much more pronounced with Staphylococcus aureus than with Escherichia coli, and the Arg-rich HNP1 kills bacteria faster than its Lys-rich analog. 3) Arg and Lys appear to have optimal chain lengths for bacterial killing as shortening Lys or lengthening Arg in HNP1 invariably becomes functionally deleterious. Our findings provide insights into the Arg/Lys disparity in defensins, and shed light on the cationicity of defensins with respect to their antimicrobial activity and specificity.	Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA; Fudan Univ, Sch Pharm, Fudan PharmCo Drug Target Res Ctr, Shanghai 200032, Peoples R China; NIH, NCI, Macromol Assembly Struct & Cell Signaling Sect, Frederick, MD 21702 USA	University System of Maryland; University of Maryland Baltimore; Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lubkowski, J (corresponding author), Univ Maryland, Inst Biotechnol, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	jacek@ncifcrf.gov; luw@umbi.umd.edu	Li, Chong/H-2515-2011; Lu, Wuyuan/J-8452-2017; Lu, Weiyue/E-7938-2010; Pazgier, Marzena/B-7295-2012; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; 	NATIONAL CANCER INSTITUTE [Z01SC010386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R21AI056264] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI056264, AI061482] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abiko Y, 2003, J DERMATOL SCI, V31, P225, DOI 10.1016/S0923-1811(03)00007-0; Alberts B., 1994, MOL BIOL CELL; Bateman A, 1996, J BIOL CHEM, V271, P10654, DOI 10.1074/jbc.271.18.10654; Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Berezovsky IN, 2005, PLOS COMPUT BIOL, V1, P322, DOI 10.1371/journal.pcbi.0010047; Brock T.P., 1991, BIOL MICROORGANISMS, V340; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; FUJII G, 1993, PROTEIN SCI, V2, P1301, DOI 10.1002/pro.5560020813; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GILIS D, 2001, GENOME BIOL, V2; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; JUKES TH, 1975, SCIENCE, V189, P50, DOI 10.1126/science.237322; JUKES TH, 1974, BIOCHEM BIOPH RES CO, V58, P80, DOI 10.1016/0006-291X(74)90893-6; Karplus PA, 1997, PROTEIN SCI, V6, P1302; KENT SBH, 1988, ANNU REV BIOCHEM, V57, P957, DOI 10.1146/annurev.bi.57.070188.004521; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Muhle SA, 2001, BIOCHEMISTRY-US, V40, P5777, DOI 10.1021/bi0100384; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2007, J BIOL CHEM, V282, P1819, DOI 10.1074/jbc.M607210200; Raj PA, 2000, BIOCHEM J, V347, P633, DOI 10.1042/0264-6021:3470633; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Tokunaga Y, 2001, J PEPT SCI, V7, P297, DOI 10.1002/psc.317; Varoga D, 2005, ARTHRITIS RHEUM-US, V52, P1736, DOI 10.1002/art.21090; WALLIS M, 1974, BIOCHEM BIOPH RES CO, V56, P711, DOI 10.1016/0006-291X(74)90663-9; WALSH CT, 2005, POSTTRANSLATIONAL MO, P121; WHITE SH, 1992, J MOL BIOL, V227, P991, DOI 10.1016/0022-2836(92)90515-L; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu ER, 1998, PEPTIDES, V19, P793, DOI 10.1016/S0196-9781(98)00016-3; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Xie C, 2005, PEPTIDES, V26, P2377, DOI 10.1016/j.peptides.2005.06.002; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2004, ARTHRITIS RHEUM, V50, P3401, DOI 10.1002/art.20604; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yang ST, 2003, FEBS LETT, V540, P229, DOI 10.1016/S0014-5793(03)00266-7; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127	75	113	117	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19653	19665		10.1074/jbc.M611003200	http://dx.doi.org/10.1074/jbc.M611003200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17452329	hybrid			2022-12-27	WOS:000247650600040
J	Zhu, W; Boachie-Adjei, O; Rawlins, BA; Frenkel, B; Boskey, AL; Ivashkiv, LB; Blobel, CP				Zhu, Wei; Boachie-Adjei, Oheneba; Rawlins, Bernard A.; Frenkel, Baruch; Boskey, Adele L.; Ivashkiv, Lionel B.; Blobel, Carl P.			A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; OSTEOBLASTIC DIFFERENTIATION; STEM/PROGENITOR CELLS; CHEMOKINE RECEPTORS; CANCER METASTASIS; SDF-1 CXCL12; HIV-1 ENTRY; MARROW; CXCR4; EXPRESSION	Stromal-derived factor 1 (SDF-1) is a chemokine with important functions in development and postnatal tissue homeostasis. SDF-1 signaling via the G-protein-coupled receptor CXCR4 regulates the recruitment of stem and precursor cells to support tissue-specific repair or regeneration. In this study we examined the contribution of SDF-1 signaling to osteogenic differentiation of mesenchymal C2C12 cells induced by bone morphogenic protein 2 (BMP2). Blocking SDF-1 signaling before BMP2 stimulation by treatment with siRNA, antibodies against SDF-1 or CXCR4, or the G-protein-coupled receptor inhibitor pertussis toxin strongly suppressed BMP2 induction of osteogenic differentiation in C2C12 cells, as evidenced by an early decrease in the expression of the myogenesis inhibitor Id1, the osteogenic master regulators Runx2 and Osx, the osteoblast-associated transcription factors JunB, Plzf, Msx2, and Dlx5, and later of the bone marker proteins osteocalcin and alkaline phosphatase. Similarly, blocking SDF-1/CXCR4 signaling strongly inhibited BMP2-induced osteogenic differentiation of ST2 bone marrow stromal cells. Moreover, we found that the interaction between SDF- 1 and BMP2 signaling was mediated via intracellular Smads and MAPK activation. Our data provide the first evidence for a co-requirement of the SDF-1/CXCR4 signaling axis in BMP2-induced osteogenic differentiation of C2C12 and ST2 cells and, thus, uncover a new potential target for modulation of osteogenesis.	Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; Hosp Special Surg, Dept Orthopaed Surg, Spinal Deform Serv, New York, NY 10021 USA; Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Hosp Special Surg, Musculoskeletal Integrit Program, New York, NY 10021 USA	University of Southern California	Zhu, W (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, Caspary Res Bldg,4th Floor,535 E 70th St, New York, NY 10021 USA.	ZhuW@HSS.EDU		Boskey, Adele/0000-0002-6181-2219				Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020; Aiuti A, 1999, EUR J IMMUNOL, V29, P1823, DOI 10.1002/(SICI)1521-4141(199906)29:06<1823::AID-IMMU1823>3.0.CO;2-B; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cei S, 2006, J PERIODONTOL, V77, P699, DOI 10.1902/jop.2006.050155; Chalaux E, 1998, J BIOL CHEM, V273, P537, DOI 10.1074/jbc.273.1.537; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Chikazu D, 2002, J BONE MINER RES, V17, P1430, DOI 10.1359/jbmr.2002.17.8.1430; DESBOIS C, 1994, J BIOL CHEM, V269, P1183; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Dominov JA, 1998, J CELL BIOL, V142, P537, DOI 10.1083/jcb.142.2.537; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Gu K, 2004, CELLS TISSUES ORGANS, V176, P28, DOI 10.1159/000075025; Gundberg CM, 2000, CLIN LAB MED, V20, P489; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hatse S, 2005, BIOCHEM PHARMACOL, V70, P752, DOI 10.1016/j.bcp.2005.05.035; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Ikeda R, 2005, J BIOL CHEM, V280, P8523, DOI 10.1074/jbc.M409442200; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Kumar RB, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-25; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Papayannopoulou T, 2003, BLOOD, V101, P4739, DOI 10.1182/blood-2002-09-2741; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Sowa H, 2003, J BIOL CHEM, V278, P21058, DOI 10.1074/jbc.M302044200; Strizki JM, 1997, J VIROL, V71, P5678, DOI 10.1128/JVI.71.7.5678-5683.1997; Taichman RS, 2002, CANCER RES, V62, P1832; Takagi M, 2004, J MOL HISTOL, V35, P81; Vaes BLT, 2002, J BONE MINER RES, V17, P2106, DOI 10.1359/jbmr.2002.17.12.2106; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yanai T, 2001, J BONE MINER METAB, V19, P345, DOI 10.1007/s007740170003; Yeh LCC, 2002, J CELL BIOCHEM, V87, P292, DOI 10.1002/jcb.10315; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404; Zachos TA, 2006, J ORTHOP RES, V24, P1279, DOI 10.1002/jor.20068; Zhang L, 2005, J BIOL CHEM, V280, P37289, DOI 10.1074/jbc.M504260200; Zhu W, 2004, J BONE MINER RES, V19, P2021, DOI 10.1359/JBMR.040821; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	67	87	93	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18676	18685		10.1074/jbc.M610232200	http://dx.doi.org/10.1074/jbc.M610232200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17439946	hybrid			2022-12-27	WOS:000247475300005
J	Hwang, J; Kalinin, A; Hwang, M; Anderson, DE; Kim, MJ; Stojadinovic, O; Tomic-Canic, M; Lee, SH; Morasso, MI				Hwang, Joonsung; Kalinin, Alexandr; Hwang, Meeyul; Anderson, D. Eric; Kim, Min Jung; Stojadinovic, Olivera; Tomic-Canic, Marjana; Lee, Seung Hun; Morasso, Maria I.			Role of scarf and its binding target proteins in epidermal calcium homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE PROTEIN; BARRIER FUNCTION; GROWTH-INHIBITION; MURINE EPIDERMIS; DIFFERENTIATION; EXPRESSION; LOCALIZATION; ANNEXINS; IDENTIFICATION; ASSOCIATION	The novel Ca2+-binding protein, Scarf ( skin calmodulin-related factor) belongs to the calmodulin-like protein family and is expressed in the differentiated layers of the epidermis. To determine the roles of Scarf during stratification, we set out to identify the binding target proteins by affinity chromatography and subsequent analysis by mass spectrometry. Several binding factors, including 14-3-3s, annexins, calreticulin, ERp72 ( endoplasmic reticulum protein 72), and nucleolin, were identified, and their interactions with Scarf were corroborated by co-immunoprecipitation and co-localization analyses. To further understand the functions of Scarf in epidermis in vivo, we altered the epidermal Ca2+ gradient by acute barrier disruption. The change in the expression levels of Scarf and its binding target proteins were determined by immunohistochemistry and Western blot analysis. The expression of Scarf, annexins, calreticulin, and ERp72 were up-regulated by Ca2+ gradient disruption, whereas the expression of 14-3-3s and nucleolin was reduced. Because annexins, calreticulin, and ERp72 have been implicated in Ca2+-induced cellular trafficking, including the secretion of lamellar bodies and Ca2+ homeostasis, we propose that the interaction of Scarf with these proteins might be crucial in the process of barrier restoration. On the other hand, down-regulation of 14-3-3s and nucleolin is potentially involved in the process of keratinocyte differentiation and growth inhibition. The calcium-dependent localization and up-regulation of Scarf and its binding target proteins were studied in mouse keratinocytes treated with ionomycin and during the wound-healing process. We found increased expression and nuclear presence of Scarf in the epidermis of the wound edge 4 and 7 days post-wounding, entailing the role of Scarf in barrier restoration. Our results suggest that Scarf plays a critical role as a Ca2+ sensor, potentially regulating the function of its binding target proteins in a Ca2+-dependent manner in the process of restoration of epidermal Ca2+ gradient as well as during epidermal barrier formation.	NIAMS, NIH, Dev Skin Biol Unit, Bethesda, MD 20892 USA; NIDDK, NIH, Proteom & Mass Spectrometry Fac, Bethesda, MD 20892 USA; Yonsei Univ, Coll Med, Dept Dermatol, Seoul 135720, South Korea; Cornell Univ, Weill Med Coll, Dept Dermatol, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yonsei University; Yonsei University Health System; Cornell University	Morasso, MI (corresponding author), NIAMS, NIH, Dev Skin Biol Unit, Bldg 50,Rm1525, Bethesda, MD 20892 USA.	morassom@mail.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041124, ZIAAR041124] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Broome AM, 2004, J INVEST DERMATOL, V122, P29, DOI 10.1046/j.0022-202X.2003.22105.x; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; DYKES PJ, 1982, ARCH DERMATOL RES, V273, P225, DOI 10.1007/BF00409250; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Elias PM, 2002, J INVEST DERMATOL, V119, P1128, DOI 10.1046/j.1523-1747.2002.19512.x; FEINGOLD KR, 1990, J CLIN INVEST, V86, P1738, DOI 10.1172/JCI114899; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 1997, BBA-MOL CELL RES, V1357, P129, DOI 10.1016/S0167-4889(97)00038-4; Ghahary A, 2005, J INVEST DERMATOL, V124, P170, DOI 10.1111/j.0022-202X.2004.23521.x; Ginisty H, 1999, J CELL SCI, V112, P761; GRUBAUER G, 1989, J LIPID RES, V30, P323; GRUBAUER G, 1987, J LIPID RES, V28, P746; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; HOLLERAN WM, 1991, J CLIN INVEST, V88, P1338, DOI 10.1172/JCI115439; Hwang M, 2005, GENE EXPR PATTERNS, V5, P801, DOI 10.1016/j.modgep.2005.03.010; Hwang M, 2003, J BIOL CHEM, V278, P47827, DOI 10.1074/jbc.M306561200; Jessop CE, 2004, BIOCHEM SOC T, V32, P655, DOI 10.1042/BST0320655; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Lee B, 2005, J MOL BIOL, V345, P1083, DOI 10.1016/j.jmb.2004.11.027; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Mauro T, 1998, J INVEST DERMATOL, V111, P1198, DOI 10.1046/j.1523-1747.1998.00421.x; Mehul B, 2000, J BIOL CHEM, V275, P12841, DOI 10.1074/jbc.275.17.12841; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; MENON GK, 1992, J INVEST DERMATOL, V98, P279, DOI 10.1111/1523-1747.ep12497866; MENON GK, 1992, CELL TISSUE RES, V270, P503, DOI 10.1007/BF00645052; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Morasso MI, 2005, BIOL CELL, V97, P173; Nelson MR, 1998, PROTEIN SCI, V7, P270; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PROKSCH E, 1991, J CLIN INVEST, V87, P1668, DOI 10.1172/JCI115183; Rety S, 2000, STRUCTURE, V8, P175, DOI 10.1016/S0969-2126(00)00093-9; Rodriguez LG, 2005, J CELL PHYSIOL, V202, P285, DOI 10.1002/jcp.20122; Rogers MS, 2001, EXP CELL RES, V267, P216, DOI 10.1006/excr.2001.5254; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; Sakaguchi M, 2003, J CELL BIOL, V163, P825, DOI 10.1083/jcb.200304017; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Tomas A, 2003, J BIOL CHEM, V278, P20210, DOI 10.1074/jbc.M212669200; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Woodard GE, 2005, CURR TOP DEV BIOL, V65, P189; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	54	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18645	18653		10.1074/jbc.M702035200	http://dx.doi.org/10.1074/jbc.M702035200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17470426	hybrid			2022-12-27	WOS:000247302000069
J	Minami, Y; Ikeda, W; Kajita, M; Fujito, T; Amano, H; Tamaru, Y; Kuramitsu, K; Sakamoto, Y; Monden, M; Takai, Y				Minami, Yukiko; Ikeda, Wataru; Kajita, Mihoko; Fujito, Tsutomu; Amano, Hisayuki; Tamaru, Yoshiyuki; Kuramitsu, Kaori; Sakamoto, Yasuhisa; Monden, Morito; Takai, Yoshimi			Necl-5/poliovirus receptor interacts in cis with integrin alpha(v)beta(3) and regulates its clustering and focal complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCES CELL-MIGRATION; SMALL G-PROTEINS; MALIGNANT GLIOMA; GROWTH-FACTOR; ADHESION; ACTIVATION; EXPRESSION; POLIOVIRUS; GENE; RAC	Integrin alpha(v)beta(3), which forms focal complexes at leading edges in moving cells, is up-regulated in cancer cells and so is implicated in their invasiveness. Necl-5, originally identified as a poliovirus receptor and also up-regulated in cancer cells, colocalizes with integrin alpha(v)beta(3) at leading edges in moving cells and enhances growth factor- induced cell movement. Here, we show that Necl-5 interacts directly, in cis, with integrin alpha(v)beta(3), and enhances integrin alpha(v)beta(3) clustering and focal complex formation at leading edges in NIH3T3 cells. The extracellular region of Necl-5, but not the cytoplasmic region, is necessary for its interaction with integrin alpha(v)beta(3); however, both regions are necessary for its action. An interaction between integrin alpha(v)beta(3) and vitronectin and PDGF-induced activation of Rac are also necessary for integrin alpha(v)beta(3) clustering. The interaction between Necl-5 and integrin alpha(v)beta(3) enhances PDGF-induced Rac activation, facilitating integrin alpha(v)beta(3) clustering presumably in a feedback amplification manner. Thus, Necl-5 has a critical role in integrin alpha(v)beta(3) clustering and focal complex formation.	Osaka Univ, Fac Med, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Med, Sch Med, Dept Surg Clin Oncol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Takai, Y (corresponding author), Osaka Univ, Fac Med, Grad Sch Med, Dept Mol Biol & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ytakai@molbio.med.osaka-u.ac.jp	Ikeda, Wataru/V-8531-2019; Amano, Hisayuki/AAE-6221-2022	Ikeda, Wataru/0000-0002-6907-9058; Sakamoto, Yasuhisa/0000-0003-1833-6197				ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; CHADENEAU C, 1994, J BIOL CHEM, V269, P15601; Chatterjee S, 2000, J NEURO-ONCOL, V46, P135, DOI 10.1023/A:1006444300504; CHIANG HS, 1994, BBA-MOL CELL RES, V1224, P506, DOI 10.1016/0167-4889(94)90288-7; Cram EJ, 2004, TRENDS CELL BIOL, V14, P55, DOI 10.1016/j.tcb.2003.12.009; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dogic D, 1998, J CELL SCI, V111, P793; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; GEHLSEN KR, 1992, CLIN EXP METASTAS, V10, P111, DOI 10.1007/BF00114587; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirota T, 2005, ONCOGENE, V24, P2229, DOI 10.1038/sj.onc.1208409; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Komuro R, 1996, GENES CELLS, V1, P943, DOI 10.1046/j.1365-2443.1996.760276.x; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Tran H, 2002, J CELL SCI, V115, P2031; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Woodard AS, 1998, J CELL SCI, V111, P469; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zamir E, 2001, J CELL SCI, V114, P3577	38	43	43	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18481	18496		10.1074/jbc.M611330200	http://dx.doi.org/10.1074/jbc.M611330200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17446174	hybrid			2022-12-27	WOS:000247302000054
J	Mishra, S; Melino, G; Murphy, LJ				Mishra, Suresh; Melino, Gerry; Murphy, Liam J.			Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; BINDING PROTEIN; GENE-PRODUCT; CELL-DEATH; IN-VIVO; APOPTOSIS; IDENTIFICATION; ACTIVATION; RHOA; GTP	Transglutaminase 2 (TG2, tissue transglutaminase) is a multifunctional protein involved in cross-linking a variety of proteins, including retinoblastoma protein (Rb). Here we show that Rb is also a substrate for the recently identified serine/threonine kinase activity of TG2 and that TG2 phosphorylates Rb at the critically important Ser(780) residue. Furthermore, phosphorylation of Rb by TG2 destabilizes the Rb center dot E2F1 complex. TG2 phosphorylation of Rb was abrogated by high Ca2+ concentrations, whereas TG2 transamidating activity was inhibited by ATP. TG2 was itself phosphorylated by protein kinase A (PKA). Phosphorylation of TG2 by PKA attenuated its transamidating activity and enhanced its kinase activity. Activation of PKA in mouse embryonic fibroblasts (MEF) with dibutyryl-cAMP enhanced phosphorylation of both TG2 and Rb by a process that was inhibited by the PKA inhibitor H89. Treatment with dibutyryl-cAMP enhanced Rb phosphorylation in MEFtg2+/+ cells but not in MEFtg2-/- cells. These data indicate that Rb is a substrate for TG2 kinase activity and suggest that phosphorylation of Rb, which results from activation of PKA in fibroblasts, is indirect and requires TG2 kinase activity.	Univ Manitoba, Dept Physiol, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 0W3, Canada; Univ Roma Tor Vergata, Dept Expt Med & Biol Sci, Inst Dermapat Immaculata Inst Hosp Care & Sci Res, Biochem Lab, I-00133 Rome, Italy	University of Manitoba; University of Manitoba; University of Rome Tor Vergata	Mishra, S (corresponding author), Univ Manitoba, John Buhler Res Ctr, Rm 843,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	mishra@cc.umanitoba.ca	Mishra, Suresh/W-1633-2019	Mishra, Suresh/0000-0002-0364-1538	Medical Research Council [MC_U132670600] Funding Source: Medline; MRC [MC_U132670600] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams PD, 1998, CURR OPIN CELL BIOL, V10, P791, DOI 10.1016/S0955-0674(98)80123-3; Bernassola F, 2002, FASEB J, V16, P1371, DOI 10.1096/fj.01-0689com; Boehm JE, 2002, J BIOL CHEM, V277, P20127, DOI 10.1074/jbc.C200147200; Campisi A, 2003, BRAIN RES, V978, P24, DOI 10.1016/S0006-8993(03)02725-2; Caraglia M, 2002, J BIOCHEM, V132, P45, DOI 10.1093/oxfordjournals.jbchem.a003197; Chen SH, 1996, J BIOL CHEM, V271, P32385, DOI 10.1074/jbc.271.50.32385; Chung J, 2002, CELL PROLIFERAT, V35, P247, DOI 10.1046/j.1365-2184.2002.00245.x; Cummings M, 1996, J PATHOL, V179, P288, DOI 10.1002/(SICI)1096-9896(199607)179:3<288::AID-PATH574>3.0.CO;2-M; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; DESDOUITS F, 1995, J BIOL CHEM, V270, P8772, DOI 10.1074/jbc.270.15.8772; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; FESUS L, 1987, FEBS LETT, V224, P104, DOI 10.1016/0014-5793(87)80430-1; FOLK JE, 1966, J BIOL CHEM, V241, P3238; Fry DW, 2004, MOL CANCER THER, V3, P1427; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Guo J, 2005, J BIOL CHEM, V280, P35992, DOI 10.1074/jbc.M504583200; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; HIEBERT SW, 1993, MOL CELL BIOL, V13, P3384, DOI 10.1128/MCB.13.6.3384; Iismaa SE, 1997, BIOCHEMISTRY-US, V36, P11655, DOI 10.1021/bi970545e; Imhof A, 1999, BIOCHEMISTRY-US, V38, P13085, DOI 10.1021/bi9912490; Kaelin WG, 1999, BIOESSAYS, V21, P950, DOI 10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D; Kang SK, 2002, BIOCHEM BIOPH RES CO, V293, P383, DOI 10.1016/S0006-291X(02)00197-3; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Lai TS, 1998, J BIOL CHEM, V273, P1776, DOI 10.1074/jbc.273.3.1776; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee SC, 2003, MOL CELLS, V16, P285; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Medina DL, 2000, J BIOL CHEM, V275, P15549, DOI 10.1074/jbc.275.20.15549; Milakovic T, 2004, J BIOL CHEM, V279, P8715, DOI 10.1074/jbc.M308479200; Mishra S, 2006, BIOCHEM BIOPH RES CO, V339, P726, DOI 10.1016/j.bbrc.2005.11.071; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Mishra S, 2006, BIOCHEM BIOPH RES CO, V347, P1166, DOI 10.1016/j.bbrc.2006.07.041; Nagy L, 1997, CELL DEATH DIFFER, V4, P534, DOI 10.1038/sj.cdd.4400290; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nurminskaya M, 2003, DEV BIOL, V263, P139, DOI 10.1016/S0012-1606(03)00445-7; Oliverio S, 1997, MOL CELL BIOL, V17, P6040, DOI 10.1128/MCB.17.10.6040; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rice RH, 1996, BIOCHEM J, V320, P547, DOI 10.1042/bj3200547; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sarang Z, 2005, HEPATOLOGY, V42, P578, DOI 10.1002/hep.20812; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Soh Y, 2000, J BIOCHEM, V127, P95, DOI 10.1093/oxfordjournals.jbchem.a022589; Szondy Z, 1997, FEBS LETT, V404, P307, DOI 10.1016/S0014-5793(97)00140-3; Szondy Z, 2006, CELL DEATH DIFFER, V13, P1827, DOI 10.1038/sj.cdd.4401889; Tucholski J, 2003, J BIOL CHEM, V278, P26838, DOI 10.1074/jbc.M303683200; VALENTINIS B, 1995, MOL ENDOCRINOL, V9, P361, DOI 10.1210/me.9.3.361; WELCH PJ, 1995, GENE DEV, V9, P31, DOI 10.1101/gad.9.1.31; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0	51	64	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18108	18115		10.1074/jbc.M607413200	http://dx.doi.org/10.1074/jbc.M607413200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17478427	hybrid			2022-12-27	WOS:000247302000017
J	Song, SH; Ozturk, N; Denaro, TR; Arat, NO; Kao, YT; Zhu, H; Zhong, D; Reppert, SM; Sancar, A				Song, Sang-Hun; Ozturk, Nuri; Denaro, Tracy R.; Arat, N. Ozlem; Kao, Ya-Ting; Zhu, Haisun; Zhong, Dongping; Reppert, Steven M.; Sancar, Aziz			Formation and function of flavin anion radical in cryptochrome 1 blue-light photoreceptor of monarch butterfly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PHOTOLYASE; ARABIDOPSIS CRYPTOCHROME-1; IN-VIVO; DROSOPHILA CRYPTOCHROME; SIGNAL-TRANSDUCTION; ELECTRON-TRANSFER; ACTION SPECTRUM; THALIANA; VITRO; GENE	The monarch butterfly ( Danaus plexippus) cryptochrome 1 ( DpCry1) belongs in the class of photosensitive insect cryptochromes. Here we purified DpCry1 expressed in a bacterial host and obtained the protein with a stoichiometric amount of the flavin cofactor in the two-electron oxidized, FAD(ox), form. Exposure of the purified protein to light converts the FAD(ox) to the FAD. flavin anion radical by intraprotein electron transfer from a Trp residue in the apoenzyme. To test whether this novel photoreduction reaction is part of the DpCry1 physiological photocycle, we mutated the Trp residue that acts as the ultimate electron donor in flavin photoreduction. The mutation, W328F, blocked the photoreduction entirely but had no measurable effect on the light-induced degradation of DpCry1 in vivo. In light of this finding and the recently published action spectrum of this class of Crys, we conclude that DpCry1 and similar insect cryptochromes do not contain flavin in the FAD(ox) form in vivo and that, most likely, the FAD(ox) ->(hv) FAD(center dot-) photoreduction reaction is not part of the insect cryptochrome photoreaction that results in proteolytic degradation of the photopigment.	Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01650 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Massachusetts System; University of Massachusetts Worcester	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Kao, Ya-Ting/AFR-9847-2022; Ozturk, Nuri/F-4140-2011; Zhong, Dongping/I-2444-2013	Kao, Ya-Ting/0000-0002-9245-6560; Ozturk, Nuri/0000-0001-5206-4127; Zhong, Dongping/0000-0001-9381-8992; Song, Sang-Hun/0000-0002-9609-3269	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031082, R37GM031082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047141] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31082] Funding Source: Medline; NINDS NIH HHS [NS047141] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmad M, 2002, PLANT PHYSIOL, V129, P774, DOI 10.1104/pp.010969; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Bouly JP, 2003, EUR J BIOCHEM, V270, P2921, DOI 10.1046/j.1432-1033.2003.03691.x; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; CHOONG YS, 1980, J BIOL CHEM, V255, P8672; DENARO TR, 2006, THESIS U N CAROLINA; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Shalitin D, 2003, PLANT CELL, V15, P2421, DOI 10.1105/tpc.013011; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200; ZHONG D, 2007, CURR OPIN CHEM BIOL, V16, P722; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	29	81	84	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17608	17612		10.1074/jbc.M702874200	http://dx.doi.org/10.1074/jbc.M702874200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17459876	Green Published, hybrid			2022-12-27	WOS:000247084500032
J	Martinez-Moreno, M; Martinez-Ruiz, A; Alvarez-Barrientos, A; Gavilanes, F; Lamas, S; Rodriguez-Crespo, I				Martinez-Moreno, Monica; Martinez-Ruiz, Antonio; Alvarez-Barrientos, Alberto; Gavilanes, Francisco; Lamas, Santiago; Rodriguez-Crespo, Ignacio			Nitric oxide down-regulates caveolin-3 levels through the interaction with myogenin, its transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; S-NITROSYLATED PROTEINS; LOOP-HELIX PROTEINS; DNA-BINDING; MUSCLE DEVELOPMENT; C2C12 MYOBLASTS; EXPRESSION; INHIBITION; INDUCTION; SYNTHASE	Certain patients suffering from chronic diseases such as AIDS or cancer experience a constant cellular secretion of tumor necrosis factor alpha and other pro-inflammatory cytokines that results in a continuous release of nitric oxide (center dot NO) to the bloodstream. One immediate consequence of the deleterious action of center dot NO is weight loss and the progressive destruction of muscular mass in a process known as cachexia. We have previously reported that caveolin-3, a specific marker of muscle cells, becomes down-regulated by the action of center dot NO on muscular myotubes. We describe herein that the changes observed in caveolin-3 levels are due to the alteration of the DNA binding activity of the muscular transcription factor myogenin. In the presence of center dot NO, the binding of transcription factors from cell nuclear extracts of muscular tissues to the E boxes present in the caveolin-3 promoter become substantially reduced. When we purified recombinant myogenin and treated it with center dot NO donors, we could detect its S-nitrosylation by three independent methods, suggesting that very likely one of the cysteine residues of the molecule is being modified. Given the role of myogenin as a regulatory protein that determines the level of multiple muscle genes expressed during late myogenesis, our results might represent a novel mode of regulation of muscle development under conditions of nitric oxide-mediated toxicity.	Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; Ctr Invest Biol, Inst Reina Sofia Invest Nefrol, Madrid 28040, Spain; Inst Salud Carlos III, Fdn Ctr Nacl Invest Cardiovasc, Madrid 28040, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Instituto de Salud Carlos III	Rodriguez-Crespo, I (corresponding author), Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain.	nacho@bbm1.ucm.es	Alvarez-Barrientos, Alberto/L-9299-2014; Martínez, Mónica/J-9689-2014; Gavilanes, Francisco/K-9903-2014; Lamas, Santiago/G-7308-2015; Martínez-Ruiz, Antonio/A-5672-2009; Rodriguez-Crespo, J. Ignacio/M-1966-2018	Alvarez-Barrientos, Alberto/0000-0003-4761-0212; Martínez, Mónica/0000-0002-1640-6297; Gavilanes, Francisco/0000-0003-1047-2362; Lamas, Santiago/0000-0001-5166-4155; Martínez-Ruiz, Antonio/0000-0001-5394-9824; Rodriguez-Crespo, J. Ignacio/0000-0002-2582-129X				Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Chanoine C, 2004, DEV DYNAM, V231, P662, DOI 10.1002/dvdy.20174; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Cuenca J, 2006, AM J PATHOL, V169, P1567, DOI 10.2353/ajpath.2006.060109; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Fan X, 2003, J BIOL CHEM, V278, P10232, DOI 10.1074/jbc.M209911200; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Garban HJ, 2005, P NATL ACAD SCI USA, V102, P2632, DOI 10.1073/pnas.0409854102; Hongo F, 2005, BIOCHEM BIOPH RES CO, V336, P692, DOI 10.1016/j.bbrc.2005.08.150; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; Maleki SJ, 2002, BIOCHEMISTRY-US, V41, P10888, DOI 10.1021/bi025528q; Maleki SJ, 1997, PROTEIN EXPRES PURIF, V9, P91, DOI 10.1006/prep.1996.0669; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Martinez-Ruiz A, 2005, METHOD ENZYMOL, V396, P131, DOI 10.1016/S0076-6879(05)96013-8; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; Martinez-Ruiz A, 2004, ARCH BIOCHEM BIOPHYS, V423, P192, DOI 10.1016/j.abb.2003.12.006; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Navarro-Lerida I, 2004, J CELL SCI, V117, P1687, DOI 10.1242/jcs.01002; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Shi Y, 2000, FREE RADICAL BIO MED, V29, P695, DOI 10.1016/S0891-5849(00)00364-6; So HS, 1998, BIOCHEM BIOPH RES CO, V247, P809, DOI 10.1006/bbrc.1998.8788; Spinner DS, 2002, J MOL BIOL, V317, P431, DOI 10.1006/jmbi.2002.5440; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tisdale MJ, 2001, FRONT BIOSCI, V6, pD164, DOI 10.2741/Tisdale; Vinals F, 2004, J BIOL CHEM, V279, P45766, DOI 10.1074/jbc.M408059200; WILLIAMS G, 1994, AM J PHYSIOL-REG I, V267, pR1020, DOI 10.1152/ajpregu.1994.267.4.R1020; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005	39	7	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23044	23054		10.1074/jbc.M610751200	http://dx.doi.org/10.1074/jbc.M610751200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17519233	hybrid, Green Published			2022-12-27	WOS:000248577500007
J	Swiatecka-Urban, A; Talebian, L; Kanno, E; Moreau-Marquis, S; Coutermarsh, B; Hansen, K; Karlson, KH; Barnaby, R; Cheney, RE; Langford, GM; Fukuda, M; Stanton, BA				Swiatecka-Urban, Agnieszka; Talebian, Laleh; Kanno, Eiko; Moreau-Marquis, Sophie; Coutermarsh, Bonita; Hansen, Karyn; Karlson, Katherine H.; Barnaby, Roxanna; Cheney, Richard E.; Langford, George M.; Fukuda, Mitsunori; Stanton, Bruce A.			Myosin vb is required for trafficking of the cystic fibrosis transmembrane conductance regulator in Rab11a-specific apical recycling endosomes in polarized human airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; PLASMA-MEMBRANE; UNCONVENTIONAL MYOSIN; MOLECULAR MOTORS; INTRACELLULAR-TRANSPORT; INTERACTING PROTEIN-2; CFTR TRAFFICKING; ENDOCYTOSIS; RAB11A; RECEPTOR	Cystic fibrosis transmembrane conductance regulator ( CFTR)mediated Cl- secretion across fluid-transporting epithelia is regulated, in part, by modulating the number of CFTR Cl- channels in the plasma membrane by adjusting CFTR endocytosis and recycling. However, the mechanisms that regulate CFTR recycling in airway epithelial cells remain unknown, at least in part, because the recycling itineraries of CFTR in these cells are incompletely understood. In a previous study, we demonstrated that CFTR undergoes trafficking in Rab11a-specific apical recycling endosomes in human airway epithelial cells. Myosin Vb is a plus-end-directed, actin-based mechanoenzyme that facilitates protein trafficking in Rab11a-specific recycling vesicles in several cell model systems. There are no published studies examining the role of myosin Vb in airway epithelial cells. Thus, the goal of this study was to determine whether myosin Vb facilitates CFTR recycling in polarized human airway epithelial cells. Endogenous CFTR formed a complex with endogenous myosinVb and Rab11a. Silencing myosin Vb by RNA-mediated interference decreased the expression of wild-type CFTR and Delta F508-CFTR in the apical membrane and decreased CFTR-mediated Cl- secretion across polarized human airway epithelial cells. A recombinant tail domain fragment of myosin Vb attenuated the plasma membrane expression of CFTR by arresting CFTR recycling. The dominant-negative effect was dependent on the ability of the myosin Vb tail fragment to interact with Rab11a. Taken together, these data indicate that myosin Vb is required for CFTR recycling in Rab11a-specific apical recycling endosomes in polarized human airway epithelial cells.	Dartmouth Coll Sch Med, Dept Physiol, Hanover, NH 03755 USA; Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Inst Phys & Chem Res, Fukuda Initiat Res Unit, Wako, Saitama 3510198, Japan; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Dartmouth College; Dartmouth College; RIKEN; University of North Carolina; University of North Carolina Chapel Hill; Tohoku University	Swiatecka-Urban, A (corresponding author), Dartmouth Coll Sch Med, Dept Physiol, Hanover, NH 03755 USA.	asurban@pitt.edu	Swiatecka-Urban, Agnieszka/AAP-6041-2020; Fukuda, MItsunori/I-1511-2015; SWIATECKA-URBAN, AGNIESZKA/H-6494-2015	Fukuda, MItsunori/0000-0002-8620-5853; SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334; Cheney, Richard/0000-0001-6565-7888; Langford, George/0000-0001-9737-2182	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER; NCRR NIH HHS [P20-RR018787] Funding Source: Medline; NIDCD NIH HHS [R01 DC003299, R01-DC03299] Funding Source: Medline; NIDDK NIH HHS [R01-DK45811, R01-DK34533] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Batista DGJ, 2006, J HISTOCHEM CYTOCHEM, V54, P605, DOI 10.1369/jhc.5A6654.2005; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Calhoun BC, 1998, AM J PHYSIOL-CELL PH, V275, pC163, DOI 10.1152/ajpcell.1998.275.1.C163; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Chang CW, 1997, J NEUROCHEM, V69, P859; Chung YJ, 2006, LEUKEMIA, V20, P1542, DOI 10.1038/sj.leu.2404310; Desrosiers RR, 1998, BIOCHEM CELL BIOL, V76, P63, DOI 10.1139/bcb-76-1-63; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Elferink LA, 2005, METHOD ENZYMOL, V403, P732, DOI 10.1016/S0076-6879(05)03064-8; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; Gebhardt C, 2005, AM J PATHOL, V167, P243, DOI 10.1016/S0002-9440(10)62969-0; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goldenring JR, 1996, AM J PHYSIOL-GASTR L, V270, pG515, DOI 10.1152/ajpgi.1996.270.3.G515; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hamm-Alvarez SF, 1998, ADV DRUG DELIVER REV, V29, P229, DOI 10.1016/S0169-409X(97)00081-1; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Higuchi H, 2002, CURR OPIN CELL BIOL, V14, P50, DOI 10.1016/S0955-0674(01)00293-9; Hirosawa M, 1999, DNA Res, V6, P329, DOI 10.1093/dnares/6.5.329; Howard M, 1995, AM J PHYSIOL-CELL PH, V269, pC1565, DOI 10.1152/ajpcell.1995.269.6.C1565; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; HUBER LA, 1993, J CELL BIOL, V123, P47, DOI 10.1083/jcb.123.1.47; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Kashina AS, 2004, CURR BIOL, V14, P1877, DOI 10.1016/j.cub.2004.10.003; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lapierre LA, 2005, METHOD ENZYMOL, V403, P715, DOI 10.1016/S0076-6879(05)03062-4; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lehrich RW, 1998, J CLIN INVEST, V101, P737, DOI 10.1172/JCI803; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Loffing J, 1998, AM J PHYSIOL-CELL PH, V275, pC913, DOI 10.1152/ajpcell.1998.275.4.C913; Lukacs GL, 1997, BIOCHEM J, V328, P353; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mueller J, 2000, Recent Results Cancer Res, V155, P29; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Silvis MR, 2003, J BIOL CHEM, V278, P11554, DOI 10.1074/jbc.M212843200; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tuma PL, 2002, MOL BIOL CELL, V13, P3400, DOI 10.1091/mbc.02-04-0054; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; WATTS C, 1988, EMBO J, V7, P1937, DOI 10.1002/j.1460-2075.1988.tb03031.x; Weixel Kelly, 2002, Methods Mol Med, V70, P323; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XF, 2001, J CELL SCI, V114, P1091; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832	77	83	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23725	23736		10.1074/jbc.M608531200	http://dx.doi.org/10.1074/jbc.M608531200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17462998	hybrid, Green Published			2022-12-27	WOS:000248577500076
J	Hansen, JE; Tse, CM; Chan, G; Heinze, ER; Nishimura, RN; Weisbart, RH				Hansen, James E.; Tse, Chung-Ming; Chan, Grace; Heinze, Emil R.; Nishimura, Robert N.; Weisbart, Richard H.			Intranuclear protein transduction through a nucleoside salvage pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENETRATES LIVING CELLS; CANCER-CELLS; ANTIBODY; TRANSPORTERS; DELIVERY; AUTOANTIBODY; THERAPY	Regulation of gene expression by intranuclear transduction of macromolecules such as transcription factors is an alternative to gene therapy for the treatment of numerous diseases. The identification of an effective intranuclear delivery vehicle and pathway for the transport of therapeutic macromolecules across plasma and nuclear membranes, however, has posed a significant challenge. The anti-DNA antibody fragment 3E10 Fv has received attention as a novel molecular delivery vehicle due to its penetration into living cells with specific nuclear localization, absence of toxicity, and successful delivery of therapeutic cargo proteins in vitro and in vivo. Elucidation of the pathway that allows 3E10 Fv to cross cell membranes is critical to the development of new molecular therapies. Here we show that 3E10 Fv penetrates cells through a nucleoside salvage transporter. 3E10 Fv is unable to penetrate into cells deficient in the equilibrative nucleoside transporter ENT2, and reconstitution of ENT2 into ENT2-deficient cells restores 3E10 Fv transport into cell nuclei. Our results represent the first demonstration of protein transport through a nucleoside salvage pathway. We expect that our finding will facilitate a variety of methods of gene regulation in the treatment of human diseases, open up new avenues of research in nucleoside salvage pathways, and enhance our understanding of the pathophysiology of autoimmune diseases.	VAGLAHS, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, San Fernando Valley Program, Dept Med, Sylmar, CA 91342 USA; Johns Hopkins Univ, Sch Med, Div Gastroenterol, Dept Med, Baltimore, MD 21205 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weisbart, RH (corresponding author), Vet Affairs Med Ctr 111S, 16111 Plummer St, Sepulveda, CA 91343 USA.	rweisbar@ucla.edu						Crawford CR, 1998, J BIOL CHEM, V273, P5288, DOI 10.1074/jbc.273.9.5288; Hansen JE, 2007, CANCER RES, V67, P1769, DOI 10.1158/0008-5472.CAN-06-3783; Hansen JE, 2006, BRAIN RES, V1088, P187, DOI 10.1016/j.brainres.2006.03.025; Huang M, 2004, NUCLEOS NUCLEOT NUCL, V23, P1445, DOI 10.1081/NCN-200027667; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Mani RS, 1998, J BIOL CHEM, V273, P30818, DOI 10.1074/jbc.273.46.30818; Toan SV, 2003, PFLUG ARCH EUR J PHY, V447, P195, DOI 10.1007/s00424-003-1166-0; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Weisbart RH, 2004, INT J ONCOL, V25, P1867; Weisbart RH, 2003, CANCER LETT, V195, P211, DOI 10.1016/S0304-3835(03)00151-4; Weisbart RH, 1998, J AUTOIMMUN, V11, P539, DOI 10.1006/jaut.1998.0212; Weisbart RH, 2000, J IMMUNOL, V164, P6020, DOI 10.4049/jimmunol.164.11.6020; Zack DJ, 1996, J IMMUNOL, V157, P2082	15	40	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20790	20793		10.1074/jbc.C700090200	http://dx.doi.org/10.1074/jbc.C700090200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17525162	hybrid			2022-12-27	WOS:000248047500002
J	Li, B; van der Donk, WA				Li, Bo; van der Donk, Wilfred A.			Identification of essential catalytic residues of the cyclase NisC involved in the biosynthesis of nisin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT METHIONINE SYNTHASE; PEPTIDE ANTIBIOTIC NISIN; ESCHERICHIA-COLI ADA; ZINC-THIOLATE COMPLEXES; PROTEIN FARNESYLTRANSFERASE; LACTICIN-481 SYNTHETASE; LANTIBIOTIC NISIN; POSTTRANSLATIONAL MODIFICATION; LANTHIONINE FORMATION; BIOLOGICAL-ACTIVITY	Nisin is a post-translationally modified antimicrobial peptide that has been widely used in the food industry for several decades. It contains five cyclic thioether cross-links of varying sizes that are installed by a single enzyme, NisC, that catalyzes the addition of cysteines to dehydroamino acids. The recent x-ray crystal structure of NisC has provided the first insights into the catalytic residues responsible for the cyclization step during nisin biosynthesis. In this study, the conserved residues His(212), Arg(280), Asp(141), and Tyr(285) as well as the ligands to the zinc in the active site (Cys(284), Cys(330), and His(331)) were substituted by site-directed mutagenesis. Binding studies showed that all mutants had similar affinities for NisA. Activity assays showed that whereas His(212) and Asp(141) were essential for correct cyclization as judged by the antimicrobial activity of the final product, Arg(280) and Tyr(285) were not. Mutation of zinc ligands to alanine also abolished the enzymatic activity, and these mutant proteins were shown to contain decreased levels of zinc. These results show that the zinc is essential for activity and support a model in which the zinc is used to activate the cysteines in the substrate for nucleophilic attack. These findings also argue against an essential role of Arg(280) and Tyr(285) as an active site general acid/base in the mechanism of cyclization.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	van der Donk, WA (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	vddonk@uiuc.edu	Li, Bo/H-8516-2013; van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071; Li, Bo/0000-0002-8019-8891				BEDNAR RA, 1990, BIOCHEMISTRY-US, V29, P3684, DOI 10.1021/bi00467a014; Bierbaum G, 1996, APPL ENVIRON MICROB, V62, P385, DOI 10.1128/AEM.62.2.385-392.1996; Brand U, 2001, INORG CHEM, V40, P6151, DOI 10.1021/ic0105112; Bregant S, 2005, J ORG CHEM, V70, P2430, DOI 10.1021/jo048222t; Breksa AP, 1999, BIOCHEMISTRY-US, V38, P13991, DOI 10.1021/bi991003v; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Burrage S, 2000, CHEM-EUR J, V6, P1455, DOI 10.1002/(SICI)1521-3765(20000417)6:8<1455::AID-CHEM1455>3.3.CO;2-D; Chan WC, 1996, FEBS LETT, V390, P129, DOI 10.1016/0014-5793(96)00638-2; CHAN WC, 1989, FEBS LETT, V252, P29, DOI 10.1016/0014-5793(89)80884-1; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; Chatterjee C, 2006, CHEM BIOL, V13, P1109, DOI 10.1016/j.chembiol.2006.08.015; Chen P, 1998, APPL ENVIRON MICROB, V64, P2335; Chiou SJ, 2003, P NATL ACAD SCI USA, V100, P3695, DOI 10.1073/pnas.0637221100; Chiou SJ, 2000, INORG CHEM, V39, P4347, DOI 10.1021/ic000505q; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; ENGELKE G, 1992, APPL ENVIRON MICROB, V58, P3730, DOI 10.1128/AEM.58.11.3730-3743.1992; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; FUKASE K, 1992, B CHEM SOC JPN, V65, P2227, DOI 10.1246/bcsj.65.2227; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; Goulding CW, 1997, BIOCHEMISTRY-US, V36, P15749, DOI 10.1021/bi971988l; Harris CM, 2002, BIOCHEMISTRY-US, V41, P10554, DOI 10.1021/bi020349u; Helfrich M, 2007, BIOCHEMISTRY-US, V46, P3224, DOI 10.1021/bi062124f; Hightower KE, 1998, BIOCHEMISTRY-US, V37, P15555, DOI 10.1021/bi981525v; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Huang CC, 1997, J BIOL CHEM, V272, P20; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Ibrahim MM, 2005, INORG CHEM, V44, P8531, DOI 10.1021/ic0508270; Jack RW, 2000, CURR OPIN CHEM BIOL, V4, P310, DOI 10.1016/S1367-5931(00)00094-6; Ji M, 2005, INORG CHEM, V44, P3518, DOI 10.1021/ic0484147; Kluskens LD, 2005, BIOCHEMISTRY-US, V44, P12827, DOI 10.1021/bi050805p; Koponen O, 2002, MICROBIOL-SGM, V148, P3561, DOI 10.1099/00221287-148-11-3561; Krum JG, 2002, BIOCHEMISTRY-US, V41, P5005, DOI 10.1021/bi0255221; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Kuipers OP, 1996, ANTON LEEUW INT J G, V69, P161, DOI 10.1007/BF00399421; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Melnick JG, 2006, J INORG BIOCHEM, V100, P1147, DOI 10.1016/j.jinorgbio.2005.12.023; Miller LM, 2006, J AM CHEM SOC, V128, P1420, DOI 10.1021/ja057203d; Morlok MM, 2005, J AM CHEM SOC, V127, P14039, DOI 10.1021/ja0536670; Okeley NM, 2003, BIOCHEMISTRY-US, V42, P13613, DOI 10.1021/bi0354942; Okeley NM, 2000, ORG LETT, V2, P3603, DOI 10.1021/ol006485d; Osapay G, 1997, J MED CHEM, V40, P2241, DOI 10.1021/jm960850i; OSAPAY G, 1995, INT J PEPT PROT RES, V46, P290; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Parkin G, 2004, CHEM REV, V104, P699, DOI 10.1021/cr0206263; Paul M, 2005, MINI-REV ORG CHEM, V2, P23, DOI 10.2174/1570193052774108; Pejchal R, 2005, PLOS BIOL, V3, P254, DOI 10.1371/journal.pbio.0030031; Penner-Hahn J, 2007, CURR OPIN CHEM BIOL, V11, P166, DOI 10.1016/j.cbpa.2007.02.038; Rew Y, 2002, J MED CHEM, V45, P3746, DOI 10.1021/jm020108k; Rollema HS, 1996, EUR J BIOCHEM, V241, P716, DOI 10.1111/j.1432-1033.1996.00716.x; Rombach M, 2006, INORG CHEM, V45, P4571, DOI 10.1021/ic060301v; Rozema DB, 1999, BIOCHEMISTRY-US, V38, P13138, DOI 10.1021/bi990794y; Sun LJ, 2001, BIOCHEMISTRY-US, V40, P11596, DOI 10.1021/bi011001m; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wilker JJ, 1997, INORG CHEM, V36, P969, DOI 10.1021/ic961082o; WILKER JJ, 1995, J AM CHEM SOC, V117, P8682, DOI 10.1021/ja00138a031; Xie LL, 2002, BIOCHEM BIOPH RES CO, V295, P952, DOI 10.1016/S0006-291X(02)00783-0; Zhang XG, 2007, J AM CHEM SOC, V129, P2212, DOI 10.1021/ja067672v; Zhou H, 2002, ORG LETT, V4, P1335, DOI 10.1021/ol025629g; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b; Zhu YT, 2003, ORG BIOMOL CHEM, V1, P3304, DOI 10.1039/b304945k	64	66	66	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21169	21175		10.1074/jbc.M701802200	http://dx.doi.org/10.1074/jbc.M701802200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17513866	hybrid			2022-12-27	WOS:000248047500043
J	Nobles, KN; Guan, ZQ; Xiao, KH; Oas, TG; Lefkowitz, RJ				Nobles, Kelly N.; Guan, Ziqiang; Xiao, Kunhong; Oas, Terrence G.; Lefkowitz, Robert J.			The active conformation of beta-arrestin1 - Direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SIGNAL-REGULATED KINASES; BETA-ARRESTIN; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; PHOSPHORYLATION-RECOGNITION; NONVISUAL ARRESTINS; CARBOXYL-TERMINUS; BINDING STATE; ACTIVATION	beta-Arrestins are multifunctional adaptor proteins that regulate seven transmembrane-spanning receptor (7TMR) desensitization and internalization and also initiate alternative signaling pathways. Studies have shown that beta-arrestins undergo a conformational change upon interaction with agonist-occupied, phosphorylated 7TMRs. Although conformational changes have been reported for visual arrestin and beta-arrestin2, these studies are not representative of conformational changes in beta-arrestin1. Accordingly, in this study, we determine conformational changes in beta-arrestin1 using limited tryptic proteolysis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis in the presence of a phosphopeptide derived from the C terminus of the V-2 vasopressin receptor (V(2)Rpp) or the corresponding unphosphorylated peptide (V(2)Rnp). V(2)Rpp binds specifically to beta-arrestin1 causing significant conformational changes, whereas V(2)Rnp does not alter the conformation of beta-arrestin1. Upon V(2)Rpp binding, we show that the previously shielded Arg(393) becomes accessible, which indicates release of the C terminus. Moreover, we show that Arg(285) becomes more accessible, and this residue is located in a region of beta-arrestin1 responsible for stabilization of its polar core. These two findings demonstrate "activation" of beta-arrestin1, and we also show a functional consequence of the release of the C terminus of beta-arrestin1 by enhanced clathrin binding. In addition, we show marked protection of the N-domain of beta-arrestin1 in the presence of V(2)Rpp, which is consistent with previous studies suggesting the N-domain is responsible for recognizing phosphates in 7TMRs. A striking difference in conformational changes is observed in beta-arrestin1 when compared with beta-arrestin2, namely the flexibility of the inter-domain hinge region. This study represents the first direct evidence that the "receptor-bound" conformations of beta-arrestins1 and 2 are different.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Box 3821, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Oas, Terrence/F-8916-2011; Xiao, Kunhong/AAG-4275-2020; Guan, Ziqiang/AAE-5110-2019; Lefkowitz, Robert/AAW-2649-2021	Oas, Terrence/0000-0002-3067-2743; Xiao, Kunhong/0000-0002-1069-1226; 	NHLBI NIH HHS [HL70631, HL16037] Funding Source: Medline; NIGMS NIH HHS [GM069338] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R01HL070631, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; FREEDMAN NJ, 1996, RECENT PROG HORM RES, V51, P352; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McDowell JH, 2001, INVEST OPHTH VIS SCI, V42, P1439; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; PUIG J, 1995, FEBS LETT, V362, P185, DOI 10.1016/0014-5793(95)00225-X; Raman D, 2003, J NEUROCHEM, V84, P1040, DOI 10.1046/j.1471-4159.2003.01598.x; Shilton BH, 2002, EUR J BIOCHEM, V269, P3801, DOI 10.1046/j.1432-1033.2002.03071.x; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200	46	95	98	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					21370	21381		10.1074/jbc.M611483200	http://dx.doi.org/10.1074/jbc.M611483200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17513300	hybrid			2022-12-27	WOS:000248047500065
J	Ozato, K; Tailor, P; Kubota, T				Ozato, Keiko; Tailor, Prafullakumar; Kubota, Toru			The interferon regulatory factor family in host defense: Mechanism of action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE ANTIVIRAL RESPONSE; SEQUENCE-BINDING-PROTEIN; TOLL-LIKE RECEPTORS; CRYSTAL-STRUCTURE; NEGATIVE REGULATION; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; TARGET GENES; LEUKEMIA; IRF-3	Transcription factors of the interferon regulatory factor (IRF) family commands the entire type I interferon (IFN) system from induction of IFNs to diverse IFN responses, thereby providing a principal basis for host resistance against pathogens. However, the family has various additional roles. Regulating the development of the immune system, IRFs shape the establishment and execution of innate and adaptive immunity. IRFs also regulate growth and differentiation of many cell types, thus playing a role in leukemia and other cancers. In addition, evidence indicates that IRFs confer antiviral mechanisms not directly ascribed to the IFN system. This review deals with the diverse roles of IRFs in host defense and discusses the molecular mechanisms by which they regulate target gene transcription.	NIH, NICHD, Lab Mol Growth Regulat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ozato, K (corresponding author), NIH, NICHD, Lab Mol Growth Regulat, Bldg 10, Bethesda, MD 20892 USA.	ozatok@nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arguello M, 2003, ONCOGENE, V22, P964, DOI 10.1038/sj.onc.1206270; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chelbi-Alix MK, 2006, J INTERF CYTOK RES, V26, P271, DOI 10.1089/jir.2006.26.271; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; Darnell JE, 1998, J INTERF CYTOK RES, V18, P549, DOI 10.1089/jir.1998.18.549; Dror N, 2007, J BIOL CHEM, V282, P5633, DOI 10.1074/jbc.M607825200; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Karpova AY, 2001, MOL CELL BIOL, V21, P4169, DOI 10.1128/MCB.21.13.4169-4176.2001; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; Laricchia-Robbio L, 2005, P NATL ACAD SCI USA, V102, P14368, DOI 10.1073/pnas.0504014102; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Mamane Y, 2002, ONCOGENE, V21, P6751, DOI 10.1038/sj.onc.1205843; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Masumi A, 2003, J BIOL CHEM, V278, P25401, DOI 10.1074/jbc.M213037200; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; PALOMBELLA VJ, 1992, MOL CELL BIOL, V12, P3325, DOI 10.1128/MCB.12.8.3325; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sgarbanti M, 2002, J EXP MED, V195, P1359, DOI 10.1084/jem.20010753; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	54	145	158	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20065	20069		10.1074/jbc.R700003200	http://dx.doi.org/10.1074/jbc.R700003200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17502370	hybrid			2022-12-27	WOS:000247819300006
J	Zhong, XT; Desilva, T; Lin, L; Bodine, P; Bhat, RA; Presman, E; Pocas, J; Stahl, M; Kriz, R				Zhong, Xiaotian; Desilva, Thamara; Lin, Laura; Bodine, Peter; Bhat, Ramesh A.; Presman, Eleonora; Pocas, Jennifer; Stahl, Mark; Kriz, Ron			Regulation of secreted frizzled-related protein-1 by heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTORS; TYROSINE SULFATION; TYROSYLPROTEIN SULFOTRANSFERASE; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; AMINO-TERMINUS; SPEMANN ORGANIZER; LIGAND-BINDING; P-SELECTIN; WNT	Secreted Frizzled-related protein-1 (sFRP-1) belongs to a class of extracellular antagonists that modulate Wnt signaling pathways by preventing ligand-receptor interactions among Wnts and Frizzled membrane receptor complexes. sFRP-1 and Wnts are heparin-binding proteins, and their interaction can be stabilized by heparin in vitro. Here we report that heparin can specifically enhance recombinant sFRP-1 accumulation in a cell type-specific manner. The effect requires O-sulfation in heparin, and involves fibroblast growth factor-2 as well as fibroblast growth factor receptor-1. Interestingly, further investigation uncovers that heparin can also affect the post-translational modification of sFRP-1. We demonstrate that sFRP-1 is posttranslationally modified by tyrosine sulfation at tyrosines 34 and 36, which is inhibited by the treatment of heparin. The results suggest that accumulation of sFRP-1 induced by heparin is in part due to the relative stabilization of unsulfated sFRP-1 and the direct stabilization by heparin. The study has revealed a multifaceted regulation on sFRP-1 protein by heparin.	Wyeth Ayerst Res, Dept Chem Screening Sci, Cambridge, MA 02140 USA; Wyeth Ayerst Res, Dept Womens Hlth & Musculoskeletal Biol, Collegeville, PA 19426 USA	Pfizer; Pfizer	Zhong, XT (corresponding author), 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	xzhong@wyeth.com						BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhat RA, 2004, PROTEIN EXPRES PURIF, V37, P327, DOI 10.1016/j.pep.2004.06.029; Binari RC, 1997, DEVELOPMENT, V124, P2623; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Chang JHT, 1999, HUM MOL GENET, V8, P575, DOI 10.1093/hmg/8.4.575; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Dale TC, 1998, BIOCHEM J, V329, P209; Dong JF, 2001, J BIOL CHEM, V276, P16690, DOI 10.1074/jbc.M101035200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Galzie Z, 1997, BIOCHEM CELL BIOL, V75, P669, DOI 10.1139/bcb-75-6-669; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; HUTTNER WB, 1982, NATURE, V299, P273, DOI 10.1038/299273a0; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kispert A, 1996, DEVELOPMENT, V122, P3627; KLINT P, 1999, FRONT BIOSCI, V4, P165; LEE RWH, 1983, J BIOL CHEM, V258, P1326; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Ouyang YB, 1998, J BIOL CHEM, V273, P24770, DOI 10.1074/jbc.273.38.24770; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Salic AN, 1997, DEVELOPMENT, V124, P4739; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wang YS, 1996, J BIOL CHEM, V271, P4468; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wolf V, 1997, FEBS LETT, V417, P385, DOI 10.1016/S0014-5793(97)01324-0; Zhong XT, 2004, FEBS LETT, V562, P111, DOI 10.1016/S0014-5793(04)00191-7	53	29	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2007	282	28					20523	20533		10.1074/jbc.M609096200	http://dx.doi.org/10.1074/jbc.M609096200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	187AI	17500071	hybrid			2022-12-27	WOS:000247819300055
J	Baroukh, N; Ravier, MA; Loder, MK; Hill, EV; Bounacer, A; Scharfmann, R; Rutter, GA; Van Obberghen, E				Baroukh, Nadine; Ravier, Magalie A.; Loder, Merewyn K.; Hill, Elaine V.; Bounacer, Ali; Scharfmann, Raphael; Rutter, Guy A.; Van Obberghen, Emmanuel			MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 3-BETA; SENSITIVE K+ CHANNEL; INSULIN-SECRETION; TRANSCRIPTION FACTORS; C-ELEGANS; GENE-EXPRESSION; GLUCOSE; METABOLISM; DIFFERENTIATION; INVOLVEMENT	MicroRNAs (miRNAs) are short non-coding RNAs that have been implicated in fine- tuning gene regulation, although the precise roles of many are still unknown. Pancreatic development is characterized by the complex sequential expression of a gamut of transcription factors. We have performed miRNA expression profiling at two key stages of mouse embryonic pancreas development, e14.5 and e18.5. miR-124a2 expression was strikingly increased at e18.5 compared with e14.5, suggesting a possible role in differentiated beta-cells. Among the potential miR-124a gene targets identified by biocomputation, Foxa2 is known to play a role in beta-cell differentiation. To evaluate the impact of miR-124a2 on gene expression, we overexpressed or down-regulated miR-124a2 in MIN6 beta-cells. As predicted, miR-124a2 regulated Foxa2 gene expression, and that of its downstream target, pancreatic duodenum homeobox-1 (Pdx-1). Foxa2 has been described as a master regulator of pancreatic development and also of genes involved in glucose metabolism and insulin secretion, including the ATP-sensitive K+ (KATP) channel subunits, Kir6.2 and Sur-1. Correspondingly, miR-124a2 overexpression decreased, and anti-miR-124a2 increased Kir6.2 and Sur-1 mRNA levels. Moreover, miR-124a2 modified basal and glucose- or KCl-stimulated intracellular free Ca2+ concentrations in single MIN6 and INS-1 (832/13) beta-cells, without affecting the secretion of insulin or co-transfected human growth hormone, consistent with an altered sensitivity of the beta-cell exocytotic machinery to Ca2+. In conclusion, whereas the precise role of microRNA-124a2 in pancreatic development remains to be deciphered, we identify it as a regulator of a key transcriptional protein network in beta-cells responsible for modulating intracellular signaling.	INSERM, U145, F-06107 Nice, France; Univ Nice Sophia Antipolis, Fac Med, Inst Genet & Signalisat Mol, F-06107 Nice, France; Imperial Coll London, Fac Med, Dept Cell Biol, Div Med, London SW7 2AZ, England; INSERM, EMI0363, F-75015 Paris, France; Univ Paris 05, Fac Med Rene Descartes, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Van Obberghen, E (corresponding author), INSERM, U145, F-06107 Nice, France.	vanobbeg@unice.fr	Ravier, Magalie A/N-6934-2017; Ravier, Magalie/K-9911-2019; scharfmann, raphael/L-3296-2017	Ravier, Magalie A/0000-0001-6607-6559; Ravier, Magalie/0000-0001-6607-6559; Rutter, Guy/0000-0001-6360-0343; Scharfmann, Raphael/0000-0001-7619-337X				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; ANG SL, 1993, DEVELOPMENT, V119, P1301; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Shushan E, 2001, J BIOL CHEM, V276, P17533, DOI 10.1074/jbc.M009088200; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brown JR, 2005, DRUG DISCOV TODAY, V10, P595, DOI 10.1016/S1359-6446(05)03399-4; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; COOK DL, 1988, DIABETES, V37, P495, DOI 10.2337/diabetes.37.5.495; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Emmanouilidou E, 1999, CURR BIOL, V9, P915, DOI 10.1016/S0960-9822(99)80398-4; Enright AJ, 2004, GENOME BIOL, V5; Fisher RJ, 1999, PFLUG ARCH EUR J PHY, V437, P754, DOI 10.1007/s004240050842; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lantz KA, 2005, CLIN SCI, V108, P195, DOI 10.1042/CS20040309; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee CS, 2002, DIABETES, V51, P2546, DOI 10.2337/diabetes.51.8.2546; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Miki T, 1999, J MOL ENDOCRINOL, V22, P113, DOI 10.1677/jme.0.0220113; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Pouli AE, 1998, BIOCHEM J, V331, P669, DOI 10.1042/bj3310669; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Puigserver P, 2006, NAT MED, V12, P38, DOI 10.1038/nm0106-38; RAVIER M, 2007, IN PRESS METHODS MOL; Ravier MA, 2000, J BIOL CHEM, V275, P1587, DOI 10.1074/jbc.275.3.1587; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rutter GA, 2004, DIABETOLOGIA, V47, P1861, DOI 10.1007/s00125-004-1541-1; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang HY, 2002, J BIOL CHEM, V277, P17564, DOI 10.1074/jbc.M111037200; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	59	271	297	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19575	19588		10.1074/jbc.M611841200	http://dx.doi.org/10.1074/jbc.M611841200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17462994	hybrid			2022-12-27	WOS:000247650600032
J	Christiansen, B; Meinild, AK; Jensen, AA; Brauner-Osborne, H				Christiansen, Bolette; Meinild, Anne-Kristine; Jensen, Anders A.; Braeuner-Osborne, Hans			Cloning and characterization of a functional human gamma-aminobutyric acid (GABA) transporter, human GAT-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETAINE/GABA TRANSPORTER; UPTAKE INHIBITORS; NEUROTRANSMITTER TRANSPORTERS; RAT-BRAIN; EXPRESSION; LOCALIZATION; CDNA; IDENTIFICATION; PHARMACOLOGY; TIAGABINE	Plasma membrane gamma-aminobutyric acid (GABA) transporters act to terminate GABA neurotransmission in the mammalian brain. Intriguingly four distinct GABA transporters have been cloned from rat and mouse, whereas only three functional homologs of these transporters have been cloned from human. The aim of this study therefore was to search for this fourth missing human transporter. Using a bioinformatics approach, we successfully identified and cloned the full-length cDNA of a so far uncharacterized human GABA transporter ( GAT). The predicted protein displays high sequence similarity to rat GAT-2 and mouse GAT3, and in accordance with the nomenclature for rat GABA transporters, we therefore refer to the transporter as human GAT-2. We used electrophysiological and cell-based methods to demonstrate that this protein is a functional transporter of GABA. The transport was saturable and dependent on both Na+ and Cl-. Pharmacologically the transporter is distinct from the other human GABA transporters and similar to rat GAT-2 and mouse GAT3 with high sensitivity toward GABA and beta-alanine. Furthermore the GABA transport inhibitor (S)-SNAP-5114 displayed some inhibitory activity at the transporter. Expression analysis by reverse transcription-PCR showed that GAT-2 mRNA is present in human brain, kidney, lung, and testis. The finding of the human GAT-2 demonstrates for the first time that the four plasma membrane GABA transporters identified in several mammalian species are all conserved in human. Furthermore the availability of human GAT-2 enables the use of all human clones of the GABA transporters in drug development programs and functional characterization of novel inhibitors of GABA transport.	Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Fac Sci, Dept Mol Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Brauner-Osborne, H (corresponding author), Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, Universitetsparken 2, DK-2100 Copenhagen, Denmark.	hbo@molpharm.net	Jensen, Anders/AAJ-3335-2020; Bräuner-Osborne, Hans/D-7260-2011	Jensen, Anders/0000-0002-7927-5052; Bräuner-Osborne, Hans/0000-0001-9495-7388				Allen NJ, 2004, PFLUG ARCH EUR J PHY, V449, P132, DOI 10.1007/s00424-004-1318-x; Backonja MM, 2002, NEUROLOGY, V59, pS14, DOI 10.1212/WNL.59.5_suppl_2.S14; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bohme I, 2001, CURR MED CHEM, V8, P1257, DOI 10.2174/0929867013372319; Bolvig T, 1999, EUR J PHARMACOL, V375, P367, DOI 10.1016/S0014-2999(99)00263-0; BORDEN LA, 1995, RECEPTOR CHANNEL, V3, P129; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; BORDEN LA, 1995, J NEUROCHEM, V64, P977; BORDEN LA, 1994, RECEPTOR CHANNEL, V2, P207; Bowery NG, 2006, BRIT J PHARMACOL, V147, pS109, DOI 10.1038/sj.bjp.0706443; Burnham CE, 1996, BBA-BIOMEMBRANES, V1284, P4, DOI 10.1016/0005-2736(96)00118-6; CHAHINE M, 1994, PFLUG ARCH EUR J PHY, V427, P136, DOI 10.1007/BF00585952; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Clausen RP, 2006, NEUROCHEM INT, V48, P637, DOI 10.1016/j.neuint.2005.12.031; Clausen RP, 2005, BIOORGAN MED CHEM, V13, P895, DOI 10.1016/j.bmc.2004.10.029; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; Crane D, 2003, DEPRESS ANXIETY, V18, P51, DOI 10.1002/da.10104; Dalby NO, 1997, EPILEPSY RES, V28, P51, DOI 10.1016/S0920-1211(97)00033-8; Dalby NO, 2003, EUR J PHARMACOL, V479, P127, DOI 10.1016/j.ejphar.2003.08.063; DHAR TGM, 1994, J MED CHEM, V37, P2334, DOI 10.1021/jm00041a012; DURKIN MM, 1995, MOL BRAIN RES, V33, P7, DOI 10.1016/0169-328X(95)00101-W; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Gong YW, 2001, CAN J PHYSIOL PHARM, V79, P977, DOI 10.1139/cjpp-79-12-977; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hoglund PJ, 2005, BIOCHEM BIOPH RES CO, V336, P175, DOI 10.1016/j.bbrc.2005.08.048; IKEGAKI N, 1994, MOL BRAIN RES, V26, P47, DOI 10.1016/0169-328X(94)90072-8; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; IVERSEN LL, 1975, BIOCHEM PHARMACOL, V24, P933, DOI 10.1016/0006-2952(75)90422-0; Jasmin L, 2004, CNS NEUROL DISORD-DR, V3, P487, DOI 10.2174/1568007043336716; Jensen AA, 2004, BIOCHEM PHARMACOL, V67, P2115, DOI 10.1016/j.bcp.2004.02.013; JURSKY F, 1994, J EXP BIOL, V196, P283; Jursky F, 1999, J NEUROSCI RES, V55, P394, DOI 10.1002/(SICI)1097-4547(19990201)55:3<394::AID-JNR14>3.0.CO;2-E; KANNER BI, 1994, J EXP BIOL, V196, P237; Kragler A, 2005, EUR J PHARMACOL, V519, P43, DOI 10.1016/j.ejphar.2005.06.053; KRNJEVIC K, 1967, EXP BRAIN RES, V3, P320, DOI 10.1007/BF00237558; KROGSGAARDLARSEN P, 1987, EPILEPSY RES, V1, P77, DOI 10.1016/0920-1211(87)90012-X; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LIU QR, 1993, J BIOL CHEM, V268, P2106; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Mathias S, 2001, NEUROBIOL AGING, V22, P247, DOI 10.1016/S0197-4580(00)00232-3; MCELVAIN SM, 1946, J AM CHEM SOC, V68, P1049, DOI 10.1021/ja01210a040; Meinild AK, 1998, J PHYSIOL-LONDON, V508, P15, DOI 10.1111/j.1469-7793.1998.015br.x; NELSON H, 1990, FEBS LETT, V269, P181, DOI 10.1016/0014-5793(90)81149-I; Nelson N, 1998, J NEUROCHEM, V71, P1785; RADIAN R, 1990, J NEUROSCI, V10, P1319; RASOLA A, 1995, FEBS LETT, V373, P229, DOI 10.1016/0014-5793(95)01052-G; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Sacher A, 2002, J MEMBRANE BIOL, V190, P57, DOI 10.1007/s00232-002-1024-6; Sarup A, 2003, CNS NEUROL DISORD-DR, V2, P269, DOI 10.2174/1568007033482788; SAUERBERG P, 1986, J MED CHEM, V29, P1004, DOI 10.1021/jm00156a018; Schachter SC, 1999, EPILEPSIA, V40, pS17, DOI 10.1111/j.1528-1157.1999.tb00915.x; Schousboe A, 2004, BIOCHEM PHARMACOL, V68, P1557, DOI 10.1016/j.bcp.2004.06.041; Schousboe A, 2004, EUR J PHARMACOL, V500, P281, DOI 10.1016/j.ejphar.2004.07.032; SMITH KE, 1992, MOL PHARMACOL, V42, P563; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Thomsen C, 1997, BRIT J PHARMACOL, V120, P983, DOI 10.1038/sj.bjp.0700957; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; White HS, 2005, J PHARMACOL EXP THER, V312, P866, DOI 10.1124/jpet.104.068825; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649	66	42	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19331	19341		10.1074/jbc.M702111200	http://dx.doi.org/10.1074/jbc.M702111200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17502375	hybrid			2022-12-27	WOS:000247650600008
J	Kobayashi, T; Habuchi, H; Tamura, K; Ide, H; Kimata, K				Kobayashi, Takashi; Habuchi, Hiroko; Tamura, Koji; Ide, Hiroyuki; Kimata, Koji			Essential role of heparan sulfate 2-O-sulfotransferase in chick limb bud patterning and development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; EXPRESSION PATTERNS; MOUSE DEVELOPMENT; CRYSTAL-STRUCTURE; MICE DEFICIENT; BINDING-SITES; BASIC FGF; 6-O-SULFOTRANSFERASE	The interactions of heparan sulfate (HS) with heparin-binding growth factors, such as fibroblast growth factors (FGFs), depend greatly on the chain structures. O-Sulfations at various positions on the chain are major factors determining HS structure; therefore, O-sulfation patterns may play a crucial role in controlling the developmental and morphogenetic processes of various tissues and organs by spatiotemporally regulating the activities of heparin-binding growth factors. In a previous study, we found that HS-2-O-sulfotransferase is strongly expressed throughout the mesoderm of chick limb buds during the early stages of development. Here we show that inhibition of HS-2-O-sulfotransferase in the prospective limb region by small inhibitory RNA resulted in the truncation of limb buds and reduced Fgf-8 expression in the apical ectodermal ridge. The treatment also reduced Fgf-10 expression in the mesenchyme. Moreover 2-O-sulfated HS, normally abundant in the basement membranes and mesoderm under ectoderm in limb buds, was significantly reduced in the treated buds. Phosphorylation levels of ERK and Akt were up-regulated in such truncated buds. Thus, we have shown for the first time that 2-O-sulfation of HS is essential for the FGF signaling required for limb bud development and outgrowth.	Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 980, Japan	Aichi Medical University; Tohoku University	Kimata, K (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan.	kimata@amugw.aichi-med-u.ac.jp	KOBAYASHI, TAKASHI/G-3798-2014	KOBAYASHI, TAKASHI/0000-0001-9358-6829				Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Bink RJ, 2003, J BIOL CHEM, V278, P31118, DOI 10.1074/jbc.M213124200; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Cadwallader AB, 2006, DEV DYNAM, V235, P3432, DOI 10.1002/dvdy.20990; Chen E, 2005, DEV BIOL, V284, P364, DOI 10.1016/j.ydbio.2005.05.032; Church VL, 2002, INT J DEV BIOL, V46, P927; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dealy CN, 1997, DEV BIOL, V184, P343, DOI 10.1006/dbio.1997.8525; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Eblaghie MC, 2003, CURR BIOL, V13, P1009, DOI 10.1016/S0960-9822(03)00381-6; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Loo BM, 2002, J BIOL CHEM, V277, P32616, DOI 10.1074/jbc.M204961200; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; MORITA H, 1994, LAB INVEST, V71, P528; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; NISWANDER L, 1994, MOL REPROD DEV, V39, P83, DOI 10.1002/mrd.1080390113; Niu S, 1996, DEV DYNAM, V207, P25, DOI 10.1002/(SICI)1097-0177(199609)207:1<25::AID-AJA3>3.0.CO;2-Y; Nogami K, 2004, J BIOL CHEM, V279, P8219, DOI 10.1074/jbc.M307304200; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; PARR BA, 1993, DEVELOPMENT, V119, P247; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sedita J, 2004, DEV DYNAM, V231, P782, DOI 10.1002/dvdy.20173; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Smith TG, 2006, FEBS LETT, V580, P4242, DOI 10.1016/j.febslet.2006.06.081; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Tamura K, 2003, MECH DEVELOP, V120, P199, DOI 10.1016/S0925-4773(02)00411-2; Tickle C, 2001, CURR OPIN GENET DEV, V11, P476, DOI 10.1016/S0959-437X(00)00220-3; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wilson VA, 2002, GLYCOCONJUGATE J, V19, P347, DOI 10.1023/A:1025325222530; Xu XL, 1999, CELL TISSUE RES, V296, P33, DOI 10.1007/s004410051264; Yang Yingzi, 2003, Birth Defects Research, V69, P305, DOI 10.1002/bdrc.10026; YONEI S, 1995, DEV BIOL, V170, P542, DOI 10.1006/dbio.1995.1235; Yonei-Tamura S, 1999, DEV BIOL, V211, P133, DOI 10.1006/dbio.1999.9290; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6	74	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19589	19597		10.1074/jbc.M610707200	http://dx.doi.org/10.1074/jbc.M610707200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17493930	hybrid			2022-12-27	WOS:000247650600033
J	Lambert, C; Li, J; Jonscher, K; Yang, TC; Reigan, P; Quintana, M; Harvey, J; Freed, BM				Lambert, Cherie; Li, Jimei; Jonscher, Karen; Yang, Teng-Chieh; Reigan, Philip; Quintana, Megan; Harvey, Jean; Freed, Brian M.			Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappa B1 DNA binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN T-CELLS; COVALENT MODIFICATION; CIGARETTE-SMOKE; P50 SUBUNIT; ACTIVATION; LUNG; INDUCTION; LYSINE; PROLIFERATION	Cigarette smoke is a potent inhibitor of pulmonary T cell responses, resulting in decreased immune surveillance and an increased incidence of respiratory tract infections. The alpha, beta-unsaturated aldehydes in cigarette smoke ( acrolein and crotonaldehyde) inhibited production of interleukin- 2 (IL-2), IL-10, granulocyte-macrophage colony-stimulating factor, interferon-gamma, and tumor necrosis factor-alpha by human T cells but did not inhibit production of IL-8. The saturated aldehydes (acetaldehyde, propionaldehyde, and butyraldehyde) in cigarette smoke were inactive. Acrolein inhibited induction of NF-kappa B DNA binding activity after mitogenic stimulation of T cells but had no effect on induction of NFAT or AP-1. Acrolein inhibited NF-kappa B1 (p50) binding to the IL-2 promoter in a chromatin immunoprecipitation assay by > 99%. Using purified recombinant p50 in an electrophoretic mobility shift assay, we demonstrated that acrolein was 2000-fold more potent than crotonaldehyde in blocking DNA binding to an NF-kappa B consensus sequence. Matrix-assisted laser desorption/ionization time-of-flight and tandem mass spectrometry demonstrated that acrolein alkylated two amino acids (Cys-61 and Arg-307) in the DNA binding domain. Crotonaldehyde reacted with Cys-61, but not Arg-307, whereas the saturated aldehydes in cigarette smoke did not react with p50. These experiments demonstrate that aldehydes in cigarette smoke can regulate gene expression by direct modification of a transcription factor.	Clinimmune Labs, Aurora, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Allergy & Clin Immunol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Pharm, Canc Ctr,Dept Pharmaceut Sci, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Lambert, C (corresponding author), 4200 E 9th Ave,B164, Denver, CO 80262 USA.	Cherie.Lambert@uchsc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK048520] Funding Source: Medline; NIEHS NIH HHS [ES05673] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Altet MN, 1996, TUBERCLE LUNG DIS, V77, P537, DOI 10.1016/S0962-8479(96)90052-0; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin CI, 1998, CLIN EXP IMMUNOL, V113, P166; Biswal S, 2002, CHEM RES TOXICOL, V15, P180, DOI 10.1021/tx015552p; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; DANIELE RP, 1977, AM REV RESPIR DIS, V116, P997; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Finkelstein EI, 2001, AM J PHYSIOL-LUNG C, V281, pL732, DOI 10.1152/ajplung.2001.281.3.L732; Frazer-Abel AA, 2007, MOL IMMUNOL, V44, P488, DOI 10.1016/j.molimm.2006.02.013; Furuhata A, 2003, J BIOL CHEM, V278, P48658, DOI 10.1074/jbc.M309401200; Furuhata A, 2002, J BIOL CHEM, V277, P27919, DOI 10.1074/jbc.M202794200; Gebel S, 2001, TOXICOL SCI, V59, P75, DOI 10.1093/toxsci/59.1.75; Geiselhart LA, 1997, TOXICOL APPL PHARM, V143, P30, DOI 10.1006/taap.1996.8071; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Harris SG, 2002, J IMMUNOL, V168, P1372, DOI 10.4049/jimmunol.168.3.1372; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Horton ND, 1999, J BIOL CHEM, V274, P9200, DOI 10.1074/jbc.274.14.9200; Kwak MK, 2003, BIOCHEM BIOPH RES CO, V305, P662, DOI 10.1016/S0006-291X(03)00834-9; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Li L, 1999, AM J PHYSIOL-LUNG C, V277, pL550, DOI 10.1152/ajplung.1999.277.3.L550; Li Q, 1997, FUND APPL TOXICOL, V38, P158, DOI 10.1006/faat.1997.2346; Li Q, 1996, TOXICOL APPL PHARM, V139, P317, DOI 10.1006/taap.1996.0171; MAHON TM, 1995, J BIOL CHEM, V270, P28557, DOI 10.1074/jbc.270.48.28557; MATTHEWS JR, 1993, NUCLEIC ACIDS RES, V21, P1727, DOI 10.1093/nar/21.8.1727; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; McCue JM, 2003, MOL IMMUNOL, V39, P995, DOI 10.1016/S0161-5890(03)00046-4; Miguez-Burbano MJ, 2003, ADDICT BIOL, V8, P39, DOI 10.1080/1355621031000069864; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Nguyen H, 2001, TOXICOLOGY, V160, P207, DOI 10.1016/S0300-483X(00)00450-9; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Norton ND, 1997, TOXICOLOGY, V122, P111, DOI 10.1016/S0300-483X(97)00086-3; Park YS, 2005, BIOCHEM BIOPH RES CO, V327, P1058, DOI 10.1016/j.bbrc.2004.12.104; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Ranganna K, 2002, MOL CELL BIOCHEM, V240, P83, DOI 10.1023/A:1020659808981; Reddy S, 2002, FREE RADICAL BIO MED, V33, P1490, DOI 10.1016/S0891-5849(02)01079-1; Richter T, 2005, NEUROBIOL AGING, V26, P465, DOI 10.1016/j.neurobiolaging.2004.04.009; Shao BH, 2005, ANN NY ACAD SCI, V1043, P396, DOI 10.1196/annals.1333.046; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; SOPORI ML, 1989, TOXICOL APPL PHARM, V97, P489, DOI 10.1016/0041-008X(89)90254-8; Stratton K, 2001, TOB CONTROL, V10, P189, DOI 10.1136/tc.10.2.189; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; THOMAS WR, 1973, ARCH ENVIRON HEALTH, V27, P372, DOI 10.1080/00039896.1973.10666406; Tirumalai R, 2002, TOXICOL LETT, V132, P27, DOI 10.1016/S0378-4274(02)00055-3; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Valacchi G, 2005, ANTIOXID REDOX SIGN, V7, P25, DOI 10.1089/ars.2005.7.25; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Yang XM, 2004, TOXICOLOGY, V204, P209, DOI 10.1016/j.tox.2004.06.056; Zhang X, 2001, J IMMUNOL, V166, P7104, DOI 10.4049/jimmunol.166.12.7104	53	95	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19666	19675		10.1074/jbc.M611527200	http://dx.doi.org/10.1074/jbc.M611527200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17491020	hybrid			2022-12-27	WOS:000247650600041
J	Parri, M; Buricchi, F; Giannoni, E; Grimaldi, G; Mello, T; Raugei, G; Ramponi, G; Chiarugi, P				Parri, Matteo; Buricchi, Francesca; Giannoni, Elisa; Grimaldi, Giovanna; Mello, Tommaso; Raugei, Giovanni; Ramponi, Giampietro; Chiarugi, Paola			EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to Rho-dependent actino/myosin contractility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; SRC FAMILY KINASES; DENDRITIC SPINE MORPHOGENESIS; RECEPTOR-TYROSINE KINASE; AXON GUIDANCE RECEPTORS; GROWTH CONE DYNAMICS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; CARCINOMA-CELLS; EPHA RECEPTORS	Eph receptors and ephrin ligands are widely expressed in epithelial cells and mediate cell repulsive motility through heterotypic cell-cell interactions. Several Ephs, including EphA2, are greatly overexpressed in certain tumors, in correlation with poor prognosis and high vascularity in cancer tissues. The ability of several Eph receptors to regulate cell migration and invasion likely contribute to tumor progression and metastasis. We report here that in prostatic carcinoma cells ephrinA1 elicits a repulsive response that is executed through a Rho-dependent actino/myosin contractility activation, ultimately leading to retraction of the cell body. This appears to occur through assembly of an EphA2-associated complex involving the two kinases Src and focal adhesion kinase (FAK). EphrinA1-mediated repulsion leads to the selective phosphorylation of Tyr-576/577 of FAK, enhancing FAK kinase activity. The repulsive response elicited by ephrinA1 in prostatic carcinoma cells is mainly driven by a Rho-mediated phosphorylation of myosin light chain II, in which Src and FAK activation are required steps. Consequently, Src and FAK are upstream regulators of the overall response induced by ephrinA1/EphA2, instructing cells to retract the cell body and to move away, probably facilitating dissemination and tissue invasion of ephrin-sensitive carcinomas.	Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy; Ctr Res Transfer & High Educ, I-50134 Florence, Italy; Farmacogenom Fdn FriorGen, I-50019 Florence, Italy	University of Florence	Chiarugi, P (corresponding author), Univ Florence, Dept Biochem Sci, Viale Morgani 50, I-50134 Florence, Italy.	paola.chiarugi@unifi.it	Chiarugi, Paola/CDD-7988-2022; Mello, Tommaso/I-4715-2012; Grimaldi, Giovanna/K-2678-2018; Giannoni, Elisa/AAE-2092-2020; Mello, Tommaso/AAO-7831-2021	Mello, Tommaso/0000-0002-6192-6902; Grimaldi, Giovanna/0000-0003-0134-7869; Mello, Tommaso/0000-0002-6192-6902; Chiarugi, Paola/0000-0001-7655-2969; Giannoni, Elisa/0000-0001-7136-1098; raugei, giovanni/0000-0003-1294-786X				Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Cooper HM, 2002, INT J DEV BIOL, V46, P621; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Halford MM, 2003, DEV CELL, V5, P536, DOI 10.1016/S1534-5807(03)00299-5; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Hunter SG, 2006, MOL CELL BIOL, V26, P4830, DOI 10.1128/MCB.02215-05; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; MATSUDA M, 1992, J VIROL, V66, P115, DOI 10.1128/JVI.66.1.115-121.1992; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Murai KK, 2005, NEURON, V46, P161, DOI 10.1016/j.neuron.2005.04.004; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Nagashima KI, 2002, MOL BIOL CELL, V13, P4231, DOI 10.1091/mbc.E02-04-0181; Nasertorabi F, 2006, J MOL RECOGNIT, V19, P30, DOI 10.1002/jmr.755; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; OWENS LV, 1995, CANCER RES, V55, P2752; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Santiago A, 2002, DEVELOPMENT, V129, P3621; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Sieg DJ, 1999, J CELL SCI, V112, P2677; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Zelinski DP, 2001, CANCER RES, V61, P2301; Zeng GY, 2003, AM J PATHOL, V163, P2271, DOI 10.1016/S0002-9440(10)63584-5; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200	58	68	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19619	19628		10.1074/jbc.M701319200	http://dx.doi.org/10.1074/jbc.M701319200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17449913	hybrid			2022-12-27	WOS:000247650600036
J	Tanaka, T; Mizukoshi, T; Sasaki, K; Kohda, D; Masai, H				Tanaka, Taku; Mizukoshi, Toshimi; Sasaki, Kaori; Kohda, Daisuke; Masai, Hisao			Escherichia coli PriA protein, two modes of DNA binding and activation of ATP hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FACTOR-Y; HOMOLOGOUS RECOMBINATION; FORK BINDING; IN-VITRO; HELICASE; PRIMOSOME; SEQUENCE; MUTANTS; PATHWAY; DOMAIN	Escherichia coli PriA protein plays crucial roles in processing of arrested replication forks. PriA serves as a sensor/stabilizer for an arrested replication fork and eventually promotes restart of DNA replication through assembly of a primosome. PriA carries a 3' terminus binding pocket required for its high affinity binding to a specific arrested fork as well as for its biological functions. We show here that PriA binds to DNA in a manner either dependent on or independent of 3' terminus recognition. The former mode of binding requires the 3' terminus binding pocket present at the N- terminal half of the 181-residue DNA binding domain and exhibits specific bipartite interaction on the template DNA. The latter mode is independent of the pocket function, but requires the C-terminal half of the same domain. ATP hydrolysis activity of PriA can be stimulated in vitro by either of the two binding modes. We propose architecture of PriA bound to various arrested replication fork structures and discuss its implication in helicase activation and ATP hydrolysis.	Ajinomoto Co Inc, Inst Life Sci, Basic Anal Chem Grp, Kawasaki, Kanagawa 2108681, Japan; Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; Biomed Engn Res Inst, Dept Biol Struct, Suita, Osaka 5650874, Japan; Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Fukuoka 812, Japan	Ajinomoto Co Inc; Tokyo Metropolitan Institute of Medical Science; Kyushu University	Masai, H (corresponding author), Ajinomoto Co Inc, Inst Life Sci, Basic Anal Chem Grp, Kawasaki, Kanagawa 2108681, Japan.	hmasai@rinshoken.or.jp	Kohda, Daisuke/I-4990-2019	Kohda, Daisuke/0000-0001-8234-3776				Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Chen HW, 2004, J BIOL CHEM, V279, P38503, DOI 10.1074/jbc.M404769200; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; LASKEN RS, 1988, J BIOL CHEM, V263, P5512; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Liu JI, 1999, P NATL ACAD SCI USA, V96, P3552, DOI 10.1073/pnas.96.7.3552; Marians KJ, 2000, PROG NUCLEIC ACID RE, V63, P39; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; Masai H, 1999, BIOCHIMIE, V81, P847, DOI 10.1016/S0300-9084(99)00211-4; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Mizukoshi T, 2003, J BIOL CHEM, V278, P42234, DOI 10.1074/jbc.C300285200; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; OUZOUNIS CA, 1991, NUCLEIC ACIDS RES, V19, P6953, DOI 10.1093/nar/19.24.6953; Sasaki K, 2006, BBA-PROTEINS PROTEOM, V1764, P157, DOI 10.1016/j.bbapap.2005.09.007; SCHEKMAN R, 1975, J BIOL CHEM, V250, P5859; SHLOMAI J, 1980, P NATL ACAD SCI-BIOL, V77, P799, DOI 10.1073/pnas.77.2.799; SHLOMAI J, 1980, J BIOL CHEM, V255, P6794; Tanaka T, 2006, J BIOL CHEM, V281, P3484, DOI 10.1074/jbc.M510979200; Tanaka T, 2003, GENES CELLS, V8, P251, DOI 10.1046/j.1365-2443.2003.00630.x; Tanaka T, 2002, J BIOL CHEM, V277, P38062, DOI 10.1074/jbc.M204397200; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P3342, DOI 10.1073/pnas.72.9.3342; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3	33	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2007	282	27					19917	19927		10.1074/jbc.M701848200	http://dx.doi.org/10.1074/jbc.M701848200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	184OF	17483094	hybrid			2022-12-27	WOS:000247650600066
J	Auxilien, S; El Khadali, F; Rasmussen, A; Douthwaite, S; Grosjean, H				Auxilien, Sylvie; El Khadali, Fatima; Rasmussen, Anette; Douthwaite, Stephen; Grosjean, Henri			Archease from Pyrococcus abyssi improves substrate specificity and solubility of a tRNA m(5)C Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY ANALYSIS; PROTEIN-PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; MODIFIED NUCLEOSIDES; THERMOTOGA-MARITIMA; STRUCTURAL GENOMICS; HSP33 CHAPERONE; GEL-FILTRATION; IDENTIFICATION	Members of the archease superfamily of proteins are represented in all three domains of life. Archease genes are generally located adjacent to genes encoding proteins involved in DNA or RNA processing. Archease have therefore been predicted to play a modulator or chaperone role in selected steps of DNA or RNA metabolism, although the roles of archeases remain to be established experimentally. Here we report the function of one of these archeases from the hyperthermophile Pyrococcus abyssi. The corresponding gene (PAB1946) is located in a bicistronic operon immediately upstream from a second open reading frame (PAB1947), which is shown here to encode a tRNA m(5)C methyltransferase. In vitro, the purified recombinant methyltransferase catalyzes m(5)C formation at several cytosines within tRNAs with preference for C49. The specificity of the methyltransferase is increased by the archease. In solution, the archease exists as a monomer, trimer, and hexamer. Only the oligomeric states bind the methyltransferase and prevent its aggregation, in addition to hindering dimerization of the methyltransferaset-RNA complex. This P. abyssi system possibly reflects the general function of archeases in preventing protein aggregation and modulating the function of their accompanying proteins.	CNRS, LEBS, F-91198 Gif Sur Yvette, France; Univ Paris 11, Inst Genet & Microbiol, CNRS, F-91405 Orsay, France; CNRS, Lab Enzymol & Biochem Struct, F-91198 Gif Sur Yvette, France; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Southern Denmark	Auxilien, S (corresponding author), Inst Curie, CNRS, 26 Rue Ulm, F-75248 Paris, France.	Sylvie.Auxilien@lebs.cnrs-gif.fr		Douthwaite, Stephen/0000-0001-5468-8486				Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2004, PROTEINS, V56, P795, DOI 10.1002/prot.20140; Andersen NM, 2006, J MOL BIOL, V359, P777, DOI 10.1016/j.jmb.2006.04.007; Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527; Becker HF, 1997, J MOL BIOL, V274, P505, DOI 10.1006/jmbi.1997.1417; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Brule H, 1998, BIOCHIMIE, V80, P977, DOI 10.1016/S0300-9084(99)80003-0; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Bujnicki JM, 2004, NUCLEIC ACIDS RES, V32, P2453, DOI 10.1093/nar/gkh564; Canaves JM, 2004, PROTEINS, V56, P19, DOI 10.1002/prot.20141; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Graf PCF, 2002, CELL MOL LIFE SCI, V59, P1624, DOI 10.1007/PL00012489; Grosjean H, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P39; Gu WF, 2005, MOL CELL BIOL, V25, P8191, DOI 10.1128/MCB.25.18.8191-8201.2005; Gu XR, 1999, BIOCHEMISTRY-US, V38, P4053, DOI 10.1021/bi982364y; Janda I, 2004, STRUCTURE, V12, P1901, DOI 10.1016/j.str.2004.08.003; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; Jaroszewski L, 2005, PROTEINS, V61, P669, DOI 10.1002/prot.20542; KEITH JM, 1980, J BIOL CHEM, V255, P4636; Kim SJ, 2001, NAT STRUCT BIOL, V8, P459, DOI 10.1038/87639; King MY, 2002, BIOCHEMISTRY-US, V41, P11218, DOI 10.1021/bi026055q; Kirpekar F, 2001, RAPID COMMUN MASS SP, V15, P8, DOI 10.1002/1097-0231(20010115)15:1<8::AID-RCM185>3.0.CO;2-S; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Nobles KN, 2002, NUCLEIC ACIDS RES, V30, P4751, DOI 10.1093/nar/gkf595; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Romanowski MJ, 2002, PROTEINS, V47, P403, DOI 10.1002/prot.10102; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SOWERS LC, 1987, BIOCHEM BIOPH RES CO, V148, P790, DOI 10.1016/0006-291X(87)90945-4; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Tscherne JS, 1999, BIOCHEMISTRY-US, V38, P1884, DOI 10.1021/bi981880l; Vijayalakshmi J, 2001, STRUCTURE, V9, P367, DOI 10.1016/S0969-2126(01)00597-4; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; [No title captured]	44	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18711	18721		10.1074/jbc.M607459200	http://dx.doi.org/10.1074/jbc.M607459200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17470432	hybrid			2022-12-27	WOS:000247475300009
J	Bush, CF; Jones, SV; Lyle, AN; Minneman, KP; Ressler, KJ; Hall, RA				Bush, Cristina F.; Jones, Seth V.; Lyle, Alicia N.; Minneman, Kenneth P.; Ressler, Kerry J.; Hall, Randy A.			Specificity of olfactory receptor interactions with other G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; ODORANT RECEPTOR; NUCLEOTIDE RECEPTORS; SURFACE EXPRESSION; MAMMALIAN SWEET; GENE-EXPRESSION; PATCH-CLAMP; OLIGOMERIZATION; DOMAIN; RAT	Studies on olfactory receptor ( OR) pharmacology have been hindered by the poor plasma membrane localization of most ORs in heterologous cells. We previously reported that association with the beta(2)-adrenergic receptor (beta(2)-AR) facilitates functional expression of the OR M71 at the plasma membrane of HEK-293 cells. In the present study, we examined the specificity of M71 interactions with other G protein-coupled receptors (GPCRs). M71 was co-expressed in HEK-293 cells with 42 distinct GPCRs, and the vast majority of these receptors had no significant effect on M71 surface expression. However, co-expression with three subtypes of purinergic receptor (P2Y(1)R, P2Y(2)R, and A(2A)R) resulted in markedly enhanced plasma membrane localization of M71. Agonist stimulation of M71 co-expressed with P2Y1R and P2Y2R activated the mitogen-activated protein kinase pathway via coupling of M71 to G alpha(o). We also examined the ability of beta(2)-AR, P2Y(1)R, P2Y(2)R, and A(2A)R to interact with and regulate ORs beyond M71. We found that coexpression of beta(2)-AR or the purinergic receptors enhanced the surface expression for an M71 subfamily member but not for several other ORs from different subfamilies. In addition, through chimeric receptor studies, we determined that the second transmembrane domain of beta(2)-AR is necessary for beta(2)-AR facilitation of M71 plasma membrane localization. These studies shed light on the specificity of OR interactions with other GPCRs and the mechanisms governing olfactory receptor trafficking.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Hall, RA (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rhall@pharm.emory.edu	Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103; Hall, Randy/0000-0002-8318-8728; Lyle, Alicia/0000-0001-7527-9200				Alvaro JD, 1996, MOL PHARMACOL, V50, P583; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buzas B, 1997, NEUROSCIENCE, V76, P479, DOI 10.1016/S0306-4522(96)00242-4; Chen WC, 1998, GLIA, V22, P360, DOI 10.1002/(SICI)1098-1136(199804)22:4<360::AID-GLIA5>3.0.CO;2-7; Cressman VL, 1999, J BIOL CHEM, V274, P26461, DOI 10.1074/jbc.274.37.26461; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; Filippov AK, 1998, J NEUROSCI, V18, P5170, DOI 10.1523/JNEUROSCI.18-14-05170.1998; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Gayle S, 2005, CELL TISSUE RES, V319, P27, DOI 10.1007/s00441-004-0979-2; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; Gimelbrant AA, 1999, J NEUROCHEM, V72, P2301, DOI 10.1046/j.1471-4159.1999.0722301.x; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hague C, 2006, MOL PHARMACOL, V69, P45, DOI 10.1124/mol.105.014985; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Hardy A, 2005, NEUROSCIENCE, V131, P717, DOI 10.1016/j.neuroscience.2004.10.034; Harikumar KG, 2006, BIOCHEMISTRY-US, V45, P14706, DOI 10.1021/bi061107n; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hegg CC, 2004, J NEUROPHYSIOL, V91, P1492, DOI 10.1152/jn.00670.2003; Hegg CC, 2003, J NEUROSCI, V23, P8291; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; JAHN K, 1995, N-S ARCH PHARMACOL, V352, P386; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaelin-Lang A, 1999, NEUROSCI LETT, V261, P189, DOI 10.1016/S0304-3940(99)00022-1; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kawai F, 1999, NAT NEUROSCI, V2, P133, DOI 10.1038/5686; Kikkawa H, 1998, MOL PHARMACOL, V53, P128, DOI 10.1124/mol.53.1.128; Ko HJ, 2006, BIOL CHEM, V387, P59, DOI 10.1515/BC.2006.009; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee SP, 2003, BIOCHEMISTRY-US, V42, P11023, DOI 10.1021/bi0345539; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Luo AH, 2002, BRAIN RES, V941, P62, DOI 10.1016/S0006-8993(02)02566-0; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Paysan J, 2001, PFLUG ARCH EUR J PHY, V441, P579, DOI 10.1007/s004240000492; Prinster SC, 2006, J PHARMACOL EXP THER, V318, P974, DOI 10.1124/jpet.106.106526; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Thevenin D, 2005, PROTEIN SCI, V14, P2177, DOI 10.1110/ps.051409205; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Uberti MA, 2003, MOL PHARMACOL, V64, P1379, DOI 10.1124/mol.64.6.1379; Ulas J, 2000, GLIA, V30, P352, DOI 10.1002/(SICI)1098-1136(200006)30:4<352::AID-GLIA40>3.0.CO;2-6; Vasquez C, 2003, NEUROSCIENCE, V118, P603, DOI 10.1016/S0306-4522(03)00024-1; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vicentic A, 2002, J PHARMACOL EXP THER, V302, P58, DOI 10.1124/jpet.302.1.58; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Watt WC, 2001, J BIOL CHEM, V276, P2047, DOI 10.1074/jbc.M006703200; Wekesa KS, 1999, BRAIN RES, V837, P117, DOI 10.1016/S0006-8993(99)01630-3; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	62	37	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19042	19051		10.1074/jbc.M610781200	http://dx.doi.org/10.1074/jbc.M610781200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17472961	hybrid			2022-12-27	WOS:000247475300046
J	Cuervo, A; Vaney, MC; Antson, AA; Tavares, P; Oliveira, L				Cuervo, Ana; Vaney, Marie-Christine; Antson, Alfred A.; Tavares, Paulo; Oliveira, Leonor			Structural rearrangements between portal protein subunits are essential for viral DNA translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE SPP1; MECHANISM; RESOLUTION; TERMINASE; ATPASE	Transport of DNA into preformed procapsids is a general strategy for genome packing inside virus particles. In most viruses, this task is accomplished by a complex of the viral packaging ATPase with the portal protein assembled at a specialized vertex of the procapsid. Such molecular motor translocates DNA through the central tunnel of the portal protein. A central question to understand this mechanism is whether the portal is a mere conduit for DNA or whether it participates actively on DNA translocation. The most constricted part of the bacteriophage SPP1 portal tunnel is formed by twelve loops, each contributed from one individual subunit. The position of each loop is stabilized by interactions with helix alpha-5, which extends into the portal putative ATPase docking interface. Here, we have engineered intersubunit disulfide bridges between alpha-5s of adjacent portal ring subunits. Such covalent constraint blocked DNA packaging, whereas reduction of the disulfide bridges restored normal packaging activity. DNA exit through the portal in SPP1 virions was unaffected. The data demonstrate that mobility between alpha-5 helices is essential for the mechanism of viral DNA translocation. We propose that the alpha-5 structural rearrangements serve to coordinate ATPase activity with the positions of portal tunnel loops relative to the DNA double helix.	CNRS, UMR 2472, Unite Virol Mol & Struct, UMR INRA 1157, F-91198 Gif Sur Yvette, France; Univ York, Dept Chem, York Struct Biol Lab, York Y010 5YW, N Yorkshire, England	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of York - UK	Tavares, P (corresponding author), CNRS, UMR 2472, Unite Virol Mol & Struct, UMR INRA 1157, Bat 14B Ave Terrasse, F-91198 Gif Sur Yvette, France.	tavares@vms.cnrs-gif.fr	Antson, Alfred/N-2551-2016	Antson, Alfred/0000-0002-4533-3816; Cuervo, Ana/0000-0001-9414-503X; Tavares, Paulo/0000-0002-2566-4546	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Betanzos M, 2002, NAT STRUCT BIOL, V9, P704, DOI 10.1038/nsb828; Calendar, 2006, BACTERIOPHAGES, P49; Camacho AG, 2003, J BIOL CHEM, V278, P23251, DOI 10.1074/jbc.M301805200; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Catalano Carlos Enrique, 2005, P1; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; GUO PX, 1987, J MOL BIOL, V197, P219, DOI 10.1016/0022-2836(87)90120-3; Isidro A, 2004, VIROLOGY, V322, P253, DOI 10.1016/j.virol.2004.02.012; Isidro A, 2004, MOL MICROBIOL, V51, P949, DOI 10.1046/j.1365-2958.2003.03880.x; Jekow P, 1999, EUR J BIOCHEM, V264, P724, DOI 10.1046/j.1432-1327.1999.00601.x; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Oliveira L, 2005, J MOL BIOL, V353, P529, DOI 10.1016/j.jmb.2005.08.063; Oliveira L, 2006, J BIOL CHEM, V281, P21914, DOI 10.1074/jbc.M603314200; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; RAO VB, 1987, MOL BIOL, V200, P475; Saleh OA, 2004, EMBO J, V23, P2430, DOI 10.1038/sj.emboj.7600242; Sambook J., 1989, MOL CLONING LAB MANU, P743; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; TAVARES P, 1992, J MOL BIOL, V225, P81, DOI 10.1016/0022-2836(92)91027-M; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; Vinga I, 2006, MOL MICROBIOL, V61, P1609, DOI 10.1111/j.1365-2958.2006.05327.x; YEO A, 1995, J MOL BIOL, V245, P141, DOI 10.1006/jmbi.1994.0013	36	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18907	18913		10.1074/jbc.M701808200	http://dx.doi.org/10.1074/jbc.M701808200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17446176	Green Published, hybrid			2022-12-27	WOS:000247475300031
J	Peixoto, PMV; Grana, F; Roy, TJ; Dunn, CD; Flores, M; Jensen, RE; Campo, ML				Peixoto, Pablo M. V.; Grana, Fernando; Roy, Teresa J.; Dunn, Cory D.; Flores, Montana; Jensen, Robert E.; Campo, Maria Luisa			Awaking TIM22, a dynamic ligand-gated channel for protein insertion in the mitochondrial inner membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPROTEIN TRANSLOCASE; OUTER-MEMBRANE; TOM CHANNEL; IMPORT; COMPONENT; COMPLEX; CARRIER; PERMEABILITY; MACHINERY; FORMS	Aqueous channels are at the core of the translocase of the outer membrane (TOM) and the translocase of the inner membrane for the transport of preproteins (TIM23), the translocases mediating the transport of proteins across the outer and inner mitochondrial membranes. Yet, the existence of a channel associated to the translocase of the inner membrane for the insertion of multitopic protein (TIM22) complex has been arguable, as its function relates to the insertion of multispanning proteins into the inner membrane. For the first time, we report conditions for detecting a channel activity associated to the TIM22 translocase in organelle, i.e. intact mitoplasts. An internal signal peptide in the intermembrane space of mitochondria is a requisite to inducing this channel, which is otherwise silent. The channel showed slightly cationic and high conductance activity of 1000 pS with a predominant half-open substate. Despite their different composition, the channels of the three mitochondrial translocases were thus remarkably similar, in agreement with their common task as pores transiently trapping proteins en route to their final destination. The opening of the TIM22 channel was a step-up process depending on the signal peptide concentration. Interestingly, low membrane potentials kept the channel fully open, providing a threshold level of the peptide is present. Our results portray TIM22 as a dynamic channel solely active in the presence of its cargo proteins. In its fully open conformation, favored by the combined action of internal signal peptide and low membrane potential, the channel could embrace the in-transit protein. As insertion progressed and initial interaction with the signal peptide faded, the channel would close, sustaining its role as a shunt that places trapped proteins into the membrane.	Univ Extremadura, Fac Vet Sci, Dept Biochem & Mol Biol, Caceres 10071, Spain; Univ Extremadura, Dept Biochem & Mol Biol, Caceres 10071, Spain; Univ Extremadura, Dept Anim Med, Caceres 10071, Spain; Johns Hopkins Univ, Dept Cell Biol, Baltimore, MD 21205 USA	Universidad de Extremadura; Universidad de Extremadura; Universidad de Extremadura; Johns Hopkins University	Campo, ML (corresponding author), Univ Extremadura, Fac Vet Sci, Dept Biochem & Mol Biol, Avda de la Univ S-N, Caceres 10071, Spain.	mlcampo@unex.es	Dunn, Cory/B-9611-2013; Peixoto, Pablo/G-3036-2010; Peixoto, Pablo/Y-8360-2019; Campo, Maria Luisa/L-5211-2014	Peixoto, Pablo/0000-0001-5953-6027; Dunn, Cory/0000-0003-2393-5944				Adam A, 1999, EMBO J, V18, P313, DOI 10.1093/emboj/18.2.313; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; CAMPO ML, 1984, EUR J BIOCHEM, V141, P5, DOI 10.1111/j.1432-1033.1984.tb08147.x; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; DECKER GL, 1977, J ULTRA MOL STRUCT R, V59, P44, DOI 10.1016/S0022-5320(77)80027-0; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Grigoriev SM, 2004, INT REV CYTOL, V238, P227, DOI 10.1016/S0074-7696(04)38005-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; HILLE B, 2002, IONIC CHANNELS EXCIT, P351; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Koehler CM, 1998, EMBO J, V17, P6477, DOI 10.1093/emboj/17.22.6477; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kubrich M, 1998, J BIOL CHEM, V273, P16374, DOI 10.1074/jbc.273.26.16374; Kushnareva YE, 1999, ARCH BIOCHEM BIOPHYS, V366, P107, DOI 10.1006/abbi.1999.1190; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lohret TA, 1997, J CELL BIOL, V137, P377, DOI 10.1083/jcb.137.2.377; LOHRET TA, 1995, J BIOL CHEM, V270, P15950, DOI 10.1074/jbc.270.27.15950; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; Martinez-Caballero S, 2007, ANAL BIOCHEM, V362, P76, DOI 10.1016/j.ab.2006.12.015; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Milisav I, 2001, J BIOL CHEM, V276, P25856, DOI 10.1074/jbc.M102132200; Muro C, 2003, BIOPHYS J, V84, P2981, DOI 10.1016/S0006-3495(03)70024-1; OHBA M, 1987, EMBO J, V6, P2117, DOI 10.1002/j.1460-2075.1987.tb02478.x; Paschen SA, 2000, EMBO J, V19, P6392, DOI 10.1093/emboj/19.23.6392; Peixoto PM, 2004, RECENT RES DEV BIOPH, V3, P413; Pfanner N, 2002, CURR OPIN CELL BIOL, V14, P400, DOI 10.1016/S0955-0674(02)00355-1; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Reichert AS, 2004, TRENDS GENET, V20, P555, DOI 10.1016/j.tig.2004.08.012; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Sirrenberg C, 1997, J BIOL CHEM, V272, P29963, DOI 10.1074/jbc.272.47.29963; Taylor RD, 2004, BBA-BIOENERGETICS, V1658, P37, DOI 10.1016/j.bbabio.2004.04.017; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200	43	32	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					18694	18701		10.1074/jbc.M700775200	http://dx.doi.org/10.1074/jbc.M700775200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17462993	hybrid			2022-12-27	WOS:000247475300007
J	Yoshizawa, JM; Li, C; Gershon, PD				Yoshizawa, Janice M.; Li, Changzheng; Gershon, Paul D.			Saltatory forward movement of a Poly(A) polymerase during Poly(A) tail addition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA VIRUS; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURES; RNA; POLYADENYLATION; COMPLEX; BINDING; POLYADENYLYLATION; HETERODIMER; MECHANISM	Vaccinia poly(A) polymerase (VP55) interacts with >= 33-nucleotide (nt) primers via uridylates at two sites (-27/-26 and -10). It adds similar to 30-nt poly(A) tails with a rapid, processive burst in which the first few nt are added without substantial primer movement, and addition of the remaining adenylates is dependent upon a six-uridylate tract at the extreme 3' end of the primer and accompanied by polymerase translocation. Interaction of VP55 with 2-aminopurine (2-AP)-containing primers was associated with a 3-fold enhancement in 2-AP fluorescence. In stopped-flow experiments, fluorescence intensity changed with time during the polyadenylation burst in a manner dependent upon the position of 2-AP, indicating a non-uniform isomerization of the polymerase-primer complex with time consistent with a discontinuous (saltatory) translocation mechanism. Three distinct translocatory phases could be discerned: a -10(U)-binding site forward movement, a -27/-26(UU)-binding site jump to -10, then a -27/-26(UU)-binding site movement further downstream. Poly(A) tail elongation showed no apparent pauses during these isomerizations. Fluorescence changes during polyadenylation of 2-AP-containing primers with short preformed oligo(A) tails reinforced the above observations. Primers composed entirely of oligo(U) (apart from the 2-AP sensor), in which the polymerase modules might be most able to "slide" uniformly, also showed the characteristic saltatory pattern of translocation. These data indicate, for the first time, a discontinuous mode of translocation for a non-templated polymerase.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Gershon, PD (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Rm 1222, Irvine, CA 92717 USA.	pgershon@uci.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051953] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI007319-19] Funding Source: Medline; NIGMS NIH HHS [R01GM51953] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aphasizhev R, 2005, CELL MOL LIFE SCI, V62, P2194, DOI 10.1007/s00018-005-5198-9; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; Deng L, 1997, J BIOL CHEM, V272, P31542, DOI 10.1074/jbc.272.50.31542; Deng L, 1999, J MOL BIOL, V285, P1417, DOI 10.1006/jmbi.1998.2417; Gershon PD, 2000, NAT STRUCT BIOL, V7, P819, DOI 10.1038/79555; GERSHON PD, 1993, EMBO J, V12, P4705, DOI 10.1002/j.1460-2075.1993.tb06159.x; Gershon PD, 1998, SEMIN VIROL, V8, P343, DOI 10.1006/smvy.1997.0137; GERSHON PD, 1991, CELL, V66, P1269, DOI 10.1016/0092-8674(91)90048-4; GERSHON PD, 1992, GENE DEV, V6, P1575, DOI 10.1101/gad.6.8.1575; Hall TMT, 2002, CURR OPIN STRUC BIOL, V12, P82, DOI 10.1016/S0959-440X(02)00293-2; Johnson L, 2004, J MOL BIOL, V337, P843, DOI 10.1016/j.jmb.2004.01.058; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li DN, 1997, EMBO J, V16, P1103, DOI 10.1093/emboj/16.5.1103; MANLEY JL, 1995, P NATL ACAD SCI USA, V92, P1800, DOI 10.1073/pnas.92.6.1800; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; MOSS B, 1975, J BIOL CHEM, V250, P4722; Moss B, 2001, FIELDS VIROLOGY, P2849; Moure CM, 2006, MOL CELL, V22, P339, DOI 10.1016/j.molcel.2006.03.015; Oguro A, 2002, CHEM BIOL, V9, P679, DOI 10.1016/S1074-5521(02)00163-1; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	25	5	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19144	19151		10.1074/jbc.M700183200	http://dx.doi.org/10.1074/jbc.M700183200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17488726	hybrid			2022-12-27	WOS:000247475300056
J	Kobayashi, S; Lee, SH; Meng, XW; Mott, JL; Bronk, SF; Werneburg, NW; Craig, RW; Kaufmann, SH; Gores, GJ				Kobayashi, Shogo; Lee, Sun-Hee; Meng, Xue W.; Mott, Justin L.; Bronk, Steven F.; Werneburg, Nathan W.; Craig, Ruth W.; Kaufmann, Scott H.; Gores, Gregory J.			Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; MEMBRANE PERMEABILIZATION; DEPENDENT DEGRADATION; CELL LEUKEMIA-1; BCL-2 PROTEINS; EXPRESSION; ACTIVATION; RESISTANCE; INHIBITION; SURVIVAL	Mcl-1 is an antiapoptotic Bcl-2 family member that is highly regulated and when dysregulated contributes to cancer. The Mcl-1 protein is phosphorylated at multiple sites in response to different signaling events. Phosphorylations at Thr(163) (by ERK) and Ser(159) (by glycogen-synthase kinase 3 beta) have recently been shown to slow and enhance, respectively, Mcl-1 protein turnover. Phosphorylation is also known to be stimulated at other, as-yet uncharacterized sites in the G(2)/M phase of the cell cycle. Using an S peptide-tagged Mcl-1 T163A mutant, Ser(64) was identified as a novel Mcl-1 phosphorylation site by mass spectrometry. Immunoblotting demonstrated that phosphorylation at this site was maximal in cells in G(2)/M phase, was enhanced by tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) treatment, was blocked by inhibitors of CDK (but not ERK or glycogen-synthase kinase 3 beta), and was stimulated in vitro by CDK1, CDK2, and JNK1. The half-life of a nonphosphorylatable S64A Mcl-1 mutant was indistinguishable from that of the wild type polypeptide. In contrast, this mutant failed to protect cells from TRAIL-mediated apoptosis, whereas reconstitution with the phosphomimetic S64E Mcl-1 mutant rendered cells TRAIL-resistant. This anti-apoptotic phenotype of the S64E Mcl-1 mutant was also associated with enhanced binding to the proapoptotic proteins Bim, Noxa, and Bak. A pharmacological CDK inhibitor that reduced Ser(64) phosphorylation also sensitized cells to TRAIL cytotoxicity. Collectively, these observations not only identify G(2)/M-associated phosphorylation at Ser(64) as a critical determinant of the antiapoptotic activity of Mcl-1 but also elucidate a novel mechanism by which CDK1/2 inhibitors can enhance the effectiveness of the cytotoxic cytokine TRAIL.	Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Cell & Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Dartmouth College	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu		Kaufmann, Scott/0000-0002-4900-7145; Mott, Justin/0000-0002-2927-6962	NCI NIH HHS [CA 57359, R01 CA069008, CA 69008, R01 CA057359] Funding Source: Medline; NIDDK NIH HHS [DK 59427] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069008, R01CA057359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059427, R56DK059427] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akgul C, 2000, CELL MOL LIFE SCI, V57, P684, DOI 10.1007/PL00000728; BODRUG SE, 1995, CELL DEATH DIFFER, V2, P173; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Domina AM, 2000, J BIOL CHEM, V275, P21688, DOI 10.1074/jbc.M000915200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Gelinas W, 2005, GENE DEV, V19, P1263, DOI 10.1101/gad.1326205; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Henson ES, 2003, J CELL BIOCHEM, V89, P1177, DOI 10.1002/jcb.10597; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Inoshita S, 2002, J BIOL CHEM, V277, P43730, DOI 10.1074/jbc.M207951200; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Jin ZY, 2002, CELL CYCLE, V1, P82, DOI 10.4161/cc.1.1.104; Joo EK, 2004, STEM CELLS DEV, V13, P563, DOI 10.1089/scd.2004.13.563; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Krajewska M, 1996, AM J PATHOL, V148, P1567; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lam LT, 2001, GENOME BIOL, V2; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Moshinsky DJ, 2003, BIOCHEM BIOPH RES CO, V310, P1026, DOI 10.1016/j.bbrc.2003.09.114; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Rinkenberger JL, 2000, GENE DEV, V14, P23; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Selzer E, 1998, MELANOMA RES, V8, P197, DOI 10.1097/00008390-199806000-00001; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Thallinger C, 2004, CLIN CANCER RES, V10, P4185, DOI 10.1158/1078-0432.CCR-03-0774; Wang JM, 2003, MOL CELL BIOL, V23, P1896, DOI 10.1128/MCB.23.6.1896-1909.2003; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zapata JM, 1998, BREAST CANCER RES TR, V47, P129, DOI 10.1023/A:1005940832123; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou P, 1998, BLOOD, V92, P3226, DOI 10.1182/blood.V92.9.3226.421k49_3226_3239	55	94	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18407	18417		10.1074/jbc.M610010200	http://dx.doi.org/10.1074/jbc.M610010200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17463001	hybrid			2022-12-27	WOS:000247302000047
J	Long, XM; Lin, YS; Ortiz-Vega, S; Busch, S; Avruch, J				Long, Xiaomeng; Lin, Yenshou; Ortiz-Vega, Sara; Busch, Susann; Avruch, Joseph			The rheb switch 2 segment is critical for signaling to target of rapamycin complex 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; CELL-GROWTH; MAMMALIAN TARGET; RAS; ACTIVATION; GTPASE; MTOR; BINDING; TSC2; IDENTIFICATION	The small GTPase Rheb is a positive upstream regulator of the target of rapamycin ( TOR) complex 1 in mammalian cells and can bind directly to TOR complex 1. To identify the regions of the Rheb surface most critical for signaling to TOR complex 1, we created a set of 26 mutants wherein clusters of 1 - 5 putative solvent-exposed residues were changed to alanine, ultimately changing 65 residues distributed over the entire Rheb surface. The signaling function of these mutants was assessed by their ability, in comparison to wild type Rheb, to restore the phosphorylation of S6K1(Thr(389)) when expressed transiently in amino acid-deprived 293T cells. The major finding is that two mutants situated in the Rheb switch 2 segment, Y67A/I69A and I76A/ D77A, exhibit a near total loss of function, whereas extensive replacement of the switch 1 segment and other surface residues with alanines causes relatively little disturbance of Rheb rescue of S6K1 from amino acid withdrawal. This is surprising in view of the minimal impact of guanyl nucleotide on Rheb switch 2 configuration. The loss of function Rheb switch 2 mutants are well expressed and exhibit partial agonist function in amino acid-replete cells. They are unimpaired in their ability to bind GTP or mammalian ( m) TOR in vivo or in vitro, and the mTOR polypeptides retrieved with these inactive Rheb mutants exhibit kinase activity in vitro comparable with mTOR bound to wild type Rheb. We conclude that Rheb signaling to mTOR in vivo requires a Rheb switch 2-dependent interaction with an element other than the three known polypeptide components of TOR complex 1.	Massachusetts Gen Hosp, Harvard Med Sch, Diabet & Unit Serv, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Avruch, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA.	avruch@molbio.mgh.harvard.edu	Long, Samuel/AAR-8118-2021	Long, Samuel/0000-0001-7559-3232	NATIONAL CANCER INSTITUTE [R01CA073818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017776, R37DK017776, P30DK040561] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA073818, CA73818] Funding Source: Medline; NIDDK NIH HHS [R37 DK017776, P30 DK040561-12, P30 DK040561, DK17776] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashery U, 2006, CELL MOL NEUROBIOL, V26, P471, DOI 10.1007/s10571-006-9059-3; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Li WQ, 2000, GENE DEV, V14, P895; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Shao HP, 1999, ARCH BIOCHEM BIOPHYS, V371, P207, DOI 10.1006/abbi.1999.1448; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	29	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18542	18551		10.1074/jbc.M610736200	http://dx.doi.org/10.1074/jbc.M610736200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17470430	hybrid, Green Accepted			2022-12-27	WOS:000247302000059
J	Mu, JJ; Wang, Y; Luo, H; Leng, M; Zhang, JL; Yang, T; Besusso, D; Jung, SY; Qin, J				Mu, Jung-Jung; Wang, Yi; Luo, Hao; Leng, Mei; Zhang, Jinglan; Yang, Tao; Besusso, Dario; Jung, Sung Yun; Qin, Jun			A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; HUMAN CDC25A; PHOSPHORYLATION; PROTEIN; PATHWAY; KINASE; LIGASE; SMC1; COACTIVATOR; ACTIVATION	ATM (ataxia telangiectasia-mutated) and ATR (ATM-Rad3-related) are proximal checkpoint kinases that regulate DNA damage response (DDR). Identification and characterization of ATM/ ATR substrates hold the keys for the understanding of DDR. Few techniques are available to identify protein kinase substrates. Here, we screened for potential ATM/ ATR substrates using phospho-specific antibodies against known ATM/ ATR substrates. We identified proteins cross-reacting to phospho-specific antibodies in response to DNA damage by mass spectrometry. We validated a subset of the candidate substrates to be phosphorylated in an ATM/ ATR-dependent manner in vivo. Combining with a functional checkpoint screen, we identified proteins that belong to the ubiquitin-proteasome system (UPS) to be required in mammalian DNA damage checkpoint control, particularly the G(1) cell cycle checkpoint, thus revealing protein ubiquitylation as an important regulatory mechanism downstream of ATM/ ATR activation for checkpoint control.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Wang, Y (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	yiw@bcm.tmc.edu; jqin@bcm.tmc.edu	Zhang, Jinglan/AAI-1793-2020; Zhang, Jinglan/D-4752-2011	Zhang, Jinglan/0000-0002-4600-7123; Besusso, Dario/0000-0001-9793-9644	NCI NIH HHS [CA98500, CA84199] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084199, R01CA098500] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Baker RT, 1999, GENOMICS, V59, P264, DOI 10.1006/geno.1999.5879; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chehab NH, 2000, GENE DEV, V14, P278; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Wang Y, 2000, GENE DEV, V14, P927; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	32	134	139	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17330	17334		10.1074/jbc.C700079200	http://dx.doi.org/10.1074/jbc.C700079200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17478428	Green Published, hybrid			2022-12-27	WOS:000247084500002
J	Herrera, FE; Zucchelli, S; Jezierska, A; Lavina, ZS; Gustincich, S; Carloni, P				Herrera, Fernando E.; Zucchelli, Silvia; Jezierska, Aneta; Lavina, Zeno Scotto; Gustincich, Stefano; Carloni, Paolo			On the oligomeric state of DJ-1 protein and its mutants associated with Parkinson disease - A combined computational and in vitro study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; OXIDATIVE STRESS; ANTIOXIDATIVE STRESS; CRYSTAL-STRUCTURE; 2 PARTS; MUTATIONS; SURFACE; MODEL; SIMULATION	Mutations in the DJ-1 protein are present in patients suffering from familial Parkinson disease. Here we use computational methods and biological assays to investigate the relationship between DJ-1 missense mutations and the protein oligomeric state. Molecular dynamics calculations suggest that: (i) the structure of DJ-1 wild type (WT) in aqueous solution, in both oxidized and reduced forms, is similar to the crystal structure of the reduced form; (ii) the Parkinson disease-causing M26I variant is structurally similar to the WT, consistent with the experimental evidence showing the protein is a dimer as WT; (iii) R98Q is structurally similar to the WT, consistent with the fact that this is a physiological variant; and (iv) the L166P monomer rapidly evolves toward a conformation significantly different from WT, suggesting a change in its ability to oligomerize. Our combined computational and experimental approach is next used to identify a mutant (R28A) that, in contrast to L166P, destabilizes the dimer subunit-subunit interface without significantly changing secondary structure elements.	INFM, DEMOCRITOS, Int Sch Adv Studies, I-34014 Trieste, Italy; Italian Inst Technol, SISSA Unit, I-34014 Trieste, Italy; Giovanno Armenise Garvard Fdn Lab, I-34012 Trieste, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Carloni, P (corresponding author), INFM, DEMOCRITOS, Int Sch Adv Studies, Via Beirut 2-4, I-34014 Trieste, Italy.	carloni@sissa.it	Carloni, Paolo/H-8736-2013	Zucchelli, Silvia/0000-0003-4556-2990; Herrera, Fernando E./0000-0002-8595-3382; Gustincich, Stefano/0000-0002-2749-2514; Jezierska, Aneta/0000-0001-6601-9124	Telethon [GGP06268] Funding Source: Medline	Telethon(Fondazione Telethon)		Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Allard L, 2005, CLIN CHEM, V51, P2043, DOI 10.1373/clinchem.2005.053942; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Bonifati V, 2004, J MOL MED, V82, P163, DOI 10.1007/s00109-003-0512-1; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 2002, AMBER 8; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hedrich K, 2004, ANN NEUROL, V55, P145, DOI 10.1002/ana.10816; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; KORTEMME T, 2004, SCI STKE, V219, P1; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Lev N, 2006, J MOL NEUROSCI, V29, P215, DOI 10.1385/JMN:29:3:215; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Pankratz Nathan, 2004, NeuroRx, V1, P235, DOI 10.1007/BF03206607; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; WOLFENDEN R, 1982, BIOCHEMISTRY-US, V157, P105; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	62	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2007	282	34					24905	24914		10.1074/jbc.M701013200	http://dx.doi.org/10.1074/jbc.M701013200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	202VU	17504761	hybrid			2022-12-27	WOS:000248933000047
J	Nishida, M; Onohara, N; Sato, Y; Suda, R; Ogushi, M; Tanabe, S; Inoue, R; Mori, Y; Kurose, H				Nishida, Motohiro; Onohara, Naoya; Sato, Yoji; Suda, Reiko; Ogushi, Mariko; Tanabe, Shihori; Inoue, Ryuji; Mori, Yasuo; Kurose, Hitoshi			G alpha(12/13)-mediated up-regulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL CHANNELS; JUN NH2-TERMINAL KINASE; ANGIOTENSIN-II; PROTEIN-KINASE; CA2+ ENTRY; HYPERTROPHY; FIBROBLASTS; EXPRESSION; PATHWAY; G-ALPHA(12)	Sustained elevation of [Ca2+](i) has been implicated in many cellular events. We previously reported that alpha subunits of G(12) family G proteins (G alpha(12/13)) participate in sustained Ca2+ influx required for the activation of nuclear factor of activated T cells (NFAT), a Ca2+-responsive transcriptional factor, in rat neonatal cardiac fibroblasts. Here, we demonstrate that G alpha(12/13)-mediated up-regulation of canonical transient receptor potential 6 (TRPC6) channels participates in sustained Ca2+ influx and NFAT activation by endothelin (ET)-1 treatment. Expression of constitutively active G alpha(12) or G alpha(13) increased the expression of TRPC6 proteins and basal Ca2+ influx activity. The treatment with ET-1 increased TRPC6 protein levels through G alpha(12/13), reactive oxygen species, and c-Jun N-terminal kinase (JNK)-dependent pathways. NFAT is activated by sustained increase in [Ca2+](i) through up-regulated TRPC6. A G alpha(12/13)-inhibitory polypeptide derived from the regulator of the G-protein signaling domain of p115-Rho guanine nucleotide exchange factor and a JNK inhibitor, SP600125, suppressed the ET-1-induced increase in expression of marker proteins of myofibroblast formation through a G alpha(12/13)-reactive oxygen species-JNK pathway. The ET-1- induced myofibroblast formation was suppressed by overexpression of TRPC6 and CA NFAT, whereas it was enhanced by TRPC6 small interfering RNAs and cyclosporine A. These results suggest two opposite roles of G alpha(12/13) in cardiac fibroblasts. First, G alpha(12/13) mediate ET-1- induced myofibroblast formation. Second, G alpha(12/13) mediate TRPC6 up-regulation and NFAT activation that negatively regulates ET-1-induced myofibroblast formation. Furthermore, TRPC6 mediates hypertrophic responses in cardiac myocytes but suppresses fibrotic responses in cardiac fibroblasts. Thus, TRPC6 mediates opposite responses in cardiac myocytes and fibroblasts.	Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, Fukuoka 8128582, Japan; Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; Fukuoka Univ, Sch Med, Dept Physiol, Jonan Ku, Fukuoka 8140180, Japan; Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Mol Biol Lab, Kyoto 6158510, Japan	Kyushu University; National Institute of Health Sciences - Japan; Fukuoka University; Kyoto University	Kurose, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kurose@phar.kyushu-u.ac.jp	Tanabe, Shihori/AAH-6584-2019	Tanabe, Shihori/0000-0003-3706-0616; Nishida, Motohiro/0000-0002-2587-5458				Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; BRAUDINO TA, 2006, AM J PHYSIOL, V291, pH1015; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Katwa LC, 2003, AM J PHYSIOL-HEART C, V285, pH1132, DOI 10.1152/ajpheart.01141.2002; Kawano H, 2000, CIRCULATION, V101, P1130, DOI 10.1161/01.CIR.101.10.1130; Kim M, 2006, BIOCHEM BIOPH RES CO, V339, P271, DOI 10.1016/j.bbrc.2005.11.014; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Kolar F, 1996, MOL CELL BIOCHEM, V164, P253, DOI 10.1007/BF00408666; Kunichika N, 2004, AM J RESP CRIT CARE, V170, P1101, DOI 10.1164/rccm.200312-1668OC; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nagamatsu Y, 2006, J PHARMACOL SCI, V101, P144, DOI 10.1254/jphs.FP0051036; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2005, J BIOL CHEM, V280, P18434, DOI 10.1074/jbc.M409710200; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Oie E, 2000, AM J PHYSIOL-HEART C, V278, pH2115; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Seth M, 2004, P NATL ACAD SCI USA, V101, P16683, DOI 10.1073/pnas.0407537101; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Shimoyama M, 1999, CIRCULATION, V100, P2449, DOI 10.1161/01.CIR.100.24.2449; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yang GP, 2001, J MOL CELL CARDIOL, V33, P1505, DOI 10.1006/jmcc.2001.1413; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002	48	107	115	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2007	282	32					23117	23128		10.1074/jbc.M611780200	http://dx.doi.org/10.1074/jbc.M611780200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	197ST	17533154	hybrid			2022-12-27	WOS:000248577500014
J	Olson, E; Nievera, CJ; Lee, AYL; Chen, LC; Wu, XH				Olson, Erin; Nievera, Christian J.; Lee, Alan Yueh-Luen; Chen, Longchuan; Wu, Xiaohua			The mre11-Rad50-Nbs1 complex acts both upstream and downstream of ataxia telangiectasia mutated and Rad3-related protein (ATR) to regulate the S-phase checkpoint following UV treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; TELOMERASE CATALYTIC SUBUNIT; DEPENDENT NUCLEAR-DYNAMICS; FORKHEAD-ASSOCIATED DOMAIN; MRE11 COMPLEX; REPLICATION CHECKPOINT; FUNCTIONAL-ANALYSIS; IONIZING-RADIATION	The Mre11-Rad50-Nbs1 (MRN) complex is required for mediating the S-phase checkpoint following UV treatment, but the underlying mechanism is not clear. Here we demonstrate that at least two mechanisms are involved in regulating the S-phase checkpoint in an MRN-dependent manner following UV treatment. First, when replication forks are stalled, MRN is required upstream of ataxia telangiectasia mutated and Rad3-related protein (ATR) to facilitate ATR activation in a substrate and dosage-dependent manner. In particular, MRN is required for ATR-directed phosphorylation of RPA2, a critical event in mediating the S-phase checkpoint following UV treatment. Second, MRN is a downstream substrate of ATR. Nbs1 is phosphorylated by ATR at Ser-343 when replication forks are stalled, and this phosphorylation event is also important for down-regulating DNA replication following UV treatment. Moreover, we demonstrate that MRN and ATR/ATR-interacting protein ( TRIP) interact with each other, and the forkhead-associated/ breast cancer C-terminal domains (FHA/ BRCT) of Nbs1 play a significant role in mediating this interaction. Mutations in the FHA/ BRCT domains do not prevent ATR activation but specifically impair ATR-mediated Nbs1 phosphorylation at Ser-343, which results in a defect in the S-phase checkpoint. These data suggest that MRN plays critical roles both upstream and downstream of ATR to regulate the S-phase checkpoint when replication forks are stalled.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Vet Affairs Med Ctr, Dept Pathol, Long Beach, CA 90822 USA	Scripps Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	Lee, Alan Yueh-Luen/A-9141-2010; Lee, Alan Yueh-Luen/B-1097-2010	Lee, Alan Yueh-Luen/0000-0003-0252-0571	NCI NIH HHS [CA102361] Funding Source: Medline; NIDDK NIH HHS [5 T32 DK007022] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007022] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Becker E, 2006, BIOINFORMATICS, V22, P1289, DOI 10.1093/bioinformatics/btl075; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chini CCS, 2004, DNA REPAIR, V3, P1033, DOI 10.1016/j.dnarep.2004.03.001; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Franchitto A, 2002, J CELL BIOL, V157, P19, DOI 10.1083/jcb.200110009; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Itakura E, 2004, BIOCHEM BIOPH RES CO, V323, P1197, DOI 10.1016/j.bbrc.2004.08.228; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Matsuura S, 2004, ADV BIOPHYS, V38, P65, DOI 10.1016/S0065-227X(04)80076-5; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Ranganathan V, 2001, CURR BIOL, V11, P962, DOI 10.1016/S0960-9822(01)00267-6; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Tauchi H, 2001, J BIOL CHEM, V276, P12, DOI 10.1074/jbc.C000578200; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams RS, 2005, BIOCHEM CELL BIOL, V83, P721, DOI 10.1139/O05-153; Wu X, 2000, Science, V289, P11; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	70	72	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2007	282	31					22939	22952		10.1074/jbc.M702162200	http://dx.doi.org/10.1074/jbc.M702162200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194OR	17526493	hybrid			2022-12-27	WOS:000248354200071
J	Kaimori, A; Potter, J; Kaimori, JY; Wang, C; Mezey, E; Koteish, A				Kaimori, Aki; Potter, James; Kaimori, Jun-ya; Wang, Connie; Mezey, Esteban; Koteish, Ayman			Transforming growth factor-beta 1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; HEPATIC STELLATE CELLS; FETAL-RAT HEPATOCYTES; TGF-BETA; COLLAGEN PRODUCTION; CONFERS RESISTANCE; LIVER FIBROSIS; SNAIL; FIBROGENESIS; EXPRESSION	Liver fibrosis is a progressive pathologic process that involves deposition of excess extracellular matrix leading to distorted architecture and culminating in cirrhosis. The role of transforming growth factor-beta (TGF-beta) as a key molecule in the development and progression of hepatic fibrosis via the activation of hepatic stellate cells, among other fibroblast populations, is without controversy. We hereby show that TGF-beta 1 induces an epithelial-to-mesenchymal transition (EMT) state in mature hepatocytes in vitro. EMT state was marked by significant up-regulation of alpha(1) (I) collagen mRNA expression and type I collagen deposition. Similar changes were found in a " normal" mouse hepatocyte cell line (AML12), thus confirming that hepatocytes are capable of EMT changes and type I collagen synthesis. We also show that in hepatocytes in the EMT state, TGF-beta 1 induces the snail-1 transcription factor and activates the Smad2/3 pathway. Evidence for a central role of the TGF-beta 1/Smad pathway is further supported by the inhibition of EMT by Smad4 silencing using small interference RNA technology. In conclusion, TGF-beta 1, a known pro-apoptotic cytokine in mature hepatocytes, is capable of mediating phenotypic changes and plasticity in the form of EMT, resulting in collagen deposition. Our findings support a potentially crucial role for EMT in the development and progression of hepatic fibrogenesis.	Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Koteish, A (corresponding author), Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, 720 Rutland Ave,Ross Res Bldg 933C, Baltimore, MD 21205 USA.	akoteish@jhmi.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA000626] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA000626] Funding Source: Medline; NIDDK NIH HHS [P50 DK57325] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bissell DM, 2001, HEPATOLOGY, V34, P859, DOI 10.1053/jhep.2001.28457; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chagraoui J, 2003, BLOOD, V101, P2973, DOI 10.1182/blood-2002-05-1341; CHOJKIER M, 1986, J CLIN INVEST, V78, P333, DOI 10.1172/JCI112581; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dooley S, 2001, BIOCHEM BIOPH RES CO, V283, P554, DOI 10.1006/bbrc.2001.4811; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Grille SJ, 2003, CANCER RES, V63, P2172; Inoue A, 2006, J DRUG TARGET, V14, P448, DOI 10.1080/10611860600845397; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Lenferink AE, 2004, BREAST CANCER RES, V6, pR514, DOI 10.1186/bcr907; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MCGEE JO, 1972, J PATHOL, V106, pPR6; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; NAKAMURA T, 1985, BIOCHEM BIOPH RES CO, V133, P1042, DOI 10.1016/0006-291X(85)91241-0; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; OGATA I, 1991, HEPATOLOGY, V14, P361, DOI 10.1016/0270-9139(91)91427-3; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Ramadori G, 2004, LAB INVEST, V84, P153, DOI 10.1038/labinvest.3700030; Rees JRE, 2006, CANCER RES, V66, P9583, DOI 10.1158/0008-5472.CAN-06-1842; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; Sato M, 2003, CELL STRUCT FUNCT, V28, P105; Seyhan H, 2006, J CELL MOL MED, V10, P922, DOI 10.1111/j.1582-4934.2006.tb00535.x; Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V291, pG575, DOI 10.1152/ajpgi.00102.2006; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Valdes F, 2002, MOL CANCER RES, V1, P68; Valdes F, 2004, EXP CELL RES, V292, P209, DOI 10.1016/j.yexcr.2003.08.015; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yao HW, 2004, LIFE SCI, V76, P29, DOI 10.1016/j.lfs.2004.06.019; Ye L, 2006, INT J ONCOL, V29, P1149; Yokoyama K, 2003, INT J ONCOL, V22, P891; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zhang F, 2003, EXP CELL RES, V291, P275, DOI 10.1016/j.yexcr.2003.07.007	49	288	315	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22089	22101		10.1074/jbc.M700998200	http://dx.doi.org/10.1074/jbc.M700998200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17513865	hybrid			2022-12-27	WOS:000248196800056
J	Xing, WR; Singgih, A; Kapoor, A; Alarcon, CM; Baylink, DJ; Mohan, S				Xing, Weirong; Singgih, Anny; Kapoor, Anil; Alarcon, Catrina M.; Baylink, David J.; Mohan, Subburaman			Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BZIP TRANSCRIPTION FACTOR; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; PROGRESSIVE DEVELOPMENT; EXTRACELLULAR-MATRIX; COLLAGEN-SYNTHESIS; MC3T3-E1 CELLS; HIP FRACTURE	We recently found that deletion of the gulonolactone oxidase gene, which is involved in the synthesis of ascorbic acid (AA), was responsible for the fracture phenotype in spontaneous fracture mice. To explore the molecular mechanisms by which AA regulates osteoblast differentiation, we examined the effect of AA on osterix expression via Nrf1 (NF-E2-related factor-1) binding to antioxidant-responsive element (ARE) in bone marrow stromal (BMS) cells. AA treatment caused a 6-fold increase in osterix expression in mutant BMS cells at 24 h, which was unaffected by pretreatment with protein synthesis inhibitor. Sequence analyses of mouse osterix promoter revealed a putative ARE located at -1762 to -1733 upstream of the transcription start site to which Nrf potentially binds. A gel mobility shift assay revealed that nuclear proteins from AA-treated BMS cells bound to radiolabeled ARE much more strongly than nuclear extracts from AA-untreated cells. Achromatin immunoprecipitation assay with Nrf1 antibody confirmed the interaction of Nrf1 with the mouse osterix promoter. A reporter assay demonstrated that the promoter activity of mouse osterix containing an ARE was stimulated 4-fold by a 48-h treatment with AA in spontaneous fracture BMS cells. Treatment of mutant BMS cells with AA resulted in a 3.9-fold increase in the nuclear accumulation of Nrf1. Transfection of mutant BMS cells with Nrf1 small interfering RNA decreased Nrf1 protein by 4.5-fold, blocked AA induction of osterix expression, and impaired BMS cell differentiation. Our data provided the first experimental evidence that AA modulated osterix expression via a novel mechanism involving Nrf1 nuclear translocation and Nrf1 binding to ARE to activate genes critical for cell differentiation.	Loma Linda Univ, Dept Med, Loma Linda, CA 92357 USA; Jerry L Pettis Mem Vet Affairs Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA	Loma Linda University	Mohan, S (corresponding author), Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA.	Subburaman.Mohan@va.gov	Kapoor, Anil/AAQ-7184-2021	Kapoor, Anil/0000-0001-9180-8029	NATIONAL INSTITUTE ON AGING [R01AG019698] Funding Source: NIH RePORTER; NIA NIH HHS [AG19698] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amaar YG, 2005, J BONE MINER RES, V20, P1430, DOI 10.1359/JBMR.050311; ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203; Beamer WG, 2000, BONE, V27, P619, DOI 10.1016/S8756-3282(00)00369-0; BENTLEY JP, 1965, BIOCHIM BIOPHYS ACTA, V107, P519; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Chung YS, 2004, J BONE MINER RES, V19, P1395, DOI 10.1359/JBMR.040412; Derjuga A, 2004, MOL CELL BIOL, V24, P3286, DOI 10.1128/MCB.24.8.3286-3294.2004; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; GREEN J, 1995, AM J PHYSIOL-CELL PH, V268, pC1090, DOI 10.1152/ajpcell.1995.268.5.C1090; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jiao Y, 2005, MAMM GENOME, V16, P20, DOI 10.1007/s00335-004-2414-0; KAWAI T, 1992, J BIOL CHEM, V267, P21973; Koh WS, 1998, ANTICANCER RES, V18, P2487; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; Melhus H, 1999, J BONE MINER RES, V14, P129, DOI 10.1359/jbmr.1999.14.1.129; Mohan S, 2005, J BONE MINER RES, V20, P1597, DOI 10.1359/JBMR.050406; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Parsons KK, 2006, AM J PHYSIOL-ENDOC M, V290, pE1131, DOI 10.1152/ajpendo.00339.2005; PETERKOFSKY B, 1991, AM J CLIN NUTR, V54, pS1135, DOI 10.1093/ajcn/54.6.1135s; Prieschl EE, 1998, NUCLEIC ACIDS RES, V26, P2291, DOI 10.1093/nar/26.10.2291; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Shin DM, 2004, NEUROREPORT, V15, P1959, DOI 10.1097/00001756-200408260-00025; SULLIVAN TA, 1994, J BIOL CHEM, V269, P22500; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wang YZ, 2006, BIOMATERIALS, V27, P3265, DOI 10.1016/j.biomaterials.2006.01.036; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xing WR, 2006, MOL BIOTECHNOL, V34, P29, DOI 10.1385/MB:34:1:29; Xing WR, 2004, BIOCHEM BIOPH RES CO, V319, P781, DOI 10.1016/j.bbrc.2004.05.053; Xing WR, 1998, MOL ENDOCRINOL, V12, P1310, DOI 10.1210/me.12.9.1310; Xing WR, 2002, BIOL REPROD, V67, P204, DOI 10.1095/biolreprod67.1.204; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang JJ, 2006, AM J EPIDEMIOL, V163, P9, DOI 10.1093/aje/kwj005	47	66	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2007	282	30					22052	22061		10.1074/jbc.M702614200	http://dx.doi.org/10.1074/jbc.M702614200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192JG	17510056	hybrid			2022-12-27	WOS:000248196800052
J	Thakurdas, SM; Melicoff, E; Sansores-Garcia, L; Moreira, DC; Petrova, Y; Stevens, RL; Adachi, R				Thakurdas, Shakeel M.; Melicoff, Ernestina; Sansores-Garcia, Leticia; Moreira, Daniel C.; Petrova, Youlia; Stevens, Richard L.; Adachi, Roberto			The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-I; SUBSTRATE-SPECIFICITY; GRANULE PROTEASES; SERINE PROTEASES; MOUSE; EXPRESSION; MICE; TISSUE; GENE; TRANSCRIPTION	Although it has been shown that mast cell-deficient mice have diminished innate immune responses against bacteria, the most important immunoprotective factors secreted from activated mast cells have not been identified. Mouse mast cell protease 6 is a tetramer-forming tryptase. This serine protease is abundant in the secretory granules and is exocytosed upon bacterial challenge. Here we have described the generation of a mast cell protease-6-null mouse. Our discovery that mice lacking this neutral protease cannot efficiently clear Klebsiella pneumoniae from their peritoneal cavities reveals an essential role for this serine protease, and presumably its human ortholog, in innate immunity.	Univ Texas, MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; Inst Biosci & Technol, Ctr Lung Inflammat & Infect, Houston, TX 77030 USA; Tecnol Monterrey Campus Monterrey, Sch Med, Monterrey 64710, Nuevo Leon, Mexico; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Adachi, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd,Box 1100, Houston, TX 77030 USA.	radachi@mdanderson.org		Melicoff, Ernestina/0000-0001-5696-7112; Sansores-Garcia, Leticia/0000-0003-2510-225X; Moreira, Daniel/0000-0003-4082-156X; Adachi, Roberto/0000-0002-0146-0768	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054950] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA16672] Funding Source: Medline; NHLBI NIH HHS [HL-36110] Funding Source: Medline; NIAID NIH HHS [AI-54950] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bannert N, 2001, J VIROL, V75, P10808, DOI 10.1128/JVI.75.22.10808-10814.2001; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Hori Y, 2002, J IMMUNOL, V169, P1978, DOI 10.4049/jimmunol.169.4.1978; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; INAGAKI N, 1986, INT ARCH ALLER A IMM, V80, P285, DOI 10.1159/000234067; IRANI AMA, 1987, J IMMUNOL, V138, P4381; Jippo T, 2003, J EXP MED, V197, P1417, DOI 10.1084/jem.20022157; Li Y, 2001, BLOOD, V97, P3484, DOI 10.1182/blood.V97.11.3484; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; Morii E, 2004, BLOOD, V104, P1656, DOI 10.1182/blood-2004-01-0247; Morii E, 1996, BLOOD, V88, P2488, DOI 10.1182/blood.V88.7.2488.bloodjournal8872488; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; ROYET JP, 1991, PROG NEUROBIOL, V37, P433, DOI 10.1016/0301-0082(91)90009-P; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; Taub DD, 2004, CELL IMMUNOL, V230, P65, DOI 10.1016/j.cellimm.2004.09.005; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; WEG VB, 1991, EUR J PHARMACOL, V204, P157, DOI 10.1016/0014-2999(91)90700-Z; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong GW, 2002, J BIOL CHEM, V277, P41906, DOI 10.1074/jbc.M205868200	34	141	143	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2007	282	29					20809	20815		10.1074/jbc.M611842200	http://dx.doi.org/10.1074/jbc.M611842200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190GP	17456473	hybrid			2022-12-27	WOS:000248047500006
J	Feige, JN; Gelman, L; Rossi, D; Zoete, V; Metivier, R; Tudor, C; Anghel, SI; Grosdidier, A; Lathion, C; Engelborghs, Y; Michielin, O; Wahli, W; Desvergne, B				Feige, Jerome N.; Gelman, Laurent; Rossi, Daniel; Zoete, Vincent; Metivier, Raphael; Tudor, Cicerone; Anghel, Silvia I.; Grosdidier, Aurelien; Lathion, Caroline; Engelborghs, Yves; Michielin, Olivier; Wahli, Walter; Desvergne, Beatrice			The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDNA MICROARRAY DATA; PPAR-GAMMA; TRANSCRIPTIONAL ACTIVITY; ORGANOTIN COMPOUNDS; LIGAND-BINDING; HUMAN RISK; IN-VITRO; ALPHA; CHEMICALS; PROTEIN	The ability of pollutants to affect human health is a major concern, justified by the wide demonstration that reproductive functions are altered by endocrine disrupting chemicals. The definition of endocrine disruption is today extended to broader endocrine regulations, and includes activation of metabolic sensors, such as the peroxisome proliferator-activated receptors (PPARs). Toxicology approaches have demonstrated that phthalate plasticizers can directly influence PPAR activity. What is now missing is a detailed molecular understanding of the fundamental basis of endocrine disrupting chemical interference with PPAR signaling. We thus performed structural and functional analyses that demonstrate how monoethyl-hexyl-phthalate ( MEHP) directly activates PPAR gamma and promotes adipogenesis, albeit to a lower extent than the full agonist rosiglitazone. Importantly, we demonstrate that MEHP induces a selective activation of different PPAR gamma target genes. Chromatin immunoprecipitation and fluorescence microscopy in living cells reveal that this selective activity correlates with the recruitment of a specific subset of PPAR gamma coregulators that includes Med1 and PGC-1 alpha, but not p300 and SRC-1. These results highlight some key mechanisms in metabolic disruption but are also instrumental in the context of selective PPAR modulation, a promising field for new therapeutic development based on PPAR modulation.	Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Friedrich Miescher Inst, Facil Adv Imaging & Microscopy, CH-4002 Basel, Switzerland; Univ Lausanne, Natl Res Ctr Mol Oncol, Ludwig Inst, CH-1015 Lausanne, Switzerland; Univ Rennes 1, CNRS, UMR 6026, Spatiotemporal Regulat Transcript Eukaryotes, F-35042 Rennes, France; Katholieke Univ Leuven, Lab Biomol Dynam, B-3001 Heverlee, Belgium	University of Lausanne; Friedrich Miescher Institute for Biomedical Research; Ludwig Institute for Cancer Research; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; KU Leuven	Desvergne, B (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	beatrice.desvergne@unil.ch	Wahli, Walter/B-1398-2009; Michielin, Olivier/ABE-7924-2020; Wahli, Walter/I-3194-2019; Rose, Rebecca J/B-7812-2011; Desvergne, Beatrice/C-8892-2016	Wahli, Walter/0000-0002-5966-9089; Desvergne, Beatrice/0000-0001-5483-288X; Grosdidier, Aurelien/0000-0001-9873-3461; Rossi, Daniele/0000-0002-6191-8734; Gelman, Laurent/0000-0003-3277-3115				Balint B. L., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P33; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Fujimura T, 2005, J PHARMACOL SCI, V99, P342, DOI 10.1254/jphs.FP0050578; Fujimura T, 2006, J PHARMACOL EXP THER, V318, P863, DOI 10.1124/jpet.106.102459; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; GELMAN L, 2007, IN PRESS BIOCH BIOPH; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henley DV, 2006, ENDOCRINOLOGY, V147, pS25, DOI 10.1210/en.2005-1117; Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302; Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jeannin E, 1998, J BIOL CHEM, V273, P24239, DOI 10.1074/jbc.273.37.24239; Kanayama T, 2005, MOL PHARMACOL, V67, P766, DOI 10.1124/mol.104.008409; Lai DY, 2004, J ENVIRON SCI HEAL C, V22, P37, DOI 10.1081/GNC-120038005; Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809; Markey CM, 2002, J STEROID BIOCHEM, V83, P235, DOI 10.1016/S0960-0760(02)00272-8; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michalik L, 2007, J BIOL CHEM, V282, P9666, DOI 10.1074/jbc.M610523200; Minoura H, 2004, EUR J PHARMACOL, V494, P273, DOI 10.1016/j.ejphar.2004.04.038; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; *NTP CERHR EXP PAN, 2000, DI 2 ETHYLHEXYL PHTH; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Shi GQ, 2005, J MED CHEM, V48, P4457, DOI 10.1021/jm0502135; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stein M S, 1973, Environ Health Perspect, V3, P149, DOI 10.2307/3428042; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; Takeuchi S, 2006, TOXICOL APPL PHARM, V217, P235, DOI 10.1016/j.taap.2006.08.011; Tudor C, 2007, J BIOL CHEM, V282, P4417, DOI 10.1074/jbc.M608172200; Waring RH, 2005, MOL CELL ENDOCRINOL, V244, P2, DOI 10.1016/j.mce.2005.02.007; WILLIAMS DT, 1974, B ENVIRON CONTAM TOX, V11, P371, DOI 10.1007/BF01684945; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200	56	254	263	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2007	282	26					19152	19166		10.1074/jbc.M702724200	http://dx.doi.org/10.1074/jbc.M702724200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181ZQ	17468099	hybrid			2022-12-27	WOS:000247475300057
J	Dackor, R; Fritz-Six, K; Smithies, O; Caron, K				Dackor, Ryan; Fritz-Six, Kim; Smithies, Oliver; Caron, Kathleen			Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-MODIFYING PROTEINS; RECEPTOR-LIKE-RECEPTOR; CALCITONIN-RECEPTOR; ADRENOMEDULLIN RECEPTOR; ACCESSORY PROTEINS; GENE-EXPRESSION; MICE LACKING; TRAFFICKING; RAMPS; ISOFORM	RAMPs (receptor activity modifying proteins) impart remarkable effects on G protein-coupled receptor (GPCR) signaling. First identified through an interaction with the calcitonin receptor-like receptor (CLR), these single transmembrane proteins are now known to modulate the in vitro ligand binding affinity, trafficking, and second messenger pathways of numerous GPCRs. Consequently, the receptor-RAMP interface represents an attractive pharmacological target for the treatment of disease. Although the three known mammalian RAMPs differ in their sequences and tissue expression, results from in vitro biochemical and pharmacological studies suggest that they have overlapping effects on the GPCRs with which they interact. Therefore, to determine whether RAMP2 and RAMP3 have distinct functions in vivo, we generated mice with targeted deletions of either the RAMP2 or RAMP3 gene. Strikingly, we found that, although RAMP2 is required for survival, mice that lack RAMP3 appear normal until old age, at which point they have decreased weight. In addition, mice with reduced expression of RAMP2 (but not RAMP3) display remarkable subfertility. Thus, each gene has functions in vivo that cannot be accomplished by the other. Because RAMP2, RAMP3, and CLR transduce the signaling of the two potent vasodilators adrenomedullin and calcitonin gene-related peptide, we tested the effects of our genetic modifications on blood pressure, and no effects were detected. Nevertheless, our studies reveal that RAMP2 and RAMP3 have distinct physiological functions throughout embryogenesis, adulthood, and old age, and the mice we have generated provide novel genetic tools to further explore the utility of the receptor-RAMP interface as a pharmacological target.	Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Caron, K (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, CB 7545,6330 MBRB 103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	Kathleen_caron@med.unc.edu		Caron, Kathleen/0000-0002-7033-9232	NHLBI NIH HHS [R01 HL049277-14, R01 HL049277, R01 HL049277-16, R01 HL049277-15, HL49277] Funding Source: Medline; NICHD NIH HHS [HD046970] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049277] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bomberger JM, 2005, J BIOL CHEM, V280, P23926, DOI 10.1074/jbc.M501751200; Bomberger JM, 2005, J BIOL CHEM, V280, P9297, DOI 10.1074/jbc.M413786200; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Doods H, 2000, BRIT J PHARMACOL, V129, P420, DOI 10.1038/sj.bjp.0703110; Doods H, 2001, Curr Opin Investig Drugs, V2, P1261; Foord SM, 2005, J MOL NEUROSCI, V26, P265, DOI 10.1385/JMN:26:2-3:265; GIBBONS C, 2006, MOL ENDOCRINOL; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hay DL, 2004, PEPTIDES, V25, P2019, DOI 10.1016/j.peptides.2004.06.007; Hewitt SC, 2005, MOL ENDOCRINOL, V19, P657, DOI 10.1210/me.2004-0142; Julian M, 2005, EUR J MED CHEM, V40, P737, DOI 10.1016/j.ejmech.2004.10.016; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8927, DOI 10.1073/pnas.86.22.8927; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Kuwasako K, 2004, PEPTIDES, V25, P2003, DOI 10.1016/j.peptides.2004.06.002; Kuwasako K, 2004, MOL PHARMACOL, V65, P207, DOI 10.1124/mol.65.1.207; Li MY, 2006, J CLIN INVEST, V116, P2653, DOI 10.1172/JC128462; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JT, 1999, MOL CELL NEUROSCI, V14, P99, DOI 10.1006/mcne.1999.0767; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Ono Y, 2000, BIOCHEM BIOPH RES CO, V271, P197, DOI 10.1006/bbrc.2000.2606; Tam CW, 2006, CIRC RES, V98, P262, DOI 10.1161/01.RES.0000200737.63865.58; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Udawela M, 2004, SEMIN CELL DEV BIOL, V15, P299, DOI 10.1016/j.semcdb.2003.12.019	27	84	86	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18094	18099		10.1074/jbc.M703544200	http://dx.doi.org/10.1074/jbc.M703544200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17470425	Green Published, hybrid			2022-12-27	WOS:000247302000015
J	Lopez-Vinas, E; Bentebibel, A; Gurunathan, C; Morillas, M; de Arriaga, D; Serra, D; Asins, G; Hegardt, FG; Gomez-Puertas, P				Lopez-Vinas, Eduardo; Bentebibel, Assia; Gurunathan, Chandrashekaran; Morillas, Montserrat; de Arriaga, Dolores; Serra, Dolors; Asins, Guillermina; Hegardt, Fausto G.; Gomez-Puertas, Paulino			Definition by functional and structural analysis of two malonyl-CoA sites in carnitine palmitoyltransferase 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; BROWN ADIPOSE-TISSUE; AMINO-ACID-RESIDUES; HIGH-AFFINITY; AUTOMATED DOCKING; CRYSTAL-STRUCTURE; SWISS-MODEL; CPT I; INTRAMOLECULAR INTERACTIONS; PROTEIN	Carnitine palmitoyltransferase 1 (CPT1) catalyzes the conversion of palmitoyl-CoA to palmitoylcarnitine in the presence of L-carnitine, thus facilitating the entry of fatty acids to mitochondria, in a process that is physiologically inhibited by malonyl-CoA. To examine the mechanism of CPT1 liver isoform (CPT1A) inhibition by malonyl-CoA, we constructed an in silico model of both its NH2- and COOH-terminal domains. Two malonyl-CoA binding sites were found. One of these, the "CoA site" or "A site," is involved in the interactions between NH2- and COOH-terminal domains and shares the acyl-CoA hemitunnel. The other, the "opposite-to-CoA site" or "O site," is on the opposite side of the enzyme, in the catalytic channel. The two sites share the carnitine-binding locus. To prevent the interaction between NH2- and COOH-terminal regions, we produced CPT1A E26K and K561E mutants. A double mutant E26K/K561E (swap), which was expected to conserve the interaction, was also produced. Inhibition assays showed a 12-fold decrease in the sensitivity (IC50) toward malonyl-CoA for CPT1A E26K and K561E single mutants, whereas swap mutant reverts to wild-type IC50 value. We conclude that structural interaction between both domains is critical for enzyme sensitivity to malonyl-CoA inhibition at the "A site." The location of the "O site" for malonyl-CoA binding was supported by inhibition assays of expressed R243T mutant. The model is also sustained by kinetic experiments that indicated linear mixed type malonyl-CoA inhibition for carnitine. Malonyl-CoA alters the affinity of carnitine, and there appears to be an exponential inverse relation between carnitine Km and malonyl-CoA IC50.	Univ Pompeu Fabra, Dept Ciencias Expt Salud, E-08003 Barcelona, Spain; Univ Autonoma Madrid, CSIC, Ctr Mol Biol Severo Ochoa, E-28049 Madrid, Spain; Univ Barcelona, Fac Farm, Dept Mol Biol, E-08028 Barcelona, Spain; Univ Leon, Dept Mol Biol, E-24071 Leon, Spain; Inst Salud Carlos III, CIBER, Inst Fisiopatol Obesidad & Nutr, E-28049 Madrid, Spain	Pompeu Fabra University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Barcelona; Universidad de Leon; CIBER - Centro de Investigacion Biomedica en Red; Instituto de Salud Carlos III	Hegardt, FG (corresponding author), Univ Barcelona, Sch Pharm, Dept Biochem & Mol Biol, Diagonal 643, E-08028 Barcelona, Spain.	fgarciaheg@ub.edu	Morillas, Montserrat/G-6080-2015; López-Viñas, Eduardo/AAT-1124-2021; Gomez-Puertas, Paulino/G-8821-2014; Serra, Dolors/L-3657-2014	Gomez-Puertas, Paulino/0000-0003-3131-729X; Serra, Dolors/0000-0002-4936-4206; Morillas, Montserrat/0000-0001-7068-3167; de Arriaga Giner, Maria Dolores/0000-0003-4528-5815				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson RC, 1998, CURR PHARM DESIGN, V4, P1; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Bentebibel A, 2006, BIOCHEMISTRY-US, V45, P4339, DOI 10.1021/bi052186q; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIRD MI, 1985, BIOCHEM J, V230, P161, DOI 10.1042/bj2300161; BIRD MI, 1984, BIOCHEM J, V222, P639, DOI 10.1042/bj2220639; Borthwick K, 2006, J BIOL CHEM, V281, P32946, DOI 10.1074/jbc.M600843200; Cha SH, 2006, P NATL ACAD SCI USA, V103, P15410, DOI 10.1073/pnas.0607334103; COOK GA, 1994, J BIOL CHEM, V269, P8803; Cordente AG, 2004, J BIOL CHEM, V279, P33899, DOI 10.1074/jbc.M402685200; Esser V, 1996, J BIOL CHEM, V271, P6972, DOI 10.1074/jbc.271.12.6972; ESSER V, 1993, J BIOL CHEM, V268, P5817; Faye A, 2005, BIOCHEM J, V387, P67, DOI 10.1042/BJ20041533; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; GRANTHAM BD, 1986, BIOCHEM J, V233, P589, DOI 10.1042/bj2330589; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hsiao YS, 2006, BIOCHEM BIOPH RES CO, V346, P974, DOI 10.1016/j.bbrc.2006.06.006; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; Jackson VN, 2000, J BIOL CHEM, V275, P19560, DOI 10.1074/jbc.M002177200; Jackson VN, 2001, BIOCHEMISTRY-US, V40, P14629, DOI 10.1021/bi011632g; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2000, PROTEIN SCI, V9, P1487, DOI 10.1110/ps.9.8.1487; Jogl G, 2005, J BIOL CHEM, V280, P738, DOI 10.1074/jbc.M409894200; KASHFI K, 1994, BBA-LIPID LIPID MET, V1212, P245, DOI 10.1016/0005-2760(94)90259-3; Kashfi K, 1999, ADV EXP MED BIOL, V466, P27; KOLODZIEJ MP, 1990, BIOCHEM J, V267, P85, DOI 10.1042/bj2670085; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MCGARRY JD, 1975, P NATL ACAD SCI USA, V72, P4385, DOI 10.1073/pnas.72.11.4385; MILLS SE, 1984, BIOCHEM J, V219, P601, DOI 10.1042/bj2190601; Morillas M, 2004, BIOCHEM J, V379, P777, DOI 10.1042/BJ20031373; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Morillas M, 2001, J BIOL CHEM, V276, P45001, DOI 10.1074/jbc.M106920200; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nicot C, 2001, BIOCHEMISTRY-US, V40, P2260, DOI 10.1021/bi0024106; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rufer AC, 2006, STRUCTURE, V14, P713, DOI 10.1016/j.str.2006.01.008; SAGGERSON ED, 1981, FEBS LETT, V129, P225, DOI 10.1016/0014-5793(81)80170-6; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEGEL IH, 1993, ENZYME KINETICS, P170; Shi JY, 2000, BIOCHEMISTRY-US, V39, P712, DOI 10.1021/bi9918700; Shi JY, 1999, J BIOL CHEM, V274, P9421, DOI 10.1074/jbc.274.14.9421; STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336; Tress M, 2005, PROTEINS, V60, P275, DOI 10.1002/prot.20570; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G; ZAMMIT VA, 1984, BIOCHEM J, V222, P335, DOI 10.1042/bj2220335; ZAMMIT VA, 1984, BIOCHEM J, V218, P379, DOI 10.1042/bj2180379; ZAMMIT VA, 1985, BIOCHEM J, V231, P343, DOI 10.1042/bj2310343; Zhu HF, 1997, ARCH BIOCHEM BIOPHYS, V347, P53, DOI 10.1006/abbi.1997.0314	58	38	38	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2007	282	25					18212	18224		10.1074/jbc.M700885200	http://dx.doi.org/10.1074/jbc.M700885200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179PK	17452323	hybrid			2022-12-27	WOS:000247302000028
J	Kok, KH; Ng, MHJ; Ching, YP; Jin, DY				Kok, Kin Hang; Ng, Ming-Him James; Ching, Yick-Pang; Jin, Dong-Yan			Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BINDING-PROTEIN; MICRORNA MATURATION; MAMMALIAN-CELLS; PKR; ACTIVATION; EXPRESSION; DROSOPHILA; PATHWAY; DSRNA	Mammalian Dicer interacts with double-stranded RNA-binding protein TRBP or PACT to mediate RNA interference and micro-RNA processing. TRBP and PACT are structurally related but exert opposite regulatory activities on PKR. It is not understood whether TRBP and PACT are simultaneously required for Dicer. Here we show that TRBP directly interacts with PACT in vitro and in mammalian cells. TRBP and PACT form a triple complex with Dicer and facilitate the production of small interfering RNA ( siRNA) by Dicer. Knockdown of both TRBP and PACT in cultured cells leads to significant inhibition of gene silencing mediated by short hairpin RNA but not by siRNA, suggesting that TRBP and PACT function primarily at the step of siRNA production. Taken together, these findings indicate that human TRBP and PACT directly interact with each other and associate with Dicer to stimulate the cleavage of double-stranded or short hairpin RNA to siRNA. Our work significantly alters the current model for the assembly and function of the Dicer-containing complex that generates siRNA and micro-RNA in human.	Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Jin, DY (corresponding author), Univ Hong Kong, Dept Biochem, 3-F Lab Block,Fac Med Bldg,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	dyjin@hkucc.hku.hk	Kok, Kin-Hang/C-4184-2009; Ching, Yick Pang/C-4244-2009	/0000-0003-3426-332X; CHING, Yick Pang/0000-0002-6461-8358				Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chin KT, 2007, CANCER RES, V67, P1072, DOI 10.1158/0008-5472.CAN-06-3053; Ching YP, 2006, NAT CELL BIOL, V8, P717, DOI 10.1038/ncb1432; Daher A, 2001, J BIOL CHEM, V276, P33899, DOI 10.1074/jbc.M103584200; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hitti EG, 2004, FEBS LETT, V574, P25, DOI 10.1016/j.febslet.2004.07.080; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kok KH, 2006, J GEN VIROL, V87, P2639, DOI 10.1099/vir.0.81764-0; Lee JY, 2006, ONCOGENE, V25, P1143, DOI 10.1038/sj.onc.1209150; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Ong CL, 2005, J VIROL, V79, P12763, DOI 10.1128/JVI.79.20.12763-12772.2005; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706; Parrish S, 2001, RNA, V7, P1397; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200; Zhou Y, 2002, NUCLEIC ACIDS RES, V30, P1664, DOI 10.1093/nar/30.7.1664	50	166	192	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2007	282	24					17649	17657		10.1074/jbc.M611768200	http://dx.doi.org/10.1074/jbc.M611768200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176KS	17452327	hybrid, Green Submitted			2022-12-27	WOS:000247084500037
